Citrus Sinensis ID: 007423
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 604 | 2.2.26 [Sep-21-2011] | |||||||
| O04567 | 601 | Probable inactive recepto | yes | no | 0.950 | 0.955 | 0.715 | 0.0 | |
| C0LGI5 | 591 | Probable LRR receptor-lik | no | no | 0.965 | 0.986 | 0.634 | 0.0 | |
| Q9ASS4 | 620 | Probably inactive leucine | no | no | 0.922 | 0.898 | 0.436 | 1e-137 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.913 | 0.463 | 0.333 | 3e-82 | |
| Q9LJF3 | 1164 | Receptor-like protein kin | no | no | 0.811 | 0.420 | 0.366 | 6e-82 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.829 | 0.429 | 0.369 | 4e-81 | |
| O22476 | 1196 | Protein BRASSINOSTEROID I | no | no | 0.793 | 0.400 | 0.373 | 1e-79 | |
| Q8LPB4 | 1021 | Phytosulfokine receptor 1 | N/A | no | 0.769 | 0.455 | 0.391 | 5e-78 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.786 | 0.393 | 0.383 | 1e-77 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.786 | 0.393 | 0.383 | 4e-77 |
| >sp|O04567|Y1719_ARATH Probable inactive receptor kinase At1g27190 OS=Arabidopsis thaliana GN=At1g27190 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 846 bits (2185), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/579 (71%), Positives = 493/579 (85%), Gaps = 5/579 (0%)
Query: 23 EDDVKCLEGIQNSIKDPDGRLS-WSFTNTTVGAICRLTGVACWNEKENRIISLTLSSMQL 81
EDDV CL+G++NS+ DP RLS WSF N++ +IC+LTGV+CWNEKENRIISL L SMQL
Sbjct: 25 EDDVLCLQGLKNSLIDPSSRLSSWSFPNSSASSICKLTGVSCWNEKENRIISLQLQSMQL 84
Query: 82 SGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVEC 141
+G++PESL LC SLQSLDLS N LSGSIP +C WLPY+V LDLS N L G IP QIVEC
Sbjct: 85 AGEIPESLKLCRSLQSLDLSGNDLSGSIPSQICSWLPYLVTLDLSGNKLGGSIPTQIVEC 144
Query: 142 KFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGNSGLC 201
KFLN LILS+NKLSGSIP ++SRLDRL+ S+AGNDLSGTIP +LARF + F GN+GLC
Sbjct: 145 KFLNALILSDNKLSGSIPSQLSRLDRLRRLSLAGNDLSGTIPSELARFGGDDFSGNNGLC 204
Query: 202 GKPLGKCGGLSGKNLGIIIAAGVLGALGSIILGFLIWWWFFVRV-SKKKRGYGADSGKDD 260
GKPL +CG L+G+NL III AGVLGA+GS+ +G +I+WWFF+R S+KK+GYGA KDD
Sbjct: 205 GKPLSRCGALNGRNLSIIIVAGVLGAVGSLCVGLVIFWWFFIREGSRKKKGYGAGKSKDD 264
Query: 261 SSWIQVLRSHKLVQVSLFQKPIVKVKLADLLAATNSFAVENIIISTRTGVSYKAVLPDAS 320
S WI +LRSHKLVQV+LFQKPIVK+KL DL+AATN+F+ NI +S+RTGVSYKA LPD S
Sbjct: 265 SDWIGLLRSHKLVQVTLFQKPIVKIKLGDLMAATNNFSSGNIDVSSRTGVSYKADLPDGS 324
Query: 321 ALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
ALA+KRLSAC EKQFRSEMN+LG+LRHPNLVPLLG+CVVE+ERLLVYKHM NGTL+S
Sbjct: 325 ALAVKRLSACGFGEKQFRSEMNKLGELRHPNLVPLLGYCVVEDERLLVYKHMVNGTLFSQ 384
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDAR 440
LH G+ VLDW TR IG+GA++GLAWLHHGCQPPY+HQ+ISSNVIL+DDDFDAR
Sbjct: 385 LHNGGL---CDAVLDWPTRRAIGVGAAKGLAWLHHGCQPPYLHQFISSNVILLDDDFDAR 441
Query: 441 ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSG 500
ITD+GLA+LVGSRD NDSSF +GDLGE GYVAPEYSSTMVASLKGDVYGFGIVLLEL++G
Sbjct: 442 ITDYGLAKLVGSRDSNDSSFNNGDLGELGYVAPEYSSTMVASLKGDVYGFGIVLLELVTG 501
Query: 501 QKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVS 560
QKPL V EGFKG+LVDWV+ + GRS+D +D+S+ +G+D+EI+QFL++ACSCVVS
Sbjct: 502 QKPLSVINGVEGFKGSLVDWVSQYLGTGRSKDAIDRSICDKGHDEEILQFLKIACSCVVS 561
Query: 561 RPKDRPSMYQVYESLKSMAEKHGFSEPYDEFPMIFGKQD 599
RPK+RP+M QVYESLK+MA+KHG SE YDEFP++F KQ+
Sbjct: 562 RPKERPTMIQVYESLKNMADKHGVSEHYDEFPLVFNKQE 600
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGI5|Y1699_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g69990 OS=Arabidopsis thaliana GN=At1g69990 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 774 bits (1998), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/604 (63%), Positives = 475/604 (78%), Gaps = 21/604 (3%)
Query: 1 MKIRFILASLLLLSYSLLTVSIEDDVKCLEGIQNSIKDPDGRL-SWSFTNTTVGAICRLT 59
MK I ++L+S S EDDV CL+G ++S+KDP +L +WSF N++ +IC+LT
Sbjct: 1 MKTISIFFVIILMSSS----HAEDDVLCLKGFKSSLKDPSNQLNTWSFPNSS-SSICKLT 55
Query: 60 GVACWNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPY 119
GV+CWN KENRI+SL L SMQLSGQ+PESL LC SLQSLDLS N SG IP +C WLPY
Sbjct: 56 GVSCWNAKENRILSLQLQSMQLSGQIPESLKLCRSLQSLDLSFNDFSGLIPSQICSWLPY 115
Query: 120 VVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
+V LDLS N LSG IP QIV+CKFLN L L+ NKL+GSIP E++RL+RL+ S+A NDLS
Sbjct: 116 LVTLDLSGNKLSGSIPSQIVDCKFLNSLALNQNKLTGSIPSELTRLNRLQRLSLADNDLS 175
Query: 180 GTIPPDLARFPEESFDGNSGLCGKPLGKCGGLSGKNLGIIIAAGVLGALGSIILGFLIWW 239
G+IP +L+ + E+ F GN GLCGKPL CG +GKNL II+ AGV+GA+GS+ +GF ++W
Sbjct: 176 GSIPSELSHYGEDGFRGNGGLCGKPLSNCGSFNGKNLTIIVTAGVIGAVGSLCVGFGMFW 235
Query: 240 WFFVRVSKK--KRGYGADSGKDDSSWIQVLRSHKLVQVSLFQKPIVKVKLADLLAATNSF 297
WFF+R +K GYGA KDDS WI +LRSHKLVQV+LFQKPIVK+KL DL+ ATN F
Sbjct: 236 WFFIRDRRKMNNYGYGAGKCKDDSDWIGLLRSHKLVQVTLFQKPIVKIKLVDLIEATNGF 295
Query: 298 AVENIIISTRTGVSYKAVLPDASALAIKRLSA-CKLSEKQFRSEMNRLGQLRHPNLVPLL 356
NI++S+R+GVSYKA LPD S L +KRLS+ C+LSEKQFRSE+N+LGQ+RHPNLVPLL
Sbjct: 296 DSGNIVVSSRSGVSYKADLPDGSTLEVKRLSSCCELSEKQFRSEINKLGQIRHPNLVPLL 355
Query: 357 GFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHG 416
GFCVVE+E LLVYKHM NGTLYS L + DW TR+R+ +GA+RGLAWLHHG
Sbjct: 356 GFCVVEDEILLVYKHMANGTLYSQLQQWDI--------DWPTRVRVAVGAARGLAWLHHG 407
Query: 417 CQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYS 476
CQP YMHQYISSNVIL+D+DFDAR+ D+GL +LV S+D DSSF + G+FGYVAPEYS
Sbjct: 408 CQPLYMHQYISSNVILLDEDFDARVIDYGLGKLVSSQDSKDSSFSN---GKFGYVAPEYS 464
Query: 477 STMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK 536
STMVASL GDVYGFGIVLLE+++GQKP+ + EEGFK +LV+WV+ + GRS+D +D+
Sbjct: 465 STMVASLSGDVYGFGIVLLEIVTGQKPVLINNGEEGFKESLVEWVSKHLSNGRSKDAIDR 524
Query: 537 SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHG-FSEPYDEFPMIF 595
++G+G DDEIMQ LR+ACSCVVSRPK+RP M QVYESLK++ ++HG FSE DEFP+IF
Sbjct: 525 RIFGKGYDDEIMQVLRIACSCVVSRPKERPLMIQVYESLKNLGDQHGFFSEYSDEFPLIF 584
Query: 596 GKQD 599
KQ+
Sbjct: 585 NKQE 588
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASS4|Y5838_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase At5g48380 OS=Arabidopsis thaliana GN=At5g48380 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 489 bits (1260), Expect = e-137, Method: Compositional matrix adjust.
Identities = 254/582 (43%), Positives = 365/582 (62%), Gaps = 25/582 (4%)
Query: 23 EDDVKCLEGIQNSIKDPDGRLS-WSFTNTTVGAICRLTGVACWNEKENRIISLTLSSMQL 81
+ ++ CL ++ ++DP+ LS W F N T G IC+ +GV CW++ ENR++S+ LS L
Sbjct: 29 QANIDCLRTFKSQVEDPNRYLSTWVFGNETAGYICKFSGVTCWHDDENRVLSIKLSGYGL 88
Query: 82 SGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVEC 141
G P ++ LC L LDLS N+ SG +P ++ +P V LDLS N SG IP I
Sbjct: 89 RGVFPPAVKLCADLTGLDLSRNNFSGPLPANISTLIPLVTILDLSYNSFSGEIPMLISNI 148
Query: 142 KFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP--DLARFPEESFDGNSG 199
FLN L+L +N+ +G++P ++++L RLK FSV+ N L G IP +F +E F N
Sbjct: 149 TFLNTLMLQHNQFTGTLPPQLAQLGRLKTFSVSDNRLVGPIPNFNQTLQFKQELFANNLD 208
Query: 200 LCGKPLGKCGGLSGKNLGIIIAAGVLG-ALGSIILGFLIWWWFFVRVSKKKRGYGADSGK 258
LCGKPL C S ++I A V G ++++G +++++F R GA K
Sbjct: 209 LCGKPLDDCKSASSSRGKVVIIAAVGGLTAAALVVGVVLFFYF--------RKLGAVRKK 260
Query: 259 DD----SSWIQVLRSHKLVQVSLFQKPIVKVKLADLLAATNSFAVENIIISTRTGVSYKA 314
D + W + L+ K V+V +F+K + K+KL+DL+ AT F +NII + RTG YK
Sbjct: 261 QDDPEGNRWAKSLKGQKGVKVFMFKKSVSKMKLSDLMKATEEFKKDNIIATGRTGTMYKG 320
Query: 315 VLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374
L D S L IKRL + SEK+F +EM LG +++ NLVPLLG+CV +ERLL+Y++M N
Sbjct: 321 RLEDGSLLMIKRLQDSQRSEKEFDAEMKTLGSVKNRNLVPLLGYCVANKERLLMYEYMAN 380
Query: 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID 434
G LY LH D LDW +RL+I +G ++GLAWLHH C P +H+ ISS IL+
Sbjct: 381 GYLYDQLHP--ADEESFKPLDWPSRLKIAIGTAKGLAWLHHSCNPRIIHRNISSKCILLT 438
Query: 435 DDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVL 494
+F+ +I+DFGLARL+ D + S+FV+G+ G+FGYVAPEYS TMVA+ KGDVY FG+VL
Sbjct: 439 AEFEPKISDFGLARLMNPIDTHLSTFVNGEFGDFGYVAPEYSRTMVATPKGDVYSFGVVL 498
Query: 495 LELLSGQKPLDVA------GAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIM 548
LEL++GQK V EE FKGNLV+W+ L + ++ +D+SL G G DDEI
Sbjct: 499 LELVTGQKATSVTKVSEEKAEEENFKGNLVEWITKLSSESKLQEAIDRSLLGNGVDDEIF 558
Query: 549 QFLRVACSCVVSR-PKDRPSMYQVYESLKSMAEKHGFSEPYD 589
+ L+VAC+CV+ K RP+M++VY+ L+++ E + F+ D
Sbjct: 559 KVLKVACNCVLPEIAKQRPTMFEVYQLLRAIGESYNFTADDD 600
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 306 bits (784), Expect = 3e-82, Method: Compositional matrix adjust.
Identities = 207/620 (33%), Positives = 325/620 (52%), Gaps = 68/620 (10%)
Query: 13 LSYSLLTVSIEDDV-KCLEGIQNSIKDP--DGRLSWSFTNTTVGAICRLTGVACW----N 65
LSY+ L+ I +++ +CL ++ S+ + G + S + T I L+G A
Sbjct: 587 LSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPK 646
Query: 66 EKEN--RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQL 123
E N ++ L L++ QL+G +PES L SL L+L+ N L G +P L L + +
Sbjct: 647 EMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGN-LKELTHM 705
Query: 124 DLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183
DLS N+LSG + ++ + L L + NK +G IP E+ L +L+ V+ N LSG IP
Sbjct: 706 DLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIP 765
Query: 184 PDLARFPEESF--------------------------DGNSGLCGKPLGKCGGLSGKNLG 217
+ P F GN LCG+ +G + G L
Sbjct: 766 TKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIEGTKLR 825
Query: 218 IIIAAGVLGALGSIILGFLIWWWFFVRVSKKKRGYGADSGKDDSSWIQVLRSHKLV---- 273
A G+ G ++LGF I + FV ++ +DD ++ R V
Sbjct: 826 S--AWGIAG----LMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNL 879
Query: 274 --------------QVSLFQKPIVKVKLADLLAATNSFAVENIIISTRTGVSYKAVLPDA 319
+++F++P++KV+L D++ AT+ F+ +NII G YKA LP
Sbjct: 880 YFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGE 939
Query: 320 SALAIKRLSACKLS-EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378
+A+K+LS K ++F +EM LG+++HPNLV LLG+C EE+LLVY++M NG+L
Sbjct: 940 KTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLD 999
Query: 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD 438
L + VLDWS RL+I +GA+RGLA+LHHG P +H+ I ++ IL+D DF+
Sbjct: 1000 HWLRN---QTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFE 1056
Query: 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELL 498
++ DFGLARL+ + + + S+ + G FGY+ PEY + A+ KGDVY FG++LLEL+
Sbjct: 1057 PKVADFGLARLISACESHVSTVIAGT---FGYIPPEYGQSARATTKGDVYSFGVILLELV 1113
Query: 499 SGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCV 558
+G++P +E GNLV W + G++ DV+D L + ++ L++A C+
Sbjct: 1114 TGKEPTG-PDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCL 1172
Query: 559 VSRPKDRPSMYQVYESLKSM 578
P RP+M V ++LK +
Sbjct: 1173 AETPAKRPNMLDVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 305 bits (782), Expect = 6e-82, Method: Compositional matrix adjust.
Identities = 198/540 (36%), Positives = 298/540 (55%), Gaps = 50/540 (9%)
Query: 94 SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNK 153
S+ LDLS N++SGSIP+ + Y+ L+L +N L+G IP K + L LS+N
Sbjct: 640 SMIYLDLSYNAVSGSIPLGYGA-MGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHND 698
Query: 154 LSGSIPFEVSRLDRLKEFSVAGNDLSGTIP--PDLARFPEESFDGNSGLCGKPLGKCGGL 211
L G +P + L L + V+ N+L+G IP L FP + NSGLCG PL C
Sbjct: 699 LQGFLPGSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLCGVPLPPCSSG 758
Query: 212 S----------GKNLGIIIAAGVLGALGSIILGFLIWWWFFVRVSKKKRGYGADSGKDDS 261
S +++ ++AG++ + I++ LI + R +KK K
Sbjct: 759 SRPTRSHAHPKKQSIATGMSAGIVFSFMCIVM--LIMALYRARKVQKKE-------KQRE 809
Query: 262 SWIQVLRSHKL-------------VQVSLFQKPIVKVKLADLLAATNSFAVENIIISTRT 308
+I+ L + + V+ F+KP+ K+ A LL ATN F+ +++I S
Sbjct: 810 KYIESLPTSGSSSWKLSSVHEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGF 869
Query: 309 GVSYKAVLPDASALAIKRL-SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367
G YKA L D S +AIK+L +++F +EM +G+++H NLVPLLG+C + EERLL
Sbjct: 870 GDVYKAKLADGSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL 929
Query: 368 VYKHMPNGTLYSLLHGNGVDNTLSG--VLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQY 425
VY++M G+L ++LH + T G LDWS R +I +GA+RGLA+LHH C P +H+
Sbjct: 930 VYEYMKYGSLETVLH----EKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRD 985
Query: 426 ISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKG 485
+ S+ +L+D DF AR++DFG+ARLV + D + S V G GYV PEY + + KG
Sbjct: 986 MKSSNVLLDQDFVARVSDFGMARLVSALDTHLS--VSTLAGTPGYVPPEYYQSFRCTAKG 1043
Query: 486 DVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYG-RGND 544
DVY +G++LLELLSG+KP+D E G NLV W L R +++D L + D
Sbjct: 1044 DVYSYGVILLELLSGKKPIDP--EEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGD 1101
Query: 545 DEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEPYDEFPMIFGKQDPDCKE 604
E++ +L++A C+ RP RP+M QV K + + ++ DEF + K+ P +E
Sbjct: 1102 VELLHYLKIASQCLDDRPFKRPTMIQVMTMFKELVQVDTENDSLDEFLL---KETPLVEE 1158
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 302 bits (774), Expect = 4e-81, Method: Compositional matrix adjust.
Identities = 196/531 (36%), Positives = 289/531 (54%), Gaps = 30/531 (5%)
Query: 94 SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNK 153
S+ D+S N++SG IP + Y+ L+L +N ++G IP K + L LS+N
Sbjct: 640 SMIYFDISYNAVSGFIPPGYGN-MGYLQVLNLGHNRITGTIPDSFGGLKAIGVLDLSHNN 698
Query: 154 LSGSIPFEVSRLDRLKEFSVAGNDLSGTIP--PDLARFPEESFDGNSGLCGKPLGKCGGL 211
L G +P + L L + V+ N+L+G IP L FP + NSGLCG PL CG
Sbjct: 699 LQGYLPGSLGSLSFLSDLDVSNNNLTGPIPFGGQLTTFPVSRYANNSGLCGVPLRPCGSA 758
Query: 212 SGKNLGIIIAAGVLGALGSIILGFLIWWWFFV----------RVSKK--KRGYGADS--G 257
+ + I A ++I G + FV +V KK KR +S
Sbjct: 759 PRRPITSRIHAKKQTVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIESLPT 818
Query: 258 KDDSSW-IQVLRSHKLVQVSLFQKPIVKVKLADLLAATNSFAVENIIISTRTGVSYKAVL 316
SW + + + V+ F+KP+ K+ A LL ATN F+ E ++ S G YKA L
Sbjct: 819 SGSCSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQL 878
Query: 317 PDASALAIKRL-SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNG 375
D S +AIK+L +++F +EM +G+++H NLVPLLG+C V EERLLVY++M G
Sbjct: 879 RDGSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWG 938
Query: 376 TLYSLLHGNGVDNTLSGV-LDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID 434
+L ++LH G+ L+W+ R +I +GA+RGLA+LHH C P +H+ + S+ +L+D
Sbjct: 939 SLETVLHEKSSKK--GGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLD 996
Query: 435 DDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVL 494
+DF+AR++DFG+ARLV + D + S V G GYV PEY + + KGDVY +G++L
Sbjct: 997 EDFEARVSDFGMARLVSALDTHLS--VSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVIL 1054
Query: 495 LELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYG-RGNDDEIMQFLRV 553
LELLSG+KP+D E G NLV W L R +++D L + D E+ +L++
Sbjct: 1055 LELLSGKKPIDP--GEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKI 1112
Query: 554 ACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEPYDEFPMIFGKQDPDCKE 604
A C+ RP RP+M Q+ K M E DEF + K+ P +E
Sbjct: 1113 ASQCLDDRPFKRPTMIQLMAMFKEMKADTEEDESLDEFSL---KETPLVEE 1160
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 298 bits (762), Expect = 1e-79, Method: Compositional matrix adjust.
Identities = 194/520 (37%), Positives = 293/520 (56%), Gaps = 41/520 (7%)
Query: 94 SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNK 153
S+ LD+S N LSG IP ++ +PY+ L+L +N +SG IP ++ + + LN L LS+NK
Sbjct: 655 SMMFLDMSYNMLSGYIPKEIGS-MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 713
Query: 154 LSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP--DLARFPEESFDGNSGLCGKPLGKCG-- 209
L G IP +S L L E ++ N+LSG IP FP F N GLCG PL +C
Sbjct: 714 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS 773
Query: 210 ------------GLSGKNLGIIIAAGVLGAL----GSIILGFLIWWWFF-----VRVSKK 248
G +L +A G+L + G I++G + + + +
Sbjct: 774 NADGYAHHQRSHGRRPASLAGSVAMGLLFSFVCIFGLILVGREMRKRRRKKEAELEMYAE 833
Query: 249 KRGYGADSGKDDSSW-IQVLRSHKLVQVSLFQKPIVKVKLADLLAATNSFAVENIIISTR 307
G D ++++W + ++ + ++ F+KP+ K+ ADLL ATN F +++I S
Sbjct: 834 GHGNSGDRTANNTNWKLTGVKEALSINLAAFEKPLRKLTFADLLQATNGFHNDSLIGSGG 893
Query: 308 TGVSYKAVLPDASALAIKRL-SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366
G YKA+L D SA+AIK+L +++F +EM +G+++H NLVPLLG+C V +ERL
Sbjct: 894 FGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGDERL 953
Query: 367 LVYKHMPNGTLYSLLHGNGVDNTLSGV-LDWSTRLRIGMGASRGLAWLHHGCQPPYMHQY 425
LVY+ M G+L +LH D +GV L+WSTR +I +G++RGLA+LHH C P +H+
Sbjct: 954 LVYEFMKYGSLEDVLH----DPKKAGVKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRD 1009
Query: 426 ISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKG 485
+ S+ +L+D++ +AR++DFG+ARL+ + D + S V G GYV PEY + S KG
Sbjct: 1010 MKSSNVLLDENLEARVSDFGMARLMSAMDTHLS--VSTLAGTPGYVPPEYYQSFRCSTKG 1067
Query: 486 DVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGR--GN 543
DVY +G+VLLELL+G++P D + + NLV WV R DV D L
Sbjct: 1068 DVYSYGVVLLELLTGKRPTD---SPDFGDNNLVGWVKQHAKL-RISDVFDPELMKEDPAL 1123
Query: 544 DDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHG 583
+ E++Q L+VA +C+ R RP+M QV K + G
Sbjct: 1124 EIELLQHLKVAVACLDDRAWRRPTMVQVMAMFKEIQAGSG 1163
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 292 bits (748), Expect = 5e-78, Method: Compositional matrix adjust.
Identities = 194/496 (39%), Positives = 276/496 (55%), Gaps = 31/496 (6%)
Query: 98 LDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGS 157
+DLS NSL+GSI + L + L+L NN+LSG IP + L L LS+N LSG+
Sbjct: 538 IDLSYNSLNGSIWPEFGD-LRQLHVLNLKNNNLSGNIPANLSGMTSLEVLDLSHNNLSGN 596
Query: 158 IPFEVSRLDRLKEFSVAGNDLSGTIPP--DLARFPEESFDGNSGLCGKPLGKC------- 208
IP + +L L FSVA N LSG IP FP SF+GN GLCG+ C
Sbjct: 597 IPPSLVKLSFLSTFSVAYNKLSGPIPTGVQFQTFPNSSFEGNQGLCGEHASPCHITDQSP 656
Query: 209 ---GGLSGKNLGIIIAAGVLGALGSIILGFLIWWWFFVRVSKKKRGYGADSGKDDSSWIQ 265
S KN+ I+A V LG++ FL+ + + RG K D+ I+
Sbjct: 657 HGSAVKSKKNIRKIVAVAVGTGLGTV---FLLTVTLLIILRTTSRGEVDPEKKADADEIE 713
Query: 266 VLRSHKLVQVSLFQKPIV--KVKLADLLAATNSFAVENIIISTRTGVSYKAVLPDASALA 323
L S +V LF ++ L D+L +T+SF NII G+ YKA LPD + +A
Sbjct: 714 -LGSRSVV---LFHNKDSNNELSLDDILKSTSSFNQANIIGCGGFGLVYKATLPDGTKVA 769
Query: 324 IKRLSA-CKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLH 382
IKRLS +++F++E+ L + +HPNLV LLG+C + ++LL+Y +M NG+L LH
Sbjct: 770 IKRLSGDTGQMDREFQAEVETLSRAQHPNLVHLLGYCNYKNDKLLIYSYMDNGSLDYWLH 829
Query: 383 GNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARIT 442
VD S LDW TRLRI GA+ GLA+LH C+P +H+ I S+ IL+ D F A +
Sbjct: 830 -EKVDGPPS--LDWKTRLRIARGAAEGLAYLHQSCEPHILHRDIKSSNILLSDTFVAHLA 886
Query: 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQK 502
DFGLARL+ P D+ +G GY+ PEY VA+ KGDVY FG+VLLELL+G++
Sbjct: 887 DFGLARLIL---PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGRR 943
Query: 503 PLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRP 562
P+DV +L+ WV + R ++ D +Y + + +E++ L +AC C+ P
Sbjct: 944 PMDVCKPRGS--RDLISWVLQMKTEKRESEIFDPFIYDKDHAEEMLLVLEIACRCLGENP 1001
Query: 563 KDRPSMYQVYESLKSM 578
K RP+ Q+ L+++
Sbjct: 1002 KTRPTTQQLVSWLENI 1017
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis. Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 291 bits (744), Expect = 1e-77, Method: Compositional matrix adjust.
Identities = 197/514 (38%), Positives = 282/514 (54%), Gaps = 39/514 (7%)
Query: 98 LDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGS 157
LDLS N L GSIP +L + Y+ L+L +N LSG IP Q+ K + L LS N+ +G+
Sbjct: 668 LDLSYNKLEGSIPKELGA-MYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGT 726
Query: 158 IPFEVSRLDRLKEFSVAGNDLSGTIPPD--LARFPEESFDGNSGLCGKPLG---KCGGLS 212
IP ++ L L E ++ N+LSG IP FP+ F NS LCG PL G S
Sbjct: 727 IPNSLTSLTLLGEIDLSNNNLSGMIPESAPFDTFPDYRFANNS-LCGYPLPLPCSSGPKS 785
Query: 213 GKNLGIIIAAGVLGALGSIILG-----FLIWWWFFVRVSKKKRGYGAD------------ 255
N GS+ +G F I+ V + KKR +
Sbjct: 786 DANQHQKSHRRQASLAGSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGHSH 845
Query: 256 SGKDDSSW-IQVLRSHKLVQVSLFQKPIVKVKLADLLAATNSFAVENIIISTRTGVSYKA 314
S +S+W R + ++ F+KP+ K+ ADLL ATN F ++++ S G YKA
Sbjct: 846 SATANSAWKFTSAREALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKA 905
Query: 315 VLPDASALAIKRL-SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373
L D S +AIK+L +++F +EM +G+++H NLVPLLG+C V EERLLVY++M
Sbjct: 906 QLKDGSVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMK 965
Query: 374 NGTLYSLLHGNGVDNTLSGV-LDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVIL 432
G+L +LH D +G+ L+W R +I +GA+RGLA+LHH C P +H+ + S+ +L
Sbjct: 966 YGSLEDVLH----DRKKTGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVL 1021
Query: 433 IDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGI 492
+D++ +AR++DFG+ARL+ + D + S V G GYV PEY + S KGDVY +G+
Sbjct: 1022 LDENLEARVSDFGMARLMSAMDTHLS--VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGV 1079
Query: 493 VLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEI--MQF 550
VLLELL+G++P D A + NLV WV L G+ DV D+ L EI +Q
Sbjct: 1080 VLLELLTGKQPTDSADFGD---NNLVGWV-KLHAKGKITDVFDRELLKEDASIEIELLQH 1135
Query: 551 LRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGF 584
L+VAC+C+ R RP+M QV K + G
Sbjct: 1136 LKVACACLDDRHWKRPTMIQVMAMFKEIQAGSGM 1169
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 289 bits (740), Expect = 4e-77, Method: Compositional matrix adjust.
Identities = 197/514 (38%), Positives = 281/514 (54%), Gaps = 39/514 (7%)
Query: 98 LDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGS 157
LDLS N L GSIP +L + Y+ L+L +N LSG IP Q+ K + L LS N+ +G+
Sbjct: 668 LDLSYNKLEGSIPKELGA-MYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGT 726
Query: 158 IPFEVSRLDRLKEFSVAGNDLSGTIPPD--LARFPEESFDGNSGLCGKPLG---KCGGLS 212
IP ++ L L E ++ N+LSG IP FP+ F NS LCG PL G S
Sbjct: 727 IPNSLTSLTLLGEIDLSNNNLSGMIPESAPFDTFPDYRFANNS-LCGYPLPIPCSSGPKS 785
Query: 213 GKNLGIIIAAGVLGALGSIILG-----FLIWWWFFVRVSKKKRGYGAD------------ 255
N GS+ +G F I+ V + KKR +
Sbjct: 786 DANQHQKSHRRQASLAGSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGHSH 845
Query: 256 SGKDDSSW-IQVLRSHKLVQVSLFQKPIVKVKLADLLAATNSFAVENIIISTRTGVSYKA 314
S +S+W R + ++ F+KP+ K+ ADLL ATN F ++++ S G YKA
Sbjct: 846 SATANSAWKFTSAREALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKA 905
Query: 315 VLPDASALAIKRL-SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373
L D S +AIK+L +++F +EM +G+++H NLVPLLG+C V EERLLVY++M
Sbjct: 906 QLKDGSVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMK 965
Query: 374 NGTLYSLLHGNGVDNTLSGV-LDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVIL 432
G+L +LH D G+ L+W R +I +GA+RGLA+LHH C P +H+ + S+ +L
Sbjct: 966 YGSLEDVLH----DRKKIGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVL 1021
Query: 433 IDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGI 492
+D++ +AR++DFG+ARL+ + D + S V G GYV PEY + S KGDVY +G+
Sbjct: 1022 LDENLEARVSDFGMARLMSAMDTHLS--VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGV 1079
Query: 493 VLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEI--MQF 550
VLLELL+G++P D A + NLV WV L G+ DV D+ L EI +Q
Sbjct: 1080 VLLELLTGKQPTDSADFGD---NNLVGWV-KLHAKGKITDVFDRELLKEDASIEIELLQH 1135
Query: 551 LRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGF 584
L+VAC+C+ R RP+M QV K + G
Sbjct: 1136 LKVACACLDDRHWKRPTMIQVMAMFKEIQAGSGM 1169
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 604 | ||||||
| 224077382 | 609 | predicted protein [Populus trichocarpa] | 1.0 | 0.991 | 0.726 | 0.0 | |
| 224134625 | 606 | predicted protein [Populus trichocarpa] | 0.965 | 0.962 | 0.755 | 0.0 | |
| 225424823 | 611 | PREDICTED: probable inactive receptor ki | 0.966 | 0.955 | 0.726 | 0.0 | |
| 297845470 | 601 | hypothetical protein ARALYDRAFT_889992 [ | 0.950 | 0.955 | 0.720 | 0.0 | |
| 224140895 | 602 | predicted protein [Populus trichocarpa] | 0.966 | 0.970 | 0.679 | 0.0 | |
| 15223445 | 601 | putative inactive receptor kinase [Arabi | 0.950 | 0.955 | 0.715 | 0.0 | |
| 255552774 | 602 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.970 | 0.973 | 0.675 | 0.0 | |
| 359488761 | 613 | PREDICTED: probable inactive receptor ki | 0.973 | 0.959 | 0.667 | 0.0 | |
| 224055521 | 595 | predicted protein [Populus trichocarpa] | 0.953 | 0.968 | 0.672 | 0.0 | |
| 449461899 | 604 | PREDICTED: probable inactive receptor ki | 0.950 | 0.950 | 0.636 | 0.0 |
| >gi|224077382|ref|XP_002305238.1| predicted protein [Populus trichocarpa] gi|222848202|gb|EEE85749.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 907 bits (2344), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/608 (72%), Positives = 502/608 (82%), Gaps = 4/608 (0%)
Query: 1 MKIRFILASLLLLSYSLLTVSIEDDVKCLEGIQNSIKDPDGRL-SWSFTNTTVGAICRLT 59
MK +++ LL S + +IEDDV CLEG++NS DP GRL SW F N +V IC+L
Sbjct: 2 MKKNTLISFSLLFSLFAFSFAIEDDVTCLEGVKNSFTDPLGRLTSWDFNNNSVAYICKLN 61
Query: 60 GVACWNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPY 119
GV+CWNEKENRIISL L QLSG+LPESL CHSL +LDLS+N LSG IP ++C WLPY
Sbjct: 62 GVSCWNEKENRIISLQLPLFQLSGKLPESLKYCHSLTTLDLSNNDLSGPIPPEICNWLPY 121
Query: 120 VVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
VV LDLS N SGPIPP+IV CKFLN LILS NKL+GSIP+ RLDRLK FSVA NDL+
Sbjct: 122 VVTLDLSGNKFSGPIPPEIVNCKFLNSLILSGNKLTGSIPYGFGRLDRLKRFSVASNDLT 181
Query: 180 GTIPPDLARFPEESFDGNSGLCGKPLGKCGGLSGKNLGIIIAAGVLGALGSIILGFLIWW 239
G+IP +L FP+++FDGN GLCGKPLGKCGGLS K+LGIII AGV+GA GS+ILGF+IWW
Sbjct: 182 GSIPEELGVFPKDAFDGNEGLCGKPLGKCGGLSSKSLGIIIVAGVIGAGGSLILGFVIWW 241
Query: 240 WFFVRVSKKKRGYGADSGKDDSS---WIQVLRSHKLVQVSLFQKPIVKVKLADLLAATNS 296
W FV+ G WI +LRSHKLVQV+LFQKPIVK+KLAD+LAATNS
Sbjct: 242 WLFVKGKSGGGSGGVGGSGGKGDDSSWIGLLRSHKLVQVTLFQKPIVKIKLADILAATNS 301
Query: 297 FAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLL 356
F EN++ISTRTGVSY+A LPD S+LAIKRL+ CKL EKQFR EMNRLGQLRHPNLVPLL
Sbjct: 302 FDFENVVISTRTGVSYQADLPDGSSLAIKRLNTCKLGEKQFRGEMNRLGQLRHPNLVPLL 361
Query: 357 GFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHG 416
GFCVVE E+LLVYKHMPNGTLYS LHG+G + VLDW TR+R+G+GA+RGLAWLHHG
Sbjct: 362 GFCVVEVEKLLVYKHMPNGTLYSQLHGSGFGIGQTSVLDWPTRVRVGVGAARGLAWLHHG 421
Query: 417 CQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYS 476
C PPY+HQYISSNVIL+DDDFDARITDFGLARL+ S D NDSSFVHGDLGEFGYVAPEYS
Sbjct: 422 CHPPYIHQYISSNVILLDDDFDARITDFGLARLISSPDSNDSSFVHGDLGEFGYVAPEYS 481
Query: 477 STMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK 536
STMVASLKGDVYGFG+VLLEL+SGQKPLDV+ AEEGFKGNLVDWVN L GRS D +DK
Sbjct: 482 STMVASLKGDVYGFGVVLLELVSGQKPLDVSNAEEGFKGNLVDWVNQLASIGRSTDAIDK 541
Query: 537 SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEPYDEFPMIFG 596
+L G+G+DDEIMQFL+VA SCVVSRPKDRP+MYQ+YESLK MAEKHGFS+ YDEFP+IFG
Sbjct: 542 ALVGKGHDDEIMQFLKVAWSCVVSRPKDRPTMYQIYESLKGMAEKHGFSDKYDEFPLIFG 601
Query: 597 KQDPDCKE 604
KQDPD KE
Sbjct: 602 KQDPDYKE 609
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224134625|ref|XP_002327450.1| predicted protein [Populus trichocarpa] gi|222836004|gb|EEE74425.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 898 bits (2320), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/585 (75%), Positives = 502/585 (85%), Gaps = 2/585 (0%)
Query: 22 IEDDVKCLEGIQNSIKDPDGRL-SWSFTNTTVGAICRLTGVACWNEKENRIISLTLSSMQ 80
IEDD+ CLEG++ S DP GRL SW+F N +V +C+L GV+CWNEKENRIISL LSS Q
Sbjct: 22 IEDDITCLEGVKKSFTDPLGRLTSWTFNNNSVAFVCKLNGVSCWNEKENRIISLQLSSFQ 81
Query: 81 LSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVE 140
LSG+LPESL CHSL +LDLS N LSG IP ++C WLPY+V LDLS N SGPIPP+IV
Sbjct: 82 LSGKLPESLKYCHSLTTLDLSSNDLSGPIPPEICNWLPYIVSLDLSGNKFSGPIPPEIVN 141
Query: 141 CKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGNSGL 200
CKFLN LILS N+L+GSIPF + RLDRLK FSVA N+LSG+IP +L F ++SFDGN GL
Sbjct: 142 CKFLNNLILSGNQLTGSIPFGLGRLDRLKTFSVASNELSGSIPDELWAFSKDSFDGNDGL 201
Query: 201 CGKPLGKCGGLSGKNLGIIIAAGVLGALGSIILGFLIWWWFFVRVSKKKRGYGADSGK-D 259
CGKPLGKCGGLS K+LGIII AGV+GA GS+ILGF+IWWW FVR KKKRG G GK D
Sbjct: 202 CGKPLGKCGGLSSKSLGIIIVAGVVGAGGSLILGFVIWWWLFVRGGKKKRGSGGGGGKGD 261
Query: 260 DSSWIQVLRSHKLVQVSLFQKPIVKVKLADLLAATNSFAVENIIISTRTGVSYKAVLPDA 319
D SWI++LRSHKLVQV+LFQKPIVK+KLAD+LAATNSF ENI+ISTRTG SYKA LPD
Sbjct: 262 DPSWIELLRSHKLVQVTLFQKPIVKIKLADILAATNSFDFENIVISTRTGDSYKADLPDG 321
Query: 320 SALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYS 379
S+LAIKRL+ACKL EKQFR EMNRLG+LRHPNLVPLLG+C VE E+LLVYKHMPNGTLYS
Sbjct: 322 SSLAIKRLNACKLGEKQFRGEMNRLGELRHPNLVPLLGYCAVEVEKLLVYKHMPNGTLYS 381
Query: 380 LLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439
LHG+G + S VLDW TR+R+G+GA+RGLAWLHHGC PPY+HQYISSNVIL+DDDFDA
Sbjct: 382 QLHGSGFGISQSSVLDWPTRVRVGVGATRGLAWLHHGCDPPYIHQYISSNVILLDDDFDA 441
Query: 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS 499
RITDFGLARL+ S D NDSS+V+GDLGEFGY+APEYSSTMVASLKGDVYGFG+VLLEL++
Sbjct: 442 RITDFGLARLISSPDSNDSSYVNGDLGEFGYIAPEYSSTMVASLKGDVYGFGVVLLELVT 501
Query: 500 GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVV 559
GQK LDV EEGFKGNLVDWVN LV GRS+D +DK+L G+G+DDEIMQFLRVA SCVV
Sbjct: 502 GQKALDVNNEEEGFKGNLVDWVNQLVSTGRSKDAIDKALTGKGHDDEIMQFLRVAWSCVV 561
Query: 560 SRPKDRPSMYQVYESLKSMAEKHGFSEPYDEFPMIFGKQDPDCKE 604
SRPKDRPSMYQVYESLK +AEKHGFS+ YDEFP+IFGK DPD KE
Sbjct: 562 SRPKDRPSMYQVYESLKGLAEKHGFSDQYDEFPLIFGKPDPDYKE 606
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225424823|ref|XP_002268171.1| PREDICTED: probable inactive receptor kinase At1g27190-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 872 bits (2253), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/586 (72%), Positives = 501/586 (85%), Gaps = 2/586 (0%)
Query: 18 LTVSIEDDVKCLEGIQNSIKDPDGRLS-WSFTNTTVGAICRLTGVACWNEKENRIISLTL 76
+ V+IEDDV CL+G+++S+ DPD ++S W FTNT+ IC L GV+CWN +E+RIISL L
Sbjct: 25 VAVAIEDDVVCLQGLKDSLTDPDDKISTWRFTNTSASFICNLVGVSCWNAQESRIISLQL 84
Query: 77 SSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPP 136
M L G LP+SL C SLQSL LS N +SGSIP +C WLPYVV LDLS+N L+GPIPP
Sbjct: 85 PDMNLIGTLPDSLQHCRSLQSLGLSGNRISGSIPDQICTWLPYVVTLDLSHNDLTGPIPP 144
Query: 137 QIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDG 196
++V CKFLN LIL+NN LSG IP+E+ RL RLK+FSVA NDLSG+IP +L++F +++FDG
Sbjct: 145 EMVNCKFLNNLILNNNGLSGMIPYEIGRLPRLKKFSVANNDLSGSIPSELSKFEDDAFDG 204
Query: 197 NSGLCGKPLGKCGGLSGKNLGIIIAAGVLGALGSIILGFLIWWWFFVRVSKKKRGY-GAD 255
N+GLC KPLGKCGGLS K+L IIIAAG+ GA GS++LGF +WWWFFVR+++KKRGY G D
Sbjct: 205 NNGLCRKPLGKCGGLSSKSLAIIIAAGIFGAAGSLLLGFALWWWFFVRLNRKKRGYSGGD 264
Query: 256 SGKDDSSWIQVLRSHKLVQVSLFQKPIVKVKLADLLAATNSFAVENIIISTRTGVSYKAV 315
SGK SW + LR HKLVQVSLFQKPIVK+KLADL+AATN+F E ++ STRTGVSYKAV
Sbjct: 265 SGKIGGSWAERLRMHKLVQVSLFQKPIVKIKLADLMAATNNFDPEYLLCSTRTGVSYKAV 324
Query: 316 LPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNG 375
L D SALAIKRLSACKLS+KQFRSEMNRLGQLRHPNLVPLLGFC VEEE+LLVYKHMPNG
Sbjct: 325 LLDGSALAIKRLSACKLSDKQFRSEMNRLGQLRHPNLVPLLGFCAVEEEKLLVYKHMPNG 384
Query: 376 TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD 435
TLYSLLHG+ ++ +DW TRLRIG+GA+RGLAWLHHGCQPPYMHQ ISS+VIL+DD
Sbjct: 385 TLYSLLHGSTSFHSQHHSIDWPTRLRIGVGAARGLAWLHHGCQPPYMHQNISSSVILLDD 444
Query: 436 DFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLL 495
D+DARITDFGLARLV S D NDSSFV+GDLGEFGYVAPEYSSTMV SLKGDVYGFG+VLL
Sbjct: 445 DYDARITDFGLARLVASADSNDSSFVNGDLGEFGYVAPEYSSTMVPSLKGDVYGFGVVLL 504
Query: 496 ELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVAC 555
EL++GQKPL+V +EGFKGNLVDWV L+I+GRS+D +DK L+G+G DDEI+Q +RVAC
Sbjct: 505 ELVTGQKPLEVNNGDEGFKGNLVDWVIQLLISGRSKDAIDKDLWGKGYDDEIVQLMRVAC 564
Query: 556 SCVVSRPKDRPSMYQVYESLKSMAEKHGFSEPYDEFPMIFGKQDPD 601
SCV SRPK+RPSMY VY+SLKSMAEKHGFSE YDEFP++F KQDPD
Sbjct: 565 SCVGSRPKERPSMYNVYQSLKSMAEKHGFSEQYDEFPLMFSKQDPD 610
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297845470|ref|XP_002890616.1| hypothetical protein ARALYDRAFT_889992 [Arabidopsis lyrata subsp. lyrata] gi|297336458|gb|EFH66875.1| hypothetical protein ARALYDRAFT_889992 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 853 bits (2204), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/579 (72%), Positives = 494/579 (85%), Gaps = 5/579 (0%)
Query: 23 EDDVKCLEGIQNSIKDPDGRLS-WSFTNTTVGAICRLTGVACWNEKENRIISLTLSSMQL 81
EDDV CL+G++NS+ DP RLS WSF N++ +IC+LTGV+CWNEKENRIISL L SMQL
Sbjct: 25 EDDVLCLQGLKNSLIDPSSRLSSWSFPNSSASSICKLTGVSCWNEKENRIISLQLQSMQL 84
Query: 82 SGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVEC 141
+G++PESL LC SLQSLDLS N LSGSIP +C WLPY+V LDLS N L G IP QIVEC
Sbjct: 85 AGEIPESLKLCRSLQSLDLSGNDLSGSIPSQICSWLPYLVTLDLSGNKLGGSIPTQIVEC 144
Query: 142 KFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGNSGLC 201
KFLN LILS+NKLSGSIP ++SRLDRL+ S+AGNDLSGTIP +LARF + F GN GLC
Sbjct: 145 KFLNALILSDNKLSGSIPSQLSRLDRLRRLSLAGNDLSGTIPSELARFGGDDFSGNDGLC 204
Query: 202 GKPLGKCGGLSGKNLGIIIAAGVLGALGSIILGFLIWWWFFVRV-SKKKRGYGADSGKDD 260
GKPL +CG L+G+NL III AGV+GA+GS+ +G +I+WWFF+R S+KK+GYGA KDD
Sbjct: 205 GKPLSRCGALNGRNLSIIIVAGVIGAVGSLCVGLVIFWWFFIREGSRKKKGYGAGKSKDD 264
Query: 261 SSWIQVLRSHKLVQVSLFQKPIVKVKLADLLAATNSFAVENIIISTRTGVSYKAVLPDAS 320
S WI +LRSHKLVQV+LFQKPIVK+KL DL+AATN+F+ N+ +S+RTGVSYKA LPD S
Sbjct: 265 SDWIGLLRSHKLVQVTLFQKPIVKIKLGDLMAATNNFSSGNMDVSSRTGVSYKADLPDGS 324
Query: 321 ALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
ALA+KRLSAC EKQFRSEMNRLG+LRHPNLVPLLG+CVVE+ERLLVYKHMPNGTL+S
Sbjct: 325 ALAVKRLSACGFGEKQFRSEMNRLGELRHPNLVPLLGYCVVEDERLLVYKHMPNGTLFSQ 384
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDAR 440
LH G+ VLDW TRL IG+GA++GLAWLHHGCQPPY+HQ+ISSNVIL+DDDFDAR
Sbjct: 385 LHNGGL---CDAVLDWPTRLAIGVGAAKGLAWLHHGCQPPYLHQFISSNVILLDDDFDAR 441
Query: 441 ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSG 500
ITD+GLARLVGSRD NDSSF +GDLGE GYVAPEYSSTMVASLKGDVYGFGIVLLEL++G
Sbjct: 442 ITDYGLARLVGSRDSNDSSFNNGDLGELGYVAPEYSSTMVASLKGDVYGFGIVLLELVTG 501
Query: 501 QKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVS 560
QKPL V EGFKG+LVDWV+ + GRS+D +D+S+ +G+D+EI+QFL++ACSCVVS
Sbjct: 502 QKPLSVINGVEGFKGSLVDWVSQYLGTGRSKDAIDRSICDKGHDEEILQFLKIACSCVVS 561
Query: 561 RPKDRPSMYQVYESLKSMAEKHGFSEPYDEFPMIFGKQD 599
RPK+RP+M QVYESLKSMA+KHG SE YDEFP++F KQ+
Sbjct: 562 RPKERPTMIQVYESLKSMADKHGVSEHYDEFPLVFNKQE 600
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224140895|ref|XP_002323813.1| predicted protein [Populus trichocarpa] gi|222866815|gb|EEF03946.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 846 bits (2186), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/596 (67%), Positives = 496/596 (83%), Gaps = 12/596 (2%)
Query: 10 LLLLSYSLLTVSIEDDVKCLEGIQNSIKDPDGRLS-WSFTNTTVGAICRLTGVACWNEKE 68
++L++ S++ V EDDV+CL+G++NS+ +P+G+L+ W+F N++VG IC GV+CWN++E
Sbjct: 15 VILVALSVINVLGEDDVRCLQGVKNSLDNPEGKLTTWNFANSSVGFICNFVGVSCWNDRE 74
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNN 128
NRII+L L M+LSGQ+PESL C SLQ+LDLS NSLSG+IP +C W+PY+V LDLSNN
Sbjct: 75 NRIINLQLRDMKLSGQVPESLRYCQSLQNLDLSSNSLSGTIPAQICTWVPYLVTLDLSNN 134
Query: 129 HLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLAR 188
LSGPIPP + C +LNKLILSNN+LSGSIPFE+S L RLK+FSV NDL+GT+P
Sbjct: 135 DLSGPIPPDLANCTYLNKLILSNNRLSGSIPFELSGLGRLKQFSVENNDLAGTVPSFFTN 194
Query: 189 FPEESFDGNSGLCGKPLGKCGGLSGKNLGIIIAAGVLGALGSIILGFLIWWWFFVRVSKK 248
SFDGN GLCGKPL KCGGL KNL IIIAAGV GA S++LGF +WWW+ +R S++
Sbjct: 195 LDSASFDGNKGLCGKPLSKCGGLREKNLAIIIAAGVFGAASSLLLGFGVWWWYHLRYSER 254
Query: 249 KR--GYGADSGKDDSSWIQVLRSHKLVQVSLFQKPIVKVKLADLLAATNSFAVENIIIST 306
KR GYG G DD+SW Q LRSHKLVQVSLFQKP+VKVKLADL+AATN+F+ +NIIIST
Sbjct: 255 KRKGGYGFGRG-DDTSWAQRLRSHKLVQVSLFQKPLVKVKLADLIAATNNFSPDNIIIST 313
Query: 307 RTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366
RTG +YKAVLPD SALA+KRL+ CKL EKQFRSEMNRLGQ+RHPNL PLLGFCVVEEE+L
Sbjct: 314 RTGTTYKAVLPDGSALALKRLTTCKLGEKQFRSEMNRLGQIRHPNLAPLLGFCVVEEEKL 373
Query: 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYI 426
LVYKHM GTLYSLLHG+G LDWSTR RIG+GA+RGLAWLHHGCQ P+++Q +
Sbjct: 374 LVYKHMSYGTLYSLLHGSG------NALDWSTRFRIGLGAARGLAWLHHGCQRPFLYQNM 427
Query: 427 SSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGD 486
SNVIL+D+DFDARI DFGLA++ S D N+SS+V+GDLGEFGYVAPEYSSTMVASLKGD
Sbjct: 428 CSNVILVDEDFDARIMDFGLAKMTCS-DSNESSYVNGDLGEFGYVAPEYSSTMVASLKGD 486
Query: 487 VYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDE 546
VYGFG+VLLEL++GQKPLD++ AEEGFKG+LVDWVNHL +GRS+D VDK++ G+G+D+
Sbjct: 487 VYGFGVVLLELVTGQKPLDISNAEEGFKGSLVDWVNHLSSSGRSKDAVDKAICGKGHDEG 546
Query: 547 IMQFLRVACSCVVSRPKDRPSMYQVYESLKSMA-EKHGFSEPYDEFPMIFGKQDPD 601
I QFL++AC+CV++RPKDR SMY+ Y+SLK++A E H SE DEFP+IFGKQD D
Sbjct: 547 IYQFLKIACNCVIARPKDRWSMYKTYQSLKTIASEHHVLSELDDEFPLIFGKQDYD 602
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15223445|ref|NP_174039.1| putative inactive receptor kinase [Arabidopsis thaliana] gi|75097079|sp|O04567.1|Y1719_ARATH RecName: Full=Probable inactive receptor kinase At1g27190; Flags: Precursor gi|8778873|gb|AAF79872.1|AC000348_25 T7N9.25 [Arabidopsis thaliana] gi|53828509|gb|AAU94364.1| At1g27190 [Arabidopsis thaliana] gi|224589400|gb|ACN59234.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332192671|gb|AEE30792.1| putative inactive receptor kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 846 bits (2185), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/579 (71%), Positives = 493/579 (85%), Gaps = 5/579 (0%)
Query: 23 EDDVKCLEGIQNSIKDPDGRLS-WSFTNTTVGAICRLTGVACWNEKENRIISLTLSSMQL 81
EDDV CL+G++NS+ DP RLS WSF N++ +IC+LTGV+CWNEKENRIISL L SMQL
Sbjct: 25 EDDVLCLQGLKNSLIDPSSRLSSWSFPNSSASSICKLTGVSCWNEKENRIISLQLQSMQL 84
Query: 82 SGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVEC 141
+G++PESL LC SLQSLDLS N LSGSIP +C WLPY+V LDLS N L G IP QIVEC
Sbjct: 85 AGEIPESLKLCRSLQSLDLSGNDLSGSIPSQICSWLPYLVTLDLSGNKLGGSIPTQIVEC 144
Query: 142 KFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGNSGLC 201
KFLN LILS+NKLSGSIP ++SRLDRL+ S+AGNDLSGTIP +LARF + F GN+GLC
Sbjct: 145 KFLNALILSDNKLSGSIPSQLSRLDRLRRLSLAGNDLSGTIPSELARFGGDDFSGNNGLC 204
Query: 202 GKPLGKCGGLSGKNLGIIIAAGVLGALGSIILGFLIWWWFFVRV-SKKKRGYGADSGKDD 260
GKPL +CG L+G+NL III AGVLGA+GS+ +G +I+WWFF+R S+KK+GYGA KDD
Sbjct: 205 GKPLSRCGALNGRNLSIIIVAGVLGAVGSLCVGLVIFWWFFIREGSRKKKGYGAGKSKDD 264
Query: 261 SSWIQVLRSHKLVQVSLFQKPIVKVKLADLLAATNSFAVENIIISTRTGVSYKAVLPDAS 320
S WI +LRSHKLVQV+LFQKPIVK+KL DL+AATN+F+ NI +S+RTGVSYKA LPD S
Sbjct: 265 SDWIGLLRSHKLVQVTLFQKPIVKIKLGDLMAATNNFSSGNIDVSSRTGVSYKADLPDGS 324
Query: 321 ALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
ALA+KRLSAC EKQFRSEMN+LG+LRHPNLVPLLG+CVVE+ERLLVYKHM NGTL+S
Sbjct: 325 ALAVKRLSACGFGEKQFRSEMNKLGELRHPNLVPLLGYCVVEDERLLVYKHMVNGTLFSQ 384
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDAR 440
LH G+ VLDW TR IG+GA++GLAWLHHGCQPPY+HQ+ISSNVIL+DDDFDAR
Sbjct: 385 LHNGGL---CDAVLDWPTRRAIGVGAAKGLAWLHHGCQPPYLHQFISSNVILLDDDFDAR 441
Query: 441 ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSG 500
ITD+GLA+LVGSRD NDSSF +GDLGE GYVAPEYSSTMVASLKGDVYGFGIVLLEL++G
Sbjct: 442 ITDYGLAKLVGSRDSNDSSFNNGDLGELGYVAPEYSSTMVASLKGDVYGFGIVLLELVTG 501
Query: 501 QKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVS 560
QKPL V EGFKG+LVDWV+ + GRS+D +D+S+ +G+D+EI+QFL++ACSCVVS
Sbjct: 502 QKPLSVINGVEGFKGSLVDWVSQYLGTGRSKDAIDRSICDKGHDEEILQFLKIACSCVVS 561
Query: 561 RPKDRPSMYQVYESLKSMAEKHGFSEPYDEFPMIFGKQD 599
RPK+RP+M QVYESLK+MA+KHG SE YDEFP++F KQ+
Sbjct: 562 RPKERPTMIQVYESLKNMADKHGVSEHYDEFPLVFNKQE 600
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255552774|ref|XP_002517430.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223543441|gb|EEF44972.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2153), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/598 (67%), Positives = 488/598 (81%), Gaps = 12/598 (2%)
Query: 7 LASLLLLSYSLLTVSI--EDDVKCLEGIQNSIKDPDGRLS-WSFTNTTVGAICRLTGVAC 63
A+L+L+S +L++ S+ EDD KCLEG++NS+ DP G+LS W+F N++ G +C GV+C
Sbjct: 10 FATLILVSATLISSSVIGEDDAKCLEGVRNSLSDPQGKLSSWNFANSSSGFLCNFVGVSC 69
Query: 64 WNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQL 123
WN++ENRII+L L MQLSGQ+PESL C SLQ+LDLS N+LSG+IP +C WLPY+V L
Sbjct: 70 WNDQENRIINLELRDMQLSGQVPESLKYCKSLQNLDLSSNALSGTIPSQICTWLPYLVTL 129
Query: 124 DLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183
DLSNN LSG IP +V C +LN LILSNN+LSG IP+E S L RLK FSVA NDL+GTIP
Sbjct: 130 DLSNNDLSGSIPHDLVNCTYLNNLILSNNRLSGPIPYEFSSLSRLKRFSVANNDLTGTIP 189
Query: 184 PDLARFPEESFDGNSGLCGKPLG-KCGGLSGKNLGIIIAAGVLGALGSIILGFLIWWWFF 242
+ F FDGN+GLCGKPLG CGGLS KNL IIIAAGV GA S++LGF +WWW+
Sbjct: 190 SFFSNFDPADFDGNNGLCGKPLGSNCGGLSKKNLAIIIAAGVFGAAASLLLGFGVWWWYH 249
Query: 243 VRVSKK-KRGYGADSGKDDSSWIQVLRSHKLVQVSLFQKPIVKVKLADLLAATNSFAVEN 301
+R S++ KRG+G G DD+SW LRSHKLVQVSLFQKP+VKV+LADL+AATN+F EN
Sbjct: 250 LRYSRRRKRGHGIGRG-DDTSWAAKLRSHKLVQVSLFQKPLVKVRLADLIAATNNFNPEN 308
Query: 302 IIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVV 361
IIIS+RTG++YKA+LPD SALAIKRL+ CKL EK FRSEMNRLGQLRHPNL PLLGFCVV
Sbjct: 309 IIISSRTGITYKALLPDGSALAIKRLNTCKLGEKHFRSEMNRLGQLRHPNLTPLLGFCVV 368
Query: 362 EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPY 421
E+E+LLVYKHM NGTLY+LLHGNG +LDW TR RIG+GA+RGLAWLHHGCQPP+
Sbjct: 369 EDEKLLVYKHMSNGTLYALLHGNGT------LLDWPTRFRIGVGAARGLAWLHHGCQPPF 422
Query: 422 MHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA 481
+HQ I SNVIL+D+DFDARI DFGLARL+ S D N+SS+V+GDLGE GYVAPEYSSTMVA
Sbjct: 423 LHQNICSNVILVDEDFDARIMDFGLARLMTSSDSNESSYVNGDLGELGYVAPEYSSTMVA 482
Query: 482 SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGR 541
SLKGDVYGFG+VLLEL++GQKPLD+A EE FKGNLVDWVN L +GR +D +DKSL G+
Sbjct: 483 SLKGDVYGFGVVLLELVTGQKPLDIATPEEEFKGNLVDWVNQLSSSGRLKDAIDKSLCGK 542
Query: 542 GNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEPYDEFPMIFGKQD 599
G+D+EI+QFL++ +CV++RPKDR SM +VY+SLK GFSE +EFP+IFGKQD
Sbjct: 543 GHDEEILQFLKIGLNCVIARPKDRWSMLRVYQSLKVTGSDLGFSEQDEEFPLIFGKQD 600
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359488761|ref|XP_003633815.1| PREDICTED: probable inactive receptor kinase At1g27190-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2152), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/601 (66%), Positives = 489/601 (81%), Gaps = 13/601 (2%)
Query: 6 ILASLLLLSYSLLTVSI-EDDVKCLEGIQNSIKDPDGRLS-WSFTNTTVGAICRLTGVAC 63
+L ++L +L + ++ EDDVKCL G++ S+ DP G+LS WSF+N +VG++C+ GVAC
Sbjct: 18 LLTIVILCCVALFSAAVAEDDVKCLRGVKESLSDPQGKLSSWSFSNISVGSLCKFVGVAC 77
Query: 64 WNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQL 123
WN++ENRI L L M+LSG++P+ L C S+Q+LDLS N L G+IP +C WLPY+V L
Sbjct: 78 WNDRENRIFGLELPDMKLSGEIPKPLEYCQSMQTLDLSGNRLYGNIPSQICTWLPYLVTL 137
Query: 124 DLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183
DLSNN LSG IPP + C FLN L+L++N+LSG IP ++S L RLK+FSVA N L+GTIP
Sbjct: 138 DLSNNDLSGTIPPDLANCSFLNSLLLADNQLSGIIPSQLSSLGRLKKFSVANNRLTGTIP 197
Query: 184 PDLARFPEESFDGNSGLCGKPLG-KCGGLSGKNLGIIIAAGVLGALGSIILGFLIWWWFF 242
+F + FDGNSGLCG+PLG KCGGL+ K+L IIIAAGV GA S++LGF +WWWFF
Sbjct: 198 SAFGKFDKAGFDGNSGLCGRPLGSKCGGLNKKSLAIIIAAGVFGAAASLLLGFGLWWWFF 257
Query: 243 VRV-SKKKRGYGADSGKDD-SSWIQVLRSHKLVQVSLFQKPIVKVKLADLLAATNSFAVE 300
R+ ++KR YG G+DD SSW + LR+HKLVQV+LFQKPIVKVKLADL+AATN+F E
Sbjct: 258 ARLRGQRKRRYGI--GRDDHSSWTERLRAHKLVQVTLFQKPIVKVKLADLMAATNNFHPE 315
Query: 301 NIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCV 360
NII STRTG SYKA+LPD SALAIKRL+ C L EKQFRSEMNRLGQ RHPNL PLLGFC
Sbjct: 316 NIINSTRTGTSYKAILPDGSALAIKRLNTCNLGEKQFRSEMNRLGQFRHPNLAPLLGFCA 375
Query: 361 VEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPP 420
VEEE+LLVYK+M NGTLYSLLHGNG +DW+TR RIG+GA+RGLAWLHHGCQPP
Sbjct: 376 VEEEKLLVYKYMSNGTLYSLLHGNGTP------MDWATRFRIGLGAARGLAWLHHGCQPP 429
Query: 421 YMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMV 480
+H+ ISSNVILIDDDFDARI DFGLARL+ + D N SSFV+G LGEFGYVAPEYSSTMV
Sbjct: 430 LLHENISSNVILIDDDFDARIVDFGLARLMATSDSNGSSFVNGGLGEFGYVAPEYSSTMV 489
Query: 481 ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYG 540
ASLKGDVYGFG+VLLEL++GQKPL+V AEEGFKGNLV+WVN L +GR++DV+D++L G
Sbjct: 490 ASLKGDVYGFGVVLLELVTGQKPLEVTNAEEGFKGNLVEWVNQLCGSGRNKDVIDEALCG 549
Query: 541 RGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEPYDEFPMIFGKQDP 600
+G+D+EI+QFL++AC+C+ RPKDR SMYQ +ESLKSM + HGFSE YDEFP+IFGKQD
Sbjct: 550 KGHDEEILQFLKIACNCLGPRPKDRLSMYQAFESLKSMGDHHGFSEHYDEFPLIFGKQDH 609
Query: 601 D 601
D
Sbjct: 610 D 610
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224055521|ref|XP_002298520.1| predicted protein [Populus trichocarpa] gi|222845778|gb|EEE83325.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 824 bits (2129), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/587 (67%), Positives = 475/587 (80%), Gaps = 11/587 (1%)
Query: 19 TVSIEDDVKCLEGIQNSIKDPDGRL-SWSFTNTTVGAICRLTGVACWNEKENRIISLTLS 77
TV EDD +CL+G+QNS+ DP+GRL +W+F NT+VG IC GV+CWN++ENRII+L L
Sbjct: 16 TVFAEDDARCLQGVQNSLGDPEGRLATWNFGNTSVGFICNFVGVSCWNDRENRIINLELR 75
Query: 78 SMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQ 137
M+LSGQ+PESL C SLQ+LDLS NSLSG+IP +C WLPY+V LDLSNN SGPIPP
Sbjct: 76 DMKLSGQVPESLQYCKSLQNLDLSSNSLSGTIPAQICTWLPYLVTLDLSNNDFSGPIPPD 135
Query: 138 IVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGN 197
+ C +LN LILSNN+LSGSIP S L RLK+FSVA NDL+G +P + FDGN
Sbjct: 136 LANCIYLNNLILSNNRLSGSIPLGFSALGRLKKFSVANNDLTGPVPSSFNNYDSADFDGN 195
Query: 198 SGLCGKPLGKCGGLSGKNLGIIIAAGVLGALGSIILGFLIWWWFFVRVSKKKRGYGADSG 257
GLCG+PL KCGGLS KNL IIIAAGV GA S++LGF +WWW+ + S +++G G D G
Sbjct: 196 KGLCGRPLSKCGGLSKKNLAIIIAAGVFGAASSLLLGFGVWWWYQSKHSGRRKG-GYDFG 254
Query: 258 K-DDSSWIQVLRSHKLVQVSLFQKPIVKVKLADLLAATNSFAVENIIISTRTGVSYKAVL 316
+ DD++W Q LRSHKLVQVSLFQKP+VKVKL DL+AATN+F+ E+IIISTR+G +YKAVL
Sbjct: 255 RGDDTNWAQRLRSHKLVQVSLFQKPLVKVKLGDLMAATNNFSPESIIISTRSGTTYKAVL 314
Query: 317 PDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGT 376
PD SALAIKRLS CKL EKQF+ EMNRLGQ+RHPNL PLLGFCV EE+LLVYKHM NGT
Sbjct: 315 PDGSALAIKRLSTCKLGEKQFQLEMNRLGQVRHPNLAPLLGFCVAGEEKLLVYKHMSNGT 374
Query: 377 LYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD 436
LYSLLHG G LDW TR RIG GA+RGLAWLHHG QPP++HQ I SN IL+D+D
Sbjct: 375 LYSLLHGTG------NALDWPTRFRIGFGAARGLAWLHHGYQPPFLHQNICSNAILVDED 428
Query: 437 FDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLE 496
FDARI DFGLAR++ S D N+SS+V+GDLGE GYVAPEYSSTMVASLKGDVYGFG+VLLE
Sbjct: 429 FDARIMDFGLARMMTSSDSNESSYVNGDLGEIGYVAPEYSSTMVASLKGDVYGFGVVLLE 488
Query: 497 LLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACS 556
L++GQKPLD++ AEEGFKGNLVDWVN+L +GRS+D V+K++ G+G+D+EI QFL++AC
Sbjct: 489 LVTGQKPLDISTAEEGFKGNLVDWVNNLSSSGRSKDAVEKAICGKGHDEEISQFLKIACK 548
Query: 557 CVVSRPKDRPSMYQVYESLKSMAEKHG--FSEPYDEFPMIFGKQDPD 601
CV++RPKDR SMY+ Y+SLK +A +HG SE DEFP+IFGKQ D
Sbjct: 549 CVIARPKDRWSMYEAYQSLKIIANEHGLTLSEQDDEFPLIFGKQGHD 595
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449461899|ref|XP_004148679.1| PREDICTED: probable inactive receptor kinase At1g27190-like [Cucumis sativus] gi|449522849|ref|XP_004168438.1| PREDICTED: probable inactive receptor kinase At1g27190-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 778 bits (2008), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/588 (63%), Positives = 465/588 (79%), Gaps = 14/588 (2%)
Query: 18 LTVSIEDDVKCLEGIQNSIKDPDGRLS-WSFTNTTVGAIC-RLTGVACWNEKENRIISLT 75
+V EDD++CL G++N++ DP GRLS W F NT+VG +C + G++CWN++ENRI+SL
Sbjct: 25 FSVVPEDDIRCLRGVKNALVDPIGRLSSWDFKNTSVGHLCDKFVGLSCWNDRENRILSLE 84
Query: 76 LSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIP 135
L M+LSG + E L C SLQ LDLS NS SG IP +C+WLPY+V +DLSNN +G IP
Sbjct: 85 LKDMKLSGSISEDLQYCVSLQKLDLSGNSFSGEIPPHICEWLPYLVSMDLSNNQFTGSIP 144
Query: 136 PQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEESFD 195
+ C +LN LILS+N+LSG+IP E++ L RL +FSVA N L+GTIP +F +E FD
Sbjct: 145 ADLARCSYLNSLILSDNELSGTIPVELTSLGRLNKFSVANNQLTGTIPSFFDKFGKEDFD 204
Query: 196 GNSGLCGKPLGK-CGGLSGKNLGIIIAAGVLGALGSIILGFLIWWWFFVRVS-KKKRGYG 253
GNS LCG P+G CGGLS KNL IIIAAGV GA S++LGF +WWW+ R++ K++RGYG
Sbjct: 205 GNSDLCGGPVGSSCGGLSKKNLAIIIAAGVFGAAASLLLGFGLWWWYHSRMNMKRRRGYG 264
Query: 254 ADSGKDDSSWIQVLRSHKLVQVSLFQKPIVKVKLADLLAATNSFAVENIIISTRTGVSYK 313
D W LR++KLVQVSLFQKP+VKV+LADL+AATN+F ENII+S+RTG +Y+
Sbjct: 265 DGISGD---WADRLRAYKLVQVSLFQKPLVKVRLADLMAATNNFNSENIIVSSRTGTTYR 321
Query: 314 AVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373
AVLPD S LAIKRL+ CKL EK FR EMNRLG +RHPNL PLLGFCVVEEE+LLVYK+M
Sbjct: 322 AVLPDGSVLAIKRLNTCKLGEKLFRMEMNRLGSIRHPNLTPLLGFCVVEEEKLLVYKYMS 381
Query: 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI 433
NGTL SLLHGN +LDW+TR RIG+GA+RGLAWLHHGCQPP+MHQ I S+VIL+
Sbjct: 382 NGTLSSLLHGN------DEILDWATRFRIGLGAARGLAWLHHGCQPPFMHQNICSSVILV 435
Query: 434 DDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIV 493
D+D+DARI DFGLARL+ S D DSSFV+GDLGE GYVAPEY STMVASLKGDVYGFG+V
Sbjct: 436 DEDYDARIMDFGLARLMAS-DSQDSSFVNGDLGELGYVAPEYPSTMVASLKGDVYGFGVV 494
Query: 494 LLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRV 553
LLEL++GQKPL+V AEEG+KGNLVDWVN L +GR +DV+D+ L G+GND+EI+QFL++
Sbjct: 495 LLELITGQKPLEVTKAEEGYKGNLVDWVNQLSTSGRIKDVIDRDLCGKGNDEEILQFLKI 554
Query: 554 ACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEPYDEFPMIFGKQDPD 601
+C+VSRPKDR SMYQVY+S+++MA+ + F EP DEFP++ GK D D
Sbjct: 555 TMNCIVSRPKDRWSMYQVYQSMRTMAKDYSFPEPDDEFPLLLGKGDND 602
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 604 | ||||||
| TAIR|locus:2205834 | 601 | AT1G27190 [Arabidopsis thalian | 0.953 | 0.958 | 0.648 | 4.7e-206 | |
| TAIR|locus:2020558 | 591 | AT1G69990 [Arabidopsis thalian | 0.935 | 0.956 | 0.589 | 1.6e-182 | |
| TAIR|locus:2088937 | 605 | AT3G28450 [Arabidopsis thalian | 0.935 | 0.933 | 0.547 | 3.4e-164 | |
| TAIR|locus:2165981 | 620 | BIR1 "AT5G48380" [Arabidopsis | 0.925 | 0.901 | 0.394 | 1.1e-108 | |
| TAIR|locus:2051628 | 1008 | PSKR1 "phytosulfokin receptor | 0.728 | 0.436 | 0.354 | 1.3e-73 | |
| TAIR|locus:2020457 | 1166 | BRL1 "BRI1 like" [Arabidopsis | 0.622 | 0.322 | 0.383 | 1.7e-69 | |
| UNIPROTKB|Q942F3 | 1121 | P0480C01.18-1 "cDNA clone:J033 | 0.513 | 0.276 | 0.403 | 7.7e-66 | |
| TAIR|locus:2092810 | 1164 | BRL3 "BRI1-like 3" [Arabidopsi | 0.769 | 0.399 | 0.338 | 2.6e-65 | |
| TAIR|locus:2207056 | 1095 | PSY1R "PSY1 receptor" [Arabido | 0.509 | 0.281 | 0.390 | 4.9e-65 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.490 | 0.228 | 0.387 | 1.2e-63 |
| TAIR|locus:2205834 AT1G27190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1993 (706.6 bits), Expect = 4.7e-206, P = 4.7e-206
Identities = 377/581 (64%), Positives = 451/581 (77%)
Query: 21 SIEDDVKCLEGIQNSIKDPDGRLS-WSFTNTTVGAICRLTGVACWNEKENRIISLTLSSM 79
S EDDV CL+G++NS+ DP RLS WSF N++ +IC+LTGV+CWNEKENRIISL L SM
Sbjct: 23 SAEDDVLCLQGLKNSLIDPSSRLSSWSFPNSSASSICKLTGVSCWNEKENRIISLQLQSM 82
Query: 80 QLSGQLPESLHLCHXXXXXXXXXXXXXXXIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIV 139
QL+G++PESL LC IP +C WLPY+V LDLS N L G IP QIV
Sbjct: 83 QLAGEIPESLKLCRSLQSLDLSGNDLSGSIPSQICSWLPYLVTLDLSGNKLGGSIPTQIV 142
Query: 140 ECXXXXXXXXXXXXXXXXIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGNXX 199
EC IP ++SRLDRL+ S+AGNDLSGTIP +LARF + F GN
Sbjct: 143 ECKFLNALILSDNKLSGSIPSQLSRLDRLRRLSLAGNDLSGTIPSELARFGGDDFSGNNG 202
Query: 200 XXXXXXXXXXXXXXXNLGIIIAAGVLGALGSIILGFLIWWWFFVRV-SKKKRGYGADSGK 258
NL III AGVLGA+GS+ +G +I+WWFF+R S+KK+GYGA K
Sbjct: 203 LCGKPLSRCGALNGRNLSIIIVAGVLGAVGSLCVGLVIFWWFFIREGSRKKKGYGAGKSK 262
Query: 259 DDSSWIQVLRSHKLVQVSLFQKPIVKVKLADLLAATNSFAVENIIISTRTGVSYKAVLPD 318
DDS WI +LRSHKLVQV+LFQKPIVK+KL DL+AATN+F+ NI +S+RTGVSYKA LPD
Sbjct: 263 DDSDWIGLLRSHKLVQVTLFQKPIVKIKLGDLMAATNNFSSGNIDVSSRTGVSYKADLPD 322
Query: 319 ASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378
SALA+KRLSAC EKQFRSEMN+LG+LRHPNLVPLLG+CVVE+ERLLVYKHM NGTL+
Sbjct: 323 GSALAVKRLSACGFGEKQFRSEMNKLGELRHPNLVPLLGYCVVEDERLLVYKHMVNGTLF 382
Query: 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD 438
S LH G+ VLDW TR IG+GA++GLAWLHHGCQPPY+HQ+ISSNVIL+DDDFD
Sbjct: 383 SQLHNGGL---CDAVLDWPTRRAIGVGAAKGLAWLHHGCQPPYLHQFISSNVILLDDDFD 439
Query: 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELL 498
ARITD+GLA+LVGSRD NDSSF +GDLGE GYVAPEYSSTMVASLKGDVYGFGIVLLEL+
Sbjct: 440 ARITDYGLAKLVGSRDSNDSSFNNGDLGELGYVAPEYSSTMVASLKGDVYGFGIVLLELV 499
Query: 499 SGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCV 558
+GQKPL V EGFKG+LVDWV+ + GRS+D +D+S+ +G+D+EI+QFL++ACSCV
Sbjct: 500 TGQKPLSVINGVEGFKGSLVDWVSQYLGTGRSKDAIDRSICDKGHDEEILQFLKIACSCV 559
Query: 559 VSRPKDRPSMYQVYESLKSMAEKHGFSEPYDEFPMIFGKQD 599
VSRPK+RP+M QVYESLK+MA+KHG SE YDEFP++F KQ+
Sbjct: 560 VSRPKERPTMIQVYESLKNMADKHGVSEHYDEFPLVFNKQE 600
|
|
| TAIR|locus:2020558 AT1G69990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1771 (628.5 bits), Expect = 1.6e-182, P = 1.6e-182
Identities = 343/582 (58%), Positives = 429/582 (73%)
Query: 23 EDDVKCLEGIQNSIKDPDGRLS-WSFTNTTVGAICRLTGVACWNEKENRIISLTLSSMQL 81
EDDV CL+G ++S+KDP +L+ WSF N++ +IC+LTGV+CWN KENRI+SL L SMQL
Sbjct: 19 EDDVLCLKGFKSSLKDPSNQLNTWSFPNSS-SSICKLTGVSCWNAKENRILSLQLQSMQL 77
Query: 82 SGQLPESLHLCHXXXXXXXXXXXXXXXIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVEC 141
SGQ+PESL LC IP +C WLPY+V LDLS N LSG IP QIV+C
Sbjct: 78 SGQIPESLKLCRSLQSLDLSFNDFSGLIPSQICSWLPYLVTLDLSGNKLSGSIPSQIVDC 137
Query: 142 XXXXXXXXXXXXXXXXIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGNXXXX 201
IP E++RL+RL+ S+A NDLSG+IP +L+ + E+ F GN
Sbjct: 138 KFLNSLALNQNKLTGSIPSELTRLNRLQRLSLADNDLSGSIPSELSHYGEDGFRGNGGLC 197
Query: 202 XXXXXXXXXXXXXNLGIIIAAGVLGALGSIILGFLIWWWFFVRVSKKKR--GYGADSGKD 259
NL II+ AGV+GA+GS+ +GF ++WWFF+R +K GYGA KD
Sbjct: 198 GKPLSNCGSFNGKNLTIIVTAGVIGAVGSLCVGFGMFWWFFIRDRRKMNNYGYGAGKCKD 257
Query: 260 DSSWIQVLRSHKLVQVSLFQKPIVKVKLADLLAATNSFAVENIIISTRTGVSYKAVLPDA 319
DS WI +LRSHKLVQV+LFQKPIVK+KL DL+ ATN F NI++S+R+GVSYKA LPD
Sbjct: 258 DSDWIGLLRSHKLVQVTLFQKPIVKIKLVDLIEATNGFDSGNIVVSSRSGVSYKADLPDG 317
Query: 320 SALAIKRLSAC-KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378
S L +KRLS+C +LSEKQFRSE+N+LGQ+RHPNLVPLLGFCVVE+E LLVYKHM NGTLY
Sbjct: 318 STLEVKRLSSCCELSEKQFRSEINKLGQIRHPNLVPLLGFCVVEDEILLVYKHMANGTLY 377
Query: 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD 438
S L +DW TR+R+ +GA+RGLAWLHHGCQP YMHQYISSNVIL+D+DFD
Sbjct: 378 SQLQ--------QWDIDWPTRVRVAVGAARGLAWLHHGCQPLYMHQYISSNVILLDEDFD 429
Query: 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELL 498
AR+ D+GL +LV S+D DSSF +G +FGYVAPEYSSTMVASL GDVYGFGIVLLE++
Sbjct: 430 ARVIDYGLGKLVSSQDSKDSSFSNG---KFGYVAPEYSSTMVASLSGDVYGFGIVLLEIV 486
Query: 499 SGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCV 558
+GQKP+ + EEGFK +LV+WV+ + GRS+D +D+ ++G+G DDEIMQ LR+ACSCV
Sbjct: 487 TGQKPVLINNGEEGFKESLVEWVSKHLSNGRSKDAIDRRIFGKGYDDEIMQVLRIACSCV 546
Query: 559 VSRPKDRPSMYQVYESLKSMAEKHGFSEPY-DEFPMIFGKQD 599
VSRPK+RP M QVYESLK++ ++HGF Y DEFP+IF KQ+
Sbjct: 547 VSRPKERPLMIQVYESLKNLGDQHGFFSEYSDEFPLIFNKQE 588
|
|
| TAIR|locus:2088937 AT3G28450 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1598 (567.6 bits), Expect = 3.4e-164, P = 3.4e-164
Identities = 319/583 (54%), Positives = 403/583 (69%)
Query: 23 EDDVKCLEGIQNSIKDPDGRL-SWSFTNTTVGAICRLTGVACWNEKENRIISLTLSSMQL 81
EDD++CL G++ S+ DP L SW+F NTT+G +C GV+CWN +ENR+I+L L M L
Sbjct: 31 EDDIRCLRGLKASLTDPQNALKSWNFDNTTLGFLCNFVGVSCWNNQENRVINLELRDMGL 90
Query: 82 SGQLPESLHLCHXXXXXXXXXXXXXXXIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVEC 141
SG++P+SL C IP +LC WLP++V LDLSNN L+G IPP + +C
Sbjct: 91 SGKIPDSLQYCASLQKLDLSSNRLSGNIPTELCNWLPFLVSLDLSNNELNGEIPPDLAKC 150
Query: 142 XXXXXXXXXXXXXXXXIPFEVSRLDRLKEFSVAGNDLSGTIPPDLAR--FPEESFDGNXX 199
IP + S L RL FSVA NDLSG IP + + + F GN
Sbjct: 151 SFVNSLVLSDNRLSGQIPVQFSALGRLGRFSVANNDLSGRIPVFFSSPSYSSDDFSGNKG 210
Query: 200 XXXXXXXXX-XXXXXXNLGIIIAAGVLGALGSIILGFLIWWWFFVRVSKKKRGYGADSGK 258
NLGIIIAAGV GA S++L F IWW++ ++ ++++R + G
Sbjct: 211 LCGRPLSSSCGGLSKKNLGIIIAAGVFGAAASMLLAFGIWWYYHLKWTRRRRSGLTEVGV 270
Query: 259 DDSSWIQVLRSHKLVQVSLFQKPIVKVKLADLLAATNSFAVENIIISTRTGVSYKAVLPD 318
S Q LRSHKL QVSLFQKP+VKVKL DL+AATN+F ENII+STRTG +YKA+LPD
Sbjct: 271 --SGLAQRLRSHKLTQVSLFQKPLVKVKLGDLMAATNNFNSENIIVSTRTGTTYKALLPD 328
Query: 319 ASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378
SALA+K LS CKL E++FR EMN+L +LRH NL PLLGFCVVEEE+ LVYK+M NGTL+
Sbjct: 329 GSALAVKHLSTCKLGEREFRYEMNQLWELRHSNLAPLLGFCVVEEEKFLVYKYMSNGTLH 388
Query: 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD 438
SLL N G LDWSTR RIG+GA+RGLAWLHHGC+PP +HQ I S+VILID+DFD
Sbjct: 389 SLLDSN------RGELDWSTRFRIGLGAARGLAWLHHGCRPPILHQNICSSVILIDEDFD 442
Query: 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELL 498
ARI D GLARL+ D N+SSF+ GDLGEFGYVAPEYS+TM+ASLKGDVYG G+VLLEL
Sbjct: 443 ARIIDSGLARLMVPSDNNESSFMTGDLGEFGYVAPEYSTTMLASLKGDVYGLGVVLLELA 502
Query: 499 SGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCV 558
+G K V G EGFKG+LVDWV L +GR + D+++ G+G+D+EI +F+ +A +CV
Sbjct: 503 TGLKA--VGG--EGFKGSLVDWVKQLESSGRIAETFDENIRGKGHDEEISKFVEIALNCV 558
Query: 559 VSRPKDRPSMYQVYESLKSMAEKHG--FSEPYDEFPMIFGKQD 599
SRPK+R SM+Q Y+SLK++AEK G FSE D+FP+IF Q+
Sbjct: 559 SSRPKERWSMFQAYQSLKAIAEKQGYSFSEQDDDFPLIFDTQE 601
|
|
| TAIR|locus:2165981 BIR1 "AT5G48380" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1074 (383.1 bits), Expect = 1.1e-108, P = 1.1e-108
Identities = 227/576 (39%), Positives = 335/576 (58%)
Query: 25 DVKCLEGIQNSIKDPDGRLS-WSFTNTTVGAICRLTGVACWNEKENRIISLTLSSMQLSG 83
++ CL ++ ++DP+ LS W F N T G IC+ +GV CW++ ENR++S+ LS L G
Sbjct: 31 NIDCLRTFKSQVEDPNRYLSTWVFGNETAGYICKFSGVTCWHDDENRVLSIKLSGYGLRG 90
Query: 84 QLPESLHLCHXXXXXXXXXXXXXXXIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECXX 143
P ++ LC +P ++ +P V LDLS N SG IP I
Sbjct: 91 VFPPAVKLCADLTGLDLSRNNFSGPLPANISTLIPLVTILDLSYNSFSGEIPMLISNITF 150
Query: 144 XXXXXXXXXXXXXXIPFEVSRLDRLKEFSVAGNDLSGTIPP--DLARFPEESFDGNXXXX 201
+P ++++L RLK FSV+ N L G IP +F +E F N
Sbjct: 151 LNTLMLQHNQFTGTLPPQLAQLGRLKTFSVSDNRLVGPIPNFNQTLQFKQELFANNLDLC 210
Query: 202 XXXXXXXXXXXXXNLGIIIAAGVLG-ALGSIILGFLIWWWFFVRVSKKKRGYGADSGKDD 260
++I A V G ++++G +++++F + +K+ +
Sbjct: 211 GKPLDDCKSASSSRGKVVIIAAVGGLTAAALVVGVVLFFYFRKLGAVRKK----QDDPEG 266
Query: 261 SSWIQVLRSHKLVQVSLFQKPIVKVKLADLLAATNSFAVENIIISTRTGVSYKAVLPDAS 320
+ W + L+ K V+V +F+K + K+KL+DL+ AT F +NII + RTG YK L D S
Sbjct: 267 NRWAKSLKGQKGVKVFMFKKSVSKMKLSDLMKATEEFKKDNIIATGRTGTMYKGRLEDGS 326
Query: 321 ALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
L IKRL + SEK+F +EM LG +++ NLVPLLG+CV +ERLL+Y++M NG LY
Sbjct: 327 LLMIKRLQDSQRSEKEFDAEMKTLGSVKNRNLVPLLGYCVANKERLLMYEYMANGYLYDQ 386
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDAR 440
LH D LDW +RL+I +G ++GLAWLHH C P +H+ ISS IL+ +F+ +
Sbjct: 387 LHP--ADEESFKPLDWPSRLKIAIGTAKGLAWLHHSCNPRIIHRNISSKCILLTAEFEPK 444
Query: 441 ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSG 500
I+DFGLARL+ D + S+FV+G+ G+FGYVAPEYS TMVA+ KGDVY FG+VLLEL++G
Sbjct: 445 ISDFGLARLMNPIDTHLSTFVNGEFGDFGYVAPEYSRTMVATPKGDVYSFGVVLLELVTG 504
Query: 501 QKPLDVA------GAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVA 554
QK V EE FKGNLV+W+ L + ++ +D+SL G G DDEI + L+VA
Sbjct: 505 QKATSVTKVSEEKAEEENFKGNLVEWITKLSSESKLQEAIDRSLLGNGVDDEIFKVLKVA 564
Query: 555 CSCVVSR-PKDRPSMYQVYESLKSMAEKHGFSEPYD 589
C+CV+ K RP+M++VY+ L+++ E + F+ D
Sbjct: 565 CNCVLPEIAKQRPTMFEVYQLLRAIGESYNFTADDD 600
|
|
| TAIR|locus:2051628 PSKR1 "phytosulfokin receptor 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 657 (236.3 bits), Expect = 1.3e-73, Sum P(2) = 1.3e-73
Identities = 162/457 (35%), Positives = 237/457 (51%)
Query: 124 DLSNNHLSGPIPPQIVECXXXXXXXXXXXXXXXXIPFEVSRLDRLKEFSVAGNDLSGTIP 183
DL N LSG IP + IP + +L L +FSVA N+LSG IP
Sbjct: 553 DLKWNALSGSIPSSLSGMTSLEALDLSNNRLSGSIPVSLQQLSFLSKFSVAYNNLSGVIP 612
Query: 184 P--DLARFPEESFDGNXXXXXXXX--XXXXXXXXXNLGIIIAAGVLGALGSIILG--FLI 237
FP SF+ N G +G I G FL+
Sbjct: 613 SGGQFQTFPNSSFESNHLCGEHRFPCSEGTESALIKRSRRSRGGDIGMAIGIAFGSVFLL 672
Query: 238 WWWFFVRVSKKKRGYGADSGKDDSSWIQVLRSHKLVQ--VSLFQKPIVKVKLADLLAATN 295
+ + ++R D ++S + ++ V LFQ ++ DLL +TN
Sbjct: 673 TLLSLIVLRARRRSGEVDPEIEESESMNRKELGEIGSKLVVLFQSNDKELSYDDLLDSTN 732
Query: 296 SFAVENIIISTRTGVSYKAVLPDASALAIKRLSA-CKLSEKQFRSEMNRLGQLRHPNLVP 354
SF NII G+ YKA LPD +AIK+LS C E++F +E+ L + +HPNLV
Sbjct: 733 SFDQANIIGCGGFGMVYKATLPDGKKVAIKKLSGDCGQIEREFEAEVETLSRAQHPNLVL 792
Query: 355 LLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH 414
L GFC + +RLL+Y +M NG+L LH N +L W TRLRI GA++GL +LH
Sbjct: 793 LRGFCFYKNDRLLIYSYMENGSLDYWLHER---NDGPALLKWKTRLRIAQGAAKGLLYLH 849
Query: 415 HGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE 474
GC P +H+ I S+ IL+D++F++ + DFGLARL+ + + S+ + G LG Y+ PE
Sbjct: 850 EGCDPHILHRDIKSSNILLDENFNSHLADFGLARLMSPYETHVSTDLVGTLG---YIPPE 906
Query: 475 YSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534
Y VA+ KGDVY FG+VLLELL+ ++P+D+ +G + +L+ WV + R+ +V
Sbjct: 907 YGQASVATYKGDVYSFGVVLLELLTDKRPVDMC-KPKGCR-DLISWVVKMKHESRASEVF 964
Query: 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQV 571
D +Y + ND E+ + L +AC C+ PK RP+ Q+
Sbjct: 965 DPLIYSKENDKEMFRVLEIACLCLSENPKQRPTTQQL 1001
|
|
| TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 631 (227.2 bits), Expect = 1.7e-69, Sum P(2) = 1.7e-69
Identities = 152/396 (38%), Positives = 227/396 (57%)
Query: 220 IAAGVLGALGSIILGF--LIWWWFFVR-VSKK--KRGYGADS--GKDDSSW-IQVLRSHK 271
+A V+ + + F L+ + VR V KK KR +S SW + +
Sbjct: 774 VATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIESLPTSGSCSWKLSSVPEPL 833
Query: 272 LVQVSLFQKPIVKVKLADLLAATNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACK 331
+ V+ F+KP+ K+ A LL ATN F+ E ++ S G YKA L D S +AIK+L
Sbjct: 834 SINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRIT 893
Query: 332 -LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTL 390
+++F +EM +G+++H NLVPLLG+C V EERLLVY++M G+L ++LH +
Sbjct: 894 GQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKS--SKK 951
Query: 391 SGV-LDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449
G+ L+W+ R +I +GA+RGLA+LHH C P +H+ + S+ +L+D+DF+AR++DFG+ARL
Sbjct: 952 GGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARL 1011
Query: 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGA 509
V + D + S V G GYV PEY + + KGDVY +G++LLELLSG+KP+D
Sbjct: 1012 VSALDTHLS--VSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPG-- 1067
Query: 510 EEGFKGNLVDWVNHLVIAGRSRDVVDKSLY-GRGNDDEIMQFLRVACSCVVSRPKDRPSM 568
E G NLV W L R +++D L + D E+ +L++A C+ RP RP+M
Sbjct: 1068 EFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQCLDDRPFKRPTM 1127
Query: 569 YQVYESLKSMAEKHGFSEPYDEFPMIFGKQDPDCKE 604
Q+ K M E DEF + K+ P +E
Sbjct: 1128 IQLMAMFKEMKADTEEDESLDEFSL---KETPLVEE 1160
|
|
| UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 571 (206.1 bits), Expect = 7.7e-66, Sum P(3) = 7.7e-66
Identities = 131/325 (40%), Positives = 192/325 (59%)
Query: 260 DSSWIQVLRSHKLVQVSL--FQKPIVKVKLADLLAATNSFAVENIIISTRTGVSYKAVLP 317
+S W Q L L+ ++L F+KP+ + LADL+ ATN F + I S G YKA L
Sbjct: 768 NSDWRQNLSGTNLLSINLAAFEKPLQNLTLADLVEATNGFHIACQIGSGGFGDVYKAQLK 827
Query: 318 DASALAIKRL-SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGT 376
D +AIK+L +++F +EM +G+++H NLVPLLG+C EERLLVY +M G+
Sbjct: 828 DGKVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKAGEERLLVYDYMKFGS 887
Query: 377 LYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD 436
L +LH + L+W R +I +GA+RGLA+LHH C P +H+ + S+ +LID+
Sbjct: 888 LEDVLHDR---KKIGKKLNWEARRKIAVGAARGLAFLHHNCIPHIIHRDMKSSNVLIDEQ 944
Query: 437 FDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLE 496
+AR++DFG+ARL+ D + S V G GYV PEY + + KGDVY +G+VLLE
Sbjct: 945 LEARVSDFGMARLMSVVDTHLS--VSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVVLLE 1002
Query: 497 LLSGQKPLDVAGAEEGFKGNLVDWVN-HLVIAGRSRDVVDKSLYGRGN--DDEIMQFLRV 553
LL+G+ P D A+ G NLV WV H + + DV D L + E+++ L++
Sbjct: 1003 LLTGKPPTD--SADFGEDNNLVGWVKQHTKL--KITDVFDPELLKEDPSVELELLEHLKI 1058
Query: 554 ACSCVVSRPKDRPSMYQVYESLKSM 578
AC+C+ RP RP+M +V K +
Sbjct: 1059 ACACLDDRPSRRPTMLKVMAMFKEI 1083
|
|
| TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 663 (238.4 bits), Expect = 2.6e-65, Sum P(2) = 2.6e-65
Identities = 167/493 (33%), Positives = 260/493 (52%)
Query: 119 YVVQLDLSNNHLSGPIPPQIVECXXXXXXXXXXXXXXXXIPFEVSRLDRLKEFSVAGNDL 178
Y+ L+L +N L+G IP +P + L L + V+ N+L
Sbjct: 664 YLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFLPGSLGGLSFLSDLDVSNNNL 723
Query: 179 SGTIP--PDLARFPEESFDGNX----------XXXXXXXXXXXXXXXXNLGIIIAAGVLG 226
+G IP L FP + N ++ ++AG++
Sbjct: 724 TGPIPFGGQLTTFPLTRYANNSGLCGVPLPPCSSGSRPTRSHAHPKKQSIATGMSAGIVF 783
Query: 227 ALGSIILGFL-IWWWFFVRVSKKKRGYGADS--GKDDSSW-IQVLRSHKLVQVSLFQKPI 282
+ I++ + ++ V+ +K+R +S SSW + + + V+ F+KP+
Sbjct: 784 SFMCIVMLIMALYRARKVQKKEKQREKYIESLPTSGSSSWKLSSVHEPLSINVATFEKPL 843
Query: 283 VKVKLADLLAATNSFAVENIIISTRTGVSYKAVLPDASALAIKRL-SACKLSEKQFRSEM 341
K+ A LL ATN F+ +++I S G YKA L D S +AIK+L +++F +EM
Sbjct: 844 RKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTGQGDREFMAEM 903
Query: 342 NRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSG--VLDWSTR 399
+G+++H NLVPLLG+C + EERLLVY++M G+L ++LH + T G LDWS R
Sbjct: 904 ETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLH----EKTKKGGIFLDWSAR 959
Query: 400 LRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSS 459
+I +GA+RGLA+LHH C P +H+ + S+ +L+D DF AR++DFG+ARLV + D + S
Sbjct: 960 KKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSALDTHLS- 1018
Query: 460 FVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVD 519
V G GYV PEY + + KGDVY +G++LLELLSG+KP+D E G NLV
Sbjct: 1019 -VSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPE--EFGEDNNLVG 1075
Query: 520 WVNHLVIAGRSRDVVDKSLY-GRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
W L R +++D L + D E++ +L++A C+ RP RP+M QV K +
Sbjct: 1076 WAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRPFKRPTMIQVMTMFKEL 1135
Query: 579 AEKHGFSEPYDEF 591
+ ++ DEF
Sbjct: 1136 VQVDTENDSLDEF 1148
|
|
| TAIR|locus:2207056 PSY1R "PSY1 receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 537 (194.1 bits), Expect = 4.9e-65, Sum P(3) = 4.9e-65
Identities = 126/323 (39%), Positives = 191/323 (59%)
Query: 275 VSLFQKPIVKVK---LADLLAATNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSA-C 330
V LF +VK + +LL AT++F+ NII G+ YKA L + + LA+K+L+
Sbjct: 778 VLLFGNSRYEVKDLTIFELLKATDNFSQANIIGCGGFGLVYKATLDNGTKLAVKKLTGDY 837
Query: 331 KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTL 390
+ EK+F++E+ L + +H NLV L G+CV + R+L+Y M NG+L LH N
Sbjct: 838 GMMEKEFKAEVEVLSRAKHENLVALQGYCVHDSARILIYSFMENGSLDYWLHENPEG--- 894
Query: 391 SGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450
LDW RL I GAS GLA++H C+P +H+ I S+ IL+D +F A + DFGL+RL+
Sbjct: 895 PAQLDWPKRLNIMRGASSGLAYMHQICEPHIVHRDIKSSNILLDGNFKAYVADFGLSRLI 954
Query: 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAE 510
P + +G GY+ PEY VA+L+GDVY FG+V+LELL+G++P++V +
Sbjct: 955 L---PYRTHVTTELVGTLGYIPPEYGQAWVATLRGDVYSFGVVMLELLTGKRPMEVFRPK 1011
Query: 511 EGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQ 570
LV WV+ + G+ +V D L GN++ +++ L +AC CV P RP++ Q
Sbjct: 1012 --MSRELVAWVHTMKRDGKPEEVFDTLLRESGNEEAMLRVLDIACMCVNQNPMKRPNIQQ 1069
Query: 571 VYESLKSM-AEKH--GFSEPYDE 590
V + LK++ AEK+ EP +E
Sbjct: 1070 VVDWLKNIEAEKNQNNREEPEEE 1092
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 562 (202.9 bits), Expect = 1.2e-63, Sum P(2) = 1.2e-63
Identities = 119/307 (38%), Positives = 189/307 (61%)
Query: 273 VQVSLFQKPIVKVKLADLLAATNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKL 332
+ ++ F+ +++V D+L AT +F+ +II G YKA LP+ +AIKRL
Sbjct: 978 INLATFEHALLRVTADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQ 1037
Query: 333 --SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTL 390
+++F +EM +G+++HPNLVPLLG+CV +ER L+Y++M NG+L L N D L
Sbjct: 1038 FQGDREFLAEMETIGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLR-NRAD-AL 1095
Query: 391 SGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450
L W RL+I +G++RGLA+LHHG P +H+ + S+ IL+D++F+ R++DFGLAR++
Sbjct: 1096 EA-LGWPDRLKICLGSARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARII 1154
Query: 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAE 510
+ + + S+ + G FGY+ PEY TM ++ KGDVY FG+V+LELL+G+ P +
Sbjct: 1155 SACETHVSTDI---AGTFGYIPPEYGLTMKSTTKGDVYSFGVVMLELLTGRPPTGQEEVQ 1211
Query: 511 EGFKGNLVDWVNHLVIAGRSRDVVDKSL-YGRGNDDEIMQFLRVACSCVVSRPKDRPSMY 569
G GNLV WV ++ G+ ++ D L +++ + L +A C P RP+M
Sbjct: 1212 GG--GNLVGWVRWMIARGKQNELFDPCLPVSSVWREQMARVLAIARDCTADEPFKRPTML 1269
Query: 570 QVYESLK 576
+V + LK
Sbjct: 1270 EVVKGLK 1276
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O04567 | Y1719_ARATH | No assigned EC number | 0.7150 | 0.9503 | 0.9550 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00040740 | hypothetical protein (609 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 604 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-27 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-26 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-26 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-25 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-25 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-17 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-17 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-16 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-15 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-14 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-13 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-13 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-12 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-12 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-10 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-08 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-08 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-08 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-08 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-07 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-07 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-07 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-07 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-07 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-06 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-06 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-06 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-06 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-06 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-06 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-05 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-05 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-05 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-05 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-05 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-05 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-04 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-04 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-04 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-04 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-04 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-04 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-04 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-04 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-04 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-04 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-04 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-04 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-04 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-04 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 0.001 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 0.001 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.001 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 0.001 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 0.002 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 0.002 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 0.002 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 0.002 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 0.002 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 0.002 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 0.002 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 0.002 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 0.002 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 0.003 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.003 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 0.003 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.003 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.004 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 0.004 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 7e-46
Identities = 149/522 (28%), Positives = 238/522 (45%), Gaps = 59/522 (11%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDL--CKWLPYVVQLDLS 126
R+ +L LS Q SG +P L L L LS+N LSG IP +L CK L V LDLS
Sbjct: 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKL---VSLDLS 531
Query: 127 NNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
+N LSG IP E L++L LS N+LSG IP + ++ L + +++ N L G++P
Sbjct: 532 HNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTG 591
Query: 187 ARFP--EESFDGNSGLCG----KPLGKCGGLSGKNLGIIIAAGVLGALGSIIL-GFLIWW 239
A + GN LCG L C + LGA + L F +
Sbjct: 592 AFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVF 651
Query: 240 WFFVRVSKKKRGYGADSGKDDSSWIQVLRSHKLVQVSLFQKPIVK-VKLADLLAATNSFA 298
+ KR +D +W ++ F + K + + D+L++
Sbjct: 652 IRGRNNLELKR-----VENEDGTW----------ELQFFDSKVSKSITINDILSSLKE-- 694
Query: 299 VENIIISTRTGVSYKA-VLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLG 357
EN+I + G SYK + + +K ++ ++M G+L+HPN+V L+G
Sbjct: 695 -ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADM---GKLQHPNIVKLIG 750
Query: 358 FCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGC 417
C E+ L+++++ L +L L W R +I +G ++ L +LH C
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRN----------LSWERRRKIAIGIAKALRFLHCRC 800
Query: 418 QPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSS 477
P + +S I+ID + + L L+ + + F+ YVAPE
Sbjct: 801 SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DTKCFISS-----AYVAPETRE 851
Query: 478 TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKS 537
T + K D+YGFG++L+ELL+G+ P D AE G G++V+W + +D S
Sbjct: 852 TKDITEKSDIYGFGLILIELLTGKSPAD---AEFGVHGSIVEWARYCYSDCHLDMWIDPS 908
Query: 538 LYGRG--NDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577
+ G N +EI++ + +A C + P RP V ++L+S
Sbjct: 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 66/259 (25%), Positives = 110/259 (42%), Gaps = 39/259 (15%)
Query: 323 AIKRLSACKLSE--KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
A+K L + ++F E + +L HPN+V LLG C EE +V ++M G L S
Sbjct: 32 AVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSY 91
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDAR 440
L N L S L + +RG+ +L ++H+ +++ L+ ++ +
Sbjct: 92 LRKNR------PKLSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVK 142
Query: 441 ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS- 499
I+DFGL+R + D G L ++APE + K DV+ FG++L E+ +
Sbjct: 143 ISDFGLSRDLYDDDYYRKR--GGKL-PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTL 199
Query: 500 GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR---DVVDKSLYGRGNDDEIMQFLRVACS 556
G++P EE V + G LY ++M
Sbjct: 200 GEQPYPGMSNEE---------VLEYLKNGYRLPQPPNCPPELY------DLML------Q 238
Query: 557 CVVSRPKDRPSMYQVYESL 575
C P+DRP+ ++ E L
Sbjct: 239 CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 56/198 (28%), Positives = 83/198 (41%), Gaps = 26/198 (13%)
Query: 309 GVSYKAVLPDASA-LAIKRLSACKLSE--KQFRSEMNRLGQLRHPNLVPLLGFCVVEEER 365
G Y A +AIK + S ++ E+ L +L HPN+V L G E
Sbjct: 7 GTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHL 66
Query: 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQY 425
LV ++ G+L LL N G L LRI + GL +LH +
Sbjct: 67 YLVMEYCEGGSLKDLLKEN------EGKLSEDEILRILLQILEGLEYLHS-------NGI 113
Query: 426 I-----SSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE-YSSTM 479
I N++L D+ ++ DFGL++L+ S + V G Y+APE
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV----GTPAYMAPEVLLGKG 169
Query: 480 VASLKGDVYGFGIVLLEL 497
S K D++ G++L EL
Sbjct: 170 YYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 69/278 (24%), Positives = 114/278 (41%), Gaps = 43/278 (15%)
Query: 309 GVSYKAVLPDASAL-----AIKRLSACKLSE--KQFRSEMNRLGQLRHPNLVPLLGFCVV 361
G YK L A+K L + ++F E + +L HPN+V LLG C
Sbjct: 13 GEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTE 72
Query: 362 EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPY 421
EE ++V ++MP G L L N L S L + +RG+ +L +
Sbjct: 73 EEPLMIVMEYMPGGDLLDYLRKNRPK-----ELSLSDLLSFALQIARGMEYLESK---NF 124
Query: 422 MHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA 481
+H+ +++ L+ ++ +I+DFGL+R + D G L ++APE
Sbjct: 125 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK--GGKL-PIRWMAPESLKEGKF 181
Query: 482 SLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR---DVVDKS 537
+ K DV+ FG++L E+ + G++P E V + G
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE---------VLEYLKKGYRLPKPPNCPPE 232
Query: 538 LYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESL 575
LY ++M C P+DRP+ ++ E L
Sbjct: 233 LY------KLML------QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 68/265 (25%), Positives = 113/265 (42%), Gaps = 40/265 (15%)
Query: 323 AIKRLSACKLSE--KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
A+K L E K F E + +L HPN+V LLG C EE LV ++M G L
Sbjct: 27 AVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDY 86
Query: 381 L--HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD 438
L + L L + ++G+ +L ++H+ +++ L+ +D
Sbjct: 87 LRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLV 143
Query: 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEF--GYVAPEYSSTMVASLKGDVYGFGIVLLE 496
+I+DFGL+R V +D + G+ ++APE + + K DV+ FG++L E
Sbjct: 144 VKISDFGLSRDV----YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWE 199
Query: 497 LLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR----DVVDKSLYGRGNDDEIMQFL 551
+ + G P + G + V + G R + LY E+M
Sbjct: 200 IFTLGATP---------YPGLSNEEVLEYLRKG-YRLPKPEYCPDELY------ELML-- 241
Query: 552 RVACSCVVSRPKDRPSMYQVYESLK 576
SC P+DRP+ ++ E L+
Sbjct: 242 ----SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 66/262 (25%), Positives = 116/262 (44%), Gaps = 44/262 (16%)
Query: 323 AIKRLSACKLSEKQ--FRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
A+K L E++ F E + + +L HPN+V LLG C E +V ++MP G L
Sbjct: 32 AVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDF 91
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDAR 440
L +G L L++ + ++G+ +L ++H+ +++ L+ ++ +
Sbjct: 92 LRKHG------EKLTLKDLLQMALQIAKGMEYLE---SKNFVHRDLAARNCLVTENLVVK 142
Query: 441 ITDFGLARLVGSRDPNDSSFVHGDLGEF--GYVAPEYSSTMVASLKGDVYGFGIVLLELL 498
I+DFGL+R + D + G+ ++APE + K DV+ FG++L E+
Sbjct: 143 ISDFGLSRDI----YEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIF 198
Query: 499 S-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR----DVVDKSLYGRGNDDEIMQFLRV 553
+ G++P EE V L+ G R + LY E+M
Sbjct: 199 TLGEQPYPGMSNEE---------VLELLEDGY-RLPRPENCPDELY------ELML---- 238
Query: 554 ACSCVVSRPKDRPSMYQVYESL 575
C P+DRP+ ++ E L
Sbjct: 239 --QCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 66/272 (24%), Positives = 111/272 (40%), Gaps = 33/272 (12%)
Query: 309 GVSYKAVLPDASAL-AIKRLSACKLSEKQF---RSEMNRLGQLRHPNLVPLLGFCVVEEE 364
G YKA + A+K L K+ R E+ L +L HPN+V L+ ++
Sbjct: 13 GTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDH 72
Query: 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYMH 423
LV ++ G L+ L + G L +I + RGL +LH +G +H
Sbjct: 73 LYLVMEYCEGGDLFDYL-------SRGGPLSEDEAKKIALQILRGLEYLHSNGI----IH 121
Query: 424 QYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE-YSSTMVAS 482
+ + IL+D++ +I DFGLA+ + + ++FV G Y+APE
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV----GTPWYMAPEVLLGGNGYG 177
Query: 483 LKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRG 542
K DV+ G++L ELL+G+ P F G + L+ +
Sbjct: 178 PKVDVWSLGVILYELLTGKPP---------FSGENILDQLQLIRRILGPPLEFDEPKWSS 228
Query: 543 NDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574
+E + C+ P RP+ ++ +
Sbjct: 229 GSEEAKDLI---KKCLNKDPSKRPTAEEILQH 257
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 3e-20
Identities = 65/203 (32%), Positives = 97/203 (47%), Gaps = 34/203 (16%)
Query: 10 LLLLSYSLLTVSIEDDVKCLEGIQNSIKDPDGRLS-WSFTNTTVGAICRLTGVACWNEKE 68
L L++S+L ++++ L ++SI DP LS W+ + +C G+ C N
Sbjct: 18 FLFLNFSMLHA---EELELLLSFKSSINDPLKYLSNWNSSAD----VCLWQGITCNNSSR 70
Query: 69 NRIISLT----------------------LSSMQLSGQLPESL-HLCHSLQSLDLSDNSL 105
I L+ LS+ QLSG +P+ + SL+ L+LS+N+
Sbjct: 71 VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNF 130
Query: 106 SGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRL 165
+GSIP +P + LDLSNN LSG IP I L L L N L G IP ++ L
Sbjct: 131 TGSIPRG---SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL 187
Query: 166 DRLKEFSVAGNDLSGTIPPDLAR 188
L+ ++A N L G IP +L +
Sbjct: 188 TSLEFLTLASNQLVGQIPRELGQ 210
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-17
Identities = 45/122 (36%), Positives = 64/122 (52%), Gaps = 2/122 (1%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129
+ L L S L G++P+SL C SL+ + L DNS SG +P + K LP V LD+SNN+
Sbjct: 381 NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK-LPLVYFLDISNNN 439
Query: 130 LSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARF 189
L G I + + L L L+ NK G +P + RL+ ++ N SG +P L
Sbjct: 440 LQGRINSRKWDMPSLQMLSLARNKFFGGLP-DSFGSKRLENLDLSRNQFSGAVPRKLGSL 498
Query: 190 PE 191
E
Sbjct: 499 SE 500
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 3e-17
Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 33/193 (17%)
Query: 323 AIK--RLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
AIK + K ++ E+ L +L+HPN+V L E++ LV ++ G L+ L
Sbjct: 28 AIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDL 87
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQYI-SSNVILIDDDFD 438
L G + + ++ L +LH G +H+ + N IL+D+D
Sbjct: 88 LKKRGRL-SEDEARFYLRQI------LSALEYLHSKG----IVHRDLKPEN-ILLDEDGH 135
Query: 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE------YSSTMVASLKGDVYGFGI 492
++ DFGLAR + ++FV G Y+APE Y D++ G+
Sbjct: 136 VKLADFGLARQLDP-GEKLTTFV----GTPEYMAPEVLLGKGYGK------AVDIWSLGV 184
Query: 493 VLLELLSGQKPLD 505
+L ELL+G+ P
Sbjct: 185 ILYELLTGKPPFP 197
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 8e-17
Identities = 52/197 (26%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 309 GVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368
G ++ + + + +A+K L + K F +E + +LRHP L+ L C +EE +V
Sbjct: 20 GEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79
Query: 369 YKHMPNGTLYSLLHGNGVDN-TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYIS 427
+ M G+L L G L ++D + ++ GM A+L Y+H+ ++
Sbjct: 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGM------AYLE---AQNYIHRDLA 130
Query: 428 SNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDV 487
+ +L+ ++ ++ DFGLAR++ + G + APE + S+K DV
Sbjct: 131 ARNVLVGENNICKVADFGLARVIKE---DIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 488 YGFGIVLLELLS-GQKP 503
+ FGI+L E+++ G+ P
Sbjct: 188 WSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 5e-16
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 26/204 (12%)
Query: 308 TGVSYKA-VLPDASALAIKRLSACKLSEKQFRS----EMNRLGQLRHPNLVPLLGFCVVE 362
G YKA +AIK + KL K+ + E+ L + +HPN+V G + +
Sbjct: 13 FGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK 69
Query: 363 EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPY 421
+E +V + G+L LL + + L S + +GL +LH +G
Sbjct: 70 DELWIVMEFCSGGSLKDLL------KSTNQTLTESQIAYVCKELLKGLEYLHSNG----I 119
Query: 422 MHQYISSNVILIDDDFDARITDFGLA-RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMV 480
+H+ I + IL+ D + ++ DFGL+ +L ++ N + V G ++APE +
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN--TMV----GTPYWMAPEVINGKP 173
Query: 481 ASLKGDVYGFGIVLLELLSGQKPL 504
K D++ GI +EL G+ P
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPY 197
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-16
Identities = 70/268 (26%), Positives = 117/268 (43%), Gaps = 35/268 (13%)
Query: 303 IISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE 362
I S + G+ + + +AIK + +SE+ F E + +L HP LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 363 EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYM 422
LV++ M +G L L G T L + + G+A+L +
Sbjct: 72 SPICLVFEFMEHGCLSDYLR------AQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 423 HQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVAS 482
H+ +++ L+ ++ +++DFG+ R V D SS G + +PE S S
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSS--TGTKFPVKWSSPEVFSFSKYS 179
Query: 483 LKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVN--HLVIAGRSRDVVDKSLY 539
K DV+ FG+++ E+ S G+ P + E +V+ +N + R + +S+Y
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNSE-----VVETINAGFRLYKPR---LASQSVY 231
Query: 540 GRGNDDEIMQFLRVACSCVVSRPKDRPS 567
E+MQ C RP+DRPS
Sbjct: 232 ------ELMQH------CWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-16
Identities = 66/227 (29%), Positives = 97/227 (42%), Gaps = 41/227 (18%)
Query: 24 DDVKCLEGIQNSIKDPDGRLSWSFTNTTVGAICRLTGVACWNEKENR---IISLTLSSMQ 80
++V L+ +++S+ P R W+ + V +G C + I L L +
Sbjct: 372 EEVSALQTLKSSLGLPL-RFGWN-GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQG 429
Query: 81 LSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVE 140
L G +P + LQS++LS NS+ G+IP L G I
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL------------------GSITS---- 467
Query: 141 CKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL-------ARFPEES 193
L L LS N +GSIP + +L L+ ++ GN LSG +P L A F +
Sbjct: 468 ---LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF---N 521
Query: 194 FDGNSGLCGKP-LGKCGGLSGKNLGIIIAAGVLGALGSIILGFLIWW 239
F N+GLCG P L CG I IA GV A +++ + WW
Sbjct: 522 FTDNAGLCGIPGLRACGPHLSVGAKIGIAFGVSVAFLFLVICAMCWW 568
|
Length = 623 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 7e-16
Identities = 73/269 (27%), Positives = 132/269 (49%), Gaps = 53/269 (19%)
Query: 322 LAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL-LVYKHMPNGTLYSL 380
+AIK L +S + F +E N + QL+HP LV L + VV +E + ++ ++M NG+L
Sbjct: 33 VAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRL--YAVVTQEPIYIITEYMENGSLVDF 90
Query: 381 LHGN-GVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439
L G+ T++ ++D + ++ + G+A++ + Y+H+ + + IL+ +
Sbjct: 91 LKTPEGIKLTINKLIDMAAQI------AEGMAFIE---RKNYIHRDLRAANILVSETLCC 141
Query: 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS 499
+I DFGLARL+ + N+ + G + APE + ++K DV+ FGI+L E+++
Sbjct: 142 KIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 198
Query: 500 -GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR-------DVVDKSLYGRGNDDEIMQFL 551
G+ P + G N VI R D + LY E+M+
Sbjct: 199 YGRIP---------YPG----MTNPEVIQNLERGYRMPRPDNCPEELY------ELMR-- 237
Query: 552 RVACSCVVSRPKDRPSMYQVYESLKSMAE 580
C +P++RP+ +E L+S+ E
Sbjct: 238 ----LCWKEKPEERPT----FEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 9e-16
Identities = 59/210 (28%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 297 FAVENIIISTRTGVSYKAVLPDASALAIKRL-SACKLSEKQFRSEMNRLGQLRHPNLVPL 355
F +E + S G ++ + + +AIK L S L ++ F+ E+ L +LRH +L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 356 LGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSG-VLDWSTRLRIGMGASRGLAWLH 414
C V E ++ + M G+L + L + G VL ++ + + + G+A+L
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFL------RSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 415 HGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE 474
+ +H+ +++ IL+ +D ++ DFGLARL+ ++ S + + APE
Sbjct: 122 ---EQNSIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLS--SDKKIPYKWTAPE 174
Query: 475 YSSTMVASLKGDVYGFGIVLLELLS-GQKP 503
+S S K DV+ FGI+L E+ + GQ P
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 78.2 bits (191), Expect = 2e-15
Identities = 67/288 (23%), Positives = 105/288 (36%), Gaps = 22/288 (7%)
Query: 296 SFAVENIIISTRTGVSYKAVLPDASAL--AIKRLSACKLSEKQFRSEMNRLGQLRHP-NL 352
S+ + + G Y A AL K+L + ++F E+ L L HP N+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 353 VPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAW 412
V L F E LV +++ G+L LL G L S L I L +
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLK----KIGRKGPLSESEALFILAQILSALEY 116
Query: 413 LHHGCQPPYMHQYIS-SNVILIDDDFDARITDFGLARLVGSRDPN--DSSFVHGDLGEFG 469
LH +H+ I N++L D ++ DFGLA+L+ + +G G
Sbjct: 117 LHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 470 YVAPEYSSTMV---ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526
Y+APE + AS D++ GI L ELL+G P + + + L
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ-TLKIILELPT 232
Query: 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574
+ + + L+ + PK+R S
Sbjct: 233 PSLASPLSPSNPELI--SKAASDLLK---KLLAKDPKNRLSSSSDLSH 275
|
Length = 384 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 55/192 (28%), Positives = 93/192 (48%), Gaps = 32/192 (16%)
Query: 323 AIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLH 382
A+K L +S + F E + +LRH LV L C EE +V ++M G+L L
Sbjct: 34 AVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK 93
Query: 383 -GNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARI 441
G G L ++D + ++ GM A+L Y+H+ +++ IL+ ++ +I
Sbjct: 94 SGEGKKLRLPQLVDMAAQIAEGM------AYLE---SRNYIHRDLAARNILVGENLVCKI 144
Query: 442 TDFGLARLV---------GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGI 492
DFGLARL+ G++ P + APE ++ ++K DV+ FGI
Sbjct: 145 ADFGLARLIEDDEYTAREGAKFP------------IKWTAPEAANYGRFTIKSDVWSFGI 192
Query: 493 VLLELLS-GQKP 503
+L E+++ G+ P
Sbjct: 193 LLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 44/115 (38%), Positives = 63/115 (54%), Gaps = 1/115 (0%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGP 133
L L L+G +P SL +LQ L L N LSG IP + L ++ LDLS+N LSG
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS-LQKLISLDLSDNSLSGE 299
Query: 134 IPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLAR 188
IP +++ + L L L +N +G IP ++ L RL+ + N SG IP +L +
Sbjct: 300 IPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGK 354
|
Length = 968 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 57/187 (30%), Positives = 99/187 (52%), Gaps = 17/187 (9%)
Query: 320 SALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL-LVYKHMPNGTLY 378
+ +AIK L + + F E + +LRH LVPL + VV EE + +V + M G+L
Sbjct: 31 TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL--YAVVSEEPIYIVTEFMGKGSLL 88
Query: 379 SLL-HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF 437
L G+G L ++D + ++ + G+A++ + Y+H+ + + IL+ D+
Sbjct: 89 DFLKEGDGKYLKLPQLVDMAAQI------ADGMAYIE---RMNYIHRDLRAANILVGDNL 139
Query: 438 DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLEL 497
+I DFGLARL+ + N+ + G + APE + ++K DV+ FGI+L EL
Sbjct: 140 VCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
Query: 498 LS-GQKP 503
++ G+ P
Sbjct: 197 VTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 60/258 (23%), Positives = 109/258 (42%), Gaps = 47/258 (18%)
Query: 322 LAIKRLSACKLSEKQFRS---EMNRLGQLRHPNLVPLLGFCVVEEER-LLVY-KHMPNGT 376
+A+K + SE++ + E+ L L+HPN+V G EE+ L ++ +++ G+
Sbjct: 28 MAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGS 87
Query: 377 LYSLLHGNGVDNTLSGVLDWSTRLRIGMGAS------RGLAWLH-HGCQPPYMHQYISSN 429
L SLL G +L + GLA+LH +G +H+ I
Sbjct: 88 LSSLLKKFG-------------KLPEPVIRKYTRQILEGLAYLHSNG----IVHRDIKGA 130
Query: 430 VILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYG 489
IL+D D ++ DFG A+ +G + + + G ++APE D++
Sbjct: 131 NILVDSDGVVKLADFGCAKRLGDIETGEGT--GSVRGTPYWMAPEVIRGEEYGRAADIWS 188
Query: 490 FGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQ 549
G ++E+ +G+ P GN + + + +G ++ + +E
Sbjct: 189 LGCTVIEMATGKPPW-------SELGNPMAALYKIGSSGEPPEIPE------HLSEEAKD 235
Query: 550 FLRVACSCVVSRPKDRPS 567
FLR C+ PK RP+
Sbjct: 236 FLR---KCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 21/199 (10%)
Query: 319 ASALAIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGT 376
A+++AIK L +A +++FR E + L+HPN+V LLG C E+ ++++++ +G
Sbjct: 35 ATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGD 94
Query: 377 LYSLLHGN---------GVDNTLSGVLDWSTRLRIGMGASRGLAWL--HHGCQPPYMHQY 425
L+ L N D T+ LD S L I + + G+ +L HH ++H+
Sbjct: 95 LHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRD 149
Query: 426 ISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKG 485
+++ L+ + +I+DFGL+R + S D L ++ PE + +
Sbjct: 150 LAARNCLVGEGLTVKISDFGLSRDIYSADY--YRVQSKSLLPVRWMPPEAILYGKFTTES 207
Query: 486 DVYGFGIVLLELLS-GQKP 503
D++ FG+VL E+ S G +P
Sbjct: 208 DIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 57/219 (26%), Positives = 109/219 (49%), Gaps = 23/219 (10%)
Query: 295 NSFAVENIIISTRTGVSYKAVLP----DASALAIKRLSACKLSEKQ---FRSEMNRLGQL 347
+ + +I + G ++ +L A+AIK L +EKQ F SE + +GQ
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKP-GYTEKQRQDFLSEASIMGQF 63
Query: 348 RHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGM--G 405
H N++ L G + +++ ++M NG L L + D ++S+ +GM G
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDH--DG------EFSSYQLVGMLRG 115
Query: 406 ASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDL 465
+ G+ +L Y+H+ +++ IL++ + + +++DFGL+R++ DP + G
Sbjct: 116 IAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGK 171
Query: 466 GEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKP 503
+ APE + + DV+ FGIV+ E++S G++P
Sbjct: 172 IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 67/256 (26%), Positives = 115/256 (44%), Gaps = 38/256 (14%)
Query: 323 AIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLH 382
A+K L + + F +E + + LRHPNLV LLG + +V ++M G+L L
Sbjct: 33 AVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR 92
Query: 383 GNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARIT 442
G V+ + +L + G+ +L + ++H+ +++ +L+ +D A+++
Sbjct: 93 SRG-----RAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVS 144
Query: 443 DFGLARLVGSRDPNDSSFVHGDLGEF--GYVAPEYSSTMVASLKGDVYGFGIVLLELLS- 499
DFGLA+ ++S D G+ + APE S K DV+ FGI+L E+ S
Sbjct: 145 DFGLAK--------EASQGQ-DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 195
Query: 500 GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVV 559
G+ P + L D V H V G + + G E+ + ++ C
Sbjct: 196 GRVPYP--------RIPLKDVVPH-VEKGYRMEAPE------GCPPEVYKVMK---DCWE 237
Query: 560 SRPKDRPSMYQVYESL 575
P RP+ Q+ E L
Sbjct: 238 LDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-13
Identities = 48/112 (42%), Positives = 60/112 (53%), Gaps = 5/112 (4%)
Query: 81 LSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDL--CKWLPYVVQLDLSNNHLSGPIPPQI 138
LSG++P + SL LDL N+L+G IP L K L Y L L N LSGPIPP I
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQY---LFLYQNKLSGPIPPSI 280
Query: 139 VECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP 190
+ L L LS+N LSG IP V +L L+ + N+ +G IP L P
Sbjct: 281 FSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLP 332
|
Length = 968 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 55/187 (29%), Positives = 94/187 (50%), Gaps = 17/187 (9%)
Query: 320 SALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL-LVYKHMPNGTLY 378
+ +AIK L +S + F E + +LRH LV L + VV EE + +V ++M G+L
Sbjct: 31 TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLL 88
Query: 379 SLLHGN-GVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF 437
L G G L ++D + ++ GM + Y+H+ + + IL+ ++
Sbjct: 89 DFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---------YVHRDLRAANILVGENL 139
Query: 438 DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLEL 497
++ DFGLARL+ + N+ + G + APE + ++K DV+ FGI+L EL
Sbjct: 140 VCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
Query: 498 LS-GQKP 503
+ G+ P
Sbjct: 197 TTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 58/187 (31%), Positives = 97/187 (51%), Gaps = 17/187 (9%)
Query: 320 SALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL-LVYKHMPNGTLY 378
+ +A+K L +S + F E + +LRH LV L + VV EE + +V ++M G+L
Sbjct: 31 TKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQL--YAVVSEEPIYIVTEYMSKGSLL 88
Query: 379 SLLH-GNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF 437
L G G L ++D + ++ GM A++ + Y+H+ + S IL+ D
Sbjct: 89 DFLKDGEGRALKLPNLVDMAAQVAAGM------AYIE---RMNYIHRDLRSANILVGDGL 139
Query: 438 DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLEL 497
+I DFGLARL+ + N+ + G + APE + ++K DV+ FGI+L EL
Sbjct: 140 VCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
Query: 498 LS-GQKP 503
++ G+ P
Sbjct: 197 VTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 51/185 (27%), Positives = 91/185 (49%), Gaps = 16/185 (8%)
Query: 323 AIKRLSACKLSEKQ---FRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYS 379
AIK L A S+KQ F +E + +GQ HPN++ L G +++ ++M NG+L
Sbjct: 36 AIKTLKA-GSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDK 94
Query: 380 LLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439
L N G + + G + G+ +L Y+H+ +++ IL++ +
Sbjct: 95 FLREN------DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVC 145
Query: 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS 499
+++DFGL+R + D + G + APE + + DV+ FGIV+ E++S
Sbjct: 146 KVSDFGLSRRL--EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
Query: 500 -GQKP 503
G++P
Sbjct: 204 YGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-13
Identities = 43/117 (36%), Positives = 58/117 (49%), Gaps = 1/117 (0%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGP 133
L L S +G++P +L LQ L L N SG IP +L K V LDLS N+L+G
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTV-LDLSTNNLTGE 371
Query: 134 IPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP 190
IP + L KLIL +N L G IP + L+ + N SG +P + + P
Sbjct: 372 IPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLP 428
|
Length = 968 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 56/188 (29%), Positives = 100/188 (53%), Gaps = 17/188 (9%)
Query: 322 LAIKRLSACKLSEKQ---FRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378
+AIK L + +EKQ F SE + +GQ HPN++ L G +++ + M NG L
Sbjct: 35 VAIKTLKS-GYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALD 93
Query: 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD 438
S L N D + V+ LR G + G+ +L + Y+H+ +++ IL++ +
Sbjct: 94 SFLRQN--DGQFT-VIQLVGMLR---GIAAGMKYL---SEMNYVHRDLAARNILVNSNLV 144
Query: 439 ARITDFGLARLV--GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLE 496
+++DFGL+R + + DP +S + G + + APE + + DV+ +GIV+ E
Sbjct: 145 CKVSDFGLSRFLEDDTSDPTYTSSLGGKI-PIRWTAPEAIAYRKFTSASDVWSYGIVMWE 203
Query: 497 LLS-GQKP 503
++S G++P
Sbjct: 204 VMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 67/255 (26%), Positives = 107/255 (41%), Gaps = 33/255 (12%)
Query: 323 AIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLH 382
AIK + +SE F E + +L HPNLV L G C + +V ++M NG L + L
Sbjct: 32 AIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLR 91
Query: 383 GNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARIT 442
G L L + + +L ++H+ +++ L+ +D +++
Sbjct: 92 ER------KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVS 142
Query: 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQK 502
DFGLAR V D SS G + PE S K DV+ FG+++ E+ S K
Sbjct: 143 DFGLARYVLD-DQYTSSQ--GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
Query: 503 -PLDVAGAEEGFK-GNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVS 560
P E F +V+ V+ R + + +Y IM SC
Sbjct: 200 MPY------ERFSNSEVVESVSAGYRLYRPK-LAPTEVY------TIM------YSCWHE 240
Query: 561 RPKDRPSMYQVYESL 575
+P+DRP+ ++ L
Sbjct: 241 KPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-13
Identities = 44/114 (38%), Positives = 62/114 (54%), Gaps = 1/114 (0%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
+L LS+ LSG++P + SL+ LDL N L G IP L L + L L++N L G
Sbjct: 144 TLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTN-LTSLEFLTLASNQLVG 202
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
IP ++ + K L + L N LSG IP+E+ L L + N+L+G IP L
Sbjct: 203 QIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL 256
|
Length = 968 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 67/263 (25%), Positives = 121/263 (46%), Gaps = 33/263 (12%)
Query: 322 LAIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYS 379
+A+K L A +K+F E + + HPN+V LLG C++ E + ++ + M G L S
Sbjct: 29 VAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLS 88
Query: 380 LLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS-NVILIDDDFD 438
L V+ +L L I + ++G +L Q ++H+ +++ N ++ + +D
Sbjct: 89 YLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYD 145
Query: 439 AR----ITDFGLARLVGSRDPNDSSFVHGD-LGEFGYVAPEYSSTMVASLKGDVYGFGIV 493
A I DFGLAR + +D G+ L ++APE + + DV+ FG++
Sbjct: 146 ADRVVKIGDFGLARDIYK---SDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVL 202
Query: 494 LLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLR 552
+ E+L+ GQ+P N + + H+ GR + D+I Q +
Sbjct: 203 MWEILTLGQQPYPAL--------NNQEVLQHVTAGGRLQK-------PENCPDKIYQLMT 247
Query: 553 VACSCVVSRPKDRPSMYQVYESL 575
+C P +RP+ ++ E L
Sbjct: 248 ---NCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 60/259 (23%), Positives = 116/259 (44%), Gaps = 32/259 (12%)
Query: 322 LAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLL 381
+A+K L + ++F E + +++HPNLV LLG C E ++ + M G L L
Sbjct: 34 VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 93
Query: 382 HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARI 441
++ V L + S + +L + ++H+ +++ L+ ++ ++
Sbjct: 94 RECN-RQEVNAV----VLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKV 145
Query: 442 TDFGLARLVGSRDPNDSSFVH-GDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS- 499
DFGL+RL+ D+ H G + APE + S+K DV+ FG++L E+ +
Sbjct: 146 ADFGLSRLM----TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 201
Query: 500 GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVV 559
G P + G + V L+ G + G ++ + +R +C
Sbjct: 202 GMSP---------YPGIDLSQVYELLEKGYRME------RPEGCPPKVYELMR---ACWQ 243
Query: 560 SRPKDRPSMYQVYESLKSM 578
P DRPS +++++ ++M
Sbjct: 244 WNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 6e-13
Identities = 54/157 (34%), Positives = 73/157 (46%), Gaps = 11/157 (7%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129
++ISL LS LSG++PE + +L+ L L N+ +G IPV L LP + L L +N
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS-LPRLQVLQLWSNK 343
Query: 130 LSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLA-- 187
SG IP + + L L LS N L+G IP + L + + N L G IP L
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGAC 403
Query: 188 ------RFPEESFDGN--SGLCGKPLGKCGGLSGKNL 216
R + SF G S PL +S NL
Sbjct: 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNL 440
|
Length = 968 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 22/205 (10%)
Query: 321 ALAIKRLSACKLSEKQ---FRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL 377
+AIK L A +EKQ F SE + +GQ HPN++ L G + ++V ++M NG+L
Sbjct: 34 PVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL 92
Query: 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF 437
+ L + T V+ LR G + G+ +L Y+H+ +++ IL++ +
Sbjct: 93 DAFLRKHDGQFT---VIQLVGMLR---GIASGMKYL---SDMGYVHRDLAARNILVNSNL 143
Query: 438 DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLEL 497
+++DFGL+R++ DP + G + APE + + DV+ +GIV+ E+
Sbjct: 144 VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 202
Query: 498 LS-GQKPL------DVAGA-EEGFK 514
+S G++P DV A EEG++
Sbjct: 203 MSYGERPYWEMSNQDVIKAIEEGYR 227
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 64/277 (23%), Positives = 122/277 (44%), Gaps = 42/277 (15%)
Query: 309 GVSYKAVLPDASALAIK--RLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366
G YK VL + +A+K R + +++F E L Q HPN+V L+G CV ++
Sbjct: 9 GDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIY 68
Query: 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYI 426
+V + +P G+L + L L L++ + A+ G+ +L +H+ +
Sbjct: 69 IVMELVPGGSLLTFLRKKK------NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDL 119
Query: 427 SSNVILIDDDFDARITDFGLARLVGSRDPNDSSF-VHGDLGEF--GYVAPEYSSTMVASL 483
++ L+ ++ +I+DFG+ SR+ + V L + + APE + +
Sbjct: 120 AARNCLVGENNVLKISDFGM-----SREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 484 KGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRG 542
+ DV+ +GI+L E S G P + G N ++R+ ++ R
Sbjct: 175 ESDVWSYGILLWETFSLGDTP---------YPG----MSNQ-----QTRERIESG--YRM 214
Query: 543 NDDEIM--QFLRVACSCVVSRPKDRPSMYQVYESLKS 577
++ + R+ C P++RPS ++Y L+
Sbjct: 215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 9e-13
Identities = 67/262 (25%), Positives = 119/262 (45%), Gaps = 39/262 (14%)
Query: 321 ALAIKRLSACKLS--EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378
+A+K L ++ +K+F E + + QL HP +V L+G C E +LV + P G L
Sbjct: 25 EVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC-KGEPLMLVMELAPLGPLL 83
Query: 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS-NVILIDDDF 437
L + +S + + + ++ + G+A+L ++H+ +++ NV+L++
Sbjct: 84 KYLKKRR-EIPVSDLKELAHQV------AMGMAYL-ESKH--FVHRDLAARNVLLVNRHQ 133
Query: 438 DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLEL 497
A+I+DFG++R +G+ + G Y APE + S K DV+ +G+ L E
Sbjct: 134 -AKISDFGMSRALGAGSDYYRATTAGRWPLKWY-APECINYGKFSSKSDVWSYGVTLWEA 191
Query: 498 LS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGR--SRDVVDKSLYGRGNDDEIMQFLRVA 554
S G KP KG V + L R + + +Y IM
Sbjct: 192 FSYGAKPY------GEMKGAEV--IAMLESGERLPRPEECPQEIY------SIML----- 232
Query: 555 CSCVVSRPKDRPSMYQVYESLK 576
SC RP+DRP+ ++ + +
Sbjct: 233 -SCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 49/188 (26%), Positives = 97/188 (51%), Gaps = 14/188 (7%)
Query: 318 DASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL 377
+++ +A+K L +S + F E N + L+H LV L EE ++ ++M G+L
Sbjct: 29 NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSL 88
Query: 378 YSLLHGN-GVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD 436
L + G L ++D+S ++ + G+A++ + Y+H+ + + +L+ +
Sbjct: 89 LDFLKSDEGGKVLLPKLIDFSAQI------AEGMAYIE---RKNYIHRDLRAANVLVSES 139
Query: 437 FDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLE 496
+I DFGLAR++ + N+ + G + APE + ++K DV+ FGI+L E
Sbjct: 140 LMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYE 196
Query: 497 LLS-GQKP 503
+++ G+ P
Sbjct: 197 IVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-12
Identities = 44/136 (32%), Positives = 70/136 (51%), Gaps = 11/136 (8%)
Query: 47 FTNTTVGAICRLTGVACWNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLS 106
FT A+ L R+ L L S + SG++P++L ++L LDLS N+L+
Sbjct: 320 FTGKIPVALTSLP----------RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLT 369
Query: 107 GSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLD 166
G IP LC + +L L +N L G IP + C+ L ++ L +N SG +P E ++L
Sbjct: 370 GEIPEGLCS-SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLP 428
Query: 167 RLKEFSVAGNDLSGTI 182
+ ++ N+L G I
Sbjct: 429 LVYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 71/274 (25%), Positives = 121/274 (44%), Gaps = 43/274 (15%)
Query: 323 AIKRLS--ACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPNGTLYS 379
AIKR+ A K + F E+ L +L HPN++ LLG C L ++ P+G L
Sbjct: 38 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 97
Query: 380 LLHGN---------GVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNV 430
L + + N+ + L L +RG+ +L Q ++H+ +++
Sbjct: 98 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARN 154
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFG--YVAPEYSSTMVASLKGDVY 488
IL+ +++ A+I DFGL+R +V +G ++A E + V + DV+
Sbjct: 155 ILVGENYVAKIADFGLSR-------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVW 207
Query: 489 GFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEI 547
+G++L E++S G P E ++ L R ++K L DDE+
Sbjct: 208 SYGVLLWEIVSLGGTPYCGMTCAELYE--------KLPQGYR----LEKPL---NCDDEV 252
Query: 548 MQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581
+R C +P +RPS Q+ SL M E+
Sbjct: 253 YDLMR---QCWREKPYERPSFAQILVSLNRMLEE 283
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 51/185 (27%), Positives = 88/185 (47%), Gaps = 15/185 (8%)
Query: 323 AIKRLSACKLSEKQ--FRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
A+K L + KLS+ F E + L H NL+ L G V+ ++V + P G+L
Sbjct: 27 AVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGV-VLTHPLMMVTELAPLGSLLDR 85
Query: 381 LHGNGVDNTLSGVL-DWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439
L + + + L L D++ ++ GM +L ++H+ +++ IL+ D
Sbjct: 86 LRKDALGHFLISTLCDYAVQIANGM------RYLE---SKRFIHRDLAARNILLASDDKV 136
Query: 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS 499
+I DFGL R + + + H + F + APE T S DV+ FG+ L E+ +
Sbjct: 137 KIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
Query: 500 -GQKP 503
G++P
Sbjct: 196 YGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 37/216 (17%)
Query: 308 TGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL- 366
V+ K + DA+A A F +E + + QLRH NLV LLG V E+ L
Sbjct: 30 NKVAVKCIKNDATAQA-------------FLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76
Query: 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYI 426
+V ++M G+L L G VL L+ + + +L ++H+ +
Sbjct: 77 IVTEYMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDL 128
Query: 427 SSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGD 486
++ +L+ +D A+++DFGL + S V + APE S K D
Sbjct: 129 AARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-------WTAPEALREKKFSTKSD 181
Query: 487 VYGFGIVLLELLS-GQKPLD-------VAGAEEGFK 514
V+ FGI+L E+ S G+ P V E+G+K
Sbjct: 182 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK 217
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 6e-12
Identities = 50/183 (27%), Positives = 89/183 (48%), Gaps = 18/183 (9%)
Query: 322 LAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLL 381
+A+K + C ++ + F E + +L H NLV LLG ++ +V + M G L + L
Sbjct: 32 VAVKNIK-CDVTAQAFLEETAVMTKLHHKNLVRLLG-VILHNGLYIVMELMSKGNLVNFL 89
Query: 382 HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARI 441
G ++ L+ + + G+ +L +H+ +++ IL+ +D A++
Sbjct: 90 RTRG-----RALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKV 141
Query: 442 TDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-G 500
+DFGLAR VGS ++S + APE S K DV+ +G++L E+ S G
Sbjct: 142 SDFGLAR-VGSMGVDNSKL------PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYG 194
Query: 501 QKP 503
+ P
Sbjct: 195 RAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 62/212 (29%), Positives = 93/212 (43%), Gaps = 33/212 (15%)
Query: 308 TGVSYKAV-LPDASALAIKR--LSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEE 364
T V Y A+ LP+ +AIKR L C+ S + R E+ + Q HPN+V VV +E
Sbjct: 14 TAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE 73
Query: 365 RLLVYKHMPNGTLYSLL-HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMH 423
LV ++ G+L ++ G LD + + +GL +LH Q +H
Sbjct: 74 LWLVMPYLSGGSLLDIMKSSYP-----RGGLDEAIIATVLKEVLKGLEYLHSNGQ---IH 125
Query: 424 QYISSNVILIDDDFDARITDFG----LARLVGSRDPNDSSFVHGDLGEFGYVAPE----- 474
+ I + IL+ +D +I DFG LA +FV G ++APE
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV----GTPCWMAPEVMEQV 181
Query: 475 --YSSTMVASLKGDVYGFGIVLLELLSGQKPL 504
Y K D++ FGI +EL +G P
Sbjct: 182 HGYDF------KADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 6e-12
Identities = 52/185 (28%), Positives = 89/185 (48%), Gaps = 13/185 (7%)
Query: 322 LAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLL 381
+AIK + +SE +F E + +L H LV L G C + +V ++M NG L + L
Sbjct: 31 VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL 90
Query: 382 HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARI 441
+G S +L+ + G+A+L ++H+ +++ L+DD ++
Sbjct: 91 REHGKRFQPSQLLEMCKDV------CEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKV 141
Query: 442 TDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-G 500
+DFGL+R V D +S V G + PE S K DV+ FG+++ E+ S G
Sbjct: 142 SDFGLSRYV--LDDEYTSSV-GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLG 198
Query: 501 QKPLD 505
+ P +
Sbjct: 199 KMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 7e-12
Identities = 55/202 (27%), Positives = 87/202 (43%), Gaps = 52/202 (25%)
Query: 323 AIKRLSACKLSEK----QFRSEMNRLGQLRHPNLVPLLGFCVVEEERL-LVYKHMPNGTL 377
A+K L K+ ++ +E N L ++ HP +V L + EE+L LV ++ P G L
Sbjct: 22 AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGEL 80
Query: 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASR--------GLAWLH-HGCQPPYMHQYISS 428
+S L S R +R L +LH G +++ +
Sbjct: 81 FSHL---------------SKEGRFSEERARFYAAEIVLALEYLHSLG----IIYRDLKP 121
Query: 429 NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVY 488
IL+D D ++TDFGLA+ + S ++F G Y+APE L G Y
Sbjct: 122 ENILLDADGHIKLTDFGLAKELSSEGSRTNTFC----GTPEYLAPEV-------LLGKGY 170
Query: 489 G-------FGIVLLELLSGQKP 503
G G++L E+L+G+ P
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 8e-12
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 30/205 (14%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSEKQ---FRSEMNRLGQLRHPNLVPLLGFCVVEEE 364
GV YK + L +AIK++S K+ E+ E++ L L+HPN+V +G +
Sbjct: 14 GVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDS 73
Query: 365 RLLVYKHMPNGTLYSLLHGNG------VDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQ 418
++ ++ NG+L ++ G V + VL +GLA+LH +
Sbjct: 74 LYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL-------------QGLAYLH---E 117
Query: 419 PPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST 478
+H+ I + IL D ++ DFG+A + +D+S V G ++APE
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV----GTPYWMAPEVIEM 173
Query: 479 MVASLKGDVYGFGIVLLELLSGQKP 503
AS D++ G ++ELL+G P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 14/181 (7%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER--LLVYKHMPNGTLY 378
A+K L S + F E+ L L H N+V G C R L+ +++P+G+L
Sbjct: 37 AVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLR 96
Query: 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD 438
L + L +L +S+++ GM +L Y+H+ +++ IL++ +
Sbjct: 97 DYLQRHRDQINLKRLLLFSSQICKGM------DYLG---SQRYIHRDLAARNILVESEDL 147
Query: 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELL 498
+I+DFGLA+++ G+ F Y APE T S DV+ FG+ L EL
Sbjct: 148 VKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELF 206
Query: 499 S 499
+
Sbjct: 207 T 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 65/289 (22%), Positives = 132/289 (45%), Gaps = 41/289 (14%)
Query: 296 SFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPL 355
S +E + + + G + A + +A+K + +S + F +E N + L+H LV L
Sbjct: 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL 66
Query: 356 LGFCVVEEERLLVYKHMPNGTLYSLLHGN-GVDNTLSGVLDWSTRLRIGMGASRGLAWLH 414
V +E ++ + M G+L L + G L ++D+S ++ + G+A++
Sbjct: 67 HA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAFIE 119
Query: 415 HGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEF--GYVA 472
Q Y+H+ + + IL+ +I DFGLAR++ D+ + + +F + A
Sbjct: 120 ---QRNYIHRDLRAANILVSASLVCKIADFGLARVI-----EDNEYTAREGAKFPIKWTA 171
Query: 473 PEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531
PE + ++K DV+ FGI+L+E+++ G+ P E ++ + R
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALERGYRMPRP- 225
Query: 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
+ + LY + C +RP++RP+ +E ++S+ +
Sbjct: 226 ENCPEELYN------------IMMRCWKNRPEERPT----FEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 56/189 (29%), Positives = 95/189 (50%), Gaps = 22/189 (11%)
Query: 322 LAIKRLSACKLSEKQFRSEMNRLGQLRH----PNLVPLLGFCVVEEERLLVYKHMPNGTL 377
+AIK L +EK R EM R ++ H P +V ++G C E +LV + G L
Sbjct: 25 VAIKVLK--NENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEA-LMLVMEMASGGPL 81
Query: 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF 437
L G + T+S V++ ++ +GM G ++H + NV+L++ +
Sbjct: 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR--------DLAARNVLLVNQHY 133
Query: 438 DARITDFGLARLVGSRDPNDSSFVHGDLGEF--GYVAPEYSSTMVASLKGDVYGFGIVLL 495
A+I+DFGL++ +G+ +DS + G++ + APE + S + DV+ +GI +
Sbjct: 134 -AKISDFGLSKALGA---DDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMW 189
Query: 496 ELLS-GQKP 503
E S GQKP
Sbjct: 190 EAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 62/280 (22%), Positives = 117/280 (41%), Gaps = 36/280 (12%)
Query: 297 FAVENIIISTRTGVSYKAVLP-DASALAIKRLSACKLSEKQFRSEMNR---LGQLRHPNL 352
F + N I GV +K V D A+K++ K++ ++ ++ L +L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 353 VPLLGFCVVEEERL-LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLA 411
+ +++ +L +V ++ NG L+ LL L W R + GLA
Sbjct: 62 IRYYE-SFLDKGKLNIVMEYAENGDLHKLLKMQ-RGRPLPEDQVW----RFFIQILLGLA 115
Query: 412 WLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV 471
LH +H+ I S + +D + +I D G+A+L+ +++F + +G Y+
Sbjct: 116 HLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD----NTNFANTIVGTPYYL 168
Query: 472 APEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531
+PE + K DV+ G+VL E +G+ P D +G L+ +I G
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-----QGALI----LKIIRGVFP 219
Query: 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQV 571
V + ++ Q + C+ + RP +Q+
Sbjct: 220 PV------SQMYSQQLAQLID---QCLTKDYRQRPDTFQL 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 309 GVSYKAV-LPDAS----ALAIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVV 361
G YK V +P+ +AIK L + K+ E + + HP++V LLG C +
Sbjct: 21 GTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGIC-L 79
Query: 362 EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMG--ASRGLAWLHHGCQP 419
+ L+ + MP G L + + + +L+W ++ GM + L
Sbjct: 80 SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRL--------- 130
Query: 420 PYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGE--FGYVAPEYSS 477
+H+ +++ +L+ +ITDFGLA+L+ D H + G+ ++A E
Sbjct: 131 --VHRDLAARNVLVKTPQHVKITDFGLAKLLDV----DEKEYHAEGGKVPIKWMALESIL 184
Query: 478 TMVASLKGDVYGFGIVLLELLS-GQKPLD 505
+ + K DV+ +G+ + EL++ G KP +
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 63/283 (22%)
Query: 323 AIKRLS--ACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVY---KHMPNGT 376
AIK L A + + F E+ L +L HPN++ LLG C E R +Y ++ P G
Sbjct: 33 AIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC---ENRGYLYIAIEYAPYGN 89
Query: 377 LYSLLHGNGVDNT---------LSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYIS 427
L L + V T + L L+ + G+ +L + ++H+ ++
Sbjct: 90 LLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL---SEKQFIHRDLA 146
Query: 428 SNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFG--YVAPEYSSTMVASLKG 485
+ +L+ ++ ++I DFGL+R + +V +G ++A E + V + K
Sbjct: 147 ARNVLVGENLASKIADFGLSR-------GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKS 199
Query: 486 DVYGFGIVLLELLS--GQKPLDVAGAE------EGFKGNLVDWVNHLVIAGRSRDVVDKS 537
DV+ FG++L E++S G + AE +G++ ++K
Sbjct: 200 DVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-------------------MEKP 240
Query: 538 LYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
R DDE+ + +R C RP +RP Q+ L M E
Sbjct: 241 ---RNCDDEVYELMR---QCWRDRPYERPPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 6e-11
Identities = 70/273 (25%), Positives = 115/273 (42%), Gaps = 43/273 (15%)
Query: 323 AIKRLS--ACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPNGTLYS 379
AIKR+ A K + F E+ L +L HPN++ LLG C L ++ P+G L
Sbjct: 26 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 85
Query: 380 LLHGNGVDNT---------LSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNV 430
L + V T + L L +RG+ +L Q ++H+ +++
Sbjct: 86 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARN 142
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFG--YVAPEYSSTMVASLKGDVY 488
IL+ +++ A+I DFGL+R +V +G ++A E + V + DV+
Sbjct: 143 ILVGENYVAKIADFGLSR-------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVW 195
Query: 489 GFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEI 547
+G++L E++S G P E ++ L R DDE+
Sbjct: 196 SYGVLLWEIVSLGGTPYCGMTCAELYE--------KLPQGYRLEK-------PLNCDDEV 240
Query: 548 MQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
+R C +P +RPS Q+ SL M E
Sbjct: 241 YDLMR---QCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 9e-11
Identities = 46/118 (38%), Positives = 59/118 (50%), Gaps = 11/118 (9%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDL-----CKWLPYVVQLDLSNN 128
L L L G++P SL SL+ L L+ N L G IP +L KW+ Y L N
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWI-Y-----LGYN 222
Query: 129 HLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
+LSG IP +I LN L L N L+G IP + L L+ + N LSG IPP +
Sbjct: 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI 280
|
Length = 968 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 33/205 (16%)
Query: 318 DASALAIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNG 375
D +A+K L +A + K F E L +H N+V G C + ++V+++M +G
Sbjct: 34 DKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHG 93
Query: 376 TLYSLLHGNGVDN-------------TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYM 422
L L +G D TLS +L + ++ GM LA H ++
Sbjct: 94 DLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGM---VYLASQH------FV 144
Query: 423 HQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGD-LGEFGYVAPEYSSTMVA 481
H+ +++ L+ D +I DFG++R V + D V G + ++ PE S M
Sbjct: 145 HRDLATRNCLVGYDLVVKIGDFGMSRDVYT---TDYYRVGGHTMLPIRWMPPE--SIMYR 199
Query: 482 --SLKGDVYGFGIVLLELLS-GQKP 503
+ + DV+ FG+VL E+ + G++P
Sbjct: 200 KFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 26/199 (13%)
Query: 309 GVSYKAVLPDASALAIKRLSACKLSEKQ-----FRSEMNRLGQLRHPNLVPLLGFCVVEE 363
G +K L D + +A+K CK Q F SE L Q HPN+V L+G C +
Sbjct: 9 GEVFKGTLKDKTPVAVK---TCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ 65
Query: 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYM 422
+V + +P G S L + L ++ + A+ G+A+L C +
Sbjct: 66 PIYIVMELVPGGDFLSFLRKKKDE------LKTKQLVKFALDAAAGMAYLESKNC----I 115
Query: 423 HQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGE--FGYVAPEYSSTMV 480
H+ +++ L+ ++ +I+DFG+ SR +D + L + + APE +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGM-----SRQEDDGIYSSSGLKQIPIKWTAPEALNYGR 170
Query: 481 ASLKGDVYGFGIVLLELLS 499
S + DV+ +GI+L E S
Sbjct: 171 YSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 53/176 (30%), Positives = 82/176 (46%), Gaps = 21/176 (11%)
Query: 335 KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLL-HGNGVDNTLSGV 393
K+ EM L L+HPNLV G V E+ + ++ GTL LL HG +D + V
Sbjct: 44 KEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV 103
Query: 394 LDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452
++ +L GLA+LH HG +H+ I I +D + ++ DFG A + +
Sbjct: 104 --YTLQL------LEGLAYLHSHGI----VHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151
Query: 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKG-----DVYGFGIVLLELLSGQKP 503
V G Y+APE + KG D++ G V+LE+ +G++P
Sbjct: 152 NTTTMGEEVQSLAGTPAYMAPEVITG--GKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 46/187 (24%), Positives = 85/187 (45%), Gaps = 17/187 (9%)
Query: 322 LAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLL 381
+AIK ++ +SE+ F E + +L HP LV L G C ++ +V + M NG L + L
Sbjct: 31 VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL 90
Query: 382 HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARI 441
G L L + G+ +L + ++H+ +++ L+ ++
Sbjct: 91 RQR------QGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKV 141
Query: 442 TDFGLARLVGSRDPNDSSFVHGDLGEF--GYVAPEYSSTMVASLKGDVYGFGIVLLELLS 499
+DFG+ R V D + +F + PE + S K DV+ FG+++ E+ +
Sbjct: 142 SDFGMTRYV-----LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196
Query: 500 -GQKPLD 505
G+ P +
Sbjct: 197 EGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 50/198 (25%), Positives = 92/198 (46%), Gaps = 18/198 (9%)
Query: 318 DASALAIKRLSACKLS-EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGT 376
D +A+K L L+ K F+ E L L+H ++V G C + ++V+++M +G
Sbjct: 34 DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGD 93
Query: 377 LYSLLHGNGVDNTL---------SGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYIS 427
L L +G D + G L S L I + G+ +L ++H+ ++
Sbjct: 94 LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLA 150
Query: 428 SNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHG-DLGEFGYVAPEYSSTMVASLKGD 486
+ L+ + +I DFG++R V S D V G + ++ PE + + D
Sbjct: 151 TRNCLVGANLLVKIGDFGMSRDVYS---TDYYRVGGHTMLPIRWMPPESIMYRKFTTESD 207
Query: 487 VYGFGIVLLELLS-GQKP 503
V+ FG++L E+ + G++P
Sbjct: 208 VWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 26/177 (14%)
Query: 335 KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNG------VDN 388
K RSE+ L L H N+V LGF EE + +++P G++ S L G V
Sbjct: 53 KALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF 112
Query: 389 TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448
VL GLA+LH +H+ + ++ +L+D D +I+DFG+++
Sbjct: 113 FTEQVL-------------EGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK 156
Query: 449 LVGSRDPNDSSFVHGDLGEFGYVAPE--YSSTMVASLKGDVYGFGIVLLELLSGQKP 503
S D D+ G ++APE +S + S K D++ G V+LE+ +G++P
Sbjct: 157 --KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 28/203 (13%)
Query: 319 ASALAIKRLSACKLSEK--QFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGT 376
A +AIK L ++ +F+ E + + +L HPN+V LLG E+ ++++++ G
Sbjct: 34 AQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGD 93
Query: 377 LYSLL-----HGN-----GVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYI 426
L+ L H + D T+ LD L I + + G+ +L ++H+ +
Sbjct: 94 LHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDL 150
Query: 427 SSNVILIDDDFDARITDFGLARLVGSRD-----PNDSSFVHGDLGEFGYVAPEYSSTMVA 481
++ ILI + +I+D GL+R + S D P L ++ PE
Sbjct: 151 AARNILIGEQLHVKISDLGLSREIYSADYYRVQPK-------SLLPIRWMPPEAIMYGKF 203
Query: 482 SLKGDVYGFGIVLLELLS-GQKP 503
S D++ FG+VL E+ S G +P
Sbjct: 204 SSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 46/186 (24%), Positives = 84/186 (45%), Gaps = 21/186 (11%)
Query: 334 EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGV 393
+ F+ E + + HPN+V LLG C V + L++++M G L L S
Sbjct: 52 QADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLS 111
Query: 394 LDWST---------------RLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD 438
S+ +L I + G+A+L + ++H+ +++ L+ ++
Sbjct: 112 HSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMV 168
Query: 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELL 498
+I DFGL+R + S D +S D ++ PE + + DV+ +G+VL E+
Sbjct: 169 VKIADFGLSRNIYSADYYKAS--ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 226
Query: 499 S-GQKP 503
S G +P
Sbjct: 227 SYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 51/195 (26%), Positives = 91/195 (46%), Gaps = 15/195 (7%)
Query: 318 DASALAIKRLS-ACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGT 376
D +A+K L A + K F E L L+H ++V G CV + ++V+++M +G
Sbjct: 34 DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGD 93
Query: 377 LYSLLHGNGVDNTLSG------VLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNV 430
L L +G D L L S L I + G+ +L ++H+ +++
Sbjct: 94 LNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRN 150
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHG-DLGEFGYVAPEYSSTMVASLKGDVYG 489
L+ ++ +I DFG++R V S D V G + ++ PE + + DV+
Sbjct: 151 CLVGENLLVKIGDFGMSRDVYS---TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 207
Query: 490 FGIVLLELLS-GQKP 503
G+VL E+ + G++P
Sbjct: 208 LGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 23/198 (11%)
Query: 321 ALAIKRL---SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL 377
A+AIK L + L E +F+ E +L+HPN+V LLG E+ +++ + + L
Sbjct: 37 AVAIKTLKDKAEGPLRE-EFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 378 YSLL-----HGN----GVDNTLSGVLDWSTRLRIGMGASRGLAWL--HHGCQPPYMHQYI 426
+ L H + D T+ L+ + + I + G+ +L HH H+ +
Sbjct: 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVV-----HKDL 150
Query: 427 SSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGD 486
++ +L+ D + +I+D GL R V + D + L +++PE S+ D
Sbjct: 151 ATRNVLVFDKLNVKISDLGLFREVYAADY--YKLMGNSLLPIRWMSPEAIMYGKFSIDSD 208
Query: 487 VYGFGIVLLELLS-GQKP 503
++ +G+VL E+ S G +P
Sbjct: 209 IWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 316 LPDASALAIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373
+ +A+K L +A + SE N L Q+ HP+++ L G C + LL+ ++
Sbjct: 27 RAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAK 86
Query: 374 NGTLYSLLH-----------GNGVDNTLSGVLDWSTRLRIGM------GASRGLAWLHHG 416
G+L S L +G N+ L +G SRG+ +L
Sbjct: 87 YGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL--- 143
Query: 417 CQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEF--GYVAPE 474
+ +H+ +++ +L+ + +I+DFGL+R V D S+V G ++A E
Sbjct: 144 AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED----SYVKRSKGRIPVKWMAIE 199
Query: 475 YSSTMVASLKGDVYGFGIVLLELLS 499
+ + + DV+ FG++L E+++
Sbjct: 200 SLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 5e-09
Identities = 44/179 (24%), Positives = 71/179 (39%), Gaps = 27/179 (15%)
Query: 335 KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL-VYKHMPNGTLYSLLHGNGV------D 387
+FR E +L HPN+V LL L V++++P TL +L +G
Sbjct: 23 ARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETG 82
Query: 388 NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI--DDDFDARITDFG 445
+ VLD + + +H +P N+++ A++ DFG
Sbjct: 83 RLMLQVLD-------ALACAHNQGIVHRDLKP--------QNIMVSQTGVRPHAKVLDFG 127
Query: 446 LARL---VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQ 501
+ L V D + LG Y APE + D+Y +G++ LE L+GQ
Sbjct: 128 IGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 46/173 (26%), Positives = 87/173 (50%), Gaps = 17/173 (9%)
Query: 336 QFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLD 395
+F E + + HP+LV LLG C+ +L V + MP+G L +H + + +L+
Sbjct: 55 EFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLN 113
Query: 396 WSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDP 455
W ++ ++G+ +L + +H+ +++ +L+ +ITDFGLARL+
Sbjct: 114 WCVQI------AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL----E 160
Query: 456 NDSSFVHGDLGEF--GYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLD 505
D + D G+ ++A E + + DV+ +G+ + EL++ G KP D
Sbjct: 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 309 GVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNR-LGQLR---HPNLVPLLGFCVVEE 363
GV YK P A+K++ +++FR ++ R L LR P +V G E
Sbjct: 15 GVVYKVRHKPTGKIYALKKIHV--DGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG 72
Query: 364 ERLLVYKHMPNGTLYSLL--HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPY 421
E +V ++M G+L LL G + L+ + R +GL +LH +
Sbjct: 73 EISIVLEYMDGGSLADLLKKVGKIPEPVLAYI----ARQ-----ILKGLDYLHT--KRHI 121
Query: 422 MHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA 481
+H+ I + +LI+ + +I DFG+++++ + ++FV G Y++PE
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV----GTVTYMSPERIQGESY 177
Query: 482 SLKGDVYGFGIVLLELLSGQKPLDVAG 508
S D++ G+ LLE G+ P G
Sbjct: 178 SYAADIWSLGLTLLECALGKFPFLPPG 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 23/200 (11%)
Query: 318 DASALAIKRLSACKLSEKQ-FRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGT 376
D +A+K L S +Q F+ E L L+H ++V G C L+V+++M +G
Sbjct: 34 DKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGD 93
Query: 377 LYSLLHGNGVDNTL--------SGVLDWSTRLRIGMGASRG---LAWLHHGCQPPYMHQY 425
L L +G D + G L L I + G LA LH ++H+
Sbjct: 94 LNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH------FVHRD 147
Query: 426 ISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHG-DLGEFGYVAPEYSSTMVASLK 484
+++ L+ +I DFG++R + S D V G + ++ PE + +
Sbjct: 148 LATRNCLVGQGLVVKIGDFGMSRDIYS---TDYYRVGGRTMLPIRWMPPESILYRKFTTE 204
Query: 485 GDVYGFGIVLLELLS-GQKP 503
D++ FG+VL E+ + G++P
Sbjct: 205 SDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 62/261 (23%), Positives = 111/261 (42%), Gaps = 29/261 (11%)
Query: 323 AIKRLSACKLSEK--QFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
AIK ++ + +F +E + + + ++V LLG + L+V + M G L S
Sbjct: 40 AIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSY 99
Query: 381 LHGNGVDNTLSGVLDWSTRLR-IGMGA--SRGLAWLHHGCQPPYMHQYISSNVILIDDDF 437
L + + L T + I M A + G+A+L ++H+ +++ ++ +D
Sbjct: 100 LRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDL 156
Query: 438 DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLEL 497
+I DFG+ R + D L ++APE V + K DV+ FG+VL E+
Sbjct: 157 TVKIGDFGMTRDIYETDYYRKG--GKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214
Query: 498 LS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACS 556
+ ++P ++G + V VI G +D N + + L C
Sbjct: 215 ATLAEQP---------YQGLSNEEVLKFVIDG---GHLDLPE----NCPDKLLELMRMCW 258
Query: 557 CVVSRPKDRPSMYQVYESLKS 577
PK RP+ ++ SLK
Sbjct: 259 --QYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 51/203 (25%), Positives = 88/203 (43%), Gaps = 15/203 (7%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSEK---QFRSEMNRLGQLRHPNLVPLLGFCVVEEE 364
G K D L K + ++EK Q SE+N L +L+HPN+V +
Sbjct: 14 GTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN 73
Query: 365 RLL--VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPY- 421
+ L V ++ G L L+ + ++ RI L H+ P
Sbjct: 74 QTLYIVMEYCEGGDLAQLIQKCKKER---KYIEEEFIWRILTQLLLALYECHNRSDPGNT 130
Query: 422 -MHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMV 480
+H+ + I +D + + ++ DFGLA+++G +DSSF +G Y++PE + M
Sbjct: 131 VLHRDLKPANIFLDANNNVKLGDFGLAKILG----HDSSFAKTYVGTPYYMSPEQLNHMS 186
Query: 481 ASLKGDVYGFGIVLLELLSGQKP 503
K D++ G ++ EL + P
Sbjct: 187 YDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 67/286 (23%), Positives = 128/286 (44%), Gaps = 42/286 (14%)
Query: 309 GVSYKAVL--PDASAL--AIK--RLSACKLSE-KQFRSEMNRLGQLRHPNLVPLLGFCVV 361
G + L D S L A+K +L SE ++F SE + HPN++ L+G C
Sbjct: 13 GSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFE 72
Query: 362 EEER------LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHH 415
+++ M +G L+S L + + L L T L+ + + G+ +L
Sbjct: 73 ASSLQKIPKPMVILPFMKHGDLHSFLLYSRLG-GLPEKLPLQTLLKFMVDIALGMEYL-- 129
Query: 416 GCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEF--GYVAP 473
++H+ +++ ++ +D + DFGL++ + S D + G + + ++A
Sbjct: 130 -SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD----YYRQGRIAKMPVKWIAI 184
Query: 474 EYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532
E + V + K DV+ FG+ + E+ + GQ P E + D++ H + D
Sbjct: 185 ESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-----IYDYLRHGNRLKQPED 239
Query: 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
+D+ LY ++M C + PKDRP+ ++ E L+++
Sbjct: 240 CLDE-LY------DLMYS------CWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 51/188 (27%), Positives = 89/188 (47%), Gaps = 27/188 (14%)
Query: 322 LAIKRLSACKLSEKQ-FRSEMNRLGQLRHPNLVPLLGFCVVEEER--LLVYKHMPNGTLY 378
+A+K+L + F E+ L L+H N+V G C R LV +++P G+L
Sbjct: 36 VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLR 95
Query: 379 SLLHGNGVDNTLSGVLDWSTRLRIGM---GASRGLAWLHHGCQPPYMHQYISSNVILIDD 435
L + +L +++++ GM G+ R Y+H+ +++ IL++
Sbjct: 96 DYLQKHRERLDHRKLLLYASQICKGMEYLGSKR------------YVHRDLATRNILVES 143
Query: 436 DFDARITDFGLARLVGSRDPNDSSF-VHGDLGE---FGYVAPEYSSTMVASLKGDVYGFG 491
+ +I DFGL +++ P D + + GE F Y APE + S+ DV+ FG
Sbjct: 144 ENRVKIGDFGLTKVL----PQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFG 198
Query: 492 IVLLELLS 499
+VL EL +
Sbjct: 199 VVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 46/185 (24%), Positives = 78/185 (42%), Gaps = 20/185 (10%)
Query: 324 IKRLSACKLSEKQ--FRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLL 381
+K L A ++Q F E+ +L HPN++ LG C+ LLV + P G L + L
Sbjct: 27 VKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYL 86
Query: 382 HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARI 441
N ++ + R+ + GL WLH Q ++H ++ + D +I
Sbjct: 87 RSNRG--MVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKI 141
Query: 442 TDFGLARLVGSRDPNDSSFVHGDLGEFG--YVAPEYSSTMVASL-------KGDVYGFGI 492
D+GLA + P D ++ D ++APE L K +++ G+
Sbjct: 142 GDYGLAL---EQYPED-YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGV 197
Query: 493 VLLEL 497
+ EL
Sbjct: 198 TMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 65/267 (24%), Positives = 114/267 (42%), Gaps = 41/267 (15%)
Query: 322 LAIKRL-SACKLSEKQ-FRSE---MNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGT 376
+A+K L SE++ SE M+ LG H N+V LLG C + L++ ++ G
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIMSHLGN--HENIVNLLGACTIGGPILVITEYCCYGD 125
Query: 377 LYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL-HHGCQPPYMHQYISSNVILIDD 435
L + L L L ++G+A+L C +H+ +++ +L+
Sbjct: 126 LLNFLRRKR-----ESFLTLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTH 176
Query: 436 DFDARITDFGLARLVGSRDPNDSSFVHGDLGEF--GYVAPEYSSTMVASLKGDVYGFGIV 493
+I DFGLAR + NDS++V ++APE V + + DV+ +GI+
Sbjct: 177 GKIVKICDFGLARDI----MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIL 232
Query: 494 LLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLR 552
L E+ S G P + G VD + +I R + + + +IM+
Sbjct: 233 LWEIFSLGSNP---------YPGMPVDSKFYKLIKEGYR--MAQPEHAPAEIYDIMK--- 278
Query: 553 VACSCVVSRPKDRPSMYQVYESLKSMA 579
+C + P RP+ Q+ + +
Sbjct: 279 ---TCWDADPLKRPTFKQIVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 60/267 (22%), Positives = 119/267 (44%), Gaps = 38/267 (14%)
Query: 321 ALAIKRLSACKLSE-KQFRSEMNRLGQLRHPNLVPLLGFCVVEEER------LLVYKHMP 373
A+ +++ C SE + F SE + + HPN++ L+G C+ E +++ M
Sbjct: 30 AVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMK 89
Query: 374 NGTLYS-LLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVIL 432
+G L+S LL+ D L ++ + G+ +L ++H+ +++ +
Sbjct: 90 HGDLHSFLLYSRLGDCPQ--YLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCM 144
Query: 433 IDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEF--GYVAPEYSSTMVASLKGDVYGF 490
++++ + + DFGL++ + N + G + + ++A E + V + K DV+ F
Sbjct: 145 LNENMNVCVADFGLSKKI----YNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSF 200
Query: 491 GIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQ 549
G+ + E+ + GQ P G E + D++ + D +D LY +M
Sbjct: 201 GVTMWEIATRGQTPY--PGVE---NSEIYDYLRQGNRLKQPPDCLD-GLY------SLMS 248
Query: 550 FLRVACSCVVSRPKDRPSMYQVYESLK 576
SC + PKDRPS + L+
Sbjct: 249 ------SCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 36/149 (24%), Positives = 76/149 (51%), Gaps = 20/149 (13%)
Query: 317 PDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGT 376
P A+ + R K + F E+ + +L++PN++ LLG CV ++ ++ ++M NG
Sbjct: 44 PVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 377 LYSLL----------HGNGVDN-TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQY 425
L L H N + + +++ +L + ++ GM + LA L+ ++H+
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGM---KYLASLN------FVHRD 154
Query: 426 ISSNVILIDDDFDARITDFGLARLVGSRD 454
+++ L+ + + +I DFG++R + S D
Sbjct: 155 LATRNCLVGNHYTIKIADFGMSRNLYSGD 183
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 7e-08
Identities = 63/271 (23%), Positives = 119/271 (43%), Gaps = 35/271 (12%)
Query: 322 LAIKRLSA--CKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER--LLVYKHMPNGTL 377
+A+K L + + ++ E+N L L H N+V G C + + L+ +++P G+L
Sbjct: 36 VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95
Query: 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF 437
L + ++ L+ +L ++ ++ G+A+LH Y+H+ +++ +L+D+D
Sbjct: 96 RDYLPKHKLN--LAQLLLFAQQI------CEGMAYLH---SQHYIHRDLAARNVLLDNDR 144
Query: 438 DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLEL 497
+I DFGLA+ V GD F Y A E S DV+ FG+ L EL
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKENKFSYASDVWSFGVTLYEL 203
Query: 498 L----SGQKP----LDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQ 549
L S Q P ++ G ++G + R +++++ + + +
Sbjct: 204 LTHCDSKQSPPKKFEEMIGPKQG-----------QMTVVRLIELLERGMRLPCPKNCPQE 252
Query: 550 FLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
+ +C + K RP+ + LK M
Sbjct: 253 VYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 1e-07
Identities = 38/130 (29%), Positives = 61/130 (46%), Gaps = 32/130 (24%)
Query: 340 EMNRLGQLRHPNLVPLLGFCVVEEER---LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDW 396
E+ L +LRHPN+V L V + + +V+++M D+ L+G+LD
Sbjct: 48 EIKLLQKLRHPNIVRLKEI-VTSKGKGSIYMVFEYM--------------DHDLTGLLD- 91
Query: 397 STRLRIGMGASR--------GLAWLHHGCQPPYMHQYI-SSNVILIDDDFDARITDFGLA 447
S ++ + GL +LH +H+ I SN ILI++D ++ DFGLA
Sbjct: 92 SPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSN-ILINNDGVLKLADFGLA 147
Query: 448 RLVGSRDPND 457
R R+ D
Sbjct: 148 RPYTKRNSAD 157
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 50/247 (20%), Positives = 97/247 (39%), Gaps = 36/247 (14%)
Query: 337 FRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGN--GVDNTLSGVL 394
FR E++ +L H N+V LLG C E ++ ++ G L L + L
Sbjct: 55 FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114
Query: 395 DWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454
++ + + G+ L + ++H+ +++ L+ + +++ L S+D
Sbjct: 115 STKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSL-----SKD 166
Query: 455 PNDSSFVH--GDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEE 511
+S + L ++APE S K DV+ FG+++ E+ + G+ P EE
Sbjct: 167 VYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE 226
Query: 512 ---GFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSM 568
+ ++ + LY ++M C PKDRPS
Sbjct: 227 VLNRLQAGKLELPVP--------EGCPSRLY------KLMT------RCWAVNPKDRPSF 266
Query: 569 YQVYESL 575
++ +L
Sbjct: 267 SELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 65/292 (22%), Positives = 115/292 (39%), Gaps = 34/292 (11%)
Query: 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRS----EMNRLGQLR 348
+F +E I + V YKA+ L D +A+K++ ++ + + R E++ L QL
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 349 HPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLL-HGNGVDNTLSGVLDWSTRLRIGMGAS 407
HPN++ L + E +V + G L ++ H + W +++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL----C 116
Query: 408 RGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGE 467
L +H MH+ I + I ++ D GL R S+ ++ H +G
Sbjct: 117 SALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK----TTAAHSLVGT 169
Query: 468 FGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527
Y++PE + K D++ G +L E+ + Q P G K NL
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF------YGDKMNLYSLCKK---- 219
Query: 528 GRSRDVVDKSLYGRGNDDEIMQFLR-VACSCVVSRPKDRPSMYQVYESLKSM 578
++K Y D + LR + C+ P+ RP + V + K M
Sbjct: 220 ------IEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 42/192 (21%), Positives = 82/192 (42%), Gaps = 18/192 (9%)
Query: 320 SALAIKRLSACKLSE-------KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372
+ +A+K+++ + + + R E+ + +L HP+++ +LG + L + M
Sbjct: 26 TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWM 85
Query: 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVIL 432
G++ LL G + + RGL++LH + +H+ + +L
Sbjct: 86 AGGSVSHLLSK-------YGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLL 135
Query: 433 IDDD-FDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFG 491
ID RI DFG A + ++ F LG ++APE DV+ G
Sbjct: 136 IDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVG 195
Query: 492 IVLLELLSGQKP 503
V++E+ + + P
Sbjct: 196 CVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 322 LAIKRLSACKLSEKQ---FRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378
+AI L A S+KQ F +E LGQ H N+V L G ++V ++M NG L
Sbjct: 36 VAIHTLRA-GCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALD 94
Query: 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD 438
S L + G L + + G + G+ +L + Y+H+ ++++ +L++ D
Sbjct: 95 SFLRKH------EGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLV 145
Query: 439 ARITDFGLARLVGSRDPNDSSF-VHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLEL 497
+I+ F D +++ + + APE S DV+ FGIV+ E+
Sbjct: 146 CKISGFRR----LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEV 201
Query: 498 LS-GQKPL------DVAGA-EEGFK 514
+S G++P DV A E+GF+
Sbjct: 202 MSYGERPYWDMSGQDVIKAVEDGFR 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 39/182 (21%), Positives = 85/182 (46%), Gaps = 22/182 (12%)
Query: 330 CKLSEKQFRSEMNRLGQLRHPNLVPLLGF---CVVEEERL-LVYKHMPNGTLYSLLHGNG 385
K+ +E+ L ++ N++ + GF V + RL L+ ++ G L +L
Sbjct: 58 HKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL---- 113
Query: 386 VDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445
D L + T+L + + +GL L+ PY + ++S L+ +++ +I G
Sbjct: 114 -DKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKPY--KNLTSVSFLVTENYKLKIICHG 168
Query: 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA--SLKGDVYGFGIVLLELLSGQKP 503
L +++ S + +F+ Y + + + + + ++K D+Y G+VL E+ +G+ P
Sbjct: 169 LEKILSSPPFKNVNFM-------VYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIP 221
Query: 504 LD 505
+
Sbjct: 222 FE 223
|
Length = 283 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (125), Expect = 3e-07
Identities = 43/200 (21%), Positives = 81/200 (40%), Gaps = 43/200 (21%)
Query: 322 LAIKRLSACKLSEKQFR---SEMNRLGQLRHPNLVPLLGFCVVEEERLL-VYKHMPNGTL 377
+K + +SEK+ +E+ L +L HPN++ E+ +L V ++ G L
Sbjct: 28 YVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE-SFEEKGKLCIVMEYADGGDL 86
Query: 378 YSLLHGNGVDNTL---SGVLDWSTRLRIGMGASRGLAWLH--HGCQPPYMHQYISSNVIL 432
+ + +LDW +L + L +LH +H+ I I
Sbjct: 87 SQKIKKQKKEGKPFPEEQILDWFVQLCLA------LKYLHSRK-----ILHRDIKPQNIF 135
Query: 433 IDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFG---YVAPE------YSSTMVASL 483
+ + ++ DFG+++++ S + V G Y++PE Y+
Sbjct: 136 LTSNGLVKLGDFGISKVLSSTVDLAKTVV-------GTPYYLSPELCQNKPYNY------ 182
Query: 484 KGDVYGFGIVLLELLSGQKP 503
K D++ G VL EL + + P
Sbjct: 183 KSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 45/180 (25%), Positives = 89/180 (49%), Gaps = 12/180 (6%)
Query: 323 AIKRLSACKLSEK--QFRSEMNRLGQLRHPNLVPLLGFCVVEE-ERLLVYKHMPNGTLYS 379
A+K L+ E+ QF E + HPN++ LLG C+ E L+V +M +G L +
Sbjct: 27 AVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN 86
Query: 380 LLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439
+ + T+ ++ + G+ ++G+ +L ++H+ +++ ++D+ F
Sbjct: 87 FIRSETHNPTVKDLIGF------GLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTV 137
Query: 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS 499
++ DFGLAR + ++ G ++A E T + K DV+ FG++L EL++
Sbjct: 138 KVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 22/198 (11%)
Query: 312 YKAVLPDASALAIKRLSAC---KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368
Y + + A+A+K C + EK F E + Q HP++V L+G E +V
Sbjct: 27 YMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHIVKLIGVI-TENPVWIV 84
Query: 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS 428
+ P G L S L N L+ ++ +S +L S LA+L ++H+ I++
Sbjct: 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQL------STALAYLE---SKRFVHRDIAA 135
Query: 429 NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEF--GYVAPEYSSTMVASLKGD 486
+L+ ++ DFGL+R + D S+ G+ ++APE + + D
Sbjct: 136 RNVLVSSPDCVKLGDFGLSRYL-----EDESYYKASKGKLPIKWMAPESINFRRFTSASD 190
Query: 487 VYGFGIVLLELLS-GQKP 503
V+ FG+ + E+L G KP
Sbjct: 191 VWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 36/202 (17%)
Query: 316 LPDASALAIKRLSA------CKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369
L D A+K +S + + KQ E+ L +L+HPN+V LG EE+ L ++
Sbjct: 22 LDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLG-TEREEDNLYIF 80
Query: 370 -KHMPNGTLYSLLHGNG------VDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYM 422
+ +P G+L LL G + +L GL +LH +
Sbjct: 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-------------GLEYLH---DRNTV 124
Query: 423 HQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEY-SSTMVA 481
H+ I IL+D + ++ DFG+A+ V SF G ++APE +
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAKSFK----GSPYWMAPEVIAQQGGY 179
Query: 482 SLKGDVYGFGIVLLELLSGQKP 503
L D++ G +LE+ +G+ P
Sbjct: 180 GLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 51/213 (23%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 309 GVSYKAV-LPDASAL----AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVV 361
G YK + +P+ + AIK L + + K+ E + + +P++ LLG C+
Sbjct: 21 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 80
Query: 362 EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPY 421
+L + + MP G L + + + +L+W ++ ++G+ +L +
Sbjct: 81 STVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLE---ERRL 130
Query: 422 MHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGE--FGYVAPEYSSTM 479
+H+ +++ +L+ +ITDFGLA+L+G+ D H + G+ ++A E
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGA----DEKEYHAEGGKVPIKWMALESILHR 186
Query: 480 VASLKGDVYGFGIVLLELLS-GQKPLDVAGAEE 511
+ + + DV+ +G+ + EL++ G KP D A E
Sbjct: 187 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 5e-07
Identities = 45/185 (24%), Positives = 82/185 (44%), Gaps = 21/185 (11%)
Query: 323 AIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLH 382
AIK++ K +++ +E+ + +HPN+V +V +E +V ++M G+L ++
Sbjct: 48 AIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT 107
Query: 383 GNGVDNTLSGVLDWSTRLRIG--MGAS-RGLAWLH-HGCQPPYMHQYISSNVILIDDDFD 438
N V +I +GL +LH +H+ I S+ IL+ D
Sbjct: 108 QNFVRMNEP---------QIAYVCREVLQGLEYLHSQNV----IHRDIKSDNILLSKDGS 154
Query: 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELL 498
++ DFG A + +S V G ++APE K D++ GI+ +E+
Sbjct: 155 VKLADFGFAAQLTKEKSKRNSVV----GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
Query: 499 SGQKP 503
G+ P
Sbjct: 211 EGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 43/177 (24%), Positives = 84/177 (47%), Gaps = 34/177 (19%)
Query: 340 EMNRLGQLRHPNLVPLLGFCVVEEERLLVY-KHMPNGTLYSLLHGNG------VDNTLSG 392
E+ L +L+H N+V LG ++ + L ++ +++P G++ +LL+ G V N +
Sbjct: 56 EIALLKELQHENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ 114
Query: 393 VLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR---- 448
+L +GL +LH +H+ I IL+D+ +I+DFG+++
Sbjct: 115 IL-------------KGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158
Query: 449 --LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKP 503
L + S G ++APE + K D++ G +++E+L+G+ P
Sbjct: 159 NSLSTKTNGARPSL----QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 55/246 (22%), Positives = 102/246 (41%), Gaps = 36/246 (14%)
Query: 336 QFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLD 395
+F E L Q HPN+V L+G C ++ +V + + G + L G L
Sbjct: 39 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR------LK 92
Query: 396 WSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDP 455
+++ A+ G+ +L +H+ +++ L+ + +I+DFG+ SR+
Sbjct: 93 VKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGM-----SREE 144
Query: 456 NDSSFVH-GDLGEF--GYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEE 511
D + G + + + APE + S + DV+ FGI+L E S G P
Sbjct: 145 EDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPY------- 197
Query: 512 GFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQV 571
NL + ++R+ +++ + + R+ C P RPS V
Sbjct: 198 ---ANLSN--------QQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTV 246
Query: 572 YESLKS 577
++ L+S
Sbjct: 247 HQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 43/197 (21%), Positives = 91/197 (46%), Gaps = 23/197 (11%)
Query: 318 DASALAIKRLSACKLSEKQ---FRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374
D + IK++ ++++ + ++E L L HPN++ + ++ ++V ++ P
Sbjct: 24 DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPG 83
Query: 375 GTLYSLLHGNGVDNTL---SGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVI 431
GTL + N+L +L + ++ + LHH +H+ + + I
Sbjct: 84 GTLAEYIQKRC--NSLLDEDTILHFFVQILLA---------LHHVHTKLILHRDLKTQNI 132
Query: 432 LIDD-DFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGF 490
L+D +I DFG+++++ S+ S + +G Y++PE + K D++
Sbjct: 133 LLDKHKMVVKIGDFGISKILSSK-----SKAYTVVGTPCYISPELCEGKPYNQKSDIWAL 187
Query: 491 GIVLLELLSGQKPLDVA 507
G VL EL S ++ + A
Sbjct: 188 GCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 43/183 (23%), Positives = 87/183 (47%), Gaps = 16/183 (8%)
Query: 322 LAIKRLSACKLSEKQFR-SEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
+AIK+++ K +K+ +E+ + +L++PN+V L +V +E +V +++ G+L
Sbjct: 47 VAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL--- 103
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDAR 440
D +D + + + L +LH +H+ I S+ +L+ D +
Sbjct: 104 -----TDVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVK 155
Query: 441 ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSG 500
+TDFG + S+ V G ++APE + K D++ GI+ +E++ G
Sbjct: 156 LTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
Query: 501 QKP 503
+ P
Sbjct: 212 EPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 63/273 (23%), Positives = 123/273 (45%), Gaps = 33/273 (12%)
Query: 313 KAVLPDA--SALAIKRLS-ACKLSEK-QFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368
K V+ D + +AIK ++ A + E+ +F +E + + + ++V LLG + L++
Sbjct: 28 KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 87
Query: 369 YKHMPNGTLYSLLHG---NGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQY 425
+ M G L S L +N + +++ + G+A+L+ ++H+
Sbjct: 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRD 144
Query: 426 ISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLG--EFGYVAPEYSSTMVASL 483
+++ ++ +DF +I DFG+ R + D + G G +++PE V +
Sbjct: 145 LAARNCMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPVRWMSPESLKDGVFTT 200
Query: 484 KGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGN 543
DV+ FG+VL E+ + AE+ ++G + V V+ G D D
Sbjct: 201 YSDVWSFGVVLWEIAT--------LAEQPYQGMSNEQVLRFVMEGGLLDKPDNC------ 246
Query: 544 DDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576
D + + +R+ C PK RPS ++ S+K
Sbjct: 247 PDMLFELMRM---CWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 53/213 (24%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 309 GVSYKAV-LPDAS------ALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVV 361
G YK + +PD A+ + R + + K+ E + + P + LLG C+
Sbjct: 21 GTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80
Query: 362 EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPY 421
+L V + MP G L + N +L+W ++ ++G+++L +
Sbjct: 81 STVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE---EVRL 130
Query: 422 MHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGE--FGYVAPEYSSTM 479
+H+ +++ +L+ +ITDFGLARL+ D +++ + H D G+ ++A E
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLL---DIDETEY-HADGGKVPIKWMALESILHR 186
Query: 480 VASLKGDVYGFGIVLLELLS-GQKPLDVAGAEE 511
+ + DV+ +G+ + EL++ G KP D A E
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 69/274 (25%), Positives = 114/274 (41%), Gaps = 38/274 (13%)
Query: 339 SEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGN---GVDNTLSGV- 393
SEM + + +H N++ LLG C E ++ ++ G L L G D T
Sbjct: 66 SEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125
Query: 394 -----LDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447
L + + +RG+ +L C +H+ +++ +L+ +D +I DFGLA
Sbjct: 126 VPEEQLSFKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDV 506
R V D + +G L ++APE V + + DV+ FGI++ E+ + G P
Sbjct: 182 RGVHDIDYYKKT-SNGRL-PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239
Query: 507 AGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP 566
EE FK L+ G D + E+ +R C + P RP
Sbjct: 240 IPVEELFK---------LLREGHRMDKPSNCTH------ELYMLMR---ECWHAVPTQRP 281
Query: 567 SMYQVYESLKSMAEKHGFSEPYDEFPMIFGKQDP 600
+ Q+ E+L + SE Y + M F + P
Sbjct: 282 TFKQLVEALDKVLA--AVSEEYLDLSMPFEQYSP 313
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 51/182 (28%), Positives = 90/182 (49%), Gaps = 23/182 (12%)
Query: 340 EMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN-GTLYSLLHGNGVDNTLSGVLDWST 398
E N + QL +P +V ++G C E E ++ + G L L N T + +
Sbjct: 46 EANVMQQLDNPYIVRMIGIC--EAESWMLVMELAELGPLNKFLQKNK-HVTEKNITELVH 102
Query: 399 RLRIGMGASRGLAWLHHGCQPPYMHQYISS-NVILIDDDFDARITDFGLARLVGSRDPND 457
++ +GM +L + ++H+ +++ NV+L+ + A+I+DFGL++ +G+ +
Sbjct: 103 QVSMGM------KYLE---ETNFVHRDLAARNVLLVTQHY-AKISDFGLSKALGADENYY 152
Query: 458 SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGN 516
+ HG + APE + S K DV+ FG+++ E S GQKP +G KGN
Sbjct: 153 KAKTHGKW-PVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY------KGMKGN 205
Query: 517 LV 518
V
Sbjct: 206 EV 207
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 67/249 (26%), Positives = 104/249 (41%), Gaps = 40/249 (16%)
Query: 277 LFQKPIVKVKLADLLAATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEK 335
LF + L L T+++ + I G YK D S A+K L ++
Sbjct: 4 LFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE 63
Query: 336 QFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYK--HMPNGTLY---SLLHGNGVDNT 389
+ +E N L L HPN+V G + YK + G L+ L +G V
Sbjct: 64 EIEAEYNILQSLPNHPNVVKFYG---------MFYKADKLVGGQLWLVLELCNGGSVTEL 114
Query: 390 LSGVLDWSTRLRIGM------GASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443
+ G+L RL M GA GL LH+ +H+ + N IL+ + ++ D
Sbjct: 115 VKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVD 171
Query: 444 FGL-ARLVGSRDPNDSSFVHGDLGEFGYVAPE-------YSSTMVASLKGDVYGFGIVLL 495
FG+ A+L +R ++S +G ++APE Y + A + DV+ GI +
Sbjct: 172 FGVSAQLTSTRLRRNTS-----VGTPFWMAPEVIACEQQYDYSYDA--RCDVWSLGITAI 224
Query: 496 ELLSGQKPL 504
EL G PL
Sbjct: 225 ELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 409 GLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEF 468
GL LH + +++ + IL+DD RI+D GLA + + + G +G
Sbjct: 114 GLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-----SIRGRVGTV 165
Query: 469 GYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPL 504
GY+APE + +L D +G G ++ E++ GQ P
Sbjct: 166 GYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 54/197 (27%), Positives = 85/197 (43%), Gaps = 41/197 (20%)
Query: 323 AIKRLSACKLSE---KQFRSEMNRLGQLRHPNLVPLLGFCVVEEER--LLVYKHMPNGTL 377
AIK++ SE K E+ L +L HPN++ LL V + LV++ M + L
Sbjct: 28 AIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD--VFRHKGDLYLVFEFM-DTDL 84
Query: 378 YSLLHGN--GVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQYISSNVILID 434
Y L+ G+ +L + +GLA+ H HG +H+ + +LI+
Sbjct: 85 YKLIKDRQRGLPESLIKSYLYQL--------LQGLAFCHSHGI----LHRDLKPENLLIN 132
Query: 435 DDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE-------YSSTMVASLKGDV 487
+ ++ DFGLAR GS + Y APE YS+ + D+
Sbjct: 133 TEGVLKLADFGLARSFGS----PVRPYTHYVVTRWYRAPELLLGDKGYSTPV------DI 182
Query: 488 YGFGIVLLELLSGQKPL 504
+ G + ELLS + PL
Sbjct: 183 WSVGCIFAELLSRR-PL 198
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 27/198 (13%)
Query: 313 KAVL----PDASALAIKRLSACKLSEKQ---FRSEMNRLGQLRHPNLVPLLGFCVVEEER 365
KA+L D IK ++ K+S K+ R E+ L ++HPN+V + EE
Sbjct: 15 KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ---YQESFEEN 71
Query: 366 LLVYKHM---PNGTLYSLLHGN-GVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPY 421
+Y M G LY ++ GV +LDW ++ + L H
Sbjct: 72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA---------LKHVHDRKI 122
Query: 422 MHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA 481
+H+ I S I + D ++ DFG+AR++ S +G Y++PE
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNS----TVELARTCIGTPYYLSPEICENRPY 178
Query: 482 SLKGDVYGFGIVLLELLS 499
+ K D++ G VL E+ +
Sbjct: 179 NNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 53/216 (24%), Positives = 85/216 (39%), Gaps = 59/216 (27%)
Query: 323 AIKRLSACKLS----EKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERL-LVYKHMPNGT 376
AIK L +L K + E L +L HP ++ L + +EE L V ++ PNG
Sbjct: 30 AIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGE 88
Query: 377 LYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNV------ 430
L + G +L + TR A + + Y+H S +
Sbjct: 89 LLQYIRKYG---SLD---EKCTRFYA--------AEILLALE--YLH---SKGIIHRDLK 129
Query: 431 ---ILIDDDFDARITDFGLARLVGSRDPNDS--------------------SFVHGDLGE 467
IL+D D +ITDFG A+++ +S SFV G
Sbjct: 130 PENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV----GT 185
Query: 468 FGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKP 503
YV+PE + A D++ G ++ ++L+G+ P
Sbjct: 186 AEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 37/122 (30%), Positives = 57/122 (46%), Gaps = 7/122 (5%)
Query: 55 ICRLTGVACWNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLC 114
I + + + + L LS ++ LP L +L++LDLS N LS +P L
Sbjct: 128 ITDIPPLIGLLKSNLK--ELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLS 183
Query: 115 KWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVA 174
L + LDLS N +S +PP+I L +L LSNN + + +S L L ++
Sbjct: 184 N-LSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELS 240
Query: 175 GN 176
N
Sbjct: 241 NN 242
|
Length = 394 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 65/277 (23%), Positives = 115/277 (41%), Gaps = 35/277 (12%)
Query: 339 SEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGN---GVDNTLSGV- 393
SEM + + +H N++ LLG C + ++ ++ G L L G+D +
Sbjct: 66 SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 394 -----LDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448
L + + +RG+ +L +H+ +++ +L+ +D +I DFGLAR
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
Query: 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVA 507
V + D + +G L ++APE V + + DV+ FG++L E+ + G P
Sbjct: 183 DVHNIDYYKKT-TNGRL-PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240
Query: 508 GAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS 567
EE FK L+ G D + E+ +R C + P RP+
Sbjct: 241 PVEELFK---------LLKEGHRMDKPANCTH------ELYMIMR---ECWHAVPSQRPT 282
Query: 568 MYQVYESLKSMAEKHGFSEPYDEFPMIFGKQDPDCKE 604
Q+ E L + E Y + + F + P C +
Sbjct: 283 FKQLVEDLDRVLTVTSTDE-YLDLSVPFEQYSPGCPD 318
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 47/190 (24%), Positives = 89/190 (46%), Gaps = 28/190 (14%)
Query: 322 LAIKRLSACKLSEKQFRSEM--NRLGQLR---HPNLVPLLGFCVVEEERLLVYKHMPNGT 376
+A+K++ KQ R E+ N + +R HPN+V + +V +E +V + + G
Sbjct: 47 VAVKKMDL----RKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102
Query: 377 LYSLL-HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQYISSNVILID 434
L ++ H + ++ V + + L++LH G +H+ I S+ IL+
Sbjct: 103 LTDIVTHTRMNEEQIATVC---------LAVLKALSFLHAQGV----IHRDIKSDSILLT 149
Query: 435 DDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVL 494
D +++DFG V P S V G ++APE S + + D++ GI++
Sbjct: 150 SDGRVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMAPEVISRLPYGTEVDIWSLGIMV 205
Query: 495 LELLSGQKPL 504
+E++ G+ P
Sbjct: 206 IEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 36/140 (25%), Positives = 68/140 (48%), Gaps = 15/140 (10%)
Query: 321 ALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
A+ I R A K + F E+ L +L+ PN++ LLG CV E+ ++ ++M NG L
Sbjct: 50 AVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQF 109
Query: 381 LH--------GNGVDNTLSG----VLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS 428
L NG D + +S+ L + + + G+ +L ++H+ +++
Sbjct: 110 LSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLAT 166
Query: 429 NVILIDDDFDARITDFGLAR 448
L+ ++ +I DFG++R
Sbjct: 167 RNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 58/259 (22%), Positives = 114/259 (44%), Gaps = 37/259 (14%)
Query: 318 DASALAIKRLSACKLSEKQFRSEMNR---LGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374
D S + K ++ +LSEK+ R +N L L+HPN++ + + L+ ++
Sbjct: 24 DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANG 83
Query: 375 GTLYS-LLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS-NVIL 432
GTLY ++ G VL + ++ ++++H + +H+ I + N+ L
Sbjct: 84 GTLYDKIVRQKGQLFEEEMVLWYLFQI------VSAVSYIH---KAGILHRDIKTLNIFL 134
Query: 433 IDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGI 492
++ DFG+++++GS + S +G Y++PE + + K D++ G
Sbjct: 135 TKAGL-IKLGDFGISKILGS----EYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGC 189
Query: 493 VLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLR 552
VL ELL+ ++ D N ++ V +V G VV E++ +
Sbjct: 190 VLYELLTLKRTFDAT--------NPLNLVVKIV-QGNYTPVVS------VYSSELISLVH 234
Query: 553 VACSCVVSRPKDRPSMYQV 571
S + P+ RP+ +V
Sbjct: 235 ---SLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 63/259 (24%), Positives = 109/259 (42%), Gaps = 42/259 (16%)
Query: 318 DASALAIKRLSACKLSEKQFRSEMNR---LGQLRHPNLVPLLGFCVVEEERL-LVYKHMP 373
D+ IK + K+ K+ + L +++HPN+V E RL +V ++
Sbjct: 24 DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA-SFQENGRLFIVMEYCD 82
Query: 374 NGTLYSLLH-GNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYI-SSNVI 431
G L ++ GV + +L W ++ +G L H +H+ I S N+
Sbjct: 83 GGDLMKRINRQRGVLFSEDQILSWFVQISLG---------LKHIHDRKILHRDIKSQNIF 133
Query: 432 LIDDDFDARITDFGLARLVGSRDPNDS-SFVHGDLGEFGYVAPEYSSTMVASLKGDVYGF 490
L + A++ DFG+AR + NDS + +G Y++PE + K D++
Sbjct: 134 LSKNGMVAKLGDFGIARQL-----NDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSL 188
Query: 491 GIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA-GRSRDVVDKSLYGRGNDDEIMQ 549
G VL EL + + P F+GN ++ LV+ + + R I Q
Sbjct: 189 GCVLYELCTLKHP---------FEGNN---LHQLVLKICQGYFAPISPNFSRDLRSLISQ 236
Query: 550 FLRVACSCVVSRPKDRPSM 568
+V+ P+DRPS+
Sbjct: 237 LFKVS-------PRDRPSI 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 63/292 (21%), Positives = 117/292 (40%), Gaps = 71/292 (24%)
Query: 318 DASAL-AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374
DA L A+K L A + + F E+ L +L PN+ LLG C V+ ++ ++M N
Sbjct: 44 DAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMEN 103
Query: 375 GTL------YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS 428
G L + N+ S L +ST L + + G+ +L ++H+ +++
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKS--LSFSTLLYMATQIASGMRYLE---SLNFVHRDLAT 158
Query: 429 NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGD--------------LGEFGYVAPE 474
L+ ++ +I DFG++R + S +D V G LG+F
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLYS---SDYYRVQGRAPLPIRWMAWESVLLGKF------ 209
Query: 475 YSSTMVASLKGDVYGFGIVLLELLS--GQKPLD-------VAGAEEGFKGNLVDWVNHLV 525
+ K DV+ FG+ L E+L+ ++P + + A F+ + +
Sbjct: 210 -------TTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDD-----GRQI 257
Query: 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577
R + K +Y + C +DRP+ +++ L+
Sbjct: 258 YLPRPPN-CPKDIY------------ELMLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 25/189 (13%)
Query: 321 ALAIKRL----SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGT 376
+AIK++ S L+++ +R E+ L LRH N++ L + E + +
Sbjct: 37 NVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTD 95
Query: 377 LYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD 436
L+ LL ++ + RGL ++H +H+ + + ILI+++
Sbjct: 96 LHRLLTSRPLEKQFIQYFLYQIL--------RGLKYVHSA---GVVHRDLKPSNILINEN 144
Query: 437 FDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA-SLKGDVYGFGIVLL 495
D +I DFGLAR+ +DP + +V Y APE T ++ D++ G +
Sbjct: 145 CDLKICDFGLARI---QDPQMTGYVSTRY----YRAPEIMLTWQKYDVEVDIWSAGCIFA 197
Query: 496 ELLSGQKPL 504
E+L G KPL
Sbjct: 198 EMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 47/172 (27%), Positives = 77/172 (44%), Gaps = 26/172 (15%)
Query: 337 FRSEMNRLGQLRHPNLVPLLGFCVVEEER--LLVYKHMPNGTLYSLLHGNGVDNTLSGVL 394
+ E+ L L H N+V G C + L+ + +P+G+L L N L L
Sbjct: 53 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL 112
Query: 395 DWSTRLRIGMG--ASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452
++ ++ GM SR Y+H+ +++ +L++ + +I DFGL + +
Sbjct: 113 KYAVQICKGMDYLGSRQ-----------YVHRDLAARNVLVESEHQVKIGDFGLTKAI-- 159
Query: 453 RDPNDSSFVHGDLGE--FGYVAPE---YSSTMVASLKGDVYGFGIVLLELLS 499
+ V DL F Y APE S +AS DV+ FG+ L ELL+
Sbjct: 160 ETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIAS---DVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 45/178 (25%), Positives = 83/178 (46%), Gaps = 19/178 (10%)
Query: 336 QFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLL-HGNGVDNTLSGVL 394
Q E+ L + P +V G + E + +HM G+L +L + + G
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-- 106
Query: 395 DWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA-RLVGSR 453
++ + RGLA+L Q MH+ + + IL++ + ++ DFG++ +L+
Sbjct: 107 ------KVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--- 155
Query: 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEE 511
D +SFV G Y++PE S++ D++ G+ L+EL G+ P+ A+E
Sbjct: 156 DSMANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 46/172 (26%), Positives = 69/172 (40%), Gaps = 27/172 (15%)
Query: 340 EMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHG--NGVDNTLSGVLDWS 397
E+ L QLRH N+V L + LV++++ TL LL G+ W
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQ 108
Query: 398 TRLRIGMGASRGLAWLH-HGCQPPYMHQYISSNVILIDDDFDARITDFGLAR-LVGSRDP 455
+ +A+ H H +H+ I IL+ + ++ DFG AR L
Sbjct: 109 L--------LQAIAYCHSHNI----IHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156
Query: 456 NDSSFVHGDLGEFGYVAPEY--SSTMVASLKG-DVYGFGIVLLELLSGQKPL 504
+ +V Y APE T K DV+ G ++ ELL G+ PL
Sbjct: 157 PLTDYV----ATRWYRAPELLVGDTNYG--KPVDVWAIGCIMAELLDGE-PL 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 313 KAVLPDASALAIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV-Y 369
K V AS + + L +C L L H N++P+L C+ + E V Y
Sbjct: 41 KTVKDHASEIQVTLLLQESCLLYG------------LSHQNILPILHVCIEDGEPPFVLY 88
Query: 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGA--SRGLAWLH-HGCQPPYMHQYI 426
+M G L L + ST+ + M + G+++LH G +H+ I
Sbjct: 89 PYMNWGNLKLFLQ-QCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGV----IHKDI 143
Query: 427 SSNVILIDDDFDARITDFGLARLVGSRD--PNDSSFVHGDLGE---FGYVAPEYSSTMVA 481
++ +ID++ +ITD L SRD P D + GD E ++A E
Sbjct: 144 AARNCVIDEELQVKITDNAL-----SRDLFPMDYHCL-GD-NENRPVKWMALESLVNKEY 196
Query: 482 SLKGDVYGFGIVLLELLS-GQKP 503
S DV+ FG++L EL++ GQ P
Sbjct: 197 SSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 5e-06
Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 38/197 (19%)
Query: 323 AIKRLSACKLSEKQ-------FRSEMNRLGQLRHPNLVPLLGFCVVEEERL-LVYKHMPN 374
AIK++ + E + R E+ L +L+HPN++ LL + + LV++ M
Sbjct: 29 AIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNIIGLLD-VFGHKSNINLVFEFME- 85
Query: 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID 434
L ++ + T + + + RGL +LH +H+ + N +LI
Sbjct: 86 TDLEKVIKDKSIVLTPADIKSYMLMT------LRGLEYLHSNW---ILHRDLKPNNLLIA 136
Query: 435 DDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE-------YSSTMVASLKGDV 487
D ++ DFGLAR GS PN H + + Y APE Y + D+
Sbjct: 137 SDGVLKLADFGLARSFGS--PNR-KMTHQVVTRW-YRAPELLFGARHYGVGV------DM 186
Query: 488 YGFGIVLLELLSGQKPL 504
+ G + ELL + P
Sbjct: 187 WSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 5e-06
Identities = 63/247 (25%), Positives = 103/247 (41%), Gaps = 32/247 (12%)
Query: 323 AIKRLSACKLSEK----QFRSEMNRLGQLRHPNLVPLLGFCVVEEERL-LVYKHMPNGTL 377
AIK + + K Q +E + L Q + P +V L + ++ L LV +++P G L
Sbjct: 22 AIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDL 80
Query: 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQYISSNVILIDDD 436
SLL G LD L +LH +G +H+ + + ILID +
Sbjct: 81 ASLLEN-------VGSLDEDVARIYIAEIVLALEYLHSNGI----IHRDLKPDNILIDSN 129
Query: 437 FDARITDFGLAR--LVGSRD--PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGI 492
++TDFGL++ LV + +D +G Y+APE S D + G
Sbjct: 130 GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGC 189
Query: 493 VLLELLSGQKPLDVAGAEEGFK---GNLVDWVNHLVIAGRSRDVVDKSLY-------GRG 542
+L E L G P EE F+ ++W + ++ + D++ K L G
Sbjct: 190 ILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAK 249
Query: 543 NDDEIMQ 549
+ +EI
Sbjct: 250 SIEEIKN 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 41/159 (25%), Positives = 62/159 (38%), Gaps = 21/159 (13%)
Query: 344 LGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIG 403
L + HP+++ + V +V H + LY+ L S L L I
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKR------SRPLPIDQALIIE 163
Query: 404 MGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHG 463
GL +LH +H+ + + I I+D I D G A+ P
Sbjct: 164 KQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAF------ 213
Query: 464 DLGEFGYV---APEYSSTMVASLKGDVYGFGIVLLELLS 499
LG G V APE + + K D++ GIVL E+L+
Sbjct: 214 -LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 50/204 (24%), Positives = 91/204 (44%), Gaps = 25/204 (12%)
Query: 309 GVSYKAV-LPDASALAIK--RLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER 365
GV K + P +A+K RL + +KQ E++ L + P +V G +
Sbjct: 15 GVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDI 74
Query: 366 LLVYKHMPNGTL---YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYM 422
+ ++M G+L + G + L +I + +GL +LH + +
Sbjct: 75 SICMEYMDGGSLDKILKEVQGRIPERILG---------KIAVAVLKGLTYLHE--KHKII 123
Query: 423 HQYISSNVILIDDDFDARITDFGLA-RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA 481
H+ + + IL++ ++ DFG++ +LV S +FV G Y+APE
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---KTFV----GTSSYMAPERIQGNDY 176
Query: 482 SLKGDVYGFGIVLLELLSGQKPLD 505
S+K D++ G+ L+EL +G+ P
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 63/290 (21%), Positives = 114/290 (39%), Gaps = 34/290 (11%)
Query: 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRS----EMNRLGQLRHP 350
+F +E I + Y+A L D +A+K++ L + + R+ E++ L QL HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 351 NLVPLLGFCVVEEERLLVYKHMPNGTLYSLL-HGNGVDNTLSGVLDWSTRLRIGMGASRG 409
N++ + + E +V + G L ++ H + W +++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL------- 115
Query: 410 LAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFG 469
+ L H MH+ I + I ++ D GL R S+ ++ H +G
Sbjct: 116 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK----TTAAHSLVGTPY 171
Query: 470 YVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529
Y++PE + K D++ G +L E+ + Q P G K NL
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF------YGDKMNLYSLCKK------ 219
Query: 530 SRDVVDKSLYGRGNDDEIMQFLR-VACSCVVSRPKDRPSMYQVYESLKSM 578
+++ Y D + LR + C+ P+ RP + VY+ K M
Sbjct: 220 ----IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 26/74 (35%), Positives = 38/74 (51%), Gaps = 5/74 (6%)
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGF 490
IL+DD RI+D GLA V P + + G +G GY+APE + D +
Sbjct: 133 ILLDDHGHIRISDLGLAVHV----PEGQT-IKGRVGTVGYMAPEVVKNERYTFSPDWWAL 187
Query: 491 GIVLLELLSGQKPL 504
G +L E+++GQ P
Sbjct: 188 GCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 45/198 (22%), Positives = 91/198 (45%), Gaps = 17/198 (8%)
Query: 308 TGVSYKAV-LPDASALAIKRLSACKLSEKQFR-SEMNRLGQLRHPNLVPLLGFCVVEEER 365
+G Y A+ + +AIK+++ + +K+ +E+ + + ++PN+V L +V +E
Sbjct: 32 SGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91
Query: 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQY 425
+V +++ G+L D +D + + L +LH +H+
Sbjct: 92 WVVMEYLAGGSL--------TDVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIHRD 140
Query: 426 ISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKG 485
I S+ IL+ D ++TDFG + S+ V G ++APE + K
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVTRKAYGPKV 196
Query: 486 DVYGFGIVLLELLSGQKP 503
D++ GI+ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 43/177 (24%), Positives = 84/177 (47%), Gaps = 15/177 (8%)
Query: 333 SEKQFR---SEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNT 389
+EK++ E++ L L+H N+V LG C+ + + + +P G++ S+L+ G
Sbjct: 42 AEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP--L 99
Query: 390 LSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449
V T+ + G+A+LH+ C +H+ I N +++ + ++ DFG AR
Sbjct: 100 PEPVFCKYTKQIL-----DGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARR 151
Query: 450 VG--SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPL 504
+ S+ + G ++APE + K D++ G + E+ +G+ PL
Sbjct: 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (113), Expect = 1e-05
Identities = 53/212 (25%), Positives = 84/212 (39%), Gaps = 71/212 (33%)
Query: 323 AIKRL-------SAC-KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374
AIK++ C L E + ++N HPN+V L +E V+++M
Sbjct: 28 AIKKMKKKFYSWEECMNLREVKSLRKLNE-----HPNIVKLKEVFRENDELYFVFEYM-E 81
Query: 375 GTLYSLLHGNG--------VDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQY 425
G LY L+ + + + +L GLA +H HG + H+
Sbjct: 82 GNLYQLMKDRKGKPFSESVIRSIIYQILQ-------------GLAHIHKHG----FFHRD 124
Query: 426 ISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV------APE----- 474
+ +L+ +I DFGLAR + SR P + D YV APE
Sbjct: 125 LKPENLLVSGPEVVKIADFGLAREIRSRPP------YTD-----YVSTRWYRAPEILLRS 173
Query: 475 --YSSTMVASLKGDVYGFGIVLLELLSGQKPL 504
YSS + D++ G ++ EL + +PL
Sbjct: 174 TSYSSPV------DIWALGCIMAELYTL-RPL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 39/165 (23%), Positives = 78/165 (47%), Gaps = 15/165 (9%)
Query: 341 MNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRL 400
M +G L H +V LLG C +L V + P G+L + + +L+W ++
Sbjct: 60 MLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI 118
Query: 401 RIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSF 460
++G+ +L +H+ +++ IL+ D +I DFG+A L+ P+D +
Sbjct: 119 ------AKGMYYLEEHRM---VHRNLAARNILLKSDSIVQIADFGVADLL---YPDDKKY 166
Query: 461 VHGDLG-EFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKP 503
+ + ++A E + + DV+ +G+ + E++S G +P
Sbjct: 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 42/184 (22%), Positives = 85/184 (46%), Gaps = 18/184 (9%)
Query: 322 LAIKRLSACKLSEKQFR-SEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
+A+K++ K ++ +E+ + H N+V + +V +E +V + + G L +
Sbjct: 50 VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDI 109
Query: 381 L-HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439
+ H + ++ V + R L++LH +H+ I S+ IL+ D
Sbjct: 110 VTHTRMNEEQIATVC---------LSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRI 157
Query: 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS 499
+++DFG V P S V G ++APE S + + D++ GI+++E++
Sbjct: 158 KLSDFGFCAQVSKEVPKRKSLV----GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMID 213
Query: 500 GQKP 503
G+ P
Sbjct: 214 GEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 57/280 (20%), Positives = 108/280 (38%), Gaps = 54/280 (19%)
Query: 311 SYKAV-----LPDASALAIKRLSACKLSEKQFRSEMNR---LGQLRHPNLVP-----LLG 357
SY +V L D A+K + +S+K+ +N L + HPN++ L G
Sbjct: 12 SYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG 71
Query: 358 --FCVVEEERLLVYKHMPNGTLYSLL-HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH 414
C+V E + P G L + + W +++ RGL LH
Sbjct: 72 NKLCIVME-------YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL----LRGLQALH 120
Query: 415 HGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE 474
+ +H+ + S IL+ + +I D G+++++ +G Y+APE
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN------MAKTQIGTPHYMAPE 171
Query: 475 YSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534
S K D++ G +L E+ + P + ++ + + V G+ +
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---------LRYKVQRGKYPPIP 222
Query: 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574
++ F+R S + +PK RP+ ++ S
Sbjct: 223 PI------YSQDLQNFIR---SMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 46/198 (23%), Positives = 91/198 (45%), Gaps = 17/198 (8%)
Query: 308 TGVSYKAV-LPDASALAIKRLSACKLSEKQFR-SEMNRLGQLRHPNLVPLLGFCVVEEER 365
+G Y A+ + +AIK+++ + +K+ +E+ + + +HPN+V L +V +E
Sbjct: 32 SGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDEL 91
Query: 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQY 425
+V +++ G+L D +D + + L +LH +H+
Sbjct: 92 WVVMEYLAGGSL--------TDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 140
Query: 426 ISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKG 485
I S+ IL+ D ++TDFG + S+ V G ++APE + K
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVTRKAYGPKV 196
Query: 486 DVYGFGIVLLELLSGQKP 503
D++ GI+ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 53/234 (22%), Positives = 96/234 (41%), Gaps = 43/234 (18%)
Query: 346 QLRHPNLVPLLGFCVVEEERLLVYKHM----PNGTLYSLL---HGNGVDNTLSGVLDWST 398
QLRHPN+V +E +RL + + P G ++ L + + W+
Sbjct: 65 QLRHPNIVRYYK-TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-----WNI 118
Query: 399 RLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDS 458
+++ + L +LH + +H+ ++ N I++ +D ITDFGLA+ + P
Sbjct: 119 FVQMVLA----LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPE-- 167
Query: 459 SFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLV 518
S + +G Y PE K DV+ FG +L ++ + Q P + N++
Sbjct: 168 SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF--------YSTNML 219
Query: 519 DWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLR-VACSCVVSRPKDRPSMYQV 571
+V A +Y + + + V SC+ + RP + QV
Sbjct: 220 SLATKIVEA----------VYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 23/73 (31%), Positives = 37/73 (50%), Gaps = 5/73 (6%)
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGF 490
IL+DD RI+D GLA + + + G +G GY+APE + D +G
Sbjct: 133 ILLDDYGHIRISDLGLAVEIPEGET-----IRGRVGTVGYMAPEVVKNERYTFSPDWWGL 187
Query: 491 GIVLLELLSGQKP 503
G ++ E++ G+ P
Sbjct: 188 GCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 50/176 (28%), Positives = 75/176 (42%), Gaps = 36/176 (20%)
Query: 340 EMNRLGQLRHPNLVPLLGFCVVEEERL--LVYKHMPNGTLYSL-LHGNGVDNTLSGVLDW 396
E+ L QL+HPNLV L+ V +R LV+++ + L L + GV L + W
Sbjct: 50 EIRMLKQLKHPNLVNLIE--VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIW 107
Query: 397 STRLRIGMGASRGLAWLH-HGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDP 455
T + + H H C +H+ + ILI ++ DFG AR++
Sbjct: 108 QTLQ--------AVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155
Query: 456 NDSSFVHGDLGEFGYVAPE-------YSSTMVASLKGDVYGFGIVLLELLSGQKPL 504
+ + +V Y APE Y + DV+ G V ELL+GQ PL
Sbjct: 156 DYTDYV----ATRWYRAPELLVGDTQYGPPV------DVWAIGCVFAELLTGQ-PL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 64/275 (23%), Positives = 109/275 (39%), Gaps = 36/275 (13%)
Query: 317 PDASALAIKRL--SACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMP 373
+ S +A+K L A + SEM + + +H N++ LLG C E +V ++
Sbjct: 40 NETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAA 99
Query: 374 NGTLYSLLHGN---GVDNTLSGVLDWSTRL------RIGMGASRGLAWLHHGCQPPYMHQ 424
+G L L G + L +RG+ +L +H+
Sbjct: 100 HGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHR 156
Query: 425 YISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLK 484
+++ +L+ +D +I DFGLAR + D + +G L ++APE V + +
Sbjct: 157 DLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT-TNGRL-PVKWMAPEALFDRVYTHQ 214
Query: 485 GDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGN 543
DV+ FG++L E+ + G P EE FK L + ++K
Sbjct: 215 SDVWSFGVLLWEIFTLGGSPYPGIPVEELFK-LL-----------KEGYRMEKPQNC--- 259
Query: 544 DDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
E+ + C P RP+ Q+ E L M
Sbjct: 260 TQELYHLM---RDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 23/73 (31%), Positives = 35/73 (47%), Gaps = 5/73 (6%)
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGF 490
+L+DD + RI+D GLA + + G G GY+APE V D +
Sbjct: 126 VLLDDHGNVRISDLGLAV-----ELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFAL 180
Query: 491 GIVLLELLSGQKP 503
G L E+++G+ P
Sbjct: 181 GCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.3 bits (109), Expect = 2e-05
Identities = 44/198 (22%), Positives = 91/198 (45%), Gaps = 17/198 (8%)
Query: 308 TGVSYKAV-LPDASALAIKRLSACKLSEKQFR-SEMNRLGQLRHPNLVPLLGFCVVEEER 365
+G Y A+ + +AI++++ + +K+ +E+ + + ++PN+V L +V +E
Sbjct: 33 SGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92
Query: 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQY 425
+V +++ G+L D +D + + L +LH +H+
Sbjct: 93 WVVMEYLAGGSL--------TDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 426 ISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKG 485
I S+ IL+ D ++TDFG + S+ V G ++APE + K
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVTRKAYGPKV 197
Query: 486 DVYGFGIVLLELLSGQKP 503
D++ GI+ +E++ G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 43/222 (19%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSEKQ------FRSEMNRLGQLRHPNLVPLLGFCVV 361
G YKA + +A+K++ +EK R E+ L +L+HPN+VPL+ V
Sbjct: 22 GEVYKARQIKTGRVVALKKILM--HNEKDGFPITALR-EIKILKKLKHPNVVPLIDMAVE 78
Query: 362 E-----EERLLVYKHMP--NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH 414
+R VY P + L LL V T S + + +L G+ +LH
Sbjct: 79 RPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL------EGINYLH 132
Query: 415 HGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFG----- 469
+ +H+ I + ILID+ +I DFGLAR PN G ++
Sbjct: 133 ---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVT 189
Query: 470 --YVAPEYSSTMVASLKG-----DVYGFGIVLLELLSGQKPL 504
Y PE ++ + D++G G V E+ + +P+
Sbjct: 190 RWYRPPE----LLLGERRYTTAVDIWGIGCVFAEMFTR-RPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 57/272 (20%), Positives = 121/272 (44%), Gaps = 44/272 (16%)
Query: 322 LAIKRLSA---CKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER------LLVYKHM 372
+A+K L A ++F E + + HPN++ L+G + + +++ M
Sbjct: 30 VAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFM 89
Query: 373 PNGTLYSLLHGNGV-DNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVI 431
+G L++ L + + + + L T +R + + G+ +L ++H+ +++
Sbjct: 90 KHGDLHTFLLMSRIGEEPFT--LPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNC 144
Query: 432 LIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEF--GYVAPEYSSTMVASLKGDVYG 489
+++++ + DFGL++ + S D + G + ++A E + V + DV+
Sbjct: 145 MLNENMTVCVADFGLSKKIYSGD----YYRQGCASKLPVKWLALESLADNVYTTHSDVWA 200
Query: 490 FGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVD--KSLYGRGNDDE 546
FG+ + E+++ GQ P AG E + N+L+ R + D + +Y E
Sbjct: 201 FGVTMWEIMTRGQTPY--AGVENS------EIYNYLIKGNRLKQPPDCLEDVY------E 246
Query: 547 IMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
+M C C PK RPS + + L+ +
Sbjct: 247 LM------CQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 31/104 (29%), Positives = 54/104 (51%), Gaps = 14/104 (13%)
Query: 409 GLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR-LVGSRDPNDSSFVHGDLGE 467
G+A+LH + +H+ I + +LI+ + +I DFG++R L + DP +SS +G
Sbjct: 180 GIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS-----VGT 231
Query: 468 FGYVAPEYSST-----MVASLKGDVYGFGIVLLELLSGQKPLDV 506
Y++PE +T GD++ G+ +LE G+ P V
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275
|
Length = 353 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGF 490
+L+D D +I DFG+ + + + S+F G Y+APE + D + F
Sbjct: 127 VLLDKDGHIKIADFGMCKENMNGEGKASTFC----GTPDYIAPEILKGQKYNESVDWWSF 182
Query: 491 GIVLLELLSGQKPLDVAGAEEGFKGNLVD 519
G++L E+L GQ P +E F L D
Sbjct: 183 GVLLYEMLIGQSPFHGEDEDELFDSILND 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 25/74 (33%), Positives = 38/74 (51%), Gaps = 5/74 (6%)
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGF 490
IL+DD RI+D GLA + + V G +G GY+APE + + D +G
Sbjct: 133 ILLDDRGHIRISDLGLAVQI-----PEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGL 187
Query: 491 GIVLLELLSGQKPL 504
G ++ E++ GQ P
Sbjct: 188 GCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 45/199 (22%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 308 TGVSYKAVLPDASAL-AIKRLSACKLSEKQFR-SEMNRLGQLRHPNLVPLLGFCVVEEER 365
TG+ A + + L A+K++ K ++ +E+ + +H N+V + +V +E
Sbjct: 33 TGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 92
Query: 366 LLVYKHMPNGTLYSLL-HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQ 424
+V + + G L ++ H + ++ V + + L+ LH +H+
Sbjct: 93 WVVMEFLEGGALTDIVTHTRMNEEQIAAVC---------LAVLKALSVLH---AQGVIHR 140
Query: 425 YISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLK 484
I S+ IL+ D +++DFG V P S V G ++APE S + +
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMAPELISRLPYGPE 196
Query: 485 GDVYGFGIVLLELLSGQKP 503
D++ GI+++E++ G+ P
Sbjct: 197 VDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 52/190 (27%), Positives = 76/190 (40%), Gaps = 27/190 (14%)
Query: 322 LAIKRLSACKLSEKQ-FRSEMNR---LGQLRHPNLVPL-LGFCVVEEERL-LVYKHMPNG 375
A+K ++ K EK R+ +N L +L HP LV L F +EE + LV + G
Sbjct: 28 FAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ--DEENMYLVVDLLLGG 85
Query: 376 TL-YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQYISSNVILI 433
L Y L + I L +LH G +H+ I + IL+
Sbjct: 86 DLRYHLSQKVKFSEE-------QVKFWICEIVL-ALEYLHSKGI----IHRDIKPDNILL 133
Query: 434 DDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIV 493
D+ ITDF +A V + G GY+APE S+ D + G+
Sbjct: 134 DEQGHVHITDFNIATKV-----TPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVT 188
Query: 494 LLELLSGQKP 503
E L G++P
Sbjct: 189 AYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 56/231 (24%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 351 NLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVD-NTLSGVLDWSTRLRIGMGA--S 407
++V LLG + L+V + M +G L S L + G + + I M A +
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 408 RGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLG- 466
G+A+L+ ++H+ +++ ++ DF +I DFG+ R + D + G G
Sbjct: 130 DGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD----YYRKGGKGL 182
Query: 467 -EFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV 525
++APE V + D++ FG+VL E+ S AE+ ++G + V V
Sbjct: 183 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--------LAEQPYQGLSNEQVLKFV 234
Query: 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576
+ G D D + + +R+ C PK RP+ ++ LK
Sbjct: 235 MDGGYLDQPDNC------PERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 42/163 (25%), Positives = 70/163 (42%), Gaps = 36/163 (22%)
Query: 413 LHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEF---- 468
+HH +H+ I S IL+ + ++ DFG +++ ++ V D+G
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY-------AATVSDDVGRTFCGT 208
Query: 469 -GYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527
YVAPE S K D++ G++L ELL+ ++P D EE
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---------------- 252
Query: 528 GRSRDVVDKSLYGRGN--DDEIMQFLR-VACSCVVSRPKDRPS 567
V+ K+L GR + I ++ + + + S PK RPS
Sbjct: 253 -----VMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 42/198 (21%), Positives = 87/198 (43%), Gaps = 23/198 (11%)
Query: 313 KAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372
P A+ + R A K + F E+ + +L+ PN++ LL C+ + ++ ++M
Sbjct: 42 SGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYM 101
Query: 373 PNGTLYSLL-----HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYIS 427
NG L L + + +ST + + + G+ +L ++H+ ++
Sbjct: 102 ENGDLNQFLSRHEPQEAAEKADVVTI-SYSTLIFMATQIASGMKYL---SSLNFVHRDLA 157
Query: 428 SNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAP----EYSSTMVA-- 481
+ L+ ++ +I DFG++R + S D + G V P + S ++
Sbjct: 158 TRNCLVGKNYTIKIADFGMSRNLYS---GDYYRIQGRA-----VLPIRWMSWESILLGKF 209
Query: 482 SLKGDVYGFGIVLLELLS 499
+ DV+ FG+ L E+L+
Sbjct: 210 TTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 26/103 (25%), Positives = 53/103 (51%), Gaps = 18/103 (17%)
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGF 490
+L+D + ++TD+G+ + G R + +S G Y+APE L+G+ YGF
Sbjct: 127 VLLDAEGHIKLTDYGMCK-EGIRPGDTTSTF---CGTPNYIAPEI-------LRGEDYGF 175
Query: 491 -------GIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526
G+++ E+++G+ P D+ G + N D++ +++
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL 218
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 41/212 (19%)
Query: 309 GVSYKA-VLPDASALAIKRLSACKLSE---KQFRSEMNRLGQLRHPNLVPLL-----GFC 359
G+ +KA +A+K+++ +L Q E+ L +HP +V LL G
Sbjct: 14 GIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSG 73
Query: 360 VVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQP 419
V LV ++MP L +L + L + + + M +G+A++H
Sbjct: 74 FV-----LVMEYMP-SDLSEVLRD--EERPLP---EAQVKSYMRM-LLKGVAYMH---AN 118
Query: 420 PYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE----- 474
MH+ + +LI D +I DFGLARL +P S H + Y APE
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS--H-QVATRWYRAPELLYGA 175
Query: 475 --YSSTMVASLKGDVYGFGIVLLELLSGQKPL 504
Y + D++ G + ELL+G PL
Sbjct: 176 RKYDPGV------DLWAVGCIFAELLNGS-PL 200
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 47/176 (26%), Positives = 72/176 (40%), Gaps = 39/176 (22%)
Query: 347 LRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHG---NGVDNTLSGVLDWSTRLRIG 403
RHPN++ ++ M G+ SLL G+ L G I
Sbjct: 56 FRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG--------NIL 107
Query: 404 MGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFV-H 462
GA RGL +LH Q Y+H+ I ++ ILI D GL L G + S V +
Sbjct: 108 FGALRGLNYLH---QNGYIHRNIKASHILISGD--------GLVSLSGLS--HLYSLVRN 154
Query: 463 GDLGEFGYVAPEYSSTMVA--------------SLKGDVYGFGIVLLELLSGQKPL 504
G + Y P++S++++ ++K D+Y GI EL +G+ P
Sbjct: 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 61/270 (22%), Positives = 110/270 (40%), Gaps = 38/270 (14%)
Query: 320 SALAIKRLSACKLSEKQFR---SEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPNG 375
+ +A+K L + +EK SEM + + +H N++ LLG C + ++ ++ G
Sbjct: 51 TKVAVKMLKS-DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 109
Query: 376 TLYSLLHGN---------GVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYI 426
L L L + + +RG+ +L +H+ +
Sbjct: 110 NLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDL 166
Query: 427 SSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGD 486
++ +L+ +D +I DFGLAR + D + +G L ++APE + + + D
Sbjct: 167 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKT-TNGRL-PVKWMAPEALFDRIYTHQSD 224
Query: 487 VYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDD 545
V+ FG++L E+ + G P EE FK L+ G D +
Sbjct: 225 VWSFGVLLWEIFTLGGSPYPGVPVEELFK---------LLKEGHRMDKPSNC------TN 269
Query: 546 EIMQFLRVACSCVVSRPKDRPSMYQVYESL 575
E+ +R C + P RP+ Q+ E L
Sbjct: 270 ELYMMMR---DCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 45/172 (26%), Positives = 74/172 (43%), Gaps = 30/172 (17%)
Query: 344 LGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIG 403
+ QL H +LV L G C V +E ++V +++ G L LH + +L LD
Sbjct: 55 MSQLSHKHLVKLYGVC-VRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLD-------- 105
Query: 404 MGASRGLAW-LHHGCQPPYMHQYI-SSNVILIDDDF------DARITDFGLARLVGSRDP 455
++ LA LH+ +H + N+++ +++D G+ V SR+
Sbjct: 106 --VAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE 163
Query: 456 NDSSFVHGDLGEFGYVAPEYSSTMVASLK--GDVYGFGIVLLELLS-GQKPL 504
++APE ASL D + FG LLE+ S G++PL
Sbjct: 164 RVE--------RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (104), Expect = 2e-04
Identities = 47/175 (26%), Positives = 77/175 (44%), Gaps = 34/175 (19%)
Query: 340 EMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTR 399
E++ L +L+HPN+V LL E + LV+++ L L + + + +
Sbjct: 48 EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQ 106
Query: 400 LRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSS 459
L RGLA+ H +H+ + ILI+ D ++ DFGLAR G +
Sbjct: 107 LL------RGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI---PLRT 154
Query: 460 FVHGDLGE---FGYVAPE-------YSSTMVASLKGDVYGFGIVLLELLSGQKPL 504
+ H E Y APE YS+ + D++ G + E+++G KPL
Sbjct: 155 YTH----EVVTLWYRAPEILLGSKHYSTAV------DIWSVGCIFAEMITG-KPL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 44/207 (21%), Positives = 78/207 (37%), Gaps = 30/207 (14%)
Query: 309 GVSYKAVLPDASALAIKRLSACKLSEK--QFRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366
G YKA + A ++ + E+ F E++ L + +HPN+V L
Sbjct: 19 GKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYE--------- 69
Query: 367 LVYKHMPNGTLY-SLLHGNGVDN---TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYM 422
Y + + G +D+ L L + L +LH +
Sbjct: 70 -AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVI 125
Query: 423 HQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE------YS 476
H+ + + IL+ D D ++ DFG++ S +F+ G ++APE +
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI----GTPYWMAPEVVACETFK 181
Query: 477 STMVASLKGDVYGFGIVLLELLSGQKP 503
K D++ GI L+EL + P
Sbjct: 182 DNPYDY-KADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 49/211 (23%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 318 DASALAIKRL--SACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPN 374
+A +A+K L A + SEM + + +H N++ LLG C + ++ ++
Sbjct: 46 EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 105
Query: 375 GTLYSLLHGN---------GVDNTLSGVLDWSTRLRIGMGASRGLAWL-HHGCQPPYMHQ 424
G L L + + + + +RG+ +L C +H+
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC----IHR 161
Query: 425 YISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLK 484
+++ +L+ ++ +I DFGLAR V + D + +G L ++APE V + +
Sbjct: 162 DLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT-TNGRL-PVKWMAPEALFDRVYTHQ 219
Query: 485 GDVYGFGIVLLELLS-GQKPLDVAGAEEGFK 514
DV+ FG+++ E+ + G P EE FK
Sbjct: 220 SDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 43/172 (25%), Positives = 80/172 (46%), Gaps = 21/172 (12%)
Query: 338 RSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWS 397
+ E+ + + +H N+V G + E+ + ++ G+L + H G + L + +
Sbjct: 54 QQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQ--IAYV 111
Query: 398 TRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPND 457
R + +GLA+LH + MH+ I IL+ D+ D ++ DFG+A + +
Sbjct: 112 CRETL-----QGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR 163
Query: 458 SSFVHGDLGEFGYVAPEYSSTMVASLKG-----DVYGFGIVLLELLSGQKPL 504
SF+ G ++APE ++ V G D++ GI +EL Q P+
Sbjct: 164 KSFI----GTPYWMAPEVAA--VEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 52/190 (27%), Positives = 80/190 (42%), Gaps = 25/190 (13%)
Query: 322 LAIKRLSAC--KLSEK--QFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL 377
+A+K++S + +EK E+ L QL+HPN + G + E LV +
Sbjct: 49 VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME------- 101
Query: 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF 437
Y L + + L I GA +GLA+LH +H+ I + IL+ +
Sbjct: 102 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM---IHRDIKAGNILLTEPG 158
Query: 438 DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASL---KGDVYGFGIVL 494
++ DFG A + SFV G ++APE M K DV+ GI
Sbjct: 159 QVKLADFGSASKSSPAN----SFV----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 210
Query: 495 LELLSGQKPL 504
+EL + PL
Sbjct: 211 IELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 2e-04
Identities = 35/118 (29%), Positives = 48/118 (40%), Gaps = 47/118 (39%)
Query: 421 YMHQYISSNVI---------LIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV 471
Y+H S+NVI L++ + D +I DFGLAR V + G L E YV
Sbjct: 118 YLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK-----GFLTE--YV 167
Query: 472 ------APE-------YSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGN 516
APE Y+ + D++ G + ELL+ KPL F G
Sbjct: 168 VTRWYRAPELLLSSSRYTKAI------DIWSVGCIFAELLTR-KPL--------FPGR 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 26/74 (35%), Positives = 35/74 (47%), Gaps = 7/74 (9%)
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA-SLKGDVYG 489
IL+D+ RI+D GLA + P H +G GY+APE VA D +
Sbjct: 128 ILLDEHGHVRISDLGLACDFSKKKP------HASVGTHGYMAPEVLQKGVAYDSSADWFS 181
Query: 490 FGIVLLELLSGQKP 503
G +L +LL G P
Sbjct: 182 LGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 36/114 (31%), Positives = 62/114 (54%), Gaps = 12/114 (10%)
Query: 394 LDWSTRLRIGMGASRGLAWL-HHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452
LD LR ++G+ +L C +H+ +++ +L+ D A+I DFGLAR +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDI-- 262
Query: 453 RDPNDSSF-VHGDLG-EFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKP 503
NDS++ V G+ ++APE V +++ DV+ +GI+L E+ S G+ P
Sbjct: 263 --MNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 46/189 (24%), Positives = 79/189 (41%), Gaps = 21/189 (11%)
Query: 326 RLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNG 385
R+SA + +F E L+H NL+ LG C LLV + P G L L
Sbjct: 31 RVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCR 90
Query: 386 VDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445
++ D +T R+ + GL LH + ++H ++ L+ D +I D+G
Sbjct: 91 KAELMT--PDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYG 145
Query: 446 LARLVGSRD---PNDSSFVHGDLGEFGYVAPE-----YSSTMVA--SLKGDVYGFGIVLL 495
L+ D D +V ++APE + + +V + + +V+ G+ +
Sbjct: 146 LSHNKYKEDYYVTPDQLWV-----PLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIW 200
Query: 496 ELLS-GQKP 503
EL G +P
Sbjct: 201 ELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 2e-04
Identities = 22/58 (37%), Positives = 33/58 (56%), Gaps = 1/58 (1%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL 130
SL LS+ +L+ + +L+ LDLS N+L+ SI + LP + LDLS N+L
Sbjct: 4 SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 39/167 (23%), Positives = 71/167 (42%), Gaps = 26/167 (15%)
Query: 346 QLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLH---GNGVDNTLSGVLDWSTRLRI 402
L+H N+V LG + + +P G+L +LL G DN T +
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE-------QTIIFY 113
Query: 403 GMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA-RITDFGLARLVGSRDPNDSSFV 461
GL +LH +H+ I + +L++ +I+DFG ++ + +P +F
Sbjct: 114 TKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT 170
Query: 462 HGDLGEFGYVAPEYSSTMVASLKG-----DVYGFGIVLLELLSGQKP 503
G Y+APE + +G D++ G ++E+ +G+ P
Sbjct: 171 ----GTLQYMAPE---VIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 42/178 (23%), Positives = 83/178 (46%), Gaps = 19/178 (10%)
Query: 336 QFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNG-VDNTLSGVL 394
Q E+ L + P +V G + E + +HM G+L +L G + + G
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-- 106
Query: 395 DWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA-RLVGSR 453
++ + +GL +L + MH+ + + IL++ + ++ DFG++ +L+
Sbjct: 107 ------KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--- 155
Query: 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEE 511
D +SFV G Y++PE S++ D++ G+ L+E+ G+ P+ A+E
Sbjct: 156 DSMANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 41/183 (22%), Positives = 80/183 (43%), Gaps = 15/183 (8%)
Query: 321 ALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
A+ I L + + + E+ L Q P + G + + + ++ +++ G+ L
Sbjct: 33 AIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL 92
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDAR 440
L +D T +T LR + +GL +LH +H+ I + +L+ + + +
Sbjct: 93 LEPGPLDET-----QIATILREIL---KGLDYLH---SEKKIHRDIKAANVLLSEHGEVK 141
Query: 441 ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSG 500
+ DFG+A + ++FV G ++APE K D++ GI +EL G
Sbjct: 142 LADFGVAGQLTDTQIKRNTFV----GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG 197
Query: 501 QKP 503
+ P
Sbjct: 198 EPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 9/109 (8%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPV--DLCKWLPYVVQLDLSNNHL 130
+L LS LS LP+ L +L +LDLS N +S +P +L L LDLSNN +
Sbjct: 167 NLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEE---LDLSNNSI 221
Query: 131 SGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
+ + K L+ L LSNNKL + L L+ ++ N +S
Sbjct: 222 I-ELLSSLSNLKNLSGLELSNNKLEDLPES-IGNLSNLETLDLSNNQIS 268
|
Length = 394 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 62/253 (24%), Positives = 103/253 (40%), Gaps = 42/253 (16%)
Query: 322 LAIKRLS-ACKLSEKQFR---SEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL 377
+AIK++S + K S ++++ E+ L +LRHPN + G + E LV +
Sbjct: 43 VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME------- 95
Query: 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF 437
Y L + + L + GA +GLA+LH +H+ + + IL+ +
Sbjct: 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPG 152
Query: 438 DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASL---KGDVYGFGIVL 494
++ DFG A ++ + FV G ++APE M K DV+ GI
Sbjct: 153 LVKLGDFGSASIMAPAN----XFV----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204
Query: 495 LELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVA 554
+EL + PL F N + + H IA + + F
Sbjct: 205 IELAERKPPL--------FNMNAMSALYH--IAQNESPALQSGHWSE-------YFRNFV 247
Query: 555 CSCVVSRPKDRPS 567
SC+ P+DRP+
Sbjct: 248 DSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 5e-04
Identities = 27/62 (43%), Positives = 35/62 (56%), Gaps = 3/62 (4%)
Query: 94 SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQ-IVECKFLNKLILSNN 152
+L+SLDLS+N L+ IP K LP + LDLS N+L+ I P+ L L LS N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGN 58
Query: 153 KL 154
L
Sbjct: 59 NL 60
|
Length = 60 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 72/253 (28%), Positives = 108/253 (42%), Gaps = 42/253 (16%)
Query: 322 LAIKRLS-ACKLSEKQFR---SEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL 377
+AIK++S + K S ++++ E+ L QLRHPN + G + E LV +
Sbjct: 43 VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME------- 95
Query: 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF 437
Y L + + L I GA +GLA+LH + +H+ I + IL+ +
Sbjct: 96 YCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPG 152
Query: 438 DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASL---KGDVYGFGIVL 494
++ DFG A LV P + SFV G ++APE M K DV+ GI
Sbjct: 153 TVKLADFGSASLV---SPAN-SFV----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204
Query: 495 LELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVA 554
+EL + PL F N + + H IA +L D F+
Sbjct: 205 IELAERKPPL--------FNMNAMSALYH--IAQND----SPTLSSNDWSDYFRNFVD-- 248
Query: 555 CSCVVSRPKDRPS 567
SC+ P+DRPS
Sbjct: 249 -SCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 37/161 (22%), Positives = 69/161 (42%), Gaps = 25/161 (15%)
Query: 348 RHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL-----LHGNGVDNTLSGVLDWSTRLRI 402
+H N+V + +V EE ++ + + G L + L+ + VL
Sbjct: 76 QHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVL-------- 127
Query: 403 GMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVH 462
+ L +LH +H+ I S+ IL+ D +++DFG + P S V
Sbjct: 128 -----QALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV- 178
Query: 463 GDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKP 503
G ++APE S + D++ GI+++E++ G+ P
Sbjct: 179 ---GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 26/96 (27%), Positives = 47/96 (48%), Gaps = 7/96 (7%)
Query: 408 RGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGE 467
+GL +LH + +H+ I + +L+ + D ++ DFG+A + ++FV G
Sbjct: 112 KGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV----GT 164
Query: 468 FGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKP 503
++APE K D++ GI +EL G+ P
Sbjct: 165 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 24/157 (15%)
Query: 422 MHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVH-GDLG-EFGYVAPEYSSTM 479
+H+ +++ IL+ ++ +I DFGLAR + +DP+ +V GD ++APE
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDI-YKDPD---YVRKGDARLPLKWMAPESIFDK 250
Query: 480 VASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSL 538
V + + DV+ FG++L E+ S G P +E F L + R+ + +
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-----RAPEYATPEI 305
Query: 539 YGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESL 575
Y + C + P+DRP+ ++ E L
Sbjct: 306 Y------------SIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 38/168 (22%), Positives = 70/168 (41%), Gaps = 14/168 (8%)
Query: 338 RSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGN-GVDNTLSGVLDW 396
R E L +++HPN+V + +V ++ G L + G +L W
Sbjct: 46 RKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW 105
Query: 397 STRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPN 456
++ +G + H + +H+ I S I + + ++ DFG ARL+ +
Sbjct: 106 FVQMCLG---------VQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT----S 152
Query: 457 DSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPL 504
++ +G YV PE M + K D++ G +L EL + + P
Sbjct: 153 PGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 60/276 (21%), Positives = 104/276 (37%), Gaps = 35/276 (12%)
Query: 310 VSYKAVLPDASALAIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367
+ +A+K L S + E F E + + H N+V L+G R +
Sbjct: 27 YRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFI 86
Query: 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYIS 427
+ + M G L S L N L L ++G +L + ++H+ I+
Sbjct: 87 LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIA 143
Query: 428 SNVILIDD---DFDARITDFGLARLVGSRDPNDSSFVH-GD--LGEFGYVAPEYSSTMVA 481
+ L+ A+I DFG+AR D +S+ G + ++ PE +
Sbjct: 144 ARNCLLTCKGPGRVAKIADFGMAR-----DIYRASYYRKGGRAMLPIKWMPPEAFLDGIF 198
Query: 482 SLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYG 540
+ K DV+ FG++L E+ S G P +E V V G D
Sbjct: 199 TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---------VMEFVTGGGRLD------PP 243
Query: 541 RGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576
+G + + + C P+DRP+ + E ++
Sbjct: 244 KGCPGPVYRIMT---DCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 50/195 (25%), Positives = 86/195 (44%), Gaps = 18/195 (9%)
Query: 313 KAVLPDASAL-AIKRLSACKLSEK-QFRSEMNR--LGQLRHPNLVPLLGFCVVEEERLLV 368
K PDA L A+K L L + + R++M R L ++ HP +V L E + L+
Sbjct: 17 KITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLI 76
Query: 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS 428
+ G L++ L V T V + L + + L ++ +P
Sbjct: 77 LDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKP--------- 126
Query: 429 NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVY 488
IL+D++ ++TDFGL++ + SF G Y+APE + + D +
Sbjct: 127 ENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC----GTVEYMAPEVVNRRGHTQSADWW 182
Query: 489 GFGIVLLELLSGQKP 503
FG+++ E+L+G P
Sbjct: 183 SFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 49/199 (24%), Positives = 83/199 (41%), Gaps = 25/199 (12%)
Query: 309 GVSYKA-VLPDASALAIK--RLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER 365
G YKA L LA+K L +KQ SE+ L + P ++ G VE
Sbjct: 15 GTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRI 74
Query: 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQY 425
+ + M G+L ++ ++ L RI + +GL +L +H+
Sbjct: 75 SICTEFMDGGSLD--VYRKIPEHVLG---------RIAVAVVKGLTYL---WSLKILHRD 120
Query: 426 ISSNVILIDDDFDARITDFGLAR-LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLK 484
+ + +L++ ++ DFG++ LV +S +G Y+APE S +
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVSTQLV-------NSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 485 GDVYGFGIVLLELLSGQKP 503
DV+ GI +EL G+ P
Sbjct: 174 SDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 31/107 (28%), Positives = 53/107 (49%), Gaps = 5/107 (4%)
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGF 490
+++D D +I DFG+ + D S+F G Y+APE + + D + F
Sbjct: 127 VMLDRDGHIKIADFGMCKENVFGDNRASTFC----GTPDYIAPEILQGLKYTFSVDWWSF 182
Query: 491 GIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNH-LVIAGRSRDVVDK 536
G++L E+L GQ P +E F+ VD ++ I S+D+++K
Sbjct: 183 GVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEK 229
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 47/193 (24%), Positives = 84/193 (43%), Gaps = 27/193 (13%)
Query: 322 LAIKRLSACKLSE------KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY-KHMPN 374
LA+K++ S E+ L L+H +V G C+ ++E L ++ ++MP
Sbjct: 30 LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPG 88
Query: 375 GTLYSLLHGNG-VDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI 433
G++ L G + T++ TR + G+ +LH +H+ I IL
Sbjct: 89 GSVKDQLKAYGALTETVTRKY---TRQIL-----EGVEYLHSN---MIVHRDIKGANILR 137
Query: 434 DDDFDARITDFGLA-RL--VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGF 490
D + ++ DFG + RL + S S G +++PE S K DV+
Sbjct: 138 DSAGNVKLGDFGASKRLQTICSSGTGMKSVT----GTPYWMSPEVISGEGYGRKADVWSV 193
Query: 491 GIVLLELLSGQKP 503
G ++E+L+ + P
Sbjct: 194 GCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 65/267 (24%), Positives = 113/267 (42%), Gaps = 42/267 (15%)
Query: 322 LAIKRLS-ACKLSEKQFR---SEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL 377
+AIK++S + K S ++++ E+ L +++HPN + G + E LV +
Sbjct: 53 VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME------- 105
Query: 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF 437
Y L + + L I GA +GLA+LH +H+ I + IL+ +
Sbjct: 106 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPG 162
Query: 438 DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASL---KGDVYGFGIVL 494
++ DFG A + + SFV G ++APE M K DV+ GI
Sbjct: 163 QVKLADFGSASIASPAN----SFV----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 214
Query: 495 LELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVA 554
+EL + PL F N + + H IA + + + D F+
Sbjct: 215 IELAERKPPL--------FNMNAMSALYH--IAQNESPTLQSNEW----SDYFRNFVD-- 258
Query: 555 CSCVVSRPKDRPSMYQVYESLKSMAEK 581
SC+ P+DRP+ ++ + + + E+
Sbjct: 259 -SCLQKIPQDRPTSEELLKHMFVLRER 284
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 25/75 (33%), Positives = 34/75 (45%), Gaps = 7/75 (9%)
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA-SLKGDVYG 489
IL+D+ RI+D GLA + P H +G GY+APE A D +
Sbjct: 128 ILLDEHGHVRISDLGLACDFSKKKP------HASVGTHGYMAPEVLQKGTAYDSSADWFS 181
Query: 490 FGIVLLELLSGQKPL 504
G +L +LL G P
Sbjct: 182 LGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 9e-04
Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 32/198 (16%)
Query: 323 AIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCV------VEEERLLVYKHMPNG 375
AIK + E++ + E+N L + H N+ G + ++++ LV + G
Sbjct: 35 AIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAG 94
Query: 376 TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD 435
++ L+ N NTL +W I RGL+ LH Q +H+ I +L+ +
Sbjct: 95 SVTDLIK-NTKGNTLKE--EWIAY--ICREILRGLSHLH---QHKVIHRDIKGQNVLLTE 146
Query: 436 DFDARITDFG----LARLVGSRDPNDSSFVHGDLGEFGYVAPEY-----SSTMVASLKGD 486
+ + ++ DFG L R VG R+ +F+ G ++APE + K D
Sbjct: 147 NAEVKLVDFGVSAQLDRTVGRRN----TFI----GTPYWMAPEVIACDENPDATYDFKSD 198
Query: 487 VYGFGIVLLELLSGQKPL 504
++ GI +E+ G PL
Sbjct: 199 LWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 43/169 (25%), Positives = 80/169 (47%), Gaps = 20/169 (11%)
Query: 340 EMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNG-TLYSLLHGNGVDNTLSGVLDWST 398
E++ + +L+H N+V L E + +LV+++M Y HG G LD +T
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGV------RGALDPNT 101
Query: 399 RLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDS 458
+G+A+ H + +H+ + +LI+ + ++ DFGLAR G S
Sbjct: 102 VKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158
Query: 459 SFVHGDLGEFGYVAPEY---SSTMVASLKGDVYGFGIVLLELLSGQKPL 504
+ ++ Y AP+ S T S+ D++ G ++ E+++G +PL
Sbjct: 159 N----EVVTLWYRAPDVLLGSRTYSTSI--DIWSVGCIMAEMITG-RPL 200
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 40/155 (25%), Positives = 68/155 (43%), Gaps = 20/155 (12%)
Query: 422 MHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA 481
+H+ +++ IL+ ++ +I DFGLAR + +DP+ L ++APE V
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGSARL-PLKWMAPESIFDKVY 253
Query: 482 SLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYG 540
+ + DV+ FG++L E+ S G P E F L D R+ + +Y
Sbjct: 254 TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-----RAPENATPEIY- 307
Query: 541 RGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESL 575
R+ +C PK+RP+ + E L
Sbjct: 308 -----------RIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 53/213 (24%), Positives = 86/213 (40%), Gaps = 26/213 (12%)
Query: 301 NIIISTRTGVSYKAVLP-----DASALAIKRLSACKL-SEKQFR---SEMNRLGQLRHPN 351
N I + TG + +L D +AIKR K+ +KQ SE L + HP
Sbjct: 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92
Query: 352 LVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLA 411
V L G E LV + + G ++ L N G ++ ++ + + L
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF-YAAQIVLIFEYLQSLN 151
Query: 412 WLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV 471
++ +P N++L D F ++TDFG A++V +R + G Y+
Sbjct: 152 IVYRDLKP--------ENLLLDKDGF-IKMTDFGFAKVVDTR-------TYTLCGTPEYI 195
Query: 472 APEYSSTMVASLKGDVYGFGIVLLELLSGQKPL 504
APE + D + GI + E+L G P
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 19/167 (11%)
Query: 344 LGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIG 403
+ QL H +LV G CV +E ++V +++ G+L + L N +++ S +L +
Sbjct: 53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNK------NLINISWKLEV- 105
Query: 404 MGASRGLAW-LHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVH 462
++ LAW LH H + + +L+ + D + + +L DP S V
Sbjct: 106 ---AKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL---SDPGISITVL 159
Query: 463 GD---LGEFGYVAPE-YSSTMVASLKGDVYGFGIVLLELLSG-QKPL 504
L +V PE + SL D + FG L E+ SG KPL
Sbjct: 160 PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 54/258 (20%), Positives = 100/258 (38%), Gaps = 33/258 (12%)
Query: 334 EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGV 393
+KQ E+ + P +V G + E + G G +D+ V
Sbjct: 43 QKQILRELEINKSCKSPYIVKYYGAFLDESSSSI-------GIAMEYCEGGSLDSIYKKV 95
Query: 394 LDWSTR------LRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447
R +I +GL++LH +H+ I + IL+ ++ DFG++
Sbjct: 96 KKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS 152
Query: 448 -RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDV 506
LV S +F G Y+APE S+ DV+ G+ LLE+ + P
Sbjct: 153 GELVNSLA---GTFT----GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP- 204
Query: 507 AGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP 566
E ++ ++++V + ++ D+ G +E F+ C+ P RP
Sbjct: 205 --PEGEPPLGPIELLSYIVNM-PNPELKDEPGNGIKWSEEFKDFI---KQCLEKDPTRRP 258
Query: 567 SMYQVYES--LKSMAEKH 582
+ + + E +K+ +K
Sbjct: 259 TPWDMLEHPWIKAQMKKK 276
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 26/96 (27%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 408 RGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGE 467
+GL +LH +H+ I + +L+ + D ++ DFG+A + ++FV G
Sbjct: 112 KGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV----GT 164
Query: 468 FGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKP 503
++APE K D++ GI +EL G+ P
Sbjct: 165 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 39/173 (22%), Positives = 75/173 (43%), Gaps = 23/173 (13%)
Query: 338 RSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWS 397
+ E+ + +H N+V G + ++ + + G+L + H ++G L S
Sbjct: 54 QQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH-------VTGPLSES 106
Query: 398 TRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPND 457
+ +GL +LH + MH+ I IL+ D+ ++ DFG++ + +
Sbjct: 107 QIAYVSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163
Query: 458 SSFVHGDLGEFGYVAPEYSSTMVASLKG------DVYGFGIVLLELLSGQKPL 504
SF+ G ++APE ++ KG D++ GI +EL Q P+
Sbjct: 164 KSFI----GTPYWMAPEVAAV---ERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 27/87 (31%), Positives = 45/87 (51%), Gaps = 11/87 (12%)
Query: 422 MHQYISSNVILIDDDFDARITDFGLA-RLVGSRDPNDSSFVHGDLGEFGYVAPEY----S 476
+H+ + + IL+D + ++ DFG++ RLV S+ S+ G Y+APE
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA------GCAAYMAPERIDPPD 190
Query: 477 STMVASLKGDVYGFGIVLLELLSGQKP 503
++ DV+ GI L+EL +GQ P
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 28/89 (31%), Positives = 41/89 (46%), Gaps = 4/89 (4%)
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGF 490
IL+D D +I DFG+ + D +F G Y+APE + D + F
Sbjct: 127 ILLDTDGHIKIADFGMCKENMLGDAKTCTFC----GTPDYIAPEILLGQKYNTSVDWWSF 182
Query: 491 GIVLLELLSGQKPLDVAGAEEGFKGNLVD 519
G++L E+L GQ P EE F+ +D
Sbjct: 183 GVLLYEMLIGQSPFHGHDEEELFQSIRMD 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 45/215 (20%), Positives = 90/215 (41%), Gaps = 17/215 (7%)
Query: 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRS----EMNRLGQLRHP 350
+F +E I + Y+A L D +A+K++ ++ + + R E++ L QL HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 351 NLVPLLGFCVVEEERLLVYKHMPNGTLYSLL-HGNGVDNTLSGVLDWSTRLRIGMGASRG 409
N++ L + + E +V + G L ++ + + W +++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL------- 115
Query: 410 LAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFG 469
+ + H MH+ I + I ++ D GL R S+ ++ H +G
Sbjct: 116 CSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK----TTAAHSLVGTPY 171
Query: 470 YVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPL 504
Y++PE + K D++ G +L E+ + Q P
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 37/213 (17%)
Query: 312 YKAVLPDASAL-AIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGF------CVVEE 363
YKA L AIK + + E++ + E N L + HPN+ G ++
Sbjct: 23 YKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82
Query: 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLR------IGMGASRGLAWLH-HG 416
+ LV + G+ V + + G+ RL+ I RGLA+LH +
Sbjct: 83 QLWLVMELCGGGS---------VTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK 133
Query: 417 CQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE-- 474
+H+ I IL+ + + ++ DFG++ + S ++F+ G ++APE
Sbjct: 134 V----IHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI----GTPYWMAPEVI 185
Query: 475 ---YSSTMVASLKGDVYGFGIVLLELLSGQKPL 504
+ DV+ GI +EL G+ PL
Sbjct: 186 ACDEQPDASYDARSDVWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 31/203 (15%)
Query: 318 DASALAIKRLSACKLSEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEERLLVYKHMPNGT 376
+ S A+K L +++ +E N L L HPN+V G + K + NG
Sbjct: 42 NGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYG--------MYYKKDVKNGD 93
Query: 377 ----LYSLLHGNGVDNTLSGVLDWSTRLR---IGMGASRGLAWLHHGCQPPYMHQYISSN 429
+ L +G V + + G L R+ I L L H +H+ + N
Sbjct: 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGN 153
Query: 430 VILIDDDFDARITDFGL-ARLVGSRDPNDSSFVHGDLGEFGYVAPE-------YSSTMVA 481
IL+ + ++ DFG+ A+L +R ++S +G ++APE ST A
Sbjct: 154 NILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-----VGTPFWMAPEVIACEQQLDSTYDA 208
Query: 482 SLKGDVYGFGIVLLELLSGQKPL 504
+ DV+ GI +EL G PL
Sbjct: 209 --RCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 34/209 (16%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSE----KQFRSEMNRLGQLRHPNLVPLLGFCVVEE 363
G YKA + +AIK + KL + + E++ L + RHPN+V G + +
Sbjct: 17 GDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73
Query: 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMH 423
+ +V ++ G+L + G L + +GLA+LH + +H
Sbjct: 74 KLWIVMEYCGGGSLQDIYQ------VTRGPLSELQIAYVCRETLKGLAYLHETGK---IH 124
Query: 424 QYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVAS- 482
+ I IL+ +D D ++ DFG++ + + SF+ G ++APE VA+
Sbjct: 125 RDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI----GTPYWMAPE-----VAAV 175
Query: 483 -------LKGDVYGFGIVLLELLSGQKPL 504
K D++ GI +EL Q P+
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 41/182 (22%), Positives = 71/182 (39%), Gaps = 33/182 (18%)
Query: 367 LVYKHMPNGTLYSLLHGNGVDNTLSGV-LDWS----TRLRIGMGASRGLAWLHHGCQPPY 421
LV +++ G SL+ TL G+ DW+ + +G+ +H +P
Sbjct: 74 LVMEYLNGGDCASLI------KTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPEN 127
Query: 422 MHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA 481
+ LID ++TDFGL+R G + FV G Y+APE +
Sbjct: 128 L---------LIDQTGHLKLTDFGLSR-NGLENKK---FV----GTPDYLAPETILGVGD 170
Query: 482 SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFK---GNLVDWVNHLV--IAGRSRDVVDK 536
D + G V+ E L G P + F ++W + + + D++++
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINR 230
Query: 537 SL 538
L
Sbjct: 231 LL 232
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 26/171 (15%)
Query: 340 EMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHG-NGVDNTLSGVLDWST 398
E+ L QLRH NLV L+ ++ LV++ + + L L NG LD S
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--------LDESR 101
Query: 399 RLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDS 458
+ RG+ + H +H+ I IL+ ++ DFG AR + + P +
Sbjct: 102 VRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA--PGE- 155
Query: 459 SFVHGD-LGEFGYVAPEYSSTMVASLKG----DVYGFGIVLLELLSGQKPL 504
V+ D + Y APE +V K D++ G ++ E+L+G+ PL
Sbjct: 156 --VYTDYVATRWYRAPEL---LVGDTKYGRAVDIWAVGCLVTEMLTGE-PL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 30/95 (31%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 422 MHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVH-GDLG-EFGYVAPEYSSTM 479
+H+ +++ IL+ ++ +I DFGLAR + +DP+ +V GD ++APE
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDI-YKDPD---YVRKGDARLPLKWMAPETIFDR 256
Query: 480 VASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGF 513
V +++ DV+ FG++L E+ S G P +E F
Sbjct: 257 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 291
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.003
Identities = 31/106 (29%), Positives = 46/106 (43%), Gaps = 37/106 (34%)
Query: 421 YMHQYISSNVI---------LIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV 471
Y+H S NVI L++ D ++ DFGLAR + + N + L + YV
Sbjct: 122 YIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN---PVLTD--YV 173
Query: 472 A------PE-------YSSTMVASLKGDVYGFGIVLLELLSGQKPL 504
A PE Y+ + D++ G +L E+L G KPL
Sbjct: 174 ATRWYRAPEILLGSTRYTKGV------DMWSVGCILGEMLLG-KPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 24/83 (28%), Positives = 44/83 (53%), Gaps = 18/83 (21%)
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGF 490
+L+D D ++TD+G+ + G P D++ G Y+APE L+G+ YGF
Sbjct: 127 VLLDADGHIKLTDYGMCK-EGLG-PGDTTSTF--CGTPNYIAPEI-------LRGEEYGF 175
Query: 491 -------GIVLLELLSGQKPLDV 506
G+++ E+++G+ P D+
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 40/200 (20%), Positives = 79/200 (39%), Gaps = 36/200 (18%)
Query: 322 LAIKRLSACKLSEKQFR---SEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378
+A+K+++ S++ + E+ QL+HPN++P + +V+ E +V M G+
Sbjct: 28 VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87
Query: 379 SLLHGNGVD--------NTLSGVLDWSTRLRIGMGASRGLAWLHH-GCQPPYMHQYISSN 429
LL + + L VL L ++H G +H+ + ++
Sbjct: 88 DLLKTHFPEGLPELAIAFILKDVL-------------NALDYIHSKGF----IHRSVKAS 130
Query: 430 VILIDDDFDARITDFGLARLVGSRDPNDSSFVH----GDLGEFGYVAPE--YSSTMVASL 483
IL+ D ++ + + VH + +++PE + +
Sbjct: 131 HILLSGDGKVVLSGLRYSVSMIKHG-KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNE 189
Query: 484 KGDVYGFGIVLLELLSGQKP 503
K D+Y GI EL +G P
Sbjct: 190 KSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 38/211 (18%)
Query: 322 LAIKRLSAC---KLSE-KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL-LVYKHMPNGT 376
+A+KR+ KL+E + +E + L + LV LL + ++E L L +++P G
Sbjct: 29 VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGD 87
Query: 377 LYSLLHGNGVDNTLSGVLDWSTRLRIG-MGASRGLAWLHHGCQPPYMHQYISSNVILIDD 435
+LL+ GV LS + R + M + + LH + Y+H+ + LID
Sbjct: 88 FRTLLNNLGV---LS---EDHARFYMAEMFEA--VDALH---ELGYIHRDLKPENFLIDA 136
Query: 436 DFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE------YSSTMVASLKGDVYG 489
++TDFGL++ ++ + +G Y+APE Y T+ D +
Sbjct: 137 SGHIKLTDFGLSK-------GIVTYANSVVGSPDYMAPEVLRGKGYDFTV------DYWS 183
Query: 490 FGIVLLELLSGQKPLDVAGAEEGFKGNLVDW 520
G +L E L G P + E ++ NL W
Sbjct: 184 LGCMLYEFLCGFPPFSGSTPNETWE-NLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 24/83 (28%), Positives = 39/83 (46%), Gaps = 4/83 (4%)
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGF 490
+L+D + +I DFG+ + S+F G Y+APE S D +
Sbjct: 127 VLLDSEGHIKIADFGMCKEGILGGVTTSTFC----GTPDYIAPEILSYQPYGPAVDWWAL 182
Query: 491 GIVLLELLSGQKPLDVAGAEEGF 513
G++L E+L+GQ P + +E F
Sbjct: 183 GVLLYEMLAGQSPFEGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 604 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.88 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.63 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.43 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.38 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.25 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.21 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.09 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.03 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.98 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.97 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.95 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.94 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.92 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.89 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.87 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.84 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.84 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.82 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.75 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.74 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.71 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.68 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.66 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.65 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.64 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.63 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.63 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.58 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.57 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.54 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.54 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.53 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.52 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.51 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.48 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.45 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.42 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.41 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.41 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.4 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.4 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.4 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.35 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.33 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.32 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.21 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.16 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.11 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.1 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.04 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.03 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.01 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.01 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 97.95 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.95 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.91 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 97.89 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.88 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.87 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.79 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-62 Score=574.01 Aligned_cols=470 Identities=30% Similarity=0.516 Sum_probs=359.6
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|+|++|+++|.+|..+.++++|+.|+|++|.++|.+|..+.. +++|++|+|++|.++|.+|..+..+++|+.|+
T Consensus 475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 553 (968)
T PLN00113 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSS-CKKLVSLDLSHNQLSGQIPASFSEMPVLSQLD 553 (968)
T ss_pred ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcC-ccCCCEEECCCCcccccCChhHhCcccCCEEE
Confidence 46889999999999999999999999999999999999999998866 99999999999999999999999999999999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCCCC--CCCCCCcccCCCCCCCCCCC----CCCCCCCCCcceEEeee
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPD--LARFPEESFDGNSGLCGKPL----GKCGGLSGKNLGIIIAA 222 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~--~~~~~~~~~~~n~~lcg~p~----~~c~~~~~~~~~~ii~~ 222 (604)
|++|+++|.+|..+..+++|+.|++++|+++|.+|.. +..+...++.||+.+||.+. ++|..........++++
T Consensus 554 Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~ 633 (968)
T PLN00113 554 LSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYIT 633 (968)
T ss_pred CCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehh
Confidence 9999999999999999999999999999999999964 45566778999999998642 45643322221112222
Q ss_pred hhhhhHHHHHHHHHHhhheeeeeccc-ccCCCCCCCCCchhhHHhhhcccceeeeeccC-CccccCHHHHHHhhcCCCcC
Q 007423 223 GVLGALGSIILGFLIWWWFFVRVSKK-KRGYGADSGKDDSSWIQVLRSHKLVQVSLFQK-PIVKVKLADLLAATNSFAVE 300 (604)
Q Consensus 223 ~v~~~~~~ili~~~~~~~~~~r~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~ 300 (604)
+++++++++++ +++.+++.+|+++. .++. ......|. ...+.. ....++++++. ..|...
T Consensus 634 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~----~~~~~~~~----------~~~~~~~~~~~~~~~~~~---~~~~~~ 695 (968)
T PLN00113 634 CTLGAFLVLAL-VAFGFVFIRGRNNLELKRV----ENEDGTWE----------LQFFDSKVSKSITINDIL---SSLKEE 695 (968)
T ss_pred HHHHHHHHHHH-HHHHHHHHHhhhccccccc----cccccccc----------ccccccccchhhhHHHHH---hhCCcc
Confidence 22222222211 11122222222111 1110 00001110 011111 11234455554 356778
Q ss_pred cEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCchhh
Q 007423 301 NIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYS 379 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~~ 379 (604)
++||+|+||.||+|+. .++..||||+++.... ...+|++++++++|||||+++|+|..++..++||||+++|+|.+
T Consensus 696 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~ 772 (968)
T PLN00113 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSE 772 (968)
T ss_pred cEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHH
Confidence 8999999999999995 6899999999865332 22356889999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCc
Q 007423 380 LLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSS 459 (604)
Q Consensus 380 ~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 459 (604)
+++ .++|..+.+++.|+|+||+|||+.++++|+|||+||+||+++.++.+++. ||.+.......
T Consensus 773 ~l~----------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~----- 836 (968)
T PLN00113 773 VLR----------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT----- 836 (968)
T ss_pred HHh----------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCC-----
Confidence 995 27899999999999999999998878899999999999999999988886 66654432111
Q ss_pred cccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccccccccc
Q 007423 460 FVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLY 539 (604)
Q Consensus 460 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 539 (604)
...++..|||||++.+..++.|+|||||||++|||+||+.||+... .....+.+|++...........+|+.+.
T Consensus 837 ---~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 837 ---KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF---GVHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ---CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc---CCCCcHHHHHHHhcCccchhheeCcccc
Confidence 1147899999999999999999999999999999999999996432 2234577887765555555556666553
Q ss_pred C--CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 540 G--RGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 540 ~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
. ....++..++.+++.+||+.||++||||.||+++|+++.+..
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 3 234567788899999999999999999999999999987643
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-58 Score=478.80 Aligned_cols=290 Identities=44% Similarity=0.772 Sum_probs=255.3
Q ss_pred CccccCHHHHHHhhcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEecccccc-HHHHHHHHHHHhccCCCCccceeeEE
Q 007423 281 PIVKVKLADLLAATNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLS-EKQFRSEMNRLGQLRHPNLVPLLGFC 359 (604)
Q Consensus 281 ~~~~~~~~~l~~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~ 359 (604)
+...|++.++.+||++|+..+.||+|+||.||+|.+++|+.||||++...... .++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45579999999999999999999999999999999999999999999765544 66799999999999999999999999
Q ss_pred EeCC-eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC
Q 007423 360 VVEE-ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD 438 (604)
Q Consensus 360 ~~~~-~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~ 438 (604)
.+.+ +.+||||||++|+|.++|+..... +++|..|++||.++|+||+|||..+.++|||||||++|||+|++++
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 9988 599999999999999999976421 6899999999999999999999999999999999999999999999
Q ss_pred eEEcccCCccccCCCCCCCCccccCC-CCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcH
Q 007423 439 ARITDFGLARLVGSRDPNDSSFVHGD-LGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNL 517 (604)
Q Consensus 439 ~kl~DFGla~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~ 517 (604)
+||+|||+|+......... ... .||.+|+|||+...+..|.|+|||||||+++|++||++|.+..... ....+
T Consensus 216 aKlsDFGLa~~~~~~~~~~----~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~--~~~~l 289 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDTSV----STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR--GELSL 289 (361)
T ss_pred EEccCccCcccCCccccce----eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc--ccccH
Confidence 9999999997654311111 111 5899999999999999999999999999999999999998864422 13348
Q ss_pred HHHHHHHHHcCCcccccccccc-CCCCH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 518 VDWVNHLVIAGRSRDVVDKSLY-GRGND-DEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 518 ~~~~~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
.+|+...+..+++.+++|+.+. ..+.. +++.++.++|.+|++.+|++||+|.||+++|+.+...
T Consensus 290 ~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 290 VEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 9999999999999999999987 55554 6899999999999999999999999999999766543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=398.62 Aligned_cols=257 Identities=30% Similarity=0.478 Sum_probs=209.0
Q ss_pred CcEEEecCCeEEEEEEeCCCCEEEEEEecccccc---HHHHHHHHHHHhccCCCCccceeeEEEeCC-eeeEEeeecCCC
Q 007423 300 ENIIISTRTGVSYKAVLPDASALAIKRLSACKLS---EKQFRSEMNRLGQLRHPNLVPLLGFCVVEE-ERLLVYKHMPNG 375 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lv~ey~~~g 375 (604)
.+.+|+|+||+||+|.+.....||||++...... .++|.+|+.+|.+++|||||+++|+|.... ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 4569999999999999966666999999764422 458999999999999999999999999887 799999999999
Q ss_pred chhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCC-ceecCCCCCeEEeCCCC-CeEEcccCCccccCCC
Q 007423 376 TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPP-YMHQYISSNVILIDDDF-DARITDFGLARLVGSR 453 (604)
Q Consensus 376 sL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~-iiH~dlk~~NiLl~~~~-~~kl~DFGla~~~~~~ 453 (604)
+|.++++... ...+++..++.+|.|||+||.||| +.+ |||||||++|||++.++ ++||+|||+++.....
T Consensus 126 sL~~~l~~~~-----~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 126 SLSVLLHKKR-----KRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred cHHHHHhhcc-----cCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999998741 146999999999999999999999 556 99999999999999997 9999999999876542
Q ss_pred CCCCCccccCCCCcccccCccccC--CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSS--TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
. .......||..|||||++. ...|+.|+|||||||++|||+||+.||..... .+-+...+..+...
T Consensus 198 ~----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~~~~~v~~~~~Rp 265 (362)
T KOG0192|consen 198 K----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQVASAVVVGGLRP 265 (362)
T ss_pred c----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcCCCC
Confidence 2 1112245999999999999 56899999999999999999999999976432 12222233333333
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCC
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFS 585 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~ 585 (604)
.+.. .+...+..++.+||+.||++||++.||+..|+.+.......
T Consensus 266 ~~p~---------~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~ 310 (362)
T KOG0192|consen 266 PIPK---------ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA 310 (362)
T ss_pred CCCc---------cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence 2221 13345555666999999999999999999999998876543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=390.62 Aligned_cols=253 Identities=27% Similarity=0.432 Sum_probs=212.4
Q ss_pred CcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCchhh
Q 007423 300 ENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYS 379 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~~ 379 (604)
.+.||+|.||.||.|.+.....||||.++......+.|.+|+++|++++|+|||+++|+|..++..+||||||++|+|.+
T Consensus 211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~ 290 (468)
T KOG0197|consen 211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLD 290 (468)
T ss_pred HHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHH
Confidence 47899999999999999888899999999877778899999999999999999999999999889999999999999999
Q ss_pred hhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCc
Q 007423 380 LLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSS 459 (604)
Q Consensus 380 ~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 459 (604)
+|+.... ..+...+.+.++.|||+||+||+ ++.+|||||.++|||++++..+||+|||+|+....+. +.
T Consensus 291 yLr~~~~-----~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~-- 359 (468)
T KOG0197|consen 291 YLRTREG-----GLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YT-- 359 (468)
T ss_pred HhhhcCC-----CccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCc-ee--
Confidence 9987332 45888999999999999999999 8999999999999999999999999999999543322 11
Q ss_pred cccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccc
Q 007423 460 FVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSL 538 (604)
Q Consensus 460 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 538 (604)
...+..-+..|.|||.+...+++.|||||||||+||||+| |+.||..... .+ +...+..|....
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn--------~e-v~~~le~GyRlp------ 424 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN--------EE-VLELLERGYRLP------ 424 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH--------HH-HHHHHhccCcCC------
Confidence 1122334679999999999999999999999999999999 9999875432 22 333444443322
Q ss_pred cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 539 YGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 539 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
.+..+...+.+||..||+.+|++|||++.+...|+.+...
T Consensus 425 ---~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 425 ---RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ---CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 2223455677788899999999999999998888877653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=366.41 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=208.0
Q ss_pred cCHHHHHHhhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecc--ccccHHHHHHHHHHHhccCCCCccceeeEEEe
Q 007423 285 VKLADLLAATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSA--CKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVV 361 (604)
Q Consensus 285 ~~~~~l~~~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 361 (604)
+++.|++. .+.||+|..|+|||+. .++++.+|+|.+.. .....+++.+|++++++++||+||.++|.|..
T Consensus 76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 45556543 4789999999999999 56788999999953 33446789999999999999999999999999
Q ss_pred CC-eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeE
Q 007423 362 EE-ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDAR 440 (604)
Q Consensus 362 ~~-~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~k 440 (604)
.+ ...++||||.+|+|.+++... +.+++...-+|+.+|++||.|||+ ++.||||||||+|||++..+++|
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~-------g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVK 219 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRV-------GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVK 219 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEE
Confidence 88 599999999999999999765 358889999999999999999995 48999999999999999999999
Q ss_pred EcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHH
Q 007423 441 ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDW 520 (604)
Q Consensus 441 l~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 520 (604)
|+|||.++.+... ...+.+||..|||||.+.+..|+.++||||||++++|+++|+.||...... .....+.
T Consensus 220 icDFGVS~~lvnS------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~---~~~~~~L 290 (364)
T KOG0581|consen 220 ICDFGVSGILVNS------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP---YLDIFEL 290 (364)
T ss_pred eccccccHHhhhh------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC---CCCHHHH
Confidence 9999999987543 223446999999999999999999999999999999999999999754111 1122222
Q ss_pred HHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 521 VNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 521 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
+. .+..+..+ .+.....++++..|+. .|++.||.+||+++|+++.
T Consensus 291 l~-~Iv~~ppP-----~lP~~~fS~ef~~FV~---~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 291 LC-AIVDEPPP-----RLPEGEFSPEFRSFVS---CCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HH-HHhcCCCC-----CCCcccCCHHHHHHHH---HHhcCCcccCCCHHHHhcC
Confidence 22 22222222 2222235667777777 9999999999999999764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=373.98 Aligned_cols=247 Identities=21% Similarity=0.320 Sum_probs=207.8
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecc----ccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSA----CKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
..|...++||+|+|..+|.++. ..|+.||+|++.+ .....+...+||+++++++|||||+++++|++.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999994 8999999999965 2344577999999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
|+|++|+|..+++.. .++++.+...+.+||+.||.||| +.+|||||||-.|+++++++++||+|||+|..
T Consensus 98 ELC~~~sL~el~Krr-------k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~ 167 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR-------KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQ 167 (592)
T ss_pred EecCCccHHHHHHhc-------CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeee
Confidence 999999999999854 46999999999999999999999 88999999999999999999999999999999
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
+..+.....+ .+||+.|+|||++....++..+||||+||++|.|++|++||+...-.+ -.........
T Consensus 168 le~~~Erk~T----lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke--------ty~~Ik~~~Y 235 (592)
T KOG0575|consen 168 LEYDGERKKT----LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE--------TYNKIKLNEY 235 (592)
T ss_pred ecCcccccce----ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH--------HHHHHHhcCc
Confidence 8754333333 359999999999999999999999999999999999999998643222 1112111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
. - +...+.++.+++. +.|+.||.+|||+++|+..
T Consensus 236 ~----~----P~~ls~~A~dLI~---~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 S----M----PSHLSAEAKDLIR---KLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred c----c----ccccCHHHHHHHH---HHhcCCcccCCCHHHHhcC
Confidence 1 1 1123456666666 9999999999999999864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=357.11 Aligned_cols=200 Identities=26% Similarity=0.357 Sum_probs=177.9
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
++|...+.||+|+|++||+|+ ..++..||||.+...+ ...+-+..|+++|+.++|||||+++++++.++..|+|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 567777889999999999999 5568999999996543 334568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC------CCeEEccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD------FDARITDF 444 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~------~~~kl~DF 444 (604)
||.+|||.++|+.+ +.++......++.|+|.||++|| +++||||||||.||||+.. -.+||+||
T Consensus 90 yC~gGDLs~yi~~~-------~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRR-------GRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred eCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 99999999999977 35899999999999999999999 8999999999999999864 46899999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCc
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGA 509 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~ 509 (604)
|+|+.+... ......+|++.|||||++...+|+.|+|+||.|+++|||++|+.||+....
T Consensus 160 GfAR~L~~~-----~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 160 GFARFLQPG-----SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred chhhhCCch-----hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 999988532 223345699999999999999999999999999999999999999986543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=389.17 Aligned_cols=263 Identities=24% Similarity=0.370 Sum_probs=216.2
Q ss_pred CCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEeccccc--cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 296 SFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACKL--SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
+....+.||+|+||.||+|... +...||||.++.... .+.+|++|+++++.++|||||+|+|+|..++..++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 3344578999999999999843 356799999986543 45789999999999999999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCC-------CCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeE
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNT-------LSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDAR 440 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~-------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~k 440 (604)
|+|||..|||.++|+-...... .+.+|+-.+.+.||.|||.||+||- +..+|||||.++|+|+.++..+|
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEE
Confidence 9999999999999975422110 1345899999999999999999999 78999999999999999999999
Q ss_pred EcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHH
Q 007423 441 ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVD 519 (604)
Q Consensus 441 l~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 519 (604)
|+|||+++..-..+-+... ....-+.+||+||.+..++||++||||||||+|||++| |+.||.....+
T Consensus 644 IsDfGLsRdiYssDYYk~~--~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~--------- 712 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVR--GNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ--------- 712 (774)
T ss_pred ecccccchhhhhhhhhccc--CCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---------
Confidence 9999999976433222110 01224679999999999999999999999999999999 99999765443
Q ss_pred HHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 520 WVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 520 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
.|...+..|++.. .+..+..++.+||..||+.+|++||+++||...|+...+.
T Consensus 713 EVIe~i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 713 EVIECIRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHHHHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 3556666776633 2334567788888899999999999999999999987763
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=353.76 Aligned_cols=251 Identities=25% Similarity=0.342 Sum_probs=199.7
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccccc--------HHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLS--------EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER 365 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~--------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 365 (604)
+.|...+.+|+|+||.|-+|. ..+|+.||||.+++.+.. .....+|+++|++++|||||++++++...+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 446677899999999999998 778999999999754321 12356999999999999999999999999999
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC---CCeEEc
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD---FDARIT 442 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~---~~~kl~ 442 (604)
|+||||+++|+|.+++-.+ +.+....-..++.|++.|+.||| +.+|+||||||+|||+..+ ..+||+
T Consensus 252 YmVlE~v~GGeLfd~vv~n-------k~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVAN-------KYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred EEEEEEecCccHHHHHHhc-------cccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEec
Confidence 9999999999999999766 34667777899999999999999 8999999999999999866 779999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCCCCC---CcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHH
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA---SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVD 519 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~ 519 (604)
|||+|+..+ ...+++..+||+.|.|||++.+..+ ..+.|+||+||+||-+++|.+||....... .
T Consensus 322 DFGlAK~~g-----~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~----s--- 389 (475)
T KOG0615|consen 322 DFGLAKVSG-----EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP----S--- 389 (475)
T ss_pred ccchhhccc-----cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc----c---
Confidence 999999875 2345566789999999999876553 347899999999999999999997542211 1
Q ss_pred HHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 520 WVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 520 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
....+..|+..-. +..+.+-..+.++++.++|..||++|||+.|+++.
T Consensus 390 -l~eQI~~G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 390 -LKEQILKGRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred -HHHHHhcCccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1233334433211 11122223344455559999999999999999764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=341.18 Aligned_cols=257 Identities=22% Similarity=0.341 Sum_probs=202.7
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeE-EEeCCe-eeEEe
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGF-CVVEEE-RLLVY 369 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~-~~~~~~-~~lv~ 369 (604)
+|.+.++||.|.||.|||+. +.+|..||.|.++-.. ..++....|+.+|++++|||||++++. +..+.. .+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 45567889999999999998 8899999999997533 334568899999999999999999994 444444 78999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCC--ceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPP--YMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
|||..|+|...++..+.. ...++...++++..|++.||..+|... +. |+||||||.||+++.++.+||+|||++
T Consensus 100 E~c~~GDLsqmIk~~K~q---kr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQ---KRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HhhcccCHHHHHHHHHhc---cccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999754332 246899999999999999999999421 55 999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
+.+.... ++....+||+.||+||.+...+|+.|+||||+||++|||..-++||...+ +.+ ....+..
T Consensus 176 r~l~s~~----tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--------~~~-L~~KI~q 242 (375)
T KOG0591|consen 176 RFLSSKT----TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--------LLS-LCKKIEQ 242 (375)
T ss_pred hHhcchh----HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--------HHH-HHHHHHc
Confidence 9985443 33344579999999999999999999999999999999999999997531 111 2233344
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
+....+.+ +..++.+.+ |+..|+..||+.||+.-.++..++.
T Consensus 243 gd~~~~p~-----~~YS~~l~~---li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 243 GDYPPLPD-----EHYSTDLRE---LINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCCCCcH-----HHhhhHHHH---HHHHHccCCcccCCCcchHHHHHHH
Confidence 43333222 233444444 4459999999999986555555443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=377.95 Aligned_cols=257 Identities=24% Similarity=0.387 Sum_probs=216.5
Q ss_pred CCcCcEEEecCCeEEEEEEeC----CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 297 FAVENIIISTRTGVSYKAVLP----DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~~----~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
..++++||.|.||.||+|.++ ....||||.++... ..+.+|+.|+.||.++.||||++|.|+.......+||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 356789999999999999953 24579999999754 334679999999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
||+||+|+.+|+.+. +.+.+.+...+.++||.|+.||- +.++|||||.++|||++.+..+||+|||+++.+
T Consensus 711 yMENGsLDsFLR~~D------GqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 711 YMENGSLDSFLRQND------GQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred hhhCCcHHHHHhhcC------CceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999999875 34889999999999999999999 899999999999999999999999999999987
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcC-
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAG- 528 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 528 (604)
..+. .......|..-+.+|.|||.+...++|..+|||||||++||.++ |++||......+ |...+..|
T Consensus 782 edd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd---------VIkaIe~gy 851 (996)
T KOG0196|consen 782 EDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---------VIKAIEQGY 851 (996)
T ss_pred ccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH---------HHHHHHhcc
Confidence 5543 22233344445689999999999999999999999999999887 999997654432 22222222
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
+++ .+.++...+.+||+.||++|-.+||++.||+..|.+++...
T Consensus 852 RLP----------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 852 RLP----------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred CCC----------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 222 23456778999999999999999999999999999987644
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=388.69 Aligned_cols=264 Identities=22% Similarity=0.371 Sum_probs=215.0
Q ss_pred CCCcCcEEEecCCeEEEEEEeCC--CC----EEEEEEeccc--cccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 296 SFAVENIIISTRTGVSYKAVLPD--AS----ALAIKRLSAC--KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~~--~~----~vAvK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
+.+..+.||+|.||.||+|...+ |. .||||.++.. .....+|.+|..+|++++|||||+++|+|.+....++
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 34456899999999999999543 33 4999999764 3445789999999999999999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
++|||++|+|..+|++.+.....+..++..+.+.++.|||+|+.||+ ++++|||||.++|+|++....+||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999988665555677999999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
+.+...+.+.... ...-+..|||||.+..+.+|.|+|||||||++||++| |..||......+ .+.....
T Consensus 850 rDiy~~~yyr~~~--~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--------v~~~~~~ 919 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHG--EAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--------VLLDVLE 919 (1025)
T ss_pred HhhhhchheeccC--ccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH--------HHHHHHh
Confidence 9543322111110 0124579999999999999999999999999999999 999997644322 1222333
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
.|++. .+..+...+.+||..||+.+|++||++..|++++..+....
T Consensus 920 ggRL~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 920 GGRLD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred CCccC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 44221 23345567778888999999999999999999999887644
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=339.57 Aligned_cols=241 Identities=22% Similarity=0.292 Sum_probs=201.5
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc----cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL----SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
.++|+..++||+|+||.||.++ .+.++.+|+|++++... +.+....|..+|.+++||.||++...|++++..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 3578899999999999999998 56689999999976442 335688999999999999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
+||+.||.|..+|++. +.++......++.+|+.||.||| +.+|||||+||+|||+|.+|.++|+|||+++
T Consensus 104 ld~~~GGeLf~hL~~e-------g~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k 173 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE-------GRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCK 173 (357)
T ss_pred EeccCCccHHHHHHhc-------CCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccch
Confidence 9999999999999866 45888889999999999999999 8999999999999999999999999999999
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
..-.....+. ..+||+.|||||++.+..|+..+|.||+||++|||++|.+||...+ ...+...... +
T Consensus 174 ~~~~~~~~t~----tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~--------~~~~~~~I~~-~ 240 (357)
T KOG0598|consen 174 EDLKDGDATR----TFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED--------VKKMYDKILK-G 240 (357)
T ss_pred hcccCCCccc----cccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc--------HHHHHHHHhc-C
Confidence 6543332222 3469999999999999999999999999999999999999997532 3333333322 2
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP 566 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 566 (604)
+.. ..+...+.+.+++++ +.++.||++|-
T Consensus 241 k~~------~~p~~ls~~ardll~---~LL~rdp~~RL 269 (357)
T KOG0598|consen 241 KLP------LPPGYLSEEARDLLK---KLLKRDPRQRL 269 (357)
T ss_pred cCC------CCCccCCHHHHHHHH---HHhccCHHHhc
Confidence 211 112334567777777 99999999995
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=358.89 Aligned_cols=260 Identities=24% Similarity=0.390 Sum_probs=203.9
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEecccccc---HHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLS---EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
-+.+.....||+|.||+||+|++.. .||||.++..... -+.|.+||..+++-||.||+-+.|||..++. .||+.
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 3344556889999999999999854 6999999764433 3679999999999999999999999998877 99999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
+|++-+|+.+|+-.+ ..++..+.+.||.|||+|+.||| .++|||||||++||++.+++++||+|||++..-
T Consensus 468 wCeGsSLY~hlHv~e------tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQE------TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred hccCchhhhhccchh------hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 999999999998664 35899999999999999999999 899999999999999999999999999999654
Q ss_pred CCCCCCCCccccCCCCcccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSS---TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
..-.. ........|...|||||++. ..+|+..+||||||||+|||+||..||.....+.... ..
T Consensus 539 ~~w~g--~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif-----------mV 605 (678)
T KOG0193|consen 539 TRWSG--EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF-----------MV 605 (678)
T ss_pred eeecc--ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE-----------Ee
Confidence 32211 11111223778999999875 4579999999999999999999999998433322111 11
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
|+-.-..|.... ...+.+++.+|+..||..++++||.+.+|+.+|+.+..+
T Consensus 606 GrG~l~pd~s~~---~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 606 GRGYLMPDLSKI---RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cccccCccchhh---hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 221111222221 223444555566699999999999999999999988774
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=341.93 Aligned_cols=256 Identities=25% Similarity=0.358 Sum_probs=201.9
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc-cHHHHHHHHHHHhccCCCCccceeeEEEeCC--eeeEEeee
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL-SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE--ERLLVYKH 371 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lv~ey 371 (604)
++...+.||+|.||.||++.. ++|...|||.+..... ..+.+.+|+.+|++++|||||+++|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 456678999999999999994 4599999999865421 1456899999999999999999999865544 68999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC-CCCeEEcccCCcccc
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD-DFDARITDFGLARLV 450 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~-~~~~kl~DFGla~~~ 450 (604)
+++|+|.+++.+.+ +.++...+..+..||++||+||| +++||||||||+|||++. ++.+||+|||+++..
T Consensus 98 ~~~GsL~~~~~~~g------~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 98 APGGSLSDLIKRYG------GKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred cCCCcHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 99999999998764 24899999999999999999999 899999999999999999 799999999999877
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
... ...........||+.|||||++..+ ....++||||+||++.||+||++||... ....+++........
T Consensus 169 ~~~-~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~~ 240 (313)
T KOG0198|consen 169 ESK-GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGREDS 240 (313)
T ss_pred ccc-cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccCC
Confidence 531 1111112234699999999999853 3345999999999999999999999742 122333333333332
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
.+.+ +...+++.++++. +|++.||++||||.|+++.---
T Consensus 241 ~P~i------p~~ls~~a~~Fl~---~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 241 LPEI------PDSLSDEAKDFLR---KCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred CCCC------CcccCHHHHHHHH---HHhhcCcccCcCHHHHhhChhh
Confidence 2211 2234567788877 9999999999999999887543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=336.86 Aligned_cols=263 Identities=22% Similarity=0.339 Sum_probs=204.8
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc--cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL--SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+.|+..++||.|..++||+|. .+.++.||||++.-.+. +-+.+++|+..|+.++||||++++..|..+...|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 568888999999999999999 78899999999975443 346789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
|.+|++.++++..-. ..++...+..|.+++++||.||| ..+-||||||+.||||+++|.+||+|||.+..+.
T Consensus 106 Ma~GS~ldIik~~~~-----~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYP-----DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred hcCCcHHHHHHHHcc-----ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999986532 34888999999999999999999 8999999999999999999999999999987765
Q ss_pred CCCCCCCccccCCCCcccccCccccCC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSST--MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
.............+||+.|||||++.. ..|+.|+|||||||+..||++|..||....+.. +...-..+.
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk---------vLl~tLqn~ 248 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK---------VLLLTLQND 248 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH---------HHHHHhcCC
Confidence 433222222245579999999999543 469999999999999999999999997543311 111111222
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.+...--.+..+.....-..+.+++..|++.||.+|||+.++++.
T Consensus 249 pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 249 PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 221110000001111112344555559999999999999998764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=325.64 Aligned_cols=264 Identities=20% Similarity=0.232 Sum_probs=198.7
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccccc---HHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLS---EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
.|+...++|+|+||+|||++ .++|+.||||++..+..+ .+-.++|+++|++++|+|+|.++.+|......++|+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 45666789999999999999 567999999999765433 34578999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
|+. ++.+-|.... ..++.....++..|++.|+.|+| +.++|||||||+|||+..++.+||+|||+|+.+.
T Consensus 83 ~dh-TvL~eLe~~p------~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 83 CDH-TVLHELERYP------NGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLS 152 (396)
T ss_pred cch-HHHHHHHhcc------CCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhc
Confidence 988 5555554432 34788899999999999999999 8899999999999999999999999999999986
Q ss_pred CCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCcccccc------CcHHHHHHHH
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFK------GNLVDWVNHL 524 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~------~~~~~~~~~~ 524 (604)
......... +.|..|.|||.+.+ .+|+...||||.||++.||+||.+-|...++-+... +++...-...
T Consensus 153 ~pgd~YTDY----VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 153 APGDNYTDY----VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred CCcchhhhh----hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHH
Confidence 433222222 47889999998776 789999999999999999999999997654332111 0000001111
Q ss_pred HHcCC------ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 525 VIAGR------SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 525 ~~~~~------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
..... +++.-++.-.....+....-+++++..|++.||++|++-+|++.
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111 11111111111111222335678888999999999999998864
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=349.73 Aligned_cols=241 Identities=25% Similarity=0.394 Sum_probs=195.4
Q ss_pred CcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCchhh
Q 007423 300 ENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYS 379 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~~ 379 (604)
.+-+|+|+.|.||+|++ .++.||||+++.-+ ..+|+-|++++||||+.+.|+|.....+|||||||+.|.|+.
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 46799999999999998 56789999986432 247888999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCc
Q 007423 380 LLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSS 459 (604)
Q Consensus 380 ~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 459 (604)
+|+..+ .+.......+..+||.|+.||| .+.|||||||+-||||..+..+||+|||.++..... .
T Consensus 202 VLka~~-------~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-S---- 266 (904)
T KOG4721|consen 202 VLKAGR-------PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-S---- 266 (904)
T ss_pred HHhccC-------ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh-h----
Confidence 998763 5677788889999999999999 889999999999999999999999999999877433 1
Q ss_pred cccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccccccccc
Q 007423 460 FVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLY 539 (604)
Q Consensus 460 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 539 (604)
......||..|||||++...+.++|+||||||||||||+||..||.+......+.+ -| .. .+.
T Consensus 267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG-----------VG--sN----sL~ 329 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG-----------VG--SN----SLH 329 (904)
T ss_pred hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEe-----------cc--CC----ccc
Confidence 12234699999999999999999999999999999999999999976432211110 00 00 111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhch
Q 007423 540 GRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMA 579 (604)
Q Consensus 540 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~ 579 (604)
-..++.+...|.-|+..||+..|..||++++|+..|+=..
T Consensus 330 LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 330 LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 1123334445555666999999999999999999986543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=352.43 Aligned_cols=266 Identities=21% Similarity=0.325 Sum_probs=202.6
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe------CCCCEEEEEEecccc--ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCC-
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL------PDASALAIKRLSACK--LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEE- 363 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~------~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~- 363 (604)
.++|...+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|++++.++ +||||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 35688889999999999999973 235689999997533 2235689999999999 8999999999987644
Q ss_pred eeeEEeeecCCCchhhhhccCCCCC-------------------------------------------------------
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDN------------------------------------------------------- 388 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~------------------------------------------------------- 388 (604)
..+++|||+++|+|.+++.......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5789999999999999987532100
Q ss_pred CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcc
Q 007423 389 TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEF 468 (604)
Q Consensus 389 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~ 468 (604)
.....+++...+.++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++.......... .....++.
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~--~~~~~~~~ 240 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR--KGSARLPL 240 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhc--ccCCCCCc
Confidence 00134888999999999999999999 78999999999999999999999999999986533211111 11123567
Q ss_pred cccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHH
Q 007423 469 GYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEI 547 (604)
Q Consensus 469 ~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 547 (604)
.|+|||++.+..++.++|||||||++|||+| |+.||......+ . .......+..... ....+
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-------~-~~~~~~~~~~~~~------~~~~~--- 303 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-------E-FCQRLKDGTRMRA------PENAT--- 303 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-------H-HHHHHhcCCCCCC------CCCCC---
Confidence 8999999988889999999999999999997 999997532211 1 1122222221111 01122
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 548 MQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 548 ~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
..+.+++.+||+.||++|||+.||++.|+++.++
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 3455666699999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=349.03 Aligned_cols=248 Identities=24% Similarity=0.365 Sum_probs=208.4
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHH-HHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEK-QFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~-~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
.|..-..||+|+.|.||.+. ..+++.||||++...++..+ -+.+|+.+|+..+|+|||++++.|..+++.|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 46666889999999999998 77899999999987665554 47899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+|+|.+.+... .++..++..|..++++||+||| ..+|+|||||.+|||++.++.+||+|||++..+...
T Consensus 354 ggsLTDvVt~~--------~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 354 GGSLTDVVTKT--------RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred CCchhhhhhcc--------cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 99999999754 4889999999999999999999 899999999999999999999999999999988665
Q ss_pred CCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
.....+. +||+.|||||+.....|++|.||||+|++++||+-|++||-...+ ..-+......| ..++
T Consensus 423 ~~KR~Tm----VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P--------lrAlyLIa~ng-~P~l 489 (550)
T KOG0578|consen 423 QSKRSTM----VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP--------LRALYLIATNG-TPKL 489 (550)
T ss_pred cCccccc----cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh--------HHHHHHHhhcC-CCCc
Confidence 5444433 599999999999999999999999999999999999999964222 12122222223 2233
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
-.+ +..+.++++|++ +|++.||++||++.|+++.
T Consensus 490 k~~----~klS~~~kdFL~---~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 KNP----EKLSPELKDFLD---RCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCc----cccCHHHHHHHH---HHhhcchhcCCCHHHHhcC
Confidence 222 223567788888 9999999999999999864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=310.77 Aligned_cols=282 Identities=21% Similarity=0.261 Sum_probs=213.4
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccccc---HHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLS---EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
.|...+.+|+|.||+||+|. ...|+.||||+++..... .....+||+.|+.++|+||+.++++|...+...+|+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 46677899999999999999 778999999999865433 35688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
|+. +|+..|+... ..++..++..++.++++|++|+| .+.|+|||+||+|+|+++++.+||+|||+|+.+.
T Consensus 83 m~t-dLe~vIkd~~------i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 83 MPT-DLEVVIKDKN------IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFG 152 (318)
T ss_pred ccc-cHHHHhcccc------cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccC
Confidence 987 9999998764 36889999999999999999999 8999999999999999999999999999999987
Q ss_pred CCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
......... +-|.-|.|||.+.+ ..|+...||||.|||+.||+-|.+-|...++-+ +...-...-|..
T Consensus 153 ~p~~~~~~~----V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid-------QL~~If~~LGTP 221 (318)
T KOG0659|consen 153 SPNRIQTHQ----VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID-------QLSKIFRALGTP 221 (318)
T ss_pred CCCcccccc----eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH-------HHHHHHHHcCCC
Confidence 654433222 35788999997654 569999999999999999999988776543221 111111111111
Q ss_pred cc--------ccc---cc-----ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCCCCCCCCccc
Q 007423 531 RD--------VVD---KS-----LYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEPYDEFPMI 594 (604)
Q Consensus 531 ~~--------~~d---~~-----l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~~~~~~~~ 594 (604)
.+ +.| -. ......+....+.++++..++..||.+|+|+.|++++= .+ .......+..++|..
T Consensus 222 ~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf-~~~P~pt~~~~lp~p 299 (318)
T KOG0659|consen 222 TPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YF-KSLPLPTPPSKLPIP 299 (318)
T ss_pred CcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch-hh-hcCCCCCChhhCcCC
Confidence 00 000 00 00001122334557778899999999999999998741 11 122233344567777
Q ss_pred cCCCCC
Q 007423 595 FGKQDP 600 (604)
Q Consensus 595 ~~~~~~ 600 (604)
..+++|
T Consensus 300 ~~~~~~ 305 (318)
T KOG0659|consen 300 STKSNP 305 (318)
T ss_pred cccCCh
Confidence 665554
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=333.37 Aligned_cols=246 Identities=17% Similarity=0.294 Sum_probs=195.9
Q ss_pred CcEEEecCCeEEEEEEeCCCCEEEEEEecccccc----HHHHHHHHHHHhccCCCCccceeeEEEe----CCeeeEEeee
Q 007423 300 ENIIISTRTGVSYKAVLPDASALAIKRLSACKLS----EKQFRSEMNRLGQLRHPNLVPLLGFCVV----EEERLLVYKH 371 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lv~ey 371 (604)
...||+|++|.||+|.. +|+.||||+++..... .+.|.+|+++|++++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36899999999999998 7889999999764332 2567899999999999999999999977 3467899999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++|+|.+++... ..++|.....++.+++.|+.|||. ..+++||||||+|||+++++.+||+|||+++...
T Consensus 104 ~~~g~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~ 174 (283)
T PHA02988 104 CTRGYLREVLDKE-------KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174 (283)
T ss_pred CCCCcHHHHHhhC-------CCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence 9999999999764 358899999999999999999993 2478899999999999999999999999998653
Q ss_pred CCCCCCCccccCCCCcccccCccccCC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSST--MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
.... ...|+..|+|||++.+ ..++.++|||||||++|||+||+.||..... .+........+.
T Consensus 175 ~~~~-------~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--------~~~~~~i~~~~~ 239 (283)
T PHA02988 175 SPPF-------KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--------KEIYDLIINKNN 239 (283)
T ss_pred cccc-------cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcCC
Confidence 3211 1247889999999876 6789999999999999999999999975322 122222222221
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhch
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMA 579 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~ 579 (604)
... ++ ...+++ +.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 240 ~~~-~~-----~~~~~~---l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 240 SLK-LP-----LDCPLE---IKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCC-CC-----CcCcHH---HHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 111 11 112334 445555999999999999999999998764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=350.47 Aligned_cols=258 Identities=26% Similarity=0.380 Sum_probs=206.0
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCC--C--CE-EEEEEeccc----cccHHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPD--A--SA-LAIKRLSAC----KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER 365 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~--~--~~-vAvK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 365 (604)
++-...++||+|+||.||+|.+.. + .. ||||..+.. ....++|.+|+++|++++|||||+++|++..+...
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 334445899999999999999543 2 23 899998742 23346799999999999999999999999999999
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
++|||+|++|+|.++|+... ..++..+++.++.++|+||+||| +.++|||||.++|||++.++.+||+|||
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~------~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNK------KSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred EEEEEecCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccc
Confidence 99999999999999998764 24899999999999999999999 8999999999999999999999999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHH
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
+++.-.. ...... ...-+..|+|||.+....++.++|||||||++||+.+ |..||...... -++..
T Consensus 308 Ls~~~~~---~~~~~~-~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---------~v~~k 374 (474)
T KOG0194|consen 308 LSRAGSQ---YVMKKF-LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---------EVKAK 374 (474)
T ss_pred cccCCcc---eeeccc-cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---------HHHHH
Confidence 9876431 111100 0124679999999999999999999999999999999 88899754322 12333
Q ss_pred H-HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcC
Q 007423 525 V-IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHG 583 (604)
Q Consensus 525 ~-~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~ 583 (604)
+ ..+...... ...+.++..+++ +||..+|++||+|.+|.+.++.+.....
T Consensus 375 I~~~~~r~~~~------~~~p~~~~~~~~---~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 375 IVKNGYRMPIP------SKTPKELAKVMK---QCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HHhcCccCCCC------CCCHHHHHHHHH---HhccCChhhccCHHHHHHHHHHHHhccc
Confidence 3 333332221 234555555555 9999999999999999999999877543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=340.65 Aligned_cols=201 Identities=25% Similarity=0.298 Sum_probs=173.9
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccccc---HHHHHHHHHHHhccCCCCccceeeEEEeC--CeeeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLS---EKQFRSEMNRLGQLRHPNLVPLLGFCVVE--EERLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lv 368 (604)
+.|+..+.||+|.||.||+|+ +.+|+.||+|++...... .....+||.||++++||||++|.+...++ ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 346666889999999999999 788999999999765422 34567999999999999999999998876 689999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
+|||++ ||.-++..... .++..++..++.|++.||+|+| ..+|+|||||.+|||||.++.+||+|||+|+
T Consensus 197 FeYMdh-DL~GLl~~p~v------kft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGV------KFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred Eecccc-hhhhhhcCCCc------ccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEecccccee
Confidence 999998 99999876543 4889999999999999999999 8999999999999999999999999999999
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAG 508 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~ 508 (604)
++....... ....+-|.-|.|||.+.+ ..|+...|+||.|||+.||++|++.|....
T Consensus 267 ~y~~~~~~~---~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 267 FYTPSGSAP---YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred eccCCCCcc---cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 886544221 333456899999998765 569999999999999999999999997643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=339.12 Aligned_cols=254 Identities=25% Similarity=0.342 Sum_probs=206.4
Q ss_pred HhhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccccc----HHHHHHHHHHHhcc-CCCCccceeeEEEeCCee
Q 007423 292 AATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLS----EKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEER 365 (604)
Q Consensus 292 ~~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~----~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 365 (604)
....+|..++.||+|+|++||+|+ ...++.+|||++.+...- .+...+|-++|.+| .||.|++|+--|.++...
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345678899999999999999999 678999999999653221 23467888999999 899999999999999999
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
|.|+||+++|+|.++|++. +.++......+|.+|+.||+||| +.+||||||||+|||+|++|++||+|||
T Consensus 150 YFvLe~A~nGdll~~i~K~-------Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFG 219 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY-------GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFG 219 (604)
T ss_pred EEEEEecCCCcHHHHHHHh-------CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeecc
Confidence 9999999999999999876 46899999999999999999999 8999999999999999999999999999
Q ss_pred CccccCCCCCC---------CCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCc
Q 007423 446 LARLVGSRDPN---------DSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGN 516 (604)
Q Consensus 446 la~~~~~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~ 516 (604)
.|+.+...... ........+||..|.+||++.....++.+|+|+|||++|.|+.|++||...+.-
T Consensus 220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney------ 293 (604)
T KOG0592|consen 220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY------ 293 (604)
T ss_pred ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH------
Confidence 99998653322 111123467999999999999999999999999999999999999999864321
Q ss_pred HHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 517 LVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.- .+..+. ++-.+ ++..++.+.++++ +.+..||.+|+|..||.+.
T Consensus 294 -li-FqkI~~-------l~y~f-p~~fp~~a~dLv~---KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 294 -LI-FQKIQA-------LDYEF-PEGFPEDARDLIK---KLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -HH-HHHHHH-------hcccC-CCCCCHHHHHHHH---HHHccCccccccHHHHhhC
Confidence 00 111111 11111 1233455666665 9999999999999888664
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=340.00 Aligned_cols=264 Identities=23% Similarity=0.272 Sum_probs=204.6
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHH--HHHHHHHhccC-CCCccceeeEEEeCC-eeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQF--RSEMNRLGQLR-HPNLVPLLGFCVVEE-ERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~--~~Ei~~l~~l~-H~niv~l~g~~~~~~-~~~lv~ 369 (604)
++|...+.||.|.||.||+|+ ..+|..||||+++.....-++. .+|+..|++++ |||||++.+++.+.+ ..++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 457777899999999999999 7889999999998755444444 58999999998 999999999999877 899999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
|||+. +|+++++.++ ..++...+..|+.||++||+|+| ++|+.|||+||+|||+.....+||+|||+||.
T Consensus 90 E~Md~-NLYqLmK~R~------r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 90 EFMDC-NLYQLMKDRN------RLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred Hhhhh-hHHHHHhhcC------CcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccc
Confidence 99987 9999998773 46999999999999999999999 89999999999999999989999999999998
Q ss_pred cCCCCCCCCccccCCCCcccccCccccC-CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccC--------cHHHH
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSS-TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKG--------NLVDW 520 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~--------~~~~~ 520 (604)
+....+++.. +.|.-|.|||++. ...|+.+.||||+|||++|+.+-++-|.+.+..+.... .-..|
T Consensus 160 v~SkpPYTeY-----VSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 160 VRSKPPYTEY-----VSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred cccCCCcchh-----hhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 8765554433 3688999999764 56799999999999999999999999987544322110 00112
Q ss_pred HHH--HHHc-C-CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 521 VNH--LVIA-G-RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 521 ~~~--~~~~-~-~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
... +... + +......-.+ ..-.+....+.++++.+|+.+||++|||+.|.++.
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l-~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPL-KDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCCh-HHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 110 0000 0 0011100000 00111234556667779999999999999999875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=345.05 Aligned_cols=258 Identities=22% Similarity=0.370 Sum_probs=216.7
Q ss_pred CCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 296 SFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
+....++||-|.||.||.|++. ..-.||||.++.+....++|.+|..+|+.++|||+|+|+|+|..+..+|||+|||.+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 4455688999999999999964 467899999998888889999999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+||++.... .++-...+.+|.||+.|++||. .+.+|||||.++|+|+.++-.+||+|||+++++..+.
T Consensus 348 GNLLdYLRecnr~-----ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 348 GNLLDYLRECNRS-----EVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred ccHHHHHHHhchh-----hcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 9999999977542 4666778889999999999999 8999999999999999999999999999999986543
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
... ..+..-+..|.|||-+..+.++.|+|||+|||+|||+.| |..||..... .-|..++..|...
T Consensus 420 YTA---HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl---------SqVY~LLEkgyRM-- 485 (1157)
T KOG4278|consen 420 YTA---HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------SQVYGLLEKGYRM-- 485 (1157)
T ss_pred eec---ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH---------HHHHHHHhccccc--
Confidence 221 123334678999999999999999999999999999998 9999975321 1234444444332
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
+.+..|..++.+||..||+++|.+||++.||.+.++.|..+.
T Consensus 486 -------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 486 -------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred -------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 334456678888888999999999999999999998876544
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.03 Aligned_cols=267 Identities=19% Similarity=0.306 Sum_probs=199.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCC-----------------CCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccce
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPD-----------------ASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPL 355 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~-----------------~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l 355 (604)
++|...+.||+|+||.||++...+ +..||+|.+.... ....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 457778999999999999997532 3479999987532 234579999999999999999999
Q ss_pred eeEEEeCCeeeEEeeecCCCchhhhhccCCCCC------------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCcee
Q 007423 356 LGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDN------------TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMH 423 (604)
Q Consensus 356 ~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~------------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH 423 (604)
++++...+..+++|||+++|+|.+++....... .....++|.....++.|++.||.||| +.+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 999999999999999999999999986432110 01124789999999999999999999 789999
Q ss_pred cCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh--CC
Q 007423 424 QYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS--GQ 501 (604)
Q Consensus 424 ~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt--g~ 501 (604)
|||||+|||+++++.+||+|||+++......... ......++..|+|||++....++.++|||||||++|||++ +.
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR--IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeE--ecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999998653322111 1111235788999999888889999999999999999987 56
Q ss_pred CCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 502 KPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 502 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
.||...... .....+.............. .++.....+.+++.+||+.||++||||.||.+.|++
T Consensus 240 ~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 240 QPYGELTDE-----QVIENAGEFFRDQGRQVYLF------RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCcCCHH-----HHHHHHHHHhhhcccccccc------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 677543221 12222222221111100000 011122456667779999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=334.32 Aligned_cols=247 Identities=21% Similarity=0.298 Sum_probs=203.3
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
.|...+.||+|.||.||||. ...++.||+|.+.... ...+.+.+|+.++.+++++||.+++|.+..+...+++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 46667899999999999999 5678999999997543 33467899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
.+|++.+.++... .++......|.+++..|+.||| ..+.+|||||+.|||+..++.+|++|||++..+..
T Consensus 94 ~gGsv~~lL~~~~-------~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN-------ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred cCcchhhhhccCC-------CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeec
Confidence 9999999997653 3466677788999999999999 78999999999999999999999999999988754
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
..... ...+||+.|||||++....|+.|+||||+||+.+||++|.+|+....+..... .+..
T Consensus 164 ~~~rr----~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf--------------lIpk 225 (467)
T KOG0201|consen 164 TVKRR----KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF--------------LIPK 225 (467)
T ss_pred hhhcc----ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE--------------eccC
Confidence 43332 33469999999999998899999999999999999999999997654321110 1122
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
-..|.+.+ ..+..+++|+. .|++.||+.||++.++++.
T Consensus 226 ~~PP~L~~-~~S~~~kEFV~---~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 226 SAPPRLDG-DFSPPFKEFVE---ACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCCCcccc-ccCHHHHHHHH---HHhhcCcccCcCHHHHhhh
Confidence 22233333 44556677777 9999999999999998764
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=321.38 Aligned_cols=251 Identities=23% Similarity=0.380 Sum_probs=202.2
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
++|...+.||+|+||.||++...++..+|+|.+.......+++.+|++++++++||||+++++++..++..+++|||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 35777889999999999999988888999999876555667899999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.++++... ..+++..+..++.+++.||.||| +.+|+||||||+||++++++.+||+|||.++......
T Consensus 84 ~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 84 GCLLNYLRQRQ------GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred CcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 99999987542 24889999999999999999999 7899999999999999999999999999988653221
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
... ..+..++..|+|||+..+..++.++||||||+++|||++ |+.||..... .+.+... ..+...
T Consensus 155 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--------~~~~~~i-~~~~~~-- 220 (256)
T cd05114 155 YTS---SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEMI-SRGFRL-- 220 (256)
T ss_pred eec---cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHH-HCCCCC--
Confidence 111 112235678999999988889999999999999999999 8999964321 1112221 222111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESL 575 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 575 (604)
..+. ..+ ..+.+++.+||+.+|++||++.|+++.|
T Consensus 221 ~~~~----~~~---~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 221 YRPK----LAS---MTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCC----CCC---HHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1111 122 3456667799999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=336.74 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=203.3
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccH---HHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSE---KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~---~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
++|.+.+.||+|.||+||||+ ..+.+.||+|.+.+....+ +.+.+|++|+++++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 467778899999999999998 5678899999997755444 457899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+.+ +|..+|... +.++......++.+++.||.||| +.+|+|||+||.|||++..+.+|++|||+|+.+
T Consensus 82 ~a~g-~L~~il~~d-------~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD-------GKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAM 150 (808)
T ss_pred hhhh-hHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhc
Confidence 9977 999999865 46999999999999999999999 899999999999999999999999999999987
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
.... .......||+.|||||+..+..|+..+|.||+||++|||++|++||... .+.+.++....+.
T Consensus 151 ~~~t----~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--------si~~Lv~~I~~d~-- 216 (808)
T KOG0597|consen 151 STNT----SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--------SITQLVKSILKDP-- 216 (808)
T ss_pred ccCc----eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--------HHHHHHHHHhcCC--
Confidence 5432 2334456999999999999999999999999999999999999999642 2333344333221
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
...+...+. .+..+....+..||.+|.+-.+++..
T Consensus 217 ------v~~p~~~S~---~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 217 ------VKPPSTASS---SFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ------CCCcccccH---HHHHHHHHHhhcChhhcccHHHHhcC
Confidence 111112223 34444448999999999998887543
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=344.85 Aligned_cols=263 Identities=22% Similarity=0.321 Sum_probs=201.4
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe------CCCCEEEEEEecccc--ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCe
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL------PDASALAIKRLSACK--LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEE 364 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~------~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 364 (604)
.++|...+.||+|+||.||+|.. .++..||||+++... ...+.+.+|+++++.+ +||||++++++|..++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34678889999999999999963 345689999997533 2345688999999999 89999999999999999
Q ss_pred eeEEeeecCCCchhhhhccCCCCC--------------------------------------------------------
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDN-------------------------------------------------------- 388 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~-------------------------------------------------------- 388 (604)
.++||||+++|+|.++++......
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986532100
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCC
Q 007423 389 ------------TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPN 456 (604)
Q Consensus 389 ------------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 456 (604)
.....++|.....++.|+++||.||| +.+|+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 00124789999999999999999999 789999999999999999999999999999876432211
Q ss_pred CCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccccc
Q 007423 457 DSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVD 535 (604)
Q Consensus 457 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 535 (604)
. ......++..|+|||+..+..++.++|||||||++|||+| |..||....... ... .....+.... .
T Consensus 271 ~--~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~----~~~----~~~~~~~~~~--~ 338 (375)
T cd05104 271 V--VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS----KFY----KMIKEGYRML--S 338 (375)
T ss_pred c--ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH----HHH----HHHHhCccCC--C
Confidence 1 1111234678999999998899999999999999999998 899986532211 111 1122221111 0
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 536 KSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 536 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
+ ...+. ++.+++.+||+.||++||+|.||++.|++.
T Consensus 339 ~----~~~~~---~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 339 P----ECAPS---EMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred C----CCCCH---HHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1 11223 455666699999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=327.24 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=200.1
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC----CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP----DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~----~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
++|...+.||+|+||.||+|... .+..||+|.++... ...+.|.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45778899999999999999742 46689999997543 2235789999999999999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.+|++|||.+.
T Consensus 85 ~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 85 TEYMSNGALDSFLRKHE------GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred EEeCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 99999999999997542 35889999999999999999999 8899999999999999999999999999876
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
........ ......++..|+|||+..+..++.++|||||||++||+++ |+.||...... +.. .....
T Consensus 156 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------~~~-~~~~~ 223 (266)
T cd05064 156 EDKSEAIY---TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------DVI-KAVED 223 (266)
T ss_pred cccccchh---cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHH-HHHHC
Confidence 54221111 1112235678999999988899999999999999999775 99999753221 111 12222
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
+..... +......+.+++.+||+.+|++||++.||.+.|+++
T Consensus 224 ~~~~~~---------~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 224 GFRLPA---------PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCC---------CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 211110 111223455666699999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=344.56 Aligned_cols=264 Identities=22% Similarity=0.321 Sum_probs=200.9
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe------CCCCEEEEEEeccccc--cHHHHHHHHHHHhcc-CCCCccceeeEEEeCCe
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL------PDASALAIKRLSACKL--SEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEE 364 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~------~~~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 364 (604)
.++|...+.||+|+||.||++.. .++..||||+++.... ..+.+.+|+++++.+ +|+||++++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 34688889999999999999873 2345799999975432 235688999999999 89999999999999999
Q ss_pred eeEEeeecCCCchhhhhccCCCC---------------------------------------------------------
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVD--------------------------------------------------------- 387 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~--------------------------------------------------------- 387 (604)
.++||||+++|+|.++++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999999998643110
Q ss_pred ------CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCccc
Q 007423 388 ------NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFV 461 (604)
Q Consensus 388 ------~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 461 (604)
......+++....+++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++........ ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~--~~~ 271 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY--VVK 271 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce--eec
Confidence 001124788999999999999999999 789999999999999999999999999999865432211 111
Q ss_pred cCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccC
Q 007423 462 HGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYG 540 (604)
Q Consensus 462 ~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 540 (604)
....++..|||||++....++.++|||||||++|||++ |+.||....... . .......+.... .+
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-------~-~~~~~~~~~~~~--~~---- 337 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-------K-FYKMVKRGYQMS--RP---- 337 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-------H-HHHHHHcccCcc--CC----
Confidence 11235678999999988889999999999999999997 999997532211 1 111111111110 11
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhch
Q 007423 541 RGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMA 579 (604)
Q Consensus 541 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~ 579 (604)
...+. ++.+++.+||+.||++|||+.||++.|+++.
T Consensus 338 ~~~~~---~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 DFAPP---EIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11223 4455556999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=333.88 Aligned_cols=253 Identities=21% Similarity=0.318 Sum_probs=203.1
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccc----c--ccHHHHHHHHHHHhccC-CCCccceeeEEEeCCee
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSAC----K--LSEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEER 365 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~----~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 365 (604)
.+.|...+.||+|.||.||.|. ..++..||||.+... . ...+.+.+|+.++++++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 4578888999999999999998 567899999977553 1 12456778999999999 99999999999999999
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC-CCeEEccc
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD-FDARITDF 444 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~-~~~kl~DF 444 (604)
++||||+.+|+|.+++... +.+.......++.|++.|++|+| +.+|+||||||+|||+|.+ +++||+||
T Consensus 96 ~ivmEy~~gGdL~~~i~~~-------g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNK-------GRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred EEEEEecCCccHHHHHHHc-------CCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecc
Confidence 9999999999999999874 45888899999999999999999 8999999999999999999 99999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCCCC-CC-cccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHH
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMV-AS-LKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVN 522 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 522 (604)
|++..... ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..... ...+
T Consensus 166 G~s~~~~~----~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~--------~l~~ 233 (370)
T KOG0583|consen 166 GLSAISPG----EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP--------NLYR 233 (370)
T ss_pred ccccccCC----CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH--------HHHH
Confidence 99998731 112233446999999999999877 75 7899999999999999999999863221 1111
Q ss_pred HHHHcCCccccccccccCCCC-HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 523 HLVIAGRSRDVVDKSLYGRGN-DDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 523 ~~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
. +..+... + | ... +.+...+++ +|+..||.+|+|+.||+ .-..+..
T Consensus 234 k-i~~~~~~--~-p----~~~~S~~~~~Li~---~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 234 K-IRKGEFK--I-P----SYLLSPEARSLIE---KMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred H-HhcCCcc--C-C----CCcCCHHHHHHHH---HHcCCCcccCCCHHHHh-hChhhcc
Confidence 1 2222111 0 1 111 344455555 99999999999999999 5455554
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=324.32 Aligned_cols=268 Identities=21% Similarity=0.321 Sum_probs=214.7
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhcc--CCCCccceeeEEEeCC----eeeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQL--RHPNLVPLLGFCVVEE----ERLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l--~H~niv~l~g~~~~~~----~~~lv 368 (604)
......+.||+|.||.||+|.+ .|+.||||++.. .+++.+.+|.+|.+.+ ||+||..+++.-..+. +.+||
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s--rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS--RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred heeEEEEEecCccccceeeccc-cCCceEEEEecc--cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 4566778999999999999999 678899999964 3567788999988765 9999999998865443 57999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhh-----cCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHH-----GCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-----~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
.+|.++|||+|+|... .++....++++..+|.||++||. +.+|.|.|||||+.|||+.+++++.|+|
T Consensus 288 TdYHe~GSL~DyL~r~--------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLNRN--------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred eecccCCcHHHHHhhc--------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 9999999999999864 48889999999999999999994 4578999999999999999999999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCCCC----CC--cccchhhHHHHHHHHHhC----------CCCCCCC
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMV----AS--LKGDVYGFGIVLLELLSG----------QKPLDVA 507 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t--~k~DV~SfGvvl~elltg----------~~p~~~~ 507 (604)
+|+|.................+||.+|||||++.... +. ..+||||||.|+||++-+ +.||.+.
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999877555444344445668999999999876432 22 369999999999999853 5677665
Q ss_pred CccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 508 GAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
.+.+... +-++..+...+.+..++... ...+.+..+.++|..||..+|..|-|+--|.+.|.++.+
T Consensus 440 Vp~DPs~----eeMrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 440 VPSDPSF----EEMRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCH----HHHhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 4443332 22344444555555555443 245788889999999999999999999999999998875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=323.46 Aligned_cols=268 Identities=25% Similarity=0.399 Sum_probs=203.7
Q ss_pred cCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhc--cCCCCccceeeEEEeCC----eeeEEeeec
Q 007423 299 VENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQ--LRHPNLVPLLGFCVVEE----ERLLVYKHM 372 (604)
Q Consensus 299 ~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~----~~~lv~ey~ 372 (604)
..++||+|+||.||||.+.+ +.||||++.. ...+.|..|-+|.+. ++|+||++++++-.... +++||+||.
T Consensus 214 l~eli~~Grfg~V~KaqL~~-~~VAVKifp~--~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLDN-RLVAVKIFPE--QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred hHHHhhcCccceeehhhccC-ceeEEEecCH--HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 34789999999999999844 8999999964 345678888887654 58999999999877655 789999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhc------CCCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHG------CQPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~------~~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
++|+|.++|..+ .++|....+++..+++||+|||++ .+++|+|||||++|||+.+|+++.|+|||+
T Consensus 291 ~kGsL~dyL~~n--------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 291 PKGSLCDYLKAN--------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred cCCcHHHHHHhc--------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999876 589999999999999999999964 478999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCC-CC-----cccchhhHHHHHHHHHhCCCCCCCCCccccccC-----
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMV-AS-----LKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKG----- 515 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-----~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~----- 515 (604)
|..+....... ...+.+||.+|||||++.+.. +. .+.||||+|.|+|||+++-.-++. ++...|..
T Consensus 363 Al~~~p~~~~~--d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 363 ALRLEPGKPQG--DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLPFEAE 439 (534)
T ss_pred eEEecCCCCCc--chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCchhHH
Confidence 99886544332 234578999999999987642 22 378999999999999997554432 11111111
Q ss_pred ----cHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcC
Q 007423 516 ----NLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHG 583 (604)
Q Consensus 516 ----~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~ 583 (604)
...+-++..+...+.+..+......- ..+..+.+.+-.||+.||+.|.|+.=|.+++.++.....
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 12233454444444443333322222 234445556669999999999999999888888766443
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=322.59 Aligned_cols=256 Identities=23% Similarity=0.399 Sum_probs=205.7
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
.++|...+.||+|++|.||+|...+++.||||.++......+++.+|++++++++||||+++++++...+..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 35688889999999999999998788899999998665566789999999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+++|.+++..... ..+++..+..++.+++.|+.||| +.+++||||||+||++++++.+||+|||+++.....
T Consensus 85 ~~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 85 YGSLLEYLQGGAG-----RALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred CCcHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 9999999975431 35899999999999999999999 789999999999999999999999999999877532
Q ss_pred CCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
.... ..+...+..|+|||+..+..++.++||||||+++|||+| |+.||...... . +...+..+....
T Consensus 157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~-~~~~~~~~~~~~ 224 (261)
T cd05068 157 IYEA---REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--------E-VLQQVDQGYRMP 224 (261)
T ss_pred cccc---cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--------H-HHHHHHcCCCCC
Confidence 1111 112223468999999998889999999999999999999 99999643211 0 111111111100
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
........+.+++.+|++.+|++||++.++.+.|+++
T Consensus 225 ---------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 225 ---------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0111224556666799999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=323.86 Aligned_cols=255 Identities=21% Similarity=0.368 Sum_probs=204.5
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
++|...+.||+|++|.||+|...++..||+|.+.......+.+.+|++++++++|+||+++++++...+..+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 46788899999999999999988888999999876555567899999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.++++.... ..+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+++......
T Consensus 86 ~~L~~~l~~~~~-----~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 86 GSLLDFLKSDEG-----GKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CcHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999975422 35789999999999999999999 7899999999999999999999999999998764322
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
.. ......++..|+|||+.....++.++|||||||++|||+| |+.||...... + .......+.....
T Consensus 158 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~-~~~~~~~~~~~~~ 225 (261)
T cd05072 158 YT---AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--------D-VMSALQRGYRMPR 225 (261)
T ss_pred ee---ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--------H-HHHHHHcCCCCCC
Confidence 11 1112235678999999988889999999999999999999 99999643211 1 1111122211110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
. ...+ ..+.+++.+||+.+|++||+++++.+.|+.+
T Consensus 226 -----~-~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 226 -----M-ENCP---DELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -----C-CCCC---HHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0 1122 3455566699999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=324.34 Aligned_cols=250 Identities=20% Similarity=0.245 Sum_probs=195.8
Q ss_pred CCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 297 FAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
|...+.||+|+||.||++. ..+++.||||.+.... .....+.+|+.++++++|+||+++.+++...+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 6677899999999999998 5679999999986432 1234578999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++|+|.+++..... ..+++.....++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++...
T Consensus 82 ~~~g~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05631 82 MNGGDLKFHIYNMGN-----PGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIP 153 (285)
T ss_pred cCCCcHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence 999999988864321 24889999999999999999999 8899999999999999999999999999998753
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
.... .....||..|+|||++.+..++.++|||||||++|||++|+.||....... ..+-+.........
T Consensus 154 ~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~- 222 (285)
T cd05631 154 EGET-----VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-----KREEVDRRVKEDQE- 222 (285)
T ss_pred CCCe-----ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-----hHHHHHHHhhcccc-
Confidence 2211 123358999999999999999999999999999999999999997532211 01111111111100
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS-----MYQVYES 574 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~~ 574 (604)
. . ....++++. +++.+||+.||++||+ ++|+++.
T Consensus 223 ~-----~-~~~~s~~~~---~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 223 E-----Y-SEKFSEDAK---SICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred c-----C-CccCCHHHH---HHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0 0 111233444 4555999999999997 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=322.77 Aligned_cols=254 Identities=22% Similarity=0.378 Sum_probs=202.4
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
+|...+.||+|++|.||+|.. ..++.||+|.++......+++.+|++++++++||||+++++++..++..+++|||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 86 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence 467778999999999999994 5688999999876555567799999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
++|.+++..... ..+++..++.++.|+++||+||| +.+++||||||+||++++++.+||+|||+++......
T Consensus 87 ~~L~~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 87 GNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred CcHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999975432 35889999999999999999999 7899999999999999999999999999998764322
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
... .....++..|+|||+..+..++.++|||||||++|||+| |..||..... .+.... ...+...+
T Consensus 159 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~-~~~~~~~~- 225 (263)
T cd05052 159 YTA---HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYEL-LEKGYRME- 225 (263)
T ss_pred eec---cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHH-HHCCCCCC-
Confidence 111 111224568999999988899999999999999999998 9999864321 111111 11111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
. ....+. .+.+++.+||+.||++||++.|++++|+.+
T Consensus 226 ----~-~~~~~~---~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 ----R-PEGCPP---KVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ----C-CCCCCH---HHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1 111223 445555699999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.64 Aligned_cols=197 Identities=22% Similarity=0.328 Sum_probs=172.2
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
++|+..+.||+|+||.||++.. .++..||+|.+.... ...+++.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 5788889999999999999994 568899999987532 2345799999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++|+|.+++... ..+++.....++.+++.||.|||+ ..+|+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 85 MDGGSLDQVLKEA-------KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred CCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 9999999999754 347889999999999999999994 3469999999999999999999999999998653
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
.... ....|+..|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 156 ~~~~------~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 156 DSMA------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cccc------ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 3211 123488999999999988899999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=329.31 Aligned_cols=255 Identities=21% Similarity=0.310 Sum_probs=204.2
Q ss_pred hhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccccc----HHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 293 ATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLS----EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~----~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
..++|+....||+|+||.||.++ ...|..+|+|+++++... .+..+.|-.+|...++|+||+|+..|++.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 55789999999999999999998 567999999999875432 2568899999999999999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||||+|||++..+|... +.|+......++.+.+.|++.+| +.++|||||||+|+|||..|++||+||||+
T Consensus 219 iMEylPGGD~mTLL~~~-------~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK-------DTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred EEEecCCccHHHHHHhc-------CcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeecccccc
Confidence 99999999999999876 46888889999999999999999 899999999999999999999999999999
Q ss_pred cccCCCC-----------------------CC----CC----------------ccccCCCCcccccCccccCCCCCCcc
Q 007423 448 RLVGSRD-----------------------PN----DS----------------SFVHGDLGEFGYVAPEYSSTMVASLK 484 (604)
Q Consensus 448 ~~~~~~~-----------------------~~----~~----------------~~~~~~~gt~~y~aPE~~~~~~~t~k 484 (604)
.-+.... .. .. ......+||+-|||||++.+..|+..
T Consensus 289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~ 368 (550)
T KOG0605|consen 289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE 368 (550)
T ss_pred chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence 6432100 00 00 01123579999999999999999999
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCC
Q 007423 485 GDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKD 564 (604)
Q Consensus 485 ~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~ 564 (604)
+|.||+|||+|||+.|-+||....+.+.+ ..+..|...+.... + ...++++++++. +|+. ||++
T Consensus 369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~-rkI~nwr~~l~fP~------~-----~~~s~eA~DLI~---rll~-d~~~ 432 (550)
T KOG0605|consen 369 CDWWSLGCIMYEMLVGYPPFCSETPQETY-RKIVNWRETLKFPE------E-----VDLSDEAKDLIT---RLLC-DPEN 432 (550)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhhhccCCC------c-----CcccHHHHHHHH---HHhc-CHHH
Confidence 99999999999999999999876554432 24455543322111 0 112245555554 8888 9999
Q ss_pred CCC---HHHHHH
Q 007423 565 RPS---MYQVYE 573 (604)
Q Consensus 565 RPs---~~ev~~ 573 (604)
|-. +.||.+
T Consensus 433 RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 433 RLGSKGAEEIKK 444 (550)
T ss_pred hcCcccHHHHhc
Confidence 965 555543
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=330.96 Aligned_cols=258 Identities=21% Similarity=0.391 Sum_probs=202.2
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCC----EEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDAS----ALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~----~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
.+|+..+.||+|+||.||+|+. .++. .||||.++... ...+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 3588889999999999999984 3444 38999986432 3346789999999999999999999999764 5679
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
++||+++|+|.+++.... ..+++...+.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++
T Consensus 86 v~e~~~~g~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a 156 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLA 156 (316)
T ss_pred eeecCCCCCHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccccc
Confidence 999999999999997653 34889999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
+......... ...+..++..|+|||++....++.++|||||||++|||+| |+.||...... ++ .....
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--------~~-~~~~~ 225 (316)
T cd05108 157 KLLGADEKEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EI-SSILE 225 (316)
T ss_pred ccccCCCcce--eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--------HH-HHHHh
Confidence 8765332211 1112234678999999998899999999999999999998 99999643211 11 11222
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
.+.... .+ ......+.+++.+||+.+|++||++.+++..+..+..+.
T Consensus 226 ~~~~~~--~~-------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 226 KGERLP--QP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCCCCC--CC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 221111 01 112234566777999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=329.68 Aligned_cols=249 Identities=20% Similarity=0.230 Sum_probs=197.4
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
+|...+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|++++.+++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 578889999999999999995 468999999997532 123568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~g~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~ 151 (333)
T cd05600 82 YVPGGDFRTLLNNL-------GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI 151 (333)
T ss_pred CCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence 99999999999754 35788999999999999999999 789999999999999999999999999999865
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ...........
T Consensus 152 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~~ 216 (333)
T cd05600 152 VT-------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--------TWENLKYWKET 216 (333)
T ss_pred cc-------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH--------HHHHHHhcccc
Confidence 33 1122358999999999998899999999999999999999999997543221 11111110000
Q ss_pred ccccccccc--CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 531 RDVVDKSLY--GRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 531 ~~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
...+... ....++++. +++.+||..+|++||++.|+++.
T Consensus 217 --~~~~~~~~~~~~~s~~~~---~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 217 --LQRPVYDDPRFNLSDEAW---DLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred --ccCCCCCccccccCHHHH---HHHHHHhhChhhhcCCHHHHHhC
Confidence 0001000 001233444 45559999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=328.04 Aligned_cols=240 Identities=21% Similarity=0.230 Sum_probs=191.3
Q ss_pred cEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCC
Q 007423 301 NIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNG 375 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g 375 (604)
+.||+|+||.||++. ..+|+.||||+++... .....+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999998 4678999999997532 12246788999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCC
Q 007423 376 TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDP 455 (604)
Q Consensus 376 sL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 455 (604)
+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 150 (323)
T cd05571 81 ELFFHLSRE-------RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA 150 (323)
T ss_pred cHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC
Confidence 999998754 35889999999999999999999 78999999999999999999999999999875422211
Q ss_pred CCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccccc
Q 007423 456 NDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVD 535 (604)
Q Consensus 456 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 535 (604)
. .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... . .......+..
T Consensus 151 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------~-~~~~~~~~~~----- 212 (323)
T cd05571 151 T----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------K-LFELILMEEI----- 212 (323)
T ss_pred c----ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--------H-HHHHHHcCCC-----
Confidence 1 12235899999999999889999999999999999999999999643211 1 1111111111
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007423 536 KSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYE 573 (604)
Q Consensus 536 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 573 (604)
.+ ....++++.+++ .+||+.||++|| ++.|+++
T Consensus 213 -~~-p~~~~~~~~~li---~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 213 -RF-PRTLSPEAKSLL---AGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -CC-CCCCCHHHHHHH---HHHccCCHHHcCCCCCCCHHHHHc
Confidence 01 112234444444 499999999999 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=325.61 Aligned_cols=244 Identities=20% Similarity=0.241 Sum_probs=196.0
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||++.. .+++.||||++.... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 3677889999999999999994 478999999986432 12356889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.
T Consensus 81 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~ 150 (291)
T cd05612 81 EYVPGGELFSYLRNS-------GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKK 150 (291)
T ss_pred eCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchh
Confidence 999999999999755 35888999999999999999999 88999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
..... ....|++.|+|||++.+..++.++|||||||++|||+||+.||..... .+.... +..+.
T Consensus 151 ~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~-i~~~~ 214 (291)
T cd05612 151 LRDRT-------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIYEK-ILAGK 214 (291)
T ss_pred ccCCc-------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH-HHhCC
Confidence 63221 112489999999999988899999999999999999999999975322 111111 12221
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS-----MYQVYES 574 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~~ 574 (604)
.. + ....+..+.+ ++.+||+.||++||+ +.|+++.
T Consensus 215 ~~------~-~~~~~~~~~~---li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 LE------F-PRHLDLYAKD---LIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred cC------C-CccCCHHHHH---HHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11 0 0112334444 455999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.55 Aligned_cols=260 Identities=25% Similarity=0.403 Sum_probs=201.7
Q ss_pred CCCcCcEEEecCCeEEEEEEeCC------CCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 296 SFAVENIIISTRTGVSYKAVLPD------ASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~~------~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
+|...+.||+|+||.||+|.... ...||+|.++... ....+|.+|++++++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 57778899999999999998532 2579999987533 223568999999999999999999999999889999
Q ss_pred EeeecCCCchhhhhccCCCCC---------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC
Q 007423 368 VYKHMPNGTLYSLLHGNGVDN---------TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD 438 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~ 438 (604)
+|||+++|+|.+++....... .....+++...+.++.|++.||.||| +.+++||||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCCc
Confidence 999999999999997542110 01135889999999999999999999 789999999999999999999
Q ss_pred eEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcH
Q 007423 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNL 517 (604)
Q Consensus 439 ~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~ 517 (604)
+||+|||+++......... ......++..|+|||++....++.++|||||||++|||+| |..||......
T Consensus 163 ~~L~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~------- 233 (283)
T cd05048 163 VKISDFGLSRDIYSADYYR--VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ------- 233 (283)
T ss_pred EEECCCcceeecccccccc--ccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-------
Confidence 9999999998653322111 1112246788999999988889999999999999999998 99999753221
Q ss_pred HHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 518 VDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 518 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
+ +...+..+..... +......+.+++.+||+.||++||++.||++.|+++
T Consensus 234 -~-~~~~i~~~~~~~~---------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 234 -E-VIEMIRSRQLLPC---------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -H-HHHHHHcCCcCCC---------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1 1122222222211 112234455666699999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=318.15 Aligned_cols=255 Identities=24% Similarity=0.393 Sum_probs=202.4
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC----CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP----DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~----~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
++|+..+.||+|+||.||+|... +...||||.++... ....+|.+|+.++++++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 56888899999999999999863 24589999987543 2345789999999999999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+|+|+||||+||++++++.+||+|||+++
T Consensus 84 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 84 TEYMENGSLDKFLREND------GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred EEcCCCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhh
Confidence 99999999999997643 35899999999999999999999 7899999999999999999999999999999
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
......... ......++..|+|||...+..++.++||||||+++|||++ |..||...... + .......
T Consensus 155 ~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--------~-~~~~~~~ 223 (266)
T cd05033 155 RLEDSEATY--TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--------D-VIKAVED 223 (266)
T ss_pred cccccccce--eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--------H-HHHHHHc
Confidence 875221111 1112235678999999988889999999999999999998 99998643211 1 1111222
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
+..... .......+.+++.+||+.+|++||++.||++.|+++
T Consensus 224 ~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 224 GYRLPP---------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 211110 011223455666799999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=321.50 Aligned_cols=249 Identities=27% Similarity=0.453 Sum_probs=190.2
Q ss_pred cCcEEEecCCeEEEEEEeC-----CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 299 VENIIISTRTGVSYKAVLP-----DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 299 ~~~~ig~G~~g~vy~~~~~-----~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
..+.||.|.||.||+|.+. .+..|+||.++... ...++|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3478999999999999965 35789999996533 2357899999999999999999999999988889999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++|+|.++|..... ..+++..+..++.|+++||.||| +.+++|+||+++||++++++.+||+|||+++...
T Consensus 83 ~~~g~L~~~L~~~~~-----~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNK-----EPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp -TTEBHHHHHHHTCT-----TTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred ccccccccccccccc-----ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 999999999987621 35899999999999999999999 6789999999999999999999999999998763
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
..... ...........|+|||.+....++.++||||||+++|||+| |+.||.... ..++.... ..+..
T Consensus 155 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--------~~~~~~~~-~~~~~ 223 (259)
T PF07714_consen 155 EKSKY--KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--------NEEIIEKL-KQGQR 223 (259)
T ss_dssp TSSSE--EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--------HHHHHHHH-HTTEE
T ss_pred ccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccc--------cccccccc-ccccc
Confidence 22111 11112236788999999988889999999999999999999 788886432 22223232 33322
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESL 575 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 575 (604)
.... ...+ ..+.+++..||+.||++||+|.||++.|
T Consensus 224 ~~~~------~~~~---~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 LPIP------DNCP---KDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSB------TTSB---HHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ceec------cchh---HHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 2211 1122 3445566699999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=319.38 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=201.0
Q ss_pred CCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCC
Q 007423 296 SFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNG 375 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g 375 (604)
+|...+.||+|+||.||++...++..||||.++......++|.+|++++++++||||+++++++...+..+++|||+++|
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence 56677899999999999999877778999998865555678999999999999999999999999888899999999999
Q ss_pred chhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCC
Q 007423 376 TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDP 455 (604)
Q Consensus 376 sL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 455 (604)
+|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||++++++.+||+|||.++.......
T Consensus 85 ~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 85 CLLNYLREHG------KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred cHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 9999997542 24889999999999999999999 88999999999999999999999999999886543221
Q ss_pred CCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 456 NDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 456 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
.. ..+..++..|+|||+..+..++.++|||||||++|||+| |+.||...... +.... ...+.....
T Consensus 156 ~~---~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~-~~~~~~~~~- 222 (256)
T cd05113 156 TS---SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------ETVEK-VSQGLRLYR- 222 (256)
T ss_pred ee---cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHH-HhcCCCCCC-
Confidence 11 112235678999999988889999999999999999999 99998643221 11111 122211110
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
+ ...+ ..+.+++.+||+.+|++||++.+|++.|+
T Consensus 223 -~----~~~~---~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 -P----HLAS---EKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -C----CCCC---HHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1 1122 34556666999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=320.86 Aligned_cols=266 Identities=17% Similarity=0.141 Sum_probs=196.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
++|+..+.||+|+||.||+++. .+++.||||+++... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 3578889999999999999995 468899999986532 224568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|++++.+..+.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~~~~~l~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 150 (287)
T cd07848 81 YVEKNMLELLEEMP-------NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNL 150 (287)
T ss_pred cCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence 99987766554322 34889999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCcccccc-------CcHHHHHHH
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFK-------GNLVDWVNH 523 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~-------~~~~~~~~~ 523 (604)
....... .....|+..|+|||++.+..++.++|||||||++|||++|+.||......+... .....+...
T Consensus 151 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07848 151 SEGSNAN---YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL 227 (287)
T ss_pred ccccccc---ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHh
Confidence 4322111 112348899999999988889999999999999999999999997543211000 000011111
Q ss_pred HHHcCCccccccccccCCC------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 524 LVIAGRSRDVVDKSLYGRG------NDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 524 ~~~~~~~~~~~d~~l~~~~------~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
............+...... .......+.+++.+|++.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 228 FYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111100000000000000 0011234566667999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=331.11 Aligned_cols=262 Identities=21% Similarity=0.314 Sum_probs=208.2
Q ss_pred CCCcCcEEEecCCeEEEEEEeCCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 296 SFAVENIIISTRTGVSYKAVLPDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
...+.++||+|.||.|..+....+..||||.++... ..+++|.+|+++|.+++|||||+++|+|..++..++++|||+
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 455678999999999999999889999999998643 335789999999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+|+|.+++..+... .+.-....+|+.|||.|++||. +.++||||+.++|||+|.++++||+|||+++-+-..
T Consensus 619 nGDLnqFl~aheap-----t~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 619 NGDLNQFLSAHELP-----TAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred cCcHHHHHHhccCc-----ccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999877432 1344556789999999999999 889999999999999999999999999999966443
Q ss_pred CCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh--CCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS--GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
..+... ...+-+.+|||+|.+.-+++|+++|||+|||++||+++ .+.||.....+. .++-.......+...
T Consensus 691 ~yy~vq--gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~-----vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 691 DYYRVQ--GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ-----VVENAGEFFRDQGRQ 763 (807)
T ss_pred Cceeee--cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH-----HHHhhhhhcCCCCcc
Confidence 322211 11234679999999999999999999999999999976 889997544322 122111122222111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
.++ ..+.-+...+.+++++||..+-++||+++++...|++.
T Consensus 764 ~~l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 VVL------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eec------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111 12233556777888999999999999999999988764
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=329.08 Aligned_cols=244 Identities=19% Similarity=0.229 Sum_probs=195.8
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||+|.. .+++.||||.++... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 4678889999999999999995 568999999986532 12356889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 98 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 98 EFVVGGELFTHLRKA-------GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK 167 (329)
T ss_pred cCCCCChHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence 999999999999754 34788888999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
...... ...||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+.. ..+..+.
T Consensus 168 ~~~~~~-------~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~-~~i~~~~ 231 (329)
T PTZ00263 168 VPDRTF-------TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIY-EKILAGR 231 (329)
T ss_pred cCCCcc-------eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHH-HHHhcCC
Confidence 633211 12489999999999998899999999999999999999999964321 1111 1122222
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS-----MYQVYES 574 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~~ 574 (604)
.. + ....+..+.+ ++.+||+.||++||+ +.|+++.
T Consensus 232 ~~------~-p~~~~~~~~~---li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 LK------F-PNWFDGRARD---LVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred cC------C-CCCCCHHHHH---HHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11 0 1112334444 445999999999997 6777643
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=326.84 Aligned_cols=238 Identities=21% Similarity=0.233 Sum_probs=188.4
Q ss_pred EEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCch
Q 007423 303 IISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL 377 (604)
Q Consensus 303 ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL 377 (604)
||+|+||.||++.. .+++.||+|.++... ...+.+.+|++++++++||||+++++++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 68999999999994 568899999986432 2235678899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCC
Q 007423 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPND 457 (604)
Q Consensus 378 ~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 457 (604)
.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 149 (312)
T cd05585 81 FHHLQRE-------GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK- 149 (312)
T ss_pred HHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc-
Confidence 9999754 35889999999999999999999 889999999999999999999999999999864322211
Q ss_pred CccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccccccc
Q 007423 458 SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKS 537 (604)
Q Consensus 458 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 537 (604)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+...... .+...
T Consensus 150 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~--------~~~~~~~~-~~~~~------ 211 (312)
T cd05585 150 ---TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV--------NEMYRKIL-QEPLR------ 211 (312)
T ss_pred ---cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH--------HHHHHHHH-cCCCC------
Confidence 1223589999999999998999999999999999999999999974321 12222211 11110
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 007423 538 LYGRGNDDEIMQFLRVACSCVVSRPKDRPS---MYQVYE 573 (604)
Q Consensus 538 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~ev~~ 573 (604)
.....++++.+ ++.+||+.||++||+ +.|+++
T Consensus 212 -~~~~~~~~~~~---li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 212 -FPDGFDRDAKD---LLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred -CCCcCCHHHHH---HHHHHcCCCHHHcCCCCCHHHHHc
Confidence 01122344444 445999999999985 555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.51 Aligned_cols=265 Identities=22% Similarity=0.286 Sum_probs=203.2
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEecccc--ccHHHHHHHHHHHhccC-CCCccceeeEEEeCCe
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACK--LSEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEE 364 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 364 (604)
.+.|.+.+.||+|+||.||+|... .+..||||+++... ...+.+.+|+++++++. ||||+++++++...+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 456788899999999999999842 23479999997533 23457899999999996 9999999999999999
Q ss_pred eeEEeeecCCCchhhhhccCCCCC--------------------------------------------------------
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDN-------------------------------------------------------- 388 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~-------------------------------------------------------- 388 (604)
.++||||+++|+|.++|+......
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999886532100
Q ss_pred ---------------------------------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC
Q 007423 389 ---------------------------------TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD 435 (604)
Q Consensus 389 ---------------------------------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~ 435 (604)
.....+++..++.++.|+++||.||| +.+|+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence 00124788899999999999999999 789999999999999999
Q ss_pred CCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCcccccc
Q 007423 436 DFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFK 514 (604)
Q Consensus 436 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~ 514 (604)
++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--- 347 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYV--SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--- 347 (400)
T ss_pred CCEEEEEeCCcceecccccccc--ccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH---
Confidence 9999999999998764322111 1112246788999999988889999999999999999997 999986432111
Q ss_pred CcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 515 GNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
........+.... ........+.+++.+||+.||++||++.+|.+.|+++.+
T Consensus 348 -----~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 -----TFYNKIKSGYRMA---------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -----HHHHHHhcCCCCC---------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1111122221111 011122355667779999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=317.30 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=199.5
Q ss_pred CCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCC
Q 007423 296 SFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNG 375 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g 375 (604)
+|...+.||+|+||.||++...++..+|+|.+.......+++.+|++++++++||||+++++++...+..+++|||++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 46677899999999999999877889999998765555677899999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCC
Q 007423 376 TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDP 455 (604)
Q Consensus 376 sL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 455 (604)
+|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.+||+|||+++.......
T Consensus 85 ~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 85 CLLNYLRERK------GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 9999997543 35889999999999999999999 78999999999999999999999999999986543211
Q ss_pred CCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 456 NDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 456 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
.. ..+..++..|+|||...+..++.++||||||+++|||+| |+.||......+ . .. ....+.. ..
T Consensus 156 ~~---~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~---~~-~~~~~~~--~~ 221 (256)
T cd05059 156 TS---SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-----V---VE-SVSAGYR--LY 221 (256)
T ss_pred cc---cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-----H---HH-HHHcCCc--CC
Confidence 11 111224567999999988889999999999999999999 899996432211 1 11 1111111 00
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESL 575 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 575 (604)
.+ ... ...+.+++.+||..+|++|||+.|+++.|
T Consensus 222 ~~----~~~---~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RP----KLA---PTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CC----CCC---CHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11 112 23455666699999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=318.91 Aligned_cols=255 Identities=26% Similarity=0.441 Sum_probs=205.4
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccc-cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKL-SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
..+|...+.||+|+||.||+|...++..+|+|.+..... ..+++.+|++++++++|+||+++++++...+..+++|||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 346778899999999999999987899999999976543 4567899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++|+|.++++.... ..+++..+..++.+++.|+.||| +.+++|+||||+||++++++.+||+|||.+.....
T Consensus 85 ~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 85 EKGSLLAFLRSPEG-----QVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred ccCCHHHHHhcCCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999976432 35889999999999999999999 78999999999999999999999999999987643
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
..... ....++..|+|||+.....++.++||||||+++|||++ |+.||..... .+..... ..+...
T Consensus 157 ~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--------~~~~~~~-~~~~~~ 223 (261)
T cd05148 157 DVYLS----SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--------HEVYDQI-TAGYRM 223 (261)
T ss_pred ccccc----cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHH-HhCCcC
Confidence 21111 12235778999999988889999999999999999998 8999964321 1111111 111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
. ........+.+++.+||+.||++|||+.++.+.|+.+
T Consensus 224 ~---------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 P---------CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred C---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1 0111223455667799999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=325.32 Aligned_cols=244 Identities=18% Similarity=0.237 Sum_probs=189.7
Q ss_pred cEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 301 NIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
+.||+|+||.||++. ..+++.||+|.++... ...+.+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999 4568899999997532 2234577899988776 899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|..++... ..+++.....++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~-------~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~ 150 (329)
T cd05618 81 GDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 150 (329)
T ss_pred CCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC
Confidence 9999888654 35889999999999999999999 7899999999999999999999999999997542221
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
... ....||..|+|||++.+..++.++|||||||++|||+||+.||...............++.......... +
T Consensus 151 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~ 224 (329)
T cd05618 151 DTT----STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--I 224 (329)
T ss_pred Ccc----ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC--C
Confidence 111 1235899999999999989999999999999999999999999743322221222333443333322211 1
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSM 568 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 568 (604)
+...+.+ +.+++.+||+.||++||++
T Consensus 225 -----p~~~~~~---~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 -----PRSLSVK---AASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -----CCCCCHH---HHHHHHHHhcCCHHHcCCC
Confidence 1112233 4455559999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=325.13 Aligned_cols=249 Identities=17% Similarity=0.231 Sum_probs=194.2
Q ss_pred cEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 301 NIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
++||+|+||.||++. ..+++.||||.++... ...+.+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 469999999999998 4578999999997532 1224578899999988 799999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 150 (329)
T cd05588 81 GDLMFHMQRQ-------RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG 150 (329)
T ss_pred CCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC
Confidence 9999988654 35899999999999999999999 8899999999999999999999999999987532211
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
.. .....||..|+|||++.+..++.++|||||||++|||+||+.||+.....+.......++.......+... +
T Consensus 151 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~- 224 (329)
T cd05588 151 DT----TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR-I- 224 (329)
T ss_pred Cc----cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC-C-
Confidence 11 11235899999999999989999999999999999999999999754332222222334444433333221 1
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCC------HHHHHH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS------MYQVYE 573 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~ev~~ 573 (604)
+...+.++ .+++.+|++.||++||+ +.|+++
T Consensus 225 -----p~~~~~~~---~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 225 -----PRSLSVKA---SSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -----CCCCCHHH---HHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 11123334 44555999999999997 567654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=319.57 Aligned_cols=257 Identities=22% Similarity=0.325 Sum_probs=198.6
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCC----EEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDAS----ALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~----~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
++|...+.||+|+||+||+|.. .+++ .+++|.+.... ....++..|+.++++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 3567778999999999999985 4454 47778775322 22356788999999999999999999875 445789
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
++||+++|+|.+++.... ..+++.....++.|++.||+||| +.+++||||||+|||+++++.+||+|||++
T Consensus 86 i~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~ 156 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR------DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVA 156 (279)
T ss_pred EEEeCCCCcHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccc
Confidence 999999999999997543 35899999999999999999999 788999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
+......... ......++..|+|||+..+..++.++|||||||++|||+| |+.||...... .....+.
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---------~~~~~~~ 225 (279)
T cd05111 157 DLLYPDDKKY--FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---------EVPDLLE 225 (279)
T ss_pred eeccCCCccc--ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---------HHHHHHH
Confidence 8764322111 1112346778999999988889999999999999999998 99999643211 1122223
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
.+.... .+. . ....+.+++.+||..||++|||+.|+++.|..+.++
T Consensus 226 ~~~~~~--~~~----~---~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 226 KGERLA--QPQ----I---CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CCCcCC--CCC----C---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 332211 111 1 123445566699999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=330.08 Aligned_cols=265 Identities=20% Similarity=0.292 Sum_probs=201.7
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEecccc--ccHHHHHHHHHHHhcc-CCCCccceeeEEEeC-Ce
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACK--LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVE-EE 364 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~~ 364 (604)
++|.+.+.||+|+||.||+|... .++.||+|+++... ...+.+.+|++++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46788899999999999999632 34789999987533 2235678899999999 899999999988754 56
Q ss_pred eeEEeeecCCCchhhhhccCCCCC------------------------------------------------------CC
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDN------------------------------------------------------TL 390 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~------------------------------------------------------~~ 390 (604)
.++++||+++|+|.+++....... ..
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 789999999999999986432100 00
Q ss_pred CCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccc
Q 007423 391 SGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGY 470 (604)
Q Consensus 391 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y 470 (604)
...++|..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.+........ .....++..|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~--~~~~~~~~~y 241 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR--KGDARLPLKW 241 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhh--ccCCCCCccc
Confidence 125899999999999999999999 78999999999999999999999999999987643221111 1112356789
Q ss_pred cCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHH
Q 007423 471 VAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQ 549 (604)
Q Consensus 471 ~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 549 (604)
+|||++.+..++.++|||||||++|||++ |+.||......+ ........+.... . +......
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~-~--------~~~~~~~ 304 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--------EFCRRLKEGTRMR-A--------PEYATPE 304 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--------HHHHHHhccCCCC-C--------CccCCHH
Confidence 99999999999999999999999999998 999996532211 1111112221111 1 1112245
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 550 FLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 550 l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
+.+++.+||+.+|++||++.||++.|+.+.++
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 66777799999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=303.69 Aligned_cols=200 Identities=26% Similarity=0.265 Sum_probs=170.9
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccH---HHHHHHHHHHhccCCCCccceeeEEEeC--CeeeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSE---KQFRSEMNRLGQLRHPNLVPLLGFCVVE--EERLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~---~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lv 368 (604)
+.|...+.|++|.||+||+|+ ..+++.||+|+++..+... -.-.+||.+|.+++|||||.+..+.... +.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 457777899999999999999 6779999999998654221 2467999999999999999999988753 569999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
||||+. +|..++.... .++...+...+..|+++|++||| ...|+|||||++|+|+++.|.+||+|||+|+
T Consensus 156 Me~~Eh-DLksl~d~m~------q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK------QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAR 225 (419)
T ss_pred HHHHHh-hHHHHHHhcc------CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhh
Confidence 999988 9999998664 46888999999999999999999 8899999999999999999999999999999
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAG 508 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~ 508 (604)
.++..... ....+-|.-|.|||.+.+. .|++..|+||+|||+.||+++++-|...+
T Consensus 226 ~ygsp~k~----~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 226 EYGSPLKP----YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS 282 (419)
T ss_pred hhcCCccc----CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence 98754221 1222358899999987664 58999999999999999999999997643
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=324.56 Aligned_cols=240 Identities=22% Similarity=0.231 Sum_probs=190.5
Q ss_pred cEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCC
Q 007423 301 NIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNG 375 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g 375 (604)
+.||+|+||.||++. ..+|..||+|.++... .....+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999998 4678999999997532 22345778999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCC
Q 007423 376 TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDP 455 (604)
Q Consensus 376 sL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 455 (604)
+|..++... ..+++.....++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 150 (323)
T cd05595 81 ELFFHLSRE-------RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 150 (323)
T ss_pred cHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC
Confidence 999988654 35889999999999999999999 78999999999999999999999999999875422211
Q ss_pred CCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccccc
Q 007423 456 NDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVD 535 (604)
Q Consensus 456 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 535 (604)
. .....||..|+|||++.+..++.++|||||||++|||++|+.||...... ...... ..+...
T Consensus 151 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~~-~~~~~~---- 213 (323)
T cd05595 151 T----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELI-LMEEIR---- 213 (323)
T ss_pred c----cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHH-hcCCCC----
Confidence 1 12235899999999999889999999999999999999999999643221 111111 111110
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007423 536 KSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYE 573 (604)
Q Consensus 536 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 573 (604)
+ ....++++.++++ +||+.||++|| ++.++++
T Consensus 214 --~-p~~~~~~~~~li~---~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 214 --F-PRTLSPEAKSLLA---GLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred --C-CCCCCHHHHHHHH---HHccCCHHHhCCCCCCCHHHHHc
Confidence 1 1122344555555 99999999998 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=338.76 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=211.5
Q ss_pred cCcEEEecCCeEEEEEE-eCCC----CEEEEEEeccc--cccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 299 VENIIISTRTGVSYKAV-LPDA----SALAIKRLSAC--KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 299 ~~~~ig~G~~g~vy~~~-~~~~----~~vAvK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
..++||+|+||+||||. .+.| .+||||++... ....+++.+|+-+|.+++|||+++++|+|.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 45799999999999998 5555 46899988643 234578999999999999999999999998766 8899999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
||.|+|.++++.++ ..+.-...+.+..|||+||.||| +.+++||||.++|||+..-..+||.|||+++.+.
T Consensus 779 mP~G~LlDyvr~hr------~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHR------DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred cccchHHHHHHHhh------ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 99999999999875 34777889999999999999999 8999999999999999999999999999999987
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
.+...... .+..-...|||-|.+....+|.++|||||||++||++| |..|++....++ +...+..|..
T Consensus 850 ~d~~ey~~--~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e---------I~dlle~geR 918 (1177)
T KOG1025|consen 850 PDEKEYSA--PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE---------IPDLLEKGER 918 (1177)
T ss_pred cccccccc--cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH---------hhHHHhcccc
Confidence 65433322 22234678999999999999999999999999999999 999998654322 3334444432
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcC
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHG 583 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~ 583 (604)
. ..++-+..++..++.+||..|++.||+++++...+.++..+.+
T Consensus 919 L---------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 919 L---------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred C---------CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 1 2344566788888899999999999999999999998876543
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=325.77 Aligned_cols=198 Identities=21% Similarity=0.343 Sum_probs=172.0
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
.++|...+.||+|+||.||++.. .++..+|+|.+.... ...+++.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 35788899999999999999995 468899999886532 223578999999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++|+|.+++... ..+++.....++.+++.||.|||+ ..+|+||||||+|||+++++.+||+|||++...
T Consensus 84 ~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 84 HMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred cCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 99999999999754 347888999999999999999994 347999999999999999999999999999765
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
..... ....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 155 IDSMA------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred hhhcc------ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 32211 122478999999999888899999999999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=314.46 Aligned_cols=253 Identities=23% Similarity=0.382 Sum_probs=200.7
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
++|.+.+.||+|++|.||++...++..||+|.++......+.+.+|+.++++++|+|++++++++. ....+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 356778899999999999999888889999999866556678999999999999999999999874 4568899999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
++|.++++.... ..+++..+..++.+++.||.||| +.+|+||||||+||++++++.+||+|||++.......
T Consensus 85 ~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 85 GSLLDFLKDGEG-----RALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999975421 35889999999999999999999 7899999999999999999999999999998764322
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
... ..+..++..|+|||+..+..++.++||||||+++|||++ |+.||..... .+..... ..+.....
T Consensus 157 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~-~~~~~~~~ 224 (260)
T cd05070 157 YTA---RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------REVLEQV-ERGYRMPC 224 (260)
T ss_pred ccc---ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHH-HcCCCCCC
Confidence 111 112235678999999888889999999999999999999 8999964321 1111111 11111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
....+ ..+.+++.+|++.+|++|||+.++.+.|++
T Consensus 225 ------~~~~~---~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 ------PQDCP---ISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ------CCcCC---HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11122 345566669999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=323.83 Aligned_cols=241 Identities=19% Similarity=0.224 Sum_probs=191.5
Q ss_pred cEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCC
Q 007423 301 NIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNG 375 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g 375 (604)
+.||+|+||.||++. ..+++.||||.+.... .....+.+|++++++++||||+++.+++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999998 5678999999997532 22356788999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCC
Q 007423 376 TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDP 455 (604)
Q Consensus 376 sL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 455 (604)
+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~ 150 (328)
T cd05593 81 ELFFHLSRE-------RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA 150 (328)
T ss_pred CHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc
Confidence 999988654 35889999999999999999999 88999999999999999999999999999875432211
Q ss_pred CCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccccc
Q 007423 456 NDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVD 535 (604)
Q Consensus 456 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 535 (604)
. .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... +..... ..+..
T Consensus 151 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--------~~~~~~-~~~~~----- 212 (328)
T cd05593 151 T----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELI-LMEDI----- 212 (328)
T ss_pred c----cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--------HHHHHh-ccCCc-----
Confidence 1 12235899999999998888999999999999999999999999643211 111111 11111
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 007423 536 KSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYES 574 (604)
Q Consensus 536 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~ 574 (604)
.+ ....+.++.+++ .+||+.||++|| ++.|+++.
T Consensus 213 -~~-p~~~~~~~~~li---~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 213 -KF-PRTLSADAKSLL---SGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -cC-CCCCCHHHHHHH---HHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 11 112233444444 499999999997 88988764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=320.27 Aligned_cols=263 Identities=22% Similarity=0.327 Sum_probs=201.8
Q ss_pred CCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 296 SFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
+|...+.||+|+||.||+|... ....+|+|.+.... ...+++.+|++++++++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3667789999999999999842 23578999886533 223578899999999999999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCC-----------------CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCe
Q 007423 368 VYKHMPNGTLYSLLHGNGVD-----------------NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNV 430 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~-----------------~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~N 430 (604)
++||+++|+|.+++...... ......+++...+.++.|++.||.||| +.+++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 99999999999998643210 011235889999999999999999999 7899999999999
Q ss_pred EEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCc
Q 007423 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGA 509 (604)
Q Consensus 431 iLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~ 509 (604)
||+++++.+||+|||+++.......... .....++..|+|||+..+..++.++||||||+++|||+| |+.||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVK--RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhc--ccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999986533221111 111235678999999888889999999999999999999 9999864321
Q ss_pred cccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 510 EEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
.+ +......+..... ....+ ..+.+++.+||+.+|++||++.|+++.|+++..+
T Consensus 236 --------~~-~~~~~~~~~~~~~------~~~~~---~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 236 --------ER-LFNLLKTGYRMER------PENCS---EEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred --------HH-HHHHHhCCCCCCC------CCCCC---HHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 11 1122222211110 11122 3455666699999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.69 Aligned_cols=199 Identities=19% Similarity=0.274 Sum_probs=169.2
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
++|...+.||+|+||.||+|.. .++..||+|.++... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 4688889999999999999984 578999999986432 2235678999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++ +|.+++.... ..+++.....++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~~-~l~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LDS-DLKQYLDNCG------NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCc-CHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 975 9999886542 24788999999999999999999 7899999999999999999999999999997653
Q ss_pred CCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
..... .....++..|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus 155 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 155 VPTKT----YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred CCCcc----ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 32211 122347899999998765 56899999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=314.42 Aligned_cols=254 Identities=24% Similarity=0.375 Sum_probs=202.1
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
++|.+.+.||+|+||.||+|...+...||+|+++......+++.+|++++++++||||+++++++. .+..+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence 457888999999999999999777778999999865555678999999999999999999999874 4567999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++..... ..+++..+..++.|+++||+|+| +.+++||||||+||++++++.+||+|||.++......
T Consensus 85 ~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 85 GSLLDFLKGEMG-----KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CcHHHHHhhccc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999975421 34789999999999999999999 7899999999999999999999999999998764322
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
... .....++..|+|||+..+..++.++||||||+++|||+| |+.||...... + .......+...
T Consensus 157 ~~~---~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--------~-~~~~~~~~~~~-- 222 (262)
T cd05071 157 YTA---RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------E-VLDQVERGYRM-- 222 (262)
T ss_pred ccc---ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--------H-HHHHHhcCCCC--
Confidence 111 112236678999999988889999999999999999999 88888643211 1 11111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
....+....+.+++.+|++.||++||++.++.+.|+..
T Consensus 223 -------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 -------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 01112334566777799999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=331.11 Aligned_cols=193 Identities=21% Similarity=0.284 Sum_probs=167.5
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
.+|...+.||+|+||.||++. ...++.||+|... .+.+.+|++++++++||||+++++++......++++||+.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 579999999999999999998 5678999999753 2457889999999999999999999999999999999995
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
++|.+++... ..+++...+.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 167 -~~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 167 -TDLYCYLAAK-------RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred -CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 6898888654 34889999999999999999999 789999999999999999999999999999754321
Q ss_pred CCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 236 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 236 NAN---KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccc---ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 111 12234589999999999988999999999999999999999988753
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=318.59 Aligned_cols=255 Identities=22% Similarity=0.245 Sum_probs=194.2
Q ss_pred hhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccccc---------------HHHHHHHHHHHhccCCCCcccee
Q 007423 293 ATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLS---------------EKQFRSEMNRLGQLRHPNLVPLL 356 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~---------------~~~~~~Ei~~l~~l~H~niv~l~ 356 (604)
.-+.|.....||+|.||.|-+|. ..+++.||||++.+.... -++..+||.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 34678889999999999999999 678999999999653211 14688999999999999999999
Q ss_pred eEEEe--CCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC
Q 007423 357 GFCVV--EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID 434 (604)
Q Consensus 357 g~~~~--~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~ 434 (604)
.+..+ .+..|||+|||..|.+...-... ..++..+..+|..++..||+||| ..+||||||||+|+|++
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~-------~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDK-------PELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLS 244 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCc-------ccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEc
Confidence 99865 45789999999998765432111 22889999999999999999999 78999999999999999
Q ss_pred CCCCeEEcccCCccccCCCCC-CCCccccCCCCcccccCccccCCCC----CCcccchhhHHHHHHHHHhCCCCCCCCCc
Q 007423 435 DDFDARITDFGLARLVGSRDP-NDSSFVHGDLGEFGYVAPEYSSTMV----ASLKGDVYGFGIVLLELLSGQKPLDVAGA 509 (604)
Q Consensus 435 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~----~t~k~DV~SfGvvl~elltg~~p~~~~~~ 509 (604)
+++++||+|||.+........ .........+||+.|||||...++. .+.+.||||+||+||.|+.|+.||-....
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 999999999999987644321 2223345568999999999876632 35688999999999999999999965321
Q ss_pred cccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 510 EEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
-+ + .. .++...+.-+..++.-..+-+|++++|..||++|.+..+|...
T Consensus 325 ~~-----l---~~---------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 325 LE-----L---FD---------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred HH-----H---HH---------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 11 1 11 1111111111122233344455559999999999999998654
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=312.14 Aligned_cols=260 Identities=21% Similarity=0.301 Sum_probs=203.7
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||+|+ ..+++.||||.++... .....+.+|++++++++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 468888999999999999999 4578999999875421 22346889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++...... ...++......++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..
T Consensus 82 e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~ 155 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQ---KRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF 155 (267)
T ss_pred EecCCCcHHHHHHHhhhc---cCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECcccccee
Confidence 999999999988643211 134788899999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
....... .....|+..|+|||+..+..++.++||||||+++|||+||+.||..... ....+.... ....
T Consensus 156 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~------~~~~~~~~~-~~~~ 224 (267)
T cd08228 156 FSSKTTA----AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLFSLCQKI-EQCD 224 (267)
T ss_pred ccchhHH----HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc------cHHHHHHHH-hcCC
Confidence 6432211 1123478899999999888899999999999999999999999864221 112222221 1111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhch
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMA 579 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~ 579 (604)
... .. .......+.+++.+||+.+|++||++.||++.++++.
T Consensus 225 ~~~-----~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 YPP-----LP---TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCC-----CC---hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111 10 1112234556666999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=312.76 Aligned_cols=247 Identities=23% Similarity=0.302 Sum_probs=192.9
Q ss_pred cEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCch
Q 007423 301 NIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL 377 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL 377 (604)
+.||+|+||.||+|.. .+++.||+|.+.... .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999985 578999999886432 2345789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCC
Q 007423 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPND 457 (604)
Q Consensus 378 ~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 457 (604)
.+++.... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~- 150 (252)
T cd05084 81 LTFLRTEG------PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA- 150 (252)
T ss_pred HHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCccccccccc-
Confidence 99997542 34889999999999999999999 889999999999999999999999999998765321110
Q ss_pred CccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCccccccc
Q 007423 458 SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK 536 (604)
Q Consensus 458 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 536 (604)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ........+.....
T Consensus 151 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---------~~~~~~~~~~~~~~--- 217 (252)
T cd05084 151 -STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---------QTREAIEQGVRLPC--- 217 (252)
T ss_pred -ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---------HHHHHHHcCCCCCC---
Confidence 00001123457999999988889999999999999999998 88888643211 11111111111111
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 537 SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 537 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
....+ ..+.+++.+||+.+|++|||+.|+.++|+
T Consensus 218 ---~~~~~---~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 ---PELCP---DAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ---cccCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 11112 34555666999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=318.95 Aligned_cols=267 Identities=21% Similarity=0.274 Sum_probs=196.5
Q ss_pred CcCcEEEecCCeEEEEEE-----eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeC--CeeeEE
Q 007423 298 AVENIIISTRTGVSYKAV-----LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE--EERLLV 368 (604)
Q Consensus 298 ~~~~~ig~G~~g~vy~~~-----~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lv 368 (604)
...+.||+|+||+||++. ..++..||+|.++... ...+.+.+|++++++++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 667899999999998764 2467899999987543 2346788999999999999999999998753 357899
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++|+|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++
T Consensus 87 ~e~~~~~~l~~~~~~~--------~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 87 MEYVPLGSLRDYLPKH--------KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred ecCCCCCCHHHHHHHc--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccccc
Confidence 9999999999999653 4889999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
.......... ......++..|+|||......++.++||||||+++|||+||+.|+...... +. ....+........
T Consensus 156 ~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~-~~~~~~~~~~~~~ 231 (283)
T cd05080 156 AVPEGHEYYR-VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FE-EMIGPKQGQMTVV 231 (283)
T ss_pred ccCCcchhhc-cCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hh-hhhcccccccchh
Confidence 7643221110 011122566799999998888999999999999999999999998643211 00 0000000000000
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhch
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMA 579 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~ 579 (604)
...+..+.......+......+.+++.+||+.+|++|||+++|++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000011111100111112235556666999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.61 Aligned_cols=257 Identities=16% Similarity=0.211 Sum_probs=195.5
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc----cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL----SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|+..+.||+|+||.||++. ..+++.||||+++.... ....+.+|++++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 368888999999999999998 55689999999975321 2246788999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~ 150 (363)
T cd05628 81 EFLPGGDMMTLLMKK-------DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTG 150 (363)
T ss_pred cCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccc
Confidence 999999999999754 35889999999999999999999 88999999999999999999999999999976
Q ss_pred cCCCCCC-------------------------------CCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHH
Q 007423 450 VGSRDPN-------------------------------DSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELL 498 (604)
Q Consensus 450 ~~~~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ell 498 (604)
....... ........+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 230 (363)
T cd05628 151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230 (363)
T ss_pred ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH
Confidence 5321100 000012346999999999999889999999999999999999
Q ss_pred hCCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 499 SGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 499 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
+|+.||......+ .... +........+.+. ...+++..+++.-+ .|...++..||++.||++.
T Consensus 231 ~G~~Pf~~~~~~~--------~~~~-i~~~~~~~~~p~~---~~~s~~~~~li~~l-~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 231 IGYPPFCSETPQE--------TYKK-VMNWKETLIFPPE---VPISEKAKDLILRF-CCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred hCCCCCCCCCHHH--------HHHH-HHcCcCcccCCCc---CCCCHHHHHHHHHH-cCChhhcCCCCCHHHHhCC
Confidence 9999997533211 1111 1111111111111 11234555555422 2444455567999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=326.25 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=207.4
Q ss_pred CCcCcEEEecCCeEEEEEEeCC---C--CEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 297 FAVENIIISTRTGVSYKAVLPD---A--SALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~~~---~--~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
....++||.|.||.||+|.+.+ | ..||||..+.+. .+.+.|..|.-+|++++|||||+++|.|.. ...++||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence 3456789999999999998533 2 468999987633 445789999999999999999999999965 4689999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
|.++.|.|..+|+.+. ..++......++.|++.||+||| +..+|||||..+|||+.....+|++|||+++.
T Consensus 470 EL~~~GELr~yLq~nk------~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNK------DSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred ecccchhHHHHHHhcc------ccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhh
Confidence 9999999999998764 35888899999999999999999 89999999999999999999999999999999
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
+..+.-+..+. ..-+..|||||.+....+|.++|||-|||.+||+++ |..||......+.. ..+..|
T Consensus 541 ~ed~~yYkaS~---~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI---------~~iEnG 608 (974)
T KOG4257|consen 541 LEDDAYYKASR---GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI---------GHIENG 608 (974)
T ss_pred ccccchhhccc---cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE---------EEecCC
Confidence 86554333331 124678999999999999999999999999999987 99999764433211 011122
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
.. -+.++.+...+..++.+||+.+|.+||++.|+...|..+.+
T Consensus 609 eR---------lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 609 ER---------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CC---------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 21 12344566677788889999999999999999999988776
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.33 Aligned_cols=200 Identities=21% Similarity=0.259 Sum_probs=169.0
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
.++|...+.||+|+||.||+|.. .+++.||||.++... .....+.+|++++++++||||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 36788899999999999999995 478999999987533 223467889999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|++ ++|.+++.... ..++...+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++..
T Consensus 84 ~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 84 YVH-TDLCQYMDKHP------GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAK 153 (303)
T ss_pred CCC-cCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceec
Confidence 996 58888876542 34788899999999999999999 789999999999999999999999999998754
Q ss_pred CCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
...... .....++..|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus 154 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 154 SVPSHT----YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred cCCCcc----CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 322111 122347899999998765 45788999999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=312.13 Aligned_cols=256 Identities=21% Similarity=0.367 Sum_probs=201.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC-CC---CEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP-DA---SALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~-~~---~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
++|+..+.||+|+||.||+|... ++ ..+|+|.++... ...+++.+|++++++++||||+++.+++...+..+++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46778899999999999999854 33 379999986542 2345789999999999999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++++|.+++.... ..+++..+..++.|++.|++||| +.+++|||+||+||++++++.+||+|||++.
T Consensus 85 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 85 TEYMENGALDKYLRDHD------GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred EEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccce
Confidence 99999999999997543 35889999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
........... ......+..|+|||+.....++.++|||||||++|||+| |+.||..... .++..... .
T Consensus 156 ~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~~~~~i~-~ 225 (268)
T cd05063 156 VLEDDPEGTYT-TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HEVMKAIN-D 225 (268)
T ss_pred eccccccccee-ccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHh-c
Confidence 66432211111 111123467999999988889999999999999999998 9999964321 12222221 1
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
+.... ...+....+.+++.+||+.+|++||++.+|++.|+++
T Consensus 226 ~~~~~---------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 GFRLP---------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11110 0111224566777799999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=319.61 Aligned_cols=263 Identities=24% Similarity=0.386 Sum_probs=201.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC-CCC--EEEEEEeccc--cccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP-DAS--ALAIKRLSAC--KLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~-~~~--~vAvK~l~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv 368 (604)
++|...+.||+|+||.||+|... ++. .+++|.++.. ....+.+.+|++++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46788899999999999999864 333 4788888742 22345789999999999 799999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCC---------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCe
Q 007423 369 YKHMPNGTLYSLLHGNGVDN---------TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~ 439 (604)
+||+++|+|.++++...... .....+++.....++.|++.||+||| +.+|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 99999999999997542110 11135889999999999999999999 7899999999999999999999
Q ss_pred EEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHH
Q 007423 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLV 518 (604)
Q Consensus 440 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 518 (604)
||+|||++.......... ....+..|+|||+..+..++.++|||||||++|||+| |+.||..... .
T Consensus 159 kl~dfg~~~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--------~ 225 (297)
T cd05089 159 KIADFGLSRGEEVYVKKT-----MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--------A 225 (297)
T ss_pred EECCcCCCccccceeccC-----CCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence 999999986432111110 0113567999999988889999999999999999998 9999965322 1
Q ss_pred HHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcC
Q 007423 519 DWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHG 583 (604)
Q Consensus 519 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~ 583 (604)
+.... ...+.... . ....+. .+.+++.+||+.+|.+||++.+|++.|+.+.+...
T Consensus 226 ~~~~~-~~~~~~~~-----~-~~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 226 ELYEK-LPQGYRME-----K-PRNCDD---EVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HHHHH-HhcCCCCC-----C-CCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11111 11111111 0 011223 44556669999999999999999999999988663
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.40 Aligned_cols=260 Identities=22% Similarity=0.389 Sum_probs=201.7
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEeccccc--cHHHHHHHHHHHhccCCCCccceeeEEEeCCeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACKL--SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 366 (604)
++|...+.||+|+||.||+|... ++..||||.++.... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45777889999999999999853 347899999975433 3467999999999999999999999999999999
Q ss_pred EEeeecCCCchhhhhccCCCC-------CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCe
Q 007423 367 LVYKHMPNGTLYSLLHGNGVD-------NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~-------~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~ 439 (604)
++|||+++|+|.+++...... ......+++.....++.|++.|+.||| +.+++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence 999999999999999754321 111235889999999999999999999 7899999999999999999999
Q ss_pred EEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHH
Q 007423 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLV 518 (604)
Q Consensus 440 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 518 (604)
||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 162 kl~d~g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-------- 231 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYR--VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-------- 231 (280)
T ss_pred EECCcccceecccCccee--cCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------
Confidence 999999997653221110 0111235678999999999999999999999999999999 99998643221
Q ss_pred HHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 519 DWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 519 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
+.+. ....+...... ...+. .+.+++.+||+.||++||++.||++.|++
T Consensus 232 ~~~~-~~~~~~~~~~~------~~~~~---~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 232 EVIE-CITQGRLLQRP------RTCPS---EVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHH-HHHcCCcCCCC------CCCCH---HHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111 11222221111 11223 44555559999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=325.62 Aligned_cols=200 Identities=22% Similarity=0.338 Sum_probs=166.5
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCC-----eee
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE-----ERL 366 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 366 (604)
.|...+.||+|+||.||+|+ ..++..||||+++... ....++.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 36778899999999999999 5578999999986422 22356889999999999999999999886532 479
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
+||||++ ++|.+++... ..+++.....++.|+++||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 81 lv~e~~~-~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~ 149 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-------DDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGL 149 (338)
T ss_pred EEEecCC-CCHHHHHHhc-------ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcc
Confidence 9999996 5899988654 35889999999999999999999 78999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCC--CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST--MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
++......... .......||..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 150 ~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 150 ARVAFNDTPTA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred ccccccccCcc-ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 98653322111 11123458999999998765 67899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=325.28 Aligned_cols=244 Identities=20% Similarity=0.243 Sum_probs=195.7
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCC--CCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPD--ASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~--~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
++|...+.||+|+||.||+|.... +..||+|++.... ...+.+.+|+++++.++||||+++++++..++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468888999999999999998433 3689999986432 2235688999999999999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 110 ~Ey~~~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~ 179 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN-------KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179 (340)
T ss_pred EeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence 9999999999999755 35889999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
...... ....||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+..+
T Consensus 180 ~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---------~~~~~i~~~ 243 (340)
T PTZ00426 180 VVDTRT-------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---------LIYQKILEG 243 (340)
T ss_pred ecCCCc-------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---------HHHHHHhcC
Confidence 763211 1234899999999998888999999999999999999999999753221 111222222
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYES 574 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~ 574 (604)
... . +...++...++++ +|++.||++|+ +++|+++.
T Consensus 244 ~~~--~-----p~~~~~~~~~li~---~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 244 IIY--F-----PKFLDNNCKHLMK---KLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCC--C-----CCCCCHHHHHHHH---HHcccCHHHcCCCCCCCHHHHHcC
Confidence 111 1 1122344455554 99999999995 78888664
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=318.61 Aligned_cols=264 Identities=22% Similarity=0.377 Sum_probs=205.1
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEeccccc-cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACKL-SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
++|...+.||+|+||.||+++.. ++..+|+|.++.... ..+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35677789999999999999732 355799999875443 34578999999999999999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCC---------CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC
Q 007423 368 VYKHMPNGTLYSLLHGNGVD---------NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD 438 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~ 438 (604)
||||+++++|.+++...... ......+++..++.++.|++.|++||| +.+|+||||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 99999999999999754310 011134899999999999999999999 889999999999999999999
Q ss_pred eEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcH
Q 007423 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNL 517 (604)
Q Consensus 439 ~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~ 517 (604)
+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus 162 ~~l~dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------- 232 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT------- 232 (291)
T ss_pred EEECCCCcccccCCCcee--ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------
Confidence 999999999765432111 01112236788999999988889999999999999999999 99998643221
Q ss_pred HHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 518 VDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 518 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
+.. .....+...... .. ....+.+++.+||+.+|++||++.+|+++|+++.+.
T Consensus 233 -~~~-~~~~~~~~~~~~------~~---~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 233 -EVI-ECITQGRVLERP------RV---CPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -HHH-HHHhCCCCCCCC------cc---CCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 111 112222222111 11 123455666699999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=312.61 Aligned_cols=259 Identities=22% Similarity=0.318 Sum_probs=203.2
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|++|.||++. ..+++.+|||.+.... ...+++.+|+++++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 357778899999999999999 5689999999886422 22357889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++++|.+++...... ...+++.....++.+++.||.||| +.+++|+||||+||+++.++.++|+|||++..
T Consensus 82 e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQ---KRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF 155 (267)
T ss_pred EecCCCCHHHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhc
Confidence 999999999998643211 135889999999999999999999 88999999999999999999999999999887
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
....... .....|+..|+|||+..+..++.++||||||+++|||++|+.||..... ....+.... ...
T Consensus 156 ~~~~~~~----~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~- 223 (267)
T cd08229 156 FSSKTTA----AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKI-EQC- 223 (267)
T ss_pred cccCCcc----cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc------hHHHHhhhh-hcC-
Confidence 6432211 1223478899999999888899999999999999999999999964221 111111111 111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
..+.......+++ +.+++.+||+.||++||||.+|++.++++
T Consensus 224 ----~~~~~~~~~~~~~---~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 224 ----DYPPLPSDHYSEE---LRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ----CCCCCCcccccHH---HHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1111111122334 44555599999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=312.65 Aligned_cols=253 Identities=23% Similarity=0.383 Sum_probs=202.2
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
++|...++||+|+||.||+|...+++.||+|.+.......+++.+|++++++++|+||+++++++. .+..+++|||+++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMEN 84 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCC
Confidence 467788999999999999999888999999999876666678999999999999999999999864 5568999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++..... ..+++.....++.|++.||+||| +.+++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~L~~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 85 GSLVDFLKTPEG-----IKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999875432 35889999999999999999999 7899999999999999999999999999998764221
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
... .....++..|+|||+.....++.++||||||+++|||++ |+.||...... +.... ...+.....
T Consensus 157 ~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~-~~~~~~~~~ 224 (260)
T cd05067 157 YTA---REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--------EVIQN-LERGYRMPR 224 (260)
T ss_pred ccc---ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--------HHHHH-HHcCCCCCC
Confidence 111 112235678999999988889999999999999999999 99999743221 11111 111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
....+. ++.+++.+||+.+|++||+++++.+.|+.
T Consensus 225 ------~~~~~~---~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 ------PDNCPE---ELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ------CCCCCH---HHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111223 45556669999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.80 Aligned_cols=243 Identities=23% Similarity=0.392 Sum_probs=186.6
Q ss_pred CCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 297 FAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
|...+.||+|+||.||++. ..+++.||||.+.... ...+.+.+|++++++++|+||+++++++...+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 4456789999999999998 4578999999986433 224678999999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+|+|.+.. ..++.....++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 156 ~~~L~~~~-----------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 156 GGSLEGTH-----------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred CCcccccc-----------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 99986532 2456777889999999999999 789999999999999999999999999999876432
Q ss_pred CCCCCccccCCCCcccccCccccCC-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHH--H
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSST-----MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV--I 526 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~ 526 (604)
... .....||..|+|||++.. ...+.++|||||||++|||++|+.||..... .+|..... .
T Consensus 222 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--------~~~~~~~~~~~ 289 (353)
T PLN00034 222 MDP----CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--------GDWASLMCAIC 289 (353)
T ss_pred ccc----ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--------ccHHHHHHHHh
Confidence 211 122358999999998743 2345689999999999999999999973211 11211111 1
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
...... . ....+.+ +.+++.+||+.||++||++.|+++.
T Consensus 290 ~~~~~~-----~-~~~~~~~---l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 290 MSQPPE-----A-PATASRE---FRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ccCCCC-----C-CCccCHH---HHHHHHHHccCChhhCcCHHHHhcC
Confidence 111100 0 1112233 4455559999999999999999875
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=317.41 Aligned_cols=260 Identities=24% Similarity=0.351 Sum_probs=198.8
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-----CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-----PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-----~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
++|+..+.||+|+||.||+|.. .++..||+|.++... ...+.+.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3567778999999999999973 356789999997432 223578899999999999999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCC----------CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC
Q 007423 368 VYKHMPNGTLYSLLHGNGVD----------NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF 437 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~----------~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~ 437 (604)
+|||+++|+|.+++...... ......+++...+.++.|++.||.||| +.+++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 99999999999998533210 001134789999999999999999999 78999999999999999999
Q ss_pred CeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCc
Q 007423 438 DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGN 516 (604)
Q Consensus 438 ~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~ 516 (604)
.+||+|||+++.......... .....++..|+|||+..+..++.++|||||||++|||+| |..||.....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~------- 232 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRV--QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN------- 232 (283)
T ss_pred cEEeccccccccccCCcceec--ccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence 999999999987643221111 112235678999999988889999999999999999999 9999864321
Q ss_pred HHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 517 LVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
..+...+..+..... ....++ .+.+++.+||+.||++||++.+|.+.|..
T Consensus 233 --~~~~~~~~~~~~~~~------~~~~~~---~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 --QEVIEMVRKRQLLPC------SEDCPP---RMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHHHHHHcCCcCCC------CCCCCH---HHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111122222221111 011223 34455559999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=320.21 Aligned_cols=259 Identities=20% Similarity=0.225 Sum_probs=188.8
Q ss_pred CCCcCcEEEecCCeEEEEEEe--CCCCEEEEEEecccc---ccHHHHHHHHHHHhcc---CCCCccceeeEEEe-----C
Q 007423 296 SFAVENIIISTRTGVSYKAVL--PDASALAIKRLSACK---LSEKQFRSEMNRLGQL---RHPNLVPLLGFCVV-----E 362 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~--~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~-----~ 362 (604)
+|...+.||+|+||.||+|.. .++..||||+++... .....+.+|+++++++ +||||+++++++.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 577889999999999999984 346889999986432 1234566788777665 69999999999863 3
Q ss_pred CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEc
Q 007423 363 EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARIT 442 (604)
Q Consensus 363 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~ 442 (604)
...++||||++ ++|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~ 152 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA 152 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEc
Confidence 45889999996 589999875422 34889999999999999999999 7899999999999999999999999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHH
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVN 522 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 522 (604)
|||+++....... .....|+..|+|||++....++.++|||||||++|||++|++||......+. ...+.
T Consensus 153 Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~-----~~~i~ 222 (290)
T cd07862 153 DFGLARIYSFQMA-----LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-----LGKIL 222 (290)
T ss_pred cccceEeccCCcc-----cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH-----HHHHH
Confidence 9999987643211 1223488999999999888899999999999999999999999975432211 11110
Q ss_pred HHHHcC---Cc-------cccccccccC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 523 HLVIAG---RS-------RDVVDKSLYG---RGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 523 ~~~~~~---~~-------~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
...... .. .....+.... ...+.....+.+++.+|++.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 223 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000 00 0000000000 000011123445666999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=313.60 Aligned_cols=262 Identities=21% Similarity=0.341 Sum_probs=200.5
Q ss_pred hhcCCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCe
Q 007423 293 ATNSFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEE 364 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 364 (604)
.+++|+..+.||+|+||.||+|... .+..||||+++... ....++.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567888999999999999998742 35679999986432 234568899999999999999999999998899
Q ss_pred eeEEeeecCCCchhhhhccCCCCC---CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEE
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDN---TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARI 441 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~---~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl 441 (604)
.++||||+++|+|.+++....... .....+++..++.++.|++.||.||| +.+++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999987532110 01134688999999999999999999 789999999999999999999999
Q ss_pred cccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHH
Q 007423 442 TDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDW 520 (604)
Q Consensus 442 ~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 520 (604)
+|||+++.......... .....++..|+|||++.+..++.++|||||||++|||+| |+.||...... +.
T Consensus 161 ~dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--------~~ 230 (277)
T cd05062 161 GDFGMTRDIYETDYYRK--GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--------QV 230 (277)
T ss_pred CCCCCccccCCcceeec--CCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HH
Confidence 99999876533221110 011235778999999988889999999999999999999 78898643221 11
Q ss_pred HHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 521 VNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 521 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
.. ....+...... ...+ ..+.+++.+||+.||++|||+.|+++.|++
T Consensus 231 ~~-~~~~~~~~~~~------~~~~---~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 231 LR-FVMEGGLLDKP------DNCP---DMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HH-HHHcCCcCCCC------CCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11 12222221111 1122 345556669999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=313.42 Aligned_cols=258 Identities=22% Similarity=0.375 Sum_probs=198.1
Q ss_pred CCcCcEEEecCCeEEEEEEeC-C---CCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCe-----
Q 007423 297 FAVENIIISTRTGVSYKAVLP-D---ASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEE----- 364 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~~-~---~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 364 (604)
|...+.||+|+||.||+|... + +..||||+++.... ..+++.+|++.+++++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456789999999999999853 2 36799999875432 23578999999999999999999999876554
Q ss_pred -eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 365 -RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 365 -~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
.++++||+++|+|.+++....... ....+++.....++.|++.||.||| +.+++||||||+||++++++.+||+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGG-LPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccC-CcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECC
Confidence 789999999999999986542211 1135899999999999999999999 78999999999999999999999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHH
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVN 522 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 522 (604)
||+++........... ....++..|+|||+.....++.++|||||||++|||++ |..||..... .+...
T Consensus 157 fg~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--------~~~~~ 226 (273)
T cd05035 157 FGLSKKIYSGDYYRQG--RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--------HEIYD 226 (273)
T ss_pred ccceeecccccccccc--ccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH
Confidence 9999876433221111 11124678999999988889999999999999999999 8999864321 11121
Q ss_pred HHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 523 HLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 523 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
....+..... +......+.+++.+||+.||++||++.|+++.|+++
T Consensus 227 -~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 -YLRHGNRLKQ---------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -HHHcCCCCCC---------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1122211111 111234566667799999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=314.52 Aligned_cols=264 Identities=22% Similarity=0.363 Sum_probs=205.0
Q ss_pred cCCCcCcEEEecCCeEEEEEEe------CCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAVL------PDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~------~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
++|.+.+.||+|+||.||++.. .++..+|+|.+.... ...+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4677889999999999999974 234569999987543 334578999999999999999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCC------CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEE
Q 007423 368 VYKHMPNGTLYSLLHGNGVD------NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARI 441 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~------~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl 441 (604)
+|||+++++|.+++...... ......+++..++.++.|++.||+||| +.+++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence 99999999999999754210 011235899999999999999999999 789999999999999999999999
Q ss_pred cccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHH
Q 007423 442 TDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDW 520 (604)
Q Consensus 442 ~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 520 (604)
+|||+++......... ......++..|+|||++.+..++.++|||||||++|||+| |+.||...... +
T Consensus 162 ~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--------~- 230 (288)
T cd05093 162 GDFGMSRDVYSTDYYR--VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------E- 230 (288)
T ss_pred ccCCccccccCCceee--cCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------H-
Confidence 9999998653321110 1111235678999999988889999999999999999999 99998643221 1
Q ss_pred HHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 521 VNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 521 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
.......+...... ...+ ..+.+++.+||+.||.+|||+.||.+.|+.+...
T Consensus 231 ~~~~i~~~~~~~~~------~~~~---~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 231 VIECITQGRVLQRP------RTCP---KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHHcCCcCCCC------CCCC---HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11112222221111 1122 3456666699999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=314.54 Aligned_cols=257 Identities=20% Similarity=0.334 Sum_probs=194.5
Q ss_pred CcCcEEEecCCeEEEEEEeCC-CC--EEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeC------Cee
Q 007423 298 AVENIIISTRTGVSYKAVLPD-AS--ALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE------EER 365 (604)
Q Consensus 298 ~~~~~ig~G~~g~vy~~~~~~-~~--~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~ 365 (604)
.+.+.||+|+||.||+|...+ +. .||+|.++... ...+.+.+|++++++++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999999644 33 58999886532 2345688999999999999999999987532 246
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
++++||+++|+|.+++....... ....+++.....++.|++.||+||| +.+|+||||||+|||+++++.+||+|||
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGD-CPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccC-CcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence 89999999999999875332111 1135899999999999999999999 7899999999999999999999999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHH
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
+++........... ....++..|+|||+.....++.++|||||||++|||++ |+.||..... .+ ....
T Consensus 158 ~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~-~~~~ 226 (272)
T cd05075 158 LSKKIYNGDYYRQG--RIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------SE-IYDY 226 (272)
T ss_pred cccccCcccceecC--CcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HH-HHHH
Confidence 99876432211110 11135678999999998889999999999999999999 8999864321 11 1122
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
...+..... ....+ ..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 227 ~~~~~~~~~------~~~~~---~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 227 LRQGNRLKQ------PPDCL---DGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHcCCCCCC------CCCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 222221111 01112 3455666699999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=316.75 Aligned_cols=260 Identities=22% Similarity=0.331 Sum_probs=199.4
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER 365 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 365 (604)
+++|...+.||+|++|.||+|... .+..||+|.+.... .....|.+|+.++++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 466888899999999999999854 35689999886432 2345689999999999999999999999998899
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC---CeEEc
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF---DARIT 442 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~---~~kl~ 442 (604)
+++|||+++|+|.+++............++|..++.++.|++.|++||| +.+++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence 9999999999999999765432222245899999999999999999999 78999999999999998654 69999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHH
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWV 521 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 521 (604)
|||+++.......... ......+..|+|||++.+..++.++|||||||++|||+| |+.||...... +..
T Consensus 162 dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--------~~~ 231 (277)
T cd05036 162 DFGMARDIYRASYYRK--GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--------EVM 231 (277)
T ss_pred cCccccccCCccceec--CCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHH
Confidence 9999987632211100 011123568999999988889999999999999999997 99999753221 111
Q ss_pred HHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 522 NHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 522 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
.. +........ ....+ ..+.+++.+||+.+|++||++.||++.|+
T Consensus 232 ~~-~~~~~~~~~------~~~~~---~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 EF-VTGGGRLDP------PKGCP---GPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HH-HHcCCcCCC------CCCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11 111111110 01112 34556666999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.42 Aligned_cols=258 Identities=23% Similarity=0.381 Sum_probs=200.9
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCC----EEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDAS----ALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~----~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
++|...+.||+|+||+||+|. ..+++ .||+|.++... ...+++.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 467788999999999999998 44555 48999986432 234678899999999999999999999875 45779
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
++||+++|+|.++++... ..+++...+.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++
T Consensus 86 ~~~~~~~g~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK------DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred EEEcCCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCce
Confidence 999999999999997542 35889999999999999999999 889999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
+......... ...+..++..|+|||...+..++.++|||||||++|||+| |+.||...... .... ...
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~----~~~ 225 (279)
T cd05109 157 RLLDIDETEY--HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-----EIPD----LLE 225 (279)
T ss_pred eeccccccee--ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHH----HHH
Confidence 8764322111 1112234678999999988889999999999999999998 99998643221 1111 222
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
.+..... .......+.+++.+||+.||++||++.|+++.|+.+..+.
T Consensus 226 ~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 226 KGERLPQ---------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred CCCcCCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 2211111 1112234556666999999999999999999998886654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=319.60 Aligned_cols=240 Identities=19% Similarity=0.260 Sum_probs=189.7
Q ss_pred cEEEecCCeEEEEEEe----CCCCEEEEEEecccc-----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 301 NIIISTRTGVSYKAVL----PDASALAIKRLSACK-----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~----~~~~~vAvK~l~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+.||+|+||.||+++. ..++.||||.++... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999984 357899999987532 1224578899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++|+|.+++... ..+.+.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (323)
T cd05584 82 LSGGELFMHLERE-------GIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI 151 (323)
T ss_pred CCCchHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence 9999999998754 34778888889999999999999 7899999999999999999999999999987543
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
..... .....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ...... ...+..
T Consensus 152 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~~~~-~~~~~~- 217 (323)
T cd05584 152 HEGTV----THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDK-ILKGKL- 217 (323)
T ss_pred cCCCc----ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHHHHH-HHcCCC-
Confidence 22211 1223589999999999888899999999999999999999999975321 111111 112211
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYE 573 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 573 (604)
. +. ...++++. +++.+||+.||++|| ++.++++
T Consensus 218 ~-~~-----~~~~~~~~---~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 N-LP-----PYLTPEAR---DLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred C-CC-----CCCCHHHH---HHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1 11 11233444 455599999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=310.86 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=199.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
++|.....||+|++|.||++...++..+|+|.+.......+.+.+|++++++++|+|++++++++. .+..+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 457778899999999999999877778999998765555678999999999999999999999875 4568899999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.++++.... ..+++..+..++.+++.||+||| +.+++|+||||+||++++++.+||+|||+++......
T Consensus 85 ~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 85 GSLLDFLKEGDG-----KYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999975421 34789999999999999999999 7899999999999999999999999999998764322
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
... .....++..|+|||+..+..++.++|||||||++|||+| |+.||......+ . ... ...+....
T Consensus 157 ~~~---~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~---~~~-~~~~~~~~- 223 (260)
T cd05069 157 YTA---RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-----V---LEQ-VERGYRMP- 223 (260)
T ss_pred ccc---cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----H---HHH-HHcCCCCC-
Confidence 111 112235678999999988889999999999999999999 999996532211 1 111 11111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
. ....+. .+.+++.+||+.||++||++++|.+.|++
T Consensus 224 ~-----~~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 C-----PQGCPE---SLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred C-----CcccCH---HHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 011223 44555559999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.39 Aligned_cols=253 Identities=17% Similarity=0.231 Sum_probs=195.8
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|+..+.||+|+||.||++.. .+++.||||+++... ...+.+.+|++++..++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 3688889999999999999994 578999999997532 22345788999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 E~~~~g~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 150 (364)
T cd05599 81 EYLPGGDMMTLLMKK-------DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTG 150 (364)
T ss_pred CCCCCcHHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeeccccee
Confidence 999999999999754 35889999999999999999999 78999999999999999999999999999976
Q ss_pred cCCCCCCC----------------------------------CccccCCCCcccccCccccCCCCCCcccchhhHHHHHH
Q 007423 450 VGSRDPND----------------------------------SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLL 495 (604)
Q Consensus 450 ~~~~~~~~----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ 495 (604)
+....... .......+||+.|+|||++....++.++|||||||++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 230 (364)
T cd05599 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230 (364)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHH
Confidence 53211100 00011235899999999999889999999999999999
Q ss_pred HHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC---HHHHH
Q 007423 496 ELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS---MYQVY 572 (604)
Q Consensus 496 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~ev~ 572 (604)
||++|+.||...... +..... ............ ...+++..++++ +|+. +|.+|++ +.|++
T Consensus 231 el~~G~~Pf~~~~~~--------~~~~~i-~~~~~~~~~~~~---~~~s~~~~~li~---~ll~-~p~~R~~~~~~~~ll 294 (364)
T cd05599 231 EMLVGYPPFCSDNPQ--------ETYRKI-INWKETLQFPDE---VPLSPEAKDLIK---RLCC-EAERRLGNNGVNEIK 294 (364)
T ss_pred HhhcCCCCCCCCCHH--------HHHHHH-HcCCCccCCCCC---CCCCHHHHHHHH---HHcc-CHhhcCCCCCHHHHh
Confidence 999999999753321 111111 111110000000 112345555554 7886 8999998 88886
Q ss_pred H
Q 007423 573 E 573 (604)
Q Consensus 573 ~ 573 (604)
+
T Consensus 295 ~ 295 (364)
T cd05599 295 S 295 (364)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=314.03 Aligned_cols=253 Identities=21% Similarity=0.319 Sum_probs=196.3
Q ss_pred HhhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhcc-CCCCccceeeEEEeC------C
Q 007423 292 AATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVE------E 363 (604)
Q Consensus 292 ~~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~------~ 363 (604)
.+++.|+..+.||+|+||.||+|. ..+++.||+|.+.........+.+|+++++++ +||||+++++++... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 355678888999999999999998 45688999999976555567889999999998 799999999998753 4
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
..+++|||+++|+|.+++..... ..+++..+..++.|++.|++||| +.+|+|+|+||+||++++++.+||+|
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKG-----NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEcc
Confidence 57899999999999999876422 35889999999999999999999 78999999999999999999999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHH
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSS-----TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLV 518 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~ 518 (604)
||+++......... ....|+..|+|||++. ...++.++|||||||++|||++|+.||...... .
T Consensus 155 fg~~~~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-------~ 223 (272)
T cd06637 155 FGVSAQLDRTVGRR----NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------R 223 (272)
T ss_pred CCCceecccccccC----CcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-------H
Confidence 99998654322111 1234788999999875 345788999999999999999999999643211 1
Q ss_pred HHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 519 DWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 519 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.+. ........... ....+. .+.+++.+||..+|.+|||+.|+++
T Consensus 224 ~~~--~~~~~~~~~~~-----~~~~~~---~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 224 ALF--LIPRNPAPRLK-----SKKWSK---KFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHH--HHhcCCCCCCC-----CCCcCH---HHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111 11111111111 111223 3455566999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=310.17 Aligned_cols=244 Identities=19% Similarity=0.326 Sum_probs=203.4
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccH----HHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSE----KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~----~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
.|++.+.+|+|.||.|-++. ...|+.||||.+++++... -.+++||+||+.++||||+.++.+|++.+...+|||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 46667889999999999998 5789999999998765333 358899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|..+|.|++++.+. +.|+..+...+++||..|+.|+| +.+++|||||.+|||+|++.++||+|||++-++
T Consensus 134 YaS~GeLYDYiSer-------~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 134 YASGGELYDYISER-------GSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred ecCCccHHHHHHHh-------ccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhh
Confidence 99999999999876 46999999999999999999999 899999999999999999999999999999887
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA-SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
.. ..+....+|++-|.+||...+.+| ++..|.||+||+||.|+.|..||+... ....+++ +..|.
T Consensus 204 ~~-----~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--------hk~lvrQ-Is~Ga 269 (668)
T KOG0611|consen 204 AD-----KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--------HKRLVRQ-ISRGA 269 (668)
T ss_pred cc-----ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--------HHHHHHH-hhccc
Confidence 43 234455679999999999999887 578999999999999999999998532 2222333 23333
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
..+.- .+-....+++ +++..||++|.|+.+|...
T Consensus 270 YrEP~--------~PSdA~gLIR---wmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 270 YREPE--------TPSDASGLIR---WMLMVNPERRATIEDIASH 303 (668)
T ss_pred ccCCC--------CCchHHHHHH---HHHhcCcccchhHHHHhhh
Confidence 32211 1123344555 9999999999999999765
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=331.12 Aligned_cols=263 Identities=20% Similarity=0.283 Sum_probs=201.1
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEeccccc--cHHHHHHHHHHHhccC-CCCccceeeEEEeCCee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACKL--SEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEER 365 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 365 (604)
++|...+.||+|+||.||+|+.. .+..||||+++.... ..+.+.+|++++.++. |||||++++++...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 45667789999999999999853 346899999975432 2346889999999997 99999999999999999
Q ss_pred eEEeeecCCCchhhhhccCCCCC---------------------------------------------------------
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDN--------------------------------------------------------- 388 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~--------------------------------------------------------- 388 (604)
++|+||+++|+|.++++......
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999999999999997532100
Q ss_pred ----------------------------------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC
Q 007423 389 ----------------------------------TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID 434 (604)
Q Consensus 389 ----------------------------------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~ 434 (604)
.....++|...+.++.|++.||+||| +.+|+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEe
Confidence 00124788889999999999999999 78999999999999999
Q ss_pred CCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccc
Q 007423 435 DDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGF 513 (604)
Q Consensus 435 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~ 513 (604)
+++.+||+|||+++......... ......++..|+|||++....++.++|||||||++|||++ |+.||......
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~--- 348 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYI--SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN--- 348 (401)
T ss_pred CCCEEEEEecCcceecccccccc--cCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch---
Confidence 99999999999998653322111 1112246788999999988889999999999999999998 89998643211
Q ss_pred cCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhch
Q 007423 514 KGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMA 579 (604)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~ 579 (604)
+.....+..+.... .+ ...+. .+.+++.+||..+|++||+++||++.|+.+.
T Consensus 349 -----~~~~~~~~~~~~~~--~p----~~~~~---~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 -----EQFYNAIKRGYRMA--KP----AHASD---EIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -----HHHHHHHHcCCCCC--CC----CCCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11112222221111 11 11223 4455555999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.19 Aligned_cols=265 Identities=25% Similarity=0.384 Sum_probs=201.6
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCC--EEEEEEeccc--cccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDAS--ALAIKRLSAC--KLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~--~vAvK~l~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv 368 (604)
++|...+.||+|+||.||+|.. .++. .+|+|.++.. ....+++.+|++++.++ +||||+++++++..++..+++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 4677889999999999999985 3454 4688877642 22345788999999999 899999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCC---------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCe
Q 007423 369 YKHMPNGTLYSLLHGNGVDN---------TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~ 439 (604)
|||+++|+|.++++...... .....+++..++.++.|++.|++||| +.+++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence 99999999999997543110 01135889999999999999999999 8899999999999999999999
Q ss_pred EEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHH
Q 007423 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLV 518 (604)
Q Consensus 440 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 518 (604)
||+|||+++........ ....++..|+|||+..+..++.++|||||||++|||+| |..||......
T Consensus 164 kl~dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------- 230 (303)
T cd05088 164 KIADFGLSRGQEVYVKK-----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------- 230 (303)
T ss_pred EeCccccCcccchhhhc-----ccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--------
Confidence 99999998643211100 01124567999999988889999999999999999998 99999643221
Q ss_pred HHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCC
Q 007423 519 DWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFS 585 (604)
Q Consensus 519 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~ 585 (604)
+.... ...+.... .. ...+ ..+.+++.+||+.+|++||++.++++.|+.+.++....
T Consensus 231 ~~~~~-~~~~~~~~-----~~-~~~~---~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 231 ELYEK-LPQGYRLE-----KP-LNCD---DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred HHHHH-HhcCCcCC-----CC-CCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 11111 11111000 00 1112 24556666999999999999999999999988765433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=325.57 Aligned_cols=246 Identities=22% Similarity=0.288 Sum_probs=203.9
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-c---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-L---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
+-|..++.||+|+.|.|-.|+ ..+|+.+|||.+.+.. . ....+.+|+.+|+-+.||||+++++++++..+.|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 346677899999999999998 6789999999996542 1 1245889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|.|.+++-.+ ++++..+..+++.||+.|+.|+| ..+|+|||+||+|+|+|...++||+|||+|.+
T Consensus 92 Eyv~gGELFdylv~k-------G~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsL 161 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK-------GPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASL 161 (786)
T ss_pred EecCCchhHHHHHhh-------CCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeec
Confidence 999999999999876 56889999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA-SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
-..+. .....+|++.|.|||++.+.+| +.++||||.|||||.|+||+.||++.+-. -....++.|
T Consensus 162 e~~gk-----lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir---------~LLlKV~~G 227 (786)
T KOG0588|consen 162 EVPGK-----LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR---------VLLLKVQRG 227 (786)
T ss_pred ccCCc-----cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH---------HHHHHHHcC
Confidence 54332 3344569999999999999887 57899999999999999999999854321 122233444
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
...- +...+.+.+.++. ++++.||+.|.|++||++.
T Consensus 228 ~f~M-------Ps~Is~eaQdLLr---~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 228 VFEM-------PSNISSEAQDLLR---RMLDVDPSTRITTEEILKH 263 (786)
T ss_pred cccC-------CCcCCHHHHHHHH---HHhccCccccccHHHHhhC
Confidence 3321 1223445566665 9999999999999999886
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=318.70 Aligned_cols=263 Identities=22% Similarity=0.350 Sum_probs=203.1
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEeccccc--cHHHHHHHHHHHhcc-CCCCccceeeEEEeCCe
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACKL--SEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEE 364 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 364 (604)
.++|...+.||+|+||.||++... ....+|+|.+..... ...++.+|+++++++ +|+||+++++++..++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 456778899999999999999853 336899999875332 234688999999999 89999999999999999
Q ss_pred eeEEeeecCCCchhhhhccCCCC---------CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVD---------NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD 435 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~ 435 (604)
.+++|||+++|+|.++++..... ......+++..++.++.|++.||.||| +.+|+||||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcC
Confidence 99999999999999999653210 011245899999999999999999999 789999999999999999
Q ss_pred CCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCcccccc
Q 007423 436 DFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFK 514 (604)
Q Consensus 436 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~ 514 (604)
++.+||+|||+++.+........ .....++..|+|||+..+..++.++|||||||++|||++ |..||......
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---- 241 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRK--TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---- 241 (293)
T ss_pred CCeEEeCccccccccccccceec--cCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH----
Confidence 99999999999987643221111 111235678999999988889999999999999999998 99998643211
Q ss_pred CcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhch
Q 007423 515 GNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMA 579 (604)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~ 579 (604)
+ +......+.... .+......+.+++.+||+.||++||||.|+++.|+.+.
T Consensus 242 ----~-~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 ----E-LFKLLKEGYRME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ----H-HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1 111122221111 11112335666777999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=297.09 Aligned_cols=198 Identities=23% Similarity=0.297 Sum_probs=177.6
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccccc----HHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLS----EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~----~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.+|.|+||.|..++ ..+|..+|+|+++..+.- .+...+|..+|+.+.||+++++.+.+.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 467778999999999999998 556889999999875432 245778999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||.++|.|..++++. +.++......+|.+|+.|++||| +..|++||+||+|||+|.+|.+||+|||+|+.
T Consensus 124 eyv~GGElFS~Lrk~-------~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~ 193 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS-------GRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKR 193 (355)
T ss_pred eccCCccHHHHHHhc-------CCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEE
Confidence 999999999999876 46889999999999999999999 89999999999999999999999999999998
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCc
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGA 509 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~ 509 (604)
+... ....+||+.|+|||.+....+...+|.|||||++|||+.|.+||...+.
T Consensus 194 v~~r-------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 194 VSGR-------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred ecCc-------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 7432 2234699999999999999999999999999999999999999986543
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.64 Aligned_cols=242 Identities=20% Similarity=0.232 Sum_probs=190.6
Q ss_pred cEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCC
Q 007423 301 NIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNG 375 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g 375 (604)
+.||+|+||.||++. ..+++.||+|.++... .....+.+|+++++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999998 5678999999997532 12345778999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCC
Q 007423 376 TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDP 455 (604)
Q Consensus 376 sL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 455 (604)
+|.+++... ..+++.....++.|++.||.|||+ ..+|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 81 ELFFHLSRE-------RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 151 (325)
T ss_pred cHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence 999988654 358899999999999999999993 27899999999999999999999999999875432211
Q ss_pred CCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccccc
Q 007423 456 NDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVD 535 (604)
Q Consensus 456 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 535 (604)
. .....||..|+|||++.+..++.++|||||||++|||+||+.||...... .... ....+...
T Consensus 152 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--------~~~~-~i~~~~~~---- 214 (325)
T cd05594 152 T----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFE-LILMEEIR---- 214 (325)
T ss_pred c----cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--------HHHH-HHhcCCCC----
Confidence 1 12234899999999998888999999999999999999999999643211 1111 11111110
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 007423 536 KSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYES 574 (604)
Q Consensus 536 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~ 574 (604)
+ ....+.++.+++ .+||+.||++|+ ++.++++.
T Consensus 215 --~-p~~~~~~~~~li---~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 --F-PRTLSPEAKSLL---SGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred --C-CCCCCHHHHHHH---HHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0 111233444444 499999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=326.54 Aligned_cols=256 Identities=19% Similarity=0.196 Sum_probs=194.0
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
.|...+.||+|+||.||+|. ..+++.||||++.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 47778999999999999998 5678999999996532 123468899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++|+|.+++... ..+++.....++.|++.||+||| ..+|+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIRM-------EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 99999999999754 35788888999999999999999 789999999999999999999999999998643
Q ss_pred CCCCCC-------------------------------------------CCccccCCCCcccccCccccCCCCCCcccch
Q 007423 451 GSRDPN-------------------------------------------DSSFVHGDLGEFGYVAPEYSSTMVASLKGDV 487 (604)
Q Consensus 451 ~~~~~~-------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV 487 (604)
...... .........||..|+|||++.+..++.++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di 231 (381)
T cd05626 152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231 (381)
T ss_pred ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce
Confidence 210000 0000112358999999999988889999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC
Q 007423 488 YGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS 567 (604)
Q Consensus 488 ~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 567 (604)
|||||++|||+||+.||......+ .............. .+ ....+.+..+++.- +.|+..+|..||+
T Consensus 232 wSlG~il~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~-~~---~~~~s~~~~dli~~-ll~~~~~~~~R~~ 298 (381)
T cd05626 232 WSVGVILFEMLVGQPPFLAPTPTE--------TQLKVINWENTLHI-PP---QVKLSPEAVDLITK-LCCSAEERLGRNG 298 (381)
T ss_pred eehhhHHHHHHhCCCCCcCCCHHH--------HHHHHHccccccCC-CC---CCCCCHHHHHHHHH-HccCcccccCCCC
Confidence 999999999999999997533211 01111110000000 00 01123444454441 1277778888999
Q ss_pred HHHHHHH
Q 007423 568 MYQVYES 574 (604)
Q Consensus 568 ~~ev~~~ 574 (604)
+.|+++.
T Consensus 299 ~~~~l~h 305 (381)
T cd05626 299 ADDIKAH 305 (381)
T ss_pred HHHHhcC
Confidence 9999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=308.90 Aligned_cols=250 Identities=25% Similarity=0.389 Sum_probs=202.2
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
++|...+.||+|++|.||++... ++.||||.++......+++.+|+.++++++|+||+++++++...+..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 46778899999999999999864 78999999976554567899999999999999999999999988899999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
++|.+++..... ..+++..+..++.|++.||.||| ..+++|+||||+||++++++.+||+|||.++......
T Consensus 85 ~~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 85 GSLVDYLRSRGR-----AVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred CcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 999999975532 25899999999999999999999 8899999999999999999999999999998763221
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
. ....+..|+|||+.....++.++||||||+++|||++ |+.||...... .+......+.....
T Consensus 157 ~-------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---------~~~~~~~~~~~~~~ 220 (256)
T cd05039 157 D-------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---------DVVPHVEKGYRMEA 220 (256)
T ss_pred c-------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---------HHHHHHhcCCCCCC
Confidence 1 1124678999999988889999999999999999997 99998643211 11122222211111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
. ...+ ..+.+++.+||..+|++||++.|++++|+.+
T Consensus 221 ~------~~~~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 221 P------EGCP---PEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred c------cCCC---HHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0 1122 3455566699999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=312.63 Aligned_cols=266 Identities=24% Similarity=0.268 Sum_probs=194.3
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCC-----eeeEEe
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE-----ERLLVY 369 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~lv~ 369 (604)
.|...+++|.|+||+||+|+ ..+++.||||+...++. .--+|+++|++++|||||++..+|.... ...+||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 45667999999999999999 45679999999865432 2236999999999999999999887532 235899
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC-CCCeEEcccCCcc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD-DFDARITDFGLAR 448 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~-~~~~kl~DFGla~ 448 (604)
||||. +|+++++.....+ ..++...+.-+..|+.+||.||| +.+|+||||||.|+|+|. .+.+||||||-|+
T Consensus 102 eymP~-tL~~~~r~~~~~~---~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRAN---QRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HhchH-HHHHHHHHHhhcC---CCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 99998 9999998532111 34677788889999999999999 799999999999999995 5999999999999
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH---
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL--- 524 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--- 524 (604)
.+.......+.. -|..|.|||.+.+ ..||.+.||||.|||+.||+-|++-|.+.+..+ .+.+.++.+
T Consensus 175 ~L~~~epniSYi-----cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d----QL~eIik~lG~P 245 (364)
T KOG0658|consen 175 VLVKGEPNISYI-----CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD----QLVEIIKVLGTP 245 (364)
T ss_pred eeccCCCceeEE-----EeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH----HHHHHHHHhCCC
Confidence 997766654433 4788999997655 679999999999999999999999998643322 111111111
Q ss_pred ----HHc--CCccccccccccCC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhchH
Q 007423 525 ----VIA--GRSRDVVDKSLYGR-----GNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES--LKSMAE 580 (604)
Q Consensus 525 ----~~~--~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~--L~~i~~ 580 (604)
+.. ....+...+.+... .......+.++++.++++.+|.+|.++.|++.. ++++.+
T Consensus 246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 000 00001111111111 111223345566669999999999999998754 444444
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.33 Aligned_cols=257 Identities=21% Similarity=0.327 Sum_probs=201.1
Q ss_pred cCCCcCcEEEecCCeEEEEEEe------CCCCEEEEEEeccccc--cHHHHHHHHHHHhcc-CCCCccceeeEEEeCCee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL------PDASALAIKRLSACKL--SEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEER 365 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~------~~~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 365 (604)
++|...+.||+|+||.||++.. .++..||||.++.... ..+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4688899999999999999973 2355799999875432 235688999999999 799999999999999999
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
+++|||+++|+|.++++.... ..+++.+...++.+++.||+||| +.+|+|+||||+|||+++++.+|++|||
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRE-----SFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCc
Confidence 999999999999999975432 23899999999999999999999 7899999999999999999999999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHH
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
+++........ .......++..|+|||++....++.++|||||||++|||+| |+.||......+ -....
T Consensus 187 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--------~~~~~ 256 (302)
T cd05055 187 LARDIMNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--------KFYKL 256 (302)
T ss_pred ccccccCCCce--eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--------HHHHH
Confidence 99866432211 11111235678999999988889999999999999999998 999987532211 11112
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
...+..... ....++ .+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 257 ~~~~~~~~~------~~~~~~---~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 IKEGYRMAQ------PEHAPA---EIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHcCCcCCC------CCCCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 222211110 111223 455566699999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=311.17 Aligned_cols=246 Identities=22% Similarity=0.336 Sum_probs=191.9
Q ss_pred EEEecCCeEEEEEEe---CCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCC
Q 007423 302 IIISTRTGVSYKAVL---PDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNG 375 (604)
Q Consensus 302 ~ig~G~~g~vy~~~~---~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g 375 (604)
.||+|+||.||+|.+ .++..+|+|+++.... ..+++.+|+.++++++||||+++++++. .+..+++|||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 4678999999865432 2467899999999999999999999885 45678999999999
Q ss_pred chhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCC
Q 007423 376 TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDP 455 (604)
Q Consensus 376 sL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 455 (604)
+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~ 150 (257)
T cd05116 81 PLNKFLQKN-------KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN 150 (257)
T ss_pred cHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCC
Confidence 999999654 34889999999999999999999 78999999999999999999999999999987654322
Q ss_pred CCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 456 NDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 456 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
.... .....++..|+|||......++.++|||||||++|||+| |+.||..... .++.. .+..+...+.
T Consensus 151 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~-~i~~~~~~~~- 219 (257)
T cd05116 151 YYKA-KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--------NEVTQ-MIESGERMEC- 219 (257)
T ss_pred eeee-cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH-HHHCCCCCCC-
Confidence 1111 111234678999999888888999999999999999998 9999975322 12222 2222222111
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
....++++. +++.+||+.||++||++.+|.+.|+.
T Consensus 220 -----~~~~~~~l~---~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 -----PQRCPPEMY---DLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -----CCCCCHHHH---HHHHHHhccCchhCcCHHHHHHHHhc
Confidence 112233444 55559999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=293.35 Aligned_cols=247 Identities=21% Similarity=0.301 Sum_probs=200.8
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|++++.||+|.||.||.|+ ..++-.||+|++.+++ ..+.++++|+++-+.++||||.++++++.+....|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 578899999999999999999 5667899999996644 23467999999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||.++|+++..|++... ..++......++.|+|.|+.|+| .+.||||||||+|+|++..+..|++|||-+..
T Consensus 102 Eya~~gel~k~L~~~~~-----~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRM-----KRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred EecCCchHHHHHHhccc-----ccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 99999999999985432 34777778889999999999999 89999999999999999999999999998875
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
... .... ..+||.-|.+||...+..++...|+|++||+.||++.|.+||......+.+ ..+..
T Consensus 174 ~p~--~kR~----tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etY---------krI~k-- 236 (281)
T KOG0580|consen 174 APS--NKRK----TLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETY---------KRIRK-- 236 (281)
T ss_pred cCC--CCce----eeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHH---------HHHHH--
Confidence 531 1111 235999999999999999999999999999999999999999764322211 11111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.+..+| ...+.++. +++.+|+..+|.+|.+..|++..
T Consensus 237 -~~~~~p----~~is~~a~---dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 -VDLKFP----STISGGAA---DLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -ccccCC----cccChhHH---HHHHHHhccCccccccHHHHhhh
Confidence 122222 12233444 45559999999999999998763
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=317.74 Aligned_cols=243 Identities=20% Similarity=0.254 Sum_probs=188.3
Q ss_pred CCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHH---hccCCCCccceeeEEEeCCeeeEE
Q 007423 297 FAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRL---GQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l---~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
|.+.+.||+|+||.||++. ..+++.||||+++... ...+.+.+|++++ ++++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 4567899999999999998 4578999999997532 1224566676654 567899999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++|+|..+++.. .+++.....++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++
T Consensus 81 ~E~~~~~~L~~~~~~~--------~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--------VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK 149 (324)
T ss_pred EcCCCCCcHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCc
Confidence 9999999999888642 4889999999999999999999 7899999999999999999999999999987
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
......... ....|++.|+|||++.+..++.++|||||||++|||++|+.||...... +..... ..+
T Consensus 150 ~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--------~~~~~i-~~~ 216 (324)
T cd05589 150 EGMGFGDRT----STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--------EVFDSI-VND 216 (324)
T ss_pred cCCCCCCcc----cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHH-HhC
Confidence 543222111 1235899999999999888999999999999999999999999753221 111111 111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYE 573 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 573 (604)
... . ....+..+ .+++.+||+.||++|| ++.++++
T Consensus 217 ~~~--~-----p~~~~~~~---~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 217 EVR--Y-----PRFLSREA---ISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCC--C-----CCCCCHHH---HHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 111 0 11123334 4455599999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=314.54 Aligned_cols=265 Identities=21% Similarity=0.297 Sum_probs=197.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-----CCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeC--Ceee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-----PDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE--EERL 366 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-----~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 366 (604)
.+|...+.||+|+||.||++.. .++..||||+++... ...+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4677789999999999999974 357899999987543 2345789999999999999999999987543 4678
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
+|+||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+
T Consensus 84 lv~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR------ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred EEEEecCCCCHHHHHHhcC------cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcc
Confidence 9999999999999997542 34889999999999999999999 78999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccc------ccc-CcHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEE------GFK-GNLVD 519 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~------~~~-~~~~~ 519 (604)
++........... .....++..|+|||+..+..++.++|||||||++|||++|..|+......- ... .....
T Consensus 155 ~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 155 TKVLPQDKEYYKV-REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVY 233 (284)
T ss_pred cccccCCCcceee-cCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchH
Confidence 9876433221110 011123456999999988889999999999999999999887764321100 000 00001
Q ss_pred HHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 520 WVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 520 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
........+.... . ....+ ..+.+++.+||+.+|++||||.||++.|+.+
T Consensus 234 ~~~~~~~~~~~~~-----~-~~~~~---~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLP-----A-PPGCP---AEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCC-----C-CCCCC---HHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111111111100 0 01112 3455666699999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.65 Aligned_cols=252 Identities=19% Similarity=0.220 Sum_probs=196.3
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc----cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL----SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||++. ..+++.||||+++.... ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 368888999999999999998 45789999999975332 3356889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++.... ..+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~ 151 (330)
T cd05601 81 EYQPGGDLLSLLNRYE------DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAAR 151 (330)
T ss_pred CCCCCCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeE
Confidence 9999999999997652 35889999999999999999999 88999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccC------CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHH
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSS------TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNH 523 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 523 (604)
....... ......||+.|+|||++. ...++.++|||||||++|||+||+.||..... ......
T Consensus 152 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~ 220 (330)
T cd05601 152 LTANKMV---NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--------AKTYNN 220 (330)
T ss_pred CCCCCce---eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--------HHHHHH
Confidence 6433221 111235899999999876 45678999999999999999999999975322 111222
Q ss_pred HHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 524 LVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 524 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
...........+. ...+.++.+++ .+|+. +|++||++.++++.
T Consensus 221 i~~~~~~~~~~~~----~~~~~~~~~li---~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 221 IMNFQRFLKFPED----PKVSSDFLDLI---QSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHcCCCccCCCCC----CCCCHHHHHHH---HHHcc-ChhhCCCHHHHhCC
Confidence 2111111111110 11233444444 48997 99999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=319.27 Aligned_cols=235 Identities=17% Similarity=0.223 Sum_probs=186.1
Q ss_pred cEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 301 NIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
+.||+|+||.||+++. .+++.||||.++... ...+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999994 568999999987532 2234577888888876 699999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~i~~~-------~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~ 150 (320)
T cd05590 81 GDLMFHIQKS-------RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG 150 (320)
T ss_pred chHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC
Confidence 9999998754 35889999999999999999999 8899999999999999999999999999987542221
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
.. .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... +.... +..+...
T Consensus 151 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~-i~~~~~~--- 214 (320)
T cd05590 151 KT----TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEA-ILNDEVV--- 214 (320)
T ss_pred Cc----ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHHH-HhcCCCC---
Confidence 11 12235899999999999888999999999999999999999999753221 11111 1122110
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSM 568 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 568 (604)
. ....+.++.+ ++.+|++.||++||++
T Consensus 215 ~----~~~~~~~~~~---li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 Y----PTWLSQDAVD---ILKAFMTKNPTMRLGS 241 (320)
T ss_pred C----CCCCCHHHHH---HHHHHcccCHHHCCCC
Confidence 1 1122344444 4459999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=318.63 Aligned_cols=281 Identities=22% Similarity=0.353 Sum_probs=210.5
Q ss_pred cCCCcCcEEEecCCeEEEEEEe--------CCCCEEEEEEecccc--ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCC
Q 007423 295 NSFAVENIIISTRTGVSYKAVL--------PDASALAIKRLSACK--LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEE 363 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~--------~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 363 (604)
++|...+.||+|+||.||++.. .....+|+|.++... ....++.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 4677889999999999999973 134579999987533 2235688999999999 6999999999999988
Q ss_pred eeeEEeeecCCCchhhhhccCCCC---------CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVD---------NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID 434 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~ 434 (604)
..+++|||+++|+|.+++...... ......++|...+.++.|++.||.||| +.+++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence 999999999999999999754210 001135899999999999999999999 78999999999999999
Q ss_pred CCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccc
Q 007423 435 DDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGF 513 (604)
Q Consensus 435 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~ 513 (604)
+++.+||+|||+++........... ....++..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--- 243 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKT--SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--- 243 (314)
T ss_pred CCCcEEEcccccccccccccccccc--ccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 9999999999999876432211111 11124567999999988889999999999999999999 89998643211
Q ss_pred cCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCCCCCCCCcc
Q 007423 514 KGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEPYDEFPM 593 (604)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~~~~~~~ 593 (604)
+ +......+...+.. ...+ .++.+++.+||+.+|++||++.|+++.|+++.... .+++.+...
T Consensus 244 -----~-~~~~~~~~~~~~~~------~~~~---~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~--~~~~~~~~~ 306 (314)
T cd05099 244 -----E-LFKLLREGHRMDKP------SNCT---HELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV--SEEYLDLSM 306 (314)
T ss_pred -----H-HHHHHHcCCCCCCC------CCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh--cCCceeeEE
Confidence 1 11122222211110 1112 34455666999999999999999999999987654 334555555
Q ss_pred ccCCCCC
Q 007423 594 IFGKQDP 600 (604)
Q Consensus 594 ~~~~~~~ 600 (604)
.+.+-+|
T Consensus 307 ~~~~~~~ 313 (314)
T cd05099 307 PFEQYSP 313 (314)
T ss_pred ehhhcCC
Confidence 5555444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=307.55 Aligned_cols=246 Identities=23% Similarity=0.343 Sum_probs=194.8
Q ss_pred cEEEecCCeEEEEEEeCCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCchh
Q 007423 301 NIIISTRTGVSYKAVLPDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~ 378 (604)
++||+|+||.||+|...++..||+|.++... .....+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998889999999987543 22346889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCC
Q 007423 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDS 458 (604)
Q Consensus 379 ~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 458 (604)
+++.... ..+++..+..++.+++.||.|+| +.+++||||||+||++++++.+||+|||++...........
T Consensus 81 ~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 151 (250)
T cd05085 81 SFLRKKK------DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS 151 (250)
T ss_pred HHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccC
Confidence 9986543 24789999999999999999999 78999999999999999999999999999875432211111
Q ss_pred ccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccccccc
Q 007423 459 SFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKS 537 (604)
Q Consensus 459 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 537 (604)
....++..|+|||+..+..++.++||||||+++||+++ |..||...... ........+.....
T Consensus 152 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---------~~~~~~~~~~~~~~---- 215 (250)
T cd05085 152 ---GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---------QAREQVEKGYRMSC---- 215 (250)
T ss_pred ---CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---------HHHHHHHcCCCCCC----
Confidence 01124567999999988889999999999999999998 99999643211 11111222211110
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 538 LYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 538 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
.......+.+++.+||+.+|++||++.|+++.|.
T Consensus 216 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 -----PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred -----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1112245566667999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=335.10 Aligned_cols=251 Identities=17% Similarity=0.178 Sum_probs=196.0
Q ss_pred CCcCcEEEecCCeEEEEEEe-CC-CCEEEEEEeccccc-cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 297 FAVENIIISTRTGVSYKAVL-PD-ASALAIKRLSACKL-SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~-~~-~~~vAvK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
|...+.||+|++|.||++.. .+ +..||+|.+..... ....+.+|+++++.++|||||++++++..++..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 77889999999999999983 34 67888887754332 23467889999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+|+|.++++..... ...+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 149 gg~L~~~l~~~~~~---~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 149 GGDLNKQIKQRLKE---HLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCHHHHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999988643211 135888999999999999999999 789999999999999999999999999999876432
Q ss_pred CCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
... .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+...... .+.....
T Consensus 223 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~~~~~-~~~~~~~ 291 (478)
T PTZ00267 223 VSL--DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIMQQVL-YGKYDPF 291 (478)
T ss_pred ccc--ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-hCCCCCC
Confidence 211 111233589999999999988999999999999999999999999964321 12222221 2221111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
....+.+ +.+++.+||+.||++||++.+++.
T Consensus 292 ------~~~~s~~---~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 ------PCPVSSG---MKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ------CccCCHH---HHHHHHHHhccChhhCcCHHHHHh
Confidence 0112233 445555999999999999999864
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=307.89 Aligned_cols=249 Identities=23% Similarity=0.300 Sum_probs=199.4
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccc---cccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSAC---KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+|+..+.||+|++|.||++.. .+++.|++|.+... ....+.+.+|++++++++||||+++++++..++..+++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 466778999999999999984 57899999998643 23446788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++++|.+++..... ..+++.....++.+++.||.||| +.+++|+||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~ 152 (256)
T cd08529 81 AENGDLHKLLKMQRG-----RPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS 152 (256)
T ss_pred CCCCcHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceecc
Confidence 999999999976421 35889999999999999999999 7899999999999999999999999999998765
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
...... ....|+..|+|||+..+..++.++|||||||++|||+||+.||...... ........+...
T Consensus 153 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~ 219 (256)
T cd08529 153 DNTNFA----NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---------ALILKIIRGVFP 219 (256)
T ss_pred Cccchh----hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHcCCCC
Confidence 432211 1224788999999999888999999999999999999999999753211 111111222211
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
... ......+.+++.+||+.+|++||++.|+++.
T Consensus 220 ~~~---------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVS---------QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCc---------cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111 1122345566669999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=313.03 Aligned_cols=251 Identities=20% Similarity=0.231 Sum_probs=195.9
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc----cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL----SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
+|+..+.||+|+||.||++. ..+++.||||.+..... ....+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 36677899999999999998 45789999999865321 23457889999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++|+|.+++..... ..+++.....++.|++.||.||| +.+|+||||||+||++++++.++|+|||+++..
T Consensus 81 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05605 81 LMNGGDLKFHIYNMGN-----PGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEI 152 (285)
T ss_pred ccCCCcHHHHHHhcCc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence 9999999988864321 35889999999999999999999 789999999999999999999999999999875
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
..... .....|+..|+|||++.+..++.++|||||||++|||++|+.||....... ..+.+...+..+..
T Consensus 153 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~ 222 (285)
T cd05605 153 PEGET-----IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-----KREEVERRVKEDQE 222 (285)
T ss_pred CCCCc-----cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-----HHHHHHHHhhhccc
Confidence 32221 122358899999999988889999999999999999999999997532211 11111111111110
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYES 574 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~ 574 (604)
. . ....++ .+.+++.+||+.||++|| ++.++++.
T Consensus 223 -~-~-----~~~~~~---~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 -E-Y-----SEKFSE---AARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -c-c-----CcccCH---HHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0 0 011223 344555699999999999 78888553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=309.80 Aligned_cols=251 Identities=21% Similarity=0.250 Sum_probs=195.1
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
++|...+.||+|+||.||+|+ ..+++.||+|++.... ...+.+.+|+.++++++||||+++++++..++..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 468888999999999999999 4678999999986533 23456789999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++++|.++++.. ..+++..+..++.|++.|+.||| +.+|+|||+||+||++++++.+||+|||+++....
T Consensus 89 ~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 89 GGGSLQDIYHVT-------GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred CCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 999999998654 35889999999999999999999 78999999999999999999999999999987643
Q ss_pred CCCCCCccccCCCCcccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSS---TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
..... ....|+..|+|||.+. ...++.++|||||||++|||++|+.||......+... ......
T Consensus 159 ~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---------~~~~~~ 225 (267)
T cd06646 159 TIAKR----KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---------LMSKSN 225 (267)
T ss_pred ccccc----CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---------eeecCC
Confidence 22111 1224788999999874 3457889999999999999999999986432211000 000000
Q ss_pred ccccccccccC-CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 530 SRDVVDKSLYG-RGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 530 ~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
. ..+.... ...+ ..+.+++.+||+.+|++||++++|++.
T Consensus 226 ~---~~~~~~~~~~~~---~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 226 F---QPPKLKDKTKWS---STFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred C---CCCCCccccccC---HHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0 0011100 1112 344555669999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=317.91 Aligned_cols=265 Identities=20% Similarity=0.317 Sum_probs=203.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC--------CCCEEEEEEecccc--ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP--------DASALAIKRLSACK--LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEE 363 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~--------~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 363 (604)
++|.+.+.||+|+||.||++... +...+|+|.++... ....++.+|+++++++ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56888899999999999999742 23579999997532 2335688899999999 7999999999999999
Q ss_pred eeeEEeeecCCCchhhhhccCCCCC---------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDN---------TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID 434 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~ 434 (604)
..++||||+++|+|.+++....... .....++|..++.++.|++.||+||| +.+++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence 9999999999999999997543110 01135899999999999999999999 78999999999999999
Q ss_pred CCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccc
Q 007423 435 DDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGF 513 (604)
Q Consensus 435 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~ 513 (604)
+++.+||+|||+++........... ....++..|+|||+..+..++.++|||||||++|||++ |+.||.....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---- 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKT--TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 248 (307)
T ss_pred CCCcEEECCCcccccccccchhhcc--ccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH----
Confidence 9999999999998765422111111 11124568999999988889999999999999999998 8888864221
Q ss_pred cCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 514 KGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
.+... ....+...+. ....+ .++.+++.+||+.+|++||+|.||++.|+++.+..
T Consensus 249 ----~~~~~-~~~~~~~~~~------~~~~~---~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 249 ----EELFK-LLKEGHRMDK------PSNCT---NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred ----HHHHH-HHHcCCCCCC------CCcCC---HHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 11121 1222211111 01122 34555666999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.65 Aligned_cols=254 Identities=22% Similarity=0.288 Sum_probs=198.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|++++..++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 3678889999999999999994 478999999997532 23356889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 150 (350)
T cd05573 81 EYMPGGDLMNLLIRK-------DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKK 150 (350)
T ss_pred cCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence 999999999999765 35888999999999999999999 79999999999999999999999999999987
Q ss_pred cCCCCC-------------------------CCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCC
Q 007423 450 VGSRDP-------------------------NDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPL 504 (604)
Q Consensus 450 ~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~ 504 (604)
...... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf 230 (350)
T cd05573 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230 (350)
T ss_pred CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCC
Confidence 643320 0001122345899999999999989999999999999999999999999
Q ss_pred CCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 007423 505 DVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS-MYQVYES 574 (604)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~ev~~~ 574 (604)
...... ....... ... ....-+.. ...++++.. ++.+|+. ||++||+ +.|+++.
T Consensus 231 ~~~~~~--------~~~~~i~-~~~-~~~~~p~~--~~~~~~~~~---li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 231 YSDTLQ--------ETYNKII-NWK-ESLRFPPD--PPVSPEAID---LICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCHH--------HHHHHHh-ccC-CcccCCCC--CCCCHHHHH---HHHHHcc-ChhhcCCCHHHHhcC
Confidence 754321 1111111 100 00000000 012344444 4448997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.41 Aligned_cols=241 Identities=22% Similarity=0.284 Sum_probs=195.7
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeE
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 367 (604)
-++|...++||+|.||.|+.+. ..+++.+|||.+++.. .+.+..+.|..++... +||.+++++..|+++++.|.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 4678899999999999999999 4568899999998754 3346678888888777 59999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||||+.+|++..+.+. ..++......||..|+.||.||| +++||+||||-+|||+|.+|.+||+|||++
T Consensus 447 vmey~~Ggdm~~~~~~--------~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT--------DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEecCCCcEEEEEec--------ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccc
Confidence 9999999995555442 35889999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
+.-......+. ..+||+.|||||++.+..|+..+|.|||||+||||+.|+.||...+.++.+. .++
T Consensus 516 Ke~m~~g~~Ts----TfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd--------sI~-- 581 (694)
T KOG0694|consen 516 KEGMGQGDRTS----TFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD--------SIV-- 581 (694)
T ss_pred cccCCCCCccc----cccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH--------HHh--
Confidence 96532222222 3469999999999999999999999999999999999999998655443221 111
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSM 568 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 568 (604)
.|...++...+.+.. .|+.+.+..+|++|..+
T Consensus 582 ------~d~~~yP~~ls~ea~---~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 582 ------NDEVRYPRFLSKEAI---AIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ------cCCCCCCCcccHHHH---HHHHHHhccCcccccCC
Confidence 112222233344444 44559999999999866
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=308.49 Aligned_cols=249 Identities=24% Similarity=0.391 Sum_probs=194.0
Q ss_pred cEEEecCCeEEEEEEeC--C--CCEEEEEEeccccc--cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 301 NIIISTRTGVSYKAVLP--D--ASALAIKRLSACKL--SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~--~--~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
+.||+|+||.||+|+.. + +..+|+|.+..... ..+++.+|++++++++|+||+++++++. .+..+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46899999999999742 2 26899999976543 4567999999999999999999999876 4567999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++... ..+++..+..++.|++.|++||| ..+++|+||||+||++++++.+||+|||+++......
T Consensus 80 ~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~ 149 (257)
T cd05060 80 GPLLKYLKKR-------REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149 (257)
T ss_pred CcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence 9999999765 24889999999999999999999 7889999999999999999999999999998764332
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
..... .....++..|+|||...+..++.++|||||||++|||++ |+.||..... .+... ....+.....
T Consensus 150 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--------~~~~~-~~~~~~~~~~ 219 (257)
T cd05060 150 DYYRA-TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--------AEVIA-MLESGERLPR 219 (257)
T ss_pred ccccc-ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--------HHHHH-HHHcCCcCCC
Confidence 21111 111224568999999988889999999999999999998 9999964321 11111 1122211111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhch
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMA 579 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~ 579 (604)
....+ ..+.+++.+||..+|++||++.++++.|+++.
T Consensus 220 ------~~~~~---~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 220 ------PEECP---QEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ------CCCCC---HHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11112 34556666999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=316.14 Aligned_cols=265 Identities=20% Similarity=0.311 Sum_probs=203.3
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe--------CCCCEEEEEEecccc--ccHHHHHHHHHHHhcc-CCCCccceeeEEEeC
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL--------PDASALAIKRLSACK--LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVE 362 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~--------~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 362 (604)
.++|.+.+.||+|+||.||++.. .++..||+|.++... ...+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 35677889999999999999973 134579999986532 2335788999999999 899999999999999
Q ss_pred CeeeEEeeecCCCchhhhhccCCCCC---------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe
Q 007423 363 EERLLVYKHMPNGTLYSLLHGNGVDN---------TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI 433 (604)
Q Consensus 363 ~~~~lv~ey~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl 433 (604)
+..+++|||+++|+|.+++....... .....++|..+..++.|+++||.||| +.+|+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence 99999999999999999997542110 01135889999999999999999999 7899999999999999
Q ss_pred CCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCcccc
Q 007423 434 DDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEG 512 (604)
Q Consensus 434 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~ 512 (604)
++++.+||+|||+++.......... .....++..|+|||+..+..++.++||||||+++|||+| |..||....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---- 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKK--TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 244 (304)
T ss_pred cCCCcEEECCCccceeccccccccc--ccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence 9999999999999987643221111 112235678999999988889999999999999999998 788885432
Q ss_pred ccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 513 FKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
..++... ...+..... ....+ ..+.+++.+||+.+|++||+|.||++.|+++..-
T Consensus 245 ----~~~~~~~-~~~~~~~~~------~~~~~---~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 245 ----VEELFKL-LKEGHRMDK------PANCT---NELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ----HHHHHHH-HHcCCcCCC------CCCCC---HHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 2222222 222211110 01122 3445556699999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=315.87 Aligned_cols=239 Identities=21% Similarity=0.237 Sum_probs=187.0
Q ss_pred cEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 301 NIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
+.||+|+||.||+|.. .+++.||||.++... ...+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999995 568899999997532 2234567788888764 899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 150 (316)
T cd05619 81 GDLMFHIQSC-------HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD 150 (316)
T ss_pred CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC
Confidence 9999998754 34889999999999999999999 7899999999999999999999999999987542221
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
.. .....||..|+|||++.+..++.++|||||||++|||++|+.||...... +.... +..+.. ..
T Consensus 151 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~-i~~~~~--~~ 215 (316)
T cd05619 151 AK----TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--------ELFQS-IRMDNP--CY 215 (316)
T ss_pred Cc----eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--------HHHHH-HHhCCC--CC
Confidence 11 12235899999999999888999999999999999999999999753221 11111 111110 01
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMY-QVY 572 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-ev~ 572 (604)
....+.++.+ ++.+||+.||++||++. ++.
T Consensus 216 -----~~~~~~~~~~---li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 216 -----PRWLTREAKD---ILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -----CccCCHHHHH---HHHHHhccCHhhcCCChHHHH
Confidence 1122334444 44599999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=318.09 Aligned_cols=241 Identities=17% Similarity=0.216 Sum_probs=189.2
Q ss_pred cEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 301 NIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
++||+|+||.||+|.. .+++.||||+++... ...+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3689999999999984 568899999987532 2234577899998866 799999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|..++... ..+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 150 (321)
T cd05591 81 GDLMFQIQRS-------RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG 150 (321)
T ss_pred CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC
Confidence 9999988754 35889999999999999999999 7899999999999999999999999999987543222
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
.. .....||..|+|||++.+..++.++|||||||++|||+||+.||...... +..... ..+.. .
T Consensus 151 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--------~~~~~i-~~~~~---~ 214 (321)
T cd05591 151 VT----TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--------DLFESI-LHDDV---L 214 (321)
T ss_pred cc----ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--------HHHHHH-HcCCC---C
Confidence 11 12235899999999999888999999999999999999999999754321 111111 11111 0
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHHH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-------SMYQVYES 574 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-------s~~ev~~~ 574 (604)
.+ ...+.++ .+++.+|++.||++|| ++.++++.
T Consensus 215 ~p----~~~~~~~---~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 YP----VWLSKEA---VSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CC----CCCCHHH---HHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11 1123344 4455599999999999 77777644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=309.03 Aligned_cols=253 Identities=23% Similarity=0.366 Sum_probs=191.6
Q ss_pred cEEEecCCeEEEEEEeC----CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEe-CCeeeEEeeecC
Q 007423 301 NIIISTRTGVSYKAVLP----DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV-EEERLLVYKHMP 373 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~----~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lv~ey~~ 373 (604)
+.||+|+||.||+|... ++..||+|++.... ...+.+.+|+.+++.++||||+++++++.. ++..++++||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999843 24579999985432 234678899999999999999999998764 556789999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+|+|.+++.... ...++...+.++.|++.||.||| +.+++||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 81 HGDLRNFIRSET------HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 999999997542 23678888999999999999999 789999999999999999999999999999865332
Q ss_pred CCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhC-CCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSG-QKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
............++..|+|||+.....++.++|||||||++|||++| .+||.... ..+..... ..+....
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--------~~~~~~~~-~~~~~~~ 222 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--------SFDITVYL-LQGRRLL 222 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHH-hcCCCCC
Confidence 11111111223457789999999888899999999999999999995 55664321 11222221 1221111
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
. ....+ ..+.+++.+||+.+|++||++.||++.|+++..
T Consensus 223 ~------~~~~~---~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 223 Q------PEYCP---DPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred C------CCcCC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0 11112 345566679999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=308.02 Aligned_cols=253 Identities=22% Similarity=0.380 Sum_probs=201.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
++|...+.||+|+||.||++...++..+|+|.+.......+.+.+|++++++++|+||+++.+++.. ...+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAK 84 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCC
Confidence 4677889999999999999998788889999987655555779999999999999999999999877 678999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++..... ..+++..+..++.+++.||.||| +.+++|+||||+||+++.++.+||+|||.+.......
T Consensus 85 ~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 85 GSLLDFLKSDEG-----SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CcHHHHHHhCCc-----cccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999976432 35789999999999999999999 7899999999999999999999999999998664322
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
... .....++..|+|||++....++.++|||||||++||++| |+.||...... .... ....+.....
T Consensus 157 ~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-----~~~~----~~~~~~~~~~ 224 (260)
T cd05073 157 YTA---REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----EVIR----ALERGYRMPR 224 (260)
T ss_pred ccc---ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-----HHHH----HHhCCCCCCC
Confidence 111 112235678999999988889999999999999999999 99999643211 1111 1112211110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
. ...+ ..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 225 ~------~~~~---~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 P------ENCP---EELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred c------ccCC---HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 1122 345566669999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=305.58 Aligned_cols=247 Identities=24% Similarity=0.383 Sum_probs=191.4
Q ss_pred EEecCCeEEEEEEeC---CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCch
Q 007423 303 IISTRTGVSYKAVLP---DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL 377 (604)
Q Consensus 303 ig~G~~g~vy~~~~~---~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL 377 (604)
||+|+||.||+|... ++..||+|.+.... ...+.+.+|++++++++||||+++++++. .+..++||||+++|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999753 45579999986543 22356899999999999999999999885 4567899999999999
Q ss_pred hhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCC
Q 007423 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPND 457 (604)
Q Consensus 378 ~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 457 (604)
.+++.... ..+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++.........
T Consensus 82 ~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 82 NKFLSGKK------DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred HHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 99987542 35889999999999999999999 7899999999999999999999999999998654332211
Q ss_pred CccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCccccccc
Q 007423 458 SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK 536 (604)
Q Consensus 458 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 536 (604)
.. .....++..|+|||+.....++.++|||||||++||+++ |+.||..... .++. ..+..+.... .+
T Consensus 153 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~-~~~~~~~~~~-~~- 220 (257)
T cd05115 153 KA-RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------PEVM-SFIEQGKRLD-CP- 220 (257)
T ss_pred ec-cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------HHHH-HHHHCCCCCC-CC-
Confidence 11 111224578999999888889999999999999999996 9999975322 1111 2222222211 11
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 537 SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 537 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
...+++ +.+++.+||..+|++||++.+|.+.|+.+
T Consensus 221 ----~~~~~~---l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 ----AECPPE---MYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ----CCCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 112334 44555599999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=315.81 Aligned_cols=239 Identities=21% Similarity=0.245 Sum_probs=185.5
Q ss_pred cEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 301 NIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
+.||+|+||.||+|.. .+++.||||.++... ...+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 568899999997532 1224456677777654 899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++... ..++......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 150 (316)
T cd05592 81 GDLMFHIQSS-------GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE 150 (316)
T ss_pred CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC
Confidence 9999998754 35888899999999999999999 7899999999999999999999999999998653222
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
.. .....||..|+|||++.+..++.++|||||||++|||++|+.||...... +.... +.... ..+
T Consensus 151 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--------~~~~~-i~~~~--~~~ 215 (316)
T cd05592 151 GK----ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--------ELFDS-ILNDR--PHF 215 (316)
T ss_pred Cc----cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--------HHHHH-HHcCC--CCC
Confidence 11 12235899999999999888999999999999999999999999753221 11111 11111 001
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMY-QVY 572 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-ev~ 572 (604)
....+.++.++ +.+||+.||++||++. +++
T Consensus 216 -----~~~~~~~~~~l---l~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 216 -----PRWISKEAKDC---LSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred -----CCCCCHHHHHH---HHHHccCCHHHcCCChHHHH
Confidence 11223344444 4499999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=310.46 Aligned_cols=256 Identities=22% Similarity=0.377 Sum_probs=199.8
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC-C---CCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP-D---ASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~-~---~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
++|...+.||+|+||.||+|... + +..+|+|.++... ...+.+.+|+.++++++||||+++++++..++..+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46777899999999999999842 2 3479999986533 2345789999999999999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++|+|.+++.... ..+++.....++.|++.|+.||| +.+++||||||+|||++.++.+|++|||+++
T Consensus 84 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd05066 84 TEYMENGSLDAFLRKHD------GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (267)
T ss_pred EEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccc
Confidence 99999999999997543 34889999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
.......... ......++..|+|||++.+..++.++||||||+++||+++ |+.||...... .... ....
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-----~~~~----~~~~ 224 (267)
T cd05066 155 VLEDDPEAAY-TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-----DVIK----AIEE 224 (267)
T ss_pred ccccccceee-ecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-----HHHH----HHhC
Confidence 7643322111 1111223568999999998889999999999999999887 99999643221 1111 1112
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
+.... .. ...+ ..+.+++.+||+.+|++||+|.++++.|+++
T Consensus 225 ~~~~~-----~~-~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 225 GYRLP-----AP-MDCP---AALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCcCC-----CC-CCCC---HHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 21100 00 1112 3445666699999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=312.79 Aligned_cols=247 Identities=17% Similarity=0.202 Sum_probs=189.5
Q ss_pred EEecCCeEEEEEE-eCCCCEEEEEEeccccc----cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCch
Q 007423 303 IISTRTGVSYKAV-LPDASALAIKRLSACKL----SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL 377 (604)
Q Consensus 303 ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL 377 (604)
||+|+||+||++. ..+++.||||.+..... ..+.+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6899999999998 45789999999865322 124577899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCC
Q 007423 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPND 457 (604)
Q Consensus 378 ~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 457 (604)
.+++...... ...+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~- 153 (280)
T cd05608 81 RYHIYNVDEE---NPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK- 153 (280)
T ss_pred HHHHHhcccc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-
Confidence 9887543211 135899999999999999999999 789999999999999999999999999999866433221
Q ss_pred CccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccccccc
Q 007423 458 SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKS 537 (604)
Q Consensus 458 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 537 (604)
.....|++.|+|||++.+..++.++|||||||++|||+||+.||....... .... .......+..
T Consensus 154 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~----~~~~-~~~~~~~~~~------- 218 (280)
T cd05608 154 ---TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKE-LKQRILNDSV------- 218 (280)
T ss_pred ---ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch----hHHH-HHHhhcccCC-------
Confidence 122358899999999999999999999999999999999999997532211 0011 1111111100
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 007423 538 LYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYES 574 (604)
Q Consensus 538 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~ 574 (604)
......+.+ +.+++.+||+.||++|| +++|+++.
T Consensus 219 ~~~~~~~~~---~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 219 TYPDKFSPA---SKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCcccCCHH---HHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 001112233 44555599999999999 66777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=308.49 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=204.2
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
.++|.+.+.||+|++|.||++...++..||||.+.......+++.+|++++++++|+||+++++++......+++|||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 35688889999999999999998888899999998766667789999999999999999999999998889999999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+++|.+++..... ..+++..+..++.+++.|+.||| +.+++|+||||+||++++++.+||+|||.++.....
T Consensus 85 ~~~L~~~i~~~~~-----~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 85 KGSLLDFLKSGEG-----KKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred CCCHHHHHhcccc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999976432 35899999999999999999999 789999999999999999999999999999876432
Q ss_pred CCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
.... ..+..++..|+|||...+..++.++||||||+++|||+| |+.||...... ..... ...+. ..
T Consensus 157 ~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------~~~~~-~~~~~-~~ 223 (261)
T cd05034 157 EYTA---REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--------EVLEQ-VERGY-RM 223 (261)
T ss_pred hhhh---hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHH-HHcCC-CC
Confidence 1111 112224568999999988889999999999999999999 99999643211 11111 11111 10
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
... ...+ ..+.+++.+|++.+|++||+++|+.+.|+.
T Consensus 224 ~~~-----~~~~---~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRP-----PNCP---EELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCC-----CCCC---HHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 000 1112 345556669999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=304.54 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=204.9
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|+..+.||+|++|.||+|... +++.||+|.++... ...+.+.+|++++++++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888899999999999999954 89999999886321 22457899999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++...... ...+++..+..++.+++.||.||| +.+|+||||||+||+++.++.++|+|||+++.
T Consensus 82 e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~ 155 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQ---KRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRF 155 (267)
T ss_pred ecCCCCCHHHHHHHhccc---CCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeee
Confidence 999999999998643211 135889999999999999999999 78999999999999999999999999999886
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
........ ....++..|+|||...+..++.++|||||||++|||++|+.||.... ....+..... ..+.
T Consensus 156 ~~~~~~~~----~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~-~~~~ 224 (267)
T cd08224 156 FSSKTTAA----HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKI-EKCD 224 (267)
T ss_pred ccCCCccc----ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC------ccHHHHHhhh-hcCC
Confidence 64322111 12247888999999988889999999999999999999999996432 1122222111 1121
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhch
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMA 579 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~ 579 (604)
...... ......+.+++.+||+.+|++||++.+|+++|+++.
T Consensus 225 ~~~~~~--------~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 225 YPPLPA--------DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCCh--------hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111110 112234555666999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=324.78 Aligned_cols=253 Identities=17% Similarity=0.216 Sum_probs=195.2
Q ss_pred hhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 293 ATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
..++|...+.||+|+||.||+++ ..+++.||+|.++... ...+.+.+|+.+++.++||||+++++++..++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 45678889999999999999998 4578999999996432 223457889999999999999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||||+++|+|.+++... .++......++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++
T Consensus 121 v~Ey~~gg~L~~~l~~~--------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~ 189 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY--------DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (370)
T ss_pred EEcCCCCCcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccce
Confidence 99999999999998643 3677788889999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCC----CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHH
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM----VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNH 523 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 523 (604)
+......... .....||+.|+|||++... .++.++|||||||++|||+||+.||..... ......
T Consensus 190 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~ 258 (370)
T cd05596 190 MKMDANGMVR---CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSK 258 (370)
T ss_pred eeccCCCccc---CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHHHHH
Confidence 8764322111 1223589999999987643 478899999999999999999999975322 111111
Q ss_pred HHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 007423 524 LVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKD--RPSMYQVYES 574 (604)
Q Consensus 524 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~~ 574 (604)
...........+ ....+.++.+++ .+|++.+|++ ||++.|+++.
T Consensus 259 i~~~~~~~~~~~----~~~~s~~~~~li---~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 259 IMDHKNSLTFPD----DIEISKQAKDLI---CAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHcCCCcCCCCC----cCCCCHHHHHHH---HHHccChhhccCCCCHHHHhcC
Confidence 111111111110 011234445444 4999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=334.72 Aligned_cols=258 Identities=19% Similarity=0.235 Sum_probs=200.1
Q ss_pred HHhhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCC---
Q 007423 291 LAATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE--- 363 (604)
Q Consensus 291 ~~~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--- 363 (604)
....++|.+.+.||+|+||.||++. ..+++.||||++.... .....+.+|+.++..++|+||+++.+.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 3445689999999999999999998 5679999999986543 22356789999999999999999988775432
Q ss_pred -----eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC
Q 007423 364 -----ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD 438 (604)
Q Consensus 364 -----~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~ 438 (604)
..++||||+++|+|.++++..... ...+++.....++.|++.||.||| +.+|+||||||+|||++.++.
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~---~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKT---NRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGL 181 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCC
Confidence 367999999999999999754221 135889999999999999999999 789999999999999999999
Q ss_pred eEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHH
Q 007423 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLV 518 (604)
Q Consensus 439 ~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~ 518 (604)
+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..
T Consensus 182 vkL~DFGls~~~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~--------~~ 251 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDD--VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN--------ME 251 (496)
T ss_pred EEEEecccCeecccccccc--ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------HH
Confidence 9999999998764322111 1122358999999999999899999999999999999999999997432 22
Q ss_pred HHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 519 DWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 519 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
+.+... ..+.... +. ...+++ +.+++.+||+.||++||++.++++.
T Consensus 252 ~~~~~~-~~~~~~~-~~-----~~~~~~---l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 252 EVMHKT-LAGRYDP-LP-----PSISPE---MQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHH-hcCCCCC-CC-----CCCCHH---HHHHHHHHcccChhhCcCHHHHHhC
Confidence 222222 2222211 11 122334 4455559999999999999999764
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=322.57 Aligned_cols=265 Identities=20% Similarity=0.302 Sum_probs=200.9
Q ss_pred cCCCcCcEEEecCCeEEEEEEe------CCCCEEEEEEeccccc--cHHHHHHHHHHHhcc-CCCCccceeeEEEeC-Ce
Q 007423 295 NSFAVENIIISTRTGVSYKAVL------PDASALAIKRLSACKL--SEKQFRSEMNRLGQL-RHPNLVPLLGFCVVE-EE 364 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~------~~~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~~ 364 (604)
++|...+.||+|+||.||+|.. .+++.||||+++.... ..+.+.+|++++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4688889999999999999972 3578999999975332 235688999999999 689999999988654 46
Q ss_pred eeEEeeecCCCchhhhhccCCCCC--------------------------------------------------------
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDN-------------------------------------------------------- 388 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~-------------------------------------------------------- 388 (604)
.+++|||+++|+|.++++......
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999999986532100
Q ss_pred ----CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCccccCC
Q 007423 389 ----TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGD 464 (604)
Q Consensus 389 ----~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 464 (604)
.....+++.....++.|+++||+||| +.+|+||||||+|||+++++++||+|||+++.......... ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~ 241 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR--KGDA 241 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhh--cCCC
Confidence 00124788899999999999999999 88999999999999999999999999999986532211111 1112
Q ss_pred CCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCC
Q 007423 465 LGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGN 543 (604)
Q Consensus 465 ~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 543 (604)
.++..|+|||+..+..++.++||||||+++|||++ |..||...... .........+..... + ...
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~--~----~~~ 307 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------EEFCRRLKEGTRMRA--P----DYT 307 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--------HHHHHHHhccCCCCC--C----CCC
Confidence 35678999999988889999999999999999997 99998643211 111122222221111 1 111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 544 DDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 544 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
+ .++.+++..||+.||++|||+.||++.|+.+.+.
T Consensus 308 ~---~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 308 T---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred C---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1 2466777799999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=315.09 Aligned_cols=258 Identities=22% Similarity=0.311 Sum_probs=197.7
Q ss_pred CCcCcEEEecCCeEEEEEEeC------CCCEEEEEEeccccc--cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 297 FAVENIIISTRTGVSYKAVLP------DASALAIKRLSACKL--SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
|...+.||+|+||.||+|... ++..||||+++.... ..+.+.+|+.++++++||||+++++++...+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 555678999999999999853 357899999975432 235688999999999999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCC---------CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCe
Q 007423 369 YKHMPNGTLYSLLHGNGVD---------NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~ 439 (604)
+||+++++|.+++...... ......+++..+..++.|++.||.|+| +.+|+||||||+||++++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCce
Confidence 9999999999998532110 011235889999999999999999999 7899999999999999999999
Q ss_pred EEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHH
Q 007423 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLV 518 (604)
Q Consensus 440 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 518 (604)
||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||+| |..||..... .
T Consensus 164 kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~ 233 (283)
T cd05091 164 KISDLGLFREVYAADYY--KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------Q 233 (283)
T ss_pred Eecccccccccccchhe--eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence 99999998866432211 11112235778999999988889999999999999999998 8888864321 2
Q ss_pred HHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 519 DWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 519 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
++... +..+..... ....+ ..+.+++.+||+.+|++||++.||++.|+.
T Consensus 234 ~~~~~-i~~~~~~~~------~~~~~---~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 DVIEM-IRNRQVLPC------PDDCP---AWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHH-HHcCCcCCC------CCCCC---HHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 22222 222222111 11122 335566669999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=310.24 Aligned_cols=253 Identities=26% Similarity=0.387 Sum_probs=193.3
Q ss_pred cEEEecCCeEEEEEEeC-CCC--EEEEEEeccc--cccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 301 NIIISTRTGVSYKAVLP-DAS--ALAIKRLSAC--KLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~-~~~--~vAvK~l~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
++||+|+||.||+|... ++. .+|+|.++.. ....+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999964 343 4688888743 23346788999999999 899999999999999999999999999
Q ss_pred CchhhhhccCCCC---------CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 375 GTLYSLLHGNGVD---------NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 375 gsL~~~l~~~~~~---------~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
|+|.+++...... ......+++..+..++.|++.|++||| +.+++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 9999999754210 001134789999999999999999999 7899999999999999999999999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHH
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
+++....... .. ....+..|+|||+.....++.++|||||||++|||+| |+.||..... .+.....
T Consensus 158 l~~~~~~~~~---~~--~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~~ 224 (270)
T cd05047 158 LSRGQEVYVK---KT--MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELYEKL 224 (270)
T ss_pred Cccccchhhh---cc--CCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--------HHHHHHH
Confidence 9863321100 00 1123567999999988889999999999999999997 9999964321 1111111
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhch
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMA 579 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~ 579 (604)
..+...+. .......+.+++.+||+.+|.+|||+.|+++.|++|.
T Consensus 225 -~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 -PQGYRLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -hCCCCCCC---------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11111110 1111234566777999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=317.82 Aligned_cols=250 Identities=20% Similarity=0.241 Sum_probs=192.6
Q ss_pred CCCcCcEEEecCCeEEEEEEe----CCCCEEEEEEecccc-----ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCee
Q 007423 296 SFAVENIIISTRTGVSYKAVL----PDASALAIKRLSACK-----LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEER 365 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~----~~~~~vAvK~l~~~~-----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 365 (604)
+|...+.||+|+||.||+++. .+++.||+|+++... ...+.+.+|+++++++ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 467789999999999999874 368899999986432 1234578899999999 589999999999999999
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
++||||+++|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG 150 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-------DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFG 150 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCc
Confidence 9999999999999998754 35889999999999999999999 7899999999999999999999999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
+++......... .....||..|+|||++.+. .++.++|||||||++|||+||+.||....... . ...+...
T Consensus 151 ~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~-~~~~~~~ 222 (332)
T cd05614 151 LSKEFLSEEKER---TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN----T-QSEVSRR 222 (332)
T ss_pred CCccccccCCCc---cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC----C-HHHHHHH
Confidence 998653322211 1123589999999998765 47889999999999999999999997432211 1 1111111
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYE 573 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 573 (604)
.... ++.+. ...+..+.++ +.+||+.||++|| +++++++
T Consensus 223 ~~~~------~~~~~-~~~~~~~~~l---i~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 223 ILKC------DPPFP-SFIGPEAQDL---LHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HhcC------CCCCC-CCCCHHHHHH---HHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1111 11111 1223344444 4499999999999 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=306.79 Aligned_cols=249 Identities=27% Similarity=0.372 Sum_probs=196.6
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEe-CCeeeEEeeecC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVV-EEERLLVYKHMP 373 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lv~ey~~ 373 (604)
++|...+.||+|+||.||++... +..||+|.++... ..+.+.+|+.++++++|+|++++++++.. ++..++++||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 35777899999999999999864 7789999986543 34678999999999999999999998654 557899999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+|+|.++++.... ..+++...+.++.+++.||+||| +.+++||||||+||++++++.+||+|||+++.....
T Consensus 84 ~~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 84 KGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 9999999975432 24789999999999999999999 789999999999999999999999999998865322
Q ss_pred CCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
.. ...++..|+|||+.....++.++|||||||++|||++ |+.||.... ..+.... +..+....
T Consensus 156 ~~-------~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~-~~~~~~~~ 219 (256)
T cd05082 156 QD-------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPR-VEKGYKMD 219 (256)
T ss_pred CC-------CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHH-HhcCCCCC
Confidence 11 1124568999999988889999999999999999998 999986432 1122211 11221111
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
.. ...+ ..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 220 ~~------~~~~---~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 AP------DGCP---PVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CC------CCCC---HHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11 1122 3445556699999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=318.98 Aligned_cols=278 Identities=21% Similarity=0.313 Sum_probs=208.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC--------CCCEEEEEEecccc--ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP--------DASALAIKRLSACK--LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEE 363 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~--------~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 363 (604)
.+|.+.+.||+|+||.||++... .+..||+|.++... ...+++.+|+++++++ +||||+++++++..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 35778899999999999999731 12368999887532 2235789999999999 8999999999999999
Q ss_pred eeeEEeeecCCCchhhhhccCCCC---------CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVD---------NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID 434 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~ 434 (604)
..++++||+++|+|.+++...... ......++|..++.++.|++.||.||| +.+|+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence 999999999999999999754210 011235889999999999999999999 78999999999999999
Q ss_pred CCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccc
Q 007423 435 DDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGF 513 (604)
Q Consensus 435 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~ 513 (604)
+++.+||+|||+++.......... .....++..|+|||+..+..++.++|||||||++|||++ |+.||....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----- 241 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKK--TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----- 241 (334)
T ss_pred CCCcEEECCcccceeccccccccc--ccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----
Confidence 999999999999986643221111 111224567999999998889999999999999999998 888886432
Q ss_pred cCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCCCCCCCCcc
Q 007423 514 KGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEPYDEFPM 593 (604)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~~~~~~~ 593 (604)
..++.... ..+...+. .......+.+++.+||+.+|++||++.|+++.|+++...... .+++++..
T Consensus 242 ---~~~~~~~~-~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~-~~~~~~~~ 307 (334)
T cd05100 242 ---VEELFKLL-KEGHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST-DEYLDLSV 307 (334)
T ss_pred ---HHHHHHHH-HcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC-CCeeeeee
Confidence 22222222 22211111 111123455666699999999999999999999999865443 23343333
Q ss_pred ccC
Q 007423 594 IFG 596 (604)
Q Consensus 594 ~~~ 596 (604)
.++
T Consensus 308 ~~~ 310 (334)
T cd05100 308 PFE 310 (334)
T ss_pred eee
Confidence 333
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=308.79 Aligned_cols=259 Identities=22% Similarity=0.357 Sum_probs=200.9
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 366 (604)
++|...+.||+|+||.||+|... .+..||+|.+.... .....+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 46777899999999999999853 24689999986543 22356889999999999999999999999999999
Q ss_pred EEeeecCCCchhhhhccCCCCC---CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDN---TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~---~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
++|||+++|+|.+++....... .....++|..++.++.|++.||.||| +.+|+||||||+||++++++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECC
Confidence 9999999999999997543211 01134789999999999999999999 88999999999999999999999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHH
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVN 522 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 522 (604)
||+++.......... .....++..|+|||......++.++|||||||++||++| |+.||...... +...
T Consensus 163 fg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------~~~~ 232 (277)
T cd05032 163 FGMTRDIYETDYYRK--GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--------EVLK 232 (277)
T ss_pred cccchhhccCccccc--CCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--------HHHH
Confidence 999986643221111 112236788999999988889999999999999999998 99998643221 1111
Q ss_pred HHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 523 HLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 523 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
....+...... ... ...+.+++.+||+.+|++|||+.|+++.|+
T Consensus 233 -~~~~~~~~~~~------~~~---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 -FVIDGGHLDLP------ENC---PDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -HHhcCCCCCCC------CCC---CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 12222221111 111 234556666999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=307.20 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=201.1
Q ss_pred CCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCC
Q 007423 296 SFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNG 375 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g 375 (604)
+|...+.||+|+||.||++...++..+|+|.++.......+|.+|++++++++|||++++++++......++++||++++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence 56677899999999999999777889999999766556678999999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCC
Q 007423 376 TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDP 455 (604)
Q Consensus 376 sL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 455 (604)
+|.+++.... ..+++..+..++.+++.|++||| +.+++|+||||+||+++.++.+||+|||+++.......
T Consensus 85 ~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 85 CLSDYLRAQR------GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred cHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 9999987543 34789999999999999999999 78899999999999999999999999999886543211
Q ss_pred CCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 456 NDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 456 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
. ...+..++.+|+|||+..+..++.++||||||+++|||++ |+.||..... .+..... ..+. ...
T Consensus 156 ~---~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~-~~~~--~~~ 221 (256)
T cd05112 156 T---SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--------SEVVETI-NAGF--RLY 221 (256)
T ss_pred c---ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHH-hCCC--CCC
Confidence 1 1112235678999999988889999999999999999998 9999964321 1111111 1111 111
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESL 575 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 575 (604)
.+. ..+ ..+.+++.+||+.+|++||++.|+++.|
T Consensus 222 ~~~----~~~---~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 222 KPR----LAS---QSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCC----CCC---HHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 111 122 3456667799999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=309.74 Aligned_cols=256 Identities=23% Similarity=0.379 Sum_probs=198.4
Q ss_pred CCCcCcEEEecCCeEEEEEEeC-CC---CEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 296 SFAVENIIISTRTGVSYKAVLP-DA---SALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~-~~---~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
+|...+.||+|+||.||+|... ++ ..||||.++... ...++|..|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4667789999999999999853 33 369999987532 23467999999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++.... ..+++..+..++.|++.|+.||| +.+++|+||||+||++++++.+||+|||+++.
T Consensus 85 e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 85 EFMENGALDSFLRQND------GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred ecCCCCcHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccc
Confidence 9999999999987543 34889999999999999999999 78999999999999999999999999999986
Q ss_pred cCCCCCCCC-ccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 450 VGSRDPNDS-SFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 450 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
......... ....+...+..|+|||++.+..++.++|||||||++|||++ |+.||...... ....++ ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-----~~~~~i----~~ 226 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----DVINAI----EQ 226 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-----HHHHHH----Hc
Confidence 643221111 00111112457999999998889999999999999999887 99999643211 122222 11
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
..... ...+....+.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 ~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 DYRLP---------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCcCC---------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11000 0111223455666699999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=312.47 Aligned_cols=249 Identities=18% Similarity=0.303 Sum_probs=198.0
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
.+|...+.||+|++|.||+|. ..+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 467778899999999999998 4678999999987543 23467889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++++|.+++... .+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 100 ~~~~L~~~~~~~--------~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 100 AGGSLTDVVTET--------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred CCCCHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 999999998643 4788999999999999999999 78999999999999999999999999999886543
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
..... ....|+..|+|||...+..++.++|||||||++|||++|+.||...... .+.......+ ...
T Consensus 169 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--------~~~~~~~~~~-~~~ 235 (296)
T cd06654 169 EQSKR----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIATNG-TPE 235 (296)
T ss_pred ccccc----CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--------HhHHHHhcCC-CCC
Confidence 22211 1224788999999998888899999999999999999999999753221 1111111111 111
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
... .......+.+++.+||..+|++||++.||++.
T Consensus 236 ~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 236 LQN-------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCC-------ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 111 11112345556669999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=320.73 Aligned_cols=237 Identities=18% Similarity=0.244 Sum_probs=188.0
Q ss_pred cEEEecCCeEEEEEEe----CCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 301 NIIISTRTGVSYKAVL----PDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~----~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
+.||+|+||.||+++. .+|+.||+|+++.... ....+.+|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999873 4688999999975332 23457789999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 82 GGDLFTRLSKE-------VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 99999998654 35889999999999999999999 789999999999999999999999999999865432
Q ss_pred CCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
... .....|+..|+|||++.+..++.++|||||||++|||+||+.||...... +.... .......
T Consensus 152 ~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--------~~~~~-i~~~~~~-- 216 (318)
T cd05582 152 EKK----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--------ETMTM-ILKAKLG-- 216 (318)
T ss_pred CCc----eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--------HHHHH-HHcCCCC--
Confidence 111 12235899999999998888999999999999999999999999753211 11111 1111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQ 570 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 570 (604)
+ ....+..+.+ ++.+||+.||++||++.+
T Consensus 217 ~-----p~~~~~~~~~---li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 M-----PQFLSPEAQS---LLRALFKRNPANRLGAGP 245 (318)
T ss_pred C-----CCCCCHHHHH---HHHHHhhcCHhHcCCCCC
Confidence 0 1112334444 445999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=312.29 Aligned_cols=266 Identities=20% Similarity=0.305 Sum_probs=200.0
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCC-----------------CCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccce
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPD-----------------ASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPL 355 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~-----------------~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l 355 (604)
.+|...+.||+|+||.||++...+ +..||+|.+.... ...+++.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 467888999999999999987432 3468999987543 234678999999999999999999
Q ss_pred eeEEEeCCeeeEEeeecCCCchhhhhccCCCCC----CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeE
Q 007423 356 LGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDN----TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVI 431 (604)
Q Consensus 356 ~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~----~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~Ni 431 (604)
++++..++..++++||+++++|.+++....... .....+++...+.++.|++.||+||| +.+|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhce
Confidence 999999999999999999999999997653110 00125899999999999999999999 78999999999999
Q ss_pred EeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh--CCCCCCCCCc
Q 007423 432 LIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS--GQKPLDVAGA 509 (604)
Q Consensus 432 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt--g~~p~~~~~~ 509 (604)
++++++.+||+|||+++......... ......++..|+|||+..+..++.++|||||||++|||++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYR--VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eecCCCceEEccccceeecccCccee--ecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999998654322111 1112235678999999988889999999999999999998 6777754321
Q ss_pred cccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 510 EEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
. .....+.............+ .......++.+++.+||+.||++|||+.||++.|+
T Consensus 240 ~-----~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 Q-----QVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H-----HHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 11111111111111111111 11112245667777999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=311.44 Aligned_cols=265 Identities=20% Similarity=0.321 Sum_probs=204.1
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCC-----CCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEe-CCee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPD-----ASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV-EEER 365 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~-----~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~ 365 (604)
.++|...+.||+|+||.||+|...+ +..|++|+++... ...+.+.+|+.++++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578888999999999999999655 7889999986532 224568899999999999999999999876 4678
Q ss_pred eEEeeecCCCchhhhhccCCCC-CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEccc
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVD-NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDF 444 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~-~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DF 444 (604)
++++||+++|+|.+++...... ......+++..+..++.+++.||+||| +.+++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998654221 001135899999999999999999999 789999999999999999999999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHH
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNH 523 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 523 (604)
|+++.+........ .....++..|+|||+.....++.++|||||||++||+++ |+.||..... .++...
T Consensus 162 g~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~ 231 (280)
T cd05043 162 ALSRDLFPMDYHCL--GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--------FEMAAY 231 (280)
T ss_pred CCcccccCCceEEe--CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--------HHHHHH
Confidence 99986543221110 011235678999999988889999999999999999999 9999975322 122211
Q ss_pred HHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 524 LVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 524 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
...+.... .+ ...+ ..+.+++.+||..||++|||+.|+++.|+.+.++
T Consensus 232 -~~~~~~~~--~~----~~~~---~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 232 -LKDGYRLA--QP----INCP---DELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -HHcCCCCC--CC----CcCC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 11221100 00 1112 3455666699999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=323.97 Aligned_cols=254 Identities=17% Similarity=0.199 Sum_probs=192.8
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||++. ..+++.||||++.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 367888999999999999998 5678999999986432 12346788999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 81 EFLPGGDLMTMLIKY-------DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred eCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence 999999999999754 35788888999999999999999 88999999999999999999999999999964
Q ss_pred cCCCCCC------------C-------------------------------CccccCCCCcccccCccccCCCCCCcccc
Q 007423 450 VGSRDPN------------D-------------------------------SSFVHGDLGEFGYVAPEYSSTMVASLKGD 486 (604)
Q Consensus 450 ~~~~~~~------------~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~D 486 (604)
....... . ........||+.|+|||++.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 230 (377)
T cd05629 151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD 230 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCcee
Confidence 3211000 0 00001235899999999998888999999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCC-
Q 007423 487 VYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDR- 565 (604)
Q Consensus 487 V~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R- 565 (604)
||||||++|||+||+.||......+ ...............+. ...+.++.++++ +|+. +|.+|
T Consensus 231 iwSlGvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~p~~----~~~s~~~~dli~---~lL~-~~~~r~ 294 (377)
T cd05629 231 WWSLGAIMFECLIGWPPFCSENSHE--------TYRKIINWRETLYFPDD----IHLSVEAEDLIR---RLIT-NAENRL 294 (377)
T ss_pred eEecchhhhhhhcCCCCCCCCCHHH--------HHHHHHccCCccCCCCC----CCCCHHHHHHHH---HHhc-CHhhcC
Confidence 9999999999999999997532211 11111110000011010 112344555555 8887 67765
Q ss_pred --CCHHHHHHH
Q 007423 566 --PSMYQVYES 574 (604)
Q Consensus 566 --Ps~~ev~~~ 574 (604)
+++.|+++.
T Consensus 295 ~r~~~~~~l~h 305 (377)
T cd05629 295 GRGGAHEIKSH 305 (377)
T ss_pred CCCCHHHHhcC
Confidence 599998775
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=305.78 Aligned_cols=254 Identities=22% Similarity=0.286 Sum_probs=188.3
Q ss_pred EEEecCCeEEEEEEeCC---CCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCc
Q 007423 302 IIISTRTGVSYKAVLPD---ASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGT 376 (604)
Q Consensus 302 ~ig~G~~g~vy~~~~~~---~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gs 376 (604)
.||+|+||.||+|...+ +..+|+|.++... .....+.+|+.++++++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998533 4579999986543 233578899999999999999999999998888999999999999
Q ss_pred hhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCC
Q 007423 377 LYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPN 456 (604)
Q Consensus 377 L~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 456 (604)
|.++++...... ....++.....++.|++.|++||| +.+++||||||+||+++.++++||+|||+++........
T Consensus 82 L~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 82 LKGYLRSCRKAE--LMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred HHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999997543211 124677888899999999999999 789999999999999999999999999999754322111
Q ss_pred CCccccCCCCcccccCccccCCC-------CCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 457 DSSFVHGDLGEFGYVAPEYSSTM-------VASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 457 ~~~~~~~~~gt~~y~aPE~~~~~-------~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
. ......++..|+|||++... .++.++||||||+++|||++ |+.||......+ . .... ..+
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-----~---~~~~-~~~ 225 (269)
T cd05087 157 V--TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-----V---LTYT-VRE 225 (269)
T ss_pred e--cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-----H---HHHH-hhc
Confidence 1 11123467889999987532 35789999999999999996 999996532211 0 1111 111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
......++.+. ...++... +++..|| .+|++|||++||++.|+
T Consensus 226 ~~~~~~~~~~~-~~~~~~~~---~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 226 QQLKLPKPRLK-LPLSDRWY---EVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCCCCCccC-CCCChHHH---HHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11222222221 11233344 4455999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.18 Aligned_cols=239 Identities=20% Similarity=0.240 Sum_probs=186.6
Q ss_pred cEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 301 NIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
+.||+|+||.||+|.. .+++.||||.++... ...+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999994 568899999997532 2234567788887754 899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~i~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 150 (316)
T cd05620 81 GDLMFHIQDK-------GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD 150 (316)
T ss_pred CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC
Confidence 9999998754 35788999999999999999999 7899999999999999999999999999987532211
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
.. .....||..|+|||++.+..++.++|||||||++|||++|+.||...... +..... ..+.
T Consensus 151 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~~~~-~~~~----- 212 (316)
T cd05620 151 NR----ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELFESI-RVDT----- 212 (316)
T ss_pred Cc----eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHH-HhCC-----
Confidence 11 12235899999999999989999999999999999999999999753221 111111 1111
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMY-QVY 572 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-ev~ 572 (604)
+.. ....+.++.+++ .+||+.||++||++. ++.
T Consensus 213 -~~~-~~~~~~~~~~li---~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 213 -PHY-PRWITKESKDIL---EKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CCC-CCCCCHHHHHHH---HHHccCCHHHcCCChHHHH
Confidence 111 112234444444 499999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=322.26 Aligned_cols=257 Identities=16% Similarity=0.199 Sum_probs=195.6
Q ss_pred HHHHhhcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCC
Q 007423 289 DLLAATNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE 363 (604)
Q Consensus 289 ~l~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 363 (604)
++....++|...+.||+|+||.||++.. .+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++..++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 3344457899999999999999999994 568899999986422 22345789999999999999999999999999
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
..++||||+++|+|.+++... .++......++.|++.||+||| +.+|+||||||+|||+++++.+||+|
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~--------~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~D 185 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY--------DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLAD 185 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEe
Confidence 999999999999999999643 3678888999999999999999 78999999999999999999999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCCC----CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHH
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM----VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVD 519 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~ 519 (604)
||+++........ ......||+.|+|||++... .++.++||||+||++|||+||+.||..... ..
T Consensus 186 FG~a~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--------~~ 254 (370)
T cd05621 186 FGTCMKMDETGMV---RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--------VG 254 (370)
T ss_pred cccceecccCCce---ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--------HH
Confidence 9999876432211 11233589999999987653 378899999999999999999999975322 11
Q ss_pred HHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 007423 520 WVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKD--RPSMYQVYES 574 (604)
Q Consensus 520 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~~ 574 (604)
...............+. ...+.....++. .|+..+|.+ ||++.|+++.
T Consensus 255 ~~~~i~~~~~~~~~p~~----~~~s~~~~~li~---~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 255 TYSKIMDHKNSLNFPED----VEISKHAKNLIC---AFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHHHhCCcccCCCCc----ccCCHHHHHHHH---HHccCchhccCCCCHHHHhcC
Confidence 11222211111111100 112344444444 788755543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=314.95 Aligned_cols=240 Identities=20% Similarity=0.236 Sum_probs=189.2
Q ss_pred cEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 301 NIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
+.||+|+||.||++.. .+++.||||.++... ...+.+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999985 468899999997532 2234577899998887 799999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 150 (318)
T cd05570 81 GDLMFHIQRS-------GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG 150 (318)
T ss_pred CCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC
Confidence 9999988754 35899999999999999999999 8899999999999999999999999999987532221
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
... ....|+..|+|||++.+..++.++|||||||++|||+||+.||...... ..... ....... +
T Consensus 151 ~~~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--------~~~~~-i~~~~~~--~ 215 (318)
T cd05570 151 VTT----STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--------ELFQS-ILEDEVR--Y 215 (318)
T ss_pred Ccc----cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--------HHHHH-HHcCCCC--C
Confidence 111 1234889999999999999999999999999999999999999743211 11111 1111110 0
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSM-----YQVYE 573 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~ev~~ 573 (604)
....++++ .+++.+||+.||++||++ .++++
T Consensus 216 -----~~~~~~~~---~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 -----PRWLSKEA---KSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -----CCcCCHHH---HHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 11123344 455559999999999999 77755
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.65 Aligned_cols=266 Identities=19% Similarity=0.331 Sum_probs=197.7
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCC---------------CCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPD---------------ASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLG 357 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~---------------~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g 357 (604)
++|...+.||+|+||.||++.... ...||||.++... ...+.|.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 467788999999999999987532 2358999987532 23457899999999999999999999
Q ss_pred EEEeCCeeeEEeeecCCCchhhhhccCCCCC-----CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEE
Q 007423 358 FCVVEEERLLVYKHMPNGTLYSLLHGNGVDN-----TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVIL 432 (604)
Q Consensus 358 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~-----~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiL 432 (604)
++...+..++||||+++++|.+++....... .....+++..++.++.|+++||+||| +.+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence 9999999999999999999999986532110 01124789999999999999999999 789999999999999
Q ss_pred eCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh--CCCCCCCCCcc
Q 007423 433 IDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS--GQKPLDVAGAE 510 (604)
Q Consensus 433 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt--g~~p~~~~~~~ 510 (604)
+++++.+||+|||+++........ .......++..|+|||+.....++.++|||||||++|||++ |..||......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYY--RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EcCCCcEEecccccccccccCcce--eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 999999999999999865332211 11112235678999999988889999999999999999998 66777643221
Q ss_pred ccccCcHHHHHHHHHHc-CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 511 EGFKGNLVDWVNHLVIA-GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 511 ~~~~~~~~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
+ ....+...... +.......+ ...+ ..+.+++.+||+.||++||+|.+|++.|++
T Consensus 240 ~-----~~~~~~~~~~~~~~~~~~~~~----~~~~---~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 Q-----VIENTGEFFRNQGRQIYLSQT----PLCP---SPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred H-----HHHHHHHhhhhccccccCCCC----CCCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1 11111111111 111101011 1112 356666669999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=316.01 Aligned_cols=240 Identities=19% Similarity=0.211 Sum_probs=188.0
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCC-CccceeeEEEeCCeeeEEe
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHP-NLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lv~ 369 (604)
+|...+.||+|+||.||+|.. .+++.||||+++... ...+.+..|++++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 477789999999999999984 467899999997532 2235678899999999765 6888999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++.
T Consensus 81 E~~~~g~L~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05587 81 EYVNGGDLMYHIQQV-------GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE 150 (324)
T ss_pred cCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence 999999999998754 34789999999999999999999 78999999999999999999999999999875
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
....... .....||..|+|||++.+..++.++|||||||++|||+||+.||......+ -... .....
T Consensus 151 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--------~~~~-i~~~~ 217 (324)
T cd05587 151 NIFGGKT----TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--------LFQS-IMEHN 217 (324)
T ss_pred cCCCCCc----eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHH-HHcCC
Confidence 3221111 122358999999999999899999999999999999999999997532211 1111 11111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSM 568 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 568 (604)
. .. ....+.+ +.+++.+||+.||++|++.
T Consensus 218 ~------~~-~~~~~~~---~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 V------SY-PKSLSKE---AVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred C------CC-CCCCCHH---HHHHHHHHhhcCHHHcCCC
Confidence 1 00 1112333 4455559999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=341.85 Aligned_cols=268 Identities=19% Similarity=0.219 Sum_probs=202.4
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...++||+|+||.||+|.. .+++.||||+++... ...++|.+|++++++++||||+++++++...+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4688889999999999999984 568999999996532 22457899999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCC----CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 370 KHMPNGTLYSLLHGNGVD----NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~----~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
||+++|+|.+++...... ......+++...+.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998642111 011134678889999999999999999 7899999999999999999999999999
Q ss_pred CccccCCCCCC--------------CCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccc
Q 007423 446 LARLVGSRDPN--------------DSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEE 511 (604)
Q Consensus 446 la~~~~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~ 511 (604)
+++........ .........||+.|||||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99876221100 0001112358999999999999899999999999999999999999996522111
Q ss_pred cccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhchHh
Q 007423 512 GFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-SMYQVYESLKSMAEK 581 (604)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~ev~~~L~~i~~~ 581 (604)
. . ...... ++..... ..+....+.+++.+|++.||++|| +++++.+.|+...+.
T Consensus 239 -----i---~----~~~~i~---~P~~~~p-~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 -----I---S----YRDVIL---SPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred -----h---h----hhhhcc---Chhhccc-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 0 000000 0000000 011123345566699999999995 678888888877653
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.85 Aligned_cols=242 Identities=17% Similarity=0.212 Sum_probs=188.7
Q ss_pred cEEEecCCeEEEEEE-eCCCCEEEEEEeccccc----cHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 301 NIIISTRTGVSYKAV-LPDASALAIKRLSACKL----SEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
+.||+|+||.||++. ..+++.||||+++.... ..+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999 45688999999975321 234578899999888 699999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 150 (327)
T cd05617 81 GDLMFHMQRQ-------RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG 150 (327)
T ss_pred CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC
Confidence 9999988654 35899999999999999999999 7899999999999999999999999999987532211
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
.. .....||+.|+|||++.+..++.++|||||||++|||+||+.||........ ....++........... .
T Consensus 151 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~-~- 222 (327)
T cd05617 151 DT----TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD--MNTEDYLFQVILEKPIR-I- 222 (327)
T ss_pred Cc----eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc--cccHHHHHHHHHhCCCC-C-
Confidence 11 1223589999999999988999999999999999999999999975332211 12223333333222111 0
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSM 568 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 568 (604)
+...+.... +++.+|++.||++||++
T Consensus 223 -----p~~~~~~~~---~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 -----PRFLSVKAS---HVLKGFLNKDPKERLGC 248 (327)
T ss_pred -----CCCCCHHHH---HHHHHHhccCHHHcCCC
Confidence 111233344 45559999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=324.35 Aligned_cols=245 Identities=23% Similarity=0.350 Sum_probs=195.7
Q ss_pred cEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCchh
Q 007423 301 NIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~ 378 (604)
-++|+|.||+||.|+ ..+...+|||.+.... ...+-+..||.+.++++|+|||+++|.+...++.-+.||-+|+|+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 369999999999999 4556679999996532 33455789999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCC--CHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC-CCCCeEEcccCCccccCCCCC
Q 007423 379 SLLHGNGVDNTLSGVL--DWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID-DDFDARITDFGLARLVGSRDP 455 (604)
Q Consensus 379 ~~l~~~~~~~~~~~~l--~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~-~~~~~kl~DFGla~~~~~~~~ 455 (604)
++|+... +++ +..+.-.+.+||++||.||| ...|||||||-.|||++ -.|.+||+|||.++.+..-++
T Consensus 661 sLLrskW------GPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP 731 (1226)
T KOG4279|consen 661 SLLRSKW------GPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP 731 (1226)
T ss_pred HHHHhcc------CCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCc
Confidence 9998764 456 67888889999999999999 88999999999999998 678999999999998865554
Q ss_pred CCCccccCCCCcccccCccccCCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 456 NDSSFVHGDLGEFGYVAPEYSSTM--VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 456 ~~~~~~~~~~gt~~y~aPE~~~~~--~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
...++ -||..|||||++..+ .|+..+|||||||++.||.||++||...+... .....-|...
T Consensus 732 ~TETF----TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq----------AAMFkVGmyK-- 795 (1226)
T KOG4279|consen 732 CTETF----TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ----------AAMFKVGMYK-- 795 (1226)
T ss_pred ccccc----ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh----------Hhhhhhccee--
Confidence 44443 399999999998765 48889999999999999999999997543321 0111112111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
+ .++.+.+-..+.-.++++|+.+||.+||++.+++..
T Consensus 796 v----HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 796 V----HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred c----CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 0 112233334445556669999999999999998763
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=306.48 Aligned_cols=249 Identities=21% Similarity=0.318 Sum_probs=193.6
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
+|...+.||+|+||.||+|. ..+++.||+|.+.... ...+++.+|++++++++||||+++++++..++..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 56677899999999999998 5678999999986432 23457899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++|+|..+. .+++.....++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 82 DGGSLDVYR-----------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCChHHhh-----------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 999986542 3678888899999999999999 88999999999999999999999999999986533
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
... ....|+..|+|||++.+..++.++||||||+++|||+||+.||.......... ....+.... ....
T Consensus 148 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~-~~~~--- 216 (279)
T cd06619 148 SIA------KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCI-VDED--- 216 (279)
T ss_pred ccc------cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHH-hccC---
Confidence 211 12348899999999998889999999999999999999999996532221111 111111111 1111
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.+.+.....+. ++.+++.+||+.+|++||++.|+++.
T Consensus 217 --~~~~~~~~~~~---~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 217 --PPVLPVGQFSE---KFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CCCCCCCcCCH---HHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11111111223 34555669999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=332.35 Aligned_cols=262 Identities=19% Similarity=0.220 Sum_probs=187.5
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeC--------Ce
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE--------EE 364 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------~~ 364 (604)
..+|...+.||+|+||.||+|.. ..++.||||++.... ....+|+.++++++||||+++++++... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 45789999999999999999984 578999999985432 2345799999999999999999987542 24
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC-CCeEEcc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD-FDARITD 443 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~-~~~kl~D 443 (604)
.++||||+++ +|.+++...... ...+++.....++.|++.||+||| +.+|+||||||+|||++.+ +.+||+|
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~---~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARN---NHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeec
Confidence 6789999985 777776532111 135889999999999999999999 7899999999999999965 4799999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHH
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVN 522 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 522 (604)
||+++.+...... ....||+.|+|||++.+ ..++.++|||||||++|||+||++||......+. +...+.
T Consensus 215 FGla~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~----~~~i~~ 285 (440)
T PTZ00036 215 FGSAKNLLAGQRS-----VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ----LVRIIQ 285 (440)
T ss_pred cccchhccCCCCc-----ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHH
Confidence 9999876432221 12347899999998765 4689999999999999999999999975432211 111000
Q ss_pred HH-------H--HcCCc-----cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 523 HL-------V--IAGRS-----RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 523 ~~-------~--~~~~~-----~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.. . ..... ..+....+....+.....++.+++.+||+.||++|||+.|+++.
T Consensus 286 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00 0 00000 00000000000000112345566669999999999999999754
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=309.54 Aligned_cols=246 Identities=18% Similarity=0.208 Sum_probs=189.4
Q ss_pred EEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCch
Q 007423 303 IISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL 377 (604)
Q Consensus 303 ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL 377 (604)
||+|+||.||++. ..+|+.||+|++.... ...+.+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6899999999998 4569999999986432 1234567799999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCC
Q 007423 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPND 457 (604)
Q Consensus 378 ~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 457 (604)
.+++..... ..+++.....++.|++.||+||| +.+|+||||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~- 151 (277)
T cd05607 81 KYHIYNVGE-----RGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI- 151 (277)
T ss_pred HHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCcee-
Confidence 988865432 34889999999999999999999 889999999999999999999999999999876432211
Q ss_pred CccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccccccc
Q 007423 458 SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKS 537 (604)
Q Consensus 458 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 537 (604)
....|+..|+|||++.+..++.++||||+||++|||++|+.||....... ...+..... ......
T Consensus 152 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~----~~~~~~~~~-~~~~~~------ 216 (277)
T cd05607 152 ----TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV----AKEELKRRT-LEDEVK------ 216 (277)
T ss_pred ----eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh----hHHHHHHHh-hccccc------
Confidence 12348899999999988889999999999999999999999996432110 111111111 111110
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007423 538 LYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESL 575 (604)
Q Consensus 538 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 575 (604)
......+++. .+++.+||+.||++||++.|+++.+
T Consensus 217 ~~~~~~~~~~---~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 217 FEHQNFTEES---KDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cccccCCHHH---HHHHHHHhccCHhhCCCCccchhhh
Confidence 0001123344 4555599999999999998776443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=315.77 Aligned_cols=236 Identities=19% Similarity=0.198 Sum_probs=184.2
Q ss_pred cEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHH-HHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 301 NIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMN-RLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
+.||+|+||.||+|.. .+++.||||++.... ...+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999994 578999999986432 12234555555 56889999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 81 g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 150 (323)
T cd05575 81 GELFFHLQRE-------RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS 150 (323)
T ss_pred CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC
Confidence 9999998754 35888899999999999999999 7899999999999999999999999999987542222
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..... ..+... +
T Consensus 151 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i-~~~~~~--~ 215 (323)
T cd05575 151 KT----TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--------AEMYDNI-LNKPLR--L 215 (323)
T ss_pred Cc----cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--------HHHHHHH-HcCCCC--C
Confidence 11 1223589999999999988999999999999999999999999975321 1111111 111111 1
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMY 569 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 569 (604)
. ...+..+. +++.+|++.||++||++.
T Consensus 216 ~-----~~~~~~~~---~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 K-----PNISVSAR---HLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C-----CCCCHHHH---HHHHHHhhcCHHhCCCCC
Confidence 1 11233444 445599999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.71 Aligned_cols=250 Identities=19% Similarity=0.291 Sum_probs=206.1
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCe-eeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEE-RLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~lv~ 369 (604)
++|...+.+|+|+||.++..+ ..+++.+++|.+..... .++...+|+.++++++|||||.+.+.+..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 467778999999999999887 45678999999975442 33568899999999999999999999998887 99999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
+|+++|++.+.|.+.+. ..++...+..++.|++.|+.||| +..|+|||||++||++..+..+||+|||+|+.
T Consensus 84 ~Y~eGg~l~~~i~~~k~-----~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKG-----VLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKI 155 (426)
T ss_pred eecCCCCHHHHHHHHhh-----ccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhh
Confidence 99999999999987652 35889999999999999999999 88999999999999999999999999999999
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
++....... ..+||+.||.||.+.+.+|..|+||||+||++|||++-+++|...+ +...+..... +.
T Consensus 156 l~~~~~~a~----tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~--------m~~Li~ki~~-~~ 222 (426)
T KOG0589|consen 156 LNPEDSLAS----TVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN--------MSELILKINR-GL 222 (426)
T ss_pred cCCchhhhh----eecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc--------hHHHHHHHhh-cc
Confidence 976543333 3359999999999999999999999999999999999999997542 2222222211 11
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.+| .+.....++..+++ .|+..+|+.||++.+++.+
T Consensus 223 ----~~P--lp~~ys~el~~lv~---~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 ----YSP--LPSMYSSELRSLVK---SMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----CCC--CCccccHHHHHHHH---HHhhcCCccCCCHHHHhhC
Confidence 111 11234456666666 9999999999999999887
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=289.87 Aligned_cols=267 Identities=18% Similarity=0.262 Sum_probs=204.0
Q ss_pred hhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeC-----Cee
Q 007423 293 ATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE-----EER 365 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 365 (604)
..++|.+.+.+|+|+|+.||.++ +.+++.+|+|++.... .+.+..++|++..++++|||+++++++...+ ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34678899999999999999999 8889999999997655 5567799999999999999999999987643 348
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
|++++|...|+|.+.+....... ..++..+.+.|+.++++||++||.. .++++||||||.|||+.+.+.+++.|||
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg---~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKG---NFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcC---CccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence 99999999999999998654331 3589999999999999999999943 4569999999999999999999999999
Q ss_pred CccccCCCCCCCC-----ccccCCCCcccccCccccCC---CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcH
Q 007423 446 LARLVGSRDPNDS-----SFVHGDLGEFGYVAPEYSST---MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNL 517 (604)
Q Consensus 446 la~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~---~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~ 517 (604)
-+......-.... ........|..|.|||.+.- ...++++|||||||++|+|+.|..||+.....
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~------- 247 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ------- 247 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-------
Confidence 9876542211110 00112246788999998754 45789999999999999999999999743221
Q ss_pred HHHHHHHHHcCCcc-ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhch
Q 007423 518 VDWVNHLVIAGRSR-DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMA 579 (604)
Q Consensus 518 ~~~~~~~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~ 579 (604)
.+.+. .+..+.+.-+........+.+++.+|++.||.+||++.|++..++.+.
T Consensus 248 ---------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 ---------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11111 111111110111112334555555999999999999999999987653
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=312.27 Aligned_cols=261 Identities=23% Similarity=0.358 Sum_probs=201.4
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER 365 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 365 (604)
.++|+..+.||+|+||.||++... ++..||+|.++... ...+++.+|++++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888899999999999999853 46789999987533 2346799999999999999999999999999999
Q ss_pred eEEeeecCCCchhhhhccCCCC---------------CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCe
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVD---------------NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNV 430 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~---------------~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~N 430 (604)
++++||+++|+|.+++...... ......+++..++.++.|++.||.||| ..+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 9999999999999999743210 011134789999999999999999999 7899999999999
Q ss_pred EEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCc
Q 007423 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGA 509 (604)
Q Consensus 431 iLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~ 509 (604)
|++++++.+||+|||+++.......... ......+..|+|||+..+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKA--SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccc--cCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999886533221110 111124567999999988889999999999999999998 8888854322
Q ss_pred cccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 510 EEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
.++... ...+...... .. ...++.+++.+||+.+|++|||+.|+++.|++
T Consensus 239 --------~~~~~~-~~~~~~~~~~------~~---~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 --------EEVIYY-VRDGNVLSCP------DN---CPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --------HHHHHH-HhcCCCCCCC------CC---CCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 122222 2223221110 11 12345566679999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=306.13 Aligned_cols=255 Identities=20% Similarity=0.286 Sum_probs=195.8
Q ss_pred HHHhhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 290 LLAATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 290 l~~~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
++.+++++.....||+|+||.||+|. ..++..||+|.+.... ...+.+.+|++++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 45567777777899999999999999 4567889999986543 234678999999999999999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCC--CHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC-CCCeEEccc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVL--DWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD-DFDARITDF 444 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l--~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~-~~~~kl~DF 444 (604)
++||+++++|.+++.... ..+ ++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+||
T Consensus 83 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~df 153 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW------GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDF 153 (268)
T ss_pred EEecCCCCCHHHHHHHhc------ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecc
Confidence 999999999999997542 124 78888999999999999999 789999999999999986 678999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCCCC--CCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHH
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMV--ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVN 522 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 522 (604)
|++.......... ....|+..|+|||+..... ++.++|||||||++|||++|+.||....... ...|..
T Consensus 154 g~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~-----~~~~~~ 224 (268)
T cd06624 154 GTSKRLAGINPCT----ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ-----AAMFKV 224 (268)
T ss_pred hhheecccCCCcc----ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh-----hhHhhh
Confidence 9987654322211 1223788999999876543 7889999999999999999999996422110 111110
Q ss_pred HHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 523 HLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 523 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.. .. .. +.+ .....++ +.+++.+||+.+|++|||+.|+++
T Consensus 225 ~~--~~-~~----~~~-~~~~~~~---~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 225 GM--FK-IH----PEI-PESLSAE---AKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hh--hc-cC----CCC-CcccCHH---HHHHHHHHcCCCchhCCCHHHHHh
Confidence 00 00 00 111 1112233 445555999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.26 Aligned_cols=202 Identities=22% Similarity=0.261 Sum_probs=170.8
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc----cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL----SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
.|...+.||+|+||.||+|. ..+++.||||++..... ..+.+.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 47778999999999999998 56788999999975321 23468899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++|+|.+++... ..++......++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIRM-------GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 99999999998754 34778888899999999999999 789999999999999999999999999997543
Q ss_pred CCCCC-------------------------------------------CCCccccCCCCcccccCccccCCCCCCcccch
Q 007423 451 GSRDP-------------------------------------------NDSSFVHGDLGEFGYVAPEYSSTMVASLKGDV 487 (604)
Q Consensus 451 ~~~~~-------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV 487 (604)
..... ..........||+.|+|||++.+..++.++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di 231 (382)
T cd05625 152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeE
Confidence 21000 00000112358999999999998899999999
Q ss_pred hhHHHHHHHHHhCCCCCCCC
Q 007423 488 YGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 488 ~SfGvvl~elltg~~p~~~~ 507 (604)
|||||++|||+||+.||...
T Consensus 232 wSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 232 WSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred EechHHHHHHHhCCCCCCCC
Confidence 99999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=313.52 Aligned_cols=240 Identities=18% Similarity=0.208 Sum_probs=188.3
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEe
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 369 (604)
+|...+.||+|+||.||+|.. .+++.||||.++... ...+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 477789999999999999984 567899999987532 1223567788888777 5899999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.
T Consensus 81 E~~~~g~L~~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~ 150 (323)
T cd05616 81 EYVNGGDLMYQIQQV-------GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred cCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence 999999999998654 35889999999999999999999 78999999999999999999999999999975
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... +.... +....
T Consensus 151 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--------~~~~~-i~~~~ 217 (323)
T cd05616 151 NMWDGVT----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQS-IMEHN 217 (323)
T ss_pred cCCCCCc----cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--------HHHHH-HHhCC
Confidence 4322111 12235899999999999999999999999999999999999999753221 11111 11111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSM 568 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 568 (604)
.. . ....+.++ .+++.+|++.||++|++.
T Consensus 218 ~~--~-----p~~~s~~~---~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 VA--Y-----PKSMSKEA---VAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CC--C-----CCcCCHHH---HHHHHHHcccCHHhcCCC
Confidence 10 0 01123344 455559999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.28 Aligned_cols=195 Identities=20% Similarity=0.238 Sum_probs=166.9
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
..+|.+.+.||+|+||.||++.. ..++.||||.... ..+.+|++++++++|+|||++++++..++..+++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 44688899999999999999995 4578999996432 34678999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
. ++|.+++.... ..++|..++.++.|+++||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 243 ~-~~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 243 R-SDLYTYLGARL------RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred C-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 5 68998886542 35899999999999999999999 78999999999999999999999999999987643
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLD 505 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~ 505 (604)
.... ....+..||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 313 ~~~~--~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 313 SWST--PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cccc--ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 2211 11123458999999999999899999999999999999999887654
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.95 Aligned_cols=267 Identities=18% Similarity=0.292 Sum_probs=198.9
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC-----------------CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccce
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP-----------------DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPL 355 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~-----------------~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l 355 (604)
++|+..+.||+|+||.||++... ++..||+|.++... ...+++.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 45888899999999999998522 24479999987532 234679999999999999999999
Q ss_pred eeEEEeCCeeeEEeeecCCCchhhhhccCCCCC----CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeE
Q 007423 356 LGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDN----TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVI 431 (604)
Q Consensus 356 ~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~----~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~Ni 431 (604)
++++...+..+++|||+++|+|.+++....... .....+++.....++.|++.||+||| +.+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence 999999999999999999999999987643211 11134788999999999999999999 78999999999999
Q ss_pred EeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh--CCCCCCCCCc
Q 007423 432 LIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS--GQKPLDVAGA 509 (604)
Q Consensus 432 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt--g~~p~~~~~~ 509 (604)
|+++++.+||+|||+++.+....... ......++..|+|||+.....++.++|||||||++|||+| |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYR--IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCccee--ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999998653322111 0111124678999998888889999999999999999998 7788864322
Q ss_pred cccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 510 EEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
.+ .................. + ....+...+.+++.+||+.||++||++.||.+.|++
T Consensus 240 ~~-----~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQ-----VIENTGEFFRDQGRQVYL-P-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH-----HHHHHHHHHhhccccccC-C-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 111111111111111100 0 011122456667779999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=307.07 Aligned_cols=263 Identities=17% Similarity=0.271 Sum_probs=199.1
Q ss_pred CCCcCcEEEecCCeEEEEEEe-----CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeC--Ceee
Q 007423 296 SFAVENIIISTRTGVSYKAVL-----PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE--EERL 366 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-----~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 366 (604)
.|...+.||+|+||.||++.. .++..||+|.++... ...+.+.+|++++++++||||+++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467778999999999999973 357889999987432 2235789999999999999999999998875 5688
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
+||||+++++|.+++.... ..++|..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+
T Consensus 85 lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK------NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred EEEEccCCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcc
Confidence 9999999999999986542 24899999999999999999999 88999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccc-------cccCcHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEE-------GFKGNLVD 519 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~-------~~~~~~~~ 519 (604)
++......... .......++..|+|||+..+..++.++|||||||++|||+|++.|........ ........
T Consensus 156 ~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05079 156 TKAIETDKEYY-TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR 234 (284)
T ss_pred ccccccCccce-eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH
Confidence 98764322211 11112346778999999888889999999999999999999887653211000 00001111
Q ss_pred HHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 520 WVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 520 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
++ .....+..... .......+.+++.+||+.+|++||++.|+++.|+.+
T Consensus 235 ~~-~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LV-RVLEEGKRLPR---------PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HH-HHHHcCccCCC---------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11 11222211111 111223566666699999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.75 Aligned_cols=252 Identities=18% Similarity=0.234 Sum_probs=196.5
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc------cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL------SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
++|...+.||+|++|.||++. ..+++.||+|.+..... ..+.+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 468889999999999999998 45789999999864321 12468899999999999999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
++||+++++|.+++... ..+++.....++.+++.||.||| +.+|+||||||+||++++++.+||+|||++
T Consensus 82 v~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~ 151 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-------GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS 151 (263)
T ss_pred EEEECCCCcHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 99999999999998754 34788899999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
+.......... ......++..|+|||+..+..++.++||||||+++|||++|+.||...... .-.......
T Consensus 152 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~ 222 (263)
T cd06625 152 KRLQTICSSGT-GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM--------AAIFKIATQ 222 (263)
T ss_pred eeccccccccc-cccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH--------HHHHHHhcc
Confidence 86543211111 001224678999999999888999999999999999999999999642111 101111111
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
. ....+ ....+.. +.+++.+||..+|++|||+.|+++.
T Consensus 223 ~-~~~~~-----~~~~~~~---~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 P-TNPQL-----PSHVSPD---ARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred C-CCCCC-----CccCCHH---HHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1 11111 1112233 4455559999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=309.50 Aligned_cols=262 Identities=20% Similarity=0.280 Sum_probs=199.8
Q ss_pred HHHHHHhhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhcc-CCCCccceeeEEE----
Q 007423 287 LADLLAATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCV---- 360 (604)
Q Consensus 287 ~~~l~~~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~---- 360 (604)
++++..++++|+..+.||+|+||.||++. ..+++.+|+|.++.......++.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 34556678899999999999999999998 45688999999875444456788999999999 6999999999885
Q ss_pred -eCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCe
Q 007423 361 -VEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439 (604)
Q Consensus 361 -~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~ 439 (604)
.++..+++|||+++++|.+++...... ...+++..+..++.|+++||.||| +.+|+||||||+||++++++.+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKR---GERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhcc---CccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence 345689999999999999987643111 135788999999999999999999 7899999999999999999999
Q ss_pred EEcccCCccccCCCCCCCCccccCCCCcccccCccccCC-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCcccccc
Q 007423 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-----MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFK 514 (604)
Q Consensus 440 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~ 514 (604)
||+|||+++......... ....|+..|+|||++.. ..++.++|||||||++|||+||+.||.......
T Consensus 164 kl~dfg~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--- 236 (286)
T cd06638 164 KLVDFGVSAQLTSTRLRR----NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--- 236 (286)
T ss_pred EEccCCceeecccCCCcc----ccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH---
Confidence 999999998764322111 12248899999998753 447889999999999999999999996432111
Q ss_pred CcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 515 GNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
... . ..........++ ...+ ..+.+++.+||+.||++|||+.||++.
T Consensus 237 ----~~~-~-~~~~~~~~~~~~----~~~~---~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 237 ----ALF-K-IPRNPPPTLHQP----ELWS---NEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ----HHh-h-ccccCCCcccCC----CCcC---HHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 100 0 001111111111 1112 245566669999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.63 Aligned_cols=258 Identities=22% Similarity=0.378 Sum_probs=202.2
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC-CCC----EEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP-DAS----ALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~-~~~----~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
++|...+.||+|+||.||+|... ++. .||+|.+.... ....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45677799999999999999853 333 58999886543 234578899999999999999999999987 78899
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
++||+++|+|.+++.... ..+++...+.++.|++.|++||| +.+++||||||+||++++++.+||+|||++
T Consensus 86 v~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~ 156 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK------DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLA 156 (279)
T ss_pred EEecCCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccc
Confidence 999999999999997653 34889999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
+......... ...+..++..|+|||......++.++||||||+++||++| |+.||..... .++. ..+.
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~-~~~~ 225 (279)
T cd05057 157 KLLDVDEKEY--HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VEIP-DLLE 225 (279)
T ss_pred ccccCcccce--ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HHHH-HHHh
Confidence 8765322211 1112224568999999888889999999999999999999 9999975322 1222 2222
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
.+.... .+ .. +...+.+++.+||..+|++||++.++++.|+++..+.
T Consensus 226 ~~~~~~--~~----~~---~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 226 KGERLP--QP----PI---CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred CCCCCC--CC----CC---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 221111 11 11 1234556666999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=306.96 Aligned_cols=264 Identities=20% Similarity=0.295 Sum_probs=200.6
Q ss_pred hhcCCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEeccccc--cHHHHHHHHHHHhccCCCCccceeeEEEeCCe
Q 007423 293 ATNSFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACKL--SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEE 364 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 364 (604)
.+++|.+.+.||+|+||.||+|... .+..||+|.++.... ....+.+|+.++++++||||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567888999999999999999743 245899999864432 23468899999999999999999999999899
Q ss_pred eeEEeeecCCCchhhhhccCCCCC---CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEE
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDN---TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARI 441 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~---~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl 441 (604)
.++||||+++|+|.+++....... ......++.....++.|++.||.||| +++|+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997532110 01124577888999999999999999 889999999999999999999999
Q ss_pred cccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHH
Q 007423 442 TDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDW 520 (604)
Q Consensus 442 ~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 520 (604)
+|||+++.......... .....++..|+|||...+..++.++|||||||++|||++ |+.||..... .++
T Consensus 161 ~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--------~~~ 230 (288)
T cd05061 161 GDFGMTRDIYETDYYRK--GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQV 230 (288)
T ss_pred CcCCccccccccccccc--cCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHH
Confidence 99999986533221111 011124678999999988889999999999999999999 7889864322 111
Q ss_pred HHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhch
Q 007423 521 VNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMA 579 (604)
Q Consensus 521 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~ 579 (604)
... ...+..... ....+ ..+.+++.+||+.||++|||+.|+++.|++..
T Consensus 231 ~~~-~~~~~~~~~------~~~~~---~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 231 LKF-VMDGGYLDQ------PDNCP---ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHH-HHcCCCCCC------CCCCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111 112211111 01112 34555666999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.68 Aligned_cols=240 Identities=20% Similarity=0.208 Sum_probs=185.1
Q ss_pred cEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHH-HHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 301 NIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMN-RLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
+.||+|+||.||+++. .+++.||+|.+.... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999994 567899999986532 12234455544 56889999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++... ..++......++.|+++||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~ 150 (325)
T cd05602 81 GELFYHLQRE-------RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 150 (325)
T ss_pred CcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC
Confidence 9999999754 34677888889999999999999 7899999999999999999999999999997543222
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+...... ..... .
T Consensus 151 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~-~~~~~--~ 215 (325)
T cd05602 151 GT----TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNIL-NKPLQ--L 215 (325)
T ss_pred CC----cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--------HHHHHHHH-hCCcC--C
Confidence 11 1223589999999999998999999999999999999999999975322 11111111 11110 1
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
. ...+..+.++++ +|++.||.+||++.+.+.
T Consensus 216 ~-----~~~~~~~~~li~---~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 216 K-----PNITNSARHLLE---GLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred C-----CCCCHHHHHHHH---HHcccCHHHCCCCCCCHH
Confidence 1 122344555555 999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=316.15 Aligned_cols=241 Identities=20% Similarity=0.206 Sum_probs=186.6
Q ss_pred cEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHH-HHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 301 NIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMN-RLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
+.||+|+||.||+++ ..+|+.||||++.... ...+++..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999998 5678999999986432 22345566665 47789999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|..++... ..+++.....++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 150 (325)
T cd05604 81 GELFFHLQRE-------RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS 150 (325)
T ss_pred CCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC
Confidence 9999988654 35889999999999999999999 7899999999999999999999999999987542221
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
... ....||..|+|||++.+..++.++|||||||++|||++|+.||..... .+..... ..+.. ..
T Consensus 151 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~~-~~~~~--~~ 215 (325)
T cd05604 151 DTT----TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--------AEMYDNI-LHKPL--VL 215 (325)
T ss_pred CCc----ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH--------HHHHHHH-HcCCc--cC
Confidence 111 223589999999999998999999999999999999999999975322 1111111 11111 11
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
. ...+.... +++.+|++.+|++||++.+.++.
T Consensus 216 ~-----~~~~~~~~---~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 216 R-----PGASLTAW---SILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred C-----CCCCHHHH---HHHHHHhccCHHhcCCCCCCHHH
Confidence 1 11233344 45559999999999988644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=301.37 Aligned_cols=249 Identities=20% Similarity=0.268 Sum_probs=197.6
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
+|...+.||+|+||.||++. ..++..+|+|.++... ...+.+.+|+.++++++|+||+++.+++..++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 36677899999999999998 4578999999986432 23467889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++|+|.+++..... ..++......++.+++.||.||| +.+|+|+||||+||++++++.++++|||.+.....
T Consensus 81 ~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQRG-----KLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 99999998865322 34788899999999999999999 88999999999999999999999999999986643
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
..... ....|+..|+|||+..+..++.++||||||+++|+|++|+.||..... ...... ...+....
T Consensus 153 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~~~~~-~~~~~~~~ 219 (255)
T cd08219 153 PGAYA----CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--------KNLILK-VCQGSYKP 219 (255)
T ss_pred ccccc----ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--------HHHHHH-HhcCCCCC
Confidence 22211 122478899999999888899999999999999999999999974321 111111 12222221
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.. ...+. .+.+++.+||+.||++||++.||+..
T Consensus 220 ~~------~~~~~---~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LP------SHYSY---ELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CC------cccCH---HHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11 11223 34455569999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=310.32 Aligned_cols=197 Identities=21% Similarity=0.342 Sum_probs=170.5
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
++|...+.||+|+||.||++. ..++..+|+|.++... ...+++.+|++++++++||||+++++++..++..+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 368888999999999999998 4568889999886432 2235688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++++|.++++.. ..+++.....++.|+++||.|||+ ..+++||||||+|||+++++.+||+|||++....
T Consensus 81 ~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 81 MDGGSLDQVLKKA-------GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred cCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 9999999999754 357889999999999999999994 3589999999999999999999999999987653
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
.... ....|+..|+|||+..+..++.++|||||||++|||+||+.||..
T Consensus 152 ~~~~------~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 152 DSMA------NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred cccc------ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 2211 123478899999998888899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=322.95 Aligned_cols=253 Identities=19% Similarity=0.213 Sum_probs=192.3
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
+|...+.||+|+||.||+++ ..+++.||||.+.... ...+.+.+|++++++++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 57888999999999999998 5568999999986432 123567899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++|+|.+++... ..++......++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..+
T Consensus 82 ~~~~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 82 YIPGGDMMSLLIRL-------GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred CCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 99999999999764 34788888889999999999999 789999999999999999999999999998533
Q ss_pred CCCCC---------------------------------------CCCccccCCCCcccccCccccCCCCCCcccchhhHH
Q 007423 451 GSRDP---------------------------------------NDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFG 491 (604)
Q Consensus 451 ~~~~~---------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfG 491 (604)
..... ..........||+.|||||++.+..++.++||||||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 231 (376)
T cd05598 152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231 (376)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecc
Confidence 10000 000001123689999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC---CH
Q 007423 492 IVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP---SM 568 (604)
Q Consensus 492 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~ 568 (604)
|++|||+||+.||...... ++.... ..... ....+. ....+.+..+++. +|+ .+|++|+ ++
T Consensus 232 vilyell~G~~Pf~~~~~~--------~~~~~i-~~~~~-~~~~~~--~~~~s~~~~~li~---~l~-~~p~~R~~~~t~ 295 (376)
T cd05598 232 VILYEMLVGQPPFLADTPA--------ETQLKV-INWET-TLHIPS--QAKLSREASDLIL---RLC-CGAEDRLGKNGA 295 (376)
T ss_pred ceeeehhhCCCCCCCCCHH--------HHHHHH-hccCc-cccCCC--CCCCCHHHHHHHH---HHh-cCHhhcCCCCCH
Confidence 9999999999999754321 111111 11110 000000 0112334444444 655 4999999 88
Q ss_pred HHHHHH
Q 007423 569 YQVYES 574 (604)
Q Consensus 569 ~ev~~~ 574 (604)
.|+++.
T Consensus 296 ~ell~h 301 (376)
T cd05598 296 DEIKAH 301 (376)
T ss_pred HHHhCC
Confidence 888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.41 Aligned_cols=262 Identities=19% Similarity=0.232 Sum_probs=193.5
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCC-----eee
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE-----ERL 366 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 366 (604)
+|+..+.||+|+||.||++. ..+++.||||++.... ...+++.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47778999999999999999 4679999999986432 23357889999999999999999999998776 789
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
+|+||+. ++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+
T Consensus 81 lv~e~~~-~~l~~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~ 149 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-------QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGL 149 (372)
T ss_pred EEeeccc-cCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccc
Confidence 9999997 5788877543 35889999999999999999999 78999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccC--------cH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKG--------NL 517 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~--------~~ 517 (604)
++........ ......++..|+|||++.+. .++.++|||||||++|||++|+.||......+.... ..
T Consensus 150 a~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~ 226 (372)
T cd07853 150 ARVEEPDESK---HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226 (372)
T ss_pred eeecccCccc---cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 9865432211 11223478899999988764 478999999999999999999999975432211000 00
Q ss_pred HH------HHHHHHHcCCc-ccccccc-ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 518 VD------WVNHLVIAGRS-RDVVDKS-LYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 518 ~~------~~~~~~~~~~~-~~~~d~~-l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.+ .....+..... ....... ......+ ..+.+++.+|++.||++|||+.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQAT---HEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCC---HHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00 00111111100 0000000 0001112 344556669999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=329.87 Aligned_cols=261 Identities=20% Similarity=0.278 Sum_probs=201.6
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCC-CEEEEEEeccc-cccHHHHHHHHHHHhccC-CCCccceeeE-EEe------CCe
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDA-SALAIKRLSAC-KLSEKQFRSEMNRLGQLR-HPNLVPLLGF-CVV------EEE 364 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~-~~vAvK~l~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~-~~~------~~~ 364 (604)
.+..+.+.|.+|||+.||.+....+ ..||+|++-.. ...-+.+.+||++|++|+ |||||.+++. ... .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3456779999999999999996655 99999998543 333467889999999996 9999999993 322 136
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEccc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDF 444 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DF 444 (604)
++|.||||++|.|-+++..+.. ..|+..++++|+.|+++|+++||. ++++|||||||.+||||+.++..|||||
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq-----~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQ-----TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHh-----ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 7899999999999999975532 248999999999999999999995 4889999999999999999999999999
Q ss_pred CCccccCCCC--CCCCccc---cCCCCcccccCcccc---CCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCc
Q 007423 445 GLARLVGSRD--PNDSSFV---HGDLGEFGYVAPEYS---STMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGN 516 (604)
Q Consensus 445 Gla~~~~~~~--~~~~~~~---~~~~gt~~y~aPE~~---~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~ 516 (604)
|-|....... ......+ -....|+.|+|||++ .+..+++|+|||++||+||-|+..+.||+..+..
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------ 264 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------ 264 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce------
Confidence 9886432211 0000000 012468999999964 5778999999999999999999999999864321
Q ss_pred HHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 517 LVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
.+++....-+..+.....+.+||..||+.||++||++.+|+..+.+|....
T Consensus 265 ---------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 ---------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 111111111112334455666666999999999999999999998887654
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=315.37 Aligned_cols=196 Identities=23% Similarity=0.249 Sum_probs=166.0
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCC------
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE------ 363 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 363 (604)
.++|...+.||+|+||.||++. ..++..||||++.... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 4678889999999999999998 4568999999996432 23456889999999999999999999986543
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
..++||||+++ +|.+.++. .+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM---------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc---------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEec
Confidence 46999999975 66666642 3778888999999999999999 78999999999999999999999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
||+++....... .....||..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 167 fg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 167 FGLARTACTNFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred CCCccccccCcc-----CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 999976532211 12234789999999999989999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=306.81 Aligned_cols=254 Identities=26% Similarity=0.440 Sum_probs=193.8
Q ss_pred cEEEecCCeEEEEEEeCC-------CCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 301 NIIISTRTGVSYKAVLPD-------ASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~-------~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+.||+|+||.||+|+..+ +..+|||.+.... ....++.+|++++++++||||+++++++...+..+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998532 2579999886433 2346789999999999999999999999998999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC-----CeEEcccCC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF-----DARITDFGL 446 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~-----~~kl~DFGl 446 (604)
+++|+|.+++............+++..++.++.|++.||.||| +.+++|+||||+||+++.+. .+|++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999754322111234789999999999999999999 78899999999999999877 899999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
++.......... .....++..|+|||++.+..++.++|||||||++|||+| |+.||...... +.... .
T Consensus 158 ~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--------~~~~~-~ 226 (269)
T cd05044 158 ARDIYKSDYYRK--EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--------EVLQH-V 226 (269)
T ss_pred cccccccccccc--CcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--------HHHHH-H
Confidence 986543221111 111235678999999998889999999999999999998 99999643221 11111 1
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
..+..... ....++ .+.+++.+||..+|++||++.+|++.|++
T Consensus 227 ~~~~~~~~------~~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 227 TAGGRLQK------PENCPD---KIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred hcCCccCC------cccchH---HHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111110 111233 44556669999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=307.39 Aligned_cols=260 Identities=20% Similarity=0.312 Sum_probs=199.9
Q ss_pred cCHHHHHHhhcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhcc-CCCCccceeeEEEe-
Q 007423 285 VKLADLLAATNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVV- 361 (604)
Q Consensus 285 ~~~~~l~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~- 361 (604)
.++.++..+.+.|+..+.||+|+||.||+|.. .+++.+|+|.+........++..|+.+++++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34556666778899999999999999999994 6789999999866544556788999999998 79999999999863
Q ss_pred -----CCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC
Q 007423 362 -----EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD 436 (604)
Q Consensus 362 -----~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~ 436 (604)
....+++|||+++|+|.+++..... ..+++..+..++.|++.|+.||| +.+|+|+|+||+||+++++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~ 157 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-----NALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTEN 157 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCC
Confidence 4578999999999999999875432 24778888999999999999999 7899999999999999999
Q ss_pred CCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccc
Q 007423 437 FDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSS-----TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEE 511 (604)
Q Consensus 437 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~ 511 (604)
+.++|+|||++.......... ....|+..|+|||++. ...++.++|||||||++|||+||+.||.......
T Consensus 158 ~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~ 233 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTVGRR----NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233 (282)
T ss_pred CCEEEeeCcchhhhhccccCC----CcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh
Confidence 999999999988653222111 1234788999999875 3457889999999999999999999996432111
Q ss_pred cccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 512 GFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
. ... ..... .+.......+. .+.+++.+||+.||.+||++.|+++
T Consensus 234 ~--------~~~-~~~~~-----~~~~~~~~~~~---~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 234 A--------LFL-IPRNP-----PPKLKSKKWSK---KFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred h--------hhh-HhhCC-----CCCCcccccCH---HHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 000 01110 11111111223 4555556999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.37 Aligned_cols=263 Identities=24% Similarity=0.318 Sum_probs=202.3
Q ss_pred cCHHHHHHhhcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhcc-CCCCccceeeEEEeC
Q 007423 285 VKLADLLAATNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVE 362 (604)
Q Consensus 285 ~~~~~l~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 362 (604)
+++.++..++++|...+.||+|+||.||++.. .+++.+|+|.+.......+++.+|+.+++++ +|||++++++++...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 44456677789999999999999999999984 6789999999976544556788999999999 899999999998753
Q ss_pred -----CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC
Q 007423 363 -----EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF 437 (604)
Q Consensus 363 -----~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~ 437 (604)
+..++|+||+++|+|.++++..... ...+++..+..++.|++.||.||| +.+++||||||+||++++++
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLIC---GQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEG 165 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCC
Confidence 3589999999999999988643211 135889999999999999999999 78999999999999999999
Q ss_pred CeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCC-----CCCcccchhhHHHHHHHHHhCCCCCCCCCcccc
Q 007423 438 DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-----VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEG 512 (604)
Q Consensus 438 ~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~ 512 (604)
.+||+|||+++......... ....|+..|+|||++... .++.++|||||||++|||++|+.||.......
T Consensus 166 ~~kl~dfg~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~- 240 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRLRR----NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK- 240 (291)
T ss_pred CEEEeecccchhcccccccc----cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-
Confidence 99999999998764322111 122478899999987543 36889999999999999999999996432110
Q ss_pred ccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 513 FKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
. +.. ...+......++ ......+.+++.+||+.+|++||++.|+++
T Consensus 241 ---~----~~~-~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 241 ---T----LFK-IPRNPPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ---H----HHH-HhcCCCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 111 111111111111 112234556666999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=301.68 Aligned_cols=249 Identities=20% Similarity=0.310 Sum_probs=198.6
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCC-CCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPD-ASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
++|+..+.||+|++|.||+|...+ +..+|+|.++.... .+++.+|++++++++||||+++++++..+...++++||++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 568888999999999999999654 88999999875433 5789999999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+++|.+++.... ..+++.....++.|++.|+.||| ..+++|+|++|+||++++++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~------~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 82 AGSVSDIMKITN------KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred CCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 999999986543 35899999999999999999999 789999999999999999999999999999876443
Q ss_pred CCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
..... ...++..|+|||+..+..++.++|||||||++|||+||+.||........ . ........
T Consensus 153 ~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-------~--~~~~~~~~--- 216 (256)
T cd06612 153 MAKRN----TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-------I--FMIPNKPP--- 216 (256)
T ss_pred ccccc----cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-------h--hhhccCCC---
Confidence 21111 12378899999999888899999999999999999999999975322110 0 00000000
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
+... ........+.+++.+||+.||++|||+.||++
T Consensus 217 --~~~~--~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 217 --PTLS--DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --CCCC--chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0000 01111234555666999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=305.80 Aligned_cols=258 Identities=21% Similarity=0.368 Sum_probs=197.9
Q ss_pred CCCcCcEEEecCCeEEEEEEe------CCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 296 SFAVENIIISTRTGVSYKAVL------PDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~------~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
++...+.||+|+||.||++.. .++..+|+|.++... ...+.+.+|++++++++|+||+++++++...+..+++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 566678999999999999963 245689999987543 3346799999999999999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCC--------CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeE
Q 007423 369 YKHMPNGTLYSLLHGNGVD--------NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDAR 440 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~--------~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~k 440 (604)
+||+++|+|.+++...... ......+++..++.++.|++.|++||| +.+++||||||+|||+++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEE
Confidence 9999999999999754311 001134889999999999999999999 88999999999999999999999
Q ss_pred EcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHH
Q 007423 441 ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVD 519 (604)
Q Consensus 441 l~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 519 (604)
|+|||+++......... ......+++.|+|||+..+..++.++|||||||++|||+| |++||...... +
T Consensus 163 L~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~ 232 (280)
T cd05092 163 IGDFGMSRDIYSTDYYR--VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--------E 232 (280)
T ss_pred ECCCCceeEcCCCceee--cCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--------H
Confidence 99999997653321111 0111235678999999988889999999999999999999 99998643221 1
Q ss_pred HHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 520 WVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 520 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
.... ...+..... + ...+.. +.+++.+||+.||++||++.||.+.|+
T Consensus 233 ~~~~-~~~~~~~~~--~----~~~~~~---~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 233 AIEC-ITQGRELER--P----RTCPPE---VYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHH-HHcCccCCC--C----CCCCHH---HHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111 112211111 1 112233 445555999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=299.45 Aligned_cols=264 Identities=20% Similarity=0.276 Sum_probs=196.3
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccc---cccHHHHHHHHHHHhccCCCCccceeeEEEe-----CCe
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSAC---KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVV-----EEE 364 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~~~ 364 (604)
...|...+.||+|+||.|..+. ..+|+.||||++... ....++..+|+.+|+.++|+||+.+++.+.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 3445556889999999999998 678999999999742 2344678899999999999999999999876 235
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEccc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDF 444 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DF 444 (604)
.|+|+|+|+. +|...++.. ..++-.....+..|+++||.|+| +.+|+|||+||+|+|++.+..+||+||
T Consensus 101 vYiV~elMet-DL~~iik~~-------~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 101 VYLVFELMET-DLHQIIKSQ-------QDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred eEEehhHHhh-HHHHHHHcC-------ccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccc
Confidence 8999999955 999999865 34888889999999999999999 899999999999999999999999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccC-CCCCCcccchhhHHHHHHHHHhCCCCCCCCCcccccc------CcH
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSS-TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFK------GNL 517 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~------~~~ 517 (604)
|+|+..... .......+-+.|.-|.|||.+. ...||...||||.|||+.||++|++-|.+...-+... +..
T Consensus 170 GLAR~~~~~--~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 170 GLARYLDKF--FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP 247 (359)
T ss_pred cceeecccc--CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence 999988543 2223334456789999999764 5679999999999999999999999997543211110 000
Q ss_pred H---------HHHHHHHHcC-CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 518 V---------DWVNHLVIAG-RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 518 ~---------~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
. +.++..+..- ......-..+. ...+....++++ +++..||.+|+|++|.++.
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLle---kmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLE---KMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHH---HHhccCccccCCHHHHhcC
Confidence 0 0111111111 00000000011 122334444444 9999999999999999775
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=312.74 Aligned_cols=236 Identities=20% Similarity=0.206 Sum_probs=182.9
Q ss_pred cEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHH-HHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 301 NIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMN-RLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
++||+|+||.||+++. .+++.||+|.+.... ....++.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999994 578999999986432 12234555654 67889999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|..++... ..++......++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 150 (321)
T cd05603 81 GELFFHLQRE-------RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE 150 (321)
T ss_pred CCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC
Confidence 9999888654 34778888899999999999999 7899999999999999999999999999987542221
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... +..+.. .
T Consensus 151 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~-i~~~~~-~-- 214 (321)
T cd05603 151 ET----TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--------SQMYDN-ILHKPL-Q-- 214 (321)
T ss_pred Cc----cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--------HHHHHH-HhcCCC-C--
Confidence 11 1223589999999999888899999999999999999999999975321 111111 111111 0
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMY 569 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 569 (604)
+ ....+. .+.+++.+|++.||++||++.
T Consensus 215 ---~-~~~~~~---~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 ---L-PGGKTV---AACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ---C-CCCCCH---HHHHHHHHHccCCHhhcCCCC
Confidence 0 111223 344555599999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=309.15 Aligned_cols=263 Identities=21% Similarity=0.279 Sum_probs=201.9
Q ss_pred CCCcCcEEEecCCeEEEEEEeC-----CCCEEEEEEecccccc--HHHHHHHHHHHhccCCCCccceeeEEEe--CCeee
Q 007423 296 SFAVENIIISTRTGVSYKAVLP-----DASALAIKRLSACKLS--EKQFRSEMNRLGQLRHPNLVPLLGFCVV--EEERL 366 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~-----~~~~vAvK~l~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~ 366 (604)
.|...+.||+|+||.||++... .+..||||.++..... .+.|.+|++++++++||||+++++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4566789999999999999853 3689999999765443 5679999999999999999999999877 55789
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
++|||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 85 lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR------DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred EEEecCCCCCHHHHHHhCc------cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccc
Confidence 9999999999999997653 24899999999999999999999 78999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccc-------cCcHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGF-------KGNLVD 519 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~-------~~~~~~ 519 (604)
+........... ......++..|+|||......++.++||||||+++|||+||+.|+......... ......
T Consensus 156 ~~~~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05038 156 AKVLPEDKDYYY-VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234 (284)
T ss_pred ccccccCCccee-ccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence 987753221111 111123456799999998888999999999999999999999998643221100 000111
Q ss_pred HHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 520 WVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 520 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
+ ......+.... .......++.+++.+||+.+|++||||.||+++|+.+
T Consensus 235 ~-~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 L-LELLKEGERLP---------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred H-HHHHHcCCcCC---------CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1 11111111100 0111224566777799999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.68 Aligned_cols=258 Identities=23% Similarity=0.390 Sum_probs=199.5
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCC----EEEEEEeccccc--cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDAS----ALAIKRLSACKL--SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~----~vAvK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
++|...+.||+|+||.||+|.. .++. .||+|.+..... ...++.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 3567778999999999999984 4454 478888865332 234688999999999999999999998754 4679
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
++||+++|+|.+++.... ..+++...+.++.|++.||.||| +.+|+||||||+||++++++.+||+|||++
T Consensus 86 v~e~~~~g~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK------DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred eehhcCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEcccccc
Confidence 999999999999987543 34889999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
+......... ...+..++..|+|||++.+..++.++|||||||++|||+| |+.||...... .. .....
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-----~~----~~~~~ 225 (303)
T cd05110 157 RLLEGDEKEY--NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-----EI----PDLLE 225 (303)
T ss_pred ccccCccccc--ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HH----HHHHH
Confidence 8764322111 1112235678999999988889999999999999999998 99998643211 11 12222
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
.+.... .+ ......+.+++.+||..+|++||++.|+++.|+++.+..
T Consensus 226 ~~~~~~--~~-------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 226 KGERLP--QP-------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred CCCCCC--CC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 221111 00 112235566777999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=320.49 Aligned_cols=196 Identities=18% Similarity=0.245 Sum_probs=168.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC---CCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP---DASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~---~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
..|...+.||+|+||.||++... .+..||||.+... +.+.+|++++++++||||+++++++......+++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 46888999999999999999743 3578999988643 3456899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+. ++|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 168 ~~-~~l~~~l~~~-------~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 168 YK-CDLFTYVDRS-------GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred cC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 96 5888888433 35899999999999999999999 7899999999999999999999999999998664
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
...... ......||..|+|||++....++.++|||||||++|||++|+.||...
T Consensus 237 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 237 AHPDTP--QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred cccccc--cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 322211 112345899999999999889999999999999999999999999654
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=317.64 Aligned_cols=257 Identities=18% Similarity=0.233 Sum_probs=195.3
Q ss_pred HHHHhhcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCC
Q 007423 289 DLLAATNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE 363 (604)
Q Consensus 289 ~l~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 363 (604)
++....++|...+.||+|+||.||++.. .+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++..++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 4445567899999999999999999994 568899999986422 12345788999999999999999999999999
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
..++||||+++|+|.+++... .++......++.|++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~D 185 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY--------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLAD 185 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEe
Confidence 999999999999999998643 3677888899999999999999 88999999999999999999999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCCC----CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHH
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM----VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVD 519 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~ 519 (604)
||+++......... .....||+.|+|||++... .++.++|||||||++|||++|+.||..... ..
T Consensus 186 fG~a~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~ 254 (371)
T cd05622 186 FGTCMKMNKEGMVR---CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VG 254 (371)
T ss_pred CCceeEcCcCCccc---ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HH
Confidence 99998764322111 1233589999999987653 378899999999999999999999975322 11
Q ss_pred HHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 007423 520 WVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKD--RPSMYQVYES 574 (604)
Q Consensus 520 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~~ 574 (604)
...............+. ...+.+...++ .+|+..++.+ ||++.|+++.
T Consensus 255 ~~~~i~~~~~~~~~~~~----~~~s~~~~~li---~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 255 TYSKIMNHKNSLTFPDD----NDISKEAKNLI---CAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHHHHHcCCCcccCCCc----CCCCHHHHHHH---HHHcCChhhhcCCCCHHHHhcC
Confidence 11122111111111110 11234444444 4898744433 7789988875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=298.90 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=198.4
Q ss_pred cEEEecCCeEEEEEEeCC----CCEEEEEEecccccc--HHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 301 NIIISTRTGVSYKAVLPD----ASALAIKRLSACKLS--EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~----~~~vAvK~l~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
+.||+|+||.||++.... +..||+|.++..... .+.+.+|++.+++++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999543 889999999765433 46789999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCC--CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 375 GTLYSLLHGNGVD--NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 375 gsL~~~l~~~~~~--~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++|.+++...... ......+++..+..++.|++.||.||| +.+++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999765210 000135899999999999999999999 89999999999999999999999999999987754
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
.... .......++..|+|||......++.++||||+|+++|||++ |+.||..... .+.. .....+...
T Consensus 158 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~-~~~~~~~~~ 226 (262)
T cd00192 158 DDYY--RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVL-EYLRKGYRL 226 (262)
T ss_pred cccc--ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHH-HHHHcCCCC
Confidence 3211 11223347889999999988889999999999999999999 6999975421 1111 112222111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
.. ......++.+++.+||+.+|++|||+.|+++.|+
T Consensus 227 ~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 PK---------PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CC---------CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 10 1111234556666999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=308.17 Aligned_cols=245 Identities=20% Similarity=0.288 Sum_probs=194.1
Q ss_pred CCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 297 FAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
|+..+.||+|+||.||+|.. .++..||+|.++... ...+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 44457799999999999984 568899999986432 233568899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+++|.+++... .+++..+..++.|+++|+.||| +.+++|+||+|+||++++++.+|++|||++......
T Consensus 86 ~~~L~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 86 GGSALDLLKPG--------PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCcHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 99999988642 4788999999999999999999 789999999999999999999999999999876432
Q ss_pred CCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
.... ....++..|+|||++.+..++.++|||||||++|||+||+.|+....... +. .....+.
T Consensus 155 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~-~~~~~~~---- 217 (277)
T cd06642 155 QIKR----NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--------VL-FLIPKNS---- 217 (277)
T ss_pred chhh----hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--------HH-hhhhcCC----
Confidence 2111 12247889999999998889999999999999999999999986432111 11 1111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.+.+. ......+.+++.+||+.+|++||+|.||++.
T Consensus 218 -~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 218 -PPTLE----GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -CCCCC----cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11111 1122345566669999999999999999874
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=319.30 Aligned_cols=243 Identities=26% Similarity=0.333 Sum_probs=198.5
Q ss_pred CCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccH---HHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 297 FAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSE---KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~---~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
|...+.||.|+||.||.+. ..+.+.||||++..+. ... .++.+||..|++++|||+|.+.|+|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 4455789999999999998 6788999999997543 222 4688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
|-+ +-.|++.-++ .++....+..|..+.+.||+||| +.+.||||||+.|||+.+.+.+||+|||.|....
T Consensus 108 ClG-SAsDlleVhk------KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 108 CLG-SASDLLEVHK------KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred Hhc-cHHHHHHHHh------ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcC
Confidence 955 7777765432 45888899999999999999999 8899999999999999999999999999998764
Q ss_pred CCCCCCCccccCCCCcccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSS---TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
+.+ ..+||+.|||||++. .+.|+-|+||||+||++.||..+++|+...+.- .-..+... +
T Consensus 178 PAn--------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM--------SALYHIAQ-N 240 (948)
T KOG0577|consen 178 PAN--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQ-N 240 (948)
T ss_pred chh--------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH--------HHHHHHHh-c
Confidence 322 235999999999875 467999999999999999999999998654321 11122222 1
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
. .|.+....+++....|++ .|++.-|.+|||..++++.
T Consensus 241 e-----sPtLqs~eWS~~F~~Fvd---~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 241 E-----SPTLQSNEWSDYFRNFVD---SCLQKIPQERPTSEELLKH 278 (948)
T ss_pred C-----CCCCCCchhHHHHHHHHH---HHHhhCcccCCcHHHHhhc
Confidence 1 233445567888888888 9999999999999887653
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.56 Aligned_cols=197 Identities=22% Similarity=0.234 Sum_probs=166.7
Q ss_pred hhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeC------
Q 007423 293 ATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE------ 362 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 362 (604)
..++|...+.||+|+||.||++. ...++.||||++.... ...+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 44688889999999999999998 4568899999997532 2235678899999999999999999988643
Q ss_pred CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEc
Q 007423 363 EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARIT 442 (604)
Q Consensus 363 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~ 442 (604)
...+++|||+++ ++.+.+.. .+++..+..++.|+++||.||| +.+|+||||||+|||+++++.+||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM---------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh---------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEe
Confidence 346899999975 67776642 3788889999999999999999 8899999999999999999999999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
|||+++....... .....||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 162 Dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 162 DFGLARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred eCcccccCCCccc-----cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999986543211 12235889999999998888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=302.64 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=194.8
Q ss_pred cEEEecCCeEEEEEEeCC--C--CEEEEEEeccccc--cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 301 NIIISTRTGVSYKAVLPD--A--SALAIKRLSACKL--SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~--~--~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
+.||+|++|.||+|...+ + ..||||.++.... ..+.+.+|++++++++||||+++++++.. ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998533 3 3699999976543 34678999999999999999999999988 889999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++..... ..++|.....++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+++......
T Consensus 80 ~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 80 GSLLDRLRKDAL-----GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred CcHHHHHHhccc-----ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccc
Confidence 999999976531 25899999999999999999999 8899999999999999999999999999998775432
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
..... .....++..|+|||+..+..++.++|||||||++|||+| |+.||...... +.............
T Consensus 152 ~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~- 221 (257)
T cd05040 152 DHYVM-EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--------QILKKIDKEGERLE- 221 (257)
T ss_pred cceec-ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHhcCCcCC-
Confidence 11111 112246788999999988889999999999999999999 99999643221 11222111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
. .... ...+.+++.+||+.+|++||++.|+++.|.
T Consensus 222 -~----~~~~---~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -R----PEAC---PQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -C----CccC---CHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 0111 234556666999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.95 Aligned_cols=259 Identities=20% Similarity=0.201 Sum_probs=188.4
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhcc---CCCCccceeeEEEe-----CC
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQL---RHPNLVPLLGFCVV-----EE 363 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~-----~~ 363 (604)
+|...+.||+|+||.||+|. ..+++.||+|.++... .....+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 36778899999999999998 4578999999986432 1224566788777665 79999999998864 24
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
..+++|||+++ +|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~d 151 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP-----PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLAD 151 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECc
Confidence 57899999985 89888865422 24889999999999999999999 78999999999999999999999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHH
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNH 523 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 523 (604)
||+++........ ....|+..|+|||++.+..++.++||||+||++|||++|++||......+. +.... .
T Consensus 152 fg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~----~~~~~-~ 221 (288)
T cd07863 152 FGLARIYSCQMAL-----TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ----LGKIF-D 221 (288)
T ss_pred cCccccccCcccC-----CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH----HHHHH-H
Confidence 9999876432211 122478899999999888899999999999999999999999965322111 10100 0
Q ss_pred HHHcC----Cc------ccccccccc---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 524 LVIAG----RS------RDVVDKSLY---GRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 524 ~~~~~----~~------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
..... .. .....+... ....++....+.+++.+|++.||++|||+.|++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 222 LIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 00 000000000 0000111234456666999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=310.15 Aligned_cols=240 Identities=18% Similarity=0.210 Sum_probs=188.2
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeeEEe
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 369 (604)
+|...+.||+|+||.||++. ..+++.||||.++... ...+.+..|..++..+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 36677899999999999998 4578999999987532 22345778999988885 577888999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++.
T Consensus 81 Ey~~~g~L~~~i~~~-------~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~ 150 (323)
T cd05615 81 EYVNGGDLMYHIQQV-------GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred cCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccc
Confidence 999999999998754 35889999999999999999999 78999999999999999999999999999875
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
....... .....||..|+|||++.+..++.++|||||||++|||+||+.||...... ...... ....
T Consensus 151 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i-~~~~ 217 (323)
T cd05615 151 HMVDGVT----TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--------ELFQSI-MEHN 217 (323)
T ss_pred cCCCCcc----ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHH-HhCC
Confidence 4322211 12234899999999998888999999999999999999999999753221 111111 1111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSM 568 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 568 (604)
.. . ....+. ++.+++.+|++.+|++|++.
T Consensus 218 ~~------~-p~~~~~---~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 VS------Y-PKSLSK---EAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CC------C-CccCCH---HHHHHHHHHcccCHhhCCCC
Confidence 11 0 011223 34455559999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=308.56 Aligned_cols=249 Identities=22% Similarity=0.251 Sum_probs=194.1
Q ss_pred CCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 297 FAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
|+..+.||+|+||.||++. ..+++.||||.+.... ...+.+.+|+.++++++|+||+++.+.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 6667899999999999998 4578999999986432 1224577899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++|+|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++....
T Consensus 82 ~~g~~L~~~l~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 82 MNGGDLKFHIYHMGE-----AGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 153 (285)
T ss_pred cCCCcHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence 999999998864422 24889999999999999999999 8899999999999999999999999999987653
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
.... .....|+..|+|||++.+..++.++|||||||++|||++|+.||....... ..+-....... ..
T Consensus 154 ~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-----~~~~~~~~~~~--~~ 221 (285)
T cd05630 154 EGQT-----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-----KREEVERLVKE--VQ 221 (285)
T ss_pred CCcc-----ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-----hHHHHHhhhhh--hh
Confidence 2221 122358999999999998889999999999999999999999997532110 00001111110 00
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS-----MYQVYE 573 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~ 573 (604)
. .. ....+.++. +++.+||+.||++||| +.|+++
T Consensus 222 ~----~~-~~~~~~~~~---~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 E----EY-SEKFSPDAR---SLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred h----hc-CccCCHHHH---HHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0 00 111223344 4555999999999999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=302.06 Aligned_cols=238 Identities=20% Similarity=0.327 Sum_probs=183.8
Q ss_pred cEEEecCCeEEEEEEeCC-------------CCEEEEEEeccccc-cHHHHHHHHHHHhccCCCCccceeeEEEeCCeee
Q 007423 301 NIIISTRTGVSYKAVLPD-------------ASALAIKRLSACKL-SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~-------------~~~vAvK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 366 (604)
+.||+|+||.||+|.+.+ ...||+|.+..... ....|.+|+.++++++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 22588998765432 2346888999999999999999999999998999
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC-------e
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD-------A 439 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~-------~ 439 (604)
++|||+++|+|..++.... ..+++..+..++.|+++||+||| +.+|+||||||+|||++.++. +
T Consensus 81 lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS------DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred EEEecccCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCcee
Confidence 9999999999999886542 35889999999999999999999 889999999999999986654 8
Q ss_pred EEcccCCccccCCCCCCCCccccCCCCcccccCccccC-CCCCCcccchhhHHHHHHHHH-hCCCCCCCCCccccccCcH
Q 007423 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSS-TMVASLKGDVYGFGIVLLELL-SGQKPLDVAGAEEGFKGNL 517 (604)
Q Consensus 440 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~k~DV~SfGvvl~ell-tg~~p~~~~~~~~~~~~~~ 517 (604)
|++|||++....... ...++..|+|||++. +..++.++|||||||++|||+ +|+.|+......
T Consensus 152 ~l~d~g~~~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------- 216 (262)
T cd05077 152 KLSDPGIPITVLSRQ--------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA------- 216 (262)
T ss_pred EeCCCCCCccccCcc--------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-------
Confidence 999999987653211 123678899999876 466899999999999999998 588887542111
Q ss_pred HHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007423 518 VDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESL 575 (604)
Q Consensus 518 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 575 (604)
+. ... ..+.. ... .... ..+.+++.+||+.||++||++.||++.+
T Consensus 217 -~~-~~~-~~~~~-~~~------~~~~---~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 217 -EK-ERF-YEGQC-MLV------TPSC---KELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -HH-HHH-HhcCc-cCC------CCCh---HHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 10 011 11111 011 1112 3455666699999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=305.83 Aligned_cols=257 Identities=20% Similarity=0.301 Sum_probs=200.3
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
++|+..+.||+|+||.||++. ..+++.||+|.+.... ...+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 356677899999999999998 5578999999876432 2346789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++|+|.+++... +.+++.....++.+++.||.|||+ ..+++||||||+||++++++.++|+|||++....
T Consensus 85 ~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 85 MDCGSLDRIYKKG-------GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred CCCCCHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 9999999998754 358899999999999999999994 3589999999999999999999999999987542
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCcccc---ccCcHHHHHHHHHHcC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEG---FKGNLVDWVNHLVIAG 528 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~ 528 (604)
.... ....|+..|+|||++.+..++.++|||||||++|||+||+.||......+. ......++........
T Consensus 156 ~~~~------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd06620 156 NSIA------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP 229 (284)
T ss_pred hhcc------CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc
Confidence 2111 122478999999998888899999999999999999999999975433211 1111222332222111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESL 575 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 575 (604)
. +.+. ..+....+.+++.+||+.||++|||+.|+++..
T Consensus 230 -~-----~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 -P-----PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -C-----CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1 1111 011223455666699999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=303.65 Aligned_cols=250 Identities=22% Similarity=0.255 Sum_probs=193.7
Q ss_pred CCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc----cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 297 FAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL----SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
|...+.||+|+||.||++. ..+++.||+|.+..... ..+.+.+|++++++++|+||+++.+++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 5566889999999999998 46789999999865321 224578899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++|+|.+++..... ..+++.....++.|++.||.||| +.+|+||||||+||++++++.+||+|||++....
T Consensus 82 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 82 MNGGDLKFHIYNMGN-----PGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred ccCccHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 999999988865421 25899999999999999999999 8899999999999999999999999999997653
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
.... .....|+..|+|||++.+..++.++|||||||++|||+||+.||....... ..+-+...+....
T Consensus 154 ~~~~-----~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-----~~~~~~~~~~~~~-- 221 (285)
T cd05632 154 EGES-----IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-----KREEVDRRVLETE-- 221 (285)
T ss_pred CCCc-----ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHhhhccc--
Confidence 2211 122358999999999988889999999999999999999999997432211 0011111111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS-----MYQVYES 574 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~~ 574 (604)
... ....+.+ +.+++.+||+.||++||+ +.|+++.
T Consensus 222 ~~~-----~~~~~~~---~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 222 EVY-----SAKFSEE---AKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccc-----CccCCHH---HHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 001 1112233 445555999999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=299.92 Aligned_cols=238 Identities=22% Similarity=0.327 Sum_probs=187.0
Q ss_pred cEEEecCCeEEEEEEeCCCC-----------EEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 301 NIIISTRTGVSYKAVLPDAS-----------ALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~~~-----------~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
+.||+|+||.||+|...+.. .|++|.+.........|.+|+.++++++||||+++++++.. +..++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999965433 57888876544336789999999999999999999999988 7789999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC-------CeEEc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF-------DARIT 442 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~-------~~kl~ 442 (604)
||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++ .+||+
T Consensus 80 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 80 EYVKFGPLDVFLHREK------NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EcCCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeC
Confidence 9999999999997653 25889999999999999999999 78999999999999999887 79999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCCC--CCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHH
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM--VASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVD 519 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 519 (604)
|||+++...... ...++..|+|||++... .++.++|||||||++|||++ |..||...... +
T Consensus 151 Dfg~a~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--------~ 214 (259)
T cd05037 151 DPGIPITVLSRE--------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--------E 214 (259)
T ss_pred CCCccccccccc--------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--------h
Confidence 999998754311 12356789999998776 78999999999999999999 57777543211 1
Q ss_pred HHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 520 WVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 520 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
+..... ...... .... ..+.+++.+||+.+|++|||+.||++.|+
T Consensus 215 ~~~~~~-~~~~~~--------~~~~---~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 215 KERFYQ-DQHRLP--------MPDC---AELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HHHHHh-cCCCCC--------CCCc---hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111111 111000 0011 45556666999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=307.20 Aligned_cols=248 Identities=19% Similarity=0.302 Sum_probs=197.2
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
.+|...+.||+|++|.||++. ..+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 468888999999999999999 5679999999987543 33456889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++++|.+++.+. .+++..+..++.+++.||.||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 99 ~~~~L~~~~~~~--------~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 99 AGGSLTDVVTET--------CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred CCCCHHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 999999998643 4788999999999999999999 78999999999999999999999999999986643
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
..... ....++..|+|||...+..++.++|||||||++|+|+||+.||.......... .. .......
T Consensus 168 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--------~~-~~~~~~~ 234 (297)
T cd06656 168 EQSKR----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--------LI-ATNGTPE 234 (297)
T ss_pred CccCc----CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--------ee-ccCCCCC
Confidence 32211 12247889999999988889999999999999999999999996532211100 00 0011111
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
...+ ...+.. +.+++.+||+.+|++||++.||++
T Consensus 235 ~~~~----~~~~~~---~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 LQNP----ERLSAV---FRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCc----cccCHH---HHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 112233 345555999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=305.59 Aligned_cols=237 Identities=20% Similarity=0.288 Sum_probs=182.6
Q ss_pred EEEecCCeEEEEEEeCC-------------------------CCEEEEEEeccccc-cHHHHHHHHHHHhccCCCCccce
Q 007423 302 IIISTRTGVSYKAVLPD-------------------------ASALAIKRLSACKL-SEKQFRSEMNRLGQLRHPNLVPL 355 (604)
Q Consensus 302 ~ig~G~~g~vy~~~~~~-------------------------~~~vAvK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l 355 (604)
.||+|+||.||+|.+.. ...||+|.+..... ...+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 13588998865332 23568899999999999999999
Q ss_pred eeEEEeCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC
Q 007423 356 LGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD 435 (604)
Q Consensus 356 ~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~ 435 (604)
++++...+..++||||+++|+|..++.... ..+++..++.++.|+++||+||| +.+|+||||||+|||+++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~ 152 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK------GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLAR 152 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEec
Confidence 999999999999999999999999986542 35889999999999999999999 789999999999999975
Q ss_pred CC-------CeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHH-hCCCCCCC
Q 007423 436 DF-------DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELL-SGQKPLDV 506 (604)
Q Consensus 436 ~~-------~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~ell-tg~~p~~~ 506 (604)
.+ .+|++|||++....... ...++..|+|||++.+ ..++.++|||||||++|||+ +|+.||..
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~~--------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 224 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSRE--------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224 (274)
T ss_pred cCcccCccceeeecCCcccccccccc--------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence 43 37999999886542211 1136788999998765 56899999999999999994 79999864
Q ss_pred CCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007423 507 AGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESL 575 (604)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 575 (604)
....+ ...+ ..... . .... . ...+.+++.+||+.+|++||++.+|++.|
T Consensus 225 ~~~~~-----~~~~----~~~~~--~-----~~~~-~---~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 225 RTPSE-----KERF----YEKKH--R-----LPEP-S---CKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred cChHH-----HHHH----HHhcc--C-----CCCC-C---ChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 32211 1111 11110 0 0001 1 12455666799999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=307.56 Aligned_cols=200 Identities=21% Similarity=0.241 Sum_probs=168.1
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+|...+.||+|++|.||+|.. .++..||||+++... ...+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 467778999999999999995 578999999986432 2235788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
++ ++|.+++...... ..+++.....++.|++.||.||| +.+++||||||+||++++++.+||+|||++....
T Consensus 81 ~~-~~l~~~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLPKG----QYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCCCC----CcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 97 6898888654321 35889999999999999999999 7899999999999999999999999999998654
Q ss_pred CCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
..... .....++..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 153 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 153 IPVRV----YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred CCccc----ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 32211 112246889999998765 45788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=321.49 Aligned_cols=249 Identities=21% Similarity=0.332 Sum_probs=200.9
Q ss_pred cCcEEEecCCeEEEEEEeC--CCC--EEEEEEecccccc--HHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 299 VENIIISTRTGVSYKAVLP--DAS--ALAIKRLSACKLS--EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 299 ~~~~ig~G~~g~vy~~~~~--~~~--~vAvK~l~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
..++||+|.||+|++|.+. .|+ .||||.++..... ...|.+|+.+|-+++|||+++|+|+..+ ....+|+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3478999999999999864 343 6899999876543 4789999999999999999999999987 6788999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
+.|+|.+.|+.... ..|.......++.|||.||.||. .+++|||||.++|+|+-....+||+|||+.+.++.
T Consensus 193 plGSLldrLrka~~-----~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKK-----AILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred ccchHHHHHhhccc-----cceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999987321 45777888899999999999999 89999999999999999999999999999999876
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
.+..... .....-.+.|+|||.+....++.++|||+|||++|||+| |+.||...... + +.+.+.++.
T Consensus 265 ned~Yvm-~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--------q-IL~~iD~~e-- 332 (1039)
T KOG0199|consen 265 NEDMYVM-APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--------Q-ILKNIDAGE-- 332 (1039)
T ss_pred CCcceEe-cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--------H-HHHhccccc--
Confidence 5443321 112234678999999999999999999999999999999 89999754321 1 111122221
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESL 575 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 575 (604)
.-+.+..+.+++.++++.||..+|++|||+..|.+.+
T Consensus 333 -------rLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 333 -------RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred -------cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 1123345667888888899999999999999997543
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=298.66 Aligned_cols=252 Identities=20% Similarity=0.306 Sum_probs=195.7
Q ss_pred CCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccc-------cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 296 SFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKL-------SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
+|...+.||+|+||.||+|...+++.+|||.++.... ..+.+.+|++++++++|+||+++++++...+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 3667789999999999999988899999999864321 124588999999999999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
+||+++++|.+++... ..+++.....++.|++.||+||| +.+|+|+||+|+||++++++.+||+|||+++
T Consensus 81 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 150 (265)
T cd06631 81 MEFVPGGSISSILNRF-------GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCAR 150 (265)
T ss_pred EecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhH
Confidence 9999999999999754 34788899999999999999999 7889999999999999999999999999998
Q ss_pred ccCCCCCC--CCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 449 LVGSRDPN--DSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 449 ~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
........ .........|+..|+|||+..+..++.++|||||||++|||+||+.||...... .........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~~ 223 (265)
T cd06631 151 RLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-------AAMFYIGAH 223 (265)
T ss_pred hhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-------HHHHHhhhc
Confidence 65321111 111112335788999999999888999999999999999999999999643211 111000000
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.+... ... ...++++. +++.+||+.+|++||++.|+++
T Consensus 224 ~~~~~-----~~~-~~~~~~~~---~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 224 RGLMP-----RLP-DSFSAAAI---DFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred cCCCC-----CCC-CCCCHHHH---HHHHHHhcCCcccCCCHHHHhc
Confidence 01111 111 12233444 4455999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=301.61 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=186.1
Q ss_pred EEEecCCeEEEEEEeCC---CCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCc
Q 007423 302 IIISTRTGVSYKAVLPD---ASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGT 376 (604)
Q Consensus 302 ~ig~G~~g~vy~~~~~~---~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gs 376 (604)
.||+|+||.||+|...+ ...+|+|.+.... .....|.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997433 4578888876432 223568899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCC
Q 007423 377 LYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPN 456 (604)
Q Consensus 377 L~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 456 (604)
|.+++....... ....++.....++.|++.|++||| +.+|+||||||+|||+++++++||+|||+++........
T Consensus 82 L~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 82 LKNYLRSNRGMV--AQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred HHHHHHhccccc--cccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999997653211 123567888999999999999999 789999999999999999999999999998754322111
Q ss_pred CCccccCCCCcccccCccccC-------CCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 457 DSSFVHGDLGEFGYVAPEYSS-------TMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 457 ~~~~~~~~~gt~~y~aPE~~~-------~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
.. .....++..|+|||+.. ...++.++|||||||++|||++ |+.||...... +-.......+
T Consensus 157 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--------~~~~~~~~~~ 226 (269)
T cd05042 157 IT--KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--------QVLKQVVREQ 226 (269)
T ss_pred ec--cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhhcc
Confidence 11 11223567899999853 3456889999999999999999 78888643221 1111112222
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
.....++.... ..+.... +++..|| .||++|||++||++.|.
T Consensus 227 -~~~~~~~~~~~-~~~~~~~---~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 227 -DIKLPKPQLDL-KYSDRWY---EVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred -CccCCCCcccc-cCCHHHH---HHHHHHh-cCcccccCHHHHHHHhc
Confidence 12222222211 1223333 4445888 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=307.91 Aligned_cols=200 Identities=19% Similarity=0.271 Sum_probs=168.4
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
++|...+.||+|+||.||+|.. .+++.||+|.++... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 4577889999999999999984 468899999986432 2234678899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++ +|.+++.... ..+++.....++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++...
T Consensus 86 ~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 86 LDK-DLKQYMDDCG------NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCC-CHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 975 8888876542 34788999999999999999999 7899999999999999999999999999997653
Q ss_pred CCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAG 508 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~ 508 (604)
...... ....++..|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 156 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 156 VPTKTY----SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred CCcccc----ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 322111 12247889999998754 468899999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.92 Aligned_cols=203 Identities=18% Similarity=0.241 Sum_probs=173.1
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|+..+.||+|+||.||++.. .+++.||||.++... ...+.+.+|+.++.+++||||+++++.+..++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3677889999999999999984 568999999996432 22346788999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++... ..++......++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~ 150 (360)
T cd05627 81 EFLPGGDMMTLLMKK-------DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTG 150 (360)
T ss_pred eCCCCccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence 999999999999754 35888999999999999999999 89999999999999999999999999999875
Q ss_pred cCCCCCC-------------------------------CCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHH
Q 007423 450 VGSRDPN-------------------------------DSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELL 498 (604)
Q Consensus 450 ~~~~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ell 498 (604)
....... .........||+.|+|||++.+..++.++|||||||++|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~ 230 (360)
T cd05627 151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230 (360)
T ss_pred cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence 5321100 000011346899999999999999999999999999999999
Q ss_pred hCCCCCCCC
Q 007423 499 SGQKPLDVA 507 (604)
Q Consensus 499 tg~~p~~~~ 507 (604)
||+.||...
T Consensus 231 tG~~Pf~~~ 239 (360)
T cd05627 231 IGYPPFCSE 239 (360)
T ss_pred cCCCCCCCC
Confidence 999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=327.55 Aligned_cols=203 Identities=17% Similarity=0.214 Sum_probs=164.9
Q ss_pred HHHHhhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccCCC------CccceeeEEEe
Q 007423 289 DLLAATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHP------NLVPLLGFCVV 361 (604)
Q Consensus 289 ~l~~~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~------niv~l~g~~~~ 361 (604)
++...+++|.+.+.||+|+||.||+|. ...++.||||+++......+++..|++++++++|. +++++++++..
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 334456789999999999999999998 45688999999975433345566777777777554 58888888876
Q ss_pred C-CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC---
Q 007423 362 E-EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF--- 437 (604)
Q Consensus 362 ~-~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~--- 437 (604)
. .+.++|||++ +++|.+++... ..+++.....|+.|++.||.|||+ +.+||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~-------~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH-------GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccc
Confidence 4 5788999988 66899888754 358899999999999999999993 25899999999999998665
Q ss_pred -------------CeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCC
Q 007423 438 -------------DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPL 504 (604)
Q Consensus 438 -------------~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~ 504 (604)
.+||+|||.+...... . ....||..|+|||++.+..++.++|||||||++|||+||+.||
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~~---~----~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERHS---R----TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCccc---c----ccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 4999999987643211 1 1235899999999999999999999999999999999999999
Q ss_pred CCCC
Q 007423 505 DVAG 508 (604)
Q Consensus 505 ~~~~ 508 (604)
+...
T Consensus 346 ~~~~ 349 (467)
T PTZ00284 346 DTHD 349 (467)
T ss_pred CCCC
Confidence 7543
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=299.57 Aligned_cols=247 Identities=24% Similarity=0.376 Sum_probs=194.4
Q ss_pred cEEEecCCeEEEEEEeCCCCEEEEEEeccccc--cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCchh
Q 007423 301 NIIISTRTGVSYKAVLPDASALAIKRLSACKL--SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~ 378 (604)
++||+|++|.||++...+++.||+|.++.... ..+++.+|++++++++|+||+++++++......+++|||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36899999999999976799999999875432 3467999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCC
Q 007423 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDS 458 (604)
Q Consensus 379 ~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 458 (604)
+++.... ..+++.....++.+++.|+.||| +.+++||||||+||++++++.+||+|||+++..........
T Consensus 81 ~~l~~~~------~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 151 (251)
T cd05041 81 TFLRKKK------NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS 151 (251)
T ss_pred HHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec
Confidence 9997542 24788999999999999999999 78999999999999999999999999999986532111110
Q ss_pred ccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccccccc
Q 007423 459 SFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKS 537 (604)
Q Consensus 459 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 537 (604)
. ....++..|+|||...+..++.++|||||||++|||+| |..||...... .. ......+... .
T Consensus 152 ~--~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--------~~-~~~~~~~~~~--~--- 215 (251)
T cd05041 152 D--GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--------QT-RERIESGYRM--P--- 215 (251)
T ss_pred c--ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--------HH-HHHHhcCCCC--C---
Confidence 0 01123567999999988889999999999999999999 88888643211 11 1111111100 0
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 538 LYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 538 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
.+......+.+++.+||..+|++|||+.|+++.|+
T Consensus 216 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 216 ----APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ----CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 01112235666666999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=301.89 Aligned_cols=251 Identities=20% Similarity=0.248 Sum_probs=193.6
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
++|...+.||+|+||.||+|. ..+++.||+|.++... .....+.+|+.+++.++||||+++++++..++..++++||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 356667889999999999998 4678999999987543 22346788999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++++|.+++... ..+++.....++.|++.|+.||| ..+++|+||||+||+++.++.+||+|||++.....
T Consensus 89 ~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 89 GGGSLQDIYHVT-------GPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred CCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 999999998654 35889999999999999999999 78999999999999999999999999999876643
Q ss_pred CCCCCCccccCCCCcccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSS---TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
..... ....|+..|+|||++. ...++.++|||||||++|||++|+.||....... .+........
T Consensus 159 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--------~~~~~~~~~~ 226 (267)
T cd06645 159 TIAKR----KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--------ALFLMTKSNF 226 (267)
T ss_pred ccccc----ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--------hHHhhhccCC
Confidence 22111 1234889999999874 4558899999999999999999999986432111 0111111110
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
....... ....++. +.+++.+|++.+|++||++.+|++
T Consensus 227 ~~~~~~~---~~~~~~~---~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 227 QPPKLKD---KMKWSNS---FHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCcccc---cCCCCHH---HHHHHHHHccCCchhCcCHHHHhc
Confidence 1110000 0011233 445555999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=302.84 Aligned_cols=249 Identities=18% Similarity=0.208 Sum_probs=191.9
Q ss_pred CCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 297 FAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
|+..+.||+|+||.||+|.. .++..+|+|.+.... ...+.+.+|+++++.++||||+++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 44567899999999999995 457889999986533 3345788999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|..++.... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 87 ~~l~~~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 87 GAVDAVMLELE------RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred CcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 99999876532 35899999999999999999999 7899999999999999999999999999987653221
Q ss_pred CCCCccccCCCCcccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSS-----TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
.. .....++..|+|||++. ...++.++|||||||++|||++|++||...... +.+.... ...
T Consensus 158 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~-~~~ 224 (282)
T cd06643 158 QR----RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--------RVLLKIA-KSE 224 (282)
T ss_pred cc----cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--------HHHHHHh-hcC
Confidence 11 11234788999999873 345788999999999999999999999643211 1111111 111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
......+ ...+.++ .+++.+||+.||++||++.++++.
T Consensus 225 ~~~~~~~----~~~~~~~---~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 225 PPTLAQP----SRWSSEF---KDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCCCCCc----cccCHHH---HHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111 1122344 455559999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=302.18 Aligned_cols=246 Identities=19% Similarity=0.258 Sum_probs=196.9
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
.|...+.||+|+||.||+|.. .++..||||.++... ...+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 355668899999999999985 568899999986432 23457889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++|+|.+++... .+++.....++.+++.|++|+| +.+++|+||+|+||++++++.++|+|||++.....
T Consensus 85 ~~~~L~~~i~~~--------~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 85 GGGSALDLLRAG--------PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 999999998643 4788889999999999999999 78999999999999999999999999999987643
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
..... ....++..|+|||+..+..++.++|||||||++|||+||+.||....... ... ....+..
T Consensus 154 ~~~~~----~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~-~~~~~~~-- 218 (277)
T cd06640 154 TQIKR----NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------VLF-LIPKNNP-- 218 (277)
T ss_pred Ccccc----ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------Hhh-hhhcCCC--
Confidence 22111 12247888999999988889999999999999999999999996432211 111 1111111
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
+ .........+.+++.+||+.+|++||++.|+++.
T Consensus 219 ---~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 ---P----TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ---C----CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1 1122334456667779999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=299.95 Aligned_cols=256 Identities=21% Similarity=0.345 Sum_probs=198.6
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCC----CCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPD----ASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~----~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
++|...+.||+|+||.||+|...+ ...||||...... ...+.+.+|+.++++++||||+++++++.. +..+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 346778999999999999998533 3478999886532 234578999999999999999999998875 457899
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++|+|.+++.... ..+++..+..++.+++.||.||| +.+++||||||+||+++.++.+||+|||+++
T Consensus 85 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~ 155 (270)
T cd05056 85 MELAPLGELRSYLQVNK------YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155 (270)
T ss_pred EEcCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceee
Confidence 99999999999997542 24899999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
.......... ....++..|+|||......++.++||||||+++|||++ |+.||......+ ...+ ...
T Consensus 156 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-----~~~~----~~~ 223 (270)
T cd05056 156 YLEDESYYKA---SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-----VIGR----IEN 223 (270)
T ss_pred ecccccceec---CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHH----HHc
Confidence 7643321111 11224568999999888889999999999999999986 999996532211 1111 112
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
+..... ....+. .+.+++.+|+..+|++|||+.|+++.|+++..+
T Consensus 224 ~~~~~~------~~~~~~---~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 224 GERLPM------PPNCPP---TLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred CCcCCC------CCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 211111 111223 444555599999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=314.24 Aligned_cols=200 Identities=19% Similarity=0.232 Sum_probs=164.0
Q ss_pred CcEEEec--CCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 300 ENIIIST--RTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 300 ~~~ig~G--~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
.++||+| +|++||++. ..+|+.||||+++... ...+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4689999 678999998 5679999999997542 223457789999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+|+|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.++++||+........
T Consensus 83 ~~~l~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 83 YGSAKDLICTHFM-----DGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred CCcHHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence 9999999965421 24889999999999999999999 789999999999999999999999999865543211
Q ss_pred CCCC---CccccCCCCcccccCccccCC--CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 454 DPND---SSFVHGDLGEFGYVAPEYSST--MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 454 ~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
.... ........++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 1100 001111246778999999875 45889999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=309.28 Aligned_cols=254 Identities=18% Similarity=0.183 Sum_probs=192.9
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||+++ ..+++.||||.+.... ...+.+.+|+.++..++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 367888999999999999999 4568999999986422 12345889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++.... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 81 e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 151 (331)
T cd05597 81 DYYVGGDLLTLLSKFE------DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLR 151 (331)
T ss_pred ecCCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceee
Confidence 9999999999997532 34888899999999999999999 88999999999999999999999999999876
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCC-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSST-----MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
......... ....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .+.....
T Consensus 152 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~--------~~~~~~i 220 (331)
T cd05597 152 LLADGTVQS---NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKI 220 (331)
T ss_pred cCCCCCccc---cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH--------HHHHHHH
Confidence 543222111 11248999999998763 4578899999999999999999999964321 1222222
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhcc--CCCCCCCCCHHHHHHH
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCV--VSRPKDRPSMYQVYES 574 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl--~~dP~~RPs~~ev~~~ 574 (604)
.......... +. ....++++..+++ +|+ ..++..||++.++++.
T Consensus 221 ~~~~~~~~~~-~~--~~~~~~~~~~li~---~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 221 MNHKEHFQFP-PD--VTDVSEEAKDLIR---RLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HcCCCcccCC-Cc--cCCCCHHHHHHHH---HHccCcccccCCCCHHHHhcC
Confidence 1111111111 10 0123445566655 544 4455558899988776
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=313.89 Aligned_cols=192 Identities=22% Similarity=0.275 Sum_probs=163.9
Q ss_pred hhcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 293 ATNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
...+|...+.||+|+||.||+|.. ..+..||+|..... ....|+.++++++||||+++++++...+..++|+||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 445799999999999999999995 45788999975432 245699999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+. ++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 139 ~~-~~l~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 139 YS-SDLYTYLTKRS------RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred cC-CcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 95 58998886542 35899999999999999999999 7899999999999999999999999999997542
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPL 504 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~ 504 (604)
.... ..+..||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 209 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VAPA-----FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCcc-----cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 2111 12234899999999999989999999999999999999865554
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=298.76 Aligned_cols=253 Identities=19% Similarity=0.273 Sum_probs=185.9
Q ss_pred EEEecCCeEEEEEEeCCC---CEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCc
Q 007423 302 IIISTRTGVSYKAVLPDA---SALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGT 376 (604)
Q Consensus 302 ~ig~G~~g~vy~~~~~~~---~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gs 376 (604)
.||+|+||.||+|...++ ..+++|.++... ...+.+.+|+.+++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975433 346677765432 234679999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCC
Q 007423 377 LYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPN 456 (604)
Q Consensus 377 L~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 456 (604)
|.++++..... ....++.....++.|+++||+||| +.+++||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~- 154 (268)
T cd05086 82 LKSYLSQEQWH---RRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY- 154 (268)
T ss_pred HHHHHHhhhcc---cccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchh-
Confidence 99999764321 124667778899999999999999 78999999999999999999999999999864322110
Q ss_pred CCccccCCCCcccccCccccCC-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 457 DSSFVHGDLGEFGYVAPEYSST-------MVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 457 ~~~~~~~~~gt~~y~aPE~~~~-------~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
........++..|+|||+... ..++.++|||||||++|||++ |+.||..... .+....... +
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~-~ 224 (268)
T cd05086 155 -IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--------REVLNHVIK-D 224 (268)
T ss_pred -hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHh-h
Confidence 001112347889999998743 245789999999999999997 5678754221 122222222 2
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
......++.+... .++...+ ++..|| .+|++||+++||++.|.
T Consensus 225 ~~~~~~~~~~~~~-~~~~~~~---l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 225 QQVKLFKPQLELP-YSERWYE---VLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cccccCCCccCCC-CcHHHHH---HHHHHh-hCcccCCCHHHHHHHhc
Confidence 2233344433322 2333444 444899 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.85 Aligned_cols=249 Identities=18% Similarity=0.310 Sum_probs=197.8
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
.+|...+.||.|++|.||+|. ..+++.||+|.+.... ...+.+.+|+++++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 357788999999999999998 5679999999986533 23467889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++++|.+++... .+++..+..++.+++.|++||| +.+++||||||+||++++++.+||+|||++.....
T Consensus 99 ~~~~L~~~~~~~--------~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 99 AGGSLTDVVTET--------CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred CCCcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 999999988643 4789999999999999999999 88999999999999999999999999999886643
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
..... ....++..|+|||...+..++.++|||||||++|||+||+.||...... ....... ......
T Consensus 168 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~--------~~~~~~~-~~~~~~ 234 (296)
T cd06655 168 EQSKR----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIA-TNGTPE 234 (296)
T ss_pred ccccC----CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHH-hcCCcc
Confidence 32211 1224788999999998888999999999999999999999999753221 1111111 111111
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
...+ ...+.. +.+++.+||..||++||++.+|++.
T Consensus 235 ~~~~----~~~~~~---~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 235 LQNP----EKLSPI---FRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cCCc----ccCCHH---HHHHHHHHhhcChhhCCCHHHHhhC
Confidence 1111 112233 4455559999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=315.37 Aligned_cols=196 Identities=22% Similarity=0.243 Sum_probs=166.6
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeC------C
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE------E 363 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 363 (604)
.++|...+.||+|+||.||++. ...++.||||++.... ...+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 4678889999999999999998 4568899999997532 2335688999999999999999999987643 3
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
..++||||+++ +|.+.+.. .+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~D 169 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM---------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 169 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh---------cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEe
Confidence 57999999975 77777642 3778889999999999999999 78999999999999999999999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
||+++....... .....||..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 170 fG~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 170 FGLARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CCCccccCCCCc-----ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 999986543211 12234889999999999989999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=302.00 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=193.9
Q ss_pred CCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHH---HHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 297 FAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEK---QFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~---~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
|...+.||+|+||+||+++. .+++.||+|.+........ ...+|+.++++++||||+++++++......+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 45568999999999999995 4567899999976543332 3456999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++++|.+++... ..+++..+..++.|+++||.||| +.+|+|+||||+||++++++.++|+|||.+.....
T Consensus 81 ~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~ 150 (260)
T PF00069_consen 81 PGGSLQDYLQKN-------KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE 150 (260)
T ss_dssp TTEBHHHHHHHH-------SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS
T ss_pred cccccccccccc-------ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 999999999832 35889999999999999999999 78999999999999999999999999999986411
Q ss_pred CCCCCCccccCCCCcccccCccccC-CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSS-TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
. ........++..|+|||+.. ....+.++||||+|+++|+|++|+.||......+ .......... .
T Consensus 151 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~-----~~~~~~~~~~-~--- 217 (260)
T PF00069_consen 151 N----NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD-----QLEIIEKILK-R--- 217 (260)
T ss_dssp T----TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH-----HHHHHHHHHH-T---
T ss_pred c----ccccccccccccccccccccccccccccccccccccccccccccccccccccchh-----hhhhhhhccc-c---
Confidence 1 11222345789999999988 7889999999999999999999999997541111 1111111110 0
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
............. ..+.+++.+||+.||++||++.|+++
T Consensus 218 ~~~~~~~~~~~~~---~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 218 PLPSSSQQSREKS---EELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHTTSHTTSH---HHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccccccchhH---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000112 45555666999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=299.83 Aligned_cols=247 Identities=24% Similarity=0.381 Sum_probs=195.0
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
++|...+.||+|+||.||++.. .++.||+|.++... ..+.+.+|+.++++++|||++++++++... ..+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 3577889999999999999975 67789999986532 346789999999999999999999998654 47899999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++..... ..+++..+..++.|++.|+.||| +.+++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 83 GNLVNFLRTRGR-----ALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154 (254)
T ss_pred CCHHHHHHhcCc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence 999999975432 34789999999999999999999 7899999999999999999999999999987643211
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
. ....+..|+|||++.+..++.++|||||||++|||++ |+.||..... .++. .....+...+.
T Consensus 155 ~-------~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~-~~~~~~~~~~~ 218 (254)
T cd05083 155 D-------NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--------KEVK-ECVEKGYRMEP 218 (254)
T ss_pred C-------CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--------HHHH-HHHhCCCCCCC
Confidence 1 1124568999999988889999999999999999998 9999864322 1111 22222211111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
. ...+ ..+.+++.+||+.+|++||+++++++.|++
T Consensus 219 ~------~~~~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 P------EGCP---ADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred C------CcCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0 1122 344556669999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=295.49 Aligned_cols=249 Identities=19% Similarity=0.313 Sum_probs=199.2
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+|+..+.||.|+||.||.++ ..+++.+++|.+.... ...+++.+|++++++++|+||+++++++...+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 46778999999999999988 5678999999986432 2345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++|+|.+++..... ..+++..+..++.|++.|+.||| +.+++|+||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 81 ANGGTLYDKIVRQKG-----QLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG 152 (256)
T ss_pred cCCCcHHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence 999999999975421 35889999999999999999999 7889999999999999999999999999998764
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
..... .....++..|+|||+..+..++.++||||||+++|||++|+.||.... ..+.+... ..+...
T Consensus 153 ~~~~~----~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~-~~~~~~ 219 (256)
T cd08221 153 SEYSM----AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN--------PLNLVVKI-VQGNYT 219 (256)
T ss_pred ccccc----ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHH-HcCCCC
Confidence 43321 122347899999999988888999999999999999999999996432 12222222 122222
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
... ...+. .+.+++.+||..+|++||++.|+++.
T Consensus 220 ~~~------~~~~~---~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 PVV------SVYSS---ELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCc------cccCH---HHHHHHHHHcccCcccCCCHHHHhhC
Confidence 111 11223 34455559999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=299.29 Aligned_cols=263 Identities=18% Similarity=0.163 Sum_probs=195.2
Q ss_pred CCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCC-ccceeeEEEeCC------ee
Q 007423 297 FAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPN-LVPLLGFCVVEE------ER 365 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~------~~ 365 (604)
|...++||+|.||+||+|+ ..+|+.||+|+++.... ......+|+.++++++|+| ||.+.+++.+.. ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 4445679999999999999 67899999999976543 2345789999999999999 999999999877 78
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
++|+||+.. +|.+++....... ..++-..+..++.|+++||+||| +++|+||||||.|||+++++.+||+|||
T Consensus 93 ~lvfe~~d~-DL~~ymd~~~~~~---~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 93 YLVFEFLDR-DLKKYMDSLPKKP---QGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred EEEEEeecc-cHHHHHHhccccc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence 899999977 9999997654211 23666789999999999999999 8999999999999999999999999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
+|+...-.... ....++|.-|.|||++.+. .|++..||||+||++.||+++++-|......+. +..-.+.+
T Consensus 166 lAra~~ip~~~----yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q----l~~If~~l 237 (323)
T KOG0594|consen 166 LARAFSIPMRT----YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ----LFRIFRLL 237 (323)
T ss_pred hHHHhcCCccc----ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH----HHHHHHHc
Confidence 99976533221 2233578899999987765 699999999999999999999999976443111 00000000
Q ss_pred HHc---CCc--cccccc--cc---c-CCCC----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 525 VIA---GRS--RDVVDK--SL---Y-GRGN----DDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 525 ~~~---~~~--~~~~d~--~l---~-~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
-.. .+. ....+- .. . .... +.......+++.+|++.+|++|.|++.++.+
T Consensus 238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000 000 000000 00 0 0000 0111355667779999999999999998875
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=300.66 Aligned_cols=250 Identities=19% Similarity=0.244 Sum_probs=194.0
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
+.|.+.+.||+|+||.||+|.. .++..||+|.+.... ...+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 4577788999999999999995 558999999986543 23467889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++++|..++.... ..+++..+..++.|++.|+.||| +.+++|||+||+||+++.++.+||+|||++.....
T Consensus 92 ~~~~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 92 PGGAVDAIMLELD------RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred CCCcHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 9999988876542 34889999999999999999999 78999999999999999999999999999875432
Q ss_pred CCCCCCccccCCCCcccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSS-----TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
..... ....++..|+|||++. ...++.++|||||||++|||+||+.||..... ....... ..
T Consensus 163 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~-~~ 229 (292)
T cd06644 163 TLQRR----DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKI-AK 229 (292)
T ss_pred ccccc----ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHHHH-hc
Confidence 21111 1223788999999874 34568899999999999999999999864321 1111111 11
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
........ ......++.+++.+||+.+|++||++.|+++
T Consensus 230 ~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 230 SEPPTLSQ-------PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCCccCCC-------CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11111111 1111234555666999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=301.45 Aligned_cols=246 Identities=23% Similarity=0.310 Sum_probs=196.5
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
+|...+.||.|++|.||+|.. .+++.||+|.+.... .....+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 567778899999999999994 568999999986532 22356889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++++|.+++... .+++.....++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||+++....
T Consensus 82 ~~~~L~~~~~~~--------~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 82 GGGSCLDLLKPG--------KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred CCCcHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 999999998743 4889999999999999999999 78999999999999999999999999999987754
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
...... ...++..|+|||+..+..++.++|||||||++|||+||+.||...... ... .....+....
T Consensus 151 ~~~~~~----~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------~~~-~~~~~~~~~~ 217 (274)
T cd06609 151 TMSKRN----TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--------RVL-FLIPKNNPPS 217 (274)
T ss_pred cccccc----cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--------HHH-HHhhhcCCCC
Confidence 322111 224788899999998888999999999999999999999999643211 111 1111111111
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.. ....++ .+.+++.+||..+|++|||++++++
T Consensus 218 ~~-----~~~~~~---~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 218 LE-----GNKFSK---PFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred Cc-----ccccCH---HHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11 111223 3445555999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=299.33 Aligned_cols=250 Identities=19% Similarity=0.263 Sum_probs=191.1
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc------ccHHHHHHHHHHHhccCCCCccceeeEEEe--CCee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK------LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV--EEER 365 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~ 365 (604)
.+|...+.||+|+||.||++.. .++..||+|++.... ...+.+.+|++++++++||||+++++++.. +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688889999999999999984 568999999986432 112458899999999999999999998875 3567
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
++++||+++++|.+++... ..+++.....++.|++.||.||| +.+|+||||||+||++++++.+||+|||
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg 151 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-------GALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFG 151 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCC
Confidence 8999999999999999754 34788999999999999999999 7899999999999999999999999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHH
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
+++......... .......++..|+|||++.+..++.++|||||||++|||+||+.||..... ...+....
T Consensus 152 ~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~--------~~~~~~~~ 222 (266)
T cd06651 152 ASKRLQTICMSG-TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA--------MAAIFKIA 222 (266)
T ss_pred CccccccccccC-CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch--------HHHHHHHh
Confidence 998653221111 111223478899999999888899999999999999999999999964211 11111111
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.... .+.+. ...++.+..+ .+||..+|++||+|+||++
T Consensus 223 ~~~~-----~~~~~-~~~~~~~~~l----i~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 223 TQPT-----NPQLP-SHISEHARDF----LGCIFVEARHRPSAEELLR 260 (266)
T ss_pred cCCC-----CCCCc-hhcCHHHHHH----HHHhcCChhhCcCHHHHhc
Confidence 1111 11111 1112223333 3688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=300.19 Aligned_cols=247 Identities=19% Similarity=0.296 Sum_probs=200.8
Q ss_pred CCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCC
Q 007423 297 FAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNG 375 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g 375 (604)
|.+..++|+|+||.||++. ...|+.||||.+.... +-+++.+|+.+|++++.|++|+++|.|......++|||||..|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 5556789999999999998 5679999999986543 4567899999999999999999999999989999999999999
Q ss_pred chhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCC
Q 007423 376 TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDP 455 (604)
Q Consensus 376 sL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 455 (604)
++.+.++-++ .+++..++..+....+.||+||| ...-||||||+.|||++-++.+||+|||.|..+.....
T Consensus 114 SiSDI~R~R~------K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 114 SISDIMRARR------KPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred cHHHHHHHhc------CCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 9999998654 46999999999999999999999 77889999999999999999999999999987743222
Q ss_pred CCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccccc
Q 007423 456 NDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVD 535 (604)
Q Consensus 456 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 535 (604)
.. ....||+.|||||++..-.|..++||||+|++..||..|++||.+..+-.... -++.-..
T Consensus 185 KR----NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF--------------MIPT~PP 246 (502)
T KOG0574|consen 185 KR----NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF--------------MIPTKPP 246 (502)
T ss_pred hh----CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE--------------eccCCCC
Confidence 22 23359999999999999999999999999999999999999997644322111 0111111
Q ss_pred cccc-CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 536 KSLY-GRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 536 ~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
|.+. ++.++.+..++++ +|+..+|++|-|+.++++.
T Consensus 247 PTF~KPE~WS~~F~DFi~---~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 247 PTFKKPEEWSSEFNDFIR---SCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCChHhhhhHHHHHHH---HHhcCCHHHHHHHHHHhhh
Confidence 2221 1234445555555 9999999999999887653
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=297.99 Aligned_cols=249 Identities=19% Similarity=0.276 Sum_probs=195.9
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEe-CCeeeEEee
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV-EEERLLVYK 370 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lv~e 370 (604)
+|+..+.||+|++|.||++. ..+++.||+|++.... ...+.+.+|++++++++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47778999999999999998 4567899999986432 233568899999999999999999998764 446789999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++++|.+++..... ..+++.++..++.+++.|++||| +.+++|+||||+||++++++.++|+|||+++..
T Consensus 81 ~~~~~~l~~~l~~~~~-----~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 81 FCEGGDLYHKLKEQKG-----KLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152 (257)
T ss_pred ccCCCcHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEe
Confidence 9999999999975321 35889999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
....... ....++..|+|||+..+..++.++||||||++++||++|+.||+... ...+... ...+..
T Consensus 153 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--------~~~~~~~-~~~~~~ 219 (257)
T cd08223 153 ENQCDMA----STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYR-IIEGKL 219 (257)
T ss_pred cccCCcc----ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHH-HHhcCC
Confidence 4322211 12247889999999998889999999999999999999999996422 1222222 122222
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
... .......+.+++.+||+.+|++||++.|+++.
T Consensus 220 ~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPM---------PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCC---------ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111 11122345556669999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=300.69 Aligned_cols=199 Identities=23% Similarity=0.271 Sum_probs=169.5
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
++|+..+.||+|++|.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 35777889999999999999954 68999999986432 223568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++++|..++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 81 ~~~~~~l~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07847 81 YCDHTVLNELEKNP-------RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARIL 150 (286)
T ss_pred ccCccHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceec
Confidence 99998888876543 34889999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
....... ....++..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 151 ~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 151 TGPGDDY----TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred CCCcccc----cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 4432111 12236788999998765 55789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=300.69 Aligned_cols=239 Identities=21% Similarity=0.324 Sum_probs=183.6
Q ss_pred cEEEecCCeEEEEEEeCC--------CCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 301 NIIISTRTGVSYKAVLPD--------ASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~--------~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+.||+|+||.||+|.... ...||+|.+.... ...+++.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 358999999999998432 2348888875433 2346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC--------eEEcc
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD--------ARITD 443 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~--------~kl~D 443 (604)
+++|+|.++++... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++. +|++|
T Consensus 81 ~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 81 VKFGSLDTYLKKNK------NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred CCCCcHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecc
Confidence 99999999997653 24889999999999999999999 889999999999999987765 59999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCC-CCCCCCCccccccCcHHHHH
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQ-KPLDVAGAEEGFKGNLVDWV 521 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~ 521 (604)
||++....... ...++..|+|||++.+ ..++.++|||||||++|||++|. .|+..... ....
T Consensus 152 ~g~~~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--------~~~~ 215 (258)
T cd05078 152 PGISITVLPKE--------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--------QKKL 215 (258)
T ss_pred cccccccCCch--------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--------HHHH
Confidence 99887543211 1136788999999876 45789999999999999999985 55543211 1111
Q ss_pred HHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 522 NHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 522 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
. .. .. ...+. .... .++.+++.+||+.||++|||++||++.|+
T Consensus 216 ~-~~-~~-~~~~~------~~~~---~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 216 Q-FY-ED-RHQLP------APKW---TELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred H-HH-Hc-cccCC------CCCc---HHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1 11 11 11111 1111 34556666999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=290.99 Aligned_cols=249 Identities=21% Similarity=0.269 Sum_probs=198.3
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccc---cccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSAC---KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
+.|+..+.||+|.|++||++. .+.|+.+|+|.+... ..+-+++.+|+.|-+.++|||||++...+.+....|+|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 456666889999999999998 678999999988542 2345788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC---CCeEEcccCCc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD---FDARITDFGLA 447 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~---~~~kl~DFGla 447 (604)
+|.+|+|..-|-.. ..++....-.+..||+++|.|+| ..+|||||+||.|+|+-.. --+||+|||+|
T Consensus 91 ~m~G~dl~~eIV~R-------~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR-------EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred cccchHHHHHHHHH-------HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceE
Confidence 99999987655333 34677888889999999999999 8999999999999999633 34899999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
..+. ......|.+||++|||||+....+|+..+|||+-||+||-|+.|.+||.+..... +...+..
T Consensus 161 i~l~-----~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---------lye~I~~ 226 (355)
T KOG0033|consen 161 IEVN-----DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---------LYEQIKA 226 (355)
T ss_pred EEeC-----CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---------HHHHHhc
Confidence 9885 2233457789999999999999999999999999999999999999997632211 1122222
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
+.. ++..+.+ +...++.+.+++ +|+..||++|.|+.|.++
T Consensus 227 g~y-d~~~~~w--~~is~~Ak~Lvr---rML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 227 GAY-DYPSPEW--DTVTPEAKSLIR---RMLTVNPKKRITADEALK 266 (355)
T ss_pred ccc-CCCCccc--CcCCHHHHHHHH---HHhccChhhhccHHHHhC
Confidence 221 1111111 223467777777 999999999999988754
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=304.61 Aligned_cols=202 Identities=20% Similarity=0.254 Sum_probs=161.3
Q ss_pred CcEEEecCCeEEEEEEeC---CCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEe--CCeeeEEeeecCC
Q 007423 300 ENIIISTRTGVSYKAVLP---DASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVV--EEERLLVYKHMPN 374 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~~~---~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lv~ey~~~ 374 (604)
.+.||+|+||+||+|... +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...+++|||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 468999999999999853 46789999987543 23457889999999999999999999864 4567899999965
Q ss_pred CchhhhhccCCCC--CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe----CCCCCeEEcccCCcc
Q 007423 375 GTLYSLLHGNGVD--NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI----DDDFDARITDFGLAR 448 (604)
Q Consensus 375 gsL~~~l~~~~~~--~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl----~~~~~~kl~DFGla~ 448 (604)
+|.+++...... ......+++.....++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 888877533211 011135889999999999999999999 7899999999999999 456789999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
........ ........||+.|+|||++.+ ..++.++||||+||++|||+||++||...
T Consensus 161 ~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 161 LFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCCcc-ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 76432211 111223458999999998876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=303.54 Aligned_cols=252 Identities=19% Similarity=0.306 Sum_probs=193.8
Q ss_pred CCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 296 SFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
+|+..+.||+|+||.||++... ++..||+|.++... ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5677789999999999999954 78999999986432 22357889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++++|.+++..... ...+++.....++.+++.||.|||+ +.+|+|+||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~l~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 82 DAGSLDKLYAGGVA----TEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred CCCCHHHHHHhccc----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 99999998875321 1358999999999999999999994 36899999999999999999999999999976532
Q ss_pred CCCCCCccccCCCCcccccCccccCCCC------CCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMV------ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
... ....++..|+|||++.+.. ++.++|||||||++|||+||+.||...... ....-.. ...
T Consensus 156 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~-~~~ 223 (286)
T cd06622 156 SLA------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFAQLS-AIV 223 (286)
T ss_pred Ccc------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----hHHHHHH-HHh
Confidence 211 1123778999999875443 488999999999999999999999643211 0111011 111
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.+.... + +......+.+++.+||+.+|++||++.+++..
T Consensus 224 ~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 224 DGDPPT-----L----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hcCCCC-----C----CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111111 1 11122344455569999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=295.27 Aligned_cols=252 Identities=22% Similarity=0.287 Sum_probs=197.8
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
++|...+.||+|++|.||++.. .+++.+|+|.+.... ...+.+.+|++++++++||||+++++++...+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5688889999999999999985 567899999987543 23467899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++++|.+++.... ..++......++.|++.||.||| +.+++|+||||+||++++++.+||+|||++.....
T Consensus 83 ~~~~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 83 GGGSLQDIYQVTR------GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred CCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 9999999987542 35889999999999999999999 78999999999999999999999999999986643
Q ss_pred CCCCCCccccCCCCcccccCccccCCC---CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTM---VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
..... ....++..|+|||..... .++.++||||||+++|||+||+.||....... -... .....
T Consensus 154 ~~~~~----~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--------~~~~-~~~~~ 220 (262)
T cd06613 154 TIAKR----KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--------ALFL-ISKSN 220 (262)
T ss_pred hhhcc----ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHHH-HHhcc
Confidence 22111 122478889999998776 78999999999999999999999997532211 0111 11110
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.. .+.. .........+.+++.+||..+|.+|||+.||+.
T Consensus 221 ~~---~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 221 FP---PPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CC---Cccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0011 011122234556666999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.79 Aligned_cols=254 Identities=20% Similarity=0.343 Sum_probs=196.9
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc-------cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL-------SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
+|...+.||+|++|.||++. ..+++.||+|.++.... ..+.+.+|++++++++|+||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 46778999999999999998 57789999999864321 23568899999999999999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC-CeEEcccCC
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF-DARITDFGL 446 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~-~~kl~DFGl 446 (604)
|+||+++++|.+++... ..+++.....++.|++.||.||| +.+++|+||||+||+++.++ .+||+|||.
T Consensus 81 v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~ 150 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-------GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGA 150 (268)
T ss_pred EEeccCCCcHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence 99999999999999754 35889999999999999999999 78999999999999998765 599999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
+..................++..|+|||+..+..++.++||||+|++++||++|+.||...... ...........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~ 225 (268)
T cd06630 151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-----NHLALIFKIAS 225 (268)
T ss_pred ccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-----chHHHHHHHhc
Confidence 9876543211111111234788999999998888999999999999999999999999643211 11111111111
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
..... ..+.....++.+++.+|++.+|++||++.|+++
T Consensus 226 ~~~~~---------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 ATTAP---------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred cCCCC---------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11110 111222345556666999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=287.48 Aligned_cols=250 Identities=20% Similarity=0.312 Sum_probs=198.3
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-----cc----HHHHHHHHHHHhcc-CCCCccceeeEEEeCC
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-----LS----EKQFRSEMNRLGQL-RHPNLVPLLGFCVVEE 363 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-----~~----~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 363 (604)
+.|...+++|.|..++|.++. ...|.+.|+|++.... .. .++-.+|+.||+++ .||+|+++.++|+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 456777899999999999887 5678999999985321 11 13456899999999 6999999999999999
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
..++|+|.|+.|.|.|+|... -.++.....+|+.|+.+|++||| ...|||||+||+|||+|+++++||+|
T Consensus 97 F~FlVFdl~prGELFDyLts~-------VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK-------VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh-------eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEec
Confidence 999999999999999999765 35889999999999999999999 89999999999999999999999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCC------CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcH
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST------MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNL 517 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~ 517 (604)
||++..+.... ..+..+||++|+|||.+.. ..|+...|+|+.||++|.|+.|-+||.....
T Consensus 167 FGFa~~l~~Ge-----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------- 233 (411)
T KOG0599|consen 167 FGFACQLEPGE-----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------- 233 (411)
T ss_pred cceeeccCCch-----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--------
Confidence 99999885543 2344579999999997653 3478889999999999999999999964210
Q ss_pred HHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 518 VDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 518 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
-.+...+..|+.. ...+.+.+.....-+++.+|++.||.+|.|++|+++.
T Consensus 234 -mlMLR~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 234 -MLMLRMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred -HHHHHHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 0122233344321 1112222223334445559999999999999999764
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=307.99 Aligned_cols=254 Identities=18% Similarity=0.183 Sum_probs=191.7
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||+++. ..++.+|+|.+.... ...+.+.+|+.++..++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 3678889999999999999995 457889999986422 12245788999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++.... ..+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ey~~~g~L~~~l~~~~------~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~ 151 (332)
T cd05623 81 DYYVGGDLLTLLSKFE------DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 151 (332)
T ss_pred eccCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchhee
Confidence 9999999999997542 34888999999999999999999 88999999999999999999999999999976
Q ss_pred cCCCCCCCCccccCCCCcccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSS-----TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
........ .....||+.|+|||++. ...++.++|||||||++|||++|+.||..... .+.....
T Consensus 152 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i 220 (332)
T cd05623 152 LMEDGTVQ---SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKI 220 (332)
T ss_pred cccCCcce---ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--------HHHHHHH
Confidence 53322111 11235899999999875 34578999999999999999999999974321 2222222
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhccCC--CCCCCCCHHHHHHH
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVS--RPKDRPSMYQVYES 574 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPs~~ev~~~ 574 (604)
........ +... ....++++.++++ +|+.. ++..|+++.|+++.
T Consensus 221 ~~~~~~~~-~p~~--~~~~s~~~~~li~---~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 221 MNHKERFQ-FPAQ--VTDVSEDAKDLIR---RLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred hCCCcccc-CCCc--cccCCHHHHHHHH---HHccChhhhcCCCCHHHHhCC
Confidence 21111111 1100 0122345555555 65544 44447899999766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.01 Aligned_cols=252 Identities=20% Similarity=0.263 Sum_probs=196.1
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
.++|.+.+.||+|++|.||++.. .++..||+|.++... ...+.+.+|++++++++||||+++++++..++..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 34577788999999999999995 568999999986543 2335788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++++|.+++.... ..+++.....++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~~L~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 84 CDGGALDSIMLELE------RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred cCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 99999999987542 35889999999999999999999 7899999999999999999999999999987653
Q ss_pred CCCCCCCccccCCCCcccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSS-----TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
...... ....++..|+|||++. ...++.++||||||+++|||++|+.||..... .+.... ..
T Consensus 155 ~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~--------~~~~~~-~~ 221 (280)
T cd06611 155 STLQKR----DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP--------MRVLLK-IL 221 (280)
T ss_pred cccccc----ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH--------HHHHHH-Hh
Confidence 322111 1224788999999864 34578899999999999999999999964321 111111 11
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.+....... ....+.+ +.+++.+||+.+|++||++.+|++.
T Consensus 222 ~~~~~~~~~----~~~~~~~---~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 222 KSEPPTLDQ----PSKWSSS---FNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred cCCCCCcCC----cccCCHH---HHHHHHHHhccChhhCcCHHHHhcC
Confidence 111111111 1112233 4455559999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=305.71 Aligned_cols=199 Identities=19% Similarity=0.269 Sum_probs=168.0
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
++|...+.||+|+||.||+|.. .+++.||+|.++... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 4577889999999999999984 468899999986432 2335678899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
++ ++|.+++.... ..+++.....++.|+++||+||| +.+|+|+||||+||++++++.+||+|||+++...
T Consensus 86 ~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDDCG------NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 97 58998886542 34788999999999999999999 8899999999999999999999999999997653
Q ss_pred CCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
..... .....++..|+|||+..+ ..++.++|||||||++|||+||+.||...
T Consensus 156 ~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 156 IPTKT----YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred CCCCc----ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 32211 112246889999998765 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=295.08 Aligned_cols=249 Identities=19% Similarity=0.303 Sum_probs=193.6
Q ss_pred CCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccccc----------HHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 007423 297 FAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLS----------EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER 365 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~----------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 365 (604)
|.....||+|++|.||+|.. .+++.||+|.+...... .+.+.+|++++++++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 56678999999999999984 56889999988643211 14578999999999999999999999999999
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
++++||+++++|.+++... ..+++.....++.|++.||+||| +.+++||||+|+||++++++.+||+|||
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg 151 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY-------GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFG 151 (267)
T ss_pred EEEEEecCCCCHHHHHHhc-------cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccC
Confidence 9999999999999999754 35788899999999999999999 7899999999999999999999999999
Q ss_pred CccccCCCCCCC--CccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHH
Q 007423 446 LARLVGSRDPND--SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNH 523 (604)
Q Consensus 446 la~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 523 (604)
.++......... ........|+..|+|||...+..++.++|||||||++|||+||+.||...... .-+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~ 223 (267)
T cd06628 152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--------QAIFK 223 (267)
T ss_pred CCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--------HHHHH
Confidence 998775321111 00111224788999999998888999999999999999999999999743211 00111
Q ss_pred HHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 524 LVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 524 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
..... .+... ...++.+. +++.+||+.||++||++.||++
T Consensus 224 -~~~~~-----~~~~~-~~~~~~~~---~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 -IGENA-----SPEIP-SNISSEAI---DFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -HhccC-----CCcCC-cccCHHHH---HHHHHHccCCchhCcCHHHHhh
Confidence 11111 11111 11233444 4455999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=293.72 Aligned_cols=248 Identities=20% Similarity=0.293 Sum_probs=197.7
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+|+..+.||+|+||.+|++. ..+++.||+|++.... ...+++.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 36778999999999999998 5678999999986432 2345789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++++|.+++..... ..+++...+.++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 81 CEGGDLYKKINAQRG-----VLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN 152 (256)
T ss_pred CCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence 999999999875421 24789999999999999999999 7899999999999999999999999999998664
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
...... ....|+..|+|||+..+..++.++|||||||+++||+||+.||.... ..+.+.... .+...
T Consensus 153 ~~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~-~~~~~ 219 (256)
T cd08218 153 STVELA----RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN--------MKNLVLKII-RGSYP 219 (256)
T ss_pred cchhhh----hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC--------HHHHHHHHh-cCCCC
Confidence 322111 11247888999999988889999999999999999999999996422 222222222 22221
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.. ....+ .++.+++.+||+.+|++||+|.||++
T Consensus 220 ~~------~~~~~---~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 PV------SSHYS---YDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CC------cccCC---HHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11 01122 34555566999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=294.43 Aligned_cols=259 Identities=24% Similarity=0.383 Sum_probs=199.7
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
++|+..+.||.|++|.||+|. ..++..+|+|++.... ...+.+.+|+++++.++|+||+++++.+..++..++++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 368888999999999999999 4578899999986533 2346789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++++|.+++...... ..+++.....++.|++.|++||| +.+++|+||||+||++++++.+||+|||++..+.
T Consensus 81 ~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 81 LSGGSLLDIMKSSYPR----GGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA 153 (267)
T ss_pred cCCCcHHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence 9999999999754221 35889999999999999999999 7899999999999999999999999999998775
Q ss_pred CCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
..............|+..|+|||++... .++.++|||||||++|||++|+.||....... ... ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~~~----~~~~~~-- 223 (267)
T cd06610 154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK----VLM----LTLQND-- 223 (267)
T ss_pred cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh----hHH----HHhcCC--
Confidence 4332211111223478899999988766 78999999999999999999999997532211 111 111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
........ ........+.+++.+||+.||++||++.|+++
T Consensus 224 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 PPSLETGA---DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCcCCcc---ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00011000 00112234556666999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=296.80 Aligned_cols=258 Identities=21% Similarity=0.371 Sum_probs=195.0
Q ss_pred CCcCcEEEecCCeEEEEEEeC----CCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCC------
Q 007423 297 FAVENIIISTRTGVSYKAVLP----DASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE------ 363 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~~----~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 363 (604)
|...+.||+|+||.||+|... .+..||||.+.... ...+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456688999999999999843 36789999987532 22456889999999999999999999886532
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
..++++||+++|+|.+++....... ....+++.....++.|++.||+||| +.+|+||||||+||++++++.+||+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGE-EPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECc
Confidence 2478999999999998875332111 1134789999999999999999999 78999999999999999999999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHH
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVN 522 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 522 (604)
||+++........... ....++..|++||......++.++|||||||++|||++ |++||...... ....
T Consensus 157 fg~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-----~~~~--- 226 (273)
T cd05074 157 FGLSKKIYSGDYYRQG--CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----EIYN--- 226 (273)
T ss_pred ccccccccCCcceecC--CCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-----HHHH---
Confidence 9999876432211110 11235678999999988889999999999999999999 88988643211 1111
Q ss_pred HHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 523 HLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 523 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
....+..... .......+.+++.+||+.+|++||++.|+++.|+++
T Consensus 227 -~~~~~~~~~~---------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 227 -YLIKGNRLKQ---------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -HHHcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111111110 011224566777799999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.04 Aligned_cols=200 Identities=21% Similarity=0.216 Sum_probs=170.8
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||+++. .+++.||+|.+.... ...+.+.+|+.++..++|+||+++++++..++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688889999999999999994 568899999986422 12345788999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++.... ..+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 Ey~~gg~L~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~ 151 (331)
T cd05624 81 DYYVGGDLLTLLSKFE------DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLK 151 (331)
T ss_pred eCCCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceee
Confidence 9999999999997532 34788899999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCC-----CCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSST-----MVASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
......... ....||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 152 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 152 MNQDGTVQS---SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ccCCCceee---ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 643322111 12358999999998765 4578899999999999999999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=308.75 Aligned_cols=197 Identities=23% Similarity=0.301 Sum_probs=166.4
Q ss_pred HhhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeC-----
Q 007423 292 AATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE----- 362 (604)
Q Consensus 292 ~~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----- 362 (604)
+..++|...+.||+|+||.||+|. ..++..||||++.... ...+.+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 345678889999999999999998 5678899999987532 2235678999999999999999999987543
Q ss_pred -CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEE
Q 007423 363 -EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARI 441 (604)
Q Consensus 363 -~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl 441 (604)
...++++|++ +++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+|||+++++.+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl 159 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ--------KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRI 159 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEE
Confidence 3468999988 67998887532 4889999999999999999999 789999999999999999999999
Q ss_pred cccCCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 442 TDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 442 ~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
+|||+++...... .+..||..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 ~Dfg~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 160 LDFGLARQADDEM-------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred cCCccceecCCCc-------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 9999998653321 12347899999998866 56889999999999999999999999653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=296.97 Aligned_cols=259 Identities=21% Similarity=0.344 Sum_probs=198.8
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEecccccc--HHHHHHHHHHHhccCCCCccceeeEEEeCCeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACKLS--EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 366 (604)
++|.....||+|+||.||+|+.. +...||+|.+...... .+.+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46778899999999999999853 3467999988654332 467999999999999999999999999888999
Q ss_pred EEeeecCCCchhhhhccCCCCC--CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEccc
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDN--TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDF 444 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DF 444 (604)
+||||+++|+|.+++....... .....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997553210 00125899999999999999999999 789999999999999999999999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHH
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNH 523 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 523 (604)
|+++........ ......++..|+|||...+..++.++||||||+++|||++ |..||...... ..+.
T Consensus 162 ~~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--------~~~~- 229 (275)
T cd05046 162 SLSKDVYNSEYY---KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--------EVLN- 229 (275)
T ss_pred ccccccCccccc---ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--------HHHH-
Confidence 998754322111 1122346778999999888888999999999999999999 88888542211 1111
Q ss_pred HHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 524 LVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 524 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
....+...... ....++ .+.+++.+||+.+|++||++.|+++.|.
T Consensus 230 ~~~~~~~~~~~-----~~~~~~---~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 RLQAGKLELPV-----PEGCPS---RLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHcCCcCCCC-----CCCCCH---HHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11222211111 011223 4555666999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=304.51 Aligned_cols=202 Identities=21% Similarity=0.255 Sum_probs=161.0
Q ss_pred CcEEEecCCeEEEEEEeC---CCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEe--CCeeeEEeeecCC
Q 007423 300 ENIIISTRTGVSYKAVLP---DASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVV--EEERLLVYKHMPN 374 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~~~---~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lv~ey~~~ 374 (604)
...||+|+||.||+|... ++..||+|.++... ....+.+|++++++++||||+++++++.. +...++++||+++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 368999999999999854 45789999987543 23467899999999999999999999864 4578999999875
Q ss_pred CchhhhhccCCCC--CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe----CCCCCeEEcccCCcc
Q 007423 375 GTLYSLLHGNGVD--NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI----DDDFDARITDFGLAR 448 (604)
Q Consensus 375 gsL~~~l~~~~~~--~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl----~~~~~~kl~DFGla~ 448 (604)
+|.+++...... ......+++..+..++.|++.||.||| +.+|+||||||+|||+ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 788777532111 111235889999999999999999999 7899999999999999 566789999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
......... .......||..|+|||++.+ ..++.++|||||||++|||+||++||...
T Consensus 161 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPL-ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccc-cccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 764332111 11223357899999998866 45799999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=313.09 Aligned_cols=197 Identities=22% Similarity=0.298 Sum_probs=172.9
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccC-C-----CCccceeeEEEeCCeeeEE
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLR-H-----PNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~-H-----~niv~l~g~~~~~~~~~lv 368 (604)
.|.+.++||+|.||.|.+|. ..+++.||||+++....--.+...|+.+|..++ | -|+|+++++|..+++.|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 68889999999999999999 667999999999987766677888999999997 4 3999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC--CCCeEEcccCC
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD--DFDARITDFGL 446 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~--~~~~kl~DFGl 446 (604)
+|.+.. +|+++|+.+... .++......++.||+.||.+|| +.+|||+||||+||||.+ ...+||+|||.
T Consensus 267 fELL~~-NLYellK~n~f~-----Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKFR-----GLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred ehhhhh-hHHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccc
Confidence 999966 999999987653 5899999999999999999999 899999999999999974 44799999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAG 508 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~ 508 (604)
+......-. +. .=+..|.|||++.+.+|+.+.||||||||+.||.||.+-|...+
T Consensus 338 Sc~~~q~vy---tY----iQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 338 SCFESQRVY---TY----IQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred ccccCCcce---ee----eeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 987643211 22 23678999999999999999999999999999999988887644
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=300.32 Aligned_cols=263 Identities=21% Similarity=0.217 Sum_probs=193.8
Q ss_pred CCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccccc------HHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 297 FAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLS------EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
|...+.||+|++|.||+|.. .+++.||||+++..... ...+..|++++++++|+||+++++++...+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 66778999999999999994 56899999999754322 345778999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+ +|+|.+++.... ..+++..+..++.|+++||.||| ..+|+|+||||+||+++.++.+||+|||+++.
T Consensus 82 e~~-~~~L~~~i~~~~------~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~ 151 (298)
T cd07841 82 EFM-ETDLEKVIKDKS------IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARS 151 (298)
T ss_pred ccc-CCCHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeee
Confidence 999 889999997542 25899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHH-----HH
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWV-----NH 523 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-----~~ 523 (604)
........ ....++..|+|||.+.+ ..++.++|||||||++|||++|.+||......+... ...... ..
T Consensus 152 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 226 (298)
T cd07841 152 FGSPNRKM----THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG-KIFEALGTPTEEN 226 (298)
T ss_pred ccCCCccc----cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHH-HHHHHcCCCchhh
Confidence 65432111 12236788999998754 457899999999999999999988876432211000 000000 00
Q ss_pred HHHcCCccccccccccCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 524 LVIAGRSRDVVDKSLYGRG-----NDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 524 ~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
................... .......+.+++.+||+.||++|||+.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000000000 01122455667779999999999999999883
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=298.22 Aligned_cols=261 Identities=19% Similarity=0.253 Sum_probs=196.7
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeC--CeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE--EERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lv~ 369 (604)
++|...+.||.|++|.||++.. .+++.+|+|.+.... ...+++.+|++++++++||||+++++++... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3577788999999999999995 568899999987532 2346789999999999999999999998653 4689999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++++|.+++...... ...++......++.|++.||.||| ..+++|+||+|+||++++++.++|+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKR---GGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EecCCCCHHHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccc
Confidence 999999999887542211 135788999999999999999999 78999999999999999999999999999876
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
....... ...++..|+|||...+..++.++||||+||++|||+||+.||........ ...+.... .....
T Consensus 155 ~~~~~~~------~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~-~~~~~ 224 (287)
T cd06621 155 LVNSLAG------TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL---GPIELLSY-IVNMP 224 (287)
T ss_pred ccccccc------cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC---ChHHHHHH-HhcCC
Confidence 5322111 12367889999999888899999999999999999999999975432111 11122111 11111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.....+........+ ..+.+++.+||+.+|++|||+.||++.
T Consensus 225 ~~~~~~~~~~~~~~~---~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 225 NPELKDEPGNGIKWS---EEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred chhhccCCCCCCchH---HHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 111111100001122 345566669999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=292.26 Aligned_cols=253 Identities=26% Similarity=0.329 Sum_probs=196.8
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+|...+.||+|+||.||+|.. .++..||+|.++.... ..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 366778999999999999984 5789999999875443 346789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++++|.+++... ..+++..+..++.+++.|+.||| +.+++|+||+|+||++++++.+||+|||++....
T Consensus 81 ~~~~~L~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~ 150 (264)
T cd06626 81 CSGGTLEELLEHG-------RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK 150 (264)
T ss_pred CCCCcHHHHHhhc-------CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccC
Confidence 9999999999754 24788899999999999999999 7899999999999999999999999999998765
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCC---CCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMV---ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
..............++..|+|||++.+.. .+.++||||||+++|||++|+.||...... ..... ....+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-------~~~~~-~~~~~ 222 (264)
T cd06626 151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-------FQIMF-HVGAG 222 (264)
T ss_pred CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-------HHHHH-HHhcC
Confidence 43322221122335788999999987766 889999999999999999999999642110 01111 11111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.... +... ...+.. +.+++.+||+.+|++||++.|++.
T Consensus 223 ~~~~-~~~~---~~~~~~---~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 HKPP-IPDS---LQLSPE---GKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCC-CCcc---cccCHH---HHHHHHHHccCCcccCCCHHHHhc
Confidence 1111 1100 011233 345555999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.17 Aligned_cols=254 Identities=21% Similarity=0.307 Sum_probs=195.1
Q ss_pred CCCcCcEEEecCCeEEEEEEeCC--CCEEEEEEecccc-----------ccHHHHHHHHHHHhc-cCCCCccceeeEEEe
Q 007423 296 SFAVENIIISTRTGVSYKAVLPD--ASALAIKRLSACK-----------LSEKQFRSEMNRLGQ-LRHPNLVPLLGFCVV 361 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~~--~~~vAvK~l~~~~-----------~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~ 361 (604)
+|+..+.||+|+||.||+|.... ++.+|||.+.... ...+++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46777899999999999999654 7889999875321 112457788888865 799999999999999
Q ss_pred CCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEE
Q 007423 362 EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARI 441 (604)
Q Consensus 362 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl 441 (604)
++..+++|||+++++|.+++...... ...+++..++.++.|++.||.|||+ ..+++|+||||+||++++++.+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEK---KQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEE
Confidence 99999999999999999988542111 1358899999999999999999993 367999999999999999999999
Q ss_pred cccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHH
Q 007423 442 TDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWV 521 (604)
Q Consensus 442 ~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 521 (604)
+|||++....... ......|+..|+|||+..+..++.++||||||+++|||++|+.||..... ....
T Consensus 156 ~dfg~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--------~~~~ 222 (269)
T cd08528 156 TDFGLAKQKQPES-----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--------LSLA 222 (269)
T ss_pred ecccceeeccccc-----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH--------HHHH
Confidence 9999998764332 11223478899999999888899999999999999999999999864321 1111
Q ss_pred HHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 522 NHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 522 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
... ..+....... ...+.+ +.+++.+||+.||++||++.||..+++
T Consensus 223 ~~~-~~~~~~~~~~-----~~~~~~---l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 223 TKI-VEAVYEPLPE-----GMYSED---VTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHH-hhccCCcCCc-----ccCCHH---HHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111 1121111111 112233 445555999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=295.85 Aligned_cols=250 Identities=18% Similarity=0.216 Sum_probs=190.2
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc------ccHHHHHHHHHHHhccCCCCccceeeEEEeC--Cee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK------LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE--EER 365 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 365 (604)
.+|...+.||+|+||.||+|.. .++..||||.+.... ...+.+.+|++++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688889999999999999984 568999999885321 1124688899999999999999999988763 467
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
+++|||+++++|.+++... ..+++...+.++.+++.||+||| +.+++|+||||+||+++.++.+||+|||
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg 151 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-------GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFG 151 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCc
Confidence 8999999999999998754 24788889999999999999999 7889999999999999999999999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHH
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
+++......... .......|+..|+|||+..+..++.++|||||||++|||++|+.||...... .. .....
T Consensus 152 ~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~-~~~~~ 222 (265)
T cd06652 152 ASKRLQTICLSG-TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-------AA-IFKIA 222 (265)
T ss_pred cccccccccccc-cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-------HH-HHHHh
Confidence 998653211111 1112234788999999998888999999999999999999999999642111 11 11111
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
. ... .+. .+......+.+++.+|+. +|++||+++||++
T Consensus 223 ~-~~~----~~~----~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 223 T-QPT----NPV----LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred c-CCC----CCC----CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1 111 111 111222334445558884 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=313.61 Aligned_cols=239 Identities=21% Similarity=0.214 Sum_probs=182.3
Q ss_pred EEecCCeEEEEEE-eCCCCEEEEEEeccccc----cHHHHHHHHHHHhcc---CCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 303 IISTRTGVSYKAV-LPDASALAIKRLSACKL----SEKQFRSEMNRLGQL---RHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 303 ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
||+|+||.||+|+ ..+++.||||++..... ....+..|..++.+. +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6899999999998 45689999999864321 123355677777665 699999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++... ..+++.....++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~-------~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 150 (330)
T cd05586 81 GELFWHLQKE-------GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN 150 (330)
T ss_pred ChHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC
Confidence 9999998754 35889999999999999999999 7899999999999999999999999999987543222
Q ss_pred CCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
.. .....||..|+|||++.+. .++.++|||||||++|||+||+.||..... .+.. ..+..+...
T Consensus 151 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--------~~~~-~~i~~~~~~-- 215 (330)
T cd05586 151 KT----TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--------QQMY-RNIAFGKVR-- 215 (330)
T ss_pred CC----ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--------HHHH-HHHHcCCCC--
Confidence 11 1223589999999988654 479999999999999999999999965321 1111 112222111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS----MYQVYE 573 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~ev~~ 573 (604)
+.....+++..++++ +||+.||++||+ +.|+++
T Consensus 216 ----~~~~~~~~~~~~li~---~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 216 ----FPKNVLSDEGRQFVK---GLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ----CCCccCCHHHHHHHH---HHcCCCHHHCCCCCCCHHHHhc
Confidence 111112344455554 999999999984 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.47 Aligned_cols=245 Identities=20% Similarity=0.339 Sum_probs=199.2
Q ss_pred CcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccc-----cccHHHHHHHHHHHhccCCCCccceeeEEEeCCe--eeEEe
Q 007423 298 AVENIIISTRTGVSYKAVL-PDASALAIKRLSAC-----KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEE--RLLVY 369 (604)
Q Consensus 298 ~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~--~~lv~ 369 (604)
....+||+|+|-+||||.. .+|.+||.-.++.. ....++|..|+.+|+.|+|||||+++.++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 3457899999999999994 56888886544322 2233679999999999999999999999987655 67899
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC-CCCCeEEcccCCcc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID-DDFDARITDFGLAR 448 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~-~~~~~kl~DFGla~ 448 (604)
|.|..|+|..|+++.+ .++......+++||++||.|||++ .|+|||||||..||+|+ ..|.+||+|+|+|.
T Consensus 123 EL~TSGtLr~Y~kk~~-------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR-------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT 194 (632)
T ss_pred ecccCCcHHHHHHHhc-------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHH
Confidence 9999999999998873 588889999999999999999976 79999999999999998 56899999999999
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
........ ...||+.|||||+.. ..|.+.+||||||+.++||+|+..||..... ..-+...+..|
T Consensus 195 l~r~s~ak------svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--------~AQIYKKV~SG 259 (632)
T KOG0584|consen 195 LLRKSHAK------SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--------PAQIYKKVTSG 259 (632)
T ss_pred Hhhccccc------eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--------HHHHHHHHHcC
Confidence 87543221 235999999999887 6799999999999999999999999964322 12234445556
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
..+..+.. ..+.+++++++ +|+.. .++|||+.|+++.
T Consensus 260 iKP~sl~k-----V~dPevr~fIe---kCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 260 IKPAALSK-----VKDPEVREFIE---KCLAT-KSERLSAKELLKD 296 (632)
T ss_pred CCHHHhhc-----cCCHHHHHHHH---HHhcC-chhccCHHHHhhC
Confidence 54444332 23567788887 99999 9999999999864
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=291.15 Aligned_cols=245 Identities=24% Similarity=0.328 Sum_probs=194.1
Q ss_pred CCcCcEEEecCCeEEEEEEeC-CCCEEEEEEecccc------ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 297 FAVENIIISTRTGVSYKAVLP-DASALAIKRLSACK------LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
|...+.||+|++|.||+|... +++.|++|.+.... ...+.+.+|++++++++|+||+++++++..++..++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 566789999999999999965 78999999986432 12356889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++++|.+++... ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.+||+|||++..
T Consensus 82 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~ 151 (258)
T cd06632 82 ELVPGGSLAKLLKKY-------GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQ 151 (258)
T ss_pred EecCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCcccee
Confidence 999999999999754 34789999999999999999999 78999999999999999999999999999887
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMV-ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
...... .....|+..|++||...... ++.++|+|||||++|||++|+.||..... .+.........
T Consensus 152 ~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~ 218 (258)
T cd06632 152 VVEFSF-----AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--------VAAVFKIGRSK 218 (258)
T ss_pred cccccc-----ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--------HHHHHHHHhcc
Confidence 643221 12234788999999887666 89999999999999999999999964321 11111111111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.... + ....++.+ .+++.+||+.+|++||++.|+++
T Consensus 219 ~~~~-~-----~~~~~~~~---~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 219 ELPP-I-----PDHLSDEA---KDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCCC-c-----CCCcCHHH---HHHHHHHhhcCcccCcCHHHHhc
Confidence 1111 1 11122334 44555999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=300.37 Aligned_cols=263 Identities=20% Similarity=0.229 Sum_probs=193.9
Q ss_pred CCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 296 SFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+|+..+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+++++.++||||+++++++..++..++|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 5777899999999999999964 589999999864321 245688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++++|.++.... ..+++..++.++.|+++||.||| +.+++|+|++|+||++++++.+||+|||++....
T Consensus 82 ~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 82 VDHTVLDDLEKYP-------NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 151 (286)
T ss_pred CCccHHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence 9999988876543 24889999999999999999999 7899999999999999999999999999998764
Q ss_pred CCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHH-------HHH
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDW-------VNH 523 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~-------~~~ 523 (604)
..... .....++..|+|||+..+ ..++.++|||||||++|||++|++||......+... ....+ ...
T Consensus 152 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 226 (286)
T cd07846 152 APGEV----YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLY-HIIKCLGNLIPRHQE 226 (286)
T ss_pred CCccc----cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHH-HHHHHhCCCchhhHH
Confidence 33211 112347889999998765 447889999999999999999999996432111000 00000 000
Q ss_pred HHHcCCc-cccccccccCC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 524 LVIAGRS-RDVVDKSLYGR-----GNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 524 ~~~~~~~-~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
....... .....+..... ..+.....+.+++.+||+.+|++||++.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000 00000000000 00111244666777999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=301.93 Aligned_cols=243 Identities=19% Similarity=0.277 Sum_probs=191.5
Q ss_pred CcEEEecCCeEEEEEEe-CCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCch
Q 007423 300 ENIIISTRTGVSYKAVL-PDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL 377 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL 377 (604)
...||+|+||.||++.. .++..||||.+.... ...+.+.+|+.++++++|+||+++++.+..++..+++|||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 36799999999999984 578999999986533 3345688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCC
Q 007423 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPND 457 (604)
Q Consensus 378 ~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 457 (604)
.+++... .+++.....++.+++.||.||| +.+|+||||||+||++++++.+||+|||++..........
T Consensus 107 ~~~~~~~--------~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 107 TDIVTHT--------RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred HHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 9988532 4788999999999999999999 7899999999999999999999999999987654322211
Q ss_pred CccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccccccc
Q 007423 458 SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKS 537 (604)
Q Consensus 458 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 537 (604)
....|+..|+|||+..+..++.++|||||||++|||++|+.||...... .-+. ..... . .+.
T Consensus 176 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~-~~~~~-~----~~~ 237 (292)
T cd06658 176 ----KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--------QAMR-RIRDN-L----PPR 237 (292)
T ss_pred ----ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHH-HHHhc-C----CCc
Confidence 1224788999999998888999999999999999999999999643211 1011 11111 1 111
Q ss_pred ccC-CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 538 LYG-RGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 538 l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
... ...++.+.. ++.+||..||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~---li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 238 VKDSHKVSSVLRG---FLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccccccCHHHHH---HHHHHccCChhHCcCHHHHhhC
Confidence 100 112234444 4459999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=331.17 Aligned_cols=254 Identities=21% Similarity=0.264 Sum_probs=192.6
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEe--CCeeeE
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV--EEERLL 367 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~l 367 (604)
.++|.+.+.||+|+||.||++. ...+..||+|.+.... .....|..|+.++++++|||||++++++.. .+..++
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 4578889999999999999999 4567889999986532 234568899999999999999999998865 356899
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcC----CCCceecCCCCCeEEeCC--------
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGC----QPPYMHQYISSNVILIDD-------- 435 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~----~~~iiH~dlk~~NiLl~~-------- 435 (604)
||||+++|+|.++|...... ...+++..++.|+.||+.||.|||... ..+||||||||+|||++.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~---~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKM---FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 99999999999999753211 135899999999999999999999532 146999999999999964
Q ss_pred ---------CCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCC--CCCCcccchhhHHHHHHHHHhCCCCC
Q 007423 436 ---------DFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST--MVASLKGDVYGFGIVLLELLSGQKPL 504 (604)
Q Consensus 436 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~SfGvvl~elltg~~p~ 504 (604)
...+||+|||+++.+..... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM-----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc-----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 34589999999987643221 112358999999998754 45889999999999999999999999
Q ss_pred CCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 505 DVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
..... ....+. .+..+. . +.....+.+ +.+++..||+.+|++||++.|++.
T Consensus 244 ~~~~~-------~~qli~-~lk~~p--~-----lpi~~~S~e---L~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 244 HKANN-------FSQLIS-ELKRGP--D-----LPIKGKSKE---LNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcCCc-------HHHHHH-HHhcCC--C-----CCcCCCCHH---HHHHHHHHhcCChhHCcCHHHHhc
Confidence 64321 122221 111111 1 111112233 445555999999999999999984
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=302.97 Aligned_cols=253 Identities=20% Similarity=0.241 Sum_probs=195.1
Q ss_pred CCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEeccccc----cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 296 SFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACKL----SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
+|...+.||+|++|.||++... +++.||+|.+..... ..+.+.+|+++++.++||||+++++++......+++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5777899999999999999954 589999999975432 23568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++++|.+++..... ..+++.....++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~~~~~L~~~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 82 YCPGGELFRLLQRQPG-----KCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred ecCCCCHHHHHHhCCC-----CccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 9999999999875421 35889999999999999999999 789999999999999999999999999998765
Q ss_pred CCCCCCCC-------------------------ccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007423 451 GSRDPNDS-------------------------SFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLD 505 (604)
Q Consensus 451 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~ 505 (604)
........ .......|+..|+|||+..+..++.++||||||+++|||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 32211000 01112357889999999988889999999999999999999999997
Q ss_pred CCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 007423 506 VAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS----MYQVYE 573 (604)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~ev~~ 573 (604)
...... .+ .... ..... . +. ....++. +.+++.+||+.||++||+ +.|+++
T Consensus 234 ~~~~~~-------~~-~~~~-~~~~~-~--~~--~~~~~~~---~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 234 GSNRDE-------TF-SNIL-KKEVT-F--PG--SPPVSSS---ARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCchHH-------HH-HHHh-cCCcc-C--CC--ccccCHH---HHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 533211 11 1111 11110 0 00 0012334 444555999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=294.95 Aligned_cols=254 Identities=21% Similarity=0.284 Sum_probs=198.4
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEe--CCeeeEEe
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV--EEERLLVY 369 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lv~ 369 (604)
+|...+.||+|+||.||++. ..+++.||+|.+.... ...+++.+|++++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 36677899999999999998 5678999999986432 233568899999999999999999998864 45678999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcC--CCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGC--QPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~--~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||+++++|.+++...... ...+++...+.++.+++.||.|||..+ +.+++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKE---RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999754211 146899999999999999999999544 678999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
......... .....++..|+|||++....++.++||||||+++|+|++|+.||..... .. +......
T Consensus 158 ~~~~~~~~~----~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~-~~~~~~~ 224 (265)
T cd08217 158 KILGHDSSF----AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--------LQ-LASKIKE 224 (265)
T ss_pred ccccCCccc----ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--------HH-HHHHHhc
Confidence 876543221 1223478899999999888899999999999999999999999975321 11 1122222
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
+....+ .......+.+++.+|++.+|++||++.||++.
T Consensus 225 ~~~~~~---------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 GKFRRI---------PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCCCC---------ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 222111 11122345566669999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=298.78 Aligned_cols=256 Identities=23% Similarity=0.326 Sum_probs=197.1
Q ss_pred HhhcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhcc-CCCCccceeeEEEeCC------
Q 007423 292 AATNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEE------ 363 (604)
Q Consensus 292 ~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~------ 363 (604)
.++++|...+.||+|++|.||+|.. .+++.+++|.+.......+++.+|+++++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 3567899999999999999999995 4678999999876655567899999999999 7999999999997644
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
..+++|||+++++|.+++...... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++.+||+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKK---GKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECC
Confidence 489999999999999988653211 135889999999999999999999 88999999999999999999999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCC-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHH
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-----MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLV 518 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~ 518 (604)
||++.......... ....|+..|+|||++.. ..++.++|||||||++|||+||+.||.......
T Consensus 157 ~~~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------- 225 (275)
T cd06608 157 FGVSAQLDSTLGRR----NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------- 225 (275)
T ss_pred Cccceecccchhhh----cCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-------
Confidence 99987654322111 12347889999998643 346789999999999999999999996432110
Q ss_pred HHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 519 DWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 519 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
. ... ...+....... .......+.+++.+||..||++|||+.|+++
T Consensus 226 ~-~~~-~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 226 A-LFK-IPRNPPPTLKS-------PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred H-HHH-hhccCCCCCCc-------hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 111 11111111111 1112234455566999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=290.92 Aligned_cols=249 Identities=25% Similarity=0.410 Sum_probs=196.7
Q ss_pred CcCcEEEecCCeEEEEEEeCC-----CCEEEEEEeccccc--cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 298 AVENIIISTRTGVSYKAVLPD-----ASALAIKRLSACKL--SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 298 ~~~~~ig~G~~g~vy~~~~~~-----~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
...+.||.|+||.||+++..+ +..||+|.++.... ..+.+.+|++++++++|+||+++++++...+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456889999999999999543 48899999976543 45679999999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++++|.+++..... ..+++..+..++.|++.|++||| +.+++|+||||+||++++++.++|+|||+++..
T Consensus 82 ~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 82 YMEGGDLLDYLRKNRP-----KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred ccCCCCHHHHHHhhhh-----ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceec
Confidence 9999999999976431 12899999999999999999999 889999999999999999999999999999876
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
......... ...++..|+|||...+..++.++||||+|++++||++ |+.||..... .+.... ...+.
T Consensus 154 ~~~~~~~~~---~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~-~~~~~ 221 (258)
T smart00219 154 YDDDYYKKK---GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEY-LKKGY 221 (258)
T ss_pred ccccccccc---cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHH-HhcCC
Confidence 543221111 1236789999999988889999999999999999998 8888864221 111111 12222
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESL 575 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 575 (604)
..... ...+ .++.+++.+|+..||++|||+.|+++.|
T Consensus 222 ~~~~~------~~~~---~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 RLPKP------ENCP---PEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCC------CcCC---HHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11110 1122 3455566699999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=299.99 Aligned_cols=201 Identities=22% Similarity=0.243 Sum_probs=167.9
Q ss_pred hhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 293 ATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++++|...+.||+|+||.||+|. ..+++.||+|+++... .....+.+|++++++++|+||+++.+++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 45778889999999999999998 4578999999986432 22346789999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+. +++.+++.... ..+++.....++.|++.||.||| ..+|+|+||||+||+++.++.+||+|||+++.
T Consensus 83 e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 152 (291)
T cd07870 83 EYMH-TDLAQYMIQHP------GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARA 152 (291)
T ss_pred eccc-CCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccc
Confidence 9996 67877765432 24778888899999999999999 78999999999999999999999999999976
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
........ ....++..|+|||+..+ ..++.++|||||||++|||+||+.||+..
T Consensus 153 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 153 KSIPSQTY----SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred cCCCCCCC----CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 53322111 12246889999998865 35788999999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=296.54 Aligned_cols=245 Identities=18% Similarity=0.279 Sum_probs=194.6
Q ss_pred CCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 297 FAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
|...+.||+|+||.||+|.. .++..||||.+.... ...+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 55678899999999999984 578999999986432 223568899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+++|.+++... .+++.....++.+++.|+.||| +.+++|+||||+||++++++.++|+|||++......
T Consensus 86 ~~~l~~~i~~~--------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 86 GGSALDLLEPG--------PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred CCcHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 99999998642 4789999999999999999999 789999999999999999999999999998766432
Q ss_pred CCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
.... ....++..|+|||+..+..++.++|||||||++|||++|+.||..... ..+... ...+....
T Consensus 155 ~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~~~-~~~~~~~~- 220 (277)
T cd06641 155 QIKR----NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--------MKVLFL-IPKNNPPT- 220 (277)
T ss_pred hhhh----ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--------HHHHHH-HhcCCCCC-
Confidence 2111 112478889999999888889999999999999999999999964221 111111 11111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
++ ...+ ..+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~-----~~~~---~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LE-----GNYS---KPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CC-----cccC---HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11 1112 334455569999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=290.49 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=195.4
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+|...+.||+|++|.||++. ..+++.+|||.+.... ...+.+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 36777899999999999998 4578999999986532 2345788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC-CCeEEcccCCcccc
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD-FDARITDFGLARLV 450 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~-~~~kl~DFGla~~~ 450 (604)
+++++|.+++..... ..+++..+..++.+++.|+.||| +.+++|+||||+||+++++ ..+||+|||+++..
T Consensus 81 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 81 APGGTLAEYIQKRCN-----SLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred CCCCCHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 999999999976432 34889999999999999999999 7899999999999999854 56899999999876
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
...... ....++..|+|||...+..++.++||||||+++|||++|+.||..... ...+..... +..
T Consensus 153 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--------~~~~~~~~~-~~~ 218 (256)
T cd08220 153 SSKSKA-----YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL--------PALVLKIMS-GTF 218 (256)
T ss_pred CCCccc-----cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch--------HHHHHHHHh-cCC
Confidence 433211 112478899999999888899999999999999999999999964321 111212111 111
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
....+ ..+. .+.+++.+||+.+|++|||+.|+++
T Consensus 219 ~~~~~------~~~~---~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 APISD------RYSP---DLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCC------CcCH---HHHHHHHHHccCChhhCCCHHHHhh
Confidence 11111 1223 3445555999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=295.26 Aligned_cols=247 Identities=19% Similarity=0.290 Sum_probs=194.3
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccC---CCCccceeeEEEeCCeeeEEe
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLR---HPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lv~ 369 (604)
.|+..+.||+|+||.||+|. ..++..||+|.++... ...+++.+|++++++++ |||++++++++..+...+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 36667899999999999999 4678999999986432 23457889999999997 999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++++|.+++... .+++.....++.+++.||.||| +.+|+|+||+|+||++++++.++|+|||++..
T Consensus 82 e~~~~~~L~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06917 82 EYAEGGSVRTLMKAG--------PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL 150 (277)
T ss_pred ecCCCCcHHHHHHcc--------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceee
Confidence 999999999998643 4889999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
........ ....|+..|+|||...+ ..++.++|||||||++|||++|+.||...... .+... ....
T Consensus 151 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--------~~~~~-~~~~ 217 (277)
T cd06917 151 LNQNSSKR----STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF--------RAMML-IPKS 217 (277)
T ss_pred cCCCcccc----ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh--------hhhhc-cccC
Confidence 65433211 12247889999998765 44689999999999999999999999643211 11110 0011
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
..+.+..... ...+.+++.+||+.||++||++.|+++.
T Consensus 218 -----~~~~~~~~~~---~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 218 -----KPPRLEDNGY---SKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred -----CCCCCCcccC---CHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1111111112 2345566669999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=304.46 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=205.0
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc----cHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeeE
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL----SEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~l 367 (604)
...|...+.||.|.||.||+++. .+|+.+|+|.+.+... +.+.+.+|+++|+++. |||||.+.+++.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 34577789999999999999995 4599999999976432 3467899999999998 9999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC----CCeEEcc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD----FDARITD 443 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~----~~~kl~D 443 (604)
|||++.+|.|.+.+... .++......++.|++.++.||| +.+|+|||+||+|+|+... +.+|++|
T Consensus 114 vmEL~~GGeLfd~i~~~--------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEecCCchHHHHHHHc--------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEee
Confidence 99999999999999754 1788999999999999999999 8999999999999999733 4799999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHH
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNH 523 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 523 (604)
||+++.... .......+||+.|+|||++....|+..+||||.||++|.|+.|.+||........+ .
T Consensus 183 FGla~~~~~-----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~---------~ 248 (382)
T KOG0032|consen 183 FGLAKFIKP-----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF---------L 248 (382)
T ss_pred CCCceEccC-----CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH---------H
Confidence 999998754 12234457999999999999999999999999999999999999999865432211 1
Q ss_pred HHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 524 LVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 524 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.+..+.. ++.++.+ +..++.++++++ .++..||.+|+|+.++++.
T Consensus 249 ~i~~~~~-~f~~~~w--~~is~~akd~i~---~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 AILRGDF-DFTSEPW--DDISESAKDFIR---KLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHcCCC-CCCCCCc--cccCHHHHHHHH---HhcccCcccCCCHHHHhcC
Confidence 2233332 2222211 122456666666 9999999999999999984
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=302.68 Aligned_cols=197 Identities=21% Similarity=0.267 Sum_probs=165.6
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+|...+.||+|+||.||+|.. .+|+.||+|+++.... ..+.+.+|++++++++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 366778999999999999994 5789999999864321 234678899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
++ ++|.+++.... ..+++.....++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 81 CD-QDLKKYFDSCN------GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFG 150 (284)
T ss_pred CC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence 97 48888876532 35899999999999999999999 7899999999999999999999999999998664
Q ss_pred CCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
..... .....++..|+|||++.+. .++.++|||||||++|||+||+.|+..
T Consensus 151 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~ 202 (284)
T cd07839 151 IPVRC----YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202 (284)
T ss_pred CCCCC----cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 32211 1123468899999987664 478999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=293.58 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=192.9
Q ss_pred CCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc-----------cHHHHHHHHHHHhccCCCCccceeeEEEeCCe
Q 007423 297 FAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL-----------SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEE 364 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~-----------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 364 (604)
|...+.||+|++|.||+|. ..+++.||+|.++.... ..+.+.+|++++++++||||+++++++...+.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 5567899999999999998 45789999998853210 11357889999999999999999999999999
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEccc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDF 444 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DF 444 (604)
.++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+++||||+|+||++++++.+|++||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~ 152 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTY-------GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDF 152 (272)
T ss_pred eEEEEecCCCCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeec
Confidence 99999999999999999765 35888999999999999999999 789999999999999999999999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCCCC--CCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHH
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMV--ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVN 522 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 522 (604)
|+++......... ......|+..|+|||+..... ++.++||||||+++||+++|+.||..... .....
T Consensus 153 ~~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~~- 222 (272)
T cd06629 153 GISKKSDDIYDND--QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-------IAAMF- 222 (272)
T ss_pred ccccccccccccc--ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-------HHHHH-
Confidence 9998653221111 112234788999999877654 78999999999999999999999964221 11111
Q ss_pred HHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 523 HLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 523 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
... .......+++... .+....+.+++.+||+.+|++||++.||++.
T Consensus 223 ~~~-~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 223 KLG-NKRSAPPIPPDVS----MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred Hhh-ccccCCcCCcccc----ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111 1111111111111 1112344455559999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=297.61 Aligned_cols=199 Identities=20% Similarity=0.272 Sum_probs=167.5
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc--cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL--SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
++|...+.||+|++|.||+|.. .+++.||||.+..... ....+.+|++++++++|+||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 4678889999999999999995 4789999999865322 234577899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++ +|.+++.... ..+++.....++.|+++||.||| +.+|+||||||+||++++++.+||+|||+++...
T Consensus 85 ~~~-~L~~~~~~~~------~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 85 LDT-DLKQYMDDCG------GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred CCC-CHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 985 9999887543 34789999999999999999999 7899999999999999999999999999987543
Q ss_pred CCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
...... ....++..|+|||+..+ ..++.++||||+||++|||++|+.||...
T Consensus 155 ~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 155 VPSKTY----SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred CCCccc----cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 211111 11236788999998765 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=296.76 Aligned_cols=199 Identities=22% Similarity=0.296 Sum_probs=167.5
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+|+..+.||+|++|.||+|+. .+++.||||+++.... ..+.+.+|++++++++||||+++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 477788999999999999984 5789999999864321 235688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+. ++|.+++..... ..+++.....++.|++.||+||| ..+++|+||+|+||++++++.+||+|||+++...
T Consensus 81 ~~-~~l~~~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 81 LH-QDLKKFMDASPL-----SGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred cc-cCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 96 589888865432 35889999999999999999999 7899999999999999999999999999998664
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCC-CCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMV-ASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
..... .....++..|+|||+..+.. ++.++|||||||++|||+||+.||...
T Consensus 152 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 152 VPVRT----YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred cCccc----cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 32211 11223678899999876544 688999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=298.13 Aligned_cols=249 Identities=20% Similarity=0.319 Sum_probs=196.7
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
++|...+.||+|+||.||++. ..++..||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 567788999999999999998 4578899999986432 33467889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++++|.+++... .+++..+..++.+++.|+.||| +.+++|+|+||+||+++.++.+||+|||++.....
T Consensus 99 ~~~~L~~~~~~~--------~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 99 AGGSLTDVVTET--------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred CCCcHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 999999998643 3788999999999999999999 88999999999999999999999999999876643
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
..... ....++..|+|||......++.++|||||||++||+++|+.||......+.. ......+ ...
T Consensus 168 ~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~--------~~~~~~~-~~~ 234 (293)
T cd06647 168 EQSKR----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--------YLIATNG-TPE 234 (293)
T ss_pred ccccc----ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe--------eehhcCC-CCC
Confidence 32211 1224788999999988888999999999999999999999999753321110 0000011 000
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.. ........+.+++.+||+.+|++||++.+++..
T Consensus 235 -----~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 -----LQ--NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -----CC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 011112234455559999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=298.05 Aligned_cols=256 Identities=17% Similarity=0.170 Sum_probs=196.0
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
+|...+.||+|+||.||++. ...++.||+|.+.... ...+.+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 67788999999999999998 4568899999986542 123467899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++++|.+++... ..+++.....++.+++.||.||| +.+++||||||+||+++.++.+||+|||+++..
T Consensus 82 ~~~g~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~ 151 (305)
T cd05609 82 YVEGGDCATLLKNI-------GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIG 151 (305)
T ss_pred cCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence 99999999999654 35889999999999999999999 789999999999999999999999999998742
Q ss_pred CCCCCC-----------CCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHH
Q 007423 451 GSRDPN-----------DSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVD 519 (604)
Q Consensus 451 ~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~ 519 (604)
...... .........++..|+|||++....++.++|||||||++|||+||+.||..... .+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--------~~ 223 (305)
T cd05609 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--------EE 223 (305)
T ss_pred CcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HH
Confidence 111000 00000122467889999999888899999999999999999999999964321 12
Q ss_pred HHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 520 WVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 520 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
+...... +... .+... ...+.++ .+++.+||+.||++||++.++.+.|+.
T Consensus 224 ~~~~~~~-~~~~---~~~~~-~~~~~~~---~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 224 LFGQVIS-DDIE---WPEGD-EALPADA---QDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHHh-cccC---CCCcc-ccCCHHH---HHHHHHHhccChhhccCccCHHHHHhC
Confidence 2222211 1111 11110 1123334 455559999999999997766666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=299.78 Aligned_cols=244 Identities=18% Similarity=0.265 Sum_probs=192.0
Q ss_pred CcEEEecCCeEEEEEEe-CCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCch
Q 007423 300 ENIIISTRTGVSYKAVL-PDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL 377 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL 377 (604)
...||+|+||.||++.. .+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++..++..++++||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 35799999999999984 578999999986432 3345788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCC
Q 007423 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPND 457 (604)
Q Consensus 378 ~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 457 (604)
.+++... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..........
T Consensus 106 ~~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 106 TDIVSQT--------RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred HHHHhhc--------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence 9987542 4789999999999999999999 7899999999999999999999999999987654322211
Q ss_pred CccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccccccc
Q 007423 458 SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKS 537 (604)
Q Consensus 458 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 537 (604)
....|+..|+|||++.+..++.++|||||||++|||++|+.||...... +-... ...........
T Consensus 175 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~-~~~~~~~~~~~-- 239 (297)
T cd06659 175 ----KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--------QAMKR-LRDSPPPKLKN-- 239 (297)
T ss_pred ----cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH-HhccCCCCccc--
Confidence 1234789999999998888999999999999999999999999643211 11111 11111100000
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 538 LYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 538 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
....++.+. +++.+||+.+|++||++.|+++.
T Consensus 240 --~~~~~~~l~---~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 --AHKISPVLR---DFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred --cCCCCHHHH---HHHHHHhcCCcccCcCHHHHhhC
Confidence 011223344 45559999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=328.00 Aligned_cols=265 Identities=24% Similarity=0.347 Sum_probs=208.1
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC--------CCCEEEEEEecccc--ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP--------DASALAIKRLSACK--LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEE 363 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~--------~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 363 (604)
++....+.+|+|.||.|++|... ....||||.++... ...+.+..|+++|+.+ +|+||+.++|+|..++
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34455669999999999999732 14579999998643 3356799999999999 6999999999999999
Q ss_pred eeeEEeeecCCCchhhhhccCC---------CCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNG---------VDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID 434 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~---------~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~ 434 (604)
..++|+||+.+|+|.++|+..+ ........++..+.+.++.|||.|++||+ +.++||||+.++|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEec
Confidence 9999999999999999998776 10000023889999999999999999999 88999999999999999
Q ss_pred CCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccc
Q 007423 435 DDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGF 513 (604)
Q Consensus 435 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~ 513 (604)
++..+||+|||+|+.......+......+. -+..|||||.+....|+.|+|||||||+|||++| |..||.....
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~---- 527 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP---- 527 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCc-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc----
Confidence 999999999999996644333221111111 2567999999999999999999999999999999 9999965221
Q ss_pred cCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 514 KGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
..+. ...+..|...+. +..+..++.++|..||+.+|++||++.|+.+.++.+..
T Consensus 528 ---~~~l-~~~l~~G~r~~~---------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 528 ---TEEL-LEFLKEGNRMEQ---------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred ---HHHH-HHHHhcCCCCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 1111 224455544332 22344566677889999999999999999999998654
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=290.86 Aligned_cols=249 Identities=21% Similarity=0.291 Sum_probs=196.4
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+|...+.||+|+||.||++.. .++..||+|.+.... ...+.+.+|++++++++|+||+++++.+...+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 467788999999999999995 568899999986532 2345788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC-CeEEcccCCcccc
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF-DARITDFGLARLV 450 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~-~~kl~DFGla~~~ 450 (604)
+++++|.+++..... ..+++..+..++.++++||.||| +.+++|+||||+||++++++ .+||+|||.+...
T Consensus 81 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 81 CDGGDLMKRINRQRG-----VLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred CCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 999999999975432 24789999999999999999999 78999999999999999775 5799999999876
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
....... ....|+..|+|||+.....++.++|||||||++|||++|+.||.... ..+++.... .+..
T Consensus 153 ~~~~~~~----~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~ 219 (257)
T cd08225 153 NDSMELA----YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKIC-QGYF 219 (257)
T ss_pred cCCcccc----cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHh-cccC
Confidence 4322111 11247889999999988889999999999999999999999996432 222332222 1211
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
... . ...+.. +.+++.+||..+|++|||+.|+++.
T Consensus 220 ~~~-~-----~~~~~~---~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 API-S-----PNFSRD---LRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCC-C-----CCCCHH---HHHHHHHHhccChhhCcCHHHHhhC
Confidence 111 1 112233 4455559999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=300.65 Aligned_cols=245 Identities=27% Similarity=0.307 Sum_probs=191.0
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
..|...+.||+|+||.||+|.. .+++.||+|.+.... ...+++.+|++++++++||||+++.+++..++..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4477788999999999999984 578999999986432 12246889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||++ |++.+++.... ..+++..+..++.|++.||.||| +.+|+||||+|+||++++++.+||+|||++..
T Consensus 95 e~~~-g~l~~~~~~~~------~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 95 EYCL-GSASDILEVHK------KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred HhhC-CCHHHHHHHcc------cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCccee
Confidence 9997 57777775432 35889999999999999999999 78999999999999999999999999999876
Q ss_pred cCCCCCCCCccccCCCCcccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSS---TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
..... ...++..|+|||++. ...++.++||||||+++|||+||+.||...... ...... .
T Consensus 165 ~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~--------~~~~~~-~ 227 (307)
T cd06607 165 VSPAN--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHI-A 227 (307)
T ss_pred cCCCC--------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH--------HHHHHH-h
Confidence 53221 123778999999874 456889999999999999999999998643211 111111 1
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.... +.......+ ..+.+++.+||+.+|++||++.+|+..
T Consensus 228 ~~~~-----~~~~~~~~~---~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 228 QNDS-----PTLSSNDWS---DYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred cCCC-----CCCCchhhC---HHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1111 111111122 345556669999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=296.05 Aligned_cols=265 Identities=20% Similarity=0.194 Sum_probs=195.2
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+|+..+.||+|++|.||+|.. .+++.||||+++... ...+.+.+|++++++++|+||+++++++..++..+++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 577889999999999999995 468899999986532 2346789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
++++.+..+.... ..+++.....++.+++.|+.||| ..+++|+|++|+||++++++.+||+|||++....
T Consensus 82 ~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~ 151 (288)
T cd07833 82 VERTLLELLEASP-------GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALR 151 (288)
T ss_pred CCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence 9987776655432 34889999999999999999999 7899999999999999999999999999998765
Q ss_pred CCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCc-------HHHHHHH
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGN-------LVDWVNH 523 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~-------~~~~~~~ 523 (604)
...... .....++..|+|||++.+. .++.++||||||+++|||++|+.||......+..... ...+...
T Consensus 152 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07833 152 ARPASP---LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL 228 (288)
T ss_pred CCcccc---ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhh
Confidence 433211 1122467889999998877 7899999999999999999999999753221100000 0000000
Q ss_pred HHHcCC-----ccccccccccC-CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 524 LVIAGR-----SRDVVDKSLYG-RGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 524 ~~~~~~-----~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
...... .....++.... ........++.+++.+||+.+|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000 00000000000 001111345666777999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=293.43 Aligned_cols=252 Identities=21% Similarity=0.333 Sum_probs=198.0
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
+|+..+.||+|++|.||++.. .+++.||+|++.... ...+++.+|++++++++||||+++++++..++..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 566678899999999999995 468999999987543 33467899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCC-CCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQ-PPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~-~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
++++|.+++.... ..++......++.|++.|++||| + .+++|+||||+||++++++.+||+|||.+....
T Consensus 82 ~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 82 DGGSLDKILKEVQ------GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred CCCcHHHHHHHcc------CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 9999999997542 35788899999999999999999 6 899999999999999999999999999987653
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
...... ..++..|+|||+..+..++.++||||||+++|+|++|+.||...... .....+.+..... +...
T Consensus 153 ~~~~~~------~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~-~~~~ 222 (265)
T cd06605 153 NSLAKT------FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP---PDGIFELLQYIVN-EPPP 222 (265)
T ss_pred HHHhhc------ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc---cccHHHHHHHHhc-CCCC
Confidence 221111 34788999999998889999999999999999999999999653211 1122222222221 1111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
. +.....+. .+.+++.+||..||++|||+.|+++.
T Consensus 223 ~-----~~~~~~~~---~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 R-----LPSGKFSP---DFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred C-----CChhhcCH---HHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1 11111223 34455559999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=295.86 Aligned_cols=251 Identities=20% Similarity=0.295 Sum_probs=189.2
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHH-HhccCCCCccceeeEEEeCCeeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNR-LGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
++|...+.||+|+||.||++.. .+|+.||+|+++... ....++..|+.+ ++..+||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 3678889999999999999984 579999999987543 233456667765 666789999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCC-CceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQP-PYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~-~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
|++ |+|.+++...... ...+++.....++.|++.||.||| +. +++||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~~-~~l~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~ 153 (283)
T cd06617 81 VMD-TSLDKFYKKVYDK---GLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGY 153 (283)
T ss_pred hhc-ccHHHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 997 6888887643211 135899999999999999999999 54 899999999999999999999999999986
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCC----CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHH
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSST----MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
....... ....++..|+|||++.+ ..++.++|+|||||++|||++|+.||..... . .+......
T Consensus 154 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~-~~~~~~~~ 221 (283)
T cd06617 154 LVDSVAK-----TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT------P-FQQLKQVV 221 (283)
T ss_pred ccccccc-----ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc------C-HHHHHHHH
Confidence 5322111 11247888999998754 4468899999999999999999999964211 0 11111111
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.+..... .....+++ +.+++.+||..+|++||++.|+++
T Consensus 222 -~~~~~~~-----~~~~~~~~---l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 222 -EEPSPQL-----PAEKFSPE---FQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -hcCCCCC-----CccccCHH---HHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111 11112233 445555999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=287.27 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=200.2
Q ss_pred CCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 296 SFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
+|...+.||+|++|.||++... +++.||||++.... ...+.+.+|++.+.+++|+||+++++++...+..++++||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5778899999999999999954 59999999987543 23567999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCC-CCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQ-PPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~-~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
++++|.+++... ..++...+..++.|+++|++||| + .+++|+||+|+||+++.++.++|+|||.+....
T Consensus 82 ~~~~L~~~l~~~-------~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 82 DGGSLADLLKKV-------GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred CCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999754 35889999999999999999999 7 999999999999999999999999999998775
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
....... ...++..|+|||......++.++||||||+++|||+||+.||...... ...+...... .....
T Consensus 152 ~~~~~~~----~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~~-~~~~~ 221 (264)
T cd06623 152 NTLDQCN----TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-----SFFELMQAIC-DGPPP 221 (264)
T ss_pred cCCCccc----ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-----CHHHHHHHHh-cCCCC
Confidence 4332221 123778999999998888999999999999999999999999754320 1111111111 11111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
. ......++ .+.+++.+||..+|++||++.|+++.
T Consensus 222 ~-----~~~~~~~~---~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 S-----LPAEEFSP---EFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred C-----CCcccCCH---HHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1 11110223 44455559999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=293.86 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=200.3
Q ss_pred hhcCCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 293 ATNSFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
.++.|...+.+|+|++|.||++... ++..||+|.++......+.+.+|++++++++|+|++++++++...+..++++||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 4556777889999999999999965 689999999976544456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++++|.+++.... ..+++..+..++.+++.||.||| +.+++|+|++|+||+++.++.+||+|||++....
T Consensus 97 ~~~~~L~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 97 MDGGSLTDIITQNF------VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred cCCCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 99999999998653 25899999999999999999999 7999999999999999999999999999987654
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
...... ....++..|++||+..+..++.++|||||||++|||+||+.||...... ....... .....
T Consensus 168 ~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--------~~~~~~~-~~~~~ 234 (286)
T cd06614 168 KEKSKR----NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--------RALFLIT-TKGIP 234 (286)
T ss_pred cchhhh----ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHH-hcCCC
Confidence 322111 1223678899999988888999999999999999999999998643211 1111111 11111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
...++ ...+. .+.+++.+||+.+|.+||++.+|++
T Consensus 235 ~~~~~----~~~~~---~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 235 PLKNP----EKWSP---EFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCcch----hhCCH---HHHHHHHHHhccChhhCcCHHHHhh
Confidence 11111 11223 3445556999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=298.59 Aligned_cols=199 Identities=25% Similarity=0.248 Sum_probs=167.9
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEecccccc---HHHHHHHHHHHhccCCCCccceeeEEEeC--CeeeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACKLS---EKQFRSEMNRLGQLRHPNLVPLLGFCVVE--EERLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lv 368 (604)
++|...+.||+|+||.||+|... +++.+|+|.++..... ...+.+|++++++++||||+++++++... ...+++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46777899999999999999954 6889999999753322 23577899999999999999999999877 889999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++ +|.+++.... ..+++.....++.|++.||+||| +.+++|+||||+||++++++.+||+|||+++
T Consensus 85 ~e~~~~-~L~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~ 154 (293)
T cd07843 85 MEYVEH-DLKSLMETMK------QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAR 154 (293)
T ss_pred ehhcCc-CHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCcee
Confidence 999974 9999887543 24899999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
......... ....++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 155 EYGSPLKPY----TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred eccCCcccc----ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 765432111 122467889999987654 4689999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=302.80 Aligned_cols=263 Identities=19% Similarity=0.258 Sum_probs=192.6
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCC-----ee
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE-----ER 365 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~ 365 (604)
+++|...+.||+|+||.||+|. ..+++.||||.++... .....+.+|++++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 4678899999999999999998 5678999999986422 23456888999999999999999999876543 57
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
++++||+++ +|.+++... .+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 84 ~lv~e~~~~-~l~~~~~~~--------~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg 151 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ--------HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFG 151 (336)
T ss_pred EEEehhccc-CHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECccc
Confidence 999999975 888877543 4889999999999999999999 7899999999999999999999999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
+++.......... ......|+..|+|||.+.+ ..++.++|||||||++|||+||+.||....... ...++...
T Consensus 152 ~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-----~~~~~~~~ 225 (336)
T cd07849 152 LARIADPEHDHTG-FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-----QLNLILGV 225 (336)
T ss_pred ceeeccccccccC-CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHH
Confidence 9987643222111 1223357889999998654 568899999999999999999999996432110 00000000
Q ss_pred HHc-----------CCccccccc-cccCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 525 VIA-----------GRSRDVVDK-SLYGRGN-----DDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 525 ~~~-----------~~~~~~~d~-~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
... ......... ....... +....++.+++.+||+.+|++|||+.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 226 LGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred cCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 000000000 0000000 0112345667779999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=293.30 Aligned_cols=242 Identities=22% Similarity=0.255 Sum_probs=194.0
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
+|...+.||+|++|.||++.. .+++.||+|.+.... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 577889999999999999984 568999999986532 223568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.+||+|||+++..
T Consensus 82 ~~~~~~L~~~~~~~-------~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 151 (290)
T cd05580 82 YVPGGELFSHLRKS-------GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV 151 (290)
T ss_pred cCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence 99999999999765 35889999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
.... ....+++.|+|||...+...+.++||||||+++|||++|+.||..... .........+..
T Consensus 152 ~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~~~~ 215 (290)
T cd05580 152 KGRT-------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---------IQIYEKILEGKV 215 (290)
T ss_pred CCCC-------CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHhcCCc
Confidence 4331 122478899999998888889999999999999999999999964321 111111122211
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYE 573 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 573 (604)
. + ....+..+.++ +.+||..||++|| +++|+++
T Consensus 216 ~------~-~~~~~~~l~~l---i~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 R------F-PSFFSPDAKDL---IRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred c------C-CccCCHHHHHH---HHHHccCCHHHccCcccCCHHHHHc
Confidence 1 1 11123344444 4599999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=291.32 Aligned_cols=198 Identities=24% Similarity=0.293 Sum_probs=169.2
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+|...+.||+|++|.||+|.. .+++.||||++.... ...+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 366778999999999999994 578999999986543 2246789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+ +++|.+++.... ..+++..+..++.|+++||+||| +.+++|+||||+||++++++.++|+|||++....
T Consensus 81 ~-~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~ 150 (286)
T cd07832 81 M-PSDLSEVLRDEE------RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFS 150 (286)
T ss_pred c-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence 9 999999987543 35899999999999999999999 7899999999999999999999999999998764
Q ss_pred CCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
..... ......++..|+|||++.+. .++.++||||+|+++|||+||++||..
T Consensus 151 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 203 (286)
T cd07832 151 EEEPR---LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG 203 (286)
T ss_pred CCCCC---ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence 43211 11223478899999987654 468999999999999999999888864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=291.02 Aligned_cols=246 Identities=18% Similarity=0.298 Sum_probs=194.2
Q ss_pred CCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 297 FAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
|...+.||+|++|.||++. ..+++.+|+|++.... ...+.+.+|+.++++++||||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 4445799999999999998 4678999999986433 2345688999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
++|.+++... .+++..+..++.|++.|++||| +.+|+||||+|+||+++.++.++|+|||++.......
T Consensus 101 ~~L~~~~~~~--------~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 101 GALTDIVTHT--------RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred CCHHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 9999998752 3788999999999999999999 7899999999999999999999999999887654322
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
... ....|+..|+|||...+..++.++|||||||++|||++|+.||..... ........ .+......
T Consensus 170 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--------~~~~~~~~-~~~~~~~~ 236 (285)
T cd06648 170 PRR----KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--------LQAMKRIR-DNLPPKLK 236 (285)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHH-hcCCCCCc
Confidence 111 123478899999999888899999999999999999999999864221 12222211 11111110
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.+ ...+ ..+.+++.+||+.+|++||++.|+++
T Consensus 237 ~~----~~~~---~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 NL----HKVS---PRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cc----ccCC---HHHHHHHHHHcccChhhCcCHHHHcc
Confidence 00 0112 34555566999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=296.94 Aligned_cols=253 Identities=19% Similarity=0.289 Sum_probs=188.3
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeeEEeee
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+|...+.||+|+||.||++. ..+++.||+|.+.... .....+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 34456789999999999998 4568999999986532 23456889999999996 99999999999998899999999
Q ss_pred cCCCchhhhh---ccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 372 MPNGTLYSLL---HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 372 ~~~gsL~~~l---~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
++. ++.++. .... ...+++.....++.+++.||+|||+ ..+++||||||+||+++.++.+||+|||+++
T Consensus 85 ~~~-~l~~l~~~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 156 (288)
T cd06616 85 MDI-SLDKFYKYVYEVL-----KSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISG 156 (288)
T ss_pred ccC-CHHHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhH
Confidence 864 554433 2211 1358899999999999999999994 3589999999999999999999999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCC---CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHH
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM---VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
......... ...|+..|+|||++... .++.++|||||||++|||++|+.||.... ...+-+....
T Consensus 157 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~ 224 (288)
T cd06616 157 QLVDSIAKT-----RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVV 224 (288)
T ss_pred HhccCCccc-----cccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhc
Confidence 654322111 12378899999988765 68999999999999999999999996421 1111111111
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.+.. +.+...........+.+++.+||+.+|++|||+.||++.
T Consensus 225 -~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 225 -KGDP-----PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CCCC-----CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 111111111122345556669999999999999999774
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=291.82 Aligned_cols=260 Identities=21% Similarity=0.194 Sum_probs=189.8
Q ss_pred CCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccC-CCCccceeeEEEeC--CeeeEEee
Q 007423 297 FAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLR-HPNLVPLLGFCVVE--EERLLVYK 370 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lv~e 370 (604)
|...+.||+|+||.||+|. ..++..||+|+++... .......+|+.++.++. |+||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 4556889999999999998 5578999999987532 22334567999999885 99999999999987 88999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|++ |+|.+.+.... ..++|..+..++.|++.||+||| +.+++||||||+||++++ +.+||+|||+++..
T Consensus 81 ~~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~ 149 (282)
T cd07831 81 LMD-MNLYELIKGRK------RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGI 149 (282)
T ss_pred cCC-ccHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEeccccccc
Confidence 997 58888886542 35899999999999999999999 789999999999999999 99999999999876
Q ss_pred CCCCCCCCccccCCCCcccccCccccC-CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccc-------cCcHHHHHH
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSS-TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGF-------KGNLVDWVN 522 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~-------~~~~~~~~~ 522 (604)
....... ...++..|+|||+.. ...++.++|||||||++|||++|+.||......+.. .....+|.
T Consensus 150 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 223 (282)
T cd07831 150 YSKPPYT-----EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVL- 223 (282)
T ss_pred ccCCCcC-----CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHH-
Confidence 4332211 123688999999764 455788999999999999999999999754321100 00011111
Q ss_pred HHHHcCCccccccccccCCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 523 HLVIAGRSRDVVDKSLYGRG----NDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 523 ~~~~~~~~~~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.............+...... .......+.+++.+||+.+|++||++.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 11111111111011000000 0112345666777999999999999999976
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=288.83 Aligned_cols=254 Identities=20% Similarity=0.220 Sum_probs=198.9
Q ss_pred CCCcCcEEEecCCeEEEEEEeCC-CCEEEEEEecccccc----HHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 296 SFAVENIIISTRTGVSYKAVLPD-ASALAIKRLSACKLS----EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~~-~~~vAvK~l~~~~~~----~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
+|...+.||.|.-|+||.+.+.+ +..+|+|++.+.... ..+...|-+||+.++||.+..|++.++.+...|++||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45556889999999999999655 589999999764432 2356779999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
||++|+|..+.+.... ..++......+|.+++.||+||| -.+||.|||||+|||+.++|.+.|+||-++...
T Consensus 158 yCpGGdL~~LrqkQp~-----~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPG-----KRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred cCCCccHHHHHhhCCC-----CccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999886643 46899999999999999999999 899999999999999999999999999987543
Q ss_pred CCC-------C------------------------C-C--------------------CCccccCCCCcccccCccccCC
Q 007423 451 GSR-------D------------------------P-N--------------------DSSFVHGDLGEFGYVAPEYSST 478 (604)
Q Consensus 451 ~~~-------~------------------------~-~--------------------~~~~~~~~~gt~~y~aPE~~~~ 478 (604)
... . . . ........+||-.|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 210 0 0 0 0011223479999999999999
Q ss_pred CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhcc
Q 007423 479 MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCV 558 (604)
Q Consensus 479 ~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl 558 (604)
...+.++|.|+|||++|||+.|+.||...+..+.+. ..+. ..+.-...++....+-+|+.+.|
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~--------NIv~---------~~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR--------NIVG---------QPLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH--------HHhc---------CCCcCCCCCcchhHHHHHHHHHh
Confidence 999999999999999999999999998766554321 1111 11110111122233444555999
Q ss_pred CCCCCCCCC----HHHHHHH
Q 007423 559 VSRPKDRPS----MYQVYES 574 (604)
Q Consensus 559 ~~dP~~RPs----~~ev~~~ 574 (604)
..||.+|.. +.||.+.
T Consensus 373 vKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred ccChhhhhccccchHHhhcC
Confidence 999999998 7777553
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=291.70 Aligned_cols=259 Identities=20% Similarity=0.220 Sum_probs=191.7
Q ss_pred CCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 297 FAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
|+..+.||.|++|.||+|.. .+|..||||++.... ...+.+.+|++++++++|||++++++++..++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 45678999999999999984 579999999986533 22356889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
+ ++|.+++..... ..+++..+..++.|+++||+||| +.+++||||+|+||++++++.+||+|||+++....
T Consensus 81 ~-~~l~~~~~~~~~-----~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 81 D-LDLKKYMDSSPL-----TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV 151 (283)
T ss_pred C-cCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence 5 689999875431 25899999999999999999999 78999999999999999999999999999976543
Q ss_pred CCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH-------
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL------- 524 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------- 524 (604)
..... ....++..|+|||++.+. .++.++||||||+++|||+||+.||........ ..+..+..
T Consensus 152 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~ 223 (283)
T cd07835 152 PVRTY----THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ----LFRIFRTLGTPDEDV 223 (283)
T ss_pred Ccccc----CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCChHH
Confidence 22111 112367889999987654 578899999999999999999999965322110 01100000
Q ss_pred -----HHcC---CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 525 -----VIAG---RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 525 -----~~~~---~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
...+ ........... .........+.+++.+|++.||++|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 224 WPGVTSLPDYKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhchhhhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 00000000000 000111134556666999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=295.96 Aligned_cols=203 Identities=20% Similarity=0.236 Sum_probs=166.5
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCC-------
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE------- 363 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------- 363 (604)
++|...+.||+|+||.||+|.. .+++.||||.+.... .....+.+|++++++++||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 4688889999999999999994 578999999986432 22345678999999999999999999987654
Q ss_pred -eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEc
Q 007423 364 -ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARIT 442 (604)
Q Consensus 364 -~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~ 442 (604)
..++||||+.+ +|.+++.... ..+++.....++.|++.||.||| +.+++|+||||+||+++.++.+||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~ 161 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKN------VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLA 161 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEEC
Confidence 35999999975 8888876542 24889999999999999999999 7899999999999999999999999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
|||++..................++..|+|||+..+. .++.++||||||+++|||+||+.||...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 9999987644322211122233578889999987654 4688999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=297.38 Aligned_cols=246 Identities=26% Similarity=0.313 Sum_probs=191.2
Q ss_pred CCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 297 FAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
|...+.||+|+||.||+++ ..++..||+|.+.... ...+++.+|++++++++|||++++++++..+...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 5567889999999999999 4578999999986432 1224688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
++ |+|.+.+.... ..+++..+..++.+++.|+.||| +.+|+||||+|+||++++++.+||+|||++....
T Consensus 107 ~~-g~l~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 107 CL-GSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred CC-CCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 97 58888775432 35899999999999999999999 7899999999999999999999999999987543
Q ss_pred CCCCCCCccccCCCCcccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSS---TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
... ...|+..|+|||++. ...++.++|||||||++|||++|+.||..... ..........+
T Consensus 177 ~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~ 240 (317)
T cd06635 177 PAN--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNE 240 (317)
T ss_pred Ccc--------cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHhcc
Confidence 211 123788999999873 45688999999999999999999999864211 11111111111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
... ......+.. +.+++.+||+.+|++||++.||++..-.
T Consensus 241 -~~~-----~~~~~~~~~---l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 241 -SPT-----LQSNEWSDY---FRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred -CCC-----CCCccccHH---HHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 111 111122333 4455559999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=300.58 Aligned_cols=269 Identities=19% Similarity=0.239 Sum_probs=194.8
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEe----CCee
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV----EEER 365 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~ 365 (604)
.++|+..+.||+|++|.||+|. ..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3678888999999999999998 5579999999986532 234567889999999999999999998763 3467
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
++|+||+. |+|.+++... ..+++.....++.|++.||.||| ..+|+||||||+||++++++.+||+|||
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg 152 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD-------QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFG 152 (334)
T ss_pred EEEEehhh-hhHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccc
Confidence 99999996 5899988654 34899999999999999999999 7899999999999999999999999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCcccccc-------CcH
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFK-------GNL 517 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~-------~~~ 517 (604)
+++.................|+..|+|||.+.. ..++.++|||||||++|||++|+.||.......... ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~ 232 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS 232 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh
Confidence 998764332222222223457889999998755 458899999999999999999999997543211000 000
Q ss_pred HHHHHHHHHcCCccccccc-cccCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 518 VDWVNHLVIAGRSRDVVDK-SLYGRGN-----DDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 518 ~~~~~~~~~~~~~~~~~d~-~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
...... ..........+. ....... ......+.+++.+||+.+|++||++.+++..
T Consensus 233 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 233 EEVLNR-IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hHhhhh-hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000 000000000000 0000000 1112345566669999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=292.47 Aligned_cols=202 Identities=22% Similarity=0.206 Sum_probs=165.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc---cHHHHHHHHHHHhccC-CCCccceeeEEEeCCe-----
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL---SEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEE----- 364 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~----- 364 (604)
++|+..+.||+|+||.||+|.. .+++.||||.++.... ..+.+.+|++++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3578889999999999999994 5789999999865322 2356888999999995 6999999999987665
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC-CCCeEEcc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD-DFDARITD 443 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~-~~~~kl~D 443 (604)
.+++|||+++ +|.+++....... ...+++.....++.|++.||.||| ..+|+||||||+||+++. ++.+||+|
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~d 154 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGP--GRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIAD 154 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEee
Confidence 7999999985 8988886542210 135899999999999999999999 789999999999999998 89999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
||+++......... ....+++.|+|||++.+ ..++.++||||||+++|||+||+.||..
T Consensus 155 fg~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 214 (295)
T cd07837 155 LGLGRAFSIPVKSY----THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG 214 (295)
T ss_pred cccceecCCCcccc----CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence 99998653321111 11236788999998754 4578999999999999999999999965
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=299.67 Aligned_cols=197 Identities=22% Similarity=0.254 Sum_probs=166.8
Q ss_pred hhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeC------
Q 007423 293 ATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE------ 362 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 362 (604)
..++|...+.||+|+||.||++. ..+++.||||.+.... ...+++.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 34678889999999999999999 5679999999986432 2235678899999999999999999988643
Q ss_pred CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEc
Q 007423 363 EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARIT 442 (604)
Q Consensus 363 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~ 442 (604)
...++||||+.+ +|.+.+.. .++......++.|++.||+||| ..+|+||||||+||+++.++.+||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~---------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~ 160 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM---------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL 160 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh---------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEc
Confidence 346999999964 88887753 2778888999999999999999 7899999999999999999999999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
|||+++....... .....++..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 161 Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 161 DFGLARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred cCccceeCCCCCC-----CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 9999987643221 11224788999999999889999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=292.27 Aligned_cols=264 Identities=19% Similarity=0.239 Sum_probs=193.7
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
+|+..+.||.|++|.||+|.. .+++.||||.++... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 477789999999999999995 568999999987543 22456788999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++ +|.+++...... ..+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|||+++....
T Consensus 81 ~~-~l~~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 81 DK-DLKKYMDTHGVR----GALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI 152 (284)
T ss_pred Cc-cHHHHHHhcCCC----CCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence 85 898888654321 35899999999999999999999 78999999999999999999999999999976543
Q ss_pred CCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcH--------HHHHHH
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNL--------VDWVNH 523 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~--------~~~~~~ 523 (604)
..... ....++..|++||+..+ ..++.++|||||||++|||++|+.||......+...... ..| ..
T Consensus 153 ~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 227 (284)
T cd07836 153 PVNTF----SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW-PG 227 (284)
T ss_pred Ccccc----ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH-HH
Confidence 21111 12246788999998755 456889999999999999999999997543221110000 000 00
Q ss_pred HHHcCCcc----ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 524 LVIAGRSR----DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 524 ~~~~~~~~----~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
........ ...+... ....+.....+.+++.+|++.||++||++.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 228 ISQLPEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HhcCchhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 0000000 0000111234556666999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=293.16 Aligned_cols=258 Identities=12% Similarity=0.154 Sum_probs=180.1
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCC----CCEEEEEEecccccc---H---------HHHHHHHHHHhccCCCCccceeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPD----ASALAIKRLSACKLS---E---------KQFRSEMNRLGQLRHPNLVPLLGF 358 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~----~~~vAvK~l~~~~~~---~---------~~~~~Ei~~l~~l~H~niv~l~g~ 358 (604)
+.|.+.+.||+|+||.||+|...+ +..+|+|........ + .....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 568889999999999999999544 455666654322111 1 112234455667799999999997
Q ss_pred EEeCC----eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC
Q 007423 359 CVVEE----ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID 434 (604)
Q Consensus 359 ~~~~~----~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~ 434 (604)
+.... ..++++|++.. ++.+.+... ...++.....++.|++.||+||| +.+|+||||||+|||++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~ 160 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI-------KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVD 160 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhh-------ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEc
Confidence 76543 34678887754 566665432 23567788899999999999999 78999999999999999
Q ss_pred CCCCeEEcccCCccccCCCCCCC---CccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccc
Q 007423 435 DDFDARITDFGLARLVGSRDPND---SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEE 511 (604)
Q Consensus 435 ~~~~~kl~DFGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~ 511 (604)
.++.+||+|||+++.+....... ........||+.|+|||+..+..++.++|||||||++|||+||+.||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 99999999999998764322111 111122358999999999999999999999999999999999999997642211
Q ss_pred cc-cCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007423 512 GF-KGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESL 575 (604)
Q Consensus 512 ~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 575 (604)
.. .....++.... ..+.. .....+++ +.+++..||..+|++||++.++.+.+
T Consensus 241 ~~~~~~~~~~~~~~-~~~~~--------~~~~~~~~---~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 NLIHAAKCDFIKRL-HEGKI--------KIKNANKF---IYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHhHHHHHHHh-hhhhh--------ccCCCCHH---HHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 10 00011111111 11111 01122334 44555599999999999999999876
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=287.90 Aligned_cols=246 Identities=21% Similarity=0.195 Sum_probs=195.4
Q ss_pred CCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 296 SFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
+|...+.||.|+||.||++... +++.||+|.+.... ...+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4677899999999999999954 68999999986432 234678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++++|.+++... ..+++.....++.|+++||.||| ..+++|+||+|+||++++++.++|+|||++...
T Consensus 81 ~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~ 150 (258)
T cd05578 81 LLLGGDLRYHLSQK-------VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKV 150 (258)
T ss_pred CCCCCCHHHHHHhc-------CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence 99999999999754 35889999999999999999999 789999999999999999999999999998876
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
..... .....|+..|+|||+.....++.++||||||+++|+|++|+.||...... ..++....... .
T Consensus 151 ~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~--~ 217 (258)
T cd05578 151 TPDTL-----TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQET--A 217 (258)
T ss_pred CCCcc-----ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhcc--c
Confidence 43321 12234788999999998888999999999999999999999999754321 12222221111 1
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSM--YQVY 572 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~ev~ 572 (604)
..... ...+ ..+.+++.+||+.||.+||++ +|++
T Consensus 218 ~~~~~-----~~~~---~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYP-----ATWS---TEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCc-----ccCc---HHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11111 1122 344455559999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=306.51 Aligned_cols=248 Identities=22% Similarity=0.324 Sum_probs=193.9
Q ss_pred CCcCcEEEecCCeEEEEEEeCC-CCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 297 FAVENIIISTRTGVSYKAVLPD-ASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~~~-~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
|.+.-.||.|+||.||+++-.+ +-..|-|++.... ..-+.|.-||+||..+.||+||+|++.|..++..++..|||++
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 4455679999999999998544 4455677775432 3346789999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|-...++-+-+ ..|...++.-+..+++.||.||| +..|||||||+.|||+.-+|.++|+|||.+.......
T Consensus 114 GAVDaimlEL~------r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~ 184 (1187)
T KOG0579|consen 114 GAVDAIMLELG------RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR 184 (1187)
T ss_pred chHhHHHHHhc------cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHH
Confidence 99988876543 46889999999999999999999 8899999999999999999999999999986543222
Q ss_pred CCCCccccCCCCcccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSS-----TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
....+ ..||++|||||+.. ..+|+.++|||||||+|.||..+.+|-...++ .. |...+....
T Consensus 185 qkRDs----FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--------MR-VllKiaKSe 251 (1187)
T KOG0579|consen 185 QKRDS----FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MR-VLLKIAKSE 251 (1187)
T ss_pred hhhcc----ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--------HH-HHHHHhhcC
Confidence 22222 34999999999754 56799999999999999999999999764322 11 111122222
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.+.++.| ..+.....++++ +|+..||..||++.++++
T Consensus 252 PPTLlqP----S~Ws~~F~DfLk---~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 252 PPTLLQP----SHWSRSFSDFLK---RCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CCcccCc----chhhhHHHHHHH---HHHhcCCccCCCHHHHhh
Confidence 3333332 334555566666 999999999999999865
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=297.19 Aligned_cols=251 Identities=19% Similarity=0.277 Sum_probs=194.6
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEecccc---ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACK---LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 370 (604)
..|++.+.||+||.+.||++.-.+.+.+|+|++.... ..-.-|.+|++.|.++ .|.+||++++|-..++..|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 4577889999999999999999899999999886433 2235699999999999 59999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|=+. +|..+|+..... ...| .+..+..|++.++.++| ..+|||.||||.|+|+-+ |.+||+|||+|..+
T Consensus 441 ~Gd~-DL~kiL~k~~~~-----~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 441 CGDI-DLNKILKKKKSI-----DPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred cccc-cHHHHHHhccCC-----CchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 8755 999999876532 2335 67788999999999999 899999999999999876 47999999999988
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCC-----------CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHH
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTM-----------VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVD 519 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~ 519 (604)
..+.... .....+||+.||+||.+..+ +.+.++||||+|||||+|+.|+.||... ...
T Consensus 510 ~~DTTsI--~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---------~n~ 578 (677)
T KOG0596|consen 510 QPDTTSI--VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---------INQ 578 (677)
T ss_pred Cccccce--eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH---------HHH
Confidence 6544322 22355799999999976432 2567999999999999999999999531 113
Q ss_pred HHHHHHHcCCccccccccccCCCCH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 520 WVNHLVIAGRSRDVVDKSLYGRGND-DEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 520 ~~~~~~~~~~~~~~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
|.+. ..+.||...-+++. ..-..++++|..||..||++||+..|+++.
T Consensus 579 ~aKl-------~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 579 IAKL-------HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHH-------HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 3322 22333321001100 011227778889999999999999999764
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=290.09 Aligned_cols=241 Identities=21% Similarity=0.260 Sum_probs=182.0
Q ss_pred EEEecCCeEEEEEEe-CCCCEEEEEEeccccc----cHHHHHHHHHHHh---ccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 302 IIISTRTGVSYKAVL-PDASALAIKRLSACKL----SEKQFRSEMNRLG---QLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 302 ~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~---~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
+||+|+||.||++.. .+++.+|+|.+..... ....+.+|..+++ ..+||||+.+.+++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999994 5689999999865321 1233445554433 3479999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++......
T Consensus 81 ~~~L~~~i~~~-------~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~ 150 (279)
T cd05633 81 GGDLHYHLSQH-------GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 150 (279)
T ss_pred CCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc
Confidence 99999998754 35899999999999999999999 789999999999999999999999999998755322
Q ss_pred CCCCCccccCCCCcccccCccccC-CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSS-TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
.. ....|+..|+|||... +..++.++|||||||++|||+||+.||....... ..........
T Consensus 151 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~----- 213 (279)
T cd05633 151 KP------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD------KHEIDRMTLT----- 213 (279)
T ss_pred Cc------cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC------HHHHHHHhhc-----
Confidence 11 1224889999999876 4568899999999999999999999997532211 1111111110
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYES 574 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~ 574 (604)
.+..+. ...+.++.++ +.+|++.||++|| +++|+++.
T Consensus 214 -~~~~~~-~~~~~~~~~l---i~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 214 -VNVELP-DSFSPELKSL---LEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -CCcCCc-cccCHHHHHH---HHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 011111 1123344444 4599999999999 59888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=279.57 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=198.1
Q ss_pred CCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEeccccc-cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 296 SFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACKL-SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
+|...+.||+|++|.||++... ++..+++|++..... ..+.+.+|++++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3667789999999999999964 789999999976443 45679999999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+++|.+++.... ..+++..+..++.++++|+.||| ..+++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 81 GGSLKDLLKSTN------QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCcHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 999999987642 35899999999999999999999 789999999999999999999999999999876543
Q ss_pred CCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
.. .....++..|++||+......+.++||||||+++++|++|+.||..... ......... ......
T Consensus 152 ~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~~~~ 217 (253)
T cd05122 152 KA-----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP--------MKALFKIAT-NGPPGL 217 (253)
T ss_pred cc-----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch--------HHHHHHHHh-cCCCCc
Confidence 21 1122478899999999888899999999999999999999999974321 111111111 111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
... ...+. .+.+++.+||+.||++|||+.|+++
T Consensus 218 ~~~----~~~~~---~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 218 RNP----EKWSD---EFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred Ccc----cccCH---HHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 01123 3455555999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=298.19 Aligned_cols=272 Identities=20% Similarity=0.229 Sum_probs=191.5
Q ss_pred cEEEec--CCeEEEEEEe-CCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 301 NIIIST--RTGVSYKAVL-PDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 301 ~~ig~G--~~g~vy~~~~-~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
..||+| +||+||++.. .+++.||||.+..... ..+.+.+|+.+++.++||||+++++++..++..++++||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 8999999984 6899999999865332 235688999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++..... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+|++||+.+.......
T Consensus 84 ~~l~~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~ 155 (328)
T cd08226 84 GSANSLLKTYFP-----EGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG 155 (328)
T ss_pred CCHHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence 999999876432 24888999999999999999999 7899999999999999999999999998654332211
Q ss_pred CCCCc---cccCCCCcccccCccccCCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCc-------------
Q 007423 455 PNDSS---FVHGDLGEFGYVAPEYSSTM--VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGN------------- 516 (604)
Q Consensus 455 ~~~~~---~~~~~~gt~~y~aPE~~~~~--~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~------------- 516 (604)
..... ......++..|+|||++.+. .++.++|||||||++|||++|+.||............
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence 11000 00011245679999998663 4789999999999999999999999753221100000
Q ss_pred ----HHHHH-----------HHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhch
Q 007423 517 ----LVDWV-----------NHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES--LKSMA 579 (604)
Q Consensus 517 ----~~~~~-----------~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~--L~~i~ 579 (604)
...+. ......+......+..+...........+.+++.+||+.||++|||+.|+++. ++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 00000 00000000001111111111122344567778889999999999999999753 44444
Q ss_pred H
Q 007423 580 E 580 (604)
Q Consensus 580 ~ 580 (604)
+
T Consensus 316 ~ 316 (328)
T cd08226 316 E 316 (328)
T ss_pred H
Confidence 4
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=292.61 Aligned_cols=246 Identities=18% Similarity=0.250 Sum_probs=202.4
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccccc---HHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLS---EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
-|..++.||+|.|.+|-.++ .-.|..||||++.+.+.+ ..++.+|++.|+-+.|||||+++.+.......|||.|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 35566889999999999998 568999999999876644 35789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC-CCCCeEEcccCCcccc
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID-DDFDARITDFGLARLV 450 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~-~~~~~kl~DFGla~~~ 450 (604)
-.+|+|++||.++. ..+......+++.||..|+.|+| +..+|||||||+||.+- .-|-+||.|||++-.+
T Consensus 99 GD~GDl~DyImKHe------~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHE------EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred cCCchHHHHHHhhh------ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 99999999998764 34888899999999999999999 88999999999998765 6688999999999776
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVAS-LKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
.+... ....+|+..|-|||.+.+..|+ ++.||||+|||||-|+.|++||...+..+..
T Consensus 170 ~PG~k-----L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------- 228 (864)
T KOG4717|consen 170 QPGKK-----LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------- 228 (864)
T ss_pred CCcch-----hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh----------------
Confidence 54432 2334699999999999888875 5789999999999999999999876554321
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
..+.|-.. ..++....++-+++.+|+..||++|.+.+||+..
T Consensus 229 -TmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 229 -TMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred -hhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 22233222 2234444555566669999999999999998753
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=290.93 Aligned_cols=200 Identities=21% Similarity=0.232 Sum_probs=165.1
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
++|+..+.||+|++|.||+|.. .+++.||+|.+..... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4678889999999999999995 5789999999864322 23568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC-CCCeEEcccCCccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD-DFDARITDFGLARL 449 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~-~~~~kl~DFGla~~ 449 (604)
|++ ++|.+++..... ..+++.....++.|++.||+||| +.+++|+||+|+||+++. ++.+||+|||++..
T Consensus 82 ~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~ 152 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-----FAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (294)
T ss_pred ccc-ccHHHHHHhCCC-----CCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccc
Confidence 996 588888754321 23578888899999999999999 789999999999999984 56799999999986
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
....... .....++..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 153 ~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 153 FGIPVRT----FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred cCCCccc----cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 5432111 112246789999998765 45789999999999999999999999753
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=284.10 Aligned_cols=241 Identities=19% Similarity=0.234 Sum_probs=189.1
Q ss_pred EEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCch
Q 007423 303 IISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL 377 (604)
Q Consensus 303 ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL 377 (604)
||.|++|.||++.. .+++.||+|.+.... ...+.+.+|++++++++||||+++++++..+...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 58899999999995 458999999986532 2345789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCC
Q 007423 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPND 457 (604)
Q Consensus 378 ~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 457 (604)
.+++.+. ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.+||+|||+++........
T Consensus 81 ~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~- 149 (262)
T cd05572 81 WTILRDR-------GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT- 149 (262)
T ss_pred HHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccc-
Confidence 9999764 24788999999999999999999 789999999999999999999999999999876443211
Q ss_pred CccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccccccc
Q 007423 458 SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKS 537 (604)
Q Consensus 458 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 537 (604)
....++..|++||......++.++|+||||+++|||++|+.||..... +..+....... +......
T Consensus 150 ----~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~~~~~~--- 215 (262)
T cd05572 150 ----WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDILK-GNGKLEF--- 215 (262)
T ss_pred ----ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHhc-cCCCCCC---
Confidence 112478899999998888899999999999999999999999975321 11222222111 1111000
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 007423 538 LYGRGNDDEIMQFLRVACSCVVSRPKDRPS-----MYQVYE 573 (604)
Q Consensus 538 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~ 573 (604)
+...+ ..+.+++.+||+.+|++||+ ++|+++
T Consensus 216 --~~~~~---~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 216 --PNYID---KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred --CcccC---HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 01112 34555555999999999999 555544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=330.85 Aligned_cols=253 Identities=27% Similarity=0.340 Sum_probs=204.2
Q ss_pred hhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccccc---HHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 293 ATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLS---EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
.+-++.....||.|.||.||.|. .++|...|||-++..... -+...+|+.++..++|||+|+++|+-..++..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34456677899999999999998 788999999998653322 24578999999999999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
||||++|+|.+.+...+ ..+..-...+..|++.|++||| +.+||||||||.||+++.++.+|++|||.|.
T Consensus 1313 MEyC~~GsLa~ll~~gr-------i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR-------IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHhccCcHHHHHHhcc-------hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeeccccee
Confidence 99999999999997653 3566667778999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCC---CCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHH-H
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMV---ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNH-L 524 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-~ 524 (604)
.+..........+.+..||+.|||||++.+.. ...++||||+|||++||+||++||.... .+|... .
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d---------ne~aIMy~ 1453 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD---------NEWAIMYH 1453 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc---------chhHHHhH
Confidence 87654323333445667999999999987643 5668999999999999999999996432 245332 3
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
+..|..+.+.. ..+.+-.++++ .|+..||+.|.++.|+++
T Consensus 1454 V~~gh~Pq~P~------~ls~~g~dFle---~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1454 VAAGHKPQIPE------RLSSEGRDFLE---HCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HhccCCCCCch------hhhHhHHHHHH---HHHhcCchhhhHHHHHHH
Confidence 44454443322 24556778888 999999999988876654
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=291.41 Aligned_cols=259 Identities=22% Similarity=0.202 Sum_probs=192.7
Q ss_pred CCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeC--CeeeEEee
Q 007423 297 FAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE--EERLLVYK 370 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lv~e 370 (604)
|...+.||+|++|.||+|.. .+++.+|+|++.... ...+.+.+|++++++++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 45668899999999999985 468999999997542 2235688999999999999999999999987 78999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++ +|.+++.... ..+++.....++.|+++||+||| ..+++|+||||+||++++++.+||+|||++...
T Consensus 81 ~~~~-~l~~~~~~~~------~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~ 150 (287)
T cd07840 81 YMDH-DLTGLLDSPE------VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPY 150 (287)
T ss_pred cccc-cHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeec
Confidence 9985 8988886542 35889999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc--
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA-- 527 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 527 (604)
...... ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||........ ...+......
T Consensus 151 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-----~~~~~~~~~~~~ 222 (287)
T cd07840 151 TKRNSA---DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-----LEKIFELCGSPT 222 (287)
T ss_pred cCCCcc---cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHHHhCCCc
Confidence 543211 1122346788999997654 4578999999999999999999999975432110 0000000000
Q ss_pred ---------------CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 528 ---------------GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 528 ---------------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
..........+.......+...+.+++.+||+.+|++||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 223 DENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000000000001345677777999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=293.56 Aligned_cols=256 Identities=19% Similarity=0.229 Sum_probs=185.9
Q ss_pred cEEEecCCeEEEEEEeCCCCEEEEEEeccc---cccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCch
Q 007423 301 NIIISTRTGVSYKAVLPDASALAIKRLSAC---KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL 377 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL 377 (604)
+.+|.|+++.||++.. +++.||||+++.. ....+.+.+|++++++++|+||+++++++...+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3444555555555554 7899999998654 22335789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCC-
Q 007423 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPN- 456 (604)
Q Consensus 378 ~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~- 456 (604)
.+++..... ..+++.....++.|++.||+||| +.+|+||||||+||++++++.+||+|||.+.........
T Consensus 87 ~~~l~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 87 EDLLKTHFP-----EGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred HHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 999975422 24788889999999999999999 789999999999999999999999999998765322110
Q ss_pred --CCccccCCCCcccccCccccCC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 457 --DSSFVHGDLGEFGYVAPEYSST--MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 457 --~~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
.........++..|+|||++.. ..++.++|||||||++|||++|+.||........ ..+ . ..+....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~----~~~---~--~~~~~~~ 229 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM----LLE---K--VRGTVPC 229 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHH---H--HhccCcc
Confidence 0111122346778999998765 3578999999999999999999999975322110 000 0 0000000
Q ss_pred c--------------------cccccc----CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 533 V--------------------VDKSLY----GRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 533 ~--------------------~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
. .++... .........++.+++.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred ccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 000000 00011122356667779999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=296.73 Aligned_cols=270 Identities=18% Similarity=0.221 Sum_probs=196.0
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccc---cccHHHHHHHHHHHhccCCCCccceeeEEEeC-----Ce
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSAC---KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE-----EE 364 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 364 (604)
.+.|...+.||+|+||.||++. ..+++.||||.++.. ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 3568888999999999999998 567899999998643 22345678899999999999999999988654 34
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEccc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDF 444 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DF 444 (604)
.++++||+. ++|.+++... ..+++.....++.|++.||.||| +.+++||||||+||+++.++.+||+||
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Df 152 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-------QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDF 152 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcC
Confidence 799999996 6898888654 35889999999999999999999 789999999999999999999999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCcccccc-------C-
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFK-------G- 515 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~-------~- 515 (604)
|+++........ .....++..|+|||++.. ..++.++|||||||++|||++|+.||.......... .
T Consensus 153 g~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 228 (337)
T cd07858 153 GLARTTSEKGDF----MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP 228 (337)
T ss_pred ccccccCCCccc----ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999876432211 112246889999998754 468899999999999999999999996432110000 0
Q ss_pred --cHHHH-----HHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhchHh
Q 007423 516 --NLVDW-----VNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES--LKSMAEK 581 (604)
Q Consensus 516 --~~~~~-----~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~--L~~i~~~ 581 (604)
....+ ...... ......++.... ..+....++.+++.+||+.+|++|||+.|+++. ++.+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 229 SEEDLGFIRNEKARRYIR--SLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred ChHHhhhcCchhhhHHHH--hcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 00000 000000 000000000000 001122345566669999999999999999887 6665443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=279.38 Aligned_cols=250 Identities=21% Similarity=0.299 Sum_probs=198.1
Q ss_pred CCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeC--CeeeEEe
Q 007423 296 SFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE--EERLLVY 369 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lv~ 369 (604)
+|...+.||+|++|.||+|... +++.|++|++.... ...+.+.+|++++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999954 78999999987544 2346789999999999999999999999988 8899999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++++|.+++... ..+++..+..++.+++.|++||| +.+++|+|++|+||++++++.+||+|||.+..
T Consensus 81 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 150 (260)
T cd06606 81 EYVSGGSLSSLLKKF-------GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKR 150 (260)
T ss_pred EecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence 999999999999755 25899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
....... .......++..|+|||.......+.++||||||++++||++|+.||..... ....+........
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~ 221 (260)
T cd06606 151 LGDIETG--EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-------PMAALYKIGSSGE 221 (260)
T ss_pred ccccccc--ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHhccccCC
Confidence 7543321 001123478899999999888899999999999999999999999975321 1111111111011
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
...+ ....+ ..+.+++.+|++.+|++||++.|+++
T Consensus 222 ~~~~------~~~~~---~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 PPEI------PEHLS---EEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcCC------CcccC---HHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1111 11122 34455555999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=289.72 Aligned_cols=200 Identities=26% Similarity=0.279 Sum_probs=166.6
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeC--CeeeE
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVE--EERLL 367 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 367 (604)
.++|...+.||+|+||.||+|.. .+|+.||+|+++.... ....+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 35788889999999999999994 5689999999864321 123567899999999999999999998765 46899
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||||+.+ +|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|||++
T Consensus 86 v~e~~~~-~l~~~l~~~~------~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~ 155 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP------TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLA 155 (309)
T ss_pred EEecCCC-CHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcccee
Confidence 9999975 8888886542 35899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
+......... ....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 156 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 156 RTYGLPAKPM----TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred eecCCccCCC----CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 8765332111 12235778999998765 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=290.04 Aligned_cols=263 Identities=22% Similarity=0.261 Sum_probs=193.3
Q ss_pred CCcCcEEEecCCeEEEEEEeC-CCCEEEEEEeccccc--cHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeeEEeeec
Q 007423 297 FAVENIIISTRTGVSYKAVLP-DASALAIKRLSACKL--SEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
|...+.||+|++|.||+|+.. +++.||||++..... ......+|+..+++++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456789999999999999964 578999999865332 2334567999999999 999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
+|+|.+++..... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||+++....
T Consensus 81 -~~~l~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDRKG-----KPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhccc-----ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 7899998876531 35899999999999999999999 78999999999999999999999999999986643
Q ss_pred CCCCCCccccCCCCcccccCccccC-CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccC--------cHHHHHHH
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSS-TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKG--------NLVDWVNH 523 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~--------~~~~~~~~ 523 (604)
.... ....++..|+|||++. ...++.++||||||++++||++|+.||......+.... ....|...
T Consensus 152 ~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07830 152 RPPY-----TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226 (283)
T ss_pred CCCc-----CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhH
Confidence 2221 1224788999999774 44578999999999999999999999965432111000 00112111
Q ss_pred HHHcCCcccccccccc---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 524 LVIAGRSRDVVDKSLY---GRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 524 ~~~~~~~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
..........+..... ..........+.+++.+||+.+|++|||+.|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 227 YKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 1111111111000000 0000011245666777999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=283.66 Aligned_cols=250 Identities=20% Similarity=0.271 Sum_probs=191.5
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc------ccHHHHHHHHHHHhccCCCCccceeeEEEeC--Cee
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK------LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE--EER 365 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 365 (604)
.+|...+.||+|+||.||+|. ..++..||+|.+.... ...+.+.+|++++++++|+||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 367888999999999999998 4568999999874321 1224688999999999999999999998764 457
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
++++||+++++|.+++... ..+++.....++.+++.||.||| +.+++|+||||+||+++.++.++|+|||
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg 151 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-------GALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFG 151 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccc
Confidence 8999999999999998754 24788899999999999999999 7899999999999999999999999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHH
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
+++......... .......++..|+|||+..+..++.++|||||||++|||++|+.||...... .-+....
T Consensus 152 ~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~ 222 (264)
T cd06653 152 ASKRIQTICMSG-TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--------AAIFKIA 222 (264)
T ss_pred cccccccccccC-ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--------HHHHHHH
Confidence 998653211111 1112234788999999998888999999999999999999999999643111 1111111
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.......+ .....+++.++++ +||+ +|..||++.+++.
T Consensus 223 -~~~~~~~~-----p~~~~~~~~~~i~---~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 223 -TQPTKPML-----PDGVSDACRDFLK---QIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -cCCCCCCC-----CcccCHHHHHHHH---HHhc-CcccCccHHHHhc
Confidence 11111111 1223344555555 9999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=291.93 Aligned_cols=205 Identities=21% Similarity=0.224 Sum_probs=166.8
Q ss_pred CCcCcEEEecCCeEEEEEEeC---CCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeC--CeeeE
Q 007423 297 FAVENIIISTRTGVSYKAVLP---DASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE--EERLL 367 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~~---~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 367 (604)
|...+.||+|++|.||+|... +++.||+|.+.... ...+.+.+|++++++++||||+++++++... +..++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 667789999999999999953 58999999997632 2235678899999999999999999999987 78999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC----CCCeEEcc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD----DFDARITD 443 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~----~~~~kl~D 443 (604)
||||+++ +|.+++....... ...++......++.|++.||.||| +.+|+||||||+||+++. ++.+||+|
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAK--RVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCC--CcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 9999975 6777665332211 135888999999999999999999 789999999999999999 99999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAG 508 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~ 508 (604)
||+++........ ........++..|+|||++.+ ..++.++|||||||+++||++|++||....
T Consensus 156 fg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 156 LGLARLFNAPLKP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred CccccccCCCccc-ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 9999876433221 111123347889999998765 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=286.92 Aligned_cols=251 Identities=19% Similarity=0.326 Sum_probs=189.2
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCC-CCEEEEEEeccccc--cHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPD-ASALAIKRLSACKL--SEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~-~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lv~e 370 (604)
++|...+.||+|++|.||+|...+ ++.||||.++.... ...++..|++++.+.. ||||+++++++..+...+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 457778999999999999999654 89999999975432 2345677887776664 9999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++ ++.+++.... ..+++..+..++.+++.|++|||+ ..+|+||||+|+||++++++.+||+|||++...
T Consensus 95 ~~~~-~l~~l~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 95 LMST-CLDKLLKRIQ------GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred ccCc-CHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 9864 7777765432 358999999999999999999993 358999999999999999999999999998766
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCC----CCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMV----ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
....... ...++..|+|||++.+.. ++.++||||||+++|||++|+.||...... .+.......
T Consensus 166 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~ 233 (296)
T cd06618 166 VDSKAKT-----RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQ 233 (296)
T ss_pred cCCCccc-----CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhc
Confidence 4322111 123678999999887553 788999999999999999999999642111 111111111
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
+........ ...++ .+.+++.+||+.||++||++.++++.
T Consensus 234 -~~~~~~~~~----~~~~~---~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 234 -EEPPSLPPN----EGFSP---DFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -CCCCCCCCC----CCCCH---HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111110 01223 45555669999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=282.39 Aligned_cols=249 Identities=18% Similarity=0.244 Sum_probs=187.2
Q ss_pred HHHHHhhcCCCcCcEE--EecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhcc-CCCCccceeeEEEeCC
Q 007423 288 ADLLAATNSFAVENII--ISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEE 363 (604)
Q Consensus 288 ~~l~~~~~~~~~~~~i--g~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 363 (604)
.+...-.++|...+.+ |+|+||.||++. ..++..+|+|.+........ |+.....+ +||||+++++++...+
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 3444445666666666 999999999998 46788999999865332211 22222222 7999999999999999
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC-CeEEc
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF-DARIT 442 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~-~~kl~ 442 (604)
..++||||+++|+|.+++... ..+++.....++.|+++||.||| +.+++||||||+||+++.++ .++|+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE-------GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEe
Confidence 999999999999999999754 25899999999999999999999 78899999999999999888 99999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHH
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVN 522 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 522 (604)
|||+++....... ..++..|+|||++.+..++.++|||||||++|||+||+.||.....++ -....+..
T Consensus 153 dfg~~~~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~~~ 221 (267)
T PHA03390 153 DYGLCKIIGTPSC--------YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---LDLESLLK 221 (267)
T ss_pred cCccceecCCCcc--------CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch---hhHHHHHH
Confidence 9999886642211 137889999999998889999999999999999999999997432211 01122221
Q ss_pred HHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 007423 523 HLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS-MYQVYE 573 (604)
Q Consensus 523 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~ev~~ 573 (604)
.. ....... ...+.. +.+++.+||+.+|++||+ ++|+++
T Consensus 222 ~~---~~~~~~~------~~~~~~---~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 222 RQ---QKKLPFI------KNVSKN---ANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hh---cccCCcc------cccCHH---HHHHHHHHhccChhhCCchHHHHhc
Confidence 11 1000110 112233 444555999999999996 688864
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=278.57 Aligned_cols=246 Identities=24% Similarity=0.373 Sum_probs=196.6
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+|+..+.||+|++|.||++.. .+++.||+|.+..... ..+.+.+|++++++++|+|++++++++..++..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 366778999999999999984 4688999999976543 345789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++++|.+++... ..+++..+..++.|++.|+.||| +.+|+||||||+||+++.++.+||+|||.+....
T Consensus 81 ~~~~~L~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 150 (254)
T cd06627 81 AENGSLRQIIKKF-------GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLN 150 (254)
T ss_pred CCCCcHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecC
Confidence 9999999998754 35899999999999999999999 7899999999999999999999999999998775
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
...... ....++..|+|||...+..++.++||||+|+++|||++|+.||..... .... ... ......
T Consensus 151 ~~~~~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-------~~~~-~~~-~~~~~~ 217 (254)
T cd06627 151 DVSKDD----ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-------MAAL-FRI-VQDDHP 217 (254)
T ss_pred CCcccc----cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-------HHHH-HHH-hccCCC
Confidence 433221 122478899999998887789999999999999999999999964321 1111 111 111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
. +. ...++.+ .+++.+||+.+|++||++.|++.
T Consensus 218 ~-~~-----~~~~~~~---~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 P-LP-----EGISPEL---KDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred C-CC-----CCCCHHH---HHHHHHHHhCChhhCcCHHHHhc
Confidence 1 11 1122344 45555999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=283.55 Aligned_cols=248 Identities=21% Similarity=0.284 Sum_probs=198.6
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+|+..+.||+|++|.||++. ..+++.+|+|.+.... ....++.+|++++++++|+||+++.+++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 46777899999999999998 5578899999986532 2235678999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++++|.+++...... ...+++.....++.+++.||+||| +.+++|+||+|+||++++++.+||+|||+++...
T Consensus 81 ~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~ 154 (256)
T cd08530 81 APFGDLSKAISKRKKK---RKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK 154 (256)
T ss_pred cCCCCHHHHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence 9999999998753211 135889999999999999999999 8899999999999999999999999999998775
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
.... ....++..|++||...+..++.++|+||||+++|||++|+.||...... + .......+...
T Consensus 155 ~~~~------~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--------~-~~~~~~~~~~~ 219 (256)
T cd08530 155 KNMA------KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--------D-LRYKVQRGKYP 219 (256)
T ss_pred cCCc------ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------H-HHHHHhcCCCC
Confidence 4311 1224788999999998888999999999999999999999999753221 1 11112222221
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.. ......++.+++.+|++.+|++||++.|+++
T Consensus 220 ~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 PI---------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CC---------chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11 1122344566666999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=293.83 Aligned_cols=265 Identities=19% Similarity=0.210 Sum_probs=190.5
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCC------e
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE------E 364 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~ 364 (604)
++|...+.||+|+||.||+|. ..+++.||||+++... .....+.+|++++++++||||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 678888999999999999999 4579999999986432 22356889999999999999999999987542 4
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEccc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDF 444 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DF 444 (604)
.++|+||+.. +|.+++. ..+++.....++.|++.||+||| +.+++||||||+||+++.++.+||+||
T Consensus 95 ~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~df 161 (342)
T cd07879 95 FYLVMPYMQT-DLQKIMG---------HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDF 161 (342)
T ss_pred EEEEeccccc-CHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeC
Confidence 6899999975 7776652 24788999999999999999999 789999999999999999999999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccC-------c
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKG-------N 516 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~-------~ 516 (604)
|+++...... .+..++..|+|||++.+ ..++.++|||||||++|||++|+.||........... .
T Consensus 162 g~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (342)
T cd07879 162 GLARHADAEM-------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 234 (342)
T ss_pred CCCcCCCCCC-------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9987653211 12246788999998765 4688999999999999999999999975321110000 0
Q ss_pred HHHHHHHHHHc------CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhchH
Q 007423 517 LVDWVNHLVIA------GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES--LKSMAE 580 (604)
Q Consensus 517 ~~~~~~~~~~~------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~--L~~i~~ 580 (604)
...+....... ..........+.. ..+.....+.+++.+||+.||++||++.|++.. ++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000000000 0000000000000 000112235566669999999999999999854 665543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=286.49 Aligned_cols=243 Identities=21% Similarity=0.218 Sum_probs=186.7
Q ss_pred EEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCch
Q 007423 303 IISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL 377 (604)
Q Consensus 303 ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL 377 (604)
||+|+||.||++. ..+++.||+|.+.... ...+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 5899999999998 4578999999986432 2234577899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCC
Q 007423 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPND 457 (604)
Q Consensus 378 ~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 457 (604)
.+++..... ..+++.....++.|++.||.||| ..+++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 150 (277)
T cd05577 81 KYHIYNVGE-----PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK-- 150 (277)
T ss_pred HHHHHHcCc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--
Confidence 999975532 25889999999999999999999 78999999999999999999999999999886543211
Q ss_pred CccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccccccc
Q 007423 458 SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKS 537 (604)
Q Consensus 458 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 537 (604)
.....++..|+|||+..+..++.++|||||||++|||++|+.||....... ....+.... ... +.
T Consensus 151 ---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~----~~~---~~ 215 (277)
T cd05577 151 ---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-----EKEELKRRT----LEM---AV 215 (277)
T ss_pred ---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-----cHHHHHhcc----ccc---cc
Confidence 112347789999999888889999999999999999999999996532210 001111100 000 00
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007423 538 LYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYE 573 (604)
Q Consensus 538 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 573 (604)
......++.+.+++ .+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~~~~li---~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 216 EYPDKFSPEAKDLC---EALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCCccCCHHHHHHH---HHHccCChhHccCCCcccHHHHHh
Confidence 01112234444444 499999999999 5555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=286.19 Aligned_cols=262 Identities=22% Similarity=0.195 Sum_probs=194.1
Q ss_pred CCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 297 FAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
|...+.||+|++|.||++.. .+++.+|+|+++.... ..+.+.+|++++++++|+||+++++++..++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 45568899999999999985 5789999999865432 2457889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++ +|.+++.... ..+++..+..++.+++.||.||| +.+|+|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~-~l~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~ 150 (283)
T cd05118 81 DT-DLYKLIKDRQ------RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGS 150 (283)
T ss_pred CC-CHHHHHHhhc------ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence 75 8888887542 35899999999999999999999 78999999999999999999999999999987754
Q ss_pred CCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcH-------HHHHHHH
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNL-------VDWVNHL 524 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~ 524 (604)
.... .....++..|+|||...+. .++.++||||||+++|+|+||+.||......+...... ..+....
T Consensus 151 ~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 151 PVRP----YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred Cccc----ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccc
Confidence 3311 1123477889999988766 78999999999999999999999996533211100000 0000000
Q ss_pred HH---cC--CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 525 VI---AG--RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 525 ~~---~~--~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.. .. ......+... ....+....++.+++.+||+.||.+||++.|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 00 0000000000 0001122345667777999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=314.03 Aligned_cols=202 Identities=20% Similarity=0.208 Sum_probs=158.3
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCC--CCEEEEE------------------EeccccccHHHHHHHHHHHhccCCCCcc
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPD--ASALAIK------------------RLSACKLSEKQFRSEMNRLGQLRHPNLV 353 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~--~~~vAvK------------------~l~~~~~~~~~~~~Ei~~l~~l~H~niv 353 (604)
.++|.+.+.||+|+||.||++.... +..+++| ++.......+.+.+|++++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4679999999999999999987432 2222222 1111122235688999999999999999
Q ss_pred ceeeEEEeCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe
Q 007423 354 PLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI 433 (604)
Q Consensus 354 ~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl 433 (604)
++++++...+..++++|++. ++|.+++....... ...........++.|++.||.||| +.+|+||||||+|||+
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~--~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl 300 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDW--KDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFL 300 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccc--cccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 99999999999999999985 47887775432211 112335567789999999999999 7899999999999999
Q ss_pred CCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCC
Q 007423 434 DDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPL 504 (604)
Q Consensus 434 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~ 504 (604)
+.++.+||+|||+++.+....... ..+..||..|+|||++.+..++.++|||||||++|||++|+.++
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAF---DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccc---cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999998764322211 12335899999999999989999999999999999999987643
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=291.39 Aligned_cols=246 Identities=22% Similarity=0.296 Sum_probs=201.4
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
+.|..-++||+|+||.||-+. ..+|+.+|.|++.+.. ..+.-..+|-.+|.+++.+.||.+-..|++.+..++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 457888999999999999998 5569999999985432 23345788999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
..|.+|+|.-+|.+.+. ..++....+.+|.+|+.||++|| ...||.||+||+|||+|++|+++|+|.|+|..
T Consensus 265 tlMNGGDLkfHiyn~g~-----~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN-----PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EeecCCceeEEeeccCC-----CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEe
Confidence 99999999999987753 35899999999999999999999 88999999999999999999999999999998
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
+..... ..+.+||.+|||||++....|+...|.||+||++|||+.|+.||...... .-.+.+.+.+..
T Consensus 337 i~~g~~-----~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK-----vk~eEvdrr~~~-- 404 (591)
T KOG0986|consen 337 IPEGKP-----IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK-----VKREEVDRRTLE-- 404 (591)
T ss_pred cCCCCc-----cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh-----hhHHHHHHHHhc--
Confidence 754433 34557999999999999999999999999999999999999999753211 011112222221
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSM 568 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 568 (604)
|+.-.++..+++.+.+.+ .-++.||++|...
T Consensus 405 -----~~~ey~~kFS~eakslc~---~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 405 -----DPEEYSDKFSEEAKSLCE---GLLTKDPEKRLGC 435 (591)
T ss_pred -----chhhcccccCHHHHHHHH---HHHccCHHHhccC
Confidence 222233445677888887 7888999999654
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=288.10 Aligned_cols=244 Identities=25% Similarity=0.306 Sum_probs=188.9
Q ss_pred CCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 297 FAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
|+..+.||+|++|.||+|+ ..++..||+|.+.... ...+++.+|++++++++|+|++++.+++......++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 5556789999999999999 4568899999986421 2234688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+. |++.+++.... ..+++..+..++.+++.|+.||| +.+++||||||+||++++++.+||+|||++....
T Consensus 97 ~~-~~l~~~~~~~~------~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 97 CL-GSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred cC-CCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 96 58888775432 34789999999999999999999 7899999999999999999999999999987654
Q ss_pred CCCCCCCccccCCCCcccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSS---TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
... ...++..|+|||++. ...++.++|||||||++|||++|+.||..... ....... ..+
T Consensus 167 ~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~-~~~ 229 (308)
T cd06634 167 PAN--------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHI-AQN 229 (308)
T ss_pred Ccc--------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH--------HHHHHHH-hhc
Confidence 321 123788999999864 34578899999999999999999999864321 1111111 111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESL 575 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 575 (604)
..... .....+.. +.+++.+||+.+|++||++.++++.-
T Consensus 230 ~~~~~-----~~~~~~~~---~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 230 ESPAL-----QSGHWSEY---FRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CCCCc-----CcccccHH---HHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 11111 11122333 44555599999999999999998763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=286.61 Aligned_cols=259 Identities=21% Similarity=0.211 Sum_probs=190.8
Q ss_pred CCcCcEEEecCCeEEEEEEeC-CCCEEEEEEeccccc---cHHHHHHHHHHHhcc---CCCCccceeeEEEeCCe-----
Q 007423 297 FAVENIIISTRTGVSYKAVLP-DASALAIKRLSACKL---SEKQFRSEMNRLGQL---RHPNLVPLLGFCVVEEE----- 364 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~----- 364 (604)
|+..+.||+|+||.||+|+.. +++.||+|+++.... ....+.+|+++++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456789999999999999965 589999999974322 124567788877666 69999999999988776
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEccc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDF 444 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DF 444 (604)
.+++|||+++ +|.+++..... ..+++..+..++.|++.||.||| +.+++|+|++|+||++++++.+||+||
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-----~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~df 151 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-----PGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADF 151 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEecc
Confidence 8999999975 89988865421 24899999999999999999999 789999999999999999999999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
|++......... ....++..|+|||+..+..++.++|||||||++|||+||++||......+. ...+....
T Consensus 152 g~~~~~~~~~~~-----~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~----~~~~~~~~ 222 (287)
T cd07838 152 GLARIYSFEMAL-----TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ----LDKIFDVI 222 (287)
T ss_pred CcceeccCCccc-----ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH----HHHHHHHc
Confidence 999876433211 122367889999999888899999999999999999999999875432211 11111100
Q ss_pred HHcCCc---------ccccccccc---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 525 VIAGRS---------RDVVDKSLY---GRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 525 ~~~~~~---------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
...+.. ......... ....++....+.+++.+||+.||++||++.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000 000000000 0001122345566777999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=286.55 Aligned_cols=202 Identities=23% Similarity=0.263 Sum_probs=167.3
Q ss_pred hhcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCC-----
Q 007423 293 ATNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE----- 363 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 363 (604)
..++|+..+.||+|+||.||+|.. .+++.||||+++... .....+.+|++++++++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 456788899999999999999995 568999999986432 22356788999999999999999999987654
Q ss_pred -----eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC
Q 007423 364 -----ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD 438 (604)
Q Consensus 364 -----~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~ 438 (604)
..++++||+++ ++.+.+.... ..+++.....++.|++.||+||| +.+|+|+||||+||++++++.
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGL------VHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCc
Confidence 78999999986 7777776432 35899999999999999999999 789999999999999999999
Q ss_pred eEEcccCCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 439 ~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
+||+|||++.......... .....++..|+|||++.+ ..++.++|||||||++|||++|++||...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 155 IKLADFGLARLYNSEESRP---YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred EEeCcccccccccCCcccc---cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999998764432211 112235778999998754 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=286.30 Aligned_cols=243 Identities=19% Similarity=0.293 Sum_probs=190.3
Q ss_pred cEEEecCCeEEEEEEe-CCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCchh
Q 007423 301 NIIISTRTGVSYKAVL-PDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~ 378 (604)
..||+|+||.||++.. .+++.||||++.... ...+.+.+|+.++++++|+||+++++++...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999985 678999999986433 23456889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCC
Q 007423 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDS 458 (604)
Q Consensus 379 ~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 458 (604)
+++... .+++.....++.|++.|++||| +.+++|+||+|+||++++++.++|+|||++..........
T Consensus 106 ~~~~~~--------~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~- 173 (292)
T cd06657 106 DIVTHT--------RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR- 173 (292)
T ss_pred HHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccccc-
Confidence 987532 4789999999999999999999 7899999999999999999999999999987654322111
Q ss_pred ccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccc
Q 007423 459 SFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSL 538 (604)
Q Consensus 459 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 538 (604)
....|+..|+|||+..+..++.++|||||||++|||++|+.||..... .+.+.. ...+...... ..
T Consensus 174 ---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--------~~~~~~-~~~~~~~~~~--~~ 239 (292)
T cd06657 174 ---KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKM-IRDNLPPKLK--NL 239 (292)
T ss_pred ---cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH-HHhhCCcccC--Cc
Confidence 122478899999998888889999999999999999999999864221 111111 1111110000 00
Q ss_pred cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 539 YGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 539 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
...+.. +.+++.+||+.+|.+||++.|+++.
T Consensus 240 --~~~~~~---l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 240 --HKVSPS---LKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred --ccCCHH---HHHHHHHHHhCCcccCcCHHHHhcC
Confidence 111223 3445559999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=283.32 Aligned_cols=247 Identities=24% Similarity=0.274 Sum_probs=190.3
Q ss_pred EEecCCeEEEEEEeC-CCCEEEEEEeccccc----cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCch
Q 007423 303 IISTRTGVSYKAVLP-DASALAIKRLSACKL----SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL 377 (604)
Q Consensus 303 ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL 377 (604)
||+|+||.||++... +++.+|+|.+..... ..+.+.+|++++++++||||+++++.+..++..+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 578999999999965 499999999865432 235688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCC
Q 007423 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPND 457 (604)
Q Consensus 378 ~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 457 (604)
.+++... ..+++..+..++.|+++||+||| +.+++|+||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~l~~~-------~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 150 (265)
T cd05579 81 ASLLENV-------GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN 150 (265)
T ss_pred HHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc
Confidence 9999754 25889999999999999999999 7899999999999999999999999999987653321100
Q ss_pred ----CccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 458 ----SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 458 ----~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
........++..|+|||.......+.++||||||+++|||+||+.||...... +..... ..+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~-~~~~~~~~ 221 (265)
T cd05579 151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--------EIFQNI-LNGKIEWP 221 (265)
T ss_pred cccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHH-hcCCcCCC
Confidence 00112234678899999988888899999999999999999999999753221 111111 11111100
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
.. ...+.. +.+++.+||+.+|++|||+.++.+.|+
T Consensus 222 ---~~--~~~~~~---~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 222 ---ED--VEVSDE---AIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ---cc--ccCCHH---HHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00 001233 445555999999999999966655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=292.19 Aligned_cols=266 Identities=21% Similarity=0.241 Sum_probs=194.5
Q ss_pred HHHHhhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEe-CC
Q 007423 289 DLLAATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV-EE 363 (604)
Q Consensus 289 ~l~~~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~ 363 (604)
++...+++|...+.||.|+||.||++. ..+++.||||++.... ...+.+.+|++++++++||||+++.+++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 445678889999999999999999998 5589999999885422 234678899999999999999999999876 55
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
..++++||+ +++|.+++... .+++.....++.|+++||.||| +.+|+||||+|+||++++++.+||+|
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~--------~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~d 151 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR--------PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICD 151 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCc
Confidence 788999998 45898888643 3678888899999999999999 78999999999999999999999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccc-------cC
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGF-------KG 515 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~-------~~ 515 (604)
||.+....... ....++..|+|||++.+ ..++.++|||||||++|||+||+.||......... ..
T Consensus 152 fg~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~ 224 (328)
T cd07856 152 FGLARIQDPQM-------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGT 224 (328)
T ss_pred cccccccCCCc-------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99987543211 12236788999998765 56899999999999999999999999653221100 00
Q ss_pred cHHHHHHHHHHcCCccccccc-cccCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 516 NLVDWVNHLVIAGRSRDVVDK-SLYGRGND-----DEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~d~-~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
...+|........ ..+.+.. ......+. .....+.+++.+||+.+|++||++.|++..
T Consensus 225 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 225 PPDDVINTICSEN-TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCHHHHHhccchh-hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0011111110000 0000000 00000000 012345566669999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=277.00 Aligned_cols=250 Identities=18% Similarity=0.279 Sum_probs=198.6
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+|...+.||.|++|.||++.. .++..||+|++.... ...+++.+|++++++++|||++++.+.+..++..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 467778999999999999995 468999999997543 3345788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++++|.+++...... ...+++.....++.+++.||.||| +.+++|+||+|+||++++++.++|+|||.+....
T Consensus 81 ~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 154 (258)
T cd08215 81 ADGGDLSQKIKKQKKE---GKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS 154 (258)
T ss_pred cCCCcHHHHHHHhhcc---CCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecc
Confidence 9999999999764211 135899999999999999999999 7899999999999999999999999999998764
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
..... .....|+..|+|||......++.++||||+|+++++|++|+.||..... .+...... .....
T Consensus 155 ~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~~ 221 (258)
T cd08215 155 STVDL----AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--------LELALKIL-KGQYP 221 (258)
T ss_pred cCcce----ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--------HHHHHHHh-cCCCC
Confidence 43211 1122478899999998888899999999999999999999999964321 11122211 11111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.. ....+. .+.+++.+||..+|++||++.|+++
T Consensus 222 ~~------~~~~~~---~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 PI------PSQYSS---ELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CC------CCCCCH---HHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11 111223 4455555999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=283.57 Aligned_cols=240 Identities=20% Similarity=0.246 Sum_probs=181.6
Q ss_pred EEEecCCeEEEEEEe-CCCCEEEEEEeccccc----cHHHHHHHHH---HHhccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 302 IIISTRTGVSYKAVL-PDASALAIKRLSACKL----SEKQFRSEMN---RLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 302 ~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ei~---~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
+||+|+||.||++.. .+++.||+|.+..... ....+..|.. .++...||||+++.+++..++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 479999999999984 5689999999864321 1223444443 4445589999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+|+|.+++... ..+++..+..++.|++.|+.||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 81 g~~L~~~l~~~-------~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~ 150 (278)
T cd05606 81 GGDLHYHLSQH-------GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 150 (278)
T ss_pred CCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc
Confidence 99999988654 35899999999999999999999 789999999999999999999999999998765322
Q ss_pred CCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
.. ....|+..|+|||++.+. .++.++||||+||++|||++|+.||....... . .........
T Consensus 151 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~-----~-~~~~~~~~~----- 213 (278)
T cd05606 151 KP------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----K-HEIDRMTLT----- 213 (278)
T ss_pred CC------cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc-----h-HHHHHHhhc-----
Confidence 11 122488999999998644 68999999999999999999999997532211 0 011111111
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYE 573 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 573 (604)
.++.+.. ..+.+ +.+++.+|+..+|++|| ++.|+++
T Consensus 214 -~~~~~~~-~~s~~---~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 214 -MAVELPD-SFSPE---LRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -cCCCCCC-cCCHH---HHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1111111 11233 44455599999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=281.11 Aligned_cols=242 Identities=21% Similarity=0.198 Sum_probs=183.4
Q ss_pred cEEEecCCeEEEEEEe-CCCCEEEEEEecccccc----HHHHHHHHHH-HhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 301 NIIISTRTGVSYKAVL-PDASALAIKRLSACKLS----EKQFRSEMNR-LGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
+.||+|++|.||+|.. .+++.||||.++..... ...+..|..+ ....+|+|++++++++..++..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999984 56899999998653321 1234455554 4555899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.+||+|||+++.....
T Consensus 82 ~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 150 (260)
T cd05611 82 GDCASLIKTL-------GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN- 150 (260)
T ss_pred CCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceecccc-
Confidence 9999999754 35788899999999999999999 789999999999999999999999999998764321
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
....++..|+|||...+..++.++||||||+++|||+||+.||...... ..... ...+....
T Consensus 151 -------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~-~~~~~~~~-- 212 (260)
T cd05611 151 -------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--------AVFDN-ILSRRINW-- 212 (260)
T ss_pred -------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHH-HHhcccCC--
Confidence 1123778899999988888899999999999999999999999643221 11111 11111110
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESL 575 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 575 (604)
.... ....+. .+.+++.+||+.+|++||++.++.+.|
T Consensus 213 ~~~~-~~~~~~---~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 213 PEEV-KEFCSP---EAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred CCcc-cccCCH---HHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 0000 011223 345555599999999999876665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=290.71 Aligned_cols=201 Identities=21% Similarity=0.271 Sum_probs=163.4
Q ss_pred CCCcCcEEEecCCeEEEEEEeC-C--CCEEEEEEecccc---ccHHHHHHHHHHHhcc-CCCCccceeeEEEeC----Ce
Q 007423 296 SFAVENIIISTRTGVSYKAVLP-D--ASALAIKRLSACK---LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVE----EE 364 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~-~--~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~----~~ 364 (604)
+|...+.||+|+||.||++... . +..||||++.... ...+.+.+|+++++++ .||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3667789999999999999943 4 7899999986421 2245688999999999 599999999976432 35
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEccc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDF 444 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DF 444 (604)
.++++||+. ++|.+++... ..+++.....++.|++.||.||| ..+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Df 149 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-------QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDF 149 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcC
Confidence 688889886 5899988644 35889999999999999999999 789999999999999999999999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
|+++.................|+..|+|||+..+ ..++.++|||||||++|||++|+.||...
T Consensus 150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred CCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 9998764322211111223458899999998765 46889999999999999999999999753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=296.04 Aligned_cols=248 Identities=21% Similarity=0.307 Sum_probs=200.6
Q ss_pred hhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccccc---HHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 293 ATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLS---EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
....|.+...||+|.|+.|..+. ...+..||||.++++..+ ...+.+|+++|+.++|||||+++.+...+...|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 34678888999999999999998 557999999999876533 34588999999999999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+.+|.+++++..++ .+.......+..|+.+|++|+| .+.|+|||||++||||+.++.+||+|||++.
T Consensus 134 ~eya~~ge~~~yl~~~g-------r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG-------RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred EEeccCchhHHHHHhcc-------cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccce
Confidence 99999999999998774 3445777888999999999999 8899999999999999999999999999999
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA-SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
.+.... .....+|++.|.|||++.+..+ ++++|+||+|+++|-|+.|..||+...-.+. +..+..
T Consensus 204 ~~~~~~-----~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L---------r~rvl~ 269 (596)
T KOG0586|consen 204 FFDYGL-----MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL---------RPRVLR 269 (596)
T ss_pred eecccc-----cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc---------cchhee
Confidence 885322 2233469999999999998775 6899999999999999999999986432110 111111
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
++.+ .+.+...+.+.+++ +.+..+|.+|+++++|.+.
T Consensus 270 gk~r-------Ip~~ms~dce~lLr---k~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 270 GKYR-------IPFYMSCDCEDLLR---KFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeec-------ccceeechhHHHHH---HhhccCccccCCHHHhhhh
Confidence 1111 11223334455555 9999999999999999664
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=284.64 Aligned_cols=254 Identities=20% Similarity=0.225 Sum_probs=194.0
Q ss_pred CCCcCcEEEecCCeEEEEEEe----CCCCEEEEEEecccc-----ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCee
Q 007423 296 SFAVENIIISTRTGVSYKAVL----PDASALAIKRLSACK-----LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEER 365 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~----~~~~~vAvK~l~~~~-----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 365 (604)
+|...+.||+|++|.||++.. .+++.||||.++... ...+.+.+|++++.++ +||||+++.+.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 366778999999999999873 357899999986432 1235688999999999 599999999999999999
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
++||||+++|+|.+++... ..+++.....++.|+++||.||| ..+++||||||+||+++.++.++|+|||
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg 150 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-------EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFG 150 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-------CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECc
Confidence 9999999999999998654 34788999999999999999999 7899999999999999999999999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCCCC--CCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHH
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMV--ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNH 523 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 523 (604)
+++.......... ....|+..|+|||...+.. .+.++||||||+++|||+||+.||...... ....+....
T Consensus 151 ~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~~~~~ 223 (288)
T cd05583 151 LSKEFLAEEEERA---YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ----NSQSEISRR 223 (288)
T ss_pred ccccccccccccc---ccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc----chHHHHHHH
Confidence 9886543321111 1224788999999887654 788999999999999999999999642211 111121111
Q ss_pred HHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 524 LVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 524 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
.. ... +... ...+.+ +.+++.+||+.||++|||+.++.+.|+.
T Consensus 224 ~~-~~~------~~~~-~~~~~~---l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 224 IL-KSK------PPFP-KTMSAE---ARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HH-ccC------CCCC-cccCHH---HHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 11 111 0010 111233 3445559999999999999988777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=292.13 Aligned_cols=268 Identities=19% Similarity=0.263 Sum_probs=191.9
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccc---cccHHHHHHHHHHHhcc-CCCCccceeeEEEeC--Ceee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSAC---KLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVE--EERL 366 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~--~~~~ 366 (604)
.++|...+.||+|+||.||+|.. .+++.+|||++... ......+.+|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 45678889999999999999995 46889999998542 12234577899999999 999999999998653 3679
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
+||||++ ++|.+++... .++|..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+
T Consensus 86 lv~e~~~-~~L~~~~~~~--------~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN--------ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred EEecccc-cCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 9999997 5999888643 4788999999999999999999 78999999999999999999999999999
Q ss_pred ccccCCCCCCC-CccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCc-------H
Q 007423 447 ARLVGSRDPND-SSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGN-------L 517 (604)
Q Consensus 447 a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~-------~ 517 (604)
++......... ........|+..|+|||++.+ ..++.++||||||+++|||+||+.||......+..... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 98764332110 111122347889999998754 45788999999999999999999999653321110000 0
Q ss_pred HHHHHHHHHcCCcccccc----ccc--cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 518 VDWVNHLVIAGRSRDVVD----KSL--YGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 518 ~~~~~~~~~~~~~~~~~d----~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.+..... .........+ ... ...........+.+++.+||+.||++|||+.++++.
T Consensus 234 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 234 AEDIESI-KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHH-HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000 0000000000 000 000000112345666679999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=284.36 Aligned_cols=243 Identities=25% Similarity=0.300 Sum_probs=188.1
Q ss_pred CCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 297 FAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
|...+.||+|+||.||+|+. .+++.||+|++.... ...+.+.+|++++++++|||++++++++......+++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 44557899999999999984 578999999986432 1224688899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+. |++.+++.... ..+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.+||+|||++....
T Consensus 103 ~~-~~l~~~l~~~~------~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~ 172 (313)
T cd06633 103 CL-GSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS 172 (313)
T ss_pred CC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence 96 57888776432 35889999999999999999999 7899999999999999999999999999986432
Q ss_pred CCCCCCCccccCCCCcccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSS---TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
.. ....|+..|+|||++. ...++.++|||||||++|||++|+.||..... ...+..... .
T Consensus 173 ~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~-~ 235 (313)
T cd06633 173 PA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQ-N 235 (313)
T ss_pred CC--------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHh-c
Confidence 11 1224788999999874 45688899999999999999999999865321 111111111 1
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
...... ....+.. +.+++.+||+.+|++||++.++++.
T Consensus 236 ~~~~~~-----~~~~~~~---l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 236 DSPTLQ-----SNEWTDS---FRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCCC-----ccccCHH---HHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 1112233 4445559999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=282.29 Aligned_cols=250 Identities=18% Similarity=0.232 Sum_probs=190.2
Q ss_pred CCCcCcEEEecCCeEEEEEEe----CCCCEEEEEEecccc-----ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCee
Q 007423 296 SFAVENIIISTRTGVSYKAVL----PDASALAIKRLSACK-----LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEER 365 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~----~~~~~vAvK~l~~~~-----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 365 (604)
+|...+.||+|+||.||++.. .+|..||+|+++... ...+++.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 366778999999999999984 478999999986532 2235688999999999 589999999999998899
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
++|+||+++++|.+++... ..+++.....++.|+++||.||| +.+++||||||+|||+++++.+||+|||
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg 150 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-------ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFG 150 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCc
Confidence 9999999999999999754 34788888999999999999999 7899999999999999999999999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHH
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM--VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNH 523 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 523 (604)
+++......... .....|+..|+|||..... .++.++||||||+++|||+||+.||...... ....++...
T Consensus 151 ~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----~~~~~~~~~ 223 (290)
T cd05613 151 LSKEFHEDEVER---AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK----NSQAEISRR 223 (290)
T ss_pred cceecccccccc---cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc----ccHHHHHHH
Confidence 998764322111 1123478899999988653 4678999999999999999999999643211 112222221
Q ss_pred HHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007423 524 LVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYE 573 (604)
Q Consensus 524 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 573 (604)
..... .. . ....+. .+.+++.+||+.||++|| ++.+++.
T Consensus 224 ~~~~~--~~-----~-~~~~~~---~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 224 ILKSE--PP-----Y-PQEMSA---LAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred hhccC--CC-----C-CccCCH---HHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 11111 00 0 011222 344555599999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=289.62 Aligned_cols=201 Identities=22% Similarity=0.300 Sum_probs=169.3
Q ss_pred HHHHHHhhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeC
Q 007423 287 LADLLAATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE 362 (604)
Q Consensus 287 ~~~l~~~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 362 (604)
..++...+++|...+.||+|+||.||++. ..+++.||+|+++... ...+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 45677788999999999999999999998 5678999999997532 2235688999999999999999999988643
Q ss_pred ------CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC
Q 007423 363 ------EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD 436 (604)
Q Consensus 363 ------~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~ 436 (604)
...+++++++ +++|.+++... .+++..+..++.|+++||.||| +.+|+||||||+||+++++
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~ 156 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ--------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNED 156 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCC
Confidence 3367888877 77998887643 4889999999999999999999 7899999999999999999
Q ss_pred CCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 437 FDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 437 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
+.+||+|||+++...... ....++..|+|||+..+ ..++.++|||||||++|||++|+.||..
T Consensus 157 ~~~kl~dfg~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 157 CELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred CCEEEecccccccccccc-------cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999988653211 12247889999998765 5678899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=268.20 Aligned_cols=246 Identities=19% Similarity=0.339 Sum_probs=187.5
Q ss_pred CcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeeEEeeecCCC
Q 007423 300 ENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEERLLVYKHMPNG 375 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lv~ey~~~g 375 (604)
...||+|..|.|+++. ...|..+|||.+.... .+.+++...+.++.+.+ .|.||+.+|||......++.||.|.-
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 3569999999999998 5568999999997643 34467888888877665 79999999999999999999999854
Q ss_pred chhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCC
Q 007423 376 TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDP 455 (604)
Q Consensus 376 sL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 455 (604)
-+..+++... .++++...-++...++.||.||.. +++|||||+||+|||+|+.|++|++|||++-.+..+..
T Consensus 176 C~ekLlkrik------~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 176 CAEKLLKRIK------GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHHHHhc------CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 5555555432 457777777888899999999986 78999999999999999999999999999987754433
Q ss_pred CCCccccCCCCcccccCccccCC---CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 456 NDSSFVHGDLGEFGYVAPEYSST---MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 456 ~~~~~~~~~~gt~~y~aPE~~~~---~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
+.. ..|.+.|||||.+.- ..|+.++|||||||+++||+||+.||.....+ + + +...+.. ..+.
T Consensus 248 htr-----sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--F-----e-~ltkvln-~ePP 313 (391)
T KOG0983|consen 248 HTR-----SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--F-----E-VLTKVLN-EEPP 313 (391)
T ss_pred ccc-----ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--H-----H-HHHHHHh-cCCC
Confidence 222 248899999998753 46899999999999999999999999753221 1 1 1111222 2222
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.+++. ...+....++++ .|+..|+.+||...++++.
T Consensus 314 ~L~~~---~gFSp~F~~fv~---~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 314 LLPGH---MGFSPDFQSFVK---DCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCcc---cCcCHHHHHHHH---HHhhcCcccCcchHHHhcC
Confidence 22221 124445555555 9999999999999887653
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=290.13 Aligned_cols=204 Identities=25% Similarity=0.293 Sum_probs=165.2
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCC------
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE------ 363 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 363 (604)
.++|...+.||+|++|.||+|. ..+++.||||++.... .....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4678889999999999999999 4578999999985422 12346788999999999999999999875433
Q ss_pred --eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEE
Q 007423 364 --ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARI 441 (604)
Q Consensus 364 --~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl 441 (604)
..++++||+.. ++...+.... ..+++..+..++.|+++||+||| +.+|+|+||||+||++++++.+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~------~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l 156 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS------VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKI 156 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEE
Confidence 46999999975 6777766432 35899999999999999999999 789999999999999999999999
Q ss_pred cccCCccccCCCCCCCC-------ccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 442 TDFGLARLVGSRDPNDS-------SFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 442 ~DFGla~~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
+|||+++.......... .......++..|+|||+..+ ..++.++|||||||++|||++|++||...
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 99999986643221111 11122346788999998754 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=288.89 Aligned_cols=261 Identities=19% Similarity=0.219 Sum_probs=190.9
Q ss_pred hhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCC-----
Q 007423 293 ATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE----- 363 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 363 (604)
..++|...+.||+|+||.||++. ..++..||||++..... ..+.+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 45678889999999999999998 56799999999864322 2356889999999999999999999987643
Q ss_pred -eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEc
Q 007423 364 -ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARIT 442 (604)
Q Consensus 364 -~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~ 442 (604)
..++||||+ +++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~--------~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE--------KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEe
Confidence 358999999 66898887532 4889999999999999999999 7899999999999999999999999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccC------
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKG------ 515 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~------ 515 (604)
|||++....... ....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........
T Consensus 161 dfg~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~ 233 (343)
T cd07880 161 DFGLARQTDSEM-------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG 233 (343)
T ss_pred ecccccccccCc-------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999998653221 12236889999998765 4578999999999999999999999975322110000
Q ss_pred -cHHHHHHHHHHcC------CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 516 -NLVDWVNHLVIAG------RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 516 -~~~~~~~~~~~~~------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
...+|........ .........+. .........+.+++.+|++.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0001111000000 00000000000 000011224556677999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=290.26 Aligned_cols=257 Identities=21% Similarity=0.193 Sum_probs=189.1
Q ss_pred CcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccH---------------HHHHHHHHHHhccCCCCccceeeEEEeCC
Q 007423 300 ENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSE---------------KQFRSEMNRLGQLRHPNLVPLLGFCVVEE 363 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~---------------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 363 (604)
.+.||+|+||+||+|. ..+++.||||.++...... ..+.+|++++++++||||+++++++..++
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 4779999999999999 4578999999986432111 24778999999999999999999999999
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
..+++|||++ |+|.+++... ..+++.....++.|++.||.||| +.+++|+||||+||+++.++.+||+|
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~-------~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRK-------IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECC
Confidence 9999999997 5999988654 34888999999999999999999 78999999999999999999999999
Q ss_pred cCCccccCCCCC----------CCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCcccc
Q 007423 444 FGLARLVGSRDP----------NDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEG 512 (604)
Q Consensus 444 FGla~~~~~~~~----------~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~ 512 (604)
||+++....... ..........++..|+|||++.+. .++.++|||||||++|||+||+.||......+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 242 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999987642110 001111223467889999988654 468999999999999999999999975432211
Q ss_pred ccCcHHHHHHHHHHcCCcc---c------------cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 513 FKGNLVDWVNHLVIAGRSR---D------------VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~---~------------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
...+.......... . ...+... ........++.+++.+||+.+|++||++.|++.
T Consensus 243 -----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 -----LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred -----HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11111111000000 0 0000000 000111234556667999999999999999986
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=290.35 Aligned_cols=265 Identities=23% Similarity=0.283 Sum_probs=198.3
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCC-----eee
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE-----ERL 366 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 366 (604)
+|...+.||.|++|.||+|+. .+++.||||++.... ...+.+.+|+++++.++|+||+++.+++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 367788999999999999995 458999999986532 23467899999999999999999999998765 789
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
++|||+++ +|.+++... ..+++..+..++.+++.||+||| +.+|+||||||.||++++++.++|+|||+
T Consensus 81 lv~e~~~~-~l~~~l~~~-------~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~ 149 (330)
T cd07834 81 IVTELMET-DLHKVIKSP-------QPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGL 149 (330)
T ss_pred EEecchhh-hHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCc
Confidence 99999984 899988754 35889999999999999999999 78999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
+......... ........++..|+|||++.+. .++.++||||||+++|+|++|+.||......+. .....
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~--------~~~i~ 220 (330)
T cd07834 150 ARGVDPDEDE-KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ--------LNLIV 220 (330)
T ss_pred eEeecccccc-cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH--------HHHHH
Confidence 9876543211 0112223478899999998877 789999999999999999999999975432211 00000
Q ss_pred Hc-CC-------------cccccc---ccc---cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhchH
Q 007423 526 IA-GR-------------SRDVVD---KSL---YGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES--LKSMAE 580 (604)
Q Consensus 526 ~~-~~-------------~~~~~d---~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~--L~~i~~ 580 (604)
.. +. ....+. ... .....+.....+.+++.+||+.+|++||++.++++. ++++..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 221 EVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred HhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00 00 000000 000 000001112345556669999999999999999875 555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=281.16 Aligned_cols=262 Identities=21% Similarity=0.226 Sum_probs=192.7
Q ss_pred CCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 297 FAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
|+..+.||+|.+|.||+|+. .+++.||+|.+.... ...+.+.+|++++++++|+|++++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 44567899999999999995 469999999987542 22356889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
+ ++|.+++.... ..+++..+..++.+++.||.||| +.+|+||||+|+||++++++.+||+|||.++....
T Consensus 81 ~-~~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 81 D-MDLKKYLDKRP------GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred C-cCHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 8 59999997652 24889999999999999999999 78999999999999999999999999999987643
Q ss_pred CCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccC--------cHHHHHHH
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKG--------NLVDWVNH 523 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~--------~~~~~~~~ 523 (604)
.... .....++..|+|||..... .++.++|||||||++|||++|+.||......+.... ....|...
T Consensus 151 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07829 151 PLRT----YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226 (282)
T ss_pred Cccc----cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh
Confidence 2211 1122356789999988766 789999999999999999999999965332110000 00001000
Q ss_pred HHH---cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 524 LVI---AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 524 ~~~---~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
... ............ ....+.....+.+++.+||+.||++||++.|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 227 TKLPDYKPTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000 000000000000 0000011234666677999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=277.82 Aligned_cols=249 Identities=17% Similarity=0.200 Sum_probs=189.1
Q ss_pred CCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEecccc------ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 296 SFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACK------LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
.|.+.+.||+|+||.||++... .+..+++|.++... ....++..|+.++++++||||+++++++......+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 3677789999999999999843 34556666654311 2234577899999999999999999999998899999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++++|.+++...... ...+++...+.++.|++.|+.||| +.+++|+|+||+||++++ ..+||+|||+++
T Consensus 81 ~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~ 153 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHT---GKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSR 153 (260)
T ss_pred EEeCCCCCHHHHHHHHhhc---ccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCcee
Confidence 9999999999988643211 135899999999999999999999 789999999999999986 469999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
......... ....|+..|+|||...+..++.++||||||+++|+|++|+.||.... ........ ..+
T Consensus 154 ~~~~~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--------~~~~~~~~-~~~ 220 (260)
T cd08222 154 LLMGSCDLA----TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------FLSVVLRI-VEG 220 (260)
T ss_pred ecCCCcccc----cCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHH-HcC
Confidence 764322211 12237889999999888888999999999999999999999986321 11111111 112
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.... . .......+.+++.+||+.+|++||++.|+++
T Consensus 221 ~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 PTPS-----L----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCC-----C----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1111 1 1112234555666999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=280.15 Aligned_cols=249 Identities=22% Similarity=0.280 Sum_probs=195.5
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeeEEe
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 369 (604)
+|...+.||+|++|.||++.. .+++.||+|.+.... ...+.+.+|++++++++ ||||+++++++..++..+++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 577889999999999999995 579999999986532 22356889999999998 999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++++|.+++... ..+++.....++.|++.||.||| +.+++|+|++|+||+++.++.++++|||++..
T Consensus 82 e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~ 151 (280)
T cd05581 82 EYAPNGELLQYIRKY-------GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKV 151 (280)
T ss_pred cCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccc
Confidence 999999999999765 35899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCC----------------CccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccc
Q 007423 450 VGSRDPND----------------SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGF 513 (604)
Q Consensus 450 ~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~ 513 (604)
........ ........++..|+|||+.....++.++||||||++++|+++|+.||......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--- 228 (280)
T cd05581 152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY--- 228 (280)
T ss_pred cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---
Confidence 64332110 01112234678999999988888999999999999999999999999753210
Q ss_pred cCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH----HHHHH
Q 007423 514 KGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSM----YQVYE 573 (604)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~ev~~ 573 (604)
....... .... .+ ....++ .+.+++.+||+.+|++||++ .|+++
T Consensus 229 -----~~~~~~~-~~~~--~~-----~~~~~~---~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 -----LTFQKIL-KLEY--SF-----PPNFPP---DAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -----HHHHHHH-hcCC--CC-----CCccCH---HHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0011111 1100 00 011123 34455559999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=297.84 Aligned_cols=199 Identities=21% Similarity=0.295 Sum_probs=170.1
Q ss_pred CCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCC------eeeE
Q 007423 297 FAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE------ERLL 367 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~l 367 (604)
+...+.||+|+||.||+|+ ...|+.||||.++... ...+...+|+++|++++|+|||++++.-.... ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3445789999999999999 7889999999997632 34567889999999999999999999765433 5689
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC--CCCC--eEEcc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID--DDFD--ARITD 443 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~--~~~~--~kl~D 443 (604)
|||||.+|||+..|...... ..|+..+.+.+..+++.||.||| +.+|+||||||.||++- .+++ -||+|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~----~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENA----YGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred EEeecCCCcHHHHhcCcccc----cCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeec
Confidence 99999999999999876443 35899999999999999999999 89999999999999984 3333 79999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
||.|+.+.... .+...+||..|.+||.... ..|+..+|.|||||++||.+||..||...
T Consensus 168 fG~Arel~d~s-----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 168 FGAARELDDNS-----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccccccCCCCC-----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 99999875433 3445579999999999984 78999999999999999999999999754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=309.16 Aligned_cols=254 Identities=22% Similarity=0.268 Sum_probs=184.3
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeC--------
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE-------- 362 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-------- 362 (604)
-.+|+..++||+|+||.|||++ .-||+.+|||++.-.. ..-..+.+|+.++.+++|||||+++..+...
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 3567788999999999999998 6699999999997543 3335688999999999999999987643210
Q ss_pred --------------------------------------------------------------------------------
Q 007423 363 -------------------------------------------------------------------------------- 362 (604)
Q Consensus 363 -------------------------------------------------------------------------------- 362 (604)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhh
Q 007423 363 -------------------------------EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLA 411 (604)
Q Consensus 363 -------------------------------~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~ 411 (604)
...||-||||+.-.++++++.+... -.-....+++.+|++||.
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~------~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN------SQRDEAWRLFREILEGLA 711 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc------hhhHHHHHHHHHHHHHHH
Confidence 0136778888887777777655321 024566789999999999
Q ss_pred HhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC--------------CCCCCCCccccCCCCcccccCccccC
Q 007423 412 WLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG--------------SRDPNDSSFVHGDLGEFGYVAPEYSS 477 (604)
Q Consensus 412 yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~--------------~~~~~~~~~~~~~~gt~~y~aPE~~~ 477 (604)
|+| +.+||||||||.||++|++..+||+|||+|+... ...........+.+||.-|+|||+..
T Consensus 712 YIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 999 8889999999999999999999999999998722 00111111334568999999999887
Q ss_pred CC---CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHH
Q 007423 478 TM---VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVA 554 (604)
Q Consensus 478 ~~---~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~ 554 (604)
+. +|+.|+|+||+|||++||+. ||...-. ...+...++.+.++.- +.+ ..+....=.+++
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--------Ra~iL~~LR~g~iP~~--~~f----~~~~~~~e~slI 851 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME--------RASILTNLRKGSIPEP--ADF----FDPEHPEEASLI 851 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCchHH--------HHHHHHhcccCCCCCC--ccc----ccccchHHHHHH
Confidence 65 49999999999999999984 5653211 0111222334444332 111 122222333455
Q ss_pred hhccCCCCCCCCCHHHHHH
Q 007423 555 CSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 555 ~~Cl~~dP~~RPs~~ev~~ 573 (604)
.++++.||.+|||+.|+++
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHhcCCCccCCCHHHHhh
Confidence 5999999999999999976
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=288.10 Aligned_cols=200 Identities=21% Similarity=0.281 Sum_probs=163.1
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeC----------
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE---------- 362 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~---------- 362 (604)
.+|...+.||.|+||.||+|. ..+++.||+|.+.... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 568888999999999999998 4678999999986543 3346788999999999999999999876543
Q ss_pred ----CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC-CCC
Q 007423 363 ----EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID-DDF 437 (604)
Q Consensus 363 ----~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~-~~~ 437 (604)
...++++||++ ++|.+++... .+++.....++.|++.||.||| +.+|+||||||+||+++ ++.
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~ 152 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG--------PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCc
Confidence 35789999997 5898887532 4788999999999999999999 78999999999999998 556
Q ss_pred CeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 438 DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 438 ~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
.+|++|||.++.......... ......++..|+|||+... ..++.++|||||||++|||++|+.||...
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKG-YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred eEEECCcccceecCCcccccc-ccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 789999999986643221111 1112246888999997644 56788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=287.17 Aligned_cols=196 Identities=23% Similarity=0.314 Sum_probs=165.5
Q ss_pred hhcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCe----
Q 007423 293 ATNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEE---- 364 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~---- 364 (604)
..++|...+.||+|++|.||+|.. .+++.||||++.... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 356788889999999999999995 568899999986432 223567889999999999999999998876554
Q ss_pred --eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEc
Q 007423 365 --RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARIT 442 (604)
Q Consensus 365 --~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~ 442 (604)
.++|+||+ +++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~ 160 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ--------KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKIL 160 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEc
Confidence 89999998 56999988642 4889999999999999999999 7899999999999999999999999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
|||++...... .....++..|+|||...+ ..++.++|||||||++|||+||+.||...
T Consensus 161 dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 161 DFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred ccccccccccc-------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999866332 112246888999998754 46789999999999999999999999643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=269.09 Aligned_cols=235 Identities=22% Similarity=0.239 Sum_probs=186.8
Q ss_pred EEecCCeEEEEEEe-CCCCEEEEEEeccccc----cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCch
Q 007423 303 IISTRTGVSYKAVL-PDASALAIKRLSACKL----SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL 377 (604)
Q Consensus 303 ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL 377 (604)
||.|++|.||++.. .+++.+|+|.+..... ..+.+..|++++++++||||+++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 58999999999995 4689999999865432 235788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCC
Q 007423 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPND 457 (604)
Q Consensus 378 ~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 457 (604)
.+++... ..+++.....++.|++.|+.|+| +.+++|+||+|+||++++++.++|+|||++.........
T Consensus 81 ~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~- 149 (250)
T cd05123 81 FSHLSKE-------GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR- 149 (250)
T ss_pred HHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCc-
Confidence 9999754 24889999999999999999999 789999999999999999999999999999876433211
Q ss_pred CccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccccccc
Q 007423 458 SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKS 537 (604)
Q Consensus 458 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 537 (604)
.....++..|++||...+...+.++|+||||+++||+++|+.||..... ......... +.. .
T Consensus 150 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~------~ 211 (250)
T cd05123 150 ---TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILK-DPL------R 211 (250)
T ss_pred ---ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhc-CCC------C
Confidence 1223478899999999888889999999999999999999999964321 111111111 111 0
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 007423 538 LYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQ 570 (604)
Q Consensus 538 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 570 (604)
. ....+.+ +.+++.+||..||++||++.+
T Consensus 212 ~-~~~~~~~---l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 212 F-PEFLSPE---ARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred C-CCCCCHH---HHHHHHHHhcCCHhhCCCccc
Confidence 0 1111233 445555999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=270.37 Aligned_cols=250 Identities=20% Similarity=0.283 Sum_probs=185.7
Q ss_pred CcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEeeecCCC
Q 007423 300 ENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPNG 375 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~g 375 (604)
...||.|.||+|+|-. .+.|+..|||+++... .+.++++.|.+...+- +-||||+++|.+..++..|+.||.|.-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 3579999999999987 6779999999997644 3456788999875554 689999999999999999999999964
Q ss_pred chhhh---hccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 376 TLYSL---LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 376 sL~~~---l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
||..+ +.... ...++....-.|......||.||-. ...|||||+||+|||+|..|.+||+|||++-.+..
T Consensus 148 SlDklYk~vy~vq-----~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQ-----KSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred hHHHHHHHHHHHH-----hccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 65443 22211 1347777777888888999999986 67899999999999999999999999999977643
Q ss_pred CCCCCCccccCCCCcccccCccccCC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSST--MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
+-.. ....|...|||||.+.. ..|+.++||||+||+|+|++||+.||..-. +..+.+.+.+. |..
T Consensus 221 SiAk-----T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-------svfeql~~Vv~-gdp 287 (361)
T KOG1006|consen 221 SIAK-----TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-------SVFEQLCQVVI-GDP 287 (361)
T ss_pred HHHh-----hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-------HHHHHHHHHHc-CCC
Confidence 2111 12348889999998753 358999999999999999999999996421 23333333333 322
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
+.+..+ ...-..+..+..++ ..|+..|-.+||...++.+.
T Consensus 288 p~l~~~-~~~~~~s~~~~~fi---ntCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 288 PILLFD-KECVHYSFSMVRFI---NTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CeecCc-ccccccCHHHHHHH---HHHhhcccccCcchhhhhcC
Confidence 222111 11111233444444 49999999999999988653
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=293.37 Aligned_cols=258 Identities=22% Similarity=0.315 Sum_probs=206.7
Q ss_pred HHHHHHhhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhcc-CCCCccceeeEEEe---
Q 007423 287 LADLLAATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVV--- 361 (604)
Q Consensus 287 ~~~l~~~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~--- 361 (604)
++.+-..++-|++.+.||+|.+|.||+++ .++++.+|||++......++++..|.++++.. .|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 33444456778889999999999999999 78899999999988777778899999999888 69999999999874
Q ss_pred --CCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCe
Q 007423 362 --EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439 (604)
Q Consensus 362 --~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~ 439 (604)
++..|||||||.+||..|++++-.. ..+.|..+..|.+.++.|+.+|| ...++|||+|-.|||+..++.+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g-----~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKG-----NRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcc-----cchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcE
Confidence 5689999999999999999987642 46899999999999999999999 8899999999999999999999
Q ss_pred EEcccCCccccCCCCCCCCccccCCCCcccccCccccCCC-----CCCcccchhhHHHHHHHHHhCCCCCCCCCcccccc
Q 007423 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-----VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFK 514 (604)
Q Consensus 440 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~ 514 (604)
|+.|||++..+........+ ..||+.|||||++... .|+.++|+||+||+..||.-|.+|+.+..+.
T Consensus 163 KLvDFGvSaQldsT~grRnT----~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---- 234 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTVGRRNT----FIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---- 234 (953)
T ss_pred EEeeeeeeeeeecccccccC----cCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh----
Confidence 99999999887543322222 3599999999998654 3678999999999999999999999764331
Q ss_pred CcHHHHHHHHHHcCCcccccccccc-CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 515 GNLVDWVNHLVIAGRSRDVVDKSLY-GRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
+.+.. +..-..|.+. .+.+. +++.+.+..|+..|-++||++.++++
T Consensus 235 -------raLF~---IpRNPPPkLkrp~kWs---~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 235 -------RALFL---IPRNPPPKLKRPKKWS---KKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -------hhhcc---CCCCCCccccchhhHH---HHHHHHHHHHHhhccccCcchhhhcc
Confidence 11111 1111222222 22233 45555666999999999999988754
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-32 Score=302.73 Aligned_cols=144 Identities=22% Similarity=0.314 Sum_probs=129.0
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc----cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL----SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|.+.+.||+|+||.||+|.. .+++.||||+++.... ....+.+|+.+++.++||||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 5688889999999999999995 4789999999965321 2356889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
||+++++|.+++... ..+++...+.++.|++.||.||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~-------~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY-------GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999754 34788889999999999999999 7799999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=268.79 Aligned_cols=221 Identities=19% Similarity=0.200 Sum_probs=173.1
Q ss_pred cCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCchhhhhccC
Q 007423 306 TRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGN 384 (604)
Q Consensus 306 G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~ 384 (604)
|.+|.||++. ..+++.||+|+++... .+.+|...+....||||+++++++...+..+++|||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 7899999999 5678999999997543 2344555556667999999999999999999999999999999998654
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCccccCC
Q 007423 385 GVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGD 464 (604)
Q Consensus 385 ~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 464 (604)
..+++.....++.|++.||.||| +.+|+||||||+||+++.++.++++|||.+....... .+.
T Consensus 80 -------~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-------~~~ 142 (237)
T cd05576 80 -------LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-------DGE 142 (237)
T ss_pred -------cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-------ccC
Confidence 24889999999999999999999 7899999999999999999999999999887653321 122
Q ss_pred CCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCH
Q 007423 465 LGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGND 544 (604)
Q Consensus 465 ~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 544 (604)
.++..|+|||+.....++.++||||+|+++|||++|+.|+........ .. ... .+ +...+
T Consensus 143 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~--------------~~--~~~---~~-~~~~~ 202 (237)
T cd05576 143 AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN--------------TH--TTL---NI-PEWVS 202 (237)
T ss_pred CcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc--------------cc--ccc---CC-cccCC
Confidence 356789999999888899999999999999999999988753211000 00 000 00 01122
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHH
Q 007423 545 DEIMQFLRVACSCVVSRPKDRPSMYQ 570 (604)
Q Consensus 545 ~~~~~l~~l~~~Cl~~dP~~RPs~~e 570 (604)
+.+. +++.+|++.||++||++.+
T Consensus 203 ~~~~---~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 203 EEAR---SLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHH---HHHHHHccCCHHHhcCCCc
Confidence 3344 4555999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=260.10 Aligned_cols=266 Identities=19% Similarity=0.277 Sum_probs=201.4
Q ss_pred HHHHHHhhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCC
Q 007423 287 LADLLAATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEE 363 (604)
Q Consensus 287 ~~~l~~~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 363 (604)
++|+.+-|+ +.+|+|+++.|--++ +.+|.++|||++.+.. ..+.+..+|++++... .|+||++++++|+++.
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 566766665 789999999999998 8899999999997643 4567899999999999 5999999999999999
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC---eE
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD---AR 440 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~---~k 440 (604)
..|||||-|.+|+|..+|+++ ..++..+..++..+|+.||.||| .++|.|||+||+|||..+... +|
T Consensus 150 ~FYLVfEKm~GGplLshI~~~-------~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvK 219 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKR-------KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVK 219 (463)
T ss_pred eEEEEEecccCchHHHHHHHh-------hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCcee
Confidence 999999999999999999876 35889999999999999999999 899999999999999875543 79
Q ss_pred EcccCCccccCCCCCCC---CccccCCCCcccccCcccc-----CCCCCCcccchhhHHHHHHHHHhCCCCCCCCCcccc
Q 007423 441 ITDFGLARLVGSRDPND---SSFVHGDLGEFGYVAPEYS-----STMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEG 512 (604)
Q Consensus 441 l~DFGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~-----~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~ 512 (604)
|+||.+..-........ .......+|+..|||||+. ....|+.++|.||+|||+|-|++|.+||...-..+.
T Consensus 220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC 299 (463)
T KOG0607|consen 220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC 299 (463)
T ss_pred eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence 99998876543222111 1122344688899999964 235689999999999999999999999976433221
Q ss_pred --ccCcHHHHHH----HHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 513 --FKGNLVDWVN----HLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 513 --~~~~~~~~~~----~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
..+...+--+ .-+++|.. +..|+.+ ...+++.++++. ..+..||.+|-++.+++.
T Consensus 300 GWdrGe~Cr~CQ~~LFesIQEGkY-eFPdkdW--ahIS~eakdlis---nLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 300 GWDRGEVCRVCQNKLFESIQEGKY-EFPDKDW--AHISSEAKDLIS---NLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccCCCccHHHHHHHHHHHhccCC-cCChhhh--HHhhHHHHHHHH---HHHhccHHhhhhhhhccC
Confidence 1112222111 11223322 2222222 122455565555 677799999999998876
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=267.36 Aligned_cols=273 Identities=19% Similarity=0.276 Sum_probs=210.2
Q ss_pred CHHHHHHhhcCCCcCcEEEecCCeEEEEEEeCC------CCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceee
Q 007423 286 KLADLLAATNSFAVENIIISTRTGVSYKAVLPD------ASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLG 357 (604)
Q Consensus 286 ~~~~l~~~~~~~~~~~~ig~G~~g~vy~~~~~~------~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g 357 (604)
.+.++....+++....++-+|.||.||+|.+.+ .+.|-||.++... .....+..|.-.+..+.|||+.++.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 344555555667777888999999999997643 3456677765422 22345788999999999999999999
Q ss_pred EEEe-CCeeeEEeeecCCCchhhhhccCCC-CCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC
Q 007423 358 FCVV-EEERLLVYKHMPNGTLYSLLHGNGV-DNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD 435 (604)
Q Consensus 358 ~~~~-~~~~~lv~ey~~~gsL~~~l~~~~~-~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~ 435 (604)
++.. ....+.+|.++.-|+|..+|.-.+. ...-...++-.+...+|.|++.|++||| +.+|||.||.++|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehh
Confidence 9875 4568999999999999999983322 1122245777788899999999999999 899999999999999999
Q ss_pred CCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCcccccc
Q 007423 436 DFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFK 514 (604)
Q Consensus 436 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~ 514 (604)
..++||+|=.+++.+-+.+-+.-. .+..-+..||+||.+....|+..+|||||||++|||+| |+.||....+.+
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLG--DnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE--- 506 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLG--DNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE--- 506 (563)
T ss_pred heeEEeccchhccccCcccccccC--CCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH---
Confidence 999999999999877543321110 01124678999999999999999999999999999998 999997554432
Q ss_pred CcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 515 GNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
+...+.+|.... .+-.+..++..+|.-||...|++||+++|++.-|.+.-..
T Consensus 507 ------m~~ylkdGyRla---------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 507 ------MEHYLKDGYRLA---------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred ------HHHHHhccceec---------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 455566664321 1223556777888899999999999999999999876543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=260.33 Aligned_cols=254 Identities=17% Similarity=0.225 Sum_probs=193.8
Q ss_pred hhcCCCcC-cEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhcc-CCCCccceeeEEEe----CCee
Q 007423 293 ATNSFAVE-NIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVV----EEER 365 (604)
Q Consensus 293 ~~~~~~~~-~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~~ 365 (604)
.|++|.+. ++||-|-.|.|..+. ...++.+|+|++.. ....++|+++.-+. .|||||.++++|.+ ....
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 35566543 689999999999988 56788999999864 34577899986555 69999999999865 3457
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC---CCCCeEEc
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID---DDFDARIT 442 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~---~~~~~kl~ 442 (604)
.+|||.|++|.|...++.++. ..++..+.-.|+.||+.|+.||| +..|.||||||+|+|.. .+-.+||+
T Consensus 135 LiVmE~meGGeLfsriq~~g~-----~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGD-----QAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred EeeeecccchHHHHHHHHccc-----ccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEec
Confidence 799999999999999987753 46889999999999999999999 89999999999999986 44569999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHH
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVN 522 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 522 (604)
|||+|+.-..... ....+-|+.|.|||++...+|+..+|+||+||++|-|+.|-+||....... +..=++
T Consensus 207 DfGFAK~t~~~~~-----L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-----ispgMk 276 (400)
T KOG0604|consen 207 DFGFAKETQEPGD-----LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMK 276 (400)
T ss_pred ccccccccCCCcc-----ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-----CChhHH
Confidence 9999997543221 222346899999999999999999999999999999999999997643221 111123
Q ss_pred HHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 523 HLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 523 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
..+..|.. +..++ .+++-.+..-+++...+..+|.+|.|+.|++..
T Consensus 277 ~rI~~gqy-~FP~p-----EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 277 RRIRTGQY-EFPEP-----EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred hHhhccCc-cCCCh-----hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 33333322 12222 223323333344558899999999999998653
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=260.80 Aligned_cols=205 Identities=23% Similarity=0.258 Sum_probs=168.2
Q ss_pred cCCCcCcEEEecCCeEEEEEEe---CC--CCEEEEEEecccccc---HHHHHHHHHHHhccCCCCccceeeEEEe-CCee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL---PD--ASALAIKRLSACKLS---EKQFRSEMNRLGQLRHPNLVPLLGFCVV-EEER 365 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~---~~--~~~vAvK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~ 365 (604)
..|+....||+|.||.||+|+. ++ ...+|||+++..+.. .....+|+.+++.++||||+.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 3577778999999999999963 23 237999999765321 2467889999999999999999999987 7789
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC----CCeEE
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD----FDARI 441 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~----~~~kl 441 (604)
++++||.+. +|...|+.++.... ..++-.....|..||+.|+.||| +.-|+||||||.|||+..+ |.+||
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~--~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKA--KQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchh--ccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEe
Confidence 999999998 99999986654332 35888899999999999999999 8889999999999999876 99999
Q ss_pred cccCCccccCCCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 442 TDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 442 ~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
+|||+++.+...-..- ......+-|.-|.|||.+.+. .||.+.|||+.|||+.||+|-++-|..
T Consensus 178 aDlGlaR~~~~plkpl-~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPL-ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ecccHHHHhhcccccc-ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999999886432111 111223458899999987764 589999999999999999999888865
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=261.84 Aligned_cols=239 Identities=21% Similarity=0.235 Sum_probs=192.3
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc----cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL----SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|+..+++|+|.||.|..++ ...++.+|+|++++... ....-..|-++|+..+||.+..+...|+..++.|.||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 567888999999999999998 66799999999986431 2234567899999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||..+|.|.-+|.+. ..++......+...|+.||.||| +.+||.||+|.+|.|+|.+|.+||+|||+++.
T Consensus 248 eyanGGeLf~HLsre-------r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 248 EYANGGELFFHLSRE-------RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEccCceEeeehhhh-------hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchh
Confidence 999999999998765 35888888889999999999999 78999999999999999999999999999985
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
--. ........+||+.|+|||++....|+...|.|.+||++|||+.|+.||....-+. +-+. +..+.
T Consensus 318 ~I~----~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k-----LFeL----Il~ed 384 (516)
T KOG0690|consen 318 EIK----YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK-----LFEL----ILMED 384 (516)
T ss_pred ccc----ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH-----HHHH----HHhhh
Confidence 322 2223345579999999999999999999999999999999999999997532211 1111 11111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP 566 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 566 (604)
+--| ...+.+.+.++. ..+..||.+|.
T Consensus 385 ---~kFP----r~ls~eAktLLs---GLL~kdP~kRL 411 (516)
T KOG0690|consen 385 ---LKFP----RTLSPEAKTLLS---GLLKKDPKKRL 411 (516)
T ss_pred ---ccCC----ccCCHHHHHHHH---HHhhcChHhhc
Confidence 1001 122345666665 78889999995
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=281.83 Aligned_cols=240 Identities=18% Similarity=0.187 Sum_probs=192.9
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEeee
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
++.|.....+|.|+|++|-++. ..+++..+||++.... .+-.+|+.++... .||||+++.+.+.+..+.++|||+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 5677888889999999999998 6778899999997642 2344577666555 799999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe-CCCCCeEEcccCCcccc
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI-DDDFDARITDFGLARLV 450 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl-~~~~~~kl~DFGla~~~ 450 (604)
+.+|-+.+.+.... ... ..+..|+.+++.|+.||| ..++||||+||+|||+ ++.++++|+|||.++..
T Consensus 398 l~g~ell~ri~~~~-------~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 398 LDGGELLRRIRSKP-------EFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred ccccHHHHHHHhcc-------hhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 99998888876542 122 667779999999999999 7999999999999999 58899999999999987
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
+.. ..+.+-|..|.|||+.....+|+++|+||||++||||++|+.||...... .-+...+..+..
T Consensus 467 ~~~-------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--------~ei~~~i~~~~~ 531 (612)
T KOG0603|consen 467 ERS-------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--------IEIHTRIQMPKF 531 (612)
T ss_pred chh-------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--------HHHHHhhcCCcc
Confidence 554 11123578999999999999999999999999999999999999754332 112222222222
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
. ..-+++.+++++ +|++.||.+||+|.++...
T Consensus 532 s---------~~vS~~AKdLl~---~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 532 S---------ECVSDEAKDLLQ---QLLQVDPALRLGADEIGAH 563 (612)
T ss_pred c---------cccCHHHHHHHH---HhccCChhhCcChhhhccC
Confidence 2 234567777777 9999999999999998653
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=275.54 Aligned_cols=193 Identities=23% Similarity=0.353 Sum_probs=168.0
Q ss_pred CcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCC
Q 007423 300 ENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNG 375 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g 375 (604)
.+++|+|.||+||-|+ .++|+.||||.+.+.+ ..+.++++|++||.+++||.||.+--.|+..+..++|||-+.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 4789999999999999 5689999999997532 34578999999999999999999999999999999999999664
Q ss_pred chhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC---CCCeEEcccCCccccCC
Q 007423 376 TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD---DFDARITDFGLARLVGS 452 (604)
Q Consensus 376 sL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~---~~~~kl~DFGla~~~~~ 452 (604)
-|...|.... +.++......++.||+.||.||| ..+|+|+||||+|||+.+ .-++||+|||+|++++.
T Consensus 649 MLEMILSsEk------gRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE 719 (888)
T KOG4236|consen 649 MLEMILSSEK------GRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE 719 (888)
T ss_pred HHHHHHHhhc------ccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence 4555555443 46888888999999999999999 789999999999999963 35799999999999864
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
. .+-+..+||+.|+|||++..+.|...-|+||.||++|--++|..||..
T Consensus 720 k-----sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 720 K-----SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred h-----hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 3 233455799999999999999999999999999999999999999963
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=233.10 Aligned_cols=196 Identities=21% Similarity=0.263 Sum_probs=166.2
Q ss_pred CCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccccc---HHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 297 FAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLS---EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
|...++||+|.||+||+|+ ...++.||+|+++.+..+ .....+|+-+++.++|+|||++++...++....+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 4556789999999999999 777899999998754322 356889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
.. +|..+....+ +.++......++.|+++||.|+| ++.+.|||+||.|.||+.+++.|++|||+++.++.
T Consensus 84 dq-dlkkyfdsln------g~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 84 DQ-DLKKYFDSLN------GDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred hH-HHHHHHHhcC------CcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 66 8888876554 45888999999999999999999 88999999999999999999999999999998864
Q ss_pred CCCCCCccccCCCCcccccCccccCCCC-CCcccchhhHHHHHHHHHh-CCCCCCC
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMV-ASLKGDVYGFGIVLLELLS-GQKPLDV 506 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~k~DV~SfGvvl~ellt-g~~p~~~ 506 (604)
.-.. ....+-|.-|.+|.++.+.+ |++..|+||-||++.|+.. |++-|..
T Consensus 154 pvrc----ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 154 PVRC----YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred ceEe----eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 3221 12223578999999877654 8899999999999999987 6665654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=265.73 Aligned_cols=264 Identities=18% Similarity=0.232 Sum_probs=203.1
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhccCC--C----CccceeeEEEeCCeee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQLRH--P----NLVPLLGFCVVEEERL 366 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H--~----niv~l~g~~~~~~~~~ 366 (604)
++.|.+...+|+|.||.|-.+.. ..+..||||+++.-....+..+-|++++.++.+ | -+|.+.+++.-.++.|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 56788889999999999999983 447999999998766667788899999999943 2 3788888899999999
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC-----------
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD----------- 435 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~----------- 435 (604)
+|+|.+ +-|++++|.+++. .+++...+..++.|++++++||| +.+++|-||||+|||+-+
T Consensus 168 ivfell-G~S~~dFlk~N~y-----~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNY-----IPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred EEEecc-ChhHHHHhccCCc-----cccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCC
Confidence 999998 4599999987654 46889999999999999999999 899999999999999832
Q ss_pred ---------CCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 436 ---------DFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 436 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
+..+||.|||-|..-.... .. .+.|..|.|||++.+..++.++||||+||||+|+.||..-|..
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~----iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH---ST----IVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc---ce----eeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 2357999999998764332 12 2368899999999999999999999999999999999999987
Q ss_pred CCccccc---c---CcHHHH------HHHHHHcCCc-----------ccccccc----ccCCCCHHHHHHHHHHHhhccC
Q 007423 507 AGAEEGF---K---GNLVDW------VNHLVIAGRS-----------RDVVDKS----LYGRGNDDEIMQFLRVACSCVV 559 (604)
Q Consensus 507 ~~~~~~~---~---~~~~~~------~~~~~~~~~~-----------~~~~d~~----l~~~~~~~~~~~l~~l~~~Cl~ 559 (604)
....+.. . +.+... .+.....+++ ..+.++. ......+++..++++|+.+++.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 6543311 0 000000 0111111111 1111110 0112235677889999999999
Q ss_pred CCCCCCCCHHHHHH
Q 007423 560 SRPKDRPSMYQVYE 573 (604)
Q Consensus 560 ~dP~~RPs~~ev~~ 573 (604)
.||.+|+|+.|++.
T Consensus 392 fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 392 FDPARRITLREALS 405 (415)
T ss_pred cCccccccHHHHhc
Confidence 99999999999875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=294.93 Aligned_cols=258 Identities=19% Similarity=0.200 Sum_probs=199.8
Q ss_pred HHHHHhhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccc----cccHHHHHHHHHHHhccCCCCccceeeEEEeC
Q 007423 288 ADLLAATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSAC----KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE 362 (604)
Q Consensus 288 ~~l~~~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 362 (604)
.++.-..++|.+.++||+|+||.|..++ ...++.+|+|++.+- .....-|..|-.+|..-+.+.|+.+...|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 3555566789999999999999999998 456889999999762 22334688999999999999999999999999
Q ss_pred CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEc
Q 007423 363 EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARIT 442 (604)
Q Consensus 363 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~ 442 (604)
.+.|+|||||+||+|..++.... .++..-...|+..|.-||.-+| +.++|||||||.|||||..|++||+
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~-------~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLA 217 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD-------RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLA 217 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC-------CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeec
Confidence 99999999999999999998763 4778888889999999999999 8999999999999999999999999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccC----C-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcH
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSS----T-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNL 517 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~ 517 (604)
|||.+-.+..+.... ....+|||-|++||++. + +.|++.+|.||+||++|||+.|..||...+-
T Consensus 218 DFGsClkm~~dG~V~---s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl-------- 286 (1317)
T KOG0612|consen 218 DFGSCLKMDADGTVR---SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL-------- 286 (1317)
T ss_pred cchhHHhcCCCCcEE---eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH--------
Confidence 999998775433222 22347999999999764 3 5689999999999999999999999975322
Q ss_pred HHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHH
Q 007423 518 VDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS---MYQVYES 574 (604)
Q Consensus 518 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~ev~~~ 574 (604)
++-............+.+. ..-+++.+.+++ +-+ -+|+.|.. +.|+...
T Consensus 287 veTY~KIm~hk~~l~FP~~----~~VSeeakdLI~---~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 287 VETYGKIMNHKESLSFPDE----TDVSEEAKDLIE---ALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred HHHHHHHhchhhhcCCCcc----cccCHHHHHHHH---HHh-cChhhhcccccHHHHHhC
Confidence 2211111111111111111 113566666665 322 36888887 7777543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=256.69 Aligned_cols=237 Identities=24% Similarity=0.310 Sum_probs=188.0
Q ss_pred CCeEEEEEEeC-CCCEEEEEEecccccc--HHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCchhhhhcc
Q 007423 307 RTGVSYKAVLP-DASALAIKRLSACKLS--EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHG 383 (604)
Q Consensus 307 ~~g~vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~ 383 (604)
+||.||+|+.. +++.+|+|++...... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999965 5899999999754322 57899999999999999999999999999999999999999999999875
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCccccC
Q 007423 384 NGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHG 463 (604)
Q Consensus 384 ~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 463 (604)
.. .+++.....++.++++++.||| +.+++|+|++|+||++++++.++++|||.+........ ...
T Consensus 81 ~~-------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-----~~~ 145 (244)
T smart00220 81 RG-------RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL-----LTT 145 (244)
T ss_pred cc-------CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeeccccc-----ccc
Confidence 42 3789999999999999999999 78999999999999999999999999999987754321 122
Q ss_pred CCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCC
Q 007423 464 DLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGN 543 (604)
Q Consensus 464 ~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 543 (604)
..++..|++||......++.++||||||++++||++|+.||..... ...... ....+..... . ..
T Consensus 146 ~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-------~~~~~~-~~~~~~~~~~-~------~~ 210 (244)
T smart00220 146 FVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-------LLELFK-KIGKPKPPFP-P------PE 210 (244)
T ss_pred ccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------HHHHHH-HHhccCCCCc-c------cc
Confidence 3478899999999888889999999999999999999999965211 111111 1111111110 0 00
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 544 DDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 544 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
......+.+++.+|+..+|++||++.++++
T Consensus 211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 002235566667999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=284.97 Aligned_cols=269 Identities=17% Similarity=0.117 Sum_probs=166.7
Q ss_pred hhcCCCcCcEEEecCCeEEEEEEe-CC----CCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeE------EEe
Q 007423 293 ATNSFAVENIIISTRTGVSYKAVL-PD----ASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGF------CVV 361 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~~-~~----~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~------~~~ 361 (604)
..++|...+.||+|+||.||+|.. .+ +..||||++...... +....| .+....+.+++.+... +..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 456899999999999999999995 44 689999998643221 111111 1222223333332222 234
Q ss_pred CCeeeEEeeecCCCchhhhhccCCCCCC-------------CCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCC
Q 007423 362 EEERLLVYKHMPNGTLYSLLHGNGVDNT-------------LSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS 428 (604)
Q Consensus 362 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~-------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~ 428 (604)
+...++||||+++++|.+++........ ............++.|++.||.||| +.+|+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCH
Confidence 5678999999999999999875421000 0001122345679999999999999 78999999999
Q ss_pred CeEEeCC-CCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCC----------------------CCCccc
Q 007423 429 NVILIDD-DFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM----------------------VASLKG 485 (604)
Q Consensus 429 ~NiLl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~k~ 485 (604)
+|||+++ ++.+||+|||+++.+....... .....+++.|||||.+... .++.++
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~---~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYI---PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccC---CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999985 6789999999998664322211 1223578999999954321 234567
Q ss_pred chhhHHHHHHHHHhCCCCCCCCCcc-----ccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCC
Q 007423 486 DVYGFGIVLLELLSGQKPLDVAGAE-----EGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVS 560 (604)
Q Consensus 486 DV~SfGvvl~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~ 560 (604)
|||||||++|||+++..|++..... .....+...|....... ...+. .... +..+.......+++.+|++.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~-~~~~--~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR-ASPDL-RRGF--EVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc-cchhh-hhhh--hhccccchHHHHHHHHHccC
Confidence 9999999999999977665421000 00001122232111000 00000 0000 00000111233566699999
Q ss_pred CCCCCCCHHHHHHH
Q 007423 561 RPKDRPSMYQVYES 574 (604)
Q Consensus 561 dP~~RPs~~ev~~~ 574 (604)
||++|||+.|+++.
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=275.65 Aligned_cols=265 Identities=18% Similarity=0.207 Sum_probs=178.9
Q ss_pred hhcCCCcCcEEEecCCeEEEEEEe-----------------CCCCEEEEEEeccccc-cHHH--------------HHHH
Q 007423 293 ATNSFAVENIIISTRTGVSYKAVL-----------------PDASALAIKRLSACKL-SEKQ--------------FRSE 340 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~~-----------------~~~~~vAvK~l~~~~~-~~~~--------------~~~E 340 (604)
..++|.+.++||+|+||+||+|.. .+++.||||+++.... ..++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999963 2456899999865322 1122 3457
Q ss_pred HHHHhccCCCCc-----cceeeEEEe--------CCeeeEEeeecCCCchhhhhccCCCC-----------------CCC
Q 007423 341 MNRLGQLRHPNL-----VPLLGFCVV--------EEERLLVYKHMPNGTLYSLLHGNGVD-----------------NTL 390 (604)
Q Consensus 341 i~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lv~ey~~~gsL~~~l~~~~~~-----------------~~~ 390 (604)
+.++.+++|.++ ++++++|.. ++..++||||+++|+|.++++..... ...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778876654 678888753 35689999999999999999753210 001
Q ss_pred CCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccc
Q 007423 391 SGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGY 470 (604)
Q Consensus 391 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y 470 (604)
...++|..+..++.|+++||.|+| +.+|+||||||+|||++.++.+||+|||+++.......... ....+++.|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~---~~g~~tp~Y 376 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP---LYGMLDPRY 376 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCc---cccCCCcce
Confidence 123578889999999999999999 78999999999999999999999999999976533221111 111247899
Q ss_pred cCccccCCCCC----------------------CcccchhhHHHHHHHHHhCCC-CCCCCCcc----ccccCcHHHHHHH
Q 007423 471 VAPEYSSTMVA----------------------SLKGDVYGFGIVLLELLSGQK-PLDVAGAE----EGFKGNLVDWVNH 523 (604)
Q Consensus 471 ~aPE~~~~~~~----------------------t~k~DV~SfGvvl~elltg~~-p~~~~~~~----~~~~~~~~~~~~~ 523 (604)
+|||.+..... ..+.||||+||+++||++|.. |+...... .....+...|...
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~ 456 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY 456 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh
Confidence 99998653221 235799999999999999875 66432110 0011122233211
Q ss_pred HHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCC---CCCCCHHHHHH
Q 007423 524 LVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRP---KDRPSMYQVYE 573 (604)
Q Consensus 524 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~ev~~ 573 (604)
.... .+-... +..++..++++. +++..+| .+|+|++|+++
T Consensus 457 --~~~~----~~~~~~-d~~s~~~~dLi~---~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 457 --KGQK----YDFSLL-DRNKEAGWDLAC---KLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred --cccC----CCcccc-cccChHHHHHHH---HHhccCCCCcccCCCHHHHhC
Confidence 1111 111110 112344455544 8887655 78999999976
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=253.54 Aligned_cols=201 Identities=21% Similarity=0.263 Sum_probs=166.1
Q ss_pred CCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccc--c-ccHHHHHHHHHHHhccCCCCccceeeEEEeC--------Ce
Q 007423 297 FAVENIIISTRTGVSYKAV-LPDASALAIKRLSAC--K-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE--------EE 364 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~--~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------~~ 364 (604)
|....+||+|.||.||+|+ -..|+.||+|++-.. + .......+|+.+|..++|+|++.++..|... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 4445789999999999998 456788999876332 1 1235678999999999999999999988642 34
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEccc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDF 444 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DF 444 (604)
.++|+++|+. +|..+|.+... .++..++.+++.++..||.|+| ...|+|||+|+.|+||+.++.+||+||
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~v------r~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRKV------RFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCccc------cccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecc
Confidence 7999999988 89999876643 4888999999999999999999 789999999999999999999999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
|+++.+..............+-|..|.+||.+.+ ..++++.|||.-|||+.||.||.+-+...
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn 232 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN 232 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC
Confidence 9998776544433333344456899999997765 56999999999999999999999888653
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=260.86 Aligned_cols=256 Identities=21% Similarity=0.293 Sum_probs=193.9
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccH--------HHHHHHHHHHhccCCCCccceeeEEE-eCCee
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSE--------KQFRSEMNRLGQLRHPNLVPLLGFCV-VEEER 365 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~--------~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~ 365 (604)
.|-..++||+|+|+.||++. +...+.||||+-...+..+ +...+|..|.+.+.||.||++++|+. +.+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 45566889999999999999 7788999999864332221 34779999999999999999999986 45678
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC---CCCeEEc
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD---DFDARIT 442 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~---~~~~kl~ 442 (604)
|-|.|||++.+|.-+|+.+ ..++..+...|++||+.||.||.. .+++|||-||||.|||+-+ .|.+||.
T Consensus 544 CTVLEYceGNDLDFYLKQh-------klmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQH-------KLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred eeeeeecCCCchhHHHHhh-------hhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEee
Confidence 9999999999999999876 358899999999999999999984 4799999999999999963 4789999
Q ss_pred ccCCccccCCCCCCCC---ccccCCCCcccccCccccCC----CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccC
Q 007423 443 DFGLARLVGSRDPNDS---SFVHGDLGEFGYVAPEYSST----MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKG 515 (604)
Q Consensus 443 DFGla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~----~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~ 515 (604)
|||+++++..+..... .......||..|++||.+.- .+++.|+||||.|||+|..+.|+.||...-.. .
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ----Q 691 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ----Q 691 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH----H
Confidence 9999999865432211 11223469999999997543 35789999999999999999999999643211 1
Q ss_pred cHHHHHHHHHHcCCcccccccccc-CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 516 NLVDWVNHLVIAGRSRDVVDKSLY-GRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
++. ....+...-...+. .+.-+.+...+++ +|++..-++|....++..
T Consensus 692 dIL-------qeNTIlkAtEVqFP~KPvVsseAkaFIR---RCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 692 DIL-------QENTILKATEVQFPPKPVVSSEAKAFIR---RCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHH-------hhhchhcceeccCCCCCccCHHHHHHHH---HHHHhhhhhhhhHHHHcc
Confidence 111 11111111111111 1223456777777 999999999988777654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=260.64 Aligned_cols=207 Identities=21% Similarity=0.239 Sum_probs=171.3
Q ss_pred HHHhhcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc----cHHHHHHHHHHHhcc-CCCCccceeeEEEeCC
Q 007423 290 LLAATNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL----SEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEE 363 (604)
Q Consensus 290 l~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 363 (604)
...++ +|....+||+|+||.|..+.. ...+.+|||+++++.. +.+--+.|-++|.-- +-|.++++..+++.-+
T Consensus 345 ~i~~t-DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 345 RIKAT-DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred ceeec-ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 33443 588889999999999999984 4567899999987531 112234566666655 5789999999999999
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
..|.||||+.+|+|--+++.. +.+-......+|..||-||-||| +.+||.||||..|||+|.++.+||+|
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~-------GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~D 493 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQV-------GKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIAD 493 (683)
T ss_pred heeeEEEEecCchhhhHHHHh-------cccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeee
Confidence 999999999999999888765 34666678889999999999999 89999999999999999999999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccc
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEE 511 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~ 511 (604)
||+++.---. ....+..+||+.|+|||.+...+|+..+|.|||||+||||+.|++||+....++
T Consensus 494 FGmcKEni~~----~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e 557 (683)
T KOG0696|consen 494 FGMCKENIFD----GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 557 (683)
T ss_pred cccccccccC----CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 9999853222 223344579999999999999999999999999999999999999998754433
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=238.80 Aligned_cols=199 Identities=21% Similarity=0.284 Sum_probs=161.2
Q ss_pred CCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccc--cccHHHHHHHHHHH-hccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 297 FAVENIIISTRTGVSYKAV-LPDASALAIKRLSAC--KLSEKQFRSEMNRL-GQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~--~~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
......||+|++|.|-+-+ ..+|+..|||++... .+..++..+|+.+. +....|.+|.++|.+......++.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 3345679999999988777 578999999999753 34456788899875 4557899999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
.- ||..+-++.-. ....++....-+||..+.+||.|||+ +..+||||+||+||||+.+|++|++|||++-.+..
T Consensus 128 ~t-Sldkfy~~v~~---~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 128 DT-SLDKFYRKVLK---KGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred hh-hHHHHHHHHHh---cCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 65 77665432211 01457888888999999999999997 67899999999999999999999999999987743
Q ss_pred CCCCCCccccCCCCcccccCccccC----CCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSS----TMVASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
+-..+ -..|...|||||.+. ...|+.|+||||+|+++.||++++.||+.
T Consensus 202 SiAkt-----~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 202 SIAKT-----MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hhHHH-----HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 22111 123778899999764 34689999999999999999999999975
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=279.44 Aligned_cols=249 Identities=22% Similarity=0.323 Sum_probs=185.9
Q ss_pred CCCcCcEEEecCCeE-EEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEeeecC
Q 007423 296 SFAVENIIISTRTGV-SYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~-vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
.|...+++|.|..|+ ||+|.. +|+.||||++-... .+-..+||..|+.- +|||||++++.-.++++.|+..|.|.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 356678899998775 899998 67899999985432 34567899999988 69999999998888999999999997
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC---C--CCeEEcccCCcc
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD---D--FDARITDFGLAR 448 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~---~--~~~kl~DFGla~ 448 (604)
. +|.+++........ ...-.....+..|++.||++|| +.+||||||||.||||+. + ..++|+|||+++
T Consensus 587 ~-sL~dlie~~~~d~~---~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVE---MQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred h-hHHHHHhccccchh---hcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 6 99999987411100 0111344677889999999999 789999999999999975 2 569999999999
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhC-CCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSG-QKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
.+......-.. ..+..||-+|+|||++....-+..+||+|+||++|..+|| +.||......+. . +..
T Consensus 660 kl~~~~sS~~r-~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~----------N-Il~ 727 (903)
T KOG1027|consen 660 KLAGGKSSFSR-LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA----------N-ILT 727 (903)
T ss_pred ccCCCcchhhc-ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh----------h-hhc
Confidence 98765443333 4566799999999999988888899999999999999985 999975322110 0 111
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
+.. .+. .+ ......+..++ +.++++.+|..||++.+|+.
T Consensus 728 ~~~-~L~--~L-~~~~d~eA~dL---I~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 728 GNY-TLV--HL-EPLPDCEAKDL---ISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred Ccc-cee--ee-ccCchHHHHHH---HHHhcCCCcccCCCHHHHhC
Confidence 110 000 01 01111244444 44999999999999999953
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=266.41 Aligned_cols=206 Identities=22% Similarity=0.277 Sum_probs=173.0
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccH----HHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSE----KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~----~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
-|...+.||-|+||.|..+. .+....+|.|.+++..+-. .....|-.||...+.+.||+|+..|.+++..|.|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 36677889999999999987 5667789999997644322 246789999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++|++-.+|.+. +.+.+.....++.++.+|+++.| +.++|||||||.|||||.+|.+||.|||++.-+
T Consensus 710 YIPGGDmMSLLIrm-------gIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRM-------GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred ccCCccHHHHHHHh-------ccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccc
Confidence 99999999999876 46888888888999999999999 999999999999999999999999999998633
Q ss_pred C---------CCCCCC-----------------------------CccccCCCCcccccCccccCCCCCCcccchhhHHH
Q 007423 451 G---------SRDPND-----------------------------SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGI 492 (604)
Q Consensus 451 ~---------~~~~~~-----------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGv 492 (604)
. ..+... .......+||..|+|||++....++.-+|.||.||
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV 859 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence 1 000000 00112347999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCccc
Q 007423 493 VLLELLSGQKPLDVAGAEE 511 (604)
Q Consensus 493 vl~elltg~~p~~~~~~~~ 511 (604)
|||||+.|+.||......+
T Consensus 860 il~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHHHHhhCCCCccCCCCCc
Confidence 9999999999997655443
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=261.54 Aligned_cols=197 Identities=20% Similarity=0.226 Sum_probs=171.9
Q ss_pred CCcCcEEEecCCeEEEEEEeCCCC-EEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 297 FAVENIIISTRTGVSYKAVLPDAS-ALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~~~~~-~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+.....||-|+||.|=........ .+|+|.+++.. ...+.+..|-++|...+.|.||+++.-|.+....|+.||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 344567999999999988865433 48899887532 2345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
|-+|.|...|+.+ +.++..+...++..+.+|++||| .++||.|||||+|+++|.+|.+||.|||+|+.++
T Consensus 502 ClGGElWTiLrdR-------g~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 502 CLGGELWTILRDR-------GSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hcCchhhhhhhhc-------CCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 9999999999876 45777888889999999999999 8999999999999999999999999999999987
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAG 508 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~ 508 (604)
...... ..+||+.|.|||.+.....+..+|.||+||++|||+||++||....
T Consensus 572 ~g~KTw-----TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d 623 (732)
T KOG0614|consen 572 SGRKTW-----TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD 623 (732)
T ss_pred cCCcee-----eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence 654332 2359999999999999999999999999999999999999998643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=236.31 Aligned_cols=247 Identities=19% Similarity=0.263 Sum_probs=190.7
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccH----HHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSE----KQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~----~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv 368 (604)
.+|....+||+|+|..|..+.+ ...+.+|+|++++.-..+ +=...|-.+..+. +||.+|.+..+|..+...+.|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 5788889999999999999984 567889999997643221 2244566666555 799999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
.||+++|+|--++++. ..++......+...|.-||.||| +.+||.||+|..|+|+|..+.+|+.|+|+++
T Consensus 330 ieyv~ggdlmfhmqrq-------rklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEecCcceeeehhhh-------hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhh
Confidence 9999999998777655 35888899999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
.--......+ ..+||+.|+|||.+.+..|+...|.|++||+++||+.|+.||+..+.... ..+..++.-+.+.+.
T Consensus 400 e~l~~gd~ts----tfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~-d~ntedylfqvilek 474 (593)
T KOG0695|consen 400 EGLGPGDTTS----TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP-DMNTEDYLFQVILEK 474 (593)
T ss_pred cCCCCCcccc----cccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCc-ccchhHHHHHHHhhh
Confidence 5433333333 34699999999999999999999999999999999999999997654322 223344444444333
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP 566 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 566 (604)
.++- ..++ + .+...+...-++.||.+|.
T Consensus 475 qiri--prsl-----s---vkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 475 QIRI--PRSL-----S---VKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cccc--ccee-----e---hhhHHHHHHhhcCCcHHhc
Confidence 2221 0111 1 1222333478889999985
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=242.70 Aligned_cols=133 Identities=17% Similarity=0.188 Sum_probs=115.3
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccC-----C---CCccceeeEEEe---
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLR-----H---PNLVPLLGFCVV--- 361 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~-----H---~niv~l~g~~~~--- 361 (604)
.++|.+.++||.|.|++||.+. ....+.||+|+.+......+....||++|++++ | ..||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 3578899999999999999999 567889999999887777788899999999994 3 379999999974
Q ss_pred -CCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC
Q 007423 362 -EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID 434 (604)
Q Consensus 362 -~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~ 434 (604)
+.++|+|+|++ +-+|..+|..... ..++...+..|+.||+.||.|||+. .+|||-||||+|||+-
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Y-----rGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNY-----RGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCC-----CCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeee
Confidence 55899999999 5589999986643 3488899999999999999999984 4999999999999983
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=225.75 Aligned_cols=209 Identities=28% Similarity=0.410 Sum_probs=178.1
Q ss_pred EEecCCeEEEEEEeCC-CCEEEEEEeccccc--cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCchhh
Q 007423 303 IISTRTGVSYKAVLPD-ASALAIKRLSACKL--SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYS 379 (604)
Q Consensus 303 ig~G~~g~vy~~~~~~-~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~~ 379 (604)
||+|.+|.||++...+ ++.+++|++..... ..+.+.+|++.+++++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 5789999999999654 89999999976543 24679999999999999999999999999899999999999999999
Q ss_pred hhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC-CCCeEEcccCCccccCCCCCCCC
Q 007423 380 LLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD-DFDARITDFGLARLVGSRDPNDS 458 (604)
Q Consensus 380 ~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~-~~~~kl~DFGla~~~~~~~~~~~ 458 (604)
++.... ..+++..+..++.++++++.||| +.+++|+|++|.||+++. +..++|+|||.+........
T Consensus 81 ~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--- 148 (215)
T cd00180 81 LLKENE------GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--- 148 (215)
T ss_pred HHHhcc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---
Confidence 987542 24789999999999999999999 779999999999999999 89999999999987644321
Q ss_pred ccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccccccc
Q 007423 459 SFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKS 537 (604)
Q Consensus 459 ~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 537 (604)
......+...|++||..... ..+.++|+|++|+++++|
T Consensus 149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------- 187 (215)
T cd00180 149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------- 187 (215)
T ss_pred -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------
Confidence 11112367889999998776 788999999999999998
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 538 LYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 538 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ----------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 234455559999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=253.55 Aligned_cols=248 Identities=22% Similarity=0.298 Sum_probs=194.3
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
++|.....+|+|.+|.|||++ ...++..|||.++... .+-.-..+|+-+++..+|||||.++|.|...+..++.||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 567778899999999999999 6789999999998643 23345678999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
.+|+|++.-+.. ++++..++-.+.+...+|+.||| +.+-+|||||-.|||+.+.+.+|++|||.+..++.
T Consensus 95 gggslQdiy~~T-------gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 95 GGGSLQDIYHVT-------GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred CCCcccceeeec-------ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh
Confidence 999999987654 56888888889999999999999 88899999999999999999999999999887654
Q ss_pred CCCCCCccccCCCCcccccCcccc---CCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHH-cC
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYS---STMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI-AG 528 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 528 (604)
.-.... ...||+.|||||+. ..+.|..++|||+.|++..|+..-++|.....+ .+ +..+.. .+
T Consensus 165 ti~Krk----sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--------mr-~l~LmTkS~ 231 (829)
T KOG0576|consen 165 TIAKRK----SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--------MR-ALFLMTKSG 231 (829)
T ss_pred hhhhhh----cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--------HH-HHHHhhccC
Confidence 322222 33599999999975 356688999999999999999888887543211 11 111111 11
Q ss_pred C-ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 007423 529 R-SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVY 572 (604)
Q Consensus 529 ~-~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~ 572 (604)
. ....-|+ ..+.+..-.+++ .|+..+|++||++...+
T Consensus 232 ~qpp~lkDk----~kws~~fh~fvK---~altknpKkRptaeklL 269 (829)
T KOG0576|consen 232 FQPPTLKDK----TKWSEFFHNFVK---GALTKNPKKRPTAEKLL 269 (829)
T ss_pred CCCCcccCC----ccchHHHHHHHH---HHhcCCCccCCChhhhe
Confidence 1 1111221 224455555555 89999999999987654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-29 Score=232.92 Aligned_cols=198 Identities=23% Similarity=0.292 Sum_probs=162.8
Q ss_pred CcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCC-----eeeEE
Q 007423 298 AVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE-----ERLLV 368 (604)
Q Consensus 298 ~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~lv 368 (604)
...+.||-|+||+||... -++|+.||.|++..-. .+.+.+.+|+++|..++|.|+...++...... +.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 345789999999999998 5679999999986432 34578999999999999999999998876432 46889
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
+|.|.. +|...|-.. ..++-..+.-+..||++||.||| +.+|.||||||.|.|++.+-.+||+|||+++
T Consensus 136 TELmQS-DLHKIIVSP-------Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 136 TELMQS-DLHKIIVSP-------QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHh-hhhheeccC-------CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEeccccccc
Confidence 999966 787777533 46777888889999999999999 8999999999999999999999999999999
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCc
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAGA 509 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~~ 509 (604)
....++....+ ..+-|..|.|||.+.+. .|+...||||.||++.|++.++.-|...++
T Consensus 205 vee~d~~~hMT---qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 205 TWDQRDRLNMT---HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred ccchhhhhhhH---HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 87554332211 12347889999988764 589999999999999999999888876543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=221.81 Aligned_cols=192 Identities=18% Similarity=0.281 Sum_probs=163.5
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccC-CCCccceeeEEEeCC--eeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEE--ERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~--~~~lv~e 370 (604)
++|.+.+.+|+|.++.||.|. ..+.+.++||.++.- ..+.+.+|+.+|..++ ||||+++++...++. ...+++|
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 567778899999999999998 778899999999753 3577999999999997 999999999987654 4679999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC-CCCCeEEcccCCccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID-DDFDARITDFGLARL 449 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~-~~~~~kl~DFGla~~ 449 (604)
|+.+.+...+- ..++-..+..++.+++.||.|+| +.+|+|||+||.|++|| ..-.++|.|.|+|.+
T Consensus 116 ~v~n~Dfk~ly----------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 116 YVNNTDFKQLY----------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hhccccHHHHh----------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhh
Confidence 99998776654 24666788889999999999999 89999999999999999 456799999999999
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
+.+....... +.+..|..||.+.. ..++..-|+|||||++.+|+..+.||-.
T Consensus 183 YHp~~eYnVR-----VASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 183 YHPGKEYNVR-----VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred cCCCceeeee-----eehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 8766544432 35677889997754 5588899999999999999999999964
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=228.96 Aligned_cols=192 Identities=24% Similarity=0.252 Sum_probs=156.5
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCC------ee
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE------ER 365 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~ 365 (604)
+|.....+|.|.- .|-.+. .-.++.||+|++.... ...++..+|..++..+.|+||++++.++.... ..
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 3444566777766 444444 3458899999985432 23467889999999999999999999997543 57
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
|+|||||.. +|...++.. ++-.+...|..|+++|+.||| +.+|+||||||+||++..+..+||.|||
T Consensus 97 y~v~e~m~~-nl~~vi~~e---------lDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 97 YLVMELMDA-NLCQVILME---------LDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred HHHHHhhhh-HHHHHHHHh---------cchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccch
Confidence 999999965 899888732 667788899999999999999 8999999999999999999999999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
+|+...... .....+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+
T Consensus 164 ~ar~e~~~~-----~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 164 LARTEDTDF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred hhcccCccc-----ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence 998654331 12223468899999999998899999999999999999999998864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=224.96 Aligned_cols=198 Identities=26% Similarity=0.330 Sum_probs=169.6
Q ss_pred CCcCcEEEecCCeEEEEEEeCC-CCEEEEEEeccccc--cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 297 FAVENIIISTRTGVSYKAVLPD-ASALAIKRLSACKL--SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~~~-~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
|...+.||+|++|.||++...+ ++.+|+|.+..... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556889999999999999654 89999999976443 35678999999999999999999999999899999999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+++|.+++..... .+++.....++.+++.++.||| ..+++|+|++++||+++.++.++|+|||.+......
T Consensus 81 ~~~L~~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 81 GGDLFDYLRKKGG------KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCHHHHHHhccc------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 9999999976521 1788999999999999999999 779999999999999999999999999999877543
Q ss_pred CCCCCccccCCCCcccccCcccc-CCCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYS-STMVASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
... ......++..|++||.. ....++.++|||+||++++||++|+.||+.
T Consensus 152 ~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 152 LAA---LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccc---cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 210 11122467889999988 667788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=242.05 Aligned_cols=195 Identities=20% Similarity=0.255 Sum_probs=166.6
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHH---------HHHHHHHHHhccC---CCCccceeeEEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEK---------QFRSEMNRLGQLR---HPNLVPLLGFCVV 361 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~---------~~~~Ei~~l~~l~---H~niv~l~g~~~~ 361 (604)
.+|...+.+|+|+||.|+.|.. ++...|+||.+.+.+.-.+ ....||+||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 4588889999999999999994 4567899999976553221 2567999999997 9999999999999
Q ss_pred CCeeeEEeeecC-CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeE
Q 007423 362 EEERLLVYKHMP-NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDAR 440 (604)
Q Consensus 362 ~~~~~lv~ey~~-~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~k 440 (604)
++.+||+||-.. +-+|.++|..+ ..++......|..||+.|+++|| +.+|||||||-+|+.++.+|-+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k-------p~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK-------PRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc-------CccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEE
Confidence 999999999764 45899999765 35889999999999999999999 88999999999999999999999
Q ss_pred EcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCC
Q 007423 441 ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA-SLKGDVYGFGIVLLELLSGQKPLD 505 (604)
Q Consensus 441 l~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~SfGvvl~elltg~~p~~ 505 (604)
|.|||-|..... .+. -..+||..|.|||++.+.+| +..-|||++||+||.++..+.||.
T Consensus 711 lidfgsaa~~ks-gpf-----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 711 LIDFGSAAYTKS-GPF-----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EeeccchhhhcC-CCc-----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999876532 111 22359999999999999887 556899999999999999999985
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=240.95 Aligned_cols=213 Identities=19% Similarity=0.205 Sum_probs=177.6
Q ss_pred CccccCHHHHHHhhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccC------CCCcc
Q 007423 281 PIVKVKLADLLAATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLR------HPNLV 353 (604)
Q Consensus 281 ~~~~~~~~~l~~~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~------H~niv 353 (604)
+.+++.+.|++. ..|.+....|+|.|++|.+|. ...|..||||+|.......+.=.+|+++|++|+ .-|++
T Consensus 420 GYYrv~igE~LD--~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 420 GYYRVRIGELLD--SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred ceEEEehhhhhc--ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 344566666653 468888889999999999998 456889999999887666677788999999994 34899
Q ss_pred ceeeEEEeCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe
Q 007423 354 PLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI 433 (604)
Q Consensus 354 ~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl 433 (604)
+|+..|...++.|||+|-+.- +|.++|+..+.+ ..|....+..++.|+.-||..|- ..+|+|.||||.|||+
T Consensus 498 rl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~n----vGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLV 569 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRN----VGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILV 569 (752)
T ss_pred HHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcc----cceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEe
Confidence 999999999999999998854 899999877654 34778899999999999999999 7899999999999999
Q ss_pred CCC-CCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCc
Q 007423 434 DDD-FDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGA 509 (604)
Q Consensus 434 ~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~ 509 (604)
++. ..+||||||-|..+....... + .-+..|.|||.+.+..|+...|+||.||+||||.||+.-|.....
T Consensus 570 NE~k~iLKLCDfGSA~~~~eneitP--Y----LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 570 NESKNILKLCDFGSASFASENEITP--Y----LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred ccCcceeeeccCccccccccccccH--H----HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 954 568999999998875433211 1 124579999999999999999999999999999999999976543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=218.82 Aligned_cols=253 Identities=19% Similarity=0.316 Sum_probs=187.6
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhcc-CCCCccceeeE-EEeCCeeeEEeeec
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGF-CVVEEERLLVYKHM 372 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~-~~~~~~~~lv~ey~ 372 (604)
.|.+.+.+|+|.||.+-.+.. ...+.+++|.+.......++|.+|..---.+ .|.||+.-++. |+..+.++.++||+
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a 104 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA 104 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence 467778999999999999984 5678899999988777788999999865455 58999987764 56677888999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC--CCCCeEEcccCCcccc
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID--DDFDARITDFGLARLV 450 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~--~~~~~kl~DFGla~~~ 450 (604)
|.|+|.+-+...+ +......+++.|++.|+.|+| +..+||||||.+||||- +...+||+|||+.+..
T Consensus 105 P~gdL~snv~~~G--------igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 105 PRGDLRSNVEAAG--------IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccchhhhhcCccc--------ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999998876542 667788999999999999999 89999999999999994 4567999999998765
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCC-----CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHH
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTM-----VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
+.. +.....+..|.+||..... ...+.+|||.|||++|..+||+.||......+. ...+|.+.
T Consensus 174 g~t-------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~---~Y~~~~~w-- 241 (378)
T KOG1345|consen 174 GTT-------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK---PYWEWEQW-- 241 (378)
T ss_pred Cce-------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc---hHHHHHHH--
Confidence 321 1222245679999965432 246789999999999999999999985433221 23344332
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
..+......+ ... ..++.+.++.+ +-+..+|++|-...++.++...
T Consensus 242 ~~rk~~~~P~--~F~-~fs~~a~r~Fk---k~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 242 LKRKNPALPK--KFN-PFSEKALRLFK---KSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred hcccCccCch--hhc-ccCHHHHHHHH---HhcCCcccccchhHHHHHHHHH
Confidence 2222222111 111 12334445555 8899999999877777776543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=224.33 Aligned_cols=204 Identities=23% Similarity=0.246 Sum_probs=166.4
Q ss_pred HHHhhcCCCcCcEEEecCCeEEEEEEe-C---CCCEEEEEEeccccccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCe
Q 007423 290 LLAATNSFAVENIIISTRTGVSYKAVL-P---DASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEE 364 (604)
Q Consensus 290 l~~~~~~~~~~~~ig~G~~g~vy~~~~-~---~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 364 (604)
+....+.|...++||+|.|++||++.. . ..+.||+|.+.... ....+.+|+++|..+ .|.||+++.+++...+.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 334456688889999999999999983 3 56789999997543 345689999999999 58999999999999999
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC-CCCCeEEcc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID-DDFDARITD 443 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~-~~~~~kl~D 443 (604)
..+|+||++.-+..++.. .++......+...+..||.++| ..+||||||||+|+|.+ ..+.-.|.|
T Consensus 110 v~ivlp~~~H~~f~~l~~----------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR----------SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred eEEEecccCccCHHHHHh----------cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEe
Confidence 999999999988888875 3678899999999999999999 89999999999999998 456789999
Q ss_pred cCCccccCCCC------C-------C---------------------------CCccccCCCCcccccCccccCC-CCCC
Q 007423 444 FGLARLVGSRD------P-------N---------------------------DSSFVHGDLGEFGYVAPEYSST-MVAS 482 (604)
Q Consensus 444 FGla~~~~~~~------~-------~---------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~t 482 (604)
||+|....... . . .........||+||.|||++.. ...+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 99997221000 0 0 0000113469999999998754 4578
Q ss_pred cccchhhHHHHHHHHHhCCCCCCCC
Q 007423 483 LKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 483 ~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
++.||||-|||++-+++++.||-..
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred CccceeeccceeehhhccccccccC
Confidence 9999999999999999999999654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-26 Score=263.55 Aligned_cols=199 Identities=15% Similarity=0.140 Sum_probs=138.9
Q ss_pred ccCC-CCccceeeEE-------EeCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcC
Q 007423 346 QLRH-PNLVPLLGFC-------VVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGC 417 (604)
Q Consensus 346 ~l~H-~niv~l~g~~-------~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~ 417 (604)
.++| +||++++++| ......+.++||+ .++|.++|.... ..+++..++.++.||++||.|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH--- 97 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD------RSVDAFECFHVFRQIVEIVNAAH--- 97 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc------ccccHHHHHHHHHHHHHHHHHHH---
Confidence 4456 6888888887 2234567888988 559999997432 35899999999999999999999
Q ss_pred CCCceecCCCCCeEEeCC-------------------CCCeEEcccCCccccCCCCCC--------C----CccccCCCC
Q 007423 418 QPPYMHQYISSNVILIDD-------------------DFDARITDFGLARLVGSRDPN--------D----SSFVHGDLG 466 (604)
Q Consensus 418 ~~~iiH~dlk~~NiLl~~-------------------~~~~kl~DFGla~~~~~~~~~--------~----~~~~~~~~g 466 (604)
+.+|+||||||+|||++. ++.+|++|||+++........ . ........|
T Consensus 98 ~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 177 (793)
T PLN00181 98 SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAME 177 (793)
T ss_pred hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCC
Confidence 889999999999999954 455677777777643210000 0 000011347
Q ss_pred cccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHH
Q 007423 467 EFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDE 546 (604)
Q Consensus 467 t~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 546 (604)
|+.|||||++.+..++.++|||||||++|||++|.+|+.... ....... .. ..++.. ...
T Consensus 178 t~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----------~~~~~~~-~~----~~~~~~-----~~~ 237 (793)
T PLN00181 178 MSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----------RTMSSLR-HR----VLPPQI-----LLN 237 (793)
T ss_pred CcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----------HHHHHHH-Hh----hcChhh-----hhc
Confidence 889999999999999999999999999999999988864210 0111110 00 011110 111
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 547 IMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 547 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
..+...++.+||+.+|.+||+|.||++.
T Consensus 238 ~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 238 WPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred CHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 2334566679999999999999999763
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-26 Score=214.31 Aligned_cols=246 Identities=24% Similarity=0.402 Sum_probs=183.8
Q ss_pred cEEEecCCeEEEEEEeCCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCch
Q 007423 301 NIIISTRTGVSYKAVLPDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL 377 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL 377 (604)
.+|.+...|..|+|++..+ .+++|++..... -.+.|..|.-.|+-+.||||..++|.|.++....++..|||.|+|
T Consensus 196 tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 4567788899999999554 455677754322 236799999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCC
Q 007423 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPND 457 (604)
Q Consensus 378 ~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 457 (604)
+.+|++... ..++-.+..++|.++|+|++|||+- ++-|...-+.+..+++|++.+++|+- +-+++.
T Consensus 275 ynvlhe~t~-----vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfs------- 340 (448)
T KOG0195|consen 275 YNVLHEQTS-----VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFS------- 340 (448)
T ss_pred HHHHhcCcc-----EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceee-------
Confidence 999997642 3567888999999999999999963 45566677899999999999998752 111111
Q ss_pred CccccCCCCcccccCccccCCCCCC---cccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 458 SSFVHGDLGEFGYVAPEYSSTMVAS---LKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 458 ~~~~~~~~gt~~y~aPE~~~~~~~t---~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
....+....+.||+||.++..+-+ ..+|+|||.|++||+.|++.||....+-+.- .....+| ++.-+
T Consensus 341 -fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg--------mkialeg-lrv~i 410 (448)
T KOG0195|consen 341 -FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG--------MKIALEG-LRVHI 410 (448)
T ss_pred -eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh--------hhhhhcc-ccccC
Confidence 112233457899999998876643 4799999999999999999999765443211 0111122 11112
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhch
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMA 579 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~ 579 (604)
.| +. ...+.+++.-|.++||.+||.++.|+-.|++|.
T Consensus 411 pp-----gi---s~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 411 PP-----GI---SRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CC-----Cc---cHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 11 22 234555566899999999999999999998874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-25 Score=205.75 Aligned_cols=169 Identities=20% Similarity=0.218 Sum_probs=124.5
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.++++..+ ..++|..+..++.|+++||.|||+ .+ ||+|||+++++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~ 63 (176)
T smart00750 1 VSLADILEVRG------RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ 63 (176)
T ss_pred CcHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc
Confidence 68999997542 359999999999999999999994 33 999999999999999 99998764321
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
..|++.|||||++.+..++.++|||||||++|||+||+.||..... ............ ....
T Consensus 64 ---------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-------~~~~~~~~~~~~-~~~~- 125 (176)
T smart00750 64 ---------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-------LSAILEILLNGM-PADD- 125 (176)
T ss_pred ---------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-------hcHHHHHHHHHh-ccCC-
Confidence 1378999999999999999999999999999999999999964321 111111111111 1000
Q ss_pred cccccCCCCHHHH---HHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 535 DKSLYGRGNDDEI---MQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 535 d~~l~~~~~~~~~---~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
+.. ....... ..+.+++.+||+.+|++||++.|+++.+..+..+
T Consensus 126 -~~~--~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 126 -PRD--RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred -ccc--cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 000 0011111 2466777799999999999999999998776543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-23 Score=210.87 Aligned_cols=166 Identities=19% Similarity=0.144 Sum_probs=127.7
Q ss_pred hhcCCCcCcEEEecCCeEEEEEEeC--CCCEEEEEEeccc------cccHHHHHHHHHHHhccCCCCccceeeEEEeCCe
Q 007423 293 ATNSFAVENIIISTRTGVSYKAVLP--DASALAIKRLSAC------KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEE 364 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~~~--~~~~vAvK~l~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 364 (604)
..++|...+.||+|+||+||+|... +++.||||++... ....+.|.+|+++|++++|+|+++.+.. .+.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence 3467999999999999999999853 5788899987532 1124568999999999999999963322 246
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCC-CCCeEEeCCCCCeEEcc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYI-SSNVILIDDDFDARITD 443 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dl-k~~NiLl~~~~~~kl~D 443 (604)
.++||||+++++|... ... . ...++.++++||.||| +.+|+|||| ||+|||++.++.+||+|
T Consensus 93 ~~LVmE~~~G~~L~~~-~~~-------~------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RPH-------G------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred cEEEEEccCCCCHHHh-Ccc-------c------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEE
Confidence 7999999999999632 110 1 1356789999999999 789999999 99999999999999999
Q ss_pred cCCccccCCCCCCCC----ccccCCCCcccccCccccCC
Q 007423 444 FGLARLVGSRDPNDS----SFVHGDLGEFGYVAPEYSST 478 (604)
Q Consensus 444 FGla~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~ 478 (604)
||+|+.+........ ..+....+++.|+|||++..
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999998754321111 11234568889999998764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=211.72 Aligned_cols=220 Identities=26% Similarity=0.390 Sum_probs=163.8
Q ss_pred HhccCCCCccceeeEEEeCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCcee
Q 007423 344 LGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMH 423 (604)
Q Consensus 344 l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH 423 (604)
|+.+.|.|+.+++|.+.+++..+.|.+||..|+|.+.+.... ..++|.....+.++++.||+|+|+ ++-..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~------~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~h 72 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED------IKLDYFFILSFIRDISKGLAYLHN--SPIGYH 72 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc------cCccHHHHHHHHHHHHHHHHHHhc--Ccceee
Confidence 467899999999999999999999999999999999998753 358999999999999999999994 343499
Q ss_pred cCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCC---C----CCcccchhhHHHHHHH
Q 007423 424 QYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM---V----ASLKGDVYGFGIVLLE 496 (604)
Q Consensus 424 ~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~----~t~k~DV~SfGvvl~e 496 (604)
+.++++|+++|..+.+|++|||+............ ........-|.|||.+... . .+.++||||||++++|
T Consensus 73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~--~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEA--HHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred eeeccccceeeeeEEEEechhhhcccccccccccc--cchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 99999999999999999999999987743100000 0011134579999987653 1 4678999999999999
Q ss_pred HHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 497 LLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 497 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
+++++.||+.....+.. ..+..+ +.. .....+.|.+.... +....++.++..||..+|++||++++|-..++
T Consensus 151 i~~r~~~~~~~~~~~~~-~eii~~----~~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~ 222 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVEDP-DEIILR----VKK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLL 222 (484)
T ss_pred HHhccCccccccccCCh-HHHHHH----HHh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence 99999999864433211 112222 222 12223333332111 22225677777999999999999999999888
Q ss_pred hchHh
Q 007423 577 SMAEK 581 (604)
Q Consensus 577 ~i~~~ 581 (604)
.+...
T Consensus 223 ~~~~~ 227 (484)
T KOG1023|consen 223 TINKG 227 (484)
T ss_pred hhccc
Confidence 77653
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=218.62 Aligned_cols=153 Identities=29% Similarity=0.430 Sum_probs=121.3
Q ss_pred CchhhHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCccccccCCCC---CCcEEEEEecCCcceeeCCcccccCCCCCE
Q 007423 21 SIEDDVKCLEGIQNSIKDPDGRLSWSFTNTTVGAICRLTGVACWNEK---ENRIISLTLSSMQLSGQLPESLHLCHSLQS 97 (604)
Q Consensus 21 ~~~~d~~al~~~~~~~~~~~~~~~w~~~~~~~~~~c~~~gv~c~~~~---~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~ 97 (604)
..+.|+.||+.+|..+.++. ..+|+.. .+....|.|.||.|.... ...|+.|+|++|+|+|.+|..++.|++|+.
T Consensus 369 t~~~~~~aL~~~k~~~~~~~-~~~W~g~-~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~ 446 (623)
T PLN03150 369 TLLEEVSALQTLKSSLGLPL-RFGWNGD-PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQS 446 (623)
T ss_pred cCchHHHHHHHHHHhcCCcc-cCCCCCC-CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCE
Confidence 34679999999999997653 2478632 211222479999996322 135899999999999999999999999999
Q ss_pred EEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeeccccccccCCChhhhcC-CCccEEEccCC
Q 007423 98 LDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRL-DRLKEFSVAGN 176 (604)
Q Consensus 98 L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l-~~L~~l~l~~N 176 (604)
|+|++|+|+|.+|..+.. +++|+.|||++|+|+|.+|..++++++|+.|+|++|+|+|.+|..+..+ .++..+++.+|
T Consensus 447 L~Ls~N~l~g~iP~~~~~-l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N 525 (623)
T PLN03150 447 INLSGNSIRGNIPPSLGS-ITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525 (623)
T ss_pred EECCCCcccCcCChHHhC-CCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCC
Confidence 999999999999988866 8999999999999999999999999999999999999999999877653 23344444444
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-20 Score=193.30 Aligned_cols=267 Identities=19% Similarity=0.204 Sum_probs=194.2
Q ss_pred CCCcCcEEEecCCeEEEEEEeCC--CCEEEEEEecccc-ccHHHHHHHHHHHhccCC----CCccceeeEE-EeCCeeeE
Q 007423 296 SFAVENIIISTRTGVSYKAVLPD--ASALAIKRLSACK-LSEKQFRSEMNRLGQLRH----PNLVPLLGFC-VVEEERLL 367 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~~--~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H----~niv~l~g~~-~~~~~~~l 367 (604)
.|.+.+.||+|+||.||.+.... ...+|+|...... .....+..|+.++..+.+ +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 78899999999999999999544 3578888875432 112267788888888863 5888888888 47778899
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC-----CCeEEc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD-----FDARIT 442 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~-----~~~kl~ 442 (604)
||+.+ +.+|.++..... ...++-.+.++|+.|++.+|+++| +.+++||||||.|+++... ..+.+.
T Consensus 99 VM~l~-G~sL~dl~~~~~-----~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-----PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred EEecc-CccHHHHHHhCC-----CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEE
Confidence 99988 669999775443 146899999999999999999999 8999999999999999854 469999
Q ss_pred ccCCcc--ccCCCCCC---CCcc-ccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCc
Q 007423 443 DFGLAR--LVGSRDPN---DSSF-VHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGN 516 (604)
Q Consensus 443 DFGla~--~~~~~~~~---~~~~-~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~ 516 (604)
|||+++ .+...... .... ....+||..|+++....+...+.+.|+||++.++.|+..|..||........
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---- 245 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---- 245 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch----
Confidence 999998 33222111 0111 1244699999999999999999999999999999999999999965432111
Q ss_pred HHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCC
Q 007423 517 LVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFS 585 (604)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~ 585 (604)
... +...... ..... .....+.+..++.. .+-..+..++|....+...++....+.+..
T Consensus 246 ~~~-~~~~~~~----~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~ 304 (322)
T KOG1164|consen 246 KSK-FEKDPRK----LLTDR--FGDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKDVFDSEGSK 304 (322)
T ss_pred HHH-HHHHhhh----hcccc--ccCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHHHHHhcCCC
Confidence 000 1111110 01110 11223444555554 455589999999999999998887765333
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-20 Score=189.29 Aligned_cols=263 Identities=25% Similarity=0.311 Sum_probs=192.0
Q ss_pred CCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccc----cHHHHHHHHHHHhccCCC-CccceeeEEEeCCeeeEEeee
Q 007423 297 FAVENIIISTRTGVSYKAVLPDASALAIKRLSACKL----SEKQFRSEMNRLGQLRHP-NLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lv~ey 371 (604)
|.....+|.|+||.||++... ..+|+|.+..... ....+.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 455678999999999999976 7899999875332 356799999999999988 799999999777778999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC-CeEEcccCCcccc
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF-DARITDFGLARLV 450 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~-~~kl~DFGla~~~ 450 (604)
+.++++.+++...... ..+.......+..+++.++.|+| ..+++|||+||+||+++... .++++|||.++..
T Consensus 80 ~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 80 VDGGSLEDLLKKIGRK----GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred CCCCcHHHHHHhcccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 9999999777654211 24788899999999999999999 78899999999999999888 7999999999866
Q ss_pred CCCCCCCC--ccccCCCCcccccCccccCC---CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHH
Q 007423 451 GSRDPNDS--SFVHGDLGEFGYVAPEYSST---MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 451 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
........ .......|+..|+|||.... ...+...|+||+|++++++++|..||...... ..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-----~~~~~~~~~~ 227 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-----SATSQTLKII 227 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-----ccHHHHHHHH
Confidence 44322111 12234468999999999887 57889999999999999999999997643221 0011111111
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
...... .................+.+++..|+..+|..|.++.+....
T Consensus 228 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 228 LELPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HhcCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111111 000000000001112344555559999999999998887664
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.9e-21 Score=226.75 Aligned_cols=160 Identities=34% Similarity=0.580 Sum_probs=115.6
Q ss_pred ccCchhhHHHHHHHHHhCCCCCCCC-CCCCCCCCCCCCCCccccccCCCCCCcEEEEEecCCcceeeCCcccccCCCCCE
Q 007423 19 TVSIEDDVKCLEGIQNSIKDPDGRL-SWSFTNTTVGAICRLTGVACWNEKENRIISLTLSSMQLSGQLPESLHLCHSLQS 97 (604)
Q Consensus 19 ~~~~~~d~~al~~~~~~~~~~~~~~-~w~~~~~~~~~~c~~~gv~c~~~~~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~ 97 (604)
+...++|..||+.||+++.+|.+.+ +|+. ..++|.|.||+|.+ .++|+.|+|++|+++|.+|+.+..+++|+.
T Consensus 24 ~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~----~~~~c~w~gv~c~~--~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~ 97 (968)
T PLN00113 24 SMLHAEELELLLSFKSSINDPLKYLSNWNS----SADVCLWQGITCNN--SSRVVSIDLSGKNISGKISSAIFRLPYIQT 97 (968)
T ss_pred cCCCHHHHHHHHHHHHhCCCCcccCCCCCC----CCCCCcCcceecCC--CCcEEEEEecCCCccccCChHHhCCCCCCE
Confidence 3445689999999999998887766 8963 23689999999974 468999999999999999999999999999
Q ss_pred EEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCc
Q 007423 98 LDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGND 177 (604)
Q Consensus 98 L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~ 177 (604)
|+|++|.++|.+|..++..+++|++|+|++|+++|.+|. +.+++|++|+|++|++++.+|..++++++|++|++++|.
T Consensus 98 L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~ 175 (968)
T PLN00113 98 INLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV 175 (968)
T ss_pred EECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCc
Confidence 999999999999988874577777777777777665553 234444444444444444444444444444444444444
Q ss_pred ccCCCCCCC
Q 007423 178 LSGTIPPDL 186 (604)
Q Consensus 178 l~g~ip~~~ 186 (604)
+++.+|..+
T Consensus 176 l~~~~p~~~ 184 (968)
T PLN00113 176 LVGKIPNSL 184 (968)
T ss_pred ccccCChhh
Confidence 444444433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-22 Score=217.20 Aligned_cols=256 Identities=20% Similarity=0.179 Sum_probs=185.5
Q ss_pred CcCcEEEecCCeEEEEEE-eCCCCEEEEEEecc---ccccH----HHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 298 AVENIIISTRTGVSYKAV-LPDASALAIKRLSA---CKLSE----KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 298 ~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~---~~~~~----~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
...+++|.|++|.|+... ..+....+.|..+. ....+ ..+..|+-+-..++|+|++..+..+.......-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 356889999999777776 44444445443321 11111 12567888888999999988888777666555569
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
|||++ +|..++... ..+...++-.+..|+..|+.|+| ..+|.|||+|++|+++..++.+||+|||.+..
T Consensus 401 E~~~~-Dlf~~~~~~-------~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~v 469 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-------GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASV 469 (601)
T ss_pred hcccH-HHHHHHhcc-------cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCccee
Confidence 99999 999999764 24777888999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLK-GDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k-~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
.............+.+|+-.|+|||++.+..|+++ .||||.||++..|++|+.||......+... ......+
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~~~ 542 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNYSD 542 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhcccc
Confidence 75544433345567789999999999999998875 799999999999999999998654432210 0000000
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.......+. ............++.++++.||.+|.||.+|++.
T Consensus 543 ~~~~~~~~~---~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 543 QRNIFEGPN---RLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccccccChH---HHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000000000 0011223344456679999999999999999864
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.9e-19 Score=173.07 Aligned_cols=270 Identities=17% Similarity=0.177 Sum_probs=203.4
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
-+|.+.++||+|.||+.+.|+ +-+++.||||.-.. +....++..|....+.+. -+.|-..+.|-..+-+-.||+|.+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 368889999999999999999 88999999997533 223457888999888885 478888877777777888999998
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC-----CCeEEcccCCc
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD-----FDARITDFGLA 447 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~-----~~~kl~DFGla 447 (604)
+.||+|+..-.+ ..++..++..+|+|++.-++|+| ++.+|-|||||+|+||... ..+.+.|||+|
T Consensus 107 -GPSLEDLFD~Cg------R~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 107 -GPSLEDLFDLCG------RRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred -CcCHHHHHHHhc------CcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 669999887554 35889999999999999999999 8899999999999999743 34899999999
Q ss_pred cccCCCCCCCCcc---ccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 448 RLVGSRDPNDSSF---VHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 448 ~~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
+.+.......... .+...||.+||+--...+...+.+-|.=|+|-++...+-|..||....+.. ..+.-+.+
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t-----nK~kYeKI 251 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT-----NKEKYEKI 251 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc-----hHHHHHHh
Confidence 9986654433222 233459999999998888889999999999999999999999998654322 11111111
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCCC
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSE 586 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~ 586 (604)
-+.+....++. ..+..++++...++.+.+ .+-.+-|..+-+...+..+.+..+...
T Consensus 252 -Ge~Kr~T~i~~--Lc~g~P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~dvldr~g~t~ 307 (449)
T KOG1165|consen 252 -GETKRSTPIEV--LCEGFPEEFATYLRYVRR---LDFFETPDYDYLRKLFDDVLDRLGETD 307 (449)
T ss_pred -ccccccCCHHH--HHhcCHHHHHHHHHHHHh---cCcccCCCHHHHHHHHHHHHHhcCCcc
Confidence 11111111111 123456677766665543 456777999888888888888877765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.6e-20 Score=175.72 Aligned_cols=139 Identities=16% Similarity=0.101 Sum_probs=107.7
Q ss_pred CcEEEecCCeEEEEEEeCCCCEEEEEEeccccc---cH-------HH-----------------HHHHHHHHhccCCCCc
Q 007423 300 ENIIISTRTGVSYKAVLPDASALAIKRLSACKL---SE-------KQ-----------------FRSEMNRLGQLRHPNL 352 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~---~~-------~~-----------------~~~Ei~~l~~l~H~ni 352 (604)
...||+|++|.||+|...+|+.||||+++.... .. .. ..+|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 367999999999999987999999999965321 10 11 2349999999988877
Q ss_pred cceeeEEEeCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEE
Q 007423 353 VPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVIL 432 (604)
Q Consensus 353 v~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiL 432 (604)
.....+.. ...++||||++++++....... ..++......++.|++.+|.|+|| ..+|+||||||+|||
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-------~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIl 150 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-------APLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLL 150 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEE
Confidence 44333322 2248999999987766543222 247888999999999999999943 678999999999999
Q ss_pred eCCCCCeEEcccCCcccc
Q 007423 433 IDDDFDARITDFGLARLV 450 (604)
Q Consensus 433 l~~~~~~kl~DFGla~~~ 450 (604)
+++ +.++|+|||+|...
T Consensus 151 i~~-~~v~LiDFG~a~~~ 167 (190)
T cd05147 151 YHD-GKLYIIDVSQSVEH 167 (190)
T ss_pred EEC-CcEEEEEccccccC
Confidence 984 68999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=168.08 Aligned_cols=211 Identities=18% Similarity=0.187 Sum_probs=166.6
Q ss_pred HHHHHHhhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccCC-CCccceeeEEEeCCe
Q 007423 287 LADLLAATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLRH-PNLVPLLGFCVVEEE 364 (604)
Q Consensus 287 ~~~l~~~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~ 364 (604)
++++..+ +.|...+.||+|+||.+|.|. +.+|+.||||.-+.. ....++.-|..+.+.++| ..|-.+..|..++..
T Consensus 8 ~~~~iv~-gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 8 LEELIVG-GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred hhhheec-cceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 3444433 468889999999999999999 889999999986532 223467789999999976 456566667777788
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC---CCCeEE
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD---DFDARI 441 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~---~~~~kl 441 (604)
-.+|||.. +.+|.++..-.. ..++..+.+-+|-|++.-++|+| .+++|||||||+|+|..- ...+.+
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~------R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~L 155 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCS------RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYL 155 (341)
T ss_pred ceeeeecc-CccHHHHHHHHh------hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEE
Confidence 89999998 669999886443 34888999999999999999999 788999999999999873 346899
Q ss_pred cccCCccccCCCCCCCCcc---ccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCc
Q 007423 442 TDFGLARLVGSRDPNDSSF---VHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGA 509 (604)
Q Consensus 442 ~DFGla~~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~ 509 (604)
+|||+|+.+.......... -+...||..|.+--...+...+.+.|+=|.|.+|....-|..||....+
T Consensus 156 IDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 156 IDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred EeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 9999999875433222211 1233588999887766666778899999999999999999999986543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.1e-19 Score=169.86 Aligned_cols=138 Identities=19% Similarity=0.122 Sum_probs=109.8
Q ss_pred CcEEEecCCeEEEEEEeCCCCEEEEEEecccccc---------------------------HHHHHHHHHHHhccCCCCc
Q 007423 300 ENIIISTRTGVSYKAVLPDASALAIKRLSACKLS---------------------------EKQFRSEMNRLGQLRHPNL 352 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~---------------------------~~~~~~Ei~~l~~l~H~ni 352 (604)
...||+|++|.||+|...+|+.||||+++..... ...+..|.+.+.+++|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999778999999998753210 1123578999999999988
Q ss_pred cceeeEEEeCCeeeEEeeecCCCchhhh-hccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCC-CCceecCCCCCe
Q 007423 353 VPLLGFCVVEEERLLVYKHMPNGTLYSL-LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQ-PPYMHQYISSNV 430 (604)
Q Consensus 353 v~l~g~~~~~~~~~lv~ey~~~gsL~~~-l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~-~~iiH~dlk~~N 430 (604)
.....+... ..++||||++++++... +.. ..++......++.+++.++.++| . .+|+||||||+|
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--------~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~N 148 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--------VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYN 148 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--------ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhh
Confidence 555444333 24899999998855433 322 23677888999999999999999 5 899999999999
Q ss_pred EEeCCCCCeEEcccCCccccC
Q 007423 431 ILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 431 iLl~~~~~~kl~DFGla~~~~ 451 (604)
|+++ ++.++|+|||+++...
T Consensus 149 Ill~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 149 ILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EEEE-CCCEEEEEcccceecC
Confidence 9999 7899999999998763
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.1e-20 Score=202.60 Aligned_cols=251 Identities=20% Similarity=0.240 Sum_probs=177.3
Q ss_pred CCCcCcEEEecCCeEEEEEEeCCCCEEEEEEecccc--ccHHHHHHHHHH--HhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 296 SFAVENIIISTRTGVSYKAVLPDASALAIKRLSACK--LSEKQFRSEMNR--LGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
++...+.+|++.|=.|.+|+.+.|. |+||++-+.. ..-+.|.++++- ..-.+|||.+++.-+-......|||=+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4566788999999999999998887 8999974322 233444443332 4555899999988877777778899999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
..+ +|+|.|.-+ ..+...+...|+.|++.|+.-+| ..+|.|||||.+||||.....+.|+||.-.|..-
T Consensus 103 vkh-nLyDRlSTR-------PFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtY 171 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTR-------PFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTY 171 (1431)
T ss_pred Hhh-hhhhhhccc-------hHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCcc
Confidence 977 999999754 34778889999999999999999 8999999999999999999999999998776432
Q ss_pred --CCCCCCCccc-cCCCCcccccCccccCC----------CC-CCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCc
Q 007423 452 --SRDPNDSSFV-HGDLGEFGYVAPEYSST----------MV-ASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGN 516 (604)
Q Consensus 452 --~~~~~~~~~~-~~~~gt~~y~aPE~~~~----------~~-~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~ 516 (604)
.+++..-.+. -...--..|+|||.+.. .. .+++.||||.||++.||++ |++||....
T Consensus 172 LPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-------- 243 (1431)
T KOG1240|consen 172 LPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-------- 243 (1431)
T ss_pred CCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH--------
Confidence 2222222221 11122357999996543 12 5788999999999999988 788886321
Q ss_pred HHHHHHHHHHcCCcccccccc-ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 007423 517 LVDWVNHLVIAGRSRDVVDKS-LYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577 (604)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~d~~-l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 577 (604)
+..+ +.+. -.++. +.....+. .+-++++.|++.||++|.++++.++.-.+
T Consensus 244 L~aY-----r~~~---~~~~e~~Le~Ied~---~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 244 LLAY-----RSGN---ADDPEQLLEKIEDV---SLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred HHhH-----hccC---ccCHHHHHHhCcCc---cHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 1110 1111 11111 00111122 23345559999999999999999998443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.1e-19 Score=172.59 Aligned_cols=169 Identities=12% Similarity=0.135 Sum_probs=130.1
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHH----------HHHHHHHHHhccCCCCccceeeEEEeC-
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEK----------QFRSEMNRLGQLRHPNLVPLLGFCVVE- 362 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~~- 362 (604)
.++|...+++|.|+||.||.... ++..+|||.+.......+ .+.+|++.+.+++|++|.....++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 46799999999999999999665 577899999975332222 267999999999999999999886643
Q ss_pred -------CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC
Q 007423 363 -------EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD 435 (604)
Q Consensus 363 -------~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~ 435 (604)
+..+++|||+++.+|.++.. ++. ....+++.++..+| ..+++|||+||+||++++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSK 170 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-----------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeC
Confidence 35789999999999987632 221 24558899999999 889999999999999998
Q ss_pred CCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHH
Q 007423 436 DFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELL 498 (604)
Q Consensus 436 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ell 498 (604)
++ +++.|||..+......... .+.....+..++|+||||+++.-..
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~d----------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAKD----------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhHH----------------HHHHHhHhcccccccceeEeehHHH
Confidence 88 9999999887552211110 1223334567899999999877654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-18 Score=162.65 Aligned_cols=187 Identities=19% Similarity=0.091 Sum_probs=137.9
Q ss_pred CcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccH-----HHHHHHHHHHhccC-CCCccceeeEEEeCCeeeEEeee
Q 007423 298 AVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSE-----KQFRSEMNRLGQLR-HPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 298 ~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~-----~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lv~ey 371 (604)
.....+++|+||+||.+.- ++..++.+.+....... ..|.+|+++|+++. |+++.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3457899999999996665 77788888886544322 25789999999995 5889998886 346999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCC-CCCeEEeCCCCCeEEcccCCcccc
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYI-SSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dl-k~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
+++.+|.+.+.. ....+..++++++.++| ..+|+|||| ||+|||++.++.++|+|||++...
T Consensus 80 I~G~~L~~~~~~--------------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~ 142 (218)
T PRK12274 80 LAGAAMYQRPPR--------------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRG 142 (218)
T ss_pred ecCccHHhhhhh--------------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence 999888754321 11346788999999999 889999999 799999999999999999999865
Q ss_pred CCCCCC----CCcc-----ccCCCCcccccCccccCC--CCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 451 GSRDPN----DSSF-----VHGDLGEFGYVAPEYSST--MVASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 451 ~~~~~~----~~~~-----~~~~~gt~~y~aPE~~~~--~~~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
...... .... ..-...++.|++|+...- ..--.+.+.++-|.-+|.++||+.+...
T Consensus 143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 432210 0000 001125677888874332 2222567888999999999999988754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=159.07 Aligned_cols=136 Identities=13% Similarity=0.100 Sum_probs=104.9
Q ss_pred CCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccc-cccHHHHHHHHHHHhcc-----CCCCccceeeEEEeCC---eee-
Q 007423 297 FAVENIIISTRTGVSYKAVLPDASALAIKRLSAC-KLSEKQFRSEMNRLGQL-----RHPNLVPLLGFCVVEE---ERL- 366 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ei~~l~~l-----~H~niv~l~g~~~~~~---~~~- 366 (604)
++..+.||+|+||.||. .++....+||++... ....+++.+|+.+++.+ .||||++++|++.++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34568999999999996 333333479988653 22456799999999999 5799999999998863 434
Q ss_pred EEeee--cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHh-hHhhhcCCCCceecCCCCCeEEeCC----CCCe
Q 007423 367 LVYKH--MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGL-AWLHHGCQPPYMHQYISSNVILIDD----DFDA 439 (604)
Q Consensus 367 lv~ey--~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL-~yLH~~~~~~iiH~dlk~~NiLl~~----~~~~ 439 (604)
+|+|| +++|+|.+++.+. .++.. ..++.+++.++ +||| +.+|+||||||+|||++. +..+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~--------~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC--------RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred EEecCCCCcchhHHHHHHcc--------cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcE
Confidence 78999 6689999999653 14443 35677888788 9999 889999999999999973 3479
Q ss_pred EEcccCCc
Q 007423 440 RITDFGLA 447 (604)
Q Consensus 440 kl~DFGla 447 (604)
+|+||+-+
T Consensus 149 ~LiDg~G~ 156 (210)
T PRK10345 149 VVCDNIGE 156 (210)
T ss_pred EEEECCCC
Confidence 99995433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.9e-19 Score=184.20 Aligned_cols=184 Identities=21% Similarity=0.235 Sum_probs=153.8
Q ss_pred EEecCCeEEEEEE----eCCCCEEEEEEeccccc---cHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeeEEeeecCC
Q 007423 303 IISTRTGVSYKAV----LPDASALAIKRLSACKL---SEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 303 ig~G~~g~vy~~~----~~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
+|+|.||.|+.+. .+.++.+|.|.+++... .......|..++..++ ||.+|++...+..+...+++.+|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6889999988754 34577889888865321 1124556788888886 99999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|...+... ..+.......+...++-+++++| +.+|+|||+|++||+++.+|.+|+.|||+++..-...
T Consensus 82 g~lft~l~~~-------~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 82 GDLFTRLSKE-------VMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred chhhhccccC-------CchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 9999988765 24667777788889999999999 8999999999999999999999999999999764332
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
.. +||..|||||+.. .....+|.||||++++||+||..||..
T Consensus 152 ~~--------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 152 IA--------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hc--------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 21 5899999999988 567899999999999999999999964
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.9e-18 Score=166.59 Aligned_cols=234 Identities=21% Similarity=0.274 Sum_probs=144.3
Q ss_pred CCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCC-----------CCccceeeEEE
Q 007423 297 FAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRH-----------PNLVPLLGFCV 360 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H-----------~niv~l~g~~~ 360 (604)
+...+.||.|+++.||.+.. ..++.+|||...... ..-+++.+|.-....+.+ +-++++ +...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~-d~~~ 92 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL-DLLR 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S-EEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee-EEEE
Confidence 34568899999999999995 558999999874322 223567777766655433 222222 2211
Q ss_pred ---------eCC--------eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCcee
Q 007423 361 ---------VEE--------ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMH 423 (604)
Q Consensus 361 ---------~~~--------~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH 423 (604)
... ..+++|+-+ .+||.+++..-.........+....++.+..|+++.+++|| ..+++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence 111 235677777 45888876421000000123556778888899999999999 789999
Q ss_pred cCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCC--------CCCCcccchhhHHHHHH
Q 007423 424 QYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST--------MVASLKGDVYGFGIVLL 495 (604)
Q Consensus 424 ~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~k~DV~SfGvvl~ 495 (604)
+||||+|++++.+|.++|+||+.....+..... ...+..|.+||.... ..+|.+.|.|++|+++|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 999999999999999999999887765432111 124577999996533 34788999999999999
Q ss_pred HHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCC
Q 007423 496 ELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDR 565 (604)
Q Consensus 496 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 565 (604)
.|..|+.||......... +| + +. ... ..++.++.+++ ..++.||++|
T Consensus 242 ~lWC~~lPf~~~~~~~~~-----~~-----------~-f~--~C~-~~Pe~v~~LI~---~lL~~~~~~R 288 (288)
T PF14531_consen 242 SLWCGRLPFGLSSPEADP-----EW-----------D-FS--RCR-DMPEPVQFLIR---GLLQRNPEDR 288 (288)
T ss_dssp HHHHSS-STCCCGGGSTS-----GG-----------G-GT--TSS----HHHHHHHH---HHT-SSGGGS
T ss_pred HHHHccCCCCCCCccccc-----cc-----------c-ch--hcC-CcCHHHHHHHH---HHccCCcccC
Confidence 999999999864332111 00 0 00 111 33455555555 9999999988
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.4e-17 Score=158.79 Aligned_cols=146 Identities=16% Similarity=0.104 Sum_probs=111.7
Q ss_pred HHHhhcCCCcCcEEEecCCeEEEEEE--eCCCCEEEEEEeccccc-------------------------cHHHHHHHHH
Q 007423 290 LLAATNSFAVENIIISTRTGVSYKAV--LPDASALAIKRLSACKL-------------------------SEKQFRSEMN 342 (604)
Q Consensus 290 l~~~~~~~~~~~~ig~G~~g~vy~~~--~~~~~~vAvK~l~~~~~-------------------------~~~~~~~Ei~ 342 (604)
+......|.+.+.||+|++|.||+|. ..+|+.||||.++.... ....+.+|++
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 34444457788999999999999998 67899999999864321 0123568999
Q ss_pred HHhccCCCC--ccceeeEEEeCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCC
Q 007423 343 RLGQLRHPN--LVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPP 420 (604)
Q Consensus 343 ~l~~l~H~n--iv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ 420 (604)
++.++.+.. +.+.+++ ...++||||+++++|....... ..+.......++.+++.++.+|| ..+
T Consensus 103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH---~~g 168 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-------VEPEEEEEFELYDDILEEMRKLY---KEG 168 (237)
T ss_pred HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-------CCcchHHHHHHHHHHHHHHHHHH---hcC
Confidence 999997633 3333332 2358999999998887654322 12445566789999999999999 788
Q ss_pred -ceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 421 -YMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 421 -iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+|||+||+||+++ ++.++|+|||.+...
T Consensus 169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999999999 789999999998754
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.9e-17 Score=183.04 Aligned_cols=200 Identities=19% Similarity=0.200 Sum_probs=159.6
Q ss_pred HHHHhhcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccC---CCCccceeeEEEeCCee
Q 007423 289 DLLAATNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLR---HPNLVPLLGFCVVEEER 365 (604)
Q Consensus 289 ~l~~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~ 365 (604)
+.......|.+...||+|+||.||+|...+|+.||+|+=+.....+ |.--.+++.+|+ -+-|..+..++...+.-
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 3444556788999999999999999998889999999976554332 322233344444 24556666666677788
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC-------CCCC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID-------DDFD 438 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~-------~~~~ 438 (604)
++|+||.+.|+|.+++... ..++|.....++.++++-++.|| ..+|||+||||.|+||. +...
T Consensus 770 ~lv~ey~~~Gtlld~~N~~-------~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTN-------KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred eeeeeccccccHHHhhccC-------CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccc
Confidence 9999999999999999844 46899999999999999999999 88999999999999994 2355
Q ss_pred eEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCC
Q 007423 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQK 502 (604)
Q Consensus 439 ~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~ 502 (604)
++|+|||-+--+..-. ......+.++|-.+-.+|...+..++.++|-|.++-+++-|+.|+.
T Consensus 840 l~lIDfG~siDm~lfp--~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFP--DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEEEecccceeeeEcC--CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 8999999986553211 1234556678889999999999999999999999999999999874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=152.65 Aligned_cols=143 Identities=17% Similarity=0.103 Sum_probs=111.2
Q ss_pred HHHHhhcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccc-----------------------cHHHHHHHHHHHh
Q 007423 289 DLLAATNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKL-----------------------SEKQFRSEMNRLG 345 (604)
Q Consensus 289 ~l~~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~-----------------------~~~~~~~Ei~~l~ 345 (604)
++......|...+.||+|+||.||++...+|+.||||++..... ....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 44444445777899999999999999988899999998754220 0123567899999
Q ss_pred ccCCCC--ccceeeEEEeCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCcee
Q 007423 346 QLRHPN--LVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMH 423 (604)
Q Consensus 346 ~l~H~n--iv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH 423 (604)
++.|++ +...++ ....+++|||+++++|...... .....++.+++.++.++| ..+|+|
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------------~~~~~~~~~i~~~l~~lh---~~gi~H 148 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------------EDPEEVLDEILEEIVKAY---KHGIIH 148 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------------ccHHHHHHHHHHHHHHHH---HCCCCc
Confidence 998874 444433 2456899999999998765421 234568889999999999 789999
Q ss_pred cCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 424 QYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 424 ~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
||+||+||+++++++++|+|||++....
T Consensus 149 ~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 149 GDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCCcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999999986553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.4e-16 Score=152.63 Aligned_cols=133 Identities=17% Similarity=0.223 Sum_probs=112.8
Q ss_pred cEEEecCCeEEEEEEeCCCCEEEEEEeccccc---------cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 301 NIIISTRTGVSYKAVLPDASALAIKRLSACKL---------SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~---------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+.||+|++|.||+|.. ++..|+||+...... ....+.+|++++..++|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 677899998653211 123578899999999999998888887777888999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
+++++|.+++... .+ .+..++.+++.+|.++| ..+++|+|++|.|||++ ++.++|+|||.++.
T Consensus 81 ~~G~~L~~~~~~~----------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN----------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc----------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988532 12 77889999999999999 78999999999999999 78899999998764
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.6e-16 Score=173.50 Aligned_cols=137 Identities=18% Similarity=0.200 Sum_probs=111.0
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEE-eccc-c-------ccHHHHHHHHHHHhccCCCCccceeeEEEeCCe
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPDASALAIKR-LSAC-K-------LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEE 364 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~-l~~~-~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 364 (604)
...|...+.||+|+||+||+|.+.+.. +++|+ +... . ...+.+.+|++++++++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344566789999999999999875544 34443 2211 1 112458899999999999999988888888778
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEccc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDF 444 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DF 444 (604)
.++||||+++++|.+++. ....++.+++++|.||| +.+++|||+||+|||+ +++.++|+||
T Consensus 411 ~~lv~E~~~g~~L~~~l~---------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE---------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CEEEEEecCCCcHHHHHH---------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeC
Confidence 899999999999998774 34678999999999999 8899999999999999 5778999999
Q ss_pred CCcccc
Q 007423 445 GLARLV 450 (604)
Q Consensus 445 Gla~~~ 450 (604)
|+++..
T Consensus 472 Gla~~~ 477 (535)
T PRK09605 472 GLGKYS 477 (535)
T ss_pred cccccC
Confidence 998753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.1e-16 Score=149.52 Aligned_cols=129 Identities=16% Similarity=0.216 Sum_probs=106.4
Q ss_pred EEEecCCeEEEEEEeCCCCEEEEEEecccc----c-----cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 302 IIISTRTGVSYKAVLPDASALAIKRLSACK----L-----SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 302 ~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~----~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
.||+|++|.||+|.. ++..|++|...... . ..+++.+|+++++.++|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999985 67889999864321 1 1245778999999999988766666666777789999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
++++|.+++.... . .++.+++++|.++| ..+++|+|++|.||+++ ++.+++.|||+++.
T Consensus 80 ~g~~l~~~~~~~~-------~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-------D-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-------H-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875321 0 78899999999999 88999999999999999 78999999998875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1e-16 Score=165.36 Aligned_cols=126 Identities=22% Similarity=0.270 Sum_probs=106.1
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
..++.|++|...+|.+||.+.... ...+|...+.++.|++.|+.| ++.+|+|+||.||....+.++||.|
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~----e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG----EERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc----cccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhh
Confidence 478999999999999999765432 357788999999999999998 5799999999999999999999999
Q ss_pred cCCccccCCCCCC--CCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh
Q 007423 444 FGLARLVGSRDPN--DSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS 499 (604)
Q Consensus 444 FGla~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt 499 (604)
||+.......... .........||..||+||.+.+..|+.|+||||+|++++|+++
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 9998766443200 1112234569999999999999999999999999999999997
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3e-15 Score=148.50 Aligned_cols=198 Identities=21% Similarity=0.214 Sum_probs=131.3
Q ss_pred CCCCccceeeEEEeC---------------------------CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHH
Q 007423 348 RHPNLVPLLGFCVVE---------------------------EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRL 400 (604)
Q Consensus 348 ~H~niv~l~g~~~~~---------------------------~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~ 400 (604)
+|||||++.++|.+. ...|+||.-.+. +|.+++... ..+.....
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~--------~~s~r~~~ 344 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR--------HRSYRTGR 344 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC--------CCchHHHH
Confidence 699999999987642 135788887765 888888644 25556667
Q ss_pred HHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC--CCC--CeEEcccCCccccCC---CCCCCCccccCCCCcccccCc
Q 007423 401 RIGMGASRGLAWLHHGCQPPYMHQYISSNVILID--DDF--DARITDFGLARLVGS---RDPNDSSFVHGDLGEFGYVAP 473 (604)
Q Consensus 401 ~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~--~~~--~~kl~DFGla~~~~~---~~~~~~~~~~~~~gt~~y~aP 473 (604)
-+..|+++|+.||| +++|.|||+|+.|||+. +|. .+.|+|||.+-.-.. .-++.+..+ ..-|.-.-|||
T Consensus 345 ~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~V-d~GGNa~lmAP 420 (598)
T KOG4158|consen 345 VILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEV-DLGGNAKLMAP 420 (598)
T ss_pred HHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccc-cCCCcceecch
Confidence 78889999999999 89999999999999984 443 468999998753221 011111111 12366778999
Q ss_pred cccCCCC------CCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHH
Q 007423 474 EYSSTMV------ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEI 547 (604)
Q Consensus 474 E~~~~~~------~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 547 (604)
|+....+ --.|+|.|+.|-+.||+++...||...+.. ..+... .++..++.+.+ .-+..+
T Consensus 421 Ei~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem---~L~~r~-----Yqe~qLPalp~------~vpp~~ 486 (598)
T KOG4158|consen 421 EIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM---LLDTRT-----YQESQLPALPS------RVPPVA 486 (598)
T ss_pred hhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh---eechhh-----hhhhhCCCCcc------cCChHH
Confidence 9875432 135999999999999999999999763221 101111 11112222111 122334
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007423 548 MQFLRVACSCVVSRPKDRPSMYQVYESL 575 (604)
Q Consensus 548 ~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 575 (604)
.+++. ..++.||++|++..-....|
T Consensus 487 rqlV~---~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 487 RQLVF---DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHH---HHhcCCccccCCccHHHhHH
Confidence 44444 78999999999876555544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.5e-16 Score=170.59 Aligned_cols=211 Identities=22% Similarity=0.239 Sum_probs=142.3
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
..+|...+.|-.|++|.||..+.. ..+.+|+| +.+... +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l----ilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL----ILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch----hhhc--cccccCCccee-------------------
Confidence 357888899999999999999854 45677874 332211 1111 33333444443
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
|+-.+.++..+ .++- +.+.+++|+| ..+|+|||+||.|.+|..-+..|+.|||+.+....
T Consensus 136 --gDc~tllk~~g-------~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 --GDCATLLKNIG-------PLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred --chhhhhcccCC-------CCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 55556565432 2221 2267899999 89999999999999999999999999999975422
Q ss_pred CCCCC----------Cc-cccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHH
Q 007423 453 RDPND----------SS-FVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWV 521 (604)
Q Consensus 453 ~~~~~----------~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 521 (604)
..... .. .-+..+||+.|+|||++....|+..+|.|++|+++||.+-|..||.....++.+...+.+.+
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i 275 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI 275 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence 11000 00 11344799999999999999999999999999999999999999987666554322111110
Q ss_pred HHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC
Q 007423 522 NHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP 566 (604)
Q Consensus 522 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 566 (604)
...+- | +....++..+++ +.++.+|.+|-
T Consensus 276 -------~wpE~-d-----ea~p~Ea~dli~---~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 276 -------EWPEE-D-----EALPPEAQDLIE---QLLRQNPLCRL 304 (1205)
T ss_pred -------ccccc-C-----cCCCHHHHHHHH---HHHHhChHhhc
Confidence 01111 1 223345566666 88899999994
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.8e-15 Score=141.32 Aligned_cols=134 Identities=19% Similarity=0.133 Sum_probs=97.2
Q ss_pred CcEEEecCCeEEEEEEeCCCCEEEEEEeccccccH---HH----------------------HHHHHHHHhccCCCC--c
Q 007423 300 ENIIISTRTGVSYKAVLPDASALAIKRLSACKLSE---KQ----------------------FRSEMNRLGQLRHPN--L 352 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~---~~----------------------~~~Ei~~l~~l~H~n--i 352 (604)
.+.||+|+||.||+|...+++.||||+++...... .. ...|.+.+.++++.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998789999999986432111 11 135666666664443 3
Q ss_pred cceeeEEEeCCeeeEEeeecCCCchhhh-hccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCC-CCceecCCCCCe
Q 007423 353 VPLLGFCVVEEERLLVYKHMPNGTLYSL-LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQ-PPYMHQYISSNV 430 (604)
Q Consensus 353 v~l~g~~~~~~~~~lv~ey~~~gsL~~~-l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~-~~iiH~dlk~~N 430 (604)
.+.+++ ...+++|||++++.+... +... ... .....++.+++.++.++| . .+|+|+|+||+|
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~--------~~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~N 145 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV--------RLL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYN 145 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh--------hhc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhh
Confidence 333332 246899999999654321 2111 011 456788999999999999 6 899999999999
Q ss_pred EEeCCCCCeEEcccCCcccc
Q 007423 431 ILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 431 iLl~~~~~~kl~DFGla~~~ 450 (604)
|+++ ++.++++|||.+...
T Consensus 146 ili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 146 ILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred EEEE-CCcEEEEECcccccc
Confidence 9999 889999999999755
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.6e-14 Score=131.17 Aligned_cols=134 Identities=18% Similarity=0.082 Sum_probs=113.0
Q ss_pred CcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCC--CCccceeeEEEeCCeeeEEeeecCCCch
Q 007423 300 ENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRH--PNLVPLLGFCVVEEERLLVYKHMPNGTL 377 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lv~ey~~~gsL 377 (604)
.+.||+|.++.||++...+ ..++||....... ...+.+|+.+++.++| .++.+++++...++..++++||++++.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 4679999999999999755 7899999865433 5678999999999977 5899999888877889999999988766
Q ss_pred hhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 378 ~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
..+ +......++.+++++++++|.....+++|+|++|+||++++++.+++.|||.++.
T Consensus 81 ~~~--------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV--------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC--------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 543 3456778899999999999954346799999999999999989999999998874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.6e-14 Score=136.92 Aligned_cols=135 Identities=18% Similarity=0.209 Sum_probs=104.8
Q ss_pred CcEEE-ecCCeEEEEEEeCCCCEEEEEEecccc--------------ccHHHHHHHHHHHhccCCCCc--cceeeEEEeC
Q 007423 300 ENIII-STRTGVSYKAVLPDASALAIKRLSACK--------------LSEKQFRSEMNRLGQLRHPNL--VPLLGFCVVE 362 (604)
Q Consensus 300 ~~~ig-~G~~g~vy~~~~~~~~~vAvK~l~~~~--------------~~~~~~~~Ei~~l~~l~H~ni--v~l~g~~~~~ 362 (604)
...|| .|+.|+||+.... +..++||+..... .....+.+|++++.+++|++| ...+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 36788 8999999999874 6789999875321 112457889999999998875 6677765432
Q ss_pred C----eeeEEeeecCC-CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC
Q 007423 363 E----ERLLVYKHMPN-GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF 437 (604)
Q Consensus 363 ~----~~~lv~ey~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~ 437 (604)
. ..++|+||+++ .+|.+++... .++.. .+.+++.++.+|| ..+|+|||+||.|||++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--------~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA--------PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDG 179 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC--------CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCC
Confidence 2 23599999997 6898887542 23332 3568899999999 89999999999999999888
Q ss_pred CeEEcccCCcccc
Q 007423 438 DARITDFGLARLV 450 (604)
Q Consensus 438 ~~kl~DFGla~~~ 450 (604)
.++|+|||.++..
T Consensus 180 ~v~LIDfg~~~~~ 192 (239)
T PRK01723 180 KFWLIDFDRGELR 192 (239)
T ss_pred CEEEEECCCcccC
Confidence 9999999988754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=7.6e-15 Score=161.59 Aligned_cols=255 Identities=24% Similarity=0.279 Sum_probs=182.3
Q ss_pred CCCcCcEEEecCCeEEEEEEe--CCCCEEEEEEeccccc---cHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeeEEe
Q 007423 296 SFAVENIIISTRTGVSYKAVL--PDASALAIKRLSACKL---SEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~--~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 369 (604)
.|...+-||+|.|+.|-.... .....+|+|.+..... ..+....|..+-..+. |+|++++++.....+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 355556799999999887764 3345677777754332 2244556888888886 999999999999999999999
Q ss_pred eecCCCchhhhh-ccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC-CeEEcccCCc
Q 007423 370 KHMPNGTLYSLL-HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF-DARITDFGLA 447 (604)
Q Consensus 370 ey~~~gsL~~~l-~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~-~~kl~DFGla 447 (604)
+|..+|++.+.+ .... ...+-.....+..|+..++.|+|. ..++.|||+||+|.+++..+ ..|++|||+|
T Consensus 101 ~~s~g~~~f~~i~~~~~------~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDS------TGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred CcccccccccccccCCc------cCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhh
Confidence 999999999988 4331 124445667788999999999995 57899999999999999999 9999999999
Q ss_pred cccCCCCCCCCccccCCCC-cccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHH
Q 007423 448 RLVGSRDPNDSSFVHGDLG-EFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
..+.... ..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++....... ....|....
T Consensus 173 t~~~~~~-g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~---~~~~~~~~~- 247 (601)
T KOG0590|consen 173 TAYRNKN-GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG---RYSSWKSNK- 247 (601)
T ss_pred ccccccC-CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc---cceeecccc-
Confidence 8876521 22222334467 9999999988874 557789999999999999999999976543321 112222111
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
+... .. . -.........++ .+++..+|+.|.+.+++..
T Consensus 248 --~~~~--~~--~-~~~~~~~~~~~l---~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 --GRFT--QL--P-WNSISDQAHDLL---HKILKENPSNRLSIEELKL 285 (601)
T ss_pred --cccc--cC--c-cccCChhhhhcc---cccccCCchhccccccccc
Confidence 0000 00 0 011122333333 3888899999999888754
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.5e-13 Score=151.67 Aligned_cols=116 Identities=37% Similarity=0.626 Sum_probs=105.9
Q ss_pred CCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEc
Q 007423 94 SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSV 173 (604)
Q Consensus 94 ~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l 173 (604)
.++.|+|++|.|+|.+|.++.. +++|+.|+|++|+|+|.+|..++.+++|+.|||++|+|+|.+|..++++++|+.|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~-L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISK-LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHHHhC-CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEEC
Confidence 4789999999999999999876 999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCcccCCCCCCCCCC----CCcccCCCCCCCCCCC-CCCCC
Q 007423 174 AGNDLSGTIPPDLARF----PEESFDGNSGLCGKPL-GKCGG 210 (604)
Q Consensus 174 ~~N~l~g~ip~~~~~~----~~~~~~~n~~lcg~p~-~~c~~ 210 (604)
++|+|+|.+|..++.. ....+.+|+.+|+.|. ..|..
T Consensus 498 s~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~~ 539 (623)
T PLN03150 498 NGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGP 539 (623)
T ss_pred cCCcccccCChHHhhccccCceEEecCCccccCCCCCCCCcc
Confidence 9999999999887653 3456789999999764 67753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.9e-11 Score=130.65 Aligned_cols=139 Identities=18% Similarity=0.160 Sum_probs=99.3
Q ss_pred CcEEEecCCeEEEEEEeCCCCEEEEEEeccccccH-----------------------------------------HHHH
Q 007423 300 ENIIISTRTGVSYKAVLPDASALAIKRLSACKLSE-----------------------------------------KQFR 338 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~-----------------------------------------~~~~ 338 (604)
.+.||+|++|.||+|++.+|+.||||+.+..-... -.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36899999999999999999999999986431000 0144
Q ss_pred HHHHHHhccC----CCCccceeeEEE-eCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHH-HhhH
Q 007423 339 SEMNRLGQLR----HPNLVPLLGFCV-VEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASR-GLAW 412 (604)
Q Consensus 339 ~Ei~~l~~l~----H~niv~l~g~~~-~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~-gL~y 412 (604)
+|.+.+.+++ |.+-+.+-..+. .....++||||+++++|.++...... .. .+..++..+++ .+..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~------~~---~~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA------GL---DRKALAENLARSFLNQ 272 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc------CC---CHHHHHHHHHHHHHHH
Confidence 5666555552 333334433332 23457899999999999887653211 12 23456666665 4677
Q ss_pred hhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 413 LHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 413 LH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
+| ..+++|+|++|.||++++++++++.|||++..+
T Consensus 273 l~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 273 VL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 88 789999999999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=5.1e-13 Score=129.96 Aligned_cols=156 Identities=21% Similarity=0.294 Sum_probs=115.5
Q ss_pred HHhccCCCCccceeeEEEeC-----CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcC
Q 007423 343 RLGQLRHPNLVPLLGFCVVE-----EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGC 417 (604)
Q Consensus 343 ~l~~l~H~niv~l~g~~~~~-----~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~ 417 (604)
-+-++.|-|||++..|+.+. .+...+.|||..|++..+|++...+. ..+....-.++.-||..||.|||. |
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~---~a~~~~~wkkw~tqIlsal~yLhs-~ 195 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ---KALFQKAWKKWCTQILSALSYLHS-C 195 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh---hhhhHHHHHHHHHHHHhhhhhhhc-c
Confidence 34556799999999998653 34678999999999999998754332 346666778899999999999995 6
Q ss_pred CCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCC-CCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHH
Q 007423 418 QPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDP-NDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLE 496 (604)
Q Consensus 418 ~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~e 496 (604)
.++|+|+++..+-|++..++-+|+.--.... ...... .......-..+-++|.+||+......+..+|||+||...+|
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 8999999999999999988888875321111 100000 00000001125688999999888888899999999999999
Q ss_pred HHhCCCC
Q 007423 497 LLSGQKP 503 (604)
Q Consensus 497 lltg~~p 503 (604)
|..+..-
T Consensus 275 mailEiq 281 (458)
T KOG1266|consen 275 MAILEIQ 281 (458)
T ss_pred HHHheec
Confidence 9887653
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.3e-14 Score=126.87 Aligned_cols=122 Identities=26% Similarity=0.437 Sum_probs=105.8
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|.||+|.|+ .+|+.++.|.+|+.|++++|.++ .+|.++.+ +++|+.|+++-|++. .+|..++.++.|++||
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~iss-l~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISS-LPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhh-chhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 46888999999998 68999999999999999999998 89999876 999999999999997 7899999999999999
Q ss_pred cccccccc-CCChhhhcCCCccEEEccCCcccCCCCCCCCCCCCcccC
Q 007423 149 LSNNKLSG-SIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEESFD 195 (604)
Q Consensus 149 ls~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~ 195 (604)
|+.|+++. .+|..+..+..|+.|+|+.|.|. -+|+.++++...+..
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil 155 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQIL 155 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEE
Confidence 99999985 56888888888888889998886 678777777655443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.4e-11 Score=128.72 Aligned_cols=141 Identities=18% Similarity=0.210 Sum_probs=92.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCC-CCEEEEEEeccccc-----------------------------------cHH---
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPD-ASALAIKRLSACKL-----------------------------------SEK--- 335 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~-~~~vAvK~l~~~~~-----------------------------------~~~--- 335 (604)
..|+. +.+|+|++|.||+|++.+ |+.||||+.+..-. ..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 789999999999999877 99999999964310 001
Q ss_pred ---HHHHHHHHHhccC----CCCccceeeEEEe-CCeeeEEeeecCCCchhhh--hccCCCCCCCCCCCCHHHHHHHHHH
Q 007423 336 ---QFRSEMNRLGQLR----HPNLVPLLGFCVV-EEERLLVYKHMPNGTLYSL--LHGNGVDNTLSGVLDWSTRLRIGMG 405 (604)
Q Consensus 336 ---~~~~Ei~~l~~l~----H~niv~l~g~~~~-~~~~~lv~ey~~~gsL~~~--l~~~~~~~~~~~~l~~~~~~~ia~~ 405 (604)
+|.+|+..+.+++ +.+.+.+-.++.+ ....++||||++++.+.++ +...+ .+ +..++..
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--------~d---~~~la~~ 267 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--------TD---MKLLAER 267 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--------CC---HHHHHHH
Confidence 1344555444442 4444444444433 3457899999999999774 22221 11 1112222
Q ss_pred HHHH-hhHhhhcCCCCceecCCCCCeEEeCCCC----CeEEcccCCcccc
Q 007423 406 ASRG-LAWLHHGCQPPYMHQYISSNVILIDDDF----DARITDFGLARLV 450 (604)
Q Consensus 406 ia~g-L~yLH~~~~~~iiH~dlk~~NiLl~~~~----~~kl~DFGla~~~ 450 (604)
.++. +.-++ ..+++|+|+||.||+++.++ ++++.|||+...+
T Consensus 268 ~v~~~~~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 268 GVEVFFTQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHHHHHHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 1111 12223 56899999999999999887 9999999998766
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.2e-13 Score=118.98 Aligned_cols=126 Identities=28% Similarity=0.450 Sum_probs=102.5
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCC-CCcccccCCccccee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG-PIPPQIVECKFLNKL 147 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g-~iP~~~~~~~~L~~l 147 (604)
-.++.|++++|++. .+|.+++.++.|+.|+++-|.|. .+|..|++ +|.|++|||++|+++- .+|..+.-++.|+.|
T Consensus 56 ~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs-~p~levldltynnl~e~~lpgnff~m~tlral 132 (264)
T KOG0617|consen 56 KNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGS-FPALEVLDLTYNNLNENSLPGNFFYMTTLRAL 132 (264)
T ss_pred hhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCC-CchhhhhhccccccccccCCcchhHHHHHHHH
Confidence 35788999999998 69999999999999999999998 88999877 9999999999999863 578888888888888
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCC---CCcccCCCCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARF---PEESFDGNSG 199 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~---~~~~~~~n~~ 199 (604)
.|+.|.|. -+|..++++++|+.|.+..|.+- ++|.+++.+ ......||..
T Consensus 133 yl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 133 YLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred HhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence 88888887 67778888888888888888875 667665543 3445566643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.21 E-value=7e-11 Score=109.94 Aligned_cols=130 Identities=13% Similarity=0.071 Sum_probs=94.1
Q ss_pred cEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCchhhh
Q 007423 301 NIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~~~ 380 (604)
+.++.|.++.||++... +..|++|...........+.+|+.+++.+.+.++++-+-.+ .....++||||+++.++.+.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~-~~~~~~lv~e~i~G~~l~~~ 81 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF-DPETGVLITEFIEGSELLTE 81 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE-eCCCCeEEEEecCCCccccc
Confidence 46788999999999864 77899999765432234567899999998766655433222 33345899999999877543
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcC--CCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGC--QPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 381 l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~--~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
- . ....++.+++++++.||... ...++|+|++|.||+++ ++.+++.|||.+.
T Consensus 82 ~------------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 82 D------------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred c------------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 0 0 11235678899999999421 12369999999999999 5689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.3e-11 Score=126.43 Aligned_cols=248 Identities=18% Similarity=0.191 Sum_probs=172.0
Q ss_pred CCcCcEEEe--cCCeEEEEEEe---CCCCEEEEEEecccc---ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeE
Q 007423 297 FAVENIIIS--TRTGVSYKAVL---PDASALAIKRLSACK---LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 297 ~~~~~~ig~--G~~g~vy~~~~---~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 367 (604)
|.....+|. |.+|.+|.+.. .++..+|+|+-+... .....=.+|+....++ .|+|.++....+..++..++
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 344567888 99999999875 568889999843211 2223334677777777 49999998899999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHH----HhhHhhhcCCCCceecCCCCCeEEeCCC-CCeEEc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASR----GLAWLHHGCQPPYMHQYISSNVILIDDD-FDARIT 442 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~----gL~yLH~~~~~~iiH~dlk~~NiLl~~~-~~~kl~ 442 (604)
-.|++. .+|.++.+... ..++-.....+..+..+ |+.++| ...++|-|+||.||++..+ ...++.
T Consensus 196 qtE~~~-~sl~~~~~~~~------~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 196 QTELCG-ESLQSYCHTPC------NFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred eecccc-chhHHhhhccc------ccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecC
Confidence 999996 58888876542 12444555566666667 999999 8999999999999999988 889999
Q ss_pred ccCCccccCCCCCCCCcc-ccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHH
Q 007423 443 DFGLARLVGSRDPNDSSF-VHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWV 521 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 521 (604)
|||+...+....-..... .....|...|++||...+ -++...|+||+|.+..|..++..+..... ...|.
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~--------~~~W~ 336 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGK--------NSSWS 336 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCC--------CCCcc
Confidence 999998886544222211 122247788999998765 46889999999999999999877654321 11221
Q ss_pred HHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 522 NHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 522 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
+ .+.+. +.+. .. +...-.... ....+++.+|-.|++.+++..
T Consensus 337 ~--~r~~~---ip~e-~~-~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 Q--LRQGY---IPLE-FC-EGGSSSLRS---VTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred c--ccccc---Cchh-hh-cCcchhhhh---HHHHhcCcchhhhhHHHHHhc
Confidence 1 01111 1111 10 111222222 455899999999999887754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.7e-11 Score=125.00 Aligned_cols=244 Identities=17% Similarity=0.113 Sum_probs=169.0
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe--CCCCEEEEEEecccc---ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeE
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL--PDASALAIKRLSACK---LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~--~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 367 (604)
+.+|.....||.|.|+.||+... .++..+++|.+...- .++..-..|+-+...+ -|.++++....+..-...++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 45788889999999999998873 568889999886532 2222334666666655 58888888777776667789
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC-CCeEEcccCC
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD-FDARITDFGL 446 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~-~~~kl~DFGl 446 (604)
--||++++++...+.-. ..++...++++..+++.++.++| ++.++|+|+||+||++..+ +..+++|||.
T Consensus 344 p~e~~~~~s~~l~~~~~-------~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTS-------QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred chhhhcCcchhhhhHHH-------HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccc
Confidence 99999999887665211 34677788999999999999999 8999999999999999876 8899999999
Q ss_pred ccccCCCCCCCCccccCCCCccccc--CccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYV--APEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
+..+....... .+.-++. +++......+-.++|+||||..+.|.+++..--.. ...|. .
T Consensus 414 ~t~~~~~~~~~-------~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~----------~~~~~--~ 474 (524)
T KOG0601|consen 414 WTRLAFSSGVF-------HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES----------GVQSL--T 474 (524)
T ss_pred ccccceecccc-------cccccccccchhhccccccccccccccccccccccccCcccCcc----------cccce--e
Confidence 87532211110 0222333 45555666788899999999999999998654321 11111 1
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
+..+.... ..... .++..++......++..||.+.+.....+
T Consensus 475 i~~~~~p~---------~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 475 IRSGDTPN---------LPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred eecccccC---------CCchH-HhhhhhhhhhcCCccccchhhhhhcccch
Confidence 11111111 11111 34444555788899999999887765443
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.8e-11 Score=127.92 Aligned_cols=82 Identities=40% Similarity=0.522 Sum_probs=47.4
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
.++.|+||+|+|. ..|..|-+-+++-.|+||+|++. +||..++-.|+.|-+||||+|+|. .+|+.+-.+..|++|+|
T Consensus 104 dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~L 180 (1255)
T KOG0444|consen 104 DLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKL 180 (1255)
T ss_pred cceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhc
Confidence 4566666666666 45666666666666666666665 566555555555556666666654 45555555555555555
Q ss_pred ccccc
Q 007423 150 SNNKL 154 (604)
Q Consensus 150 s~N~l 154 (604)
|+|.|
T Consensus 181 s~NPL 185 (1255)
T KOG0444|consen 181 SNNPL 185 (1255)
T ss_pred CCChh
Confidence 55543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.03 E-value=3e-09 Score=100.31 Aligned_cols=134 Identities=15% Similarity=0.096 Sum_probs=95.0
Q ss_pred cEEEecCCeEEEEEEeCC-------CCEEEEEEecccc---c--------c------------HHHH----HHHHHHHhc
Q 007423 301 NIIISTRTGVSYKAVLPD-------ASALAIKRLSACK---L--------S------------EKQF----RSEMNRLGQ 346 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~-------~~~vAvK~l~~~~---~--------~------------~~~~----~~Ei~~l~~ 346 (604)
..||.|.-+.||.|.-.+ +..+|||..+.+. . + .+.+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998553 4799999874311 0 0 1122 379999998
Q ss_pred cCC--CCccceeeEEEeCCeeeEEeeecCCCchhh-hhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHh-hhcCCCCce
Q 007423 347 LRH--PNLVPLLGFCVVEEERLLVYKHMPNGTLYS-LLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL-HHGCQPPYM 422 (604)
Q Consensus 347 l~H--~niv~l~g~~~~~~~~~lv~ey~~~gsL~~-~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yL-H~~~~~~ii 422 (604)
+.. -++-+.+++ ...++||||+.++.+.. .++.. .++......+..+++.+|..+ | ..++|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--------~~~~~~~~~i~~~i~~~l~~l~H---~~glV 147 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--------KLNDEEMKNAYYQVLSMMKQLYK---ECNLV 147 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--------ccCHHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 854 344444543 45789999997654422 22211 234445567788999999998 6 78999
Q ss_pred ecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 423 HQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 423 H~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+|+++.|||+++ +.+.|+|||.+...
T Consensus 148 HGDLs~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 148 HADLSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred cCCCCHHHEEEEC-CcEEEEECCCceeC
Confidence 9999999999974 57999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.7e-09 Score=103.68 Aligned_cols=141 Identities=18% Similarity=0.204 Sum_probs=107.9
Q ss_pred cEEEecCCeEEEEEEeCCCCEEEEEEeccccc--cHHHHHHHHHHHhccCCC--CccceeeEEEeC---CeeeEEeeecC
Q 007423 301 NIIISTRTGVSYKAVLPDASALAIKRLSACKL--SEKQFRSEMNRLGQLRHP--NLVPLLGFCVVE---EERLLVYKHMP 373 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~~---~~~~lv~ey~~ 373 (604)
+.++.|..+.+|++...+|..+++|....... ...++.+|+++++.+++. ++.+++.+.... +..+++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56889999999999987778999999765432 345788999999999764 456677776553 25689999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhc-------------------------------------
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHG------------------------------------- 416 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~------------------------------------- 416 (604)
+.++.+.+.. ..++......++.+++++|.+||+.
T Consensus 84 G~~l~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 84 GRVLRDRLLR--------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred CEecCCCCCC--------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 9888775531 1366677778888888888888841
Q ss_pred ----------------CCCCceecCCCCCeEEeCC--CCCeEEcccCCccc
Q 007423 417 ----------------CQPPYMHQYISSNVILIDD--DFDARITDFGLARL 449 (604)
Q Consensus 417 ----------------~~~~iiH~dlk~~NiLl~~--~~~~kl~DFGla~~ 449 (604)
....++|+|+.+.||+++. +..+.|.||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1245799999999999998 56689999987763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.5e-10 Score=126.62 Aligned_cols=206 Identities=23% Similarity=0.253 Sum_probs=142.4
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|.+.+-+-+|.++.++-+. ...|...++|...... ...+..+++-+++-..+||-++....-+......++++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 455566667778888887765 3334444444433211 11123334444444456677776655555677889999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
+|..+++|...|+... ..+..........+.++.+||| ...+.|+|++|.|.++..++.-+++|||+...
T Consensus 884 ~~~~~~~~~Skl~~~~-------~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSG-------CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred HHhccCCchhhhhcCC-------CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccc
Confidence 9999999999998764 2332233344556778899999 66699999999999999999999999985543
Q ss_pred cCCCCC--------C----------------CC---ccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCC
Q 007423 450 VGSRDP--------N----------------DS---SFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQK 502 (604)
Q Consensus 450 ~~~~~~--------~----------------~~---~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~ 502 (604)
.+.... . .. ..-....||+.|.+||...+......+|.|++|++++|.++|.+
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 321100 0 00 01123368999999999999999999999999999999999999
Q ss_pred CCCCCCcc
Q 007423 503 PLDVAGAE 510 (604)
Q Consensus 503 p~~~~~~~ 510 (604)
||......
T Consensus 1034 p~na~tpq 1041 (1205)
T KOG0606|consen 1034 PFNAETPQ 1041 (1205)
T ss_pred CCCCcchh
Confidence 99865443
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.6e-10 Score=115.42 Aligned_cols=105 Identities=30% Similarity=0.436 Sum_probs=75.7
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCccc-ccCCcccceee
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQ-IVECKFLNKLI 148 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~-~~~~~~L~~l~ 148 (604)
+++.|+|++|-|. .+|.+++.+..|+.||+|.|+|- .+|..+.. +..|+.+-.++|++. .+|++ +.++.+|.+||
T Consensus 436 kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~-lq~lEtllas~nqi~-~vd~~~l~nm~nL~tLD 511 (565)
T KOG0472|consen 436 KLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYE-LQTLETLLASNNQIG-SVDPSGLKNMRNLTTLD 511 (565)
T ss_pred cceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhh-HHHHHHHHhcccccc-ccChHHhhhhhhcceec
Confidence 4555777777666 57777777777777777777776 67765443 455555555666664 55554 77888888888
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCccc
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 179 (604)
|.+|.+. .||+.+++|.+|++|.+.||+|.
T Consensus 512 L~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 512 LQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cCCCchh-hCChhhccccceeEEEecCCccC
Confidence 8888887 77778888888888888888886
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.6e-10 Score=113.90 Aligned_cols=127 Identities=30% Similarity=0.429 Sum_probs=105.8
Q ss_pred cEEEEEecCCcce-----------------------eeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEcc
Q 007423 70 RIISLTLSSMQLS-----------------------GQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLS 126 (604)
Q Consensus 70 ~v~~l~l~~n~l~-----------------------g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls 126 (604)
-|+.++++.|+|. +.+|..++.+++|+.|+|++|-|. .+|.++++ +..|+.||+|
T Consensus 389 ~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~-lv~Lq~LnlS 466 (565)
T KOG0472|consen 389 IVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGS-LVRLQTLNLS 466 (565)
T ss_pred ceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhh-hhhhheeccc
Confidence 4888888888876 235556788999999999999997 89999887 8889999999
Q ss_pred CCcCCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCC---cccCCCCCC
Q 007423 127 NNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE---ESFDGNSGL 200 (604)
Q Consensus 127 ~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~---~~~~~n~~l 200 (604)
.|+|- .+|..+..+..|+.+-.++|++...-|+.+.+|.+|..|||.+|.+. .||+.++++.+ ....|||.-
T Consensus 467 ~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 467 FNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 99997 88999888888999888889987555566999999999999999997 89999888765 346677654
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.7e-10 Score=120.72 Aligned_cols=106 Identities=30% Similarity=0.450 Sum_probs=86.9
Q ss_pred cEEEEEecCCcceeeCCc-ccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCC----------------
Q 007423 70 RIISLTLSSMQLSGQLPE-SLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG---------------- 132 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~-~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g---------------- 132 (604)
....|+||+|++. +||. -+.+|+.|-.||||+|.|. .+|+.+.. |..|++|+||+|.|.-
T Consensus 127 n~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RR-L~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLh 203 (1255)
T KOG0444|consen 127 NSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRR-LSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLH 203 (1255)
T ss_pred CcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHH-HhhhhhhhcCCChhhHHHHhcCccchhhhhhh
Confidence 5778999999998 5664 4679999999999999998 89998865 8888888888886532
Q ss_pred ---------CCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCccc
Q 007423 133 ---------PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 133 ---------~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 179 (604)
.||.++-.+.+|..+|||.|+|. .+|..+-++.+|+.|+||+|.++
T Consensus 204 ms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it 258 (1255)
T KOG0444|consen 204 MSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT 258 (1255)
T ss_pred cccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee
Confidence 37778888888888889998887 78888888888888888888764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=6.8e-09 Score=110.98 Aligned_cols=165 Identities=16% Similarity=0.188 Sum_probs=121.7
Q ss_pred eCCCCEEEEEEeccccc-cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCchhhhhccCCCCCCCCCCC
Q 007423 316 LPDASALAIKRLSACKL-SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVL 394 (604)
Q Consensus 316 ~~~~~~vAvK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l 394 (604)
..++.+|.|...+.... ..+...+-++.|+.+|||||++++..+..++..|+|+|-+. .|..++.+.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---------- 101 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---------- 101 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----------
Confidence 55788888888865443 22456778889999999999999999999999999999774 466666543
Q ss_pred CHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCcc
Q 007423 395 DWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE 474 (604)
Q Consensus 395 ~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE 474 (604)
.-......+.||+.||.|||+ ...++|++|.-..|+++..|+-||++|-++.....-.. ......--..|..|+
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~----~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA----PAKSLYLIESFDDPE 175 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc----ccccchhhhcccChh
Confidence 233445568899999999997 56899999999999999999999999987764422111 000001112355666
Q ss_pred ccCCCCCCcccchhhHHHHHHHHHhC
Q 007423 475 YSSTMVASLKGDVYGFGIVLLELLSG 500 (604)
Q Consensus 475 ~~~~~~~t~k~DV~SfGvvl~elltg 500 (604)
.+.... -..|.|-||++++|++.|
T Consensus 176 ~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCccc--cchhhhhHHHHHHHHhCc
Confidence 443322 345999999999999998
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.6e-10 Score=126.41 Aligned_cols=106 Identities=30% Similarity=0.392 Sum_probs=79.6
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
.|+.|+|.+|.|+...-+-|.+...|+.|+|++|+|. ++|......+..|+.|+||+|.|+ .+|..+.+|..|++|..
T Consensus 360 ~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a 437 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA 437 (1081)
T ss_pred HHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence 5666777777777777667777777777777777775 777776666777777777777776 67777777777777777
Q ss_pred cccccccCCChhhhcCCCccEEEccCCccc
Q 007423 150 SNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 179 (604)
.+|++. .+| .+..+++|+.+|+|.|+++
T Consensus 438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~ 465 (1081)
T KOG0618|consen 438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLS 465 (1081)
T ss_pred cCCcee-ech-hhhhcCcceEEecccchhh
Confidence 777776 566 6777777777777777775
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.1e-08 Score=91.49 Aligned_cols=130 Identities=18% Similarity=0.243 Sum_probs=95.1
Q ss_pred cEEEecCCeEEEEEEeCCCCEEEEEE-ecccc----cc----HHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 301 NIIISTRTGVSYKAVLPDASALAIKR-LSACK----LS----EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~~~~vAvK~-l~~~~----~~----~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
..+++|+-..+|.+.+.+. .+.+|. +++.- .+ .+.-.+|+.++.+++--.|-.-.=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3577899999999976433 355553 33211 11 13456899999998755554444555677778899999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
+++..|.+.+... ...++..+-+-+.-|| ..+|+|+|+.++||++.++. +.+.|||++..
T Consensus 81 I~G~~lkd~l~~~--------------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888643 2345566666677899 89999999999999998875 99999999874
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.9e-09 Score=120.91 Aligned_cols=108 Identities=28% Similarity=0.317 Sum_probs=57.5
Q ss_pred cEEEEEecCCcceeeCCcccccC-----------------CCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCC
Q 007423 70 RIISLTLSSMQLSGQLPESLHLC-----------------HSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l-----------------~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g 132 (604)
.++.|+|++|+|++ +|....++ ++|+.|+|++|.|+ .+|.. .++|+.|+|++|+|+
T Consensus 343 ~Lq~LdLS~N~Ls~-LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt-~LP~l----~s~L~~LdLS~N~Ls- 415 (788)
T PRK15387 343 GLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLT-SLPVL----PSELKELMVSGNRLT- 415 (788)
T ss_pred ccceEecCCCccCC-CCCCCcccceehhhccccccCcccccccceEEecCCccc-CCCCc----ccCCCEEEccCCcCC-
Confidence 46667777776664 44321111 23444444444444 23321 234555555555555
Q ss_pred CCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCC
Q 007423 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLAR 188 (604)
Q Consensus 133 ~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~ 188 (604)
.+|.. ..+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|+|.+|..+..
T Consensus 416 sIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~ 467 (788)
T PRK15387 416 SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE 467 (788)
T ss_pred CCCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence 24432 234556666666665 56666666666667777777766666655433
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.3e-09 Score=98.05 Aligned_cols=104 Identities=36% Similarity=0.453 Sum_probs=42.5
Q ss_pred cEEEEEecCCcceeeCCcccc-cCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccc-cCCccccee
Q 007423 70 RIISLTLSSMQLSGQLPESLH-LCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQI-VECKFLNKL 147 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~-~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~-~~~~~L~~l 147 (604)
+++.|+|.+|+++ .+ ..++ .+++|+.||||+|.++ .|+. +. .+++|++|+|++|+++ .++..+ ..+++|+.|
T Consensus 20 ~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~-~l~~-l~-~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQIT-KLEG-LP-GLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL 93 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---TT------TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred ccccccccccccc-cc-cchhhhhcCCCEEECCCCCCc-cccC-cc-ChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence 5788999999998 34 3566 6899999999999998 6763 43 4899999999999998 565555 468999999
Q ss_pred eccccccccCC-ChhhhcCCCccEEEccCCccc
Q 007423 148 ILSNNKLSGSI-PFEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 148 ~ls~N~l~g~~-p~~~~~l~~L~~l~l~~N~l~ 179 (604)
+|++|++..-- =..+..+++|+.|++.+|+++
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 99999998421 245778899999999999886
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.2e-10 Score=117.23 Aligned_cols=113 Identities=26% Similarity=0.258 Sum_probs=61.7
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
.+..|+|..|+++..--..+-+|+.|+.||||+|.+. .|-.+-++..++|++||||+|+++-.-|.++..+..|+.|+|
T Consensus 270 kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~-rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 270 KMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQ-RIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred ccceeecccchhhhhhcccccccchhhhhccchhhhh-eeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 4556666666665433445556666666666666665 332222233566666666666666444445555555555555
Q ss_pred cccccccCCChhhhcCCCccEEEccCCcccCCCC
Q 007423 150 SNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 183 (604)
++|.++-.--..+.-+++|+.|||++|.+++.|-
T Consensus 349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IE 382 (873)
T KOG4194|consen 349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIE 382 (873)
T ss_pred cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEe
Confidence 5555553333334445555555555555554443
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.75 E-value=4e-09 Score=80.10 Aligned_cols=59 Identities=46% Similarity=0.552 Sum_probs=28.5
Q ss_pred CCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeeccccc
Q 007423 94 SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNK 153 (604)
Q Consensus 94 ~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~N~ 153 (604)
+|+.|+|++|+++ .||.+.+..+++|++|++++|+++..-|..+..+++|+.|++++|+
T Consensus 2 ~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 4455555555554 4444444445555555555555543333344445555555555444
|
... |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.2e-07 Score=86.27 Aligned_cols=143 Identities=16% Similarity=0.149 Sum_probs=102.0
Q ss_pred cCcEEEecCCeEEEEEEeCCCCEEEEEEe-ccc--------cccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 299 VENIIISTRTGVSYKAVLPDASALAIKRL-SAC--------KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 299 ~~~~ig~G~~g~vy~~~~~~~~~vAvK~l-~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
...++-+|+-+.|+++.. .|+...||.- .+. +...++..+|++++.+++--.|.--.-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457889999999999987 5666666643 221 122345778999999987555544444556666678999
Q ss_pred eecCC-CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC---CeEEcccC
Q 007423 370 KHMPN-GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF---DARITDFG 445 (604)
Q Consensus 370 ey~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~---~~kl~DFG 445 (604)
||+++ .++.+++...... ...-.....++..|-+-+.-|| ...|+|+||..+||++..++ .+.+.|||
T Consensus 90 E~~~g~~~vk~~i~~~~~~-----~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfg 161 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED-----ESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFG 161 (229)
T ss_pred EeccchhHHHHHHHHHccC-----cccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeec
Confidence 99977 4788888755322 1111222567788888899999 88999999999999997543 46899999
Q ss_pred Ccccc
Q 007423 446 LARLV 450 (604)
Q Consensus 446 la~~~ 450 (604)
++...
T Consensus 162 ls~~s 166 (229)
T KOG3087|consen 162 LSSVS 166 (229)
T ss_pred chhcc
Confidence 98643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=6.6e-08 Score=90.90 Aligned_cols=124 Identities=22% Similarity=0.242 Sum_probs=79.8
Q ss_pred EEEEEEeCCCCEEEEEEeccccc----------------------c-----HHHHHHHHHHHhccCCCC--ccceeeEEE
Q 007423 310 VSYKAVLPDASALAIKRLSACKL----------------------S-----EKQFRSEMNRLGQLRHPN--LVPLLGFCV 360 (604)
Q Consensus 310 ~vy~~~~~~~~~vAvK~l~~~~~----------------------~-----~~~~~~Ei~~l~~l~H~n--iv~l~g~~~ 360 (604)
.||.|..++|..+|||.-+.... . .....+|.+.|.++..-. +-+.+++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 48999999999999998753210 0 022568999999997664 4444433
Q ss_pred eCCeeeEEeeecC--CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhH-hhhcCCCCceecCCCCCeEEeCCCC
Q 007423 361 VEEERLLVYKHMP--NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAW-LHHGCQPPYMHQYISSNVILIDDDF 437 (604)
Q Consensus 361 ~~~~~~lv~ey~~--~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~y-LH~~~~~~iiH~dlk~~NiLl~~~~ 437 (604)
....+||||++ +..+..+.. .. ++......+..+++..+.. +| ..+|+|+|+.+.|||++++
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~-~~--------~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~- 143 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKD-VD--------LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG- 143 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHH-CG--------GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-
T ss_pred --eCCEEEEEecCCCccchhhHHh-cc--------ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-
Confidence 23579999998 544444332 21 1122345566677775555 46 7899999999999999988
Q ss_pred CeEEcccCCcccc
Q 007423 438 DARITDFGLARLV 450 (604)
Q Consensus 438 ~~kl~DFGla~~~ 450 (604)
.+.+.|||.+...
T Consensus 144 ~~~iIDf~qav~~ 156 (188)
T PF01163_consen 144 KVYIIDFGQAVDS 156 (188)
T ss_dssp CEEE--GTTEEET
T ss_pred eEEEEecCcceec
Confidence 9999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.3e-09 Score=116.37 Aligned_cols=103 Identities=29% Similarity=0.427 Sum_probs=90.2
Q ss_pred CcEEEEEecCCcceeeCC-cccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 69 NRIISLTLSSMQLSGQLP-ESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p-~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
-.+..|+|++|+|. .+| ..+.++..|+.|+||+|.|+ .||.++.. +..|++|...+|++. .+| ++.+++.|+.+
T Consensus 383 ~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~-~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~l 457 (1081)
T KOG0618|consen 383 KHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVAN-LGRLHTLRAHSNQLL-SFP-ELAQLPQLKVL 457 (1081)
T ss_pred cceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHh-hhhhHHHhhcCCcee-ech-hhhhcCcceEE
Confidence 36899999999998 455 56899999999999999999 99998877 899999999999998 778 89999999999
Q ss_pred ecccccccc-CCChhhhcCCCccEEEccCCc
Q 007423 148 ILSNNKLSG-SIPFEVSRLDRLKEFSVAGND 177 (604)
Q Consensus 148 ~ls~N~l~g-~~p~~~~~l~~L~~l~l~~N~ 177 (604)
|+|.|+|+- .+|.... .++|++|||+||.
T Consensus 458 DlS~N~L~~~~l~~~~p-~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 458 DLSCNNLSEVTLPEALP-SPNLKYLDLSGNT 487 (1081)
T ss_pred ecccchhhhhhhhhhCC-CcccceeeccCCc
Confidence 999999994 4454333 2799999999996
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=4.3e-08 Score=110.74 Aligned_cols=76 Identities=25% Similarity=0.439 Sum_probs=38.5
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
+.+.|+|++++|+ .+|..+. +.|+.|+|++|+|+ .+|..+ .++|+.|+|++|+|+ .+|..+. .+|+.|+|
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l---~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENL---QGNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhh---ccCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 3566677766666 3555443 35556666666665 455443 234555555555554 3444332 13444444
Q ss_pred cccccc
Q 007423 150 SNNKLS 155 (604)
Q Consensus 150 s~N~l~ 155 (604)
++|+++
T Consensus 249 s~N~L~ 254 (754)
T PRK15370 249 SINRIT 254 (754)
T ss_pred cCCccC
Confidence 444443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.2e-08 Score=106.58 Aligned_cols=111 Identities=24% Similarity=0.266 Sum_probs=86.5
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
.+.++.|+|.+|-++..-..+|..++.|+.||||.|.++ .||..-+..-.+++.|+|++|+++-.=-..+.++.+|..|
T Consensus 124 sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tl 202 (873)
T KOG4194|consen 124 SGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTL 202 (873)
T ss_pred ccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhh-cccCCCCCCCCCceEEeeccccccccccccccccchheee
Confidence 456888888888887666677888888888888888888 7776544434678888888888875555677888888889
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCccc
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 179 (604)
.|+.|+++--.+..|.+|++|+.|+|..|++.
T Consensus 203 kLsrNrittLp~r~Fk~L~~L~~LdLnrN~ir 234 (873)
T KOG4194|consen 203 KLSRNRITTLPQRSFKRLPKLESLDLNRNRIR 234 (873)
T ss_pred ecccCcccccCHHHhhhcchhhhhhcccccee
Confidence 99999998444456677888999999888773
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.9e-07 Score=90.11 Aligned_cols=140 Identities=9% Similarity=0.037 Sum_probs=99.1
Q ss_pred cEEEecCCeEEEEEEeCCCCEEEEEEecccccc------------HHHHHHHHHHHhccCCCC--ccceeeEEEe-----
Q 007423 301 NIIISTRTGVSYKAVLPDASALAIKRLSACKLS------------EKQFRSEMNRLGQLRHPN--LVPLLGFCVV----- 361 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~------------~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~----- 361 (604)
+.+-......|++..+ +|+.+.||+....... ...+.+|...+.++...+ +...+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4454444555777666 6678999976432210 114778999888884333 3444556543
Q ss_pred CCeeeEEeeecCCC-chhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC-----
Q 007423 362 EEERLLVYKHMPNG-TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD----- 435 (604)
Q Consensus 362 ~~~~~lv~ey~~~g-sL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~----- 435 (604)
....++|+|++++- +|.+++..... ...+...+..++.+++..+.-|| ..+|+|+|++++|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~-----~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT-----NPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCC
Confidence 23478999999986 78888753211 12445667789999999999999 899999999999999985
Q ss_pred --CCCeEEcccCCccc
Q 007423 436 --DFDARITDFGLARL 449 (604)
Q Consensus 436 --~~~~kl~DFGla~~ 449 (604)
+..+.++||+.++.
T Consensus 179 ~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 179 EEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCceEEEEECCcccc
Confidence 46799999998764
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.1e-08 Score=76.15 Aligned_cols=61 Identities=36% Similarity=0.450 Sum_probs=54.8
Q ss_pred CCCcEEEccCCcCCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcc
Q 007423 118 PYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDL 178 (604)
Q Consensus 118 ~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l 178 (604)
|+|++|+|++|+++..-+..+..+++|++|++++|+++...|..+..+++|++|++++|++
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5789999999999954446788999999999999999987788999999999999999975
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.63 E-value=3.2e-07 Score=95.45 Aligned_cols=172 Identities=22% Similarity=0.273 Sum_probs=126.6
Q ss_pred CeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEe----CCeeeEEeeecCC-Cchhhh
Q 007423 308 TGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV----EEERLLVYKHMPN-GTLYSL 380 (604)
Q Consensus 308 ~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lv~ey~~~-gsL~~~ 380 (604)
-.+.||+. -.||..|++|++...+ ........-++..+++.|+|+|++..++.. +...++||+|.|+ ++|+++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35789998 5689999999995432 122234456788999999999999998873 3468899999987 578775
Q ss_pred hccCCCC--------CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 381 LHGNGVD--------NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 381 l~~~~~~--------~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
--..... .......+....+.++.|+..||.++| +.+..-+-|.+++||++.+.+++|+..|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 4322111 111234677888999999999999999 67788899999999999999999999888776533
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCC
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKP 503 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p 503 (604)
+.. |-+.. -.+-|.-.||.+++.|.||..-
T Consensus 446 d~~------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT------------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC------------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 220 11111 2356888999999999999544
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.6e-07 Score=106.06 Aligned_cols=104 Identities=32% Similarity=0.537 Sum_probs=87.8
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .||..+ .+.|+.|+|++|++. .+|..+. ++|+.|+
T Consensus 199 ~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l---~~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~ 268 (754)
T PRK15370 199 EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATL---PDTIQEMELSINRIT-ELPERLP--SALQSLD 268 (754)
T ss_pred cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhh---hccccEEECcCCccC-cCChhHh--CCCCEEE
Confidence 36889999999999 5887665 69999999999999 789765 357999999999998 8898775 5899999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~ 186 (604)
|++|+|+ .+|..+. .+|+.|++++|+|+ .+|..+
T Consensus 269 Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l 302 (754)
T PRK15370 269 LFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHL 302 (754)
T ss_pred CcCCccC-ccccccC--CCCcEEECCCCccc-cCcccc
Confidence 9999999 5887654 58999999999998 466543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.6e-07 Score=105.77 Aligned_cols=37 Identities=35% Similarity=0.599 Sum_probs=28.7
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCCh
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPV 111 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~ 111 (604)
.++.|+|++|+|+. +|.. +++|++|+|++|+|+ .||.
T Consensus 223 ~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lt-sLP~ 259 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLT-SLPV 259 (788)
T ss_pred CCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccC-cccC
Confidence 57888899998884 6642 578889999999888 5664
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.5e-06 Score=85.69 Aligned_cols=263 Identities=13% Similarity=0.137 Sum_probs=149.6
Q ss_pred cCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhcc-CCCCccceeeEE----E--eCCe-eeEEe
Q 007423 299 VENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFC----V--VEEE-RLLVY 369 (604)
Q Consensus 299 ~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~----~--~~~~-~~lv~ 369 (604)
....+|+|+.+.+|.-- ..| .|| |+........ -.+.++.|.+. .||-+..=+.+= . +++. .-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d--~VA-KIYh~Pppa~--~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD--QVA-KIYHAPPPAA--QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchhhc--hhh-eeecCCCchH--HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 35779999999999542 212 233 5554322111 11223333333 455433211110 0 1122 34566
Q ss_pred eecCCC-chhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 370 KHMPNG-TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 370 ey~~~g-sL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
..+++- -+.++....... ......+|...+++++.+|.+.+-|| ..+-+-+|+.++|+|++++..+.|.|-.-..
T Consensus 90 P~v~g~~pI~~~y~p~tRR-qs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRR-QSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred ccCCCccchhhhcCchhhc-ccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEccccee
Confidence 655543 123333221111 11134789999999999999999999 7788889999999999999999998743222
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccC-----CCCCCcccchhhHHHHHHHHHhC-CCCCCCCCccccccCcHHHHHH
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSS-----TMVASLKGDVYGFGIVLLELLSG-QKPLDVAGAEEGFKGNLVDWVN 522 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~SfGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~ 522 (604)
.- .......+.+|...|.+||.-. +-..+...|-|.+||++++++.| +.||..............
T Consensus 166 i~-----~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---- 236 (637)
T COG4248 166 IN-----ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---- 236 (637)
T ss_pred ec-----cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch----
Confidence 21 1112233456889999999532 34457789999999999999886 999976432211111110
Q ss_pred HHHHcCCcccccc--------cccc-CCCCHHHHHHHHHHHhhccCC--CCCCCCCHHHHHHHHHhchHhc
Q 007423 523 HLVIAGRSRDVVD--------KSLY-GRGNDDEIMQFLRVACSCVVS--RPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 523 ~~~~~~~~~~~~d--------~~l~-~~~~~~~~~~l~~l~~~Cl~~--dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
..+..|......| |... -..-+..+..++. +|+.. ++.-|||++.-+..|.++.++.
T Consensus 237 ~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~---qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 237 TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQ---QAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHH---HHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 0111111111111 1000 0111234444444 78865 3668999998888888776644
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.3e-09 Score=110.55 Aligned_cols=121 Identities=31% Similarity=0.475 Sum_probs=77.2
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
.++.|+|+.|+++ .+|..++.|+ |+.|.+++|+++ .+|.+++ .++.|..||.|.|++. .+|..++.+.+|+.|++
T Consensus 122 ~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig-~~~tl~~ld~s~nei~-slpsql~~l~slr~l~v 196 (722)
T KOG0532|consen 122 ALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIG-LLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNV 196 (722)
T ss_pred HHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccc-cchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHH
Confidence 4555666666666 4666666555 566666666665 6666665 3666666666666665 56666666777777777
Q ss_pred cccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCC---cccCCCC
Q 007423 150 SNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE---ESFDGNS 198 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~---~~~~~n~ 198 (604)
..|++. .+|..+..| .|..||+|.|+++ .||..|.++.. .....||
T Consensus 197 rRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNP 245 (722)
T KOG0532|consen 197 RRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNP 245 (722)
T ss_pred hhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCC
Confidence 777766 556666643 4777888888887 77877665543 3344554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.3e-07 Score=87.44 Aligned_cols=101 Identities=33% Similarity=0.356 Sum_probs=52.0
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCC-CcccccCCccccee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGP-IPPQIVECKFLNKL 147 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~-iP~~~~~~~~L~~l 147 (604)
.+++.|+|++|+++. ++ .+..++.|+.|+|++|.++ .|+..+...+++|+.|+|++|++... -=..+..+++|+.|
T Consensus 42 ~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L 118 (175)
T PF14580_consen 42 DKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVL 118 (175)
T ss_dssp TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EE
T ss_pred cCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCccee
Confidence 478999999999984 54 4788999999999999999 78766544589999999999999632 11456789999999
Q ss_pred eccccccccCCC----hhhhcCCCccEEEc
Q 007423 148 ILSNNKLSGSIP----FEVSRLDRLKEFSV 173 (604)
Q Consensus 148 ~ls~N~l~g~~p----~~~~~l~~L~~l~l 173 (604)
+|.+|.++.. + ..+..+++|+.||-
T Consensus 119 ~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 119 SLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp E-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred eccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 9999999854 3 23567888888875
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.7e-08 Score=105.34 Aligned_cols=110 Identities=29% Similarity=0.492 Sum_probs=99.5
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
-+..|.+++|+++ .+|..++.+..|..||.|.|.+- ++|+.++. +.+|+.|++..|++. .+|+++. .-.|..||+
T Consensus 144 pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~-l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDf 218 (722)
T KOG0532|consen 144 PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGY-LTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDF 218 (722)
T ss_pred cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhh-HHHHHHHHHhhhhhh-hCCHHHh-CCceeeeec
Confidence 3788999999998 79999999999999999999998 89999987 999999999999998 7899998 556999999
Q ss_pred cccccccCCChhhhcCCCccEEEccCCcccCCCCCCC
Q 007423 150 SNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~ 186 (604)
|.|+++ .||..+.+|..|++|.|.+|.|. .-|..+
T Consensus 219 ScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqI 253 (722)
T KOG0532|consen 219 SCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQI 253 (722)
T ss_pred ccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHH
Confidence 999999 89999999999999999999997 335443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=5.3e-08 Score=104.70 Aligned_cols=153 Identities=17% Similarity=0.278 Sum_probs=98.4
Q ss_pred HHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCcc-----ccCCCCcccccCccccCC
Q 007423 404 MGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSF-----VHGDLGEFGYVAPEYSST 478 (604)
Q Consensus 404 ~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~ 478 (604)
.+++.|+.|+|. +.++||++|.|++|.++..+..||+.|+.+............. ..-..-...|.|||++..
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345589999997 7899999999999999999999999999887654422111000 000112457999999999
Q ss_pred CCCCcccchhhHHHHHHHHH-hCCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhc
Q 007423 479 MVASLKGDVYGFGIVLLELL-SGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSC 557 (604)
Q Consensus 479 ~~~t~k~DV~SfGvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C 557 (604)
...+.++|+||+||++|.+. .|+.-+...+....+ ...... ..... ......-+.++.+-+. +.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-----~~~~~~---~~~~~----~~~s~~~p~el~~~l~---k~ 248 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-----SFSRNL---LNAGA----FGYSNNLPSELRESLK---KL 248 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchh-----hhhhcc---ccccc----ccccccCcHHHHHHHH---HH
Confidence 88899999999999999998 455544432211111 000000 00000 0011122344444444 78
Q ss_pred cCCCCCCCCCHHHHHH
Q 007423 558 VVSRPKDRPSMYQVYE 573 (604)
Q Consensus 558 l~~dP~~RPs~~ev~~ 573 (604)
+..++..||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 8999999998777644
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.2e-07 Score=66.10 Aligned_cols=40 Identities=33% Similarity=0.652 Sum_probs=28.6
Q ss_pred hhhHHHHHHHHHhCC-CCCCCC-CCCCCCCCCCCCCCccccccC
Q 007423 23 EDDVKCLEGIQNSIK-DPDGRL-SWSFTNTTVGAICRLTGVACW 64 (604)
Q Consensus 23 ~~d~~al~~~~~~~~-~~~~~~-~w~~~~~~~~~~c~~~gv~c~ 64 (604)
++|++||++||+++. +|.+.+ +|+.++ ..++|+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~--~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSS--DSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT----S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcC--CCCCeeeccEEeC
Confidence 579999999999998 566777 898653 2578999999994
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.45 E-value=4.5e-07 Score=108.96 Aligned_cols=112 Identities=21% Similarity=0.265 Sum_probs=65.0
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
.++.|+|++|++. .+|..+..+++|+.|+|++|+.-+.+|. +.. +++|+.|+|++|.....+|..+.++++|+.|++
T Consensus 612 ~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~-l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 612 NLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSM-ATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred CCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-ccc-CCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 4555666666655 4555556666666666665554445553 332 566666666665555566666666666666666
Q ss_pred cccccccCCChhhhcCCCccEEEccCCcccCCCCCC
Q 007423 150 SNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPD 185 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~ 185 (604)
++|+.-+.+|..+ ++++|+.|++++|...+.+|..
T Consensus 689 ~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~ 723 (1153)
T PLN03210 689 SRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI 723 (1153)
T ss_pred CCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc
Confidence 6654444555543 4566666666666544455543
|
syringae 6; Provisional |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.42 E-value=8e-08 Score=98.99 Aligned_cols=112 Identities=24% Similarity=0.278 Sum_probs=82.0
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCC---CCEEEcCCCCCCC----cCChhhhhcC-CCCcEEEccCCcCCCC----Cc
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHS---LQSLDLSDNSLSG----SIPVDLCKWL-PYVVQLDLSNNHLSGP----IP 135 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~---L~~L~Ls~N~l~g----~ip~~~~~~l-~~L~~l~ls~N~l~g~----iP 135 (604)
...++.|+|++|.+.+..+..+..+.. |++|+|++|++++ .+...+.. + ++|+.|+|++|.+++. ++
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~-~~~~L~~L~L~~n~l~~~~~~~~~ 158 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKD-LPPALEKLVLGRNRLEGASCEALA 158 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHh-CCCCceEEEcCCCcCCchHHHHHH
Confidence 457889999999888766766666666 9999999998873 22233333 5 7889999999998854 33
Q ss_pred ccccCCcccceeeccccccccC----CChhhhcCCCccEEEccCCcccC
Q 007423 136 PQIVECKFLNKLILSNNKLSGS----IPFEVSRLDRLKEFSVAGNDLSG 180 (604)
Q Consensus 136 ~~~~~~~~L~~l~ls~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~g 180 (604)
..+..+.+|+.|+|++|++++. ++..+..+++|+.|++++|.+++
T Consensus 159 ~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 207 (319)
T cd00116 159 KALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTD 207 (319)
T ss_pred HHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccCh
Confidence 4456677889999999988853 34445566789999999888763
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2e-06 Score=83.41 Aligned_cols=134 Identities=18% Similarity=0.114 Sum_probs=92.2
Q ss_pred CCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccc-----------------------cHHHHHHHHHHHhccCCC--C
Q 007423 297 FAVENIIISTRTGVSYKAVLPDASALAIKRLSACKL-----------------------SEKQFRSEMNRLGQLRHP--N 351 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~-----------------------~~~~~~~Ei~~l~~l~H~--n 351 (604)
..+.+.||-|.-+.||.|..+.|.++|||.=+.... ++....+|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345689999999999999999999999996432110 112366899999998644 4
Q ss_pred ccceeeEEEeCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeE
Q 007423 352 LVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVI 431 (604)
Q Consensus 352 iv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~Ni 431 (604)
+-+-+++ +...+||||+++-.|...--. .-+.... ...|++-+.-.- ..++||+|+.+=||
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~~---------~en~~~i---l~~il~~~~~~~---~~GiVHGDlSefNI 233 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRLD---------VENPDEI---LDKILEEVRKAY---RRGIVHGDLSEFNI 233 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccCc---------ccCHHHH---HHHHHHHHHHHH---HcCccccCCchheE
Confidence 4444443 467899999988666543210 1112233 333333333333 46899999999999
Q ss_pred EeCCCCCeEEcccCCccc
Q 007423 432 LIDDDFDARITDFGLARL 449 (604)
Q Consensus 432 Ll~~~~~~kl~DFGla~~ 449 (604)
++++++.+.+.||-.+..
T Consensus 234 lV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 234 LVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred EEecCCCEEEEeCccccc
Confidence 999999999999976653
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.41 E-value=8.6e-08 Score=98.75 Aligned_cols=112 Identities=23% Similarity=0.292 Sum_probs=87.4
Q ss_pred CcEEEEEecCCccee----eCCcccccC-CCCCEEEcCCCCCCCcCChhhh---hcCCCCcEEEccCCcCCCC----Ccc
Q 007423 69 NRIISLTLSSMQLSG----QLPESLHLC-HSLQSLDLSDNSLSGSIPVDLC---KWLPYVVQLDLSNNHLSGP----IPP 136 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g----~~p~~l~~l-~~L~~L~Ls~N~l~g~ip~~~~---~~l~~L~~l~ls~N~l~g~----iP~ 136 (604)
..++.|++++|++++ .+...+..+ ++|+.|+|++|.+++..+..+. ..++.|+.|+|++|.+++. ++.
T Consensus 108 ~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~ 187 (319)
T cd00116 108 SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAE 187 (319)
T ss_pred CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHH
Confidence 359999999999983 344566777 9999999999999965433222 2367899999999999853 445
Q ss_pred cccCCcccceeeccccccccC----CChhhhcCCCccEEEccCCcccC
Q 007423 137 QIVECKFLNKLILSNNKLSGS----IPFEVSRLDRLKEFSVAGNDLSG 180 (604)
Q Consensus 137 ~~~~~~~L~~l~ls~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~g 180 (604)
.+..+++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++
T Consensus 188 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 188 GLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 566778999999999999854 34456677889999999999875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.40 E-value=6.3e-08 Score=93.66 Aligned_cols=101 Identities=28% Similarity=0.367 Sum_probs=57.4
Q ss_pred EEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeecc
Q 007423 71 IISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILS 150 (604)
Q Consensus 71 v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls 150 (604)
++.||||+|.++ .+-.+..-++.++.|+||+|.+. .+-. +. .|++|+.||||+|.++ .+-..-..+.+.+.|+|+
T Consensus 286 LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La-~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 286 LTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LA-ELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hh-hcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 555666666665 45556666666666666666665 3332 32 2666666666666665 333333445555666666
Q ss_pred ccccccCCChhhhcCCCccEEEccCCcc
Q 007423 151 NNKLSGSIPFEVSRLDRLKEFSVAGNDL 178 (604)
Q Consensus 151 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l 178 (604)
+|.+.. + +.+.++-+|..||+++|++
T Consensus 361 ~N~iE~-L-SGL~KLYSLvnLDl~~N~I 386 (490)
T KOG1259|consen 361 QNKIET-L-SGLRKLYSLVNLDLSSNQI 386 (490)
T ss_pred hhhHhh-h-hhhHhhhhheeccccccch
Confidence 666541 1 2344555666666666665
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.40 E-value=6.8e-07 Score=107.47 Aligned_cols=115 Identities=21% Similarity=0.357 Sum_probs=94.9
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|+|++|...+.+|.++++|++|+.|+|++|..-+.+|..+ .+++|+.|+|++|..-..+|.. ..+|+.|+
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~--~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~ 852 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI--NLESLESLDLSGCSRLRTFPDI---STNISDLN 852 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC--CccccCEEECCCCCcccccccc---ccccCEeE
Confidence 368889999998888899999999999999999976666899876 3899999999998766667753 36789999
Q ss_pred ccccccccCCChhhhcCCCccEEEccC-CcccCCCCCCCCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAG-NDLSGTIPPDLARFP 190 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~-N~l~g~ip~~~~~~~ 190 (604)
|++|+++ .+|.++..+++|+.|++++ |++. .+|..+..++
T Consensus 853 Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~ 893 (1153)
T PLN03210 853 LSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLK 893 (1153)
T ss_pred CCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCccccccc
Confidence 9999998 6899999999999999998 4554 5776655443
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=7.3e-08 Score=96.62 Aligned_cols=132 Identities=24% Similarity=0.319 Sum_probs=104.5
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEc-cCCcCCCCCc-ccccCCcccce
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDL-SNNHLSGPIP-PQIVECKFLNK 146 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~l-s~N~l~g~iP-~~~~~~~~L~~ 146 (604)
...+.|+|..|+|+-..|..+..+++|+.||||+|+++ .|-+..+..+++|..|-+ ++|+++ .+| ..++++.+|+.
T Consensus 67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is-~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqr 144 (498)
T KOG4237|consen 67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNIS-FIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQR 144 (498)
T ss_pred CcceEEEeccCCcccCChhhccchhhhceecccccchh-hcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHH
Confidence 35788999999999766678999999999999999999 666555666888877655 559998 555 56889999999
Q ss_pred eeccccccccCCChhhhcCCCccEEEccCCcccCCCCC-CCCC---CCCcccCCCCCCCCC
Q 007423 147 LILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP-DLAR---FPEESFDGNSGLCGK 203 (604)
Q Consensus 147 l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~-~~~~---~~~~~~~~n~~lcg~ 203 (604)
|.+.-|+++-.....+..+++|..|.+-.|.+. .|+. .+.. ....-.+-|++.|-.
T Consensus 145 LllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdC 204 (498)
T KOG4237|consen 145 LLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDC 204 (498)
T ss_pred HhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCcccccc
Confidence 999999999888888999999999999999886 4443 3332 223344567777754
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.35 E-value=9.6e-08 Score=92.42 Aligned_cols=108 Identities=25% Similarity=0.260 Sum_probs=86.7
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
...|..|+||+|++.- + ..+..|.+|+.||||+|.|+ .+-..- ..|-+.++|.|+.|.+.. + ..++.+.+|..|
T Consensus 306 ~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh-~KLGNIKtL~La~N~iE~-L-SGL~KLYSLvnL 379 (490)
T KOG1259|consen 306 APKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWH-LKLGNIKTLKLAQNKIET-L-SGLRKLYSLVNL 379 (490)
T ss_pred ccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhH-hhhcCEeeeehhhhhHhh-h-hhhHhhhhheec
Confidence 4589999999999972 3 34899999999999999998 444332 237889999999999852 2 347888899999
Q ss_pred eccccccccCC-ChhhhcCCCccEEEccCCcccCC
Q 007423 148 ILSNNKLSGSI-PFEVSRLDRLKEFSVAGNDLSGT 181 (604)
Q Consensus 148 ~ls~N~l~g~~-p~~~~~l~~L~~l~l~~N~l~g~ 181 (604)
|+++|++.--- -..+++++.|..+.|.+|.+++.
T Consensus 380 Dl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 380 DLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred cccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 99999998321 13578999999999999999864
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=7.5e-08 Score=82.91 Aligned_cols=108 Identities=28% Similarity=0.329 Sum_probs=69.6
Q ss_pred EEEEecCCcceeeCC---cccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 72 ISLTLSSMQLSGQLP---ESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 72 ~~l~l~~n~l~g~~p---~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++|++.+|- .++ ..+.....|+..+|++|.|- .+|..+...++.++.|+|++|.++ .+|.++..++.|+.||
T Consensus 30 h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 30 HFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN 106 (177)
T ss_pred hhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence 34556655543 233 23445555666677777776 667666665666777777777776 6777777777777777
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP 184 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~ 184 (604)
++.|.|+ ..|..+..|.+|..|+..+|... +||.
T Consensus 107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~ 140 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDV 140 (177)
T ss_pred cccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcH
Confidence 7777776 45556666777777777777664 5554
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=6.7e-08 Score=83.20 Aligned_cols=117 Identities=19% Similarity=0.289 Sum_probs=95.5
Q ss_pred CCcEEEEEecCCcceeeCCccccc-CCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccce
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHL-CHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNK 146 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~-l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~ 146 (604)
.-.++.++|++|.|. .+|+.+.. .+.++.|+|++|.++ .+|.++.. ++.|+.|++++|.|+ ..|.-+..+.+|..
T Consensus 52 ~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aa-m~aLr~lNl~~N~l~-~~p~vi~~L~~l~~ 127 (177)
T KOG4579|consen 52 GYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAA-MPALRSLNLRFNPLN-AEPRVIAPLIKLDM 127 (177)
T ss_pred CceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhh-hHHhhhcccccCccc-cchHHHHHHHhHHH
Confidence 347888999999998 56766654 468999999999999 99999877 899999999999998 77888888999999
Q ss_pred eeccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCC
Q 007423 147 LILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARF 189 (604)
Q Consensus 147 l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~ 189 (604)
||..+|.+. +||..+..-+..-..++.+|.+.+.-|..+..+
T Consensus 128 Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa~ 169 (177)
T KOG4579|consen 128 LDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQAL 169 (177)
T ss_pred hcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccccc
Confidence 999999987 788775544555556677888887777655444
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=6.8e-05 Score=81.17 Aligned_cols=138 Identities=17% Similarity=0.176 Sum_probs=91.9
Q ss_pred cEEEecCCeEEEEEEeCCCCEEEEEEeccccccH-------------------------------H----------HHHH
Q 007423 301 NIIISTRTGVSYKAVLPDASALAIKRLSACKLSE-------------------------------K----------QFRS 339 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~-------------------------------~----------~~~~ 339 (604)
+.|+.++-|.||+|++.+|+.||||+.+..-... + .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6899999999999999999999999986421100 0 1335
Q ss_pred HHHHHhccC----CCCccceeeEEEe-CCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHh-hHh
Q 007423 340 EMNRLGQLR----HPNLVPLLGFCVV-EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGL-AWL 413 (604)
Q Consensus 340 Ei~~l~~l~----H~niv~l~g~~~~-~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL-~yL 413 (604)
|..-+.+++ +..=+.+-..|.+ .....|+|||++|-.+.+...-.. ...+ +..++..++++. ..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~------~g~d---~k~ia~~~~~~f~~q~ 281 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS------AGID---RKELAELLVRAFLRQL 281 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh------cCCC---HHHHHHHHHHHHHHHH
Confidence 665555552 2222344444433 466789999999988888743221 1133 233333333322 112
Q ss_pred hhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 414 HHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 414 H~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
- ..+++|.|..|.||+++.+++.-+-|||+...+
T Consensus 282 ~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 282 L---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred H---hcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 2 458999999999999999999999999988755
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.16 E-value=1e-06 Score=93.78 Aligned_cols=101 Identities=39% Similarity=0.584 Sum_probs=46.0
Q ss_pred EEEEEecCCcceeeCCcccccCC-CCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 71 IISLTLSSMQLSGQLPESLHLCH-SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 71 v~~l~l~~n~l~g~~p~~l~~l~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
++.|++.+|+++ .+|+....++ +|+.|++++|.+. .+|..+.. ++.|+.|++++|+++ .+|...+.++.|+.|++
T Consensus 118 l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~-l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 118 LTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRN-LPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193 (394)
T ss_pred eeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhc-cccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence 444444444444 3444444442 4444555554444 44333322 444444555544444 44444444444444445
Q ss_pred cccccccCCChhhhcCCCccEEEccCC
Q 007423 150 SNNKLSGSIPFEVSRLDRLKEFSVAGN 176 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L~~l~l~~N 176 (604)
++|+++ .+|..+.....|+.+.+++|
T Consensus 194 s~N~i~-~l~~~~~~~~~L~~l~~~~N 219 (394)
T COG4886 194 SGNKIS-DLPPEIELLSALEELDLSNN 219 (394)
T ss_pred cCCccc-cCchhhhhhhhhhhhhhcCC
Confidence 544444 34433333334444444444
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.6e-05 Score=76.43 Aligned_cols=106 Identities=23% Similarity=0.246 Sum_probs=82.3
Q ss_pred HHHHHHHHHHhccCC--CCccceeeEEEeCC----eeeEEeeecCCC-chhhhhccCCCCCCCCCCCCHHHHHHHHHHHH
Q 007423 335 KQFRSEMNRLGQLRH--PNLVPLLGFCVVEE----ERLLVYKHMPNG-TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGAS 407 (604)
Q Consensus 335 ~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~----~~~lv~ey~~~g-sL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia 407 (604)
..+.+|...+.++.. -.+.+.+++..... ..++|+|++++- +|.+++.... ..+......++.+++
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-------~~~~~~~~~ll~~l~ 128 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-------QLDPSQRRELLRALA 128 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-------ccchhhHHHHHHHHH
Confidence 457788888877753 34456666665532 358999999884 7999887532 144556778999999
Q ss_pred HHhhHhhhcCCCCceecCCCCCeEEeCCCC---CeEEcccCCcccc
Q 007423 408 RGLAWLHHGCQPPYMHQYISSNVILIDDDF---DARITDFGLARLV 450 (604)
Q Consensus 408 ~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~---~~kl~DFGla~~~ 450 (604)
+.+.-|| ..+|+|+|++++|||++.+. .+.+.||+-++..
T Consensus 129 ~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 129 RLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 89999999999999999876 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.1e-06 Score=93.59 Aligned_cols=182 Identities=16% Similarity=0.080 Sum_probs=128.3
Q ss_pred cEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCC-ccceeeEEEeCCeeeEEeeecCCC-chh
Q 007423 301 NIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPN-LVPLLGFCVVEEERLLVYKHMPNG-TLY 378 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lv~ey~~~g-sL~ 378 (604)
+-.++++++.+||.+-...+...++.+... ....-++++|.+++||| .+..++-+..++..+++++|+..| +-.
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 345678889999887433334446655432 44566899999999999 777777777788889999999887 222
Q ss_pred hhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCC
Q 007423 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDS 458 (604)
Q Consensus 379 ~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 458 (604)
....... ..+...+...+.+.-.++++|+| +-.=+|+| ||+..+ ...|..||+....+....
T Consensus 324 ~~~~~se------~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---- 385 (829)
T KOG0576|consen 324 LEMTVSE------IALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---- 385 (829)
T ss_pred ccCChhh------Hhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc----
Confidence 1111100 12333334445566678999999 44457888 776665 578999999988775433
Q ss_pred ccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007423 459 SFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLD 505 (604)
Q Consensus 459 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~ 505 (604)
..+...+++.|+|||+.....+..+.|+|+.|+--.+|.-|-+|-.
T Consensus 386 -~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 -KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred -ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 1223358999999999999999999999999987778887877754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.04 E-value=9.4e-05 Score=70.20 Aligned_cols=136 Identities=14% Similarity=0.100 Sum_probs=98.1
Q ss_pred EecCCeEEEEEEeCCCCEEEEEEecc----c---cccHHHHHHHHHHHhccCCC--CccceeeEEE-eC----CeeeEEe
Q 007423 304 ISTRTGVSYKAVLPDASALAIKRLSA----C---KLSEKQFRSEMNRLGQLRHP--NLVPLLGFCV-VE----EERLLVY 369 (604)
Q Consensus 304 g~G~~g~vy~~~~~~~~~vAvK~l~~----~---~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~-~~----~~~~lv~ 369 (604)
|.||.+-|++-.+.+. .+=+|+-.. + ...+..|.+|...+.++..- .+.+.. ++. .. -..+||+
T Consensus 27 ~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 4577888888776444 688887641 1 12456799999999998533 233334 332 11 2367999
Q ss_pred eecCC-CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC--eEEcccCC
Q 007423 370 KHMPN-GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD--ARITDFGL 446 (604)
Q Consensus 370 ey~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~--~kl~DFGl 446 (604)
|-+++ -+|.+++.+... ...+...+..+..++++.+.-|| ..++.|+|+.+.||+++.++. +++.||--
T Consensus 105 e~L~g~~~L~~~l~~~~~-----~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 105 EDMAGFISIADWYAQHAV-----SPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EeCCCCccHHHHHhcCCc-----CCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 97764 488888865421 23566778899999999999999 899999999999999986566 99999976
Q ss_pred ccc
Q 007423 447 ARL 449 (604)
Q Consensus 447 a~~ 449 (604)
++.
T Consensus 177 ~r~ 179 (216)
T PRK09902 177 SRR 179 (216)
T ss_pred cch
Confidence 553
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.03 E-value=2.1e-06 Score=91.42 Aligned_cols=105 Identities=35% Similarity=0.484 Sum_probs=90.6
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
+++.|++++|++. .+|..+.++++|+.|++++|.++ .+|...+. ++.|+.|++++|+++ .+|..+..+..|+.|.+
T Consensus 141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~-~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~ 216 (394)
T COG4886 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSN-LSNLNNLDLSGNKIS-DLPPEIELLSALEELDL 216 (394)
T ss_pred hcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhh-hhhhhheeccCCccc-cCchhhhhhhhhhhhhh
Confidence 7999999999998 67788999999999999999999 88886544 899999999999998 89988878888999999
Q ss_pred cccccccCCChhhhcCCCccEEEccCCccc
Q 007423 150 SNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 179 (604)
++|++. .++..+.++..+..+.+.+|++.
T Consensus 217 ~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~ 245 (394)
T COG4886 217 SNNSII-ELLSSLSNLKNLSGLELSNNKLE 245 (394)
T ss_pred cCCcce-ecchhhhhcccccccccCCceee
Confidence 999644 56667788888888888888775
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.01 E-value=7.8e-05 Score=72.75 Aligned_cols=138 Identities=11% Similarity=0.106 Sum_probs=83.0
Q ss_pred cEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCc--cceeeEEEeCCeeeEEeeecCCCc-h
Q 007423 301 NIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNL--VPLLGFCVVEEERLLVYKHMPNGT-L 377 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~ni--v~l~g~~~~~~~~~lv~ey~~~gs-L 377 (604)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-.+ .+.+++....+...++||++++.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 57899999999984 24467778775422 34557889999988864433 556777766777789999998863 2
Q ss_pred hhh---------------------hccCCCCCCCCCCCCHHHHHH-HHH----------HHHH-HhhHhhh-cCCCCcee
Q 007423 378 YSL---------------------LHGNGVDNTLSGVLDWSTRLR-IGM----------GASR-GLAWLHH-GCQPPYMH 423 (604)
Q Consensus 378 ~~~---------------------l~~~~~~~~~~~~l~~~~~~~-ia~----------~ia~-gL~yLH~-~~~~~iiH 423 (604)
... ||..... ......... +.. .+.+ ...+|.. ...+.++|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~-----~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCD-----TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC-----CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 111 1111000 011111000 000 0000 1112211 12346789
Q ss_pred cCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 424 QYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 424 ~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
+|+.|.||++++++ +.|.||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999887 9999998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.7e-07 Score=100.50 Aligned_cols=104 Identities=31% Similarity=0.384 Sum_probs=62.9
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
.+...+.+.|.|. .+-.+|.-++.|+.||||+|.|+ .+- . ..+|++|.+|||++|.|. .+|.--..--.|+.|+|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~-~v~-~-Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFT-KVD-N-LRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhh-hhH-H-HHhcccccccccccchhc-cccccchhhhhheeeee
Confidence 4555666666665 45556666777777777777776 332 2 344777777777777775 45542221123777777
Q ss_pred cccccccCCChhhhcCCCccEEEccCCcccC
Q 007423 150 SNNKLSGSIPFEVSRLDRLKEFSVAGNDLSG 180 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g 180 (604)
++|.++- + ..+.+|.+|+.||+++|-+++
T Consensus 240 rnN~l~t-L-~gie~LksL~~LDlsyNll~~ 268 (1096)
T KOG1859|consen 240 RNNALTT-L-RGIENLKSLYGLDLSYNLLSE 268 (1096)
T ss_pred cccHHHh-h-hhHHhhhhhhccchhHhhhhc
Confidence 7777662 2 135566667777777776653
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.95 E-value=5.5e-06 Score=83.44 Aligned_cols=91 Identities=20% Similarity=0.189 Sum_probs=76.3
Q ss_pred ccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeeccccccccCCChhhhcCCC
Q 007423 88 SLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDR 167 (604)
Q Consensus 88 ~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~ 167 (604)
.+..|++|+.|+|++|.+++ |-+..+..+..|+.|.|..|++.-.--..+.+++.|++|+|.+|+++-.-|.++..+.+
T Consensus 269 cf~~L~~L~~lnlsnN~i~~-i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~ 347 (498)
T KOG4237|consen 269 CFKKLPNLRKLNLSNNKITR-IEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFS 347 (498)
T ss_pred HHhhcccceEeccCCCccch-hhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccce
Confidence 47889999999999999995 44444455899999999999987444456788899999999999999888888889999
Q ss_pred ccEEEccCCccc
Q 007423 168 LKEFSVAGNDLS 179 (604)
Q Consensus 168 L~~l~l~~N~l~ 179 (604)
|..|+|-.|.|.
T Consensus 348 l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 348 LSTLNLLSNPFN 359 (498)
T ss_pred eeeeehccCccc
Confidence 999999999884
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.95 E-value=8e-06 Score=57.10 Aligned_cols=36 Identities=44% Similarity=0.767 Sum_probs=15.3
Q ss_pred CCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCC
Q 007423 94 SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLS 131 (604)
Q Consensus 94 ~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~ 131 (604)
+|++|+|++|.++ .||+++.. |++|+.|+|++|+++
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~-l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSN-LPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTT-CTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhC-CCCCCEEEecCCCCC
Confidence 3444444444444 34443332 444444444444443
|
... |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.91 E-value=8.3e-06 Score=57.00 Aligned_cols=37 Identities=41% Similarity=0.618 Sum_probs=27.1
Q ss_pred CCCcEEEccCCcCCCCCcccccCCcccceeeccccccc
Q 007423 118 PYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLS 155 (604)
Q Consensus 118 ~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~N~l~ 155 (604)
++|++|+|++|+++ .+|+.+++|++|+.|++++|+++
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 45778888888887 67777788888888888888777
|
... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.89 E-value=6.7e-07 Score=96.07 Aligned_cols=105 Identities=30% Similarity=0.247 Sum_probs=84.8
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|+|++|+++. . ..|..|+.|.+||||.|.|. .+|.--...+ +|+.|+|+||.++.. ..+.++.+|+.||
T Consensus 187 ~ale~LnLshNk~~~-v-~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lrnN~l~tL--~gie~LksL~~LD 260 (1096)
T KOG1859|consen 187 PALESLNLSHNKFTK-V-DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLRNNALTTL--RGIENLKSLYGLD 260 (1096)
T ss_pred HHhhhhccchhhhhh-h-HHHHhcccccccccccchhc-cccccchhhh-hheeeeecccHHHhh--hhHHhhhhhhccc
Confidence 357889999999984 3 37899999999999999998 7875222223 499999999999733 4688999999999
Q ss_pred ccccccccCCC-hhhhcCCCccEEEccCCccc
Q 007423 149 LSNNKLSGSIP-FEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 149 ls~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~ 179 (604)
|+.|-|++.-- ..+..|..|+.|+|.||.+-
T Consensus 261 lsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 261 LSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 99999997532 23667889999999999873
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.88 E-value=4.3e-05 Score=72.10 Aligned_cols=104 Identities=22% Similarity=0.245 Sum_probs=81.6
Q ss_pred HHHHHHhccCC-CCccceeeEEEeCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcC
Q 007423 339 SEMNRLGQLRH-PNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGC 417 (604)
Q Consensus 339 ~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~ 417 (604)
.|.-+++.+.+ +++.+++|+| ..+++.||.+.+++...-..-. .-..-+|..|.+||.++++.+.++++..
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~----~~~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLS----QFLQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccc----cccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 58888888876 6999999999 3478999999876653210000 0013579999999999999999999765
Q ss_pred CCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 418 QPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 418 ~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
...+.-.|++++|+-+++++++|+.|...+...
T Consensus 80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 556777999999999999999999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00027 Score=68.19 Aligned_cols=151 Identities=16% Similarity=0.130 Sum_probs=96.2
Q ss_pred cCHHHHHHhhcCCCcCcEEE---ecCCeEEEEEEeCCCCEEEEEEeccccccH----------HH---------------
Q 007423 285 VKLADLLAATNSFAVENIII---STRTGVSYKAVLPDASALAIKRLSACKLSE----------KQ--------------- 336 (604)
Q Consensus 285 ~~~~~l~~~~~~~~~~~~ig---~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~----------~~--------------- 336 (604)
.++..+........+....| +|.-..||+|...++..+|||+.+...... ..
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 45555666556665555555 556668999998899999999986432110 01
Q ss_pred HHHHHHHHhccCC--CCccceeeEEEeCCeeeEEeeecCCCc-hhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHh
Q 007423 337 FRSEMNRLGQLRH--PNLVPLLGFCVVEEERLLVYKHMPNGT-LYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL 413 (604)
Q Consensus 337 ~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lv~ey~~~gs-L~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yL 413 (604)
..+|+.-|+++.. -.+-+-+++. .-.|||||+.... -.-.|... .+.......+..++++.+.-|
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv--------~~e~~e~~~~~~~~v~~~~~l 182 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV--------PLELEEAEGLYEDVVEYMRRL 182 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC--------CcCchhHHHHHHHHHHHHHHH
Confidence 2357766766632 2222333332 3469999996531 11122211 122224555666777777777
Q ss_pred hhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 414 HHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 414 H~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
-. ..++||+||+.=|||+. ++.+.|+|||.|...
T Consensus 183 ~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 183 YK--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred HH--hcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence 63 47899999999999999 779999999988754
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00026 Score=69.03 Aligned_cols=143 Identities=19% Similarity=0.119 Sum_probs=84.5
Q ss_pred cEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCC--ccceeeEEEe---CCeeeEEeeecCCC
Q 007423 301 NIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPN--LVPLLGFCVV---EEERLLVYKHMPNG 375 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~---~~~~~lv~ey~~~g 375 (604)
+.++.|..+.||+....+ ..+++|..... .....+.+|..+++.+.... +.+++.+... ....+++|+|+++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 578999999999999877 69999997654 34567888999988885443 4455654433 33568999999998
Q ss_pred chhh----------------hh---ccCCCCCCCCCCCCHHH---------HHHH------------HHHHHH-HhhHhh
Q 007423 376 TLYS----------------LL---HGNGVDNTLSGVLDWST---------RLRI------------GMGASR-GLAWLH 414 (604)
Q Consensus 376 sL~~----------------~l---~~~~~~~~~~~~l~~~~---------~~~i------------a~~ia~-gL~yLH 414 (604)
.+.. .+ +..... .....+.. .... ...+.+ .+..++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPP---FSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTT---CCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhccccccc---ccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 7777 11 111000 00111111 0000 011112 233333
Q ss_pred h----cCCCCceecCCCCCeEEeC-CCCCeEEcccCCcc
Q 007423 415 H----GCQPPYMHQYISSNVILID-DDFDARITDFGLAR 448 (604)
Q Consensus 415 ~----~~~~~iiH~dlk~~NiLl~-~~~~~kl~DFGla~ 448 (604)
. .....++|+|+.+.|||++ +++.+.|.||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1 1356799999999999999 55666899998665
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 604 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-51 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-50 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-32 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-32 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-24 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-11 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-08 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-08 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-06 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-05 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-05 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-05 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-05 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-05 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-05 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-05 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-05 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-05 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-05 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-04 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-04 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-04 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-04 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-04 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-04 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-04 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-04 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-04 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-04 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-04 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-04 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-04 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 7e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-04 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 308 bits (792), Expect = e-101
Identities = 111/294 (37%), Positives = 173/294 (58%), Gaps = 10/294 (3%)
Query: 287 LADLLAATNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKL--SEKQFRSEMNRL 344
L +L A+++F+ +NI+ G YK L D + +A+KRL + E QF++E+ +
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI 81
Query: 345 GQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGM 404
H NL+ L GFC+ ERLLVY +M NG++ S L LDW R RI +
Sbjct: 82 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ---PPLDWPKRQRIAL 138
Query: 405 GASRGLAWLHHGCQPPYMHQYI-SSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHG 463
G++RGLA+LH C P +H+ + ++N IL+D++F+A + DFGLA+L+ +D + ++ V
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAAN-ILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV-- 195
Query: 464 DLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNH 523
G G++APEY ST +S K DV+G+G++LLEL++GQ+ D+A L+DWV
Sbjct: 196 -RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 524 LVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKS 577
L+ + +VD L G D+E+ Q ++VA C S P +RP M +V L+
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 2e-86
Identities = 105/334 (31%), Positives = 165/334 (49%), Gaps = 28/334 (8%)
Query: 246 SKKKRGYGADSGKDDSSWIQVLRSHKLVQVSLFQKPIVKVKLADLLAATNSFAVENIIIS 305
SK + + + SS++ S++ V L DL ATN+F + +I
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYR-------------VPLVDLEEATNNFDHKFLIGH 49
Query: 306 TRTGVSYKAVLPDASALAIKRLSACKL-SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEE 364
G YK VL D + +A+KR + ++F +E+ L RHP+LV L+GFC E
Sbjct: 50 GVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109
Query: 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQ 424
+L+YK+M NG L L+G+ + + + W RL I +GA+RGL +LH +H+
Sbjct: 110 MILIYKYMENGNLKRHLYGSDLP---TMSMSWEQRLEICIGAARGLHYLHTRA---IIHR 163
Query: 425 YI-SSNVILIDDDFDARITDFGLARLVGSRDPND-SSFVHGDLGEFGYVAPEYSSTMVAS 482
+ S N IL+D++F +ITDFG+++ D S+ V G GY+ PEY +
Sbjct: 164 DVKSIN-ILLDENFVPKITDFGISKKGTELDQTHLSTVV---KGTLGYIDPEYFIKGRLT 219
Query: 483 LKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRG 542
K DVY FG+VL E+L + + + E NL +W G+ +VD +L +
Sbjct: 220 EKSDVYSFGVVLFEVLCARSAIVQSLPRE--MVNLAEWAVESHNNGQLEQIVDPNLADKI 277
Query: 543 NDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576
+ + +F A C+ +DRPSM V L+
Sbjct: 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 2e-80
Identities = 88/307 (28%), Positives = 147/307 (47%), Gaps = 32/307 (10%)
Query: 287 LADLLAATNSFAVENIIISTRT------GVSYKAVLPDASALAIKRLSACKLS-----EK 335
+L TN+F I + GV YK + + + +A+K+L+A ++
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75
Query: 336 QFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLD 395
QF E+ + + +H NLV LLGF ++ LVY +MPNG+L L + L
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG----TPPLS 131
Query: 396 WSTRLRIGMGASRGLAWLHHGCQPPYMHQYI-SSNVILIDDDFDARITDFGLARLVGSRD 454
W R +I GA+ G+ +LH +H+ I S+N IL+D+ F A+I+DFGLAR
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSAN-ILLDEAFTAKISDFGLARASEKFA 187
Query: 455 PND-SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGF 513
+S + +G Y+APE + + K D+Y FG+VLLE+++G +D +
Sbjct: 188 QTVMTSRI---VGTTAYMAPEALRGEI-TPKSDIYSFGVVLLEIITGLPAVDEHREPQ-- 241
Query: 514 KGNLVDWVNHLVIAGRS-RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVY 572
L+D + ++ D +DK + + + VA C+ + RP + +V
Sbjct: 242 --LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 573 ESLKSMA 579
+ L+ M
Sbjct: 299 QLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 3e-59
Identities = 72/316 (22%), Positives = 116/316 (36%), Gaps = 35/316 (11%)
Query: 287 LADLLAATNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQ 346
+L + + + R G +KA L + +A+K Q E+ L
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEYEVYSLPG 74
Query: 347 LRHPNLVPLLGFCV----VEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRI 402
++H N++ +G V+ + L+ G+L L N V+ W+ I
Sbjct: 75 MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--------VVSWNELCHI 126
Query: 403 GMGASRGLAWLHH-------GCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDP 455
+RGLA+LH G +P H+ I S +L+ ++ A I DFGLA +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 456 NDSSFVHGDLGEFGYVAPEY-----SSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAE 510
+ HG +G Y+APE + A L+ D+Y G+VL EL S D G
Sbjct: 187 AGDT--HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD--GPV 242
Query: 511 EGFKGNLVDWVNHLVIAGRSRDVVDK-----SLYGRGNDDEIMQFL-RVACSCVVSRPKD 564
+ + + + ++VV L M L C +
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 565 RPSMYQVYESLKSMAE 580
R S V E + M
Sbjct: 303 RLSAGCVGERITQMQR 318
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 59/324 (18%), Positives = 115/324 (35%), Gaps = 42/324 (12%)
Query: 288 ADLLAATNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSE--MNRLG 345
++ ++ + +I R G YK L D +A+K S + + F +E + R+
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA--NRQNFINEKNIYRVP 62
Query: 346 QLRHPNLVPLLGFCV-----VEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRL 400
+ H N+ + E LLV ++ PNG+L L + DW +
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--------TSDWVSSC 114
Query: 401 RIGMGASRGLAWLH------HGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454
R+ +RGLA+LH +P H+ ++S +L+ +D I+DFGL+ +
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 455 PNDSSFV----HGDLGEFGYVAPEY-------SSTMVASLKGDVYGFGIVLLELLSGQKP 503
++G Y+APE A + D+Y G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 504 LDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK-----SLYGRGNDDEIM--QFLRVACS 556
L + ++ V + + +V + ++ +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 557 CVVSRPKDRPSMYQVYESLKSMAE 580
C + R + E + +
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMM 318
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 5e-41
Identities = 62/272 (22%), Positives = 110/272 (40%), Gaps = 50/272 (18%)
Query: 323 AIKRLSACKLSE---KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL--VYKHMPNGTL 377
+K L S + F E RL HPN++P+LG C + MP G+L
Sbjct: 37 VVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSL 96
Query: 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF 437
Y++LH + V+D S ++ + +RG+A+LH +P ++S ++ID+D
Sbjct: 97 YNVLHEGT-----NFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDM 150
Query: 438 DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE---YSSTMVASLKGDVYGFGIVL 494
ARI+ + S G + +VAPE D++ F ++L
Sbjct: 151 TARISMADVKFSFQSP---------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLL 201
Query: 495 LELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGR-----GNDDEIMQ 549
EL++ + P F ++++ I + V + L R G + +
Sbjct: 202 WELVTREVP---------FAD-----LSNMEIGMK---VALEGL--RPTIPPGISPHVSK 242
Query: 550 FLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581
++ C+ P RP + L+ M +K
Sbjct: 243 LMK---ICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-39
Identities = 66/272 (24%), Positives = 115/272 (42%), Gaps = 51/272 (18%)
Query: 323 AIKRLSACKLSE---KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYS 379
A+K L +F E+ + +LRHPN+V +G +V +++ G+LY
Sbjct: 64 AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 380 LLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439
LLH +G LD RL + ++G+ +LH+ PP +H+ + S +L+D +
Sbjct: 124 LLHKSGAREQ----LDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTV 178
Query: 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE------YSSTMVASLKGDVYGFGIV 493
++ DFGL+RL S + S G ++APE + K DVY FG++
Sbjct: 179 KVCDFGLSRLKASTFLSSKSAA----GTPEWMAPEVLRDEPSNE------KSDVYSFGVI 228
Query: 494 LLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGR-----GNDDEIM 548
L EL + Q+P + +N + V K R + ++
Sbjct: 229 LWELATLQQP---------WGN-----LNPAQVVA---AVGFKCK--RLEIPRNLNPQVA 269
Query: 549 QFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
+ C + P RPS + + L+ + +
Sbjct: 270 AIIE---GCWTNEPWKRPSFATIMDLLRPLIK 298
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 56/287 (19%), Positives = 110/287 (38%), Gaps = 49/287 (17%)
Query: 323 AIKRLSACKLSE---KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYS 379
AI+ + + +E K F+ E+ Q RH N+V +G C+ ++ TLYS
Sbjct: 59 AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118
Query: 380 LLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439
++ + VLD + +I +G+ +LH +H+ + S + D+
Sbjct: 119 VVRDAKI------VLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNG-KV 168
Query: 440 RITDFGLARLVGSRDPND-SSFVHGDLGEFGYVAPEYSSTMVA---------SLKGDVYG 489
ITDFGL + G + G ++APE + S DV+
Sbjct: 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA 228
Query: 490 FGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV----VDKSLYGRGNDD 545
G + EL + + P FK + + + G ++ + K +
Sbjct: 229 LGTIWYELHAREWP---------FKTQPAEAIIWQMGTGMKPNLSQIGMGKEIS------ 273
Query: 546 EIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH-GFSEPYDEF 591
+I+ C ++RP+ ++ + L+ + +++ S P +
Sbjct: 274 DILL------FCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW 314
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-38
Identities = 59/266 (22%), Positives = 112/266 (42%), Gaps = 33/266 (12%)
Query: 323 AIKRLSACKLSE---KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYS 379
A+K L+ + + F++E+ L + RH N++ +G+ + +V + +LY
Sbjct: 50 AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYH 108
Query: 380 LLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439
LH + + + I +RG+ +LH +H+ + SN I + +D
Sbjct: 109 HLHASE------TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTV 159
Query: 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE---YSSTMVASLKGDVYGFGIVLLE 496
+I DFGLA + S G ++APE + S + DVY FGIVL E
Sbjct: 160 KIGDFGLATEK--SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYE 217
Query: 497 LLSGQKP-LDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVAC 555
L++GQ P ++ ++ + V + + R K + +M
Sbjct: 218 LMTGQLPYSNINNRDQIIEM--VGRGSLSPDLSKVRSNCPKRMK------RLMA------ 263
Query: 556 SCVVSRPKDRPSMYQVYESLKSMAEK 581
C+ + +RPS ++ ++ +A +
Sbjct: 264 ECLKKKRDERPSFPRILAEIEELARE 289
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-38
Identities = 44/140 (31%), Positives = 72/140 (51%), Gaps = 5/140 (3%)
Query: 71 IISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL 130
S+T+S +L+G++P + +L +DLS N L G V ++ L+ N L
Sbjct: 176 FTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGS-DKNTQKIHLAKNSL 233
Query: 131 SGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPD--LAR 188
+ + ++ K LN L L NN++ G++P +++L L +V+ N+L G IP L R
Sbjct: 234 AFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQR 292
Query: 189 FPEESFDGNSGLCGKPLGKC 208
F ++ N LCG PL C
Sbjct: 293 FDVSAYANNKCLCGSPLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-36
Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 7/172 (4%)
Query: 23 EDDVKCLEGIQNSIKDPDGRLSWSFTNTTVGAICRLTGVACWNE-KENRIISLTLSSMQL 81
D + L I+ + +P SW TT GV C + + R+ +L LS + L
Sbjct: 5 PQDKQALLQIKKDLGNPTTLSSW--LPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 82 SGQ--LPESLHLCHSLQSLDLSD-NSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQI 138
+P SL L L + N+L G IP + K L + L +++ ++SG IP +
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK-LTQLHYLYITHTNVSGAIPDFL 121
Query: 139 VECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP 190
+ K L L S N LSG++P +S L L + GN +SG IP F
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS 173
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 51/279 (18%), Positives = 100/279 (35%), Gaps = 32/279 (11%)
Query: 323 AIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFC----VVEEERLLVYKHMPNGTLY 378
A+K + + +E+ + +RH N++ + + L+ + NG+LY
Sbjct: 64 AVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLY 123
Query: 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-----HGCQPPYMHQYISSNVILI 433
L LD + L++ + GL LH +P H+ + S IL+
Sbjct: 124 DYLKST--------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175
Query: 434 DDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE------YSSTMVASLKGDV 487
+ I D GLA S + +G Y+ PE + + + D+
Sbjct: 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADM 235
Query: 488 YGFGIVLLELLSGQKPLDVAGAEEGFKGNLV------DWVNHLVIAGRSRDVVDKSLYGR 541
Y FG++L E+ + + +LV + + +V + R
Sbjct: 236 YSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSD 295
Query: 542 GNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
++ + + C P R + +V ++L M+E
Sbjct: 296 ECLRQMGKLMT---ECWAHNPASRLTALRVKKTLAKMSE 331
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 61/272 (22%), Positives = 116/272 (42%), Gaps = 33/272 (12%)
Query: 323 AIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLH 382
AIK++ + K F E+ +L ++ HPN+V L G C+ LV ++ G+LY++LH
Sbjct: 35 AIKQIESESE-RKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLH 91
Query: 383 GNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYI-SSNVILIDDDFDARI 441
G + + + S+G+A+LH +H+ + N++L+ +I
Sbjct: 92 GAEPLPY----YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKI 147
Query: 442 TDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQ 501
DFG A + + + + G ++APE S K DV+ +GI+L E+++ +
Sbjct: 148 CDFGTACDI-------QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR 200
Query: 502 KPLDVAGAEEGFKG-NLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVS 560
KP F + + +R + K+L I + C
Sbjct: 201 KP---------FDEIGGPAFRIMWAVHNGTRPPLIKNL-----PKPIESLMT---RCWSK 243
Query: 561 RPKDRPSMYQVYESLKSMAEKHGFSEPYDEFP 592
P RPSM ++ + + + ++ ++P
Sbjct: 244 DPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 64/290 (22%), Positives = 117/290 (40%), Gaps = 55/290 (18%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSE--------KQFRSEMNRLGQLRHPNLVPLLGFC 359
G+ +K + D S +AIK L ++F+ E+ + L HPN+V L G
Sbjct: 33 GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92
Query: 360 VVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQP 419
+V + +P G LY L + WS +LR+ + + G+ ++ + P
Sbjct: 93 H--NPPRMVMEFVPCGDLYHRLLDKAHP------IKWSVKLRLMLDIALGIEYMQN-QNP 143
Query: 420 PYMHQYISSNVILID-----DDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE 474
P +H+ + S I + A++ DFGL++ + S G LG F ++APE
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVS---GLLGNFQWMAPE 196
Query: 475 --YSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR- 531
+ + K D Y F ++L +L+G+ P + + + ++N + G R
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPF------DEYSYGKIKFINMIREEGL-RP 249
Query: 532 ---DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
+ L +++ C PK RP + + L +
Sbjct: 250 TIPEDCPPRLR------NVIE------LCWSGDPKKRPHFSYIVKELSEL 287
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 48/282 (17%), Positives = 102/282 (36%), Gaps = 32/282 (11%)
Query: 323 AIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCV----VEEERLLVYKHMPNGTLY 378
A+K S+ + +E+ + LRH N++ + + LV + +G+L+
Sbjct: 69 AVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLF 128
Query: 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-----HGCQPPYMHQYISSNVILI 433
L+ + +++ + + GLA LH +P H+ + S IL+
Sbjct: 129 DYLNRY--------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 180
Query: 434 DDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE------YSSTMVASLKGDV 487
+ I D GLA S + +G Y+APE + + D+
Sbjct: 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 240
Query: 488 YGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDW------VNHLVIAGRSRDVVDKSLYGR 541
Y G+V E+ + + +LV + +V + R +
Sbjct: 241 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC 300
Query: 542 GNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHG 583
+ + +R C + R + ++ ++L ++++ G
Sbjct: 301 EALRVMAKIMR---ECWYANGAARLTALRIKKTLSQLSQQEG 339
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 51/277 (18%), Positives = 101/277 (36%), Gaps = 32/277 (11%)
Query: 323 AIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE----ERLLVYKHMPNGTLY 378
A+K S+ +E+ LRH N++ + + + L+ + G+LY
Sbjct: 35 AVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLY 94
Query: 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-----HGCQPPYMHQYISSNVILI 433
L LD + LRI + + GLA LH +P H+ + S IL+
Sbjct: 95 DYLQLT--------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 146
Query: 434 DDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE------YSSTMVASLKGDV 487
+ I D GLA + + +G Y+APE + + D+
Sbjct: 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206
Query: 488 YGFGIVLLELLSGQKPLDVAGAEEGFKGNLV------DWVNHLVIAGRSRDVVDKSLYGR 541
+ FG+VL E+ + + ++V + + +V + R + +
Sbjct: 207 WAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSD 266
Query: 542 GNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
+ + ++ C P R + ++ ++L +
Sbjct: 267 PTLTSLAKLMK---ECWYQNPSARLTALRIKKTLTKI 300
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-34
Identities = 44/176 (25%), Positives = 67/176 (38%), Gaps = 27/176 (15%)
Query: 65 NEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLD 124
N+ + + ++ G E L+ + +++ G ++ LD
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN-NGSMMFLD 638
Query: 125 LSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP 184
+S N LSG IP +I +L L L +N +SGSIP EV L L ++ N L G IP
Sbjct: 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 698
Query: 185 DLA--------------------------RFPEESFDGNSGLCGKPLGKCGGLSGK 214
++ FP F N GLCG PL +C +
Sbjct: 699 AMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNAD 754
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 46/128 (35%), Positives = 64/128 (50%), Gaps = 1/128 (0%)
Query: 64 WNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQL 123
+N + L L + +G++P +L C L SL LS N LSG+IP L L + L
Sbjct: 389 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGS-LSKLRDL 447
Query: 124 DLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183
L N L G IP +++ K L LIL N L+G IP +S L S++ N L+G IP
Sbjct: 448 KLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507
Query: 184 PDLARFPE 191
+ R
Sbjct: 508 KWIGRLEN 515
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-31
Identities = 46/121 (38%), Positives = 63/121 (52%), Gaps = 1/121 (0%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129
++SL LS LSG +P SL L+ L L N L G IP +L + + L L N
Sbjct: 419 ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY-VKTLETLILDFND 477
Query: 130 LSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARF 189
L+G IP + C LN + LSNN+L+G IP + RL+ L ++ N SG IP +L
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537
Query: 190 P 190
Sbjct: 538 R 538
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-30
Identities = 58/150 (38%), Positives = 79/150 (52%), Gaps = 9/150 (6%)
Query: 70 RIISLTLSSMQLSGQLPESL-HLCHSLQSLDLSDNSLSGSIPVDLCK-WLPYVVQLDLSN 127
+ L LS + SG+LPESL +L SL +LDLS N+ SG I +LC+ + +L L N
Sbjct: 344 GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQN 403
Query: 128 NHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLA 187
N +G IPP + C L L LS N LSG+IP + L +L++ + N L G IP +L
Sbjct: 404 NGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELM 463
Query: 188 RFPE-ESFD--GNSGLCGK-P--LGKCGGL 211
E+ N L G+ P L C L
Sbjct: 464 YVKTLETLILDFND-LTGEIPSGLSNCTNL 492
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-30
Identities = 43/144 (29%), Positives = 64/144 (44%), Gaps = 2/144 (1%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGP 133
L L L G++P+ L +L++L L N L+G IP L + + LSNN L+G
Sbjct: 447 LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN-CTNLNWISLSNNRLTGE 505
Query: 134 IPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEES 193
IP I + L L LSNN SG+IP E+ L + N +GTIP + + +
Sbjct: 506 IPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKI 565
Query: 194 FDGN-SGLCGKPLGKCGGLSGKNL 216
+G + G +
Sbjct: 566 AANFIAGKRYVYIKNDGMKKECHG 589
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-29
Identities = 41/116 (35%), Positives = 57/116 (49%), Gaps = 3/116 (2%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L +SS Q G +P SLQ L L++N +G IP L + LDLS NH G
Sbjct: 251 LLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYG 308
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDLA 187
+PP C L L LS+N SG +P + ++ LK ++ N+ SG +P L
Sbjct: 309 AVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLT 364
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 45/177 (25%), Positives = 78/177 (44%), Gaps = 15/177 (8%)
Query: 19 TVSIEDDVKCLEGIQNSIKDPDGRLSWSFTNTTVGAICRLTGVACWNEKENRIISLTLSS 78
+ S+ ++ L ++ + D + WS +N C GV C + +++ S+ LSS
Sbjct: 7 SQSLYREIHQLISFKDVLPDKNLLPDWS-SNKNP---CTFDGVTCRD---DKVTSIDLSS 59
Query: 79 MQLS---GQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIP 135
L+ + SL L+SL LS++ ++GS+ C + LDLS N LSGP+
Sbjct: 60 KPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKC--SASLTSLDLSRNSLSGPVT 117
Query: 136 P--QIVECKFLNKLILSNNKLSGSIPFE-VSRLDRLKEFSVAGNDLSGTIPPDLARF 189
+ C L L +S+N L +L+ L+ ++ N +SG
Sbjct: 118 TLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLS 174
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-28
Identities = 40/117 (34%), Positives = 56/117 (47%), Gaps = 3/117 (2%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L LS G +P C L+SL LS N+ SG +P+D + + LDLS N SG
Sbjct: 298 GLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSG 357
Query: 133 PIPPQIVECKF-LNKLILSNNKLSGSIPFEVSR--LDRLKEFSVAGNDLSGTIPPDL 186
+P + L L LS+N SG I + + + L+E + N +G IPP L
Sbjct: 358 ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-27
Identities = 40/115 (34%), Positives = 57/115 (49%), Gaps = 6/115 (5%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L +S ++SG + S C +L+ LD+S N+ S IP L + LD+S N LSG
Sbjct: 182 HLAISGNKISGDVDVSR--CVNLEFLDVSSNNFSTGIP-FLGD-CSALQHLDISGNKLSG 237
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLA 187
I C L L +S+N+ G IP L L+ S+A N +G IP L+
Sbjct: 238 DFSRAISTCTELKLLNISSNQFVGPIP--PLPLKSLQYLSLAENKFTGEIPDFLS 290
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-26
Identities = 41/119 (34%), Positives = 56/119 (47%), Gaps = 5/119 (4%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L +SS S +P L C +LQ LD+S N LSG + + L++S+N G
Sbjct: 204 FLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAIST-CTELKLLNISSNQFVG 261
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVS-RLDRLKEFSVAGNDLSGTIPPDLARFP 190
PIPP K L L L+ NK +G IP +S D L ++GN G +PP
Sbjct: 262 PIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS 318
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-26
Identities = 40/116 (34%), Positives = 53/116 (45%), Gaps = 7/116 (6%)
Query: 73 SLTLSSMQLSGQLPESLHL--CHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL 130
SL LS LSG + L C L+ L++S N+L V L + LDLS N +
Sbjct: 104 SLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSI 163
Query: 131 SGPIPPQIVE---CKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183
SG V C L L +S NK+SG + SR L+ V+ N+ S IP
Sbjct: 164 SGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIP 217
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 36/121 (29%), Positives = 54/121 (44%), Gaps = 6/121 (4%)
Query: 73 SLTLSSMQLSGQLPESLHL-CHSLQSLDLSDNSLSGSIPVDLCKW--LPYVVQLDLSNNH 129
L +SS L S L +SL+ LDLS NS+SG+ V + L +S N
Sbjct: 130 FLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNK 189
Query: 130 LSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARF 189
+SG + + C L L +S+N S IP + L+ ++GN LSG ++
Sbjct: 190 ISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTC 246
Query: 190 P 190
Sbjct: 247 T 247
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-22
Identities = 27/115 (23%), Positives = 45/115 (39%), Gaps = 7/115 (6%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGP 133
L LS+ SG +P L C SL LDL+ N +G+IP + K ++ N ++G
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ-----SGKIAANFIAGK 573
Query: 134 IPPQIVECKFLNKLILSNN--KLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
I + + N + G +++RL ++ G P
Sbjct: 574 RYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-19
Identities = 20/118 (16%), Positives = 43/118 (36%), Gaps = 5/118 (4%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKW-LPYVVQLDLSNN 128
+I L L++ +G +P ++ QS ++ N ++G V + + +
Sbjct: 539 SLIWLDLNTNLFNGTIPAAM----FKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLL 594
Query: 129 HLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
G Q+ N +++ G + ++ N LSG IP ++
Sbjct: 595 EFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-34
Identities = 62/274 (22%), Positives = 104/274 (37%), Gaps = 54/274 (19%)
Query: 323 AIKRLSACKLSE-----KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL 377
A+K + + R E L+HPN++ L G C+ E LV + G L
Sbjct: 34 AVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPL 93
Query: 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF 437
+L G + + + +RG+ +LH P +H+ + S+ ILI
Sbjct: 94 NRVLSGK--------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKV 145
Query: 438 DAR--------ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYG 489
+ ITDFGLAR + G + ++APE + S DV+
Sbjct: 146 ENGDLSNKILKITDFGLAREW------HRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWS 199
Query: 490 FGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGR-----GND 544
+G++L ELL+G+ P F+G ++ L +A V L
Sbjct: 200 YGVLLWELLTGEVP---------FRG-----IDGLAVAY---GVAMNKL--ALPIPSTCP 240
Query: 545 DEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
+ + + C P RPS + + L ++
Sbjct: 241 EPFAKLME---DCWNPDPHSRPSFTNILDQLTTI 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 57/302 (18%), Positives = 106/302 (35%), Gaps = 65/302 (21%)
Query: 312 YKAVL-PDASALAIKRLSAC-KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369
K + +K L + +++ F E+ + L HPN++ +G ++ +
Sbjct: 27 IKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86
Query: 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSN 429
+++ GTL ++ WS R+ + G+A+LH +H+ ++S+
Sbjct: 87 EYIKGGTLRGIIKSMD------SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSH 137
Query: 430 VILIDDDFDARITDFGLARLVGSRD----------PNDSSFVHGDLGEFGYVAPE----- 474
L+ ++ + + DFGLARL+ D + +G ++APE
Sbjct: 138 NCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR 197
Query: 475 -YSSTMVASLKGDVYGFGIVLLELLSGQKP--------LDVAGAEEGFKGNLVDWVNHLV 525
Y K DV+ FGIVL E++ +D GF
Sbjct: 198 SYDE------KVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--------DRY 243
Query: 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFS 585
S + I C P+ RPS ++ L+++
Sbjct: 244 CP----PNCPPSFF------PITV------RCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287
Query: 586 EP 587
P
Sbjct: 288 LP 289
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 59/277 (21%), Positives = 107/277 (38%), Gaps = 60/277 (21%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
A+K + + +F E L Q HPN+V L+G C ++ +V + + G +
Sbjct: 143 AVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTF 202
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDAR 440
L G L T L++ A+ G+ +L +H+ +++ L+ + +
Sbjct: 203 LRTEG------ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLK 253
Query: 441 ITDFGLARLVGSRDPNDSSFVHGDLGEFGY--VAPEYSSTMVASLKGDVYGFGIVLLELL 498
I+DFG++R + G L + APE + S + DV+ FGI+L E
Sbjct: 254 ISDFGMSREE----ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETF 309
Query: 499 S-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK------------SLYGRGNDD 545
S G P + N + V+K +++
Sbjct: 310 SLGASP---------YPN----LSNQQTR-----EFVEKGGRLPCPELCPDAVF------ 345
Query: 546 EIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582
+M+ C P RPS +Y+ L+S+ ++H
Sbjct: 346 RLME------QCWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 3e-22
Identities = 63/283 (22%), Positives = 119/283 (42%), Gaps = 45/283 (15%)
Query: 323 AIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLH 382
A+K L + ++F E + +++HPNLV LLG C E ++ + M G L L
Sbjct: 249 AVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 308
Query: 383 GNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARIT 442
+ L + S + +L ++H+ +++ L+ ++ ++
Sbjct: 309 ECN-----RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVA 360
Query: 443 DFGLARLVGSRDPNDSSFVHGDLGEFGY--VAPEYSSTMVASLKGDVYGFGIVLLELLS- 499
DFGL+RL+ ++ +F APE + S+K DV+ FG++L E+ +
Sbjct: 361 DFGLSRLM-----TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 415
Query: 500 GQKPLDVAGAEEGFKGNLVDWVNHLVIAG----RSRDVVDKSLYGRGNDDEIMQFLRVAC 555
G P + G + V L+ R + +Y E+M+
Sbjct: 416 GMSP---------YPGIDLSQVYELLEKDYRMERPEGCPE-KVY------ELMR------ 453
Query: 556 SCVVSRPKDRPSMYQVYESLKSMAEKHGFSEPYDEFPMIFGKQ 598
+C P DRPS +++++ ++M ++ S DE GK+
Sbjct: 454 ACWQWNPSDRPSFAEIHQAFETMFQE---SSISDEVEKELGKR 493
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 72/297 (24%), Positives = 120/297 (40%), Gaps = 75/297 (25%)
Query: 309 GVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368
GV +A+K + +SE +F E + +L HP LV G C E +V
Sbjct: 22 GVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81
Query: 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL--HHGCQPPYMHQYI 426
+++ NG L + L +G L+ S L + G+A+L H ++H+ +
Sbjct: 82 TEYISNGCLLNYLRSHG------KGLEPSQLLEMCYDVCEGMAFLESHQ-----FIHRDL 130
Query: 427 SSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGY--VAPE------YSST 478
++ L+D D +++DFG+ R V D +V +F APE YSS
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYV-----LDDQYVSSVGTKFPVKWSAPEVFHYFKYSS- 184
Query: 479 MVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK- 536
K DV+ FGI++ E+ S G+ P + + N V+ V +
Sbjct: 185 -----KSDVWAFGILMWEVFSLGKMP---------YDL----YTNSEVV-----LKVSQG 221
Query: 537 -----------SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582
++Y +IM SC P+ RP+ Q+ S++ + EK
Sbjct: 222 HRLYRPHLASDTIY------QIMY------SCWHELPEKRPTFQQLLSSIEPLREKD 266
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 4e-21
Identities = 65/295 (22%), Positives = 116/295 (39%), Gaps = 75/295 (25%)
Query: 309 GVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368
G+ + + +AIK + +SE+ F E + +L HP LV L G C+ + LV
Sbjct: 22 GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81
Query: 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL--HHGCQPPYMHQYI 426
+ M +G L L G+ T L + + G+A+L +H+ +
Sbjct: 82 TEFMEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEAC-----VIHRDL 130
Query: 427 SSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGY--VAPE------YSST 478
++ L+ ++ +++DFG+ R V D + +F +PE YSS
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFV-----LDDQYTSSTGTKFPVKWASPEVFSFSRYSS- 184
Query: 479 MVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK- 536
K DV+ FG+++ E+ S G+ P + + N V+ + +
Sbjct: 185 -----KSDVWSFGVLMWEVFSEGKIPYE-------------NRSNSEVV-----EDISTG 221
Query: 537 -----------SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
+Y +IM C RP+DRP+ ++ L +AE
Sbjct: 222 FRLYKPRLASTHVY------QIMN------HCWRERPEDRPAFSRLLRQLAEIAE 264
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-21
Identities = 27/120 (22%), Positives = 44/120 (36%)
Query: 71 IISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL 130
+I L +S + SL+ L ++ NS + D+ L + LDLS L
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 131 SGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP 190
P L L +S+N F L+ L+ + N + + +L FP
Sbjct: 483 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 542
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 28/117 (23%), Positives = 40/117 (34%), Gaps = 1/117 (0%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNN 128
+L LS L S LQ LDLS + L ++ L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQS-LSHLSTLILTGN 86
Query: 129 HLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPD 185
+ L KL+ L+ F + L LKE +VA N + P+
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-18
Identities = 23/120 (19%), Positives = 44/120 (36%), Gaps = 2/120 (1%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L LS ++ + L +L L+ N + L + +L +L+
Sbjct: 56 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLAL-GAFSGLSSLQKLVAVETNLAS 114
Query: 133 PIPPQIVECKFLNKLILSNNKL-SGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE 191
I K L +L +++N + S +P S L L+ ++ N + DL +
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-17
Identities = 24/118 (20%), Positives = 47/118 (39%), Gaps = 3/118 (2%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129
+ L+ + + G +S SL+ LDLS N + + + L + LD +++
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLG-LEQLEHLDFQHSN 407
Query: 130 LSGPIPPQI-VECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
L + + + L L +S+ + + L L+ +AGN PD+
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-17
Identities = 20/123 (16%), Positives = 38/123 (30%), Gaps = 2/123 (1%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNN 128
+ L LS + + + L+ LD ++L + L ++ LD+S+
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 129 HLSGPIPPQIVECKFLNKLILSNNKLSGSI-PFEVSRLDRLKEFSVAGNDLSGTIPPDLA 187
H L L ++ N + P + L L ++ L P
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 188 RFP 190
Sbjct: 492 SLS 494
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 23/115 (20%), Positives = 40/115 (34%), Gaps = 4/115 (3%)
Query: 76 LSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIP 135
+ ++P++L S ++LDLS N L P + LDLS +
Sbjct: 14 CMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFS-FPELQVLDLSRCEIQTIED 69
Query: 136 PQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP 190
L+ LIL+ N + S L L++ +L+ +
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-15
Identities = 20/118 (16%), Positives = 40/118 (33%), Gaps = 5/118 (4%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L+ + +L+ L+++ N + + L + LDLS+N +
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 133 PIPPQIVECK----FLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
+ L LS N ++ P + RL + ++ N S +
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTC 220
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 29/202 (14%), Positives = 57/202 (28%), Gaps = 32/202 (15%)
Query: 11 LLLSYSLLTVSIEDDVKCLEGIQN-SIKDPDGRLSWSFTNTTVGAICRLTGVACWNEKEN 69
L L + ++++ C++G+ + + N L G+ +E
Sbjct: 205 LTLRNNFDSLNVMKT--CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129
R+ L + + + ++ S L ++ + L+L N
Sbjct: 263 RLAYLDYYL----DDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQH---LELVNCK 315
Query: 130 LS-------------------GPIPPQIVECKFLNKLILSNNKLS--GSIPFEVSRLDRL 168
G V+ L L LS N LS G L
Sbjct: 316 FGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 169 KEFSVAGNDLSGTIPPDLARFP 190
K ++ N + T+ +
Sbjct: 376 KYLDLSFNGVI-TMSSNFLGLE 396
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 9e-10
Identities = 18/96 (18%), Positives = 36/96 (37%), Gaps = 2/96 (2%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129
+ L +S +SLQ LD S N + S +L + + L+L+ N
Sbjct: 495 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554
Query: 130 LSGPIPPQ--IVECKFLNKLILSNNKLSGSIPFEVS 163
+ Q + K +L++ ++ + P +
Sbjct: 555 FACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ 590
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 22/182 (12%), Positives = 39/182 (21%), Gaps = 36/182 (19%)
Query: 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSN 127
+SL LS ++ P + L L L +N S ++ + L + L
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234
Query: 128 NHLSG---------------------------------PIPPQIVECKFLNKLILSNNKL 154
I ++ L + +
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294
Query: 155 SGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGNSGLCGKPLGKCGGLSGK 214
F S + + L +F N G L
Sbjct: 295 ERVKDF--SYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFL 352
Query: 215 NL 216
+L
Sbjct: 353 DL 354
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 65/285 (22%), Positives = 113/285 (39%), Gaps = 59/285 (20%)
Query: 309 GVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368
G + + +AIK L +S + F E + +LRH LV L EE +V
Sbjct: 198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 256
Query: 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS 428
++M G+L L G L + + + G+A++ Y+H+ + +
Sbjct: 257 TEYMSKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRA 308
Query: 429 NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGY--VAPEYSSTMVASLKGD 486
IL+ ++ ++ DFGLARL+ D+ + +F APE + ++K D
Sbjct: 309 ANILVGENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 487 VYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK--------- 536
V+ FGI+L EL + G+ P VN V+ D V++
Sbjct: 364 VWSFGILLTELTTKGRVPYP-------------GMVNREVL-----DQVERGYRMPCPPE 405
Query: 537 ---SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
SL+ ++M C P++RP+ + L+
Sbjct: 406 CPESLH------DLMC------QCWRKEPEERPTFEYLQAFLEDY 438
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 6e-20
Identities = 65/285 (22%), Positives = 113/285 (39%), Gaps = 59/285 (20%)
Query: 309 GVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368
G + + +AIK L +S + F E + +LRH LV L EE +V
Sbjct: 281 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 339
Query: 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS 428
++M G+L L G L + + + G+A++ Y+H+ + +
Sbjct: 340 TEYMSKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRA 391
Query: 429 NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGY--VAPEYSSTMVASLKGD 486
IL+ ++ ++ DFGLARL+ D+ + +F APE + ++K D
Sbjct: 392 ANILVGENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 487 VYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK--------- 536
V+ FGI+L EL + G+ P VN V+ D V++
Sbjct: 447 VWSFGILLTELTTKGRVPYP-------------GMVNREVL-----DQVERGYRMPCPPE 488
Query: 537 ---SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
SL+ ++M C P++RP+ + L+
Sbjct: 489 CPESLH------DLMC------QCWRKEPEERPTFEYLQAFLEDY 521
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 6e-20
Identities = 53/290 (18%), Positives = 103/290 (35%), Gaps = 63/290 (21%)
Query: 309 GVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368
GV +AIK + +SE +F E + L H LV L G C + ++
Sbjct: 38 GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97
Query: 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL--HHGCQPPYMHQYI 426
++M NG L + L L + + +L ++H+ +
Sbjct: 98 TEYMANGCLLNYLREMR------HRFQTQQLLEMCKDVCEAMEYLESKQ-----FLHRDL 146
Query: 427 SSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGY--VAPEYSSTMVASLK 484
++ L++D +++DFGL+R V D + +F PE S K
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYV-----LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 485 GDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK------- 536
D++ FG+++ E+ S G+ P + + N + + +
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYE-------------RFTNSETA-----EHIAQGLRLYRP 243
Query: 537 -----SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581
+Y IM SC + +RP+ + ++ + ++
Sbjct: 244 HLASEKVY------TIMY------SCWHEKADERPTFKILLSNILDVMDE 281
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-20
Identities = 21/126 (16%), Positives = 47/126 (37%), Gaps = 12/126 (9%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSL--------SGSIPVDLCKWLPYVV 121
+ + + + +LP L +Q ++++ N D +
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPV-GEKIQ 308
Query: 122 QLDLSNNHL-SGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSG 180
+ + N+L + P+ + + K L L N+L G +P +L ++A N ++
Sbjct: 309 IIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE 367
Query: 181 TIPPDL 186
IP +
Sbjct: 368 -IPANF 372
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 24/130 (18%), Positives = 47/130 (36%), Gaps = 8/130 (6%)
Query: 73 SLTLSSMQL-SGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLS 131
+ + L + + SL L L+ N L G +P + L+L+ N ++
Sbjct: 309 IIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGS-EIKLASLNLAYNQIT 366
Query: 132 GPIPPQIVE-CKFLNKLILSNNKLSGSIP--FEVSRLDRLKEFSVAGNDLSGTIPPDLAR 188
IP + + L ++NKL IP F+ + + + N++ +
Sbjct: 367 E-IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
Query: 189 FPEESFDGNS 198
F G +
Sbjct: 425 LDPTPFKGIN 434
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 29/128 (22%), Positives = 48/128 (37%), Gaps = 17/128 (13%)
Query: 73 SLTLSSMQLSG-------QLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKW-LPYVVQLD 124
S+ L L+ E+ + L S+DL N L+ + D LPY+V +D
Sbjct: 461 SINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGID 519
Query: 125 LSNNHLSGPIPPQIVECKFL------NKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDL 178
LS N S P Q + L N+ N+ P ++ L + + ND+
Sbjct: 520 LSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578
Query: 179 SGTIPPDL 186
+ +
Sbjct: 579 R-KVNEKI 585
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-18
Identities = 26/180 (14%), Positives = 57/180 (31%), Gaps = 20/180 (11%)
Query: 24 DDVKCLEGIQNSIKDPDGRLS---------WSFTNTTVGAICRLTGVACWNEKENRIISL 74
D L+ I +++ + W+F N + GV+ + R+ L
Sbjct: 30 KDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELDMWGAQPGVSLNSN--GRVTGL 86
Query: 75 TLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSG----SIPVDLCKWLPYVVQLDLSNNHL 130
+L SG++P+++ L+ L L + P + Q H
Sbjct: 87 SLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISA-NMSDEQKQKMRMHY 145
Query: 131 SGPIPPQIVECKFLN--KLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLAR 188
F + K ++++ SI + + N+++ + + R
Sbjct: 146 QKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMR 204
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-18
Identities = 23/129 (17%), Positives = 39/129 (30%), Gaps = 12/129 (9%)
Query: 73 SLTLSSMQLSGQLPESLHLCH--SLQSLDLSDNSLSGSIPVDLCK-----WLPYVVQLDL 125
S+ L +L+ L + L +DLS NS S P Q D
Sbjct: 492 SIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDA 549
Query: 126 SNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPD 185
N P I C L +L + +N + + ++ + + N
Sbjct: 550 QGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSY 606
Query: 186 LARFPEESF 194
+ + E
Sbjct: 607 VCPYIEAGM 615
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 29/136 (21%), Positives = 53/136 (38%), Gaps = 10/136 (7%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKW-LPYVVQLDLSNNHLS 131
SL L+ Q++ +++L + N L IP + + +D S N +
Sbjct: 357 SLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIG 415
Query: 132 G-------PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP 184
P+ P + ++ + LSNN++S S L ++ GN L+ IP
Sbjct: 416 SVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPK 474
Query: 185 DLARFPEESFDGNSGL 200
+ + E+F L
Sbjct: 475 NSLKDENENFKNTYLL 490
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 10/108 (9%), Positives = 32/108 (29%), Gaps = 7/108 (6%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
+ S ++ + +++ L+ + ++ + + +
Sbjct: 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWE------NENSEYAQQYK 239
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSG 180
+ K L + + N +P + L ++ +VA N
Sbjct: 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS 287
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 13/82 (15%), Positives = 26/82 (31%), Gaps = 4/82 (4%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGP 133
+ + PE + LC SL L + N + + + + LD+ +N
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPNI---SVLDIKDNPNISI 602
Query: 134 IPPQIVECKFLNKLILSNNKLS 155
+ +L +K
Sbjct: 603 DLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 20/124 (16%), Positives = 39/124 (31%), Gaps = 14/124 (11%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSL------DLSDNSLSGSIPVDLCKWLPYVVQLDLSN 127
+ LS S P +L+ D N P + P + QL + +
Sbjct: 518 IDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITL-CPSLTQLQIGS 575
Query: 128 NHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGN---DLSGTIPP 184
N + + +I ++ L + +N V + + + D+ G
Sbjct: 576 NDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCDAL 632
Query: 185 DLAR 188
D+ R
Sbjct: 633 DIKR 636
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 25/180 (13%), Positives = 48/180 (26%), Gaps = 30/180 (16%)
Query: 66 EKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKW--------- 116
++ I+ + LS + + + + L L +L+ + S G W
Sbjct: 12 LTDDAIVPIKLS--RTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMW 69
Query: 117 ----------LPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSG----SIPFEV 162
V L L SG +P I + L L L ++ P +
Sbjct: 70 GAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGI 129
Query: 163 SRLDRLKEFSVAGNDLSGTIPPDLAR-----FPEESFDGNSGLCGKPLGKCGGLSGKNLG 217
S ++ T R ++ + + L +G
Sbjct: 130 SANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIG 189
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 65/299 (21%), Positives = 118/299 (39%), Gaps = 61/299 (20%)
Query: 309 GVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368
G + A + +A+K + +S + F +E N + L+H LV L +E ++
Sbjct: 202 GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-TKEPIYII 260
Query: 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS 428
+ M G+L L + L + + G+A++ Q Y+H+ + +
Sbjct: 261 TEFMAKGSLLDFLKSDEGSKQPLPKL-----IDFSAQIAEGMAFIE---QRNYIHRDLRA 312
Query: 429 NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGY--VAPEYSSTMVASLKGD 486
IL+ +I DFGLAR++ D+ + + +F APE + ++K D
Sbjct: 313 ANILVSASLVCKIADFGLARVI-----EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 487 VYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK--------- 536
V+ FGI+L+E+++ G+ P + G N VI +++
Sbjct: 368 VWSFGILLMEIVTYGRIP---------YPG----MSNPEVI-----RALERGYRMPRPEN 409
Query: 537 ---SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEPYDEFP 592
LY IM C +RP++RP+ + L Y+E P
Sbjct: 410 CPEELY------NIMM------RCWKNRPEERPTFEYIQSVLDDF--YTATESQYEEIP 454
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-19
Identities = 31/120 (25%), Positives = 48/120 (40%), Gaps = 1/120 (0%)
Query: 71 IISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL 130
I L L+ QL + L SLD+ N++S P +LC+ LP + L+L +N L
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEP-ELCQKLPMLKVLNLQHNEL 85
Query: 131 SGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP 190
S C L +L L +N + + L ++ N LS T +
Sbjct: 86 SQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE 145
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-19
Identities = 24/138 (17%), Positives = 47/138 (34%), Gaps = 2/138 (1%)
Query: 55 ICRLTGVACWNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLC 114
+ LT + + + L L+ ++S ++ L+ LDL N + +
Sbjct: 367 LRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEW 426
Query: 115 KWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSG--SIPFEVSRLDRLKEFS 172
+ L + ++ LS N L +L+L L S P L L
Sbjct: 427 RGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILD 486
Query: 173 VAGNDLSGTIPPDLARFP 190
++ N+++ L
Sbjct: 487 LSNNNIANINDDMLEGLE 504
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-18
Identities = 29/121 (23%), Positives = 50/121 (41%), Gaps = 1/121 (0%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129
++ SL + +S PE L+ L+L N LS + + +L L +N
Sbjct: 50 QLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFA-FCTNLTELHLMSNS 108
Query: 130 LSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARF 189
+ V+ K L L LS+N LS + +L+ L+E ++ N + +L F
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIF 168
Query: 190 P 190
Sbjct: 169 A 169
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-16
Identities = 27/119 (22%), Positives = 47/119 (39%), Gaps = 4/119 (3%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKW-LPYVVQLDLSNNHLS 131
+L LS LS + +LQ L LS+N + +L + + +L+LS+N +
Sbjct: 125 TLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK 184
Query: 132 GPIPPQIVECKFLNKLILSNNKLSGSIP---FEVSRLDRLKEFSVAGNDLSGTIPPDLA 187
P L L L+N +L S+ ++ S++ + LS T
Sbjct: 185 EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 9e-16
Identities = 25/135 (18%), Positives = 46/135 (34%), Gaps = 4/135 (2%)
Query: 69 NRIISLTLSSMQLSGQLP-ESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSN 127
+ L L ++ +L + ++ + LS N +P + +L L
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFAL-VPSLQRLMLRR 463
Query: 128 NHLSG--PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPD 185
L P + L L LSNN ++ + L++L+ + N+L+
Sbjct: 464 VALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHA 523
Query: 186 LARFPEESFDGNSGL 200
P G S L
Sbjct: 524 NPGGPIYFLKGLSHL 538
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 30/136 (22%), Positives = 53/136 (38%), Gaps = 5/136 (3%)
Query: 70 RIISLTLSSMQLSGQLPESLHL---CHSLQSLDLSDNSLSGSIPVDLCKW-LPYVVQLDL 125
R+ L L+++QL L E L L S+++L LS++ LS + + LDL
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 126 SNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP- 184
S N+L+ L L N + + L ++ ++ + +I
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315
Query: 185 DLARFPEESFDGNSGL 200
L + + SF L
Sbjct: 316 SLPKIDDFSFQWLKCL 331
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-15
Identities = 30/139 (21%), Positives = 47/139 (33%), Gaps = 12/139 (8%)
Query: 63 CWNEKENRIISLTLSSMQLSGQLPESLHLCH--SLQSLDLSDNSLSGSIPVDLCKWLPYV 120
C I +L+LS+ QLS + +L LDLS N+L+ D WLP +
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN-DSFAWLPQL 274
Query: 121 VQLDLSNNHLSGPIPPQIVECKFLNKLILSNN---------KLSGSIPFEVSRLDRLKEF 171
L N++ + + L L + L F L L+
Sbjct: 275 EYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHL 334
Query: 172 SVAGNDLSGTIPPDLARFP 190
++ ND+ G
Sbjct: 335 NMEDNDIPGIKSNMFTGLI 353
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-15
Identities = 25/129 (19%), Positives = 40/129 (31%), Gaps = 10/129 (7%)
Query: 65 NEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLD 124
K + L LS L+ +S L+ L N++ L L V L+
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHG-LFNVRYLN 302
Query: 125 LSNN---------HLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAG 175
L + L K L L + +N + G + L LK S++
Sbjct: 303 LKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSN 362
Query: 176 NDLSGTIPP 184
+ S
Sbjct: 363 SFTSLRTLT 371
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 7e-15
Identities = 23/118 (19%), Positives = 43/118 (36%), Gaps = 7/118 (5%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLS-------GSIPVDLCKWLPYVVQLDL 125
L LS+ ++ + L L+ LDL N+L+ P+ K L ++ L+L
Sbjct: 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNL 543
Query: 126 SNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183
+N + L + L N L+ + LK ++ N ++
Sbjct: 544 ESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 27/127 (21%), Positives = 43/127 (33%), Gaps = 11/127 (8%)
Query: 74 LTLSSMQLSG--QLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLS 131
L L + L P +L LDLS+N+++ L L + LDL +N+L+
Sbjct: 459 LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEG-LEKLEILDLQHNNLA 517
Query: 132 --------GPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183
G + L+ L L +N L LK + N+L+
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 184 PDLARFP 190
Sbjct: 578 SVFNNQV 584
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-14
Identities = 24/107 (22%), Positives = 40/107 (37%), Gaps = 12/107 (11%)
Query: 94 SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNK 153
S + D S L+ +P DL + L+L++N L L L + N
Sbjct: 5 SHEVADCSHLKLT-QVPDDL---PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 154 LSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGNSGL 200
+S P +L LK ++ N+LS ++F + L
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSD--------KTFAFCTNL 99
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 26/135 (19%), Positives = 46/135 (34%), Gaps = 8/135 (5%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129
+ L L S E L+ +DL N+L+ + L+L N
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNN-QVSLKSLNLQKNL 595
Query: 130 LSGPIPPQIVECKF--LNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTI----P 183
++ + ++ F L +L + N + ++ + E +LS P
Sbjct: 596 ITS-VEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTP 654
Query: 184 PDLARFPEESFDGNS 198
P FP FD +S
Sbjct: 655 PHYHGFPVRLFDTSS 669
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 60/291 (20%), Positives = 116/291 (39%), Gaps = 77/291 (26%)
Query: 323 AIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLH 382
A+K L + ++F E + +++HPNLV LLG C E ++ + M G L L
Sbjct: 42 AVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 101
Query: 383 GNGVDNTLSGVLDWSTRLRIGMGASRGLAWL--HHGCQPPYMHQYISSNVILIDDDFDAR 440
+ L + S + +L + ++H+ +++ L+ ++ +
Sbjct: 102 ECN-----RQEVSAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVK 151
Query: 441 ITDFGLARLVGSRDPNDSSFVHGDLGEFGY--VAPE------YSSTMVASLKGDVYGFGI 492
+ DFGL+RL+ ++ +F APE +S K DV+ FG+
Sbjct: 152 VADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPESLAYNKFSI------KSDVWAFGV 200
Query: 493 VLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK------------SLY 539
+L E+ + G P + G V ++++K +Y
Sbjct: 201 LLWEIATYGMSP---------YPG----IDLSQVY-----ELLEKDYRMERPEGCPEKVY 242
Query: 540 GRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEPYDE 590
E+M+ +C P DRPS +++++ ++M ++ S DE
Sbjct: 243 ------ELMR------ACWQWNPSDRPSFAEIHQAFETMFQE---SSISDE 278
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 9e-19
Identities = 53/277 (19%), Positives = 106/277 (38%), Gaps = 65/277 (23%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
AIK L + + K+ E + + +P++ LLG C + L+ + MP G L
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDY 106
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL--HHGCQPPYMHQYISSNVILIDDDFD 438
+ + + +L+W ++G+ +L +H+ +++ +L+
Sbjct: 107 VREHKDNIGSQYLLNWCV------QIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQH 155
Query: 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEF--GYVAPEYSSTMVASLKGDVYGFGIVLLE 496
+ITDFGLA+L+G + H + G+ ++A E + + + DV+ +G+ + E
Sbjct: 156 VKITDFGLAKLLG----AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 211
Query: 497 LLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK------------SLYGRGN 543
L++ G KP D + +++K +Y
Sbjct: 212 LMTFGSKPYD-------------GIPASEIS-----SILEKGERLPQPPICTIDVY---- 249
Query: 544 DDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
IM+ C + RP ++ MA
Sbjct: 250 --MIMR------KCWMIDADSRPKFRELIIEFSKMAR 278
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 67/285 (23%), Positives = 119/285 (41%), Gaps = 59/285 (20%)
Query: 309 GVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368
G + + +A+K L +S F +E N + QL+H LV L V +E ++
Sbjct: 27 GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYII 85
Query: 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS 428
++M NG+L L L + L + + G+A++ + Y+H+ + +
Sbjct: 86 TEYMENGSLVDFLKTPS-----GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRA 137
Query: 429 NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGY--VAPEYSSTMVASLKGD 486
IL+ D +I DFGLARL+ D+ + + +F APE + ++K D
Sbjct: 138 ANILVSDTLSCKIADFGLARLI-----EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 487 VYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK--------- 536
V+ FGI+L E+++ G+ P + G N VI +++
Sbjct: 193 VWSFGILLTEIVTHGRIP---------YPG----MTNPEVI-----QNLERGYRMVRPDN 234
Query: 537 ---SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
LY ++M+ C RP+DRP+ + L+
Sbjct: 235 CPEELY------QLMR------LCWKERPEDRPTFDYLRSVLEDF 267
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 58/266 (21%), Positives = 104/266 (39%), Gaps = 42/266 (15%)
Query: 312 YKAV-LPDASALAIKRLSACKLSEK---QFRSEMNRLGQLRHPNLVPLLGFCVV---EEE 364
YK + +A L KL++ +F+ E L L+HPN+V ++
Sbjct: 43 YKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102
Query: 365 RLLVY-KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMH 423
+++ + M +GTL + L V + + W ++ +GL +L H PP +H
Sbjct: 103 CIVLVTELMTSGTLKTYLKRFKVMK-IKVLRSWCRQIL------KGLQFL-HTRTPPIIH 154
Query: 424 QYISSNVILID-DDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVAS 482
+ + + I I +I D GLA L R + + G ++APE
Sbjct: 155 RDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKAVI----GTPEFMAPEMYEEK-YD 207
Query: 483 LKGDVYGFGIVLLELLSGQKP-LDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGR 541
DVY FG+ +LE+ + + P + A + ++ V +G DK
Sbjct: 208 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR---------RVTSGVKPASFDKVA--- 255
Query: 542 GNDDEIMQFLRVACSCVVSRPKDRPS 567
E+ + + C+ +R S
Sbjct: 256 --IPEVKEIIE---GCIRQNKDERYS 276
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 9e-18
Identities = 28/136 (20%), Positives = 49/136 (36%), Gaps = 18/136 (13%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYV-------VQ 122
++TLS ++ E + ++ LS+N ++ SIP + K
Sbjct: 674 NASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTT 732
Query: 123 LDLSNNHLSGPIPPQIVECKF--LNKLILSNNKLSGSIPFEVSRLDRLKEFS------VA 174
+DL N L+ + L+ + +S N S S P + +LK F
Sbjct: 733 IDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAE 790
Query: 175 GNDLSGTIPPDLARFP 190
GN + P + P
Sbjct: 791 GNRILRQWPTGITTCP 806
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-16
Identities = 26/142 (18%), Positives = 48/142 (33%), Gaps = 17/142 (11%)
Query: 73 SLTLSSMQLSGQLPESLHLCH--SLQSLDLSDNSLSGSIPVDLC-----KWLPYVVQLDL 125
++ L +L+ L + L ++D+S N S S P K Q D
Sbjct: 732 TIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDA 789
Query: 126 SNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPD 185
N + P I C L +L + +N + + ++ +L +A N
Sbjct: 790 EGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTS 846
Query: 186 LARFPEES-----FDGNSGLCG 202
+ + E +D + G
Sbjct: 847 VCPYIEAGMYVLLYDKTQDIRG 868
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 3e-16
Identities = 24/209 (11%), Positives = 55/209 (26%), Gaps = 32/209 (15%)
Query: 32 IQNSIKDPDGRLSWSFTNTTVGAICRLTGVACWNEKENRIISLTLSSMQLSGQLPESLHL 91
+ + N + GV N R+ L+L+ G++P+++
Sbjct: 288 YYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNN--GRVTGLSLAGFGAKGRVPDAIGQ 345
Query: 92 CHSLQSLDLSDNSLSGSIPV------------------------DLCKWLPYVVQLDLSN 127
L+ L +S + S + + + DL
Sbjct: 346 LTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQ 405
Query: 128 NHLS-----GPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTI 182
+ ++ PI ++ N+++ I + RL +L+ A + +
Sbjct: 406 DAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDN 464
Query: 183 PPDLARFPEESFDGNSGLCGKPLGKCGGL 211
+ L
Sbjct: 465 IAVDWEDANSDYAKQYENEELSWSNLKDL 493
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 3e-15
Identities = 24/120 (20%), Positives = 42/120 (35%), Gaps = 8/120 (6%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSG-SIPVDLCKWLPYVVQLDLSN 127
NR IS + +L + +Q + N+L L K + + LD +
Sbjct: 525 NRGISAAQLKADWT-RLADDEDTGPKIQIFYMGYNNLEEFPASASLQK-MVKLGLLDCVH 582
Query: 128 NHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDL 186
N + L L L N++ IP + + D+++ + N L IP
Sbjct: 583 NKVR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIF 638
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 7e-15
Identities = 20/133 (15%), Positives = 47/133 (35%), Gaps = 8/133 (6%)
Query: 74 LTLSSMQLSGQLPESL-HLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L Q+ ++PE ++ L S N L + K + + +D S N +
Sbjct: 600 LKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGS 658
Query: 133 -----PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLA 187
+ + + LS N++ + + ++ N ++ +IP +
Sbjct: 659 EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSL 717
Query: 188 RFPEESFDGNSGL 200
+ + ++ L
Sbjct: 718 KPKDGNYKNTYLL 730
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 19/194 (9%), Positives = 59/194 (30%), Gaps = 25/194 (12%)
Query: 7 LASLLLLSYSLLTVSIEDDVKCLEGIQNSIKDPDGRLSWSFTNTTVGAICRLTGVACWNE 66
+ + Y + + + + + +Q++I N + I + + ++
Sbjct: 379 RKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR----------NPEMKPIKKDSRISL--- 425
Query: 67 KENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLS 126
+ + + +++ + +++ LQ + +++ + + +
Sbjct: 426 ---KDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWE------DANSD 475
Query: 127 NNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP--P 184
K L + L N +P + L L+ ++A N
Sbjct: 476 YAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKA 535
Query: 185 DLARFPEESFDGNS 198
D R ++ G
Sbjct: 536 DWTRLADDEDTGPK 549
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 25/128 (19%), Positives = 45/128 (35%), Gaps = 17/128 (13%)
Query: 73 SLTLSSMQLSGQLPE-----SLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSN 127
S+ S ++ + + + ++ LS N + P +L + + LSN
Sbjct: 648 SVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK-FPTELFATGSPISTIILSN 706
Query: 128 NHLS-------GPIPPQIVECKFLNKLILSNNKLSGSIP--FEVSRLDRLKEFSVAGNDL 178
N ++ P L + L NKL+ S+ F + L L V+ N
Sbjct: 707 NLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCF 765
Query: 179 SGTIPPDL 186
S + P
Sbjct: 766 S-SFPTQP 772
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 15/151 (9%), Positives = 37/151 (24%), Gaps = 22/151 (14%)
Query: 64 WNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIP------------V 111
+ K + ++ + + + + + L ++LD +
Sbjct: 247 IDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNK 306
Query: 112 DLCKW----------LPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFE 161
+L W V L L+ G +P I + L L + + S
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF 366
Query: 162 VSRLDRLKEFSVAGNDLSGTIPPDLARFPEE 192
+ + + +
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 64/297 (21%), Positives = 117/297 (39%), Gaps = 77/297 (25%)
Query: 309 GVSYKAVLPDASAL---AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE 363
G + V AIK L K ++ E + QL +P +V L+G V +
Sbjct: 24 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG--VCQA 81
Query: 364 ERL-LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL--HHGCQPP 420
E L LV + G L+ L G + +S V + S G+ +L +
Sbjct: 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH------QVSMGMKYLEEKN----- 130
Query: 421 YMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE------ 474
++H+ +++ +L+ + A+I+DFGL++ +G+ D ++ G + APE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW-PLKWYAPECINFRK 189
Query: 475 YSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533
+SS + DV+ +G+ + E LS GQKP +K V+
Sbjct: 190 FSS------RSDVWSYGVTMWEALSYGQKP---------YKK----MKGPEVM-----AF 225
Query: 534 VDK------------SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
+++ LY +M C + + +DRP V + +++
Sbjct: 226 IEQGKRMECPPECPPELY------ALMS------DCWIYKWEDRPDFLTVEQRMRAC 270
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 62/310 (20%), Positives = 112/310 (36%), Gaps = 72/310 (23%)
Query: 309 GVSYKAVLPDAS----ALAIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE 362
GV Y D + AIK L + F E + L HPN++ L+G +
Sbjct: 35 GVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94
Query: 363 EERLL-VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPY 421
E + +M +G L + + T+ ++ + ++ GM
Sbjct: 95 EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGM----------------- 137
Query: 422 MHQYISS-----------NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGY 470
+Y++ N ++D+ F ++ DFGLAR + R+ +
Sbjct: 138 --EYLAEQKFVHRDLAARN-CMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKW 194
Query: 471 VAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPL-DVAGAEEGFKGNLVDWVNHLVIAG 528
A E T + K DV+ FG++L ELL+ G P + + + H + G
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD----------LTHFLAQG 244
Query: 529 RSRDVVDK------SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582
R + + SLY ++MQ C + P RP+ + ++ +
Sbjct: 245 R---RLPQPEYCPDSLY------QVMQ------QCWEADPAVRPTFRVLVGEVEQIVSAL 289
Query: 583 GFSEPYDEFP 592
+ Y + P
Sbjct: 290 -LGDHYVQLP 298
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 61/302 (20%), Positives = 104/302 (34%), Gaps = 99/302 (32%)
Query: 323 AIKRLSACKLSEKQ----FRSEMNRLGQLRHPNLVPLLGFCVVEEERL-LVYKHMPNGTL 377
A+K L LS+ + F E+N + L H NL+ L G VV + +V + P G+L
Sbjct: 50 AVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG--VVLTPPMKMVTELAPLGSL 107
Query: 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS--------- 428
L + L + ++ ++ GM Y+ S
Sbjct: 108 LDRLRKHQGHFLLGTLSRYAVQVAEGM-------------------GYLESKRFIHRDLA 148
Query: 429 --NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGY--VAPE------YSST 478
N +L+ +I DFGL R + ND +V + + + APE +S
Sbjct: 149 ARN-LLLATRDLVKIGDFGLMRAL---PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH- 203
Query: 479 MVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK- 536
D + FG+ L E+ + GQ+P + G ++ +DK
Sbjct: 204 -----ASDTWMFGVTLWEMFTYGQEP---------WIG----LNGSQIL-----HKIDKE 240
Query: 537 ------------SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGF 584
+Y +M C +P+DRP+ + + L
Sbjct: 241 GERLPRPEDCPQDIY------NVMV------QCWAHKPEDRPTFVALRDFLLEAQPTDMR 288
Query: 585 SE 586
+E
Sbjct: 289 AE 290
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 48/291 (16%), Positives = 87/291 (29%), Gaps = 96/291 (32%)
Query: 323 AIKRLSACKLSEKQ-FRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLL 381
+K L + + F + + +L H +LV G CV +E +LV + + G+L + L
Sbjct: 44 LLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL 103
Query: 382 HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS-----------NV 430
N + L+ + +L M ++ N+
Sbjct: 104 KKNKNCINILWKLEVAKQLAAAM-------------------HFLEENTLIHGNVCAKNI 144
Query: 431 ILIDDDFDAR-------ITDFGLARLVGSRDPNDSSFVHGDLGEFGY------VAPE--- 474
+LI ++ ++D G++ V +D V PE
Sbjct: 145 LLIREEDRKTGNPPFIKLSDPGISITVLPKD--------------ILQERIPWVPPECIE 190
Query: 475 ----YSSTMVASLKGDVYGFGIVLLELLS-GQKPL-DVAGAEEGFKGNLVDWVNHLVIAG 528
+ D + FG L E+ S G KPL +
Sbjct: 191 NPKNLNL------ATDKWSFGTTLWEICSGGDKPLSALDSQR----------KLQFYEDR 234
Query: 529 -RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
+ L ++ +C+ P RPS + L S+
Sbjct: 235 HQLPAPKAAELA------NLIN------NCMDYEPDHRPSFRAIIRDLNSL 273
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 63/308 (20%), Positives = 107/308 (34%), Gaps = 70/308 (22%)
Query: 323 AIKRL-SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER--LLVYKHMPNGTLYS 379
A+K+L + ++ F+ E+ L L +V G + LV +++P+G L
Sbjct: 56 AVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD 115
Query: 380 LLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS----------- 428
L + S +L +S+++ GM +Y+ S
Sbjct: 116 FLQRHRARLDASRLLLYSSQICKGM-------------------EYLGSRRCVHRDLAAR 156
Query: 429 NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVY 488
N IL++ + +I DFGLA+L+ G F Y APE S + S + DV+
Sbjct: 157 N-ILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-APESLSDNIFSRQSDVW 214
Query: 489 GFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK----------- 536
FG+VL EL + K + G D +++
Sbjct: 215 SFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL-------SRLLELLEEGQRLPAPP 267
Query: 537 ----SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEPYDEFP 592
++ E+M+ C P+DRPS + L + E +
Sbjct: 268 ACPAEVH------ELMK------LCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTA 315
Query: 593 MIFGKQDP 600
GK
Sbjct: 316 HPEGKHHS 323
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 62/295 (21%), Positives = 110/295 (37%), Gaps = 99/295 (33%)
Query: 323 AIKRLSACKLSE--KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
AIK L A + F SE + +GQ HPN++ L G ++V ++M NG+L +
Sbjct: 81 AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS-----------N 429
L + T+ ++ + GM +Y+S N
Sbjct: 141 LRTHDGQFTIMQLVGMLRGVGAGM-------------------RYLSDLGYVHRDLAARN 181
Query: 430 VILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV-----APE------YSST 478
+L+D + +++DFGL+R++ +D + G G + APE +SS
Sbjct: 182 -VLVDSNLVCKVSDFGLSRVLE----DDPDAAYTTTG--GKIPIRWTAPEAIAFRTFSS- 233
Query: 479 MVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK- 536
DV+ FG+V+ E+L+ G++P + N VI V++
Sbjct: 234 -----ASDVWSFGVVMWEVLAYGERPYW-------------NMTNRDVI-----SSVEEG 270
Query: 537 -----------SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
+L+ ++M C RP Q+ L ++
Sbjct: 271 YRLPAPMGCPHALH------QLML------DCWHKDRAQRPRFSQIVSVLDALIR 313
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 4e-17
Identities = 62/290 (21%), Positives = 115/290 (39%), Gaps = 63/290 (21%)
Query: 309 GVSYKAVLPDASAL---AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE 363
G + V AIK L K ++ E + QL +P +V L+G C E
Sbjct: 350 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 408
Query: 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL--HHGCQPPY 421
+LV + G L+ L G + +S V + S G+ +L + +
Sbjct: 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH------QVSMGMKYLEEKN-----F 457
Query: 422 MHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA 481
+H+ +++ +L+ + A+I+DFGL++ +G+ D ++ G + APE +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW-PLKWYAPECINFRKF 516
Query: 482 SLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK---- 536
S + DV+ +G+ + E LS GQKP +K V+ +++
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKP---------YKK----MKGPEVM-----AFIEQGKRM 558
Query: 537 --------SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
LY +M C + + +DRP V + +++
Sbjct: 559 ECPPECPPELY------ALMS------DCWIYKWEDRPDFLTVEQRMRAC 596
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 40/188 (21%), Positives = 81/188 (43%), Gaps = 23/188 (12%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
IK + + + S + M +G L H ++V LLG C LV +++P G+L
Sbjct: 46 CIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDH 104
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMG--ASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD 438
+ + +L+W ++ GM G +H+ +++ +L+
Sbjct: 105 VRQHRGALGPQLLLNWGVQIAKGMYYLEEHG-----------MVHRNLAARNVLLKSPSQ 153
Query: 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEF--GYVAPEYSSTMVASLKGDVYGFGIVLLE 496
++ DFG+A L+ P D + + ++A E + + DV+ +G+ + E
Sbjct: 154 VQVADFGVADLL----PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWE 209
Query: 497 LLS-GQKP 503
L++ G +P
Sbjct: 210 LMTFGAEP 217
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 53/277 (19%), Positives = 105/277 (37%), Gaps = 65/277 (23%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
AIK L + + K+ E + + +P++ LLG C + L+ + MP G L
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDY 106
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL--HHGCQPPYMHQYISSNVILIDDDFD 438
+ + + +L+W ++G+ +L +H+ +++ +L+
Sbjct: 107 VREHKDNIGSQYLLNWCV------QIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQH 155
Query: 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEF--GYVAPEYSSTMVASLKGDVYGFGIVLLE 496
+ITDFGLA+L+G + H + G+ ++A E + + + DV+ +G+ + E
Sbjct: 156 VKITDFGLAKLLG----AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 211
Query: 497 LLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK------------SLYGRGN 543
L++ G KP D + +++K +Y
Sbjct: 212 LMTFGSKPYD-------------GIPASEIS-----SILEKGERLPQPPICTIDVY---- 249
Query: 544 DDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
IM C + RP ++ MA
Sbjct: 250 --MIMV------KCWMIDADSRPKFRELIIEFSKMAR 278
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 26/118 (22%), Positives = 45/118 (38%), Gaps = 6/118 (5%)
Query: 70 RIISLTLSSMQLSG-QLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNN 128
R+ L L ++ E +L+ L+L N + + + + LDLS+N
Sbjct: 145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV--FAKLKTLDLSSN 201
Query: 129 HLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
L+ + P+ + + L NNKL I + L+ F + GN D
Sbjct: 202 KLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 26/118 (22%), Positives = 43/118 (36%), Gaps = 9/118 (7%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNN 128
NR ++ L L +++ LDLS N LS I + L+LS+N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLSSN 68
Query: 129 HLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
L + L L L+NN + E+ ++ A N++S +
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR 118
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 22/100 (22%), Positives = 38/100 (38%), Gaps = 4/100 (4%)
Query: 85 LPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFL 144
+ E + + ++D+SL L + V +LDLS N LS + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 145 NKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP 184
L LS+N L ++ L L+ + N + +
Sbjct: 61 ELLNLSSNVLYETLDL--ESLSTLRTLDLNNNYVQ-ELLV 97
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 25/118 (21%), Positives = 45/118 (38%), Gaps = 4/118 (3%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
++ L++ +++ +Q LDL N + +L + L+L N +
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP 190
+ Q+V L L LS+NKL+ + E + S+ N L I L
Sbjct: 184 -VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 9e-10
Identities = 24/113 (21%), Positives = 50/113 (44%), Gaps = 12/113 (10%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L LSS L + + L +L++LDL++N + + V P + L +NN++S
Sbjct: 62 LLNLSSNVLY-ETLDLESL-STLRTLDLNNNYVQ-ELLV-----GPSIETLHAANNNISR 113
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPD 185
+ + + L+NNK++ + R++ + N++ T+
Sbjct: 114 -VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFA 162
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 53/283 (18%), Positives = 98/283 (34%), Gaps = 59/283 (20%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER--LLVYKHMPNGTLY 378
A+K L + + E+ L L H N+V G C + L+ + +P+G+L
Sbjct: 54 AVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLK 113
Query: 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYI-----SSNVILI 433
L N L L ++ +G+ +L QY+ + N +L+
Sbjct: 114 EYLPKNKNKINLKQQLKYAV------QICKGMDYLGS-------RQYVHRDLAARN-VLV 159
Query: 434 DDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIV 493
+ + +I DFGL + + + + D F Y APE + DV+ FG+
Sbjct: 160 ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY-APECLMQSKFYIASDVWSFGVT 218
Query: 494 LLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK---------------S 537
L ELL+ G + +V+
Sbjct: 219 LHELLTYCDSDSSPMALFLKMIGPTHGQMTV-------TRLVNTLKEGKRLPCPPNCPDE 271
Query: 538 LYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
+Y ++M+ C +P +R S + E +++ +
Sbjct: 272 VY------QLMR------KCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 55/292 (18%), Positives = 109/292 (37%), Gaps = 93/292 (31%)
Query: 323 AIKRLSACKLSEKQ--FRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
AIK L A +++ F E +GQ H N++ L G + +++ ++M NG L
Sbjct: 77 AIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF 136
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL--HHGCQPPYMHQYISSNVILIDDDFD 438
L + ++ ++ G + G+ +L + Y+H+ +++ IL++ +
Sbjct: 137 LREKDGEFSVLQLVGMLR------GIAAGMKYLANMN-----YVHRDLAARNILVNSNLV 185
Query: 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV-----------APE------YSSTMVA 481
+++DFGL+R++ D E Y APE ++S
Sbjct: 186 CKVSDFGLSRVL------------EDDPEATYTTSGGKIPIRWTAPEAISYRKFTS---- 229
Query: 482 SLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK---- 536
DV+ FGIV+ E+++ G++P + NH V+ ++
Sbjct: 230 --ASDVWSFGIVMWEVMTYGERPYW-------------ELSNHEVM-----KAINDGFRL 269
Query: 537 --------SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
++Y ++M C RP + L +
Sbjct: 270 PTPMDCPSAIY------QLMM------QCWQQERARRPKFADIVSILDKLIR 309
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 56/290 (19%), Positives = 105/290 (36%), Gaps = 71/290 (24%)
Query: 323 AIKRLSACKLSEKQ-FRSEMNRLGQLRHPNLVPLLGFCVVEEER--LLVYKHMPNGTLYS 379
A+K+L + F E+ L L+H N+V G C R L+ +++P G+L
Sbjct: 43 AVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 102
Query: 380 LLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS----------- 428
L + +L +++++ GM +Y+ +
Sbjct: 103 YLQKHKERIDHIKLLQYTSQICKGM-------------------EYLGTKRYIHRDLATR 143
Query: 429 NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEF--GYVAPEYSSTMVASLKGD 486
N IL++++ +I DFGL +++ + F + GE + APE + S+ D
Sbjct: 144 N-ILVENENRVKIGDFGLTKVLPQ---DKEFFKVKEPGESPIFWYAPESLTESKFSVASD 199
Query: 487 VYGFGIVLLELLS-GQKPLDVAGAEEGFKGNL--VDWVNHLVIAGRSRDVVDK------- 536
V+ FG+VL EL + +K GN + +I +++
Sbjct: 200 VWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI-----ELLKNNGRLPRP 254
Query: 537 -----SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581
+Y IM C + RPS + + + +
Sbjct: 255 DGCPDEIY------MIMT------ECWNNNVNQRPSFRDLALRVDQIRDN 292
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 22/117 (18%), Positives = 39/117 (33%), Gaps = 1/117 (0%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129
+++ L +S SL +L ++ NS + ++ + LDLS
Sbjct: 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQ 484
Query: 130 LSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
L L L +S+N L ++L L + N + T L
Sbjct: 485 LEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGIL 540
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 23/140 (16%), Positives = 41/140 (29%), Gaps = 10/140 (7%)
Query: 62 ACWNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVV 121
+ + N + L LS + + LQ LD ++L L ++
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLL 427
Query: 122 QLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSG 180
LD+S + + LN L ++ N + V + L ++ L
Sbjct: 428 YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ 487
Query: 181 TIPPDLARFPEESFDGNSGL 200
FD L
Sbjct: 488 --------ISWGVFDTLHRL 499
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 28/116 (24%), Positives = 43/116 (37%), Gaps = 1/116 (0%)
Query: 71 IISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL 130
++ LS L S LQ LDLS + +I L ++ L L+ N +
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE-TIEDKAWHGLHHLSNLILTGNPI 92
Query: 131 SGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
P L L+ KL+ F + +L LK+ +VA N + P
Sbjct: 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAY 148
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 26/120 (21%), Positives = 44/120 (36%), Gaps = 2/120 (1%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L LS ++ ++ H H L +L L+ N + S L + L L+
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ-SFSPGSFSGLTSLENLVAVETKLAS 118
Query: 133 PIPPQIVECKFLNKLILSNNKLSG-SIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE 191
I + L KL +++N + +P S L L ++ N + DL E
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 6e-14
Identities = 21/107 (19%), Positives = 39/107 (36%), Gaps = 2/107 (1%)
Query: 74 LTLSSMQLSGQLPES-LHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L ++ + +L LDLS L I + L + L++S+N+L
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLE-QISWGVFDTLHRLQLLNMSHNNLLF 511
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
+ L+ L S N++ S L F++ N ++
Sbjct: 512 LDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 26/117 (22%), Positives = 37/117 (31%), Gaps = 5/117 (4%)
Query: 73 SLTLSSMQLSGQLPESLHL--CHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL 130
L LS LS S +SL+ LDLS N I L + LD ++ L
Sbjct: 354 YLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI--IMSANFMGLEELQHLDFQHSTL 411
Query: 131 SGPIPPQ-IVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
+ + L L +S L L +AGN ++
Sbjct: 412 KRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV 468
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 22/119 (18%), Positives = 46/119 (38%), Gaps = 7/119 (5%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
+L +L+ + +L+ L+++ N + L +V +DLS N++
Sbjct: 108 NLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167
Query: 133 PIPPQIVE-----CKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
I ++ + L +S N + I + + +L E ++ GN S I
Sbjct: 168 -ITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTC 224
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 29/131 (22%), Positives = 46/131 (35%), Gaps = 15/131 (11%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWL--PYVVQLDLSNNHL 130
SLTL+ + S + SL LDLS N+LS L + LDLS N
Sbjct: 332 SLTLTMNKGS--ISFKKVALPSLSYLDLSRNALS-FSGCCSYSDLGTNSLRHLDLSFNGA 388
Query: 131 SGPIPPQIVECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDLARF 189
+ + + L L ++ L F L++L ++ +
Sbjct: 389 II-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI--------D 439
Query: 190 PEESFDGNSGL 200
+ F G + L
Sbjct: 440 FDGIFLGLTSL 450
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 25/118 (21%), Positives = 38/118 (32%), Gaps = 13/118 (11%)
Query: 83 GQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECK 142
G L + + ++ + D LS +P D+ +DLS N L
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDI---PSSTKNIDLSFNPLKILKSYSFSNFS 56
Query: 143 FLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGNSGL 200
L L LS ++ L L + GN + F SF G + L
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS--------FSPGSFSGLTSL 106
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 25/123 (20%), Positives = 46/123 (37%), Gaps = 11/123 (8%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129
+ +++L+ + + E + QSL + L P LP++ L L+ N
Sbjct: 286 NVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-QFP---TLDLPFLKSLTLTMNK 339
Query: 130 LSGPIPPQIVECKFLNKLILSNNKLS--GSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLA 187
S I + V L+ L LS N LS G + + L+ ++ N + +
Sbjct: 340 GS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFM 396
Query: 188 RFP 190
Sbjct: 397 GLE 399
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 21/131 (16%), Positives = 36/131 (27%), Gaps = 22/131 (16%)
Query: 71 IISLTLSSMQLSGQLPESLHLCH--------------SLQSLDLSDNSLSGSIPVDLCKW 116
I L ++ + Q+ SL + L L L N S +I +
Sbjct: 168 ITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQN 227
Query: 117 LPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI--------LSNNKLSGSIPFEVSRLDRL 168
L + L +I E + L L+ + L +
Sbjct: 228 LAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANV 287
Query: 169 KEFSVAGNDLS 179
S+AG +
Sbjct: 288 SAMSLAGVSIK 298
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 55/290 (18%), Positives = 106/290 (36%), Gaps = 71/290 (24%)
Query: 323 AIKRLSACKLSEKQ-FRSEMNRLGQLRHPNLVPLLGFCVVEEER--LLVYKHMPNGTLYS 379
A+K+L + F E+ L L+H N+V G C R L+ +++P G+L
Sbjct: 74 AVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 133
Query: 380 LLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS----------- 428
L + +L +++++ GM +Y+ +
Sbjct: 134 YLQKHKERIDHIKLLQYTSQICKGM-------------------EYLGTKRYIHRDLATR 174
Query: 429 NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEF--GYVAPEYSSTMVASLKGD 486
N IL++++ +I DFGL +++ + + + GE + APE + S+ D
Sbjct: 175 N-ILVENENRVKIGDFGLTKVLPQ---DKEYYKVKEPGESPIFWYAPESLTESKFSVASD 230
Query: 487 VYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDW--VNHLVIAGRSRDVVDK------- 536
V+ FG+VL EL + +K GN + +I +++
Sbjct: 231 VWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI-----ELLKNNGRLPRP 285
Query: 537 -----SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581
+Y IM C + RPS + + + ++
Sbjct: 286 DGCPDEIY------MIMT------ECWNNNVNQRPSFRDLALRVDQIRDQ 323
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 31/114 (27%), Positives = 42/114 (36%), Gaps = 14/114 (12%)
Query: 73 SLTLSSMQ---LSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129
L L + SG LQ LDLS NSL + C W + L+LS
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264
Query: 130 LS---GPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSG 180
L +P + L+ L LS N+L P L ++ S+ GN
Sbjct: 265 LKQVPKGLPAK------LSVLDLSYNRLD-RNPSP-DELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 27/150 (18%), Positives = 47/150 (31%), Gaps = 15/150 (10%)
Query: 56 CRLTGVACWNEKENR---IISLTLSSMQLSGQLPE----SLHLCHSLQSLDLSDNSLSGS 108
+TG A E + L L ++ + + L L+ L ++ +
Sbjct: 105 LEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL-N 163
Query: 109 IPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKF----LNKLILSNNK---LSGSIPFE 161
+ + P + LDLS+N G C L L L N SG
Sbjct: 164 FSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL 223
Query: 162 VSRLDRLKEFSVAGNDLSGTIPPDLARFPE 191
+ +L+ ++ N L +P
Sbjct: 224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 27/134 (20%), Positives = 51/134 (38%), Gaps = 12/134 (8%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCH--SLQSLDLSDNSLSG--SIPVDLCKWL-PYVVQL 123
+ + LTL +++++G P L L L+L + S + + +L +WL P + L
Sbjct: 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVL 154
Query: 124 DLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVS----RLDRLKEFSVAGN--- 176
++ H Q+ L+ L LS+N G + + L+ ++
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214
Query: 177 DLSGTIPPDLARFP 190
SG A
Sbjct: 215 TPSGVCSALAAARV 228
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 23/107 (21%), Positives = 37/107 (34%), Gaps = 8/107 (7%)
Query: 92 CHSLQSLDLSDNSLSGSIPVDLCKWLPY--VVQLDLSNNHLSGPIPPQIVECKF--LNKL 147
SL+ L + + I + L + +L L N ++G PP ++E LN L
Sbjct: 67 SLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNIL 126
Query: 148 ILSNNKLSGSIPFEVS----RLDRLKEFSVAGNDLSGTIPPDLARFP 190
L N + + LK S+A + FP
Sbjct: 127 NLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 22/61 (36%), Positives = 24/61 (39%), Gaps = 6/61 (9%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
SL LS L Q+P+ L L LDLS N L P LP V L L N
Sbjct: 257 SLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNPSPDE--LPQVGNLSLKGNPFLD 310
Query: 133 P 133
Sbjct: 311 S 311
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 5e-16
Identities = 61/314 (19%), Positives = 108/314 (34%), Gaps = 90/314 (28%)
Query: 309 GVSYKAVLPDASAL----AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE 362
G Y+ V + A+K ++++F SE + L HP++V L+G E
Sbjct: 26 GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII-EE 84
Query: 363 EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYM 422
E ++ + P G L L N + ++ +S ++ M
Sbjct: 85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM------------------ 126
Query: 423 HQYISS-----------NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEF--G 469
Y+ S N IL+ ++ DFGL+R + D + +
Sbjct: 127 -AYLESINCVHRDIAVRN-ILVASPECVKLGDFGLSRYI-----EDEDYYKASVTRLPIK 179
Query: 470 YVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528
+++PE + + DV+ F + + E+LS G++P F N VI
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP---------FFW----LENKDVI-- 224
Query: 529 RSRDVVDK------------SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576
V++K LY +M C P DRP ++ SL
Sbjct: 225 ---GVLEKGDRLPKPDLCPPVLY------TLMT------RCWDYDPSDRPRFTELVCSLS 269
Query: 577 SMAEKHGFSEPYDE 590
+ + + E
Sbjct: 270 DVYQME--KDIAME 281
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 63/277 (22%), Positives = 111/277 (40%), Gaps = 74/277 (26%)
Query: 323 AIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL-LVYKHMPNGTLYSLL 381
A+K + + + F +E + + QLRH NLV LLG V E+ L +V ++M G+L L
Sbjct: 220 AVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL 278
Query: 382 HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYI-----SSNVILIDDD 436
G VL L+ + + +L + ++ + N +L+ +D
Sbjct: 279 RSRG-----RSVLGGDCLLKFSLDVCEAMEYLEG-------NNFVHRDLAARN-VLVSED 325
Query: 437 FDARITDFGLARLVGSRDPNDSSFVHGDLGEFGY--VAPEYSSTMVASLKGDVYGFGIVL 494
A+++DFGL + + + + D G+ APE S K DV+ FGI+L
Sbjct: 326 NVAKVSDFGLTK-----EASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 376
Query: 495 LELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK------------SLYGR 541
E+ S G+ P + V+ V+K ++Y
Sbjct: 377 WEIYSFGRVP---------YPR----IPLKDVV-----PRVEKGYKMDAPDGCPPAVY-- 416
Query: 542 GNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
++M+ +C RP+ Q+ E L+ +
Sbjct: 417 ----DVMK------NCWHLDAATRPTFLQLREQLEHI 443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 63/281 (22%), Positives = 113/281 (40%), Gaps = 71/281 (25%)
Query: 323 AIKRLSACKLSEKQ--FRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
AIK L +++ F E + +GQ HPN++ L G + ++V ++M NG+L S
Sbjct: 77 AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMG--ASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD 438
L + T+ ++ + GM + G Y+H+ +++ ILI+ +
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYLSDMG-----------YVHRDLAARNILINSNLV 185
Query: 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE------YSSTMVASLKGDVYGFGI 492
+++DFGL R++ DP + G + +PE ++S DV+ +GI
Sbjct: 186 CKVSDFGLGRVLED-DPEAAYTTRGGKIPIRWTSPEAIAYRKFTS------ASDVWSYGI 238
Query: 493 VLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK------------SLY 539
VL E++S G++P + N VI VD+ +LY
Sbjct: 239 VLWEVMSYGERPYW-------------EMSNQDVI-----KAVDEGYRLPPPMDCPAALY 280
Query: 540 GRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
++M C +RP Q+ L +
Sbjct: 281 ------QLML------DCWQKDRNNRPKFEQIVSILDKLIR 309
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 64/304 (21%), Positives = 121/304 (39%), Gaps = 54/304 (17%)
Query: 309 GVSYKAVLPDASAL----AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE 362
G Y L D A+K L QF +E + HPN++ LLG C+
Sbjct: 103 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162
Query: 363 EE-RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL--HHGCQP 419
E L+V +M +G L + + + T+ + G+ ++G+ +L
Sbjct: 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTV------KDLIGFGLQVAKGMKFLASKK---- 212
Query: 420 PYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM 479
++H+ +++ ++D+ F ++ DFGLAR + ++ + G ++A E T
Sbjct: 213 -FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 480 VASLKGDVYGFGIVLLELLS-GQKP-LDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK- 536
+ K DV+ FG++L EL++ G P DV + + ++ GR + +
Sbjct: 272 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----------ITVYLLQGR---RLLQP 318
Query: 537 -----SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEPYDEF 591
LY E+M C + + RPS ++ + ++ E Y
Sbjct: 319 EYCPDPLY------EVML------KCWHPKAEMRPSFSELVSRISAIFSTF-IGEHYVHV 365
Query: 592 PMIF 595
+
Sbjct: 366 NATY 369
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 59/307 (19%), Positives = 108/307 (35%), Gaps = 97/307 (31%)
Query: 309 GVSYKAVLPDASAL---AIKRL---SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE 362
G K + A+K L + + + +E N + QL +P +V ++G + E
Sbjct: 31 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG--ICE 88
Query: 363 EERL-LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPY 421
E LV + G L L N +++ ++ +GM
Sbjct: 89 AESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGM----------------- 130
Query: 422 MHQYISS-----------NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGY 470
+Y+ N +L+ A+I+DFGL++ + + + + HG +
Sbjct: 131 --KYLEESNFVHRDLAARN-VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW-PVKW 186
Query: 471 VAPE------YSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNH 523
APE +SS K DV+ FG+++ E S GQKP ++G
Sbjct: 187 YAPECINYYKFSS------KSDVWSFGVLMWEAFSYGQKP---------YRG----MKGS 227
Query: 524 LVIAGRSRDVVDK------------SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQV 571
V +++K +Y ++M C ++RP V
Sbjct: 228 EVT-----AMLEKGERMGCPAGCPREMY------DLMN------LCWTYDVENRPGFAAV 270
Query: 572 YESLKSM 578
L++
Sbjct: 271 ELRLRNY 277
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 9e-16
Identities = 59/285 (20%), Positives = 108/285 (37%), Gaps = 78/285 (27%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
AIK ++F E + Q HP++V L+G E ++ + G L S
Sbjct: 47 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSF 105
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL--HHGCQPPYMHQYISSNVILIDDDFD 438
L L+ ++ ++ S LA+L ++H+ I++ +L+ +
Sbjct: 106 LQVRKYSLDLASLILYAY------QLSTALAYLESKR-----FVHRDIAARNVLVSSNDC 154
Query: 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEF--GYVAPE------YSSTMVASLKGDVYGF 490
++ DFGL+R + DS++ G+ ++APE ++S DV+ F
Sbjct: 155 VKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPESINFRRFTS------ASDVWMF 203
Query: 491 GIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK------------S 537
G+ + E+L G KP F+G N+ VI ++ +
Sbjct: 204 GVCMWEILMHGVKP---------FQG----VKNNDVI-----GRIENGERLPMPPNCPPT 245
Query: 538 LYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582
LY +M C P RP ++ L ++ E+
Sbjct: 246 LY------SLMT------KCWAYDPSRRPRFTELKAQLSTILEEE 278
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 9e-16
Identities = 58/278 (20%), Positives = 107/278 (38%), Gaps = 66/278 (23%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
AIK ++F E + Q HP++V L+G E ++ + G L S
Sbjct: 422 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSF 480
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL--HHGCQPPYMHQYISSNVILIDDDFD 438
L L+ ++ ++ S LA+L ++H+ I++ +L+ +
Sbjct: 481 LQVRKFSLDLASLILYAY------QLSTALAYLESKR-----FVHRDIAARNVLVSSNDC 529
Query: 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEF--GYVAPEYSSTMVASLKGDVYGFGIVLLE 496
++ DFGL+R + DS++ G+ ++APE + + DV+ FG+ + E
Sbjct: 530 VKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 584
Query: 497 LLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK------------SLYGRGN 543
+L G KP F+G N+ VI ++ +LY
Sbjct: 585 ILMHGVKP---------FQG----VKNNDVI-----GRIENGERLPMPPNCPPTLY---- 622
Query: 544 DDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581
+M C P RP ++ L ++ E+
Sbjct: 623 --SLMT------KCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 62/285 (21%), Positives = 104/285 (36%), Gaps = 61/285 (21%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER--LLVYKHMPNGTLY 378
A+K L A ++ E++ L L H +++ G C LV +++P G+L
Sbjct: 64 AVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLR 123
Query: 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS---------- 428
L + + L+ +L ++ ++ GM Y+ +
Sbjct: 124 DYLPRHSI--GLAQLLLFAQQICEGM-------------------AYLHAQHYIHRDLAA 162
Query: 429 -NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDV 487
N +L+D+D +I DFGLA+ V GD F Y APE DV
Sbjct: 163 RN-VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFYYASDV 220
Query: 488 YGFGIVLLELLS-GQKPLDVAGAEEGFKGN-----LVDWVNHLVIAGRSR----DVVDKS 537
+ FG+ L ELL+ G V + L+ G R D
Sbjct: 221 WSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE-RLPRPDKCPAE 279
Query: 538 LYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582
+Y +M+ +C + RP+ + LK++ EK+
Sbjct: 280 VY------HLMK------NCWETEASFRPTFENLIPILKTVHEKY 312
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 57/296 (19%), Positives = 116/296 (39%), Gaps = 88/296 (29%)
Query: 323 AIKRLSACKLSEKQ-FRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLL 381
A+K L L+ ++ F+ E L L+H ++V G C + ++V+++M +G L L
Sbjct: 49 AVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFL 108
Query: 382 HGNGVDNTLSGVLDWSTR---------LRIGMGASRGLAWL--HHGCQPPYMHQYISSNV 430
+G D + L I + G+ +L H ++H+ +++
Sbjct: 109 RAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH-----FVHRDLATRN 163
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGY-------------VAPE--- 474
L+ + +I DFG++R V S D Y + PE
Sbjct: 164 CLVGANLLVKIGDFGMSRDVYSTD---------------YYRVGGHTMLPIRWMPPESIM 208
Query: 475 ---YSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530
+++ + DV+ FG++L E+ + G++P E V + GR
Sbjct: 209 YRKFTT------ESDVWSFGVILWEIFTYGKQPWFQLSNTE---------VIECITQGR- 252
Query: 531 RDVVDK------SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
V+++ +Y ++M C P+ R ++ ++Y+ L ++ +
Sbjct: 253 --VLERPRVCPKEVY------DVML------GCWQREPQQRLNIKEIYKILHALGK 294
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 65/291 (22%), Positives = 110/291 (37%), Gaps = 98/291 (33%)
Query: 323 AIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL-LVYKHMPNGTLYSLL 381
A+K + + + F +E + + QLRH NLV LLG V E+ L +V ++M G+L L
Sbjct: 48 AVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL 106
Query: 382 HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYI-----SSNVILIDDD 436
G VL L+ + + +L + ++ + N +L+ +D
Sbjct: 107 RSRG-----RSVLGGDCLLKFSLDVCEAMEYLEG-------NNFVHRDLAARN-VLVSED 153
Query: 437 FDARITDFGLARLV-----GSRDPNDSSFVHGDLGEFGYV---APE------YSSTMVAS 482
A+++DFGL + + P V APE +S+
Sbjct: 154 NVAKVSDFGLTKEASSTQDTGKLP---------------VKWTAPEALREKKFST----- 193
Query: 483 LKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK----- 536
K DV+ FGI+L E+ S G+ P + V+ V+K
Sbjct: 194 -KSDVWSFGILLWEIYSFGRVP---------YPR----IPLKDVV-----PRVEKGYKMD 234
Query: 537 -------SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
++Y E+M+ +C RPS Q+ E L+ +
Sbjct: 235 APDGCPPAVY------EVMK------NCWHLDAAMRPSFLQLREQLEHIKT 273
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 21/114 (18%), Positives = 34/114 (29%), Gaps = 1/114 (0%)
Query: 71 IISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL 130
L S L + +L LDL+ + I D + + L L+ N L
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY-WIHEDTFQSQHRLDTLVLTANPL 93
Query: 131 SGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP 184
+ K L L +S + L+ + N +S P
Sbjct: 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLP 147
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 28/123 (22%), Positives = 44/123 (35%), Gaps = 4/123 (3%)
Query: 65 NEKENRIISLTLSSMQLSGQLPESLHLCH--SLQSLDLSDNSLSGSIPVDLCKWLPYVVQ 122
N + T M P S++S++L + +I + + +
Sbjct: 224 NSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF-NISSNTFHCFSGLQE 282
Query: 123 LDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTI 182
LDL+ HLS +P +V L KL+LS NK S L S+ GN +
Sbjct: 283 LDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLEL 341
Query: 183 PPD 185
Sbjct: 342 GTG 344
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 29/147 (19%), Positives = 46/147 (31%), Gaps = 19/147 (12%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL-- 130
L LS+ + S SL L + N+ + + L + +LDLS++ +
Sbjct: 305 KLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364
Query: 131 SGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPD----- 185
S Q+ L L LS N+ +L+ +A L
Sbjct: 365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNL 424
Query: 186 ------------LARFPEESFDGNSGL 200
L E+ FDG L
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPAL 451
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 27/116 (23%), Positives = 40/116 (34%), Gaps = 4/116 (3%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
SL LS + E+ C L+ LDL+ L + L + L+LS++ L
Sbjct: 380 SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEV---SRLDRLKEFSVAGNDLSGTIPPD 185
L L L N + L RL+ ++ DLS I
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS-IDQH 494
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-14
Identities = 27/120 (22%), Positives = 46/120 (38%), Gaps = 4/120 (3%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
+L L++ L +L +L+ L +S SI + L L +NH+S
Sbjct: 85 TLVLTANPLIFMAETALSGPKALKHLFFIQTGIS-SIDFIPLHNQKTLESLYLGSNHISS 143
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSV--AGNDLSGTIPPDLARFP 190
P+ + L L NN + ++S L + S+ GND++ I P
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSA 202
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-14
Identities = 21/119 (17%), Positives = 40/119 (33%), Gaps = 1/119 (0%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L+ Q+ ++ H L +L L+ N L + + L +S
Sbjct: 61 FLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI-FMAETALSGPKALKHLFFIQTGISS 119
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE 191
+ K L L L +N +S + ++LK N + D++ +
Sbjct: 120 IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQ 178
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 21/111 (18%), Positives = 40/111 (36%), Gaps = 4/111 (3%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
+ ++ L+ ++P +L +S + L+ S N L + L + LDL+ +
Sbjct: 16 TYNCENLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSR-LINLTFLDLTRCQIYW 71
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183
L+ L+L+ N L +S LK +S
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDF 122
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 9e-13
Identities = 30/119 (25%), Positives = 47/119 (39%), Gaps = 4/119 (3%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPV--DLCKWLPYVVQLDLSN 127
+ L LS L + +LQ L+L N + + L + L LS
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485
Query: 128 NHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
LS K +N + LS+N+L+ S +S L + ++A N +S I P L
Sbjct: 486 CDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHIS-IILPSL 542
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 28/111 (25%), Positives = 44/111 (39%), Gaps = 5/111 (4%)
Query: 74 LTLSSMQLSG---QLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL 130
L L Q SL L+ L LS LS SI L + +DLS+N L
Sbjct: 454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS-SIDQHAFTSLKMMNHVDLSHNRL 512
Query: 131 SGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGT 181
+ + + L L++N +S +P + L + + ++ N L T
Sbjct: 513 TS-SSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 27/123 (21%), Positives = 41/123 (33%), Gaps = 10/123 (8%)
Query: 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSN 127
+ I + ++QL LQSL+LS N S+ + K P + LDL+
Sbjct: 359 HDDIETSDCCNLQLRN--------LSHLQSLNLSYNEPL-SLKTEAFKECPQLELLDLAF 409
Query: 128 NHLSGPIPP-QIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
L L L LS++ L S L L+ ++ GN
Sbjct: 410 TRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469
Query: 187 ARF 189
Sbjct: 470 NSL 472
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 22/121 (18%), Positives = 36/121 (29%), Gaps = 4/121 (3%)
Query: 73 SLTLSSMQLSGQLPESLHLCH--SLQSLDLSDNSLSGSIPVDLCKW-LPYVVQLDLSNNH 129
SL Q + + L SL D P V ++L ++
Sbjct: 206 SLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHY 265
Query: 130 LSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARF 189
L +L L+ LS +P + L LK+ ++ N + F
Sbjct: 266 FFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNF 324
Query: 190 P 190
P
Sbjct: 325 P 325
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 18/115 (15%), Positives = 30/115 (26%), Gaps = 12/115 (10%)
Query: 86 PESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLN 145
+ ++ + + L+ IP L L+ S N L L
Sbjct: 5 DQKCIEKEVNKTYNCENLGLN-EIPGTL---PNSTECLEFSFNVLPTIQNTTFSRLINLT 60
Query: 146 KLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGNSGL 200
L L+ ++ RL + N L E + G L
Sbjct: 61 FLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIF--------MAETALSGPKAL 107
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 36/159 (22%), Positives = 58/159 (36%), Gaps = 28/159 (17%)
Query: 7 LASL--LLLSYSLLTVSIEDDVKCLEGIQ------NSIKDPDGRLSWSFTNTTVGAICRL 58
L L L LS+SLL +S E L +Q N + + + S
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG------- 476
Query: 59 TGVACWNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLP 118
R+ L LS LS + + +DLS N L+ S ++ L
Sbjct: 477 -----------RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT-SSSIEALSHLK 524
Query: 119 YVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGS 157
+ L+L++NH+S +P + + L N L +
Sbjct: 525 GIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 26/156 (16%), Positives = 48/156 (30%), Gaps = 18/156 (11%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLP--YVVQLDLSN 127
+ SL L S +S L+ LD +N++ D+ L + L+L+
Sbjct: 130 TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSS-LQQATNLSLNLNG 188
Query: 128 NHLSGPIPPQIVECKFLNKLILSNNKLSGSIP--FEVSRLDRLKEFSVAGNDLSGTIPPD 185
N ++G I P + L + I + S + L + D
Sbjct: 189 NDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE------ 241
Query: 186 LARFPEESFDGNSGLCGKPLGKCGGLSGKNLGIIIA 221
F+G + + + L I +
Sbjct: 242 --DISPAVFEGLCEMSVESI----NLQKHYFFNISS 271
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 53/286 (18%), Positives = 92/286 (32%), Gaps = 73/286 (25%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
A+K L + E F E + + H N+V +G + R ++ + M G L S
Sbjct: 64 AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSF 123
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSN----------- 429
L + L L + + G Y+ N
Sbjct: 124 LRETRPRPSQPSSLAMLDLLHVARDIACGCQ-------------YLEENHFIHRDIAARN 170
Query: 430 --VILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFG--YVAPE------YSSTM 479
+ A+I DFG+AR + + G ++ PE ++S
Sbjct: 171 CLLTCPGPGRVAKIGDFGMARDIYRAS----YYRKGGCAMLPVKWMPPEAFMEGIFTS-- 224
Query: 480 VASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAG----RSRDVV 534
K D + FG++L E+ S G P + V V +G ++
Sbjct: 225 ----KTDTWSFGVLLWEIFSLGYMP---------YPSKSNQEVLEFVTSGGRMDPPKNCP 271
Query: 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
+Y IM C +P+DRP+ + E ++ +
Sbjct: 272 GP-VY------RIMT------QCWQHQPEDRPNFAIILERIEYCTQ 304
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 63/297 (21%), Positives = 116/297 (39%), Gaps = 54/297 (18%)
Query: 309 GVSYKAVLPDASAL----AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE 362
G Y L D A+K L QF +E + HPN++ LLG C+
Sbjct: 39 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98
Query: 363 EE-RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL--HHGCQP 419
E L+V +M +G L + + + G+ ++G+ +L
Sbjct: 99 EGSPLVVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKYLASKK---- 148
Query: 420 PYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM 479
++H+ +++ ++D+ F ++ DFGLAR + ++ G ++A E T
Sbjct: 149 -FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 480 VASLKGDVYGFGIVLLELLS-GQKPL-DVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK- 536
+ K DV+ FG++L EL++ G P DV + + ++ GR + +
Sbjct: 208 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----------ITVYLLQGR---RLLQP 254
Query: 537 -----SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEPY 588
LY E+M C + + RPS ++ + ++ E Y
Sbjct: 255 EYCPDPLY------EVML------KCWHPKAEMRPSFSELVSRISAIFSTF-IGEHY 298
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 61/310 (19%), Positives = 118/310 (38%), Gaps = 76/310 (24%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
AIK + +A +F +E + + + ++V LLG + L++ + M G L S
Sbjct: 59 AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 118
Query: 381 LHGN---GVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF 437
L +N + S +++ + G+A+L+ ++H+ +++ ++ +DF
Sbjct: 119 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF 175
Query: 438 DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV------------APE------YSSTM 479
+I DFG+ R + D Y +PE +++
Sbjct: 176 TVKIGDFGMTRDIYETD--------------YYRKGGKGLLPVRWMSPESLKDGVFTT-- 219
Query: 480 VASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR----DVV 534
DV+ FG+VL E+ + ++P ++G + V V+ G D
Sbjct: 220 ----YSDVWSFGVVLWEIATLAEQP---------YQGLSNEQVLRFVMEGG-LLDKPDNC 265
Query: 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEPYDEFPMI 594
L+ E+M+ C PK RPS ++ S+K E F
Sbjct: 266 PDMLF------ELMR------MCWQYNPKMRPSFLEIISSIKEEMEP---GFREVSFYYS 310
Query: 595 FGKQDPDCKE 604
+ P+ +E
Sbjct: 311 EENKLPEPEE 320
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 53/286 (18%), Positives = 92/286 (32%), Gaps = 73/286 (25%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
A+K L + E F E + + H N+V +G + R ++ + M G L S
Sbjct: 105 AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSF 164
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSN----------- 429
L + L L + + G Y+ N
Sbjct: 165 LRETRPRPSQPSSLAMLDLLHVARDIACGCQ-------------YLEENHFIHRDIAARN 211
Query: 430 --VILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFG--YVAPE------YSSTM 479
+ A+I DFG+AR + + G ++ PE ++S
Sbjct: 212 CLLTCPGPGRVAKIGDFGMARDIYRAG----YYRKGGCAMLPVKWMPPEAFMEGIFTS-- 265
Query: 480 VASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAG----RSRDVV 534
K D + FG++L E+ S G P + V V +G ++
Sbjct: 266 ----KTDTWSFGVLLWEIFSLGYMP---------YPSKSNQEVLEFVTSGGRMDPPKNCP 312
Query: 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
+Y IM C +P+DRP+ + E ++ +
Sbjct: 313 GP-VY------RIMT------QCWQHQPEDRPNFAIILERIEYCTQ 345
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 4e-15
Identities = 46/170 (27%), Positives = 72/170 (42%), Gaps = 19/170 (11%)
Query: 337 FRSEMNRLGQLRHPNLVPLLGFCVVEEERL--LVYKHMPNGTLYSLLHGNGVDNTLSGVL 394
F E++ QL H N+V + V EE+ LV +++ TL + +G L
Sbjct: 58 FEREVHNSSQLSHQNIVSM--IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-------L 108
Query: 395 DWSTRLRIGMGASRGLAWLH-HGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453
T + G+ H +H+ I ILID + +I DFG+A+ +
Sbjct: 109 SVDTAINFTNQILDGIKHAHDMR----IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164
Query: 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKP 503
++ V LG Y +PE + D+Y GIVL E+L G+ P
Sbjct: 165 SLTQTNHV---LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 5e-15
Identities = 58/294 (19%), Positives = 108/294 (36%), Gaps = 87/294 (29%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
AIK L A ++FR E +L+HPN+V LLG ++ +++ + +G L+
Sbjct: 43 AIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEF 102
Query: 381 LHGN---------GVDNTLSGVLDWSTRLRIGMGASRGLAWL--HHGCQPPYMHQYISSN 429
L D T+ L+ + + + G+ +L HH +H+ +++
Sbjct: 103 LVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATR 157
Query: 430 VILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV------------APE--- 474
+L+ D + +I+D GL R V + D Y APE
Sbjct: 158 NVLVYDKLNVKISDLGLFREVYAADY--------------YKLLGNSLLPIRWMAPEAIM 203
Query: 475 ---YSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530
+S D++ +G+VL E+ S G +P ++ V ++ +
Sbjct: 204 YGKFSI------DSDIWSYGVVLWEVFSYGLQPYCGYSNQD---------VVEMIRNRQ- 247
Query: 531 RDVVDK------SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
V+ +Y +M C P RP ++ L++
Sbjct: 248 --VLPCPDDCPAWVY------ALMI------ECWNEFPSRRPRFKDIHSRLRAW 287
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 61/305 (20%), Positives = 114/305 (37%), Gaps = 90/305 (29%)
Query: 323 AIKRLSACKLSEKQ-FRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLL 381
A+K L S +Q F+ E L L+H ++V G C L+V+++M +G L L
Sbjct: 75 AVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL 134
Query: 382 --------HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL--HHGCQPPYMHQYISSNVI 431
G ++ G L L + + G+ +L H ++H+ +++
Sbjct: 135 RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH-----FVHRDLATRNC 189
Query: 432 LIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGY-------------VAPE---- 474
L+ +I DFG++R + S D Y + PE
Sbjct: 190 LVGQGLVVKIGDFGMSRDIYSTD---------------YYRVGGRTMLPIRWMPPESILY 234
Query: 475 --YSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531
+++ + DV+ FG+VL E+ + G++P E + GR
Sbjct: 235 RKFTT------ESDVWSFGVVLWEIFTYGKQPWYQLSNTE---------AIDCITQGR-- 277
Query: 532 DVVDK------SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFS 585
+++ +Y IM+ C P+ R S+ V+ L+++A+
Sbjct: 278 -ELERPRACPPEVY------AIMR------GCWQREPQQRHSIKDVHARLQALAQA---P 321
Query: 586 EPYDE 590
Y +
Sbjct: 322 PVYLD 326
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 69/303 (22%), Positives = 106/303 (34%), Gaps = 89/303 (29%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
A+K L A + F+ E + + +PN+V LLG C V + L++++M G L
Sbjct: 81 AVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF 140
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQ------YISS------ 428
L S L S +S G L Q Q Y+S
Sbjct: 141 LRSMSPHTVCS--LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198
Query: 429 -----NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV------------ 471
N L+ ++ +I DFGL+R + S D Y
Sbjct: 199 DLATRNC-LVGENMVVKIADFGLSRNIYSAD--------------YYKADGNDAIPIRWM 243
Query: 472 APE------YSSTMVASLKGDVYGFGIVLLELLS-GQKP-LDVAGAEEGFKGNLVDWVNH 523
PE Y++ + DV+ +G+VL E+ S G +P +A E V +
Sbjct: 244 PPESIFYNRYTT------ESDVWAYGVVLWEIFSYGLQPYYGMAHEE----------VIY 287
Query: 524 LVIAGRSR----DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMA 579
V G + LY +M+ C P DRPS ++ L+ M
Sbjct: 288 YVRDGN-ILACPENCPLELY------NLMR------LCWSKLPADRPSFCSIHRILQRMC 334
Query: 580 EKH 582
E+
Sbjct: 335 ERA 337
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 61/294 (20%), Positives = 120/294 (40%), Gaps = 55/294 (18%)
Query: 309 GVSYKAVLPDASAL----AIKRLSACKLSEKQ---FRSEMNRLGQLRHPNLVPLLGFCVV 361
G + L A+K + S+++ F SE + HPN++ LLG C+
Sbjct: 48 GSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107
Query: 362 EE-----ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL--H 414
+ +++ M G L++ L + ++ + T L+ + + G+ +L
Sbjct: 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG-PKHIPLQTLLKFMVDIALGMEYLSNR 166
Query: 415 HGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEF--GYVA 472
+ ++H+ +++ ++ DD + DFGL++ + S D + G + + ++A
Sbjct: 167 N-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD----YYRQGRIAKMPVKWIA 217
Query: 473 PEYSSTMVASLKGDVYGFGIVLLELLS-GQKPL-DVAGAEEGFKGNLVDWVNHLVIAGRS 530
E + V + K DV+ FG+ + E+ + G P V E + ++ G
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE----------MYDYLLHGH- 266
Query: 531 R----DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
R + LY EIM SC + P DRP+ + L+ + E
Sbjct: 267 RLKQPEDCLDELY------EIMY------SCWRTDPLDRPTFSVLRLQLEKLLE 308
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 56/305 (18%), Positives = 121/305 (39%), Gaps = 56/305 (18%)
Query: 309 GVSYKAVLPDASAL----AIKRLSACKLSEKQ---FRSEMNRLGQLRHPNLVPLLGFCVV 361
G +A L A+K L A ++ F E + + HP++ L+G +
Sbjct: 37 GSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96
Query: 362 EEER------LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL-- 413
+ +++ M +G L++ L + + L T +R + + G+ +L
Sbjct: 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN-PFNLPLQTLVRFMVDIACGMEYLSS 155
Query: 414 HHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEF--GYV 471
+ ++H+ +++ ++ +D + DFGL+R + S D + G + ++
Sbjct: 156 RN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD----YYRQGCASKLPVKWL 206
Query: 472 APEYSSTMVASLKGDVYGFGIVLLELLS-GQKP-LDVAGAEEGFKGNLVDWVNHLVIAGR 529
A E + + ++ DV+ FG+ + E+++ GQ P + AE + + +I G
Sbjct: 207 ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE----------IYNYLIGGN 256
Query: 530 SR----DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFS 585
R + +Y ++M C + PK RPS + L+++
Sbjct: 257 -RLKQPPECMEEVY------DLMY------QCWSADPKQRPSFTCLRMELENILGHLSVL 303
Query: 586 EPYDE 590
+
Sbjct: 304 STSQD 308
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 58/302 (19%), Positives = 103/302 (34%), Gaps = 102/302 (33%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPNGTLYS 379
A+K L A + SEM + + +H N++ LLG C + ++ ++ G L
Sbjct: 117 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 176
Query: 380 LL---------HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS-- 428
L + ++ + + + +RG+ Y++S
Sbjct: 177 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGME-------------YLASQK 223
Query: 429 ---------NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV-------- 471
NV L+ ++ +I DFGLAR + + D Y
Sbjct: 224 CIHRDLAARNV-LVTENNVMKIADFGLARDINNID--------------YYKKTTNGRLP 268
Query: 472 ----APE------YSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDW 520
APE Y+ + DV+ FG+++ E+ + G P + G V+
Sbjct: 269 VKWMAPEALFDRVYTH------QSDVWSFGVLMWEIFTLGGSP---------YPGIPVEE 313
Query: 521 VNHLVIAGRSR----DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576
+ L+ G R LY +M C + P RP+ Q+ E L
Sbjct: 314 LFKLLKEGH-RMDKPANCTNELY------MMM------RDCWHAVPSQRPTFKQLVEDLD 360
Query: 577 SM 578
+
Sbjct: 361 RI 362
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 60/317 (18%), Positives = 108/317 (34%), Gaps = 103/317 (32%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPNGTLYS 379
A+K L A + SEM + + +H N++ LLG C + ++ ++ G L
Sbjct: 71 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 380 LL---------HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS-- 428
L + ++ + + + +RG+ Y++S
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGME-------------YLASQK 177
Query: 429 ---------NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV-------- 471
NV L+ ++ +I DFGLAR + + D Y
Sbjct: 178 CIHRDLAARNV-LVTENNVMKIADFGLARDINNID--------------YYKKTTNGRLP 222
Query: 472 ----APE------YSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDW 520
APE Y+ + DV+ FG+++ E+ + G P + G V+
Sbjct: 223 VKWMAPEALFDRVYTH------QSDVWSFGVLMWEIFTLGGSP---------YPGIPVEE 267
Query: 521 VNHLVIAGRSR----DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576
+ L+ G R LY +M+ C + P RP+ Q+ E L
Sbjct: 268 LFKLLKEGH-RMDKPANCTNELY------MMMR------DCWHAVPSQRPTFKQLVEDLD 314
Query: 577 SMAEKHGFSEPYDEFPM 593
+ +E Y +
Sbjct: 315 RILTL-TTNEEYLDLSQ 330
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 54/270 (20%), Positives = 99/270 (36%), Gaps = 37/270 (13%)
Query: 323 AIKRLSACKLSEKQ-FRSEMNRLGQLRHPNLVPLLGFCVVEEER----LLVYKHMPNGTL 377
A+KR+ + +++ + E + HPN++ L+ +C+ E L+ GTL
Sbjct: 58 ALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTL 117
Query: 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYI-SSNVILIDDD 436
++ + L L + +G RGL +H Y H+ + +N IL+ D+
Sbjct: 118 WNEIERLKDKGNF---LTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTN-ILLGDE 170
Query: 437 FDARITDFGLARL--VGSRDPNDSSFVHGDLGEFG---YVAPE---YSSTMVASLKGDVY 488
+ D G + + + + Y APE S V + DV+
Sbjct: 171 GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVW 230
Query: 489 GFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIM 548
G VL ++ G+ P D KG+ V L + + +
Sbjct: 231 SLGCVLYAMMFGEGPYD----MVFQKGDSV----ALAVQNQLSIPQSPRHS-----SALW 277
Query: 549 QFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
Q L S + P RP + + L+++
Sbjct: 278 QLLN---SMMTVDPHQRPHIPLLLSQLEAL 304
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 72/312 (23%), Positives = 117/312 (37%), Gaps = 90/312 (28%)
Query: 309 GVSYKAVL---PDASALAIKRL--SACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVE 362
G KA + AIKR+ A K + F E+ L +L HPN++ LLG C
Sbjct: 39 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98
Query: 363 EERLLVYKHMPNGTLYSLLHGN---------GVDNTLSGVLDWSTRLRIGMGASRGLAWL 413
L ++ P+G L L + + N+ + L L +RG
Sbjct: 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG---- 154
Query: 414 HHGCQPPYMHQYISS-----------NVILIDDDFDARITDFGLARLVGSRDPNDSSFVH 462
M Y+S N+ L+ +++ A+I DFGL+R +V
Sbjct: 155 --------M-DYLSQKQFIHRDLAARNI-LVGENYVAKIADFGLSR-------GQEVYVK 197
Query: 463 GDLGEF--GYVAPE------YSSTMVASLKGDVYGFGIVLLELLS-GQKPL-DVAGAEEG 512
+G ++A E Y++ DV+ +G++L E++S G P + AE
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTT------NSDVWSYGVLLWEIVSLGGTPYCGMTCAE-- 249
Query: 513 FKGNLVDWVNHLVIAGRSR----DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSM 568
+ + G R D +Y ++M+ C +P +RPS
Sbjct: 250 --------LYEKLPQGY-RLEKPLNCDDEVY------DLMR------QCWREKPYERPSF 288
Query: 569 YQVYESLKSMAE 580
Q+ SL M E
Sbjct: 289 AQILVSLNRMLE 300
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 60/303 (19%), Positives = 101/303 (33%), Gaps = 89/303 (29%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
A+K L +A + SE N L Q+ HP+++ L G C + LL+ ++ G+L
Sbjct: 57 AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF 116
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQ------YISS------ 428
L + S L G + Q Y++
Sbjct: 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERA--LTMGDLISFAWQISQGMQYLAEMKLVHR 174
Query: 429 -----NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV------------ 471
N+ L+ + +I+DFGL+R V D YV
Sbjct: 175 DLAARNI-LVAEGRKMKISDFGLSRDVYEED--------------SYVKRSQGRIPVKWM 219
Query: 472 APE------YSSTMVASLKGDVYGFGIVLLELLS-GQKPL-DVAGAEEGFKGNLVDWVNH 523
A E Y++ + DV+ FG++L E+++ G P + + +
Sbjct: 220 AIESLFDHIYTT------QSDVWSFGVLLWEIVTLGGNPYPGIPPER----------LFN 263
Query: 524 LVIAGRSR----DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMA 579
L+ G R D + +Y +M C P RP + + L+ M
Sbjct: 264 LLKTGH-RMERPDNCSEEMY------RLML------QCWKQEPDKRPVFADISKDLEKMM 310
Query: 580 EKH 582
K
Sbjct: 311 VKR 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 27/121 (22%), Positives = 45/121 (37%), Gaps = 11/121 (9%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKW--------LPYVVQLDL 125
LTL+ L LP S+ + L+ L + +P L L + L L
Sbjct: 132 LTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRL 190
Query: 126 SNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPD 185
+ +P I + L L + N+ LS ++ + L +L+E + G PP
Sbjct: 191 EWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPI 248
Query: 186 L 186
Sbjct: 249 F 249
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 30/117 (25%), Positives = 56/117 (47%), Gaps = 5/117 (4%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
SL L + LP S+ +L+SL + ++ LS ++ + LP + +LDL
Sbjct: 187 SLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHH-LPKLEELDLRGCTALR 243
Query: 133 PIPPQIVECKFLNKLILSN-NKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLAR 188
PP L +LIL + + L ++P ++ RL +L++ + G +P +A+
Sbjct: 244 NYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 25/121 (20%), Positives = 44/121 (36%), Gaps = 4/121 (3%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSN-NHLS 131
SL + + LS L ++H L+ LDL + + P + +L L + ++L
Sbjct: 210 SLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGG-RAPLKRLILKDCSNLL 267
Query: 132 GPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE 191
+P I L KL L +P +++L V + + P
Sbjct: 268 T-LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPA 326
Query: 192 E 192
E
Sbjct: 327 E 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 23/136 (16%), Positives = 48/136 (35%), Gaps = 6/136 (4%)
Query: 64 WNEKENRIISLTLSSMQLSGQLPESLHLCHS--LQSLDLSDNSLSGSIPVDLCKWLPYVV 121
W + + + + + + L +L+L L P + L ++
Sbjct: 50 WRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR-LSHLQ 107
Query: 122 QLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGT 181
+ + L +P + + L L L+ N L ++P ++ L+RL+E S+
Sbjct: 108 HMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTE 165
Query: 182 IPPDLARFPEESFDGN 197
+P LA
Sbjct: 166 LPEPLASTDASGEHQG 181
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 24/122 (19%), Positives = 50/122 (40%), Gaps = 14/122 (11%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGP 133
+T+ + L +LP+++ L++L L+ N L ++P + L + +L +
Sbjct: 109 MTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIAS-LNRLRELSIRACPELTE 165
Query: 134 IPPQIVECKF---------LNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP 184
+P + L L L + S+P ++ L LK + + LS + P
Sbjct: 166 LPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGP 223
Query: 185 DL 186
+
Sbjct: 224 AI 225
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-11
Identities = 25/131 (19%), Positives = 47/131 (35%), Gaps = 14/131 (10%)
Query: 67 KENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLS 126
+ ++L L S+ L Q P+ LQ + + L +P + + + L L+
Sbjct: 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQ-FAGLETLTLA 135
Query: 127 NNHLSGPIPPQIVECKFLNKLILS-NNKL--------SGSIPFEVSRLDRLKEFSVAGND 177
N L +P I L +L + +L S E L L+ +
Sbjct: 136 RNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTG 194
Query: 178 LSGTIPPDLAR 188
+ ++P +A
Sbjct: 195 IR-SLPASIAN 204
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 15/128 (11%), Positives = 31/128 (24%), Gaps = 22/128 (17%)
Query: 83 GQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKW----------------LPYVVQLDLS 126
G H ++L ++ L +W +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 127 NNHLSG--PIPPQIVECKFLN--KLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTI 182
+ + L L + L P + RL L+ ++ L +
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 183 PPDLARFP 190
P + +F
Sbjct: 120 PDTMQQFA 127
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 47/187 (25%), Positives = 76/187 (40%), Gaps = 21/187 (11%)
Query: 323 AIKRLSACKLSEKQFRSEMNR----LGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378
A+K +S S+ FR+ M R G+L+ P++VP+ F ++ + + + + L
Sbjct: 63 ALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLA 122
Query: 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQYIS-SNVILIDDD 436
++L G L + I L H G H+ + N IL+ D
Sbjct: 123 AMLRRQGP-------LAPPRAVAIVRQIGSALDAAHAAG----ATHRDVKPEN-ILVSAD 170
Query: 437 FDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLE 496
A + DFG+A +G Y+APE S A+ + D+Y VL E
Sbjct: 171 DFAYLVDFGIASATTDEKLTQLGNT---VGTLYYMAPERFSESHATYRADIYALTCVLYE 227
Query: 497 LLSGQKP 503
L+G P
Sbjct: 228 CLTGSPP 234
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 25/118 (21%), Positives = 45/118 (38%), Gaps = 4/118 (3%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
++ L++ +++ +Q LDL N + +L + L+L N +
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP 190
+ Q+V L L LS+NKL+ + E + S+ N L I L
Sbjct: 184 -VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 22/100 (22%), Positives = 38/100 (38%), Gaps = 4/100 (4%)
Query: 85 LPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFL 144
+ E + + ++D+SL L + V +LDLS N LS + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 145 NKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP 184
L LS+N L ++ L L+ + N + +
Sbjct: 61 ELLNLSSNVLYETLDL--ESLSTLRTLDLNNNYVQ-ELLV 97
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 26/118 (22%), Positives = 43/118 (36%), Gaps = 9/118 (7%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNN 128
NR ++ L L +++ LDLS N LS I + L+LS+N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLSSN 68
Query: 129 HLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
L + L L L+NN + E+ ++ A N++S +
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR 118
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 24/114 (21%), Positives = 50/114 (43%), Gaps = 11/114 (9%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L LSS L + + L +L++LDL++N + + V P + L +NN++S
Sbjct: 62 LLNLSSNVLY-ETLDLESL-STLRTLDLNNNYVQ-ELLV-----GPSIETLHAANNNISR 113
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
+ + + L+NNK++ + R++ + N++ +L
Sbjct: 114 -VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 17/130 (13%), Positives = 33/130 (25%), Gaps = 6/130 (4%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNN 128
+ ++L + +L + ++L +L+ DL N D V ++
Sbjct: 214 AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV--QTVAKQ 270
Query: 129 HLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLAR 188
+ EC DRL + L + R
Sbjct: 271 TVKKLTGQNEEECTVPTLGHYGAYCCE---DLPAPFADRLIALKRKEHALLSGQGSETER 327
Query: 189 FPEESFDGNS 198
E +
Sbjct: 328 LECERENQAR 337
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 60/301 (19%), Positives = 105/301 (34%), Gaps = 84/301 (27%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPNGTLYS 379
A+K L A + SEM + + +H N++ LLG C + ++ ++ G L
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164
Query: 380 LL---------HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL--HHGCQPPYMHQYISS 428
L + + L + +RG+ +L +H+ +++
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAA 219
Query: 429 NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV------------APE-- 474
+L+ +D +I DFGLAR + D Y APE
Sbjct: 220 RNVLVTEDNVMKIADFGLARDIHHID--------------YYKKTTNGRLPVKWMAPEAL 265
Query: 475 ----YSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529
Y+ + DV+ FG++L E+ + G P + G V+ + L+ G
Sbjct: 266 FDRIYTH------QSDVWSFGVLLWEIFTLGGSP---------YPGVPVEELFKLLKEGH 310
Query: 530 SR----DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFS 585
R LY +M+ C + P RP+ Q+ E L +
Sbjct: 311 -RMDKPSNCTNELY------MMMR------DCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357
Query: 586 E 586
E
Sbjct: 358 E 358
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 67/293 (22%), Positives = 112/293 (38%), Gaps = 81/293 (27%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPNGTLYS 379
A+K L +A ++ SE+ + L +H N+V LLG C L++ ++ G L +
Sbjct: 80 AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 380 LLHGNGVDNTLSGVLDWSTR-------LRIGMGASRGLAWLHHGCQPPYMHQYISS---- 428
L + L ++G+A +++S
Sbjct: 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMA-------------FLASKNCI 186
Query: 429 -------NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEF--GYVAPE----- 474
NV L+ + A+I DFGLAR + NDS+++ ++APE
Sbjct: 187 HRDVAARNV-LLTNGHVAKIGDFGLARDIM----NDSNYIVKGNARLPVKWMAPESIFDC 241
Query: 475 -YSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDW-VNHLVIAGRSR 531
Y+ + DV+ +GI+L E+ S G P + G LV+ LV G +
Sbjct: 242 VYTV------QSDVWSYGILLWEIFSLGLNP---------YPGILVNSKFYKLVKDGY-Q 285
Query: 532 ----DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
K++Y IMQ +C P RP+ Q+ L+ A+
Sbjct: 286 MAQPAFAPKNIY------SIMQ------ACWALEPTHRPTFQQICSFLQEQAQ 326
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 62/299 (20%), Positives = 108/299 (36%), Gaps = 52/299 (17%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSEKQFR----SEMNRLGQLRHPNLVPLLGFCVVEE 363
Y+A L D +A+K++ L + + R E++ L QL HPN++ +E+
Sbjct: 46 SEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA-SFIED 104
Query: 364 ERLLVYKHM---PNGTLYSLLHGNGVDNTL---SGVLDWSTRLRIGMGASRGLAWLHHGC 417
L + + G L ++ L V + +L L +H
Sbjct: 105 NELNIV--LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL------CSALEHMH--- 153
Query: 418 QPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFG---YVAPE 474
MH+ I + I ++ D GL R S+ S V G Y++PE
Sbjct: 154 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-------GTPYYMSPE 206
Query: 475 YSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV- 533
+ K D++ G +L E+ + Q P F G+ ++ + L D
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP---------FYGDKMNLYS-LCKKIEQCDYP 256
Query: 534 -VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEPYDEF 591
+ Y +E+ Q + C+ P+ RP + VY+ K M S +
Sbjct: 257 PLPSDHY----SEELRQLVN---MCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHH 308
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 5e-13
Identities = 58/281 (20%), Positives = 104/281 (37%), Gaps = 53/281 (18%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSEK---QFRSEMNRLGQLRHPNLVPLLGFCVVEEE 364
G K D L K L ++E SE+N L +L+HPN+V +++
Sbjct: 20 GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD-RIIDRT 78
Query: 365 RLLVYKHM---PNGTLYSLLHGNGVDNTL---SGVLDWSTRLRIGMGASRGLAWLHHGCQ 418
+Y M G L S++ + VL T+L + L H
Sbjct: 79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL------TLALKECHRRSD 132
Query: 419 PPY--MHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE-- 474
+ +H+ + + +D + ++ DFGLAR++ +FV G Y++PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV----GTPYYMSPEQM 188
Query: 475 ----YSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530
Y+ K D++ G +L EL + P F + + G+
Sbjct: 189 NRMSYNE------KSDIWSLGCLLYELCALMPP---------FTAFSQKELAGKIREGKF 233
Query: 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQV 571
R + Y DE+ + + + + RPS+ ++
Sbjct: 234 RRI--PYRY----SDELNEIIT---RMLNLKDYHRPSVEEI 265
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 9e-13
Identities = 23/116 (19%), Positives = 51/116 (43%), Gaps = 10/116 (8%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNN 128
+++ +L + + + + ++L ++ S+N L+ P+ K L +V + ++NN
Sbjct: 46 DQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITPL---KNLTKLVDILMNNN 100
Query: 129 HLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP 184
++ P + L L L NN+++ P L L ++ N +S I
Sbjct: 101 QIADITP--LANLTNLTGLTLFNNQITDIDPL--KNLTNLNRLELSSNTISD-ISA 151
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 30/111 (27%), Positives = 49/111 (44%), Gaps = 9/111 (8%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L +SS ++S L +L+SL ++N +S P+ + L +L L+ N L
Sbjct: 181 RLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILTNL---DELSLNGNQLKD 235
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183
+ L L L+NN++S P S L +L E + N +S P
Sbjct: 236 IGT--LASLTNLTDLDLANNQISNLAPL--SGLTKLTELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 40/172 (23%), Positives = 65/172 (37%), Gaps = 16/172 (9%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L + Q+S L +L +L+L++N L P+ K L L L N++S
Sbjct: 269 ELKLGANQISN--ISPLAGLTALTNLELNENQLEDISPISNLKNL---TYLTLYFNNISD 323
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP-PDLARFPE 191
P + L +L NNK+S + L + S N +S P +L R +
Sbjct: 324 ISP--VSSLTKLQRLFFYNNKVSDVSSL--ANLTNINWLSAGHNQISDLTPLANLTRITQ 379
Query: 192 ESFDGNSGLCGKPLGKCGGLSGKNL-----GIIIAAGVLGALGSIILGFLIW 238
+ + P+ +S N G +IA + GS + W
Sbjct: 380 LGLNDQA-WTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITW 430
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 9e-11
Identities = 30/108 (27%), Positives = 41/108 (37%), Gaps = 9/108 (8%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L++ Q+S L L L L N +S P+ L L+L+ N L
Sbjct: 247 DLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTAL---TNLELNENQLED 301
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSG 180
P I K L L L N +S P S L +L+ N +S
Sbjct: 302 ISP--ISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFYNNKVSD 345
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 9e-10
Identities = 19/113 (16%), Positives = 42/113 (37%), Gaps = 9/113 (7%)
Query: 71 IISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL 130
+ L ++ S + +L + V+ L Q++ SNN L
Sbjct: 26 KMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKSIDGVEYLNNL---TQINFSNNQL 80
Query: 131 SGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183
+ P + L ++++NN+++ P + L L ++ N ++ P
Sbjct: 81 TDITP--LKNLTKLVDILMNNNQIADITPL--ANLTNLTGLTLFNNQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 14/97 (14%), Positives = 31/97 (31%), Gaps = 7/97 (7%)
Query: 87 ESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNK 146
+ L +++ ++ L V L + + L +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLGIK--SIDGVEYLNNLTQ 72
Query: 147 LILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183
+ SNN+L+ P L +L + + N ++ P
Sbjct: 73 INFSNNQLTDITPL--KNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 30/124 (24%), Positives = 51/124 (41%), Gaps = 16/124 (12%)
Query: 69 NRIISLT-------LSSMQLSGQL--PESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPY 119
N I ++ L + Q+ + L +L+ LD+S N +S L K L
Sbjct: 144 NTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD--ISVLAK-LTN 200
Query: 120 VVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
+ L +NN +S P + L++L L+ N+L + L L + +A N +S
Sbjct: 201 LESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTL--ASLTNLTDLDLANNQIS 256
Query: 180 GTIP 183
P
Sbjct: 257 NLAP 260
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 27/111 (24%), Positives = 47/111 (42%), Gaps = 10/111 (9%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
LTL + Q++ + L +L L+LS N++S + L QL N ++
Sbjct: 116 GLTLFNNQITD--IDPLKNLTNLNRLELSSNTISDISALSGLTSL---QQLSFGNQ-VTD 169
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183
P + L +L +S+NK+S ++L L+ N +S P
Sbjct: 170 LKP--LANLTTLERLDISSNKVSDISVL--AKLTNLESLIATNNQISDITP 216
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 20/109 (18%), Positives = 34/109 (31%), Gaps = 7/109 (6%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L + ++S SL ++ L N +S P+ L + QL L++ +
Sbjct: 335 RLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPL---ANLTRITQLGLNDQAWTN 389
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGT 181
N + L P +S E + N S T
Sbjct: 390 APVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 15/90 (16%), Positives = 33/90 (36%), Gaps = 6/90 (6%)
Query: 94 SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNK 153
L S ++ ++ I D L ++ L +++ + + + L
Sbjct: 2 PLGSATITQDTPINQIFTD--TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG 57
Query: 154 LSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183
+ SI V L+ L + + + N L+ P
Sbjct: 58 IK-SID-GVEYLNNLTQINFSNNQLTDITP 85
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 28/194 (14%), Positives = 52/194 (26%), Gaps = 21/194 (10%)
Query: 323 AIKRLSACKLSEKQ-FRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLL 381
+K E M RL + + + +LV + GTL + +
Sbjct: 99 VLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAI 158
Query: 382 HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-----HG---CQPPYMHQYISSNVILI 433
N NT V+ + M + +H HG +
Sbjct: 159 --NLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216
Query: 434 DDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA----SLKGDVYG 489
D + D G + + G+ E M++ + + D +G
Sbjct: 217 DLSAGLALIDLGQSIDMKLFPKGT--IFTAKCETSGFQCVE----MLSNKPWNYQIDYFG 270
Query: 490 FGIVLLELLSGQKP 503
+ +L G
Sbjct: 271 VAATVYCMLFGTYM 284
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 62/305 (20%), Positives = 102/305 (33%), Gaps = 105/305 (34%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPNGTLYS 379
A+K L SA + SE+ L L H N+V LLG C + L++ ++ G L +
Sbjct: 57 AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 116
Query: 380 LL-----------HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS 428
L + LD L ++G+A +++S
Sbjct: 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA-------------FLAS 163
Query: 429 -----------NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV------ 471
N IL+ +I DFGLAR + + YV
Sbjct: 164 KNCIHRDLAARN-ILLTHGRITKICDFGLARDIKNDS--------------NYVVKGNAR 208
Query: 472 ------APE------YSSTMVASLKGDVYGFGIVLLELLS-GQKP-LDVAGAEEGFKGNL 517
APE Y+ + DV+ +GI L EL S G P + +
Sbjct: 209 LPVKWMAPESIFNCVYTF------ESDVWSYGIFLWELFSLGSSPYPGMPVDSK------ 256
Query: 518 VDWVNHLVIAGRSR----DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573
++ G R + +Y +IM+ +C + P RP+ Q+ +
Sbjct: 257 ---FYKMIKEGF-RMLSPEHAPAEMY------DIMK------TCWDADPLKRPTFKQIVQ 300
Query: 574 SLKSM 578
++
Sbjct: 301 LIEKQ 305
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 58/304 (19%), Positives = 92/304 (30%), Gaps = 98/304 (32%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPNGTLYS 379
A+K L A + SE+ + QL H N+V LLG C + L++++ G L +
Sbjct: 79 AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 138
Query: 380 LLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQ----------YISS- 428
L + + + + L + ++
Sbjct: 139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVL-------TFEDLLCFAYQVAKGMEFLEFK 191
Query: 429 ----------NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV------- 471
N +L+ +I DFGLAR + S YV
Sbjct: 192 SCVHRDLAARN-VLVTHGKVVKICDFGLARDIMSDS--------------NYVVRGNARL 236
Query: 472 -----APE------YSSTMVASLKGDVYGFGIVLLELLS-GQKPL-DVAGAEEGFKGNLV 518
APE Y+ K DV+ +GI+L E+ S G P +
Sbjct: 237 PVKWMAPESLFEGIYTI------KSDVWSYGILLWEIFSLGVNPYPGIPVDAN------- 283
Query: 519 DWVNHLVIAGRSR----DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574
L+ G + + +Y IMQ SC + RPS +
Sbjct: 284 --FYKLIQNGF-KMDQPFYATEEIY------IIMQ------SCWAFDSRKRPSFPNLTSF 328
Query: 575 LKSM 578
L
Sbjct: 329 LGCQ 332
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 28/130 (21%), Positives = 49/130 (37%), Gaps = 15/130 (11%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
+ + QL+ LPE SL+ L + +N L+ +P + + LD+S N L
Sbjct: 144 YINADNNQLT-MLPELPT---SLEVLSVRNNQLT-FLP----ELPESLEALDVSTNLLES 194
Query: 133 PIPPQIVECKFLNK----LILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLAR 188
+P V + N+++ IP + LD + N LS I L++
Sbjct: 195 -LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252
Query: 189 FPEESFDGNS 198
+
Sbjct: 253 QTAQPDYHGP 262
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 28/116 (24%), Positives = 52/116 (44%), Gaps = 17/116 (14%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L+ + LS LP++L + L+++ N+L S+P + LD +N LS
Sbjct: 63 ELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPAS----LEYLDACDNRLST 114
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLAR 188
+P K L+ + NN+L+ +P + L+ + + N L+ +P
Sbjct: 115 -LPELPASLKHLD---VDNNQLT-MLPELPALLEYI---NADNNQLT-MLPELPTS 161
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 27/116 (23%), Positives = 47/116 (40%), Gaps = 9/116 (7%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKW---LPYVVQLDLSNNH 129
L++ + QL+ LPE SL++LD+S N L S+P + + N
Sbjct: 164 VLSVRNNQLT-FLPELPE---SLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENR 218
Query: 130 LSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPD 185
++ IP I+ +IL +N LS I +S+ ++ S +
Sbjct: 219 ITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 28/118 (23%), Positives = 44/118 (37%), Gaps = 19/118 (16%)
Query: 76 LSSMQLSG----QLPESLHLCH--SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129
L G + L C L L+ +LS S+P +L + L+++ N
Sbjct: 36 WEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNLPPQI---TVLEITQNA 91
Query: 130 LSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLA 187
L +P L L +N+LS ++P LK V N L+ +P A
Sbjct: 92 LI-SLPELPAS---LEYLDACDNRLS-TLP---ELPASLKHLDVDNNQLT-MLPELPA 140
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 12/98 (12%), Positives = 27/98 (27%), Gaps = 4/98 (4%)
Query: 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSN 127
E I +++ +PE++ ++ L DN LS S +
Sbjct: 206 EETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGPR 263
Query: 128 NHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRL 165
+ + + +VS++
Sbjct: 264 IYF--SMSDGQQNTLHRPLADAVTAWFPENKQSDVSQI 299
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 27/116 (23%), Positives = 47/116 (40%), Gaps = 15/116 (12%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L + +L+ LP L+ L +S N L+ S+PV + +L +S N L+
Sbjct: 205 KLWAYNNRLT-SLPALPS---GLKELIVSGNRLT-SLPVLPSEL----KELMVSGNRLTS 255
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLAR 188
+P L+ + N+L+ +P + L ++ GN LS R
Sbjct: 256 -LPMLPSGLLSLS---VYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALR 305
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 24/98 (24%), Positives = 44/98 (44%), Gaps = 10/98 (10%)
Query: 91 LCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILS 150
L + L++ ++ L+ ++P L + L + +N+L+ +P E L L +S
Sbjct: 38 LNNGNAVLNVGESGLT-TLPDCLPAHI---TTLVIPDNNLTS-LPALPPE---LRTLEVS 89
Query: 151 NNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLAR 188
N+L+ S+P L L FS L +P L +
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCK 125
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 33/129 (25%), Positives = 53/129 (41%), Gaps = 24/129 (18%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCK-------------WLPY 119
+L +S QL+ LP L L ++P LCK P
Sbjct: 85 TLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPG 142
Query: 120 VVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
+ +L +S+N L+ +P L KL NN+L+ S+P L+E SV+ N L+
Sbjct: 143 LQELSVSDNQLAS-LPALP---SELCKLWAYNNQLT-SLPML---PSGLQELSVSDNQLA 194
Query: 180 GTIPPDLAR 188
++P +
Sbjct: 195 -SLPTLPSE 202
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 35/114 (30%), Positives = 53/114 (46%), Gaps = 18/114 (15%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L + QL+ LP LQ L +SDN L+ S+P + +L NN L+
Sbjct: 165 KLWAYNNQLT-SLPMLPS---GLQELSVSDNQLA-SLPTLPSEL----YKLWAYNNRLT- 214
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
+P L +LI+S N+L+ S+P S L L V+GN L+ ++P
Sbjct: 215 SLPALPSG---LKELIVSGNRLT-SLPVLPSELKEL---MVSGNRLT-SLPMLP 260
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 21/100 (21%), Positives = 39/100 (39%), Gaps = 10/100 (10%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L +S +L+ LP L+ L +S N L+ S+P+ + L + N L+
Sbjct: 225 ELIVSGNRLT-SLPVLPS---ELKELMVSGNRLT-SLPMLPSGL----LSLSVYRNQLTR 275
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFS 172
+P ++ + L N LS + + +S
Sbjct: 276 -LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYS 314
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 20/99 (20%), Positives = 38/99 (38%), Gaps = 4/99 (4%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
SL++ QL+ +LPESL S +++L N LS + + + S +
Sbjct: 265 SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAP--GYSGPIIRF 320
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEF 171
+ + + + + L + E + DR F
Sbjct: 321 DMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMF 359
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 55/285 (19%), Positives = 96/285 (33%), Gaps = 46/285 (16%)
Query: 323 AIKRLSACKL-SEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEER-------LLVYKHMP 373
A+KRL + + + E+ + +L HPN+V + +E L+ +
Sbjct: 57 ALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC 116
Query: 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI 433
G L L G L T L+I R + +H +PP +H+ + +L+
Sbjct: 117 KGQLVEFL----KKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLL 171
Query: 434 DDDFDARITDFGLARLV-----GSRDPNDSSFVHGDLGEFG---YVAPE---YSSTMVAS 482
+ ++ DFG A + S + V ++ Y PE S
Sbjct: 172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG 231
Query: 483 LKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRG 542
K D++ G +L L Q P F+ L I +
Sbjct: 232 EKQDIWALGCILYLLCFRQHP---------FEDG-----AKLRIVNGKYSIPPHDTQYTV 277
Query: 543 NDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEP 587
I L+V P++R S+ +V L+ +A +
Sbjct: 278 FHSLIRAMLQV-------NPEERLSIAEVVHQLQEIAAARNVNPK 315
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 32/122 (26%), Positives = 47/122 (38%), Gaps = 11/122 (9%)
Query: 73 SLTLSSMQLSGQLPESLHLCH--SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL 130
+ LS +L L L LQ L L+ N S P + QL L N L
Sbjct: 405 LIHLSENRLE-NLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENML 463
Query: 131 SGPIPPQIVECKF-----LNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPP 184
++ F L L L++N L+ S+P V S L L+ S+ N L+ +
Sbjct: 464 QLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLT-VLSH 521
Query: 185 DL 186
+
Sbjct: 522 ND 523
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 27/126 (21%), Positives = 47/126 (37%), Gaps = 4/126 (3%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLS-GSIPVDLCKWLPYVVQLDLSNN 128
+ L L S ++ P++ L L L LS + + L + +LDLS N
Sbjct: 74 NLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKN 133
Query: 129 HLSG-PIPPQIVECKFLNKLILSNNKLSGSIP--FEVSRLDRLKEFSVAGNDLSGTIPPD 185
+ + P + L + S+N++ E + L FS+A N L + D
Sbjct: 134 QIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVD 193
Query: 186 LARFPE 191
+
Sbjct: 194 WGKCMN 199
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 23/118 (19%), Positives = 39/118 (33%), Gaps = 4/118 (3%)
Query: 71 IISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL 130
L LS + S LQ L+L +I + + LP + LDL ++ +
Sbjct: 26 TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85
Query: 131 SGPIPPQI-VECKFLNKLILSNNKLSGSI--PFEVSRLDRLKEFSVAGNDLSGTIPPD 185
+ P L +L L LS ++ L L ++ N +
Sbjct: 86 YF-LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHP 142
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 21/116 (18%), Positives = 42/116 (36%), Gaps = 3/116 (2%)
Query: 65 NEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLD 124
+ + L LS + L+ L+L+ N ++ I + L + L+
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLN 320
Query: 125 LSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLS 179
LS N L + + L N ++ I + L++L+ + N L+
Sbjct: 321 LSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 31/147 (21%), Positives = 54/147 (36%), Gaps = 27/147 (18%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVV------------ 121
+ L ++ ++ LQ+LDL DN+L+ + +P +
Sbjct: 343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT---IHFIPSIPDIFLSGNKLVTLPKI 399
Query: 122 -----QLDLSNNHLSG-PIPPQIVECKFLNKLILSNNKLSGSIPFEV--SRLDRLKEFSV 173
+ LS N L I ++ L LIL+ N+ S S + S L++ +
Sbjct: 400 NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFL 458
Query: 174 AGNDLSGTIPPDLARFPEESFDGNSGL 200
N L +L + F+G S L
Sbjct: 459 GENMLQLAWETEL---CWDVFEGLSHL 482
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 19/109 (17%), Positives = 34/109 (31%), Gaps = 14/109 (12%)
Query: 93 HSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNN 152
+ +L+ +P L +L LS N++ + L L L +
Sbjct: 4 FDGRIAFYRFCNLT-QVPQVL----NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQ 58
Query: 153 KLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGNSGL 200
+I E L L+ + + + + PD F G L
Sbjct: 59 YTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDA-------FQGLFHL 99
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 22/114 (19%), Positives = 42/114 (36%), Gaps = 7/114 (6%)
Query: 73 SLTLSSMQLSGQL--PESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL 130
L L LS + +L LDLS N + L + +D S+N +
Sbjct: 101 ELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160
Query: 131 SGPIPPQI---VECKFLNKLILSNNKLSGSIPFEVSR-LDRLKEFSVAGNDLSG 180
+ ++ K L+ L+ N L + + + ++ + + D+SG
Sbjct: 161 FL-VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG 213
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 32/189 (16%), Positives = 62/189 (32%), Gaps = 31/189 (16%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L+L+S +L+ L + L +L+ LD+S N L + D+ L + D+++N
Sbjct: 508 GLSLNSNRLT-VLSHN-DLPANLEILDISRNQLL-APNPDVFVSLSVL---DITHNKFIC 561
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEE 192
F+N L +N ++G D+ P +
Sbjct: 562 ECELS----TFINWLNHTNVTIAGPP-----------------ADIYCVYPDSFSGVSLF 600
Query: 193 SFDGNSGLCGKPLGKCGGLSGKNLGIIIAAGVLGALGSIILGFLIWWWFFVRVSKKKRGY 252
S + L +L I+ + L +I+ + F+ +R
Sbjct: 601 SLSTEGCDEEEVLKSLKF----SLFIVCTVTLTLFLMTILTVTKFRGFCFICYKTAQRLV 656
Query: 253 GADSGKDDS 261
D +
Sbjct: 657 FKDHPQGTE 665
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 25/147 (17%), Positives = 47/147 (31%), Gaps = 22/147 (14%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L LS + + + L+ LD ++L + L ++ LD+S+ H
Sbjct: 377 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 133 PIPPQIVE-CKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPD----- 185
I L L ++ N + ++ + L L ++ L + P
Sbjct: 436 -AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSL 493
Query: 186 ------------LARFPEESFDGNSGL 200
L P+ FD + L
Sbjct: 494 SSLQVLNMASNQLKSVPDGIFDRLTSL 520
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 29/113 (25%), Positives = 43/113 (38%), Gaps = 1/113 (0%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
+L LS L S LQ LDLS + +I + L ++ L L+ N +
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS 90
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPD 185
L KL+ L+ F + L LKE +VA N + P+
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 26/112 (23%), Positives = 45/112 (40%), Gaps = 4/112 (3%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGP 133
L +S + SL+ L ++ NS + D+ L + LDLS L
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ- 484
Query: 134 IPPQI-VECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIP 183
+ P L L +++N+L S+P + RL L++ + N + P
Sbjct: 485 LSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 25/119 (21%), Positives = 48/119 (40%), Gaps = 5/119 (4%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129
+ L+ + + G +S SL+ LDLS N + ++ + L + LD +++
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLG-LEQLEHLDFQHSN 407
Query: 130 LSGPIPPQIV--ECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
L + V + L L +S+ + + L L+ +AGN PD+
Sbjct: 408 LKQ-MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 24/127 (18%), Positives = 48/127 (37%), Gaps = 6/127 (4%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL-S 131
+L L+ + + SLQ L + +L+ S+ L + +L++++N + S
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQS 138
Query: 132 GPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE 191
+P L L LS+NK+ ++ L ++ DLS +
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP-LLNLSLDLSLN---PMNFIQP 194
Query: 192 ESFDGNS 198
+F
Sbjct: 195 GAFKEIR 201
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 23/110 (20%), Positives = 42/110 (38%), Gaps = 5/110 (4%)
Query: 76 LSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIP 135
+ ++P++L S ++LDLS N L + P + LDLS +
Sbjct: 14 CMELNFY-KIPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 136 PQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPD 185
L+ LIL+ N + S L L++ +L+ ++
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENF 118
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 22/105 (20%), Positives = 32/105 (30%), Gaps = 14/105 (13%)
Query: 97 SLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSG 156
+ + + IP +L LDLS N L L L LS ++
Sbjct: 11 TYQCMELNFY-KIPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ- 65
Query: 157 SIPFEV-SRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGNSGL 200
+I L L + GN + +F G S L
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQ--------SLALGAFSGLSSL 102
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 27/201 (13%), Positives = 58/201 (28%), Gaps = 30/201 (14%)
Query: 11 LLLSYSLLTVSIEDDVKCLEGIQN-SIKDPDGRLSWSFTNTTVGAICRLTGVACWNEKEN 69
L L + ++++ C++G+ + + N L G+ +E
Sbjct: 205 LTLRNNFDSLNVMKT--CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVV-------- 121
R+ L + + + ++ S L ++ ++
Sbjct: 263 RLAYLDYYLDDI----IDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQ 318
Query: 122 ----------QLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLS--GSIPFEVSRLDRLK 169
+L ++N V+ L L LS N LS G LK
Sbjct: 319 FPTLKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 170 EFSVAGNDLSGTIPPDLARFP 190
++ N + T+ +
Sbjct: 377 YLDLSFNGVI-TMSSNFLGLE 396
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 58/312 (18%), Positives = 100/312 (32%), Gaps = 104/312 (33%)
Query: 323 AIKRL--SACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEE-RLLVYKHMPNGTLY 378
A+K L A + SE+ L + H N+V LLG C +++ + G L
Sbjct: 61 AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 120
Query: 379 SLL---------HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS- 428
+ L + ++ L + ++G+ +++S
Sbjct: 121 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME-------------FLASR 167
Query: 429 ----------NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV------- 471
N+ L+ + +I DFGLAR + YV
Sbjct: 168 KCIHRDLAARNI-LLSEKNVVKICDFGLARDIYKDP--------------DYVRKGDARL 212
Query: 472 -----APE------YSSTMVASLKGDVYGFGIVLLELLS-GQKPL-DVAGAEEGFKGNLV 518
APE Y+ + DV+ FG++L E+ S G P V EE
Sbjct: 213 PLKWMAPETIFDRVYTI------QSDVWSFGVLLWEIFSLGASPYPGVKIDEE------- 259
Query: 519 DWVNHLVIAGRSR----DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574
+ G R D +Y + M C P RP+ ++ E
Sbjct: 260 --FCRRLKEGT-RMRAPDYTTPEMY------QTML------DCWHGEPSQRPTFSELVEH 304
Query: 575 LKSMAEKHGFSE 586
L ++ + + +
Sbjct: 305 LGNLLQANAQQD 316
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 41/174 (23%), Positives = 74/174 (42%), Gaps = 21/174 (12%)
Query: 337 FRSEMNRLGQLRHPNLVPLL--GFCVVEEERL--LVYKHMPNGTLYSLLHGNGVDNTLSG 392
FR E L HP +V + G L +V +++ TL ++H G
Sbjct: 59 FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP------ 112
Query: 393 VLDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451
+ + + A + L + H +G +H+ + I+I ++ DFG+AR +
Sbjct: 113 -MTPKRAIEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIA 167
Query: 452 SRDPN--DSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKP 503
+ ++ V +G Y++PE + + DVY G VL E+L+G+ P
Sbjct: 168 DSGNSVTQTAAV---IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 40/129 (31%), Positives = 61/129 (47%), Gaps = 13/129 (10%)
Query: 74 LTLSSMQLS--GQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLS 131
L L QL ++ E SLQ LD+S NS+S C W ++ L++S+N L+
Sbjct: 353 LILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412
Query: 132 GPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE 191
I + + L L +NK+ SIP +V +L+ L+E +VA N L P+
Sbjct: 413 DTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK--------SVPD 461
Query: 192 ESFDGNSGL 200
FD + L
Sbjct: 462 GIFDRLTSL 470
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 20/92 (21%), Positives = 36/92 (39%), Gaps = 7/92 (7%)
Query: 94 SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVE-CKFLNKLILSNN 152
L++S N +S + L + L +S+N + + + + + L L LS+N
Sbjct: 22 KTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEYLDLSHN 79
Query: 153 KLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP 184
KL I LK ++ N +P
Sbjct: 80 KLV-KISCH--PTVNLKHLDLSFNAFD-ALPI 107
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 29/113 (25%), Positives = 40/113 (35%), Gaps = 5/113 (4%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL-SG 132
L +S ++ L+ LDLS N L I C + LDLS N +
Sbjct: 50 LIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KIS---CHPTVNLKHLDLSFNAFDAL 105
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPD 185
PI + L L LS L S ++ L+ K V G P+
Sbjct: 106 PICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPE 158
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 26/116 (22%), Positives = 46/116 (39%), Gaps = 7/116 (6%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGP 133
L +S +S + L+ L +S N + + + + K+ + LDLS+N L
Sbjct: 26 LNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLVK- 83
Query: 134 IPPQIVECKFLNKLILSNNKLSGSIPF--EVSRLDRLKEFSVAGNDLSGTIPPDLA 187
I L L LS N ++P E + +LK ++ L + +A
Sbjct: 84 ISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 15/123 (12%), Positives = 31/123 (25%), Gaps = 4/123 (3%)
Query: 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSN 127
I ++ L S +L + + + + + + +
Sbjct: 251 YFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG-FPQSYIYEIFSNMNIKNFTV 309
Query: 128 NHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDL 186
+ + L SNN L+ FE L L+ + N L +
Sbjct: 310 SGTRMVHMLCPSKISPFLHLDFSNNLLT-DTVFENCGHLTELETLILQMNQLK-ELSKIA 367
Query: 187 ARF 189
Sbjct: 368 EMT 370
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 9e-12
Identities = 22/107 (20%), Positives = 40/107 (37%), Gaps = 7/107 (6%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L + + Q+S ++ L+ L++ N +S ++ L L L+NN L
Sbjct: 247 WLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDISVLNNLSQL---NSLFLNNNQLGN 301
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
I L L LS N ++ P + L ++ A +
Sbjct: 302 EDMEVIGGLTNLTTLFLSQNHITDIRPL--ASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 1e-11
Identities = 19/111 (17%), Positives = 38/111 (34%), Gaps = 8/111 (7%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
SL L + L L L ++++ + P+ L L L+ N +
Sbjct: 136 SLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTPIANLTDL---YSLSLNYNQIED 191
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183
P + L+ N+++ P + + RL + N ++ P
Sbjct: 192 ISP--LASLTSLHYFTAYVNQITDITPV--ANMTRLNSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 18/116 (15%), Positives = 47/116 (40%), Gaps = 9/116 (7%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNN 128
I L ++ +++ + + +L+ L+L+ N ++ P+ L + L + N
Sbjct: 44 ESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITDISPL---SNLVKLTNLYIGTN 98
Query: 129 HLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP 184
++ + L +L L+ + +S P + L ++ ++ N + P
Sbjct: 99 KIT--DISALQNLTNLRELYLNEDNISDISPL--ANLTKMYSLNLGANHNLSDLSP 150
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 3e-11
Identities = 23/111 (20%), Positives = 43/111 (38%), Gaps = 7/111 (6%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
SL + + +++ L L L++ N +S V L L++ +N +S
Sbjct: 225 SLKIGNNKITD--LSPLANLSQLTWLEIGTNQISDINAVKDLTKL---KMLNVGSNQISD 279
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183
+ LN L L+NN+L + L L ++ N ++ P
Sbjct: 280 ISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 5e-11
Identities = 20/118 (16%), Positives = 41/118 (34%), Gaps = 9/118 (7%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
T Q++ + L SL + +N ++ P+ L L++ N +S
Sbjct: 203 YFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSPLANLSQL---TWLEIGTNQISD 257
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP 190
I + + L L + +N++S + L +L + N L +
Sbjct: 258 -INA-VKDLTKLKMLNVGSNQISDISVL--NNLSQLNSLFLNNNQLGNEDMEVIGGLT 311
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 18/112 (16%), Positives = 40/112 (35%), Gaps = 10/112 (8%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
+L ++ Q+ L S++ + + L + +L ++ ++
Sbjct: 4 TLATLPAPIN-QI-FPDADLAEGIRAVLQKASVTDVVTQE---ELESITKLVVAGEKVAS 58
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP 184
I I L L L+ N+++ P S L +L + N ++ I
Sbjct: 59 -IQG-IEYLTNLEYLNLNGNQITDISPL--SNLVKLTNLYIGTNKIT-DISA 105
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 3e-07
Identities = 15/89 (16%), Positives = 36/89 (40%), Gaps = 7/89 (7%)
Query: 95 LQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKL 154
+L ++ P L ++ L ++ + E + + KL+++ K+
Sbjct: 2 AATLATLPAPINQIFPDAD---LAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV 56
Query: 155 SGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183
+ SI + L L+ ++ GN ++ P
Sbjct: 57 A-SIQ-GIEYLTNLEYLNLNGNQITDISP 83
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 37/271 (13%), Positives = 80/271 (29%), Gaps = 52/271 (19%)
Query: 321 ALAIKRLSACKLSEKQFRSEMNRLGQ---LRHPNLVPLLGFCVVEEER----LLVYKHMP 373
L ++ L K ++KQ + + + ++ P ++ + E +
Sbjct: 129 VLRLRLLRGIK-NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 187
Query: 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQYIS-SNVI 431
L + ++ L RL++ + R LA LH +G +H Y+ + I
Sbjct: 188 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVD-I 242
Query: 432 LIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE-----YSSTMVASLKGD 486
++D +T F G+ + A + + D
Sbjct: 243 VLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPP---ETTAERMLPFGQHHPTLMTFAFD 299
Query: 487 VYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR---SRDVVDKSLYGRGN 543
+ G+ + + P + + + + V ++L
Sbjct: 300 TWTLGLAIYWIWCADLP---------NTDDAALGGSEWIFRSCKNIPQPV--RAL----- 343
Query: 544 DDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574
+ FLR +DR Q E+
Sbjct: 344 ---LEGFLRY-------PKEDRLLPLQAMET 364
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 31/146 (21%), Positives = 57/146 (39%), Gaps = 21/146 (14%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
LTL L+ E+L H L L L +++ +I K L + L++S+
Sbjct: 156 QLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLD 214
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPD------ 185
+ P + L L +++ L+ ++P+ L L+ +++ N +S TI
Sbjct: 215 TMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELL 272
Query: 186 -----------LARFPEESFDGNSGL 200
LA +F G + L
Sbjct: 273 RLQEIQLVGGQLAVVEPYAFRGLNYL 298
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 30/133 (22%), Positives = 49/133 (36%), Gaps = 13/133 (9%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129
L L ++ + L+ L+L++N +S ++ L + L L +N
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNR 91
Query: 130 LSGPIPPQI-VECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDLA 187
L IP + L KL +S NK+ + + L LK V NDL
Sbjct: 92 LKL-IPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-------- 141
Query: 188 RFPEESFDGNSGL 200
+F G + L
Sbjct: 142 YISHRAFSGLNSL 154
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 24/110 (21%), Positives = 51/110 (46%), Gaps = 7/110 (6%)
Query: 73 SLTLSSMQLSGQLPE-SLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLS 131
SL+++ L+ +P ++ L+ L+LS N +S +I + L + ++ L L+
Sbjct: 228 SLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA 285
Query: 132 GPIPPQI-VECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLS 179
+ P +L L +S N+L+ ++ V + L+ + N L+
Sbjct: 286 V-VEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 23/129 (17%), Positives = 45/129 (34%), Gaps = 11/129 (8%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
SL + L + +SL+ L L +L+ SIP + L ++ L L + +++
Sbjct: 132 SLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINA 190
Query: 133 PIPPQIVE-CKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE 191
I + L L +S+ ++ L S+ +L+ P
Sbjct: 191 -IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT--------AVPY 241
Query: 192 ESFDGNSGL 200
+ L
Sbjct: 242 LAVRHLVYL 250
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 20/109 (18%), Positives = 37/109 (33%), Gaps = 14/109 (12%)
Query: 93 HSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNN 152
+++ ++P + LDL N + + L +L L+ N
Sbjct: 11 AQDRAVLCHRKRFV-AVPEGI---PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN 66
Query: 153 KLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGNSGL 200
+S ++ + L L+ + N L IP + F G S L
Sbjct: 67 IVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGV-------FTGLSNL 106
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 45/203 (22%), Positives = 81/203 (39%), Gaps = 24/203 (11%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSEKQFRS---EMNRLGQLRHPNLVPLLGFCVVEEE 364
G + D IK ++ ++S K+ E+ L ++HPN+V E
Sbjct: 38 GKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE-SFEENG 96
Query: 365 RL-LVYKHMPNGTLYSLLHGNGVDNTL---SGVLDWSTRLRIGMGASRGLAWLHHGCQPP 420
L +V + G L+ ++ L +LDW ++ L +H
Sbjct: 97 SLYIVMDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQI------CLALKHVH---DRK 145
Query: 421 YMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMV 480
+H+ I S I + D ++ DFG+AR++ S + + G Y++PE
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI----GTPYYLSPEICENKP 201
Query: 481 ASLKGDVYGFGIVLLELLSGQKP 503
+ K D++ G VL EL + +
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHA 224
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 41/213 (19%), Positives = 76/213 (35%), Gaps = 31/213 (14%)
Query: 308 TGVSYKAV-LPDASALAIKRLSACKLSEKQF---RSEMNRLGQLRHPNLVPLLGFCVVEE 363
A P + ++R++ S + + E++ HPN+VP + +
Sbjct: 40 LMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99
Query: 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYM 422
E +V M G+ L+ ++ I G + L ++H G Y+
Sbjct: 100 ELWVVTSFMAYGSAKDLIC-----THFMDGMNELAIAYILQGVLKALDYIHHMG----YV 150
Query: 423 HQYISSNVILIDDDFDARITDFGLARLV---GSRDPNDSSFVHGDLGEFGYVAPE----- 474
H+ + ++ ILI D ++ + G R F + +++PE
Sbjct: 151 HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN 210
Query: 475 ---YSSTMVASLKGDVYGFGIVLLELLSGQKPL 504
Y + K D+Y GI EL +G P
Sbjct: 211 LQGYDA------KSDIYSVGITACELANGHVPF 237
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 28/143 (19%), Positives = 53/143 (37%), Gaps = 7/143 (4%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129
++ + LS +L + L+ L +S+N L ++ + +P + LDLS+NH
Sbjct: 255 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP-IPTLKVLDLSHNH 312
Query: 130 LSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGT-IPPDLAR 188
L + + L L L +N + ++ LK +++ ND +
Sbjct: 313 LLH-VERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWDCNSLRALFRN 368
Query: 189 FPEESFDGNSGLCGKPLGKCGGL 211
+ D C GL
Sbjct: 369 VARPAVDDADQHCKIDYQLEHGL 391
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 9e-11
Identities = 26/134 (19%), Positives = 52/134 (38%), Gaps = 13/134 (9%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNN 128
N +T + + L ++ L+L+D + I + + +L + N
Sbjct: 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFN 109
Query: 129 HLSGPIPPQI-VECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDL 186
+ +PP + L L+L N LS S+P + +L S++ N+L
Sbjct: 110 AIRY-LPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE------- 160
Query: 187 ARFPEESFDGNSGL 200
R +++F + L
Sbjct: 161 -RIEDDTFQATTSL 173
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 27/116 (23%), Positives = 49/116 (42%), Gaps = 6/116 (5%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L+ +Q+ + H++Q L + N++ +P + + +P + L L N LS
Sbjct: 79 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS 137
Query: 133 PIPPQI-VECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDL 186
+P I L L +SNN L I + L+ ++ N L+ + L
Sbjct: 138 -LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSL 190
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 27/146 (18%), Positives = 55/146 (37%), Gaps = 28/146 (19%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129
++ +L++S+ L ++ SLQ+L LS N L+ + + L +P + ++S N
Sbjct: 148 KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL---IPSLFHANVSYNL 203
Query: 130 LSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP----- 184
LS + + +L S+N ++ + V L + N+L+
Sbjct: 204 LS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYP 254
Query: 185 ----------DLARFPEESFDGNSGL 200
+L + F L
Sbjct: 255 GLVEVDLSYNELEKIMYHPFVKMQRL 280
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 25/130 (19%), Positives = 51/130 (39%), Gaps = 13/130 (10%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
+T + + L ++ L+L+D + I + + +L + N +
Sbjct: 49 IVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY 107
Query: 133 PIPPQI-VECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDLARFP 190
+PP + L L+L N LS S+P + +L S++ N+L R
Sbjct: 108 -LPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE--------RIE 157
Query: 191 EESFDGNSGL 200
+++F + L
Sbjct: 158 DDTFQATTSL 167
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 24/110 (21%), Positives = 47/110 (42%), Gaps = 6/110 (5%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129
++ + LS +L + L+ L +S+N L ++ + +P + LDLS+NH
Sbjct: 249 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP-IPTLKVLDLSHNH 306
Query: 130 LSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
L + + L L L +N + ++ LK +++ ND
Sbjct: 307 LLH-VERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 27/146 (18%), Positives = 55/146 (37%), Gaps = 28/146 (19%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129
++ +L++S+ L ++ SLQ+L LS N L+ + + L +P + ++S N
Sbjct: 142 KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL---IPSLFHANVSYNL 197
Query: 130 LSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP----- 184
LS + + +L S+N ++ + V L + N+L+
Sbjct: 198 LS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYP 248
Query: 185 ----------DLARFPEESFDGNSGL 200
+L + F L
Sbjct: 249 GLVEVDLSYNELEKIMYHPFVKMQRL 274
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 26/114 (22%), Positives = 44/114 (38%), Gaps = 14/114 (12%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
+ + QL +LPE L L ++ +NSL +P + + NN L
Sbjct: 177 FIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLS----LESIVAGNNILE- 228
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
P++ FL + NN L ++P L+ +V N L+ +P
Sbjct: 229 -ELPELQNLPFLTTIYADNNLLK-TLPDL---PPSLEALNVRDNYLT-DLPELP 276
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 29/129 (22%), Positives = 46/129 (35%), Gaps = 24/129 (18%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPV---------------DLCKWL 117
SL S L+ +LPE SL + + +LS P+ +L
Sbjct: 95 SLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQN-S 152
Query: 118 PYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGND 177
++ +D+ NN L +P L + NN+L +P E+ L L N
Sbjct: 153 SFLKIIDVDNNSLKK-LPDLPPS---LEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNS 206
Query: 178 LSGTIPPDL 186
L +P
Sbjct: 207 LK-KLPDLP 214
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 28/132 (21%), Positives = 46/132 (34%), Gaps = 31/132 (23%)
Query: 71 IISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL 130
+ L SS ++ L + SL+ L++S+N L +P + + +L S NHL
Sbjct: 299 LYYLNASSNEIR-SLCDLPP---SLEELNVSNNKLI-ELPALPPR----LERLIASFNHL 349
Query: 131 SGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRL----------------DRLKEFSVA 174
+ +P K L+ + N L P + LK+ V
Sbjct: 350 AE-VPELPQNLKQLH---VEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVE 404
Query: 175 GNDLSGTIPPDL 186
N L P
Sbjct: 405 TNPLR-EFPDIP 415
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 27/135 (20%), Positives = 44/135 (32%), Gaps = 25/135 (18%)
Query: 70 RIISLT------LSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCK-------- 115
R +S T S L+ ++P S + + + P +
Sbjct: 6 RNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSR 64
Query: 116 ----WLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEF 171
+L+L+N LS +P L L+ S N L+ +P L L
Sbjct: 65 LRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVD 119
Query: 172 SVAGNDLSGTIPPDL 186
+ LS +PP L
Sbjct: 120 NNNLKALSD-LPPLL 133
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 31/114 (27%), Positives = 49/114 (42%), Gaps = 18/114 (15%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
+L + L+ LPE SL LD+S+N SG L + P + L+ S+N +
Sbjct: 261 ALNVRDNYLT-DLPELPQ---SLTFLDVSENIFSG-----LSELPPNLYYLNASSNEIRS 311
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
+ L +L +SNNKL +P RL+ + N L+ +P
Sbjct: 312 -LCDLPPS---LEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPELP 356
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 20/122 (16%), Positives = 39/122 (31%), Gaps = 24/122 (19%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKW-----------LPYVV 121
L S L+ ++PE +L+ L + N L P +P +
Sbjct: 341 RLIASFNHLA-EVPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELP 395
Query: 122 Q----LDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGND 177
Q L + N L P + L +++ ++ F D+L++ +
Sbjct: 396 QNLKQLHVETNPLRE-FPDIPESVEDLR---MNSERVVDPYEFAHETTDKLEDDVFEHHH 451
Query: 178 LS 179
Sbjct: 452 HH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 13/93 (13%), Positives = 30/93 (32%), Gaps = 10/93 (10%)
Query: 68 ENRIISL-----TLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQ 122
N + ++ ++++ L E L +L+ L + N L P V
Sbjct: 366 YNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPES----VED 420
Query: 123 LDLSNNHLSGPIPPQIVECKFLNKLILSNNKLS 155
L +++ + P L + ++
Sbjct: 421 LRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 13/61 (21%), Positives = 25/61 (40%), Gaps = 1/61 (1%)
Query: 134 IPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEES 193
I P+ V FL + + ++ L+ +P E + E+ A ++ PP E +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 194 F 194
Sbjct: 62 V 62
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 36/201 (17%), Positives = 68/201 (33%), Gaps = 41/201 (20%)
Query: 310 VSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369
V K ++ A A +E L ++ HP++V + F VE
Sbjct: 109 VVLKGLVHSGDAEAQAM----------AMAERQFLAEVVHPSIVQIFNF--VEHTD---- 152
Query: 370 KHMPNGTLY---SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQY 425
+ Y + G + + L + + + L++LH G ++
Sbjct: 153 -RHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIG----LVYND 207
Query: 426 IS-SNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM--VAS 482
+ N++L ++ ++ D G + ++ G G+ APE T VA+
Sbjct: 208 LKPENIMLTEEQ--LKLIDLGAVSRIN-----SFGYL---YGTPGFQAPEIVRTGPTVAT 257
Query: 483 LKGDVYGFGIVLLELLSGQKP 503
D+Y G L L
Sbjct: 258 ---DIYTVGRTLAALTLDLPT 275
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 23/155 (14%), Positives = 42/155 (27%), Gaps = 18/155 (11%)
Query: 56 CRLTGVACWNEKENRI-------ISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGS 108
C N +++ + LS ++ S LQ L + +
Sbjct: 10 VIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLV 69
Query: 109 IPVDLCKWLPYVVQLDLSNNHLSGPIPPQI-VECKFLNKLILSNNKL-SGSIPFEV-SRL 165
I + + L ++ L L N + L L L+ L + L
Sbjct: 70 IRNNTFRGLSSLIILKLDYNQFLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPL 128
Query: 166 DRLKEFSVAGNDLSGTIPPDLARFPEESFDGNSGL 200
L+ + N++ I P F
Sbjct: 129 TSLEMLVLRDNNIK-KIQPASF------FLNMRRF 156
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 35/196 (17%), Positives = 65/196 (33%), Gaps = 21/196 (10%)
Query: 11 LLLSYSLLTVSIEDDVKCLEGIQNSIKDPDGRLSWSFTNTTVGAICRLTGVACWNEKENR 70
L LS + S+ ++ + +
Sbjct: 217 LDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASG 276
Query: 71 IISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL 130
+ + LS ++ L L+ L L+ N ++ I + L ++++L+LS N L
Sbjct: 277 VKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL 335
Query: 131 SGPIPPQIVECKF-----LNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPP 184
I ++ F L L LS N + ++ + L LKE ++ N L
Sbjct: 336 GS-IDSRM----FENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK----- 384
Query: 185 DLARFPEESFDGNSGL 200
P+ FD + L
Sbjct: 385 ---SVPDGIFDRLTSL 397
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 26/142 (18%), Positives = 51/142 (35%), Gaps = 24/142 (16%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCK--WLPYVVQLDLSNNHLS 131
++ L + + S+ +LDLS N S+ + L LSN++
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM 252
Query: 132 GPIPPQ-----IVECKF-------LNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDL 178
G F + LS +K+ ++ V S L++ ++A N++
Sbjct: 253 GSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEI 311
Query: 179 SGTIPPDLARFPEESFDGNSGL 200
+ I + +F G + L
Sbjct: 312 N-KIDDN-------AFWGLTHL 325
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 42/364 (11%), Positives = 86/364 (23%), Gaps = 69/364 (18%)
Query: 245 VSKKKRGYGADSGKDDSSWIQVLRSHKLVQV-SLFQKPIVKVKLADLLAATNSFAVENII 303
++ + ++ V + V SL + K+KL + L +V ++
Sbjct: 23 GYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRV-GDRSVVFLV 81
Query: 304 ISTRTGVSYKAVLPDASALAIKRLSACKLS----EKQFRSEMNRLGQLRHPNLVPLLGFC 359
+ A+K + + ++ +L +
Sbjct: 82 RDVERLEDF----------ALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRR 131
Query: 360 --------------------------VVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGV 393
LL+ + L L G
Sbjct: 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGD 190
Query: 394 LDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQYIS-SNVILIDDDFDARITDFGLARLVG 451
+ R A L G +H + + N + I D + D VG
Sbjct: 191 EGILALHILTAQLIRLAANLQSKGL----VHGHFTPDN-LFIMPDGRLMLGDVSALWKVG 245
Query: 452 SRDPNDSSFVHGDLGEFGYVAPEY--SSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGA 509
+R P S Y E+ +ST + + + G+ + + P +
Sbjct: 246 TRGPASS-------VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 510 EEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMY 569
+ + + I +FL + R
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVK---TLIGRFLNF-------DRRRRLLPL 348
Query: 570 QVYE 573
+ E
Sbjct: 349 EAME 352
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 28/121 (23%), Positives = 52/121 (42%), Gaps = 11/121 (9%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L +++ SL ++L L LS NS+S ++ P++ +L L+NN L
Sbjct: 196 ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVK 254
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEV-------SRLDRLKEFSVAGNDLSGT-IPP 184
+P + + K++ + L NN +S +I ++ S+ N + I P
Sbjct: 255 -VPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 312
Query: 185 D 185
Sbjct: 313 S 313
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 17/117 (14%), Positives = 47/117 (40%), Gaps = 11/117 (9%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSL-SGSIPVDLCKWLPYVVQLDLSNNHLS 131
L + +++ + + + ++L N L S I + + + + +++ +++
Sbjct: 125 ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184
Query: 132 GPIPPQIVECKF--LNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPD 185
IP + L +L L NK++ + L+ L + ++ N +S +
Sbjct: 185 T-IPQGL----PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNG 234
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 29/156 (18%), Positives = 58/156 (37%), Gaps = 24/156 (15%)
Query: 56 CRLTGVACWNEK-----EN---RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSG 107
C L V C + ++ L L + +++ +L +L L +N +S
Sbjct: 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS- 89
Query: 108 SIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKF--LNKLILSNNKLSGSIPFEV-SR 164
I L + +L LS N L +P ++ L +L + N+++ + V +
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLKE-LPEKM----PKTLQELRVHENEIT-KVRKSVFNG 143
Query: 165 LDRLKEFSVAGNDLSGTIPPDLARFPEESFDGNSGL 200
L+++ + N L + +F G L
Sbjct: 144 LNQMIVVELGTNPLK------SSGIENGAFQGMKKL 173
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 18/89 (20%), Positives = 34/89 (38%), Gaps = 10/89 (11%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVD------LCKWLPYVVQLDLS 126
L L++ +L ++P L +Q + L +N++S +I + + L
Sbjct: 244 ELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLF 301
Query: 127 NNHLS-GPIPPQIVEC-KFLNKLILSNNK 153
+N + I P C + L N K
Sbjct: 302 SNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 22/112 (19%), Positives = 38/112 (33%), Gaps = 10/112 (8%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L LS +S SL L+ L L++N L +P L Y+ + L NN++S
Sbjct: 220 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL-ADHKYIQVVYLHNNNISA 277
Query: 133 ------PIPPQIVECKFLNKLILSNNKLS-GSIPFEV-SRLDRLKEFSVAGN 176
P + + + L +N + I + +
Sbjct: 278 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 28/115 (24%), Positives = 43/115 (37%), Gaps = 4/115 (3%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
SL LS +++ L C +LQ L L + ++ +I D L + LDLS+NHLS
Sbjct: 30 SLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSS 88
Query: 133 PIPPQ-IVECKFLNKLILSNNKLSG-SIPFEVSRLDRLKEFSVAGNDLSGTIPPD 185
+ L L L N + L L+ + + I
Sbjct: 89 -LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI 142
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 27/119 (22%), Positives = 46/119 (38%), Gaps = 13/119 (10%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSG-SIPVDLCKWLPYVVQLDLSN 127
N ++ L + G P SLQ+L LS N L ++ L + LD+S
Sbjct: 344 NLMVEEYLKNSACKGAWP-------SLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISR 396
Query: 128 NHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
N P+P + + L LS+ + + + L+ V+ N+L + L
Sbjct: 397 NTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFL 450
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 27/148 (18%), Positives = 49/148 (33%), Gaps = 19/148 (12%)
Query: 56 CRLTGVACWNEKENRIIS------------LTLSSMQLSGQLPESLHLCHSLQSLDLSDN 103
C L G+ +N E+ ++S L + L L L ++ + + ++
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320
Query: 104 SLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQ---IVECKFLNKLILSNNKLS--GSI 158
+ +P + L + LDLS N + L L+LS N L
Sbjct: 321 KVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKT 379
Query: 159 PFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
+ L L ++ N +P
Sbjct: 380 GEILLTLKNLTSLDISRNTFH-PMPDSC 406
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 28/128 (21%), Positives = 49/128 (38%), Gaps = 19/128 (14%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
SL +S +P+S ++ L+LS + + + + LD+SNN+L
Sbjct: 391 SLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI---PQTLEVLDVSNNNLDS 445
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEE 192
+ L +L +S NKL ++P L ++ N L P+
Sbjct: 446 -FSLFLPR---LQELYISRNKLK-TLPDASL-FPVLLVMKISRNQLK--------SVPDG 491
Query: 193 SFDGNSGL 200
FD + L
Sbjct: 492 IFDRLTSL 499
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 22/128 (17%), Positives = 37/128 (28%), Gaps = 9/128 (7%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGP 133
L LS LS SL+ L+L N L L + L + N
Sbjct: 79 LDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSE 138
Query: 134 IPPQ-IVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEE 192
I LN+L + L + + + ++ ++ + E
Sbjct: 139 IRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA--------FLLEI 190
Query: 193 SFDGNSGL 200
D S +
Sbjct: 191 FADILSSV 198
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 26/110 (23%), Positives = 42/110 (38%), Gaps = 14/110 (12%)
Query: 92 CHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSN 151
C + D S + SIP L + LDLS N ++ + C L LIL +
Sbjct: 4 CDASGVCDGRSRSFT-SIPSGL---TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 152 NKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGNSGL 200
++++ +I + L L+ ++ N LS F S L
Sbjct: 60 SRIN-TIEGDAFYSLGSLEHLDLSDNHLS--------SLSSSWFGPLSSL 100
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 25/112 (22%), Positives = 46/112 (41%), Gaps = 16/112 (14%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129
++ L LSS + + + +L+ LD+S+N+L S + L P + +L +S N
Sbjct: 411 KMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFL----PRLQELYISRNK 462
Query: 130 LSGPIPPQIVECKFLNKL---ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDL 178
L + + L +S N+L RL L++ + N
Sbjct: 463 LK-----TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 13/120 (10%), Positives = 34/120 (28%), Gaps = 2/120 (1%)
Query: 73 SLTLSSMQLSGQLPE-SLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLS 131
+L + +++ ++ SL L++ SL + K + + L L + +
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESA 185
Query: 132 GPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE 191
+ + L L + L+ + + S +
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 26/190 (13%), Positives = 62/190 (32%), Gaps = 20/190 (10%)
Query: 11 LLLSYSLLTVSIEDDVKCLEGIQNSIKDPDGRLSWSFTNTTVGAICRLTGVACWNEKENR 70
L L S +E L ++ ++ D L+ + + + + R
Sbjct: 177 LTLHLSESAFLLEIFADILSSVR-YLELRDTNLARFQFSP----LPVDEVSSPMKKLAFR 231
Query: 71 IISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKW----------LPYV 120
LT S +L + L L ++ D +L+G + + +
Sbjct: 232 GSVLTDESFN---ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTI 288
Query: 121 VQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLS 179
+L + +L + + + ++ + N+K+ +P L L+ ++ N +
Sbjct: 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMV 347
Query: 180 GTIPPDLARF 189
+ A
Sbjct: 348 EEYLKNSACK 357
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 2e-10
Identities = 29/126 (23%), Positives = 49/126 (38%), Gaps = 7/126 (5%)
Query: 55 ICRLTGVACWNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLC 114
L + + + L L+ L+ + L + LDLS N L ++P L
Sbjct: 427 SKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALA 483
Query: 115 KWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSG-SIPFEVSRLDRLKEFSV 173
L + L S+N L + + L +L+L NN+L + + RL ++
Sbjct: 484 A-LRCLEVLQASDNALEN-VDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNL 540
Query: 174 AGNDLS 179
GN L
Sbjct: 541 QGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 6e-10
Identities = 27/110 (24%), Positives = 45/110 (40%), Gaps = 6/110 (5%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129
R L + + ++ L L+ L+ + + L V LDLS+N
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV---LCHLEQLLLVTHLDLSHNR 474
Query: 130 LSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
L +PP + + L L S+N L ++ V+ L RL+E + N L
Sbjct: 475 LRA-LPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ 521
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 45/204 (22%), Positives = 82/204 (40%), Gaps = 24/204 (11%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSE-KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366
G+ Y L + +AIK + + E+ L+H N+V LG
Sbjct: 36 GIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95
Query: 367 LVYKHMPNGTLYSLL-HGNGVDNTLSGVLDWSTR--LRIGMGASRGLAWLH-HGCQPPYM 422
+ + +P G+L +LL G + + T+ L GL +LH + +
Sbjct: 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE-------GLKYLHDNQI----V 144
Query: 423 HQYI-SSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE--YSSTM 479
H+ I NV++ +I+DFG ++ + +P +F G Y+APE
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT----GTLQYMAPEIIDKGPR 200
Query: 480 VASLKGDVYGFGIVLLELLSGQKP 503
D++ G ++E+ +G+ P
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPP 224
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 35/260 (13%), Positives = 74/260 (28%), Gaps = 56/260 (21%)
Query: 332 LSEKQFRSEMNRLGQLRHPNLVPLLG-FCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTL 390
+F + + + ++ + + L + ++
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 391 SGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQYIS-SNVILIDDDFDARITDFGLAR 448
L RL++ + R LA LH +G +H Y+ + I++D +T F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVD-IVLDQRGGVFLTGFEHLV 254
Query: 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMV-----------ASLKGDVYGFGIVLLEL 497
G+R + G+ PE + + D + G+V+ +
Sbjct: 255 RDGARVVSS--------VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
Query: 498 LSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR---SRDVVDKSLYGRGNDDEIMQFLRVA 554
P + + + + V ++L + FLR
Sbjct: 307 WCADLP---------ITKDAALGGSEWIFRSCKNIPQPV--RAL--------LEGFLRY- 346
Query: 555 CSCVVSRPKDRPSMYQVYES 574
+DR Q E+
Sbjct: 347 ------PKEDRLLPLQAMET 360
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 42/211 (19%), Positives = 67/211 (31%), Gaps = 51/211 (24%)
Query: 323 AIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM---------- 372
AIK++ + SE+ L L H +V + + +
Sbjct: 35 AIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQM 94
Query: 373 ---PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSN 429
NGTLY L+H ++ ++ L+ Y+H S
Sbjct: 95 EYCENGTLYDLIHSENLNQQRDEYWRLFRQI------LEALS---------YIH---SQG 136
Query: 430 V---------ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFG----------Y 470
+ I ID+ + +I DFGLA+ V G Y
Sbjct: 137 IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMY 196
Query: 471 VAPE-YSSTMVASLKGDVYGFGIVLLELLSG 500
VA E T + K D+Y GI+ E++
Sbjct: 197 VATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 9e-10
Identities = 24/116 (20%), Positives = 40/116 (34%), Gaps = 5/116 (4%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L +S + SL+ L ++ NS + D+ L + LDLS L
Sbjct: 130 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 189
Query: 133 PIPPQIVEC-KFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDL 186
+ P L L +S+N S+ L+ L+ + N + T
Sbjct: 190 -LSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQE 242
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 21/120 (17%), Positives = 41/120 (34%), Gaps = 13/120 (10%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L LS + + + L+ LD ++L + L ++ LD+S+ H
Sbjct: 82 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 140
Query: 133 PIPPQIVECKF-----LNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDL 186
I F L L ++ N + ++ + L L ++ L + P
Sbjct: 141 -AFNGI----FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTA 194
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 23/116 (19%), Positives = 34/116 (29%), Gaps = 4/116 (3%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLS-GSIPVDLCKWLPYVVQLDLSNNHLS 131
L L S +L L L LS N LS + LDLS N +
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 91
Query: 132 GPIPPQIVECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDL 186
+ + + L L ++ L F V L L ++ +
Sbjct: 92 T-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGI 145
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 25/121 (20%), Positives = 42/121 (34%), Gaps = 11/121 (9%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L ++ E L L L L N + I +LP + +L L NN LS
Sbjct: 197 ELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSR 255
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEV-------SRLDRLKEFSVAGNDLS-GTIPP 184
+P + + K L + L N ++ + + S+ N + + P
Sbjct: 256 -VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313
Query: 185 D 185
Sbjct: 314 A 314
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 26/113 (23%), Positives = 50/113 (44%), Gaps = 8/113 (7%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGP 133
L +S +L+ +P+ L +L L L N + +I ++ + +L L +N +
Sbjct: 177 LRISEAKLT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRM- 231
Query: 134 IPPQI-VECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPD 185
I L +L L NNKLS +P + L L+ + N+++ + +
Sbjct: 232 IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVN 282
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 33/142 (23%), Positives = 54/142 (38%), Gaps = 19/142 (13%)
Query: 56 CRLTGVACWNEK-----EN---RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSG 107
C L V C + + L L + +S + L +L L +N +S
Sbjct: 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS- 91
Query: 108 SIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKF--LNKLILSNNKLSGSIPFEV-SR 164
I L + +L +S NHL IPP + L +L + +N++ +P V S
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLVE-IPPNL----PSSLVELRIHDNRIR-KVPKGVFSG 145
Query: 165 LDRLKEFSVAGNDL-SGTIPPD 185
L + + GN L + P
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPG 167
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 28/124 (22%), Positives = 46/124 (37%), Gaps = 18/124 (14%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNN 128
N + + G L L +S+ L+ IP DL + +L L +N
Sbjct: 157 NPLENSGFEPGAFDGL---------KLNYLRISEAKLT-GIPKDL---PETLNELHLDHN 203
Query: 129 HLSGPIPPQI-VECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDL 186
+ I + + L +L L +N++ I S L L+E + N LS +P L
Sbjct: 204 KIQA-IELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGL 260
Query: 187 ARFP 190
Sbjct: 261 PDLK 264
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 19/89 (21%), Positives = 33/89 (37%), Gaps = 10/89 (11%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVD------LCKWLPYVVQLDLS 126
L L + +LS ++P L LQ + L N+++ + V+ Y + L
Sbjct: 245 ELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLF 302
Query: 127 NNHLS-GPIPPQIVEC-KFLNKLILSNNK 153
NN + + P C + N K
Sbjct: 303 NNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 40/184 (21%), Positives = 68/184 (36%), Gaps = 16/184 (8%)
Query: 322 LAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLL 381
A+K++ E E+ L P +VPL G + + + G+L L+
Sbjct: 86 CAVKKVRL----EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI 141
Query: 382 HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD-FDAR 440
G L L A GL +LH +H + ++ +L+ D A
Sbjct: 142 -------KQMGCLPEDRALYYLGQALEGLEYLHTRRI---LHGDVKADNVLLSSDGSRAA 191
Query: 441 ITDFGLARLVGSRDPNDSSFVHGDL-GEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS 499
+ DFG A + S + G ++APE K D++ ++L +L+
Sbjct: 192 LCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN 251
Query: 500 GQKP 503
G P
Sbjct: 252 GCHP 255
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 47/192 (24%), Positives = 76/192 (39%), Gaps = 30/192 (15%)
Query: 323 AIKRLSACKLS----EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378
A+K L +L E Q R E+ LRHPN++ L G+ L+ ++ P GT+Y
Sbjct: 38 ALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY 97
Query: 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQYISSNVILIDDDF 437
L + T I A+ L++ H +H+ I +L+
Sbjct: 98 RELQKLS---KFD---EQRTATYITELAN-ALSYCHSKRV----IHRDIKPENLLLGSAG 146
Query: 438 DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVAS----LKGDVYGFGIV 493
+ +I DFG + SS G Y+ PE M+ K D++ G++
Sbjct: 147 ELKIADFGWSVHA------PSSRRTDLCGTLDYLPPE----MIEGRMHDEKVDLWSLGVL 196
Query: 494 LLELLSGQKPLD 505
E L G+ P +
Sbjct: 197 CYEFLVGKPPFE 208
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 66/334 (19%), Positives = 110/334 (32%), Gaps = 94/334 (28%)
Query: 317 PDASALAIKRL--SACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLV-YKHM 372
+A+K L A + SE+ L + H N+V LLG C L+V +
Sbjct: 50 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFC 109
Query: 373 PNGTLYSLLHG----------------NGVDNTLSGVLDWSTRLRI----------GMGA 406
G L + L G D + +D RL G
Sbjct: 110 KFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169
Query: 407 SRGLAWLHHGCQPPYMH--------------------QYISSN----------VILIDDD 436
+ L+ + P ++ ++++S IL+ +
Sbjct: 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 229
Query: 437 FDARITDFGLARLVGSRDPNDSSFVHGDLGEF--GYVAPEYSSTMVASLKGDVYGFGIVL 494
+I DFGLAR + D +V ++APE V +++ DV+ FG++L
Sbjct: 230 NVVKICDFGLARDIY----KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 285
Query: 495 LELLS-GQKPL-DVAGAEEGFKGNLVDWVNHLVIAGRSR----DVVDKSLYGRGNDDEIM 548
E+ S G P V EE + G R D +Y + M
Sbjct: 286 WEIFSLGASPYPGVKIDEE---------FCRRLKEGT-RMRAPDYTTPEMY------QTM 329
Query: 549 QFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582
C P RP+ ++ E L ++ + +
Sbjct: 330 L------DCWHGEPSQRPTFSELVEHLGNLLQAN 357
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 38/150 (25%), Positives = 65/150 (43%), Gaps = 19/150 (12%)
Query: 47 FTNTTVGAICRLTGVACWNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLS 106
FT++ L + + N + + ++ SL++LD+S NSL+
Sbjct: 365 FTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNM--------SSLETLDVSLNSLN 416
Query: 107 GSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLD 166
C W ++ L+LS+N L+G + + + L L NN++ SIP +V+ L
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPK--VKVLDLHNNRIM-SIPKDVTHLQ 473
Query: 167 RLKEFSVAGNDLSGTIPPDLARFPEESFDG 196
L+E +VA N L P+ FD
Sbjct: 474 ALQELNVASNQLK--------SVPDGVFDR 495
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 29/146 (19%), Positives = 49/146 (33%), Gaps = 7/146 (4%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
+L+LS +S + L+ L LS N + S+ + + + LD+S+N L
Sbjct: 56 ALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQN 114
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPF--EVSRLDRLKEFSVAGNDLSGTIPPDLARFP 190
I + L L LS N +P E L +L ++ +A
Sbjct: 115 -ISCCPM--ASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLH 170
Query: 191 EESFDGNSGLCGKPLGKCGGLSGKNL 216
+ G+ L N
Sbjct: 171 LSCILLDLVSYHIKGGETESLQIPNT 196
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 21/92 (22%), Positives = 43/92 (46%), Gaps = 7/92 (7%)
Query: 94 SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQI-VECKFLNKLILSNN 152
++L LS NS+S + + +L + L LS+N + + + + + L L +S+N
Sbjct: 53 RTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVSHN 110
Query: 153 KLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP 184
+L +I + L+ ++ ND +P
Sbjct: 111 RLQ-NISC--CPMASLRHLDLSFNDFD-VLPV 138
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 25/181 (13%), Positives = 52/181 (28%), Gaps = 4/181 (2%)
Query: 6 ILASLLLLSYSLLTVSIEDDVKCLEGIQNSIKDPDGR-LSWSFTNTTVGAICR-LTGVAC 63
+ +L L S + ++ E+ + + + + P ++ TT +
Sbjct: 216 SVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWP 275
Query: 64 WNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQL 123
+ I +LT++ + S SL + + L +
Sbjct: 276 RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL-FSKEALYSVFAEMNIK 334
Query: 124 DLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183
LS + L + N + S+ S L RL+ + N L
Sbjct: 335 MLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFF 393
Query: 184 P 184
Sbjct: 394 K 394
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 24/116 (20%), Positives = 48/116 (41%), Gaps = 13/116 (11%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNN 128
++ L + +L + L +LD S N ++ + V K L +L+ N
Sbjct: 148 TQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELDVSQNKLL---NRLNCDTN 201
Query: 129 HLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP 184
+++ + + + L L S+NKL+ I + L +L F + N L+ +
Sbjct: 202 NITK-LD--LNQNIQLTFLDCSSNKLT-EIDV--TPLTQLTYFDCSVNPLT-ELDV 250
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 19/111 (17%), Positives = 41/111 (36%), Gaps = 12/111 (10%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNN 128
+ SL + ++ + + L L + N+++ ++ + L L +N
Sbjct: 42 ATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT-TLDLSQNTNL---TYLACDSN 95
Query: 129 HLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
L+ + + L L NKL+ + S+ L + A N L+
Sbjct: 96 KLTN-LD--VTPLTKLTYLNCDTNKLT-KLDV--SQNPLLTYLNCARNTLT 140
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 22/119 (18%), Positives = 43/119 (36%), Gaps = 17/119 (14%)
Query: 69 NRIISLTLSSMQ------LSG-QLPE-SLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYV 120
N++ L +S + L E + L LD N + V +
Sbjct: 116 NKLTKLDVSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLDVT---PQTQL 172
Query: 121 VQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
LD S N ++ + + + K LN+L N ++ + ++ +L + N L+
Sbjct: 173 TTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNIT-KLDL--NQNIQLTFLDCSSNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 19/107 (17%), Positives = 48/107 (44%), Gaps = 9/107 (8%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
S ++ ++ S +L SLD ++S++ + + L + +L ++N+++
Sbjct: 22 SEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD---MTGIEKLTGLTKLICTSNNITT 78
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
+ + + L L +NKL+ ++ + L +L + N L+
Sbjct: 79 -LD--LSQNTNLTYLACDSNKLT-NLDV--TPLTKLTYLNCDTNKLT 119
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 15/113 (13%), Positives = 31/113 (27%), Gaps = 13/113 (11%)
Query: 71 IISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL 130
+ S L+ +L S L +L L I + L Y
Sbjct: 235 LTYFDCSVNPLT-ELDVST--LSKLTTLHCIQTDLL-EIDLTHNTQLIY---FQAEGCRK 287
Query: 131 SGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183
+ + L L ++ + S+ +L + +L+ +
Sbjct: 288 IKELD--VTHNTQLYLLDCQAAGIT-ELDL--SQNPKLVYLYLNNTELT-ELD 334
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 26/117 (22%), Positives = 38/117 (32%), Gaps = 18/117 (15%)
Query: 68 ENRIISLTLSSMQ------LSG-QLPE-SLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPY 119
N+I L +S + + + L+ L LD S N L+ I V L Y
Sbjct: 179 FNKITELDVSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNKLT-EIDVTPLTQLTY 237
Query: 120 VVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGN 176
D S N L+ + L L L I ++ +L F G
Sbjct: 238 ---FDCSVNPLT-ELDVST--LSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGC 285
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 19/113 (16%), Positives = 37/113 (32%), Gaps = 16/113 (14%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L + ++ +L L L L L++ L+ + V L L N H+
Sbjct: 301 LLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELDVSHNTKL---KSLSCVNAHIQD 353
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRL------KEFSVAGNDLS 179
+ + LN + + ++P E + L GN ++
Sbjct: 354 -FSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMN 403
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 50/274 (18%), Positives = 92/274 (33%), Gaps = 48/274 (17%)
Query: 323 AIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMP--NGTLYS 379
A+KR+ E+ L + HPN++ +C E +Y + N L
Sbjct: 43 AVKRML--IDFCDIALMEIKLLTESDDHPNVIRY--YCS-ETTDRFLYIALELCNLNLQD 97
Query: 380 LLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYMH-------------QY 425
L+ V + + + + + G+A LH +H
Sbjct: 98 LVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK----IIHRDLKPQNILVSTSSR 153
Query: 426 ISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE-------YSST 478
+++ ++ I+DFGL + + S + + ++ G G+ APE +
Sbjct: 154 FTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTK 213
Query: 479 MVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKS 537
+ D++ G V +LS G+ P F N +I G K
Sbjct: 214 RRLTRSIDIFSMGCVFYYILSKGKHP---------FGDKYSRESN--IIRGIFSLDEMKC 262
Query: 538 LYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQV 571
L+ R E + + P RP+ +V
Sbjct: 263 LHDRSLIAEATDLIS---QMIDHDPLKRPTAMKV 293
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 65/217 (29%), Positives = 95/217 (43%), Gaps = 37/217 (17%)
Query: 308 TGVSYKAV-LPDASALAIKR--LSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEE 364
T V A P +AIKR L C+ S + E+ + Q HPN+V VV++E
Sbjct: 28 TAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87
Query: 365 RLLVYKHMPNGTLYSLL-HGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYM 422
LV K + G++ ++ H SGVLD ST I GL +LH +G +
Sbjct: 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG----QI 143
Query: 423 HQYISSNVILIDDDFDARITDFGL-ARLVGSRDPNDSS----FVHGDLGEFG---YVAPE 474
H+ + + IL+ +D +I DFG+ A L D + FV G ++APE
Sbjct: 144 HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-------GTPCWMAPE 196
Query: 475 -------YSSTMVASLKGDVYGFGIVLLELLSGQKPL 504
Y K D++ FGI +EL +G P
Sbjct: 197 VMEQVRGYDF------KADIWSFGITAIELATGAAPY 227
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 5e-09
Identities = 44/201 (21%), Positives = 69/201 (34%), Gaps = 48/201 (23%)
Query: 323 AIKRLSACKLS----EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378
A+K L +L E Q R E+ LRHPN++ + + + L+ + P G LY
Sbjct: 43 ALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELY 102
Query: 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVI------- 431
L +G + + + A L + H VI
Sbjct: 103 KELQKHG---RFD---EQRSATFMEELAD-ALHYCH------------ERKVIHRDIKPE 143
Query: 432 --LIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKG---- 485
L+ + +I DFG + S G Y+ PE M+ K
Sbjct: 144 NLLMGYKGELKIADFGWSVHA------PSLRRRTMCGTLDYLPPE----MIEG-KTHDEK 192
Query: 486 -DVYGFGIVLLELLSGQKPLD 505
D++ G++ E L G P D
Sbjct: 193 VDLWCAGVLCYEFLVGMPPFD 213
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 32/146 (21%), Positives = 50/146 (34%), Gaps = 22/146 (15%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGP 133
L L S L+ + L+ LDLSDN+ S+ L + L L L
Sbjct: 61 LWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE- 119
Query: 134 IPPQI-VECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPD------ 185
+ P + L L L +N L ++P + L L + GN +S ++P
Sbjct: 120 LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLH 177
Query: 186 -----------LARFPEESFDGNSGL 200
+A +F L
Sbjct: 178 SLDRLLLHQNRVAHVHPHAFRDLGRL 203
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 33/147 (22%), Positives = 50/147 (34%), Gaps = 22/147 (14%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
+ L ++S S C +L L L N L+ I L + QLDLS+N
Sbjct: 36 RIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLR 94
Query: 133 PIPPQI-VECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPD----- 185
+ P L+ L L L + + L L+ + N L +P D
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDL 152
Query: 186 ------------LARFPEESFDGNSGL 200
++ PE +F G L
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSL 179
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 23/99 (23%), Positives = 36/99 (36%), Gaps = 13/99 (13%)
Query: 94 SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKF-----LNKLI 148
+ Q + L N +S +P + + L L +N L+ I F L +L
Sbjct: 33 ASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLAR-IDAAA----FTGLALLEQLD 86
Query: 149 LSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDL 186
LS+N S+ L RL + L + P L
Sbjct: 87 LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGL 124
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 28/106 (26%), Positives = 44/106 (41%), Gaps = 7/106 (6%)
Query: 74 LTLSSMQLSGQLPE-SLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L L LP+ + +L L L N +S S+P + L + +L L N ++
Sbjct: 134 LYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 133 PIPPQIVE-CKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGN 176
+ P L L L N LS ++P E + L L+ + N
Sbjct: 192 -VHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 8e-04
Identities = 21/122 (17%), Positives = 39/122 (31%), Gaps = 23/122 (18%)
Query: 97 SLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSG 156
+ L ++PV + ++ L N +S C+ L L L +N L+
Sbjct: 15 TTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA- 69
Query: 157 SIPFEV-SRLDRLKEFSVAGNDLSGTIPPD-----------------LARFPEESFDGNS 198
I + L L++ ++ N ++ P L F G +
Sbjct: 70 RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLA 129
Query: 199 GL 200
L
Sbjct: 130 AL 131
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 39/192 (20%), Positives = 68/192 (35%), Gaps = 34/192 (17%)
Query: 323 AIKRLSACKLSEK---QFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378
A+KR + K + +E+ ++ +HP V L E L + + +L
Sbjct: 86 AVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ-AWEEGGILYLQTELCGPSLQ 144
Query: 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQYI-SSNVILIDDD 436
G + V + LA LH G +H + +N I +
Sbjct: 145 QHCEAWGASLPEAQVWGYLRDT------LLALAHLHSQG----LVHLDVKPAN-IFLGPR 193
Query: 437 FDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE-----YSSTMVASLKGDVYGFG 491
++ DFGL +G+ + GD Y+APE Y + DV+ G
Sbjct: 194 GRCKLGDFGLLVELGTAGAGEV--QEGDP---RYMAPELLQGSYGT------AADVFSLG 242
Query: 492 IVLLELLSGQKP 503
+ +LE+ +
Sbjct: 243 LTILEVACNMEL 254
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 8e-09
Identities = 39/143 (27%), Positives = 56/143 (39%), Gaps = 21/143 (14%)
Query: 56 CRLTGVACWNEKENRIIS-----------LTLSSMQLSGQLPESLHLCHSLQSLDLSDNS 104
V C + + L LS L +L L L+L
Sbjct: 10 ASHLEVNCDK---RNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 105 LSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEV-S 163
L+ + VD LP + LDLS+N L +P L L +S N+L+ S+P
Sbjct: 67 LT-KLQVD--GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALR 121
Query: 164 RLDRLKEFSVAGNDLSGTIPPDL 186
L L+E + GN+L T+PP L
Sbjct: 122 GLGELQELYLKGNELK-TLPPGL 143
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 28/93 (30%), Positives = 43/93 (46%), Gaps = 16/93 (17%)
Query: 74 LTLSSMQLSGQLPESL--HLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLS 131
L +S +L+ LP L LQ L L N L ++P L P + +L L+NN+L+
Sbjct: 105 LDVSFNRLT-SLPLGALRGL-GELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT 161
Query: 132 GPIPPQIVECKF-----LNKLILSNNKLSGSIP 159
+P + L+ L+L N L +IP
Sbjct: 162 E-LPAGL----LNGLENLDTLLLQENSLY-TIP 188
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 8e-09
Identities = 35/130 (26%), Positives = 57/130 (43%), Gaps = 14/130 (10%)
Query: 74 LTLSSMQLSGQLPE-SLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L LS LS E + +L SL LS N L+ I + +P + LDLS+NHL
Sbjct: 44 LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT 102
Query: 133 PIPPQI-VECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDLARFP 190
+ + + + L L+L NN + + + +L++ ++ N +S RFP
Sbjct: 103 -LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS--------RFP 152
Query: 191 EESFDGNSGL 200
E + L
Sbjct: 153 VELIKDGNKL 162
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 28/113 (24%), Positives = 44/113 (38%), Gaps = 18/113 (15%)
Query: 92 CH-SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKF--LNKLI 148
C + L S L ++P L Y LDLS+N+LS + + + L+ L+
Sbjct: 16 CLCASNILSCSKQQLP-NVPQSL---PSYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLL 70
Query: 149 LSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGNSGL 200
LS+N L+ I E + L+ ++ N L E F L
Sbjct: 71 LSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH--------TLDEFLFSDLQAL 114
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 23/104 (22%), Positives = 44/104 (42%), Gaps = 6/104 (5%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGP 133
L LSS L +L+ L L +N + + + + + + +L LS N +S
Sbjct: 93 LDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISR- 150
Query: 134 IPPQIVEC----KFLNKLILSNNKLSGSIPFEVSRLDRLKEFSV 173
P ++++ L L LS+NKL ++ +L + +
Sbjct: 151 FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 9e-09
Identities = 51/281 (18%), Positives = 98/281 (34%), Gaps = 58/281 (20%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367
G +KA D IKR+ K + ++ E+ L +L H N+V G +
Sbjct: 25 GQVFKAKHRIDGKTYVIKRV---KYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81
Query: 368 VYKHM----------------PNGTLYSLLHG-NGVDNTLSGVLDWSTRLRIGMGASRGL 410
GTL + G L+ ++ ++G+
Sbjct: 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQI------TKGV 135
Query: 411 AWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGY 470
++H +++ + + I + D +I DFGL + + D + G Y
Sbjct: 136 DYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN-DGKRTRSK----GTLRY 187
Query: 471 VAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530
++PE S+ + D+Y G++L ELL A E + +I
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFET--SKFFTDLRDGII---- 236
Query: 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQV 571
++ D + L+ + +P+DRP+ ++
Sbjct: 237 -----SDIF----DKKEKTLLQ---KLLSKKPEDRPNTSEI 265
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 41/229 (17%), Positives = 72/229 (31%), Gaps = 56/229 (24%)
Query: 323 AIKRLSACKLS------EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGT 376
AIK ++ K+ ++ ++E+ + +L HPN+ L E+ LV + G
Sbjct: 55 AIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGH 114
Query: 377 LYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPP---------------- 420
L L+ D+T +D A
Sbjct: 115 LLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174
Query: 421 --------YMHQYISSNV---------ILIDDDFDAR--ITDFGLARLVGSRDPNDSSFV 461
Y+H + + L + + DFGL++ + + +
Sbjct: 175 RQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGM 231
Query: 462 HGDLGEFGYVAPEYSSTMVASLKGDVYGF-------GIVLLELLSGQKP 503
G +VAPE V + + YG G++L LL G P
Sbjct: 232 TTKAGTPYFVAPE-----VLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 20/136 (14%), Positives = 43/136 (31%), Gaps = 18/136 (13%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L + + L P+SL ++ L L + V L+L + L
Sbjct: 178 ELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDT 236
Query: 133 PIPPQIVECKF--------LNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP 184
++ + + +++ L + ++++ L E + N L
Sbjct: 237 FHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS---- 291
Query: 185 DLARFPEESFDGNSGL 200
P+ FD + L
Sbjct: 292 ----VPDGIFDRLTSL 303
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 31/116 (26%), Positives = 47/116 (40%), Gaps = 4/116 (3%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
SL LS+ +++ L C +LQ+L L+ N ++ +I D L + LDLS N+LS
Sbjct: 56 SLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSN 114
Query: 133 PIPPQI-VECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDL 186
+ L L L N + S L +L+ V D I
Sbjct: 115 -LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 27/125 (21%), Positives = 47/125 (37%), Gaps = 20/125 (16%)
Query: 94 SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKF-----LNKLI 148
+++SLDLS+N ++ I + + L L++N ++ I F L L
Sbjct: 53 AVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINT-IEEDS----FSSLGSLEHLD 106
Query: 149 LSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGNSGLCGKPLGK 207
LS N LS ++ L L ++ GN T+ F + L +G
Sbjct: 107 LSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSL------FSHLTKLQILRVGN 158
Query: 208 CGGLS 212
+
Sbjct: 159 MDTFT 163
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 26/131 (19%), Positives = 38/131 (29%), Gaps = 15/131 (11%)
Query: 74 LTLSSMQLSGQLPESL--HLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLS 131
L LS LS L S L SL L+L N L L + L + N
Sbjct: 105 LDLSYNYLS-NLSSSWFKPL-SSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162
Query: 132 GPIPPQIVE-CKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDLARF 189
I + FL +L + + L S + + + +
Sbjct: 163 TKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI--------LL 213
Query: 190 PEESFDGNSGL 200
E D S +
Sbjct: 214 LEIFVDVTSSV 224
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 21/115 (18%), Positives = 43/115 (37%), Gaps = 10/115 (8%)
Query: 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSG-------SIPVDLCKWLPYVVQ 122
+ L L Q L + + S++ L+L D L + +
Sbjct: 199 NVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRN 258
Query: 123 LDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGN 176
+ +++ L + + + L +L S N+L S+P + RL L++ + N
Sbjct: 259 VKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 25/106 (23%), Positives = 49/106 (46%), Gaps = 7/106 (6%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L+ L ++P L L LDLS N LS +I + L ++ +L + + +
Sbjct: 189 YLNLAMCNLR-EIPNLTPL-IKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQV 245
Query: 133 PIPPQIVEC-KFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGN 176
I + + L ++ L++N L+ +P ++ + L L+ + N
Sbjct: 246 -IERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 31/120 (25%), Positives = 54/120 (45%), Gaps = 9/120 (7%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNN 128
N+ + L ++P+ + + + L+L +N + I V+ K L ++ L LS N
Sbjct: 43 NQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRN 98
Query: 129 HLSGPIPPQI-VECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDL 186
H+ I LN L L +N+L+ +IP L +LKE + N + +IP
Sbjct: 99 HIRT-IEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYA 155
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 36/171 (21%), Positives = 58/171 (33%), Gaps = 48/171 (28%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L LS + + + +L +L+L DN L+ +IP +L + +L L NN +
Sbjct: 92 ILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES 150
Query: 133 PIPP------------------QIVE--------CKFLNKLILSNNKLSGSIPFEVSRLD 166
IP ++ L L L+ L IP ++ L
Sbjct: 151 -IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLI 207
Query: 167 RLKEFSVAGNDLSGTIPPD-----------------LARFPEESFDGNSGL 200
+L E ++GN LS I P + +FD L
Sbjct: 208 KLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSL 257
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 35/130 (26%), Positives = 52/130 (40%), Gaps = 12/130 (9%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L Q+ S L+ L LS N + +I + L + L+L +N L+
Sbjct: 68 LLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTT 126
Query: 133 PIPPQIVEC-KFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDLARFP 190
IP L +L L NN + SIP +R+ L+ DL L+
Sbjct: 127 -IPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRL-----DLGEL--KRLSYIS 177
Query: 191 EESFDGNSGL 200
E +F+G S L
Sbjct: 178 EGAFEGLSNL 187
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 26/106 (24%), Positives = 45/106 (42%), Gaps = 7/106 (6%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L + +P L L+ L++S N I L + +L + N+ +S
Sbjct: 200 YLNLGMCNIK-DMPNLTPL-VGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSL 256
Query: 133 PIPPQIVEC-KFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGN 176
I + L +L L++N LS S+P ++ + L L E + N
Sbjct: 257 -IERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 31/146 (21%), Positives = 51/146 (34%), Gaps = 24/146 (16%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLS-NNHLSG 132
L L L+ + L+ L L +N + SIP +P +++LDL L
Sbjct: 128 LELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEY 186
Query: 133 PIPPQI-VECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPD------ 185
I L L L + +P ++ L L+E ++GN I P
Sbjct: 187 -ISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLS 242
Query: 186 -----------LARFPEESFDGNSGL 200
++ +FDG + L
Sbjct: 243 SLKKLWVMNSQVSLIERNAFDGLASL 268
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 28/120 (23%), Positives = 52/120 (43%), Gaps = 9/120 (7%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNN 128
N+ + + LS ++P+ + + + L+L +N++ I D + L ++ L L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRN 109
Query: 129 HLSGPIPPQI-VECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDL 186
+ I LN L L +N L+ IP L +L+E + N + +IP
Sbjct: 110 SIRQ-IEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYA 166
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 27/110 (24%), Positives = 43/110 (39%), Gaps = 6/110 (5%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L + + + SL +L+L DN L+ IP ++L + +L L NN +
Sbjct: 103 VLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIES 161
Query: 133 PIPPQI-VECKFLNKLILS-NNKLSGSIPFEV-SRLDRLKEFSVAGNDLS 179
IP L +L L KL I L LK ++ ++
Sbjct: 162 -IPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK 209
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 29/115 (25%), Positives = 44/115 (38%), Gaps = 5/115 (4%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
+L LS L S LQ LDLS + +I + L ++ L L+ N +
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS 90
Query: 133 PIPPQI-VECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPD 185
+ L KL+ L+ S+ L LKE +VA N + P+
Sbjct: 91 -LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 23/100 (23%), Positives = 39/100 (39%), Gaps = 14/100 (14%)
Query: 94 SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKF-----LNKLI 148
S ++LDLS N L + P + LDLS + I + L+ LI
Sbjct: 29 STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQT-IEDGA----YQSLSHLSTLI 82
Query: 149 LSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDLA 187
L+ N + S+ S L L++ +L+ ++
Sbjct: 83 LTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPI 120
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 30/134 (22%), Positives = 53/134 (39%), Gaps = 17/134 (12%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPV-DLCKWLPYVVQLDLSNNHLS 131
L L+ + +L+ L+++ N + S + + L + LDLS+N +
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 132 GPIPPQI----VECKFLN-KLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186
I + LN L LS N ++ I + RLKE ++ N L ++P +
Sbjct: 163 S-IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGI 219
Query: 187 ARFPEESFDGNSGL 200
FD + L
Sbjct: 220 -------FDRLTSL 226
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 44/219 (20%), Positives = 77/219 (35%), Gaps = 42/219 (19%)
Query: 309 GVSYKAV-LPDASALAIK--RLSACKLSEKQFRSEMNRLGQLRHPNLV---------PLL 356
GV ++A D AIK RL +L+ ++ E+ L +L HP +V
Sbjct: 19 GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78
Query: 357 GFCVVEEERLLVYKHM---PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL 413
++ +Y M L ++ + S L I + + + +L
Sbjct: 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMN----GRCTIEERERSVCLHIFLQIAEAVEFL 134
Query: 414 HHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFG---- 469
H MH+ + + I D ++ DFGL + + +
Sbjct: 135 H---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQV 191
Query: 470 ----YVAPE------YSSTMVASLKGDVYGFGIVLLELL 498
Y++PE YS K D++ G++L ELL
Sbjct: 192 GTKLYMSPEQIHGNSYSH------KVDIFSLGLILFELL 224
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 47/262 (17%), Positives = 88/262 (33%), Gaps = 101/262 (38%)
Query: 309 GVSYKAVL-PDASALAIKRLSACKLSEKQFR----SEMNRLGQLRHPNLVPLLGFCVVEE 363
G ++AIK++ + + +FR M L L HPN+V L +
Sbjct: 37 GTVQLGKEKSTGMSVAIKKV----IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92
Query: 364 ER-------LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGAS--------- 407
ER +V +++P+ TL R ++
Sbjct: 93 ERDRRDIYLNVVMEYVPD--------------TLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 408 -RGLAWLHHGCQPPYMHQYISSNV---------ILID-DDFDARITDFGLARLVGSRDPN 456
R + +H S NV +L++ D ++ DFG A+ + +PN
Sbjct: 139 IRSIG---------CLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
Query: 457 DSSFVHGDLGEFGYV------APE-------YSSTMVASLKGDVYGFGIVLLELLSGQKP 503
+ Y+ APE Y++ + D++ G + E++ G+ P
Sbjct: 189 VA-----------YICSRYYRAPELIFGNQHYTTAV------DIWSVGCIFAEMMLGE-P 230
Query: 504 LDVAGAEEGFKGNLVDWVNHLV 525
+ F+G+ + L
Sbjct: 231 I--------FRGD--NSAGQLH 242
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-08
Identities = 22/108 (20%), Positives = 38/108 (35%), Gaps = 4/108 (3%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L + ++ +L SL LD+S ++ SI + LP V +DLS N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT-LPKVNSIDLSYNGAIT 150
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSG 180
I P + L L + + + +L + + G
Sbjct: 151 DIMP-LKTLPELKSLNIQFDGVHDYRGI--EDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-08
Identities = 18/116 (15%), Positives = 49/116 (42%), Gaps = 5/116 (4%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNN 128
N + +TL+++ ++ + H+++ L +++ + P+ L +L +
Sbjct: 44 NSLTYITLANINVTD--LTGIEYAHNIKDLTINNIHATNYNPISGLSNL---ERLRIMGK 98
Query: 129 HLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP 184
++ P + L L +S++ SI +++ L ++ ++ N I P
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 7e-07
Identities = 14/94 (14%), Positives = 36/94 (38%), Gaps = 5/94 (5%)
Query: 94 SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNK 153
SL + L++ +++ ++ + L ++N H + P I L +L +
Sbjct: 45 SLTYITLANINVTDLTGIEYAHNI---KDLTINNIHATNYNP--ISGLSNLERLRIMGKD 99
Query: 154 LSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLA 187
++ +S L L ++ + +I +
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 34/259 (13%), Positives = 65/259 (25%), Gaps = 59/259 (22%)
Query: 337 FRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDW 396
S RL ++ P + +L L+V + + G+L + +
Sbjct: 78 TLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---------PSP 128
Query: 397 STRLRIGMGASRGLAWLH-HGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDP 455
+R + H G + + + D D + +D
Sbjct: 129 VGAIRAMQSLAAAADAAHRAG----VALSIDHPSRVRVSIDGDVVLAYPATMPDANPQD- 183
Query: 456 NDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKG 515
D+ G G L LL + PL AG G
Sbjct: 184 ------------------------------DIRGIGASLYALLVNRWPLPEAGVRSGLAP 213
Query: 516 NLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS--MYQVYE 573
D + + + + V R + + + +
Sbjct: 214 AERDTAGQPIEPADIDRDIPFQI-----SAVAAR-------SVQGDGGIRSASTLLNLMQ 261
Query: 574 SLKSMAEKHGFSEPYDEFP 592
++A++ P DE P
Sbjct: 262 QATAVADRTEVLGPIDEAP 280
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 53/232 (22%), Positives = 93/232 (40%), Gaps = 80/232 (34%)
Query: 309 GVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNR----LGQLRHPNLVPLLGFCVVEEE 364
GV ++A L ++ +AIK++ Q + NR + ++HPN+V L F +
Sbjct: 54 GVVFQAKLVESDEVAIKKV-------LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGD 106
Query: 365 RL------LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGAS----------R 408
+ LV +++P T+ +L+ M R
Sbjct: 107 KKDEVFLNLVLEYVPE--------------TVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 409 GLAWLH-HGCQPPYMHQYI-SSNVILIDDDFDA-RITDFGLARLVGSRDPNDSSFVHGDL 465
LA++H G H+ I N +L+D ++ DFG A+++ + +PN S
Sbjct: 153 SLAYIHSIG----ICHRDIKPQN-LLLDPPSGVLKLIDFGSAKILIAGEPNVS------- 200
Query: 466 GEFGYV------APE-------YSSTMVASLKGDVYGFGIVLLELLSGQKPL 504
Y+ APE Y++ + D++ G V+ EL+ GQ PL
Sbjct: 201 ----YICSRYYRAPELIFGATNYTTNI------DIWSTGCVMAELMQGQ-PL 241
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 59/233 (25%), Positives = 90/233 (38%), Gaps = 81/233 (34%)
Query: 309 GVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNR----LGQLRHPNLVPLLGFCVVEE 363
GV Y+A L +AIK++ Q + NR + +L H N+V L F
Sbjct: 68 GVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 120
Query: 364 ERL------LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGAS---------- 407
E+ LV ++P T+ V +R + +
Sbjct: 121 EKKDEVYLNLVLDYVPE--------------TVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 408 RGLAWLH-HGCQPPYMHQYI-SSNVILIDDDFDA-RITDFGLARLVGSRDPNDSSFVHGD 464
R LA++H G H+ I N +L+D D ++ DFG A+ + +PN S
Sbjct: 167 RSLAYIHSFG----ICHRDIKPQN-LLLDPDTAVLKLCDFGSAKQLVRGEPNVS------ 215
Query: 465 LGEFGYV------APE-------YSSTMVASLKGDVYGFGIVLLELLSGQKPL 504
Y+ APE Y+S++ DV+ G VL ELL GQ P+
Sbjct: 216 -----YICSRYYRAPELIFGATDYTSSI------DVWSAGCVLAELLLGQ-PI 256
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 58/291 (19%), Positives = 103/291 (35%), Gaps = 51/291 (17%)
Query: 309 GVSYKAVL-PDASALAIK--RLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER 365
GV +K P +A K L Q E+ L + P +V G + E
Sbjct: 47 GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106
Query: 366 LLVYKHMPNGTLYSLLHGNGV--DNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMH 423
+ +HM G+L +L G + L ++ + +GL +L + MH
Sbjct: 107 SICMEHMDGGSLDQVLKKAGRIPEQILG---------KVSIAVIKGLTYLREKHK--IMH 155
Query: 424 QYI-SSNVILIDDDFDARITDFGLA-RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA 481
+ + SN IL++ + ++ DFG++ +L+ S +SFV G Y++PE
Sbjct: 156 RDVKPSN-ILVNSRGEIKLCDFGVSGQLIDSMA---NSFV----GTRSYMSPERLQGTHY 207
Query: 482 SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGR 541
S++ D++ G+ L+E+ G+ P+ A+E + L
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 542 GNDDEIM---------------------QFLRVACS----CVVSRPKDRPS 567
G D F C++ P +R
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 318
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 25/109 (22%), Positives = 50/109 (45%), Gaps = 9/109 (8%)
Query: 71 IISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL 130
I L ++ + + +S+ + +++ + S+ + ++LP V +L L+ N L
Sbjct: 23 TIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQ-GI-QYLPNVTKLFLNGNKL 77
Query: 131 SGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
+ I P + K L L L NK+ + + L +LK S+ N +S
Sbjct: 78 TD-IKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 22/111 (19%), Positives = 46/111 (41%), Gaps = 9/111 (8%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNN 128
N I + ++ + + + + ++ L L+ N L+ I L L + L L N
Sbjct: 43 NSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT-DIK-PLTN-LKNLGWLFLDEN 97
Query: 129 HLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
+ + + + K L L L +N +S I + L +L+ + N ++
Sbjct: 98 KIKD-LSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT 144
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 2e-04
Identities = 11/85 (12%), Positives = 32/85 (37%), Gaps = 7/85 (8%)
Query: 95 LQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKL 154
+ + I D ++ +L ++ + E ++++I +N+ +
Sbjct: 1 MGETITVSTPIK-QIFPD--DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI 55
Query: 155 SGSIPFEVSRLDRLKEFSVAGNDLS 179
S+ + L + + + GN L+
Sbjct: 56 K-SVQG-IQYLPNVTKLFLNGNKLT 78
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 27/126 (21%), Positives = 41/126 (32%), Gaps = 19/126 (15%)
Query: 69 NRIISLT-------LSSMQLSGQL---PESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLP 118
N I + L S+ L L L +L L DN +S I L
Sbjct: 119 NGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DIVP--LAGLT 175
Query: 119 YVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDL 178
+ L LS NH+S + + K L+ L L + + S L +
Sbjct: 176 KLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV----KNT 229
Query: 179 SGTIPP 184
G++
Sbjct: 230 DGSLVT 235
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 9e-08
Identities = 25/106 (23%), Positives = 45/106 (42%), Gaps = 5/106 (4%)
Query: 73 SLTLSSMQLS-GQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLS 131
L L + + + G+L L+ L + L+ + L + +L+LS+N +S
Sbjct: 21 ELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS---IANLPKLNKLKKLELSDNRVS 77
Query: 132 GPIPPQIVECKFLNKLILSNNKLSG-SIPFEVSRLDRLKEFSVAGN 176
G + +C L L LS NK+ S + +L+ LK +
Sbjct: 78 GGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-05
Identities = 18/90 (20%), Positives = 36/90 (40%), Gaps = 6/90 (6%)
Query: 92 CHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLS--GPIPPQIVECKFLNKLIL 149
++ L L ++ + L + L N L+ +P + L KL L
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLEL 71
Query: 150 SNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
S+N++SG + + L +++GN +
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 1e-07
Identities = 39/200 (19%), Positives = 72/200 (36%), Gaps = 43/200 (21%)
Query: 323 AIKRLSACKLS----EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378
AIK + + ++ ++E+ QL+HP+++ L + LV + NG +
Sbjct: 40 AIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMN 99
Query: 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVI------- 431
L + A + + G Y+H S ++
Sbjct: 100 RYLKNRV------KPFSENE-------ARHFMHQIITGML--YLH---SHGILHRDLTLS 141
Query: 432 --LIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA----SLKG 485
L+ + + +I DFGLA + + G Y++PE + L+
Sbjct: 142 NLLLTRNMNIKIADFGLATQL----KMPHEKHYTLCGTPNYISPE----IATRSAHGLES 193
Query: 486 DVYGFGIVLLELLSGQKPLD 505
DV+ G + LL G+ P D
Sbjct: 194 DVWSLGCMFYTLLIGRPPFD 213
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 26/133 (19%), Positives = 50/133 (37%), Gaps = 21/133 (15%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGP 133
+ L + P + L+ +DLS+N +S + D + L + L L N ++
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE- 94
Query: 134 IPPQIVECKF-----LNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDLA 187
+P + F L L+L+ NK++ + + L L S+ N L
Sbjct: 95 LPKSL----FEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-------- 141
Query: 188 RFPEESFDGNSGL 200
+ +F +
Sbjct: 142 TIAKGTFSPLRAI 154
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 30/107 (28%), Positives = 49/107 (45%), Gaps = 9/107 (8%)
Query: 74 LTLSSMQLSGQLPESL--HLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLS 131
+ LS+ Q+S +L L SL SL L N ++ +P L + L + L L+ N ++
Sbjct: 61 IDLSNNQIS-ELAPDAFQGL-RSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN 117
Query: 132 GPIPPQI-VECKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGN 176
+ + LN L L +NKL +I S L ++ +A N
Sbjct: 118 C-LRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 24/109 (22%), Positives = 47/109 (43%), Gaps = 9/109 (8%)
Query: 71 IISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL 130
I L ++ + + +S+ + +++ + + +LP V +L L+ N L
Sbjct: 26 TIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQGIQ---YLPNVTKLFLNGNKL 80
Query: 131 SGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
+ I P + K L L L NK+ + + L +LK S+ N +S
Sbjct: 81 TD-IKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 22/111 (19%), Positives = 46/111 (41%), Gaps = 9/111 (8%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNN 128
N I + ++ + + + + ++ L L+ N L+ I L L + L L N
Sbjct: 46 NSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT-DIK-PLAN-LKNLGWLFLDEN 100
Query: 129 HLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
+ + + + K L L L +N +S I + L +L+ + N ++
Sbjct: 101 KVKD-LSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT 147
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 26/99 (26%), Positives = 44/99 (44%), Gaps = 9/99 (9%)
Query: 74 LTLSSMQLS-GQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L + + + G++ +L+ L L + L V LP + +L+LS N + G
Sbjct: 29 LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS---VSNLPKLPKLKKLELSENRIFG 85
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEF 171
+ + L L LS NKL ++S L+ LK+
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKLK-----DISTLEPLKKL 119
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 22/102 (21%), Positives = 38/102 (37%), Gaps = 12/102 (11%)
Query: 80 QLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLS--GPIPPQ 137
+L + P ++ + L L + + L + L L N L +P
Sbjct: 17 ELRNRTPAAV------RELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPK- 69
Query: 138 IVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
L KL LS N++ G + +L L +++GN L
Sbjct: 70 ---LPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 41/210 (19%), Positives = 66/210 (31%), Gaps = 54/210 (25%)
Query: 323 AIKRLSACKLSEKQ--FRSEMNRLGQLRHPNLVPLLGFCVVEEER----LLVYKHMPNGT 376
AIK + E L +L H N+V L F + EE +L+ + P G+
Sbjct: 38 AIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGS 95
Query: 377 LYSLLHGNGVDNTLS--GVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNV---- 430
LY++L L L + GM ++ + +
Sbjct: 96 LYTVLEEPSNAYGLPESEFLIVLRDVVGGMN---------------HLR---ENGIVHRN 137
Query: 431 -----ILIDDDFDAR----ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE-YSSTMV 480
I+ D + +TDFG AR + D G Y+ P+ Y ++
Sbjct: 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELE-----DDEQFVSLYGTEEYLHPDMYERAVL 192
Query: 481 ASLKGDVYG-------FGIVLLELLSGQKP 503
YG G+ +G P
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 27/195 (13%), Positives = 65/195 (33%), Gaps = 51/195 (26%)
Query: 334 EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGV 393
F++E+ + +++ + G +E ++Y++M N ++ V
Sbjct: 87 YDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV------- 139
Query: 394 LDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS--------NVI---------LIDDD 436
LD + I + + + ++S N+ L+D +
Sbjct: 140 LDKNYTCFIPIQVIKC-----------IIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN 188
Query: 437 FDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKG------DVYGF 490
+++DFG + + + G G + ++ PE ++ D++
Sbjct: 189 GRVKLSDFGESEYM------VDKKIKGSRGTYEFMPPE----FFSNESSYNGAKVDIWSL 238
Query: 491 GIVLLELLSGQKPLD 505
GI L + P
Sbjct: 239 GICLYVMFYNVVPFS 253
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 41/201 (20%), Positives = 84/201 (41%), Gaps = 22/201 (10%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSEK--QFRSEMNRLGQLRHPNLVPLLGFCVVEEER 365
G +K + +AIK + + ++ + E+ L Q P + G + + +
Sbjct: 36 GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95
Query: 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQ 424
++ +++ G+ LL +D T I +GL +LH +H+
Sbjct: 96 WIIMEYLGGGSALDLLEPGPLDETQIAT--------ILREILKGLDYLHSEKK----IHR 143
Query: 425 YISSNVILIDDDFDARITDFGL-ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASL 483
I + +L+ + + ++ DFG+ +L ++ + +FV G ++APE
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN-TFV----GTPFWMAPEVIKQSAYDS 198
Query: 484 KGDVYGFGIVLLELLSGQKPL 504
K D++ GI +EL G+ P
Sbjct: 199 KADIWSLGITAIELARGEPPH 219
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 41/210 (19%), Positives = 66/210 (31%), Gaps = 54/210 (25%)
Query: 323 AIKRLSACKLSEKQ--FRSEMNRLGQLRHPNLVPLLGFCVVEEER----LLVYKHMPNGT 376
AIK + E L +L H N+V L F + EE +L+ + P G+
Sbjct: 38 AIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGS 95
Query: 377 LYSLLHGNGVDNTLS--GVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNV---- 430
LY++L L L + GM ++ + +
Sbjct: 96 LYTVLEEPSNAYGLPESEFLIVLRDVVGGMN---------------HLR---ENGIVHRN 137
Query: 431 -----ILIDDDFDAR----ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE-YSSTMV 480
I+ D + +TDFG AR + D G Y+ P+ Y ++
Sbjct: 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELE-----DDEQFVSLYGTEEYLHPDMYERAVL 192
Query: 481 ASLKGDVYG-------FGIVLLELLSGQKP 503
YG G+ +G P
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 22/114 (19%), Positives = 50/114 (43%), Gaps = 9/114 (7%)
Query: 66 EKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDL 125
+ I +L+ ++ E + ++L L+L DN ++ + K L + +L+L
Sbjct: 38 ADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT-DLAP--LKNLTKITELEL 92
Query: 126 SNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
S N L + I + + L L++ +++ P + L L+ + N ++
Sbjct: 93 SGNPLKN-VSA-IAGLQSIKTLDLTSTQITDVTPL--AGLSNLQVLYLDLNQIT 142
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 22/107 (20%), Positives = 41/107 (38%), Gaps = 9/107 (8%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L Q++ L +LQ L + + +S P+ L + L +N +S
Sbjct: 133 VLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSDLTPL---ANLSKLTTLKADDNKISD 187
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
I P + L ++ L NN++S P L ++ ++
Sbjct: 188 -ISP-LASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 24/107 (22%), Positives = 43/107 (40%), Gaps = 9/107 (8%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L Q++ L +L + L+LS N L + L + LDL++ ++
Sbjct: 67 GLELKDNQIT-DLAPLKNL-TKITELELSGNPLKNVSAIA---GLQSIKTLDLTSTQITD 121
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
P + L L L N+++ P + L L+ S+ +S
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQITNISPL--AGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 16/114 (14%), Positives = 43/114 (37%), Gaps = 10/114 (8%)
Query: 71 IISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL 130
I + ++ + + +L ++ V L ++ L+L +N +
Sbjct: 21 AIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTIEGVQY---LNNLIGLELKDNQI 75
Query: 131 SGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP 184
+ + P + + +L LS N L ++ ++ L +K + ++ + P
Sbjct: 76 TD-LAP-LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQIT-DVTP 124
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 18/79 (22%), Positives = 32/79 (40%), Gaps = 5/79 (6%)
Query: 87 ESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNK 146
L L +L DN +S P+ L +++ L NN +S + P + L
Sbjct: 167 TPLANLSKLTTLKADDNKISDISPLASLPNL---IEVHLKNNQISD-VSP-LANTSNLFI 221
Query: 147 LILSNNKLSGSIPFEVSRL 165
+ L+N ++ F + L
Sbjct: 222 VTLTNQTITNQPVFYNNNL 240
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 43/199 (21%), Positives = 87/199 (43%), Gaps = 17/199 (8%)
Query: 308 TGVSYKAV-LPDASALAIKRLSACKLSEKQ-FRSEMNRLGQLRHPNLVPLLGFCVVEEER 365
TG+ A +A+K + K ++ +E+ + +H N+V + +V EE
Sbjct: 58 TGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117
Query: 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQY 425
++ + + G L ++ L+ + + LA+LH +H+
Sbjct: 118 WVLMEFLQGGALTDIVS--------QVRLNEEQIATVCEAVLQALAYLH---AQGVIHRD 166
Query: 426 ISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKG 485
I S+ IL+ D +++DFG + P S V G ++APE S + + +
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV----GTPYWMAPEVISRSLYATEV 222
Query: 486 DVYGFGIVLLELLSGQKPL 504
D++ GI+++E++ G+ P
Sbjct: 223 DIWSLGIMVIEMVDGEPPY 241
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 35/126 (27%), Positives = 59/126 (46%), Gaps = 13/126 (10%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L S +LS ++ H L+ L L+DN L ++P + K L + L +++N L
Sbjct: 41 KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA 99
Query: 133 PIPPQIVEC-KFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDLARFP 190
+P + + L +L L N+L S+P V L +L S+ N+L ++P +
Sbjct: 100 -LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV---- 152
Query: 191 EESFDG 196
FD
Sbjct: 153 ---FDK 155
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 30/98 (30%), Positives = 45/98 (45%), Gaps = 14/98 (14%)
Query: 94 SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKF-----LNKLI 148
+ LDL N LS S+P L + L L++N L +P I F L L
Sbjct: 38 DTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQT-LPAGI----FKELKNLETLW 91
Query: 149 LSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPD 185
+++NKL ++P V +L L E + N L ++PP
Sbjct: 92 VTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPR 127
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 8e-07
Identities = 28/184 (15%), Positives = 57/184 (30%), Gaps = 28/184 (15%)
Query: 331 KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM---PNGTLYSLLHGNGVD 387
S + ++ ++ + +G ++ +Y M L ++
Sbjct: 99 LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMN----R 154
Query: 388 NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYI-----SSNVILIDDDFDARIT 442
+ L I + + + +LH + SN I D ++
Sbjct: 155 RCSLEDREHGVCLHIFIQIAEAVEFLHS-------KGLMHRDLKPSN-IFFTMDDVVKVG 206
Query: 443 DFGLARLVGSRDPNDSSFVHGDLGEFG--------YVAPEYSSTMVASLKGDVYGFGIVL 494
DFGL + + + Y++PE S K D++ G++L
Sbjct: 207 DFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLIL 266
Query: 495 LELL 498
ELL
Sbjct: 267 FELL 270
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 38/206 (18%), Positives = 73/206 (35%), Gaps = 28/206 (13%)
Query: 324 IKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER--------LLVYKHMPNG 375
++ + K E+ E+ + +L HPN+V V + + LL ++ G
Sbjct: 47 CRQELSPKNRERWCL-EIQIMKKLNHPNVVSA--REVPDGLQKLAPNDLPLLAMEYCEGG 103
Query: 376 TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQYIS-SNVILI 433
L L+ L + S L +LH + +H+ + N++L
Sbjct: 104 DLRKYLNQFENCCGLKE----GPIRTLLSDISSALRYLHENR----IIHRDLKPENIVLQ 155
Query: 434 DDDFDAR--ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFG 491
I D G A+ + + +G Y+APE ++ D + FG
Sbjct: 156 PGPQRLIHKIIDLGYAKEL-----DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFG 210
Query: 492 IVLLELLSGQKPLDVAGAEEGFKGNL 517
+ E ++G +P + G +
Sbjct: 211 TLAFECITGFRPFLPNWQPVQWHGKV 236
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 22/129 (17%), Positives = 50/129 (38%), Gaps = 28/129 (21%)
Query: 94 SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPP----QIVECKFLNKLIL 149
L L++N + + K LP + +++ SNN ++ I +N+++L
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASG---VNEILL 88
Query: 150 SNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPD-----------------LARFPE 191
++N+L ++ ++ L+ LK + N ++ + D +
Sbjct: 89 TSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAP 146
Query: 192 ESFDGNSGL 200
+FD L
Sbjct: 147 GAFDTLHSL 155
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 43/199 (21%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 308 TGVSYKAV-LPDASALAIKRLSACKLSEKQ-FRSEMNRLGQLRHPNLVPLLGFCVVEEER 365
+G Y A+ + +AI++++ + +K+ +E+ + + ++PN+V L +V +E
Sbjct: 33 SGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92
Query: 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQY 425
+V +++ G+L ++ +D + + L +LH +H+
Sbjct: 93 WVVMEYLAGGSLTDVVTETCMDEGQIAA--------VCRECLQALEFLHSNQV---IHRD 141
Query: 426 ISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKG 485
I S+ IL+ D ++TDFG + S+ V G ++APE + K
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVTRKAYGPKV 197
Query: 486 DVYGFGIVLLELLSGQKPL 504
D++ GI+ +E++ G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPPY 216
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 34/126 (26%), Positives = 50/126 (39%), Gaps = 42/126 (33%)
Query: 421 YMHQYISSNVI---------LIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV 471
+H SNVI LI+ + D ++ DFGLAR++ ++S G +V
Sbjct: 127 VLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 472 ------APE-------YSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLV 518
APE YS M DV+ G +L EL +P+ F G
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAM------DVWSCGCILAELFLR-RPI--------FPGR-- 226
Query: 519 DWVNHL 524
D+ + L
Sbjct: 227 DYRHQL 232
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 40/195 (20%), Positives = 72/195 (36%), Gaps = 32/195 (16%)
Query: 323 AIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMP--NGTLYS 379
A+KR+ E+ L + HPN++ E++R Y + TL
Sbjct: 52 AVKRIL--PECFSFADREVQLLRESDEHPNVIRYFC---TEKDRQFQYIAIELCAATLQE 106
Query: 380 LLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQYI-SSNVILIDDDF 437
+ + L+ T L+ + GLA LH +H+ + N+++ +
Sbjct: 107 YVEQKDFAHLG---LEPITLLQ---QTTSGLAHLHSLN----IVHRDLKPHNILISMPNA 156
Query: 438 DAR----ITDFGLARLVGSRDPNDSSF--VHGDLGEFGYVAPEY---SSTMVASLKGDVY 488
+ I+DFGL + + SF G G G++APE + D++
Sbjct: 157 HGKIKAMISDFGLCKKL---AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIF 213
Query: 489 GFGIVLLELLSGQKP 503
G V ++S
Sbjct: 214 SAGCVFYYVISEGSH 228
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 20/82 (24%), Positives = 30/82 (36%), Gaps = 8/82 (9%)
Query: 90 HLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149
++D SDN + L + L L ++NN + L +LIL
Sbjct: 39 ATLDQFDAIDFSDNEIRKLDGFPLLRRLKT---LLVNNNRICRIGEGLDQALPDLTELIL 95
Query: 150 SNNKLSGSIPFEVSRLDRLKEF 171
+NN L E+ LD L
Sbjct: 96 TNNSLV-----ELGDLDPLASL 112
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 9e-06
Identities = 19/95 (20%), Positives = 32/95 (33%), Gaps = 8/95 (8%)
Query: 87 ESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLS--GPIPPQIVECKFL 144
+ LDL + I +L L +D S+N + P + L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIE-NLGATLDQFDAIDFSDNEIRKLDGFPL----LRRL 66
Query: 145 NKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
L+++NN++ L L E + N L
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 41/212 (19%), Positives = 71/212 (33%), Gaps = 50/212 (23%)
Query: 323 AIKRLSACKLS----EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378
A K + L ++ E++ L H ++V GF + +V + +L
Sbjct: 44 AGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLL 103
Query: 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS-------NVI 431
L + +R Y+ Q + VI
Sbjct: 104 ELHKRRK---------------ALTEPEARY-----------YLRQIVLGCQYLHRNRVI 137
Query: 432 ---------LIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVAS 482
+++D + +I DFGLA V D G Y+APE S S
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEY----DGERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 483 LKGDVYGFGIVLLELLSGQKPLDVAGAEEGFK 514
+ DV+ G ++ LL G+ P + + +E +
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 225
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 41/203 (20%), Positives = 68/203 (33%), Gaps = 50/203 (24%)
Query: 323 AIKRLSACKLS----EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378
A K + L ++ E++ L H ++V GF + +V + +L
Sbjct: 70 AGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLL 129
Query: 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS-------NVI 431
L L+ + R Y+ Q + VI
Sbjct: 130 ELHKRRK---ALT---EPEARY--------------------YLRQIVLGCQYLHRNRVI 163
Query: 432 ---------LIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVAS 482
+++D + +I DFGLA V D G Y+APE S S
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEY----DGERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 483 LKGDVYGFGIVLLELLSGQKPLD 505
+ DV+ G ++ LL G+ P +
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFE 242
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 3e-06
Identities = 51/190 (26%), Positives = 75/190 (39%), Gaps = 64/190 (33%)
Query: 340 EMNRLGQLRHPNLVPLLGFCVVEEERL-LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWST 398
E+ L QL+HPNLV LL + RL LV+++ D+T+ LD
Sbjct: 52 EIRMLKQLKHPNLVNLLE-VFRRKRRLHLVFEYC--------------DHTVLHELD--- 93
Query: 399 RLRIGMGAS----------RGLAWLH-HGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447
R + G+ + + + H H C +H+ + ILI ++ DFG A
Sbjct: 94 RYQRGVPEHLVKSITWQTLQAVNFCHKHNC----IHRDVKPENILITKHSVIKLCDFGFA 149
Query: 448 RLVGSRDPNDSSFVHGDLGEFGYV------APE-------YSSTMVASLKGDVYGFGIVL 494
RL+ P+D + V +PE Y + DV+ G V
Sbjct: 150 RLLTG--PSD-YYDD-------EVATRWYRSPELLVGDTQYGPPV------DVWAIGCVF 193
Query: 495 LELLSGQKPL 504
ELLSG PL
Sbjct: 194 AELLSG-VPL 202
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 42/189 (22%), Positives = 68/189 (35%), Gaps = 62/189 (32%)
Query: 340 EMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTR 399
E+ L QLRH NLV LL C ++ LV++ + D+T+ L+
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV--------------DHTILDDLE---L 116
Query: 400 LRIGMGAS----------RGLAWLH-HGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448
G+ G+ + H H +H+ I IL+ ++ DFG AR
Sbjct: 117 FPNGLDYQVVQKYLFQIINGIGFCHSHNI----IHRDIKPENILVSQSGVVKLCDFGFAR 172
Query: 449 LVGSRDPNDSSFVHGDLGEFGYV------APE-------YSSTMVASLKGDVYGFGIVLL 495
+ + + V APE Y + DV+ G ++
Sbjct: 173 TLAAPGE---VYDD-------EVATRWYRAPELLVGDVKYGKAV------DVWAIGCLVT 216
Query: 496 ELLSGQKPL 504
E+ G +PL
Sbjct: 217 EMFMG-EPL 224
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 45/210 (21%), Positives = 76/210 (36%), Gaps = 66/210 (31%)
Query: 323 AIKRLSACK-LSEKQF---RSEMNRLGQLRHPNLVPLLGFCVVEEERL-LVYKHMPNGTL 377
AIK L + E + E + + +L HP V L F ++E+L + NG L
Sbjct: 59 AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGEL 117
Query: 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASR--------GLAWLHHGCQPPYMHQYISSN 429
+ G +R L +LH
Sbjct: 118 LKYIRKIG---------------SFDETCTRFYTAEIVSALEYLH------------GKG 150
Query: 430 VI---------LIDDDFDARITDFGLARLVGSRDPND--SSFVHGDLGEFGYVAPEYSST 478
+I L+++D +ITDFG A+++ +SFV G YV+PE
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV----GTAQYVSPE---- 202
Query: 479 MVASLKG-----DVYGFGIVLLELLSGQKP 503
+ + K D++ G ++ +L++G P
Sbjct: 203 -LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 22/120 (18%), Positives = 50/120 (41%), Gaps = 12/120 (10%)
Query: 66 EKENRIISLTLSSMQLSGQ------LPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPY 119
E+ +++ ++L G + +L + + L LS N++ I L +
Sbjct: 15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSG-MEN 71
Query: 120 VVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
+ L L N + I L +L +S N+++ S+ + +L L+ ++ N ++
Sbjct: 72 LRILSLGRNLIKK-IENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKIT 128
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 6e-06
Identities = 19/94 (20%), Positives = 38/94 (40%), Gaps = 3/94 (3%)
Query: 86 PESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVE-CKFL 144
L +L L + + + + + L + L + + L + P L
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRL 82
Query: 145 NKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDL 178
++L LS N L S+ ++ + L+E ++GN L
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 7e-06
Identities = 21/82 (25%), Positives = 37/82 (45%), Gaps = 3/82 (3%)
Query: 74 LTLSSMQLSGQLP-ESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L + + Q L L L++L + + L + D + P + +L+LS N L
Sbjct: 36 LYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALES 94
Query: 133 PIPPQIVECKFLNKLILSNNKL 154
+ + V+ L +L+LS N L
Sbjct: 95 -LSWKTVQGLSLQELVLSGNPL 115
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 46/211 (21%), Positives = 72/211 (34%), Gaps = 70/211 (33%)
Query: 323 AIKRLSACKLSEK---QFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYS 379
AIK + +S + E+ L L HPN++ L F + LV + G L+
Sbjct: 66 AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD 125
Query: 380 LLHGNG----------VDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSN 429
+ + LSGV Y+H N
Sbjct: 126 EIIHRMKFNEVDAAVIIKQVLSGVT--------------------------YLH---KHN 156
Query: 430 V---------ILI---DDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE--- 474
+ +L+ + D +I DFGL+ + + + LG Y+APE
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-----ENQKKMKERLGTAYYIAPEVLR 211
Query: 475 --YSSTMVASLKGDVYGFGIVLLELLSGQKP 503
Y K DV+ G++L LL+G P
Sbjct: 212 KKYDE------KCDVWSIGVILFILLAGYPP 236
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 8e-06
Identities = 18/93 (19%), Positives = 37/93 (39%), Gaps = 7/93 (7%)
Query: 87 ESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNK 146
+ +L S++ + L V + N+++ + + L +
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVSQK---ELSGVQNFNGDNSNIQS-LAG-MQFFTNLKE 67
Query: 147 LILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
L LS+N++S + + L +L+E SV N L
Sbjct: 68 LHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK 98
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 17/109 (15%), Positives = 40/109 (36%), Gaps = 10/109 (9%)
Query: 71 IISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHL 130
+ L ++ S +Q+ + ++++ + L +L LS+N +
Sbjct: 21 AVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQSLAGMQFFTNL---KELHLSHNQI 75
Query: 131 SGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179
S + P + + L +L ++ N+L L + N+L
Sbjct: 76 SD-LSP-LKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELR 119
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 9e-06
Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 13/95 (13%)
Query: 96 QSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKF-----LNKLILS 150
L L+DN L L LP++V+L+L N L+G I P F + +L L
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNA----FEGASHIQELQLG 86
Query: 151 NNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPP 184
NK+ I ++ L +LK ++ N +S + P
Sbjct: 87 ENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMP 119
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 48/212 (22%), Positives = 74/212 (34%), Gaps = 71/212 (33%)
Query: 323 AIKRLSACKLSEK----QFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378
A+K +S ++ +K E+ L QL HPN++ L F + LV + G L+
Sbjct: 55 AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELF 114
Query: 379 SLLHGNG----------VDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS 428
+ + LSG+ YMH +
Sbjct: 115 DEIISRKRFSEVDAARIIRQVLSGIT--------------------------YMH---KN 145
Query: 429 NV---------ILI---DDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE-- 474
+ +L+ D + RI DFGL+ S + +G Y+APE
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-----EASKKMKDKIGTAYYIAPEVL 200
Query: 475 ---YSSTMVASLKGDVYGFGIVLLELLSGQKP 503
Y K DV+ G++L LLSG P
Sbjct: 201 HGTYDE------KCDVWSTGVILYILLSGCPP 226
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 47/241 (19%), Positives = 98/241 (40%), Gaps = 21/241 (8%)
Query: 269 SHKLVQVSLFQKPIVKVKLADLLAATN---SFAVENIIISTRTGVSYKAV-LPDASALAI 324
S + VQ+ + +K KL + F V + G YKA+ +AI
Sbjct: 1 SLETVQLRNPPRRQLK-KLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAI 59
Query: 325 KRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGN 384
K++ + ++ E++ + Q P++V G + +V ++ G++ ++
Sbjct: 60 KQVPV-ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR-- 116
Query: 385 GVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQYISSNVILIDDDFDARITD 443
+ L I +GL +LH +H+ I + IL++ + A++ D
Sbjct: 117 ----LRNKTLTEDEIATILQSTLKGLEYLHFMRK----IHRDIKAGNILLNTEGHAKLAD 168
Query: 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKP 503
FG+A + ++ + G ++APE + + D++ GI +E+ G+ P
Sbjct: 169 FGVAGQLTDTMAKRNTVI----GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
Query: 504 L 504
Sbjct: 225 Y 225
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 40/229 (17%), Positives = 75/229 (32%), Gaps = 72/229 (31%)
Query: 312 YKAVLPDASALAIKRLSACKLSEK---QFRSEMNRLGQLRHPNL--VPLLGFCVVEEERL 366
++ + AIK ++ + + +R+E+ L +L+ + + L + + ++ +
Sbjct: 73 FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-EITDQYI 131
Query: 367 LVYKHMPNGTLYSLLHGNG----------VDNTLSGVLDWSTRLRIGMGASRGLAWLHHG 416
+ N L S L N L V
Sbjct: 132 YMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH---------------------- 169
Query: 417 CQPPYMHQYISSNV---------ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGD--L 465
+HQ+ + LI D ++ DFG+A + D++ V D +
Sbjct: 170 ----TIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQM----QPDTTSVVKDSQV 217
Query: 466 GEFGYVAPE-----------YSSTMVASLKGDVYGFGIVLLELLSGQKP 503
G Y+ PE S S K DV+ G +L + G+ P
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 36/217 (16%), Positives = 71/217 (32%), Gaps = 48/217 (22%)
Query: 312 YKAVLPDASALAIKRLSACKLSEK---QFRSEMNRLGQLRHPNL--VPLLGFCVVEEERL 366
++ + AIK ++ + + +R+E+ L +L+ + + L + + ++ +
Sbjct: 45 FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-EITDQYI 103
Query: 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYI 426
+ N L S L +D R + +H
Sbjct: 104 YMVMECGNIDLNSWLKKKKS-------IDPWERKSYWKNMLEAVHTIH------------ 144
Query: 427 SSNV---------ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE--- 474
+ LI D ++ DFG+A + + S +G Y+ PE
Sbjct: 145 QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQM--QPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 475 --------YSSTMVASLKGDVYGFGIVLLELLSGQKP 503
S S K DV+ G +L + G+ P
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 28/136 (20%), Positives = 48/136 (35%), Gaps = 21/136 (15%)
Query: 73 SLTLSSMQLSGQLPE--SLHLCHSLQSLDLSDNSLSGSIPVDLCKWLP-YVVQLDLSNNH 129
L + + L P+ ++ L+++DN SIPV+ + L + L L NN
Sbjct: 109 FLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNG 167
Query: 130 LSGPIPPQIVECKFLNKLILSNNKLSGSIP---FE--VSRLDRLKEFSVAGNDLSGTIPP 184
+ + L+ + L+ NK I F S L D+S T
Sbjct: 168 FTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL--------DVSQT--- 215
Query: 185 DLARFPEESFDGNSGL 200
+ P + + L
Sbjct: 216 SVTALPSKGLEHLKEL 231
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 20/117 (17%), Positives = 35/117 (29%), Gaps = 4/117 (3%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
+L L L + ++ + +S + + L V +++ N
Sbjct: 35 TLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT 94
Query: 133 PIPPQI-VECKFLNKLILSNNKLSGSIPFE--VSRLDRLKEFSVAGNDLSGTIPPDL 186
I P E L L + N L P V D + N +IP +
Sbjct: 95 YIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 43/208 (20%), Positives = 80/208 (38%), Gaps = 30/208 (14%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSEKQ-FRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366
G YKA + A K + E + + E+ L HP +V LLG + +
Sbjct: 33 GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92
Query: 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQY 425
++ + P G + +++ L L + L +LH +H+
Sbjct: 93 IMIEFCPGGAVDAIM------LELDRGLTEPQIQVVCRQMLEALNFLHSKRI----IHRD 142
Query: 426 ISSNVILIDDDFDARITDFGL-ARLVGSRDPNDSSFVHGDLGEFG---YVAPEYSSTMVA 481
+ + +L+ + D R+ DFG+ A+ + + D SF+ G ++APE
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD-SFI-------GTPYWMAPEVVMCETM 194
Query: 482 SLKG-----DVYGFGIVLLELLSGQKPL 504
D++ GI L+E+ + P
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEPPH 222
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 24/78 (30%), Positives = 36/78 (46%), Gaps = 15/78 (19%)
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKG----- 485
IL+D+ RI+D GLA + P+ + V G GY+APE ++
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKPH--ASV----GTHGYMAPE----VLQKGVAYDSSA 372
Query: 486 DVYGFGIVLLELLSGQKP 503
D + G +L +LL G P
Sbjct: 373 DWFSLGCMLFKLLRGHSP 390
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 47/235 (20%), Positives = 83/235 (35%), Gaps = 65/235 (27%)
Query: 296 SFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEK---------QFRSEMNRLGQ 346
+ + +T AI+ +S K + +E+ L +
Sbjct: 147 ACGEVKLAFERKTCKKV----------AIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 347 LRHPNLVPLLGFCVVEEERL-LVYKHMPNGTLYSLLHGNG----------VDNTLSGVLD 395
L HP ++ + + E +V + M G L+ + GN L V
Sbjct: 197 LNHPCIIKIKN--FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV-- 252
Query: 396 WSTRLRIGMGASRGLAWLH-HGCQPPYMHQYISS-NVILIDDDFDAR--ITDFGLARLVG 451
+LH +G +H+ + NV+L + D ITDFG ++++G
Sbjct: 253 ---------------QYLHENGI----IHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293
Query: 452 SRDPNDSSFVHGDLGEFGYVAPE---YSSTMVASLKGDVYGFGIVLLELLSGQKP 503
++S + G Y+APE T + D + G++L LSG P
Sbjct: 294 -----ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 29/152 (19%), Positives = 50/152 (32%), Gaps = 20/152 (13%)
Query: 56 CRLTGVACWNEKENRI--------ISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSG 107
C C K I I L +L + L+ +++S N +
Sbjct: 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 108 SIPVDLCKWLPYVVQLDLSN-NHLSGPIPPQI-VECKFLNKLILSNNKLSGSIP-FEVSR 164
I D+ LP + ++ + N+L I P+ L L++SN + +P
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLY-INPEAFQNLPNLQYLLISNTGIK-HLPDVHKIH 126
Query: 165 LDRLKEFSVAGNDLSGTIPPDLARFPEESFDG 196
+ + N TI + SF G
Sbjct: 127 SLQKVLLDIQDNINIHTIERN-------SFVG 151
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 21/103 (20%), Positives = 36/103 (34%), Gaps = 7/103 (6%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNN 128
+ L L+ + + + + +N+L +P D+ V LD+S
Sbjct: 154 FESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRT 212
Query: 129 HLSGPIPPQIVECKFLNKL-ILSNNKLSGSIPFEVSRLDRLKE 170
+ +P +E L KL S L E +L L E
Sbjct: 213 RIH-SLPSYGLEN--LKKLRARSTYNLKKLPTLE--KLVALME 250
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 25/91 (27%), Positives = 40/91 (43%), Gaps = 16/91 (17%)
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGF 490
IL+D+ ITDF +A ++ ++ G Y+APE M +S KG Y F
Sbjct: 146 ILLDEHGHVHITDFNIAAMLPRETQI-TTMA----GTKPYMAPE----MFSSRKGAGYSF 196
Query: 491 -------GIVLLELLSGQKPLDVAGAEEGFK 514
G+ ELL G++P + + +
Sbjct: 197 AVDWWSLGVTAYELLRGRRPYHIRSSTSSKE 227
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 22/80 (27%), Positives = 37/80 (46%), Gaps = 18/80 (22%)
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYG- 489
+L+DDD + RI+D GLA + + + G G++APE L G+ Y
Sbjct: 320 VLLDDDGNVRISDLGLAVELKAGQTKTKGYA----GTPGFMAPEL-------LLGEEYDF 368
Query: 490 ------FGIVLLELLSGQKP 503
G+ L E+++ + P
Sbjct: 369 SVDYFALGVTLYEMIAARGP 388
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 33/126 (26%), Positives = 53/126 (42%), Gaps = 49/126 (38%)
Query: 421 YMHQYISSNVI---------LIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV 471
Y+H S+NV+ L++ D +I DFGLAR+ + G L E YV
Sbjct: 143 YIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT-----GFLTE--YV 192
Query: 472 ------APE-------YSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLV 518
APE Y+ ++ D++ G +L E+LS +P+ F G
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSI------DIWSVGCILAEMLSN-RPI--------FPGK-- 235
Query: 519 DWVNHL 524
+++ L
Sbjct: 236 HYLDQL 241
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 40/229 (17%), Positives = 75/229 (32%), Gaps = 72/229 (31%)
Query: 312 YKAVLPDASALAIKRLSACKLSEK---QFRSEMNRLGQLRHPNL--VPLLGFCVVEEERL 366
++ + AIK ++ + + +R+E+ L +L+ + + L + + ++ +
Sbjct: 26 FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-EITDQYI 84
Query: 367 LVYKHMPNGTLYSLLHGNG----------VDNTLSGVLDWSTRLRIGMGASRGLAWLHHG 416
+ N L S L N L V
Sbjct: 85 YMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH---------------------- 122
Query: 417 CQPPYMHQYISSNV---------ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGD--L 465
+HQ+ + LI D ++ DFG+A + D++ V D +
Sbjct: 123 ----TIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQM----QPDTTSVVKDSQV 170
Query: 466 GEFGYVAPE-----------YSSTMVASLKGDVYGFGIVLLELLSGQKP 503
G Y+ PE S S K DV+ G +L + G+ P
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 33/128 (25%), Positives = 52/128 (40%), Gaps = 20/128 (15%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L Q++ P +L+ L L N L ++PV + L + LDL N L+
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 133 PIPPQIVECKF-----LNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLA 187
+P + F L +L + NKL+ +P + RL L ++ N L
Sbjct: 103 -LPSAV----FDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-------- 148
Query: 188 RFPEESFD 195
P +FD
Sbjct: 149 SIPHGAFD 156
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 27/137 (19%), Positives = 48/137 (35%), Gaps = 53/137 (38%)
Query: 421 YMHQYISSNVI---------LIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEF--- 468
Y+H S ++ L++ + ++ DFGL+R + ++
Sbjct: 124 YLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 469 --------GYV------APE-------YSSTMVASLKGDVYGFGIVLLELLSGQKPLDVA 507
YV APE Y+ + D++ G +L E+L G KP+
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGI------DMWSLGCILGEILCG-KPI--- 230
Query: 508 GAEEGFKGNLVDWVNHL 524
F G+ +N L
Sbjct: 231 -----FPGS--STMNQL 240
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 26/153 (16%), Positives = 48/153 (31%), Gaps = 47/153 (30%)
Query: 421 YMHQYISSNVI---------LIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEF--- 468
++H S +I L++ D ++ DFGLAR + S + + E
Sbjct: 144 FIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 469 ---------GYV------APE-------YSSTMVASLKGDVYGFGIVLLELLSGQKPLDV 506
+V APE Y+ ++ D++ G + ELL+ +
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSI------DIWSTGCIFAELLNMLQSHIN 254
Query: 507 AGAEEG--FKGN--LVDWVNHLVIAGRSRDVVD 535
F G+ + + D
Sbjct: 255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRD 287
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 26/80 (32%), Positives = 35/80 (43%), Gaps = 19/80 (23%)
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYG- 489
IL+DD RI+D GLA V V G GY+APE +K + Y
Sbjct: 317 ILLDDHGHIRISDLGLAVHVPEGQTI-KGRV----GTVGYMAPEV-------VKNERYTF 364
Query: 490 ------FGIVLLELLSGQKP 503
G +L E+++GQ P
Sbjct: 365 SPDWWALGCLLYEMIAGQSP 384
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 48/204 (23%), Positives = 78/204 (38%), Gaps = 53/204 (25%)
Query: 323 AIKRLSACKLSE---KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL--LVYKHMPNGTL 377
AIK + +L+ ++ E+ + L HPN+V L F V+E E+ L+ ++ G +
Sbjct: 44 AIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEV 101
Query: 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAW-LHHGCQPPYMHQYISSNV------ 430
+ L +G R+ +R + Q Y HQ +
Sbjct: 102 FDYLVAHG---------------RMKEKEARSKFRQIVSAVQ--YCHQK---RIVHRDLK 141
Query: 431 ---ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE------YSSTMVA 481
+L+D D + +I DFG + + G Y APE Y V
Sbjct: 142 AENLLLDADMNIKIADFGFSNEF-----TVGGKLDAFCGAPPYAAPELFQGKKYDGPEV- 195
Query: 482 SLKGDVYGFGIVLLELLSGQKPLD 505
DV+ G++L L+SG P D
Sbjct: 196 ----DVWSLGVILYTLVSGSLPFD 215
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 39/212 (18%), Positives = 69/212 (32%), Gaps = 67/212 (31%)
Query: 319 ASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378
+ ++ +E++ L L HPN++ L ++ LV + G L+
Sbjct: 75 DKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELF 134
Query: 379 SLLHGNG----------VDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS 428
+ + LSG+ Y+H
Sbjct: 135 EQIINRHKFDECDAANIMKQILSGIC--------------------------YLH---KH 165
Query: 429 NV---------ILI---DDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE-- 474
N+ IL+ + + +I DFGL+ + + LG Y+APE
Sbjct: 166 NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF-----SKDYKLRDRLGTAYYIAPEVL 220
Query: 475 ---YSSTMVASLKGDVYGFGIVLLELLSGQKP 503
Y+ K DV+ G+++ LL G P
Sbjct: 221 KKKYNE------KCDVWSCGVIMYILLCGYPP 246
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 45/203 (22%), Positives = 71/203 (34%), Gaps = 45/203 (22%)
Query: 323 AIKRLSACKLSEK----QFRSEMNRLGQLRHPNLVPLLGFCVVEEERL-LVYKHMPNGTL 377
A+K ++ + ++ FR E + L + L F +E L LV ++ G L
Sbjct: 90 AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDL 148
Query: 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASR--------GLAWLH-HGCQPPYMHQYISS 428
+LL G RI +R + +H G Y+H+ I
Sbjct: 149 LTLLSKFGE--------------RIPAEMARFYLAEIVMAIDSVHRLG----YVHRDIKP 190
Query: 429 NVILIDDDFDARITDFGLA-RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDV 487
+ IL+D R+ DFG +L V G Y++PE +
Sbjct: 191 DNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV----GTPDYLSPEILQAVGGGPGTGS 246
Query: 488 YG-------FGIVLLELLSGQKP 503
YG G+ E+ GQ P
Sbjct: 247 YGPECDWWALGVFAYEMFYGQTP 269
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 45/276 (16%), Positives = 92/276 (33%), Gaps = 103/276 (37%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSEKQFRS-EMNRLGQLRHPNLVPLLGFCVVEEERL 366
G+ + + A+K++ L + ++++ E++ + L H N++ L+ + +
Sbjct: 21 GIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76
Query: 367 LVYKHMPNGTLYSLLHGNG------------------------VDNTLSGVLDWSTRLRI 402
P+ NG V +TL VL R
Sbjct: 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGR 136
Query: 403 GMGAS----------RGLAWLHHGCQPPYMHQYISSNV---------ILID-DDFDARIT 442
+ + R + ++H S + +L++ D ++
Sbjct: 137 SIPMNLISIYIYQLFRAVGFIH------------SLGICHRDIKPQNLLVNSKDNTLKLC 184
Query: 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYV------APE-------YSSTMVASLKGDVYG 489
DFG A+ + +P+ + Y+ APE Y+ ++ D++
Sbjct: 185 DFGSAKKLIPSEPSVA-----------YICSRFYRAPELMLGATEYTPSI------DLWS 227
Query: 490 FGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV 525
G V EL+ G+ PL F G ++ LV
Sbjct: 228 IGCVFGELILGK-PL--------FSGE--TSIDQLV 252
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 36/187 (19%), Positives = 68/187 (36%), Gaps = 57/187 (30%)
Query: 340 EMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTR 399
E+ L +L+H N+V L +++ LV++ D L D
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC--------------DQDLKKYFD---S 93
Query: 400 LRIGMGAS----------RGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449
+ +GL + H +H+ + +LI+ + + ++ +FGLAR
Sbjct: 94 CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA 150
Query: 450 VGSRDPNDSSFVHGDLGEFGYV-----APE-------YSSTMVASLKGDVYGFGIVLLEL 497
G S+ V V P+ YS+++ D++ G + EL
Sbjct: 151 FGIPVRCYSAEV---------VTLWYRPPDVLFGAKLYSTSI------DMWSAGCIFAEL 195
Query: 498 LSGQKPL 504
+ +PL
Sbjct: 196 ANAGRPL 202
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 28/126 (22%), Positives = 46/126 (36%), Gaps = 53/126 (42%)
Query: 421 YMHQYISSNVI---------LIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV 471
+H + V+ L+ D+ D I DF LAR + D N + YV
Sbjct: 149 VLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTA-DANKT----------HYV 194
Query: 472 ------APE-------YSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLV 518
APE ++ + D++ G V+ E+ + K L F+G+
Sbjct: 195 THRWYRAPELVMQFKGFTKLV------DMWSAGCVMAEMFNR-KAL--------FRGS-- 237
Query: 519 DWVNHL 524
+ N L
Sbjct: 238 TFYNQL 243
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 35/193 (18%), Positives = 70/193 (36%), Gaps = 58/193 (30%)
Query: 340 EMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTL---YSLLHGNGVDNTLSGVLDW 396
E+ L L+H N+V L+ + + + + L + ++ L+G+L
Sbjct: 66 EIKILQLLKHENVVNLIE--ICRTKASPYNRCKGSIYLVFDF-------CEHDLAGLLS- 115
Query: 397 STRLRIGMGAS----------RGLAWLHHGCQPPYMHQYI-SSNVILIDDDFDARITDFG 445
+ + S GL ++H +H+ + ++N +LI D ++ DFG
Sbjct: 116 --NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAAN-VLITRDGVLKLADFG 169
Query: 446 LARLVGSRDPNDSSFVHGDLGEFG-------YVAPE-------YSSTMVASLKGDVYGFG 491
LAR + + Y PE Y + D++G G
Sbjct: 170 LARAFSLAKNSQP-------NRYTNRVVTLWYRPPELLLGERDY-GPPI-----DLWGAG 216
Query: 492 IVLLELLSGQKPL 504
++ E+ + P+
Sbjct: 217 CIMAEMWTR-SPI 228
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 48/193 (24%), Positives = 78/193 (40%), Gaps = 33/193 (17%)
Query: 322 LAIKRLSACKLSEKQ-FRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
A K + S+K+ R E+ + LRHP LV L + E +++Y+ M G L+
Sbjct: 185 FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEK 244
Query: 381 LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQPPYMHQYIS-SNVILIDDDFD 438
+ N +S + +R GL +H + Y+H + N++ +
Sbjct: 245 V--ADEHNKMSE-DEAVEYMRQVCK---GLCHMHENN----YVHLDLKPENIMFTTKRSN 294
Query: 439 A-RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGF------- 490
++ DFGL + DP S V G + APE V +G G+
Sbjct: 295 ELKLIDFGLTAHL---DPKQS--VKVTTGTAEFAAPE-----V--AEGKPVGYYTDMWSV 342
Query: 491 GIVLLELLSGQKP 503
G++ LLSG P
Sbjct: 343 GVLSYILLSGLSP 355
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 35/212 (16%), Positives = 67/212 (31%), Gaps = 71/212 (33%)
Query: 322 LAIKRLSACKLSEKQ-FRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSL 380
K ++ +K ++E++ + QL HP L+ L + E +L+ + + G L+
Sbjct: 79 FVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDR 138
Query: 381 LHGNGVDNT-----------LSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSN 429
+ + G+ +MH +
Sbjct: 139 IAAEDYKMSEAEVINYMRQACEGLK--------------------------HMH---EHS 169
Query: 430 V---------ILIDDDFDARI--TDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST 478
+ I+ + + + DFGLA + N V + APE
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKL-----NPDEIVKVTTATAEFAAPE---- 220
Query: 479 MVASLKGDVYGF-------GIVLLELLSGQKP 503
+ + + GF G++ LLSG P
Sbjct: 221 -I--VDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 26/119 (21%), Positives = 43/119 (36%), Gaps = 40/119 (33%)
Query: 421 YMHQYISSNV---------ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV 471
++H S+ + I++ D +I DFGLAR G+ + YV
Sbjct: 142 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---------MMTP--YV 187
Query: 472 ------APEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524
APE M D++ G ++ E++ G L F G D ++
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVL--------FPGT--DHIDQW 235
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 36/129 (27%), Positives = 53/129 (41%), Gaps = 21/129 (16%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L S L+ + L L+L N L ++ + L + L L+NN L+
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLAS 97
Query: 133 PIPPQIVECKF-----LNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDL 186
+P + F L+KL L N+L S+P V RL +LKE + N L
Sbjct: 98 -LPLGV----FDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ------- 144
Query: 187 ARFPEESFD 195
P +FD
Sbjct: 145 -SIPAGAFD 152
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.0 bits (100), Expect = 2e-04
Identities = 23/150 (15%), Positives = 49/150 (32%), Gaps = 17/150 (11%)
Query: 55 ICRLTGVACWNEKENRIISLTLSSMQLSGQLPESL--HLCHSLQSLDL---SDNSLSGSI 109
I ++ + + SL + S L + E + +L+ L L ++
Sbjct: 179 IKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGD 238
Query: 110 PVDLCKWL-----PYVVQLDLSNNHLSGPIPPQIVECKFLNKLI---LSNNKLSGS---- 157
P + L + + + +E L +L +S L+
Sbjct: 239 MNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARL 298
Query: 158 IPFEVSRLDRLKEFSVAGNDLSGTIPPDLA 187
+ V ++ LK ++ N LS + +L
Sbjct: 299 LLDHVDKIKHLKFINMKYNYLSDEMKKELQ 328
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 23/124 (18%), Positives = 47/124 (37%), Gaps = 28/124 (22%)
Query: 340 EMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTR 399
E++ L +L+H N++ L L++++ +N L +D +
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA--------------ENDLKKYMDKNPD 128
Query: 400 LRIGMGAS------RGLAWLHHGCQPPYMHQYISSNVILIDDDFDAR-----ITDFGLAR 448
+ + + S G+ + H +H+ + +L+ + I DFGLAR
Sbjct: 129 VSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
Query: 449 LVGS 452
G
Sbjct: 186 AFGI 189
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 26/119 (21%), Positives = 43/119 (36%), Gaps = 40/119 (33%)
Query: 421 YMHQYISSNV---------ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV 471
++H S+ + I++ D +I DFGLAR G+ YV
Sbjct: 179 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT-----------PYV 224
Query: 472 ------APEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524
APE M D++ G ++ E++ K L F G D+++
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KIL--------FPGR--DYIDQW 272
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 3e-04
Identities = 22/79 (27%), Positives = 38/79 (48%), Gaps = 11/79 (13%)
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE-YSSTMVASLKG---- 485
IL+DDD + ++TDFG + + + G Y+APE +M + G
Sbjct: 155 ILLDDDMNIKLTDFGFSCQLD-----PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKE 209
Query: 486 -DVYGFGIVLLELLSGQKP 503
D++ G+++ LL+G P
Sbjct: 210 VDMWSTGVIMYTLLAGSPP 228
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 55/236 (23%), Positives = 93/236 (39%), Gaps = 50/236 (21%)
Query: 297 FAVENIIISTRT-GVSYKAVLPDAS---ALAIKRLSACKLSEKQFRSEMNRLGQLRHPNL 352
F E + T G YKA D A+K++ +S R E+ L +L+HPN+
Sbjct: 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-EIALLRELKHPNV 80
Query: 353 VPLLGFCVVEEERL--LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGAS--- 407
+ L + +R L++ + + L+ ++ + +L GM S
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKK----PVQLPRGMVKSLLY 135
Query: 408 ---RGLAWLH-HGCQPPYMHQYI-SSNVILIDDDFDAR----ITDFGLARLVGSRDPNDS 458
G+ +LH + +H+ + +N IL+ + R I D G ARL S P
Sbjct: 136 QILDGIHYLHANW----VLHRDLKPAN-ILVMGEGPERGRVKIADMGFARLFNS--PLK- 187
Query: 459 SFVHGDLGE---FGYVAPE-------YSSTMVASLKGDVYGFGIVLLELLSGQKPL 504
D F Y APE Y+ + D++ G + ELL+ +P+
Sbjct: 188 PLADLD-PVVVTFWYRAPELLLGARHYTKAI------DIWAIGCIFAELLTS-EPI 235
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 31/126 (24%), Positives = 53/126 (42%), Gaps = 55/126 (43%)
Query: 421 YMHQYISSNV---------ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV 471
Y+H S+ V + +++D + +I DFGLAR + ++ YV
Sbjct: 141 YIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----------EMTG--YV 184
Query: 472 ------APE-------YSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLV 518
APE Y+ T+ D++ G ++ E+L+G K L FKG
Sbjct: 185 VTRWYRAPEVILSWMHYNQTV------DIWSVGCIMAEMLTG-KTL--------FKGK-- 227
Query: 519 DWVNHL 524
D+++ L
Sbjct: 228 DYLDQL 233
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 31/126 (24%), Positives = 52/126 (41%), Gaps = 55/126 (43%)
Query: 421 YMHQYISSNVI---------LIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV 471
Y+H ++ +I +++D + +I DFGLAR S GYV
Sbjct: 143 YIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT-------------GYV 186
Query: 472 ------APE-------YSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLV 518
APE Y+ T+ D++ G ++ E+++G K L FKG+
Sbjct: 187 VTRWYRAPEVILNWMRYTQTV------DIWSVGCIMAEMITG-KTL--------FKGS-- 229
Query: 519 DWVNHL 524
D ++ L
Sbjct: 230 DHLDQL 235
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 45/219 (20%), Positives = 80/219 (36%), Gaps = 47/219 (21%)
Query: 309 GVSYKAV-LPDASALAIK--RLSACKLSEKQFRSEMN-RLGQLRHPNLVPLLGFCVVEEE 364
GV K +P +A+K R + +K+ +++ + + P V G E +
Sbjct: 21 GVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80
Query: 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRL------RIGMGASRGLAWLHHGCQ 418
+ + M +D V+D + +I + + L LH
Sbjct: 81 VWICMELM----------DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130
Query: 419 PPYMHQYI-SSNVILIDDDFDARITDFGL-ARLVGSRDPNDSSFVHGDLGEFGYVAPE-- 474
+H+ + SN +LI+ ++ DFG+ LV + G Y+APE
Sbjct: 131 --VIHRDVKPSN-VLINALGQVKMCDFGISGYLVDDVAKD--IDA----GCKPYMAPERI 181
Query: 475 --------YSSTMVASLKGDVYGFGIVLLELLSGQKPLD 505
YS K D++ GI ++EL + P D
Sbjct: 182 NPELNQKGYSV------KSDIWSLGITMIELAILRFPYD 214
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 25/84 (29%), Positives = 35/84 (41%), Gaps = 21/84 (25%)
Query: 429 NVILIDDDFDAR--ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGD 486
N++ DA I DFGL+++V + G GY APE + L+G
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVE-----HQVLMKTVCGTPGYCAPE-----I--LRGC 225
Query: 487 VYG-------FGIVLLELLSGQKP 503
YG GI+ LL G +P
Sbjct: 226 AYGPEVDMWSVGIITYILLCGFEP 249
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 39/205 (19%), Positives = 74/205 (36%), Gaps = 46/205 (22%)
Query: 323 AIK-----RLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER--LLVYKHMPNG 375
A+K +L E + E+ L +LRH N++ L+ EE++ +V ++ G
Sbjct: 34 AVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG 93
Query: 376 TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASR--------GLAWLH-HGCQPPYMHQYI 426
+ +LD R + + GL +LH G +H+ I
Sbjct: 94 --------------MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG----IVHKDI 135
Query: 427 SSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKG- 485
+L+ +I+ G+A + +D G + PE + L
Sbjct: 136 KPGNLLLTTGGTLKISALGVAEALHPFAADD--TCRTSQGSPAFQPPE----IANGLDTF 189
Query: 486 -----DVYGFGIVLLELLSGQKPLD 505
D++ G+ L + +G P +
Sbjct: 190 SGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 25/127 (19%), Positives = 45/127 (35%), Gaps = 50/127 (39%)
Query: 421 YMHQYISSNVI---------LID-DDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGY 470
Y+H S+NV+ I+ +D +I DFGLAR++ +
Sbjct: 135 YIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS-------EG 184
Query: 471 V------APE-------YSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNL 517
+ +P Y+ + D++ G + E+L+G K L F G
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAI------DMWAAGCIFAEMLTG-KTL--------FAGA- 228
Query: 518 VDWVNHL 524
+ +
Sbjct: 229 -HELEQM 234
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 23/75 (30%), Positives = 34/75 (45%), Gaps = 16/75 (21%)
Query: 434 DDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE-----YSSTMVASLKGDVY 488
+ D D +I DFGL+ ++ + +G Y+APE Y K DV+
Sbjct: 158 EKDCDIKIIDFGLSTCF-----QQNTKMKDRIGTAYYIAPEVLRGTYDE------KCDVW 206
Query: 489 GFGIVLLELLSGQKP 503
G++L LLSG P
Sbjct: 207 SAGVILYILLSGTPP 221
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 29/105 (27%), Positives = 49/105 (46%), Gaps = 16/105 (15%)
Query: 408 RGLAWLHHGCQPPYMHQYI-SSNVILIDDDFDARITDFGL-ARLVGSRDPNDSSFVHGDL 465
+ L +L + +H+ + SN IL+D+ ++ DFG+ RLV + +
Sbjct: 135 KALYYLKE--KHGVIHRDVKPSN-ILLDERGQIKLCDFGISGRLVDDKAKD--RSA---- 185
Query: 466 GEFGYVAPE-----YSSTMVASLKGDVYGFGIVLLELLSGQKPLD 505
G Y+APE + ++ DV+ GI L+EL +GQ P
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 5e-04
Identities = 40/188 (21%), Positives = 70/188 (37%), Gaps = 60/188 (31%)
Query: 340 EMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTR 399
E++ L L+H N+V L E+ LV++++ D L LD
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL--------------DKDLKQYLD---D 92
Query: 400 LRIGMGAS----------RGLAWLH-HGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448
+ RGLA+ H +H+ + +LI++ + ++ DFGLAR
Sbjct: 93 CGNIINMHNVKLFLFQLLRGLAYCHRQKV----LHRDLKPQNLLINERGELKLADFGLAR 148
Query: 449 LVGSRDPNDSSFVHGDLGEFGYV-----APE-------YSSTMVASLKGDVYGFGIVLLE 496
+ V V P+ YS+ + D++G G + E
Sbjct: 149 AKSIPTKTYDNEV---------VTLWYRPPDILLGSTDYSTQI------DMWGVGCIFYE 193
Query: 497 LLSGQKPL 504
+ +G +PL
Sbjct: 194 MATG-RPL 200
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 41.3 bits (98), Expect = 5e-04
Identities = 29/123 (23%), Positives = 53/123 (43%), Gaps = 30/123 (24%)
Query: 340 EMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTR 399
E++ L +L+H N+V L ++ +LV++H+ D L +LD
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKRLVLVFEHL--------------DQDLKKLLD---V 92
Query: 400 LRIGMGAS----------RGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449
G+ + G+A+ H +H+ + +LI+ + + +I DFGLAR
Sbjct: 93 CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA 149
Query: 450 VGS 452
G
Sbjct: 150 FGI 152
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 6e-04
Identities = 49/227 (21%), Positives = 83/227 (36%), Gaps = 69/227 (30%)
Query: 309 GVSYKAV-LPDASALAIK--RLSACKLSEKQFRS----EMNRLGQLRHPNLVPLLGFCVV 361
YKA +AIK +L ++ E+ L +L HPN++ LL
Sbjct: 24 ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD-AFG 82
Query: 362 EEERL-LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGAS----------RGL 410
+ + LV+ M + L ++ + + S +GL
Sbjct: 83 HKSNISLVFDFM--------------ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGL 125
Query: 411 AWLH-HGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFG 469
+LH H +H+ + N +L+D++ ++ DFGLA+ GS + + V
Sbjct: 126 EYLHQHWI----LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-------- 173
Query: 470 YV-----APE-------YSSTMVASLKGDVYGFGIVLLELLSGQKPL 504
V APE Y + D++ G +L ELL P
Sbjct: 174 -VTRWYRAPELLFGARMYGVGV------DMWAVGCILAELLLR-VPF 212
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 46/213 (21%), Positives = 84/213 (39%), Gaps = 33/213 (15%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLG-----FCVV 361
G YK + AIK + E++ + E+N L + H N+ G
Sbjct: 38 GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97
Query: 362 EEERL-LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH-HGCQP 419
+++L LV + G++ L+ NT L I RGL+ LH H
Sbjct: 98 MDDQLWLVMEFCGAGSVTDLIK-----NTKGNTLKEEWIAYICREILRGLSHLHQHKV-- 150
Query: 420 PYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFG---YVAPEYS 476
+H+ I +L+ ++ + ++ DFG++ + ++F+ G ++APE
Sbjct: 151 --IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-------GTPYWMAPEVI 201
Query: 477 STMVASLKG-----DVYGFGIVLLELLSGQKPL 504
+ D++ GI +E+ G PL
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 6e-04
Identities = 46/187 (24%), Positives = 76/187 (40%), Gaps = 58/187 (31%)
Query: 340 EMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTR 399
E++ L +L HPN+V L+ E LV++ M + L VLD
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFM--------------EKDLKKVLD---E 111
Query: 400 LRIGMGAS----------RGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449
+ G+ S RG+A H +H+ + +LI+ D ++ DFGLAR
Sbjct: 112 NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARA 168
Query: 450 VGSRDPNDSSFVHGDLGEFGYV-----APE-------YSSTMVASLKGDVYGFGIVLLEL 497
G + + V V AP+ YS+++ D++ G + E+
Sbjct: 169 FGIPVRSYTHEV---------VTLWYRAPDVLMGSKKYSTSV------DIWSIGCIFAEM 213
Query: 498 LSGQKPL 504
++G KPL
Sbjct: 214 ITG-KPL 219
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 26/92 (28%), Positives = 40/92 (43%), Gaps = 13/92 (14%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L Q + +P+ L L +DLS+N +S ++ + ++ L LS N L
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRC 92
Query: 133 PIPPQIVECKF-----LNKLILSNNKLSGSIP 159
IPP+ F L L L N +S +P
Sbjct: 93 -IPPRT----FDGLKSLRLLSLHGNDIS-VVP 118
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 35/129 (27%), Positives = 51/129 (39%), Gaps = 21/129 (16%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L L + L SL L L N L S+P + L + L+LS N L
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 133 PIPPQIVECKF-----LNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGTIPPDL 186
+P + F L +L L+ N+L S+P V +L +LK+ + N L
Sbjct: 91 -LPNGV----FDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK------- 137
Query: 187 ARFPEESFD 195
P+ FD
Sbjct: 138 -SVPDGVFD 145
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 9e-04
Identities = 22/76 (28%), Positives = 37/76 (48%), Gaps = 11/76 (14%)
Query: 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE-YSSTMVASLKG---- 485
IL+DD+ R++DFG + + + G GY+APE +M + G
Sbjct: 231 ILLDDNMQIRLSDFGFSCHLE-----PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKE 285
Query: 486 -DVYGFGIVLLELLSG 500
D++ G++L LL+G
Sbjct: 286 VDLWACGVILFTLLAG 301
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 9e-04
Identities = 16/68 (23%), Positives = 27/68 (39%), Gaps = 4/68 (5%)
Query: 94 SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLS----GPIPPQIVECKFLNKLIL 149
+QSLD+ LS + +L L + L + L+ I + L +L L
Sbjct: 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63
Query: 150 SNNKLSGS 157
+N+L
Sbjct: 64 RSNELGDV 71
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 9e-04
Identities = 33/211 (15%), Positives = 65/211 (30%), Gaps = 70/211 (33%)
Query: 322 LAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLL 381
K + + + E++ L RH N++ L EE +++++ + ++ +
Sbjct: 33 YMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI 92
Query: 382 HGNGVDNT-----------LSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNV 430
+ + + + ++H S N+
Sbjct: 93 NTSAFELNEREIVSYVHQVCEALQ--------------------------FLH---SHNI 123
Query: 431 ---------ILIDDDFDA--RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM 479
I+ + +I +FG AR + P D+ Y APE
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDN--FRLLFTAPEYYAPE----- 173
Query: 480 VASLKGDVYGF-------GIVLLELLSGQKP 503
V + DV G ++ LLSG P
Sbjct: 174 V--HQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 604 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.86 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.85 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.84 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.83 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.74 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.72 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.69 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.69 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.61 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.6 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.59 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.59 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.58 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.58 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.57 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.56 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.56 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.54 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.53 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.53 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.53 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.52 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.52 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.51 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.51 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.5 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.5 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.5 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.5 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.49 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.49 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.49 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.49 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.49 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.48 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.47 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.47 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.46 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.46 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.45 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.45 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.45 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.44 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.44 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.43 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.43 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.42 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.42 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.42 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.42 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.42 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.41 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.41 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.4 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.4 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.4 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.4 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.4 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.39 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.38 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.38 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.38 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.37 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.37 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.37 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.37 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.37 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.37 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.36 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.35 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.34 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.34 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.34 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.34 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.34 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.34 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.34 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.33 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.33 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.32 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.32 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.32 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.32 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.32 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.31 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.31 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.3 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.3 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.3 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.29 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.27 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.27 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.26 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.25 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.25 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.25 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.23 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.22 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.21 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.2 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.19 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.18 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.18 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.18 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.16 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.16 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.16 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.16 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.15 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.14 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.14 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.14 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.12 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.12 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.11 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.11 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.11 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.1 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.1 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.09 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.08 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.05 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.05 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.01 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.98 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.95 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.95 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.94 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.92 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.88 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.86 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.79 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.71 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.71 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.68 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.63 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.49 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.47 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.45 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.38 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.21 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.19 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.16 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.12 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.11 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.08 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.94 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.93 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.92 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.81 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.79 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.71 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.58 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.49 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.31 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.21 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.14 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.09 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.07 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.05 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.91 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.77 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.73 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.62 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.53 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.33 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.3 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.27 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.17 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.12 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.85 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.73 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.51 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.96 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 94.89 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 94.27 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.1 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 94.06 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 93.58 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.15 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 92.77 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 91.87 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 91.5 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 89.38 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 85.9 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 81.73 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.2 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-54 Score=442.34 Aligned_cols=264 Identities=22% Similarity=0.370 Sum_probs=205.0
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
++|...+.||+|+||.||+|++. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+++..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45677789999999999999864 47889999997643 335679999999999999999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCC--------CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCe
Q 007423 368 VYKHMPNGTLYSLLHGNGVD--------NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~--------~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~ 439 (604)
|||||++|+|.++|+..... .....+++|..++.|+.|+|+||+||| +.+||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence 99999999999999765321 112246999999999999999999999 7899999999999999999999
Q ss_pred EEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHH
Q 007423 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLV 518 (604)
Q Consensus 440 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 518 (604)
||+|||+++......... ......||+.|||||++.+..++.++|||||||++|||+| |+.||..... .
T Consensus 198 Ki~DFGla~~~~~~~~~~--~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--------~ 267 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYR--VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--------T 267 (329)
T ss_dssp EECCCC------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--------H
T ss_pred EEcccccceeccCCCcce--ecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--------H
Confidence 999999999764332211 1123458999999999999999999999999999999999 8999975432 1
Q ss_pred HHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 519 DWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 519 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
+ +...+..+...+. +...++ ++.+++.+||+.||++||||.||++.|+.+.+.
T Consensus 268 ~-~~~~i~~g~~~~~------p~~~~~---~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 268 E-AIDCITQGRELER------PRACPP---EVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp H-HHHHHHHTCCCCC------CTTCCH---HHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred H-HHHHHHcCCCCCC------cccccH---HHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1 2222333332211 112233 455666699999999999999999999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=441.79 Aligned_cols=259 Identities=23% Similarity=0.333 Sum_probs=207.2
Q ss_pred CCcCcEEEecCCeEEEEEEeC------CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 297 FAVENIIISTRTGVSYKAVLP------DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
+...+.||+|+||+||+|.+. +++.||||+++... ...++|.+|+.++++++|||||+++|+|..++..++|
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 445688999999999999863 46789999997533 3457899999999999999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCC---------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCe
Q 007423 369 YKHMPNGTLYSLLHGNGVDN---------TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~ 439 (604)
||||++|+|.++|+...... .....++|..++.|+.|||+||+||| +.+||||||||+|||+++++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCCE
Confidence 99999999999997543211 11246999999999999999999999 7899999999999999999999
Q ss_pred EEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHH
Q 007423 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLV 518 (604)
Q Consensus 440 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 518 (604)
||+|||+++......... ......||+.|||||++.+..++.++|||||||++|||+| |+.||..... .
T Consensus 185 Ki~DFGlar~~~~~~~~~--~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--------~ 254 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYK--LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------Q 254 (308)
T ss_dssp EECCSCCBCGGGGGGCBC--SSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--------H
T ss_pred EECCcccceeccCCCcee--EecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--------H
Confidence 999999998764322111 1223468999999999999999999999999999999999 8999975432 1
Q ss_pred HHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 519 DWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 519 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
+ +...+..+...+.. .++...+.+++.+||+.||++||||.||++.|+.+
T Consensus 255 ~-~~~~i~~~~~~~~p---------~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 255 D-VVEMIRNRQVLPCP---------DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp H-HHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred H-HHHHHHcCCCCCCc---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 22333444332221 12223456667799999999999999999999865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-54 Score=435.37 Aligned_cols=260 Identities=24% Similarity=0.378 Sum_probs=200.8
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+++...+.||+|+||+||+|++.+ .||||+++... ...++|.+|+++|++++|||||+++|++. ++..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEc
Confidence 456778899999999999998754 69999997533 23467999999999999999999999885 4568999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
|++|+|.++|+... ..++|..++.|+.|+|+||+||| +.+||||||||+|||+++++.+||+|||+|+...
T Consensus 113 ~~gGsL~~~l~~~~------~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 113 CEGSSLYKHLHVQE------TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp CSSCBHHHHHHTSC------CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred CCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 99999999997653 35999999999999999999999 7899999999999999999999999999998764
Q ss_pred CCCCCCCccccCCCCcccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSS---TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
..... .......||+.|||||++. ...++.++|||||||++|||+||+.||..... ...+...+..+
T Consensus 184 ~~~~~--~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~--------~~~~~~~~~~~ 253 (307)
T 3omv_A 184 RWSGS--QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN--------RDQIIFMVGRG 253 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------HHHHHHHHHTT
T ss_pred cCCcc--eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhcC
Confidence 32221 1123346999999999875 34689999999999999999999999975322 12223333333
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
....... .........+.+++.+||+.||++||||.||++.|+.+...
T Consensus 254 ~~~p~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 254 YASPDLS-----KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp CCCCCST-----TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred CCCCCcc-----cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 2221111 11112223455666699999999999999999999887653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=439.25 Aligned_cols=264 Identities=22% Similarity=0.353 Sum_probs=209.5
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
++|...+.||+|+||.||+|++. ++..||||+++... ...++|.+|+++|++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45777899999999999999853 47789999997643 335679999999999999999999999999999999
Q ss_pred EeeecCCCchhhhhccCCC------CCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEE
Q 007423 368 VYKHMPNGTLYSLLHGNGV------DNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARI 441 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~------~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl 441 (604)
|||||++|+|.++|+..+. .......++|..++.++.|+|+||+||| +++||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence 9999999999999976421 0111246999999999999999999999 789999999999999999999999
Q ss_pred cccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHH
Q 007423 442 TDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDW 520 (604)
Q Consensus 442 ~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 520 (604)
+|||+|+......... ......||+.|||||++.+..++.++|||||||++|||+| |+.||..... .+
T Consensus 170 ~DFGla~~~~~~~~~~--~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------~~- 238 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYR--VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NE- 238 (299)
T ss_dssp CCCSCHHHHTGGGCEE--ETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HH-
T ss_pred CCcccceecCCCCcee--ecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HH-
Confidence 9999998764322111 1122348999999999999999999999999999999999 8999975432 12
Q ss_pred HHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 521 VNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 521 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
+...+..+...... ...++ ++.+++.+||+.||++||||+||++.|+++.+.
T Consensus 239 ~~~~i~~~~~~~~p------~~~~~---~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 239 VIECITQGRVLQRP------RTCPQ---EVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHHHHTCCCCCC------TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCC------ccchH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 22233334332211 12223 455666699999999999999999999998774
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-54 Score=436.73 Aligned_cols=277 Identities=18% Similarity=0.260 Sum_probs=207.6
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCC----eeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE----ERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lv~e 370 (604)
+++...+.||+|+||+||+|++ +|+.||||+++........+..|+..+.+++|||||+++|+|..++ ..+||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 3566778999999999999998 6889999999765433333455677778899999999999998654 5799999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcC-----CCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGC-----QPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
||++|+|.++|+.. .++|..+.+++.|+++||+|||+.+ .++||||||||+|||+++++++||+|||
T Consensus 82 y~~~gsL~~~l~~~--------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY--------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp CCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred CCCCCcHHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 99999999999754 4889999999999999999999542 3599999999999999999999999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCCC------CCCcccchhhHHHHHHHHHhCCCCCCCCCcccc-cc----
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM------VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEG-FK---- 514 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~-~~---- 514 (604)
+|+................+||+.|||||++.+. .++.++|||||||++|||+||++|+........ +.
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 9988754332222222334699999999988654 467899999999999999999988754322111 10
Q ss_pred -CcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcC
Q 007423 515 -GNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHG 583 (604)
Q Consensus 515 -~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~ 583 (604)
....+.+...+..+..+..+.... ...+....+.+++.+||+.||++||||.||++.|+++.++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~rp~~p~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGG---GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred ccchHHHHHHHHhcccCCCCCCccc---cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence 011222333333332222121111 123456677888889999999999999999999999987543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=420.03 Aligned_cols=261 Identities=18% Similarity=0.162 Sum_probs=206.7
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
.+.|...+.||+|+||.||+|+ ..+|+.||||+++.... ..+|++++++++|||||++++++.+++..|+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 3467778899999999999999 56799999999975432 246999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC-CeEEcccCCccccC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF-DARITDFGLARLVG 451 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~-~~kl~DFGla~~~~ 451 (604)
++|+|.++|+.. +.+++.....++.|++.||+||| +.+||||||||+|||++.++ .+||+|||+|+.+.
T Consensus 133 ~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 133 EGGSLGQLIKQM-------GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp TTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred CCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 999999999765 35999999999999999999999 88999999999999999887 69999999999875
Q ss_pred CCCCCCC-ccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 452 SRDPNDS-SFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 452 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
....... ......+||+.|||||++.+..++.++|||||||++|||+||+.||......+ +. .... .+..
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~---~~i~-~~~~ 273 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-----LC---LKIA-SEPP 273 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-----CH---HHHH-HSCC
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-----HH---HHHH-cCCC
Confidence 4322211 11123469999999999999999999999999999999999999997543322 11 1111 1211
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCC
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGF 584 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~ 584 (604)
. . ..+ ....++++.++++ +||+.||++|||+.|+++.|..+.++.+.
T Consensus 274 ~-~--~~~-~~~~s~~~~~li~---~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 274 P-I--REI-PPSCAPLTAQAIQ---EGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp G-G--GGS-CTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred C-c--hhc-CccCCHHHHHHHH---HHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 1 0 011 1223344555554 99999999999999999999998877654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=420.51 Aligned_cols=249 Identities=18% Similarity=0.280 Sum_probs=202.6
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
..|+..+.||+|+||+||+|+ ..+|+.||||+++... ...+.+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 458888999999999999999 4679999999996543 33456889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++|+|.+++... .+++.....++.|++.||+||| +.+||||||||+|||++.++.+||+|||+|+.+..
T Consensus 154 ~gg~L~~~l~~~--------~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 154 EGGALTDIVTHT--------RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp TTEEHHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCcHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 999999999753 4889999999999999999999 78999999999999999999999999999998754
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
.... ....+||+.|||||++.+..|+.++||||+||++|||+||+.||..... .+.... +..+....
T Consensus 223 ~~~~----~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~-i~~~~~~~ 289 (346)
T 4fih_A 223 EVPR----RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKM-IRDNLPPR 289 (346)
T ss_dssp SSCC----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHH-HHHSSCCC
T ss_pred CCCc----ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHH-HHcCCCCC
Confidence 3222 2234699999999999999999999999999999999999999975322 111111 22221111
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.... ...++++.+++ .+||+.||++|||+.|+++.
T Consensus 290 ~~~~----~~~s~~~~dli---~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 290 LKNL----HKVSPSLKGFL---DRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CSCG----GGSCHHHHHHH---HHHSCSSTTTSCCHHHHTTC
T ss_pred CCcc----ccCCHHHHHHH---HHHcCCChhHCcCHHHHhcC
Confidence 1110 11234455554 49999999999999998763
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-52 Score=425.96 Aligned_cols=249 Identities=20% Similarity=0.297 Sum_probs=198.1
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
++|...+.||+|+||+||+|+ ..+|+.||||+++... ...+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 578889999999999999999 5679999999997543 234679999999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
||++|+|.++|...+. ..+++.....|+.||+.||+||| +.+||||||||+|||+++++.+||+|||+|+..
T Consensus 104 y~~gg~L~~~i~~~~~-----~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG-----VLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175 (350)
T ss_dssp CCTTCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred CCCCCcHHHHHHHcCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceee
Confidence 9999999999975432 35789999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
.... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||...+. .+.+... ..+..
T Consensus 176 ~~~~----~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i-~~~~~ 242 (350)
T 4b9d_A 176 NSTV----ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM--------KNLVLKI-ISGSF 242 (350)
T ss_dssp CHHH----HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHH-HHTCC
T ss_pred cCCc----ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHH-HcCCC
Confidence 3211 112233599999999999999999999999999999999999999975322 2222222 22322
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
... ....++++.++++ +||+.||++|||+.|+++
T Consensus 243 ~~~------~~~~s~~~~~li~---~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 PPV------SLHYSYDLRSLVS---QLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCC------CTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHT
T ss_pred CCC------CccCCHHHHHHHH---HHccCChhHCcCHHHHhc
Confidence 211 1123345555554 999999999999999976
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=425.75 Aligned_cols=274 Identities=19% Similarity=0.282 Sum_probs=214.7
Q ss_pred HHHHHHhhcCCCcCcEEEecCCeEEEEEEeCC------CCEEEEEEecccc--ccHHHHHHHHHHHhccCC-CCccceee
Q 007423 287 LADLLAATNSFAVENIIISTRTGVSYKAVLPD------ASALAIKRLSACK--LSEKQFRSEMNRLGQLRH-PNLVPLLG 357 (604)
Q Consensus 287 ~~~l~~~~~~~~~~~~ig~G~~g~vy~~~~~~------~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H-~niv~l~g 357 (604)
..+.+...++|...+.||+|+||.||+|.... ++.||||+++... ...++|.+|+++|++++| ||||+++|
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 34444456788999999999999999998432 3579999997643 234679999999999965 89999999
Q ss_pred EEEeC-CeeeEEeeecCCCchhhhhccCCCC---------CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCC
Q 007423 358 FCVVE-EERLLVYKHMPNGTLYSLLHGNGVD---------NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYIS 427 (604)
Q Consensus 358 ~~~~~-~~~~lv~ey~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk 427 (604)
+|..+ +..++|||||++|+|.++|+..... ......++|..++.++.|||+||+||| +.+|||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccC
Confidence 99764 5689999999999999999754321 011245899999999999999999999 7899999999
Q ss_pred CCeEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 007423 428 SNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDV 506 (604)
Q Consensus 428 ~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~ 506 (604)
|+|||+++++.+||+|||+|+.+...... .......||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~--~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCc--eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999976443221 11223458999999999999999999999999999999998 9999975
Q ss_pred CCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 507 AGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
.... +.+...+..+...... +..++ ++.+++.+||+.||++||||.||++.|+.+.+..
T Consensus 291 ~~~~--------~~~~~~i~~g~~~~~p------~~~~~---~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 291 VKID--------EEFCRRLKEGTRMRAP------DYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CCCS--------HHHHHHHHHTCCCCCC------TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCHH--------HHHHHHHHcCCCCCCC------ccCCH---HHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 3221 2233334444332221 12233 4555666999999999999999999999998753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=408.07 Aligned_cols=243 Identities=23% Similarity=0.319 Sum_probs=192.3
Q ss_pred CcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEe----CCeeeEEe
Q 007423 298 AVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV----EEERLLVY 369 (604)
Q Consensus 298 ~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lv~ 369 (604)
...+.||+|+||+||+|. ..++..||||++.... ...+.|.+|+++|++++|||||++++++.+ ++..++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 455789999999999998 4568999999996533 234679999999999999999999999875 34579999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCC--ceecCCCCCeEEeC-CCCCeEEcccCC
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPP--YMHQYISSNVILID-DDFDARITDFGL 446 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--iiH~dlk~~NiLl~-~~~~~kl~DFGl 446 (604)
|||++|+|.++++.. ..+++.....++.||+.||+||| +.+ ||||||||+|||++ .++.+||+|||+
T Consensus 109 Ey~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp ECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred eCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcC
Confidence 999999999999764 35899999999999999999999 555 99999999999998 478999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
|+..... .....+||+.|||||++.+ .++.++|||||||++|||+||+.||..... ... +...+.
T Consensus 179 a~~~~~~------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-------~~~-~~~~i~ 243 (290)
T 3fpq_A 179 ATLKRAS------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQ-IYRRVT 243 (290)
T ss_dssp GGGCCTT------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHH-HHHHHT
T ss_pred CEeCCCC------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-------HHH-HHHHHH
Confidence 9864321 1233469999999998865 699999999999999999999999964321 111 222223
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.+......++ ..++++.+ ++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~-----~~~~~~~~---li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 244 SGVKPASFDK-----VAIPEVKE---IIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTCCCGGGGG-----CCCHHHHH---HHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCCCCCCc-----cCCHHHHH---HHHHHccCChhHCcCHHHHhc
Confidence 3322221221 22334444 555999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=410.74 Aligned_cols=248 Identities=19% Similarity=0.243 Sum_probs=204.4
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||+||+|+ ..+++.||||++.... ...+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 579999999999999999999 5679999999997532 23467899999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
|||++|+|.+++... +.+++.....++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+|+.
T Consensus 112 Ey~~gG~L~~~i~~~-------~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~ 181 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 181 (311)
T ss_dssp CCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence 999999999999765 35899999999999999999999 78999999999999999999999999999998
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
+...... ......+||+.|||||++.+..++.++||||+||++|||+||+.||...+. .+.... +..+.
T Consensus 182 ~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~-i~~~~ 250 (311)
T 4aw0_A 182 LSPESKQ--ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------GLIFAK-IIKLE 250 (311)
T ss_dssp CCTTTTC--CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH-HHHTC
T ss_pred cCCCCCc--ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH-HHcCC
Confidence 7543222 122344699999999999999999999999999999999999999975322 111222 22222
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.. + +...++++.++++ +||+.||++|||++|+..
T Consensus 251 ~~------~-p~~~s~~~~dli~---~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 251 YD------F-PEKFFPKARDLVE---KLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp CC------C-CTTCCHHHHHHHH---HHSCSSGGGSTTSGGGTC
T ss_pred CC------C-CcccCHHHHHHHH---HHccCCHhHCcChHHHcC
Confidence 11 1 1123345555555 999999999999998743
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=421.88 Aligned_cols=249 Identities=18% Similarity=0.283 Sum_probs=203.6
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
+.|...+.||+|+||.||+|+ ..+|+.||||++.... ...+.+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 468888999999999999999 5679999999996543 33456899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++|+|.+++... .+++.....|+.|++.||+||| +.+||||||||+|||++.++.+||+|||+|+.+..
T Consensus 231 ~gG~L~~~i~~~--------~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 231 EGGALTDIVTHT--------RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp TTEEHHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred CCCcHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 999999999753 4889999999999999999999 78999999999999999999999999999998754
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
..... ...+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .+.... +..+....
T Consensus 300 ~~~~~----~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~-i~~~~~~~ 366 (423)
T 4fie_A 300 EVPRR----KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKM-IRDNLPPR 366 (423)
T ss_dssp SCCCB----CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHH-HHHSCCCC
T ss_pred CCccc----cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHH-HHcCCCCC
Confidence 33222 234699999999999999999999999999999999999999975322 111222 22221111
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
... ....++++.++++ +||+.||++|||+.|+++.
T Consensus 367 ~~~----~~~~s~~~~dli~---~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 367 LKN----LHKVSPSLKGFLD---RLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CSC----TTSSCHHHHHHHH---HHSCSSTTTSCCHHHHTTC
T ss_pred Ccc----cccCCHHHHHHHH---HHcCCChhHCcCHHHHhcC
Confidence 111 1123445555555 9999999999999998763
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=398.77 Aligned_cols=244 Identities=17% Similarity=0.282 Sum_probs=188.7
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||+||+|. ..+|+.||||+++... ...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 579999999999999999999 5679999999996532 22457999999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+ +|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+|+.
T Consensus 93 Ey~-~g~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~ 161 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-------DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNI 161 (275)
T ss_dssp ECC-CEEHHHHHHHS-------CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred eCC-CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCee
Confidence 999 68999999765 35999999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA-SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
...... ....+||+.|||||++.+..+ +.++||||+||++|||+||+.||...+. .+.... +..+
T Consensus 162 ~~~~~~-----~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--------~~~~~~-i~~~ 227 (275)
T 3hyh_A 162 MTDGNF-----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--------PVLFKN-ISNG 227 (275)
T ss_dssp ------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH-HHHT
T ss_pred cCCCCc-----cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHH-HHcC
Confidence 643221 123469999999999988776 5799999999999999999999975322 222222 2222
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
... + +...++++.+++ .+||+.||++|||++|+++
T Consensus 228 ~~~------~-p~~~s~~~~~li---~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 228 VYT------L-PKFLSPGAAGLI---KRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCC------C-CTTSCHHHHHHH---HHHSCSSGGGSCCHHHHHH
T ss_pred CCC------C-CCCCCHHHHHHH---HHHccCChhHCcCHHHHHc
Confidence 211 1 112334555554 4999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-50 Score=404.58 Aligned_cols=246 Identities=18% Similarity=0.246 Sum_probs=192.5
Q ss_pred cCCCcCcEEEecCCeEEEEEEe----CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAVL----PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~----~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
++|++.+.||+|+||+||+|+. ..++.||||+++... ....++.+|+++|++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5699999999999999999984 247899999997533 223468899999999999999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
|||||++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+|
T Consensus 104 vmEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla 173 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-------VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLS 173 (304)
T ss_dssp EECCCTTCEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred EEEcCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccc
Confidence 99999999999999765 35899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
+......... ...+||+.|||||++.+..++.++||||+||++|||+||+.||...+. .+..... ..
T Consensus 174 ~~~~~~~~~~----~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i-~~ 240 (304)
T 3ubd_A 174 KESIDHEKKA----YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--------KETMTMI-LK 240 (304)
T ss_dssp EC-----CCC----CSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH-HH
T ss_pred eeccCCCccc----cccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--------HHHHHHH-Hc
Confidence 8654322221 234699999999999999999999999999999999999999975432 1222222 22
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSM-----YQVYE 573 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~ev~~ 573 (604)
+... . +...++++.++++ +||+.||++|||+ +|+++
T Consensus 241 ~~~~------~-p~~~s~~~~~li~---~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 241 AKLG------M-PQFLSPEAQSLLR---MLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCCC------C-CTTSCHHHHHHHH---HHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCC------C-CCcCCHHHHHHHH---HHcccCHHHCCCCCcCCHHHHHc
Confidence 2211 0 1123345555554 9999999999984 56654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=395.25 Aligned_cols=252 Identities=20% Similarity=0.275 Sum_probs=186.6
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCC--------
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE-------- 363 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-------- 363 (604)
++|+..+.||+|+||+||+|+ ..+|+.||||+++... ...+.+.+|+++|++++|||||++++++...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 358888999999999999998 5679999999996433 23467999999999999999999999987644
Q ss_pred ----eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCe
Q 007423 364 ----ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439 (604)
Q Consensus 364 ----~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~ 439 (604)
..|+|||||++|+|.+++...... ...++...+.++.|++.||+||| +.+|+||||||+|||++.++.+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~----~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~v 157 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTI----EERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVV 157 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSG----GGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCC----ChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcE
Confidence 368999999999999999865322 34667788999999999999999 7899999999999999999999
Q ss_pred EEcccCCccccCCCCCCCC--------ccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccc
Q 007423 440 RITDFGLARLVGSRDPNDS--------SFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEE 511 (604)
Q Consensus 440 kl~DFGla~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~ 511 (604)
||+|||+|+.+........ ....+.+||+.|||||++.+..++.++|||||||++|||++ ||....
T Consensus 158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--- 231 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--- 231 (299)
T ss_dssp EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH---
T ss_pred EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc---
Confidence 9999999998754322111 11234469999999999999999999999999999999996 775310
Q ss_pred cccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 512 GFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.....+ ........+... .+......+++.+||+.||++|||+.|+++
T Consensus 232 ----~~~~~~-~~~~~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 ----ERVRTL-TDVRNLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ----HHHHHH-HHHHTTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHHHH-HHHhcCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001111 111222221111 112223445666999999999999999976
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=394.38 Aligned_cols=202 Identities=19% Similarity=0.289 Sum_probs=171.1
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeC------Ce
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVE------EE 364 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~ 364 (604)
++|...+.||+|+||+||+|. ..+|+.||||+++.... ..+.+.+|+++|++++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 568899999999999999999 56799999999975432 235688999999999999999999998643 56
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEccc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDF 444 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DF 444 (604)
.|+|||||+ |+|.+++... ..+++.....++.|++.||.||| +.+||||||||+|||++.++.+||+||
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~-------~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DF 202 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS-------QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDF 202 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEeCCC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeec
Confidence 899999996 7899999765 46999999999999999999999 789999999999999999999999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
|+|+.+..............+||+.|||||++.+. .++.++||||+||++|||+||++||...
T Consensus 203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 99987654322222233345799999999987765 5699999999999999999999999754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=386.29 Aligned_cols=291 Identities=37% Similarity=0.639 Sum_probs=245.2
Q ss_pred ccccCHHHHHHhhcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccc--cHHHHHHHHHHHhccCCCCccceeeEE
Q 007423 282 IVKVKLADLLAATNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKL--SEKQFRSEMNRLGQLRHPNLVPLLGFC 359 (604)
Q Consensus 282 ~~~~~~~~l~~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~ 359 (604)
...+++.++...+++|...+.||+|+||.||+|...+++.||||++..... ....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456788999999999999999999999999999988899999999975432 223689999999999999999999999
Q ss_pred EeCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCe
Q 007423 360 VVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439 (604)
Q Consensus 360 ~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~ 439 (604)
...+..++||||+++|+|.+++...... ...++|..+..++.|++.||.|||+.+.++|+||||||+|||+++++.+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPES---QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTT---CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhcccc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 9999999999999999999999865422 1358999999999999999999996444599999999999999999999
Q ss_pred EEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHH
Q 007423 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVD 519 (604)
Q Consensus 440 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~ 519 (604)
||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||+.............+
T Consensus 174 kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 250 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250 (326)
T ss_dssp EECCCSSCEECCSSSSC---EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred EeccCccccccCccccc---ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence 99999999876432221 122335899999999998888999999999999999999999999743322233345667
Q ss_pred HHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 520 WVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 520 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
|+.............+.........++...+.+++.+||+.||++|||+.||++.|++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 77666666667777777777777888889999999999999999999999999999864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=378.38 Aligned_cols=287 Identities=34% Similarity=0.536 Sum_probs=241.2
Q ss_pred cCHHHHHHhhcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCC
Q 007423 285 VKLADLLAATNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE 363 (604)
Q Consensus 285 ~~~~~l~~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 363 (604)
+.+.++...+++|...+.||+|+||.||+|...+++.||||++.... ...+.+.+|++++++++||||+++++++..++
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34445667889999999999999999999998889999999987543 34567999999999999999999999999999
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
..++||||+++|+|.+++...... ...++|..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLP---TMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCC---SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECC
T ss_pred eEEEEEEcCCCCcHHHHHhccCCC---ccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEee
Confidence 999999999999999999765321 135899999999999999999999 78999999999999999999999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHH
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNH 523 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 523 (604)
||+++......... ......||..|+|||++.+..++.++|||||||++|||+||+.||......+ ......|...
T Consensus 183 fg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~ 258 (321)
T 2qkw_B 183 FGISKKGTELDQTH--LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE--MVNLAEWAVE 258 (321)
T ss_dssp CTTCEECSSSSCCC--CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS--CCCHHHHTHH
T ss_pred cccccccccccccc--cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH--HHHHHHHhhh
Confidence 99998754322111 1122348999999999988889999999999999999999999997654432 2345667666
Q ss_pred HHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 524 LVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 524 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
....+.....+++........+....+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp HHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 6666677777777776666778888899999999999999999999999999988763
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=376.77 Aligned_cols=202 Identities=19% Similarity=0.254 Sum_probs=170.5
Q ss_pred HhhcCCCcCcEEEecCCeEEEEEEe----CCCCEEEEEEeccccccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeee
Q 007423 292 AATNSFAVENIIISTRTGVSYKAVL----PDASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERL 366 (604)
Q Consensus 292 ~~~~~~~~~~~ig~G~~g~vy~~~~----~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 366 (604)
+..+.|.+.+.||+|+||+||+|+. ..++.||||++.... ...++.+|+++|+++ +|||||++++++.+++..+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 3457899999999999999999973 246789999986543 346788999999998 6999999999999999999
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC-CCeEEcccC
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD-FDARITDFG 445 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~-~~~kl~DFG 445 (604)
+||||+++|+|.+++. .+++.....++.|++.||+||| +.+|+||||||+|||++.+ +.+||+|||
T Consensus 97 lvmE~~~g~~L~~~~~----------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN----------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp EEEECCCCCCHHHHHT----------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEeCCCcccHHHHHc----------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 9999999999999983 3788999999999999999999 7899999999999999876 799999999
Q ss_pred CccccCCCCCC------------------------CCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhC
Q 007423 446 LARLVGSRDPN------------------------DSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSG 500 (604)
Q Consensus 446 la~~~~~~~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg 500 (604)
+|+........ ........+||+.|||||++.+. .++.++||||+||++|||+||
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 99865432110 00112334699999999988765 589999999999999999999
Q ss_pred CCCCCCC
Q 007423 501 QKPLDVA 507 (604)
Q Consensus 501 ~~p~~~~ 507 (604)
+.||...
T Consensus 244 ~~Pf~~~ 250 (361)
T 4f9c_A 244 RYPFYKA 250 (361)
T ss_dssp CSSSSCC
T ss_pred CCCCCCC
Confidence 9999643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=394.33 Aligned_cols=250 Identities=19% Similarity=0.342 Sum_probs=202.9
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
++|.+.+.||+|+||.||+|. ..+|+.||||++.... ...+.+.+|+++|++++|||||++++++.+++..++|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 578999999999999999999 5679999999997644 33467899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC--CCeEEcccCCcccc
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD--FDARITDFGLARLV 450 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~--~~~kl~DFGla~~~ 450 (604)
++|+|.++|.... ..+++.....++.||+.||.||| +.+|+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 237 ~gg~L~~~i~~~~------~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 237 SGGELFEKVADEH------NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp CCCBHHHHHTCTT------SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred CCCcHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 9999999996543 35889999999999999999999 7899999999999999854 78999999999987
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
.... .....+||+.|||||++.+..++.++||||+||++|||++|+.||...... +.... +..+..
T Consensus 308 ~~~~-----~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--------~~~~~-i~~~~~ 373 (573)
T 3uto_A 308 DPKQ-----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------ETLRN-VKSCDW 373 (573)
T ss_dssp CTTS-----EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHH-HHTTCC
T ss_pred cCCC-----ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHH-HHhCCC
Confidence 4322 122346999999999999999999999999999999999999999754322 11111 222211
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
. ..++ .. ...++++.+++ .+||+.||++|||+.|+++
T Consensus 374 ~-~~~~-~~-~~~s~~~~dli---~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 374 N-MDDS-AF-SGISEDGKDFI---RKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp C-CCSG-GG-TTSCHHHHHHH---HTTSCSSGGGSCCHHHHHH
T ss_pred C-CCcc-cc-cCCCHHHHHHH---HHHccCChhHCcCHHHHhc
Confidence 1 1111 11 12234455554 4999999999999999976
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=390.40 Aligned_cols=247 Identities=21% Similarity=0.273 Sum_probs=196.8
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHH---HHHHHHhccCCCCccceeeEEEeCCeee
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFR---SEMNRLGQLRHPNLVPLLGFCVVEEERL 366 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~---~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 366 (604)
++|.+.++||+|+||.||+|+ ..+|+.||||++++.. .....+. .++++++.++|||||++++++.+++..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 679999999999999999999 5679999999996532 1222333 4467788889999999999999999999
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
+|||||++|+|.++|... +.+++.....|+.||+.||+||| +.+||||||||+|||++.++.+||+|||+
T Consensus 269 lVmEy~~GGdL~~~l~~~-------~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGl 338 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH-------GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGL 338 (689)
T ss_dssp EEECCCCSCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccce
Confidence 999999999999999765 35899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
|+....... ...+||+.|||||++.. ..|+.++||||+||++|||+||++||...... ...+ +....
T Consensus 339 A~~~~~~~~------~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~-----~~~~-i~~~i 406 (689)
T 3v5w_A 339 ACDFSKKKP------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHE-IDRMT 406 (689)
T ss_dssp CEECSSCCC------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC-----CHHH-HHHHH
T ss_pred eeecCCCCC------CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHH-HHHhh
Confidence 997754321 23469999999999864 57999999999999999999999999753221 1111 11111
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS-----MYQVYE 573 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~ 573 (604)
...... .....++++.++++ +||+.||++|++ +.||++
T Consensus 407 ~~~~~~-------~p~~~S~~a~dLI~---~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 407 LTMAVE-------LPDSFSPELRSLLE---GLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHCCCC-------CCTTSCHHHHHHHH---HHTCSCGGGCTTCSSSTHHHHTT
T ss_pred cCCCCC-------CCccCCHHHHHHHH---HHccCCHhHCCCCCCCCHHHHhc
Confidence 122111 11223455555555 999999999998 677754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=365.92 Aligned_cols=271 Identities=25% Similarity=0.323 Sum_probs=211.1
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCC----eeeEEe
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE----ERLLVY 369 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lv~ 369 (604)
.++|...+.||+|+||.||+|+.. ++.||||+++........+.+|+.++++++||||+++++++.... ..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 457888999999999999999875 789999999766555566778999999999999999999998754 469999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCC----------CceecCCCCCeEEeCCCCCe
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQP----------PYMHQYISSNVILIDDDFDA 439 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~----------~iiH~dlk~~NiLl~~~~~~ 439 (604)
||+++|+|.++++.. .++|..+..++.|++.||.||| +. +|+||||||+|||++.++.+
T Consensus 102 e~~~~g~L~~~l~~~--------~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN--------VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp ECCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred ecCCCCCHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 999999999999754 4889999999999999999999 66 99999999999999999999
Q ss_pred EEcccCCccccCCCCCCCCccccCCCCcccccCccccCC-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCcccccc
Q 007423 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-----MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFK 514 (604)
Q Consensus 440 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~ 514 (604)
||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..........
T Consensus 171 kL~DFg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAG--DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp EECCCTTCEEECTTSCCC--CCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred EEccCCcccccccccCcc--ccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 999999998775433221 1223458999999998876 356778999999999999999999997543321110
Q ss_pred --------CcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 515 --------GNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 515 --------~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
....++.. ..........+..... .......+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus 249 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 249 FEEEIGQHPSLEDMQE-VVVHKKKRPVLRDYWQ---KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp THHHHCSSCCHHHHHH-HHTTSCCCCCCCGGGG---SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhhhccCCchhhhhh-hhhcccCCCCcccccc---ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 01122221 1222222222221111 1234455777777999999999999999999999998754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=354.04 Aligned_cols=283 Identities=30% Similarity=0.493 Sum_probs=225.7
Q ss_pred ccccCHHHHHHhhcCCCcC------cEEEecCCeEEEEEEeCCCCEEEEEEecccc-----ccHHHHHHHHHHHhccCCC
Q 007423 282 IVKVKLADLLAATNSFAVE------NIIISTRTGVSYKAVLPDASALAIKRLSACK-----LSEKQFRSEMNRLGQLRHP 350 (604)
Q Consensus 282 ~~~~~~~~l~~~~~~~~~~------~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~-----~~~~~~~~Ei~~l~~l~H~ 350 (604)
...+++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ...+.+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4568899999999999887 8999999999999987 68899999986422 2346799999999999999
Q ss_pred CccceeeEEEeCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCe
Q 007423 351 NLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNV 430 (604)
Q Consensus 351 niv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~N 430 (604)
||+++++++...+..++||||+++|+|.+++...... ..+++..+..++.|++.||.||| +.+|+||||||+|
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~N 163 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT----PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSAN 163 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGC----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGG
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCC----CCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHH
Confidence 9999999999999999999999999999999754221 35899999999999999999999 7899999999999
Q ss_pred EEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCcc
Q 007423 431 ILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAE 510 (604)
Q Consensus 431 iLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~ 510 (604)
|++++++.+||+|||+++........ .......||+.|+|||...+ .++.++||||||+++|||+||+.||......
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQT--VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSSC--EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred EEEcCCCcEEEeeccccccccccccc--ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 99999999999999999876432211 11223358999999998765 4789999999999999999999999764332
Q ss_pred ccccCcHHHHHHHHHHc-CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 511 EGFKGNLVDWVNHLVIA-GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 511 ~~~~~~~~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
. ....+....... ....+.+++.+ ..........+.+++.+||+.||++|||+.||++.|+++..
T Consensus 241 ~----~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 241 Q----LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp S----BTTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred H----HHHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2 122222222111 11223333332 23455666778888889999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=358.27 Aligned_cols=261 Identities=25% Similarity=0.413 Sum_probs=200.7
Q ss_pred hhcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEecccccc---HHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 293 ATNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLS---EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
..++|.+.+.||+|+||.||+|.. +++.||||++...... .+++.+|++++++++||||+++++++...+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 356788899999999999999987 6889999999754322 357889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCC--ceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPP--YMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||+++|+|.+++...... ..+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||+|||++
T Consensus 114 e~~~~~~L~~~l~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAR----EQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp ECCTTCBHHHHHHSTTHH----HHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred ecCCCCcHHHHHhhcCCC----CCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999999865321 24889999999999999999999 667 999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
+........ .....||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+........
T Consensus 187 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--------~~~~~~~~~~ 254 (309)
T 3p86_A 187 RLKASTFLS----SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--------AQVVAAVGFK 254 (309)
T ss_dssp -------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--------HHHHHHHHHS
T ss_pred ccccccccc----cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhc
Confidence 865432211 1223589999999999999999999999999999999999999975322 1112221112
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
...... ....+.+ +.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus 255 ~~~~~~------~~~~~~~---l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 255 CKRLEI------PRNLNPQ---VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CCCCCC------CTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCCCCC------CccCCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 111111 1122334 445555999999999999999999999998764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=356.20 Aligned_cols=266 Identities=20% Similarity=0.308 Sum_probs=210.5
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccc-cccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSAC-KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
++|...+.||+|+||.||++.. .+++.||+|++... ....+.|.+|++++++++||||+++++++..++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 4678889999999999999994 56899999998653 334567999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++....
T Consensus 90 ~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 90 KGGTLRGIIKSMD------SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp TTCBHHHHHHHCC------TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred CCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 9999999998643 35899999999999999999999 78999999999999999999999999999987643
Q ss_pred CCCCCC----------ccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccC-cHHHHH
Q 007423 453 RDPNDS----------SFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKG-NLVDWV 521 (604)
Q Consensus 453 ~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~-~~~~~~ 521 (604)
...... .......||+.|+|||++.+..++.++|||||||++|||++|..|+........... ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~ 240 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc
Confidence 322110 001134589999999999999999999999999999999999999875433221111 111111
Q ss_pred HHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCCC
Q 007423 522 NHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSE 586 (604)
Q Consensus 522 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~ 586 (604)
. . .. ....++ .+.+++.+||+.||++|||+.|+++.|+.+........
T Consensus 241 ~----~---------~~-~~~~~~---~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~ 288 (310)
T 3s95_A 241 D----R---------YC-PPNCPP---SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL 288 (310)
T ss_dssp H----H---------TC-CTTCCT---THHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCC
T ss_pred c----c---------cC-CCCCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCcc
Confidence 0 0 00 011122 34455669999999999999999999999987654433
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=352.42 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=210.9
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
++|...+.||+|+||.||+|...++..||||++.......+++.+|++++++++||||+++++++..++..++||||+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 56788899999999999999988899999999987776778899999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 90 GCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CcHHHHHHhcC------cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 99999997543 35899999999999999999999 7899999999999999999999999999998764321
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
. ....+..++..|+|||++.+..++.++||||+|+++|||+| |+.||...... +.... ...+...
T Consensus 161 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--------~~~~~-~~~~~~~-- 226 (269)
T 4hcu_A 161 Y---TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVED-ISTGFRL-- 226 (269)
T ss_dssp H---HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHH-HHTTCCC--
T ss_pred c---ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHH-HhcCccC--
Confidence 1 11122346788999999988889999999999999999999 99999753221 11211 2222111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
..+ ...++. +.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 227 ~~~----~~~~~~---~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 227 YKP----RLASTH---VYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCC----TTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCC----CcCCHH---HHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 111 112334 44555599999999999999999999998874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=348.78 Aligned_cols=249 Identities=18% Similarity=0.308 Sum_probs=202.4
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
.++|...+.||+|+||.||+|. ..+++.||||++.... ...+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 3578899999999999999999 5679999999986533 3456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++|+|.+++... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 99 ~~~~~L~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 99 LAGGSLTDVVTET--------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp CTTCBHHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 9999999999754 4889999999999999999999 7899999999999999999999999999998765
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
...... ....||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+........+..
T Consensus 168 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~~~~~~~~- 234 (297)
T 3fxz_A 168 PEQSKR----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIATNGTP- 234 (297)
T ss_dssp STTCCB----CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHHCSC-
T ss_pred Cccccc----CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCC-
Confidence 433221 233589999999999988999999999999999999999999975322 1112222222211
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
....+ ...++. +.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~----~~~~~~---~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 235 ELQNP----EKLSAI---FRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CCSCG----GGSCHH---HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCc----cccCHH---HHHHHHHHccCChhHCcCHHHHhh
Confidence 11111 112233 445555999999999999999976
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=361.21 Aligned_cols=261 Identities=24% Similarity=0.376 Sum_probs=206.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC----CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP----DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~----~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
++|...+.||+|+||.||+|... .+..||||+++... ...+.|.+|++++++++||||+++++++..++..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 46778899999999999999963 34569999997532 3346799999999999999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++|+|.++++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 129 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD------GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EECCTTCBHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred eeCCCCCcHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 99999999999997543 35899999999999999999999 7899999999999999999999999999999
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
......... ....+..+|..|+|||++.+..++.++|||||||++|||++ |+.||...... +.. ..+..
T Consensus 200 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~~~-~~~~~ 269 (325)
T 3kul_A 200 VLEDDPDAA-YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--------DVI-SSVEE 269 (325)
T ss_dssp ECC----CC-EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHH-HHHHT
T ss_pred ccccCccce-eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--------HHH-HHHHc
Confidence 775432221 12223346788999999988889999999999999999999 99999653221 111 12222
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcC
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHG 583 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~ 583 (604)
+..... ....++ .+.+++.+||+.||++|||+.||++.|+.+.+...
T Consensus 270 ~~~~~~------~~~~~~---~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 270 GYRLPA------PMGCPH---ALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp TCCCCC------CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred CCCCCC------CCCcCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 211110 111223 44555669999999999999999999999987543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=365.97 Aligned_cols=266 Identities=21% Similarity=0.329 Sum_probs=209.4
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe--------CCCCEEEEEEeccccc--cHHHHHHHHHHHhcc-CCCCccceeeEEEeC
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL--------PDASALAIKRLSACKL--SEKQFRSEMNRLGQL-RHPNLVPLLGFCVVE 362 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~--------~~~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 362 (604)
.++|...+.||+|+||.||+|.. .++..||||+++.... ..+++.+|+++++++ +||||+++++++..+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 35788889999999999999984 2355799999975432 335789999999999 899999999999999
Q ss_pred CeeeEEeeecCCCchhhhhccCCCC---------CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe
Q 007423 363 EERLLVYKHMPNGTLYSLLHGNGVD---------NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI 433 (604)
Q Consensus 363 ~~~~lv~ey~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl 433 (604)
+..++||||+++|+|.+++...... ......+++..++.++.|++.||+||| +.+|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence 9999999999999999999765321 001135899999999999999999999 7899999999999999
Q ss_pred CCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCcccc
Q 007423 434 DDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEG 512 (604)
Q Consensus 434 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~ 512 (604)
+.++.+||+|||+++.......... .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKK--TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCT--TTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-
T ss_pred CCCCCEEEccccCCcccCcccceec--ccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence 9999999999999987654322111 122347889999999988899999999999999999999 999997543221
Q ss_pred ccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 513 FKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
+ ...+..+..... ....++ .+.+++.+||+.||++||++.|+++.|+.+....
T Consensus 314 ----~----~~~~~~~~~~~~------~~~~~~---~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 314 ----L----FKLLKEGHRMDK------PANCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp ----H----HHHHHTTCCCCC------CTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----H----HHHHhcCCCCCC------CCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1 122222222111 111223 4455556999999999999999999999987653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=351.88 Aligned_cols=267 Identities=21% Similarity=0.324 Sum_probs=201.9
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhc--cCCCCccceeeEEEeC----CeeeE
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQ--LRHPNLVPLLGFCVVE----EERLL 367 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~----~~~~l 367 (604)
.++|...+.||+|+||.||+|.. +++.||||++... ..+.+.+|.+++.. ++||||+++++++... ...++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 45788899999999999999987 6889999999653 34556666666655 7999999999997653 45789
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcC-----CCCceecCCCCCeEEeCCCCCeEEc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGC-----QPPYMHQYISSNVILIDDDFDARIT 442 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~iiH~dlk~~NiLl~~~~~~kl~ 442 (604)
||||+++|+|.++++.. .+++..+..++.|++.||.|||... +.+|+||||||+|||++.++.+||+
T Consensus 84 v~e~~~~g~L~~~l~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQLT--------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EECCCTTCBHHHHHTTC--------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred ehhhccCCCHHHHHhhc--------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 99999999999999643 4889999999999999999999432 5789999999999999999999999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCCC------CCCcccchhhHHHHHHHHHhC----------CCCCCC
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM------VASLKGDVYGFGIVLLELLSG----------QKPLDV 506 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~t~k~DV~SfGvvl~elltg----------~~p~~~ 506 (604)
|||+++.................||+.|+|||++.+. .++.++|||||||++|||+|| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 9999987644322211112233589999999998776 456799999999999999999 788764
Q ss_pred CCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 507 AGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
...... .... .............+.... ........+.+++.+||+.||++|||+.||++.|+++
T Consensus 236 ~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDP---SFED-MRKVVCVDQQRPNIPNRW---FSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSC---CHHH-HHHHHTTSCCCCCCCGGG---GGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCc---chhh-hhHHHhccCCCCCCChhh---ccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 332211 1111 222222221111111111 1123456677777799999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=368.52 Aligned_cols=261 Identities=23% Similarity=0.370 Sum_probs=197.6
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC----CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP----DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~----~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
++|...+.||+|+||.||+|+.. ++..||||+++... ...++|.+|++++++++||||+++++++...+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57889999999999999999854 57789999997542 2346799999999999999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++|+|.++++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 125 ~e~~~~~sL~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD------AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp EECCTTCBHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EeCCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 99999999999997653 35899999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
......... ....+..++..|+|||++.+..++.++|||||||++|||++ |+.||...... + +...+..
T Consensus 196 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--------~-~~~~i~~ 265 (373)
T 2qol_A 196 VLEDDPEAA-YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------D-VIKAVDE 265 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--------H-HHHHHHT
T ss_pred ccccCCccc-eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--------H-HHHHHHc
Confidence 775432211 11122235778999999988899999999999999999998 99999653221 1 1122222
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcC
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHG 583 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~ 583 (604)
+.... ........+.+++.+||+.||++||++.||++.|+++.+..+
T Consensus 266 ~~~~~---------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 266 GYRLP---------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp TEECC---------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred CCCCC---------CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 21111 111122345566669999999999999999999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=348.95 Aligned_cols=260 Identities=19% Similarity=0.266 Sum_probs=208.5
Q ss_pred ccCHHHHHHhhcC----------CCcCcEEEecCCeEEEEEEeC-CCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCC
Q 007423 284 KVKLADLLAATNS----------FAVENIIISTRTGVSYKAVLP-DASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPN 351 (604)
Q Consensus 284 ~~~~~~l~~~~~~----------~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~n 351 (604)
.++.+++..+++. |...+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4777888887764 666779999999999999954 79999999997543 34567899999999999999
Q ss_pred ccceeeEEEeCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeE
Q 007423 352 LVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVI 431 (604)
Q Consensus 352 iv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~Ni 431 (604)
|+++++++...+..++||||+++|+|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NI 172 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--------RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSI 172 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGE
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHE
Confidence 999999999999999999999999999998643 4899999999999999999999 78999999999999
Q ss_pred EeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccc
Q 007423 432 LIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEE 511 (604)
Q Consensus 432 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~ 511 (604)
|++.++.+||+|||+++......... ....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-- 246 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVPKR----KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-- 246 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSCCB----CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--
T ss_pred EECCCCcEEEeeeeeeeecccCcccc----ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--
Confidence 99999999999999998765432221 233589999999999998999999999999999999999999975322
Q ss_pred cccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 512 GFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.+..... ........... ...++++ .+++.+||+.||++|||+.|+++.
T Consensus 247 ------~~~~~~~-~~~~~~~~~~~----~~~~~~l---~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 247 ------VQAMKRL-RDSPPPKLKNS----HKVSPVL---RDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ------HHHHHHH-HHSSCCCCTTG----GGSCHHH---HHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ------HHHHHHH-hcCCCCCcCcc----ccCCHHH---HHHHHHHccCChhhCcCHHHHhcC
Confidence 1112222 22211111110 0122334 445559999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=345.75 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=211.1
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
.++|...+.||+|+||.||+|...++..||||+++......+++.+|++++++++||||+++++++..++..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 35688889999999999999998888899999998776677889999999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 87 NGCLLNYLRSHG------KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp TCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred CCcHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999997642 34899999999999999999999 789999999999999999999999999999876433
Q ss_pred CCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
.. ....+..+|..|+|||++.+..++.++||||||+++|||+| |+.||...... +.... ...+...
T Consensus 158 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~-~~~~~~~- 224 (268)
T 3sxs_A 158 QY---VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--------EVVLK-VSQGHRL- 224 (268)
T ss_dssp CE---EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHH-HHTTCCC-
T ss_pred hh---hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--------HHHHH-HHcCCCC-
Confidence 21 11223346788999999988889999999999999999999 99999753221 11111 1222111
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
..+ ...+++ +.+++.+||+.||++|||+.|+++.|+.+.++
T Consensus 225 -~~~----~~~~~~---l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 225 -YRP----HLASDT---IYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -CCC----TTSCHH---HHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -CCC----CcChHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 111 112334 44555599999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=371.06 Aligned_cols=260 Identities=24% Similarity=0.349 Sum_probs=207.5
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
.++|...+.||+|+||.||+|... +++.||||.++... ...++|.+|++++++++||||+++++++..++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457888899999999999999964 78999999987542 223468899999999999999999999999899999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++|+|.++++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 193 ~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp CCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred cCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 999999999997542 34889999999999999999999 789999999999999999999999999999865
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
........ .....++..|+|||++....++.++|||||||++|||+| |+.||...... .+...+..+.
T Consensus 264 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---------~~~~~~~~~~ 332 (377)
T 3cbl_A 264 ADGVYAAS--GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---------QTREFVEKGG 332 (377)
T ss_dssp TTSEEECC--SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---------HHHHHHHTTC
T ss_pred CCCceeec--CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---------HHHHHHHcCC
Confidence 32211000 001125678999999988889999999999999999999 99999753221 1222333332
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
.... ....++ .+.+++.+||+.||++|||+.||++.|+++.+++
T Consensus 333 ~~~~------~~~~~~---~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 333 RLPC------PELCPD---AVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp CCCC------CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCC------CCCCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 2111 111223 4455566999999999999999999999998753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=377.43 Aligned_cols=260 Identities=21% Similarity=0.369 Sum_probs=210.2
Q ss_pred hhcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 293 ATNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
..++|...+.||+|+||.||+|...++..||||+++......++|.+|+++|++++||||+++++++. .+..++||||+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 35678888999999999999999988899999999876667788999999999999999999999986 66789999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++|+|.++++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 265 ~~g~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 265 AKGSLLDFLKSDEG-----SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp TTCBHHHHHHSHHH-----HTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred CCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 99999999975421 24789999999999999999999 78999999999999999999999999999987643
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
... ....+..++..|+|||++....++.++|||||||++|||+| |+.||..... .+.. ..+..+...
T Consensus 337 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--------~~~~-~~i~~~~~~ 404 (454)
T 1qcf_A 337 NEY---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVI-RALERGYRM 404 (454)
T ss_dssp HHH---HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHH-HHHHHTCCC
T ss_pred Cce---eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--------HHHH-HHHHcCCCC
Confidence 211 11122346789999999988889999999999999999999 9999975322 1112 222222111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
.. + ...+ ..+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus 405 ~~--~----~~~~---~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 405 PR--P----ENCP---EELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp CC--C----TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CC--C----CCCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 11 1 1122 34556666999999999999999999999987643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=360.12 Aligned_cols=275 Identities=15% Similarity=0.189 Sum_probs=209.8
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCC------CCEEEEEEecccccc------------HHHHHHHHHHHhccCCCCccce
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPD------ASALAIKRLSACKLS------------EKQFRSEMNRLGQLRHPNLVPL 355 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~------~~~vAvK~l~~~~~~------------~~~~~~Ei~~l~~l~H~niv~l 355 (604)
.++|...+.||+|+||.||+|.... ++.||||++...... ...+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578899999999999999998654 478999998654311 0224457777888899999999
Q ss_pred eeEEEeC----CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeE
Q 007423 356 LGFCVVE----EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVI 431 (604)
Q Consensus 356 ~g~~~~~----~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~Ni 431 (604)
++++... ...++||||+ +|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Ni 183 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA------KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNL 183 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHE
Confidence 9999764 4589999999 999999997643 35899999999999999999999 78999999999999
Q ss_pred EeC--CCCCeEEcccCCccccCCCCCCC---CccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 432 LID--DDFDARITDFGLARLVGSRDPND---SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 432 Ll~--~~~~~kl~DFGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
|++ .++.+||+|||+++.+....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999 88999999999998765332111 1111234589999999999999999999999999999999999999974
Q ss_pred CCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCCC
Q 007423 507 AGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSE 586 (604)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~ 586 (604)
..... ....+..... ......++++.+.....++++.++ +..||+.||++||++.+|++.|+++.++.+...
T Consensus 264 ~~~~~----~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l---i~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 335 (364)
T 3op5_A 264 NLKDP----KYVRDSKIRY-RENIASLMDKCFPAANAPGEIAKY---METVKLLDYTEKPLYENLRDILLQGLKAIGSKD 335 (364)
T ss_dssp GTTCH----HHHHHHHHHH-HHCHHHHHHHHSCTTCCCHHHHHH---HHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred cccCH----HHHHHHHHHh-hhhHHHHHHHhcccccCHHHHHHH---HHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence 32211 1111111111 122333444433323334445544 449999999999999999999999999877665
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=350.67 Aligned_cols=273 Identities=21% Similarity=0.303 Sum_probs=203.1
Q ss_pred hhcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhcc--CCCCccceeeEEEeC----Ceee
Q 007423 293 ATNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQL--RHPNLVPLLGFCVVE----EERL 366 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l--~H~niv~l~g~~~~~----~~~~ 366 (604)
..++|...+.||+|+||.||+|+.. ++.||||++.... ...+.+|.+++... +||||+++++++... ...+
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 3467999999999999999999875 8999999986533 34455566665554 999999999999887 6889
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcC-----CCCceecCCCCCeEEeCCCCCeEE
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGC-----QPPYMHQYISSNVILIDDDFDARI 441 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~iiH~dlk~~NiLl~~~~~~kl 441 (604)
+||||+++|+|.++++.. .+++..+..++.|++.||.|||+.+ .++|+||||||+|||++.++.+||
T Consensus 112 lv~e~~~~g~L~~~l~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKST--------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EEECCCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred EEEeccCCCcHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 999999999999999654 4889999999999999999999321 129999999999999999999999
Q ss_pred cccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcc------cchhhHHHHHHHHHhC----------CCCCC
Q 007423 442 TDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLK------GDVYGFGIVLLELLSG----------QKPLD 505 (604)
Q Consensus 442 ~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k------~DV~SfGvvl~elltg----------~~p~~ 505 (604)
+|||+++.................||+.|+|||++.+...+.+ +|||||||++|||+|| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999998765433222221223468999999999887766655 9999999999999999 56664
Q ss_pred CCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcC
Q 007423 506 VAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHG 583 (604)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~ 583 (604)
....... ....................... ..+....+.+++.+||+.||++|||+.||++.|+++.++..
T Consensus 264 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 264 DLVPSDP----SYEDMREIVCIKKLRPSFPNRWS---SDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp TTSCSSC----CHHHHHHHHTTSCCCCCCCGGGG---GSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred hhcCCCC----chhhhHHHHhhhccCccccccch---hhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 3322111 11112222222222221111111 12455667777789999999999999999999999988653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=350.12 Aligned_cols=258 Identities=19% Similarity=0.315 Sum_probs=208.6
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
.++|...+.||+|+||.||++...++..||||+++......+++.+|++++++++||||+++++++..++..++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 45788889999999999999998888899999998776677889999999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 103 ~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 103 NGCLLNYLREMR------HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp TCBHHHHHHCGG------GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred CCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 999999997642 35899999999999999999999 789999999999999999999999999999876432
Q ss_pred CCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
.. ....+..+|+.|+|||++.+..++.++||||||+++|||+| |+.||...... +.. ..+..+...
T Consensus 174 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--------~~~-~~~~~~~~~- 240 (283)
T 3gen_A 174 EY---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETA-EHIAQGLRL- 240 (283)
T ss_dssp HH---HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHH-HHHHTTCCC-
T ss_pred cc---ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--------HHH-HHHhcccCC-
Confidence 11 11122346788999999988889999999999999999999 99999753221 111 112222111
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
.. ....++. +.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 241 -~~----~~~~~~~---l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 241 -YR----PHLASEK---VYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -CC----CTTCCHH---HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CC----CCcCCHH---HHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 01 1122333 44555599999999999999999999998875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=350.91 Aligned_cols=247 Identities=20% Similarity=0.267 Sum_probs=201.2
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
.++|...+.||+|+||.||+|.. .+|+.||||++..... ..+++.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788899999999999999994 7899999999975432 3356889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 94 e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-------GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNE 163 (328)
T ss_dssp CCCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred ECCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence 999999999999754 35889999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVAS-LKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
..... ......||+.|+|||++.+..++ .++||||+||++|||+||+.||..... .+.. ..+..+
T Consensus 164 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~-~~i~~~ 229 (328)
T 3fe3_A 164 FTVGG-----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--------KELR-ERVLRG 229 (328)
T ss_dssp GSSSC-----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH-HHHHHC
T ss_pred cCCCC-----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--------HHHH-HHHHhC
Confidence 64322 12334689999999998877764 799999999999999999999975322 2222 222222
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.... +...+.++. +++.+||+.||++|||+.|+++.
T Consensus 230 ~~~~-------p~~~s~~~~---~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 230 KYRI-------PFYMSTDCE---NLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CCCC-------CTTSCHHHH---HHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCC-------CCCCCHHHH---HHHHHHCCCChhHCcCHHHHhcC
Confidence 2110 112233444 45559999999999999999764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=345.63 Aligned_cols=266 Identities=21% Similarity=0.284 Sum_probs=206.6
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||++. ..+++.||||++.... ...+.+.+|+.++++++||||+++++++..++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 468888999999999999999 5578999999985422 22357899999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 91 e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 91 EYIEGPTLSEYIESH-------GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp ECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred eCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 999999999999754 35899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
........ .....||+.|+|||++.+..++.++||||||+++|||+||+.||...... ....... .+.
T Consensus 161 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--------~~~~~~~-~~~ 228 (294)
T 4eqm_A 161 LSETSLTQ---TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV--------SIAIKHI-QDS 228 (294)
T ss_dssp C----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH--------HHHHHHH-SSC
T ss_pred cccccccc---cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHh-hcc
Confidence 64322111 12235899999999999888999999999999999999999999753221 1111111 111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhchHhcCCCCC
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-SMYQVYESLKSMAEKHGFSEP 587 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~ev~~~L~~i~~~~~~~~~ 587 (604)
.... ..... ...++ .+.+++.+||+.||++|| +++++.+.|+.+..+....+.
T Consensus 229 ~~~~-~~~~~-~~~~~---~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~ 282 (294)
T 4eqm_A 229 VPNV-TTDVR-KDIPQ---SLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANED 282 (294)
T ss_dssp CCCH-HHHSC-TTSCH---HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCC
T ss_pred CCCc-chhcc-cCCCH---HHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcc
Confidence 1111 01111 11223 344555599999999998 999999999998776554443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=348.29 Aligned_cols=269 Identities=20% Similarity=0.294 Sum_probs=203.0
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-----CCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeC--Ceee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-----PDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE--EERL 366 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-----~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 366 (604)
++|...+.||+|+||.||+|.+ .+++.||||++.... ...+.+.+|++++++++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5688889999999999999984 368899999997643 3346789999999999999999999998653 4589
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
+||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 90 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp EEEECCTTCBHHHHHHHCG------GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred EEEEeCCCCCHHHHHHhcc------cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 9999999999999997653 34899999999999999999999 78999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCcc-------ccccCcHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAE-------EGFKGNLVD 519 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~-------~~~~~~~~~ 519 (604)
++......... .......++..|+|||++.+..++.++||||||+++|||+||..|+...... .........
T Consensus 161 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 161 TKVLPQDKEFF-KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp CC--------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred cccccCCccee-eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 98765432211 1112234678899999998888999999999999999999999998642111 000001111
Q ss_pred HHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 520 WVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 520 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
........+..... ....++ .+.+++.+||+.||++|||+.|+++.|+++.++.
T Consensus 240 ~~~~~~~~~~~~~~------~~~~~~---~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 240 HLIELLKNNGRLPR------PDGCPD---EIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHTTCCCCC------CTTCCH---HHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHhccCcCCC------CcCcCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 12222222221111 112233 4455556999999999999999999999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=356.12 Aligned_cols=256 Identities=22% Similarity=0.397 Sum_probs=199.0
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCE----EEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASA----LAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~----vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
++|...+.||+|+||.||+|.. .+++. ||+|.++... ...+++.+|+.++++++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 4688889999999999999984 44544 5888875432 34578999999999999999999999998754 789
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
++||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 94 v~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEECCTTCBHHHHHHHST------TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred EEEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcce
Confidence 999999999999998653 35899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
+......... ......+|..|+|||++.+..++.++|||||||++|||+| |+.||......+ + ...+.
T Consensus 165 ~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~----~~~~~ 233 (327)
T 3poz_A 165 KLLGAEEKEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----I----SSILE 233 (327)
T ss_dssp HHHTTTCC---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----H----HHHHH
T ss_pred eEccCCcccc--cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-----H----HHHHH
Confidence 9875433221 1223346889999999998899999999999999999999 999997543221 1 12222
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
.+..... .......+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 234 ~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 234 KGERLPQ---------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTCCCCC---------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred cCCCCCC---------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 2221111 11122345566669999999999999999999998865
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=347.98 Aligned_cols=247 Identities=21% Similarity=0.224 Sum_probs=200.7
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||++.. .+++.||||+++... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 5788899999999999999994 579999999996532 23467889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 85 E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 154 (337)
T 1o6l_A 85 EYANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp ECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred eCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhh
Confidence 999999999999754 35889999999999999999999 78999999999999999999999999999986
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+...... .+.
T Consensus 155 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~-~~~ 221 (337)
T 1o6l_A 155 GISDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELIL-MEE 221 (337)
T ss_dssp SCCTTCC----BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-HCC
T ss_pred cccCCCc----ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHHHHHHH-cCC
Confidence 4322211 1233589999999999999999999999999999999999999975322 11122222 221
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYES 574 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~ 574 (604)
.. + +...++++.++++ +||+.||++|| ++.||++.
T Consensus 222 ~~------~-p~~~s~~~~~li~---~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 IR------F-PRTLSPEAKSLLA---GLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CC------C-CTTSCHHHHHHHH---HHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CC------C-CCCCCHHHHHHHH---HHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11 1 1122344555554 99999999999 89998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=378.27 Aligned_cols=259 Identities=22% Similarity=0.380 Sum_probs=210.7
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
..+|...+.||+|+||.||+|... ++..||||.++......++|.+|+++|++++||||++++++|...+..++||||+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 456788899999999999999965 4889999999876666788999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++|+|.++++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 299 ~~g~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 299 TYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp TTCBHHHHHHHSCT-----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred CCCCHHHHHHhcCc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999976432 35889999999999999999999 78999999999999999999999999999987643
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
... ....+..++..|+|||++....++.++|||||||++|||+| |+.||...... .+ ...+..+...
T Consensus 371 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-----~~----~~~~~~~~~~ 438 (495)
T 1opk_A 371 DTY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QV----YELLEKDYRM 438 (495)
T ss_dssp CCE---ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GH----HHHHHTTCCC
T ss_pred Cce---eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-----HH----HHHHHcCCCC
Confidence 221 11123346789999999988889999999999999999999 99999754321 11 1222222111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
.. ....++ .+.+++.+||+.||++|||+.||++.|+.+.++
T Consensus 439 ~~------~~~~~~---~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 439 ER------PEGCPE---KVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CC------CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CC------CCCCCH---HHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 11 111223 455566699999999999999999999988653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=348.13 Aligned_cols=252 Identities=17% Similarity=0.205 Sum_probs=203.4
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
.++|...+.||+|+||.||+|.. .+++.||+|.++......+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 35788899999999999999994 56889999999866555677899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC--CCCeEEcccCCcccc
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD--DFDARITDFGLARLV 450 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~--~~~~kl~DFGla~~~ 450 (604)
++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+++..
T Consensus 84 ~g~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 84 SGLDIFERINTSA------FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCBHHHHHTSSS------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred CCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 9999999997542 35899999999999999999999 789999999999999997 789999999999876
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+....... +..
T Consensus 155 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~-~~~ 220 (321)
T 1tki_A 155 KPGDN-----FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMN-AEY 220 (321)
T ss_dssp CTTCE-----EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHH-TCC
T ss_pred CCCCc-----cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHc-CCC
Confidence 43221 1223589999999999988899999999999999999999999975322 122222222 211
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.. +.... ...+++ +.+++.+||+.||++|||+.|+++.
T Consensus 221 ~~--~~~~~-~~~s~~---~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 221 TF--DEEAF-KEISIE---AMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CC--CHHHH-TTSCHH---HHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC--Chhhh-ccCCHH---HHHHHHHHcCCChhHCcCHHHHhcC
Confidence 10 00000 112233 4455559999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=371.67 Aligned_cols=258 Identities=24% Similarity=0.361 Sum_probs=204.5
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
.++|...+.||+|+||.||+|...++..||||+++......++|.+|+++|++++||||+++++++.. +..++||||++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 45678889999999999999998888889999998766667889999999999999999999999865 67899999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+|+|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 262 ~gsL~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 262 KGSLLDFLKGETG-----KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp TCBHHHHHSHHHH-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 9999999975321 24889999999999999999999 789999999999999999999999999999876432
Q ss_pred CCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
... ...+..++..|+|||++....++.++|||||||++|||+| |+.||...... + +...+..+....
T Consensus 334 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--------~-~~~~i~~~~~~~ 401 (452)
T 1fmk_A 334 EYT---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------E-VLDQVERGYRMP 401 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------H-HHHHHHTTCCCC
T ss_pred cee---cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--------H-HHHHHHcCCCCC
Confidence 211 1123346789999999988889999999999999999999 99999753221 1 122222332111
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
. ....+ ..+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus 402 ~------~~~~~---~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 402 C------PPECP---ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp C------CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred C------CCCCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 1 01122 3455566699999999999999999999988754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=350.00 Aligned_cols=250 Identities=18% Similarity=0.266 Sum_probs=200.9
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc-------cHHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL-------SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER 365 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 365 (604)
.+.|...+.||+|+||.||++.. .+|+.||||.++.... ..+.+.+|++++++++||||+++++++...+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 45688899999999999999994 5799999999965321 346799999999999999999999999999999
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC----CeEE
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF----DARI 441 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~----~~kl 441 (604)
++||||+++|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+|||+++++ .+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl 160 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK-------ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKL 160 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC-------SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred EEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEE
Confidence 9999999999999999754 35899999999999999999999 78999999999999998776 7999
Q ss_pred cccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHH
Q 007423 442 TDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWV 521 (604)
Q Consensus 442 ~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 521 (604)
+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +..
T Consensus 161 ~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--------~~~ 227 (361)
T 2yab_A 161 IDFGLAHEIEDGVE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETL 227 (361)
T ss_dssp CCCSSCEECCTTCC-----CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHH
T ss_pred EecCCceEcCCCCc-----cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHH
Confidence 99999987654322 12335899999999999889999999999999999999999999753221 111
Q ss_pred HHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 522 NHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 522 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.. +..+... .++... ...++++.+ ++.+||..||++|||+.|+++
T Consensus 228 ~~-i~~~~~~--~~~~~~-~~~s~~~~~---li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 228 AN-ITAVSYD--FDEEFF-SQTSELAKD---FIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HH-HHTTCCC--CCHHHH-TTSCHHHHH---HHHHHSCSSTTTSCCHHHHHT
T ss_pred HH-HHhcCCC--CCchhc-cCCCHHHHH---HHHHHCCCChhHCcCHHHHhc
Confidence 11 1222111 111111 112334444 455999999999999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=361.43 Aligned_cols=275 Identities=19% Similarity=0.284 Sum_probs=212.2
Q ss_pred cCHHHHHHhhcCCCcCcEEEecCCeEEEEEEe------CCCCEEEEEEecccc--ccHHHHHHHHHHHhcc-CCCCccce
Q 007423 285 VKLADLLAATNSFAVENIIISTRTGVSYKAVL------PDASALAIKRLSACK--LSEKQFRSEMNRLGQL-RHPNLVPL 355 (604)
Q Consensus 285 ~~~~~l~~~~~~~~~~~~ig~G~~g~vy~~~~------~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l 355 (604)
+...+.....++|...+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 33445555678899999999999999999973 346789999997643 2335799999999999 79999999
Q ss_pred eeEEEeCC-eeeEEeeecCCCchhhhhccCCCCCC---------------------------------------------
Q 007423 356 LGFCVVEE-ERLLVYKHMPNGTLYSLLHGNGVDNT--------------------------------------------- 389 (604)
Q Consensus 356 ~g~~~~~~-~~~lv~ey~~~gsL~~~l~~~~~~~~--------------------------------------------- 389 (604)
++++...+ ..++||||+++|+|.++++.......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998755 48999999999999999976532100
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCC
Q 007423 390 --------------LSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDP 455 (604)
Q Consensus 390 --------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 455 (604)
....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 0122889999999999999999999 78999999999999999999999999999987643221
Q ss_pred CCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 456 NDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 456 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
. .......||..|+|||++.+..++.++|||||||++|||+| |+.||......+ .+......+......
T Consensus 249 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~ 318 (359)
T 3vhe_A 249 Y--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--------EFCRRLKEGTRMRAP 318 (359)
T ss_dssp C--EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--------HHHHHHHHTCCCCCC
T ss_pred c--hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--------HHHHHHHcCCCCCCC
Confidence 1 11223357889999999988889999999999999999999 999997543211 112222222211111
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
...+++ +.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 319 ------~~~~~~---l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 319 ------DYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp ------TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCHH---HHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 112233 45555699999999999999999999998875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=348.39 Aligned_cols=276 Identities=21% Similarity=0.319 Sum_probs=201.2
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHH--HHHHHhccCCCCccceeeEEEe-----CCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRS--EMNRLGQLRHPNLVPLLGFCVV-----EEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~--Ei~~l~~l~H~niv~l~g~~~~-----~~~~~l 367 (604)
++|...+.||+|+||.||+|+. +++.||||+++... ...+.. |+..+..++||||+++++++.. ....++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 5788899999999999999976 68899999997543 334444 4444556899999999987653 235689
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCC---------CceecCCCCCeEEeCCCCC
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQP---------PYMHQYISSNVILIDDDFD 438 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~---------~iiH~dlk~~NiLl~~~~~ 438 (604)
||||+++|+|.+++... ..++..+..++.|++.||.||| +. +|+||||||+|||++.++.
T Consensus 90 v~e~~~~g~L~~~l~~~--------~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSLH--------TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EECCCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred EEecCCCCcHHHHHhhc--------ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCc
Confidence 99999999999999754 3578999999999999999999 56 9999999999999999999
Q ss_pred eEEcccCCccccCCCCCC----CCccccCCCCcccccCccccCC-------CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 439 ARITDFGLARLVGSRDPN----DSSFVHGDLGEFGYVAPEYSST-------MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 439 ~kl~DFGla~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~-------~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
+||+|||+++.+...... .........||..|+|||++.+ ..++.++|||||||++|||+||..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 999999999876532211 1111223458999999999876 45678999999999999999998776543
Q ss_pred CccccccCcH---------HHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 508 GAEEGFKGNL---------VDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 508 ~~~~~~~~~~---------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
.......... .+..............+.... .........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 2222111111 111112222222111111111 11223455677777799999999999999999999999
Q ss_pred hHhcCCCC
Q 007423 579 AEKHGFSE 586 (604)
Q Consensus 579 ~~~~~~~~ 586 (604)
.+.+..-.
T Consensus 317 l~~~~~~~ 324 (336)
T 3g2f_A 317 MMIWERNK 324 (336)
T ss_dssp HHCCCC--
T ss_pred HHHHHhcc
Confidence 98775544
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=363.12 Aligned_cols=253 Identities=25% Similarity=0.363 Sum_probs=204.7
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCC-eeeEEeeec
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE-ERLLVYKHM 372 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lv~ey~ 372 (604)
.++|...+.||+|+||.||+|... ++.||||+++... ..+.|.+|+++|++++||||+++++++...+ ..++||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 456888899999999999999974 7799999997654 4567999999999999999999999988765 789999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++|+|.++++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 270 ~~g~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 270 AKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp TTCBHHHHHHHHCT-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred CCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 99999999986532 24789999999999999999999 78999999999999999999999999999986532
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
... ...++..|+|||++.+..++.++|||||||++|||+| |+.||......+ . ...+..+...
T Consensus 342 ~~~-------~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----~----~~~i~~~~~~ 405 (450)
T 1k9a_A 342 TQD-------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----V----VPRVEKGYKM 405 (450)
T ss_dssp ------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-----H----HHHHHTTCCC
T ss_pred ccc-------CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----H----HHHHHcCCCC
Confidence 111 1136789999999998899999999999999999999 999997543221 1 1222233221
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
.. ....++ .+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 406 ~~------p~~~~~---~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 406 DA------PDGCPP---AVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CC------CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CC------CCcCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 11 112223 445556699999999999999999999998763
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=342.14 Aligned_cols=268 Identities=16% Similarity=0.200 Sum_probs=207.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCC--eeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE--ERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lv~ 369 (604)
+.|...+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 4688889999999999999995 458999999997533 33467889999999999999999999998765 779999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe----CCCCCeEEcccC
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI----DDDFDARITDFG 445 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl----~~~~~~kl~DFG 445 (604)
||+++|+|.+++...... ..+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||
T Consensus 89 e~~~~~~L~~~l~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNA----YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp ECCTTCBHHHHHHSGGGT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred eCCCCCCHHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 999999999999865321 24899999999999999999999 7899999999999999 788889999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccC--------CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcH
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSS--------TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNL 517 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~ 517 (604)
+++........ ....||..|+|||++. +..++.++|||||||++|||+||+.||........ .
T Consensus 162 ~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~ 232 (319)
T 4euu_A 162 AARELEDDEQF-----VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR----N 232 (319)
T ss_dssp TCEECCTTCCB-----CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG----C
T ss_pred CceecCCCCce-----eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch----h
Confidence 99877543221 2235899999999875 56789999999999999999999999975332221 1
Q ss_pred HHHHHHHHHcCCc---cccc---------cccc--cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 518 VDWVNHLVIAGRS---RDVV---------DKSL--YGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 518 ~~~~~~~~~~~~~---~~~~---------d~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
.+.+......... ..+. ++.+ ...........+.+++.+||+.||++|||++|+++.....
T Consensus 233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 2222222221110 0000 0000 1122344555667777799999999999999999988754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=339.57 Aligned_cols=270 Identities=16% Similarity=0.144 Sum_probs=211.2
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
++|...+.||+|+||.||+|. ..+++.||||++.... ..+.+.+|+++++++ +|+|++++++++......++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 568889999999999999999 5789999999986432 234688999999999 7999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC-----eEEcccCCc
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD-----ARITDFGLA 447 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~-----~kl~DFGla 447 (604)
+++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++. +||+|||++
T Consensus 89 -~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 89 -GPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp -CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred -CCCHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999999998653 35899999999999999999999 889999999999999987766 999999999
Q ss_pred cccCCCCCCCC---ccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 448 RLVGSRDPNDS---SFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 448 ~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
+.......... .......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~~~~~ 233 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-----NKQKYERI 233 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC-----HHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc-----cHHHHHHH
Confidence 87754322111 11233458999999999999899999999999999999999999997643211 11111111
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCCC
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSE 586 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~ 586 (604)
... ...... +... ...++ .+.+++.+||+.||++||++.+|++.|+++.++.+..+
T Consensus 234 ~~~-~~~~~~-~~~~-~~~~~---~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~ 289 (298)
T 1csn_A 234 GEK-KQSTPL-RELC-AGFPE---EFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 289 (298)
T ss_dssp HHH-HHHSCH-HHHT-TTSCH---HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred Hhh-ccCccH-HHHH-hhCcH---HHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCC
Confidence 111 000000 0011 11223 44455559999999999999999999999999876654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=338.10 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=210.1
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
++|...+.||+|+||.||++...++..||||+++......+++.+|++++++++||||+++++++..++..++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 56788899999999999999988889999999987766678899999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 88 GCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp CBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CcHHHHHhhCc------ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 99999997653 35889999999999999999999 7899999999999999999999999999998764321
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
. .......++..|+|||+..+..++.++||||||+++|||+| |+.||..... .+.... +..+....
T Consensus 159 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~-i~~~~~~~- 225 (267)
T 3t9t_A 159 Y---TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVED-ISTGFRLY- 225 (267)
T ss_dssp H---HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHH-HHTTCCCC-
T ss_pred c---cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--------HHHHHH-HhcCCcCC-
Confidence 1 11122346788999999988889999999999999999999 8999975322 111211 22221111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
.+ ...+.+ +.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 226 -~~----~~~~~~---l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 226 -KP----RLASTH---VYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -CC----TTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -CC----ccCcHH---HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11 112334 44555599999999999999999999998764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=358.82 Aligned_cols=265 Identities=20% Similarity=0.301 Sum_probs=207.4
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 366 (604)
++|...+.||+|+||.||+|... ++..||||+++... ....++.+|+.++++++||||+++++++...+..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56888899999999999999843 46689999997532 33457899999999999999999999999999999
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC---CeEEcc
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF---DARITD 443 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~---~~kl~D 443 (604)
+||||+++|+|.+++............+++..++.++.|++.||.||| +.+|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 999999999999999865432223346899999999999999999999 78999999999999999544 599999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHH
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVN 522 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 522 (604)
||+++.......... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||..... .+..
T Consensus 228 FG~a~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~~~- 296 (367)
T 3l9p_A 228 FGMARDIYRAGYYRK--GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVL- 296 (367)
T ss_dssp CHHHHHHHHHSSCTT--CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHH-
T ss_pred Ccccccccccccccc--CCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHH-
Confidence 999986532211111 112247889999999988889999999999999999998 9999975322 1112
Q ss_pred HHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 523 HLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 523 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
..+..+..... ....+. .+.+++.+||+.||++|||+.||++.|+.+.+..
T Consensus 297 ~~i~~~~~~~~------~~~~~~---~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 297 EFVTSGGRMDP------PKNCPG---PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HHHHTTCCCCC------CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHHcCCCCCC------CccCCH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 22222221111 011223 3455666999999999999999999999987754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=353.06 Aligned_cols=251 Identities=18% Similarity=0.254 Sum_probs=197.1
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccccc----HHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeE
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLS----EKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 367 (604)
.++|...++||+|+||.||+++. .+++.||||+++..... .+.+.+|..++.++ +||||+++++++..++..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 35788999999999999999994 56889999999754322 23578899999887 89999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 131 V~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla 200 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200 (396)
T ss_dssp EEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEcCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeeccee
Confidence 99999999999999764 35899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
+........ ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......+++......
T Consensus 201 ~~~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 276 (396)
T 4dc2_A 201 KEGLRPGDT----TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 276 (396)
T ss_dssp BCCCCTTCC----BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred eecccCCCc----cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence 864322211 2234699999999999999999999999999999999999999975433221111222333333333
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSM 568 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 568 (604)
+... + +...+.++.+ ++.+||+.||++||++
T Consensus 277 ~~~~------~-p~~~s~~~~~---li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 277 KQIR------I-PRSLSVKAAS---VLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCCC------C-CTTSCHHHHH---HHHHHTCSCTTTSTTC
T ss_pred cccC------C-CCcCCHHHHH---HHHHHhcCCHhHcCCC
Confidence 2221 0 1122344444 4559999999999995
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=349.94 Aligned_cols=269 Identities=15% Similarity=0.128 Sum_probs=211.2
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEeee
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
.++|...+.||+|+||.||+|. ..+++.||||.+.... ..+++.+|+++++++ +||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 3578889999999999999999 5679999999986533 234688999999999 999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC-----eEEcccCC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD-----ARITDFGL 446 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~-----~kl~DFGl 446 (604)
+ +|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+|||+
T Consensus 87 ~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 87 L-GPSLEDLFDLCD------RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp C-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred C-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 9 899999997642 35899999999999999999999 789999999999999998877 99999999
Q ss_pred ccccCCCCCCCC---ccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHH
Q 007423 447 ARLVGSRDPNDS---SFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNH 523 (604)
Q Consensus 447 a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 523 (604)
++.......... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ...+....
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~-----~~~~~~~~ 231 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD-----TLKERYQK 231 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS-----SHHHHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc-----cHHHHHHH
Confidence 997654332211 0112346899999999999999999999999999999999999999764322 12221111
Q ss_pred HHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCC
Q 007423 524 LVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFS 585 (604)
Q Consensus 524 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~ 585 (604)
... ....... ..+ ....+ .+.+++..||+.||++||++.+|.+.|+++.++.+..
T Consensus 232 i~~-~~~~~~~-~~~-~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~ 286 (330)
T 2izr_A 232 IGD-TKRATPI-EVL-CENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYM 286 (330)
T ss_dssp HHH-HHHHSCH-HHH-TTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHh-hhccCCH-HHH-hccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 111 0000000 000 11122 4555666999999999999999999999999887664
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=352.68 Aligned_cols=270 Identities=20% Similarity=0.311 Sum_probs=212.1
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe--------CCCCEEEEEEeccccc--cHHHHHHHHHHHhcc-CCCCccceeeEEEeC
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL--------PDASALAIKRLSACKL--SEKQFRSEMNRLGQL-RHPNLVPLLGFCVVE 362 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~--------~~~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 362 (604)
.++|...+.||+|+||.||+|.. ..+..||||+++.... ..+++.+|+++++++ +||||+++++++..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 45788889999999999999984 2335799999975432 336789999999999 999999999999999
Q ss_pred CeeeEEeeecCCCchhhhhccCCCCC---------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe
Q 007423 363 EERLLVYKHMPNGTLYSLLHGNGVDN---------TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI 433 (604)
Q Consensus 363 ~~~~lv~ey~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl 433 (604)
+..++||||+++|+|.+++....... .....+++..++.++.|++.||.||| +.+|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence 99999999999999999997653210 11135899999999999999999999 7899999999999999
Q ss_pred CCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCcccc
Q 007423 434 DDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEG 512 (604)
Q Consensus 434 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~ 512 (604)
++++.+||+|||+++......... ......+|..|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--- 299 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYK--KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 299 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTC--CCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred cCCCcEEEcccCcccccccccccc--cccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 999999999999998765432211 1122347889999999998899999999999999999999 9999975322
Q ss_pred ccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCCC
Q 007423 513 FKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSE 586 (604)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~ 586 (604)
.+ +...+..+...... ...+++ +.+++.+||+.||++|||+.||++.|+++.......+
T Consensus 300 -----~~-~~~~~~~~~~~~~~------~~~~~~---l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 300 -----EE-LFKLLKEGHRMDKP------SNCTNE---LYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp -----HH-HHHHHHTTCCCCCC------SSCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred -----HH-HHHHHHcCCCCCCC------ccCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 12 22222333221111 112333 4455559999999999999999999999987654443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=340.99 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=190.1
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccc-----cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKL-----SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||+|... ++.||||+++.... ..+.+.+|++++++++||||+++++++..++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 56888899999999999999974 88999999865322 2367899999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC--------CCCeEE
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD--------DFDARI 441 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~--------~~~~kl 441 (604)
||+++++|.+++... .+++.....++.|++.||.|||.....+|+||||||+||+++. ++.+||
T Consensus 86 e~~~~~~L~~~~~~~--------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK--------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp ECCTTEEHHHHHTSS--------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EcCCCCCHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 999999999998643 4889999999999999999999432223999999999999986 678999
Q ss_pred cccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHH
Q 007423 442 TDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWV 521 (604)
Q Consensus 442 ~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 521 (604)
+|||+++........ ...||+.|+|||++.+..++.++||||||+++|||+||+.||...... ...
T Consensus 158 ~Dfg~~~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~ 223 (271)
T 3dtc_A 158 TDFGLAREWHRTTKM------SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--------AVA 223 (271)
T ss_dssp CCCCC-------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH--------HHH
T ss_pred ccCCccccccccccc------CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHH
Confidence 999999866432211 224899999999998888999999999999999999999999753221 111
Q ss_pred HHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 522 NHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 522 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
.. .......... ....++ .+.+++.+||+.||++|||+.|+++.|++|
T Consensus 224 ~~-~~~~~~~~~~-----~~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 224 YG-VAMNKLALPI-----PSTCPE---PFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HH-HHTSCCCCCC-----CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred Hh-hhcCCCCCCC-----CcccCH---HHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11 1112111111 112223 344555599999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=342.95 Aligned_cols=249 Identities=18% Similarity=0.265 Sum_probs=199.8
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc-------ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK-------LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 366 (604)
+.|...+.||+|+||.||++.. .+++.||||.++... ...+.+.+|++++++++||||+++++++..++..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4688889999999999999994 568999999986432 13577999999999999999999999999999999
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC----CeEEc
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF----DARIT 442 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~----~~kl~ 442 (604)
+||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||+++++ .+||+
T Consensus 91 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK-------ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp EEEECCCSCBHHHHHTTS-------SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred EEEEcCCCCCHHHHHHhc-------CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 999999999999999754 35899999999999999999999 78999999999999999877 79999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHH
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVN 522 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 522 (604)
|||+++........ ....||+.|+|||++.+..++.++|||||||++|||+||+.||...... +...
T Consensus 161 Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~ 227 (326)
T 2y0a_A 161 DFGLAHKIDFGNEF-----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLA 227 (326)
T ss_dssp CCTTCEECCTTSCC-----CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHH
T ss_pred ECCCCeECCCCCcc-----ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--------HHHH
Confidence 99999877433221 2235899999999999889999999999999999999999999753221 1111
Q ss_pred HHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 523 HLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 523 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.... .... . ..... ...+.+ +.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~-~~~~-~-~~~~~-~~~~~~---~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 228 NVSA-VNYE-F-EDEYF-SNTSAL---AKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHH-TCCC-C-CHHHH-TTSCHH---HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHh-cCCC-c-Ccccc-ccCCHH---HHHHHHHHccCChhhCCCHHHHhc
Confidence 1111 1110 0 00000 112233 445555999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=340.63 Aligned_cols=262 Identities=23% Similarity=0.311 Sum_probs=202.4
Q ss_pred CCcCcEEEecCCeEEEEEEe-CCCC---EEEEEEeccccc--cHHHHHHHHHHHhccCCCCccceeeEEEeCCee-eEEe
Q 007423 297 FAVENIIISTRTGVSYKAVL-PDAS---ALAIKRLSACKL--SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER-LLVY 369 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~-~~~~---~vAvK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-~lv~ 369 (604)
|...+.||+|+||.||+|.. .++. .||+|.+..... ..+.+.+|++++++++||||+++++++...+.. +++|
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 45568999999999999984 3333 799999975332 346789999999999999999999999876655 9999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+.+|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++.
T Consensus 103 e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQ------RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp CCCTTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred ecccCCCHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 9999999999997643 35889999999999999999999 78999999999999999999999999999986
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
................++..|+|||...+..++.++||||||+++|||+||..|+...... ... ......+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~----~~~----~~~~~~~~ 245 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP----FDL----THFLAQGR 245 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG----GGH----HHHHHTTC
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH----HHH----HHHhhcCC
Confidence 6432211112222335789999999999999999999999999999999965554322111 111 11222222
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCC
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGF 584 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~ 584 (604)
.... ....+++ +.+++.+||+.||++|||+.|+++.|+++.+....
T Consensus 246 ~~~~------~~~~~~~---l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 246 RLPQ------PEYCPDS---LYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp CCCC------CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred CCCC------CccchHH---HHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 1111 1122334 44555599999999999999999999999987643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=340.22 Aligned_cols=257 Identities=22% Similarity=0.255 Sum_probs=196.9
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
++|...+.||+|+||.||+|...+++.||||+++.... ..+.+.+|++++++++||||+++++++..++..++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 56888899999999999999988899999999975432 236788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++ +|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 101 MEK-DLKKVLDENK------TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp CSE-EHHHHHHTCT------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred CCC-CHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 985 8888887553 34899999999999999999999 7899999999999999999999999999998764
Q ss_pred CCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
..... .....||+.|+|||++.+ ..++.++||||+||++|||+||+.||......+ ....+.........
T Consensus 171 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~~~~~~~~ 241 (311)
T 3niz_A 171 IPVRS----YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-----QLPKIFSILGTPNP 241 (311)
T ss_dssp SCCC-------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-----HHHHHHHHHCCCCT
T ss_pred CCccc----ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHHCCCCh
Confidence 32221 122358999999998865 568999999999999999999999997643322 11111111111000
Q ss_pred cc----------------cccccc---cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 531 RD----------------VVDKSL---YGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 531 ~~----------------~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.. ..+... .....+ .++.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 242 REWPQVQELPLWKQRTFQVFEKKPWSSIIPGFC---QEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCC---HHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhhhhccchhhhcccccccCCcHHHhCcccC---HHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 000000 001112 24455666999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=350.03 Aligned_cols=270 Identities=23% Similarity=0.336 Sum_probs=210.1
Q ss_pred HHhhcCCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeC
Q 007423 291 LAATNSFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE 362 (604)
Q Consensus 291 ~~~~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 362 (604)
....++|...+.||+|+||.||+|... +++.||||.++... ...+.+.+|++++++++||||+++++++..+
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 334578999999999999999999863 35789999997543 2346799999999999999999999999999
Q ss_pred CeeeEEeeecCCCchhhhhccCCCCC-----------------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecC
Q 007423 363 EERLLVYKHMPNGTLYSLLHGNGVDN-----------------TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQY 425 (604)
Q Consensus 363 ~~~~lv~ey~~~gsL~~~l~~~~~~~-----------------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~d 425 (604)
+..++||||+++|+|.+++....... .....+++..++.++.|+++||.||| +.+|+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 99999999999999999997642110 00145899999999999999999999 78999999
Q ss_pred CCCCeEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCC
Q 007423 426 ISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPL 504 (604)
Q Consensus 426 lk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~ 504 (604)
|||+|||++.++.+||+|||+++......... ......+|..|+|||++.+..++.++|||||||++|||+| |+.||
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYK--ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCcccc--ccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999998764322111 1122347889999999888889999999999999999999 99999
Q ss_pred CCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcC
Q 007423 505 DVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHG 583 (604)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~ 583 (604)
..... .+ +...+..+...... ...+. .+.+++.+||+.||++||++.||++.|+++.++..
T Consensus 278 ~~~~~--------~~-~~~~~~~~~~~~~~------~~~~~---~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 278 YGMAH--------EE-VIYYVRDGNILACP------ENCPL---ELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TTSCH--------HH-HHHHHHTTCCCCCC------TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCCCh--------HH-HHHHHhCCCcCCCC------CCCCH---HHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 75322 11 22223333322111 12233 34555569999999999999999999999987653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.63 Aligned_cols=259 Identities=25% Similarity=0.380 Sum_probs=198.9
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
++|...+.||+|+||.||++... ++.||||++... ...+.|.+|++++++++||||+++++++. +..++||||+++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~ 83 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG 83 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence 46778899999999999999874 788999999653 34567999999999999999999999875 458999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC-eEEcccCCccccCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD-ARITDFGLARLVGSR 453 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~-~kl~DFGla~~~~~~ 453 (604)
|+|.+++...... ..+++..++.++.|+++||.|||+....+|+||||||+|||++.++. +||+|||+++.....
T Consensus 84 ~~L~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 84 GSLYNVLHGAEPL----PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CBHHHHHHCSSSE----ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCHHHHHhccCCC----CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 9999999865321 34789999999999999999999433378999999999999998876 799999999765322
Q ss_pred CCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
. ....||..|+|||++.+..++.++|||||||++|||+||+.||...... ...... ....+.....
T Consensus 160 ~-------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~-~~~~~~~~~~ 225 (307)
T 2eva_A 160 M-------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP------AFRIMW-AVHNGTRPPL 225 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS------HHHHHH-HHHTTCCCCC
T ss_pred c-------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc------HHHHHH-HHhcCCCCCc
Confidence 1 1224899999999999989999999999999999999999999753221 111111 1122222111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCC
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGF 584 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~ 584 (604)
. ...++. +.+++.+||+.||++|||+.|+++.|+.+.+.+..
T Consensus 226 ~------~~~~~~---l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 226 I------KNLPKP---IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp B------TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred c------cccCHH---HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 1 112233 44555599999999999999999999999876643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=353.16 Aligned_cols=269 Identities=22% Similarity=0.361 Sum_probs=197.8
Q ss_pred CCCcCcEEEecCCeEEEEEEeC--CC--CEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEe-CCeeeEE
Q 007423 296 SFAVENIIISTRTGVSYKAVLP--DA--SALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV-EEERLLV 368 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~--~~--~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lv 368 (604)
.|...+.||+|+||.||+|... ++ ..||||.++... ...++|.+|+.++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3566789999999999999853 22 368999986532 334679999999999999999999999764 4578999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++|+|.+++.... ..+++..+..++.|+++||.||| +.+|+||||||+|||+++++.+||+|||+++
T Consensus 170 ~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp EECCTTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EECCCCCCHHHHHhhcc------cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccc
Confidence 99999999999997653 34789999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
..............+..+|..|+|||++.+..++.++|||||||++|||+| |.+||...... .... ....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~-----~~~~----~~~~ 311 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITV----YLLQ 311 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-----CHHH----HHHT
T ss_pred cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-----HHHH----HHHc
Confidence 764332222112223457889999999988899999999999999999999 77787653321 1111 1222
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCCCCCCCCc
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEPYDEFP 592 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~~~~~~ 592 (604)
+... ..+ ...++ .+.+++.+||+.||++|||+.|+++.|+++...+... .+..++
T Consensus 312 ~~~~--~~p----~~~~~---~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~-~~~~~~ 366 (373)
T 3c1x_A 312 GRRL--LQP----EYCPD---PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE-HYVHVN 366 (373)
T ss_dssp TCCC--CCC----TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC-CBCCCC
T ss_pred CCCC--CCC----CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc-ceeecc
Confidence 2211 111 12233 3455566999999999999999999999999876533 344443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=356.52 Aligned_cols=252 Identities=18% Similarity=0.215 Sum_probs=200.4
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
.++|...+.||+|+||.||+|. ..+|+.||+|++..... ..+.+.+|++++++++||||+++++++..++..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 4678899999999999999998 56789999999975432 3356899999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC---CCCCeEEcccCC
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID---DDFDARITDFGL 446 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~---~~~~~kl~DFGl 446 (604)
||+++|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+|||++ +++.+||+|||+
T Consensus 90 E~~~gg~L~~~i~~~-------~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 90 DLVTGGELFEDIVAR-------EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp CCCBCCBHHHHHHHC-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EeCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 999999999999765 35899999999999999999999 78999999999999998 467899999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
++........ ..+..||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+.. ..+.
T Consensus 160 a~~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--------~~~~-~~i~ 226 (444)
T 3soa_A 160 AIEVEGEQQA----WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--------HRLY-QQIK 226 (444)
T ss_dssp CBCCCTTCCB----CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHH-HHHH
T ss_pred eEEecCCCce----eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--------HHHH-HHHH
Confidence 9876433221 2234599999999999998999999999999999999999999975322 1111 2222
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.+... ...+.. ...++++. +++.+||+.||++|||+.|+++.
T Consensus 227 ~~~~~-~~~~~~--~~~s~~~~---~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 227 AGAYD-FPSPEW--DTVTPEAK---DLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HTCCC-CCTTTT--TTSCHHHH---HHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hCCCC-CCcccc--ccCCHHHH---HHHHHHcCCChhHCCCHHHHhcC
Confidence 22211 111110 12234444 45559999999999999999863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.04 Aligned_cols=250 Identities=19% Similarity=0.251 Sum_probs=195.8
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv 368 (604)
++|...+.||+|+||.||+++. .+++.||||+++... ...+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 4688889999999999999995 568899999997542 2234578999999988 899999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~e~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~ 158 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 158 (345)
T ss_dssp ECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCB
T ss_pred EeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccc
Confidence 9999999999999754 35899999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.........+......+
T Consensus 159 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~ 234 (345)
T 3a8x_A 159 EGLRPGDT----TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 234 (345)
T ss_dssp CSCCTTCC----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC
T ss_pred cccCCCCc----ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC
Confidence 64322211 22345899999999999989999999999999999999999999753322111111122222222222
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSM 568 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 568 (604)
... + +...+.++.+ ++.+||+.||++||++
T Consensus 235 ~~~------~-p~~~s~~~~~---li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 235 QIR------I-PRSLSVKAAS---VLKSFLNKDPKERLGC 264 (345)
T ss_dssp CCC------C-CTTSCHHHHH---HHHHHTCSSTTTSTTC
T ss_pred CCC------C-CCCCCHHHHH---HHHHHhcCCHhHCCCC
Confidence 211 1 1122344444 4559999999999995
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=339.48 Aligned_cols=247 Identities=21% Similarity=0.271 Sum_probs=191.6
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc---------------------------cHHHHHHHHHHHhc
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL---------------------------SEKQFRSEMNRLGQ 346 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~---------------------------~~~~~~~Ei~~l~~ 346 (604)
++|...+.||+|+||.||+|. ..+++.||||++..... ..+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 568888999999999999998 45789999999865321 12458899999999
Q ss_pred cCCCCccceeeEEEe--CCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceec
Q 007423 347 LRHPNLVPLLGFCVV--EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQ 424 (604)
Q Consensus 347 l~H~niv~l~g~~~~--~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~ 424 (604)
++||||+++++++.. .+..++||||+++|+|.+++.. ..+++.....++.|++.||.||| +.+|+||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~ 161 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--------KPLSEDQARFYFQDLIKGIEYLH---YQKIIHR 161 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 999999999999987 5688999999999999887643 35899999999999999999999 7899999
Q ss_pred CCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCC---CCcccchhhHHHHHHHHHhCC
Q 007423 425 YISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMV---ASLKGDVYGFGIVLLELLSGQ 501 (604)
Q Consensus 425 dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~k~DV~SfGvvl~elltg~ 501 (604)
||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+
T Consensus 162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 237 (298)
T 2zv2_A 162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSDA----LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237 (298)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECSSSSC----EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSS
T ss_pred CCCHHHEEECCCCCEEEecCCCccccccccc----cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 9999999999999999999999987643221 122345899999999987655 478899999999999999999
Q ss_pred CCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 502 KPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 502 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.||.... ...+... +..+.... .+ ....++++ .+++.+||+.||++|||+.|+++
T Consensus 238 ~pf~~~~--------~~~~~~~-~~~~~~~~-~~----~~~~~~~l---~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 238 CPFMDER--------IMCLHSK-IKSQALEF-PD----QPDIAEDL---KDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSCCSS--------HHHHHHH-HHHCCCCC-CS----SSCCCHHH---HHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCcc--------HHHHHHH-HhcccCCC-CC----ccccCHHH---HHHHHHHhhcChhhCCCHHHHhc
Confidence 9997432 1122222 22221111 00 01223344 44555999999999999999865
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=343.44 Aligned_cols=265 Identities=22% Similarity=0.336 Sum_probs=208.5
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe------CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL------PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER 365 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~------~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 365 (604)
.++|...+.||+|+||.||+|.. .++..||||+++... ...+.+.+|++++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45788889999999999999984 345789999997543 2336789999999999999999999999999999
Q ss_pred eEEeeecCCCchhhhhccCCCCC-----------------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDN-----------------TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS 428 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~-----------------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~ 428 (604)
++||||+++|+|.+++....... .....+++..+..++.|+++||.||| +.+|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence 99999999999999997653210 00124889999999999999999999 78999999999
Q ss_pred CeEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCC
Q 007423 429 NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVA 507 (604)
Q Consensus 429 ~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~ 507 (604)
+||++++++.+||+|||+++......... ......+++.|+|||+..+..++.++|||||||++|||+| |+.||...
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYV--KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEE--CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred heEEEcCCCCEEEccccccccccccccce--eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999998764432211 1122346789999999988889999999999999999999 99999754
Q ss_pred CccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 508 GAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
.... + ...+..+..... ....+++ +.+++.+||+.||++||++.|+++.|+++.++
T Consensus 257 ~~~~-----~----~~~~~~~~~~~~------~~~~~~~---~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 257 PPER-----L----FNLLKTGHRMER------PDNCSEE---MYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CGGG-----H----HHHHHTTCCCCC------CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CHHH-----H----HHHhhcCCcCCC------CccCCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 3221 1 122222221111 1122333 44555599999999999999999999998775
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.58 Aligned_cols=251 Identities=21% Similarity=0.251 Sum_probs=200.0
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
.++|...+.||+|+||.||+|.. .+++.||||++..... ..+.+.+|++++++++||||+++++++..++..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46789999999999999999984 5789999999975432 2356889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC---CCeEEcccCC
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD---FDARITDFGL 446 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~---~~~kl~DFGl 446 (604)
||+++|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+|||++.+ +.+||+|||+
T Consensus 108 e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR-------EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp CCCCSCBHHHHHTTC-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred ecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 999999999998754 35899999999999999999999 7899999999999999865 4599999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
++....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+.. ..+.
T Consensus 178 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--------~~~~-~~i~ 243 (362)
T 2bdw_A 178 AIEVNDSEA-----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLY-AQIK 243 (362)
T ss_dssp CBCCTTCCS-----CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH-HHHH
T ss_pred ceEecCCcc-----cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHH-HHHH
Confidence 987643221 1234589999999999988999999999999999999999999975321 1112 2222
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.+.... ..+.. ...++++ .+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~-~~~~~--~~~~~~~---~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 244 AGAYDY-PSPEW--DTVTPEA---KSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HTCCCC-CTTGG--GGSCHHH---HHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hCCCCC-Ccccc--cCCCHHH---HHHHHHHcCCChhhCcCHHHHhcC
Confidence 222111 01100 0112344 455559999999999999998753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=348.77 Aligned_cols=252 Identities=21% Similarity=0.267 Sum_probs=197.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
++|...+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 5788899999999999999984 578999999986433 2235688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 87 CSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp CTTEEGGGGSBTT-------TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred CCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 9999999999754 35899999999999999999999 7899999999999999999999999999998664
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVA-SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
..... .......||+.|+|||++.+..+ +.++|||||||++|||+||+.||....... .....| ......
T Consensus 157 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~----~~~~~~ 227 (323)
T 3tki_A 157 YNNRE--RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDW----KEKKTY 227 (323)
T ss_dssp ETTEE--CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS---HHHHHH----HTTCTT
T ss_pred cCCcc--cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHH----hccccc
Confidence 22211 11223458999999999877665 789999999999999999999997543211 011111 111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
. .+. ...++ .+.+++.+||+.||++|||+.|+++.
T Consensus 228 ~---~~~---~~~~~---~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 L---NPW---KKIDS---APLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp S---TTG---GGSCH---HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C---Ccc---ccCCH---HHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 000 01123 34455569999999999999999764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=345.86 Aligned_cols=245 Identities=19% Similarity=0.285 Sum_probs=197.7
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||+|. ..+++.||||++.... ...+.+.+|+++++.++||||+++++++..++..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 568889999999999999999 4778999999986432 12357899999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+ +|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++.
T Consensus 89 E~~-~g~l~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~ 157 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK-------KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI 157 (336)
T ss_dssp CCC-CEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred ECC-CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEecccee
Confidence 999 78999988754 35899999999999999999999 77999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA-SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||+.....+....
T Consensus 158 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~------------- 219 (336)
T 3h4j_B 158 MTDGNF-----LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK------------- 219 (336)
T ss_dssp TTTSBT-----TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-------------
T ss_pred ccCCcc-----cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-------------
Confidence 643321 223358999999999988776 7899999999999999999999975433221110
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
..... . ......+.++. +++.+||+.||++|||+.|+++.
T Consensus 220 -i~~~~-~-~~p~~~s~~~~---~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 220 -VNSCV-Y-VMPDFLSPGAQ---SLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -CCSSC-C-CCCTTSCHHHH---HHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -HHcCC-C-CCcccCCHHHH---HHHHHHcCCChhHCcCHHHHHhC
Confidence 00000 0 01122234444 45559999999999999999764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=337.38 Aligned_cols=257 Identities=21% Similarity=0.331 Sum_probs=194.1
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCC----CCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPD----ASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~----~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
.++|...+.||+|+||.||+|.... +..||||+++... ...+.+.+|+.++++++||||+++++++ .++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 3568888999999999999998532 4579999987532 2346789999999999999999999997 4567899
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 93 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp EEECCTTEEHHHHHHHTT------TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred EEecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccc
Confidence 999999999999997553 35899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
+......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ... .+.
T Consensus 164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-----~~~----~i~ 231 (281)
T 1mp8_A 164 RYMEDSTYYK---ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIG----RIE 231 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHH----HHH
T ss_pred cccCcccccc---cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-----HHH----HHH
Confidence 8764332111 112236788999999988889999999999999999997 999997543221 111 122
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
.+..... ....+++ +.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 232 ~~~~~~~------~~~~~~~---l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 232 NGERLPM------PPNCPPT---LYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp TTCCCCC------CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCC------CCCCCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 2221111 1122334 44555599999999999999999999998775
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=332.86 Aligned_cols=251 Identities=23% Similarity=0.403 Sum_probs=200.5
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeC--CeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE--EERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lv~ 369 (604)
++|...+.||+|+||.||+|+.. ++.||||+++... ...+.+.+|++++++++||||+++++++... +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46888899999999999999984 8899999997543 2345799999999999999999999999876 7789999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCC--ceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPP--YMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||+++|+|.+++..... ..+++..+..++.|++.||.||| +.+ |+||||||+||++++++.+||+|||++
T Consensus 89 e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTN-----FVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp ECCTTCBHHHHHHSCSS-----CCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred cccCCCcHHHHHhhccc-----CCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccce
Confidence 99999999999986532 25899999999999999999999 666 999999999999999999999999887
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCc---ccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASL---KGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~---k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
..... ....||+.|+|||++.+..++. ++|||||||++|||+||+.||..... .+.....
T Consensus 161 ~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~ 223 (271)
T 3kmu_A 161 FSFQS---------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--------MEIGMKV 223 (271)
T ss_dssp CTTSC---------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH--------HHHHHHH
T ss_pred eeecc---------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh--------HHHHHHH
Confidence 64321 1224789999999987655444 79999999999999999999975322 1122222
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
...+..... . ...+++ +.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 224 ~~~~~~~~~-~-----~~~~~~---~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 224 ALEGLRPTI-P-----PGISPH---VSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHSCCCCCC-C-----TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HhcCCCCCC-C-----CCCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 222222111 1 122334 4455559999999999999999999998865
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=343.48 Aligned_cols=271 Identities=19% Similarity=0.323 Sum_probs=194.2
Q ss_pred HhhcCCCcCcEEEecCCeEEEEEEeCC-C---CEEEEEEeccc---cccHHHHHHHHHHHhccCCCCccceeeEEEeCCe
Q 007423 292 AATNSFAVENIIISTRTGVSYKAVLPD-A---SALAIKRLSAC---KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEE 364 (604)
Q Consensus 292 ~~~~~~~~~~~ig~G~~g~vy~~~~~~-~---~~vAvK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 364 (604)
...++|...+.||+|+||.||+|.... + ..||||.++.. ....+++.+|++++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345678999999999999999998544 3 27999999753 2334679999999999999999999999987665
Q ss_pred e------eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC
Q 007423 365 R------LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD 438 (604)
Q Consensus 365 ~------~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~ 438 (604)
. ++||||+++|+|.+++....... ....+++..+..++.|++.||.||| +.+|+||||||+|||+++++.
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGE-NPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSC
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccc-cccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCC
Confidence 5 99999999999999986432111 1125899999999999999999999 789999999999999999999
Q ss_pred eEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcH
Q 007423 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNL 517 (604)
Q Consensus 439 ~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~ 517 (604)
+||+|||+++......... ......+++.|+|||.+.+..++.++|||||||++|||+| |+.||......+ .
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~ 248 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYR--QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-----I 248 (323)
T ss_dssp EEECCCCC-------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----H
T ss_pred EEEeecccccccccccccc--ccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-----H
Confidence 9999999998764332211 1122346789999999988889999999999999999999 999997543221 1
Q ss_pred HHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCCC
Q 007423 518 VDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSE 586 (604)
Q Consensus 518 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~ 586 (604)
. .....+..... ....++ .+.+++.+||+.||++|||+.|+++.|+++.+......
T Consensus 249 ---~-~~~~~~~~~~~------~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 249 ---Y-NYLIGGNRLKQ------PPECME---EVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp ---H-HHHHTTCCCCC------CTTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred ---H-HHHhcCCCCCC------CCccCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 1 11222211111 011223 44555669999999999999999999999988664443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=334.99 Aligned_cols=257 Identities=21% Similarity=0.283 Sum_probs=195.1
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
++|...+.||+|+||.||+|...+++.||||++..... ..+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46788899999999999999988899999999965432 236788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++ +|.+++.... ..+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE------GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFG 151 (288)
T ss_dssp CSE-EHHHHHHTST------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred cCC-CHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence 985 9999887543 35889999999999999999999 7899999999999999999999999999998764
Q ss_pred CCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
..... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+ ....+.........
T Consensus 152 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~ 222 (288)
T 1ob3_A 152 IPVRK----YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-----QLMRIFRILGTPNS 222 (288)
T ss_dssp C-------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCCCCT
T ss_pred ccccc----cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHHCCCCh
Confidence 32211 122348999999998865 458999999999999999999999997543211 00111111100000
Q ss_pred c---c-----ccccccc----------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 531 R---D-----VVDKSLY----------GRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 531 ~---~-----~~d~~l~----------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
. . ..++... ....+++ +.+++.+||+.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDES---GIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHH---HHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhchhhhcccccccccccccCccHHHHhhhcCHH---HHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0 0000000 0112333 445555999999999999999975
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=345.28 Aligned_cols=267 Identities=22% Similarity=0.319 Sum_probs=209.4
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe------CCCCEEEEEEecccc--ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCe
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL------PDASALAIKRLSACK--LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEE 364 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~------~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 364 (604)
.++|...+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|+++++++ +||||+++++++..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 35688889999999999999984 356789999997543 2346789999999999 99999999999999999
Q ss_pred eeEEeeecCCCchhhhhccCCCCC-----------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDN-----------TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI 433 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~-----------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl 433 (604)
.++||||+++|+|.+++....... .....+++..+..++.|++.||.||| +.+|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence 999999999999999997653210 00124899999999999999999999 7899999999999999
Q ss_pred CCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCcccc
Q 007423 434 DDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEG 512 (604)
Q Consensus 434 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~ 512 (604)
+.++.+||+|||+++........ .......+|..|+|||++.+..++.++||||||+++|||+| |+.||.......
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 255 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS- 255 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTS--EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-
T ss_pred cCCCCEEEccccccccccccccc--eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-
Confidence 99999999999999876543221 11122346789999999888889999999999999999999 999997543211
Q ss_pred ccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 513 FKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
........+... .. ....+++ +.+++.+||+.||++|||+.|+++.|+++.++.
T Consensus 256 -------~~~~~~~~~~~~-~~-----~~~~~~~---l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 256 -------KFYKMIKEGFRM-LS-----PEHAPAE---MYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp -------HHHHHHHHTCCC-CC-----CTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -------HHHHHhccCCCC-CC-----cccCCHH---HHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 111222222111 11 1122334 445555999999999999999999999988764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=334.23 Aligned_cols=251 Identities=27% Similarity=0.446 Sum_probs=197.2
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc--c-H-----HHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL--S-E-----KQFRSEMNRLGQLRHPNLVPLLGFCVVEEER 365 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~--~-~-----~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 365 (604)
++|...+.||+|+||.||+|.. .+++.||||++..... . . +.+.+|++++++++||||+++++++....
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 5688889999999999999994 6799999999864321 1 1 57899999999999999999999986544
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCC--ceecCCCCCeEEeCCCCC-----
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPP--YMHQYISSNVILIDDDFD----- 438 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--iiH~dlk~~NiLl~~~~~----- 438 (604)
++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+ |+||||||+|||++.++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA------HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred eEEEEecCCCCHHHHHhccc------CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCcee
Confidence 79999999999999887553 35899999999999999999999 667 999999999999987776
Q ss_pred eEEcccCCccccCCCCCCCCccccCCCCcccccCcccc--CCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCc
Q 007423 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYS--STMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGN 516 (604)
Q Consensus 439 ~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~ 516 (604)
+||+|||+++..... .....||+.|+|||++ ....++.++|||||||++|||++|+.||......
T Consensus 168 ~kl~Dfg~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------ 234 (287)
T 4f0f_A 168 AKVADFGLSQQSVHS-------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------ 234 (287)
T ss_dssp EEECCCTTCBCCSSC-------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC------
T ss_pred EEeCCCCcccccccc-------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc------
Confidence 999999999854321 2234589999999998 4456789999999999999999999999753221
Q ss_pred HHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 517 LVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
...+.......+.... .. ...+++ +.+++.+||+.||++|||+.|+++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~-~~-----~~~~~~---l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 235 KIKFINMIREEGLRPT-IP-----EDCPPR---LRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHHHHHHSCCCCC-CC-----TTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHHHHHhccCCCCC-CC-----cccCHH---HHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1222222222222111 11 122334 44555599999999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=342.98 Aligned_cols=252 Identities=19% Similarity=0.233 Sum_probs=195.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCC--------
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE-------- 363 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-------- 363 (604)
++|...+.||+|+||.||+|+. .+++.||||+++... ...+.+.+|++++++++||||+++++++...+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 5688889999999999999995 479999999996432 34577999999999999999999999986543
Q ss_pred -------------------------------------------------eeeEEeeecCCCchhhhhccCCCCCCCCCCC
Q 007423 364 -------------------------------------------------ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVL 394 (604)
Q Consensus 364 -------------------------------------------------~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l 394 (604)
..++||||+++|+|.+++...... ...
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~----~~~ 161 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL----EDR 161 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG----GGS
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc----cch
Confidence 379999999999999999865432 346
Q ss_pred CHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCC--------ccccCCCC
Q 007423 395 DWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDS--------SFVHGDLG 466 (604)
Q Consensus 395 ~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~--------~~~~~~~g 466 (604)
++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......... .......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 78889999999999999999 78999999999999999999999999999998754321111 11223468
Q ss_pred cccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHH
Q 007423 467 EFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDE 546 (604)
Q Consensus 467 t~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 546 (604)
|+.|+|||++.+..++.++|||||||++|||++|..|+.. ... ............. ....
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------~~~-~~~~~~~~~~~~~---------~~~~ 298 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------RVR-IITDVRNLKFPLL---------FTQK 298 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------HHH-HHHHHHTTCCCHH---------HHHH
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------HHH-HHHHhhccCCCcc---------cccC
Confidence 9999999999988999999999999999999998776521 011 1111112211111 1122
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 547 IMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 547 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
...+.+++.+||+.||++|||+.|+++
T Consensus 299 ~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 299 YPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp CHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 234556677999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=336.07 Aligned_cols=260 Identities=23% Similarity=0.366 Sum_probs=208.7
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
.++|...+.||+|+||.||+|...++..||||.++......+.+.+|++++++++||||+++++++. .+..++||||++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence 3568888999999999999999888889999999876666788999999999999999999999986 456899999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+++|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 91 ~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 91 NGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp TCBHHHHTTSHHH-----HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCHHHHHhcCCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 9999999975321 25899999999999999999999 789999999999999999999999999999876432
Q ss_pred CCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
... ......++..|+|||+..+..++.++||||||+++|||+| |+.||..... .+... .+..+....
T Consensus 163 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~-~~~~~~~~~ 230 (279)
T 1qpc_A 163 EYT---AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQ-NLERGYRMV 230 (279)
T ss_dssp CEE---CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHH-HHHTTCCCC
T ss_pred ccc---cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--------HHHHH-HHhcccCCC
Confidence 211 1122346788999999988889999999999999999999 9999975322 11111 222221111
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcC
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHG 583 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~ 583 (604)
. ....+++ +.+++.+||+.||++|||+.++++.|+++.....
T Consensus 231 --~----~~~~~~~---l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 231 --R----PDNCPEE---LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp --C----CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred --C----cccccHH---HHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 0 1122334 4455559999999999999999999999887643
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=374.91 Aligned_cols=260 Identities=23% Similarity=0.362 Sum_probs=209.4
Q ss_pred hhcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 293 ATNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
..++|...+.||+|+||.||+|...++..||||+++......++|.+|+++|++++||||+++++++.. +..++||||+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 345688889999999999999998888899999998766667889999999999999999999999865 6789999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++|+|.++++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++....
T Consensus 344 ~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 344 SKGSLLDFLKGETG-----KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp TTEEHHHHHSHHHH-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred cCCcHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 99999999975321 24889999999999999999999 78999999999999999999999999999987642
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
... ....+..++..|+|||++....++.++|||||||++|||+| |+.||..... .+ +...+..+...
T Consensus 416 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~-~~~~i~~~~~~ 483 (535)
T 2h8h_A 416 NEY---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------RE-VLDQVERGYRM 483 (535)
T ss_dssp HHH---HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HH-HHHHHHTTCCC
T ss_pred Cce---ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HH-HHHHHHcCCCC
Confidence 110 11122346789999999988889999999999999999999 9999975322 11 12222333211
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
.. ....++ .+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus 484 ~~------~~~~~~---~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 484 PC------PPECPE---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp CC------CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred CC------CCCCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 11 011223 4555666999999999999999999999886543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=346.86 Aligned_cols=262 Identities=21% Similarity=0.337 Sum_probs=200.0
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCC-----CCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPD-----ASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~-----~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
..|...+.||+|+||.||+|.... +..||||.++... .....+.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 356667899999999999998532 2359999997543 234568999999999999999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 124 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD------GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp EEECCTTEEHHHHHHHTT------TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEeCCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcc
Confidence 999999999999997643 35899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
+......... .......+|..|+|||++.+..++.++|||||||++|||+| |+.||..... .+ +...+.
T Consensus 195 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~-~~~~~~ 264 (333)
T 1mqb_A 195 RVLEDDPEAT-YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HE-VMKAIN 264 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HH-HHHHHH
T ss_pred hhhccccccc-cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HH-HHHHHH
Confidence 8765432211 11122346788999999988889999999999999999999 9999964322 11 112222
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCC
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGF 584 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~ 584 (604)
.+..... ....++ .+.+++.+||+.||++||++.|+++.|+++.+....
T Consensus 265 ~~~~~~~------~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 265 DGFRLPT------PMDCPS---AIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp TTCCCCC------CTTCBH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred CCCcCCC------cccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 2211110 011223 345556699999999999999999999998875543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=342.93 Aligned_cols=261 Identities=21% Similarity=0.376 Sum_probs=211.6
Q ss_pred hhcCCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 293 ATNSFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
..++|...+.||+|+||.||+|... ++..||||.+.......+++.+|++++++++||||+++++++..++..++||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 3467888899999999999999954 588999999987666678899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++|+|.+++..... ..+++..+..++.+++.||.||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 91 ~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 91 MTYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp CTTEEHHHHHHHCCT-----TTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CCCCcHHHHHHhccc-----CCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999976432 35899999999999999999999 7799999999999999999999999999998764
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
.... .......++..|+|||++.+..++.++||||||+++|||++ |+.||....... .. ........
T Consensus 163 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-----~~----~~~~~~~~ 230 (288)
T 3kfa_A 163 GDTY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VY----ELLEKDYR 230 (288)
T ss_dssp SSSS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----HH----HHHHTTCC
T ss_pred CCcc---ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HH----HHHhccCC
Confidence 3221 12223346788999999988889999999999999999999 999997543211 11 11121111
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
... ....++. +.+++.+||+.||++|||+.|+++.|+.+.++.
T Consensus 231 ~~~------~~~~~~~---l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 231 MER------PEGCPEK---VYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CCC------CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCC------CCCCCHH---HHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 110 1122333 445555999999999999999999999987754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=350.92 Aligned_cols=256 Identities=21% Similarity=0.338 Sum_probs=199.4
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCE----EEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASA----LAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~----vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
++|...+.||+|+||.||+|.. .+++. ||+|.+.... ...+.+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 4677889999999999999984 45554 7888775432 22346788999999999999999999986 456889
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 92 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR------GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp EEECCTTCBSHHHHHSSG------GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred EEEeCCCCCHHHHHHHcc------ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcc
Confidence 999999999999997653 35888999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
+......... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||...... . +...+.
T Consensus 163 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~----~~~~~~ 231 (325)
T 3kex_A 163 DLLPPDDKQL--LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-----E----VPDLLE 231 (325)
T ss_dssp GGSCCCTTCC--C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-----H----HHHHHH
T ss_pred cccCcccccc--cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-----H----HHHHHH
Confidence 9875433221 1123347889999999988889999999999999999999 99999754321 1 112222
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
.+..... +. ..+ ..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 232 ~~~~~~~--~~----~~~---~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 232 KGERLAQ--PQ----ICT---IDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TTCBCCC--CT----TBC---TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred cCCCCCC--CC----cCc---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 2221111 11 111 234456669999999999999999999998865
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=349.58 Aligned_cols=270 Identities=21% Similarity=0.272 Sum_probs=205.7
Q ss_pred CCcCcEEEecCCeEEEEEEe-----CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeC--CeeeE
Q 007423 297 FAVENIIISTRTGVSYKAVL-----PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE--EERLL 367 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~-----~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 367 (604)
|...+.||+|+||.||++.+ .+++.||||+++... ...+.+.+|++++++++||||+++++++... ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 47789999999999998864 267899999997643 2346789999999999999999999999884 57899
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||||+++|+|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 113 v~e~~~~~~L~~~l~~~--------~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH--------SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp EECCCTTCBHHHHGGGS--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred EEecccCCcHHHHHhhC--------CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccc
Confidence 99999999999999754 3889999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccc----cccCc--HHHHH
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEE----GFKGN--LVDWV 521 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~----~~~~~--~~~~~ 521 (604)
+......... .......+|..|+|||++.+..++.++||||||+++|||+||+.||....... ..... ....+
T Consensus 182 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 260 (318)
T 3lxp_A 182 KAVPEGHEYY-RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260 (318)
T ss_dssp EECCTTCSEE-EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred cccccccccc-ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence 8775432111 11122347888999999988889999999999999999999999986421110 00000 00111
Q ss_pred HHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCCCC
Q 007423 522 NHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEP 587 (604)
Q Consensus 522 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~ 587 (604)
......+..... ....+ ..+.+++.+||+.||++|||+.|+++.|+++.+++....|
T Consensus 261 ~~~~~~~~~~~~------~~~~~---~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 261 TELLERGERLPR------PDKCP---AEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp HHHHHTTCCCCC------CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred HHHHhcccCCCC------Ccccc---HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 122222211111 11122 3455556699999999999999999999999988765544
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=336.76 Aligned_cols=262 Identities=22% Similarity=0.357 Sum_probs=201.7
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCC----CCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEe-CCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPD----ASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV-EEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~----~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~l 367 (604)
..|...+.||+|+||.||+|...+ ...||||.++... ...+++.+|++++++++||||+++++++.. ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457778999999999999998533 2358999987533 234678999999999999999999999754 567899
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++
T Consensus 105 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp EEECCTTCBHHHHHHCTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred EEeCCCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccc
Confidence 999999999999997643 35889999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
+..............+..+|+.|+|||.+.+..++.++||||||+++|||+| |.+||...... ... ....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-----~~~----~~~~ 246 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DIT----VYLL 246 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT-----THH----HHHH
T ss_pred ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH-----HHH----HHHh
Confidence 8765432222222234457889999999988889999999999999999999 55666543221 111 1112
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcC
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHG 583 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~ 583 (604)
.+.... . ....++. +.+++.+||+.||++|||+.|+++.|+++...+.
T Consensus 247 ~~~~~~--~----~~~~~~~---l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 247 QGRRLL--Q----PEYCPDP---LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp TTCCCC--C----CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred cCCCCC--C----CccCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 221111 1 1122333 4455559999999999999999999999988654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=345.36 Aligned_cols=253 Identities=18% Similarity=0.279 Sum_probs=198.7
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc------ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK------LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
+.|...+.||+|+||.||+|. ..+++.||||++.... ...+.+.+|++++++++||||+++++++..++..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 468889999999999999998 4579999999986422 235779999999999999999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC---eEEccc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD---ARITDF 444 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~---~kl~DF 444 (604)
||||+++|+|.+++...... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++. +||+||
T Consensus 104 v~e~~~g~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADA---GFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEeCCCCCCHHHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999887643211 134889999999999999999999 789999999999999986554 999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
|+++........ .....||+.|+|||++.+..++.++|||||||++|||+||+.||.... .+....
T Consensus 178 g~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~- 243 (351)
T 3c0i_A 178 GVAIQLGESGLV----AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEG- 243 (351)
T ss_dssp TTCEECCTTSCB----CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHH-
T ss_pred cceeEecCCCee----ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHH-
Confidence 999877543221 223458999999999998899999999999999999999999997521 111111
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
+..+.... ++... ...+++ +.+++.+||+.||++|||+.|+++
T Consensus 244 i~~~~~~~--~~~~~-~~~s~~---~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 244 IIKGKYKM--NPRQW-SHISES---AKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHTCCCC--CHHHH-TTSCHH---HHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHcCCCCC--Ccccc-ccCCHH---HHHHHHHHCCCChhHCcCHHHHhc
Confidence 22222111 11000 112233 445555999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=335.71 Aligned_cols=260 Identities=25% Similarity=0.407 Sum_probs=193.5
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
.++|...+.||+|+||.||+|+... .||||+++.... ..+.+.+|++++++++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4568888999999999999998643 599999975432 235689999999999999999999965 5566899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 100 ~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 100 WCEGSSLYHHLHASE------TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp CCCEEEHHHHHTTC---------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred ecCCCcHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccc
Confidence 999999999997553 35899999999999999999999 789999999999999999999999999999865
Q ss_pred CCCCCCCCccccCCCCcccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSS---TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
...... .......||..|+|||++. ...++.++||||||+++|||+||+.||...... +.+......
T Consensus 171 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~ 240 (289)
T 3og7_A 171 SRWSGS--HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--------DQIIEMVGR 240 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--------HHHHHHHHH
T ss_pred cccccc--ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--------HHHHHHhcc
Confidence 432111 1122335899999999876 567888999999999999999999999753221 112222333
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
+........ . ....+ ..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 241 ~~~~~~~~~-~-~~~~~---~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 241 GSLSPDLSK-V-RSNCP---KRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TSCCCCTTS-S-CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cccCcchhh-c-cccCC---HHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 322221111 0 11122 345555569999999999999999999999865
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=347.64 Aligned_cols=247 Identities=17% Similarity=0.231 Sum_probs=196.1
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeE
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 367 (604)
.++|...+.||+|+||.||+|+. .+++.||||+++... ...+.+.+|.++++.+ +||||+++++++...+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 36799999999999999999994 568999999997532 2335688999999988 79999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 102 v~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a 171 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS-------RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171 (353)
T ss_dssp EEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccce
Confidence 99999999999999764 35899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
+........ ....+||+.|+|||++.+..++.++|||||||++|||+||+.||...... +..... ..
T Consensus 172 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i-~~ 238 (353)
T 3txo_A 172 KEGICNGVT----TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAI-LN 238 (353)
T ss_dssp BCSCC-------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHH-HH
T ss_pred eecccCCcc----ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--------HHHHHH-Hc
Confidence 864322211 12335899999999998888999999999999999999999999754321 112222 22
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSM------YQVYE 573 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~ev~~ 573 (604)
+... .....++++.. ++.+||+.||++||++ .||++
T Consensus 239 ~~~~-------~p~~~~~~~~~---li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 239 DEVV-------YPTWLHEDATG---ILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCCC-------CCTTSCHHHHH---HHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCC-------CCCCCCHHHHH---HHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 2111 01122344444 4459999999999998 66654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=341.97 Aligned_cols=275 Identities=19% Similarity=0.295 Sum_probs=210.7
Q ss_pred HhhcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhc--cCCCCccceeeEEEeCC----ee
Q 007423 292 AATNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQ--LRHPNLVPLLGFCVVEE----ER 365 (604)
Q Consensus 292 ~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~----~~ 365 (604)
...++|...+.||+|+||.||+|+. +++.||||+++.. ..+.+.+|++++.. ++||||+++++++.... ..
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 3456799999999999999999997 5899999999643 35678889988877 79999999999998876 78
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcC-----CCCceecCCCCCeEEeCCCCCeE
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGC-----QPPYMHQYISSNVILIDDDFDAR 440 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~iiH~dlk~~NiLl~~~~~~k 440 (604)
++||||+++|+|.+++... .+++..+..++.|++.||.|||... +.+|+||||||+|||++.++.+|
T Consensus 116 ~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNRY--------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp EEEECCCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred EEEEeecCCCcHHHHHhcc--------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence 9999999999999999753 4889999999999999999999421 46899999999999999999999
Q ss_pred EcccCCccccCCCCCCCCccccCCCCcccccCccccCCC------CCCcccchhhHHHHHHHHHhC----------CCCC
Q 007423 441 ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM------VASLKGDVYGFGIVLLELLSG----------QKPL 504 (604)
Q Consensus 441 l~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~t~k~DV~SfGvvl~elltg----------~~p~ 504 (604)
|+|||+++.................||..|+|||++.+. .++.++|||||||++|||+|| +.||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 999999987654332111112233589999999988765 334789999999999999999 6777
Q ss_pred CCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCC
Q 007423 505 DVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGF 584 (604)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~ 584 (604)
......+ .....+.. .+........+.... ...+....+.+++.+||+.||++|||+.||++.|+++.++.+.
T Consensus 268 ~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~ 340 (342)
T 1b6c_B 268 YDLVPSD---PSVEEMRK-VVCEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 340 (342)
T ss_dssp TTTSCSS---CCHHHHHH-HHTTSCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC-
T ss_pred cccCcCc---ccHHHHHH-HHHHHHhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcC
Confidence 6432211 11222222 222222221111111 1124556677788899999999999999999999999887643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=336.63 Aligned_cols=243 Identities=19% Similarity=0.248 Sum_probs=199.6
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||+++. .+|+.||||+++... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 5688889999999999999994 579999999997532 23456889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 86 e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~ 155 (318)
T 1fot_A 86 DYIEGGELFSLLRKS-------QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKY 155 (318)
T ss_dssp CCCCSCBHHHHHHHT-------SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCccee
Confidence 999999999999765 35889999999999999999999 88999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
..... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....... +.
T Consensus 156 ~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~-~~ 219 (318)
T 1fot_A 156 VPDVT-------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILN-AE 219 (318)
T ss_dssp CSSCB-------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHH-CC
T ss_pred cCCcc-------ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-CC
Confidence 64321 123589999999999999999999999999999999999999975322 111222222 21
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYE 573 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 573 (604)
.. . ....++++.++++ +|++.||++|| ++.||++
T Consensus 220 ~~------~-p~~~~~~~~~li~---~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 220 LR------F-PPFFNEDVKDLLS---RLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CC------C-CTTSCHHHHHHHH---HHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CC------C-CCCCCHHHHHHHH---HHhccCHHHcCCCcCCCHHHHhc
Confidence 11 0 1122344555554 99999999999 8888874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=345.48 Aligned_cols=251 Identities=21% Similarity=0.306 Sum_probs=186.2
Q ss_pred hhcCCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 293 ATNSFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
..+.|...+.||+|+||.||+|... +++.||||+++... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 3467888999999999999999954 68899999997543 346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC---CCCeEEcccCCcc
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD---DFDARITDFGLAR 448 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~---~~~~kl~DFGla~ 448 (604)
+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+++
T Consensus 130 ~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 130 VTGGELFDRIVEK-------GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp CCSCBHHHHHTTC-------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred CCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 9999999999754 35899999999999999999999 789999999999999975 8899999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... +.....+..+
T Consensus 200 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~~i~~~ 266 (349)
T 2w4o_A 200 IVEHQVL-----MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--------QFMFRRILNC 266 (349)
T ss_dssp ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--------HHHHHHHHTT
T ss_pred ccCcccc-----cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--------HHHHHHHHhC
Confidence 7643211 12235899999999999989999999999999999999999999653221 1111122222
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
... ...+ .. ...+.+ +.+++.+||+.||++|||+.|+++
T Consensus 267 ~~~-~~~~-~~-~~~~~~---~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 267 EYY-FISP-WW-DEVSLN---AKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CCC-CCTT-TT-TTSCHH---HHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCc-cCCc-hh-hhCCHH---HHHHHHHHccCChhhCcCHHHHhc
Confidence 111 1111 00 112334 445555999999999999999976
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=350.20 Aligned_cols=267 Identities=22% Similarity=0.297 Sum_probs=205.7
Q ss_pred hhcCCCcCcEEEecCCeEEEEEEe------CCCCEEEEEEecccc--ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCC
Q 007423 293 ATNSFAVENIIISTRTGVSYKAVL------PDASALAIKRLSACK--LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEE 363 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~~------~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 363 (604)
..++|...+.||+|+||.||+|.. .++..||||.++... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 346788899999999999999985 245689999997532 2336789999999999 8999999999999999
Q ss_pred eeeEEeeecCCCchhhhhccCCCCC----------------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCC
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDN----------------TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYIS 427 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~----------------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk 427 (604)
..++||||+++|+|.+++....... .....+++..+..++.|++.||.||| +.+|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence 9999999999999999997653210 00124899999999999999999999 7899999999
Q ss_pred CCeEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 007423 428 SNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDV 506 (604)
Q Consensus 428 ~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~ 506 (604)
|+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNY--VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccc--eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999876433221 11222346789999999988889999999999999999998 9999975
Q ss_pred CCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 507 AGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
..... ........+..... ....+++ +.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 278 ~~~~~--------~~~~~~~~~~~~~~------~~~~~~~---l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 278 IPVDA--------NFYKLIQNGFKMDQ------PFYATEE---IYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CCCSH--------HHHHHHHTTCCCCC------CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCcHH--------HHHHHHhcCCCCCC------CCCCCHH---HHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 43211 11222222211111 1112334 44555599999999999999999999988664
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=332.68 Aligned_cols=273 Identities=17% Similarity=0.220 Sum_probs=207.2
Q ss_pred hhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEE-EeCCeeeEEee
Q 007423 293 ATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFC-VVEEERLLVYK 370 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lv~e 370 (604)
..++|...+.||+|+||.||+|. ..+++.||||++.... ..+++.+|++++++++|++++..++++ ...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 35679999999999999999999 4778999999875432 223588899999999998888777766 56778899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe---CCCCCeEEcccCCc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI---DDDFDARITDFGLA 447 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl---~~~~~~kl~DFGla 447 (604)
|+ +|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||+ ++++.+||+|||++
T Consensus 86 ~~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp CC-CCBHHHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred cc-CCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 99 899999997543 35899999999999999999999 7899999999999999 78899999999999
Q ss_pred cccCCCCCCCC---ccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 448 RLVGSRDPNDS---SFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 448 ~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
+.......... .......||..|+|||++.+..++.++|||||||++|||+||+.||......... .....+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~ 233 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--QKYERISEK 233 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS--SHHHHHHHH
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh--hhhhhhhcc
Confidence 87754332111 1112345899999999999989999999999999999999999999764332211 111111111
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCCCC
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEP 587 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~ 587 (604)
...... +.. ....++ .+.+++.+||+.||++|||+.||++.|+++.++.+....
T Consensus 234 ~~~~~~-----~~~-~~~~~~---~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~ 287 (296)
T 4hgt_A 234 KMSTPI-----EVL-CKGYPS---EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 287 (296)
T ss_dssp HHHSCH-----HHH-TTTSCH---HHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTT
T ss_pred cccchh-----hhh-hccCCH---HHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCcc
Confidence 111100 000 011223 344555599999999999999999999999998887653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=368.79 Aligned_cols=256 Identities=22% Similarity=0.343 Sum_probs=201.0
Q ss_pred EEEecCCeEEEEEEeC---CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCc
Q 007423 302 IIISTRTGVSYKAVLP---DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGT 376 (604)
Q Consensus 302 ~ig~G~~g~vy~~~~~---~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gs 376 (604)
.||+|+||.||+|... ++..||||+++... ...++|.+|+++|++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999853 46679999997532 345789999999999999999999999976 56899999999999
Q ss_pred hhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCC
Q 007423 377 LYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPN 456 (604)
Q Consensus 377 L~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 456 (604)
|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++........
T Consensus 422 L~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 492 (613)
T 2ozo_A 422 LHKFLVGKR------EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY 492 (613)
T ss_dssp HHHHHTTCT------TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred HHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence 999997543 35899999999999999999999 789999999999999999999999999999876433221
Q ss_pred CCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccccc
Q 007423 457 DSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVD 535 (604)
Q Consensus 457 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 535 (604)
... .....++..|+|||++.+..++.++|||||||++|||+| |+.||......+ +...+..+......
T Consensus 493 ~~~-~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---------~~~~i~~~~~~~~p- 561 (613)
T 2ozo_A 493 YTA-RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---------VMAFIEQGKRMECP- 561 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---------HHHHHHTTCCCCCC-
T ss_pred eee-ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---------HHHHHHcCCCCCCC-
Confidence 111 112235689999999988899999999999999999998 999997543211 22223333222111
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCCC
Q 007423 536 KSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSE 586 (604)
Q Consensus 536 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~ 586 (604)
...+ ..+.+++.+||+.||++||++.+|++.|+.+........
T Consensus 562 -----~~~~---~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~ 604 (613)
T 2ozo_A 562 -----PECP---PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604 (613)
T ss_dssp -----TTCC---HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred -----CcCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence 1122 345556669999999999999999999999887765544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=348.23 Aligned_cols=207 Identities=18% Similarity=0.240 Sum_probs=175.4
Q ss_pred hcCCCcCcEEEec--CCeEEEEEEe-CCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 294 TNSFAVENIIIST--RTGVSYKAVL-PDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 294 ~~~~~~~~~ig~G--~~g~vy~~~~-~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
.++|...+.||+| +||.||+|.. .+++.||||+++.... ..+.+.+|++++++++|||||++++++..++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4578889999999 9999999995 5799999999975432 23568889999999999999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||||+++|+|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||.+
T Consensus 104 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM-----DGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT-----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred EEEccCCCCHHHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence 9999999999999976532 35899999999999999999999 789999999999999999999999999998
Q ss_pred cccCCCCC---CCCccccCCCCcccccCccccCC--CCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 007423 448 RLVGSRDP---NDSSFVHGDLGEFGYVAPEYSST--MVASLKGDVYGFGIVLLELLSGQKPLDVAG 508 (604)
Q Consensus 448 ~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~SfGvvl~elltg~~p~~~~~ 508 (604)
........ ..........||..|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 65432110 01111122358899999999877 578999999999999999999999997543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=344.31 Aligned_cols=247 Identities=21% Similarity=0.250 Sum_probs=198.8
Q ss_pred hhcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeee
Q 007423 293 ATNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERL 366 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 366 (604)
..++|...+.||+|+||.||+|+. .+++.||||+++... ...+.+..|.+++.++ +||||+++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 456899999999999999999995 568999999997532 2345688899999887 9999999999999999999
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
+||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 95 lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGM 164 (345)
T ss_dssp EEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChh
Confidence 999999999999999754 35899999999999999999999 78999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +..... .
T Consensus 165 a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i-~ 231 (345)
T 1xjd_A 165 CKENMLGDAK----TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSI-R 231 (345)
T ss_dssp CBCCCCTTCC----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHH-H
T ss_pred hhhcccCCCc----ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHH-H
Confidence 9864322211 22345899999999999989999999999999999999999999753221 111122 2
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMY-QVY 572 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-ev~ 572 (604)
.+... . ....+.++.++ +.+||+.||++||++. ||+
T Consensus 232 ~~~~~------~-p~~~s~~~~~l---i~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 232 MDNPF------Y-PRWLEKEAKDL---LVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HCCCC------C-CTTSCHHHHHH---HHHHSCSSGGGSBTTBSCGG
T ss_pred hCCCC------C-CcccCHHHHHH---HHHHhcCCHhHcCCChHHHH
Confidence 22110 1 11223444444 4599999999999997 664
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=345.14 Aligned_cols=256 Identities=22% Similarity=0.385 Sum_probs=196.8
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCE----EEEEEeccc--cccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASA----LAIKRLSAC--KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~----vAvK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
++|...+.||+|+||.||+|.. .+++. ||+|.+... ....+++.+|+.++++++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 5688889999999999999984 45554 577777542 234678999999999999999999999998765 789
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
++||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 94 v~~~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EECCCSSCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred EEEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 999999999999997653 35899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
+......... ...+..+|..|+|||++.+..++.++|||||||++|||+| |+.||......+ + ...+.
T Consensus 165 ~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~----~~~~~ 233 (327)
T 3lzb_A 165 KLLGAEEKEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----I----SSILE 233 (327)
T ss_dssp -----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----H----HHHHH
T ss_pred eEccCccccc--cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----H----HHHHH
Confidence 8764432211 1223346889999999988899999999999999999999 999997543221 1 12222
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
.+..... ....+. .+.+++.+||+.||++||++.|+++.|+++.+
T Consensus 234 ~~~~~~~------~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 234 KGERLPQ------PPICTI---DVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTCCCCC------CTTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred cCCCCCC------CccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2221111 011223 34555669999999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=342.29 Aligned_cols=268 Identities=20% Similarity=0.311 Sum_probs=207.7
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe--------CCCCEEEEEEecccc--ccHHHHHHHHHHHhcc-CCCCccceeeEEEeC
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL--------PDASALAIKRLSACK--LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVE 362 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~--------~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 362 (604)
.++|...+.||+|+||.||+|.. .++..||||+++... ...+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 46788899999999999999985 356789999997543 2345789999999999 899999999999999
Q ss_pred CeeeEEeeecCCCchhhhhccCCCCC---------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe
Q 007423 363 EERLLVYKHMPNGTLYSLLHGNGVDN---------TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI 433 (604)
Q Consensus 363 ~~~~lv~ey~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl 433 (604)
+..++||||+++|+|.+++....... .....+++..++.++.|++.||.||| +.+|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence 99999999999999999998653210 01134899999999999999999999 7899999999999999
Q ss_pred CCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCcccc
Q 007423 434 DDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEG 512 (604)
Q Consensus 434 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~ 512 (604)
+.++.+||+|||+++......... ......+++.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--- 265 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYK--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 265 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEE--CCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred cCCCCEEEcccccccccccccccc--ccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---
Confidence 999999999999998764322111 1122346789999999888889999999999999999999 9999975322
Q ss_pred ccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCC
Q 007423 513 FKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGF 584 (604)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~ 584 (604)
.+.. ..+..+..... ....+.+ +.+++.+||+.||++|||+.|+++.|+++.....-
T Consensus 266 -----~~~~-~~~~~~~~~~~------~~~~~~~---l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 266 -----EELF-KLLKEGHRMDK------PANCTNE---LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp -----HHHH-HHHHHTCCCCC------CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -----HHHH-HHHhcCCCCCC------CccCCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 1112 22222221111 1112233 44555599999999999999999999999876533
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=347.95 Aligned_cols=253 Identities=18% Similarity=0.234 Sum_probs=192.8
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
.++|...+.||+|+||.||+++. .+++.||||++.......+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 45788899999999999999994 57899999999766555677999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC--eEEcccCCcccc
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD--ARITDFGLARLV 450 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~--~kl~DFGla~~~ 450 (604)
++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++. +||+|||+++..
T Consensus 99 ~~~~L~~~l~~~-------~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 99 SGGELYERICNA-------GRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp CSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred CCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 999999999754 35899999999999999999999 789999999999999987765 999999999854
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLK-GDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k-~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
..... .....||+.|+|||++.+..++.+ +|||||||++|||++|+.||....... .....+..... ..
T Consensus 169 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~~~~~~~~-~~ 238 (361)
T 3uc3_A 169 VLHSQ-----PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR----DYRKTIQRILS-VK 238 (361)
T ss_dssp -----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC----CHHHHHHHHHT-TC
T ss_pred cccCC-----CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH----HHHHHHHHHhc-CC
Confidence 32211 122358999999999887777655 899999999999999999997543321 22222222221 11
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.. ..+ ....+.++. +++.+||+.||++|||+.|+++.
T Consensus 239 ~~-~~~----~~~~s~~~~---~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 239 YS-IPD----DIRISPECC---HLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CC-CCT----TSCCCHHHH---HHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CC-CCC----cCCCCHHHH---HHHHHHccCChhHCcCHHHHHhC
Confidence 11 000 011233444 45559999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=330.56 Aligned_cols=272 Identities=17% Similarity=0.228 Sum_probs=209.8
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEE-EeCCeeeEEeee
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFC-VVEEERLLVYKH 371 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lv~ey 371 (604)
.++|...+.||+|+||.||+|. ..+++.||||++.... ..+++.+|++++++++|++++..++++ ...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 4678899999999999999999 4789999999986543 234688999999999998877777666 456778999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe---CCCCCeEEcccCCcc
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI---DDDFDARITDFGLAR 448 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl---~~~~~~kl~DFGla~ 448 (604)
+ +++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||+ ++++.+||+|||+++
T Consensus 87 ~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 87 L-GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp C-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred c-CCCHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 9 889999997442 35899999999999999999999 7899999999999999 488899999999998
Q ss_pred ccCCCCCCCC---ccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHH
Q 007423 449 LVGSRDPNDS---SFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 449 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
.......... .......||..|+|||++.+..++.++|||||||++|||+||+.||........ ......+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~ 234 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK--RQKYERISEKK 234 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS--SSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh--hhhhhhhcccc
Confidence 7754332111 111234589999999999998999999999999999999999999976433221 11111111111
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCCCC
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEP 587 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~ 587 (604)
..... +.+. ...+++ +.+++.+||+.||++|||+.||++.|+++.++.+.+..
T Consensus 235 ~~~~~-----~~~~-~~~~~~---l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~ 287 (296)
T 3uzp_A 235 MSTPI-----EVLC-KGYPSE---FATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 287 (296)
T ss_dssp HHSCH-----HHHT-TTSCHH---HHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSS
T ss_pred cCCch-----HHHH-hhCCHH---HHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccc
Confidence 11100 0010 112233 44555599999999999999999999999998877653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=343.33 Aligned_cols=248 Identities=21% Similarity=0.254 Sum_probs=197.8
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||++. ..+++.||||++.... ...+.+.+|++++++++|||||++++++...+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 568889999999999999998 4568999999996532 23467889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 95 e~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN-------VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp CCCTTEEHHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeee
Confidence 999999999999764 35899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCC---CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSST---MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
...... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||...... ......... .
T Consensus 165 ~~~~~~-----~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-----~~~~~~~~~-~ 233 (384)
T 4fr4_A 165 LPRETQ-----ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST-----SSKEIVHTF-E 233 (384)
T ss_dssp CCTTCC-----BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-----CHHHHHHHH-H
T ss_pred ccCCCc-----eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-----cHHHHHHHH-h
Confidence 643221 223459999999999864 45899999999999999999999999753221 111211111 1
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS-MYQVYE 573 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~ev~~ 573 (604)
..... .....+.++ .+++.+||+.||++||+ +.+|.+
T Consensus 234 ~~~~~-------~p~~~s~~~---~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 234 TTVVT-------YPSAWSQEM---VSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HCCCC-------CCTTSCHHH---HHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred hcccC-------CCCcCCHHH---HHHHHHHhcCCHhHhcccHHHHHc
Confidence 11110 011223344 44555999999999998 666654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=332.01 Aligned_cols=198 Identities=21% Similarity=0.253 Sum_probs=169.0
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
++|...+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 4688889999999999999994 568999999996533 223678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++ ++.+.+.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~-~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAF 151 (292)
T ss_dssp CCSE-EHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCCC-CHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9976 6666665432 35899999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCC-CCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMV-ASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
....... ....||..|+|||++.+.. ++.++|||||||++|||+||..|+..
T Consensus 152 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~ 204 (292)
T 3o0g_A 152 GIPVRCY----SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CSCCSCC----CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred CCccccc----cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence 4332221 2235899999999887665 79999999999999999999888643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=345.03 Aligned_cols=252 Identities=18% Similarity=0.269 Sum_probs=201.0
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
.+.|...+.||+|+||.||+|.. .+++.||+|.+.... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 35788999999999999999984 578999999997543 3345789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC--CCCCeEEcccCCccc
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID--DDFDARITDFGLARL 449 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~--~~~~~kl~DFGla~~ 449 (604)
+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++ .++.+||+|||+++.
T Consensus 130 ~~gg~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 130 LSGGELFDRIAAED------YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp CCCCBHHHHTTCTT------CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred CCCCcHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEeccccee
Confidence 99999999997542 35899999999999999999999 78999999999999997 457799999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+....... ..
T Consensus 201 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~i~~-~~ 266 (387)
T 1kob_A 201 LNPDEI-----VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQNVKR-CD 266 (387)
T ss_dssp CCTTSC-----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHH-CC
T ss_pred cCCCcc-----eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-CC
Confidence 643221 1223589999999999998999999999999999999999999975322 111222211 11
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.. .++... ...++++. +++.+||+.||++|||+.|+++.
T Consensus 267 ~~--~~~~~~-~~~s~~~~---~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 267 WE--FDEDAF-SSVSPEAK---DFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CC--CCSSTT-TTSCHHHH---HHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CC--CCcccc-ccCCHHHH---HHHHHHcCCChhHCcCHHHHhhC
Confidence 11 111111 11233444 45559999999999999999863
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=345.92 Aligned_cols=246 Identities=21% Similarity=0.283 Sum_probs=192.3
Q ss_pred cCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCc
Q 007423 299 VENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGT 376 (604)
Q Consensus 299 ~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gs 376 (604)
..+.||+|+||.||+|. ..+|+.||||+++... ...+++.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 35689999999999998 4679999999997643 345679999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe--CCCCCeEEcccCCccccCCCC
Q 007423 377 LYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI--DDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 377 L~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl--~~~~~~kl~DFGla~~~~~~~ 454 (604)
|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||+ ++++.+||+|||+++......
T Consensus 173 L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 173 LFDRIIDES------YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EHHHHHHTG------GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred HHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 999987542 35899999999999999999999 7899999999999999 567889999999999775432
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
.. ....||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+........... ..
T Consensus 244 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~~~--~~ 308 (373)
T 2x4f_A 244 KL-----KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--------AETLNNILACRWD--LE 308 (373)
T ss_dssp BC-----CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCC--SC
T ss_pred cc-----ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhccCC--CC
Confidence 21 123589999999999988899999999999999999999999975322 1222222221111 11
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
+.. . ...++++. +++.+||+.||++|||+.|+++
T Consensus 309 ~~~-~-~~~~~~~~---~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 309 DEE-F-QDISEEAK---EFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SGG-G-TTSCHHHH---HHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhh-h-ccCCHHHH---HHHHHHcCCChhhCCCHHHHhc
Confidence 111 0 11234444 4555999999999999999987
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=330.90 Aligned_cols=247 Identities=20% Similarity=0.285 Sum_probs=179.7
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||+|.. .+++.||||.+.... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5688899999999999999994 679999999996432 12367899999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++++|.+++.... ..+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 91 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV------KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp ECCTTEEHHHHHHTCS------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 9999999999997643 35899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
........ ....||+.|+|||...+..++.++||||||+++|||+||+.||......+... .-.
T Consensus 162 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------------~~~ 225 (278)
T 3cok_A 162 LKMPHEKH----YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------------KVV 225 (278)
T ss_dssp CC--------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------------CC
T ss_pred ccCCCCcc----eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------------HHh
Confidence 64322211 12348999999999998889999999999999999999999997543221100 000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
... ... ....+.++ .+++.+||+.||++|||+.|+++
T Consensus 226 ~~~---~~~-~~~~~~~~---~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 226 LAD---YEM-PSFLSIEA---KDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SSC---CCC-CTTSCHHH---HHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcc---cCC-ccccCHHH---HHHHHHHcccCHhhCCCHHHHhc
Confidence 000 011 11223344 45555999999999999999876
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.17 Aligned_cols=271 Identities=15% Similarity=0.227 Sum_probs=207.7
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC---------CCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccc-----------
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP---------DASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVP----------- 354 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~---------~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~----------- 354 (604)
++|...+.||+|+||.||+|... +++.||||.+... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 57888999999999999999965 3889999998653 46889999999999999998
Q ss_pred ----eeeEEEe-CCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCC
Q 007423 355 ----LLGFCVV-EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSN 429 (604)
Q Consensus 355 ----l~g~~~~-~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~ 429 (604)
+++++.. ++..++||||+ +|+|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~ 188 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-----HVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAE 188 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-----GCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGG
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHH
Confidence 6778776 67889999999 9999999986421 35899999999999999999999 789999999999
Q ss_pred eEEeCCCC--CeEEcccCCccccCCCCCCC---CccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCC
Q 007423 430 VILIDDDF--DARITDFGLARLVGSRDPND---SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPL 504 (604)
Q Consensus 430 NiLl~~~~--~~kl~DFGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~ 504 (604)
|||++.++ .+||+|||+++......... ........||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999988 89999999998765322111 11112336899999999999989999999999999999999999999
Q ss_pred CCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCC
Q 007423 505 DVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGF 584 (604)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~ 584 (604)
....... ..+........ .......+........++++.+ ++.+||+.||++|||+.||++.|+++.++.+.
T Consensus 269 ~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~---li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 269 TNCLPNT---EDIMKQKQKFV--DKPGPFVGPCGHWIRPSETLQK---YLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp GGGTTCH---HHHHHHHHHHH--HSCCCEECTTSCEECCCHHHHH---HHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ccCCcCH---HHHHHHHHhcc--CChhhhhhhccccCCCcHHHHH---HHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 7532111 11112111111 1122222211111122344444 45599999999999999999999999998876
Q ss_pred CC
Q 007423 585 SE 586 (604)
Q Consensus 585 ~~ 586 (604)
..
T Consensus 341 ~~ 342 (352)
T 2jii_A 341 SP 342 (352)
T ss_dssp CT
T ss_pred Cc
Confidence 64
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=340.88 Aligned_cols=267 Identities=19% Similarity=0.193 Sum_probs=199.0
Q ss_pred HHHhhcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc------ccHHHHHHHHHHHhccCCCCccceeeEEEeC
Q 007423 290 LLAATNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK------LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE 362 (604)
Q Consensus 290 l~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 362 (604)
+....++|...+.||+|+||.||+|.. .++..||||++.... ...+.+.+|++++++++||||+++++++...
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 455567899999999999999999984 678899999986432 2346789999999999999999999999999
Q ss_pred CeeeEEeeecCCCchhhhhccCCCCC---------------------------------CCCCCCCHHHHHHHHHHHHHH
Q 007423 363 EERLLVYKHMPNGTLYSLLHGNGVDN---------------------------------TLSGVLDWSTRLRIGMGASRG 409 (604)
Q Consensus 363 ~~~~lv~ey~~~gsL~~~l~~~~~~~---------------------------------~~~~~l~~~~~~~ia~~ia~g 409 (604)
+..++||||+++|+|.+++....... .....+++.....++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999985211000 001123567788899999999
Q ss_pred hhHhhhcCCCCceecCCCCCeEEeCCCC--CeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCC--CCCCccc
Q 007423 410 LAWLHHGCQPPYMHQYISSNVILIDDDF--DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST--MVASLKG 485 (604)
Q Consensus 410 L~yLH~~~~~~iiH~dlk~~NiLl~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~k~ 485 (604)
|.||| +.+|+||||||+|||++.++ .+||+|||+++.................||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999 78999999999999998666 89999999998764322222222234458999999998865 6789999
Q ss_pred chhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCC
Q 007423 486 DVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDR 565 (604)
Q Consensus 486 DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 565 (604)
|||||||++|||+||+.||...... +............. .+.. ...++++ .+++.+||+.||++|
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~--~~~~--~~~~~~~---~~li~~~l~~~p~~R 322 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA--------DTISQVLNKKLCFE--NPNY--NVLSPLA---RDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCTT--SGGG--GGSCHHH---HHHHHHHSCSCTTTS
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH--------HHHHHHHhcccccC--Cccc--ccCCHHH---HHHHHHHcCCChhHC
Confidence 9999999999999999999754321 12222222221111 1110 0122344 445559999999999
Q ss_pred CCHHHHHHH
Q 007423 566 PSMYQVYES 574 (604)
Q Consensus 566 Ps~~ev~~~ 574 (604)
|++.|+++.
T Consensus 323 ps~~~~l~h 331 (345)
T 3hko_A 323 FDAMRALQH 331 (345)
T ss_dssp CCHHHHHHS
T ss_pred CCHHHHhcC
Confidence 999999873
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=342.59 Aligned_cols=245 Identities=25% Similarity=0.310 Sum_probs=196.3
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc----cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL----SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
+.|...+.||+|+||.||+|. ..+++.||||++..... ..+++.+|++++++++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 458888999999999999999 56899999999964321 2256889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||++ |+|.+++.... ..+++..+..++.|+++||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 134 e~~~-g~l~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 203 (348)
T ss_dssp ECCS-EEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred ecCC-CCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence 9997 68888886432 35899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSS---TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
..... ...||+.|+|||++. ...++.++|||||||++|||+||+.||..... .........
T Consensus 204 ~~~~~--------~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--------~~~~~~~~~ 267 (348)
T 1u5q_A 204 MAPAN--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQ 267 (348)
T ss_dssp SSSBC--------CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHH
T ss_pred cCCCC--------cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHh
Confidence 64321 224899999999873 56789999999999999999999999965322 222222222
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.. ... ......++.+.++ +.+||+.||++|||+.|+++.
T Consensus 268 ~~-~~~-----~~~~~~~~~l~~l---i~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 268 NE-SPA-----LQSGHWSEYFRNF---VDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp SC-CCC-----CCCTTSCHHHHHH---HHHHTCSSGGGSCCHHHHTTC
T ss_pred cC-CCC-----CCCCCCCHHHHHH---HHHHcccChhhCcCHHHHhhC
Confidence 22 111 1112233444544 459999999999999999764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=352.98 Aligned_cols=258 Identities=17% Similarity=0.201 Sum_probs=202.8
Q ss_pred HHHHHhhcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeC
Q 007423 288 ADLLAATNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE 362 (604)
Q Consensus 288 ~~l~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 362 (604)
.++....++|...+.||+|+||.||+|+. .+++.||||+++... ...+.+.+|+++++.++|||||++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 45555678899999999999999999995 568999999996532 1223588999999999999999999999999
Q ss_pred CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEc
Q 007423 363 EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARIT 442 (604)
Q Consensus 363 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~ 442 (604)
+..++||||+++|+|.++++.. .+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~--------~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~ 210 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY--------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLA 210 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred CEEEEEEeCCCCCcHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEe
Confidence 9999999999999999999753 3788999999999999999999 7899999999999999999999999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCCCC----CCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHH
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMV----ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLV 518 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~ 518 (604)
|||+++....... ......+||+.|+|||++.+.. ++.++|||||||++|||+||+.||......
T Consensus 211 DFG~a~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------- 279 (410)
T 3v8s_A 211 DFGTCMKMNKEGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------- 279 (410)
T ss_dssp CCTTCEECCTTSE---EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--------
T ss_pred ccceeEeeccCCc---ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--------
Confidence 9999987643221 1122346999999999887654 789999999999999999999999754321
Q ss_pred HHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 007423 519 DWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKD--RPSMYQVYES 574 (604)
Q Consensus 519 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~~ 574 (604)
+...............+ ....++++..+++ +||..+|++ ||++.||++.
T Consensus 280 ~~~~~i~~~~~~~~~p~----~~~~s~~~~~li~---~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 280 GTYSKIMNHKNSLTFPD----DNDISKEAKNLIC---AFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHHHHHTHHHHCCCCT----TCCCCHHHHHHHH---HHSSCGGGCTTSSCHHHHHTS
T ss_pred hHHHHHHhccccccCCC----cccccHHHHHHHH---HHccChhhhCCCCCHHHHhcC
Confidence 11111111100000000 0123345555555 999999988 9999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=332.88 Aligned_cols=262 Identities=21% Similarity=0.339 Sum_probs=205.8
Q ss_pred cCCCcCc-EEEecCCeEEEEEEeC---CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 295 NSFAVEN-IIISTRTGVSYKAVLP---DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 295 ~~~~~~~-~ig~G~~g~vy~~~~~---~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
++|...+ .||+|+||.||+|... ++..||||+++... ...+++.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3444445 8999999999999843 57789999997643 3346799999999999999999999999 55678999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSK 158 (287)
T ss_dssp EECCTTEEHHHHHTTCT------TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEeCCCCCHHHHHHhCC------ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECccccee
Confidence 99999999999997543 35899999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
.......... ......+|+.|+|||++.+..++.++||||||+++|||+| |+.||...... +. ...+..
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~-~~~i~~ 228 (287)
T 1u59_A 159 ALGADDSYYT-ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EV-MAFIEQ 228 (287)
T ss_dssp ECTTCSCEEC-CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HH-HHHHHT
T ss_pred eeccCcceee-ccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--------HH-HHHHhc
Confidence 7754322111 1122346889999999988889999999999999999999 99999753221 11 122222
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCC
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFS 585 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~ 585 (604)
+..... ....+++ +.+++.+||+.||++||++.|+++.|+++..+.+..
T Consensus 229 ~~~~~~------~~~~~~~---l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 229 GKRMEC------PPECPPE---LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp TCCCCC------CTTCCHH---HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred CCcCCC------CCCcCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 221111 1122334 445555999999999999999999999998766443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=341.95 Aligned_cols=243 Identities=17% Similarity=0.188 Sum_probs=199.6
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||+++. .+|+.||||+++... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 5788899999999999999994 579999999996532 23467889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 121 e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~ 190 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp ECCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEccccccee
Confidence 999999999999764 35889999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
..... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.... +..+.
T Consensus 191 ~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~-i~~~~ 254 (350)
T 1rdq_E 191 VKGRT-------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEK-IVSGK 254 (350)
T ss_dssp CSSCB-------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH-HHHCC
T ss_pred ccCCc-------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHHHH-HHcCC
Confidence 64321 123589999999999998999999999999999999999999975322 122222 22222
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS-----MYQVYE 573 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~ 573 (604)
.. + ....+.++.++ +.+||+.||++||+ +.||++
T Consensus 255 ~~------~-p~~~~~~~~~l---i~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 255 VR------F-PSHFSSDLKDL---LRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CC------C-CTTCCHHHHHH---HHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CC------C-CCCCCHHHHHH---HHHHhhcCHHhccCCccCCHHHHHh
Confidence 11 1 11223444444 44999999999998 788865
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=336.85 Aligned_cols=205 Identities=20% Similarity=0.277 Sum_probs=160.5
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
.++|...+.||+|+||.||+|. ..+++.||||+++... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4578888999999999999999 4578999999986533 233678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|++ |+|.+++....... ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~~-~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGN-TPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp CCC-CBHHHHHHHHHSSS-CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred ecC-CCHHHHHHhccccc-cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 998 59999886532111 1135889999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
....... ....||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 159 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 159 GIPVNTF----SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp TSCCCCC----CCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCcccC----CCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4332211 22358999999998876 46899999999999999999999999754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=356.62 Aligned_cols=263 Identities=17% Similarity=0.176 Sum_probs=204.8
Q ss_pred CHHHHHHhhcCCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEeccccc----cHHHHHHHHHHHhccCCCCccceeeEEE
Q 007423 286 KLADLLAATNSFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACKL----SEKQFRSEMNRLGQLRHPNLVPLLGFCV 360 (604)
Q Consensus 286 ~~~~l~~~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 360 (604)
.+.++...+++|...++||+|+||.||+|+.. +++.||||+++.... ..+.+.+|+.++.+++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34566667789999999999999999999954 578999999965321 1234889999999999999999999999
Q ss_pred eCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeE
Q 007423 361 VEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDAR 440 (604)
Q Consensus 361 ~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~k 440 (604)
+++..++||||+++|+|.+++.... ..+++.....++.|++.||.||| +.+|+||||||+|||++.++.+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~------~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vk 215 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE------DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIR 215 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEE
Confidence 9999999999999999999997642 35899999999999999999999 78999999999999999999999
Q ss_pred EcccCCccccCCCCCCCCccccCCCCcccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccC
Q 007423 441 ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSS-----TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKG 515 (604)
Q Consensus 441 l~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~ 515 (604)
|+|||+++........ .....+||+.|+|||++. ...++.++|||||||++|||+||+.||......+
T Consensus 216 L~DFGla~~~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~---- 288 (437)
T 4aw2_A 216 LADFGSCLKLMEDGTV---QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE---- 288 (437)
T ss_dssp ECCCTTCEECCTTSCE---ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----
T ss_pred EcchhhhhhcccCCCc---ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH----
Confidence 9999999876433221 112246999999999886 5678999999999999999999999997543221
Q ss_pred cHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 007423 516 NLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKD--RPSMYQVYES 574 (604)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~~ 574 (604)
............. -+... ...++++.++++ +|+..+|++ ||+++|+++.
T Consensus 289 ----~~~~i~~~~~~~~--~p~~~-~~~s~~~~dLi~---~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 289 ----TYGKIMNHKERFQ--FPTQV-TDVSENAKDLIR---RLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ----HHHHHHTHHHHCC--CCSSC-CCSCHHHHHHHH---TTSSCGGGCTTTTTTHHHHTS
T ss_pred ----HHHhhhhcccccc--CCccc-ccCCHHHHHHHH---HHhcccccccCCCCHHHHhCC
Confidence 1111111000000 01000 123445555555 999888888 9999999764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=349.62 Aligned_cols=270 Identities=16% Similarity=0.219 Sum_probs=209.5
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCC--eeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE--ERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lv~ 369 (604)
+.|...+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 4688889999999999999995 458999999997533 33467889999999999999999999998755 679999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe----CCCCCeEEcccC
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI----DDDFDARITDFG 445 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl----~~~~~~kl~DFG 445 (604)
||+++|+|.+++...... ..+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||
T Consensus 89 e~~~~g~L~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNA----YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCCTTEEHHHHTTSGGGT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred ecCCCCCHHHHHHhhhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 999999999999765321 23899999999999999999999 7899999999999999 778889999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCC--------CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcH
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST--------MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNL 517 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~ 517 (604)
+++....... .....||..|+|||++.+ ..++.++|||||||++|||+||+.||....... ..
T Consensus 162 ~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~----~~ 232 (396)
T 4eut_A 162 AARELEDDEQ-----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR----RN 232 (396)
T ss_dssp GCEECCCGGG-----SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT----TC
T ss_pred CceEccCCCc-----cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc----ch
Confidence 9987643221 123358999999998754 567889999999999999999999997533221 11
Q ss_pred HHHHHHHHHcCCcccccc-------------ccc--cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 518 VDWVNHLVIAGRSRDVVD-------------KSL--YGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 518 ~~~~~~~~~~~~~~~~~d-------------~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
.+.+..... +.....+. ..+ ...........+.+++.+||+.||++||++.|+++.++++.+.
T Consensus 233 ~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 233 KEVMYKIIT-GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHHHHH-SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHHHHHhc-CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 222222222 21111000 000 1122344555666777899999999999999999999988764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=343.38 Aligned_cols=200 Identities=20% Similarity=0.268 Sum_probs=176.5
Q ss_pred HhhcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhccC-----CCCccceeeEEEeCCee
Q 007423 292 AATNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQLR-----HPNLVPLLGFCVVEEER 365 (604)
Q Consensus 292 ~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~-----H~niv~l~g~~~~~~~~ 365 (604)
...++|...+.||+|+||.||+|.. .+++.||||+++......+.+..|++++++++ ||||+++++++...+..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 3457899999999999999999994 67899999999865555677888999999996 99999999999999999
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC----------
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD---------- 435 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~---------- 435 (604)
++||||+ +++|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNNY-----NGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred EEEEcCC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccch
Confidence 9999999 8899999986532 24889999999999999999999 789999999999999985
Q ss_pred ---------------CCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhC
Q 007423 436 ---------------DFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSG 500 (604)
Q Consensus 436 ---------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg 500 (604)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||+||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-------CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred hcccccccccccccCCCCEEEEeccCceecCCCC-------cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence 7889999999998653321 123489999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 007423 501 QKPLDVA 507 (604)
Q Consensus 501 ~~p~~~~ 507 (604)
+.||...
T Consensus 256 ~~pf~~~ 262 (360)
T 3llt_A 256 SLLFRTH 262 (360)
T ss_dssp SCSCCCS
T ss_pred CCCCCCC
Confidence 9999754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=342.74 Aligned_cols=258 Identities=13% Similarity=0.116 Sum_probs=205.8
Q ss_pred hhcCCCcCcEEEecCCeEEEEEE------eCCCCEEEEEEeccccccHHHHHHHHHHHhccC---CCCccceeeEEEeCC
Q 007423 293 ATNSFAVENIIISTRTGVSYKAV------LPDASALAIKRLSACKLSEKQFRSEMNRLGQLR---HPNLVPLLGFCVVEE 363 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~------~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~ 363 (604)
..++|...+.||+|+||.||+|. ..+++.||||+++.. ...++.+|++++++++ |+||+++++++..++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 45678889999999999999993 557899999999754 3567888888888887 999999999999999
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC--------
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD-------- 435 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~-------- 435 (604)
..++||||+++|+|.+++...... ....+++..+..++.|++.||+||| +.+|+||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNT--PEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTS--TTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC---
T ss_pred CcEEEEeccCCCcHHHHHHHhhcc--cccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccc
Confidence 999999999999999999742111 0145999999999999999999999 789999999999999998
Q ss_pred ---CCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCcccc
Q 007423 436 ---DFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEG 512 (604)
Q Consensus 436 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~ 512 (604)
++.+||+|||+++.+..... ........||..|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPK--GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCT--TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred ccccCCEEEeeCchhhhhhccCC--CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence 89999999999976532211 122334569999999999999999999999999999999999999995321110
Q ss_pred ccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCC-CCHHHHHHHHHhchHhc
Q 007423 513 FKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDR-PSMYQVYESLKSMAEKH 582 (604)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~ev~~~L~~i~~~~ 582 (604)
..++..+......+...++++ .|++.+|.+| |+++++.+.|+++.+..
T Consensus 293 -------------------~~~~~~~~~~~~~~~~~~~~~---~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 -------------------CKPEGLFRRLPHLDMWNEFFH---VMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp -------------------EEECSCCTTCSSHHHHHHHHH---HHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -------------------eeechhccccCcHHHHHHHHH---HHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 001111111123455566665 9999999999 68999999999988764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=337.55 Aligned_cols=246 Identities=18% Similarity=0.230 Sum_probs=189.8
Q ss_pred cCCCcCcEEEecCCeEEEEEEe----CCCCEEEEEEecccc-----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL----PDASALAIKRLSACK-----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER 365 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~----~~~~~vAvK~l~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 365 (604)
++|...+.||+|+||.||+++. .+++.||||+++... .....+.+|++++++++||||+++++++..++..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5788899999999999999985 578999999997542 2234578999999999999999999999999999
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
++||||+++|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE-------GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred EEEEeCCCCCcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCC
Confidence 9999999999999999754 35889999999999999999999 7899999999999999999999999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHH
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......
T Consensus 167 ~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~ 234 (327)
T 3a62_A 167 LCKESIHDGTV----THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--------KKTIDKIL 234 (327)
T ss_dssp CC--------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHH
T ss_pred cccccccCCcc----ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHH
Confidence 99865322211 1233589999999999888899999999999999999999999975322 11122222
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYE 573 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 573 (604)
. +... + ....+.++.+ ++.+||+.||++|| ++.|+++
T Consensus 235 ~-~~~~------~-p~~~~~~~~~---li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 235 K-CKLN------L-PPYLTQEARD---LLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp H-TCCC------C-CTTSCHHHHH---HHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred h-CCCC------C-CCCCCHHHHH---HHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1 1111 0 1122344444 44599999999999 6777765
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=336.36 Aligned_cols=255 Identities=18% Similarity=0.248 Sum_probs=196.9
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC-CC-------CEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP-DA-------SALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER 365 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~-~~-------~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 365 (604)
++|...+.||+|+||.||+|... ++ ..||+|.+.... ...+.+.+|++++++++||||+++++++..++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 56888899999999999999843 33 479999996543 4457799999999999999999999999999999
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC-------
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD------- 438 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~------- 438 (604)
++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK------NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG------GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred EEEEECCCCCCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccc
Confidence 99999999999999998653 34889999999999999999999 789999999999999998877
Q ss_pred -eEEcccCCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCc
Q 007423 439 -ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGN 516 (604)
Q Consensus 439 -~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~ 516 (604)
+||+|||+++..... . ...|+..|+|||++.+ ..++.++|||||||++|||+||..|+.....
T Consensus 159 ~~kl~Dfg~~~~~~~~-----~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~------- 223 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK-----D---ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD------- 223 (289)
T ss_dssp EEEECCCCSCTTTSCH-----H---HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-------
T ss_pred eeeeccCcccccccCc-----c---ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-------
Confidence 999999998755321 1 1137889999998877 6789999999999999999996554432111
Q ss_pred HHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCC
Q 007423 517 LVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFS 585 (604)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~ 585 (604)
................ ..++ .+.+++.+||+.||++|||+.|+++.|+++....+..
T Consensus 224 ~~~~~~~~~~~~~~~~---------~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 224 SQRKLQFYEDRHQLPA---------PKAA---ELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp HHHHHHHHHTTCCCCC---------CSSC---TTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred hHHHHHHhhccCCCCC---------CCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 1111111111111111 1122 2445555999999999999999999999988755443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=334.56 Aligned_cols=264 Identities=21% Similarity=0.310 Sum_probs=198.2
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||+|. ..+++.||||+++... ...+++.+|++++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 578889999999999999999 4679999999997422 23457899999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++...... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 112 e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQ---KRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp ECCCSCBHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred ecCCCCCHHHHHHHhccc---ccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 999999999998642111 135889999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
........ ....|+..|+|||++.+..++.++||||||+++|||+||+.||..... ........ +..+.
T Consensus 186 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~ 254 (310)
T 2wqm_A 186 FSSKTTAA----HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKK-IEQCD 254 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C------CHHHHHHH-HHTTC
T ss_pred ecCCCccc----cccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch------hHHHHHHH-hhccc
Confidence 64322111 123488999999999988999999999999999999999999964321 12222222 22222
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcC
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHG 583 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~ 583 (604)
..... ....++++. +++.+||+.||++|||+.||++.|+++.....
T Consensus 255 ~~~~~-----~~~~~~~l~---~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 255 YPPLP-----SDHYSEELR---QLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp SCCCC-----TTTSCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CCCCc-----ccccCHHHH---HHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 22111 112234444 45559999999999999999999999987653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=337.95 Aligned_cols=260 Identities=21% Similarity=0.290 Sum_probs=194.0
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc----cHHHHHHHHHHHhccCCCCccceeeEEEeCCe----e
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL----SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEE----R 365 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----~ 365 (604)
++|...+.||+|+||.||++. ..+++.||||+++.... ..+.+.+|++++++++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 568889999999999999999 57789999999975422 23568899999999999999999999876543 4
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
++||||+++|+|.++++.. ..+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 92 ~lv~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 161 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFG 161 (311)
T ss_dssp EEEEECCCEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred EEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeecc
Confidence 9999999999999999754 35899999999999999999999 7899999999999999999999999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHH
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
+++......... .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+......
T Consensus 162 ~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~ 232 (311)
T 3ork_A 162 IARAIADSGNSV-TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHV 232 (311)
T ss_dssp CC-------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHH
T ss_pred Cccccccccccc-ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHh
Confidence 998764432111 112233589999999999988999999999999999999999999975322 12222222
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHH-HHHHHHhchH
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQ-VYESLKSMAE 580 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e-v~~~L~~i~~ 580 (604)
....... .......++++ .+++.+||+.||++||++.+ +...+..+..
T Consensus 233 ~~~~~~~----~~~~~~~~~~l---~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 233 REDPIPP----SARHEGLSADL---DAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HCCCCCH----HHHSTTCCHHH---HHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred cCCCCCc----ccccCCCCHHH---HHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 2221111 11111223344 45555999999999996555 4555655543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=334.78 Aligned_cols=261 Identities=19% Similarity=0.242 Sum_probs=197.1
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc----cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL----SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
-++|...+.||+|+||.||++.. .+++.||||+++.... ..+.+.+|++++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 36789999999999999999995 5788999999975432 236788999999999999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 113 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~ 182 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ-------GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIAS 182 (309)
T ss_dssp EECCCCEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC--
T ss_pred EEecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCc
Confidence 9999999999999754 35899999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
........ ......|+..|+|||++.+..++.++||||||+++|||+||+.||..... ..+.......
T Consensus 183 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~~~~~~ 250 (309)
T 2h34_A 183 ATTDEKLT---QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---------SVMGAHINQA 250 (309)
T ss_dssp -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---------HHHHHHHHSC
T ss_pred cccccccc---cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---------HHHHHHhccC
Confidence 76432211 11233589999999999988999999999999999999999999974321 1122222221
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhchHhcC
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-SMYQVYESLKSMAEKHG 583 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~ev~~~L~~i~~~~~ 583 (604)
.. . +.......+.++. +++.+||+.||++|| +++++++.|+.+.+...
T Consensus 251 ~~-~---~~~~~~~~~~~l~---~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 251 IP-R---PSTVRPGIPVAFD---AVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp CC-C---GGGTSTTCCTHHH---HHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred CC-C---ccccCCCCCHHHH---HHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 11 1 1111112233444 455599999999999 99999999998766543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=341.14 Aligned_cols=247 Identities=16% Similarity=0.184 Sum_probs=198.3
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEecccc----ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeE
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACK----LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 367 (604)
.++|...+.||+|+||.||++... +++.||||+++... ...+.+.+|..++..+ +||||+++++++...+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 357889999999999999999954 58899999997532 2346688999999988 89999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 99 v~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a 168 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV-------GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168 (353)
T ss_dssp EEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence 99999999999999754 35899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
+........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+...... .
T Consensus 169 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~-~ 235 (353)
T 2i0e_A 169 KENIWDGVT----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIM-E 235 (353)
T ss_dssp BCCCCTTCC----BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-H
T ss_pred cccccCCcc----cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--------HHHHHHHH-h
Confidence 864322211 2234599999999999999999999999999999999999999975322 12222222 2
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS-----MYQVYE 573 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~ 573 (604)
+... . +...+.++.++ +.+||+.||++||+ +.||++
T Consensus 236 ~~~~------~-p~~~s~~~~~l---i~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 236 HNVA------Y-PKSMSKEAVAI---CKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp CCCC------C-CTTSCHHHHHH---HHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCC------C-CCCCCHHHHHH---HHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 2111 0 11223444444 45999999999995 466654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=337.99 Aligned_cols=243 Identities=19% Similarity=0.182 Sum_probs=189.0
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc---cHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL---SEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||+||+|.. .+++.||||++..... ...++..|+..+.++ +||||+++++++..++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 5688899999999999999995 4799999999865332 233456666666555 8999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+ +|+|.+++.... ..++|..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 137 e~~-~~~L~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG------ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp ECC-CCBHHHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred ecc-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeee
Confidence 999 669999887543 35899999999999999999999 67899999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
....... ....||+.|+|||++.+ .++.++|||||||++|||++|..|+... ..| ..+..+.
T Consensus 207 ~~~~~~~-----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~--~~~~~~~ 268 (311)
T 3p1a_A 207 LGTAGAG-----EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGW--QQLRQGY 268 (311)
T ss_dssp CC-----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHH--HHHTTTC
T ss_pred cccCCCC-----cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHH--HHHhccC
Confidence 6433221 12348999999998876 7899999999999999999997776431 111 1112222
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
... ... ...++ .+.+++.+||+.||++|||+.|+++
T Consensus 269 ~~~----~~~-~~~~~---~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 269 LPP----EFT-AGLSS---ELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CCH----HHH-TTSCH---HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCc----ccc-cCCCH---HHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111 111 11223 3455555999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=335.11 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=202.3
Q ss_pred hcCCCcCc-EEEecCCeEEEEEEe---CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeee
Q 007423 294 TNSFAVEN-IIISTRTGVSYKAVL---PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366 (604)
Q Consensus 294 ~~~~~~~~-~ig~G~~g~vy~~~~---~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 366 (604)
.++|...+ .||+|+||.||+|.. ..++.||||+++... ...+++.+|++++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 999999999999953 346889999997542 2246799999999999999999999999 566789
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
+||||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 94 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 163 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL 163 (291)
T ss_dssp EEEECCTTEEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEeCCCCCHHHHHHhC-------cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCc
Confidence 999999999999999764 35889999999999999999999 78999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
++.......... ......++..|+|||++.+..++.++||||||+++|||+| |+.||...... + +...+
T Consensus 164 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~-~~~~~ 233 (291)
T 1xbb_A 164 SKALRADENYYK-AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------E-VTAML 233 (291)
T ss_dssp CEECCTTCSEEE-C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------H-HHHHH
T ss_pred ceeeccCCCccc-ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------H-HHHHH
Confidence 987654322111 1112236788999999988889999999999999999999 99999753221 1 22222
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
..+..... ....+++ +.+++.+||+.||++||++.||++.|+++....
T Consensus 234 ~~~~~~~~------~~~~~~~---l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 234 EKGERMGC------PAGCPRE---MYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp HTTCCCCC------CTTCCHH---HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HcCCCCCC------CCCCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 23322111 1122334 445555999999999999999999999987653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=327.50 Aligned_cols=246 Identities=21% Similarity=0.299 Sum_probs=197.3
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
.++|...+.||+|+||.||+|. ..++..||||++.... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4678889999999999999998 4567899999986432 2245788999999999999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 88 ~e~~~~~~l~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~ 157 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV 157 (279)
T ss_dssp ECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred EecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccc
Confidence 9999999999999754 35889999999999999999999 8899999999999999999999999999986
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
....... ....|+..|+|||.+.+..++.++||||||+++|||++|+.||..... .+..... ...
T Consensus 158 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~-~~~ 222 (279)
T 3fdn_A 158 HAPSSRR------TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRI-SRV 222 (279)
T ss_dssp CC--------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHH-HHT
T ss_pred cCCcccc------cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH--------HHHHHHH-HhC
Confidence 5432211 123489999999999998999999999999999999999999975322 1111111 111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
... . ....++.+. +++.+||+.||++|||+.|+++.
T Consensus 223 ~~~------~-~~~~~~~~~---~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 223 EFT------F-PDFVTEGAR---DLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCC------C-CTTSCHHHH---HHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCC------C-CCcCCHHHH---HHHHHHhccChhhCCCHHHHhhC
Confidence 110 0 112233444 45559999999999999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=353.78 Aligned_cols=247 Identities=19% Similarity=0.214 Sum_probs=191.7
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
.++|...+.||+|+||.||++. ..+++.||||+++... .....+.+|++++++++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 3578899999999999999998 5679999999997532 2235678899999999999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCC-CCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQ-PPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~-~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
|||+++|+|.+++... ..+++..+..++.|++.||+||| + .+|+||||||+|||++.++.+||+|||++
T Consensus 227 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a 296 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE-------RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296 (446)
T ss_dssp ECCCSSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred EeeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCc
Confidence 9999999999999754 35899999999999999999999 5 78999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
+........ .....||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+.......
T Consensus 297 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~- 363 (446)
T 4ejn_A 297 KEGIKDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILM- 363 (446)
T ss_dssp CTTCC---------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-
T ss_pred eeccCCCcc----cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHHh-
Confidence 864332211 2234599999999999999999999999999999999999999975322 111222221
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYE 573 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 573 (604)
+... . ....++++. +++.+||+.||++|| ++.|+++
T Consensus 364 ~~~~------~-p~~~~~~~~---~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 364 EEIR------F-PRTLGPEAK---SLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCCC------C-CTTSCHHHH---HHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCC------C-CccCCHHHH---HHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1111 0 111233444 455599999999999 9999976
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=345.75 Aligned_cols=272 Identities=21% Similarity=0.239 Sum_probs=204.6
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-----CCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEe--CCeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-----PDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV--EEERL 366 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-----~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~ 366 (604)
++|...+.||+|+||.||++.. .+++.||||++.... ...+.+.+|++++++++||||+++++++.. ....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4688889999999999999983 468899999997643 334669999999999999999999999874 55689
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
+||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 103 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR------ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred EEEeecCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEccccc
Confidence 9999999999999997542 34899999999999999999999 78999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCcccc------ccCcHHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEG------FKGNLVDW 520 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~------~~~~~~~~ 520 (604)
++......... .......||..|+|||++.+..++.++||||||+++|||+||+.||........ ........
T Consensus 174 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 174 AKLLPLDKDYY-VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252 (327)
T ss_dssp CEECCTTCSEE-ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred ceecccCCccc-eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence 98774332111 111223478889999999888899999999999999999999999864221100 00001111
Q ss_pred HHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCC
Q 007423 521 VNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFS 585 (604)
Q Consensus 521 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~ 585 (604)
+......+..... ....++ .+.+++.+||+.||++|||+.|+++.|+.+.......
T Consensus 253 ~~~~~~~~~~~~~------~~~~~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 253 LLELLEEGQRLPA------PPACPA---EVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp HHHHHHTTCCCCC------CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred HHHHhhcccCCCC------CCcccH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 1122222211111 112233 3455555999999999999999999999987755433
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=335.61 Aligned_cols=267 Identities=19% Similarity=0.289 Sum_probs=203.0
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-----CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeC--Cee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-----PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE--EER 365 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-----~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 365 (604)
+.|...+.||+|+||.||+|.+ .+++.||||+++... ...+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3577789999999999999983 468899999997532 3346799999999999999999999999876 568
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK------NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT------TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccc
Confidence 99999999999999996542 35899999999999999999999 7899999999999999999999999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCcc------ccccCcHHH
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAE------EGFKGNLVD 519 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~------~~~~~~~~~ 519 (604)
+++........ ........||..|+|||++.+..++.++||||||+++|||+||+.|+...... .........
T Consensus 172 ~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 172 LTKAIETDKEY-YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp TCEECCTTCCE-EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred ccccccCCCcc-eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence 99877543211 11122335788899999998888999999999999999999999986431100 000001111
Q ss_pred HHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 520 WVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 520 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
........+..... ....+++ +.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 251 ~~~~~~~~~~~~~~------~~~~~~~---l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 251 RLVNTLKEGKRLPC------PPNCPDE---VYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHHHTTCCCCC------CTTCCHH---HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHhccCCCCC------CCCCCHH---HHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 11222222221111 1122334 4455559999999999999999999998753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=333.49 Aligned_cols=270 Identities=21% Similarity=0.342 Sum_probs=198.9
Q ss_pred HHHHhhcCCCcCcEEEecCCeEEEEEEeC----CCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEe
Q 007423 289 DLLAATNSFAVENIIISTRTGVSYKAVLP----DASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVV 361 (604)
Q Consensus 289 ~l~~~~~~~~~~~~ig~G~~g~vy~~~~~----~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 361 (604)
++....++|...+.||+|+||.||+|... .+..||||+++.... ..+.+.+|++++++++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 33345567888999999999999999843 345899999975432 23568999999999999999999999987
Q ss_pred CC-----eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC
Q 007423 362 EE-----ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD 436 (604)
Q Consensus 362 ~~-----~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~ 436 (604)
.+ ..++||||+++|+|.+++....... ....+++..++.++.|++.||.||| +.+|+||||||+||+++.+
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLET-GPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDD 183 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTT-SCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTT
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhc-CCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCC
Confidence 54 3499999999999999985432211 1246899999999999999999999 8899999999999999999
Q ss_pred CCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccC
Q 007423 437 FDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKG 515 (604)
Q Consensus 437 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~ 515 (604)
+.+||+|||+++.......... .....+++.|+|||...+..++.++||||||+++|||+| |+.||......+
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 257 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQ--GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---- 257 (313)
T ss_dssp SCEEECSCSCC------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----
T ss_pred CcEEEeecCcceecccccccCc--ccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH----
Confidence 9999999999987643321111 112246789999999988899999999999999999999 899997543221
Q ss_pred cHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 516 NLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
. . .....+...... ...++ .+.+++.+||+.||++|||+.|+++.|+++.++.
T Consensus 258 -~---~-~~~~~~~~~~~~------~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 258 -M---Y-DYLLHGHRLKQP------EDCLD---ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp -H---H-HHHHTTCCCCCB------TTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -H---H-HHHHcCCCCCCC------ccccH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1 1 112222211111 11223 4455556999999999999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=341.41 Aligned_cols=264 Identities=26% Similarity=0.394 Sum_probs=203.7
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCE--EEEEEecccc--ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASA--LAIKRLSACK--LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~--vAvK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv 368 (604)
++|...+.||+|+||.||+|.. .++.. ||||.++... ...+.+.+|+++++++ +||||+++++++..++..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 5788889999999999999984 45654 4999986432 2345689999999999 999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCC---------CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCe
Q 007423 369 YKHMPNGTLYSLLHGNGVD---------NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~ 439 (604)
|||+++|+|.+++...... ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence 9999999999999765310 001135899999999999999999999 7899999999999999999999
Q ss_pred EEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHH
Q 007423 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLV 518 (604)
Q Consensus 440 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 518 (604)
||+|||+++........ ....++..|+|||++.+..++.++|||||||++|||+| |+.||..... .
T Consensus 182 kL~Dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~ 248 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVKK-----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------A 248 (327)
T ss_dssp EECCTTCEESSCEECCC---------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------H
T ss_pred EEcccCcCccccccccc-----cCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------H
Confidence 99999999754321111 11236789999999988889999999999999999998 9999975322 1
Q ss_pred HHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCC
Q 007423 519 DWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGF 584 (604)
Q Consensus 519 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~ 584 (604)
+.. ..+..+.... . ....++ .+.+++.+||+.||++|||+.|+++.|+++.++...
T Consensus 249 ~~~-~~~~~~~~~~-----~-~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 249 ELY-EKLPQGYRLE-----K-PLNCDD---EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp HHH-HHGGGTCCCC-----C-CTTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred HHH-HHhhcCCCCC-----C-CCCCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 111 1112221110 0 011223 344555599999999999999999999999886543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=326.47 Aligned_cols=251 Identities=21% Similarity=0.251 Sum_probs=199.9
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
.++|...+.||+|+||.||+|.. .+++.||+|++..... ..+.+.+|++++++++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46788899999999999999984 5689999999965432 2356889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC---eEEcccCC
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD---ARITDFGL 446 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~---~kl~DFGl 446 (604)
||+++|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+||+++.++. +||+|||+
T Consensus 85 e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-------EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGL 154 (284)
T ss_dssp CCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred ecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence 999999999988754 35899999999999999999999 789999999999999986655 99999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
+......... ....||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+.... ..
T Consensus 155 ~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------~~~~~~-~~ 220 (284)
T 3kk8_A 155 AIEVNDSEAW-----HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQ-IK 220 (284)
T ss_dssp CEECCSSCBC-----CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH-HH
T ss_pred eEEcccCccc-----cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--------hHHHHH-HH
Confidence 9876433221 223589999999999999999999999999999999999999965322 111111 22
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.+.... ..+. ....++++ .+++.+||+.||++|||+.|+++.
T Consensus 221 ~~~~~~-~~~~--~~~~~~~~---~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 221 AGAYDY-PSPE--WDTVTPEA---KSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HTCCCC-CTTT--TTTSCHHH---HHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hccccC-Cchh--hcccCHHH---HHHHHHHcccChhhCCCHHHHhcC
Confidence 222111 1110 01123344 455559999999999999999873
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=335.49 Aligned_cols=250 Identities=17% Similarity=0.246 Sum_probs=200.6
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc-------ccHHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK-------LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER 365 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 365 (604)
.+.|...+.||+|+||.||++.. .+++.||||.++... ...+++.+|++++++++||||+++++++..++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 35688899999999999999994 578999999986432 1357799999999999999999999999999999
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC----CeEE
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF----DARI 441 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~----~~kl 441 (604)
++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++ .+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl 160 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK-------ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKL 160 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC-------SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred EEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEE
Confidence 9999999999999999754 35889999999999999999999 78999999999999999887 7999
Q ss_pred cccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHH
Q 007423 442 TDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWV 521 (604)
Q Consensus 442 ~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 521 (604)
+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||+||+.||...... +..
T Consensus 161 ~Dfg~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~ 227 (321)
T 2a2a_A 161 IDFGLAHEIEDGVEF-----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETL 227 (321)
T ss_dssp CCCTTCEECCTTCCC-----CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHH
T ss_pred ccCccceecCccccc-----cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--------HHH
Confidence 999999876543221 2235899999999999889999999999999999999999999753221 111
Q ss_pred HHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 522 NHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 522 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
... ..... ..++... ...++. +.+++.+||+.||++|||+.|+++
T Consensus 228 ~~i-~~~~~--~~~~~~~-~~~~~~---~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 228 ANI-TSVSY--DFDEEFF-SHTSEL---AKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHH-HTTCC--CCCHHHH-TTCCHH---HHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHH-Hhccc--ccChhhh-cccCHH---HHHHHHHHcCCChhhCcCHHHHhc
Confidence 111 11111 0111111 112233 445555999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=344.04 Aligned_cols=267 Identities=17% Similarity=0.177 Sum_probs=196.6
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC----CCCEEEEEEecccccc------------HHHHHHHHHHHhccCCCCccceeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP----DASALAIKRLSACKLS------------EKQFRSEMNRLGQLRHPNLVPLLGF 358 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~----~~~~vAvK~l~~~~~~------------~~~~~~Ei~~l~~l~H~niv~l~g~ 358 (604)
++|...+.||+|+||.||+|... ++..||||++...... .+.+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888999999999999999964 6789999998654211 1246688999999999999999999
Q ss_pred EEe----CCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC
Q 007423 359 CVV----EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID 434 (604)
Q Consensus 359 ~~~----~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~ 434 (604)
+.. ....++||||+ +++|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+|||++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN-------GTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLG 185 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG-------GBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEE
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEc
Confidence 988 67899999999 99999999764 35899999999999999999999 78999999999999999
Q ss_pred CCC--CeEEcccCCccccCCCCCC---CCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCc
Q 007423 435 DDF--DARITDFGLARLVGSRDPN---DSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGA 509 (604)
Q Consensus 435 ~~~--~~kl~DFGla~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~ 509 (604)
.++ .+||+|||+++.+...... .........||..|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 777 9999999999876432211 11112344689999999999988899999999999999999999999964211
Q ss_pred cccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 510 EEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
.. ............ .....+.........+++ +.+++.+||+.||++||++.+|++.|+.+..
T Consensus 266 ~~----~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~---l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 266 DP----VAVQTAKTNLLD-ELPQSVLKWAPSGSSCCE---IAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp CH----HHHHHHHHHHHH-TTTHHHHHHSCTTSCCHH---HHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cc----HHHHHHHHhhcc-cccHHHHhhccccccHHH---HHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 10 011111111111 111111111111122334 4455559999999999999999999987543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.05 Aligned_cols=245 Identities=20% Similarity=0.320 Sum_probs=199.8
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4688889999999999999995 579999999996532 22357899999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 96 E~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 96 EYVSGGELFDYICKN-------GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp ECCSSEEHHHHTTSS-------SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred eCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhh
Confidence 999999999999754 35899999999999999999999 88999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA-SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
...... .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||+..... .... .+..+
T Consensus 166 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--------~~~~-~i~~~ 231 (476)
T 2y94_A 166 MSDGEF-----LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--------TLFK-KICDG 231 (476)
T ss_dssp CCTTCC-----BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--------HHHH-HHHTT
T ss_pred cccccc-----ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--------HHHH-HHhcC
Confidence 643221 223358999999999887765 78999999999999999999999753221 1111 12222
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.... ....+.++. +++.+||+.||++|||+.||++
T Consensus 232 ~~~~-------p~~~s~~~~---~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 232 IFYT-------PQYLNPSVI---SLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CCCC-------CTTCCHHHH---HHHHHHTCSSTTTSCCHHHHHT
T ss_pred CcCC-------CccCCHHHH---HHHHHHcCCCchhCcCHHHHHh
Confidence 2110 112233444 4555999999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=351.32 Aligned_cols=263 Identities=18% Similarity=0.189 Sum_probs=203.5
Q ss_pred cCHHHHHHhhcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc----cHHHHHHHHHHHhccCCCCccceeeEE
Q 007423 285 VKLADLLAATNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL----SEKQFRSEMNRLGQLRHPNLVPLLGFC 359 (604)
Q Consensus 285 ~~~~~l~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~ 359 (604)
+.+.+.....++|...+.||+|+||.||+++. .+++.||||+++.... ..+.+.+|++++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 34455666678999999999999999999995 5799999999965321 123488999999999999999999999
Q ss_pred EeCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCe
Q 007423 360 VVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439 (604)
Q Consensus 360 ~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~ 439 (604)
.+++..++||||+++|+|.+++.... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~v 201 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG------ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHI 201 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCE
Confidence 99999999999999999999997542 25889999999999999999999 7899999999999999999999
Q ss_pred EEcccCCccccCCCCCCCCccccCCCCcccccCccccC-------CCCCCcccchhhHHHHHHHHHhCCCCCCCCCcccc
Q 007423 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSS-------TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEG 512 (604)
Q Consensus 440 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~ 512 (604)
||+|||+++........ .....+||+.|+|||++. ...++.++|||||||++|||+||+.||......+
T Consensus 202 kL~DFGla~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~- 277 (412)
T 2vd5_A 202 RLADFGSCLKLRADGTV---RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE- 277 (412)
T ss_dssp EECCCTTCEECCTTSCE---ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-
T ss_pred EEeechhheeccCCCcc---ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-
Confidence 99999999876433211 112235999999999876 4568999999999999999999999997543221
Q ss_pred ccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCC---CCHHHHHHH
Q 007423 513 FKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDR---PSMYQVYES 574 (604)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~ev~~~ 574 (604)
........... ..-+.. ....++++.++++ +||. +|++| |++.||++.
T Consensus 278 -------~~~~i~~~~~~--~~~p~~-~~~~s~~~~dli~---~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 278 -------TYGKIVHYKEH--LSLPLV-DEGVPEEARDFIQ---RLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp -------HHHHHHTHHHH--CCCC-----CCCHHHHHHHH---TTSS-CGGGCTTTTTHHHHHTS
T ss_pred -------HHHHHHhcccC--cCCCcc-ccCCCHHHHHHHH---HHcC-ChhhcCCCCCHHHHhcC
Confidence 11111110000 000100 1123345555555 9999 99998 589988653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=348.64 Aligned_cols=250 Identities=18% Similarity=0.256 Sum_probs=192.2
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEecccc---ccHHHHHHHHHHHhccC--CCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACK---LSEKQFRSEMNRLGQLR--HPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lv~ 369 (604)
+.|...+.||+|+||.||++...+++.||||++.... ...+.+.+|++++++++ ||||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4588899999999999999998789999999986533 23467899999999996 599999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
| +.+++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||+++.
T Consensus 136 E-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 203 (390)
T ss_dssp E-CCSEEHHHHHHHC-------SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred e-cCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence 9 5688999999865 35889999999999999999999 88999999999999996 57899999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCC-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHH
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSST-----------MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLV 518 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~ 518 (604)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..
T Consensus 204 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~ 274 (390)
T 2zmd_A 204 MQPDTTS--VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QI 274 (390)
T ss_dssp C-----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HH
T ss_pred ccCCCcc--ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-------HH
Confidence 6433211 11223459999999998754 4688999999999999999999999964321 11
Q ss_pred HHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 519 DWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 519 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
............... ....+++ +.+++.+||+.||++|||+.|+++.
T Consensus 275 ~~~~~~~~~~~~~~~------~~~~~~~---~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 275 SKLHAIIDPNHEIEF------PDIPEKD---LQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHHHHCTTSCCCC------CCCSCHH---HHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhCccccCCC------CccchHH---HHHHHHHHcccChhhCCCHHHHhhC
Confidence 112222111111110 1122334 4455559999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=330.48 Aligned_cols=257 Identities=21% Similarity=0.291 Sum_probs=200.2
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCC----CCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPD----ASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~----~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
.++|...+.||+|+||.||+|...+ +..||||.++... ...+.+.+|++++++++||||+++++++.. +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4578888999999999999998432 3369999997542 334679999999999999999999999764 45789
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 90 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK------NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLS 160 (281)
T ss_dssp EEECCTTCBHHHHHHHHT------TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred EEecCCCCCHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCC
Confidence 999999999999997542 34889999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
+......... .....++..|+|||+..+..++.++||||||+++|||+| |+.||......+ .. ....
T Consensus 161 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-----~~----~~~~ 228 (281)
T 3cc6_A 161 RYIEDEDYYK---ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-----VI----GVLE 228 (281)
T ss_dssp GCC------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-----HH----HHHH
T ss_pred cccccccccc---cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-----HH----HHHh
Confidence 8764432111 112346789999999988889999999999999999999 999997533221 11 1122
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
.+..... ....++. +.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 229 ~~~~~~~------~~~~~~~---l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 229 KGDRLPK------PDLCPPV---LYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HTCCCCC------CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCC------CCCCCHH---HHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 2211111 1112333 44555599999999999999999999988653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=342.02 Aligned_cols=241 Identities=17% Similarity=0.240 Sum_probs=197.4
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc---------cHHHHHHHHHHHhccCCCCccceeeEEEeCC
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL---------SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE 363 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~---------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 363 (604)
.++|...+.||+|+||.||+|. ..+++.||||+++.... ..+.+.+|++++++++||||+++++++...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 4678999999999999999998 56789999999975431 2235778999999999999999999999999
Q ss_pred eeeEEeeecCCC-chhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEc
Q 007423 364 ERLLVYKHMPNG-TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARIT 442 (604)
Q Consensus 364 ~~~lv~ey~~~g-sL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~ 442 (604)
..++||||+..| +|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH-------PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred EEEEEEEeCCCCccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEe
Confidence 999999999887 999999765 35899999999999999999999 7899999999999999999999999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHH
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA-SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWV 521 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 521 (604)
|||+++........ ....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 173 Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------- 236 (335)
T 3dls_A 173 DFGSAAYLERGKLF-----YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------- 236 (335)
T ss_dssp CCTTCEECCTTCCB-----CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------
T ss_pred ecccceECCCCCce-----eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------
Confidence 99999876543221 12348999999999888776 88999999999999999999999642110
Q ss_pred HHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 522 NHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 522 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
......+ ....++++. +++.+||+.||++|||+.|+++.
T Consensus 237 --------~~~~~~~---~~~~~~~l~---~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 --------VEAAIHP---PYLVSKELM---SLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --------TTTCCCC---SSCCCHHHH---HHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --------HhhccCC---CcccCHHHH---HHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 111234444 45559999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=344.43 Aligned_cols=252 Identities=17% Similarity=0.239 Sum_probs=188.9
Q ss_pred cCCCcC-cEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHh-ccCCCCccceeeEEEe----CCeeeE
Q 007423 295 NSFAVE-NIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLG-QLRHPNLVPLLGFCVV----EEERLL 367 (604)
Q Consensus 295 ~~~~~~-~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~----~~~~~l 367 (604)
++|... ++||+|+||.||++. ..+++.||||+++.. ..+.+|++++. ..+||||+++++++.. .+..++
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 455554 689999999999998 457899999999642 45778888874 4589999999999876 567899
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC---CCCeEEccc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD---DFDARITDF 444 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~---~~~~kl~DF 444 (604)
||||+++|+|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+||
T Consensus 137 v~E~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGD-----QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEECCCSEEHHHHHHCC--------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEeCCCCcHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEec
Confidence 9999999999999986532 35899999999999999999999 789999999999999997 789999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.......... ... ..
T Consensus 209 G~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~----~~ 278 (400)
T 1nxk_A 209 GFAKETTSHNS-----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GMK----TR 278 (400)
T ss_dssp TTCEECC----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC-SHH----HH
T ss_pred ccccccCCCCc-----cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH-HHH----HH
Confidence 99987643221 123358999999999999999999999999999999999999997543322111 111 11
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
+..+... ...+. ....++++ .+++.+||+.||++|||+.|+++.
T Consensus 279 i~~~~~~-~~~~~--~~~~s~~~---~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 279 IRMGQYE-FPNPE--WSEVSEEV---KMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HHHTCCC-CCTTT--TTTSCHHH---HHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHcCccc-CCCcc--cccCCHHH---HHHHHHHCCCChhHCcCHHHHhcC
Confidence 1222211 01110 01123344 445559999999999999999874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=344.83 Aligned_cols=251 Identities=18% Similarity=0.256 Sum_probs=191.8
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccc---cHHHHHHHHHHHhccCC--CCccceeeEEEeCCeeeEE
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKL---SEKQFRSEMNRLGQLRH--PNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lv 368 (604)
.+.|...+.||+|+||.||++...+++.||||++..... ..+.+.+|++++++++| |||+++++++..++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 356888899999999999999988899999999865432 23678999999999987 9999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|| +.+|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||+++
T Consensus 88 ~e-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 155 (343)
T ss_dssp EC-CCSEEHHHHHHHS-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred Ee-CCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeeccccc
Confidence 99 5688999999865 35889999999999999999999 78999999999999997 5689999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCC-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcH
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSST-----------MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNL 517 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~ 517 (604)
........ .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... .
T Consensus 156 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~ 226 (343)
T 3dbq_A 156 QMQPDTTS--VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------Q 226 (343)
T ss_dssp CC--------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-------H
T ss_pred ccCccccc--ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-------H
Confidence 76433221 11123458999999998754 6789999999999999999999999964211 1
Q ss_pred HHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 518 VDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 518 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
................ ....+.+ +.+++.+||+.||++|||+.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~------~~~~~~~---l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 227 ISKLHAIIDPNHEIEF------PDIPEKD---LQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHHHHHHCTTSCCCC------CCCSCHH---HHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHhcCCcccCC------cccCCHH---HHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111111111111110 1122233 4455559999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=326.20 Aligned_cols=249 Identities=20% Similarity=0.251 Sum_probs=198.6
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccc-cccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSAC-KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
.+.|...+.||+|+||.||+|.. .++..||+|++... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 35688899999999999999994 55789999998653 34457899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe---CCCCCeEEcccCCcc
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI---DDDFDARITDFGLAR 448 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl---~~~~~~kl~DFGla~ 448 (604)
+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||++.
T Consensus 88 ~~~~~L~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 88 CTGGELFERVVHK-------RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp CCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred cCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 9999999998754 35899999999999999999999 7899999999999999 788999999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
....... .....||+.|+|||++.+. ++.++||||||+++|||+||+.||...... +.. .....+
T Consensus 158 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~-~~~~~~ 222 (277)
T 3f3z_A 158 RFKPGKM-----MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS--------EVM-LKIREG 222 (277)
T ss_dssp ECCTTSC-----BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHH-HHHHHC
T ss_pred eccCccc-----hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH--------HHH-HHHHhC
Confidence 7643322 1223589999999988654 899999999999999999999999753221 111 112222
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.... ..... ...++ .+.+++.+||+.||++|||+.|+++
T Consensus 223 ~~~~-~~~~~--~~~~~---~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 223 TFTF-PEKDW--LNVSP---QAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CCCC-CHHHH--TTSCH---HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCC-Cchhh--hcCCH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence 2111 00000 01123 3445555999999999999999976
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=337.91 Aligned_cols=275 Identities=19% Similarity=0.285 Sum_probs=211.8
Q ss_pred HHHHHHhhcCCCcCcEEEecCCeEEEEEEe------CCCCEEEEEEeccccc--cHHHHHHHHHHHhcc-CCCCccceee
Q 007423 287 LADLLAATNSFAVENIIISTRTGVSYKAVL------PDASALAIKRLSACKL--SEKQFRSEMNRLGQL-RHPNLVPLLG 357 (604)
Q Consensus 287 ~~~l~~~~~~~~~~~~ig~G~~g~vy~~~~------~~~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g 357 (604)
..+.....++|...+.||+|+||.||+|.. .+++.||||+++.... ..+.+.+|+++++++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 344444567899999999999999999973 3568899999975432 335789999999999 7999999999
Q ss_pred EEEeCC-eeeEEeeecCCCchhhhhccCCCCCC---------CCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCC
Q 007423 358 FCVVEE-ERLLVYKHMPNGTLYSLLHGNGVDNT---------LSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYIS 427 (604)
Q Consensus 358 ~~~~~~-~~~lv~ey~~~gsL~~~l~~~~~~~~---------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk 427 (604)
++...+ ..++||||+++|+|.+++........ ....+++..+..++.|++.||.||| +.+|+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCc
Confidence 988754 58999999999999999986532100 0123789999999999999999999 7899999999
Q ss_pred CCeEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 007423 428 SNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDV 506 (604)
Q Consensus 428 ~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~ 506 (604)
|+||+++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cceEEECCCCCEEECCCccccccccCccc--eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999999999999999876432211 11222347889999999988889999999999999999999 9999975
Q ss_pred CCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcC
Q 007423 507 AGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHG 583 (604)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~ 583 (604)
....+ .+......+...... ...+. .+.+++.+||+.||++|||+.|+++.|+.+.+...
T Consensus 254 ~~~~~--------~~~~~~~~~~~~~~~------~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 254 VKIDE--------EFCRRLKEGTRMRAP------DYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CCCSH--------HHHHHHHHTCCCCCC------TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cchhH--------HHHHHhccCccCCCC------CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 33211 112222222211111 11223 34555569999999999999999999999987643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=366.91 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=197.6
Q ss_pred cEEEecCCeEEEEEEe---CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 301 NIIISTRTGVSYKAVL---PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~---~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
+.||+|+||.||+|.+ ..++.||||+++... ...+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999964 346789999997543 235789999999999999999999999964 557899999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 454 g~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 454 GPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred CCHHHHHhhC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 9999999754 35899999999999999999999 7899999999999999999999999999999875433
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
.... ......+|..|+|||++.+..++.++|||||||++|||+| |+.||...... .+...+..+.....
T Consensus 524 ~~~~-~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---------~~~~~i~~~~~~~~ 593 (635)
T 4fl3_A 524 NYYK-AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---------EVTAMLEKGERMGC 593 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---------HHHHHHHTTCCCCC
T ss_pred cccc-cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---------HHHHHHHcCCCCCC
Confidence 2111 1122346789999999998899999999999999999999 99999754321 12233333332211
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
. ...+ ..+.+++.+||+.||++||++.+|++.|+.+..+
T Consensus 594 p------~~~~---~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 594 P------AGCP---REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp C------TTCC---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred C------CCCC---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1 1122 3455566699999999999999999999987654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=338.64 Aligned_cols=250 Identities=19% Similarity=0.246 Sum_probs=177.6
Q ss_pred CcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeeEEeeecCCCch
Q 007423 300 ENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEERLLVYKHMPNGTL 377 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lv~ey~~~gsL 377 (604)
.+.||+|+||.||+|.. .+++.||||++... ....+.+|++++++++ ||||+++++++.++...++||||+++|+|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 47899999999999995 56899999999643 3567889999999997 99999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC---CeEEcccCCccccCCCC
Q 007423 378 YSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF---DARITDFGLARLVGSRD 454 (604)
Q Consensus 378 ~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~---~~kl~DFGla~~~~~~~ 454 (604)
.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+||+|||+++......
T Consensus 94 ~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 94 FERIKKK-------KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp HHHHHHC-------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred HHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 9999765 35899999999999999999999 78999999999999997655 79999999998764332
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
.. .....||..|+|||++.+..++.++|||||||++|||+||+.||........ .....+ +...+..+.... .
T Consensus 164 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~-~~~~i~~~~~~~-~ 236 (325)
T 3kn6_A 164 QP----LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-CTSAVE-IMKKIKKGDFSF-E 236 (325)
T ss_dssp ------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHH-HHHHHTTTCCCC-C
T ss_pred Cc----ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-cccHHH-HHHHHHcCCCCC-C
Confidence 21 1223479999999999999999999999999999999999999975432211 111122 222222222110 0
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.+.. ...++ .+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~--~~~s~---~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 237 GEAW--KNVSQ---EAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp SHHH--HTSCH---HHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccc--cCCCH---HHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0000 01123 4455556999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=327.95 Aligned_cols=251 Identities=21% Similarity=0.265 Sum_probs=193.1
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+.|...+.||+|+||.||++.. .++..||+|++.... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 4688889999999999999984 578999999986543 3457899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe---CCCCCeEEcccCCcc
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI---DDDFDARITDFGLAR 448 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl---~~~~~~kl~DFGla~ 448 (604)
+++|+|.+++...... ...+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||+++
T Consensus 102 ~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 102 CEGGELLERIVSAQAR---GKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp CSCCBHHHHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred CCCCcHHHHHHhhhhc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999988643111 135899999999999999999999 7899999999999999 456789999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
........ ....||..|+|||++. ..++.++||||||+++|||++|+.||...... +.........
T Consensus 176 ~~~~~~~~-----~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--------~~~~~~~~~~ 241 (285)
T 3is5_A 176 LFKSDEHS-----TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--------EVQQKATYKE 241 (285)
T ss_dssp C---------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCC
T ss_pred ecCCcccC-----cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--------HHHhhhccCC
Confidence 76432211 1234899999999875 46899999999999999999999999753221 1111111111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
...... ....+++ +.+++.+||+.||++|||+.|+++
T Consensus 242 -~~~~~~----~~~~~~~---~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 242 -PNYAVE----CRPLTPQ---AVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -CCCCC------CCCCHH---HHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -cccccc----cCcCCHH---HHHHHHHHccCChhhCcCHHHHhc
Confidence 111000 0112233 445555999999999999999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=344.02 Aligned_cols=268 Identities=21% Similarity=0.293 Sum_probs=207.2
Q ss_pred hhcCCCcCcEEEecCCeEEEEEEeC-CC-----CEEEEEEecccc--ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCC
Q 007423 293 ATNSFAVENIIISTRTGVSYKAVLP-DA-----SALAIKRLSACK--LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEE 363 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~-----~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 363 (604)
..++|...+.||+|+||.||+|... .+ ..||||.++... ...+.+.+|+++++++ +||||+++++++..++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 3467888999999999999999843 23 479999997543 2346789999999999 8999999999999999
Q ss_pred eeeEEeeecCCCchhhhhccCCCCC-------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDN-------TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD 436 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~-------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~ 436 (604)
..++||||+++|+|.+++....... .....+++..++.++.|++.||.||| +.+|+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCC
Confidence 9999999999999999987532100 00135789999999999999999999 7899999999999999999
Q ss_pred CCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccC
Q 007423 437 FDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKG 515 (604)
Q Consensus 437 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~ 515 (604)
+.+||+|||+++........ .......+|..|+|||++.+..++.++|||||||++|||+| |+.||.......
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---- 274 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS---- 274 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTS--EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH----
T ss_pred CeEEECccccccccccccce--eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH----
Confidence 99999999999866432211 11122346789999999888889999999999999999999 999997532211
Q ss_pred cHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 516 NLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
........+.... .+ ...++ .+.+++.+||+.||++|||+.||++.|+++.++.
T Consensus 275 ----~~~~~~~~~~~~~--~~----~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 275 ----KFYKLVKDGYQMA--QP----AFAPK---NIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp ----HHHHHHHHTCCCC--CC----TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----HHHHHHhcCCCCC--CC----CCCCH---HHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 1122222221111 01 11223 4455556999999999999999999999987653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=329.87 Aligned_cols=250 Identities=20% Similarity=0.264 Sum_probs=201.1
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEe-----------
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVV----------- 361 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----------- 361 (604)
..+|...+.||+|+||.||+|... +++.||||+++... +.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 356888999999999999999954 79999999997543 457789999999999999999999864
Q ss_pred -----CCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC
Q 007423 362 -----EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD 436 (604)
Q Consensus 362 -----~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~ 436 (604)
....++||||+++|+|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-----EKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEET
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCC
Confidence 3457999999999999999975421 35899999999999999999999 7899999999999999999
Q ss_pred CCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCc
Q 007423 437 FDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGN 516 (604)
Q Consensus 437 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~ 516 (604)
+.+||+|||+++........ ....|++.|+|||++.+..++.++||||||+++|||+||..|+...
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------- 224 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGKR-----TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------- 224 (284)
T ss_dssp TEEEECCCTTCEESSCCSCC-----CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------
T ss_pred CCEEECcchhheeccccccc-----cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------
Confidence 99999999999877543221 1234899999999998888999999999999999999999887421
Q ss_pred HHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 517 LVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
..+.. ....+... ...+.++. +++.+||+.||++|||+.|+++.|+.+.+..
T Consensus 225 -~~~~~-~~~~~~~~---------~~~~~~~~---~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 225 -SKFFT-DLRDGIIS---------DIFDKKEK---TLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp -HHHHH-HHHTTCCC---------TTSCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred -HHHHH-Hhhccccc---------ccCCHHHH---HHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 11111 11222211 11223344 4555999999999999999999999887654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=330.68 Aligned_cols=258 Identities=19% Similarity=0.211 Sum_probs=193.9
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc------ccHHHHHHHHHHHhccC---CCCccceeeEEEeCC
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK------LSEKQFRSEMNRLGQLR---HPNLVPLLGFCVVEE 363 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~------~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~ 363 (604)
+++|...+.||+|+||.||+|. ..+++.||||+++... .....+.+|++++++++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 5689999999999999999999 4678999999986322 12346778888877764 999999999998755
Q ss_pred -----eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC
Q 007423 364 -----ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD 438 (604)
Q Consensus 364 -----~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~ 438 (604)
..+++|||+. |+|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPP-----PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCT-----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSC
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCC
Confidence 5789999997 599999986532 24899999999999999999999 788999999999999999999
Q ss_pred eEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHH
Q 007423 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLV 518 (604)
Q Consensus 439 ~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~ 518 (604)
+||+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||+||+.||......+ ..
T Consensus 159 ~kl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~ 228 (308)
T 3g33_A 159 VKLADFGLARIYSYQMAL-----TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-----QL 228 (308)
T ss_dssp EEECSCSCTTTSTTCCCS-----GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-----HH
T ss_pred EEEeeCccccccCCCccc-----CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HH
Confidence 999999999876432221 22358999999999988889999999999999999999999997543221 11
Q ss_pred HHHHHHHHcCCcccc------cccccc----------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 519 DWVNHLVIAGRSRDV------VDKSLY----------GRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 519 ~~~~~~~~~~~~~~~------~d~~l~----------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
..+............ .+.... ....++ .+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEE---SGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCH---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccH---HHHHHHHHHhcCCCccCCCHHHHhc
Confidence 111111100000000 000000 011223 4455556999999999999999976
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=341.65 Aligned_cols=249 Identities=19% Similarity=0.217 Sum_probs=191.0
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc----cHHHHHHHHHH-HhccCCCCccceeeEEEeCCeeeE
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL----SEKQFRSEMNR-LGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
.++|...+.||+|+||.||+++. .+++.||||+++.... ..+.+.+|..+ ++.++||||+++++++...+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 35788999999999999999995 5688999999975432 23456777776 577899999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 117 v~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a 186 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE-------RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLC 186 (373)
T ss_dssp EEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBC
T ss_pred EEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccc
Confidence 99999999999999754 35888999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
+......... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+...... .
T Consensus 187 ~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~-~ 253 (373)
T 2r5t_A 187 KENIEHNSTT----STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNIL-N 253 (373)
T ss_dssp GGGBCCCCCC----CSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--------HHHHHHHH-H
T ss_pred cccccCCCcc----ccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHH-h
Confidence 8643322221 233589999999999999999999999999999999999999975322 11122222 1
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESL 575 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 575 (604)
+... + ....+.++.++++ +||+.||++||++.+.++.+
T Consensus 254 ~~~~--~-----~~~~~~~~~~li~---~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 254 KPLQ--L-----KPNITNSARHLLE---GLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp SCCC--C-----CSSSCHHHHHHHH---HHTCSSGGGSTTTTTTHHHH
T ss_pred cccC--C-----CCCCCHHHHHHHH---HHcccCHHhCCCCCCCHHHH
Confidence 2111 1 1122344555544 99999999999986444433
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=330.27 Aligned_cols=265 Identities=20% Similarity=0.203 Sum_probs=194.5
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccccc---HHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLS---EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
++|...+.||+|+||.||+|.. .+++.||||++...... .+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 4688889999999999999995 56999999998654322 3568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 83 ~~~~~~l~~~~~~~-------~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 83 YCDHTVLHELDRYQ-------RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLL 152 (311)
T ss_dssp CCSEEHHHHHHHTS-------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eCCCchHHHHHhhh-------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence 99999999988654 35899999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccC-------cHHHHHH
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKG-------NLVDWVN 522 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~-------~~~~~~~ 522 (604)
...... .....||..|+|||++.+ ..++.++||||||+++|||+||+.||......+.... ....+.
T Consensus 153 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 227 (311)
T 4agu_A 153 TGPSDY----YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ- 227 (311)
T ss_dssp C----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH-
T ss_pred cCcccc----cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccc-
Confidence 432221 122358999999998865 6689999999999999999999999976433211000 000000
Q ss_pred HHHHcCC-cc--ccccccccCC---CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 523 HLVIAGR-SR--DVVDKSLYGR---GNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 523 ~~~~~~~-~~--~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
....... .. ...++..... ..+.....+.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000 00 0000000000 000112235566669999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=333.37 Aligned_cols=253 Identities=26% Similarity=0.365 Sum_probs=196.5
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeC-CeeeEEeeec
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE-EERLLVYKHM 372 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lv~ey~ 372 (604)
.++|...+.||+|+||.||++.. .++.||||.++... ..+.+.+|++++++++||||+++++++... +..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 35788889999999999999987 48899999997543 456799999999999999999999997654 4689999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++|+|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 98 ~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 98 AKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp TTEEHHHHHHHHHH-----HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred CCCCHHHHHHhccc-----ccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 99999999975421 23789999999999999999999 78999999999999999999999999999986533
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
... ...++..|+|||...+..++.++||||||+++|||+| |+.||......+ .. ..+..+...
T Consensus 170 ~~~-------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-----~~----~~~~~~~~~ 233 (278)
T 1byg_A 170 TQD-------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VV----PRVEKGYKM 233 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-----HH----HHHTTTCCC
T ss_pred ccc-------CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----HH----HHHhcCCCC
Confidence 211 1236789999999988889999999999999999999 999997543211 11 112222111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
. . ....+++ +.+++.+||+.||++|||+.|+++.|+++...
T Consensus 234 ~-----~-~~~~~~~---l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 234 D-----A-PDGCPPA---VYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp C-----C-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C-----C-cccCCHH---HHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 1 1 1122334 44555599999999999999999999998764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=339.97 Aligned_cols=264 Identities=19% Similarity=0.256 Sum_probs=187.8
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccC-CCCccceeeEEEe--------C
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLR-HPNLVPLLGFCVV--------E 362 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--------~ 362 (604)
..+|...+.||+|+||.||+|. ..+++.||||++.... ...+.+.+|+.+++++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 3468888999999999999999 4578999999985433 33467899999999996 9999999999953 3
Q ss_pred CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCC--ceecCCCCCeEEeCCCCCeE
Q 007423 363 EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPP--YMHQYISSNVILIDDDFDAR 440 (604)
Q Consensus 363 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--iiH~dlk~~NiLl~~~~~~k 440 (604)
...+++|||+. |+|.+++...... ..+++..+..++.|++.||.||| +.+ |+||||||+|||++.++.+|
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESR----GPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTT----CSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred ceEEEEEEecC-CCHHHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEE
Confidence 45789999996 7999988652111 35899999999999999999999 666 99999999999999999999
Q ss_pred EcccCCccccCCCCCCCC--------ccccCCCCcccccCcccc---CCCCCCcccchhhHHHHHHHHHhCCCCCCCCCc
Q 007423 441 ITDFGLARLVGSRDPNDS--------SFVHGDLGEFGYVAPEYS---STMVASLKGDVYGFGIVLLELLSGQKPLDVAGA 509 (604)
Q Consensus 441 l~DFGla~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~---~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~ 509 (604)
|+|||+++.......... .......||+.|+|||++ .+..++.++|||||||++|||+||+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 999999987654322110 001123489999999988 566789999999999999999999999964321
Q ss_pred cccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCCC
Q 007423 510 EEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSE 586 (604)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~ 586 (604)
.. . ..+...... ....+.. +.+++.+||+.||++|||+.|+++.|+.+.+......
T Consensus 259 ~~--------~-----~~~~~~~~~-----~~~~~~~---~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~ 314 (337)
T 3ll6_A 259 LR--------I-----VNGKYSIPP-----HDTQYTV---FHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314 (337)
T ss_dssp --------------------CCCCT-----TCCSSGG---GHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCT
T ss_pred HH--------h-----hcCcccCCc-----ccccchH---HHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCC
Confidence 11 0 001111000 0111223 4455559999999999999999999999988765443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=337.40 Aligned_cols=266 Identities=20% Similarity=0.316 Sum_probs=204.2
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe------CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL------PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER 365 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~------~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 365 (604)
.++|...+.||+|+||.||+|.. .++..||||++.... ....++.+|+.++++++||||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 35788899999999999999984 357789999996432 3346789999999999999999999999999999
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC---CCCCeEEc
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID---DDFDARIT 442 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~---~~~~~kl~ 442 (604)
++||||+++|+|.+++............+++..++.++.|++.||.||| +.+|+||||||+|||++ ++..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999999999999876433233345899999999999999999999 78999999999999998 44569999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHH
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWV 521 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 521 (604)
|||+++.......... .....|++.|+|||++.+..++.++||||||+++|||+| |+.||..... .+..
T Consensus 186 Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~ 255 (327)
T 2yfx_A 186 DFGMARDIYRASYYRK--GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVL 255 (327)
T ss_dssp CCHHHHHHHC--------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHH
T ss_pred cccccccccccccccc--CCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--------HHHH
Confidence 9999986543221111 112247889999999988889999999999999999999 9999965322 1111
Q ss_pred HHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 522 NHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 522 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
..+..+..... ....++ .+.+++.+||+.||++||++.|+++.|+.+....
T Consensus 256 -~~~~~~~~~~~------~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 256 -EFVTSGGRMDP------PKNCPG---PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp -HHHHTTCCCCC------CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred -HHHhcCCCCCC------CCCCCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 22222221111 111223 3445556999999999999999999999887644
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=338.96 Aligned_cols=269 Identities=20% Similarity=0.298 Sum_probs=205.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-----CCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCC--eee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-----PDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE--ERL 366 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-----~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~ 366 (604)
++|...+.||+|+||.||++.. .+++.||||++.... ...+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4678889999999999999983 468899999997643 33467999999999999999999999987644 679
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
+||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 121 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp EEECCCTTCBHHHHHHHST------TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred EEEECCCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 9999999999999997653 34899999999999999999999 78999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCcc-------ccccCcHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAE-------EGFKGNLVD 519 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~-------~~~~~~~~~ 519 (604)
++......... .......++..|+|||.+.+..++.++||||||+++|||+||+.|+...... .........
T Consensus 192 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 192 TKVLPQDKEYY-KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp CEECCSSCSEE-ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred hhhcccccccc-ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 98775432111 1111224678899999998888999999999999999999999998532100 000000111
Q ss_pred HHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 520 WVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 520 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
.+...+..+..... ....++ .+.+++.+||+.||++|||+.||++.|+++.++.
T Consensus 271 ~~~~~~~~~~~~~~------~~~~~~---~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 271 HLIELLKNNGRLPR------PDGCPD---EIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHTTCCCCC------CTTCCH---HHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCCC------CCcccH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 11122222211111 111223 4455556999999999999999999999998764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.73 Aligned_cols=268 Identities=22% Similarity=0.331 Sum_probs=207.9
Q ss_pred HHHhhcCCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEe
Q 007423 290 LLAATNSFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV 361 (604)
Q Consensus 290 l~~~~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 361 (604)
.....++|...+.||+|+||.||+|... +++.||||.+.... ....++.+|++++++++||||+++++++..
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 3345678899999999999999999853 47789999997543 233568999999999999999999999999
Q ss_pred CCeeeEEeeecCCCchhhhhccCCCC---CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC
Q 007423 362 EEERLLVYKHMPNGTLYSLLHGNGVD---NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD 438 (604)
Q Consensus 362 ~~~~~lv~ey~~~gsL~~~l~~~~~~---~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~ 438 (604)
.+..++||||+++|+|.+++...... ......+++..++.++.|++.||.||| +.+|+||||||+||+++.++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCe
Confidence 99999999999999999998753110 000134789999999999999999999 789999999999999999999
Q ss_pred eEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcH
Q 007423 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNL 517 (604)
Q Consensus 439 ~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~ 517 (604)
+||+|||+++........ .......+|+.|+|||++.+..++.++||||||+++|||+| |+.||.....
T Consensus 177 ~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------- 246 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------- 246 (322)
T ss_dssp EEECCTTCCCGGGGGGCE--EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------
T ss_pred EEECcCcccccccccccc--ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH--------
Confidence 999999999866432111 11122346889999999988889999999999999999999 8999965322
Q ss_pred HHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 518 VDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 518 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
.+.. ..+..+...... ...++. +.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 247 ~~~~-~~~~~~~~~~~~------~~~~~~---l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 247 EQVL-RFVMEGGLLDKP------DNCPDM---LFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHH-HHHHTTCCCCCC------TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHH-HHHHcCCcCCCC------CCCCHH---HHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1111 222222221111 122333 4455559999999999999999999988755
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=339.43 Aligned_cols=252 Identities=17% Similarity=0.233 Sum_probs=196.5
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEeee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
.++|...+.||+|+||.||++.. .+++.||||+++.... .+.+|++++.++ +||||+++++++.+++..++||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 45788899999999999999994 5689999999975432 245688888888 799999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC----CCeEEcccCCc
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD----FDARITDFGLA 447 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~----~~~kl~DFGla 447 (604)
+++|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+|||+.++ +.+||+|||++
T Consensus 98 ~~gg~L~~~i~~~-------~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 98 MKGGELLDKILRQ-------KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp CCSCBHHHHHHTC-------TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred CCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 9999999999765 35899999999999999999999 7899999999999998533 35999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
+........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.. ..+..
T Consensus 168 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~~~-~~i~~ 237 (342)
T 2qr7_A 168 KQLRAENGL----LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD-----TPEEIL-ARIGS 237 (342)
T ss_dssp EECBCTTCC----BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS-----CHHHHH-HHHHH
T ss_pred ccCcCCCCc----eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC-----CHHHHH-HHHcc
Confidence 876543221 12335899999999998878899999999999999999999999753211 122222 22223
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
+..... . .. ....++++.++ +.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~-~-~~-~~~~s~~~~~l---i~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 238 GKFSLS-G-GY-WNSVSDTAKDL---VSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp CCCCCC-S-TT-TTTSCHHHHHH---HHHHTCSSTTTSCCHHHHTTS
T ss_pred CCcccC-c-cc-cccCCHHHHHH---HHHHCCCChhHCcCHHHHhcC
Confidence 322110 0 00 01223444544 449999999999999999763
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=326.34 Aligned_cols=256 Identities=20% Similarity=0.307 Sum_probs=200.8
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEecccc-------ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACK-------LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 366 (604)
++|...+.||+|+||.||++... +++.||||.++... ...+.+.+|++++++++||||+++++++..++..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888899999999999999954 78999999986432 13578999999999999999999999999999999
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC----CeEEc
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF----DARIT 442 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~----~~kl~ 442 (604)
+||||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .+||+
T Consensus 85 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~ 154 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-------ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLI 154 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEeecCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEE
Confidence 999999999999999754 35899999999999999999999 78999999999999999876 89999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHH
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVN 522 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 522 (604)
|||+++........ ....|++.|+|||++.+..++.++||||||+++|||+||+.||...... +...
T Consensus 155 dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~ 221 (283)
T 3bhy_A 155 DFGIAHKIEAGNEF-----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--------ETLT 221 (283)
T ss_dssp CCTTCEECC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHH
T ss_pred ecccceeccCCCcc-----cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--------HHHH
Confidence 99999876432211 2234899999999999888999999999999999999999999753221 1111
Q ss_pred HHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhchH
Q 007423 523 HLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE--SLKSMAE 580 (604)
Q Consensus 523 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~i~~ 580 (604)
. ....... .++... ...++. +.+++.+||+.||++|||+.|+++ .++.+..
T Consensus 222 ~-~~~~~~~--~~~~~~-~~~~~~---~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 222 N-ISAVNYD--FDEEYF-SNTSEL---AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp H-HHTTCCC--CCHHHH-TTCCHH---HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred H-hHhcccC--Ccchhc-ccCCHH---HHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 1 1111110 011111 112233 445555999999999999999987 3555544
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=343.34 Aligned_cols=250 Identities=20% Similarity=0.309 Sum_probs=188.7
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc---------cHHHHHHHHHHHhccCCCCccceeeEEEeCC
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL---------SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE 363 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~---------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 363 (604)
.++|...+.||+|+||.||+|. ..+++.||||++..... ....+.+|++++++++||||+++++++. .+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 5689999999999999999998 56689999999865321 1124789999999999999999999975 45
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC---CCeE
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD---FDAR 440 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~---~~~k 440 (604)
..++||||+++|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+|||++.+ ..+|
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN-------KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred ceEEEEEcCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEE
Confidence 679999999999999998754 35899999999999999999999 7899999999999999754 4599
Q ss_pred EcccCCccccCCCCCCCCccccCCCCcccccCccccCC---CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcH
Q 007423 441 ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST---MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNL 517 (604)
Q Consensus 441 l~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~ 517 (604)
|+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .+
T Consensus 283 l~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~----~~ 353 (419)
T 3i6u_A 283 ITDFGHSKILGETSL-----MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SL 353 (419)
T ss_dssp ECCSSTTTSCC----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC----CH
T ss_pred EeecccceecCCCcc-----ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH----HH
Confidence 999999987643221 123358999999998753 567889999999999999999999997533221 11
Q ss_pred HHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 518 VDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 518 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
. .....+..... +... ...++ .+.+++.+||+.||++|||+.|+++
T Consensus 354 ~----~~i~~~~~~~~--~~~~-~~~~~---~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 354 K----DQITSGKYNFI--PEVW-AEVSE---KALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp H----HHHHTTCCCCC--HHHH-TTSCH---HHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H----HHHhcCCCCCC--chhh-cccCH---HHHHHHHHHccCChhHCcCHHHHhC
Confidence 1 12222221111 0000 11123 4455566999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=323.45 Aligned_cols=245 Identities=22% Similarity=0.286 Sum_probs=192.6
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEe----CCeeeE
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV----EEERLL 367 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~l 367 (604)
.|...+.||+|+||.||+|. ..++..||+|.+.... ...+.+.+|++++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 36677889999999999998 4568899999986543 234568999999999999999999999875 356899
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCC--ceecCCCCCeEEeC-CCCCeEEccc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPP--YMHQYISSNVILID-DDFDARITDF 444 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--iiH~dlk~~NiLl~-~~~~~kl~DF 444 (604)
||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+ |+||||||+|||++ +++.+||+||
T Consensus 107 v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Df 176 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp EEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred EEEecCCCCHHHHHHHc-------cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence 99999999999999754 35889999999999999999999 666 99999999999998 7899999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
|++....... .....||+.|+|||++.+ .++.++|||||||++|||+||+.||..... ..... ..
T Consensus 177 g~~~~~~~~~------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~-~~ 241 (290)
T 1t4h_A 177 GLATLKRASF------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIY-RR 241 (290)
T ss_dssp TGGGGCCTTS------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHH-HH
T ss_pred CCcccccccc------cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc-------HHHHH-HH
Confidence 9997653321 122358999999998764 589999999999999999999999965322 11111 22
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
...+......+ ...+++ +.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~-----~~~~~~---l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 242 VTSGVKPASFD-----KVAIPE---VKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HTTTCCCGGGG-----GCCCHH---HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhccCCccccC-----CCCCHH---HHHHHHHHccCChhhCCCHHHHhh
Confidence 22222211111 112233 455555999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=325.34 Aligned_cols=252 Identities=21% Similarity=0.270 Sum_probs=198.7
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
.++|...+.||+|+||.||+|.. .+++.||||.+.... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 35688899999999999999995 478999999986433 334678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 86 ~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 86 YCSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp CCTTEEGGGGSBTT-------TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred ecCCCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 99999999999754 35899999999999999999999 789999999999999999999999999999865
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA-SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
...... .......|+..|+|||+..+..+ +.++||||||+++|||+||+.||....... .....|. ....
T Consensus 156 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~----~~~~ 226 (276)
T 2yex_A 156 RYNNRE--RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDWK----EKKT 226 (276)
T ss_dssp EETTEE--CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS---HHHHHHH----TTCT
T ss_pred CCCcch--hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHhh----hccc
Confidence 432111 11123358999999999887665 789999999999999999999997543211 0111111 1111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.. .+ . ...++. +.+++.+||+.||++|||+.|+++
T Consensus 227 ~~---~~-~--~~~~~~---~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 YL---NP-W--KKIDSA---PLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TS---TT-G--GGSCHH---HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cc---Cc-h--hhcCHH---HHHHHHHHCCCCchhCCCHHHHhc
Confidence 00 00 0 012233 445555999999999999999876
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=334.55 Aligned_cols=200 Identities=18% Similarity=0.210 Sum_probs=165.0
Q ss_pred hhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccccc---HHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 293 ATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLS---EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
..++|...+.||+|+||.||+|. ..+++.||||+++..... .+.+.+|++++++++||||+++++++..++..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 44679999999999999999998 567899999999754322 34678999999999999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe-----CCCCCeEEcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI-----DDDFDARITD 443 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl-----~~~~~~kl~D 443 (604)
|||++ |+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||+ ++++.+||+|
T Consensus 112 ~e~~~-~~L~~~~~~~-------~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKN-------PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp EECCS-EEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred EecCC-CCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECc
Confidence 99998 5999999765 35889999999999999999999 7899999999999999 4555699999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
||+++........ .....||..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 181 fg~a~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 181 FGLARAFGIPIRQ----FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp TTHHHHHC---------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCccccCCcccc----cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 9999877433221 1223479999999988764 4899999999999999999999999754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=338.80 Aligned_cols=256 Identities=20% Similarity=0.298 Sum_probs=197.0
Q ss_pred HHHHhhcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhcc-CCCCccceeeEEEe-----
Q 007423 289 DLLAATNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVV----- 361 (604)
Q Consensus 289 ~l~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----- 361 (604)
++....+.|...+.||+|+||.||+|.. .+++.||||++.......+.+.+|+++++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 3445567899999999999999999994 6789999999976655667899999999999 89999999999987
Q ss_pred -CCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeE
Q 007423 362 -EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDAR 440 (604)
Q Consensus 362 -~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~k 440 (604)
.+..++||||+++|+|.+++..... ..+++.....++.|++.||.||| +.+|+||||||+||+++.++.+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKG-----NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGG-----GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEE
T ss_pred ccceEEEEEEcCCCCcHHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEE
Confidence 4678999999999999999976431 35889999999999999999999 78999999999999999999999
Q ss_pred EcccCCccccCCCCCCCCccccCCCCcccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccC
Q 007423 441 ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSS-----TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKG 515 (604)
Q Consensus 441 l~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~ 515 (604)
|+|||++.......... ....|+..|+|||++. ...++.++|||||||++|||+||+.||......
T Consensus 170 l~Dfg~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----- 240 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVGRR----NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----- 240 (326)
T ss_dssp ECCCTTTC-----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----
T ss_pred EeeCcCceecCcCcccc----ccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-----
Confidence 99999998764322111 1234899999999876 566899999999999999999999999653221
Q ss_pred cHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 516 NLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.-... ........ ......++.+.+ ++.+||+.||++||++.|+++
T Consensus 241 ---~~~~~-~~~~~~~~-----~~~~~~~~~l~~---li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 241 ---RALFL-IPRNPAPR-----LKSKKWSKKFQS---FIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ---HHHHH-HHHSCCCC-----CSCSCSCHHHHH---HHHHHCCSSGGGSCCHHHHHT
T ss_pred ---HHHHH-hhcCcccc-----CCccccCHHHHH---HHHHHhccChhhCCCHHHHhh
Confidence 11111 11111111 111223344444 445999999999999999977
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=333.99 Aligned_cols=258 Identities=17% Similarity=0.230 Sum_probs=190.9
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccH--HHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSE--KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~--~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
++|...+.||+|+||.||+|.. .+++.||||+++...... ..+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 4688889999999999999995 478999999997543222 2456899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
++ |+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG------NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKS 151 (324)
T ss_dssp CS-EEHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred cc-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence 97 59999987653 35889999999999999999999 7899999999999999999999999999998654
Q ss_pred CCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC-
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR- 529 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 529 (604)
..... .....||..|+|||++.+ ..++.++|||||||++|||+||+.||......+ ....+........
T Consensus 152 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~i~~~~~~~~~ 222 (324)
T 3mtl_A 152 IPTKT----YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-----QLHFIFRILGTPTE 222 (324)
T ss_dssp ---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCCCCT
T ss_pred CCccc----cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhCCCCh
Confidence 32211 122357999999998766 568999999999999999999999997643221 1111111111000
Q ss_pred --ccccccc---------cc-------cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 530 --SRDVVDK---------SL-------YGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 530 --~~~~~d~---------~l-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
....... .. .....++ .+.+++.+||+.||++|||+.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 223 ETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDS---DGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp TTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCH---HHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HhchhhhcchhhcccccccccchhhhhhcCCCCH---HHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000 00 0011123 34455669999999999999999873
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=323.81 Aligned_cols=245 Identities=21% Similarity=0.292 Sum_probs=199.2
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||+|.. .+++.||||.+.... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5688889999999999999995 467899999986432 22467899999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 94 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 94 EFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVH 163 (284)
T ss_dssp CCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEeccccccc
Confidence 999999999999754 35889999999999999999999 88999999999999999999999999999976
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
...... ....|+..|+|||++.+..++.++||||||+++|||++|+.||...... +.... .....
T Consensus 164 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~-~~~~~ 228 (284)
T 2vgo_A 164 APSLRR------RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--------ETHRR-IVNVD 228 (284)
T ss_dssp CSSSCB------CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHH-HHTTC
T ss_pred Cccccc------ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--------HHHHH-Hhccc
Confidence 543211 1234899999999999888999999999999999999999999753221 11111 11111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
. .. ....++++. +++.+||+.||++|||+.|+++.
T Consensus 229 ~------~~-~~~~~~~~~---~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 229 L------KF-PPFLSDGSK---DLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp C------CC-CTTSCHHHH---HHHHHHSCSSGGGSCCHHHHHTC
T ss_pred c------CC-CCcCCHHHH---HHHHHHhhcCHhhCCCHHHHhhC
Confidence 1 01 112233444 45559999999999999999873
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=326.39 Aligned_cols=247 Identities=19% Similarity=0.286 Sum_probs=200.7
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+.|...+.||+|+||.||+|. ..+++.||||.+.... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 458888999999999999998 4678999999986532 3457899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 102 ~~~~~L~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 102 LGGGSALDLLEPG--------PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp CTTEEHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred CCCCcHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecC
Confidence 9999999998642 4889999999999999999999 7899999999999999999999999999998764
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
...... ....|+..|+|||++.+..++.++||||||+++|||+||+.||..... .... .....+...
T Consensus 171 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~-~~~~~~~~~ 237 (303)
T 3a7i_A 171 DTQIKR----NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--------MKVL-FLIPKNNPP 237 (303)
T ss_dssp TTBCCB----CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHH-HHHHHSCCC
T ss_pred cccccc----CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--------HHHH-HHhhcCCCC
Confidence 432111 223589999999999988999999999999999999999999975322 1111 112222211
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
. +. ...+.. +.+++.+||+.||++|||+.|+++.
T Consensus 238 ~-----~~-~~~~~~---l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 238 T-----LE-GNYSKP---LKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp C-----CC-SSCCHH---HHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred C-----Cc-cccCHH---HHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1 11 122334 4455559999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=349.30 Aligned_cols=196 Identities=20% Similarity=0.288 Sum_probs=153.9
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeC-----Ce
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE-----EE 364 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 364 (604)
.++|...+.||+|+||.||+|. ..+++.||||++.... ...+++.+|++++++++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 3679999999999999999998 4578999999996532 2346789999999999999999999998543 46
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEccc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDF 444 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DF 444 (604)
.|+||||+. |+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DF 200 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP-------VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDF 200 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEeccc-cchhhhcccC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeeccc
Confidence 899999984 6999998754 35899999999999999999999 789999999999999999999999999
Q ss_pred CCccccCCCCCCC-----------------------CccccCCCCcccccCcccc-CCCCCCcccchhhHHHHHHHHHhC
Q 007423 445 GLARLVGSRDPND-----------------------SSFVHGDLGEFGYVAPEYS-STMVASLKGDVYGFGIVLLELLSG 500 (604)
Q Consensus 445 Gla~~~~~~~~~~-----------------------~~~~~~~~gt~~y~aPE~~-~~~~~t~k~DV~SfGvvl~elltg 500 (604)
|+++......... .....+.+||+.|+|||++ ....++.++|||||||++|||+||
T Consensus 201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 9998764322110 0123345689999999975 566799999999999999999993
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=325.79 Aligned_cols=247 Identities=17% Similarity=0.236 Sum_probs=199.7
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||++.. .+++.||+|.+.... ...+.+.+|+.++++++||||+++++++..++..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 5688889999999999999995 468899999986532 23457889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 95 e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 95 ELCRRRSLLELHKRR-------KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp ECCTTCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 999999999988754 35899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
........ ....||..|+|||+..+..++.++||||||+++|||+||+.||...... +.... ...+.
T Consensus 165 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~-~~~~~ 231 (294)
T 2rku_A 165 VEYDGERK----KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------ETYLR-IKKNE 231 (294)
T ss_dssp CCSTTCCB----CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHH-HHTTC
T ss_pred cccCcccc----ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH-Hhhcc
Confidence 64322211 2235899999999998888999999999999999999999999753221 11111 11111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.. . ....++++ .+++.+||+.||++|||+.|+++.
T Consensus 232 ~~------~-~~~~~~~~---~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 YS------I-PKHINPVA---ASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CC------C-CTTSCHHH---HHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CC------C-ccccCHHH---HHHHHHHcccChhhCcCHHHHhhC
Confidence 10 0 11223344 445559999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=333.77 Aligned_cols=261 Identities=21% Similarity=0.230 Sum_probs=192.4
Q ss_pred HhhcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccccc------HHHHHHHHHHHhccCCCCccceeeEEEeCCe
Q 007423 292 AATNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLS------EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEE 364 (604)
Q Consensus 292 ~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 364 (604)
...++|...+.||+|+||.||+|.. .+|+.||||+++..... .+.+.+|++++++++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 3456799999999999999999995 56899999999653211 1368899999999999999999999999999
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEccc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDF 444 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DF 444 (604)
.++||||+++ +|.+++.... ..+++..+..++.|+++||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Df 156 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADF 156 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC------SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEcCCC-CHHHHHHhcC------cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEec
Confidence 9999999986 8998887653 34788899999999999999999 789999999999999999999999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHH
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNH 523 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 523 (604)
|+++......... ....||+.|+|||++.+ ..++.++|||||||++|||++|++||......+ ....
T Consensus 157 g~a~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--------~~~~ 224 (346)
T 1ua2_A 157 GLAKSFGSPNRAY----THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--------QLTR 224 (346)
T ss_dssp GGGSTTTSCCCCC----CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHH
T ss_pred ccceeccCCcccC----CcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--------HHHH
Confidence 9998764332211 22358999999998865 458999999999999999999999997543211 1111
Q ss_pred HHH-cCCcc--cc---------ccccccCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 524 LVI-AGRSR--DV---------VDKSLYGRGN-----DDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 524 ~~~-~~~~~--~~---------~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
... .+... .. +........+ ......+.+++.+||+.||++|||+.|+++.
T Consensus 225 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 225 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 111 11100 00 0000000000 0111345556669999999999999999874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=347.80 Aligned_cols=196 Identities=22% Similarity=0.235 Sum_probs=164.5
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeC------C
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE------E 363 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 363 (604)
.++|...+.||+|+||.||+|. ..+++.||||++.... ...+++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4678889999999999999998 5678999999997532 2346788999999999999999999999754 3
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~---------~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~D 207 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM---------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 207 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECC
T ss_pred eEEEEEeCCCC-CHHHHHhh---------cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEE
Confidence 57999999976 57776642 3889999999999999999999 78999999999999999999999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
||+++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 208 FG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 208 FGLARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp CCCC-----CCC-----C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEeeeecCCCcc-----cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999987643221 12335899999999999999999999999999999999999999754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=340.04 Aligned_cols=202 Identities=19% Similarity=0.299 Sum_probs=161.8
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccC-CCCccceeeEEEeCC--eee
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEE--ERL 366 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~--~~~ 366 (604)
.++|...+.||+|+||.||+|. ..+++.||||++.... ...+.+.+|+.+++++. ||||+++++++...+ ..+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 4678899999999999999998 5679999999986432 23456889999999997 999999999998654 689
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
+||||++ |+|.+++... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 88 lv~e~~~-~~L~~~~~~~--------~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRAN--------ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp EEEECCS-EEHHHHHHHT--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEecccC-cCHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 9999997 5999998753 4889999999999999999999 78999999999999999999999999999
Q ss_pred ccccCCCCCC-----------------CCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 447 ARLVGSRDPN-----------------DSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 447 a~~~~~~~~~-----------------~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
++........ ........+||+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9876431110 0111233469999999998876 67899999999999999999999999754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=331.68 Aligned_cols=264 Identities=19% Similarity=0.238 Sum_probs=193.5
Q ss_pred cCCCc-CcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEee
Q 007423 295 NSFAV-ENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 295 ~~~~~-~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 370 (604)
+.|.+ .+.||+|+||.||+|. ..+++.||||++.... ...+.+.+|++++.++ +||||+++++++..++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 34655 3789999999999999 5679999999996543 3457799999999885 79999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC---eEEcccCCc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD---ARITDFGLA 447 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~---~kl~DFGla 447 (604)
|+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++. +||+|||++
T Consensus 92 ~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 92 KMRGGSILSHIHKR-------RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp CCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred cCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 99999999999764 35889999999999999999999 789999999999999997765 999999999
Q ss_pred cccCCCCCC---CCccccCCCCcccccCccccCC-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCc---
Q 007423 448 RLVGSRDPN---DSSFVHGDLGEFGYVAPEYSST-----MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGN--- 516 (604)
Q Consensus 448 ~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~--- 516 (604)
+........ .........||..|+|||++.. ..++.++|||||||++|||+||+.||......+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 866422111 1111123358999999998764 45789999999999999999999999764332211000
Q ss_pred ---HHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 517 ---LVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 517 ---~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
....+...+..+... ..+... ...++ .+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~i~~~~~~-~~~~~~--~~~~~---~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 242 CPACQNMLFESIQEGKYE-FPDKDW--AHISC---AAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CHHHHHHHHHHHHHCCCC-CCHHHH--TTSCH---HHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred chhHHHHHHHHHhccCcc-cCchhc--ccCCH---HHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011111222222211 110000 11123 34455559999999999999999873
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=332.68 Aligned_cols=248 Identities=17% Similarity=0.231 Sum_probs=200.3
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
.++|...+.||+|+||.||++.. .+++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 35788889999999999999995 568899999986532 2346788999999999999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 120 ~e~~~~~~L~~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 189 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-------KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 189 (335)
T ss_dssp ECCCTTCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence 9999999999998754 35899999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
......... ....||..|+|||++.+..++.++||||||+++|||+||+.||..... .+..... ..+
T Consensus 190 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~-~~~ 256 (335)
T 2owb_A 190 KVEYDGERK----KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRI-KKN 256 (335)
T ss_dssp ECCSTTCCB----CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHH-HHT
T ss_pred ecccCcccc----cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHHH-hcC
Confidence 764322211 223589999999999888899999999999999999999999975322 1111111 111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
... + ....++++. +++.+||+.||++|||+.|+++.
T Consensus 257 ~~~------~-~~~~~~~~~---~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 257 EYS------I-PKHINPVAA---SLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CCC------C-CTTSCHHHH---HHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCC------C-CccCCHHHH---HHHHHHccCChhHCcCHHHHhcC
Confidence 110 0 111233444 45559999999999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=351.50 Aligned_cols=253 Identities=21% Similarity=0.252 Sum_probs=202.5
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 45688899999999999999995 579999999996532 2345688999999999999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++|+|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 263 mEy~~gg~L~~~l~~~~~-----~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~ 334 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ-----AGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAV 334 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEcCCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccce
Confidence 999999999999976532 34899999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....... .... +...+...
T Consensus 335 ~~~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~----~~~~-i~~~i~~~ 404 (576)
T 2acx_A 335 HVPEGQT-----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----KREE-VERLVKEV 404 (576)
T ss_dssp ECCTTCC-----EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC----CHHH-HHHHHHHC
T ss_pred ecccCcc-----ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch----hHHH-HHHHhhcc
Confidence 7643221 223469999999999998889999999999999999999999997543211 1111 12222221
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYES 574 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~ 574 (604)
... . ....+.++.++++ +||+.||++|| ++.||++.
T Consensus 405 ~~~------~-p~~~s~~~~dLI~---~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 PEE------Y-SERFSPQARSLCS---QLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCC------C-CTTSCHHHHHHHH---HHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ccc------C-CccCCHHHHHHHH---HhccCCHHHcCCCCCCCHHHHHhC
Confidence 110 1 1123344555544 99999999999 78888653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=341.72 Aligned_cols=262 Identities=16% Similarity=0.153 Sum_probs=199.9
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccC--------CCCccceeeEEE----e
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLR--------HPNLVPLLGFCV----V 361 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~--------H~niv~l~g~~~----~ 361 (604)
++|...+.||+|+||.||+|+ ..+++.||||+++......+.+.+|++++++++ |+||+++++++. .
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~ 116 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN 116 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence 678999999999999999998 567899999999866555678899999999996 788999999987 4
Q ss_pred CCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCC-CceecCCCCCeEEeCCCC---
Q 007423 362 EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQP-PYMHQYISSNVILIDDDF--- 437 (604)
Q Consensus 362 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~-~iiH~dlk~~NiLl~~~~--- 437 (604)
....++||||+ +|+|.+++..... ..+++..+..++.|++.||.||| +. +|+||||||+|||++.++
T Consensus 117 ~~~~~lv~e~~-~~~l~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 117 GTHICMVFEVL-GHHLLKWIIKSNY-----QGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEEEEEECCC-CCBHHHHHHHTTT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHH
T ss_pred CceEEEEEecc-CccHHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhh
Confidence 55789999999 5566666654321 35899999999999999999999 66 999999999999999765
Q ss_pred ----------------------------------------------CeEEcccCCccccCCCCCCCCccccCCCCccccc
Q 007423 438 ----------------------------------------------DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYV 471 (604)
Q Consensus 438 ----------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~ 471 (604)
.+||+|||+++...... ....||..|+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-------~~~~gt~~y~ 260 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-------TEDIQTRQYR 260 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-------CSCCSCGGGC
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-------ccCCCCCccc
Confidence 89999999998764321 1235899999
Q ss_pred CccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcc-----------cccccc---
Q 007423 472 APEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR-----------DVVDKS--- 537 (604)
Q Consensus 472 aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~d~~--- 537 (604)
|||++.+..++.++|||||||++|||+||+.||......+... ............+... ......
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 339 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTR-DEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL 339 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCH-HHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCc-hHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence 9999998889999999999999999999999997644322111 1111000000011110 000000
Q ss_pred --c--------------cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 538 --L--------------YGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 538 --l--------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
+ ......+....+.+++.+||+.||++|||+.|+++
T Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 00223556667888888999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=336.76 Aligned_cols=198 Identities=21% Similarity=0.347 Sum_probs=173.0
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
++|...+.||+|+||.||++.. .++..||+|+++... ...+.+.+|++++++++||||+++++++..++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 5688899999999999999995 478999999997542 2346789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++|+|.+++... ..+++.....++.+++.||.|||+ ..+|+||||||+|||++.++.+||+|||+++...
T Consensus 113 ~~~~~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 113 MDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 9999999999764 358899999999999999999993 2389999999999999999999999999997653
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
.... ....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 184 ~~~~------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 184 DSMA------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp HHC----------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred cccc------cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2211 1224899999999999999999999999999999999999999754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=334.10 Aligned_cols=263 Identities=19% Similarity=0.210 Sum_probs=198.0
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEe--------C
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV--------E 362 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------~ 362 (604)
++|...+.||+|+||.||+|.. .+++.||||++.... .....+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788899999999999999995 679999999986433 223578899999999999999999999987 3
Q ss_pred CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEc
Q 007423 363 EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARIT 442 (604)
Q Consensus 363 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~ 442 (604)
+..++||||+++ +|.+.+.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL------VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred ceEEEEEeccCC-CHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEc
Confidence 468999999975 8888776543 35899999999999999999999 7899999999999999999999999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHH
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWV 521 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 521 (604)
|||+++.................||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+ ....+
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~i 241 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-----QLALI 241 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHH
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHH
Confidence 999998775433222222334568999999998865 458999999999999999999999997543211 11111
Q ss_pred HHHHHcCCccccccccc-----c--------C-CCCHHH------HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 522 NHLVIAGRSRDVVDKSL-----Y--------G-RGNDDE------IMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 522 ~~~~~~~~~~~~~d~~l-----~--------~-~~~~~~------~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
... .+......-+.. . . ....+. ...+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 242 SQL--CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHH--HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHH--hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 111 111111000000 0 0 000111 1235567779999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=335.37 Aligned_cols=266 Identities=19% Similarity=0.217 Sum_probs=194.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
++|...+.||+|+||.||+|.. .+++.||||++..... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 5688889999999999999995 5689999999865432 23568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 105 ~~~~~~l~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 105 FVDHTILDDLELFP-------NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp CCSEEHHHHHHHST-------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred cCCcchHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 99999998887644 35899999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCc-------HHHHHH
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGN-------LVDWVN 522 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~-------~~~~~~ 522 (604)
...... .....||..|+|||++.+. .++.++|||||||++|||+||+.||......+..... ...+..
T Consensus 175 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (331)
T 4aaa_A 175 AAPGEV----YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE 250 (331)
T ss_dssp -------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred cCCccc----cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Confidence 432221 1223589999999988765 6899999999999999999999999754322110000 000000
Q ss_pred HHHHcCCccccccccccCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 523 HLVIAGRSRDVVDKSLYGRGND-----DEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 523 ~~~~~~~~~~~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.............+........ .....+.+++.+||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000001111100110 112345566669999999999999999763
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=348.74 Aligned_cols=249 Identities=18% Similarity=0.230 Sum_probs=198.7
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||+++. .+|+.||||++.... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 6788889999999999999995 569999999996532 23457889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++...... ...+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 265 E~~~gg~L~~~l~~~~~~---~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDED---NPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp CCCTTCBHHHHHHTSSTT---SCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EeccCCCHHHHHHHhhcc---cccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 999999999998764321 135899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... ....+..... ..+.
T Consensus 339 ~~~~~~~----~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~----~~~~~~~~~i-~~~~ 409 (543)
T 3c4z_A 339 LKAGQTK----TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----VENKELKQRV-LEQA 409 (543)
T ss_dssp CCTTCCC----BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC----CCHHHHHHHH-HHCC
T ss_pred ccCCCcc----cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc----hhHHHHHHHH-hhcc
Confidence 6543221 12235999999999999999999999999999999999999999754221 1112222222 2221
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSM 568 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 568 (604)
.. .....+.++..++ .+||+.||++||++
T Consensus 410 ~~-------~p~~~s~~~~~li---~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 410 VT-------YPDKFSPASKDFC---EALLQKDPEKRLGF 438 (543)
T ss_dssp CC-------CCTTSCHHHHHHH---HHHSCSSGGGSCCC
T ss_pred cC-------CCcccCHHHHHHH---HHhccCCHhHCCCC
Confidence 11 0112234455554 49999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=334.01 Aligned_cols=265 Identities=18% Similarity=0.265 Sum_probs=198.8
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEe----CCeeeE
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV----EEERLL 367 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~l 367 (604)
.++|...+.||+|+||.||++.. .+++.||||++.... ...+.+.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35788899999999999999994 789999999986433 345678999999999999999999999973 347889
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||||+++|+|.+++...... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 108 v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDK---GNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEeCCCCcHHHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 99999999999998753111 145899999999999999999999 789999999999999999999999999998
Q ss_pred cccCCCCCCCC-----ccccCCCCcccccCccccCCCC---CCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHH
Q 007423 448 RLVGSRDPNDS-----SFVHGDLGEFGYVAPEYSSTMV---ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVD 519 (604)
Q Consensus 448 ~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~---~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~ 519 (604)
+.......... .......||..|+|||++.... ++.++|||||||++|||++|+.||....... ....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~- 257 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---DSVA- 257 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT---SCHH-
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc---chhh-
Confidence 76532111000 0001224689999999987544 6889999999999999999999995321110 0111
Q ss_pred HHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 520 WVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 520 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
...... .. ... ....+.+ +.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 258 ---~~~~~~-~~-~~~----~~~~~~~---l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 258 ---LAVQNQ-LS-IPQ----SPRHSSA---LWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp ---HHHHCC----CCC----CTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred ---HHhhcc-CC-CCc----cccCCHH---HHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 111111 10 000 0112233 4455559999999999999999999998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.61 Aligned_cols=251 Identities=15% Similarity=0.179 Sum_probs=188.7
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccc----cccHHHHHHHH---HHHhccCCCCcccee-------eE
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSAC----KLSEKQFRSEM---NRLGQLRHPNLVPLL-------GF 358 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~----~~~~~~~~~Ei---~~l~~l~H~niv~l~-------g~ 358 (604)
.++|...+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788889999999999999994 67999999999632 23346789999 556666899999998 66
Q ss_pred EEeCCe-----------------eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCc
Q 007423 359 CVVEEE-----------------RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPY 421 (604)
Q Consensus 359 ~~~~~~-----------------~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~i 421 (604)
+..++. .++||||+ +|+|.+++............+++..++.++.|++.||+||| +.+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 665532 78999999 68999999754211111123557888999999999999999 7899
Q ss_pred eecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCC-----------CCCcccchhhH
Q 007423 422 MHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-----------VASLKGDVYGF 490 (604)
Q Consensus 422 iH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~k~DV~Sf 490 (604)
+||||||+|||++.++.+||+|||+++.... ......| ..|+|||++.+. .++.++|||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 9999999999999999999999999986432 1223347 999999998877 79999999999
Q ss_pred HHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 007423 491 GIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQ 570 (604)
Q Consensus 491 Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 570 (604)
||++|||+||+.||......... ..+... ....++++ .+++.+||+.||++|||+.|
T Consensus 300 G~il~elltg~~Pf~~~~~~~~~-----------------~~~~~~---~~~~~~~~---~~li~~~L~~dp~~Rpt~~e 356 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDAALGGS-----------------EWIFRS---CKNIPQPV---RALLEGFLRYPKEDRLLPLQ 356 (377)
T ss_dssp HHHHHHHHHSSCCC------CCS-----------------GGGGSS---CCCCCHHH---HHHHHHHTCSSGGGCCCHHH
T ss_pred HHHHHHHHHCCCCCcccccccch-----------------hhhhhh---ccCCCHHH---HHHHHHHcCCCchhCCCHHH
Confidence 99999999999999653322111 111110 01223344 44555999999999999999
Q ss_pred HHH--HHHhch
Q 007423 571 VYE--SLKSMA 579 (604)
Q Consensus 571 v~~--~L~~i~ 579 (604)
+++ .++++.
T Consensus 357 ~l~hp~f~~~~ 367 (377)
T 3byv_A 357 AMETPEYEQLR 367 (377)
T ss_dssp HHTSHHHHHHH
T ss_pred HhhChHHHHHH
Confidence 986 344443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=332.11 Aligned_cols=253 Identities=19% Similarity=0.300 Sum_probs=199.2
Q ss_pred HHhhcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc---------cHHHHHHHHHHHhcc-CCCCccceeeEE
Q 007423 291 LAATNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL---------SEKQFRSEMNRLGQL-RHPNLVPLLGFC 359 (604)
Q Consensus 291 ~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~---------~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 359 (604)
....++|...+.||+|+||.||+|.. .+|+.||||+++.... ..+.+.+|+++++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 34456799999999999999999996 4799999999864321 134578999999999 799999999999
Q ss_pred EeCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCe
Q 007423 360 VVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439 (604)
Q Consensus 360 ~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~ 439 (604)
...+..++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||+++++.+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK-------VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCE
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999754 35899999999999999999999 7899999999999999999999
Q ss_pred EEcccCCccccCCCCCCCCccccCCCCcccccCccccC------CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccc
Q 007423 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSS------TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGF 513 (604)
Q Consensus 440 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~ 513 (604)
||+|||++........ .....||+.|+|||++. ...++.++|||||||++|||+||+.||.....
T Consensus 240 kl~DfG~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---- 310 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK-----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---- 310 (365)
T ss_dssp EECCCTTCEECCTTCC-----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----
T ss_pred EEEecCcccccCCCcc-----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH----
Confidence 9999999987653322 12335899999999875 33588999999999999999999999965321
Q ss_pred cCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 514 KGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.... ..+..+.... ..+.. ...+. .+.+++.+||+.||++|||+.|+++
T Consensus 311 ----~~~~-~~i~~~~~~~-~~~~~--~~~~~---~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 311 ----ILML-RMIMEGQYQF-SSPEW--DDRSS---TVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ----HHHH-HHHHHTCCCC-CHHHH--SSSCH---HHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----HHHH-HHHHhCCCCC-CCccc--ccCCH---HHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 1122222111 00100 11122 3455556999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.28 Aligned_cols=251 Identities=19% Similarity=0.253 Sum_probs=192.9
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
.|....+||+|+||.||+|. ..+++.||||.+.... ...+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 34555699999999999999 5678999999987543 334679999999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC-CCCeEEcccCCccccCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD-DFDARITDFGLARLVGS 452 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~-~~~~kl~DFGla~~~~~ 452 (604)
+++|.+++...... ..+++..+..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||+++....
T Consensus 103 ~~~L~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 103 GGSLSALLRSKWGP----LKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEHHHHHHHTTCC----CTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCHHHHHHhhccC----CCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 99999999765321 34678899999999999999999 789999999999999987 89999999999987643
Q ss_pred CCCCCCccccCCCCcccccCccccCCCC--CCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMV--ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
..... ....|+..|+|||++.+.. ++.++||||||+++|||+||+.||...... ....... ......
T Consensus 176 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~-~~~~~~ 244 (295)
T 2clq_A 176 INPCT----ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP------QAAMFKV-GMFKVH 244 (295)
T ss_dssp ---------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH------HHHHHHH-HHHCCC
T ss_pred CCCcc----cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch------hHHHHhh-cccccc
Confidence 22211 1234899999999886543 789999999999999999999999643211 0111111 111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
+.+. ...+++ +.+++.+||+.||++||++.|+++
T Consensus 245 -----~~~~-~~~~~~---~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 245 -----PEIP-ESMSAE---AKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -----CCCC-TTSCHH---HHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -----cccc-ccCCHH---HHHHHHHHccCChhhCCCHHHHhc
Confidence 1111 122334 445555999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=327.77 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=198.1
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEe--CCeeeE
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV--EEERLL 367 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~l 367 (604)
.++|...+.||+|+||.||++.. .+++.||+|.+.... ...+.+.+|++++++++||||+++++++.. .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 35788889999999999999995 578999999997533 234568999999999999999999998865 567899
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCC-----ceecCCCCCeEEeCCCCCeEEc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPP-----YMHQYISSNVILIDDDFDARIT 442 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~-----iiH~dlk~~NiLl~~~~~~kl~ 442 (604)
||||+++|+|.+++...... ...+++..+..++.|++.||.||| +.+ |+||||||+||+++.++.+||+
T Consensus 85 v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~ 158 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKE---RQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred EEeCCCCCCHHHHHHhhccc---CCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence 99999999999999753211 134899999999999999999999 455 9999999999999999999999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHH
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVN 522 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 522 (604)
|||+++....... ......|+..|+|||++.+..++.++||||||+++|||+||+.||..... .+ +.
T Consensus 159 dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~-~~ 225 (279)
T 2w5a_A 159 DFGLARILNHDTS----FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KE-LA 225 (279)
T ss_dssp CCCHHHHC---CH----HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH-HH
T ss_pred cCchheeeccccc----cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--------HH-HH
Confidence 9999987643211 11123478999999999888899999999999999999999999975322 11 11
Q ss_pred HHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 523 HLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 523 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
..+..+...... ...++++ .+++.+||+.||++|||+.||++.+.
T Consensus 226 ~~i~~~~~~~~~------~~~~~~l---~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 226 GKIREGKFRRIP------YRYSDEL---NEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHHHTCCCCCC------TTSCHHH---HHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHhhcccccCC------cccCHHH---HHHHHHHcCCCcccCCCHHHHHhChh
Confidence 222333322111 1223344 44555999999999999999988654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=349.25 Aligned_cols=250 Identities=21% Similarity=0.268 Sum_probs=196.5
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--------------ccHHHHHHHHHHHhccCCCCccceeeE
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--------------LSEKQFRSEMNRLGQLRHPNLVPLLGF 358 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--------------~~~~~~~~Ei~~l~~l~H~niv~l~g~ 358 (604)
.++|...+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|++++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 46789999999999999999994 568899999986532 224578899999999999999999999
Q ss_pred EEeCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC-
Q 007423 359 CVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF- 437 (604)
Q Consensus 359 ~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~- 437 (604)
+..++..++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR-------HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNS 184 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCC
Confidence 99999999999999999999998754 35899999999999999999999 78999999999999998765
Q ss_pred --CeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccC
Q 007423 438 --DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKG 515 (604)
Q Consensus 438 --~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~ 515 (604)
.+||+|||+++....... .....||+.|+|||++.+ .++.++||||+||++|||++|+.||.....
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------ 252 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDYK-----LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND------ 252 (504)
T ss_dssp CSSEEECCCTTCEECCTTSC-----BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------
T ss_pred CccEEEEECCCCEEcCCCCc-----cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH------
Confidence 699999999987744321 123358999999998764 689999999999999999999999975432
Q ss_pred cHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 516 NLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.+.. ..+..+....... .. ...++++. +++.+||+.||++|||+.|+++.
T Consensus 253 --~~~~-~~i~~~~~~~~~~-~~--~~~s~~~~---~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 253 --QDII-KKVEKGKYYFDFN-DW--KNISDEAK---ELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp --HHHH-HHHHHCCCCCCHH-HH--TTSCHHHH---HHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHHH-HHHHcCCCCCCcc-cc--CCCCHHHH---HHHHHHcCCChhHCCCHHHHhcC
Confidence 1122 2222222211000 00 11233444 45559999999999999999764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=345.39 Aligned_cols=249 Identities=21% Similarity=0.282 Sum_probs=197.7
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccc---cccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSAC---KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
++|...+.||+|+||+||+|.. .+++.||||++... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 5688899999999999999994 57899999998642 2345779999999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC---CCCCeEEcccCCc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID---DDFDARITDFGLA 447 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~---~~~~~kl~DFGla 447 (604)
|+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++ .++.+||+|||++
T Consensus 102 ~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 102 LYTGGELFDEIIKR-------KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp CCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred cCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 99999999988754 35899999999999999999999 78999999999999995 4567999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
+....... .....||+.|+|||++.+ .++.++||||+||++|||++|+.||..... .+... .+..
T Consensus 172 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~-~i~~ 236 (486)
T 3mwu_A 172 TCFQQNTK-----MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILK-RVET 236 (486)
T ss_dssp TTBCCC---------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH-HHHH
T ss_pred eECCCCCc-----cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHH-HHHh
Confidence 87643321 123358999999999875 589999999999999999999999975322 11122 2222
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
+...... +.. ...++++. +++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~-~~~--~~~s~~~~---~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 237 GKYAFDL-PQW--RTISDDAK---DLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp TCCCSCS-GGG--GGSCHHHH---HHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCCCC-ccc--CCCCHHHH---HHHHHHcCCChhhCcCHHHHhcC
Confidence 2221111 100 11233444 45559999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=325.88 Aligned_cols=249 Identities=18% Similarity=0.283 Sum_probs=197.0
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
++|...+.||+|+||.||++.. .+++.||||.++... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 5688889999999999999994 579999999997543 23456889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe---CCCCCeEEcccCCccc
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI---DDDFDARITDFGLARL 449 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl---~~~~~~kl~DFGla~~ 449 (604)
++|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+||++ ++++.+||+|||+++.
T Consensus 89 ~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 89 SGGELFDRILER-------GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp CSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred CCccHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 999999998754 35889999999999999999999 7899999999999999 7889999999999876
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
..... .....|++.|+|||++.+..++.++||||||+++|||+||+.||..... .+... .+..+.
T Consensus 159 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~-~i~~~~ 223 (304)
T 2jam_A 159 EQNGI------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--------SKLFE-KIKEGY 223 (304)
T ss_dssp CCCBT------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHH-HHHHCC
T ss_pred cCCCc------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHH-HHHcCC
Confidence 43211 1122489999999999998999999999999999999999999975322 11111 122222
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.. . ..... ...+++ +.+++.+||+.||++|||+.|+++.
T Consensus 224 ~~-~-~~~~~-~~~~~~---~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 224 YE-F-ESPFW-DDISES---AKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp CC-C-CTTTT-TTSCHH---HHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CC-C-Ccccc-ccCCHH---HHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11 0 00010 112334 4455559999999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=343.53 Aligned_cols=270 Identities=20% Similarity=0.229 Sum_probs=206.4
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccCC-CCccceeeEEEeCCeeeEEeee
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLRH-PNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lv~ey 371 (604)
.++|.+.+.||+|+||.||+|. ..+++.||||++.... ..+++.+|+++++.++| ++|..+..++...+..++||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 3578899999999999999999 5679999999876433 22458899999999987 5555666666778889999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe---CCCCCeEEcccCCcc
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI---DDDFDARITDFGLAR 448 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl---~~~~~~kl~DFGla~ 448 (604)
+ +++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~-g~sL~~ll~~~~------~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 85 L-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp C-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred C-CCCHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 9 899999997542 35899999999999999999999 7899999999999999 588999999999999
Q ss_pred ccCCCCCCCC---ccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHH
Q 007423 449 LVGSRDPNDS---SFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 449 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
.......... .......||..|+|||++.+..++.++|||||||++|||++|+.||........ ......+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~i~~~~ 232 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK--KQKYEKISEKK 232 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH--HHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH--HHHHHHHhhcc
Confidence 8754332211 111234689999999999999999999999999999999999999976433211 01111111111
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCC
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFS 585 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~ 585 (604)
....... +. ...++ ++.+++..||+.||++||++.+|++.|+.+.+..+..
T Consensus 233 ~~~~~~~-----l~-~~~p~---~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~ 283 (483)
T 3sv0_A 233 VATSIEA-----LC-RGYPT---EFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQ 283 (483)
T ss_dssp HHSCHHH-----HH-TTSCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred ccccHHH-----Hh-cCCcH---HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCC
Confidence 1111111 00 11223 4555666999999999999999999999998866544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=336.22 Aligned_cols=253 Identities=18% Similarity=0.228 Sum_probs=197.4
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe----CCCCEEEEEEecccc-----ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCC
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL----PDASALAIKRLSACK-----LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEE 363 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~----~~~~~vAvK~l~~~~-----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 363 (604)
.++|...+.||+|+||.||+++. .+++.||||+++... ...+.+.+|+++++++ +||||+++++++..++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35788999999999999999986 478999999987532 2235677899999999 6999999999999999
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
..++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~D 202 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTD 202 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESC
T ss_pred eEEEEeecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEee
Confidence 999999999999999999754 35889999999999999999999 78999999999999999999999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHH
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST--MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWV 521 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 521 (604)
||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... .......
T Consensus 203 fG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----~~~~~~~ 275 (355)
T 1vzo_A 203 FGLSKEFVADETE---RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK----NSQAEIS 275 (355)
T ss_dssp SSEEEECCGGGGG---GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC----CCHHHHH
T ss_pred CCCCeecccCCCC---cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc----chHHHHH
Confidence 9999865332111 1122358999999999875 34789999999999999999999999754321 1222222
Q ss_pred HHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 007423 522 NHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYES 574 (604)
Q Consensus 522 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~ 574 (604)
....... . .. ....+.. +.+++.+||+.||++|| ++.|+++.
T Consensus 276 ~~~~~~~-~------~~-~~~~~~~---~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 276 RRILKSE-P------PY-PQEMSAL---AKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HHHHHCC-C------CC-CTTSCHH---HHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHhccC-C------CC-CcccCHH---HHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 2222111 0 01 1112233 44555599999999999 99999775
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=339.55 Aligned_cols=198 Identities=20% Similarity=0.212 Sum_probs=172.5
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhcc------CCCCccceeeEEEeCCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQL------RHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l------~H~niv~l~g~~~~~~~~~l 367 (604)
.+|...+.||+|+||.||+|. ..+++.||||+++......+++.+|+++++.+ +|+||+++++++...+..++
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 468889999999999999998 45689999999987655567788899888877 57799999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC--eEEcccC
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD--ARITDFG 445 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~--~kl~DFG 445 (604)
||||+. ++|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+|||
T Consensus 177 v~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKNKF-----QGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EECCCC-CBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEeccC-CCHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 999996 699999876532 24899999999999999999999 679999999999999998887 9999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAG 508 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~ 508 (604)
+++...... ....||+.|+|||++.+..++.++|||||||++|||+||++||....
T Consensus 248 ~a~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 248 SSCYEHQRV-------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TCEETTCCC-------CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceecCCcc-------cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 997653321 12358999999999999899999999999999999999999997643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=349.75 Aligned_cols=249 Identities=21% Similarity=0.278 Sum_probs=199.5
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccc----cccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSAC----KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
+.|...+.||+|+||.||+|.. .+++.||||++... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 4688899999999999999994 57999999998643 234578999999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe---CCCCCeEEcccCC
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI---DDDFDARITDFGL 446 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl---~~~~~~kl~DFGl 446 (604)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 106 e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 106 EVYTGGELFDEIISR-------KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp CCCCSCBHHHHHHTC-------SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred ecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 999999999998765 35899999999999999999999 7899999999999999 4678999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
++....... .....||+.|+|||++.+ .++.++||||+||++|||++|+.||...... +.. ..+.
T Consensus 176 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~-~~i~ 240 (484)
T 3nyv_A 176 STHFEASKK-----MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--------DIL-KKVE 240 (484)
T ss_dssp HHHBCCCCS-----HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHH-HHHH
T ss_pred eEEcccccc-----cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--------HHH-HHHH
Confidence 987743221 122358999999998866 6899999999999999999999999754221 112 2222
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.+...... +.. ...++++. +++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~-~~~--~~~s~~~~---~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 241 KGKYTFEL-PQW--KKVSESAK---DLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HCCCCCCS-GGG--GGSCHHHH---HHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cCCCCCCC-ccc--ccCCHHHH---HHHHHHCCCChhHCcCHHHHhhC
Confidence 23221111 000 11233444 45559999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.87 Aligned_cols=265 Identities=25% Similarity=0.385 Sum_probs=182.5
Q ss_pred hhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 293 ATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
..++|...+.||+|+||.||+|. ..+++.||||++.... ...+++.+|++++++++||||+++++++..++..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 34678889999999999999998 4578999999986532 23467889999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCC-CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 370 KHMPNGTLYSLLHGNGVD-NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~-~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
||+++|+|.+++...... ......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998641100 001145899999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCCC-CccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 449 LVGSRDPND-SSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 449 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
......... ........||+.|+|||++.. ..++.++||||||+++|||+||+.||....... ..... .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~-~ 240 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--------VLMLT-L 240 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--------HHHHH-H
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--------HHHHH-h
Confidence 764322111 111123358999999998765 568999999999999999999999997543221 01111 1
Q ss_pred cCCcccc----ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 527 AGRSRDV----VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 527 ~~~~~~~----~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.+..... .++... ...+.+ +.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~-~~~~~~---~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 241 QNDPPSLETGVQDKEML-KKYGKS---FRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TSSCCCTTC-----CCC-CCCCHH---HHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCCCccccccccchhh-hhhhHH---HHHHHHHHccCChhhCcCHHHHhh
Confidence 1111111 111111 112233 445555999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=318.28 Aligned_cols=246 Identities=18% Similarity=0.291 Sum_probs=191.6
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||+|.. .+++.||||.+.... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 4688889999999999999995 479999999986432 23457899999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 91 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 91 EYVSGGELFDYICKH-------GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 160 (276)
T ss_dssp ECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred eccCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccc
Confidence 999999999999754 35889999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA-SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
...... .....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||..... .... ..+..+
T Consensus 161 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~-~~~~~~ 226 (276)
T 2h6d_A 161 MSDGEF-----LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--------PTLF-KKIRGG 226 (276)
T ss_dssp CCC------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH-HHHHHC
T ss_pred cCCCcc-----eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------HHHH-HHhhcC
Confidence 643221 122348899999999887765 6899999999999999999999975321 1111 112222
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
... . ....+.+ +.+++.+||+.||++|||+.|+++.
T Consensus 227 ~~~------~-~~~~~~~---l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 227 VFY------I-PEYLNRS---VATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCC------C-CTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ccc------C-chhcCHH---HHHHHHHHccCChhhCCCHHHHHhC
Confidence 110 0 1112334 4455559999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=322.40 Aligned_cols=245 Identities=19% Similarity=0.250 Sum_probs=194.4
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccc---cccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEE
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSAC---KLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv 368 (604)
.++|...+.||+|+||.||+|.. .+++.||||+++.. .....++.+|+..+.++ +||||+++++++..++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 45788899999999999999995 47999999998753 23346788999999999 999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC-------------
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD------------- 435 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~------------- 435 (604)
|||+++|+|.+++...... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRI---MSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EECCTTCBHHHHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC--------------
T ss_pred EEecCCCcHHHHHHhhccc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence 9999999999999754211 135899999999999999999999 789999999999999984
Q ss_pred ------CCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 007423 436 ------DFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAG 508 (604)
Q Consensus 436 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~ 508 (604)
...+||+|||.++....... ..||..|+|||++.+. .++.++|||||||++|||++|++|+...
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~~--------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~- 234 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQV--------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG- 234 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSCC--------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-
T ss_pred ccccCCceEEEEcccccccccCCccc--------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-
Confidence 44799999999987643221 1389999999988765 5678999999999999999999876431
Q ss_pred ccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 509 AEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
. .+ .....+...... ...++++. +++.+||+.||++|||+.|+++
T Consensus 235 -------~--~~--~~~~~~~~~~~~------~~~~~~~~---~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 -------D--QW--HEIRQGRLPRIP------QVLSQEFT---ELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -------H--HH--HHHHTTCCCCCS------SCCCHHHH---HHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------h--HH--HHHHcCCCCCCC------cccCHHHH---HHHHHHhCCCcccCCCHHHHhh
Confidence 1 11 112223222211 12234444 4555999999999999999976
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=332.77 Aligned_cols=207 Identities=24% Similarity=0.249 Sum_probs=170.4
Q ss_pred CHHHHHHhhcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccc------------cHHHHHHHHHHHhccCCCCcc
Q 007423 286 KLADLLAATNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKL------------SEKQFRSEMNRLGQLRHPNLV 353 (604)
Q Consensus 286 ~~~~l~~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~------------~~~~~~~Ei~~l~~l~H~niv 353 (604)
...++....++|...+.||+|+||.||+|...+++.||||++..... ..+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 35678888999999999999999999999988899999999854221 126789999999999999999
Q ss_pred ceeeEEEeC-----CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCC
Q 007423 354 PLLGFCVVE-----EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS 428 (604)
Q Consensus 354 ~l~g~~~~~-----~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~ 428 (604)
++++++... ...++||||++ |+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp 162 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR------IVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHP 162 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCG
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCCh
Confidence 999998653 35799999998 68988887543 35899999999999999999999 78999999999
Q ss_pred CeEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 429 NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 429 ~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
+|||++.++.+||+|||+++........ ....||..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 163 GNILLADNNDITICDFNLAREDTADANK-----THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237 (362)
T ss_dssp GGEEECTTCCEEECCTTC--------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred HHEEEcCCCCEEEEecCccccccccccc-----ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999865332221 12348899999998876 67899999999999999999999999754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=346.74 Aligned_cols=254 Identities=21% Similarity=0.261 Sum_probs=196.5
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
+.|...+.||+|+||.||+|.. .++..||||+++... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4688899999999999999994 578999999997532 234678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC---CCCeEEcccCCc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD---DFDARITDFGLA 447 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~---~~~~kl~DFGla 447 (604)
|+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||++
T Consensus 117 ~~~~g~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 117 CYKGGELFDEIIHR-------MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp CCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred cCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 99999999988754 35889999999999999999999 789999999999999975 455999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
+....... .....||+.|+|||++. ..++.++||||+||++|||++|+.||..... .+.... +..
T Consensus 187 ~~~~~~~~-----~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~-i~~ 251 (494)
T 3lij_A 187 AVFENQKK-----MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--------QEILRK-VEK 251 (494)
T ss_dssp EECBTTBC-----BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH-HHH
T ss_pred eECCCCcc-----ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH-HHh
Confidence 87653321 12335899999999876 4689999999999999999999999975332 122222 222
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhch
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES--LKSMA 579 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~--L~~i~ 579 (604)
+.... ..+.. ...++++.+ ++.+||+.||++|||+.|+++. ++++.
T Consensus 252 ~~~~~-~~~~~--~~~s~~~~~---li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 252 GKYTF-DSPEW--KNVSEGAKD---LIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp TCCCC-CSGGG--TTSCHHHHH---HHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred CCCCC-Cchhc--ccCCHHHHH---HHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 22211 11111 112334444 4559999999999999999864 44443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=325.68 Aligned_cols=250 Identities=19% Similarity=0.277 Sum_probs=195.6
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
.+.|...+.||+|+||.||+|.. .+|+.||||.+.... ..+++.+|++++++++||||+++++++...+..++||||+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 45788899999999999999995 468999999997543 3467899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++|+|.+++.... ..+++..+..++.+++.||.||| +.+|+|+||||+||+++.++.+||+|||++.....
T Consensus 107 ~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 107 GAGSVSDIIRLRN------KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp TTEEHHHHHHHHT------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred CCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 9999999986432 35899999999999999999999 78999999999999999999999999999987643
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
.... .....|+..|+|||++.+..++.++||||||+++|||++|+.||...... ..... ........
T Consensus 178 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~-~~~~~~~~ 244 (314)
T 3com_A 178 TMAK----RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM--------RAIFM-IPTNPPPT 244 (314)
T ss_dssp TBSC----BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHH-HHHSCCCC
T ss_pred hccc----cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--------HHHHH-HhcCCCcc
Confidence 2211 12235899999999999888999999999999999999999999753221 11111 11111111
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
...+. ..++. +.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~----~~~~~---l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 FRKPE----LWSDN---FTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CSSGG----GSCHH---HHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCcc----cCCHH---HHHHHHHHccCChhhCcCHHHHHh
Confidence 11111 12233 445555999999999999999976
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=326.88 Aligned_cols=253 Identities=18% Similarity=0.227 Sum_probs=196.2
Q ss_pred hcCCCcC-cEEEecCCeEEEEEEe-CCCCEEEEEEecccc---ccHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeeE
Q 007423 294 TNSFAVE-NIIISTRTGVSYKAVL-PDASALAIKRLSACK---LSEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 294 ~~~~~~~-~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~l 367 (604)
.+.|... +.||+|+||.||+|.. .+++.||||+++... ....++.+|+.++++++ ||||+++++++...+..++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 4456655 7899999999999984 569999999987532 33578999999999994 6999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC---CCCeEEccc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD---DFDARITDF 444 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~---~~~~kl~DF 444 (604)
||||+++|+|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+|||++. ++.+||+||
T Consensus 107 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELA-----EMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEECCTTEEGGGGGSSCC------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EEEecCCCcHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 9999999999999865422 35899999999999999999999 789999999999999997 789999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
|+++........ ....||+.|+|||++.+..++.++|||||||++|||+||+.||...... +.....
T Consensus 179 g~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i 245 (327)
T 3lm5_A 179 GMSRKIGHACEL-----REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ--------ETYLNI 245 (327)
T ss_dssp GGCEEC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHH
T ss_pred ccccccCCcccc-----ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--------HHHHHH
Confidence 999876433211 2235899999999999999999999999999999999999999753221 111111
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.. .... ...+ .. ...++. +.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~-~~~~-~~~~-~~-~~~~~~---~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 246 SQ-VNVD-YSEE-TF-SSVSQL---ATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HH-TCCC-CCTT-TT-TTSCHH---HHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred Hh-cccc-cCch-hh-cccCHH---HHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11 1111 0000 00 112233 4455559999999999999999764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.19 Aligned_cols=192 Identities=18% Similarity=0.302 Sum_probs=168.5
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccC-CCCccceeeEEEe--CCeeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLR-HPNLVPLLGFCVV--EEERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lv~e 370 (604)
++|...+.||+|+||.||+|. ..+++.||||+++.. ..+.+.+|++++++++ ||||+++++++.. ....++|||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 578889999999999999998 577999999999743 3567999999999997 9999999999987 567899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC-CeEEcccCCccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF-DARITDFGLARL 449 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~-~~kl~DFGla~~ 449 (604)
|+++++|.+++. .+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+||+|||+++.
T Consensus 114 ~~~~~~l~~~~~----------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 114 HVNNTDFKQLYQ----------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp CCCCCCHHHHGG----------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ccCchhHHHHHH----------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 999999999884 3778899999999999999999 78999999999999999666 899999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
....... ....|+..|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 181 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 181 YHPGQEY-----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CCTTCCC-----CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred cCCCCcc-----ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 6543322 12348899999998876 6789999999999999999999999954
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=323.00 Aligned_cols=252 Identities=19% Similarity=0.261 Sum_probs=182.9
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccccc--H-HHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLS--E-KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~--~-~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
.++|...+.||+|+||.||++. ..+++.||||+++..... . +.+.++...++.++||||+++++++..++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 3578889999999999999999 467899999999754322 2 23445555688899999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCC-CceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQP-PYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~-~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
||++ |+|.+++...... ...+++..+..++.|++.||.||| +. +|+||||||+||+++.++.+||+|||+++
T Consensus 86 e~~~-~~l~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDK---GQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp ECCS-EEHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred ehhc-cchHHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 9997 5888877542110 135899999999999999999999 55 99999999999999999999999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCcccc----CCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYS----STMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
......... ...||+.|+|||++ ....++.++|||||||++|||+||+.||..... ........
T Consensus 159 ~~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~ 226 (290)
T 3fme_A 159 YLVDDVAKD-----IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-------PFQQLKQV 226 (290)
T ss_dssp ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-------HHHHHHHH
T ss_pred ccccccccc-----ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-------hHHHHHHH
Confidence 764432211 12489999999985 566789999999999999999999999974221 11112222
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
....... . .....+++ +.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~-~-----~~~~~~~~---~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 227 VEEPSPQ-L-----PADKFSAE---FVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHSCCCC-C-----CTTTSCHH---HHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hccCCCC-c-----ccccCCHH---HHHHHHHHhhcChhhCcCHHHHHh
Confidence 2222111 1 11122333 445555999999999999999987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=332.82 Aligned_cols=195 Identities=24% Similarity=0.318 Sum_probs=163.3
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCC------
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE------ 363 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 363 (604)
.+.|...+.||+|+||.||+|.. .+|+.||||++.... ...+++.+|++++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35788889999999999999994 679999999996532 22457889999999999999999999997653
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
..++||||+ +++|.+++... .+++.....++.|+++||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~--------~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~D 171 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE--------KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILD 171 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred eEEEEEecC-CCCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEe
Confidence 459999999 78999998753 4889999999999999999999 78999999999999999999999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
||+++..... .....+|..|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 172 fg~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 172 FGLARQADSE-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp CTTCEECCSS-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecccccccc-------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999876432 122358999999998776 67899999999999999999999999754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=324.77 Aligned_cols=250 Identities=22% Similarity=0.328 Sum_probs=191.7
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc---------cHHHHHHHHHHHhccCCCCccceeeEEEeCC
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL---------SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE 363 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~---------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 363 (604)
.++|...+.||+|+||.||+|.. .+++.||||.+..... ....+.+|++++++++||||+++++++..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 35688899999999999999984 5688999999865321 1234889999999999999999999987655
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC---eE
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD---AR 440 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~---~k 440 (604)
.++||||+++|+|.+++... ..+++.....++.|++.||.||| +.+|+||||||+|||++.++. +|
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN-------KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEE
T ss_pred -eEEEEecCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEE
Confidence 89999999999999998754 35889999999999999999999 789999999999999986654 99
Q ss_pred EcccCCccccCCCCCCCCccccCCCCcccccCcccc---CCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcH
Q 007423 441 ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYS---STMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNL 517 (604)
Q Consensus 441 l~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~ 517 (604)
|+|||+++...... ......||..|+|||++ ....++.++|||||||++|||+||+.||....... .+
T Consensus 158 l~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~ 228 (322)
T 2ycf_A 158 ITDFGHSKILGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SL 228 (322)
T ss_dssp ECCCTTCEECCCCH-----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS----CH
T ss_pred EccCccceeccccc-----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH----HH
Confidence 99999998764321 11223489999999986 35678999999999999999999999997543221 11
Q ss_pred HHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 518 VDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 518 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.. .+..+..... +... ...++ .+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~----~~~~~~~~~~--~~~~-~~~~~---~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 229 KD----QITSGKYNFI--PEVW-AEVSE---KALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HH----HHHHTCCCCC--HHHH-TTSCH---HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HH----HHHhCccccC--chhh-hhcCH---HHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11 1222221110 1110 11123 4455566999999999999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=340.22 Aligned_cols=201 Identities=19% Similarity=0.269 Sum_probs=166.4
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeC-----Ce
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE-----EE 364 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 364 (604)
.++|...+.||+|+||.||+|. ..+++.||||+++... ...+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4678899999999999999998 4568899999997532 2346789999999999999999999999776 56
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEccc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDF 444 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DF 444 (604)
.++||||++ |+|.+++... ..+++..+..++.|+++||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~-------~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DF 173 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP-------IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDF 173 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEecCC-cCHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccC
Confidence 899999986 5999999754 35899999999999999999999 789999999999999999999999999
Q ss_pred CCccccCCCCCCC------------------CccccCCCCcccccCcccc-CCCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007423 445 GLARLVGSRDPND------------------SSFVHGDLGEFGYVAPEYS-STMVASLKGDVYGFGIVLLELLSGQKPLD 505 (604)
Q Consensus 445 Gla~~~~~~~~~~------------------~~~~~~~~gt~~y~aPE~~-~~~~~t~k~DV~SfGvvl~elltg~~p~~ 505 (604)
|+++......... .......+||+.|+|||++ ....++.++||||+||++|||+||..||.
T Consensus 174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 9999765432110 0112345689999999985 56679999999999999999999766654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=332.34 Aligned_cols=195 Identities=22% Similarity=0.245 Sum_probs=161.3
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCC------e
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE------E 364 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~ 364 (604)
++|...+.||+|+||.||+|. ..+++.||||++.... ...+.+.+|+.++++++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 578889999999999999998 4578999999996532 23356889999999999999999999997654 6
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEccc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDF 444 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DF 444 (604)
.++||||+++ +|.+++.. .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 105 ~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Df 171 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQM---------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 171 (371)
T ss_dssp EEEEEECCSE-EHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEcCCC-CHHHHHhh---------ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEe
Confidence 8999999974 78888852 3889999999999999999999 789999999999999999999999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 172 g~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 172 GLARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp CC---------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecccccccccc-----cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 99987643211 12235899999999999889999999999999999999999999754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=325.20 Aligned_cols=251 Identities=18% Similarity=0.236 Sum_probs=194.4
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
.+.|.+.+.||+|+||.||+|.. .+++.||+|.+.... ...+.+.+|++++++++||||+++++++..++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 45788889999999999999995 468999999986543 3457899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++++|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++....
T Consensus 98 ~~~~~l~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 98 CPGGAVDAIMLELD------RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp CTTEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred CCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999987532 35899999999999999999999 7899999999999999999999999999876432
Q ss_pred CCCCCCCccccCCCCcccccCcccc-----CCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYS-----STMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
...... ....|+..|+|||++ ....++.++||||||+++|||+||+.||..... .........
T Consensus 169 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~ 236 (302)
T 2j7t_A 169 KTLQKR----DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAK 236 (302)
T ss_dssp HHHHC---------CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHH
T ss_pred cccccc----ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--------HHHHHHHhc
Confidence 111001 122488999999987 466789999999999999999999999975322 112222222
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
. .......+ ...+.+ +.+++.+||+.||++|||+.|+++
T Consensus 237 ~-~~~~~~~~----~~~~~~---l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 237 S-DPPTLLTP----SKWSVE---FRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp S-CCCCCSSG----GGSCHH---HHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred c-CCcccCCc----cccCHH---HHHHHHHHcccChhhCCCHHHHhc
Confidence 2 11111111 112233 445555999999999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=341.99 Aligned_cols=249 Identities=13% Similarity=0.063 Sum_probs=175.5
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHH---HHhccCCCCcccee-------eE
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMN---RLGQLRHPNLVPLL-------GF 358 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~---~l~~l~H~niv~l~-------g~ 358 (604)
...|...+.||+|+||.||+|. ..+++.||||+++... ...+.+.+|++ +++. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 3458888999999999999999 4578999999997643 22356778854 5555 799988754 45
Q ss_pred EEeC-----------------CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHH------HHHHHHHHHHhhHhhh
Q 007423 359 CVVE-----------------EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTR------LRIGMGASRGLAWLHH 415 (604)
Q Consensus 359 ~~~~-----------------~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~------~~ia~~ia~gL~yLH~ 415 (604)
+..+ ...++||||++ |+|.+++.... ..+++..+ ..++.|++.||+|||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~vk~~i~~qi~~aL~~LH- 211 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD------FVYVFRGDEGILALHILTAQLIRLAANLQ- 211 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH------HSCCCCHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc------cccchhhhhhhhhHHHHHHHHHHHHHHHH-
Confidence 5433 33799999999 89999997642 12445555 788899999999999
Q ss_pred cCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCC--CCCCcccchhhHHHH
Q 007423 416 GCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST--MVASLKGDVYGFGIV 493 (604)
Q Consensus 416 ~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~SfGvv 493 (604)
+.+|+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||+
T Consensus 212 --~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~i 282 (371)
T 3q60_A 212 --SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-------PASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282 (371)
T ss_dssp --HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHH
T ss_pred --HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-------cCccCCcCCcChhhccCCCCCcCccccHHHHHHH
Confidence 7899999999999999999999999999998763211 12236799999999987 679999999999999
Q ss_pred HHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 007423 494 LLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYG---RGNDDEIMQFLRVACSCVVSRPKDRPSMYQ 570 (604)
Q Consensus 494 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 570 (604)
+|||+||+.||.......... | ............... ...++.+ .+++.+||+.||++|||+.|
T Consensus 283 l~elltg~~Pf~~~~~~~~~~-----~-----~~~~~~~~~~~~~~~~~~~~~~~~~---~~li~~~L~~dP~~Rpt~~e 349 (371)
T 3q60_A 283 IYRVWCLFLPFGLVTPGIKGS-----W-----KRPSLRVPGTDSLAFGSCTPLPDFV---KTLIGRFLNFDRRRRLLPLE 349 (371)
T ss_dssp HHHHHHSSCSTTBCCTTCTTC-----C-----CBCCTTSCCCCSCCCTTSSCCCHHH---HHHHHHHTCSSTTTCCCHHH
T ss_pred HHHHHhCCCCCCCcCcccccc-----h-----hhhhhhhccccccchhhccCCCHHH---HHHHHHHcCCChhhCCCHHH
Confidence 999999999997643221000 0 000000000000000 1223444 44555999999999999999
Q ss_pred HHH
Q 007423 571 VYE 573 (604)
Q Consensus 571 v~~ 573 (604)
+++
T Consensus 350 ~l~ 352 (371)
T 3q60_A 350 AME 352 (371)
T ss_dssp HTT
T ss_pred Hhc
Confidence 964
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=331.12 Aligned_cols=201 Identities=21% Similarity=0.257 Sum_probs=172.2
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccC-CC-----CccceeeEEEeCCeee
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLR-HP-----NLVPLLGFCVVEEERL 366 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~-H~-----niv~l~g~~~~~~~~~ 366 (604)
.++|...+.||+|+||.||+|. ..+++.||||+++......+++.+|+++++.++ |+ +|+++++++..++..+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 4688999999999999999998 457889999999865555567888999988885 45 4999999999999999
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC--CCCCeEEccc
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID--DDFDARITDF 444 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~--~~~~~kl~DF 444 (604)
+||||++ |+|.+++..... ..+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+||
T Consensus 133 lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNTNF-----RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEECCC-CBHHHHHHHTTT-----SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred EEEecCC-CCHHHHHhhcCc-----CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999996 599999976532 3489999999999999999999942 46899999999999995 5788999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAG 508 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~ 508 (604)
|+++...... ....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 206 G~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 206 GSSCQLGQRI-------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TTCEETTCCC-------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCceeccccc-------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998764321 12358999999999999899999999999999999999999997543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.22 Aligned_cols=253 Identities=15% Similarity=0.252 Sum_probs=198.6
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEecccccc------------------HHHHHHHHHHHhccCCCCcccee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLS------------------EKQFRSEMNRLGQLRHPNLVPLL 356 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~------------------~~~~~~Ei~~l~~l~H~niv~l~ 356 (604)
++|...+.||+|+||.||+|.. +++.||||++...... .+.+.+|++++++++||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 5788899999999999999999 9999999998643211 17899999999999999999999
Q ss_pred eEEEeCCeeeEEeeecCCCchhhh------hccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCC-CCceecCCCCC
Q 007423 357 GFCVVEEERLLVYKHMPNGTLYSL------LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQ-PPYMHQYISSN 429 (604)
Q Consensus 357 g~~~~~~~~~lv~ey~~~gsL~~~------l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~-~~iiH~dlk~~ 429 (604)
+++...+..++||||+++|+|.++ +.... ...+++..+..++.|++.||.||| + .+|+||||||+
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~ 181 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-----TCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPS 181 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-----CCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGG
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-----ccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChH
Confidence 999999999999999999999999 54321 146899999999999999999999 5 89999999999
Q ss_pred eEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCC-CCCc-ccchhhHHHHHHHHHhCCCCCCCC
Q 007423 430 VILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASL-KGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 430 NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
||+++.++.+||+|||+++..... ......|+..|+|||+..+. .++. ++||||||+++|||+||+.||...
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hEEEcCCCcEEEeccccccccccc------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999876432 12233589999999998877 6666 999999999999999999999754
Q ss_pred CccccccCcHHHHHHHHHHcCCcccccccc-----c-------cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 508 GAEEGFKGNLVDWVNHLVIAGRSRDVVDKS-----L-------YGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~-----l-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
... .+.. ..+..+......+.. . .....+. .+.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~-------~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 256 ISL-------VELF-NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSN---EDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SCS-------HHHH-HHHTSCCCCCCCSSSSSTTTTCC--------CCCH---HHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CcH-------HHHH-HHHhccCcCCccchhhhhccccccccccchhhcCH---HHHHHHHHHccCChhhCCCHHHHhc
Confidence 321 1111 112222111110000 0 0011223 4445555999999999999999976
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.48 Aligned_cols=261 Identities=16% Similarity=0.209 Sum_probs=190.1
Q ss_pred HHhhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeC-------
Q 007423 291 LAATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE------- 362 (604)
Q Consensus 291 ~~~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------- 362 (604)
....++|...+.||+|+||.||+|. ..+|+.||||++.... +...+|++++++++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 3456789999999999999999998 5789999999986532 2234799999999999999999998543
Q ss_pred -------------------------------CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhh
Q 007423 363 -------------------------------EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLA 411 (604)
Q Consensus 363 -------------------------------~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~ 411 (604)
...++||||++ |+|.+.+...... ...+++..+..++.|+++||.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~---~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS---GRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHH
Confidence 34789999998 5888777532111 135899999999999999999
Q ss_pred HhhhcCCCCceecCCCCCeEEeC-CCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCC-CCCcccchhh
Q 007423 412 WLHHGCQPPYMHQYISSNVILID-DDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYG 489 (604)
Q Consensus 412 yLH~~~~~~iiH~dlk~~NiLl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S 489 (604)
||| +.+|+||||||+|||++ +++.+||+|||+++......... ...||..|+|||++.+. .++.++||||
T Consensus 156 ~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (383)
T 3eb0_A 156 FIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV-----AYICSRFYRAPELMLGATEYTPSIDLWS 227 (383)
T ss_dssp HHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCC-----CCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred HHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCc-----CcccCCCccCHHHhcCCCCCCcchhhhh
Confidence 999 88999999999999998 68899999999998764433222 22478999999987764 4899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH--------HH-cCCccccccccc--------cCCCCHHHHHHHHH
Q 007423 490 FGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL--------VI-AGRSRDVVDKSL--------YGRGNDDEIMQFLR 552 (604)
Q Consensus 490 fGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~-~~~~~~~~d~~l--------~~~~~~~~~~~l~~ 552 (604)
+||++|||++|+.||......+. +...+... .. .....+..-+.. .....+. .+.+
T Consensus 228 lG~il~ell~g~~pf~~~~~~~~----~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 300 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGETSIDQ----LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPS---LAID 300 (383)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCH---HHHH
T ss_pred HHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCH---HHHH
Confidence 99999999999999975432211 11111000 00 000000000000 0111223 3455
Q ss_pred HHhhccCCCCCCCCCHHHHHH
Q 007423 553 VACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 553 l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
++.+||+.||++|||+.|+++
T Consensus 301 li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 301 LLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHccCChhhCCCHHHHhc
Confidence 566999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=325.45 Aligned_cols=259 Identities=21% Similarity=0.321 Sum_probs=193.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC--CCC--EEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP--DAS--ALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~--~~~--~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 366 (604)
++|...+.||+|+||.||+|... +++ .||||+++... ...+.+.+|++++++++||||+++++++..+. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 56888899999999999999842 333 68999986532 23467899999999999999999999997655 88
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
+|+||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 97 ~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG------GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred eeEecccCCCHHHHHHhcc------CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccc
Confidence 9999999999999997542 35889999999999999999999 78999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
++......... .......+|..|+|||+..+..++.++||||||+++|||+| |+.||..... .+......
T Consensus 168 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~ 238 (291)
T 1u46_A 168 MRALPQNDDHY-VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKID 238 (291)
T ss_dssp CEECCC-CCEE-EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHH
T ss_pred cccccccccch-hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--------HHHHHHHH
Confidence 98775432211 11122346788999999988889999999999999999999 9999975322 22222222
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
..+.... . ....++ .+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 239 ~~~~~~~-~-----~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 239 KEGERLP-R-----PEDCPQ---DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp TSCCCCC-C-----CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ccCCCCC-C-----CcCcCH---HHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 2221111 0 111223 445555699999999999999999999987653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=319.20 Aligned_cols=250 Identities=19% Similarity=0.289 Sum_probs=197.6
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----------ccHHHHHHHHHHHhccC-CCCccceeeEEEe
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----------LSEKQFRSEMNRLGQLR-HPNLVPLLGFCVV 361 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----------~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~ 361 (604)
.++|...+.||+|+||.||+|.. .+++.||||.++... ...+.+.+|++++++++ ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 35788899999999999999995 578999999986432 12356889999999996 9999999999999
Q ss_pred CCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEE
Q 007423 362 EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARI 441 (604)
Q Consensus 362 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl 441 (604)
.+..++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEE
Confidence 99999999999999999999754 35899999999999999999999 789999999999999999999999
Q ss_pred cccCCccccCCCCCCCCccccCCCCcccccCccccC------CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccC
Q 007423 442 TDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSS------TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKG 515 (604)
Q Consensus 442 ~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~ 515 (604)
+|||+++....... .....|+..|+|||++. ...++.++||||||+++|||++|+.||.....
T Consensus 166 ~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------ 234 (298)
T 1phk_A 166 TDFGFSCQLDPGEK-----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------ 234 (298)
T ss_dssp CCCTTCEECCTTCC-----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------
T ss_pred ecccchhhcCCCcc-----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------
Confidence 99999987643321 12235899999999874 45688999999999999999999999965322
Q ss_pred cHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 516 NLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
...... ...+.... ..+.. ...++ .+.+++.+||+.||++|||+.|+++
T Consensus 235 --~~~~~~-~~~~~~~~-~~~~~--~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 235 --MLMLRM-IMSGNYQF-GSPEW--DDYSD---TVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp --HHHHHH-HHHTCCCC-CTTTG--GGSCH---HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --HHHHHH-HhcCCccc-Ccccc--cccCH---HHHHHHHHHccCCcccCCCHHHHHh
Confidence 111112 22222111 00100 01123 4455556999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=333.35 Aligned_cols=262 Identities=22% Similarity=0.334 Sum_probs=196.2
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
.++|...+.||+|+||.||+|.... .||||.++... ...+.+.+|+.++++++||||+++++++...+..+++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4678889999999999999998754 49999986532 223457889999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++ ++.+||+|||+++..
T Consensus 110 ~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAK------IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp CCCSEEHHHHTTSSC------CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred cccCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 999999999997653 35889999999999999999999 78999999999999998 579999999998765
Q ss_pred CCCCCC-CCccccCCCCcccccCccccCC---------CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHH
Q 007423 451 GSRDPN-DSSFVHGDLGEFGYVAPEYSST---------MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDW 520 (604)
Q Consensus 451 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---------~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 520 (604)
...... .........|+..|+|||++.. ..++.++|||||||++|||+||+.||...... ..
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~ 251 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--------AI 251 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--------HH
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HH
Confidence 322111 1111223358899999998764 45788999999999999999999999753221 11
Q ss_pred HHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCC
Q 007423 521 VNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGF 584 (604)
Q Consensus 521 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~ 584 (604)
. .....+....... ...+.+ +.+++.+||+.||++|||+.|+++.|+.+.++...
T Consensus 252 ~-~~~~~~~~~~~~~-----~~~~~~---l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 252 I-WQMGTGMKPNLSQ-----IGMGKE---ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp H-HHHHTTCCCCCCC-----SSCCTT---HHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred H-HHhccCCCCCCCc-----CCCCHH---HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1 1222222222111 112223 44555599999999999999999999999876544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=324.53 Aligned_cols=259 Identities=16% Similarity=0.231 Sum_probs=200.0
Q ss_pred cCCCcCcEEEecCCeEEEEEEe--CCCCEEEEEEeccccccHHHHHHHHHHHhccCCCC------ccceeeEEEeCCeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL--PDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPN------LVPLLGFCVVEEERL 366 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~--~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~~~ 366 (604)
++|...+.||+|+||.||+|.. .+++.||||+++......+.+.+|+++++.++|++ ++++++++...+..+
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 5788899999999999999984 46889999999866555677899999999987664 999999999999999
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC-----------
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD----------- 435 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~----------- 435 (604)
+||||+ +++|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENGF-----LPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEECC-CCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred EEEcCC-CCCHHHHHHhcCC-----CCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 999999 8899999976532 25889999999999999999999 789999999999999987
Q ss_pred --------CCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 436 --------DFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 436 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
++.+||+|||+++...... ....||..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEHH-------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSCC-------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccCCCceEeeCcccccCcccc-------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 6689999999998753321 1234899999999999889999999999999999999999999754
Q ss_pred CccccccCcHHHHHHHHH--------HcCCccccc---------------------ccc-ccCCCCHHHHHHHHHHHhhc
Q 007423 508 GAEEGFKGNLVDWVNHLV--------IAGRSRDVV---------------------DKS-LYGRGNDDEIMQFLRVACSC 557 (604)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~~---------------------d~~-l~~~~~~~~~~~l~~l~~~C 557 (604)
...+. ...+.... ......... .+. -...........+.+++.+|
T Consensus 238 ~~~~~-----~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 312 (339)
T 1z57_A 238 DSKEH-----LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKM 312 (339)
T ss_dssp CHHHH-----HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred ChHHH-----HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHH
Confidence 32210 00010000 000000000 000 00011223445677777799
Q ss_pred cCCCCCCCCCHHHHHHH
Q 007423 558 VVSRPKDRPSMYQVYES 574 (604)
Q Consensus 558 l~~dP~~RPs~~ev~~~ 574 (604)
|+.||++|||+.|+++.
T Consensus 313 L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 313 LEYDPAKRITLREALKH 329 (339)
T ss_dssp TCSSTTTSCCHHHHTTS
T ss_pred hCcCcccccCHHHHhcC
Confidence 99999999999999753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=331.47 Aligned_cols=262 Identities=13% Similarity=0.180 Sum_probs=198.7
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccC-----------CCCccceeeEEEeC
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLR-----------HPNLVPLLGFCVVE 362 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~~ 362 (604)
++|...+.||+|+||.||+|. ..+++.||||++.......+.+.+|++++++++ ||||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 568889999999999999999 467899999999876656678899999999886 89999999999865
Q ss_pred C----eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCC-CceecCCCCCeEEeC---
Q 007423 363 E----ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQP-PYMHQYISSNVILID--- 434 (604)
Q Consensus 363 ~----~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~-~iiH~dlk~~NiLl~--- 434 (604)
+ ..+++|||+ +++|.+++..... ..+++..+..++.|++.||.||| +. +|+||||||+|||++
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYEH-----RGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTTT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEE
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhhc-----cCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccC
Confidence 4 789999999 8899999976432 34889999999999999999999 66 999999999999994
Q ss_pred ---CCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccc
Q 007423 435 ---DDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEE 511 (604)
Q Consensus 435 ---~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~ 511 (604)
..+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 242 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEHY-------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBCC-------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred CCcCcceEEEcccccccccCCCC-------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 44579999999998764321 12248999999999998889999999999999999999999997543221
Q ss_pred cccCcHHHHHHHHH-HcCCccc---------------------ccccc---------ccCCCCHHHHHHHHHHHhhccCC
Q 007423 512 GFKGNLVDWVNHLV-IAGRSRD---------------------VVDKS---------LYGRGNDDEIMQFLRVACSCVVS 560 (604)
Q Consensus 512 ~~~~~~~~~~~~~~-~~~~~~~---------------------~~d~~---------l~~~~~~~~~~~l~~l~~~Cl~~ 560 (604)
. .. ..+.+.... ..+.... +.... ............+.+++.+||+.
T Consensus 243 ~-~~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 320 (373)
T 1q8y_A 243 Y-TK-DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 320 (373)
T ss_dssp ---C-HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred c-CC-hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhcc
Confidence 1 00 111111111 0111100 00000 00123345566778888899999
Q ss_pred CCCCCCCHHHHHHH
Q 007423 561 RPKDRPSMYQVYES 574 (604)
Q Consensus 561 dP~~RPs~~ev~~~ 574 (604)
||++|||+.|+++.
T Consensus 321 dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 321 DPRKRADAGGLVNH 334 (373)
T ss_dssp STTTCBCHHHHHTC
T ss_pred CccccCCHHHHhhC
Confidence 99999999999873
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=356.18 Aligned_cols=258 Identities=21% Similarity=0.329 Sum_probs=202.0
Q ss_pred hhcCCCcCcEEEecCCeEEEEEEeC----CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeee
Q 007423 293 ATNSFAVENIIISTRTGVSYKAVLP----DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~~~----~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 366 (604)
..++|...+.||+|+||.||+|... .+..||||+++... ...+.+.+|+.++++++||||+++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 3467888899999999999999853 24579999987533 23467999999999999999999999984 56689
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
+||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 467 lv~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK------FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT------TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred EEEEcCCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCC
Confidence 9999999999999997553 35899999999999999999999 78999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
++......... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... +.... +
T Consensus 538 a~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--------~~~~~-i 605 (656)
T 2j0j_A 538 SRYMEDSTYYK---ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGR-I 605 (656)
T ss_dssp CCSCCC-------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHH-H
T ss_pred CeecCCCccee---ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHH-H
Confidence 98764332211 112246789999999988889999999999999999997 99999753221 11222 2
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
..+..... ....++ .+.+++.+||+.||++|||+.||++.|+.+.++
T Consensus 606 ~~~~~~~~------~~~~~~---~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 606 ENGERLPM------PPNCPP---TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHTCCCCC------CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCCCCC------CccccH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 22221111 111223 445556699999999999999999999998765
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=328.56 Aligned_cols=272 Identities=18% Similarity=0.180 Sum_probs=187.2
Q ss_pred HHHHhhcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCe---
Q 007423 289 DLLAATNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEE--- 364 (604)
Q Consensus 289 ~l~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~--- 364 (604)
+.....++|...+.||+|+||.||+|.. .+++.||||++.......+.+.+|++.++.++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 4556678999999999999999999995 578999999986654444567788999999999999999999976433
Q ss_pred ----eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC-CCCe
Q 007423 365 ----RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD-DFDA 439 (604)
Q Consensus 365 ----~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~-~~~~ 439 (604)
.++||||+++ +|.+.+...... ...+++.....++.|++.||.|||.+ +.+|+||||||+|||++. ++.+
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRR---QVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEE
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcE
Confidence 7899999987 554444321000 13588999999999999999999943 578999999999999996 8999
Q ss_pred EEcccCCccccCCCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHH
Q 007423 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLV 518 (604)
Q Consensus 440 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~ 518 (604)
||+|||+++......... ...||..|+|||++.+. .++.++|||||||++|||+||+.||......+. +.
T Consensus 172 kl~Dfg~a~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~----~~ 242 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPNV-----AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ----LH 242 (360)
T ss_dssp EECCCTTCBCCCTTSCCC-----STTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HH
T ss_pred EEeeCCCceecCCCCCcc-----cccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH----HH
Confidence 999999998765433221 23489999999988654 489999999999999999999999976432211 11
Q ss_pred HHHHH-----------HHHcCCccccccc------cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 519 DWVNH-----------LVIAGRSRDVVDK------SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 519 ~~~~~-----------~~~~~~~~~~~d~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
..++. ........+..+. .............+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11110 0000000000000 00001111123455666669999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=357.72 Aligned_cols=247 Identities=17% Similarity=0.209 Sum_probs=199.2
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeE
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 367 (604)
.++|...+.||+|+||.||+|. ..+++.||||+++... ...+.+..|..++..+ +||||+++++++.+.+..|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 4678899999999999999999 4568899999997532 2235688899999988 79999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||||+++|+|.++++.. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 420 V~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV-------GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp EEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred EEeCcCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeeccee
Confidence 99999999999999864 35899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
+........ .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... +.... +..
T Consensus 490 ~~~~~~~~~----~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--------~~~~~-i~~ 556 (674)
T 3pfq_A 490 KENIWDGVT----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQS-IME 556 (674)
T ss_dssp EECCCTTCC----BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHH-HHS
T ss_pred eccccCCcc----cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH--------HHHHH-HHh
Confidence 864322221 22345999999999999999999999999999999999999999754321 11222 222
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSM-----YQVYE 573 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~ev~~ 573 (604)
+... .+...+.++.++++ +||+.||++||++ .||++
T Consensus 557 ~~~~-------~p~~~s~~~~~li~---~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 557 HNVA-------YPKSMSKEAVAICK---GLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SCCC-------CCTTSCHHHHHHHH---HHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCCC-------CCccCCHHHHHHHH---HHccCCHHHCCCCCCCcHHHHhc
Confidence 2111 01123344555544 9999999999997 66643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=338.41 Aligned_cols=258 Identities=20% Similarity=0.246 Sum_probs=187.5
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCe------eeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEE------RLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------~~lv 368 (604)
.+|...+.||+|+||.||+|+...+..||+|++..... ...+|++++++++||||+++++++...+. .++|
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 46888899999999999999987777799999854321 23369999999999999999999975433 7899
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC-CCCCeEEcccCCc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID-DDFDARITDFGLA 447 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~-~~~~~kl~DFGla 447 (604)
|||++++ +.+.+..... ....+++..+..++.|+++||.||| +.+|+||||||+|||++ .++.+||+|||++
T Consensus 117 ~e~~~~~-l~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 117 LEYVPET-VYRASRHYAK---LKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EECCSEE-HHHHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eeccCcc-HHHHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 9999875 4433321100 0135899999999999999999999 78999999999999999 7999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH--
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL-- 524 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 524 (604)
+......... ...||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. +...+...
T Consensus 190 ~~~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~----l~~i~~~~g~ 260 (394)
T 4e7w_A 190 KILIAGEPNV-----SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ----LVEIIKVLGT 260 (394)
T ss_dssp EECCTTCCCC-----SSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCC
T ss_pred ccccCCCCCc-----ccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCC
Confidence 8764433222 23489999999988654 589999999999999999999999976432211 11111100
Q ss_pred ------HH-c-----CCcccccccc---ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 525 ------VI-A-----GRSRDVVDKS---LYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 525 ------~~-~-----~~~~~~~d~~---l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.. . .......... ......++ .+.+++.+||+.||++|||+.|+++.
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPP---DAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCH---HHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHhhChhhhhhccccccCCcHHHhccccCCH---HHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00 0 0000000000 00011223 45556669999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=322.14 Aligned_cols=254 Identities=21% Similarity=0.262 Sum_probs=189.5
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEe-----------
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVV----------- 361 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----------- 361 (604)
.++|...+.||+|+||.||+|.. .+++.||||+++......+.+.+|++++++++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 45788899999999999999994 579999999997655455779999999999999999999999865
Q ss_pred --CCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCe
Q 007423 362 --EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439 (604)
Q Consensus 362 --~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~ 439 (604)
.+..++||||+++|+|.+++.... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~ 155 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSEN------LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNV 155 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSC------GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCE
T ss_pred ccCCceEEEEecCCCCCHHHhhhccc------cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCE
Confidence 356799999999999999997543 34788899999999999999999 7899999999999999999999
Q ss_pred EEcccCCccccCCCCCC----------CCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 007423 440 RITDFGLARLVGSRDPN----------DSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAG 508 (604)
Q Consensus 440 kl~DFGla~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~ 508 (604)
||+|||+++........ .........|+..|+|||++.+. .++.++|||||||++|||++ ||....
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~ 232 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM 232 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence 99999999876432100 01112234588999999998754 68999999999999999998 553210
Q ss_pred ccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 509 AEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
...+.... ...... ...+. ........+.+++.+||+.||++|||+.|+++
T Consensus 233 -------~~~~~~~~-~~~~~~--~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 -------ERVNILKK-LRSVSI--EFPPD----FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -------HHHHHHHH-HHSTTC--CCCTT----CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------hHHHHHHh-cccccc--ccCcc----ccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11111111 111111 11111 11122233445555999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=316.41 Aligned_cols=250 Identities=16% Similarity=0.230 Sum_probs=194.1
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc-----ccHHHHHHHHHHHhccCCCCccceeeEEEe--CCeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK-----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV--EEERL 366 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~ 366 (604)
++|...+.||+|+||.||++.. .+++.||||.++... ...+.+.+|++++++++||||+++++++.. .+..+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 5799999999999999999994 578999999997532 234679999999999999999999999853 45789
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
+||||+++| |.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 85 lv~e~~~~~-l~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPE-----KRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTT-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEehhccCC-HHHHHHhCcc-----cccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccc
Confidence 999999876 7777764321 35899999999999999999999 78999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCC--CCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMV--ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
++........ .......|+..|+|||+..+.. ++.++||||||+++|||+||+.||.... ..+....
T Consensus 156 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~- 224 (305)
T 2wtk_C 156 AEALHPFAAD--DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKLFEN- 224 (305)
T ss_dssp CEECCTTCSS--CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHH-
T ss_pred ccccCccccc--cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHHHHHH-
Confidence 9876432211 1122345899999999887643 4789999999999999999999997532 1122222
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
+..+... .. ...++++ .+++.+||+.||++|||+.|+++.
T Consensus 225 i~~~~~~------~~-~~~~~~l---~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 225 IGKGSYA------IP-GDCGPPL---SDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHCCCC------CC-SSSCHHH---HHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HhcCCCC------CC-CccCHHH---HHHHHHHccCChhhCCCHHHHhcC
Confidence 2222111 11 1123344 455559999999999999999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=330.32 Aligned_cols=194 Identities=22% Similarity=0.289 Sum_probs=165.0
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCee----
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER---- 365 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~---- 365 (604)
.++|...+.||+|+||.||+|. ..+|+.||||++..... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 3578888999999999999998 55789999999975432 246788999999999999999999999876654
Q ss_pred --eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 366 --LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 366 --~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
++||||+. |+|.+++.. .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~D 187 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM---------EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILD 187 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECS
T ss_pred eEEEEEcccc-ccHHHHhhc---------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEe
Confidence 99999997 689888742 3889999999999999999999 78999999999999999999999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
||+++...... ....||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 188 fg~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 188 FGLARHADAEM-------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp TTCC---------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCcccccccCc-------CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 99998654321 22358999999998876 67899999999999999999999999754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=329.10 Aligned_cols=203 Identities=22% Similarity=0.284 Sum_probs=171.0
Q ss_pred hhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeC-----Ce
Q 007423 293 ATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE-----EE 364 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 364 (604)
..++|...+.||+|+||.||+|. ..+++.||||++.... ...+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 34678899999999999999998 4578899999997533 2336789999999999999999999999765 36
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEccc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDF 444 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DF 444 (604)
.++||||++ |+|.+++... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Df 172 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ--------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDF 172 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEcccC-cCHHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeC
Confidence 899999997 5999998653 4889999999999999999999 789999999999999999999999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccC-CCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSS-TMVASLKGDVYGFGIVLLELLSGQKPLDVAG 508 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~k~DV~SfGvvl~elltg~~p~~~~~ 508 (604)
|+++......... .......||+.|+|||++. ...++.++|||||||++|||+||+.||....
T Consensus 173 g~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 236 (364)
T 3qyz_A 173 GLARVADPDHDHT-GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236 (364)
T ss_dssp TTCEECCGGGCBC-CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceEecCCCCCcc-ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence 9998764322211 1122346899999999764 4558999999999999999999999997643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=339.89 Aligned_cols=257 Identities=18% Similarity=0.224 Sum_probs=184.1
Q ss_pred CCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEeeecCCC
Q 007423 297 FAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHMPNG 375 (604)
Q Consensus 297 ~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~g 375 (604)
|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++..++..++||||+. |
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 4456889999999998776678999999998653 245678999999886 89999999999999999999999995 6
Q ss_pred chhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC-------------CCeEEc
Q 007423 376 TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD-------------FDARIT 442 (604)
Q Consensus 376 sL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~-------------~~~kl~ 442 (604)
+|.+++.............++..+..++.|++.||+||| +.+|+||||||+|||++.+ +.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 999999865322111011233456789999999999999 7899999999999999653 589999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCC-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCCcccccc
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-------MVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFK 514 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~ 514 (604)
|||+++.................||+.|+|||++.+ ..++.++|||||||++|||+| |+.||......+
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--- 247 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--- 247 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH---
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH---
Confidence 999999875433222212233468999999998865 568999999999999999999 999996432110
Q ss_pred CcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 515 GNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.... .+... . +.............+.+++.+||+.||++|||+.||++
T Consensus 248 -------~~i~-~~~~~-~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 -------SNII-RGIFS-L--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -------HHHH-HTCCC-C--CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------HHHh-cCCCC-c--ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111 11111 0 00011122334456667777999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=327.08 Aligned_cols=202 Identities=21% Similarity=0.301 Sum_probs=168.4
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeC-----Cee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE-----EER 365 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 365 (604)
.++|...+.||+|+||.||+|.. .+|+.||||+++... ....++.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 46788899999999999999995 578999999996433 2345688999999999999999999998764 568
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
++||||+. |+|.+++... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 90 ~lv~e~~~-~~L~~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ--------MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEeccC-ccHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecc
Confidence 99999997 6999998753 4889999999999999999999 7899999999999999999999999999
Q ss_pred CccccCCCCCCCC------ccccCCCCcccccCccccC-CCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 446 LARLVGSRDPNDS------SFVHGDLGEFGYVAPEYSS-TMVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 446 la~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~-~~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
+++.......... .......||..|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9987653221110 1112335899999999765 467899999999999999999999999754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.15 Aligned_cols=250 Identities=20% Similarity=0.267 Sum_probs=197.6
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
.++|...+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|++++++++||||+++++++...+..++|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 35789999999999999999995 478999999986432 34577999999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC---CCeEEcccCC
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD---FDARITDFGL 446 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~---~~~kl~DFGl 446 (604)
||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.+ +.+||+|||+
T Consensus 101 e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 101 ELYTGGELFDEIIKR-------KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp CCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 999999999988654 35889999999999999999999 7899999999999999754 4799999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
++......... ...|+..|+|||.+.+ .++.++||||||+++|||++|+.||..... .+... .+.
T Consensus 171 ~~~~~~~~~~~-----~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~-~~~ 235 (287)
T 2wei_A 171 STCFQQNTKMK-----DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILK-RVE 235 (287)
T ss_dssp GGTBCCCSSCS-----CHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH-HHH
T ss_pred ceeecCCCccc-----cccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--------HHHHH-HHH
Confidence 98764332211 1237899999998865 489999999999999999999999975322 11222 222
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.+....... .. ...+++ +.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~-~~--~~~~~~---~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 236 TGKYAFDLP-QW--RTISDD---AKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HCCCCCCSG-GG--TTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cCCCCCCch-hh--hhcCHH---HHHHHHHHcccChhhCcCHHHHhcC
Confidence 232211110 00 112334 4455559999999999999999873
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=337.67 Aligned_cols=258 Identities=22% Similarity=0.230 Sum_probs=188.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeC----C--eeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE----E--ERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----~--~~~l 367 (604)
..|...+.||+|+||.||+|+. .+++.||||++.... +.+.+|++++++++|||||++++++... + ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 4588889999999999999995 569999999986532 2244799999999999999999998642 1 3679
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC-CCeEEcccCC
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD-FDARITDFGL 446 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~-~~~kl~DFGl 446 (604)
||||+++ ++.+.+...... ...+++..+..++.|+++||.||| +.+|+||||||+|||++.+ +.+||+|||+
T Consensus 131 v~e~~~~-~l~~~~~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRA---KQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ehhcccc-cHHHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 9999986 676665431100 135899999999999999999999 8899999999999999954 6689999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH-
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL- 524 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 524 (604)
++......... ...||..|+|||++.+. .++.++|||||||++|||++|+.||......+ .+.+.+...
T Consensus 204 a~~~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~----~l~~i~~~lg 274 (420)
T 1j1b_A 204 AKQLVRGEPNV-----SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD----QLVEIIKVLG 274 (420)
T ss_dssp CEECCTTCCCC-----SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHC
T ss_pred hhhcccCCCce-----eeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhC
Confidence 99764432221 23489999999988654 78999999999999999999999997643221 111111100
Q ss_pred -------H-HcCCcccccccccc--------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 525 -------V-IAGRSRDVVDKSLY--------GRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 525 -------~-~~~~~~~~~d~~l~--------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
. ......+..-+.+. ....+ .++.+++.+||+.||++|||+.|+++.
T Consensus 275 ~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~---~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTP---PEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp SCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSC---HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCC---HHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 00011111111110 01112 345556669999999999999999863
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=331.64 Aligned_cols=195 Identities=23% Similarity=0.321 Sum_probs=152.9
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeC------C
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE------E 363 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 363 (604)
.++|...+.||+|+||.||+|. ..+|+.||||++.... ...+.+.+|++++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 3678889999999999999998 5678999999996532 2346788999999999999999999998754 4
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
..++++||+ +++|.+++... .+++..+..++.|+++||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~D 175 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ--------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 175 (367)
T ss_dssp CCEEEEECC-CEECC-----C--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred eEEEEeccc-CCCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEee
Confidence 579999999 67999988642 4889999999999999999999 78999999999999999999999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
||+++..... .....||..|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus 176 FG~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 233 (367)
T 2fst_X 176 FGLARHTADE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233 (367)
T ss_dssp ----------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccc-------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999875422 122358999999998876 67899999999999999999999999754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=321.81 Aligned_cols=198 Identities=16% Similarity=0.226 Sum_probs=170.2
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCC-CEEEEEEeccccccHHHHHHHHHHHhccCCCC------ccceeeEEEeCCeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDA-SALAIKRLSACKLSEKQFRSEMNRLGQLRHPN------LVPLLGFCVVEEERL 366 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~-~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~~~ 366 (604)
++|...+.||+|+||.||+|.. .++ +.||||+++......+.+.+|++++++++|++ ++.+.+++...+..+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC 98 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence 5788899999999999999984 344 68999999866555677899999999998766 899999999999999
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe-------------
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI------------- 433 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl------------- 433 (604)
+||||+ ++++.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+|||+
T Consensus 99 lv~e~~-~~~l~~~l~~~~~-----~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 99 IAFELL-GKNTFEFLKENNF-----QPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEECC-CCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred EEEecc-CCChHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccc
Confidence 999999 5677777765432 35899999999999999999999 8899999999999999
Q ss_pred ------CCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 434 ------DDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 434 ------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
+.++.+||+|||+++...... ....||..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEHH-------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSCC-------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccCCCcEEEeecCccccccccc-------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 567899999999998753321 1234899999999999889999999999999999999999999754
Q ss_pred C
Q 007423 508 G 508 (604)
Q Consensus 508 ~ 508 (604)
.
T Consensus 243 ~ 243 (355)
T 2eu9_A 243 E 243 (355)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=323.64 Aligned_cols=255 Identities=21% Similarity=0.290 Sum_probs=173.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHH-HHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMN-RLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
++|...+.||+|+||.||+|.. .+++.||||+++... ...+++..|+. +++.++||||+++++++..++..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 5688889999999999999995 578999999997543 22345666666 7888899999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCC-CceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQP-PYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~-~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
|+++ +|.+++...... ....+++..+..++.|++.||.||| +. +|+||||||+||+++.++.+||+|||+++.
T Consensus 102 ~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSV--LDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp CCSE-EHHHHHHHHHHT--TCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred ecCC-ChHHHHHHHHhh--hcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 9985 888777531100 0135889999999999999999999 55 899999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCcccc----CCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHH
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYS----STMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
....... ....||..|+|||++ .+..++.++|||||||++|||+||+.||....... +.... .
T Consensus 176 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~-~ 242 (327)
T 3aln_A 176 LVDSIAK-----TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-------DQLTQ-V 242 (327)
T ss_dssp -----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CC-C
T ss_pred ccccccc-----ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-------HHHHH-H
Confidence 6432211 122489999999998 45668999999999999999999999997532110 00000 0
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
..+...... ... ....+. .+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~-~~~-~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 243 VKGDPPQLS-NSE-EREFSP---SFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCSCCCCCC-CCS-SCCCCH---HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hcCCCCCCC-Ccc-cccCCH---HHHHHHHHHhhCChhhCcCHHHHHh
Confidence 001111110 000 011233 4455555999999999999999965
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.35 Aligned_cols=252 Identities=18% Similarity=0.250 Sum_probs=192.0
Q ss_pred hhcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEecccc---ccHHHHHHHHHHHhccC--CCCccceeeEEEeCCeeeE
Q 007423 293 ATNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACK---LSEKQFRSEMNRLGQLR--HPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~l 367 (604)
..++|...+.||+|+||.||++...+++.||||++.... ...+.+.+|++++++++ ||||+++++++..++..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 346788899999999999999998889999999996433 23467899999999997 5999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||| +.+++|.+++... ..+++..+..++.|+++||.||| +.+|+||||||+|||+++ +.+||+|||++
T Consensus 106 v~e-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp EEC-CCSEEHHHHHHHC-------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred EEe-cCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeecccc
Confidence 999 5688999999765 35889999999999999999999 789999999999999975 78999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCC-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCc
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-----------MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGN 516 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~ 516 (604)
+......... ......|++.|+|||++.+ ..++.++|||||||++|||+||+.||.....
T Consensus 174 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------- 244 (313)
T 3cek_A 174 NQMQPDTTSV--VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------- 244 (313)
T ss_dssp CC----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-------
T ss_pred ccccCccccc--cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-------
Confidence 8764332211 1123358999999998765 4688899999999999999999999964321
Q ss_pred HHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 517 LVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
................. ....+++ +.+++.+||+.||++||++.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~------~~~~~~~---l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 245 QISKLHAIIDPNHEIEF------PDIPEKD---LQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHHHHHCTTSCCCC------CCCSCHH---HHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHhcccccCC------cccchHH---HHHHHHHHccCCcccCcCHHHHhcC
Confidence 11112222211111111 1112334 4455559999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.35 Aligned_cols=259 Identities=20% Similarity=0.242 Sum_probs=194.4
Q ss_pred hhcCCCcCcEEEecCCeEEEEEEe--CCCCEEEEEEeccccc---cHHHHHHHHHHHhcc---CCCCccceeeEEE----
Q 007423 293 ATNSFAVENIIISTRTGVSYKAVL--PDASALAIKRLSACKL---SEKQFRSEMNRLGQL---RHPNLVPLLGFCV---- 360 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~~--~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l---~H~niv~l~g~~~---- 360 (604)
..++|...+.||+|+||.||+|.. .+++.||||+++.... ....+.+|+++++++ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999996 4688999999864322 123567788877766 8999999999997
Q ss_pred -eCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCe
Q 007423 361 -VEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439 (604)
Q Consensus 361 -~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~ 439 (604)
.....++||||++ |+|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~ 159 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQI 159 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT-----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCE
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCE
Confidence 4567899999998 699999976532 24889999999999999999999 7899999999999999999999
Q ss_pred EEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHH
Q 007423 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVD 519 (604)
Q Consensus 440 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~ 519 (604)
||+|||+++...... ......||..|+|||++.+..++.++|||||||++|||+||+.||......+ ...
T Consensus 160 kl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~ 229 (326)
T 1blx_A 160 KLADFGLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-----QLG 229 (326)
T ss_dssp EECSCCSCCCCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHH
T ss_pred EEecCcccccccCCC-----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-----HHH
Confidence 999999998653221 1223358999999999988889999999999999999999999997543211 111
Q ss_pred HHHHHHHcCCcccc----------cc----cc--ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 520 WVNHLVIAGRSRDV----------VD----KS--LYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 520 ~~~~~~~~~~~~~~----------~d----~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.+............ .. .. ......++++ .+++.+||+.||++|||+.|+++
T Consensus 230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 230 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG---KDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHH---HHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHH---HHHHHHHcCCCcccCCCHHHHhc
Confidence 11111000000000 00 00 0001123344 45555999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=322.67 Aligned_cols=193 Identities=22% Similarity=0.284 Sum_probs=164.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCe------
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEE------ 364 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------ 364 (604)
++|...+.||+|+||.||+|.. .+|+.||||++..... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 5688889999999999999994 5789999999975332 23578899999999999999999999987654
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEccc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDF 444 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DF 444 (604)
.++||||++ |+|.+++.. .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+||
T Consensus 104 ~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Df 170 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL---------KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDF 170 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECST
T ss_pred EEEEecccc-CCHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeec
Confidence 499999997 689888742 3889999999999999999999 789999999999999999999999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
|+++...... ....||..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 171 g~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 227 (353)
T 3coi_A 171 GLARHADAEM-------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227 (353)
T ss_dssp TCTTC---------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred ccccCCCCCc-------cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9998653221 12348999999998876 67899999999999999999999999754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.43 Aligned_cols=253 Identities=16% Similarity=0.202 Sum_probs=169.1
Q ss_pred hcCCCcC-cEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEe----CCeeeE
Q 007423 294 TNSFAVE-NIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVV----EEERLL 367 (604)
Q Consensus 294 ~~~~~~~-~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~l 367 (604)
.++|... ++||+|+||.||+|.. .+++.||||++.......+ +....++.++||||+++++++.. +...++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 4677774 5799999999999995 4799999999965432222 22233566799999999999976 445899
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC---CCCeEEccc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD---DFDARITDF 444 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~---~~~~kl~DF 444 (604)
||||+++|+|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+||
T Consensus 104 v~e~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGD-----QAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEECCTTEEHHHHHHTC-C-----CCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEeccCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence 9999999999999986532 35899999999999999999999 789999999999999986 455999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
|+++....... ....||+.|+|||++.+..++.++|||||||++|||+||+.||.......... .....
T Consensus 176 g~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~~~~~ 244 (336)
T 3fhr_A 176 GFAKETTQNAL------QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-----GMKRR 244 (336)
T ss_dssp TTCEEC----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred ccceecccccc------ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-----hHHHh
Confidence 99986643211 12347999999999988889999999999999999999999997543221100 00000
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
...+.. ....+. ....+++ +.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~-~~~~~~--~~~~~~~---~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 245 IRLGQY-GFPNPE--WSEVSED---AKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -------CCCTTT--STTCCHH---HHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhcccc-ccCchh--hccCCHH---HHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011100 000000 0122334 4455559999999999999999873
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=329.54 Aligned_cols=205 Identities=20% Similarity=0.264 Sum_probs=154.5
Q ss_pred CCc-CcEEEecCCeEEEEEEeC---CCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEe--CCeeeEEee
Q 007423 297 FAV-ENIIISTRTGVSYKAVLP---DASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVV--EEERLLVYK 370 (604)
Q Consensus 297 ~~~-~~~ig~G~~g~vy~~~~~---~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lv~e 370 (604)
|.. .++||+|+||.||+|... +++.||||++..... .+.+.+|++++++++||||+++++++.. ....++|||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e 100 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence 444 468999999999999954 578999999975433 3568899999999999999999999965 668899999
Q ss_pred ecCCCchhhhhccCCCC--CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEe----CCCCCeEEccc
Q 007423 371 HMPNGTLYSLLHGNGVD--NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILI----DDDFDARITDF 444 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~--~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl----~~~~~~kl~DF 444 (604)
|++ |+|.+++...... ......+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+||
T Consensus 101 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 101 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp CCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred CCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 997 4888887532110 001134899999999999999999999 7899999999999999 67889999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
|+++........ ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 177 g~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 177 GFARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp TCCC-----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred CCceecCCCCcc-cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 999876432111 111223458999999998876 45899999999999999999999999754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=317.39 Aligned_cols=200 Identities=21% Similarity=0.260 Sum_probs=160.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC-CCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEE------------
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP-DASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCV------------ 360 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~------------ 360 (604)
++|...+.||+|+||.||+|... +++.||||++.... ...+++.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 56888899999999999999954 58999999986543 33467899999999999999999999874
Q ss_pred --eCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC-CCC
Q 007423 361 --VEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID-DDF 437 (604)
Q Consensus 361 --~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~-~~~ 437 (604)
.....++||||++ |+|.+++... .+++.....++.|++.||+||| +.+|+||||||+||+++ +++
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQG--------PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTTC--------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTT
T ss_pred ccccCceeEEeeccC-CCHHHHhhcC--------CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCC
Confidence 3467899999998 6999998642 4889999999999999999999 78999999999999997 667
Q ss_pred CeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 438 DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 438 ~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
.+||+|||+++.......... ......++..|+|||.+.. ..++.++|||||||++|||+||+.||...
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 228 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKG-HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA 228 (320)
T ss_dssp EEEECCCTTCBCC---------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eEEEccCccccccCCCccccc-ccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence 999999999987643221111 1122347889999997754 67899999999999999999999999754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=325.25 Aligned_cols=240 Identities=19% Similarity=0.310 Sum_probs=193.5
Q ss_pred hhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc-------cHHHHHHHHHHHhccC--CCCccceeeEEEeC
Q 007423 293 ATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL-------SEKQFRSEMNRLGQLR--HPNLVPLLGFCVVE 362 (604)
Q Consensus 293 ~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~-------~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~ 362 (604)
..++|...+.||+|+||.||+|. ..+++.||||+++.... ..+.+.+|+.++++++ ||||+++++++..+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 34678899999999999999998 56789999999965432 1245778999999996 59999999999999
Q ss_pred CeeeEEeeecCC-CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC-CCCCeE
Q 007423 363 EERLLVYKHMPN-GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID-DDFDAR 440 (604)
Q Consensus 363 ~~~~lv~ey~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~-~~~~~k 440 (604)
+..++|+||+.. ++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++ +++.+|
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITER-------GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEE
T ss_pred CcEEEEEEcCCCCccHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEE
Confidence 999999999986 8999999754 35889999999999999999999 78999999999999999 788999
Q ss_pred EcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHH
Q 007423 441 ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA-SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVD 519 (604)
Q Consensus 441 l~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~ 519 (604)
|+|||+++....... ....||..|+|||++.+..+ +.++|||||||++|||+||+.||....
T Consensus 191 L~Dfg~~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----------- 253 (320)
T 3a99_A 191 LIDFGSGALLKDTVY------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------- 253 (320)
T ss_dssp ECCCTTCEECCSSCB------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------
T ss_pred EeeCccccccccccc------cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----------
Confidence 999999987643211 12348999999998876665 688999999999999999999996421
Q ss_pred HHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 520 WVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 520 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.. ..+... . ....++++ .+++.+||+.||++|||+.||++
T Consensus 254 ---~~-~~~~~~--~-----~~~~~~~~---~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 ---EI-IRGQVF--F-----RQRVSSEC---QHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ---HH-HHCCCC--C-----SSCCCHHH---HHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---hh-hccccc--c-----cccCCHHH---HHHHHHHccCChhhCcCHHHHhc
Confidence 01 111110 1 11223344 45555999999999999999976
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=329.78 Aligned_cols=251 Identities=21% Similarity=0.253 Sum_probs=183.2
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEeeec
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
..+|...+.||+|+||.||.....+++.||||++..... +.+.+|+++++++ +|||||++++++...+..++||||+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 346888899999999986655566899999999965332 2356899999999 8999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC-----CCCCeEEcccCCc
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID-----DDFDARITDFGLA 447 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~-----~~~~~kl~DFGla 447 (604)
+ |+|.+++..... ...+.....++.|++.||.||| +.+|+||||||+|||++ ....+||+|||++
T Consensus 101 ~-g~L~~~l~~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 101 A-ATLQEYVEQKDF------AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp S-EEHHHHHHSSSC------CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred C-CCHHHHHHhcCC------CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 6 699999976542 2334456789999999999999 78999999999999994 3346889999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccC---CCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHH
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSS---TMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNH 523 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 523 (604)
+......... .......||+.|+|||++. ...++.++|||||||++|||+| |+.||...... ....
T Consensus 171 ~~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---------~~~~ 240 (432)
T 3p23_A 171 KKLAVGRHSF-SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---------QANI 240 (432)
T ss_dssp ECC-------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---------HHHH
T ss_pred eeccCCCcce-eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---------HHHH
Confidence 8765332111 1122346899999999987 4567889999999999999999 99998532111 1111
Q ss_pred HHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 524 LVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 524 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
...........+ .......+.+++.+||+.||++|||+.||++
T Consensus 241 -~~~~~~~~~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 241 -LLGACSLDCLHP------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -HTTCCCCTTSCT------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -HhccCCccccCc------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111111111111 1122233456666999999999999999984
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=319.64 Aligned_cols=242 Identities=20% Similarity=0.316 Sum_probs=186.6
Q ss_pred HhhcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccccc-------HHHHHHHHHHHhcc----CCCCccceeeEE
Q 007423 292 AATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLS-------EKQFRSEMNRLGQL----RHPNLVPLLGFC 359 (604)
Q Consensus 292 ~~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~-------~~~~~~Ei~~l~~l----~H~niv~l~g~~ 359 (604)
.-.++|...+.||+|+||.||+|. ..+++.||||+++..... ...+.+|+.+++++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 345679999999999999999998 467899999999654321 22356799999998 899999999999
Q ss_pred EeCCeeeEEeee-cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC-CCC
Q 007423 360 VVEEERLLVYKH-MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID-DDF 437 (604)
Q Consensus 360 ~~~~~~~lv~ey-~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~-~~~ 437 (604)
...+..++|+|| +++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++ +++
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK-------GPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTT
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCC
Confidence 999999999999 7899999999764 35899999999999999999999 77999999999999999 889
Q ss_pred CeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCccccccCc
Q 007423 438 DARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA-SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGN 516 (604)
Q Consensus 438 ~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~ 516 (604)
.+||+|||+++....... ....|+..|+|||++.+..+ +.++||||||+++|||+||+.||....
T Consensus 178 ~~kl~dfg~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------- 243 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEPY------TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------- 243 (312)
T ss_dssp EEEECCCSSCEECCSSCB------CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------
T ss_pred eEEEEEcchhhhcccCcc------cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------
Confidence 999999999987643221 22348999999998876665 458999999999999999999996310
Q ss_pred HHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 517 LVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
... ..... . ....+.+ +.+++.+||+.||++|||+.|+++.
T Consensus 244 ------~~~-~~~~~------~-~~~~~~~---~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 ------EIL-EAELH------F-PAHVSPD---CCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ------HHH-HTCCC------C-CTTSCHH---HHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------HHh-hhccC------C-cccCCHH---HHHHHHHHccCChhhCcCHHHHhcC
Confidence 011 11110 0 1112233 4455559999999999999999863
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=312.72 Aligned_cols=249 Identities=17% Similarity=0.258 Sum_probs=175.1
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccccc--H-HHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLS--E-KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~--~-~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
++|...+.||+|+||.||+|.. .+++.||||++...... . +.+.++..+++.++||||+++++++..++..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 5688889999999999999995 57899999999754322 2 234455567888899999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCC-CCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQ-PPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~-~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
|+ ++.+..+..... ..+++..+..++.|++.||.||| + .+|+||||||+||+++.++.+||+|||+++.
T Consensus 105 ~~-~~~~~~l~~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 105 LM-GTCAEKLKKRMQ------GPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp CC-SEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred cc-CCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 99 445555554321 35889999999999999999999 5 3899999999999999999999999999976
Q ss_pred cCCCCCCCCccccCCCCcccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSS-----TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
....... ....|+..|+|||++. ...++.++|||||||++|||+||+.||..... ..+.....
T Consensus 175 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~ 242 (318)
T 2dyl_A 175 LVDDKAK-----DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-------DFEVLTKV 242 (318)
T ss_dssp -----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHHHHHHH
T ss_pred ccCCccc-----cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-------cHHHHHHH
Confidence 6432211 1224899999999884 45688999999999999999999999974221 11222222
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
... ....... ....+.++. +++.+||+.||++||++.|+++
T Consensus 243 ~~~-~~~~~~~----~~~~~~~l~---~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 243 LQE-EPPLLPG----HMGFSGDFQ---SFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHS-CCCCCCS----SSCCCHHHH---HHHHHHTCSCTTTSCCHHHHTT
T ss_pred hcc-CCCCCCc----cCCCCHHHH---HHHHHHccCChhHCcCHHHHhh
Confidence 222 1111110 011233444 4555999999999999999976
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=305.25 Aligned_cols=232 Identities=15% Similarity=0.113 Sum_probs=179.5
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccc----cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKL----SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||+|.. .+++.||||.+..... ..+.+.+|+.++++++||||+++++++..++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 5688899999999999999995 4589999999975432 2367899999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++++|.+++... ........++.|++.||.||| +.+|+||||||+|||+++++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~---------~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~---- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS---------PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA---- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC---------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC----
T ss_pred EecCCCCHHHHHhcC---------CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc----
Confidence 999999999999532 244567889999999999999 7899999999999999999999998443
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
|++| ++.++|||||||++|||+||+.||......+...... ...
T Consensus 175 --------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---------~~~ 218 (286)
T 3uqc_A 175 --------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---------RDT 218 (286)
T ss_dssp --------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---------BCT
T ss_pred --------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---------HHh
Confidence 3332 6889999999999999999999998654322110000 000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
......+.......++++ .+++.+||+.||++| |+.|+++.|+++....
T Consensus 219 ~~~~~~~~~~~~~~~~~l---~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 219 AGQPIEPADIDRDIPFQI---SAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp TSCBCCHHHHCTTSCHHH---HHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred ccCCCChhhcccCCCHHH---HHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 000000000111223344 455559999999999 9999999999987644
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=340.73 Aligned_cols=274 Identities=17% Similarity=0.201 Sum_probs=196.4
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEe------CCee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV------EEER 365 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~~ 365 (604)
++|...+.||+|+||.||+|.. .+|+.||||+++... ...+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999984 578999999987532 334678999999999999999999998755 6678
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC---eEEc
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD---ARIT 442 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~---~kl~ 442 (604)
++||||+++|+|.+++...... ..+++..+..++.+++.||.||| +.+|+||||||+||+++.++. +||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~----~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENC----CGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCT----TCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred EEEEEeCCCCCHHHHHHhcccC----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 9999999999999999865322 35888899999999999999999 789999999999999996654 9999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHH
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVN 522 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 522 (604)
|||+++........ ....||..|+|||++.+..++.++|||||||++|||+||+.||..................
T Consensus 167 DFG~a~~~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 167 DLGYAKELDQGELC-----TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241 (676)
T ss_dssp SCCCCCBTTSCCCC-----CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred cccccccccccccc-----ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence 99999876543221 2235899999999999999999999999999999999999999653211000000000000
Q ss_pred H-HHHcCCcccc--ccccc--cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHH-----HHHHHHhchH
Q 007423 523 H-LVIAGRSRDV--VDKSL--YGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQ-----VYESLKSMAE 580 (604)
Q Consensus 523 ~-~~~~~~~~~~--~d~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e-----v~~~L~~i~~ 580 (604)
. .......... ..... ...........+.+++.+||+.||++|||+.| ..+.++.+.+
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0 0000000000 00000 01112223345566666999999999999987 4566665544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=340.39 Aligned_cols=239 Identities=16% Similarity=0.203 Sum_probs=189.0
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC--CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCe-----e
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP--DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEE-----R 365 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~--~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-----~ 365 (604)
++|.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|++++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 57888999999999999999954 68999999986432 234578899999999999999999999987655 6
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
|+||||+++++|.+++.. .+++..++.++.|++.||.||| +.+|+||||||+|||++.+ .+||+|||
T Consensus 160 ~lv~E~~~g~~L~~~~~~---------~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ---------KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp EEEEECCCCEECC----C---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCT
T ss_pred EEEEEeCCCCcHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecc
Confidence 999999999999987753 4899999999999999999999 7899999999999999986 89999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHH
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
+++..... ....||+.|+|||++.+. ++.++|||||||++|||++|.+||.......
T Consensus 227 ~a~~~~~~--------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------- 283 (681)
T 2pzi_A 227 AVSRINSF--------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------- 283 (681)
T ss_dssp TCEETTCC--------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------
T ss_pred cchhcccC--------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc--------------
Confidence 99876432 122489999999988665 4889999999999999999998886421100
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhchH
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-SMYQVYESLKSMAE 580 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~ev~~~L~~i~~ 580 (604)
.... . ........+.+++.+||+.||++|| +++++...|..+..
T Consensus 284 ----~~~~-~------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 284 ----LPED-D------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ----CCTT-C------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ----cccc-c------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0000 0 0011123455666699999999999 57777777776543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.57 Aligned_cols=244 Identities=16% Similarity=0.166 Sum_probs=176.5
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCC-CCcccee---------eE
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRH-PNLVPLL---------GF 358 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H-~niv~l~---------g~ 358 (604)
+..|...+.||+|+||+||+|. ..+|+.||||+++... ...+.+.+|+.+++.++| +|..... ..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 4557778999999999999999 6679999999987322 223679999999999987 3222111 11
Q ss_pred ------------EEe-----CCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCc
Q 007423 359 ------------CVV-----EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPY 421 (604)
Q Consensus 359 ------------~~~-----~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~i 421 (604)
+.. ....+++|+++ +++|.+++............+++..++.++.|+++||+||| +.+|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence 111 12345666655 67999988421000001145889999999999999999999 7899
Q ss_pred eecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCcccc----------CCCCCCcccchhhHH
Q 007423 422 MHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYS----------STMVASLKGDVYGFG 491 (604)
Q Consensus 422 iH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~k~DV~SfG 491 (604)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++||||||
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 99999999999999999999999999875432 223347 999999988 666688999999999
Q ss_pred HHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 007423 492 IVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQV 571 (604)
Q Consensus 492 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 571 (604)
|++|||+||+.||......+... .++... ...+++ +.+++.+||+.||++||++.|+
T Consensus 305 vil~elltg~~Pf~~~~~~~~~~-----------------~~~~~~---~~~~~~---~~~li~~~l~~dP~~Rpt~~~~ 361 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAALGGSE-----------------WIFRSC---KNIPQP---VRALLEGFLRYPKEDRLLPLQA 361 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGGSCSG-----------------GGGSSC---CCCCHH---HHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHCCCCCCCcchhhhHH-----------------HHHhhc---ccCCHH---HHHHHHHHccCChhhCcCHHHH
Confidence 99999999999997543322111 111100 112234 4455559999999999998777
Q ss_pred H
Q 007423 572 Y 572 (604)
Q Consensus 572 ~ 572 (604)
+
T Consensus 362 l 362 (413)
T 3dzo_A 362 M 362 (413)
T ss_dssp T
T ss_pred H
Confidence 4
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=294.41 Aligned_cols=226 Identities=15% Similarity=0.212 Sum_probs=174.0
Q ss_pred cCCCcC-cEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHH-hccCCCCccceeeEEEe----CCeeeE
Q 007423 295 NSFAVE-NIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRL-GQLRHPNLVPLLGFCVV----EEERLL 367 (604)
Q Consensus 295 ~~~~~~-~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~----~~~~~l 367 (604)
++|... +.||+|+||.||++. ..+++.||||+++. ...+.+|++++ +..+||||+++++++.. ....++
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 456555 789999999999998 46789999999964 24577889887 66699999999999987 667899
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC---CCCeEEccc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD---DFDARITDF 444 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~---~~~~kl~DF 444 (604)
||||+++|+|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+||
T Consensus 93 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRGD-----QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EECCCCSCBHHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEeecCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 9999999999999986532 35899999999999999999999 789999999999999997 788999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
|+++... +..++.++|||||||++|||+||+.||.........
T Consensus 165 g~a~~~~--------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~----------- 207 (299)
T 3m2w_A 165 GFAKETT--------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------- 207 (299)
T ss_dssp TTCEECT--------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------
T ss_pred ccccccc--------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------
Confidence 9987542 124678999999999999999999999653221100
Q ss_pred HHcCCcccccccccc-----CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 525 VIAGRSRDVVDKSLY-----GRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
............. ....++ .+.+++.+||+.||++|||+.|+++.
T Consensus 208 --~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 208 --PGMKTRIRMGQYEFPNPEWSEVSE---EVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp --CCSCCSSCTTCCSSCHHHHTTSCH---HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHHHHHHhhccccCCchhcccCCH---HHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000000000000 011223 44555559999999999999999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=304.67 Aligned_cols=191 Identities=14% Similarity=0.081 Sum_probs=158.8
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEecccc---------ccHHHHHHHHHHHhccC---------CCCccce
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACK---------LSEKQFRSEMNRLGQLR---------HPNLVPL 355 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~---------~~~~~~~~Ei~~l~~l~---------H~niv~l 355 (604)
.++|...+.||+|+||.||+|+. +|+.||||+++... ...+.+.+|++++++++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688889999999999999987 78999999996532 12367889999998886 7777777
Q ss_pred eeEEE------------------------------eCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHH
Q 007423 356 LGFCV------------------------------VEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMG 405 (604)
Q Consensus 356 ~g~~~------------------------------~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ 405 (604)
.+.+. ..+..++||||+++|++.+.+.+ ..+++..+..++.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--------~~~~~~~~~~i~~q 169 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--------KLSSLATAKSILHQ 169 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--------TCCCHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--------cCCCHHHHHHHHHH
Confidence 77653 16789999999999987776643 24789999999999
Q ss_pred HHHHhhHhhhcCCCCceecCCCCCeEEeCCCC--------------------CeEEcccCCccccCCCCCCCCccccCCC
Q 007423 406 ASRGLAWLHHGCQPPYMHQYISSNVILIDDDF--------------------DARITDFGLARLVGSRDPNDSSFVHGDL 465 (604)
Q Consensus 406 ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~~~ 465 (604)
++.||+|||+ +.+|+||||||+|||++.++ .+||+|||+++..... . ..
T Consensus 170 i~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~----~~ 238 (336)
T 2vuw_A 170 LTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----I----VV 238 (336)
T ss_dssp HHHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----E----EE
T ss_pred HHHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----c----EE
Confidence 9999999993 36899999999999999876 8999999999976431 1 24
Q ss_pred CcccccCccccCCCCCCcccchhhHHHH-HHHHHhCCCCCC
Q 007423 466 GEFGYVAPEYSSTMVASLKGDVYGFGIV-LLELLSGQKPLD 505 (604)
Q Consensus 466 gt~~y~aPE~~~~~~~t~k~DV~SfGvv-l~elltg~~p~~ 505 (604)
||+.|+|||++.+.. +.++||||++++ .+++++|..||.
T Consensus 239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 899999999998766 899999998777 778888999984
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-30 Score=282.70 Aligned_cols=183 Identities=15% Similarity=0.070 Sum_probs=128.2
Q ss_pred EEecCCeEEEEEE-eCCCCEEEEEEecccc-----------ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEEe
Q 007423 303 IISTRTGVSYKAV-LPDASALAIKRLSACK-----------LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 303 ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-----------~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 369 (604)
.+.|+.|.++.+. ..-|+.+|||.+.... ...++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4456666655544 4468899999996431 1225699999999999 7999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||++||+|.++|... ++++.. +|+.||+.||+|+| +.+||||||||+|||+++++.+||+|||+|+.
T Consensus 322 Eyv~G~~L~d~i~~~-------~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG-------EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVT 388 (569)
T ss_dssp ECCCSEEHHHHHHTT-------CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred ecCCCCcHHHHHHhC-------CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCee
Confidence 999999999999865 345543 58899999999999 88999999999999999999999999999997
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKP 503 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p 503 (604)
........ ...+||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 389 ~~~~~~~~----~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 389 TPQDCSWP----TNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CC---CCS----HHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCCCccc----cCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 65432222 23359999999999876 467789999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-26 Score=253.63 Aligned_cols=186 Identities=13% Similarity=0.100 Sum_probs=145.6
Q ss_pred cCcEEEecCCeEEEEEEeCCCCEEEEEEeccccc---------cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 299 VENIIISTRTGVSYKAVLPDASALAIKRLSACKL---------SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 299 ~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~---------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
..+.||+|+||.||+|.. .+..+|+|+...... ..+++.+|++++++++||||+++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 357899999999999954 578899998643211 1245899999999999999998777777888889999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++.. +..++.|+++||.||| +.+|+||||||+|||+++ .+||+|||+++.
T Consensus 419 E~~~ggsL~~~l~~---------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 419 SYINGKLAKDVIED---------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp ECCCSEEHHHHSTT---------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred ECCCCCCHHHHHHH---------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEE
Confidence 99999999999864 3478999999999999 789999999999999999 999999999998
Q ss_pred cCCCCCCCCc---cccCCCCcccccCccccCC--CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007423 450 VGSRDPNDSS---FVHGDLGEFGYVAPEYSST--MVASLKGDVYGFGIVLLELLSGQKPLD 505 (604)
Q Consensus 450 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~SfGvvl~elltg~~p~~ 505 (604)
.......... ......||+.|||||++.. ..|+..+|+||..+-.++.+.++.+|.
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 7432111000 1123358999999999876 568889999999999999988887763
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.90 E-value=3.7e-24 Score=219.08 Aligned_cols=164 Identities=32% Similarity=0.500 Sum_probs=148.3
Q ss_pred CchhhHHHHHHHHHhCCCCCCCC-CCCCCCCCCCCCCC--ccccccCCCC-CCcEEEEEecCCccee--eCCcccccCCC
Q 007423 21 SIEDDVKCLEGIQNSIKDPDGRL-SWSFTNTTVGAICR--LTGVACWNEK-ENRIISLTLSSMQLSG--QLPESLHLCHS 94 (604)
Q Consensus 21 ~~~~d~~al~~~~~~~~~~~~~~-~w~~~~~~~~~~c~--~~gv~c~~~~-~~~v~~l~l~~n~l~g--~~p~~l~~l~~ 94 (604)
+.++|..||++||+++.||. .+ +|+.+ .++|. |.||+|.... .++|+.|+|++|+++| .+|+.++++++
T Consensus 3 c~~~~~~aL~~~k~~~~~~~-~l~~W~~~----~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~ 77 (313)
T 1ogq_A 3 CNPQDKQALLQIKKDLGNPT-TLSSWLPT----TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCTT----SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCHHHHHHHHHHHHhcCCcc-cccCCCCC----CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCC
Confidence 45689999999999998886 45 88642 36788 9999996421 2789999999999999 99999999999
Q ss_pred CCEEEcCC-CCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEc
Q 007423 95 LQSLDLSD-NSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSV 173 (604)
Q Consensus 95 L~~L~Ls~-N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l 173 (604)
|++|+|++ |+++|.+|..+.. +++|++|+|++|+++|.+|..+.++++|++|+|++|+++|.+|..+..+++|+.|++
T Consensus 78 L~~L~L~~~n~l~~~~p~~l~~-l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 156 (313)
T 1ogq_A 78 LNFLYIGGINNLVGPIPPAIAK-LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGG-CTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEEC
T ss_pred CCeeeCCCCCcccccCChhHhc-CCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEEC
Confidence 99999995 9999999999876 999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCcccCCCCCCCCCCC
Q 007423 174 AGNDLSGTIPPDLARFP 190 (604)
Q Consensus 174 ~~N~l~g~ip~~~~~~~ 190 (604)
++|+++|.+|..+..++
T Consensus 157 ~~N~l~~~~p~~l~~l~ 173 (313)
T 1ogq_A 157 DGNRISGAIPDSYGSFS 173 (313)
T ss_dssp CSSCCEEECCGGGGCCC
T ss_pred cCCcccCcCCHHHhhhh
Confidence 99999999998877654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4e-23 Score=207.87 Aligned_cols=152 Identities=13% Similarity=0.080 Sum_probs=122.4
Q ss_pred HHHHHHhhcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccc-------------------cHHHHHHHHHHHhcc
Q 007423 287 LADLLAATNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKL-------------------SEKQFRSEMNRLGQL 347 (604)
Q Consensus 287 ~~~l~~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~-------------------~~~~~~~Ei~~l~~l 347 (604)
+..+......|...+.||+|+||.||+|...+|+.||||.++.... ....+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3455555666777899999999999999997799999999964321 245688999999999
Q ss_pred CCCCccceeeEEEeCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCC
Q 007423 348 RHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYIS 427 (604)
Q Consensus 348 ~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk 427 (604)
+ | +++.+++.. +..++||||+++|+|.+ +... ....++.|++.||.||| +.+|+|||||
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~~-------------~~~~i~~qi~~~l~~lH---~~giiHrDlk 220 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRVE-------------NPDEVLDMILEEVAKFY---HRGIVHGDLS 220 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCCS-------------CHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cchh-------------hHHHHHHHHHHHHHHHH---HCCCEeCCCC
Confidence 9 5 677775543 55799999999999998 5311 23469999999999999 7899999999
Q ss_pred CCeEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccC
Q 007423 428 SNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSS 477 (604)
Q Consensus 428 ~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 477 (604)
|+|||++ ++.+||+|||+++.. ..|+|||++.
T Consensus 221 p~NILl~-~~~vkl~DFG~a~~~-----------------~~~~a~e~l~ 252 (282)
T 1zar_A 221 QYNVLVS-EEGIWIIDFPQSVEV-----------------GEEGWREILE 252 (282)
T ss_dssp TTSEEEE-TTEEEECCCTTCEET-----------------TSTTHHHHHH
T ss_pred HHHEEEE-CCcEEEEECCCCeEC-----------------CCCCHHHHHH
Confidence 9999999 999999999998742 3467888764
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.7e-22 Score=231.76 Aligned_cols=160 Identities=18% Similarity=0.268 Sum_probs=140.4
Q ss_pred CchhhHHHHHHHHHhCCCCCCCCCCCCCC---CCCCCCCCc------------cccccCCCCCCcEEEEEecCCcceeeC
Q 007423 21 SIEDDVKCLEGIQNSIKDPDGRLSWSFTN---TTVGAICRL------------TGVACWNEKENRIISLTLSSMQLSGQL 85 (604)
Q Consensus 21 ~~~~d~~al~~~~~~~~~~~~~~~w~~~~---~~~~~~c~~------------~gv~c~~~~~~~v~~l~l~~n~l~g~~ 85 (604)
+...|+.||++||+++.+| +|+.++ ....+.|.| .||+|+. .++|+.|+|++|+|+|.+
T Consensus 266 ~~~~d~~ALl~~k~~l~~~----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~--~~~V~~L~Ls~~~L~G~i 339 (876)
T 4ecn_A 266 EYIKDYKALKAIWEALDGK----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN--NGRVTGLSLAGFGAKGRV 339 (876)
T ss_dssp HHHHHHHHHHHHHHHTTGG----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT--TSCEEEEECTTTCCEEEE
T ss_pred cchHHHHHHHHHHHHcCCC----CCCcCCCcccccCCccccccccccccccCcCceEecC--CCCEEEEECccCCCCCcC
Confidence 3457999999999999877 697554 111223999 9999965 589999999999999999
Q ss_pred CcccccCCCCCEEEc-CCCCCCCc--------------------------------------------------------
Q 007423 86 PESLHLCHSLQSLDL-SDNSLSGS-------------------------------------------------------- 108 (604)
Q Consensus 86 p~~l~~l~~L~~L~L-s~N~l~g~-------------------------------------------------------- 108 (604)
|++|++|++|+.||| ++|.|+|.
T Consensus 340 p~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~ 419 (876)
T 4ecn_A 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKK 419 (876)
T ss_dssp CGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCC
T ss_pred chHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccc
Confidence 999999999999999 88877665
Q ss_pred --------------------CChhhhhcCCCCcEEEccCCcCCC-----------------CCccccc--CCcccceeec
Q 007423 109 --------------------IPVDLCKWLPYVVQLDLSNNHLSG-----------------PIPPQIV--ECKFLNKLIL 149 (604)
Q Consensus 109 --------------------ip~~~~~~l~~L~~l~ls~N~l~g-----------------~iP~~~~--~~~~L~~l~l 149 (604)
||..+.. +++|+.|+|++|+|+| .+|..++ ++++|+.|+|
T Consensus 420 ~~~l~l~~l~l~~~~N~L~~IP~~l~~-L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~L 498 (876)
T 4ecn_A 420 DSRISLKDTQIGNLTNRITFISKAIQR-LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVEL 498 (876)
T ss_dssp CCCCCCCTTTTTCCSCEEEEECGGGGG-CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEE
T ss_pred ccccchhhceeccccCcccchhHHHhc-CCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEEC
Confidence 8888766 9999999999999999 4999988 9999999999
Q ss_pred cccccccCCChhhhcCCCccEEEccCCc-ccC-CCCCCCC
Q 007423 150 SNNKLSGSIPFEVSRLDRLKEFSVAGND-LSG-TIPPDLA 187 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L~~l~l~~N~-l~g-~ip~~~~ 187 (604)
++|+++|.+|..+.++++|+.|++++|+ ++| .+|..++
T Consensus 499 s~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~ 538 (876)
T 4ecn_A 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWT 538 (876)
T ss_dssp ESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHH
T ss_pred cCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHH
Confidence 9999999999999999999999999998 998 8886543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.1e-21 Score=222.71 Aligned_cols=158 Identities=29% Similarity=0.408 Sum_probs=127.7
Q ss_pred hhccCchhhHHHHHHHHHhCCCCCCCC-CCCCCCCCCCCCCCccccccCCCCCCcEEEEEecCCcceee---CC------
Q 007423 17 LLTVSIEDDVKCLEGIQNSIKDPDGRL-SWSFTNTTVGAICRLTGVACWNEKENRIISLTLSSMQLSGQ---LP------ 86 (604)
Q Consensus 17 ~~~~~~~~d~~al~~~~~~~~~~~~~~-~w~~~~~~~~~~c~~~gv~c~~~~~~~v~~l~l~~n~l~g~---~p------ 86 (604)
.++++.++|..||++||+++.||. .+ +|.. ..++|+|.||+|+ .++|+.|+|+++.++|. +|
T Consensus 5 ~~~~~~~~~~~all~~k~~~~~~~-~l~~W~~----~~~~C~w~gv~C~---~~~v~~L~L~~~~l~g~~~~l~~~l~~L 76 (768)
T 3rgz_A 5 SPSQSLYREIHQLISFKDVLPDKN-LLPDWSS----NKNPCTFDGVTCR---DDKVTSIDLSSKPLNVGFSAVSSSLLSL 76 (768)
T ss_dssp ---CCHHHHHHHHHHHHTTCSCTT-SSTTCCT----TSCGGGSTTEEEE---TTEEEEEECTTSCCCEEHHHHHHHTTTC
T ss_pred ccccCCHHHHHHHHHHHhhCCCcc-cccCCCC----CCCCcCCcceEEC---CCcEEEEECCCCCcCCccCccChhHhcc
Confidence 345556889999999999999988 66 8962 2468999999996 47999999999999997 54
Q ss_pred -----------------cccccCCCCCEEEcCCCCCCCcCCh--hhhhcCCCCcEEEccCCcCCCCCcccc-cCCcccce
Q 007423 87 -----------------ESLHLCHSLQSLDLSDNSLSGSIPV--DLCKWLPYVVQLDLSNNHLSGPIPPQI-VECKFLNK 146 (604)
Q Consensus 87 -----------------~~l~~l~~L~~L~Ls~N~l~g~ip~--~~~~~l~~L~~l~ls~N~l~g~iP~~~-~~~~~L~~ 146 (604)
..++++++|++|||++|.++|.+|. .+.. +++|++|+|++|.++|.+|..+ .++++|++
T Consensus 77 ~~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~-l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~ 155 (768)
T 3rgz_A 77 TGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGS-CSGLKFLNVSSNTLDFPGKVSGGLKLNSLEV 155 (768)
T ss_dssp TTCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGG-CTTCCEEECCSSEEECCSSCCSCCCCTTCSE
T ss_pred CcccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhC-CCCCCEEECcCCccCCcCCHHHhccCCCCCE
Confidence 4677888999999999999998888 7765 8899999999999988888776 78888888
Q ss_pred eeccccccccCCChh---hhcCCCccEEEccCCcccCCCC
Q 007423 147 LILSNNKLSGSIPFE---VSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 147 l~ls~N~l~g~~p~~---~~~l~~L~~l~l~~N~l~g~ip 183 (604)
|+|++|++++.+|.. +.++++|+.|++++|.++|.+|
T Consensus 156 L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 195 (768)
T 3rgz_A 156 LDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD 195 (768)
T ss_dssp EECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCB
T ss_pred EECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCC
Confidence 888888888887766 5666677777777776666555
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-21 Score=219.85 Aligned_cols=158 Identities=19% Similarity=0.289 Sum_probs=138.7
Q ss_pred chhhHHHHHHHHHhCCCCCCC---------CCCCCCCCCCCCCCCc---cccccCCCCCCcEEEEEecCCcceeeCCccc
Q 007423 22 IEDDVKCLEGIQNSIKDPDGR---------LSWSFTNTTVGAICRL---TGVACWNEKENRIISLTLSSMQLSGQLPESL 89 (604)
Q Consensus 22 ~~~d~~al~~~~~~~~~~~~~---------~~w~~~~~~~~~~c~~---~gv~c~~~~~~~v~~l~l~~n~l~g~~p~~l 89 (604)
...|+.||.+|++++.+++-. .+|+. ..++|.| .||+|+. .++|+.|+|++|+++|.+|+++
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~----~~~~c~w~~~~GV~C~~--~~~V~~L~L~~~~l~g~lp~~l 101 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF----NKELDMWGAQPGVSLNS--NGRVTGLSLEGFGASGRVPDAI 101 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCC----SSCGGGTTCCTTEEECT--TCCEEEEECTTSCCEEEECGGG
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC----CCCcccccCCCCeEEcC--CCCEEEEEecCcccCCcCChHH
Confidence 357999999999998655311 14653 2467999 9999964 3899999999999999999999
Q ss_pred ccCCCCCEEEcCCCC-----------------------------------------------------------------
Q 007423 90 HLCHSLQSLDLSDNS----------------------------------------------------------------- 104 (604)
Q Consensus 90 ~~l~~L~~L~Ls~N~----------------------------------------------------------------- 104 (604)
++|++|++|||++|+
T Consensus 102 ~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~ 181 (636)
T 4eco_A 102 GQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181 (636)
T ss_dssp GGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCC
T ss_pred hcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCcccccccccccc
Confidence 999999999999984
Q ss_pred -------------CCCcCChhhhhcCCCCcEEEccCCcCCCC-----------------Cccccc--CCcccceeecccc
Q 007423 105 -------------LSGSIPVDLCKWLPYVVQLDLSNNHLSGP-----------------IPPQIV--ECKFLNKLILSNN 152 (604)
Q Consensus 105 -------------l~g~ip~~~~~~l~~L~~l~ls~N~l~g~-----------------iP~~~~--~~~~L~~l~ls~N 152 (604)
|+| ||.++.. +++|++|+|++|+|+|. +|..++ ++++|++|+|++|
T Consensus 182 ~l~~l~l~~~~n~l~~-ip~~l~~-l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n 259 (636)
T 4eco_A 182 TLKDTQIGQLSNNITF-VSKAVMR-LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNC 259 (636)
T ss_dssp CCCTTTTTCCSCEEEE-ECGGGGG-CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECC
T ss_pred chhhhhhccccCCCcc-CCHHHhc-ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCC
Confidence 446 8988876 99999999999999996 999999 9999999999999
Q ss_pred ccccCCChhhhcCCCccEEEccCCc-ccC-CCCCCCC
Q 007423 153 KLSGSIPFEVSRLDRLKEFSVAGND-LSG-TIPPDLA 187 (604)
Q Consensus 153 ~l~g~~p~~~~~l~~L~~l~l~~N~-l~g-~ip~~~~ 187 (604)
+++|.+|..++++++|+.|++++|+ ++| .+|..++
T Consensus 260 ~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~ 296 (636)
T 4eco_A 260 PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ 296 (636)
T ss_dssp TTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHH
T ss_pred cCCccChHHHhcCCCCCEEECcCCCCCccccchHHHH
Confidence 9999999999999999999999998 998 8887654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=5.7e-21 Score=219.04 Aligned_cols=140 Identities=38% Similarity=0.621 Sum_probs=129.6
Q ss_pred EEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeeccccc
Q 007423 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNK 153 (604)
Q Consensus 74 l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~N~ 153 (604)
++++.|.++|.+|..++++++|+.|||++|+|+|.||.+++. ++.|+.|+|++|+|+|.||..++++++|+.|||++|+
T Consensus 613 ~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~-l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~ 691 (768)
T 3rgz_A 613 CNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGS-MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691 (768)
T ss_dssp SCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGG-CTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccceecccCchhhhccccccEEECcCCcccccCCHHHhc-cccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCc
Confidence 456679999999999999999999999999999999999977 9999999999999999999999999999999999999
Q ss_pred cccCCChhhhcCCCccEEEccCCcccCCCCCC--CCCCCCcccCCCCCCCCCCCCCCCCCCCC
Q 007423 154 LSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPD--LARFPEESFDGNSGLCGKPLGKCGGLSGK 214 (604)
Q Consensus 154 l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~--~~~~~~~~~~~n~~lcg~p~~~c~~~~~~ 214 (604)
|+|.+|..+.++++|++|++++|+|+|.||.. +..++..+|.||+++||.|..+|......
T Consensus 692 l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~~~~~ 754 (768)
T 3rgz_A 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNAD 754 (768)
T ss_dssp CEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCSCC--
T ss_pred ccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCCCccC
Confidence 99999999999999999999999999999964 66788889999999999998889765443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.80 E-value=1e-20 Score=194.79 Aligned_cols=167 Identities=19% Similarity=0.282 Sum_probs=138.9
Q ss_pred cCchhhHHHHHHHHHhC-CCCCCCC-CCCCCCCCCCCCCCccccccCC-------CCCCcEEEEEecCCcceeeCCcccc
Q 007423 20 VSIEDDVKCLEGIQNSI-KDPDGRL-SWSFTNTTVGAICRLTGVACWN-------EKENRIISLTLSSMQLSGQLPESLH 90 (604)
Q Consensus 20 ~~~~~d~~al~~~~~~~-~~~~~~~-~w~~~~~~~~~~c~~~gv~c~~-------~~~~~v~~l~l~~n~l~g~~p~~l~ 90 (604)
.+..+|..||++||..+ .||.+.+ +|........++|.|.|+.|.. ....+|+.|+|++|+++ .+|+.++
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~ 101 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAF 101 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGG
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhh
Confidence 34568999999999988 4776655 7853333345789999999941 12468999999999998 7899999
Q ss_pred cCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeeccccccccCCChhhhc------
Q 007423 91 LCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSR------ 164 (604)
Q Consensus 91 ~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~------ 164 (604)
++++|++|+|++|.++ .||..+.. +++|++|+|++|+++ .+|..++++++|++|+|++|++.+.+|..+..
T Consensus 102 ~l~~L~~L~L~~n~l~-~lp~~~~~-l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~ 178 (328)
T 4fcg_A 102 RLSHLQHMTIDAAGLM-ELPDTMQQ-FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178 (328)
T ss_dssp GGTTCSEEEEESSCCC-CCCSCGGG-GTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred hCCCCCEEECCCCCcc-chhHHHhc-cCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence 9999999999999999 89988866 899999999999998 88999999999999999999999999987765
Q ss_pred ---CCCccEEEccCCcccCCCCCCCCCCCC
Q 007423 165 ---LDRLKEFSVAGNDLSGTIPPDLARFPE 191 (604)
Q Consensus 165 ---l~~L~~l~l~~N~l~g~ip~~~~~~~~ 191 (604)
+++|+.|++++|.++ .+|..++.++.
T Consensus 179 ~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~ 207 (328)
T 4fcg_A 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQN 207 (328)
T ss_dssp EEESTTCCEEEEEEECCC-CCCGGGGGCTT
T ss_pred hccCCCCCEEECcCCCcC-cchHhhcCCCC
Confidence 889999999999988 88876665543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.7e-18 Score=171.84 Aligned_cols=145 Identities=17% Similarity=0.104 Sum_probs=108.7
Q ss_pred HHHHHhhcCCCcCcEEEecCCeEEEEEEe-CCCCE--EEEEEecccccc-------------------------HHHHHH
Q 007423 288 ADLLAATNSFAVENIIISTRTGVSYKAVL-PDASA--LAIKRLSACKLS-------------------------EKQFRS 339 (604)
Q Consensus 288 ~~l~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~--vAvK~l~~~~~~-------------------------~~~~~~ 339 (604)
..+.....-|...+.||+|+||.||+|.. .+|+. ||||+++..... ...+.+
T Consensus 40 ~~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (258)
T 1zth_A 40 YKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK 119 (258)
T ss_dssp HHHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred HHHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence 34443333456778999999999999996 78989 999987543111 135789
Q ss_pred HHHHHhccCCCCc--cceeeEEEeCCeeeEEeeecCC-C----chhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhH
Q 007423 340 EMNRLGQLRHPNL--VPLLGFCVVEEERLLVYKHMPN-G----TLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAW 412 (604)
Q Consensus 340 Ei~~l~~l~H~ni--v~l~g~~~~~~~~~lv~ey~~~-g----sL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~y 412 (604)
|++++.+++|+++ ...+++ +..++||||+.+ | +|.++... .++.....++.|++.||.|
T Consensus 120 E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----------~~~~~~~~i~~qi~~~l~~ 185 (258)
T 1zth_A 120 EFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----------LKELDVEGIFNDVVENVKR 185 (258)
T ss_dssp HHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----------GGGSCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----------cChHHHHHHHHHHHHHHHH
Confidence 9999999998865 233332 356899999942 4 56655432 1233567899999999999
Q ss_pred hhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 413 LHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 413 LH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
||. +.+|+||||||.|||+++ .++|+|||+|...
T Consensus 186 lH~--~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 186 LYQ--EAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHH--TSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHH--HCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 994 468999999999999998 9999999999764
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.2e-17 Score=162.59 Aligned_cols=147 Identities=24% Similarity=0.340 Sum_probs=125.5
Q ss_pred CCCCccccccCCCC--------CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEc
Q 007423 54 AICRLTGVACWNEK--------ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDL 125 (604)
Q Consensus 54 ~~c~~~gv~c~~~~--------~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~l 125 (604)
..|+|++|.|.+.. ...++.|+|++|++++..|..+.++++|+.|+|++|.|+ .+|...+..+++|++|+|
T Consensus 17 ~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~L 95 (229)
T 3e6j_A 17 CSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDL 95 (229)
T ss_dssp CEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEEC
T ss_pred CEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC-CcChhhcccCCCcCEEEC
Confidence 56999999997532 246899999999999988999999999999999999996 777766566999999999
Q ss_pred cCCcCCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCC---CcccCCCCCCCC
Q 007423 126 SNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP---EESFDGNSGLCG 202 (604)
Q Consensus 126 s~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n~~lcg 202 (604)
++|++++..|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|++++-.+..+..++ .....+|+..|.
T Consensus 96 s~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 96 GTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred CCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 999999776667899999999999999999 8999999999999999999999955445555544 445678887764
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.72 E-value=5.8e-18 Score=172.94 Aligned_cols=137 Identities=32% Similarity=0.498 Sum_probs=99.4
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
.++.|+|++|+++|.+|..+..++ |+.|+|++|.+++.+|..+.. +++|+.|+|++|++++.+|. +..+++|+.|+|
T Consensus 175 ~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L 251 (313)
T 1ogq_A 175 LFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGS-DKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDL 251 (313)
T ss_dssp TCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCT-TSCCSEEECCSSEECCBGGG-CCCCTTCCEEEC
T ss_pred cCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhc-CCCCCEEECCCCceeeecCc-ccccCCCCEEEC
Confidence 345555555555555555555554 555555555555555544433 67777777777777766665 777888999999
Q ss_pred cccccccCCChhhhcCCCccEEEccCCcccCCCCCC--CCCCCCcccCCCCCCCCCCCCCCC
Q 007423 150 SNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPD--LARFPEESFDGNSGLCGKPLGKCG 209 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~--~~~~~~~~~~~n~~lcg~p~~~c~ 209 (604)
++|+++|.+|..+..+++|+.|++++|+++|.+|.. +..+....+.+|+.+||.|...|.
T Consensus 252 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~~C~ 313 (313)
T 1ogq_A 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPACT 313 (313)
T ss_dssp CSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred cCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCCCCC
Confidence 999999999999999999999999999999999975 233455678899999998877773
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.5e-16 Score=152.15 Aligned_cols=147 Identities=23% Similarity=0.250 Sum_probs=120.9
Q ss_pred CCCccccccCCCC--------CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEcc
Q 007423 55 ICRLTGVACWNEK--------ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLS 126 (604)
Q Consensus 55 ~c~~~gv~c~~~~--------~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls 126 (604)
.|.|++|.|.... ..+++.|+|++|++++..+..+.++++|++|+|++|.++ .+|...+..+++|++|+|+
T Consensus 6 ~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls 84 (208)
T 2o6s_A 6 SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLS 84 (208)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC-ccChhhcCCCCCcCEEECC
Confidence 3789999997432 236899999999999766667899999999999999999 5666655559999999999
Q ss_pred CCcCCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCC---CcccCCCCCCCC
Q 007423 127 NNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP---EESFDGNSGLCG 202 (604)
Q Consensus 127 ~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n~~lcg 202 (604)
+|++++..|..+..+++|+.|+|++|++++..+..+..+++|+.|++++|++++..+..+..++ .....+|+..|.
T Consensus 85 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 163 (208)
T 2o6s_A 85 TNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 163 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC
T ss_pred CCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC
Confidence 9999976666689999999999999999987777789999999999999999965554455444 445677776654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=1e-16 Score=154.98 Aligned_cols=146 Identities=17% Similarity=0.189 Sum_probs=124.1
Q ss_pred CCccccccCCCC--------CCcEEEEEecCCcceeeCCc-ccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEcc
Q 007423 56 CRLTGVACWNEK--------ENRIISLTLSSMQLSGQLPE-SLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLS 126 (604)
Q Consensus 56 c~~~gv~c~~~~--------~~~v~~l~l~~n~l~g~~p~-~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls 126 (604)
|.|+.+.|.+.. ...++.|+|++|+|++..|. .+..+++|+.|+|++|.+++..|..+. .+++|++|+|+
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~-~l~~L~~L~Ls 89 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFE-GASGVNEILLT 89 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTT-TCTTCCEEECC
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhC-CCCCCCEEECC
Confidence 778888886432 23577999999999987654 589999999999999999965555564 49999999999
Q ss_pred CCcCCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCC---cccCCCCCCCC
Q 007423 127 NNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE---ESFDGNSGLCG 202 (604)
Q Consensus 127 ~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~---~~~~~n~~lcg 202 (604)
+|++++..|..+..+++|+.|+|++|+|++..|..+..+++|+.|+|++|++++..|..+..++. ....+|+..|.
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 99999888888999999999999999999999999999999999999999999888887776554 45677876664
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=4.1e-17 Score=154.22 Aligned_cols=127 Identities=21% Similarity=0.263 Sum_probs=91.5
Q ss_pred CCccccccCCCC--------CCcEEEEEecCCcceeeCCc-ccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEcc
Q 007423 56 CRLTGVACWNEK--------ENRIISLTLSSMQLSGQLPE-SLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLS 126 (604)
Q Consensus 56 c~~~gv~c~~~~--------~~~v~~l~l~~n~l~g~~p~-~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls 126 (604)
|.|+.+.|.+.. ...++.|+|++|++++..+. .++++++|++|+|++|.+++.+|..+.. +++|+.|+|+
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls 86 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEG-ASHIQELQLG 86 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTT-CTTCCEEECC
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCC-cccCCEEECC
Confidence 677777775332 12567777777777754443 3777777888888888777666666644 7777778888
Q ss_pred CCcCCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCCC
Q 007423 127 NNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 127 ~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 183 (604)
+|++++..|..+..+++|+.|+|++|+|++.+|..+..+++|+.|++++|+++|..+
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 877777766667777777888888888777777777777777778887777776654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-16 Score=154.38 Aligned_cols=147 Identities=20% Similarity=0.220 Sum_probs=124.3
Q ss_pred CCCccccccCCCC--------CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEcc
Q 007423 55 ICRLTGVACWNEK--------ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLS 126 (604)
Q Consensus 55 ~c~~~gv~c~~~~--------~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls 126 (604)
.|.|..|.|.+.. ...++.|+|++|+|++..+..+..+++|+.|+|++|.+++..|..+.. +++|++|+|+
T Consensus 10 ~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~-l~~L~~L~Ls 88 (220)
T 2v9t_B 10 TCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQG-LRSLNSLVLY 88 (220)
T ss_dssp EEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTT-CSSCCEEECC
T ss_pred EECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhC-CcCCCEEECC
Confidence 3789999997432 236899999999999877779999999999999999999777777755 9999999999
Q ss_pred CCcCCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCC---CcccCCCCCCCC
Q 007423 127 NNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP---EESFDGNSGLCG 202 (604)
Q Consensus 127 ~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n~~lcg 202 (604)
+|++++..+..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|++++..+..+..++ .....+|+..|.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 89 GNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 9999954444578899999999999999999999999999999999999999976666666554 445678887774
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=2.2e-16 Score=147.01 Aligned_cols=128 Identities=23% Similarity=0.238 Sum_probs=103.9
Q ss_pred CCCccccccCCCC--------CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEcc
Q 007423 55 ICRLTGVACWNEK--------ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLS 126 (604)
Q Consensus 55 ~c~~~gv~c~~~~--------~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls 126 (604)
.|.|++|.|.+.. ...++.|+|++|++++..+..+.++++|++|+|++|.++ .+|...+..+++|+.|+|+
T Consensus 6 ~C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~ 84 (177)
T 2o6r_A 6 SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLH 84 (177)
T ss_dssp EEETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred EeCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcce-EeChhHccCCCccCEEECC
Confidence 3789999996432 246889999999998766666789999999999999998 5555544458999999999
Q ss_pred CCcCCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCCC
Q 007423 127 NNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 127 ~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 183 (604)
+|++++..|..+..+++|+.|+|++|++++..+..+..+++|+.|++++|+++|..|
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 999997666667889999999999999986555556788999999999999987665
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=2.3e-15 Score=155.65 Aligned_cols=144 Identities=10% Similarity=-0.006 Sum_probs=103.4
Q ss_pred HHHHhhcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccc---------------cHHH--------HHHHHHHHh
Q 007423 289 DLLAATNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKL---------------SEKQ--------FRSEMNRLG 345 (604)
Q Consensus 289 ~l~~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~---------------~~~~--------~~~Ei~~l~ 345 (604)
.+.....-|.+...||+|++|.||+|..++|+.||||+++.... .... ..+|...|.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 44444445888999999999999999988999999998753210 0111 235666777
Q ss_pred ccCCCCccceeeEEEeCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecC
Q 007423 346 QLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQY 425 (604)
Q Consensus 346 ~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~d 425 (604)
++.+.++.-..-+... ..++||||+++++|.++.... ....++.|++.+|.||| +.+|||||
T Consensus 169 rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~~~-------------~~~~l~~qll~~l~~lH---~~gIVHrD 230 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSSVP-------------DPASLYADLIALILRLA---KHGLIHGD 230 (397)
T ss_dssp HHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCCCS-------------CHHHHHHHHHHHHHHHH---HTTEECSC
T ss_pred HHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcccH-------------HHHHHHHHHHHHHHHHH---HCCCcCCC
Confidence 7755443222112112 247999999998887654311 22467889999999999 67899999
Q ss_pred CCCCeEEeCCCC----------CeEEcccCCcccc
Q 007423 426 ISSNVILIDDDF----------DARITDFGLARLV 450 (604)
Q Consensus 426 lk~~NiLl~~~~----------~~kl~DFGla~~~ 450 (604)
|||.|||+++++ .+.|+||+.+...
T Consensus 231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999999998776 3899999987643
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.2e-15 Score=156.84 Aligned_cols=120 Identities=26% Similarity=0.311 Sum_probs=87.2
Q ss_pred CcEEEEEecCCcceeeCCccccc---------CCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCccccc
Q 007423 69 NRIISLTLSSMQLSGQLPESLHL---------CHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIV 139 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~---------l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~ 139 (604)
.+++.|+|++|++.|.+|..++. +++|++|+|++|.++ .+|..+.. +++|+.|+|++|++++ +|+.++
T Consensus 150 ~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~-l~~L~~L~L~~N~l~~-l~~~l~ 226 (328)
T 4fcg_A 150 NRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIAN-LQNLKSLKIRNSPLSA-LGPAIH 226 (328)
T ss_dssp TTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGG-CTTCCEEEEESSCCCC-CCGGGG
T ss_pred cCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcC-CCCCCEEEccCCCCCc-Cchhhc
Confidence 46777788877777777776654 777777777777777 77776654 7777777777777774 666677
Q ss_pred CCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCC
Q 007423 140 ECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE 191 (604)
Q Consensus 140 ~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~ 191 (604)
.+++|+.|+|++|++.+.+|..+..+++|+.|++++|++.+.+|..+..++.
T Consensus 227 ~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~ 278 (328)
T 4fcg_A 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQ 278 (328)
T ss_dssp GCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTT
T ss_pred cCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCC
Confidence 7777777777777777777777777777777777777777777766555443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.6e-15 Score=149.61 Aligned_cols=120 Identities=23% Similarity=0.174 Sum_probs=79.8
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
.++.|+|++|++++..+..+.++++|++|+|++|.+++..|..+. .+++|++|+|++|++++..|..+..+++|+.|+|
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFD-DLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTT-TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhc-cCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 466777777777766666677777777777777777754444343 3777777777777777555556667777777777
Q ss_pred cccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCC
Q 007423 150 SNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP 190 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~ 190 (604)
++|+|++..+..+..+++|+.|++++|++++..|..+..++
T Consensus 115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 155 (251)
T 3m19_A 115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLT 155 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCc
Confidence 77777755555566677777777777777644443454433
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=3e-15 Score=141.43 Aligned_cols=125 Identities=26% Similarity=0.338 Sum_probs=74.7
Q ss_pred EEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeecccc
Q 007423 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNN 152 (604)
Q Consensus 73 ~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~N 152 (604)
.+++++|+|+ .+|..+. ++|++|+|++|.++ .||..+.. +++|+.|+|++|++++..|..+.++++|+.|+|++|
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~-l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSN-YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGG-CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhc-ccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 3455555555 4555442 46666777777666 66655543 666677777777766655556666666777777777
Q ss_pred ccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCC---CcccCCCCCCCC
Q 007423 153 KLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP---EESFDGNSGLCG 202 (604)
Q Consensus 153 ~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n~~lcg 202 (604)
+|++..|..+..+++|+.|+|++|++++-.+..+..++ .....+|+..|.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 76666666666666677777777766633222343332 334456665553
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.59 E-value=7.6e-15 Score=144.67 Aligned_cols=134 Identities=22% Similarity=0.248 Sum_probs=113.9
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
...++.|+|++|+|++..|..+.++++|++|+|++|.++ .+|...+..+++|++|+|++|++++..|..+..+++|+.|
T Consensus 58 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 136 (251)
T 3m19_A 58 LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKEL 136 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCccc-ccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEE
Confidence 357999999999999988888999999999999999999 5555544559999999999999997666667999999999
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCC---CcccCCCCCCCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP---EESFDGNSGLCG 202 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n~~lcg 202 (604)
+|++|+|++..|..+..+++|+.|++++|++++..|..+..++ .....+|+..|.
T Consensus 137 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 137 RLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred ECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 9999999987777899999999999999999976665666554 445677877664
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=3.2e-15 Score=144.44 Aligned_cols=115 Identities=14% Similarity=0.137 Sum_probs=105.1
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
..+++.|+|++|+|++..+..+.++++|++|+|++|.+++..|..+ ..+++|++|+|++|++++..|..+..+++|+.|
T Consensus 56 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 134 (220)
T 2v70_A 56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMF-KGLESLKTLMLRSNRITCVGNDSFIGLSSVRLL 134 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGG-TTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEE
T ss_pred CCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHh-cCCcCCCEEECCCCcCCeECHhHcCCCccCCEE
Confidence 3579999999999998888899999999999999999995544445 459999999999999999999999999999999
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCcccCCCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 183 (604)
+|++|+|++..|..+..+++|+.|++++|.+++..+
T Consensus 135 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 135 SLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp ECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 999999999999999999999999999999998765
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.58 E-value=5.7e-15 Score=139.44 Aligned_cols=128 Identities=23% Similarity=0.341 Sum_probs=110.6
Q ss_pred EEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeeccc
Q 007423 72 ISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSN 151 (604)
Q Consensus 72 ~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~ 151 (604)
+.|++++|+|+ .+|..+.. +|++|+|++|.+++..|..++..+++|++|+|++|++++..|..+..+++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 57999999995 78887754 9999999999998655544344599999999999999999999999999999999999
Q ss_pred cccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCC---cccCCCCCCCC
Q 007423 152 NKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE---ESFDGNSGLCG 202 (604)
Q Consensus 152 N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~---~~~~~n~~lcg 202 (604)
|+|++..|..+..+++|+.|++++|++++.+|..+..++. ....+|+..|.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 9999999988999999999999999999988988776654 44567776663
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.57 E-value=1.3e-14 Score=144.79 Aligned_cols=132 Identities=21% Similarity=0.178 Sum_probs=75.1
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|+|++|++++..+..+.++++|++|+|++|.+++..|..+ ..+++|++|+|++|++++..|..+..+++|+.|+
T Consensus 85 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVF-DKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTT-TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHh-ccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 346666666666665444555666666666666666663333223 3366666666666666654444456666666666
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCC---cccCCCCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE---ESFDGNSGLC 201 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~---~~~~~n~~lc 201 (604)
|++|++++..|..+..+++|+.|++++|++++..|..+..++. ....+|+..|
T Consensus 164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 219 (272)
T 3rfs_A 164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 219 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence 6666666555555566666666666666666544444443332 3344555444
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.1e-14 Score=145.26 Aligned_cols=119 Identities=24% Similarity=0.249 Sum_probs=85.7
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
.++.|+|++|++++..+..+.++++|++|+|++|.++ .+|..++..+++|++|+|++|++++..|..+..+++|+.|+|
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence 4677788888777655557778888888888888887 566665555778888888888887655556677778888888
Q ss_pred cccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCC
Q 007423 150 SNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARF 189 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~ 189 (604)
++|++++..|..+..+++|+.|++++|.+++..+..+..+
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 156 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKL 156 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCC
Confidence 8888877666667777788888888887774333334443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1e-14 Score=140.82 Aligned_cols=113 Identities=25% Similarity=0.236 Sum_probs=105.2
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
..+++.|+|++|++++..|..+.++++|++|+|++|.|+ .+|..++..+++|+.|+|++|++++..|..+..+++|+.|
T Consensus 55 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 133 (220)
T 2v9t_B 55 YKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLL 133 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEE
Confidence 357999999999999988999999999999999999999 7888766669999999999999999889999999999999
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCcccCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGT 181 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ 181 (604)
+|++|+|++..+..+..+++|+.|++++|++.+.
T Consensus 134 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 134 SLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred ECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 9999999988888899999999999999999864
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.1e-14 Score=162.61 Aligned_cols=121 Identities=24% Similarity=0.226 Sum_probs=104.6
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|+|++|+|++..|..|.++++|++|||++|.++ .||+..+..+++|++|+|++|+|++..|..+.++++|++|+
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~-~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~ 130 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 130 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCC-CcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence 36899999999999877788999999999999999999 56655445599999999999999976667789999999999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccC-CCCCCCCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSG-TIPPDLARFP 190 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g-~ip~~~~~~~ 190 (604)
|++|+|++..+..++++++|+.|++++|.+++ .+|..++.++
T Consensus 131 Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~ 173 (635)
T 4g8a_A 131 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 173 (635)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCT
T ss_pred CCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccch
Confidence 99999998777789999999999999999975 5666555443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.53 E-value=7.2e-15 Score=132.53 Aligned_cols=112 Identities=23% Similarity=0.302 Sum_probs=97.6
Q ss_pred CcEEEEEecCCcce-eeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 69 NRIISLTLSSMQLS-GQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 69 ~~v~~l~l~~n~l~-g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
.+++.|+|++|+++ |.+|..+..+++|+.|+|++|.+++. ..+.. +++|++|+|++|++++.+|..+..+++|+.|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~-l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPK-LNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCC-CTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhc-CCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 46889999999998 88999899999999999999999865 44544 8999999999999998899888889999999
Q ss_pred eccccccccC-CChhhhcCCCccEEEccCCcccCCCC
Q 007423 148 ILSNNKLSGS-IPFEVSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 148 ~ls~N~l~g~-~p~~~~~l~~L~~l~l~~N~l~g~ip 183 (604)
+|++|++++. .|..+..+++|+.|++++|++++..+
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 9999999973 45788999999999999999986543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.6e-14 Score=134.95 Aligned_cols=126 Identities=25% Similarity=0.259 Sum_probs=108.9
Q ss_pred CCCccccccCCCC--------CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEcc
Q 007423 55 ICRLTGVACWNEK--------ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLS 126 (604)
Q Consensus 55 ~c~~~gv~c~~~~--------~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls 126 (604)
.|.|+.|.|.+.. ...++.|+|++|+|+ .+|..+.++++|+.|+|++|.+++..|..+ ..+++|+.|+|+
T Consensus 9 ~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f-~~l~~L~~L~Ls 86 (193)
T 2wfh_A 9 TCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSF-SNMTQLLTLILS 86 (193)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTT-TTCTTCCEEECC
T ss_pred EeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHc-cCCCCCCEEECC
Confidence 3678888886432 246899999999998 789999999999999999999996545455 459999999999
Q ss_pred CCcCCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCC
Q 007423 127 NNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTI 182 (604)
Q Consensus 127 ~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~i 182 (604)
+|++++..|..+..+++|+.|+|++|+|++..+..+..+++|+.|++++|.+.+..
T Consensus 87 ~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 87 YNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 99999888888999999999999999999766667889999999999999998654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.53 E-value=7.2e-15 Score=159.26 Aligned_cols=141 Identities=21% Similarity=0.135 Sum_probs=117.9
Q ss_pred CCccccccCCCCCCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCc
Q 007423 56 CRLTGVACWNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIP 135 (604)
Q Consensus 56 c~~~gv~c~~~~~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP 135 (604)
|.++++.|.. ...++.|+|++|+|++..|..++++++|+.|+|++|.++|.+|..+...+++|+.|+|++|.|++. |
T Consensus 109 N~l~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~ 185 (487)
T 3oja_A 109 NNISRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K 185 (487)
T ss_dssp SCCCCEEECC--CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E
T ss_pred CcCCCCCccc--cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c
Confidence 5566777743 467999999999999988989999999999999999999988988875699999999999999865 4
Q ss_pred ccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCC---CcccCCCCCCCC
Q 007423 136 PQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP---EESFDGNSGLCG 202 (604)
Q Consensus 136 ~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n~~lcg 202 (604)
. +..+++|+.|+|++|+|++. |..+..+++|+.|++++|.+++ +|..+..++ ...+.+|+..|+
T Consensus 186 ~-~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 186 G-QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp C-CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHH
T ss_pred c-cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCc
Confidence 3 45699999999999999975 4458999999999999999995 787776554 445677877664
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=1.3e-14 Score=155.62 Aligned_cols=136 Identities=18% Similarity=0.210 Sum_probs=116.4
Q ss_pred CCCccc--cccCCCC-------CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEc
Q 007423 55 ICRLTG--VACWNEK-------ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDL 125 (604)
Q Consensus 55 ~c~~~g--v~c~~~~-------~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~l 125 (604)
.|.|.+ |.|.+.. ..+++.|+|++|++++..|..++++++|++|+|++|.+++.+|+..+..+++|++|+|
T Consensus 7 ~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~L 86 (455)
T 3v47_A 7 ECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86 (455)
T ss_dssp CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEEC
T ss_pred eeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeC
Confidence 365555 7775432 2468999999999999889999999999999999999999997765566999999999
Q ss_pred cCCcCCCCCcccccCCcccceeeccccccccCCChh--hhcCCCccEEEccCCcccCCCCCC-CCCCC
Q 007423 126 SNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFE--VSRLDRLKEFSVAGNDLSGTIPPD-LARFP 190 (604)
Q Consensus 126 s~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~--~~~l~~L~~l~l~~N~l~g~ip~~-~~~~~ 190 (604)
++|++++..|..++++++|++|+|++|++++.+|.. +..+++|+.|++++|++++..|.. +..++
T Consensus 87 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~ 154 (455)
T 3v47_A 87 DYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMR 154 (455)
T ss_dssp TTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCT
T ss_pred CCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCC
Confidence 999999888999999999999999999999877665 889999999999999999877765 44443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.52 E-value=2.3e-14 Score=132.51 Aligned_cols=107 Identities=22% Similarity=0.239 Sum_probs=92.7
Q ss_pred EEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeecccc
Q 007423 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNN 152 (604)
Q Consensus 73 ~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~N 152 (604)
.|++++|+|+. +|..+. ++|+.|+|++|.+++..|..+.. +++|++|+|++|+|++..|..+..+++|+.|+|++|
T Consensus 13 ~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~-l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 13 TVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDR-LTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp EEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTT-CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcC-cccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 57888888884 887764 89999999999999766766655 999999999999999766666789999999999999
Q ss_pred ccccCCChhhhcCCCccEEEccCCcccCCCC
Q 007423 153 KLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 153 ~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 183 (604)
+|++..|..+..+++|+.|+|++|.+++..+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9998777779999999999999999986643
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.51 E-value=6.1e-14 Score=139.92 Aligned_cols=115 Identities=24% Similarity=0.228 Sum_probs=102.6
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
...++.|+|++|++++..+..++++++|++|+|++|.+++ +|...+..+++|+.|+|++|++++..|..+..+++|+.|
T Consensus 108 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 186 (272)
T 3rfs_A 108 LTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDL 186 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCc-cCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEE
Confidence 3579999999999998777779999999999999999995 555544459999999999999998777778999999999
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCcccCCCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 183 (604)
+|++|++++..|..+..+++|+.|++++|.+.|..|
T Consensus 187 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 187 RLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 999999999888888999999999999999988766
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.51 E-value=3.3e-15 Score=167.39 Aligned_cols=132 Identities=15% Similarity=0.241 Sum_probs=111.3
Q ss_pred CCccccccCCCCCCcEEEEEecCCcceee-----------------CCcccc--cCCCCCEEEcCCCCCCCcCChhhhhc
Q 007423 56 CRLTGVACWNEKENRIISLTLSSMQLSGQ-----------------LPESLH--LCHSLQSLDLSDNSLSGSIPVDLCKW 116 (604)
Q Consensus 56 c~~~gv~c~~~~~~~v~~l~l~~n~l~g~-----------------~p~~l~--~l~~L~~L~Ls~N~l~g~ip~~~~~~ 116 (604)
++.+|+.-.-....+++.|+|++|+|+|. +|..++ ++++|++|+|++|.++|.+|..+..
T Consensus 193 n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~- 271 (636)
T 4eco_A 193 NNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA- 271 (636)
T ss_dssp CEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTT-
T ss_pred CCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhc-
Confidence 34556543222345789999999999986 999998 9999999999999999999988866
Q ss_pred CCCCcEEEccCCc-CCC-CCcccccCC------cccceeeccccccccCCCh--hhhcCCCccEEEccCCcccCCCCCCC
Q 007423 117 LPYVVQLDLSNNH-LSG-PIPPQIVEC------KFLNKLILSNNKLSGSIPF--EVSRLDRLKEFSVAGNDLSGTIPPDL 186 (604)
Q Consensus 117 l~~L~~l~ls~N~-l~g-~iP~~~~~~------~~L~~l~ls~N~l~g~~p~--~~~~l~~L~~l~l~~N~l~g~ip~~~ 186 (604)
+++|++|+|++|+ ++| .+|..++++ ++|+.|+|++|+++ .+|. .+.++++|+.|++++|+++|.+| .+
T Consensus 272 l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~ 349 (636)
T 4eco_A 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AF 349 (636)
T ss_dssp CSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CC
T ss_pred CCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hh
Confidence 8999999999998 998 899988886 89999999999999 8888 89999999999999999999998 66
Q ss_pred CCCC
Q 007423 187 ARFP 190 (604)
Q Consensus 187 ~~~~ 190 (604)
+.++
T Consensus 350 ~~l~ 353 (636)
T 4eco_A 350 GSEI 353 (636)
T ss_dssp EEEE
T ss_pred CCCC
Confidence 5443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=3e-14 Score=156.79 Aligned_cols=108 Identities=28% Similarity=0.328 Sum_probs=100.7
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
.++.|+|++|+|++ +|. ++++++|+.|+|++|.|+ .||..+.. +++|+.|+|++|+|++ +| .++.+++|+.|+|
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~-l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~L 515 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA-LRCLEVLQASDNALEN-VD-GVANLPRLQELLL 515 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG-CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEEC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc-CCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEEC
Confidence 47789999999997 776 999999999999999999 99998876 9999999999999997 78 8999999999999
Q ss_pred cccccccCC-ChhhhcCCCccEEEccCCcccCCCC
Q 007423 150 SNNKLSGSI-PFEVSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 150 s~N~l~g~~-p~~~~~l~~L~~l~l~~N~l~g~ip 183 (604)
++|+|++.+ |..+..+++|+.|+|++|++++..|
T Consensus 516 s~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp CSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 999999987 9999999999999999999997654
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=2.7e-14 Score=157.03 Aligned_cols=134 Identities=24% Similarity=0.259 Sum_probs=113.5
Q ss_pred CCccccccCCC----------CCCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEc
Q 007423 56 CRLTGVACWNE----------KENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDL 125 (604)
Q Consensus 56 c~~~gv~c~~~----------~~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~l 125 (604)
|.|.|+ |+.. -...++.|+|++|++++..|..+.++++|++|+|++|.+++..|..+.. +++|++|+|
T Consensus 4 C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~-l~~L~~L~L 81 (549)
T 2z81_A 4 CDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYS-LGSLEHLDL 81 (549)
T ss_dssp ECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTT-CTTCCEEEC
T ss_pred CCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccc-cccCCEEEC
Confidence 778777 7422 1247999999999999988899999999999999999999766666655 999999999
Q ss_pred cCCcCCCCCcccccCCcccceeecccccccc-CCChhhhcCCCccEEEccCCcccCCCCC-CCCCCCC
Q 007423 126 SNNHLSGPIPPQIVECKFLNKLILSNNKLSG-SIPFEVSRLDRLKEFSVAGNDLSGTIPP-DLARFPE 191 (604)
Q Consensus 126 s~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~g~ip~-~~~~~~~ 191 (604)
++|++++..|..++++++|++|+|++|++++ .+|..+.++++|+.|++++|.+.+.+|. .+..++.
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~ 149 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTS 149 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCE
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccc
Confidence 9999998877779999999999999999997 5778889999999999999997777774 5666553
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.50 E-value=5.7e-14 Score=136.44 Aligned_cols=114 Identities=25% Similarity=0.245 Sum_probs=101.2
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
...++.|+|++|+|++..+..+..+++|+.|+|++|.|+ .+|...+..+++|+.|+|++|+|+ .+|..+..+++|+.|
T Consensus 63 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L 140 (229)
T 3e6j_A 63 LINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHL 140 (229)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEE
T ss_pred ccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCC-ccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEE
Confidence 357999999999997655566799999999999999999 566555556999999999999999 899999999999999
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCcccCCCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 183 (604)
+|++|+|++..+..+..+++|+.|++++|.+++..+
T Consensus 141 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 141 ALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred ECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 999999997777778999999999999999998754
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.50 E-value=7e-14 Score=133.52 Aligned_cols=115 Identities=24% Similarity=0.219 Sum_probs=99.2
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
..+++.|+|++|++++..+..+..+++|++|+|++|.++ .+|...+..+++|++|+|++|++++..|..+..+++|+.|
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 129 (208)
T 2o6s_A 51 LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDL 129 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCC-ccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEE
Confidence 357999999999999765666899999999999999999 5665544559999999999999997766678999999999
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCcccCCCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 183 (604)
+|++|++++..+..+..+++|+.|++++|.+.+..|
T Consensus 130 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 130 RLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred ECCCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 999999998777678899999999999998876655
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=5.9e-14 Score=150.57 Aligned_cols=135 Identities=21% Similarity=0.193 Sum_probs=118.0
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|+|++|++++.+|..++++++|+.|+|++|.+++..|..+.. +++|++|+|++|++++..|..+.++++|+.|+
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 353 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWG-LTHLLKLNLSQNFLGSIDSRMFENLDKLEVLD 353 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTT-CTTCCEEECCSSCCCEECGGGGTTCTTCCEEE
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcC-cccCCEEECCCCccCCcChhHhcCcccCCEEE
Confidence 46899999999999999999999999999999999999777777755 99999999999999988899999999999999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCC---CcccCCCCCCCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP---EESFDGNSGLCGKP 204 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n~~lcg~p 204 (604)
|++|++++..|..+..+++|+.|++++|++++..+..+..++ .....+|+..|..|
T Consensus 354 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 354 LSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999999999999999999999999999999964444445444 45567888777544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.49 E-value=1.8e-14 Score=132.75 Aligned_cols=110 Identities=24% Similarity=0.272 Sum_probs=68.9
Q ss_pred CcEEEEEecCCcce-eeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 69 NRIISLTLSSMQLS-GQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 69 ~~v~~l~l~~n~l~-g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
..++.|+|++|+++ |.+|..+..+++|+.|+|++|.+++. ..+.. +++|++|+|++|++++.+|..+..+++|+.|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~-l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPK-LPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCC-CSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhcc-CCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 34666666666666 56666666666666666666666643 33333 6666666666666666666666666666666
Q ss_pred eccccccccC-CChhhhcCCCccEEEccCCcccCC
Q 007423 148 ILSNNKLSGS-IPFEVSRLDRLKEFSVAGNDLSGT 181 (604)
Q Consensus 148 ~ls~N~l~g~-~p~~~~~l~~L~~l~l~~N~l~g~ 181 (604)
+|++|++++. .+..+..+++|+.|++++|.+++.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~ 135 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNL 135 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTS
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcch
Confidence 6666666642 224566666666666666666643
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.49 E-value=3.8e-14 Score=143.81 Aligned_cols=120 Identities=22% Similarity=0.241 Sum_probs=71.3
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCC-cCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSG-SIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g-~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
.+++.|+|++|.+++..|..+..+++|++|+|++|.+++ .+|..+.. +++|+.|+|++|++++..|..+..+++|+.|
T Consensus 126 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~-l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 204 (306)
T 2z66_A 126 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE-LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 204 (306)
T ss_dssp TTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTT-CTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred cCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhh-CcCCCEEECCCCCcCCcCHHHhcCCCCCCEE
Confidence 345566666666665555556666666666666666654 34444433 5666666666666665555566666666666
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARF 189 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~ 189 (604)
+|++|++++..+..+..+++|+.|++++|++++..|..+..+
T Consensus 205 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 246 (306)
T 2z66_A 205 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 246 (306)
T ss_dssp ECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCC
T ss_pred ECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhh
Confidence 666666665555555666666666666666666555555444
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.49 E-value=1.5e-13 Score=138.40 Aligned_cols=129 Identities=29% Similarity=0.304 Sum_probs=64.3
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
.++.|+|++|+|+ .+|..+..+++|+.|+|++|.+++ +|+..+..+++|+.|+|++|++++..|..+..+++|+.|+|
T Consensus 78 ~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~-l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 155 (290)
T 1p9a_G 78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155 (290)
T ss_dssp TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCC-CCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcc-cCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEEC
Confidence 4455555555554 345555555555555555555552 33222223555555555555555443344455555555555
Q ss_pred cccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCC---CcccCCCCCCC
Q 007423 150 SNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP---EESFDGNSGLC 201 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n~~lc 201 (604)
++|+|++..+..+..+++|+.|++++|+++ .+|..+.... .....+|+..|
T Consensus 156 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp TTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 555555333333445555555555555555 4554443322 22334555554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.49 E-value=6.6e-14 Score=129.86 Aligned_cols=106 Identities=19% Similarity=0.182 Sum_probs=91.9
Q ss_pred EEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeeccc
Q 007423 72 ISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSN 151 (604)
Q Consensus 72 ~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~ 151 (604)
+.+++++|+|+ .+|..+. ++|+.|+|++|.|++..|..+.. +++|+.|+|++|+|++..|..+..+++|+.|+|++
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDH-LVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTT-CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcC-CcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 47899999996 6888775 89999999999999766766655 99999999999999975555568999999999999
Q ss_pred cccccCCChhhhcCCCccEEEccCCcccCC
Q 007423 152 NKLSGSIPFEVSRLDRLKEFSVAGNDLSGT 181 (604)
Q Consensus 152 N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ 181 (604)
|+|++..+..+..+++|+.|+|++|++.+.
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 999976666699999999999999999743
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.48 E-value=9.8e-14 Score=144.43 Aligned_cols=129 Identities=25% Similarity=0.244 Sum_probs=108.0
Q ss_pred CCCccccccCCCC--------CCcEEEEEecCCcceeeCCcccc-cCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEc
Q 007423 55 ICRLTGVACWNEK--------ENRIISLTLSSMQLSGQLPESLH-LCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDL 125 (604)
Q Consensus 55 ~c~~~gv~c~~~~--------~~~v~~l~l~~n~l~g~~p~~l~-~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~l 125 (604)
.|.+..|.|.+.. ...++.|+|++|+|++..+..+. ++++|+.|+|++|.|++..|..+ ..+++|+.|+|
T Consensus 17 ~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~-~~l~~L~~L~L 95 (361)
T 2xot_A 17 LCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAF-VPVPNLRYLDL 95 (361)
T ss_dssp EEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTT-TTCTTCCEEEC
T ss_pred EECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhc-cCCCCCCEEEC
Confidence 3677788886432 23578899999999987777777 99999999999999995444445 45999999999
Q ss_pred cCCcCCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCCCCC
Q 007423 126 SNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPD 185 (604)
Q Consensus 126 s~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~ 185 (604)
++|+|++..|..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|++++ +|..
T Consensus 96 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~ 154 (361)
T 2xot_A 96 SSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVE 154 (361)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCGG
T ss_pred CCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCHH
Confidence 9999997777778999999999999999998889999999999999999999984 5643
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.8e-14 Score=165.35 Aligned_cols=132 Identities=14% Similarity=0.194 Sum_probs=110.9
Q ss_pred CCccccccCCCCCCcEEEEEecCCccee-----------------eCCcccc--cCCCCCEEEcCCCCCCCcCChhhhhc
Q 007423 56 CRLTGVACWNEKENRIISLTLSSMQLSG-----------------QLPESLH--LCHSLQSLDLSDNSLSGSIPVDLCKW 116 (604)
Q Consensus 56 c~~~gv~c~~~~~~~v~~l~l~~n~l~g-----------------~~p~~l~--~l~~L~~L~Ls~N~l~g~ip~~~~~~ 116 (604)
+.++|++-.-....+++.|+|++|+|+| .+|+.++ +|++|+.|+|++|++.|.+|..+..
T Consensus 435 N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~- 513 (876)
T 4ecn_A 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD- 513 (876)
T ss_dssp CEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGG-
T ss_pred CcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhC-
Confidence 3455554322234578999999999998 4899988 9999999999999999999988866
Q ss_pred CCCCcEEEccCCc-CCC-CCcccccCCc-------ccceeeccccccccCCCh--hhhcCCCccEEEccCCcccCCCCCC
Q 007423 117 LPYVVQLDLSNNH-LSG-PIPPQIVECK-------FLNKLILSNNKLSGSIPF--EVSRLDRLKEFSVAGNDLSGTIPPD 185 (604)
Q Consensus 117 l~~L~~l~ls~N~-l~g-~iP~~~~~~~-------~L~~l~ls~N~l~g~~p~--~~~~l~~L~~l~l~~N~l~g~ip~~ 185 (604)
+++|+.|+|++|+ |+| .+|..+++++ +|+.|+|++|+|+ .+|. .+.++++|+.|++++|+++ .+| .
T Consensus 514 L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~ 590 (876)
T 4ecn_A 514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-A 590 (876)
T ss_dssp CSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-C
T ss_pred CCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-h
Confidence 9999999999998 998 8998888776 9999999999999 8998 8999999999999999998 888 6
Q ss_pred CCCCCC
Q 007423 186 LARFPE 191 (604)
Q Consensus 186 ~~~~~~ 191 (604)
++.++.
T Consensus 591 ~~~L~~ 596 (876)
T 4ecn_A 591 FGTNVK 596 (876)
T ss_dssp CCTTSE
T ss_pred hcCCCc
Confidence 666553
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.47 E-value=2.6e-13 Score=135.19 Aligned_cols=112 Identities=23% Similarity=0.267 Sum_probs=65.4
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
.+++.|+|++|++++..+..+.++++|++|+|++|.++ .+|...+..+++|++|+|++|++++..|..+..+++|+.|+
T Consensus 61 ~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 139 (270)
T 2o6q_A 61 TKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS 139 (270)
T ss_dssp TTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCC-CCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCC-cCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEE
Confidence 35666666666666433333456666666666666666 34433333366666666666666655555556666666666
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGT 181 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ 181 (604)
|++|++++..+..+..+++|+.|++++|.+++.
T Consensus 140 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 172 (270)
T 2o6q_A 140 LGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV 172 (270)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence 666666654444455566666666666666543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=4.8e-14 Score=157.01 Aligned_cols=133 Identities=20% Similarity=0.141 Sum_probs=91.9
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCc-CChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGS-IPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~-ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
..++.|+|++|++++..|..+.++++|++|+|++|.+++. +|..+.. +++|+.|+|++|++++..|..+..+++|+.|
T Consensus 424 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~-l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 502 (606)
T 3vq2_A 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN-TTNLTFLDLSKCQLEQISWGVFDTLHRLQLL 502 (606)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT-CTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhcc-CCCCCEEECCCCcCCccChhhhcccccCCEE
Confidence 4566777777777776677777777777777777777763 4555443 7777777777777777777777777777777
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCC----CcccCCCCCCCCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP----EESFDGNSGLCGK 203 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~----~~~~~~n~~lcg~ 203 (604)
+|++|++++.+|..+..+++|+.|++++|+++ .+|..+..++ .....+|+..|..
T Consensus 503 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c 561 (606)
T 3vq2_A 503 NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACIC 561 (606)
T ss_dssp ECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSS
T ss_pred ECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCC
Confidence 77777777777777777777777777777776 5666554443 3345677776654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=3.2e-13 Score=135.50 Aligned_cols=121 Identities=22% Similarity=0.182 Sum_probs=100.1
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCc-CCCCCcccccCCccccee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH-LSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~-l~g~iP~~~~~~~~L~~l 147 (604)
..++.|+|++|++++..+..+.++++|++|+|++|.+++..|..+.. +++|++|+|++|. ++...|..+..+++|+.|
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTG-LALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTT-CTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCC-ccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 46889999999999877778899999999999999998766766655 8999999999997 665557788899999999
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP 190 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~ 190 (604)
+|++|++++..|..+..+++|+.|++++|.+++..+..++.++
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 153 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCC
Confidence 9999999988888888899999999999999855544455544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.45 E-value=5.5e-14 Score=159.44 Aligned_cols=109 Identities=28% Similarity=0.453 Sum_probs=55.1
Q ss_pred EEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeecc
Q 007423 71 IISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILS 150 (604)
Q Consensus 71 v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls 150 (604)
++.|+|++|.+. .+|..+.++++|++|+|++|.|+ .||..+.. |++|++|+|++|+|+ .||..+++|++|+.|+|+
T Consensus 226 L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~-l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~ 301 (727)
T 4b8c_D 226 WHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKN-LSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFF 301 (727)
T ss_dssp CCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGG-GTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECC
T ss_pred CcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhC-CCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECC
Confidence 444555555554 44444455555555555555555 45544433 455555555555554 445555555555555555
Q ss_pred ccccccCCChhhhcCCCccEEEccCCcccCCCCC
Q 007423 151 NNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP 184 (604)
Q Consensus 151 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~ 184 (604)
+|+|+ .+|..++++++|+.|+|++|.|+|.+|.
T Consensus 302 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~ 334 (727)
T 4b8c_D 302 DNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLK 334 (727)
T ss_dssp SSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHH
T ss_pred CCCCC-ccChhhhcCCCccEEeCCCCccCCCChH
Confidence 55554 4454455555555555555555444443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=1.5e-13 Score=137.91 Aligned_cols=122 Identities=20% Similarity=0.178 Sum_probs=89.7
Q ss_pred CcEEEEEecCCc-ceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 69 NRIISLTLSSMQ-LSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 69 ~~v~~l~l~~n~-l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
..++.|+|++|+ +++..|..+..+++|++|+|++|.+++..|..+. .+++|++|+|++|++++..+..+..+++|+.|
T Consensus 80 ~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 158 (285)
T 1ozn_A 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFR-GLAALQYLYLQDNALQALPDDTFRDLGNLTHL 158 (285)
T ss_dssp TTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTT-TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhh-CCcCCCEEECCCCcccccCHhHhccCCCccEE
Confidence 467788888886 6655567788888888888888888765555444 37888888888888876555567778888888
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE 191 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~ 191 (604)
+|++|++++..+..+..+++|+.|++++|.+++..|..+..++.
T Consensus 159 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 202 (285)
T 1ozn_A 159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202 (285)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred ECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCccc
Confidence 88888887655556777788888888888887776766665443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.45 E-value=5.3e-14 Score=146.44 Aligned_cols=132 Identities=30% Similarity=0.340 Sum_probs=109.0
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
..+++.|+|++|+|++..|..+.++++|++|+|++|.|+ .+|...+..+++|+.|+|++|++++..|..+..+++|+.|
T Consensus 63 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 141 (361)
T 2xot_A 63 LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKL 141 (361)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred ccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCC-cCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEE
Confidence 457999999999999888888999999999999999998 4555544559999999999999998889999999999999
Q ss_pred eccccccccCCChhh----hcCCCccEEEccCCcccCCCC-CCCCCCC-----CcccCCCCCCCC
Q 007423 148 ILSNNKLSGSIPFEV----SRLDRLKEFSVAGNDLSGTIP-PDLARFP-----EESFDGNSGLCG 202 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~----~~l~~L~~l~l~~N~l~g~ip-~~~~~~~-----~~~~~~n~~lcg 202 (604)
+|++|+|++ +|..+ ..+++|+.|+|++|+|++ +| ..+..++ .....+|+..|.
T Consensus 142 ~L~~N~l~~-l~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 142 YLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKK-LPLTDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp ECCSSCCCS-CCGGGTC----CTTCCEEECCSSCCCC-CCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred ECCCCcCCe-eCHHHhcCcccCCcCCEEECCCCCCCc-cCHHHhhhccHhhcceEEecCCCccCC
Confidence 999999996 55443 578999999999999984 55 3444443 345678887774
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=1.4e-13 Score=159.35 Aligned_cols=132 Identities=22% Similarity=0.217 Sum_probs=108.3
Q ss_pred CCccccccCCCCCCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCc
Q 007423 56 CRLTGVACWNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIP 135 (604)
Q Consensus 56 c~~~gv~c~~~~~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP 135 (604)
|+|+.|++ . ...++.|+|++|++++..|..+.++++|++|||++|.+.+.|+++.+..+++|++|+|++|++++..|
T Consensus 14 ~~L~~vP~-l--p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p 90 (844)
T 3j0a_A 14 CNLTQVPQ-V--LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHP 90 (844)
T ss_dssp CCSSCCCS-S--CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECT
T ss_pred CCCCCCCC-C--CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCH
Confidence 67888887 3 46789999999999988888999999999999999988888855444558999999999999988888
Q ss_pred ccccCCcccceeeccccccccCCChh--hhcCCCccEEEccCCcccCCCC-CCCCCCC
Q 007423 136 PQIVECKFLNKLILSNNKLSGSIPFE--VSRLDRLKEFSVAGNDLSGTIP-PDLARFP 190 (604)
Q Consensus 136 ~~~~~~~~L~~l~ls~N~l~g~~p~~--~~~l~~L~~l~l~~N~l~g~ip-~~~~~~~ 190 (604)
..+.++++|+.|+|++|++++.+|.. +.++++|+.|++++|.+++..| ..++.++
T Consensus 91 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~ 148 (844)
T 3j0a_A 91 DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLN 148 (844)
T ss_dssp TSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCS
T ss_pred hHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCC
Confidence 88999999999999999998877765 7888888999999988887655 3444443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=2.3e-13 Score=151.49 Aligned_cols=122 Identities=22% Similarity=0.206 Sum_probs=96.3
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|+|++|++++..+..+.++++|++|+|++|.+++..|..+.. +++|++|+|++|++++..|..++++++|++|+
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~-l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHG-LHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT-CTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhc-hhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 46788888888888777778888888888888888888655655544 88888888888888877788888888888888
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccC-CCCCCCCCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSG-TIPPDLARFPE 191 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g-~ip~~~~~~~~ 191 (604)
|++|++++..|..++++++|+.|++++|.+++ .+|..++.++.
T Consensus 111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~ 154 (606)
T 3vq2_A 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTN 154 (606)
T ss_dssp CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTT
T ss_pred ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCC
Confidence 88888887766778888888888888888875 67776665543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.3e-13 Score=139.95 Aligned_cols=133 Identities=20% Similarity=0.219 Sum_probs=112.1
Q ss_pred CCccccccCCCC--------CCcEEEEEecCCcceeeCCc-ccccCCCCCEEEcCCCCCC--CcCChhhhhcCCCCcEEE
Q 007423 56 CRLTGVACWNEK--------ENRIISLTLSSMQLSGQLPE-SLHLCHSLQSLDLSDNSLS--GSIPVDLCKWLPYVVQLD 124 (604)
Q Consensus 56 c~~~gv~c~~~~--------~~~v~~l~l~~n~l~g~~p~-~l~~l~~L~~L~Ls~N~l~--g~ip~~~~~~l~~L~~l~ 124 (604)
|.|++|.|.+.. ...++.|+|++|+++. +|+ .+.++++|++|+|++|.++ |.+|..+.. +++|++|+
T Consensus 7 C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~-i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~-~~~L~~L~ 84 (306)
T 2z66_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFG-TTSLKYLD 84 (306)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHS-CSCCCEEE
T ss_pred eCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCc-cCHhHhhccccCCEEECCCCccCcccCccccccc-ccccCEEE
Confidence 889999997432 2479999999999994 555 4799999999999999998 445677665 89999999
Q ss_pred ccCCcCCCCCcccccCCcccceeeccccccccCCC-hhhhcCCCccEEEccCCcccCCCCCCCCCCCC
Q 007423 125 LSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIP-FEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE 191 (604)
Q Consensus 125 ls~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~ 191 (604)
|++|.++ .+|..+..+++|+.|+|++|++++..+ ..+..+++|+.|++++|.+++..|..+..++.
T Consensus 85 Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 151 (306)
T 2z66_A 85 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 151 (306)
T ss_dssp CCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTT
T ss_pred CCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcC
Confidence 9999998 588889999999999999999997655 57889999999999999998877776665543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.1e-13 Score=157.12 Aligned_cols=168 Identities=21% Similarity=0.256 Sum_probs=105.3
Q ss_pred hhhHHHHHHHHHhCCCCCC--CCCCCCCCCCCCCCCCccccccCCCC---------------CCcEEEEEecCCccee--
Q 007423 23 EDDVKCLEGIQNSIKDPDG--RLSWSFTNTTVGAICRLTGVACWNEK---------------ENRIISLTLSSMQLSG-- 83 (604)
Q Consensus 23 ~~d~~al~~~~~~~~~~~~--~~~w~~~~~~~~~~c~~~gv~c~~~~---------------~~~v~~l~l~~n~l~g-- 83 (604)
+.+..+|+.+..+...+.. .-.|.... ...+.|+++++.... ...+..++|+.|.|.+
T Consensus 131 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~ 207 (727)
T 4b8c_D 131 DCTKQALMEMADTLTDSKTAKKQQPTGDS---TPSGTATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSIDEDD 207 (727)
T ss_dssp -CCCHHHHHHHHHHHHHHTTC-----------------------------------------------------------
T ss_pred ccchhhhhhhhhhcccccCcccCCCcCCC---CccccCCCceecCCccceEEeeCCCCCcchhhHhhcCccCcccccCcc
Confidence 5677889999887632111 11343221 223567776664310 1123334445555443
Q ss_pred -------eCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeecccccccc
Q 007423 84 -------QLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSG 156 (604)
Q Consensus 84 -------~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g 156 (604)
..|..+..++.|+.|+|++|.++ .||..++. +++|++|+|++|.|+ .||..++++++|++|+|++|+|+
T Consensus 208 ~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~-l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 208 DIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFK-YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT- 283 (727)
T ss_dssp --------------CCCCCCEEECTTSCCS-CCCGGGGG-CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred ccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcC-CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence 23667889999999999999998 89999886 999999999999999 99999999999999999999999
Q ss_pred CCChhhhcCCCccEEEccCCcccCCCCCCCCCCCCc---ccCCCC
Q 007423 157 SIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEE---SFDGNS 198 (604)
Q Consensus 157 ~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~---~~~~n~ 198 (604)
.+|..++.+++|+.|+|++|.|+ .||..++.++.. ...+|.
T Consensus 284 ~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~ 327 (727)
T 4b8c_D 284 SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNP 327 (727)
T ss_dssp SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSC
T ss_pred ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCc
Confidence 89999999999999999999997 899888776543 344553
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.42 E-value=4.2e-13 Score=123.45 Aligned_cols=113 Identities=22% Similarity=0.223 Sum_probs=99.2
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCC-CcccccCCccccee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGP-IPPQIVECKFLNKL 147 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~-iP~~~~~~~~L~~l 147 (604)
..++.|+|++|++++. ..+..+++|+.|+|++|.+++.+|..+.. +++|++|+|++|++++. .+..+..+++|+.|
T Consensus 49 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L 125 (168)
T 2ell_A 49 VNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEK-LPNLTHLNLSGNKLKDISTLEPLKKLECLKSL 125 (168)
T ss_dssp GGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHH-CTTCCEEECBSSSCCSSGGGGGGSSCSCCCEE
T ss_pred CCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhh-CCCCCEEeccCCccCcchhHHHHhcCCCCCEE
Confidence 5789999999999975 78999999999999999999888876654 99999999999999863 23789999999999
Q ss_pred eccccccccCCC---hhhhcCCCccEEEccCCcccCCCCCC
Q 007423 148 ILSNNKLSGSIP---FEVSRLDRLKEFSVAGNDLSGTIPPD 185 (604)
Q Consensus 148 ~ls~N~l~g~~p---~~~~~l~~L~~l~l~~N~l~g~ip~~ 185 (604)
+|++|.+++..+ ..+..+++|+.|++++|.+. ++|..
T Consensus 126 ~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 126 DLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp ECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred EeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 999999997665 47899999999999999986 66653
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.1e-12 Score=121.89 Aligned_cols=126 Identities=23% Similarity=0.267 Sum_probs=101.4
Q ss_pred EEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeeccc
Q 007423 72 ISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSN 151 (604)
Q Consensus 72 ~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~ 151 (604)
+.+++++|+++ .+|..+ .++|+.|+|++|.+++ +|...+..+++|++|+|++|++++..|..+..+++|+.|+|++
T Consensus 10 ~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccE-eCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 57999999998 477654 4799999999999995 5555445599999999999999976666689999999999999
Q ss_pred cccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCC---CcccCCCCCCC
Q 007423 152 NKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP---EESFDGNSGLC 201 (604)
Q Consensus 152 N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n~~lc 201 (604)
|++++..+..+..+++|+.|++++|++++-.+..+..++ .....+|+..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 999987777789999999999999999854333345444 34456776555
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=2.3e-13 Score=151.81 Aligned_cols=134 Identities=22% Similarity=0.234 Sum_probs=118.3
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCc-CChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGS-IPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~-ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
..+..++++.|.+++..|..+..++.|+.|+|++|++.+. +|..+ ..+++|++|||++|++++..|..+.++++|+.|
T Consensus 445 ~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~-~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L 523 (635)
T 4g8a_A 445 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF-TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 523 (635)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCC-TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred cccccccccccccccccccccccchhhhhhhhhhcccccccCchhh-hhccccCEEECCCCccCCcChHHHcCCCCCCEE
Confidence 4678899999999999999999999999999999986554 55555 459999999999999999999999999999999
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCC----CcccCCCCCCCCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP----EESFDGNSGLCGK 203 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~----~~~~~~n~~lcg~ 203 (604)
+|++|+|++..|..+..+++|++|++++|++++..|..+..++ .....+||..|..
T Consensus 524 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C 583 (635)
T 4g8a_A 524 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 583 (635)
T ss_dssp ECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred ECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence 9999999999999999999999999999999999888877653 3457899998854
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.2e-13 Score=140.51 Aligned_cols=116 Identities=22% Similarity=0.244 Sum_probs=84.7
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCc--CChhh-hhcCCCCcEEEccCCcCCCCCcc----cccCC
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGS--IPVDL-CKWLPYVVQLDLSNNHLSGPIPP----QIVEC 141 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~--ip~~~-~~~l~~L~~l~ls~N~l~g~iP~----~~~~~ 141 (604)
.+++.|+|++|++++..|..++.+++|++|||++|.+.|. +|... ...+++|++|+|++|+++ .+|. .+..+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcC
Confidence 4789999999999888888899999999999999998763 22221 133677777788777775 3333 24566
Q ss_pred cccceeeccccccccCCChhhhcC---CCccEEEccCCcccCCCCCCC
Q 007423 142 KFLNKLILSNNKLSGSIPFEVSRL---DRLKEFSVAGNDLSGTIPPDL 186 (604)
Q Consensus 142 ~~L~~l~ls~N~l~g~~p~~~~~l---~~L~~l~l~~N~l~g~ip~~~ 186 (604)
++|+.|+|++|++++.+|..+..+ ++|+.|++++|+++ .+|..+
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~ 270 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGL 270 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhh
Confidence 777777777777777777666665 47777777777777 666654
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=4.2e-13 Score=144.95 Aligned_cols=133 Identities=21% Similarity=0.204 Sum_probs=111.8
Q ss_pred ccccccCCCC--------CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCc
Q 007423 58 LTGVACWNEK--------ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129 (604)
Q Consensus 58 ~~gv~c~~~~--------~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~ 129 (604)
|..|.|.... ...++.|+|++|++++..|..+.++++|++|+|++|.+++..|..+.. +++|++|+|++|+
T Consensus 13 ~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-l~~L~~L~L~~n~ 91 (477)
T 2id5_A 13 DRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNN-LFNLRTLGLRSNR 91 (477)
T ss_dssp TTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTT-CTTCCEEECCSSC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhC-CccCCEEECCCCc
Confidence 5677775322 246889999999999888889999999999999999999777777755 9999999999999
Q ss_pred CCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCC
Q 007423 130 LSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE 191 (604)
Q Consensus 130 l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~ 191 (604)
+++..+..+.++++|+.|+|++|++++..|..+..+++|+.|++++|.+++..|..+..++.
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 153 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNS 153 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTT
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCC
Confidence 98655556789999999999999999988989999999999999999998777766665543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.41 E-value=2.7e-13 Score=122.07 Aligned_cols=105 Identities=23% Similarity=0.223 Sum_probs=93.5
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCC-CCcccccCCcccce
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG-PIPPQIVECKFLNK 146 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g-~iP~~~~~~~~L~~ 146 (604)
..+++.|+|++|++++. ..++++++|+.|+|++|.+++.+|..+.. +++|++|+|++|++++ +.|..+..+++|+.
T Consensus 41 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~-l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~ 117 (149)
T 2je0_A 41 FEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEK-CPNLTHLNLSGNKIKDLSTIEPLKKLENLKS 117 (149)
T ss_dssp CTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHH-CTTCCEEECTTSCCCSHHHHGGGGGCTTCCE
T ss_pred cCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhh-CCCCCEEECCCCcCCChHHHHHHhhCCCCCE
Confidence 35799999999999976 78999999999999999999888876655 9999999999999997 35588999999999
Q ss_pred eeccccccccCCC---hhhhcCCCccEEEccC
Q 007423 147 LILSNNKLSGSIP---FEVSRLDRLKEFSVAG 175 (604)
Q Consensus 147 l~ls~N~l~g~~p---~~~~~l~~L~~l~l~~ 175 (604)
|++++|++++..+ ..+..+++|+.|++++
T Consensus 118 L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 118 LDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp EECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred EeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999999998766 5789999999999874
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=4e-13 Score=134.19 Aligned_cols=120 Identities=23% Similarity=0.208 Sum_probs=97.1
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
.++.|+|++|++++..+..+.++++|++|+|++|.+++..|..+ ..+++|++|+|++|++++..|..+.++++|+.|++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY-QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTT-TTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHc-cCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 58889999999987777788889999999999999885444444 44888999999999998777788888899999999
Q ss_pred cccccccCCChhhhcCCCccEEEccCCcccC-CCCCCCCCCC
Q 007423 150 SNNKLSGSIPFEVSRLDRLKEFSVAGNDLSG-TIPPDLARFP 190 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g-~ip~~~~~~~ 190 (604)
++|++++..+..+..+++|+.|++++|.+++ .+|..++.++
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~ 149 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCT
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCC
Confidence 9999987777678888899999999998875 4676665544
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.40 E-value=4e-13 Score=127.13 Aligned_cols=108 Identities=19% Similarity=0.217 Sum_probs=93.8
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|+|++|.++ .++.+..+++|++|+|++|.+++..|..+.. +++|++|+|++|++++..|..+..+++|+.|+
T Consensus 66 ~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~-l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 66 HNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSG-LTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp TTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTT-CTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcC-CCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 46889999999665 4568899999999999999999878877765 89999999999999988888999999999999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSG 180 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g 180 (604)
|++|++.+.+| .+..+++|+.|++++|.+++
T Consensus 143 L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~ 173 (197)
T 4ezg_A 143 LSYNGAITDIM-PLKTLPELKSLNIQFDGVHD 173 (197)
T ss_dssp CCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC
T ss_pred ccCCCCccccH-hhcCCCCCCEEECCCCCCcC
Confidence 99998555677 68889999999999999985
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=4.2e-13 Score=139.10 Aligned_cols=121 Identities=25% Similarity=0.219 Sum_probs=99.1
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|+|++|++++..+..+.++++|+.|+|++|.+++..|..+.. +++|++|+|++|++++..+..+.++++|++|+
T Consensus 52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 130 (353)
T 2z80_A 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSS-LGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLN 130 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTT-CTTCCEEECCSSCCSSCCHHHHTTCTTCSEEE
T ss_pred ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCC-CCCCCEEECCCCcCCcCCHhHhCCCccCCEEE
Confidence 47899999999999866668999999999999999999766666654 99999999999999964444589999999999
Q ss_pred ccccccccCCCh--hhhcCCCccEEEccCCc-ccCCCCCCCCCCCC
Q 007423 149 LSNNKLSGSIPF--EVSRLDRLKEFSVAGND-LSGTIPPDLARFPE 191 (604)
Q Consensus 149 ls~N~l~g~~p~--~~~~l~~L~~l~l~~N~-l~g~ip~~~~~~~~ 191 (604)
|++|++++ +|. .+..+++|+.|++++|+ +++..|..++.++.
T Consensus 131 L~~n~l~~-l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~ 175 (353)
T 2z80_A 131 LLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTF 175 (353)
T ss_dssp CTTCCCSS-SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCE
T ss_pred CCCCCCcc-cCchhhhccCCCCcEEECCCCccccccCHHHccCCCC
Confidence 99999994 554 78899999999999995 54333455655543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.40 E-value=4.6e-13 Score=138.41 Aligned_cols=109 Identities=25% Similarity=0.203 Sum_probs=90.5
Q ss_pred CCccccccCCCCCCcEEEEEecCC-cceeeCCcccccCCCCCEEEcCC-CCCCCcCChhhhhcCCCCcEEEccCCcCCCC
Q 007423 56 CRLTGVACWNEKENRIISLTLSSM-QLSGQLPESLHLCHSLQSLDLSD-NSLSGSIPVDLCKWLPYVVQLDLSNNHLSGP 133 (604)
Q Consensus 56 c~~~gv~c~~~~~~~v~~l~l~~n-~l~g~~p~~l~~l~~L~~L~Ls~-N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~ 133 (604)
|.|..|.|. ++ +|++ +|. |..+++|+.|+|++ |.|++..|..+. .|++|+.|+|++|+|+|.
T Consensus 8 C~~~~v~~~-------------~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~ 71 (347)
T 2ifg_A 8 HGSSGLRCT-------------RDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLR-GLGELRNLTIVKSGLRFV 71 (347)
T ss_dssp SSSSCEECC-------------SSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSC-SCCCCSEEECCSSCCCEE
T ss_pred ccCCEEEcC-------------CCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhc-cccCCCEEECCCCcccee
Confidence 777766663 44 6774 888 99999999999996 999855445554 599999999999999998
Q ss_pred CcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCC
Q 007423 134 IPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGT 181 (604)
Q Consensus 134 iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ 181 (604)
.|..+.++++|+.|+|++|+|++..|..+..+. |+.|+|++|.|...
T Consensus 72 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp CTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred CHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence 888999999999999999999965555555555 99999999999754
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=9e-13 Score=148.82 Aligned_cols=122 Identities=25% Similarity=0.238 Sum_probs=103.1
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
.+++.|+|++|++++..+..+.++++|++|+|++|.+++..|..+.. +++|++|+|++|++++..+..++++++|++|+
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQK-LPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHH-CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhc-ccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence 47889999999999866677999999999999999999777776655 89999999999999854444689999999999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE 191 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~ 191 (604)
|++|++++..|..+.++++|++|++++|.+++..|..++.++.
T Consensus 104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 146 (680)
T 1ziw_A 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146 (680)
T ss_dssp CCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTT
T ss_pred CCCCccCccChhHccccCCCCEEECCCCcccccCchhhccccc
Confidence 9999998877788899999999999999998887776665543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=5e-13 Score=145.95 Aligned_cols=114 Identities=25% Similarity=0.243 Sum_probs=74.1
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCC--cCChhhhhcCCCCcEEEccCCcCCCCCccc-ccCCcccc
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSG--SIPVDLCKWLPYVVQLDLSNNHLSGPIPPQ-IVECKFLN 145 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g--~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~-~~~~~~L~ 145 (604)
..++.|+|++|++++.+|..++++++|+.|+|++|.+++ .+|..+.. +++|++|+|++|++++.+|.. +..+++|+
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~-l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQ-MKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTT-CTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhh-CCCCCEEECCCCcCCcccccchhccCccCC
Confidence 456777777777777777777777777777777777775 45555544 677777777777777656654 55566666
Q ss_pred eeeccccccccCCChhhhcCCCccEEEccCCcccCCCCCCC
Q 007423 146 KLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186 (604)
Q Consensus 146 ~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~ 186 (604)
.|+|++|++++.+|..+. ++|+.|++++|+++ .+|..+
T Consensus 403 ~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~ 440 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQV 440 (520)
T ss_dssp EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGG
T ss_pred EEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhh
Confidence 666666666665554432 45666666666665 555543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=7.3e-13 Score=132.25 Aligned_cols=118 Identities=19% Similarity=0.183 Sum_probs=99.2
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
..+++.|+|++|++++..+..+.++++|++|+|++|.+++..|..+.. +++|++|+|++|++++..+..+..+++|+.|
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 129 (276)
T 2z62_A 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG-LSSLQKLVAVETNLASLENFPIGHLKTLKEL 129 (276)
T ss_dssp CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT-CTTCCEEECTTSCCCCSTTCCCTTCTTCCEE
T ss_pred ccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcC-CccccEEECCCCCccccCchhcccCCCCCEE
Confidence 357889999999999877778999999999999999998665555544 8999999999999987777678999999999
Q ss_pred ecccccccc-CCChhhhcCCCccEEEccCCcccCCCCCCC
Q 007423 148 ILSNNKLSG-SIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186 (604)
Q Consensus 148 ~ls~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~ 186 (604)
+|++|++++ .+|..+..+++|+.|++++|++++..+..+
T Consensus 130 ~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 169 (276)
T 2z62_A 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169 (276)
T ss_dssp ECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred ECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHh
Confidence 999999987 478889999999999999999886544443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.38 E-value=1.4e-12 Score=131.26 Aligned_cols=106 Identities=29% Similarity=0.286 Sum_probs=56.0
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
.++.|+|++|++++..|..+.++++|+.|+|++|.+++ +|.. ..+++|++|+|++|+++ .+|..+..+++|+.|+|
T Consensus 32 ~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l 107 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (290)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred CCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEEC
Confidence 45566666666665555556666666666666666553 3322 22455555555555554 44544455555555555
Q ss_pred cccccccCCChhhhcCCCccEEEccCCccc
Q 007423 150 SNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 179 (604)
++|+|++..|..+..+++|+.|++++|+++
T Consensus 108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~ 137 (290)
T 1p9a_G 108 SFNRLTSLPLGALRGLGELQELYLKGNELK 137 (290)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCC
T ss_pred CCCcCcccCHHHHcCCCCCCEEECCCCCCC
Confidence 555555444444455555555555555554
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.38 E-value=1e-12 Score=146.19 Aligned_cols=122 Identities=16% Similarity=0.122 Sum_probs=95.8
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..+..|++++|.+++..+..+.++++|+.|+|++|.+++..|..+.. +++|++|+|++|.+++..|..++.+++|++|+
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAY-AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTT-CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcC-CCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 35677888888887655555788888999999988888666656654 88888999988888887777788888889999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE 191 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~ 191 (604)
|++|+|++..|..+..+++|+.|++++|.+++..|..++.++.
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 172 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS 172 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTT
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCc
Confidence 9988888555555688888889999888888777766666554
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=7.4e-13 Score=146.10 Aligned_cols=120 Identities=17% Similarity=0.171 Sum_probs=67.2
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|+|++|.+++. |+.+..+++|+.|+|++|.+++..|...+..+++|++|+|++|.+++.+|..+..+++|+.|+
T Consensus 373 ~~L~~L~l~~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 451 (570)
T 2z63_A 373 TSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451 (570)
T ss_dssp SCCCEEECCSCSEEEE-EEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEE
T ss_pred CccCEEECCCCccccc-cccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEE
Confidence 3566667777766653 333666666666666666666544433223355566666666655555555555555555555
Q ss_pred ccccccc-cCCChhhhcCCCccEEEccCCcccCCCCCCCCCC
Q 007423 149 LSNNKLS-GSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARF 189 (604)
Q Consensus 149 ls~N~l~-g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~ 189 (604)
|++|+++ +.+|..+..+++|+.|++++|++++..|..+..+
T Consensus 452 l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 493 (570)
T 2z63_A 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 493 (570)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred CcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcc
Confidence 5555555 4455555555555555555555555445444443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.37 E-value=3.2e-13 Score=137.58 Aligned_cols=109 Identities=21% Similarity=0.257 Sum_probs=71.5
Q ss_pred CcEEEEEecCCcceeeCCccc--ccCCCCCEEEcCCCCCCCcCChhhhhcC-----CCCcEEEccCCcCCCCCcccccCC
Q 007423 69 NRIISLTLSSMQLSGQLPESL--HLCHSLQSLDLSDNSLSGSIPVDLCKWL-----PYVVQLDLSNNHLSGPIPPQIVEC 141 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l--~~l~~L~~L~Ls~N~l~g~ip~~~~~~l-----~~L~~l~ls~N~l~g~iP~~~~~~ 141 (604)
.+++.|+|++|+++|.+|..+ ..+++|++|+|++|.+++. |..+.. + ++|++|+|++|++++..|..++.+
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~-l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l 172 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAE-LQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHH-HHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHH-HHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence 356677777777776666665 6677777777777777654 655543 3 667777777777766666667777
Q ss_pred cccceeeccccccccC--CChhh--hcCCCccEEEccCCccc
Q 007423 142 KFLNKLILSNNKLSGS--IPFEV--SRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 142 ~~L~~l~ls~N~l~g~--~p~~~--~~l~~L~~l~l~~N~l~ 179 (604)
++|+.|+|++|+++|. +|..+ ..+++|+.|++++|.++
T Consensus 173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 214 (312)
T 1wwl_A 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214 (312)
T ss_dssp SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCC
T ss_pred CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCc
Confidence 7777777777776655 23333 56666777777777665
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.37 E-value=7.8e-13 Score=125.17 Aligned_cols=115 Identities=16% Similarity=0.265 Sum_probs=96.0
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
+++.|+|++|+++ .+| .+..+++|++|+|++|.++ .++.+.. +++|++|+|++|++++..|..++.+++|+.|+|
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~-l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISG-LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTT-CTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhc-CCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 5788999999998 577 6899999999999999765 3445654 899999999999999888888999999999999
Q ss_pred cccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCC
Q 007423 150 SNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP 190 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~ 190 (604)
++|++++..|..+..+++|+.|++++|.+.+.+| .+..++
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~ 159 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLP 159 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCS
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCC
Confidence 9999998888889999999999999998555676 344433
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.37 E-value=6e-13 Score=145.95 Aligned_cols=122 Identities=26% Similarity=0.392 Sum_probs=99.3
Q ss_pred Ccccc-ccCCCCCCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCc
Q 007423 57 RLTGV-ACWNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIP 135 (604)
Q Consensus 57 ~~~gv-~c~~~~~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP 135 (604)
.|.|+ .|.. ++++.|+|++|+|++ +|..+. ++|+.|+|++|.|+ .|| . .+++|+.|+|++|+|++ ||
T Consensus 49 ~~~~l~~C~~---~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip-~---~l~~L~~L~Ls~N~l~~-ip 116 (571)
T 3cvr_A 49 AVSLLKECLI---NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP-E---LPASLEYLDACDNRLST-LP 116 (571)
T ss_dssp HHHHHHHHHH---TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC-C---CCTTCCEEECCSSCCSC-CC
T ss_pred hhhhcccccc---CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc-c---ccCCCCEEEccCCCCCC-cc
Confidence 69999 7853 478999999999997 888774 88999999999998 788 3 37899999999999997 88
Q ss_pred ccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCCcccCCCC
Q 007423 136 PQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGNS 198 (604)
Q Consensus 136 ~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~n~ 198 (604)
. +.+ +|+.|+|++|+|++ +|. .+++|+.|++++|.+++ +|..+..+......+|.
T Consensus 117 ~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~~l~~L~~L~Ls~N~ 171 (571)
T 3cvr_A 117 E-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPELPTSLEVLSVRNNQ 171 (571)
T ss_dssp C-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSC
T ss_pred h-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCCcCCCcCEEECCCCC
Confidence 7 665 89999999999997 776 67889999999999986 77755555555555553
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.37 E-value=8e-13 Score=145.90 Aligned_cols=115 Identities=21% Similarity=0.244 Sum_probs=70.7
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCC--cCChhhhhcCCCCcEEEccCCcCCCCCccc-ccCCcccc
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSG--SIPVDLCKWLPYVVQLDLSNNHLSGPIPPQ-IVECKFLN 145 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g--~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~-~~~~~~L~ 145 (604)
..++.|+|++|++++.+|..++++++|+.|+|++|.+++ .+|..+.. +++|+.|+|++|++++.+|.. +..+++|+
T Consensus 353 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~-l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~ 431 (562)
T 3a79_B 353 SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKN-MSSLETLDVSLNSLNSHAYDRTCAWAESIL 431 (562)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTT-CTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred CCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcC-CCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence 456777777777777677777777777777777777764 23333433 677777777777777656553 45556666
Q ss_pred eeeccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCC
Q 007423 146 KLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLA 187 (604)
Q Consensus 146 ~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~ 187 (604)
.|+|++|++++.+|..+. ++|+.|++++|+++ .||..+.
T Consensus 432 ~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~ 470 (562)
T 3a79_B 432 VLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVT 470 (562)
T ss_dssp EEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTT
T ss_pred EEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhc
Confidence 666666666655554332 45555555555555 4554443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.8e-12 Score=133.01 Aligned_cols=130 Identities=24% Similarity=0.295 Sum_probs=110.7
Q ss_pred CCCccccccCCCC--------CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEcc
Q 007423 55 ICRLTGVACWNEK--------ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLS 126 (604)
Q Consensus 55 ~c~~~gv~c~~~~--------~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls 126 (604)
.|.|+.+.|.... ...++.|+|++|++++..|..+.++++|++|+|++|.+++..|..+.. +++|++|+|+
T Consensus 32 ~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~ 110 (332)
T 2ft3_A 32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSP-LRKLQKLYIS 110 (332)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTT-CTTCCEEECC
T ss_pred cccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhC-cCCCCEEECC
Confidence 4789999996432 246899999999999887889999999999999999999776777755 9999999999
Q ss_pred CCcCCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCccc--CCCCCCCCC
Q 007423 127 NNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS--GTIPPDLAR 188 (604)
Q Consensus 127 ~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~--g~ip~~~~~ 188 (604)
+|+++ .+|..+. ++|+.|++++|++++..+..+..+++|+.|++++|.++ |..|..+..
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~ 171 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCS
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccC
Confidence 99998 7888776 89999999999999777777899999999999999995 355555543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.2e-12 Score=145.45 Aligned_cols=128 Identities=19% Similarity=0.156 Sum_probs=106.8
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|+|++|++++..|..++++++|+.|+|++|.+++..|..+. .+++|++|+|++|.+++..|..++++++|++|+
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQ-NVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 153 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTT-TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHc-CCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence 4689999999999998888999999999999999999975555554 499999999999999954444569999999999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCCcccCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGN 197 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~n 197 (604)
|++|++++..|..+..+++|+.|++++|.+++.-+..+..+......+|
T Consensus 154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n 202 (597)
T 3oja_B 154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 202 (597)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSS
T ss_pred eeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccC
Confidence 9999999999989999999999999999998653344444443333333
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.36 E-value=9.4e-13 Score=121.54 Aligned_cols=103 Identities=25% Similarity=0.304 Sum_probs=89.0
Q ss_pred CCccccccCCCC--------CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccC
Q 007423 56 CRLTGVACWNEK--------ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSN 127 (604)
Q Consensus 56 c~~~gv~c~~~~--------~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~ 127 (604)
|.|+.+.|.+.. ...++.|+|++|+|++..|..+.++++|++|+|++|.|+ .+|...+..+++|++|+|++
T Consensus 9 C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 9 CSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCS
T ss_pred cCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcC-ccChhhccCCCCCCEEECCC
Confidence 678888886432 246889999999999988999999999999999999999 56666555699999999999
Q ss_pred CcCCCCCcccccCCcccceeeccccccccCCC
Q 007423 128 NHLSGPIPPQIVECKFLNKLILSNNKLSGSIP 159 (604)
Q Consensus 128 N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p 159 (604)
|+|++..|..+..+++|+.|+|++|.++...+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 99997666679999999999999999997654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=1.5e-12 Score=144.98 Aligned_cols=116 Identities=17% Similarity=0.096 Sum_probs=103.9
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|+|++|++++..|..++++++|++|+|++|.+++..|..+.. +++|++|+|++|++++..|..++++++|++|+
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~-l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 111 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQS-QHRLDTLVLTANPLIFMAETALSGPKALKHLF 111 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTT-CTTCCEEECTTCCCSEECTTTTSSCTTCCEEE
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccC-ccccCeeeCCCCcccccChhhhcccccccEee
Confidence 46899999999999888899999999999999999999777777755 99999999999999988899999999999999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccC-CCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSG-TIPPD 185 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g-~ip~~ 185 (604)
|++|++++..|..+..+++|++|++++|.+++ .+|..
T Consensus 112 L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 149 (606)
T 3t6q_A 112 FIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKG 149 (606)
T ss_dssp CTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTT
T ss_pred ccccCcccCCcchhccCCcccEEECCCCcccccCcccc
Confidence 99999998767788999999999999999986 44543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.34 E-value=2.5e-12 Score=137.95 Aligned_cols=132 Identities=17% Similarity=0.155 Sum_probs=109.8
Q ss_pred ccccccCCCC--------CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCc
Q 007423 58 LTGVACWNEK--------ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129 (604)
Q Consensus 58 ~~gv~c~~~~--------~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~ 129 (604)
|..|.|.+.. ...++.|+|++|++++..|..+.++++|+.|+|++|.+++..|..+. .+++|++|+|++|+
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~-~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFN-GLASLNTLELFDNW 134 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTT-TCTTCCEEECCSSC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhcc-CcccCCEEECCCCc
Confidence 4567775322 24789999999999998899999999999999999999976666665 49999999999999
Q ss_pred CCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCCCC-CCCCCC
Q 007423 130 LSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP-DLARFP 190 (604)
Q Consensus 130 l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~-~~~~~~ 190 (604)
+++..|..+..+++|+.|+|++|++++..+..+.++++|+.|++++|+..+.+|. .+..++
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~ 196 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLF 196 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCT
T ss_pred CCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCC
Confidence 9976666789999999999999999976677889999999999999776667765 344443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=9.7e-13 Score=145.18 Aligned_cols=135 Identities=19% Similarity=0.190 Sum_probs=118.5
Q ss_pred CcEEEEEecCCcceeeCC-cccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCC-CCCcccccCCcccce
Q 007423 69 NRIISLTLSSMQLSGQLP-ESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLS-GPIPPQIVECKFLNK 146 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p-~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~-g~iP~~~~~~~~L~~ 146 (604)
..++.|+|++|.+++..| ..+.++++|+.|+|++|.+++.+|..+.. +++|+.|+|++|+++ +.+|..+..+++|+.
T Consensus 396 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~ 474 (570)
T 2z63_A 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG-LSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474 (570)
T ss_dssp TTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTT-CTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred CCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhc-CCcCcEEECcCCcCccccchhhhhcccCCCE
Confidence 478899999999998776 46899999999999999999888877755 999999999999998 689999999999999
Q ss_pred eeccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCC---cccCCCCCCCCCC
Q 007423 147 LILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE---ESFDGNSGLCGKP 204 (604)
Q Consensus 147 l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~---~~~~~n~~lcg~p 204 (604)
|+|++|++++..|..+..+++|+.|++++|++++..|..+..++. ....+|+..|..+
T Consensus 475 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred EECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 999999999999999999999999999999999877766766554 4567888877644
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=9.7e-13 Score=144.58 Aligned_cols=122 Identities=21% Similarity=0.199 Sum_probs=108.7
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCC-CCcccccCCcccce
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG-PIPPQIVECKFLNK 146 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g-~iP~~~~~~~~L~~ 146 (604)
..+++.|+|++|++++..|..++++++|++|||++|.+++..|..+.. +++|++|+|++|++++ .+|..++++++|+.
T Consensus 49 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~ 127 (549)
T 2z81_A 49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGP-LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127 (549)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTT-CTTCCEEECTTCCCSSSCSSCSCTTCTTCCE
T ss_pred CCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhcc-CCCCcEEECCCCcccccchhhhhhccCCccE
Confidence 357999999999999988899999999999999999999655555654 9999999999999987 57889999999999
Q ss_pred eeccccccccCCC-hhhhcCCCccEEEccCCcccCCCCCCCCCCC
Q 007423 147 LILSNNKLSGSIP-FEVSRLDRLKEFSVAGNDLSGTIPPDLARFP 190 (604)
Q Consensus 147 l~ls~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~ 190 (604)
|+|++|++.+.+| ..+..+++|+.|++++|.+++.+|..++.++
T Consensus 128 L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~ 172 (549)
T 2z81_A 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIR 172 (549)
T ss_dssp EEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCS
T ss_pred EECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccc
Confidence 9999999777776 5789999999999999999999998887655
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.3e-12 Score=133.21 Aligned_cols=129 Identities=21% Similarity=0.113 Sum_probs=100.4
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|+|++|++++..|..++.+++|+.|+|++|.+++..|..+...+++|++|+|++|++++. |. ...+++|+.|+
T Consensus 120 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~ 197 (317)
T 3o53_A 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLD 197 (317)
T ss_dssp SSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEE
T ss_pred CCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEE
Confidence 45788888888888766778888999999999999998777777665588999999999998754 43 44588999999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCC---cccCCCCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE---ESFDGNSGLC 201 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~---~~~~~n~~lc 201 (604)
|++|++++ +|..+..+++|+.|++++|+++ .+|..+..++. ....+|+..|
T Consensus 198 Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 198 LSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251 (317)
T ss_dssp CCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBH
T ss_pred CCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccC
Confidence 99999985 4556888899999999999998 57776655443 3455665554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.34 E-value=4.7e-13 Score=136.28 Aligned_cols=113 Identities=17% Similarity=0.163 Sum_probs=73.1
Q ss_pred CcEEEEEecCCcceeeCCcccccC-----CCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCC--Ccccc--c
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLC-----HSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGP--IPPQI--V 139 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l-----~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~--iP~~~--~ 139 (604)
..++.|+|++|++++. |..++.+ ++|++|+|++|.+++..|..+.. +++|++|+|++|++.|. +|..+ .
T Consensus 121 ~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 121 PDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV-FPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp CCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC-CSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc-CCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 4567777777777765 6666665 77777777777776555455543 77777777777777655 33444 6
Q ss_pred CCcccceeecccccccc--CCCh-hhhcCCCccEEEccCCcccCCCC
Q 007423 140 ECKFLNKLILSNNKLSG--SIPF-EVSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 140 ~~~~L~~l~ls~N~l~g--~~p~-~~~~l~~L~~l~l~~N~l~g~ip 183 (604)
.+++|+.|+|++|++++ .++. .+..+++|+.|++++|++++.+|
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 245 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCC
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccc
Confidence 67777777777777763 2332 23455677777777777776554
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=2.1e-12 Score=132.36 Aligned_cols=132 Identities=20% Similarity=0.258 Sum_probs=110.9
Q ss_pred CCCccccccCCCC--------CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEcc
Q 007423 55 ICRLTGVACWNEK--------ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLS 126 (604)
Q Consensus 55 ~c~~~gv~c~~~~--------~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls 126 (604)
.|.|+.+.|.+.. ...++.|+|++|++++..+..+.++++|++|+|++|.+++..|..+.. +++|++|+|+
T Consensus 30 ~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~Ls 108 (330)
T 1xku_A 30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAP-LVKLERLYLS 108 (330)
T ss_dssp EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTT-CTTCCEEECC
T ss_pred cCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcC-CCCCCEEECC
Confidence 4789999986432 246889999999999877778999999999999999999777877765 9999999999
Q ss_pred CCcCCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCccc--CCCCCCCCCCC
Q 007423 127 NNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS--GTIPPDLARFP 190 (604)
Q Consensus 127 ~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~--g~ip~~~~~~~ 190 (604)
+|+++ .+|..+. ++|+.|++++|++++..+..+..+++|+.|++++|.++ |..|..+..++
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~ 171 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 171 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCT
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCC
Confidence 99998 7887765 78999999999999888888999999999999999985 34555444443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.5e-12 Score=143.73 Aligned_cols=119 Identities=23% Similarity=0.138 Sum_probs=98.1
Q ss_pred CccccccCCCCCCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcc
Q 007423 57 RLTGVACWNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPP 136 (604)
Q Consensus 57 ~~~gv~c~~~~~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~ 136 (604)
++++|.... ...++.|+|++|++++..|..+.++++|++|+|++|.+++..|..+.. +++|++|||++|+++ .+|.
T Consensus 42 ~L~~ip~~~--~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~-~lp~ 117 (562)
T 3a79_B 42 NLTHVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLF-NQDLEYLDVSHNRLQ-NISC 117 (562)
T ss_dssp CCCSCCTTS--CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTT-CTTCCEEECTTSCCC-EECS
T ss_pred CCccCCCCC--CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCC-CCCCCEEECCCCcCC-ccCc
Confidence 445554422 257889999999999877788999999999999999999766766654 899999999999998 7887
Q ss_pred cccCCcccceeecccccccc-CCChhhhcCCCccEEEccCCcccCC
Q 007423 137 QIVECKFLNKLILSNNKLSG-SIPFEVSRLDRLKEFSVAGNDLSGT 181 (604)
Q Consensus 137 ~~~~~~~L~~l~ls~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~g~ 181 (604)
. .+++|++|+|++|++++ .+|..++++++|+.|++++|.+++.
T Consensus 118 ~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~ 161 (562)
T 3a79_B 118 C--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL 161 (562)
T ss_dssp C--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT
T ss_pred c--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC
Confidence 7 88999999999999987 5678899999999999999988753
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=1.2e-12 Score=145.62 Aligned_cols=122 Identities=22% Similarity=0.218 Sum_probs=81.6
Q ss_pred CcEEEEEecCCcceeeCCcc-cccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCC---CCcccccCCccc
Q 007423 69 NRIISLTLSSMQLSGQLPES-LHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG---PIPPQIVECKFL 144 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~-l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g---~iP~~~~~~~~L 144 (604)
..++.|+|++|++++..|+. +.++++|+.|+|++|.+++.+|..+.. +++|+.|+|++|++++ ..+..+..+++|
T Consensus 400 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L 478 (606)
T 3t6q_A 400 PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDG-LPALQHLNLQGNHFPKGNIQKTNSLQTLGRL 478 (606)
T ss_dssp TTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTT-CTTCCEEECTTCBCGGGEECSSCGGGGCTTC
T ss_pred ccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhC-CCCCCEEECCCCCCCccccccchhhccCCCc
Confidence 45677777777777665544 677777777777777777666655544 6777777777777765 223456667777
Q ss_pred ceeeccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCC
Q 007423 145 NKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE 191 (604)
Q Consensus 145 ~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~ 191 (604)
+.|+|++|++++..|..+..+++|+.|++++|++++.+|..+..++.
T Consensus 479 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 525 (606)
T 3t6q_A 479 EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG 525 (606)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCS
T ss_pred cEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCcccc
Confidence 77777777777666666777777777777777777666665555443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=7.5e-13 Score=144.57 Aligned_cols=113 Identities=24% Similarity=0.228 Sum_probs=55.7
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCC-CCcccccCCcccceee
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG-PIPPQIVECKFLNKLI 148 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g-~iP~~~~~~~~L~~l~ 148 (604)
+++.|+|++|++++..|..++++++|++|||++|.++ .||.. .+++|++|+|++|++++ .+|..++++++|++|+
T Consensus 46 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~---~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~ 121 (520)
T 2z7x_B 46 KLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH---PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121 (520)
T ss_dssp TCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC---CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEE
T ss_pred cccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc---ccCCccEEeccCCccccccchhhhccCCcceEEE
Confidence 3445555555555444445555555555555555554 34443 24555555555555544 3445555555555555
Q ss_pred ccccccccCCChhhhcCCCc--cEEEccCCcc--cCCCCCCCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRL--KEFSVAGNDL--SGTIPPDLARF 189 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L--~~l~l~~N~l--~g~ip~~~~~~ 189 (604)
|++|++++ ..+..+++| +.|++++|.+ ++.+|..+..+
T Consensus 122 L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l 163 (520)
T 2z7x_B 122 LSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDF 163 (520)
T ss_dssp EEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTC
T ss_pred ecCcccch---hhccccccceeeEEEeeccccccccccccccccc
Confidence 55555544 123334444 5555555555 45555555443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.32 E-value=4.3e-13 Score=145.23 Aligned_cols=117 Identities=23% Similarity=0.252 Sum_probs=102.5
Q ss_pred CcEEEEEecCCcceeeCCcccc-cCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 69 NRIISLTLSSMQLSGQLPESLH-LCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~-~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
..++.|+|++|++++..|..+. .+++|+.|+|++|.|++. |.. .. +++|+.|+|++|++++ +|+.+..+++|+.|
T Consensus 144 ~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~~-~~-l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L 219 (487)
T 3oja_A 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQ-VV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWI 219 (487)
T ss_dssp SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECC-CC-CTTCCEEECCSSCCCE-ECGGGGGGTTCSEE
T ss_pred CCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-ccc-cc-CCCCCEEECCCCCCCC-CCHhHcCCCCccEE
Confidence 5799999999999999998886 899999999999999965 433 23 8999999999999996 56669999999999
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCccc-CCCCCCCCCCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS-GTIPPDLARFP 190 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~-g~ip~~~~~~~ 190 (604)
+|++|+|++ +|..+..+++|+.|++++|.++ +.+|..+..++
T Consensus 220 ~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~ 262 (487)
T 3oja_A 220 SLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262 (487)
T ss_dssp ECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCH
T ss_pred EecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCC
Confidence 999999996 8888999999999999999998 66666666554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=3.6e-12 Score=131.99 Aligned_cols=122 Identities=23% Similarity=0.220 Sum_probs=107.1
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcc--cccCCcccc
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPP--QIVECKFLN 145 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~--~~~~~~~L~ 145 (604)
..+++.|+|++|++++..|..+.++++|++|+|++|.++ .+|...+..+++|++|+|++|+++ .+|. .+..+++|+
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~ 152 (353)
T 2z80_A 75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQ 152 (353)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCC
T ss_pred CCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCC-cCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCc
Confidence 457999999999999988889999999999999999999 677774455999999999999998 5665 789999999
Q ss_pred eeeccccc-cccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCC
Q 007423 146 KLILSNNK-LSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE 191 (604)
Q Consensus 146 ~l~ls~N~-l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~ 191 (604)
.|++++|+ +++..|..+..+++|+.|++++|.+++..|..+..++.
T Consensus 153 ~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~ 199 (353)
T 2z80_A 153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQN 199 (353)
T ss_dssp EEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSE
T ss_pred EEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhcccc
Confidence 99999995 77666778999999999999999999888887776654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.1e-12 Score=133.50 Aligned_cols=121 Identities=17% Similarity=0.158 Sum_probs=93.9
Q ss_pred CCcEEEEEecCCcceeeCC----cccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCC--Ccc--ccc
Q 007423 68 ENRIISLTLSSMQLSGQLP----ESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGP--IPP--QIV 139 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p----~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~--iP~--~~~ 139 (604)
...++.|+|++|++++..| ..+..+++|++|+|++|.+++..|..+. .+++|++|+|++|++.|. +|. .++
T Consensus 116 ~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 194 (310)
T 4glp_A 116 GLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVR-AFPALTSLDLSDNPGLGERGLMAALCPH 194 (310)
T ss_dssp CBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCC-CCTTCCEEECCSCTTCHHHHHHTTSCTT
T ss_pred CCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhc-cCCCCCEEECCCCCCccchhhhHHHhhh
Confidence 3568889999999998666 3456799999999999999866666654 489999999999998763 332 236
Q ss_pred CCcccceeecccccccc--CCChh-hhcCCCccEEEccCCcccCCCCCCCCCC
Q 007423 140 ECKFLNKLILSNNKLSG--SIPFE-VSRLDRLKEFSVAGNDLSGTIPPDLARF 189 (604)
Q Consensus 140 ~~~~L~~l~ls~N~l~g--~~p~~-~~~l~~L~~l~l~~N~l~g~ip~~~~~~ 189 (604)
.+++|++|+|++|+++. .++.. +..+++|+.|++++|++++.+|..+..+
T Consensus 195 ~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 195 KFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp SSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred cCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 88899999999999972 22222 4678999999999999998888766554
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=4.4e-12 Score=135.51 Aligned_cols=116 Identities=21% Similarity=0.189 Sum_probs=67.8
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
.+++.|+|++|++++..+..+.++++|+.|+|++|+..+.+|...+..+++|+.|+|++|+++ .+| .+..+++|+.|+
T Consensus 136 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~ 213 (440)
T 3zyj_A 136 SKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELD 213 (440)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEE
T ss_pred ccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEE
Confidence 578889999998887666567777777777777655555666544444555665555555555 344 245555555555
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDL 186 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~ 186 (604)
|++|++++..|..+..+++|+.|++++|++++..|..+
T Consensus 214 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 251 (440)
T 3zyj_A 214 LSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAF 251 (440)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSS
T ss_pred CCCCccCccChhhhccCccCCEEECCCCceeEEChhhh
Confidence 55555555445555555555555555555444333333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.8e-12 Score=140.05 Aligned_cols=120 Identities=21% Similarity=0.242 Sum_probs=103.9
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
..+++.|+|++|++++..|..+.++++|++|+|++|.++ .+|...+..+++|++|+|++|++++..|..+..+++|+.|
T Consensus 55 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 133 (477)
T 2id5_A 55 FPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSL 133 (477)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCC-ccCcccccCCCCCCEEECCCCccccCChhHccccccCCEE
Confidence 357899999999999988999999999999999999998 6776654559999999999999998888899999999999
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLAR 188 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~ 188 (604)
+|++|++++..|..+..+++|+.|++++|++++..+..+..
T Consensus 134 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~ 174 (477)
T 2id5_A 134 EVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSH 174 (477)
T ss_dssp EECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTT
T ss_pred ECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcc
Confidence 99999999888888999999999999999998543333433
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.31 E-value=1.8e-12 Score=120.29 Aligned_cols=103 Identities=20% Similarity=0.209 Sum_probs=45.7
Q ss_pred EEEEEecCCcceeeCCcccccCC-CCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 71 IISLTLSSMQLSGQLPESLHLCH-SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 71 v~~l~l~~n~l~g~~p~~l~~l~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
++.|+|++|+++. +|. +..+. +|+.|+|++|.+++ + ..+.. +++|++|+|++|++++..|..+..+++|+.|+|
T Consensus 21 L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~-~-~~l~~-l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 95 (176)
T 1a9n_A 21 DRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRK-L-DGFPL-LRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 95 (176)
T ss_dssp CEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCE-E-CCCCC-CSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred ceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCc-c-ccccc-CCCCCEEECCCCcccccCcchhhcCCCCCEEEC
Confidence 4445555555542 322 33332 55555555555543 2 22222 445555555555554321122244555555555
Q ss_pred cccccccCCCh--hhhcCCCccEEEccCCccc
Q 007423 150 SNNKLSGSIPF--EVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 150 s~N~l~g~~p~--~~~~l~~L~~l~l~~N~l~ 179 (604)
++|+++ .+|. .+..+++|+.|++++|.++
T Consensus 96 ~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 96 TNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp CSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CCCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence 555553 3333 4444455555555555544
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.31 E-value=2.2e-12 Score=125.93 Aligned_cols=120 Identities=14% Similarity=0.133 Sum_probs=100.4
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCC-CCCcCChhhhhcCCCCcEEEccC-CcCCCCCcccccCCcccce
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNS-LSGSIPVDLCKWLPYVVQLDLSN-NHLSGPIPPQIVECKFLNK 146 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~-l~g~ip~~~~~~l~~L~~l~ls~-N~l~g~iP~~~~~~~~L~~ 146 (604)
..++.|+|++|++++..+..+.++++|+.|+|++|. ++ .||...+..+++|++|+|++ |++++..|..+..+++|+.
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~ 109 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence 478999999999998777789999999999999997 76 67764445599999999998 9999766678899999999
Q ss_pred eeccccccccCCChhhhcCCCcc---EEEccCC-cccCCCCCCCCCCCC
Q 007423 147 LILSNNKLSGSIPFEVSRLDRLK---EFSVAGN-DLSGTIPPDLARFPE 191 (604)
Q Consensus 147 l~ls~N~l~g~~p~~~~~l~~L~---~l~l~~N-~l~g~ip~~~~~~~~ 191 (604)
|+|++|++++ +|. +..+.+|+ .|++++| .+++-.+..+..++.
T Consensus 110 L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~ 156 (239)
T 2xwt_C 110 LGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCN 156 (239)
T ss_dssp EEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBS
T ss_pred EeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhc
Confidence 9999999997 786 78888888 9999999 887544445665553
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.30 E-value=6.7e-12 Score=134.58 Aligned_cols=118 Identities=19% Similarity=0.149 Sum_probs=68.4
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
..+++.|+|++|++++..+..+.++++|+.|+|++|+..+.+|...+..+++|+.|+|++|++++ +| .+..+++|+.|
T Consensus 146 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L 223 (452)
T 3zyi_A 146 LSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEEL 223 (452)
T ss_dssp CTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEE
T ss_pred cCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEE
Confidence 35789999999999866555666777777777766554455655444445555555555555553 23 34455555555
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLA 187 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~ 187 (604)
+|++|+|++..|..+..+++|+.|++++|++++..|..+.
T Consensus 224 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 263 (452)
T 3zyi_A 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFD 263 (452)
T ss_dssp ECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred ECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhc
Confidence 5555555555455555555555555555555444443333
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=5.7e-12 Score=134.66 Aligned_cols=132 Identities=19% Similarity=0.193 Sum_probs=108.3
Q ss_pred ccccccCCCC--------CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCc
Q 007423 58 LTGVACWNEK--------ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH 129 (604)
Q Consensus 58 ~~gv~c~~~~--------~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~ 129 (604)
|..|.|.... ...++.|+|++|++++..+..+.++++|+.|+|++|.+++..|..+ ..+++|++|+|++|+
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~-~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAF-NGLANLNTLELFDNR 123 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGG-TTCSSCCEEECCSSC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhc-cCCccCCEEECCCCc
Confidence 5677786432 2467899999999999888999999999999999999995444445 459999999999999
Q ss_pred CCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCCCC-CCCCCC
Q 007423 130 LSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP-DLARFP 190 (604)
Q Consensus 130 l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~-~~~~~~ 190 (604)
+++..+..+..+++|+.|+|++|++++..+..+..+++|+.|++++|+..+.+|. .+..++
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~ 185 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLS 185 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCS
T ss_pred CCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhccc
Confidence 9966666799999999999999999977777889999999999999776666665 344443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.30 E-value=6e-12 Score=132.16 Aligned_cols=122 Identities=16% Similarity=0.139 Sum_probs=92.9
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|++++|.++...+..+..+++|++|+|++|.+++..|..+. .+++|++|+|++|++++..|..++++++|++|+
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFA-YAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTT-TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhcc-CCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 4677888888888754344468888899999999988854444554 488899999999988877777788888899999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE 191 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~ 191 (604)
|++|+++...+..+..+++|+.|++++|.+++..|..+..++.
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 166 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS 166 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTT
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCC
Confidence 9999888433334578888899999998888666665655443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.29 E-value=4.9e-12 Score=117.29 Aligned_cols=105 Identities=18% Similarity=0.263 Sum_probs=93.0
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcc--cccCCccccee
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPP--QIVECKFLNKL 147 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~--~~~~~~~L~~l 147 (604)
.++.|+|++|+|++. +.+..+++|+.|+|++|.++ .+|+.++..+++|++|+|++|+++ .+|. .+..+++|+.|
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 118 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCccc-ccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence 789999999999975 68999999999999999999 567666455999999999999995 6787 88999999999
Q ss_pred eccccccccCCChh----hhcCCCccEEEccCCccc
Q 007423 148 ILSNNKLSGSIPFE----VSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 148 ~ls~N~l~g~~p~~----~~~l~~L~~l~l~~N~l~ 179 (604)
+|++|.++ .+|.. +..+++|+.|++++|...
T Consensus 119 ~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 119 CILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp ECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 99999998 56764 899999999999999764
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=1e-11 Score=127.20 Aligned_cols=119 Identities=24% Similarity=0.312 Sum_probs=101.3
Q ss_pred CCcEEEEEecCCcce--eeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccc
Q 007423 68 ENRIISLTLSSMQLS--GQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLN 145 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~--g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~ 145 (604)
...++.|+|++|.++ |..+..+.++++|+.|+|++|.++ .+|..+ .++|+.|+|++|++++..|..+..+++|+
T Consensus 144 l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~---~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 219 (330)
T 1xku_A 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLA 219 (330)
T ss_dssp CTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCC
T ss_pred CccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCccc---cccCCEEECCCCcCCccCHHHhcCCCCCC
Confidence 357889999999995 467888999999999999999998 688754 47899999999999888888899999999
Q ss_pred eeeccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCC
Q 007423 146 KLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE 191 (604)
Q Consensus 146 ~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~ 191 (604)
.|+|++|++++..|..+..+++|+.|++++|.++ .+|..+..++.
T Consensus 220 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~ 264 (330)
T 1xku_A 220 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 264 (330)
T ss_dssp EEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSS
T ss_pred EEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCC
Confidence 9999999999887778888999999999999998 78887766554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=6.3e-12 Score=145.42 Aligned_cols=116 Identities=25% Similarity=0.254 Sum_probs=54.0
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChh--hhhcCCCCcEEEccCCcCCCCCc-ccccCCcccce
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVD--LCKWLPYVVQLDLSNNHLSGPIP-PQIVECKFLNK 146 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~--~~~~l~~L~~l~ls~N~l~g~iP-~~~~~~~~L~~ 146 (604)
+++.|+|++|++++..|..++++++|++|+|++|.+++.+|.. +. .+++|++|+|++|.+++..| ..++++++|+.
T Consensus 74 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~-~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~ 152 (844)
T 3j0a_A 74 NLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR-NLKALTRLDLSKNQIRSLYLHPSFGKLNSLKS 152 (844)
T ss_dssp TCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCS-SCSSCCEEEEESCCCCCCCCCGGGGTCSSCCE
T ss_pred CCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCcccc-ccCCCCEEECCCCcccccccchhHhhCCCCCE
Confidence 3444455555444444444444555555555555554444332 22 24445555555555444332 23444555555
Q ss_pred eeccccccccCCChhhhcC--CCccEEEccCCcccCCCCCCC
Q 007423 147 LILSNNKLSGSIPFEVSRL--DRLKEFSVAGNDLSGTIPPDL 186 (604)
Q Consensus 147 l~ls~N~l~g~~p~~~~~l--~~L~~l~l~~N~l~g~ip~~~ 186 (604)
|+|++|++++..|..+..+ ++|+.|++++|.+++.+|..+
T Consensus 153 L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~ 194 (844)
T 3j0a_A 153 IDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDW 194 (844)
T ss_dssp EEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCC
T ss_pred EECCCCcCCeeCHHHcccccCCccceEECCCCccccccccch
Confidence 5555555544444444444 444444444444444444433
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=8.1e-12 Score=137.43 Aligned_cols=101 Identities=28% Similarity=0.350 Sum_probs=90.7
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCC-cccccCCccccee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPI-PPQIVECKFLNKL 147 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~i-P~~~~~~~~L~~l 147 (604)
..++.|+|++|+|+ .+|..+++|++|+.|+|++|.|++ || .+.. +++|+.|+|++|+|++.+ |..++.+++|+.|
T Consensus 463 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~-l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L 538 (567)
T 1dce_A 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVAN-LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538 (567)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTT-CSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred ccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCC-CCCCcEEECCCCCCCCCCCcHHHhcCCCCCEE
Confidence 47899999999999 899999999999999999999996 88 6765 999999999999999887 9999999999999
Q ss_pred eccccccccCCChh---hhcCCCccEEEc
Q 007423 148 ILSNNKLSGSIPFE---VSRLDRLKEFSV 173 (604)
Q Consensus 148 ~ls~N~l~g~~p~~---~~~l~~L~~l~l 173 (604)
+|++|+|++.+|.. +..+++|+.|++
T Consensus 539 ~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 539 NLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp ECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred EecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 99999999876632 345788999864
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.25 E-value=6.3e-12 Score=122.62 Aligned_cols=115 Identities=16% Similarity=0.137 Sum_probs=98.6
Q ss_pred CCcEEEEEecCCc-ceeeCCcccccCCCCCEEEcCC-CCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccc
Q 007423 68 ENRIISLTLSSMQ-LSGQLPESLHLCHSLQSLDLSD-NSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLN 145 (604)
Q Consensus 68 ~~~v~~l~l~~n~-l~g~~p~~l~~l~~L~~L~Ls~-N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~ 145 (604)
..+++.|+|++|+ +++..+..+.++++|++|+|++ |.++ .+|...+..+++|+.|+|++|++++ +|. +..+++|+
T Consensus 54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~-~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~ 130 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT-YIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTD 130 (239)
T ss_dssp CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCC-EECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCC
T ss_pred CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCee-EcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccc
Confidence 3579999999997 8866666899999999999998 9998 5665444559999999999999986 887 88888888
Q ss_pred ---eeecccc-ccccCCChhhhcCCCcc-EEEccCCcccCCCCCCC
Q 007423 146 ---KLILSNN-KLSGSIPFEVSRLDRLK-EFSVAGNDLSGTIPPDL 186 (604)
Q Consensus 146 ---~l~ls~N-~l~g~~p~~~~~l~~L~-~l~l~~N~l~g~ip~~~ 186 (604)
.|++++| ++++..+..+..+++|+ .|++++|.++ .+|...
T Consensus 131 ~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~ 175 (239)
T 2xwt_C 131 IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYA 175 (239)
T ss_dssp SEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTT
T ss_pred cccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhh
Confidence 9999999 99977777789999999 9999999998 777643
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=7.4e-12 Score=141.31 Aligned_cols=115 Identities=23% Similarity=0.237 Sum_probs=94.6
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
.+++.|+|++|++++..|..++++++|++|+|++|.++ .+|...+..+++|++|+|++|++++..|..++++++|++|+
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 127 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLD 127 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEE
T ss_pred CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEE
Confidence 46888899999888888888888899999999988888 56664334488888999988888876667888888888888
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP 184 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~ 184 (604)
|++|++++..|..+.++++|+.|++++|.+++..|.
T Consensus 128 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 128 LSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred CCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 888888888888888888888888888888766554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.1e-11 Score=114.90 Aligned_cols=89 Identities=27% Similarity=0.288 Sum_probs=78.9
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|+|++|+|++..|..+.++++|+.|+|++|.|++ ||..++..+++|++|+|++|+|++..|..+..+++|+.|+
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~ 111 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIY 111 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCc-cChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEE
Confidence 468899999999999889999999999999999999994 7776655599999999999999965555699999999999
Q ss_pred ccccccccCC
Q 007423 149 LSNNKLSGSI 158 (604)
Q Consensus 149 ls~N~l~g~~ 158 (604)
|++|.|+...
T Consensus 112 L~~N~~~c~~ 121 (174)
T 2r9u_A 112 LYNNPWDCEC 121 (174)
T ss_dssp CCSSCBCTTB
T ss_pred eCCCCccccc
Confidence 9999998543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.23 E-value=2e-11 Score=128.09 Aligned_cols=127 Identities=20% Similarity=0.204 Sum_probs=101.1
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCccc-ccCCccccee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQ-IVECKFLNKL 147 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~-~~~~~~L~~l 147 (604)
.+++.|+|++|++++..+..+..+++|++|+|++|.+++..|..+. .+++|++|+|++|+++ .+|.. +.++++|++|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L 146 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQ-NVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTL 146 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTT-TCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhc-CCCCCCEEECCCCccC-cCCHHHhcCCCCCcEE
Confidence 4688999999999987777899999999999999999865555554 4899999999999998 56655 5889999999
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCCcccCCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGN 197 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~n 197 (604)
+|++|++++..|..+..+++|+.|++++|.+++.-...+..+......+|
T Consensus 147 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n 196 (390)
T 3o6n_A 147 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 196 (390)
T ss_dssp ECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSS
T ss_pred ECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccc
Confidence 99999999888888999999999999999998542233333333333333
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.22 E-value=2.8e-13 Score=128.32 Aligned_cols=108 Identities=25% Similarity=0.258 Sum_probs=63.1
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
.++.|+|++|++++ +| .+.++++|+.|+|++|.++ .+|..+.. +++|+.|+|++|++++ +| .+..+++|+.|+|
T Consensus 49 ~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~-~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l 122 (198)
T 1ds9_A 49 ACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV-ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH-HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEE
T ss_pred CCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc-CCcCCEEECcCCcCCc-CC-ccccCCCCCEEEC
Confidence 45666666666665 55 5666666666666666665 55554433 5566666666666654 34 4556666666666
Q ss_pred cccccccCCC-hhhhcCCCccEEEccCCcccCCCC
Q 007423 150 SNNKLSGSIP-FEVSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 150 s~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~g~ip 183 (604)
++|++++..+ ..+..+++|+.|++++|.+++.+|
T Consensus 123 ~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 157 (198)
T 1ds9_A 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp SEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred CCCcCCchhHHHHHhcCCCCCEEEecCCccccccc
Confidence 6666653211 345566666666666666655444
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.21 E-value=2.1e-11 Score=125.09 Aligned_cols=119 Identities=18% Similarity=0.243 Sum_probs=66.4
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCC--CcCChhhhh-------------------cCCCCcEEEccCC
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLS--GSIPVDLCK-------------------WLPYVVQLDLSNN 128 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~--g~ip~~~~~-------------------~l~~L~~l~ls~N 128 (604)
.++.|+|++|++++..+..+.++++|+.|+|++|.++ |..|..+.. ..++|+.|+|++|
T Consensus 124 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n 203 (332)
T 2ft3_A 124 SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHN 203 (332)
T ss_dssp TCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSS
T ss_pred cCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCC
Confidence 3555555555555433344566666666666666664 122322211 0134555555555
Q ss_pred cCCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCC
Q 007423 129 HLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARF 189 (604)
Q Consensus 129 ~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~ 189 (604)
.+++..|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|+++ .+|..+..+
T Consensus 204 ~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l 263 (332)
T 2ft3_A 204 KIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDL 263 (332)
T ss_dssp CCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGC
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcC
Confidence 555555555666666666666666666655556666666666666666666 566554443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.20 E-value=2.4e-13 Score=128.84 Aligned_cols=106 Identities=20% Similarity=0.351 Sum_probs=94.5
Q ss_pred CcEEEEEecCCcceeeCCc------ccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCc
Q 007423 69 NRIISLTLSSMQLSGQLPE------SLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECK 142 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~------~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~ 142 (604)
.+++.++|+.+.|+|.+|. .+..+++|++|+|++|.+++ +| .+.. +++|+.|+|++|+++ .+|..+..++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~-l~~L~~L~l~~n~l~-~l~~~~~~~~ 93 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSG-MENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHH-HTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-cccc-CCCCCEEECCCCCcc-cccchhhcCC
Confidence 3566777888888888887 89999999999999999996 88 6655 999999999999998 7898888899
Q ss_pred ccceeeccccccccCCChhhhcCCCccEEEccCCcccC
Q 007423 143 FLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSG 180 (604)
Q Consensus 143 ~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g 180 (604)
+|+.|+|++|++++ +| .+..+++|+.|++++|++++
T Consensus 94 ~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~ 129 (198)
T 1ds9_A 94 TLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN 129 (198)
T ss_dssp HCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC
T ss_pred cCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc
Confidence 99999999999997 56 68899999999999999984
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.19 E-value=6.4e-11 Score=119.19 Aligned_cols=111 Identities=29% Similarity=0.379 Sum_probs=87.9
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|+|++|++++. ++ +.++++|+.|+|++|.+++ +|. +.. +++|+.|+|++|++++ + +.+..+++|+.|+
T Consensus 68 ~~L~~L~L~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~-l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~ 140 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTDI-KP-LANLKNLGWLFLDENKVKD-LSS-LKD-LKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 140 (291)
T ss_dssp TTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-GGG-GTT-CTTCCEEECTTSCCCC-C-GGGGGCTTCCEEE
T ss_pred CCCCEEEccCCccCCC-cc-cccCCCCCEEECCCCcCCC-Chh-hcc-CCCCCEEECCCCcCCC-C-hhhcCCCCCCEEE
Confidence 4688999999999864 44 8899999999999999985 553 544 8899999999999886 3 4688888999999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP 190 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~ 190 (604)
|++|++++. ..+..+++|+.|++++|.+++..| +..++
T Consensus 141 l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~ 178 (291)
T 1h6t_A 141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLT 178 (291)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCT
T ss_pred ccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCC
Confidence 999998865 567888899999999998876444 44443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.18 E-value=6e-11 Score=119.40 Aligned_cols=102 Identities=28% Similarity=0.413 Sum_probs=61.0
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
.+++.|+|++|++++ + +.+..+++|+.|+|++|.+++ +| .+.. +++|+.|+|++|++++. +.+..+++|+.|+
T Consensus 90 ~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~i~~-~~-~l~~-l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~ 162 (291)
T 1h6t_A 90 KNLGWLFLDENKVKD-L-SSLKDLKKLKSLSLEHNGISD-IN-GLVH-LPQLESLYLGNNKITDI--TVLSRLTKLDTLS 162 (291)
T ss_dssp TTCCEEECCSSCCCC-G-GGGTTCTTCCEEECTTSCCCC-CG-GGGG-CTTCCEEECCSSCCCCC--GGGGGCTTCSEEE
T ss_pred CCCCEEECCCCcCCC-C-hhhccCCCCCEEECCCCcCCC-Ch-hhcC-CCCCCEEEccCCcCCcc--hhhccCCCCCEEE
Confidence 356666666666654 2 236666666666666666663 32 3333 66666666666666643 4566666666666
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCccc
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 179 (604)
|++|++++..| +..+++|+.|++++|.++
T Consensus 163 L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~ 191 (291)
T 1h6t_A 163 LEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191 (291)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ccCCccccchh--hcCCCccCEEECCCCcCC
Confidence 66666665433 566666666666666665
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.9e-11 Score=133.97 Aligned_cols=111 Identities=27% Similarity=0.375 Sum_probs=84.1
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
.++.|+|++|+|++ +|. .+++|+.|+|++|.|++ ||. .+++|+.|+|++|+|++ +|. +. ++|+.|+|
T Consensus 121 ~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~----~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~L 187 (571)
T 3cvr_A 121 SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE----LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDV 187 (571)
T ss_dssp TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEEC
T ss_pred CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC----cCCCcCEEECCCCCCCC-cch-hh--CCCCEEEC
Confidence 68888888888887 776 68889999999999985 776 37889999999999986 777 65 88888889
Q ss_pred cccccccCCChhhhcCCCc-------cEEEccCCcccCCCCCCCCCCCCc---ccCCCC
Q 007423 150 SNNKLSGSIPFEVSRLDRL-------KEFSVAGNDLSGTIPPDLARFPEE---SFDGNS 198 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L-------~~l~l~~N~l~g~ip~~~~~~~~~---~~~~n~ 198 (604)
++|+|+ .+|. +.. +| +.|+|++|+++ .||..+..++.. ...+|+
T Consensus 188 s~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~ 241 (571)
T 3cvr_A 188 STNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNP 241 (571)
T ss_dssp CSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSS
T ss_pred cCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCc
Confidence 888888 6776 544 66 88888888887 678766555433 344554
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.18 E-value=5.6e-11 Score=117.78 Aligned_cols=103 Identities=27% Similarity=0.343 Sum_probs=78.0
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|+|++|++++ +|+ +.++++|+.|+|++|.+++ +|... . ++|+.|+|++|++++ +| .+..+++|+.|+
T Consensus 63 ~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~~-~--~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~ 134 (263)
T 1xeu_A 63 TNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGIP-S--ACLSRLFLDNNELRD-TD-SLIHLKNLEILS 134 (263)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTCC-C--SSCCEEECCSSCCSB-SG-GGTTCTTCCEEE
T ss_pred CCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCccc-c--CcccEEEccCCccCC-Ch-hhcCcccccEEE
Confidence 467888888888876 444 8888888888888888874 55422 2 778888888888875 34 578888888888
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGT 181 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ 181 (604)
|++|++++. | .+..+++|+.|++++|++++.
T Consensus 135 Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 135 IRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred CCCCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence 888888864 4 577888888888888888754
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.16 E-value=9.1e-11 Score=119.08 Aligned_cols=103 Identities=25% Similarity=0.438 Sum_probs=72.0
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
.+++.|+|++|++++ +++ +..+++|++|+|++|.+++ +| .+.. +++|+.|+|++|++++ +|. +..+++|+.|+
T Consensus 63 ~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~-l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~ 135 (308)
T 1h6u_A 63 NNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAG-LQSIKTLDLTSTQITD-VTP-LAGLSNLQVLY 135 (308)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTT-CTTCCEEECTTSCCCC-CGG-GTTCTTCCEEE
T ss_pred CCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcC-CCCCCEEECCCCCCCC-chh-hcCCCCCCEEE
Confidence 467778888887775 343 7777788888888887774 44 3443 7777777777777765 443 77777777777
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSG 180 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g 180 (604)
|++|++++..+ +..+++|+.|++++|.+++
T Consensus 136 l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~ 165 (308)
T 1h6u_A 136 LDLNQITNISP--LAGLTNLQYLSIGNAQVSD 165 (308)
T ss_dssp CCSSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred CCCCccCcCcc--ccCCCCccEEEccCCcCCC
Confidence 77777775433 6677777777777777764
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.16 E-value=4.6e-11 Score=128.13 Aligned_cols=105 Identities=21% Similarity=0.181 Sum_probs=74.4
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|+|++|++++ +| ++.+++|+.|+|++|.+++ ++ +.. +++|+.|+|++|++++ +| +..+++|+.|+
T Consensus 170 ~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~-~~--l~~-l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~ 239 (457)
T 3bz5_A 170 TQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITK-LD--LNQ-NIQLTFLDCSSNKLTE-ID--VTPLTQLTYFD 239 (457)
T ss_dssp TTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSC-CC--CTT-CTTCSEEECCSSCCSC-CC--CTTCTTCSEEE
T ss_pred CcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCe-ec--ccc-CCCCCEEECcCCcccc-cC--ccccCCCCEEE
Confidence 467888888888886 55 7778888888888888875 33 433 7788888888888876 66 77778888888
Q ss_pred ccccccccCCChhhhcCC-------CccEEEccCCcccCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLD-------RLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~-------~L~~l~l~~N~l~g~ip 183 (604)
+++|+|++..+..+.++. +|+.|++++|.+.|.+|
T Consensus 240 l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~ 281 (457)
T 3bz5_A 240 CSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ 281 (457)
T ss_dssp CCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE
T ss_pred eeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc
Confidence 888888876554444443 44555666666666665
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=6.9e-11 Score=116.85 Aligned_cols=144 Identities=12% Similarity=0.030 Sum_probs=110.2
Q ss_pred HhhcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEecccc-ccHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeeEEe
Q 007423 292 AATNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACK-LSEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 292 ~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 369 (604)
..-++|......+.|+.+.||+.... ++.+++|+..... .....+.+|+++++.+. |..+.++++++...+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 34456776677777888899999854 6899999986422 22345889999999884 677888999998888999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhc---------------------------------
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHG--------------------------------- 416 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~--------------------------------- 416 (604)
||+++.+|.+.+... .....++.++++++..||.-
T Consensus 90 e~i~G~~l~~~~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T 3tm0_A 90 SEADGVLCSEEYEDE------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp ECCSSEEHHHHCCTT------------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred EecCCeehhhccCCc------------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence 999999988764211 12346788899999999961
Q ss_pred -----------------------CCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 417 -----------------------CQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 417 -----------------------~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
....++|+|+++.|||++++..+.|.||+.+.
T Consensus 158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01458999999999999876566799998664
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.16 E-value=3.4e-11 Score=122.72 Aligned_cols=116 Identities=23% Similarity=0.278 Sum_probs=100.0
Q ss_pred CcEEEEEecCCcceeeCCcccc-cCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 69 NRIISLTLSSMQLSGQLPESLH-LCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~-~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
..++.|+|++|.+++..|..+. .+++|++|+|++|.+++ +|... . +++|+.|+|++|++++ +|+.+..+++|+.|
T Consensus 144 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~-~-l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L 219 (317)
T 3o53_A 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQV-V-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWI 219 (317)
T ss_dssp SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EECCC-C-CTTCCEEECCSSCCCE-ECGGGGGGTTCSEE
T ss_pred CCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-ccccc-c-cccCCEEECCCCcCCc-chhhhcccCcccEE
Confidence 5799999999999998887774 89999999999999984 45433 3 8999999999999985 66679999999999
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCccc-CCCCCCCCCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS-GTIPPDLARF 189 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~-g~ip~~~~~~ 189 (604)
+|++|+++ .+|..+..+++|+.|++++|+++ +.+|..+..+
T Consensus 220 ~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~ 261 (317)
T 3o53_A 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261 (317)
T ss_dssp ECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTC
T ss_pred ECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhcc
Confidence 99999999 58888999999999999999998 5555555444
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.16 E-value=6.6e-11 Score=121.94 Aligned_cols=108 Identities=23% Similarity=0.302 Sum_probs=72.7
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
.+++.|+|++|++++ +++ +..+++|+.|+|++|.+++ ++ .+. .+++|+.|+|++|++++. +.+..+++|+.|+
T Consensus 221 ~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~~-~~~-~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~ 293 (347)
T 4fmz_A 221 TRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-IN-AVK-DLTKLKMLNVGSNQISDI--SVLNNLSQLNSLF 293 (347)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CG-GGT-TCTTCCEEECCSSCCCCC--GGGGGCTTCSEEE
T ss_pred CcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-Ch-hHh-cCCCcCEEEccCCccCCC--hhhcCCCCCCEEE
Confidence 356667777777664 333 6677777777777777763 33 333 367777777777777653 3466777777777
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 183 (604)
|++|++++..|..+..+++|+.|++++|++++..|
T Consensus 294 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp CCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred CcCCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence 77777777777777777777777777777775544
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.15 E-value=9.4e-11 Score=129.78 Aligned_cols=106 Identities=29% Similarity=0.403 Sum_probs=72.5
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..|+.|+|++|+|++..| +..|++|+.|+|++|.|++ +| .+.. +++|+.|+|++|++++ + +.+..+++|+.|+
T Consensus 65 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~-l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~ 137 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKD-LKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 137 (605)
T ss_dssp TTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTT-CTTCCEEECTTSCCCC-C-GGGGGCTTCSEEE
T ss_pred CCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhcc-CCCCCEEEecCCCCCC-C-ccccCCCccCEEE
Confidence 457777777777776333 7777777777777777764 44 4443 7777777777777765 3 3467777777777
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 183 (604)
|++|+|++. ..+..+++|+.|+|++|.+++..|
T Consensus 138 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 138 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp CCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence 777777754 456677777777777777765544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.14 E-value=4.1e-11 Score=128.42 Aligned_cols=108 Identities=34% Similarity=0.505 Sum_probs=62.7
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCC--cCChhh-------------hhcCCCCcEEEccCCcCCCCC
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSG--SIPVDL-------------CKWLPYVVQLDLSNNHLSGPI 134 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g--~ip~~~-------------~~~l~~L~~l~ls~N~l~g~i 134 (604)
.++.|+|++|++++ +|.. +++|+.|+|++|.++| .+|..+ ....++|+.|+|++|++++ +
T Consensus 258 ~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~-l 332 (454)
T 1jl5_A 258 SLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-L 332 (454)
T ss_dssp TCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSC-C
T ss_pred ccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccCcCCcCCEEECcCCcCCcccCCcCcCCEEECCCCcccc-c
Confidence 45555666665554 4432 2445555555555554 333221 1111467777777777775 6
Q ss_pred cccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccC--CCCCCCCCC
Q 007423 135 PPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSG--TIPPDLARF 189 (604)
Q Consensus 135 P~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g--~ip~~~~~~ 189 (604)
|.. +++|+.|+|++|+++ .+|. .+++|+.|++++|+++| .+|..+..+
T Consensus 333 p~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L 382 (454)
T 1jl5_A 333 PAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDL 382 (454)
T ss_dssp CCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE
T ss_pred ccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhh
Confidence 654 466777777777777 4665 35677777777777777 666665443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.14 E-value=1.2e-10 Score=124.78 Aligned_cols=106 Identities=28% Similarity=0.402 Sum_probs=68.2
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
.++.|+|++|++++ +| +++++++|++|+|++|.+++ +|.. .++|++|+|++|++++ +| .++++++|+.|++
T Consensus 132 ~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 132 LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 56667777777765 66 47777777777777777764 6642 3467777777777765 55 5677777777777
Q ss_pred cccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCC
Q 007423 150 SNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP 190 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~ 190 (604)
++|++++ +|.. ..+|+.|++++|.++ .+|. ++.++
T Consensus 203 ~~N~l~~-l~~~---~~~L~~L~l~~n~l~-~lp~-~~~l~ 237 (454)
T 1jl5_A 203 DNNSLKK-LPDL---PLSLESIVAGNNILE-ELPE-LQNLP 237 (454)
T ss_dssp CSSCCSS-CCCC---CTTCCEEECCSSCCS-SCCC-CTTCT
T ss_pred CCCcCCc-CCCC---cCcccEEECcCCcCC-cccc-cCCCC
Confidence 7777775 4432 236667777777666 5663 44433
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.14 E-value=1e-10 Score=129.44 Aligned_cols=112 Identities=28% Similarity=0.397 Sum_probs=94.8
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
..+|+.|+|++|+|++ +| .+..|++|+.|+|++|.+++ +| .+.. +++|+.|+|++|++++. +.+..+++|+.|
T Consensus 86 l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~-~l~~-l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L 158 (605)
T 1m9s_A 86 LKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-IN-GLVH-LPQLESLYLGNNKITDI--TVLSRLTKLDTL 158 (605)
T ss_dssp CTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-CG-GGGG-CTTCSEEECCSSCCCCC--GGGGSCTTCSEE
T ss_pred CCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-Cc-cccC-CCccCEEECCCCccCCc--hhhcccCCCCEE
Confidence 3578999999999986 44 79999999999999999985 54 4554 99999999999999975 679999999999
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP 190 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~ 190 (604)
+|++|+|++..| +..+++|+.|+|++|++++ +| .+..++
T Consensus 159 ~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~ 197 (605)
T 1m9s_A 159 SLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLK 197 (605)
T ss_dssp ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCT
T ss_pred ECcCCcCCCchh--hccCCCCCEEECcCCCCCC-Ch-HHccCC
Confidence 999999998777 8899999999999999985 44 344443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.12 E-value=1.5e-10 Score=114.77 Aligned_cols=104 Identities=23% Similarity=0.359 Sum_probs=89.1
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|+|++|+++ .+| .+..+++|+.|+|++|.+++ +|. +.. +++|+.|+|++|++++ +|.... .+|+.|+
T Consensus 41 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~-l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~ 112 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKD-LTKLEELSVNRNRLKN-LNGIPS--ACLSRLF 112 (263)
T ss_dssp TTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTT-CSSCCEEECCSSCCSC-CTTCCC--SSCCEEE
T ss_pred CcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hcc-CCCCCEEECCCCccCC-cCcccc--CcccEEE
Confidence 46889999999998 466 79999999999999999995 555 544 9999999999999986 565333 8999999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 183 (604)
|++|++++ +| .+..+++|+.|++++|++++ +|
T Consensus 113 L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~ 144 (263)
T 1xeu_A 113 LDNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IV 144 (263)
T ss_dssp CCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CG
T ss_pred ccCCccCC-Ch-hhcCcccccEEECCCCcCCC-Ch
Confidence 99999997 44 68999999999999999985 44
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.12 E-value=1e-10 Score=125.78 Aligned_cols=107 Identities=26% Similarity=0.346 Sum_probs=85.9
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
...++.|+|++|++++. |+ +..+++|+.|+|++|.+++..| +. .+++|+.|+|++|++++..| +..+++|+.|
T Consensus 264 l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~~~~--~~-~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L 336 (466)
T 1o6v_A 264 LTKLTELKLGANQISNI-SP-LAGLTALTNLELNENQLEDISP--IS-NLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336 (466)
T ss_dssp CTTCSEEECCSSCCCCC-GG-GTTCTTCSEEECCSSCCSCCGG--GG-GCTTCSEEECCSSCCSCCGG--GGGCTTCCEE
T ss_pred CCCCCEEECCCCccCcc-cc-ccCCCccCeEEcCCCcccCchh--hc-CCCCCCEEECcCCcCCCchh--hccCccCCEe
Confidence 35688899999998864 33 8888999999999999886433 43 48889999999999887655 7788888889
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCcccCCCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 183 (604)
++++|++++. ..+..+++|+.|++++|++++.+|
T Consensus 337 ~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~ 370 (466)
T 1o6v_A 337 FFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP 370 (466)
T ss_dssp ECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG
T ss_pred ECCCCccCCc--hhhccCCCCCEEeCCCCccCccch
Confidence 9998888875 367888888888888888887766
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.11 E-value=2.7e-10 Score=122.15 Aligned_cols=103 Identities=18% Similarity=0.230 Sum_probs=74.1
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
..+++.|+|++|++++ ++ ++++++|++|+|++|.+.|.++ +.. +++|+.|+|++|++++ +| ++.+++|+.|
T Consensus 126 l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~~--~~~-l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L 196 (457)
T 3bz5_A 126 NPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKLD--VTP-QTQLTTLDCSFNKITE-LD--VSQNKLLNRL 196 (457)
T ss_dssp CTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCCC--CTT-CTTCCEEECCSSCCCC-CC--CTTCTTCCEE
T ss_pred CCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCcccccc--ccc-CCcCCEEECCCCccce-ec--cccCCCCCEE
Confidence 3578888888888887 43 7778888888888887766774 333 7777777777777775 55 6677777777
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCcccCCCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 183 (604)
++++|++++. .+..+++|+.|++++|++++ +|
T Consensus 197 ~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip 228 (457)
T 3bz5_A 197 NCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID 228 (457)
T ss_dssp ECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC
T ss_pred ECcCCcCCee---ccccCCCCCEEECcCCcccc-cC
Confidence 7777777764 25667777777777777775 55
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.11 E-value=1.2e-10 Score=118.08 Aligned_cols=105 Identities=22% Similarity=0.320 Sum_probs=87.8
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
..+++.|+|++|++++ + +.+..+++|+.|+|++|.+++ +|. +. .+++|+.|+|++|++++. |+ +..+++|+.|
T Consensus 84 l~~L~~L~L~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~~-l~-~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L 156 (308)
T 1h6u_A 84 LTKITELELSGNPLKN-V-SAIAGLQSIKTLDLTSTQITD-VTP-LA-GLSNLQVLYLDLNQITNI-SP-LAGLTNLQYL 156 (308)
T ss_dssp CCSCCEEECCSCCCSC-C-GGGTTCTTCCEEECTTSCCCC-CGG-GT-TCTTCCEEECCSSCCCCC-GG-GGGCTTCCEE
T ss_pred CCCCCEEEccCCcCCC-c-hhhcCCCCCCEEECCCCCCCC-chh-hc-CCCCCCEEECCCCccCcC-cc-ccCCCCccEE
Confidence 4579999999999986 3 468999999999999999985 554 54 489999999999999864 43 8889999999
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCcccCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGT 181 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ 181 (604)
+|++|++++. |. +..+++|+.|++++|.+++.
T Consensus 157 ~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~ 188 (308)
T 1h6u_A 157 SIGNAQVSDL-TP-LANLSKLTTLKADDNKISDI 188 (308)
T ss_dssp ECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC
T ss_pred EccCCcCCCC-hh-hcCCCCCCEEECCCCccCcC
Confidence 9999999864 43 88899999999999999754
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.11 E-value=1.2e-10 Score=120.22 Aligned_cols=104 Identities=19% Similarity=0.173 Sum_probs=86.8
Q ss_pred CEEEcCCC-CCCCcCChhhhhcCCCCcEEEccC-CcCCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEc
Q 007423 96 QSLDLSDN-SLSGSIPVDLCKWLPYVVQLDLSN-NHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSV 173 (604)
Q Consensus 96 ~~L~Ls~N-~l~g~ip~~~~~~l~~L~~l~ls~-N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l 173 (604)
..+++++| +|+ .||. +.. +++|+.|+|++ |+|++..|..+.++++|+.|+|++|+|++..|..+.++++|+.|+|
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~-~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 87 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPG-AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCS-CSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CEEEcCCCCCCC-ccCC-CCC-CCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeC
Confidence 45799998 898 6998 755 89999999996 9999888889999999999999999999999999999999999999
Q ss_pred cCCcccCCCCCCCCC--CCCcccCCCCCCCC
Q 007423 174 AGNDLSGTIPPDLAR--FPEESFDGNSGLCG 202 (604)
Q Consensus 174 ~~N~l~g~ip~~~~~--~~~~~~~~n~~lcg 202 (604)
++|+|++-.|..+.. +......+|+..|.
T Consensus 88 ~~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 88 SFNALESLSWKTVQGLSLQELVLSGNPLHCS 118 (347)
T ss_dssp CSSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred CCCccceeCHHHcccCCceEEEeeCCCccCC
Confidence 999999544444443 34445667776663
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.2e-10 Score=120.10 Aligned_cols=105 Identities=23% Similarity=0.279 Sum_probs=92.0
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
..+++.|+|++|.+++ + +.+..+++|+.|+|++|.+++ +| .+. .+++|+.|+|++|++++..|..+..+++|+.|
T Consensus 242 l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~~~-~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 316 (347)
T 4fmz_A 242 LSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-IS-VLN-NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316 (347)
T ss_dssp CTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-CG-GGG-GCTTCSEEECCSSCCCGGGHHHHHTCTTCSEE
T ss_pred CCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-Ch-hhc-CCCCCCEEECcCCcCCCcChhHhhccccCCEE
Confidence 4579999999999986 3 579999999999999999985 54 344 49999999999999999999999999999999
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCccc
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 179 (604)
+|++|++++..| +..+++|+.|++++|.++
T Consensus 317 ~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 317 FLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp ECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred EccCCccccccC--hhhhhccceeehhhhccc
Confidence 999999998777 789999999999999885
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.10 E-value=6.8e-11 Score=122.27 Aligned_cols=128 Identities=18% Similarity=0.128 Sum_probs=87.1
Q ss_pred CCccccccCCCC--------CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcE-EEcc
Q 007423 56 CRLTGVACWNEK--------ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQ-LDLS 126 (604)
Q Consensus 56 c~~~gv~c~~~~--------~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~-l~ls 126 (604)
|.|+.|.|.+.. ...++.|+|++|+|+..-+..|.+|++|++|+|++|.+.+.||...+..+++|+. ++++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 678888885322 1356778888888874333467788888888888888777777766555776654 5666
Q ss_pred CCcCCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCCC
Q 007423 127 NNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 127 ~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 183 (604)
+|++++..|..+..+++|++|++++|++++..+..+....++..+++++|+--..+|
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~ 145 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 145 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEEC
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccccccc
Confidence 777776666677778888888888888876655555556667777776543323444
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.09 E-value=1.9e-10 Score=123.73 Aligned_cols=111 Identities=32% Similarity=0.404 Sum_probs=94.4
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
.+++.|+|++|.+++..| +..+++|+.|+|++|.+++ +|. +.. +++|+.|+|++|++++..| +..+++|+.|+
T Consensus 243 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~-l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 315 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISP-LAG-LTALTNLELNENQLEDISP--ISNLKNLTYLT 315 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC-CGG-GTT-CTTCSEEECCSSCCSCCGG--GGGCTTCSEEE
T ss_pred CCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCc-ccc-ccC-CCccCeEEcCCCcccCchh--hcCCCCCCEEE
Confidence 578999999999997554 8999999999999999996 444 544 9999999999999997544 88999999999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP 190 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~ 190 (604)
|++|++++..| +..+++|+.|++++|.+++. + .++.++
T Consensus 316 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~l~~l~ 353 (466)
T 1o6v_A 316 LYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-S-SLANLT 353 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-G-GGTTCT
T ss_pred CcCCcCCCchh--hccCccCCEeECCCCccCCc-h-hhccCC
Confidence 99999998776 68999999999999999864 3 444444
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.08 E-value=1e-10 Score=115.08 Aligned_cols=128 Identities=13% Similarity=0.102 Sum_probs=94.8
Q ss_pred ecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCC--ccceeeEEEeCCeeeEEeeecCCCchhhhhc
Q 007423 305 STRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPN--LVPLLGFCVVEEERLLVYKHMPNGTLYSLLH 382 (604)
Q Consensus 305 ~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~ 382 (604)
.|..+.||+....+|..+++|..... ....+.+|+++++.+.+.+ +.+++++...++..++||||+++.+|. ..
T Consensus 30 gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~ 105 (264)
T 1nd4_A 30 GCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS 105 (264)
T ss_dssp TTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS
T ss_pred CCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC
Confidence 45568999998877888999997653 2245788999999886545 445888888777889999999998874 21
Q ss_pred cCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcC---------------------------------------------
Q 007423 383 GNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGC--------------------------------------------- 417 (604)
Q Consensus 383 ~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~--------------------------------------------- 417 (604)
. .+ ...++.++++.+..||...
T Consensus 106 ~----------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 106 H----------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp C----------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred c----------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 1 11 1246667777777777421
Q ss_pred ----------CCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 418 ----------QPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 418 ----------~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
...++|+|++|.||+++++..+.|.||+.+..
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999997653
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.08 E-value=1.6e-11 Score=128.66 Aligned_cols=129 Identities=17% Similarity=0.219 Sum_probs=101.7
Q ss_pred CcEEEEEecCCcce-eeCC---cccccCCCCCEEEcCCCCCC--C---cCChhhhhcCCCCcEEEccCCcCC----CCCc
Q 007423 69 NRIISLTLSSMQLS-GQLP---ESLHLCHSLQSLDLSDNSLS--G---SIPVDLCKWLPYVVQLDLSNNHLS----GPIP 135 (604)
Q Consensus 69 ~~v~~l~l~~n~l~-g~~p---~~l~~l~~L~~L~Ls~N~l~--g---~ip~~~~~~l~~L~~l~ls~N~l~----g~iP 135 (604)
.+++.|+|++|+++ +.+| ..+..+++|+.|+|++|.++ | .+|..+.. +++|+.|+|++|.++ +.+|
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~-~~~L~~L~Ls~n~l~~~g~~~l~ 237 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAY-CQELKVLDLQDNTFTHLGSSALA 237 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGG-CTTCCEEECCSSCCHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhc-CCCccEEECcCCCCCcHHHHHHH
Confidence 57899999999997 4555 57788999999999999998 3 23435544 899999999999996 6788
Q ss_pred ccccCCcccceeeccccccccC----CChhhhc--CCCccEEEccCCcccC----CCCCCC----CCCCCcccCCCC
Q 007423 136 PQIVECKFLNKLILSNNKLSGS----IPFEVSR--LDRLKEFSVAGNDLSG----TIPPDL----ARFPEESFDGNS 198 (604)
Q Consensus 136 ~~~~~~~~L~~l~ls~N~l~g~----~p~~~~~--l~~L~~l~l~~N~l~g----~ip~~~----~~~~~~~~~~n~ 198 (604)
..+..+++|+.|+|++|++++. +|..+.. +++|+.|+|++|.+++ .+|..+ ..+......+|+
T Consensus 238 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~ 314 (386)
T 2ca6_A 238 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 314 (386)
T ss_dssp HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSB
T ss_pred HHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCc
Confidence 8999999999999999999876 6666644 8899999999999987 477644 344444455553
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.05 E-value=1.8e-11 Score=125.53 Aligned_cols=107 Identities=25% Similarity=0.366 Sum_probs=73.0
Q ss_pred CcEEEEEecCCcceee-CCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCC-cCCC-CCcccccCCcccc
Q 007423 69 NRIISLTLSSMQLSGQ-LPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNN-HLSG-PIPPQIVECKFLN 145 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~-~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N-~l~g-~iP~~~~~~~~L~ 145 (604)
.+++.|+|++|++++. +|..+..+++|++|+|++|.+++.+|..+.. +++|++|+|++| .+++ .+|..+.++++|+
T Consensus 93 ~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~-~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~ 171 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAK-NSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 171 (336)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTT-CTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhc-CCCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence 4577777777777655 6666777777777777777777666666655 677777777777 5654 2565566677777
Q ss_pred eeecccc-ccccC-CChhhhcCC-CccEEEccCC
Q 007423 146 KLILSNN-KLSGS-IPFEVSRLD-RLKEFSVAGN 176 (604)
Q Consensus 146 ~l~ls~N-~l~g~-~p~~~~~l~-~L~~l~l~~N 176 (604)
.|+|++| ++++. +|..+..++ +|+.|++++|
T Consensus 172 ~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~ 205 (336)
T 2ast_B 172 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 205 (336)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred EEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCC
Confidence 7777777 66654 555566666 6777777666
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.05 E-value=2e-10 Score=127.35 Aligned_cols=82 Identities=26% Similarity=0.307 Sum_probs=39.8
Q ss_pred CCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEE
Q 007423 93 HSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFS 172 (604)
Q Consensus 93 ~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~ 172 (604)
++|+.|+|++|.|++ || ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+.++++|+.|+
T Consensus 221 ~~L~~L~Ls~N~L~~-lp----~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~ 290 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP----VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVN 290 (622)
T ss_dssp TTCCEEECCSSCCSC-CC----CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEE
T ss_pred CCCCEEEccCCccCc-CC----CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEE
Confidence 344444444444442 44 11344555555555554 3443 3444555555555555 4455555555555555
Q ss_pred ccCCcccCCCCC
Q 007423 173 VAGNDLSGTIPP 184 (604)
Q Consensus 173 l~~N~l~g~ip~ 184 (604)
+++|+++|.+|.
T Consensus 291 L~~N~l~~~~~~ 302 (622)
T 3g06_A 291 LEGNPLSERTLQ 302 (622)
T ss_dssp CCSCCCCHHHHH
T ss_pred ecCCCCCCcCHH
Confidence 555555544444
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.01 E-value=1.8e-11 Score=128.34 Aligned_cols=112 Identities=19% Similarity=0.275 Sum_probs=95.9
Q ss_pred CcEEEEEecCCccee----eCCcccccC---------CCCCEEEcCCCCCC-CcCC---hhhhhcCCCCcEEEccCCcCC
Q 007423 69 NRIISLTLSSMQLSG----QLPESLHLC---------HSLQSLDLSDNSLS-GSIP---VDLCKWLPYVVQLDLSNNHLS 131 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g----~~p~~l~~l---------~~L~~L~Ls~N~l~-g~ip---~~~~~~l~~L~~l~ls~N~l~ 131 (604)
.+++.|+|++|++++ .++..+..+ ++|++|+|++|.++ +.+| ..+.. +++|++|+|++|+++
T Consensus 122 ~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~-~~~L~~L~L~~n~l~ 200 (386)
T 2ca6_A 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS-HRLLHTVKMVQNGIR 200 (386)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHH-CTTCCEEECCSSCCC
T ss_pred CCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHh-CCCcCEEECcCCCCC
Confidence 579999999999963 356778777 99999999999998 5666 34444 899999999999997
Q ss_pred --C---CCcccccCCcccceeeccccccc----cCCChhhhcCCCccEEEccCCcccCC
Q 007423 132 --G---PIPPQIVECKFLNKLILSNNKLS----GSIPFEVSRLDRLKEFSVAGNDLSGT 181 (604)
Q Consensus 132 --g---~iP~~~~~~~~L~~l~ls~N~l~----g~~p~~~~~l~~L~~l~l~~N~l~g~ 181 (604)
| .+|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|+|++|.+++.
T Consensus 201 ~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~ 259 (386)
T 2ca6_A 201 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259 (386)
T ss_dssp HHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred HhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchh
Confidence 3 45558899999999999999997 78899999999999999999999765
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.98 E-value=7.9e-11 Score=120.75 Aligned_cols=108 Identities=23% Similarity=0.257 Sum_probs=57.8
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCc-CChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGS-IPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~-ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
.++.|++++|.+++..+. +.++++|++|+|++|.+++. +|..+.. +++|++|+|++|++++.+|..++.+++|+.|+
T Consensus 71 ~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~-~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 71 GVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQ-CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTT-BCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred cceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhh-CCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 345555555555544333 44555555555555555543 4443332 55555555555555555555555555555555
Q ss_pred cccc-cccc-CCChhhhcCCCccEEEccCC-ccc
Q 007423 149 LSNN-KLSG-SIPFEVSRLDRLKEFSVAGN-DLS 179 (604)
Q Consensus 149 ls~N-~l~g-~~p~~~~~l~~L~~l~l~~N-~l~ 179 (604)
|++| .+++ .+|..+..+++|+.|++++| .++
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~ 182 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFT 182 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCC
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcC
Confidence 5555 4554 24444555555555555555 554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.95 E-value=7.6e-10 Score=122.75 Aligned_cols=111 Identities=27% Similarity=0.371 Sum_probs=76.1
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
.++.|++++|+|+ .+|..+. ++|+.|+|++|+|+ .||. .+++|++|+|++|+++ .+|. .+++|++|+|
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~----~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~L 108 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLT-SLPV---LPPGLLELSI 108 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC----CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEE
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC----cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEEC
Confidence 4677888888887 6777665 77888888888887 6775 2677888888888877 4665 5677777777
Q ss_pred cccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCCcccCCC
Q 007423 150 SNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGN 197 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~n 197 (604)
++|++++ +|. .+++|+.|++++|++++ +|..+.++......+|
T Consensus 109 s~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~l~~L~~L~Ls~N 151 (622)
T 3g06_A 109 FSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVLPPGLQELSVSDN 151 (622)
T ss_dssp CSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSS
T ss_pred cCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCCCCCCCEEECcCC
Confidence 7777774 443 45667777777777663 5655544444444444
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.95 E-value=2.1e-10 Score=119.08 Aligned_cols=109 Identities=28% Similarity=0.278 Sum_probs=51.1
Q ss_pred EEEEEecCCcceeeCC----cccccCC-CCCEEEcCCCCCCCcCChhhhhc----CCCCcEEEccCCcCCCCCcccccCC
Q 007423 71 IISLTLSSMQLSGQLP----ESLHLCH-SLQSLDLSDNSLSGSIPVDLCKW----LPYVVQLDLSNNHLSGPIPPQIVEC 141 (604)
Q Consensus 71 v~~l~l~~n~l~g~~p----~~l~~l~-~L~~L~Ls~N~l~g~ip~~~~~~----l~~L~~l~ls~N~l~g~iP~~~~~~ 141 (604)
++.|+|++|++++..+ ..+.+++ +|++|+|++|.+++..+..+... .++|++|+|++|++++..+..++..
T Consensus 24 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~ 103 (362)
T 3goz_A 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKT 103 (362)
T ss_dssp CCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHH
T ss_pred ceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHH
Confidence 5555555555554333 3444454 55555555555554444333321 1455555555555554444433222
Q ss_pred -----cccceeeccccccccCCChhhhc-----CCCccEEEccCCccc
Q 007423 142 -----KFLNKLILSNNKLSGSIPFEVSR-----LDRLKEFSVAGNDLS 179 (604)
Q Consensus 142 -----~~L~~l~ls~N~l~g~~p~~~~~-----l~~L~~l~l~~N~l~ 179 (604)
++|+.|+|++|++++..+..+.. .++|+.|++++|.++
T Consensus 104 l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 151 (362)
T 3goz_A 104 LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG 151 (362)
T ss_dssp HHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGG
T ss_pred HHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCC
Confidence 45555555555555444333222 135555555555554
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.94 E-value=2.9e-10 Score=118.05 Aligned_cols=110 Identities=26% Similarity=0.211 Sum_probs=93.6
Q ss_pred EEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCC----hhhhhcCC-CCcEEEccCCcCCCCCcccccCC-----c
Q 007423 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIP----VDLCKWLP-YVVQLDLSNNHLSGPIPPQIVEC-----K 142 (604)
Q Consensus 73 ~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip----~~~~~~l~-~L~~l~ls~N~l~g~iP~~~~~~-----~ 142 (604)
.+.|+.|+++|.+|..+...++|++|||++|.+++.-+ ..+ ..++ +|++|+|++|++++..+..+..+ +
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l-~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 80 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAF-ANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHH-HTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHH-HhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence 46899999999999988888889999999999985444 333 3477 89999999999998888888775 9
Q ss_pred ccceeeccccccccCCChhhhcC-----CCccEEEccCCcccCCCC
Q 007423 143 FLNKLILSNNKLSGSIPFEVSRL-----DRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 143 ~L~~l~ls~N~l~g~~p~~~~~l-----~~L~~l~l~~N~l~g~ip 183 (604)
+|+.|+|++|++++..+..+... ++|+.|++++|.+++..+
T Consensus 81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~ 126 (362)
T 3goz_A 81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSS 126 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCH
T ss_pred CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHH
Confidence 99999999999998888765554 899999999999986544
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.92 E-value=3e-09 Score=110.27 Aligned_cols=140 Identities=14% Similarity=0.171 Sum_probs=104.8
Q ss_pred CcEEEecCCeEEEEEEeCCCCEEEEEEec--ccc--ccHHHHHHHHHHHhccC--CCCccceeeEEEeC---CeeeEEee
Q 007423 300 ENIIISTRTGVSYKAVLPDASALAIKRLS--ACK--LSEKQFRSEMNRLGQLR--HPNLVPLLGFCVVE---EERLLVYK 370 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~~~~~~~vAvK~l~--~~~--~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~---~~~~lv~e 370 (604)
.+.++.|.++.||+....+ ..+++|+.. ... .....+.+|+++++.++ +..+.++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4567889999999988755 578888876 332 12346888999999997 45578888888765 45899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcC---------------------------------
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGC--------------------------------- 417 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~--------------------------------- 417 (604)
|+++..+.+... ..++...+..++.++++.|..||...
T Consensus 122 ~v~G~~l~~~~~---------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 122 FVSGRVLWDQSL---------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp CCCCBCCCCTTC---------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred ecCCeecCCCcc---------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 999977754211 23677888899999999999999620
Q ss_pred ----------------------CCCceecCCCCCeEEeCCCCC--eEEcccCCccc
Q 007423 418 ----------------------QPPYMHQYISSNVILIDDDFD--ARITDFGLARL 449 (604)
Q Consensus 418 ----------------------~~~iiH~dlk~~NiLl~~~~~--~kl~DFGla~~ 449 (604)
...++|+|+++.|||++.++. +.|.||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997653 68999998864
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.88 E-value=2.2e-09 Score=110.80 Aligned_cols=107 Identities=14% Similarity=0.116 Sum_probs=91.6
Q ss_pred EEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcc-cccCCcccc-eeecc
Q 007423 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPP-QIVECKFLN-KLILS 150 (604)
Q Consensus 73 ~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~-~~~~~~~L~-~l~ls 150 (604)
.++.++++|+ .+|..+ .++|++|+|++|+++ .||...+..+++|++|+|++|++.+.+|. .+.++++|. .++++
T Consensus 13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 5789999999 688877 478999999999998 78887556699999999999999888876 467888876 47778
Q ss_pred ccccccCCChhhhcCCCccEEEccCCcccCCCC
Q 007423 151 NNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 151 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 183 (604)
+|+++...|..+..+++|+.|++++|.+++..+
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~ 121 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD 121 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCC
T ss_pred CCcccccCchhhhhccccccccccccccccCCc
Confidence 899998888889999999999999999985433
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.86 E-value=1.5e-10 Score=113.90 Aligned_cols=127 Identities=25% Similarity=0.293 Sum_probs=87.1
Q ss_pred CCCCccccccCCCCCCcEEEEEecC---CcceeeCCcc------------------------cccCCCCCE--EEcCCCC
Q 007423 54 AICRLTGVACWNEKENRIISLTLSS---MQLSGQLPES------------------------LHLCHSLQS--LDLSDNS 104 (604)
Q Consensus 54 ~~c~~~gv~c~~~~~~~v~~l~l~~---n~l~g~~p~~------------------------l~~l~~L~~--L~Ls~N~ 104 (604)
.+|+|.|+.|... ..+|+.+...+ ..+.|.++++ +...+.|.. ++++.|.
T Consensus 76 ~l~~~~g~i~~~~-~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~ 154 (267)
T 3rw6_A 76 ALKAVNYKILDRE-NRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR 154 (267)
T ss_dssp HHHHTTSSCBCTT-SCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred HHHhcCcEEECCC-CCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence 4689999999742 34777776655 3445555431 122222332 4555563
Q ss_pred CCCcCChh---hhhcCCCCcEEEccCCcCCC--CCcccccCCcccceeeccccccccCCChhhhcCC--CccEEEccCCc
Q 007423 105 LSGSIPVD---LCKWLPYVVQLDLSNNHLSG--PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLD--RLKEFSVAGND 177 (604)
Q Consensus 105 l~g~ip~~---~~~~l~~L~~l~ls~N~l~g--~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~--~L~~l~l~~N~ 177 (604)
.. .++.. +...+++|+.|+||+|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.
T Consensus 155 ~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Np 231 (267)
T 3rw6_A 155 RS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNS 231 (267)
T ss_dssp HH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTST
T ss_pred HH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCc
Confidence 22 22221 12348999999999999998 6778888999999999999999975 3345555 89999999999
Q ss_pred ccCCCCC
Q 007423 178 LSGTIPP 184 (604)
Q Consensus 178 l~g~ip~ 184 (604)
+++.+|.
T Consensus 232 l~~~~~~ 238 (267)
T 3rw6_A 232 LCDTFRD 238 (267)
T ss_dssp TGGGCSS
T ss_pred CccccCc
Confidence 9987773
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.79 E-value=5.3e-10 Score=119.75 Aligned_cols=129 Identities=22% Similarity=0.252 Sum_probs=92.4
Q ss_pred CcEEEEEecCCcceee----CCcccccCCCCCEEEcCCCCCCCcCChhhhh----cCCCCcEEEccCCcCCCC----Ccc
Q 007423 69 NRIISLTLSSMQLSGQ----LPESLHLCHSLQSLDLSDNSLSGSIPVDLCK----WLPYVVQLDLSNNHLSGP----IPP 136 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~----~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~----~l~~L~~l~ls~N~l~g~----iP~ 136 (604)
.+++.|+|++|++++. ++..+.++++|++|+|++|.+++..+..+.. ..++|+.|+|++|.+++. +|.
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 335 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHH
Confidence 5788999999999865 6777888999999999999887544433333 235888888888888765 566
Q ss_pred cccCCcccceeeccccccccCCChhhhc-----CCCccEEEccCCcccC----CCCCCCC---CCCCcccCCC
Q 007423 137 QIVECKFLNKLILSNNKLSGSIPFEVSR-----LDRLKEFSVAGNDLSG----TIPPDLA---RFPEESFDGN 197 (604)
Q Consensus 137 ~~~~~~~L~~l~ls~N~l~g~~p~~~~~-----l~~L~~l~l~~N~l~g----~ip~~~~---~~~~~~~~~n 197 (604)
.+..+++|+.|+|++|++++..+..+.. .++|+.|++++|.+++ .+|..+. .+......+|
T Consensus 336 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N 408 (461)
T 1z7x_W 336 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNN 408 (461)
T ss_dssp HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSS
T ss_pred HHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCC
Confidence 6777788888888888888765554443 5688888888888875 5554432 3333344444
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.71 E-value=5.8e-09 Score=102.60 Aligned_cols=80 Identities=28% Similarity=0.305 Sum_probs=67.2
Q ss_pred ccCCCCCEEEcCCCCCCC--cCChhhhhcCCCCcEEEccCCcCCCCCcccccCCc--ccceeeccccccccCCCh-----
Q 007423 90 HLCHSLQSLDLSDNSLSG--SIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECK--FLNKLILSNNKLSGSIPF----- 160 (604)
Q Consensus 90 ~~l~~L~~L~Ls~N~l~g--~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~--~L~~l~ls~N~l~g~~p~----- 160 (604)
.++++|+.|+||+|.|++ .+|..+.. +++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+++.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~-l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~ 243 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQK-APNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYI 243 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHH-STTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhh-CCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHH
Confidence 578999999999999998 67766655 99999999999999975 4455555 999999999999998873
Q ss_pred --hhhcCCCccEEE
Q 007423 161 --EVSRLDRLKEFS 172 (604)
Q Consensus 161 --~~~~l~~L~~l~ 172 (604)
.+..+++|+.||
T Consensus 244 ~~il~~~P~L~~LD 257 (267)
T 3rw6_A 244 SAIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHHCTTCCEES
T ss_pred HHHHHHCcccCeEC
Confidence 367788888886
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.71 E-value=7.6e-09 Score=104.54 Aligned_cols=190 Identities=18% Similarity=0.158 Sum_probs=117.5
Q ss_pred CcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccC-CCCc--cceeeEEEeCC---eeeEEeeecC
Q 007423 300 ENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLR-HPNL--VPLLGFCVVEE---ERLLVYKHMP 373 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~-H~ni--v~l~g~~~~~~---~~~lv~ey~~ 373 (604)
.+.++.|....||+.. ..+++|..... .....+.+|+++++.+. +..+ .+.+......+ ..|+||||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 3568999999999763 56888886533 23467889999998884 3332 23333332222 3488999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhh--------------------------------------
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHH-------------------------------------- 415 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-------------------------------------- 415 (604)
+.++.+... ..++..++..++.++++.+..||.
T Consensus 100 G~~l~~~~~---------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 100 GVPLTPLLL---------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp CEECCHHHH---------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred CeECCcccc---------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 988765332 125556666777777777777774
Q ss_pred -----------------cCCCCceecCCCCCeEEeCC--CCCeEEcccCCccccCCCCCCCCcccc-CCCCc-------c
Q 007423 416 -----------------GCQPPYMHQYISSNVILIDD--DFDARITDFGLARLVGSRDPNDSSFVH-GDLGE-------F 468 (604)
Q Consensus 416 -----------------~~~~~iiH~dlk~~NiLl~~--~~~~kl~DFGla~~~~~~~~~~~~~~~-~~~gt-------~ 468 (604)
...+.++|+|+++.||++++ ...+.|.||+.+..-.....-...... ...+. .
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence 11245899999999999998 556789999988754221000000000 00000 0
Q ss_pred cc--cC-ccccCCCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007423 469 GY--VA-PEYSSTMVASLKGDVYGFGIVLLELLSGQKPLD 505 (604)
Q Consensus 469 ~y--~a-PE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~ 505 (604)
.| .. |+.... .....+.|+++.++|++.+|..+|.
T Consensus 251 ~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 251 HYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 11 11 121110 1123588999999999999988763
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.68 E-value=2.4e-09 Score=114.57 Aligned_cols=111 Identities=22% Similarity=0.227 Sum_probs=65.2
Q ss_pred cEEEEEecCCccee----eCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCC----CCcEEEccCCcCCC----CCccc
Q 007423 70 RIISLTLSSMQLSG----QLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLP----YVVQLDLSNNHLSG----PIPPQ 137 (604)
Q Consensus 70 ~v~~l~l~~n~l~g----~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~----~L~~l~ls~N~l~g----~iP~~ 137 (604)
+++.|+|++|++++ .++..+..+++|++|||++|.++...+..++..++ +|++|+|++|+++. .+|..
T Consensus 29 ~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~ 108 (461)
T 1z7x_W 29 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 108 (461)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHH
Confidence 45666666666653 24555666666666666666665444444444344 46666666666652 45666
Q ss_pred ccCCcccceeeccccccccCCChhhhc-----CCCccEEEccCCcccC
Q 007423 138 IVECKFLNKLILSNNKLSGSIPFEVSR-----LDRLKEFSVAGNDLSG 180 (604)
Q Consensus 138 ~~~~~~L~~l~ls~N~l~g~~p~~~~~-----l~~L~~l~l~~N~l~g 180 (604)
+..+++|+.|+|++|.+++..+..+.. .++|+.|++++|++++
T Consensus 109 l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~ 156 (461)
T 1z7x_W 109 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSA 156 (461)
T ss_dssp TTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBG
T ss_pred HccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCH
Confidence 666666666666666666544433322 3456666666666654
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.63 E-value=6.2e-09 Score=108.33 Aligned_cols=111 Identities=24% Similarity=0.216 Sum_probs=68.6
Q ss_pred CcEEEEEecCCcceeeCCccc-ccCCCCCEEEcCCCCCCCcCChhhhh----cCCCCcEEEccCCcCCC----CCccccc
Q 007423 69 NRIISLTLSSMQLSGQLPESL-HLCHSLQSLDLSDNSLSGSIPVDLCK----WLPYVVQLDLSNNHLSG----PIPPQIV 139 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l-~~l~~L~~L~Ls~N~l~g~ip~~~~~----~l~~L~~l~ls~N~l~g----~iP~~~~ 139 (604)
..++.|+|++|+++..-...+ ..+++|+.|+|++|.|+..-...+.. ..+.|+.|+|++|.++. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 367888888887764332222 23556777777777776432222221 24667777777777753 2444456
Q ss_pred CCcccceeeccccccccC----CChhhhcCCCccEEEccCCccc
Q 007423 140 ECKFLNKLILSNNKLSGS----IPFEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 140 ~~~~L~~l~ls~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~ 179 (604)
.+++|++|+|++|+|+.. ++..+...++|+.|+|++|.++
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence 677777777777777642 3445556667777777777765
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.49 E-value=2.1e-08 Score=110.84 Aligned_cols=109 Identities=11% Similarity=0.044 Sum_probs=58.0
Q ss_pred cEEEEEecCCcceeeCCccccc-CCCCCEEEcC----CCCCCCc-----CChhhhhcCCCCcEEEccCC--cCCCCCccc
Q 007423 70 RIISLTLSSMQLSGQLPESLHL-CHSLQSLDLS----DNSLSGS-----IPVDLCKWLPYVVQLDLSNN--HLSGPIPPQ 137 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~-l~~L~~L~Ls----~N~l~g~-----ip~~~~~~l~~L~~l~ls~N--~l~g~iP~~ 137 (604)
+++.|+|+.|++++..+..++. +++|+.|+|+ .|++++. ++..+. .+++|+.|+|+++ .+++..+..
T Consensus 379 ~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~-~~~~L~~L~L~~~~~~l~~~~~~~ 457 (592)
T 3ogk_B 379 ELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLI-GCKKLRRFAFYLRQGGLTDLGLSY 457 (592)
T ss_dssp TCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHH-HCTTCCEEEEECCGGGCCHHHHHH
T ss_pred cCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHH-hCCCCCEEEEecCCCCccHHHHHH
Confidence 5666777777776666555554 6667777774 5666642 222222 2555555555422 244443433
Q ss_pred ccC-Ccccceeecccccccc-CCChhhhcCCCccEEEccCCccc
Q 007423 138 IVE-CKFLNKLILSNNKLSG-SIPFEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 138 ~~~-~~~L~~l~ls~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~ 179 (604)
++. +++|+.|+|++|++++ .++..+..+++|+.|++++|.++
T Consensus 458 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~ 501 (592)
T 3ogk_B 458 IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS 501 (592)
T ss_dssp HHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCB
T ss_pred HHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCc
Confidence 332 4555555555555554 23333444555555555555554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.47 E-value=7.1e-09 Score=107.85 Aligned_cols=111 Identities=17% Similarity=0.161 Sum_probs=86.5
Q ss_pred CcEEEEEecCCcceeeCCcccccC-----CCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccc-----
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLC-----HSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQI----- 138 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l-----~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~----- 138 (604)
..++.|+|++|.|+..-...+..+ ++|+.|||++|.++..-...+...+++|+.|+|++|+++..-...+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 358899999999986544444433 7999999999999754444555557889999999999975433333
Q ss_pred cCCcccceeecccccccc----CCChhhhcCCCccEEEccCCccc
Q 007423 139 VECKFLNKLILSNNKLSG----SIPFEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 139 ~~~~~L~~l~ls~N~l~g----~~p~~~~~l~~L~~l~l~~N~l~ 179 (604)
...++|+.|+|++|+|+. .++..+...++|+.|+|++|.++
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~ 196 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG 196 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCC
Confidence 246789999999999985 35556678899999999999986
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.38 E-value=8.4e-08 Score=89.36 Aligned_cols=110 Identities=13% Similarity=0.161 Sum_probs=86.4
Q ss_pred CcEEEEEecCC-cceee----CCcccccCCCCCEEEcCCCCCCCc----CChhhhhcCCCCcEEEccCCcCCCC----Cc
Q 007423 69 NRIISLTLSSM-QLSGQ----LPESLHLCHSLQSLDLSDNSLSGS----IPVDLCKWLPYVVQLDLSNNHLSGP----IP 135 (604)
Q Consensus 69 ~~v~~l~l~~n-~l~g~----~p~~l~~l~~L~~L~Ls~N~l~g~----ip~~~~~~l~~L~~l~ls~N~l~g~----iP 135 (604)
..++.|+|++| ++... +...+...++|++|+|++|.++.. |...+.. .+.|++|+|++|.++.. +.
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~-n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKV-NNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHH-CSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHh-CCCcCEEECcCCcCCHHHHHHHH
Confidence 56899999999 88743 455677889999999999999732 2333333 57899999999999743 56
Q ss_pred ccccCCcccceeec--cccccccC----CChhhhcCCCccEEEccCCccc
Q 007423 136 PQIVECKFLNKLIL--SNNKLSGS----IPFEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 136 ~~~~~~~~L~~l~l--s~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~ 179 (604)
..+...++|+.|+| ++|.++.. +...+...++|+.|++++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 67788889999999 88999864 3445566689999999999874
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.21 E-value=4.5e-07 Score=100.11 Aligned_cols=105 Identities=12% Similarity=0.163 Sum_probs=78.8
Q ss_pred cEEEEEecCCc-cee-eCCcccccCCCCCEEEcCCCCCCCc----CChhhhhcCCCCcEEEccCCcCC----CCCccccc
Q 007423 70 RIISLTLSSMQ-LSG-QLPESLHLCHSLQSLDLSDNSLSGS----IPVDLCKWLPYVVQLDLSNNHLS----GPIPPQIV 139 (604)
Q Consensus 70 ~v~~l~l~~n~-l~g-~~p~~l~~l~~L~~L~Ls~N~l~g~----ip~~~~~~l~~L~~l~ls~N~l~----g~iP~~~~ 139 (604)
+++.|+|+++. ++. .++....++++|++|+|++|.+++. ++.-+ ..+++|+.|+|++|.++ +.++..+.
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~-~~~~~L~~L~L~~n~~~~~~~~~l~~~~~ 217 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELA-QHNTSLEVLNFYMTEFAKISPKDLETIAR 217 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHH-HHCCCCCEEECTTCCCSSCCHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHH-hcCCCccEEEeeccCCCccCHHHHHHHHh
Confidence 48899998886 221 1333345889999999999988765 33333 34889999999999987 34555667
Q ss_pred CCcccceeeccccccccCCChhhhcCCCccEEEccCC
Q 007423 140 ECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGN 176 (604)
Q Consensus 140 ~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N 176 (604)
++++|+.|+|++|.+++ +|..+..+++|+.|+++++
T Consensus 218 ~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~ 253 (592)
T 3ogk_B 218 NCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSL 253 (592)
T ss_dssp HCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBC
T ss_pred hCCCCcEEeccCccHHH-HHHHHhhhhHHHhhccccc
Confidence 88899999999998886 7778888888888888753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=1.2e-05 Score=80.96 Aligned_cols=135 Identities=14% Similarity=0.116 Sum_probs=88.5
Q ss_pred cEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCC---CccceeeEEE-eCCeeeEEeeecCCCc
Q 007423 301 NIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHP---NLVPLLGFCV-VEEERLLVYKHMPNGT 376 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~-~~~~~~lv~ey~~~gs 376 (604)
+.++.|....||+. +..++||.-.. ......+.+|+++|+.+.+. .+-+.+.++. ..+..+++|||+++.+
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 56788888899987 56788888532 22346788999999999753 2445555654 3455789999999987
Q ss_pred hhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhh-----------------------------------------
Q 007423 377 LYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHH----------------------------------------- 415 (604)
Q Consensus 377 L~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~----------------------------------------- 415 (604)
+.+.... .++...+..++.++++.|..||.
T Consensus 100 l~~~~~~---------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 100 LGEDGMA---------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CHHHHHT---------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred Cchhhhh---------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 7653211 12223333333333333333332
Q ss_pred ----------------cCCCCceecCCCCCeEEeCC---CCC-eEEcccCCccc
Q 007423 416 ----------------GCQPPYMHQYISSNVILIDD---DFD-ARITDFGLARL 449 (604)
Q Consensus 416 ----------------~~~~~iiH~dlk~~NiLl~~---~~~-~kl~DFGla~~ 449 (604)
...+.++|+|+++.||++++ ++. ..|.||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 12456799999999999997 455 48999997764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=1.7e-05 Score=78.14 Aligned_cols=134 Identities=19% Similarity=0.175 Sum_probs=91.3
Q ss_pred EEEecCCe-EEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeeEEeeecCCCchh
Q 007423 302 IIISTRTG-VSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEERLLVYKHMPNGTLY 378 (604)
Q Consensus 302 ~ig~G~~g-~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lv~ey~~~gsL~ 378 (604)
.+..|..| .||+... .++..+.+|+-... ....+.+|...|+.+. +--+-++++++...+..++|||++++.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 45556555 6898774 45677889986532 2356788999998884 323567788888889999999999998776
Q ss_pred hhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhh-------------------------------------------
Q 007423 379 SLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHH------------------------------------------- 415 (604)
Q Consensus 379 ~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~------------------------------------------- 415 (604)
+..... ......++.++++.|.-||.
T Consensus 109 ~~~~~~-----------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 109 QVLEEY-----------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp HHHHHC-----------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred ccccCC-----------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 654221 01122344444445555542
Q ss_pred ------------cCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 416 ------------GCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 416 ------------~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
.....++|+|+.+.|||++++..+-|.||+.+.
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 012247999999999999987767799998765
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.11 E-value=3.4e-06 Score=85.95 Aligned_cols=85 Identities=21% Similarity=0.242 Sum_probs=54.9
Q ss_pred CCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccc-eeeccccccccCCChhhhcCCCccE
Q 007423 92 CHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLN-KLILSNNKLSGSIPFEVSRLDRLKE 170 (604)
Q Consensus 92 l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~-~l~ls~N~l~g~~p~~~~~l~~L~~ 170 (604)
+++|+.|+|++|+++ .||...+..+++|+.|+|++| ++.--+..+.+|.+|+ .+++++ +++-.-+..+..+.+|+.
T Consensus 225 ~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~ 301 (329)
T 3sb4_A 225 MPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRY 301 (329)
T ss_dssp CTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEE
T ss_pred cCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCE
Confidence 667777777777766 666666666777777777766 4422234466677777 777766 555333456666777777
Q ss_pred EEccCCccc
Q 007423 171 FSVAGNDLS 179 (604)
Q Consensus 171 l~l~~N~l~ 179 (604)
+++++|+++
T Consensus 302 l~l~~n~i~ 310 (329)
T 3sb4_A 302 VLATGDKIT 310 (329)
T ss_dssp EEECSSCCC
T ss_pred EEeCCCccC
Confidence 777777665
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.08 E-value=4.1e-07 Score=100.43 Aligned_cols=111 Identities=15% Similarity=0.138 Sum_probs=82.9
Q ss_pred CcEEEEEecCCcceeeCCcccc-cCCCCCEEEcC--C----CCCCCcCCh-----hhhhcCCCCcEEEccCCcCCCCCcc
Q 007423 69 NRIISLTLSSMQLSGQLPESLH-LCHSLQSLDLS--D----NSLSGSIPV-----DLCKWLPYVVQLDLSNNHLSGPIPP 136 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~-~l~~L~~L~Ls--~----N~l~g~ip~-----~~~~~l~~L~~l~ls~N~l~g~iP~ 136 (604)
.+++.|.++.|++++..+..+. ++++|+.|+|+ + |+++ ..|. .+...+++|+.|+|++ ++++..+.
T Consensus 372 ~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~-~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~ 449 (594)
T 2p1m_B 372 PKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLT-LEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFE 449 (594)
T ss_dssp TTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTT-CCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHH
T ss_pred hhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccccc-CCchhhHHHHHHhhCCCccEEeecC-cccHHHHH
Confidence 4678888899999877666666 58999999998 4 6666 2332 1234488999999977 67666666
Q ss_pred cccC-CcccceeeccccccccCCChhh-hcCCCccEEEccCCcccCC
Q 007423 137 QIVE-CKFLNKLILSNNKLSGSIPFEV-SRLDRLKEFSVAGNDLSGT 181 (604)
Q Consensus 137 ~~~~-~~~L~~l~ls~N~l~g~~p~~~-~~l~~L~~l~l~~N~l~g~ 181 (604)
.++. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|.+++.
T Consensus 450 ~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~ 496 (594)
T 2p1m_B 450 YIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDK 496 (594)
T ss_dssp HHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHH
T ss_pred HHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHH
Confidence 6665 8889999999999887655555 6688899999999988543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.94 E-value=1.8e-06 Score=95.25 Aligned_cols=108 Identities=18% Similarity=0.120 Sum_probs=66.8
Q ss_pred CcEEEEEecCCcceeeCCcccc-cCCCCCEEEcCCC-CCCCcCChhhhhcCCCCcEEEccCCcCCCCCccccc----CCc
Q 007423 69 NRIISLTLSSMQLSGQLPESLH-LCHSLQSLDLSDN-SLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIV----ECK 142 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~-~l~~L~~L~Ls~N-~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~----~~~ 142 (604)
.+++.|+|++|.+++..+..+. .+++|+.|+|++| .++..-...+...+++|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 3577777777777766666665 5777777777777 444321223333477777788877777665444333 556
Q ss_pred ccceeeccccc--cccC-CChhhhcCCCccEEEccCC
Q 007423 143 FLNKLILSNNK--LSGS-IPFEVSRLDRLKEFSVAGN 176 (604)
Q Consensus 143 ~L~~l~ls~N~--l~g~-~p~~~~~l~~L~~l~l~~N 176 (604)
+|+.|+|++|. ++.. ++.....+++|+.|++++|
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 77777777776 2211 1122244577777777777
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.93 E-value=1.2e-06 Score=90.29 Aligned_cols=108 Identities=17% Similarity=0.158 Sum_probs=73.2
Q ss_pred CcEEEEEecCCc-ceeeCCcccccCCCCCEEEcCCCCCCCcCChhhh-hcCCCCcEEEccC--CcCCCC-----Ccccc-
Q 007423 69 NRIISLTLSSMQ-LSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLC-KWLPYVVQLDLSN--NHLSGP-----IPPQI- 138 (604)
Q Consensus 69 ~~v~~l~l~~n~-l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~-~~l~~L~~l~ls~--N~l~g~-----iP~~~- 138 (604)
..++.|+|++|. + .+++ + .+++|+.|+|..|.++...-..+. ..+|+|+.|+|+. |...|. +.+.+
T Consensus 172 P~L~~L~L~g~~~l--~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~ 247 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL--SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS 247 (362)
T ss_dssp TTCCEEEEECCBTC--BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSC
T ss_pred CCCcEEEEeCCCCc--eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHh
Confidence 578999998873 3 2444 4 388999999988877643333333 1488999999863 332222 11122
Q ss_pred -cCCcccceeeccccccccCCChhhh---cCCCccEEEccCCcccC
Q 007423 139 -VECKFLNKLILSNNKLSGSIPFEVS---RLDRLKEFSVAGNDLSG 180 (604)
Q Consensus 139 -~~~~~L~~l~ls~N~l~g~~p~~~~---~l~~L~~l~l~~N~l~g 180 (604)
..+++|++|+|++|.++...+..+. .+++|+.|+|+.|.+++
T Consensus 248 ~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d 293 (362)
T 2ra8_A 248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD 293 (362)
T ss_dssp TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence 2478899999999998865554444 46789999999998865
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.81 E-value=6.6e-06 Score=76.38 Aligned_cols=95 Identities=17% Similarity=0.214 Sum_probs=73.4
Q ss_pred eCCcccccCCCCCEEEcCCC-CCCCc----CChhhhhcCCCCcEEEccCCcCCCC----CcccccCCcccceeecccccc
Q 007423 84 QLPESLHLCHSLQSLDLSDN-SLSGS----IPVDLCKWLPYVVQLDLSNNHLSGP----IPPQIVECKFLNKLILSNNKL 154 (604)
Q Consensus 84 ~~p~~l~~l~~L~~L~Ls~N-~l~g~----ip~~~~~~l~~L~~l~ls~N~l~g~----iP~~~~~~~~L~~l~ls~N~l 154 (604)
.+...+...+.|++|+|++| .++.. +...+.. .+.|++|+|++|++... +...+...++|+.|+|++|++
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~-~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i 105 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKT-NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI 105 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTT-CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHh-CCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcC
Confidence 34456778999999999999 88632 2223323 68899999999999632 445566778999999999999
Q ss_pred ccC----CChhhhcCCCccEEEc--cCCccc
Q 007423 155 SGS----IPFEVSRLDRLKEFSV--AGNDLS 179 (604)
Q Consensus 155 ~g~----~p~~~~~l~~L~~l~l--~~N~l~ 179 (604)
+.. +...+...++|+.|+| ++|.++
T Consensus 106 ~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 106 SGSGILALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp CHHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred CHHHHHHHHHHHHhCCCceEEEecCCCCCCC
Confidence 864 4566777789999999 889885
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.79 E-value=2.9e-05 Score=78.95 Aligned_cols=101 Identities=14% Similarity=0.084 Sum_probs=64.6
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCc-EEEccCCcCCCCCcccccCCcccceee
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVV-QLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~-~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
.++.|+|++|+++..-+..+.+|++|+.|+|++| ++ .|+...+..+++|+ .|+|++ +++..-+..+.+|++|+.|+
T Consensus 227 ~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~ 303 (329)
T 3sb4_A 227 NLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL 303 (329)
T ss_dssp TCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred CCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence 4667777777666433445677777777777776 54 56666666677777 777766 55423345666777777777
Q ss_pred ccccccccCCChhhhcCCCccEEEc
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSV 173 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l 173 (604)
+++|+++..-+..+.++++|+.++.
T Consensus 304 l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 304 ATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp ECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred eCCCccCccchhhhcCCcchhhhcc
Confidence 7777776544556666666766653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=3.7e-05 Score=79.07 Aligned_cols=79 Identities=3% Similarity=-0.056 Sum_probs=53.6
Q ss_pred cEE-EecCCeEEEEEEeC-------CCCEEEEEEecccc---c-cHHHHHHHHHHHhccCC---CCccceeeEEEeC---
Q 007423 301 NII-ISTRTGVSYKAVLP-------DASALAIKRLSACK---L-SEKQFRSEMNRLGQLRH---PNLVPLLGFCVVE--- 362 (604)
Q Consensus 301 ~~i-g~G~~g~vy~~~~~-------~~~~vAvK~l~~~~---~-~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~~--- 362 (604)
+.| +.|....+|+.... ++..+++|.-.... . ....+.+|+++++.+.. -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 67778889988754 26678888765432 1 12457788888888742 2456677776554
Q ss_pred CeeeEEeeecCCCchhh
Q 007423 363 EERLLVYKHMPNGTLYS 379 (604)
Q Consensus 363 ~~~~lv~ey~~~gsL~~ 379 (604)
+..++||||+++..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999876653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.0003 Score=71.45 Aligned_cols=143 Identities=16% Similarity=0.213 Sum_probs=79.8
Q ss_pred EEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccC-----CCCcccee-e--EEEeCCeeeEEeeecC
Q 007423 302 IIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLR-----HPNLVPLL-G--FCVVEEERLLVYKHMP 373 (604)
Q Consensus 302 ~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~-----H~niv~l~-g--~~~~~~~~~lv~ey~~ 373 (604)
.++.|..+.||+....+| .+++|+.... .+++..|+++++.+. .|.++... | +....+..+++|||++
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 344566889999987655 4889998752 233445555555442 34444311 1 1234667899999999
Q ss_pred CCchh--------------hhhccCCCCC----CC---CCCCCHHHHHH-------------------------------
Q 007423 374 NGTLY--------------SLLHGNGVDN----TL---SGVLDWSTRLR------------------------------- 401 (604)
Q Consensus 374 ~gsL~--------------~~l~~~~~~~----~~---~~~l~~~~~~~------------------------------- 401 (604)
+..+. ..+|...... .. ...-.|.....
T Consensus 115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (346)
T 2q83_A 115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG 194 (346)
T ss_dssp CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence 86542 1122110000 00 01123432110
Q ss_pred HHHHHHHHhhHhhh----------cCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 402 IGMGASRGLAWLHH----------GCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 402 ia~~ia~gL~yLH~----------~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
+...+..++.+|+. .....++|+|+.+.|||++.+..+.|.||+.+.
T Consensus 195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11123345566652 125789999999999999877889999998664
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00032 Score=73.21 Aligned_cols=74 Identities=19% Similarity=0.113 Sum_probs=48.9
Q ss_pred CcEEEecCCeEEEEEEeC-CCCEEEEEEecccc--------ccHHHHHHHHHHHhccCC--CCcc-ceeeEEEeCCeeeE
Q 007423 300 ENIIISTRTGVSYKAVLP-DASALAIKRLSACK--------LSEKQFRSEMNRLGQLRH--PNLV-PLLGFCVVEEERLL 367 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~~~-~~~~vAvK~l~~~~--------~~~~~~~~Ei~~l~~l~H--~niv-~l~g~~~~~~~~~l 367 (604)
.+.+|.|..+.||++... +++.++||...... ...+.+..|.++++.+.+ +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 357889999999999854 56889999864321 122456789998887742 4444 44433 4556789
Q ss_pred EeeecCCC
Q 007423 368 VYKHMPNG 375 (604)
Q Consensus 368 v~ey~~~g 375 (604)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00014 Score=74.79 Aligned_cols=108 Identities=17% Similarity=0.189 Sum_probs=70.6
Q ss_pred CcEEEEEecCCcc---------eeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCccccc
Q 007423 69 NRIISLTLSSMQL---------SGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIV 139 (604)
Q Consensus 69 ~~v~~l~l~~n~l---------~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~ 139 (604)
.+|+.|.+.++.. .+.+++.+..+++|+.|+|++|.-. .+|. + . +++|+.|+|..|.++......+.
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~-~~~L~~L~L~~~~l~~~~l~~l~ 214 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-P-RPNLKSLEIISGGLPDSVVEDIL 214 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-B-CTTCSEEEEECSBCCHHHHHHHH
T ss_pred chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-c-CCCCcEEEEecCCCChHHHHHHH
Confidence 4677888866543 2345566778899999999887311 3454 3 3 78899999988877543333443
Q ss_pred --CCcccceeeccc--cccccC--C---Chhh--hcCCCccEEEccCCcccC
Q 007423 140 --ECKFLNKLILSN--NKLSGS--I---PFEV--SRLDRLKEFSVAGNDLSG 180 (604)
Q Consensus 140 --~~~~L~~l~ls~--N~l~g~--~---p~~~--~~l~~L~~l~l~~N~l~g 180 (604)
.+++|+.|+|+. |+..|. + ...+ ..+++|+.|+|++|.+..
T Consensus 215 ~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~ 266 (362)
T 2ra8_A 215 GSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQN 266 (362)
T ss_dssp HSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHH
T ss_pred HccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCch
Confidence 688999998863 333222 1 1112 246889999999988764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0018 Score=64.98 Aligned_cols=142 Identities=16% Similarity=0.165 Sum_probs=92.0
Q ss_pred CcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccC---CCCccceeeEEEeCCeeeEEeeecCCCc
Q 007423 300 ENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLR---HPNLVPLLGFCVVEEERLLVYKHMPNGT 376 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lv~ey~~~gs 376 (604)
.+.|+.|....+|+... ++..++||+.... ....+..|.+.|+.+. ...+.+.++++...+..++||||+++..
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 35688899999999886 4678888987543 3567889999988884 3567788888887888999999999876
Q ss_pred hh-----------hhhccCCC--CCCCC-------------CCCCHHHHH---HHHH--H--------------HHHHh-
Q 007423 377 LY-----------SLLHGNGV--DNTLS-------------GVLDWSTRL---RIGM--G--------------ASRGL- 410 (604)
Q Consensus 377 L~-----------~~l~~~~~--~~~~~-------------~~l~~~~~~---~ia~--~--------------ia~gL- 410 (604)
+. ..|+.... .-... -.-+|.... ++.. + +...+
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 42 12332211 00000 012465432 1111 1 11111
Q ss_pred hHhh-hcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 411 AWLH-HGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 411 ~yLH-~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
..|. ....+.++|+|+.+.|++++.++ +.|.||.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2232 12357899999999999999887 8899873
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0037 Score=61.84 Aligned_cols=76 Identities=20% Similarity=0.185 Sum_probs=53.7
Q ss_pred CcCcEEEecCCeEEEEEEeCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCC---CccceeeEEEeCCeeeEEeeecC
Q 007423 298 AVENIIISTRTGVSYKAVLPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHP---NLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 298 ~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
...+.+|.|..+.||+..+.||+.|.||+-.... .....|..|++.|+.+.-. -+.+.+++ . ..+++|||++
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~ 93 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVD 93 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCC
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeec
Confidence 3446789999999999999999999999865432 2234678899998888422 23333433 2 3478999988
Q ss_pred CCch
Q 007423 374 NGTL 377 (604)
Q Consensus 374 ~gsL 377 (604)
.+..
T Consensus 94 ~~~~ 97 (288)
T 3f7w_A 94 ERPP 97 (288)
T ss_dssp CCCC
T ss_pred ccCC
Confidence 7543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0098 Score=59.82 Aligned_cols=146 Identities=12% Similarity=0.039 Sum_probs=82.7
Q ss_pred cEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCC--ccceeeE-----EEeCCeeeEEeeecC
Q 007423 301 NIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPN--LVPLLGF-----CVVEEERLLVYKHMP 373 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~-----~~~~~~~~lv~ey~~ 373 (604)
..++ |....||+....+|+.+++|.........+.+..|..+++.+.... +.+++.. ....+..+++|||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 3465 7788999988777878999998644334566777888877774222 3333332 223456788999998
Q ss_pred CCchhh--------------hhccC--CCCCCCCCCCCHHHH----------------------HHHHHHHHHHhhHhhh
Q 007423 374 NGTLYS--------------LLHGN--GVDNTLSGVLDWSTR----------------------LRIGMGASRGLAWLHH 415 (604)
Q Consensus 374 ~gsL~~--------------~l~~~--~~~~~~~~~l~~~~~----------------------~~ia~~ia~gL~yLH~ 415 (604)
+..+.. .+|.. .........+++... ...+..++..+.-...
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 754321 01111 000000011232211 0011111111211110
Q ss_pred -cCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 416 -GCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 416 -~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
.....++|+|+++.|||++ + .+.|.||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1245689999999999999 4 899999987653
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00074 Score=58.45 Aligned_cols=56 Identities=23% Similarity=0.318 Sum_probs=37.6
Q ss_pred EEEecCCcce-eeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCC
Q 007423 73 SLTLSSMQLS-GQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLS 131 (604)
Q Consensus 73 ~l~l~~n~l~-g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~ 131 (604)
.++.++++|+ ..+|..+. ++|+.|+|++|+|+ .||...+..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence 5666777775 34554432 35777888888887 677766666777777777777663
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0012 Score=69.01 Aligned_cols=89 Identities=11% Similarity=0.128 Sum_probs=39.2
Q ss_pred cccccCCCCCEEEcCCCCCC----CcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeeccccccccCCChhh
Q 007423 87 ESLHLCHSLQSLDLSDNSLS----GSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEV 162 (604)
Q Consensus 87 ~~l~~l~~L~~L~Ls~N~l~----g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~ 162 (604)
..+.+|++|+.++|.+|.+. ..|+...+..+++|+.++|.+ +++---...+.+|.+|+.++|..| ++-.-+..+
T Consensus 265 ~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF 342 (401)
T 4fdw_A 265 RAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAF 342 (401)
T ss_dssp TTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSS
T ss_pred hHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhC
Confidence 34445555555555554442 124444444455555555552 233111223444555555555333 332222334
Q ss_pred hcCCCccEEEccCCcc
Q 007423 163 SRLDRLKEFSVAGNDL 178 (604)
Q Consensus 163 ~~l~~L~~l~l~~N~l 178 (604)
.++ +|+.+++++|.+
T Consensus 343 ~~~-~L~~l~l~~n~~ 357 (401)
T 4fdw_A 343 NNT-GIKEVKVEGTTP 357 (401)
T ss_dssp SSS-CCCEEEECCSSC
T ss_pred CCC-CCCEEEEcCCCC
Confidence 444 555555555543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0012 Score=57.14 Aligned_cols=57 Identities=21% Similarity=0.231 Sum_probs=34.6
Q ss_pred CEEEcCCCCCC-CcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeeccccccc
Q 007423 96 QSLDLSDNSLS-GSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLS 155 (604)
Q Consensus 96 ~~L~Ls~N~l~-g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~N~l~ 155 (604)
..+|.+++.|+ ..||..+ -++|+.|+|++|+|+..-+..+..+.+|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~l---p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAF---PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCC---CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCC---CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 36777777775 4667543 245777777777776333333455556666666666553
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0053 Score=64.37 Aligned_cols=79 Identities=9% Similarity=0.050 Sum_probs=47.8
Q ss_pred CCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCC---CCCcccchhhHHHHH
Q 007423 418 QPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM---VASLKGDVYGFGIVL 494 (604)
Q Consensus 418 ~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~k~DV~SfGvvl 494 (604)
.+.++|+|+++.|||++++. ++|.||+.+..-.....- ...... -...|++|+..... ......++.+....+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGN--LILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHH--HHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHH--HHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 67899999999999999776 999999988753211000 000000 01346666654311 112234556778888
Q ss_pred HHHHhC
Q 007423 495 LELLSG 500 (604)
Q Consensus 495 ~elltg 500 (604)
|+..++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0052 Score=61.20 Aligned_cols=71 Identities=10% Similarity=0.049 Sum_probs=43.5
Q ss_pred CcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCcc-ceeeEEEeCCeeeEEeeec-CCCch
Q 007423 300 ENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLV-PLLGFCVVEEERLLVYKHM-PNGTL 377 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lv~ey~-~~gsL 377 (604)
.+.++.|....+|+. ..+.+|+-...........+|+.+++.+....+. +++++ ..+.-++++||+ ++.++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 577888999999998 5688888754211111124577777776433333 44443 344457899999 55444
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0065 Score=60.96 Aligned_cols=162 Identities=10% Similarity=0.067 Sum_probs=85.3
Q ss_pred cCHHHHHHhhcCCCcC-----cEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCC--ccceee
Q 007423 285 VKLADLLAATNSFAVE-----NIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPN--LVPLLG 357 (604)
Q Consensus 285 ~~~~~l~~~~~~~~~~-----~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g 357 (604)
++.+++...-..|... +.|+.|....+|+....+| .+++|..... ...+.+..|+++++.+.... +.+++.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 3445555555555542 3355677788999987666 5788887642 12234566777776663222 222221
Q ss_pred ------EEEeCCeeeEEeeecCCCchhh--------------hhccC--CCCCCC---CCCCCHHHHHHH----------
Q 007423 358 ------FCVVEEERLLVYKHMPNGTLYS--------------LLHGN--GVDNTL---SGVLDWSTRLRI---------- 402 (604)
Q Consensus 358 ------~~~~~~~~~lv~ey~~~gsL~~--------------~l~~~--~~~~~~---~~~l~~~~~~~i---------- 402 (604)
+....+..+++++|+++..+.. .+|.. ...... .....|.....-
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1123456789999998865321 12211 000000 001124331110
Q ss_pred --HHHHHHHhhHhhh----cCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 403 --GMGASRGLAWLHH----GCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 403 --a~~ia~gL~yLH~----~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
...+.+.+++++. .....++|+|+.+.|||++++..+.|.||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 0113334444432 124579999999999999987656899998664
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0038 Score=65.07 Aligned_cols=106 Identities=11% Similarity=0.088 Sum_probs=81.4
Q ss_pred CcEEEEEecCCcce-----eeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcc
Q 007423 69 NRIISLTLSSMQLS-----GQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKF 143 (604)
Q Consensus 69 ~~v~~l~l~~n~l~-----g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~ 143 (604)
..++.++|.+|.+. -.-+..+.+|++|+.++|. |+++ .|+...+..+++|+.|+|.+| ++---+..+.+| +
T Consensus 271 ~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~-~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~ 346 (401)
T 4fdw_A 271 PELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIR-ILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-G 346 (401)
T ss_dssp TTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCC-EECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-C
T ss_pred CCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceE-EEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-C
Confidence 36788888888765 2334678999999999999 5576 888888888999999999766 553334568888 9
Q ss_pred cceeeccccccccCCChhhhcCC-CccEEEccCCcc
Q 007423 144 LNKLILSNNKLSGSIPFEVSRLD-RLKEFSVAGNDL 178 (604)
Q Consensus 144 L~~l~ls~N~l~g~~p~~~~~l~-~L~~l~l~~N~l 178 (604)
|+.+++++|.+.-..+..+..++ .+..|++..|.+
T Consensus 347 L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 347 IKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp CCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred CCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 99999999998755555566663 678888877654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0015 Score=60.50 Aligned_cols=108 Identities=13% Similarity=0.213 Sum_probs=63.0
Q ss_pred CcEEEEEecCC-cceee----CCcccccCCCCCEEEcCCCCCCCc----CChhhhhcCCCCcEEEccCCcCCCC----Cc
Q 007423 69 NRIISLTLSSM-QLSGQ----LPESLHLCHSLQSLDLSDNSLSGS----IPVDLCKWLPYVVQLDLSNNHLSGP----IP 135 (604)
Q Consensus 69 ~~v~~l~l~~n-~l~g~----~p~~l~~l~~L~~L~Ls~N~l~g~----ip~~~~~~l~~L~~l~ls~N~l~g~----iP 135 (604)
..++.|+|++| ++... +-..|..-+.|+.|+|++|.+.-. |-..+.. =+.|+.|+|++|++... |-
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~-N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIET-SPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHH-CSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhc-CCccCeEecCCCcCCHHHHHHHH
Confidence 46778888875 66421 344556667888888888887621 1112222 35678888888887532 22
Q ss_pred ccccCCcccceeecccc---cccc----CCChhhhcCCCccEEEccCCc
Q 007423 136 PQIVECKFLNKLILSNN---KLSG----SIPFEVSRLDRLKEFSVAGND 177 (604)
Q Consensus 136 ~~~~~~~~L~~l~ls~N---~l~g----~~p~~~~~l~~L~~l~l~~N~ 177 (604)
..+..-+.|+.|+|++| .+.. .|-..+..-+.|..|+++.|.
T Consensus 120 ~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 33445566778888754 2222 133344445667777776554
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.30 E-value=0.0015 Score=59.49 Aligned_cols=35 Identities=6% Similarity=0.052 Sum_probs=22.2
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCC
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNS 104 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~ 104 (604)
+++.|||+++.++..--..+..|++|+.|+|+++.
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~ 96 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCH 96 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCT
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCC
Confidence 57777777776654333445667777777777664
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.27 E-value=0.0013 Score=59.74 Aligned_cols=92 Identities=14% Similarity=0.156 Sum_probs=64.0
Q ss_pred CCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCc-CCCCCcccccCC----cccceeecccc-ccccCC
Q 007423 85 LPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH-LSGPIPPQIVEC----KFLNKLILSNN-KLSGSI 158 (604)
Q Consensus 85 ~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~-l~g~iP~~~~~~----~~L~~l~ls~N-~l~g~~ 158 (604)
+|.....--.|+.||||++.++-.=-..+ ..+++|+.|+|+++. ++..-=..++.+ ++|+.|+|+++ ++|..=
T Consensus 53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L-~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~G 131 (176)
T 3e4g_A 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHM-EGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKG 131 (176)
T ss_dssp SCCCSTTCCCEEEEEEESCCCCGGGGGGG-TTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHH
T ss_pred CCcccCCCceEeEEeCcCCCccHHHHHHh-cCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHH
Confidence 34432233579999999999873211234 349999999999985 653222335553 47999999996 487543
Q ss_pred ChhhhcCCCccEEEccCCc
Q 007423 159 PFEVSRLDRLKEFSVAGND 177 (604)
Q Consensus 159 p~~~~~l~~L~~l~l~~N~ 177 (604)
-..+.++++|+.|++++..
T Consensus 132 l~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 132 IIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HHHGGGCTTCCEEEEESCT
T ss_pred HHHHhcCCCCCEEECCCCC
Confidence 3467789999999999874
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.17 E-value=0.016 Score=59.75 Aligned_cols=142 Identities=17% Similarity=0.167 Sum_probs=79.9
Q ss_pred cEEEecCCeEEEEEEeCC--------CCEEEEEEeccccccHHHHHHHHHHHhccCCCCc-cceeeEEEeCCeeeEEeee
Q 007423 301 NIIISTRTGVSYKAVLPD--------ASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNL-VPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~--------~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lv~ey 371 (604)
+.+..|....+|+...++ +..+.+|+-...........+|.++++.+.-..+ .++++++. + .+||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEEE
Confidence 456567778899988653 4788888863322234556689999888743333 45555543 3 289999
Q ss_pred cCCCchhhh-----------------hccCCCCCCCCCCCC--HHHHHHHHHHHHH-------------------HhhHh
Q 007423 372 MPNGTLYSL-----------------LHGNGVDNTLSGVLD--WSTRLRIGMGASR-------------------GLAWL 413 (604)
Q Consensus 372 ~~~gsL~~~-----------------l~~~~~~~~~~~~l~--~~~~~~ia~~ia~-------------------gL~yL 413 (604)
+++.+|..- ||....... .... |....++..++.. .+..|
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~--~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFT--KEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSC--CSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCC--CCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 998655311 122211101 1122 4444444433321 12222
Q ss_pred h----h-cCCCCceecCCCCCeEEeCCC----CCeEEcccCCcc
Q 007423 414 H----H-GCQPPYMHQYISSNVILIDDD----FDARITDFGLAR 448 (604)
Q Consensus 414 H----~-~~~~~iiH~dlk~~NiLl~~~----~~~kl~DFGla~ 448 (604)
. . .....++|+|+.+.|||++.+ +.+.+.||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 1 124568999999999999876 689999998664
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.12 E-value=0.022 Score=59.79 Aligned_cols=72 Identities=14% Similarity=0.136 Sum_probs=48.4
Q ss_pred cEEEecCCeEEEEEEeCC--------CCEEEEEEeccccccHHHHHHHHHHHhccCCCCc-cceeeEEEeCCeeeEEeee
Q 007423 301 NIIISTRTGVSYKAVLPD--------ASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNL-VPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~--------~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lv~ey 371 (604)
+.|+.|....+|+...++ +..+.+|+.... ...+.+.+|..+++.+...++ .++++.+. + .+|+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEE
Confidence 467778889999998753 478888887432 122456689999888854444 45565542 2 389999
Q ss_pred cCCCch
Q 007423 372 MPNGTL 377 (604)
Q Consensus 372 ~~~gsL 377 (604)
+++.++
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986444
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.85 E-value=0.016 Score=59.52 Aligned_cols=73 Identities=12% Similarity=0.059 Sum_probs=42.3
Q ss_pred cEEEecCCeEEEEEEeCC---------CCEEEEEEeccccccHHHHHHHHHHHhccCCCCcc-ceeeEEEeCCeeeEEee
Q 007423 301 NIIISTRTGVSYKAVLPD---------ASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLV-PLLGFCVVEEERLLVYK 370 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~---------~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lv~e 370 (604)
..++.|....+|+....+ +..+.+|..............|.++++.+...+++ ++++.. . -++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 356677778899988654 26788887654221111235688888777533433 555443 2 368999
Q ss_pred ecCCCch
Q 007423 371 HMPNGTL 377 (604)
Q Consensus 371 y~~~gsL 377 (604)
|+++..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.73 E-value=0.051 Score=54.69 Aligned_cols=32 Identities=19% Similarity=0.276 Sum_probs=27.7
Q ss_pred CCCceecCCCCCeEEeCCC----CCeEEcccCCccc
Q 007423 418 QPPYMHQYISSNVILIDDD----FDARITDFGLARL 449 (604)
Q Consensus 418 ~~~iiH~dlk~~NiLl~~~----~~~kl~DFGla~~ 449 (604)
...++|+|+.+.|||++.+ ..+.|.||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 5679999999999999874 6789999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.51 E-value=0.061 Score=56.87 Aligned_cols=73 Identities=15% Similarity=0.012 Sum_probs=45.4
Q ss_pred cEEEecCCeEEEEEEeCC-CCEEEEEEeccccccHHHHHHHHHHHhccCCCCcc-ceeeEEEeCCeeeEEeeecCCCch
Q 007423 301 NIIISTRTGVSYKAVLPD-ASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLV-PLLGFCVVEEERLLVYKHMPNGTL 377 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lv~ey~~~gsL 377 (604)
+.|+.|-...+|+....+ +..+.+|+........-.-.+|..+++.+...+++ ++++++ .+ .+||||+++.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 467778888999998765 46788887643211100114788888888655553 566655 22 259999987554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.96 E-value=0.086 Score=53.32 Aligned_cols=32 Identities=19% Similarity=0.241 Sum_probs=28.0
Q ss_pred CCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 418 QPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 418 ~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
...++|+|+.+.||++++++.+.|.||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 45799999999999999878899999987654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=94.89 E-value=0.014 Score=54.10 Aligned_cols=88 Identities=15% Similarity=0.155 Sum_probs=62.2
Q ss_pred ccccCCCCCEEEcCCC-CCCCc----CChhhhhcCCCCcEEEccCCcCCC----CCcccccCCcccceeeccccccccC-
Q 007423 88 SLHLCHSLQSLDLSDN-SLSGS----IPVDLCKWLPYVVQLDLSNNHLSG----PIPPQIVECKFLNKLILSNNKLSGS- 157 (604)
Q Consensus 88 ~l~~l~~L~~L~Ls~N-~l~g~----ip~~~~~~l~~L~~l~ls~N~l~g----~iP~~~~~~~~L~~l~ls~N~l~g~- 157 (604)
-+.+-+.|+.|+|++| .+.-. |-..+.. =+.|+.|+|++|++.- .|-..+...+.|+.|+|++|+|+..
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~-N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~G 114 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACN-SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL 114 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTT-CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhh-CCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHH
Confidence 3556789999999986 66411 1122222 4679999999999962 2444556778999999999999853
Q ss_pred ---CChhhhcCCCccEEEccCC
Q 007423 158 ---IPFEVSRLDRLKEFSVAGN 176 (604)
Q Consensus 158 ---~p~~~~~l~~L~~l~l~~N 176 (604)
|-..+..-..|+.|+|++|
T Consensus 115 a~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 115 LARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHHHhhCCceeEEECCCC
Confidence 2334445567999999875
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=94.27 E-value=0.11 Score=53.57 Aligned_cols=85 Identities=14% Similarity=0.334 Sum_probs=46.9
Q ss_pred ccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCC-cccccCCcccceeeccccccccCCChhhhcCC
Q 007423 88 SLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPI-PPQIVECKFLNKLILSNNKLSGSIPFEVSRLD 166 (604)
Q Consensus 88 ~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~i-P~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~ 166 (604)
.+.+++.|+.+++. +.++ .|+...+..+.+|+.++|..| ++ .| ...+.+|.+|+.+.|..| ++-.=..++.++.
T Consensus 283 aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~ 357 (394)
T 4gt6_A 283 AFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCT 357 (394)
T ss_dssp TTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCT
T ss_pred ccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCC
Confidence 34555666666664 3343 555555555666666666543 33 22 234566667777666543 4422234556666
Q ss_pred CccEEEccCCc
Q 007423 167 RLKEFSVAGND 177 (604)
Q Consensus 167 ~L~~l~l~~N~ 177 (604)
+|+.+++.+|.
T Consensus 358 ~L~~i~~~~~~ 368 (394)
T 4gt6_A 358 ALNNIEYSGSR 368 (394)
T ss_dssp TCCEEEESSCH
T ss_pred CCCEEEECCce
Confidence 67777766654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.10 E-value=0.48 Score=44.22 Aligned_cols=100 Identities=15% Similarity=0.089 Sum_probs=63.9
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
.-+|.+.|...+ .+++..+.+.+..|.+.+|.-+-.. ..+ ..+=+.|..|++..+|.+...+ +.+.
T Consensus 32 ~vSL~eIL~~~~------~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----- 97 (229)
T 2yle_A 32 ALSLEEILRLYN------QPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD----- 97 (229)
T ss_dssp EEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C--------
T ss_pred cccHHHHHHHcC------CCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc-----
Confidence 347889887654 5799999999999999887665210 011 1223346889999998888764 1111
Q ss_pred CCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS 499 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt 499 (604)
. ....+.+||... ...+.+.=|||+|+++|.-+-
T Consensus 98 -~----------~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -A----------GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp --------------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -c----------cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0 112356888764 345788899999999999885
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=94.06 E-value=0.072 Score=55.01 Aligned_cols=101 Identities=18% Similarity=0.300 Sum_probs=66.4
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCc-ccccCCcccceee
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIP-PQIVECKFLNKLI 148 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP-~~~~~~~~L~~l~ 148 (604)
.++.+.+. ++++..-...+.+|++|+.++|..| ++ .|....+..+.+|+.+.|.++ ++ .|+ ..+.+|++|+.++
T Consensus 289 ~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~ 363 (394)
T 4gt6_A 289 ALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIE 363 (394)
T ss_dssp TCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEE
T ss_pred ccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEE
Confidence 34555554 3344323356888999999999865 65 788777777999999999765 55 454 5688999999999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcc
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDL 178 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l 178 (604)
+.+|.... ..+.....|+.+.+..|.+
T Consensus 364 ~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 364 YSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp ESSCHHHH---HTCBCCCCC----------
T ss_pred ECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 99987653 3456667888888877654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=93.58 E-value=0.1 Score=53.37 Aligned_cols=84 Identities=15% Similarity=0.226 Sum_probs=42.0
Q ss_pred cccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCc-ccccCCcccceeeccccccccCCChhhhcC
Q 007423 87 ESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIP-PQIVECKFLNKLILSNNKLSGSIPFEVSRL 165 (604)
Q Consensus 87 ~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP-~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l 165 (604)
..+.++..|+.+.+..+ ++ .|+...+..+..|+.+.+..+ +. .++ ..+.+|.+|+.+++.+|.++-.-...+.++
T Consensus 234 ~~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c 309 (379)
T 4h09_A 234 GAFYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDC 309 (379)
T ss_dssp TTTTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTC
T ss_pred ccccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc-ce-eccccccccccccccccccccccceehhhhhcCC
Confidence 34455666666666544 33 444444444555666655433 22 122 234555666666665555552223345555
Q ss_pred CCccEEEcc
Q 007423 166 DRLKEFSVA 174 (604)
Q Consensus 166 ~~L~~l~l~ 174 (604)
.+|+.+.|.
T Consensus 310 ~~L~~i~lp 318 (379)
T 4h09_A 310 VKLSSVTLP 318 (379)
T ss_dssp TTCCEEECC
T ss_pred CCCCEEEcC
Confidence 556665554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=92.77 E-value=0.13 Score=53.04 Aligned_cols=85 Identities=18% Similarity=0.192 Sum_probs=64.8
Q ss_pred cccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCC-cccccCCcccceeeccccccccCCChhhhcC
Q 007423 87 ESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPI-PPQIVECKFLNKLILSNNKLSGSIPFEVSRL 165 (604)
Q Consensus 87 ~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~i-P~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l 165 (604)
..+..+++|+.+.+.+| ++ .|+...+..+++|+.++|.++ ++ .| ...+.+|++|+.+++..| ++-.-..++..+
T Consensus 291 ~~F~~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C 365 (394)
T 4fs7_A 291 KTFYGCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGC 365 (394)
T ss_dssp TTTTTCTTCCEEEECTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTBTTC
T ss_pred ccccccccccccccccc-cc-eechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-ccEehHHHhhCC
Confidence 35778999999999765 55 687776777899999999755 54 34 356788999999999877 653334567888
Q ss_pred CCccEEEccCC
Q 007423 166 DRLKEFSVAGN 176 (604)
Q Consensus 166 ~~L~~l~l~~N 176 (604)
.+|+.+++..|
T Consensus 366 ~~L~~i~lp~~ 376 (394)
T 4fs7_A 366 INLKKVELPKR 376 (394)
T ss_dssp TTCCEEEEEGG
T ss_pred CCCCEEEECCC
Confidence 89999998765
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=91.87 E-value=0.19 Score=51.82 Aligned_cols=98 Identities=11% Similarity=0.080 Sum_probs=68.6
Q ss_pred EEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCc-ccccCCcccceeec
Q 007423 71 IISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIP-PQIVECKFLNKLIL 149 (604)
Q Consensus 71 v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP-~~~~~~~~L~~l~l 149 (604)
++.+.+..+... .-...+..+..|+.+.+..+. ||...+..+.+|+.+.+.+| ++ .|+ ..+.+|.+|+.++|
T Consensus 255 l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~----i~~~~F~~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~l 327 (394)
T 4fs7_A 255 LESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVI----VPEKTFYGCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDL 327 (394)
T ss_dssp CCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSE----ECTTTTTTCTTCCEEEECTT-CC-EECTTTTTTCTTCCEECC
T ss_pred ceeEEcCCCcce-eeccccccccccceeccCcee----eccccccccccccccccccc-cc-eechhhhcCCCCCCEEEe
Confidence 445555554332 234467788999999887754 55555566899999999765 44 343 45788999999999
Q ss_pred cccccccCCChhhhcCCCccEEEccCC
Q 007423 150 SNNKLSGSIPFEVSRLDRLKEFSVAGN 176 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L~~l~l~~N 176 (604)
.++ ++-.-..++.++.+|+.+++..|
T Consensus 328 p~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 328 PYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp CTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred CCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 754 65333456788899999998765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=91.50 E-value=0.38 Score=50.14 Aligned_cols=73 Identities=10% Similarity=0.046 Sum_probs=44.6
Q ss_pred cEEEecCCeEEEEEEeCC--------CCEEEEEEeccccccHHHHHHHHHHHhccCCCCc-cceeeEEEeCCeeeEEeee
Q 007423 301 NIIISTRTGVSYKAVLPD--------ASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNL-VPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~--------~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lv~ey 371 (604)
+.+..|-...+|+...++ +..+.+|+-.......-.-.+|..+++.+.-.++ .++++.+ . -++||||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence 456567788899988753 5788888864322111112467888777743333 3444432 2 3689999
Q ss_pred cCCCch
Q 007423 372 MPNGTL 377 (604)
Q Consensus 372 ~~~gsL 377 (604)
+++..|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998664
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=89.38 E-value=0.95 Score=46.04 Aligned_cols=83 Identities=18% Similarity=0.347 Sum_probs=36.7
Q ss_pred ccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeeccccccccCCChhhhcCCC
Q 007423 88 SLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDR 167 (604)
Q Consensus 88 ~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~ 167 (604)
.+.++.+|+.+++..+ +. .|+...+..+++|+.+++.+|.++---...+.+|.+|+.++|..| ++-.=..++.++.+
T Consensus 258 aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~ 334 (379)
T 4h09_A 258 LLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKA 334 (379)
T ss_dssp TTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred ccceeehhcccccccc-ce-eccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCC
Confidence 3444555555555432 32 344444444555555555555444111233445555555555433 33111223444444
Q ss_pred ccEEEc
Q 007423 168 LKEFSV 173 (604)
Q Consensus 168 L~~l~l 173 (604)
|+.+.+
T Consensus 335 L~~i~i 340 (379)
T 4h09_A 335 LSTISY 340 (379)
T ss_dssp CCCCCC
T ss_pred CCEEEE
Confidence 444443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.90 E-value=0.27 Score=33.02 Aligned_cols=26 Identities=31% Similarity=0.301 Sum_probs=9.8
Q ss_pred eehhhhhHHHHHHHHHHhhheeeeec
Q 007423 221 AAGVLGALGSIILGFLIWWWFFVRVS 246 (604)
Q Consensus 221 ~~~v~~~~~~ili~~~~~~~~~~r~~ 246 (604)
++++.+.++.++++.+.++++.|||+
T Consensus 14 A~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 14 ATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred EeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 33444333333333333334444433
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.73 E-value=0.41 Score=32.06 Aligned_cols=25 Identities=32% Similarity=0.387 Sum_probs=9.2
Q ss_pred eehhhhhHHHHHHHHHHhhheeeee
Q 007423 221 AAGVLGALGSIILGFLIWWWFFVRV 245 (604)
Q Consensus 221 ~~~v~~~~~~ili~~~~~~~~~~r~ 245 (604)
++++.+.+..++++.+.++++.|||
T Consensus 13 A~gVVgGv~~v~ii~~~~~~~~RRR 37 (44)
T 2l2t_A 13 AAGVIGGLFILVIVGLTFAVYVRRK 37 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEeehHHHHHHHHHHHHHHHHhhhh
Confidence 3334333333333333333444443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.20 E-value=7.6 Score=35.96 Aligned_cols=123 Identities=12% Similarity=0.105 Sum_probs=82.0
Q ss_pred HHHHHhccCCCCccceeeEEEeCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCC
Q 007423 340 EMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQP 419 (604)
Q Consensus 340 Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~ 419 (604)
|+.+|.. .||+.+.. .+-..++...+.|+.-+.+-=...++ .++...+++++.+++.-..+++
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik----------~~~~~eKlr~l~ni~~l~~~~~----- 98 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK----------SFTKNEKLRYLLNIKNLEEVNR----- 98 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG----------GSCHHHHHHHHHHGGGGGGGGG-----
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH----------hcCHHHHHHHHHHHHHHHHHhc-----
Confidence 4444433 68888876 55666777777776654332222232 3678899999999998776666
Q ss_pred CceecCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh
Q 007423 420 PYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS 499 (604)
Q Consensus 420 ~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt 499 (604)
.-+|--+.|+|++++.++.|++.-.|+...+.+.. .+...=.-.+=+++..+++
T Consensus 99 ~r~tf~L~P~NL~f~~~~~p~i~~RGik~~l~P~~--------------------------~~ee~fL~qyKAliiall~ 152 (215)
T 4ann_A 99 TRYTFVLAPDELFFTRDGLPIAKTRGLQNVVDPLP--------------------------VSEAEFLTRYKALVICAFN 152 (215)
T ss_dssp SSEECCCSGGGEEECTTSCEEESCCEETTTBSCCC--------------------------CCHHHHHHHHHHHHHHHHC
T ss_pred CceEEEEecceEEEcCCCCEEEEEccCccCCCCCC--------------------------CCHHHHHHHHHHHHHHHHc
Confidence 24677888999999999999999888754432210 0111112356678888999
Q ss_pred CCCCCC
Q 007423 500 GQKPLD 505 (604)
Q Consensus 500 g~~p~~ 505 (604)
++..|+
T Consensus 153 ~K~~Fe 158 (215)
T 4ann_A 153 EKQSFD 158 (215)
T ss_dssp TTCCHH
T ss_pred CCCCHH
Confidence 998885
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 604 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-47 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-42 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-41 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-41 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-40 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-39 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-39 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-38 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-38 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-36 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-36 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-35 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-35 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-34 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-34 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-34 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-33 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-32 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-32 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-32 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-31 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-31 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-29 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-29 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-29 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-26 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-26 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-26 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-25 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-25 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-24 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-24 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-24 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-24 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-23 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-22 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-22 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-22 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-21 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-21 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-20 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-20 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-19 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-17 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-17 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-17 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-15 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-15 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-12 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-06 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 5e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 1e-47
Identities = 65/290 (22%), Positives = 114/290 (39%), Gaps = 29/290 (10%)
Query: 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSE-KQFRSEMNRLGQLRHPNLV 353
V I S G YK A+ + ++A + + F++E+ L + RH N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 354 PLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL 413
+G+ + +V + +LY LH + + I ++G+ +L
Sbjct: 68 LFMGYST-APQLAIVTQWCEGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDYL 120
Query: 414 HHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAP 473
H +H+ + SN I + +D +I DFGLA + + G ++AP
Sbjct: 121 HA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF--EQLSGSILWMAP 175
Query: 474 EY---SSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530
E S + DVY FGIVL EL++GQ P N D + +V G
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS--------NINNRDQIIFMVGRGYL 227
Query: 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
+ K + R+ C+ + +RP Q+ S++ +A
Sbjct: 228 SPDLSKV-----RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-47
Identities = 49/293 (16%), Positives = 110/293 (37%), Gaps = 27/293 (9%)
Query: 309 GVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE----E 364
G ++ +A+K S+ + +E+ + LRH N++ + + +
Sbjct: 17 GEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75
Query: 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGC-----QP 419
LV + +G+L+ L+ + +++ + + GLA LH +P
Sbjct: 76 LWLVSDYHEHGSLFDYLNRYT--------VTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127
Query: 420 PYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM 479
H+ + S IL+ + I D GLA S + +G Y+APE
Sbjct: 128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187
Query: 480 V------ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLV--DWVNHLVIAGRSR 531
+ + + D+Y G+V E+ + + +LV D +
Sbjct: 188 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 247
Query: 532 DVVDKSLYGRGNDDEIMQFL-RVACSCVVSRPKDRPSMYQVYESLKSMAEKHG 583
+ ++ R E ++ + ++ C + R + ++ ++L ++++ G
Sbjct: 248 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-45
Identities = 56/272 (20%), Positives = 109/272 (40%), Gaps = 29/272 (10%)
Query: 309 GVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368
G+ + + +AIK + +SE+ F E + +L HP LV L G C+ + LV
Sbjct: 19 GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78
Query: 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS 428
++ M +G L L T L + + G + + + +H+ +++
Sbjct: 79 FEFMEHGCLSDYLRTQRGLF------AAETLLGMCLDVCEG---MAYLEEACVIHRDLAA 129
Query: 429 NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVY 488
L+ ++ +++DFG+ R V + + G + +PE S S K DV+
Sbjct: 130 RNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 489 GFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIM 548
FG+++ E+ S K + +V+ ++ + R
Sbjct: 187 SFGVLMWEVFSEGKIPYENRSNS----EVVEDISTGFRLYKPRLAST------------- 229
Query: 549 QFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
++ C RP+DRP+ ++ L +AE
Sbjct: 230 HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 5e-45
Identities = 63/270 (23%), Positives = 114/270 (42%), Gaps = 29/270 (10%)
Query: 309 GVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368
G + + +A+K L +S F +E N + QL+H LV L +E ++
Sbjct: 27 GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYII 85
Query: 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS 428
++M NG+L L L + L + + G+A++ Y+H+ + +
Sbjct: 86 TEYMENGSLVDFLKTPS-----GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRA 137
Query: 429 NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVY 488
IL+ D +I DFGLARL+ + N+ + G + APE + ++K DV+
Sbjct: 138 ANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 489 GFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIM 548
FGI+L E+++ + + G V + G + + +E+
Sbjct: 195 SFGILLTEIVTHGRIP--------YPGMTNPEVIQNLERGY------RMVRPDNCPEELY 240
Query: 549 QFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
Q +R C RP+DRP+ + L+
Sbjct: 241 QLMR---LCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (390), Expect = 4e-43
Identities = 66/320 (20%), Positives = 119/320 (37%), Gaps = 47/320 (14%)
Query: 286 KLADLLAATNSFAVENIIISTRTGVSYKAVLPDASAL------AIKRLSACKLS--EKQF 337
KL L N+ I G ++A P A+K L + + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 338 RSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLS------ 391
+ E + + +PN+V LLG C V + L++++M G L L S
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 392 -----------GVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDAR 440
L + +L I + G+A+L ++H+ +++ L+ ++ +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 441 ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSG 500
I DFGL+R + S D + D ++ PE + + DV+ +G+VL E+ S
Sbjct: 181 IADFGLSRNIYSADYYKAD--GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 501 QKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVS 560
+ G + V + V G ++ ++ + C
Sbjct: 239 GLQP--------YYGMAHEEVIYYVRDGNILAC---------PENCPLELYNLMRLCWSK 281
Query: 561 RPKDRPSMYQVYESLKSMAE 580
P DRPS ++ L+ M E
Sbjct: 282 LPADRPSFCSIHRILQRMCE 301
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (382), Expect = 4e-42
Identities = 56/297 (18%), Positives = 123/297 (41%), Gaps = 29/297 (9%)
Query: 295 NSFAVENIIISTRTGVSYKAVLPDASAL-AIKRLSACKLSEKQFRSEMNRLGQLRHPNLV 353
+++ + + G Y+ V S A+K L + ++F E + +++HPNLV
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 354 PLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWL 413
LLG C E ++ + M G L L + L + S + +L
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYL 131
Query: 414 HHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAP 473
+ ++H+ +++ L+ ++ ++ DFGL+RL+ + + + AP
Sbjct: 132 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAP 185
Query: 474 EYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533
E + S+K DV+ FG++L E+ + + G + V ++
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQV---------YEL 228
Query: 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEPYDE 590
++K + + + +C P DRPS +++++ ++M ++ S+ ++
Sbjct: 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 285
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 5e-42
Identities = 48/268 (17%), Positives = 94/268 (35%), Gaps = 29/268 (10%)
Query: 309 GVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368
GV +AIK + +SE +F E + L H LV L G C + ++
Sbjct: 18 GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77
Query: 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISS 428
++M NG L + L L + + +L ++H+ +++
Sbjct: 78 TEYMANGCLLNYLREMR------HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAA 128
Query: 429 NVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVY 488
L++D +++DFGL+R V + S + + PE S K D++
Sbjct: 129 RNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWSPPEVLMYSKFSSKSDIW 185
Query: 489 GFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIM 548
FG+++ E+ S K ++ + G
Sbjct: 186 AFGVLMWEIYSLGKMP--------YERFTNSETAEHIAQGLRLYR---------PHLASE 228
Query: 549 QFLRVACSCVVSRPKDRPSMYQVYESLK 576
+ + SC + +RP+ + ++
Sbjct: 229 KVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-41
Identities = 62/284 (21%), Positives = 111/284 (39%), Gaps = 29/284 (10%)
Query: 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVP 354
S +E + G + + +AIK L +S + F E + +LRH LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 355 LLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH 414
L EE +V ++M G+L L G L + + + G+A++
Sbjct: 77 LYAVV-SEEPIYIVTEYMSKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVE 130
Query: 415 HGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE 474
Y+H+ + + IL+ ++ ++ DFGLARL+ + N+ + G + APE
Sbjct: 131 R---MNYVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPE 184
Query: 475 YSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534
+ ++K DV+ FGI+L EL + + + G + V V G
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVP--------YPGMVNREVLDQVERGYRMPC- 235
Query: 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
+ + C C P++RP+ + L+
Sbjct: 236 --------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 148 bits (374), Expect = 6e-41
Identities = 62/311 (19%), Positives = 116/311 (37%), Gaps = 44/311 (14%)
Query: 287 LADLLAATNSFA---------VENIIISTRTGVSYKAVLPDAS----ALAIKRL--SACK 331
D A FA +E +I + G L +AIK L +
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 332 LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLS 391
+ F SE + +GQ HPN++ L G +++ + M NG+L S L N
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN------D 122
Query: 392 GVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451
G + + G + G+ +L Y+H+ +++ IL++ + +++DFGL+R +
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 452 SRDPNDSSF-VHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGA 509
+ + G + APE + DV+ +GIV+ E++S G++P
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239
Query: 510 EEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMY 569
++ + +++ D ++ C RP
Sbjct: 240 QDVI------------------NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 570 QVYESLKSMAE 580
Q+ +L M
Sbjct: 282 QIVNTLDKMIR 292
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-40
Identities = 56/280 (20%), Positives = 106/280 (37%), Gaps = 33/280 (11%)
Query: 309 GVSYKAVLPDAS----ALAIKRLSACKLSE--KQFRSEMNRLGQLRHPNLVPLLGFCVVE 362
G Y L D A+K L+ QF +E + HPN++ LLG C+
Sbjct: 41 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 100
Query: 363 EER-LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPY 421
E L+V +M +G L + + + G+ ++G+ +
Sbjct: 101 EGSPLVVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGM---KFLASKKF 151
Query: 422 MHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA 481
+H+ +++ ++D+ F ++ DFGLAR + ++ + G ++A E T
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 211
Query: 482 SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGR 541
+ K DV+ FG++L EL++ P N D +L+ R
Sbjct: 212 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 255
Query: 542 GNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581
+ V C + + RPS ++ + ++
Sbjct: 256 -PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 4e-40
Identities = 58/296 (19%), Positives = 117/296 (39%), Gaps = 34/296 (11%)
Query: 289 DLLAATNSFAVENIIISTRT-GVSYKAVLPDAS---ALAIKRL--SACKLSEKQFRSEMN 342
L ++ + +I + G + V +AIK L K ++ E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 343 RLGQLRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRI 402
+ QL +P +V L+G C E +LV + G L+ L G + S +
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR------EEIPVSNVAEL 114
Query: 403 GMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVH 462
S G+ +L ++H+ +++ +L+ + A+I+DFGL++ +G+ D ++
Sbjct: 115 LHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171
Query: 463 GDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVN 522
G + APE + S + DV+ +G+ + E LS + +K V
Sbjct: 172 G-KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP--------YKKMKGPEVM 222
Query: 523 HLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
+ G+ + + E+ + C + + +DRP V + +++
Sbjct: 223 AFIEQGKRMECPPEC------PPELYALMS---DCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 9e-40
Identities = 56/277 (20%), Positives = 104/277 (37%), Gaps = 37/277 (13%)
Query: 309 GVSYKAVLPDASA---LAIKRLSACKLSE---KQFRSEMNRLGQLRHPNLVPLLGFCVVE 362
G K +A+K L + +E N + QL +P +V ++G C
Sbjct: 21 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-A 79
Query: 363 EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYM 422
E +LV + G L L N + + + S G+ +L ++
Sbjct: 80 ESWMLVMEMAELGPLNKYLQQNRH-------VKDKNIIELVHQVSMGMKYLEE---SNFV 129
Query: 423 HQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVAS 482
H+ +++ +L+ A+I+DFGL++ + + + + HG + APE + S
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPVKWYAPECINYYKFS 188
Query: 483 LKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGR 541
K DV+ FG+++ E S GQKP ++G V ++ G
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKP---------YRGMKGSEVTAMLEKGERMGC-------- 231
Query: 542 GNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
+ + C ++RP V L++
Sbjct: 232 -PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-39
Identities = 62/271 (22%), Positives = 108/271 (39%), Gaps = 35/271 (12%)
Query: 309 GVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL-L 367
G + +A+K + + + F +E + + QLRH NLV LLG V E+ L +
Sbjct: 21 GDVMLGDY-RGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78
Query: 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYIS 427
V ++M G+L L G VL L+ + + +L ++H+ ++
Sbjct: 79 VTEYMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLA 130
Query: 428 SNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDV 487
+ +L+ +D A+++DFGL + S + APE S K DV
Sbjct: 131 ARNVLVSEDNVAKVSDFGLTKEASSTQ-------DTGKLPVKWTAPEALREKKFSTKSDV 183
Query: 488 YGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEI 547
+ FGI+L E+ S + + + V V G D D +
Sbjct: 184 WSFGILLWEIYSFGRVP--------YPRIPLKDVVPRVEKGYKMDAPDGC------PPAV 229
Query: 548 MQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
+ ++ +C RPS Q+ E L+ +
Sbjct: 230 YEVMK---NCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-39
Identities = 69/303 (22%), Positives = 120/303 (39%), Gaps = 40/303 (13%)
Query: 295 NSFAVENIIISTRTGVSYKAVLPDAS---ALAIKRLS--ACKLSEKQFRSEMNRLGQL-R 348
N +++I G KA + AIKR+ A K + F E+ L +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 349 HPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGV---------DNTLSGVLDWSTR 399
HPN++ LLG C L ++ P+G L L + V N+ + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 400 LRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSS 459
L +RG + + Q ++H+ +++ IL+ +++ A+I DFGL+R
Sbjct: 130 LHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 460 FVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVD 519
++A E + V + DV+ +G++L E++S + G
Sbjct: 187 R-----LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--------YCGMTCA 233
Query: 520 WVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMA 579
+ + G + DDE+ +R C +P +RPS Q+ SL M
Sbjct: 234 ELYEKLPQGYRLEKPLNC------DDEVYDLMR---QCWREKPYERPSFAQILVSLNRML 284
Query: 580 EKH 582
E+
Sbjct: 285 EER 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-39
Identities = 58/293 (19%), Positives = 109/293 (37%), Gaps = 34/293 (11%)
Query: 295 NSFAVENIIISTRTGVSYKAVLPDAS-----ALAIKRLSACKLS--EKQFRSEMNRLGQL 347
+ + +I + G YK +L +S +AIK L A F E +GQ
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 348 RHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGAS 407
H N++ L G + +++ ++M NG L L G + + G
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK------DGEFSVLQLVGMLRGI- 119
Query: 408 RGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGE 467
A + + Y+H+ +++ IL++ + +++DFGL+R++ DP + G
Sbjct: 120 --AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED-DPEATYTTSGGKIP 176
Query: 468 FGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527
+ APE S + DV+ FGIV+ E+++ + + NH V+
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY------------WELSNHEVM- 223
Query: 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
++ D ++ C RP + L +
Sbjct: 224 ----KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-38
Identities = 53/307 (17%), Positives = 110/307 (35%), Gaps = 43/307 (14%)
Query: 293 ATNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSE--KQFRSEMNRLGQLRH 349
+ F + + + GV +K P +A K + Q E+ L +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 350 PNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRG 409
P +V G + E + +HM G+L +L G + ++ + +G
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKG 116
Query: 410 LAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFG 469
L +L MH+ + + IL++ + ++ DFG++ + S + +G
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDSMANSFVGTRS 168
Query: 470 YVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEE-------GFKGNLVDWVN 522
Y++PE S++ D++ G+ L+E+ G+ P+ A+E +G+ +
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228
Query: 523 HLVIAGRSRDVVDKSLYGRGNDDEIM------------------QFLRVACSCVVSRPKD 564
GR E++ +F C++ P +
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288
Query: 565 RPSMYQV 571
R + Q+
Sbjct: 289 RADLKQL 295
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 4e-38
Identities = 59/273 (21%), Positives = 107/273 (39%), Gaps = 33/273 (12%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSE---KQFRSEMNRLGQLRHPNLVPLLGFCVVEEE 364
G K D L K L ++E + SE+N L +L+HPN+V +
Sbjct: 18 GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 77
Query: 365 RLL--VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLH--HGCQPP 420
L V ++ G L S++ + LD LR+ + L H
Sbjct: 78 TTLYIVMEYCEGGDLASVITKGTKER---QYLDEEFVLRVMTQLTLALKECHRRSDGGHT 134
Query: 421 YMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMV 480
+H+ + + +D + ++ DFGLAR++ D+SF +G Y++PE + M
Sbjct: 135 VLHRDLKPANVFLDGKQNVKLGDFGLARILNH----DTSFAKAFVGTPYYMSPEQMNRMS 190
Query: 481 ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYG 540
+ K D++ G +L EL + P F + + G+ R + +
Sbjct: 191 YNEKSDIWSLGCLLYELCALMPP---------FTAFSQKELAGKIREGKFRRIPYRY--- 238
Query: 541 RGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573
DE+ + + + + RPS+ ++ E
Sbjct: 239 ---SDELNEIIT---RMLNLKDYHRPSVEEILE 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 60/295 (20%), Positives = 106/295 (35%), Gaps = 46/295 (15%)
Query: 309 GVSYKAVLPDAS------ALAIKRLSACKLSE--KQFRSEMNRLGQL-RHPNLVPLLGFC 359
G A S +A+K L S + SE+ + QL H N+V LLG C
Sbjct: 51 GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110
Query: 360 VVEEERLLVYKHMPNGTLYSLLHGNG----------------VDNTLSGVLDWSTRLRIG 403
+ L++++ G L + L + VL + L
Sbjct: 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 170
Query: 404 MGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHG 463
++G+ +L +H+ +++ +L+ +I DFGLAR + S +
Sbjct: 171 YQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS--NYVVRGN 225
Query: 464 DLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNH 523
++APE + ++K DV+ +GI+L E+ S + G VD +
Sbjct: 226 ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--------YPGIPVDANFY 277
Query: 524 LVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
+I + +EI ++ SC + RPS + L
Sbjct: 278 KLIQNGFKMDQPFYA-----TEEIYIIMQ---SCWAFDSRKRPSFPNLTSFLGCQ 324
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (337), Expect = 5e-36
Identities = 58/274 (21%), Positives = 102/274 (37%), Gaps = 40/274 (14%)
Query: 309 GVSYKAVLPD-ASALAIKRLSACKLSE---KQFRSEMNRLGQLRHPNLVPLLGFCVVEEE 364
YK + + +A L KL++ ++F+ E L L+HPN+V +
Sbjct: 23 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82
Query: 365 R----LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPP 420
+LV + M +GTL + L V + +GL +LH PP
Sbjct: 83 GKKCIVLVTELMTSGTLKTYLKRFKV-------MKIKVLRSWCRQILKGLQFLHTRT-PP 134
Query: 421 YMHQYI-SSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM 479
+H+ + N+ + +I D GLA L +SF +G ++APE
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLK------RASFAKAVIGTPEFMAPEMYEEK 188
Query: 480 VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLY 539
DVY FG+ +LE+ + + P + N I R V + +
Sbjct: 189 Y-DESVDVYAFGMCMLEMATSEYPYS-------------ECQNAAQIYRRVTSGVKPASF 234
Query: 540 GRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573
+ E+ + + C+ +R S+ +
Sbjct: 235 DKVAIPEVKEIIE---GCIRQNKDERYSIKDLLN 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-35
Identities = 64/296 (21%), Positives = 120/296 (40%), Gaps = 37/296 (12%)
Query: 309 GVSYKAVL------PDASALAIKRL--SACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCV 360
G+ Y+ V + +AIK + +A +F +E + + + ++V LLG
Sbjct: 34 GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93
Query: 361 VEEERLLVYKHMPNGTLYSLLHGNG---VDNTLSGVLDWSTRLRIGMGASRGLAWLHHGC 417
+ L++ + M G L S L +N + S +++ + G+A+L+
Sbjct: 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-- 151
Query: 418 QPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSS 477
++H+ +++ ++ +DF +I DFG+ R + D L +++PE
Sbjct: 152 -NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG--LLPVRWMSPESLK 208
Query: 478 TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKS 537
V + DV+ FG+VL E+ + + ++G + V V+ G D
Sbjct: 209 DGVFTTYSDVWSFGVVLWEIATLAEQP--------YQGLSNEQVLRFVMEGGLLDKP--- 257
Query: 538 LYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEP---YDE 590
D+ + C PK RPS ++ S+K E GF E Y E
Sbjct: 258 ------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP-GFREVSFYYSE 306
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-35
Identities = 57/290 (19%), Positives = 107/290 (36%), Gaps = 41/290 (14%)
Query: 309 GVSYKAVL------PDASALAIKRL--SACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFC 359
G +A A +A+K L SA + SE+ L L H N+V LLG C
Sbjct: 37 GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96
Query: 360 VVEEERLLVYKHMPNGTLYSLLHGNGVDNTLS-----------GVLDWSTRLRIGMGASR 408
+ L++ ++ G L + L S LD L ++
Sbjct: 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156
Query: 409 GLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEF 468
G+A+L +H+ +++ IL+ +I DFGLAR + ++ ++
Sbjct: 157 GMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI--KNDSNYVVKGNARLPV 211
Query: 469 GYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528
++APE V + + DV+ +GI L EL S + +
Sbjct: 212 KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS----------------PYPGMPVDS 255
Query: 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
+ ++ + + + + +C + P RP+ Q+ + ++
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-35
Identities = 59/276 (21%), Positives = 103/276 (37%), Gaps = 35/276 (12%)
Query: 309 GVSYKAVLPDAS----ALAIKRLSACKLSEKQ----FRSEMNRLGQLRHPNLVPLLGFCV 360
GV + S ++A+K L LS+ + F E+N + L H NL+ L G
Sbjct: 22 GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV- 80
Query: 361 VEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPP 420
+ +V + P G+L L + G T R + + G+ +L
Sbjct: 81 LTPPMKMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQVAEGMGYLES---KR 131
Query: 421 YMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMV 480
++H+ +++ +L+ +I DFGL R + D + H F + APE T
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR-KVPFAWCAPESLKTRT 190
Query: 481 ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYG 540
S D + FG+ L E+ + + + G + H + R
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEP--------WIGLNGSQILHKIDKEGERLPRP----- 237
Query: 541 RGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576
+D V C +P+DRP+ + + L
Sbjct: 238 ---EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 3e-34
Identities = 54/272 (19%), Positives = 93/272 (34%), Gaps = 36/272 (13%)
Query: 309 GVSYKAVLPDASAL-AIKRLSACKLSE-KQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366
G YKA + S L A K + E + + E++ L HPN+V LL E
Sbjct: 26 GKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 85
Query: 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYI 426
++ + G + +++ L S + L +LH +H+ +
Sbjct: 86 ILIEFCAGGAVDAVMLELE------RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 136
Query: 427 SSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEY-----SSTMVA 481
+ IL D D ++ DFG++ SF+ G ++APE S
Sbjct: 137 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMCETSKDRPY 192
Query: 482 SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGR 541
K DV+ GI L+E+ + P V + + S +
Sbjct: 193 DYKADVWSLGITLIEMAEIEPP---------HHELNPMRVLLKIAKSEPPTLAQPSRW-- 241
Query: 542 GNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573
FL+ C+ R + Q+ +
Sbjct: 242 --SSNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 129 bits (325), Expect = 5e-34
Identities = 58/273 (21%), Positives = 100/273 (36%), Gaps = 43/273 (15%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSE----KQFRSEMNRLGQLRHPNLVPLLGFCVVEE 363
G Y A + ++ +AIK++S + E+ L +LRHPN + G + E
Sbjct: 29 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88
Query: 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMH 423
LV ++ L L + GA +GLA+LH +H
Sbjct: 89 TAWLVMEYCLGSASDLLEVHK-------KPLQEVEIAAVTHGALQGLAYLH---SHNMIH 138
Query: 424 QYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM---V 480
+ + + IL+ + ++ DFG A ++ +SFV G ++APE M
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAP----ANSFV----GTPYWMAPEVILAMDEGQ 190
Query: 481 ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYG 540
K DV+ GI +EL + P + + S +
Sbjct: 191 YDGKVDVWSLGITCIELAERKPP---------LFNMNAMSALYHIAQNESPALQSGHW-- 239
Query: 541 RGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573
+ F+ SC+ P+DRP+ + +
Sbjct: 240 ---SEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 7e-34
Identities = 54/270 (20%), Positives = 91/270 (33%), Gaps = 40/270 (14%)
Query: 309 GVSYKAVLPDASAL-AIKRLSACKLS----EKQFRSEMNRLGQLRHPNLVPLLGFCVVEE 363
G Y A + + A+K L +L E Q R E+ LRHPN++ L G+
Sbjct: 20 GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 79
Query: 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMH 423
L+ ++ P GT+Y L D + L++ H +H
Sbjct: 80 RVYLILEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCH---SKRVIH 129
Query: 424 QYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASL 483
+ I +L+ + +I DFG + SS G Y+ PE +
Sbjct: 130 RDIKPENLLLGSAGELKIADFGWSVHA------PSSRRTTLCGTLDYLPPEMIEGRMHDE 183
Query: 484 KGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGN 543
K D++ G++ E L G+ P F+ N + +
Sbjct: 184 KVDLWSLGVLCYEFLVGKPP---------FEANTYQETYKRISRVEFT-------FPDFV 227
Query: 544 DDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573
+ + + P RP + +V E
Sbjct: 228 TEGARDLIS---RLLKHNPSQRPMLREVLE 254
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 7e-33
Identities = 49/265 (18%), Positives = 108/265 (40%), Gaps = 33/265 (12%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSEKQ-FRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366
G Y A+ + +AI++++ + +K+ +E+ + + ++PN+V L +V +E
Sbjct: 34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93
Query: 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYI 426
+V +++ G+L ++ + D + + L +LH +H+ I
Sbjct: 94 VVMEYLAGGSLTDVVTETCM--------DEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 427 SSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGD 486
S+ IL+ D ++TDFG + S+ V G ++APE + K D
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVTRKAYGPKVD 198
Query: 487 VYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDE 546
++ GI+ +E++ G+ P + +L+ + ++ +
Sbjct: 199 IWSLGIMAIEMIEGEPP---------YLNENPLRALYLIATNGTPELQNPEKL----SAI 245
Query: 547 IMQFLRVACSCVVSRPKDRPSMYQV 571
FL C+ + R S ++
Sbjct: 246 FRDFLN---RCLDMDVEKRGSAKEL 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 3e-32
Identities = 50/291 (17%), Positives = 107/291 (36%), Gaps = 36/291 (12%)
Query: 297 FAVENIIISTRTGVSYKAVLPD-----ASALAIKRL--SACKLSEKQFRSEMNRLGQLRH 349
F ++ S G YK + +AIK L + + K+ E + + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 350 PNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRG 409
P++ LLG C + L+ + MP G L + + + L + ++G
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNI------GSQYLLNWCVQIAKG 123
Query: 410 LAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFG 469
+ +L +H+ +++ +L+ +ITDFGLA+L+G+ + + G
Sbjct: 124 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIK 178
Query: 470 YVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529
++A E + + + DV+ +G+ + EL++ + G ++ ++ G
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--------YDGIPASEISSILEKGE 230
Query: 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580
+ + C + RP ++ MA
Sbjct: 231 RLPQ---------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 125 bits (314), Expect = 3e-32
Identities = 50/269 (18%), Positives = 94/269 (34%), Gaps = 33/269 (12%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSEKQ-FRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366
GV ++ + A K + S+K+ R E+ + LRHP LV L + E +
Sbjct: 40 GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 99
Query: 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYI 426
++Y+ M G L+ + + + +GL +H Y+H +
Sbjct: 100 MIYEFMSGGELFEKVADEH------NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDL 150
Query: 427 SSNVILIDDDFDARI--TDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLK 484
I+ + DFGL + + + G + APE +
Sbjct: 151 KPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-----GTAEFAAPEVAEGKPVGYY 205
Query: 485 GDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGND 544
D++ G++ LLSG P +E + N D +
Sbjct: 206 TDMWSVGVLSYILLSGLSPFGGENDDETLR-------NVKSCDWNMDDSAFSGI-----S 253
Query: 545 DEIMQFLRVACSCVVSRPKDRPSMYQVYE 573
++ F+R +++ P R +++Q E
Sbjct: 254 EDGKDFIR---KLLLADPNTRMTIHQALE 279
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 3e-32
Identities = 54/279 (19%), Positives = 103/279 (36%), Gaps = 36/279 (12%)
Query: 309 GVSYKAVLPD----ASALAIKRLSACKLSE--KQFRSEMNRLGQLRHPNLVPLLGFCVVE 362
G ++ + A A+AIK C ++F E + Q HP++V L+G E
Sbjct: 21 GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79
Query: 363 EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYM 422
++ + G L S L LD ++ + S LA+L ++
Sbjct: 80 NPVWIIMELCTLGELRSFLQVR------KYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 423 HQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVAS 482
H+ I++ +L+ + ++ DFGL+R + +S ++APE + +
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP---IKWMAPESINFRRFT 187
Query: 483 LKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRG 542
DV+ FG+ + E+L F+G + V + G +
Sbjct: 188 SASDVWMFGVCMWEILMHGVKP--------FQGVKNNDVIGRIENGERLPMPPNC----- 234
Query: 543 NDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581
+ + C P RP ++ L ++ E+
Sbjct: 235 -PPTLYSLMT---KCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 2e-31
Identities = 54/269 (20%), Positives = 95/269 (35%), Gaps = 32/269 (11%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSE--KQFRSEMNRLGQLRHPNLVPLLGFCVVEEER 365
G AV A+A+K + + + + + E+ L H N+V G +
Sbjct: 19 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 78
Query: 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQY 425
L ++ G L+ + + + R G+ +LH H+
Sbjct: 79 YLFLEYCSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRD 128
Query: 426 ISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEY-SSTMVASLK 484
I +L+D+ + +I+DFGLA + R N ++ G YVAPE +
Sbjct: 129 IKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 485 GDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGND 544
DV+ GIVL +L+G+ P D DW + + D
Sbjct: 187 VDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEKKTYLNPWKKI----------D 233
Query: 545 DEIMQFLRVACSCVVSRPKDRPSMYQVYE 573
+ L +V P R ++ + +
Sbjct: 234 SAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-31
Identities = 52/290 (17%), Positives = 104/290 (35%), Gaps = 42/290 (14%)
Query: 309 GVSYKAVLP--------DASALAIKRLSACKLSE--KQFRSEMNRLGQL-RHPNLVPLLG 357
G A + +A+K L + + SEM + + +H N++ LLG
Sbjct: 27 GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 86
Query: 358 FCVVEEERLLVYKHMPNGTLYSLLHGNG---------VDNTLSGVLDWSTRLRIGMGASR 408
C + ++ ++ G L L + L + +R
Sbjct: 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVAR 146
Query: 409 GLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEF 468
G + + +H+ +++ +L+ +D +I DFGLAR + D +
Sbjct: 147 G---MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR--LPV 201
Query: 469 GYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528
++APE + + + DV+ FG++L E+ + + G V+ + L+ G
Sbjct: 202 KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPGVPVEELFKLLKEG 253
Query: 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578
D + + + C + P RP+ Q+ E L +
Sbjct: 254 HRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 1e-29
Identities = 46/281 (16%), Positives = 94/281 (33%), Gaps = 38/281 (13%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSEKQ----FRSEMNRLGQLRHPNLVPLLGFCVVEE 363
A L + AIK L + ++ E + + +L HP V L +E
Sbjct: 22 STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 81
Query: 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMH 423
+ + NG L + G D + + ++ L + +H
Sbjct: 82 KLYFGLSYAKNGELLKYIRKI-------GSFDETCTRFY---TAEIVSALEYLHGKGIIH 131
Query: 424 QYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASL 483
+ + IL+++D +ITDFG A+++ + + + +G YV+PE + A
Sbjct: 132 RDLKPENILLNEDMHIQITDFGTAKVLS--PESKQARANSFVGTAQYVSPELLTEKSACK 189
Query: 484 KGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGN 543
D++ G ++ +L++G P F+ + +I +
Sbjct: 190 SSDLWALGCIIYQLVAGLPP---------FRAGNEYLIFQKIIKLEYD-------FPEKF 233
Query: 544 DDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGF 584
+ + +V R ++ H F
Sbjct: 234 FPKARDLVE---KLLVLDATKRLGCEEMEGYGPLK--AHPF 269
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 117 bits (295), Expect = 1e-29
Identities = 48/269 (17%), Positives = 93/269 (34%), Gaps = 33/269 (12%)
Query: 309 GVSYKAV-LPDASALAIKRLS-ACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366
GV ++ V K ++ L + ++E++ + QL HP L+ L + E +
Sbjct: 43 GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102
Query: 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYI 426
L+ + + G L+ + + + + A GL +H + +H I
Sbjct: 103 LILEFLSGGELFDRIAAED------YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDI 153
Query: 427 SSNVILIDDDFDARI--TDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLK 484
I+ + + + DFGLA + N V + APE
Sbjct: 154 KPENIMCETKKASSVKIIDFGLATKL-----NPDEIVKVTTATAEFAAPEIVDREPVGFY 208
Query: 485 GDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGND 544
D++ G++ LLSG P E + N + S+
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFAGEDDLETLQ-------NVKRCDWEFDEDAFSSV-----S 256
Query: 545 DEIMQFLRVACSCVVSRPKDRPSMYQVYE 573
E F++ + + P+ R +++ E
Sbjct: 257 PEAKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 1e-29
Identities = 45/268 (16%), Positives = 88/268 (32%), Gaps = 32/268 (11%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367
G+ ++ V K + + + E++ L RH N++ L EE ++
Sbjct: 19 GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78
Query: 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYIS 427
+++ + ++ ++ + + L+ + L +LH H I
Sbjct: 79 IFEFISGLDIFERINTSAFE------LNEREIVSYVHQVCEALQFLH---SHNIGHFDIR 129
Query: 428 SNVILIDDDFDAR--ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKG 485
I+ + I +FG AR + D F Y APE V S
Sbjct: 130 PENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-----TAPEYYAPEVHQHDVVSTAT 184
Query: 486 DVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDD 545
D++ G ++ LLSG P F + ++ + +
Sbjct: 185 DMWSLGTLVYVLLSGINP---------FLAETNQQIIENIMNA---EYTFDEEAFKEISI 232
Query: 546 EIMQFLRVACSCVVSRPKDRPSMYQVYE 573
E M F+ +V K R + + +
Sbjct: 233 EAMDFVD---RLLVKERKSRMTASEALQ 257
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 116 bits (292), Expect = 2e-29
Identities = 51/266 (19%), Positives = 90/266 (33%), Gaps = 30/266 (11%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLS--EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER 365
A +AIK ++ L E +E+ L +++HPN+V L
Sbjct: 23 SEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL 82
Query: 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQY 425
L+ + + G L+ + G R+ + +LH +
Sbjct: 83 YLIMQLVSGGELFDRIVEK-------GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKP 135
Query: 426 ISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKG 485
+ +D+D I+DFGL+++ + S + G GYVAPE + S
Sbjct: 136 ENLLYYSLDEDSKIMISDFGLSKME-----DPGSVLSTACGTPGYVAPEVLAQKPYSKAV 190
Query: 486 DVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDD 545
D + G++ LL G P F + ++ + S Y D
Sbjct: 191 DCWSIGVIAYILLCGYPP---------FYDENDAKLFEQILKA---EYEFDSPYWDDISD 238
Query: 546 EIMQFLRVACSCVVSRPKDRPSMYQV 571
F+R + P+ R + Q
Sbjct: 239 SAKDFIR---HLMEKDPEKRFTCEQA 261
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 4e-29
Identities = 49/293 (16%), Positives = 99/293 (33%), Gaps = 40/293 (13%)
Query: 309 GVSYKAV------LPDASALAIKRLSACKLSE--KQFRSEMNRLGQLRHPNLVPLLGFCV 360
G +A +A+K L + SE+ L + H V L
Sbjct: 27 GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86
Query: 361 VEEER--LLVYKHMPNGTLYSLLHGNG---------VDNTLSGVLDWSTRLRIGMGASRG 409
+ +++ + G L + L ++ L + ++G
Sbjct: 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 146
Query: 410 LAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFG 469
+ +L +H+ +++ IL+ + +I DFGLAR + D
Sbjct: 147 MEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP--DYVRKGDARLPLK 201
Query: 470 YVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529
++APE V +++ DV+ FG++L E+ S + + + G
Sbjct: 202 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-------PGVKIDEEFCRRLKEGT 254
Query: 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582
D + E+ Q + C P RP+ ++ E L ++ + +
Sbjct: 255 RMRAPDYT------TPEMYQTML---DCWHGEPSQRPTFSELVEHLGNLLQAN 298
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (277), Expect = 1e-27
Identities = 45/290 (15%), Positives = 88/290 (30%), Gaps = 30/290 (10%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367
G Y + +AIK K Q E ++ +P + +C E + +
Sbjct: 21 GDIYLGTDIAAGEEVAIKLECV-KTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79
Query: 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYIS 427
+ + +L L + T L + + ++H ++H+ +
Sbjct: 80 MVMELLGPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVK 130
Query: 428 SNVILI---DDDFDARITDFGLARLVGSRDPNDSSFVHGD---LGEFGYVAPEYSSTMVA 481
+ L+ I DFGLA+ + + G Y + +
Sbjct: 131 PDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ 190
Query: 482 SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGR 541
S + D+ G VL+ G P A + + +
Sbjct: 191 SRRDDLESLGYVLMYFNLGSLPWQGLKAA--------TKRQKYERISEKKMSTPIEVLCK 242
Query: 542 GNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSE--PYD 589
G E +L C R D+P + + +++ + GFS +D
Sbjct: 243 GYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 289
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 108 bits (269), Expect = 1e-26
Identities = 53/280 (18%), Positives = 99/280 (35%), Gaps = 34/280 (12%)
Query: 309 GVSYKAVLPDASALAIKRLSACKLSE---KQFRSEMNRLGQLRHPNLVPLLGFCVVEEER 365
GV YKA A+K++ K E E++ L +L+H N+V L ++
Sbjct: 16 GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL 75
Query: 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQY 425
+LV++H+ L G L+ T + G+A+ H +H+
Sbjct: 76 VLVFEHLDQDLKKLLDVCE-------GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 426 ISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE-YSSTMVASLK 484
+ +LI+ + + +I DFGLAR G + + Y AP+ + S
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDVLMGSKKYSTT 181
Query: 485 GDVYGFGIVLLELLSGQKP-------------LDVAGAEEGFKGNLVDWVNHLVIAGRSR 531
D++ G + E+++G + G V +
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQV 571
+ + + +G D+ + L + P R + Q
Sbjct: 242 EPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQA 278
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 107 bits (268), Expect = 1e-26
Identities = 53/283 (18%), Positives = 103/283 (36%), Gaps = 35/283 (12%)
Query: 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSE----KQFRSEMNRLGQLR 348
++ + + I+ + A L +A+K L A + +FR E L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 349 HPNLVPLLGFCVVEEERL----LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGM 404
HP +V + E +V +++ TL ++H G + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-------MTPKRAIEV-- 116
Query: 405 GASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGD 464
+ L+ Q +H+ + I+I ++ DFG+AR + N +
Sbjct: 117 -IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD-SGNSVTQTAAV 174
Query: 465 LGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524
+G Y++PE + + DVY G VL E+L+G+ P F G+ V +
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP---------FTGDSPVSVAYQ 225
Query: 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS 567
+ D + S G ++ + + P++R
Sbjct: 226 HVRE---DPIPPSARHEGLSADLDAVVL---KALAKNPENRYQ 262
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 105 bits (262), Expect = 9e-26
Identities = 41/292 (14%), Positives = 83/292 (28%), Gaps = 32/292 (10%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367
GV ++ L + +AIK + Q R E L +P + + E +
Sbjct: 19 GVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77
Query: 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYIS 427
+ + +L LL G T + +H + +++ I
Sbjct: 78 LVIDLLGPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIK 128
Query: 428 SNVILIDDDFD-----ARITDFGLARLVGSRDPNDSSFVHGD---LGEFGYVAPEYSSTM 479
+ LI + DFG+ + G Y++
Sbjct: 129 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR 188
Query: 480 VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLY 539
S + D+ G V + L G P G + + + + R++
Sbjct: 189 EQSRRDDLEALGHVFMYFLRGSLPWQ--GLKAATNKQKYERIGEKKQSTPLRELCA---- 242
Query: 540 GRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSE--PYD 589
G +E +++ P + + E+ +E +D
Sbjct: 243 --GFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD 289
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 1e-25
Identities = 50/286 (17%), Positives = 108/286 (37%), Gaps = 38/286 (13%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSE--KQFRSEMNRLGQLRHPNLVPLLGFC----VV 361
G+ A + +AIK++S + ++ E+ L + RH N++ + +
Sbjct: 22 GMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81
Query: 362 EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPY 421
+ + + + H+ LY LL L RGL ++H
Sbjct: 82 QMKDVYLVTHLMGADLYKLLKTQH--------LSNDHICYFLYQILRGLKYIH---SANV 130
Query: 422 MHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEY-SSTMV 480
+H+ + + +L++ D +I DFGLAR+ D + + F+ + Y APE ++
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADP-DHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 481 ASLKGDVYGFGIVLLELLSGQKP---------------LDVAGAEEGFKGNLVDWVNHLV 525
+ D++ G +L E+LS + + + ++E + + +
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQV 571
++ ++ V + D + + L + P R + Q
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQA 292
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 2e-25
Identities = 52/268 (19%), Positives = 85/268 (31%), Gaps = 39/268 (14%)
Query: 309 GVSYKAVLPDASAL-AIKRLSACKLSEKQFRSEMNR-----LGQLRHPNLVPLLGFCVVE 362
G + A + AIK L + HP L + +
Sbjct: 16 GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 75
Query: 363 EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYM 422
E V +++ G L + D S GL +L +
Sbjct: 76 ENLFFVMEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIILGLQFL---HSKGIV 125
Query: 423 HQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVAS 482
++ + + IL+D D +I DFG+ + D ++F G Y+APE +
Sbjct: 126 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC----GTPDYIAPEILLGQKYN 181
Query: 483 LKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRG 542
D + FG++L E+L GQ P F G + + H + Y R
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSP---------FHGQDEEELFHSIRMDNPF-------YPRW 225
Query: 543 NDDEIMQFLRVACSCVVSRPKDRPSMYQ 570
+ E L V P+ R +
Sbjct: 226 LEKEAKDLLV---KLFVREPEKRLGVRG 250
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 104 bits (260), Expect = 5e-25
Identities = 56/285 (19%), Positives = 92/285 (32%), Gaps = 41/285 (14%)
Query: 295 NSFAVENIIISTRTGVSYKAVLPDASAL-AIKRLSACKLSEKQ-------FRSEMNRLGQ 346
N F+V II G Y D + A+K L ++ KQ R ++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 347 LRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGA 406
P +V + ++ + M G L+ L +GV + +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-------EADMRFYAAEI 116
Query: 407 SRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLG 466
GL +H +++ + IL+D+ RI+D GLA + P+ S G
Sbjct: 117 ILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV------G 167
Query: 467 EFGYVAPEYSSTMVA-SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV 525
GY+APE VA D + G +L +LL G P + D
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR--------QHKTKDKHEIDR 219
Query: 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQ 570
+ + S E+ L + R
Sbjct: 220 MTLTMAVELPDSF-----SPELRSLLE---GLLQRDVNRRLGCLG 256
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 2e-24
Identities = 59/298 (19%), Positives = 100/298 (33%), Gaps = 40/298 (13%)
Query: 296 SFAVENIIISTRTGVSYKAVLPDASAL-AIKRLSACKLSEKQFRSEMNRLGQLRHPNLVP 354
S+ +I + GV Y+A L D+ L AIK++ ++ E+ + +L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNRELQIMRKLDHCNIVR 77
Query: 355 LLGFCVVEEER------LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASR 408
L F E+ LV ++P H + L R
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY----SRAKQTLPVIYVKLYMYQLFR 133
Query: 409 GLAWLHHGCQPPYMHQYI-SSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGE 467
LA++H H+ I N++L D ++ DFG A+ + +PN S
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS----- 185
Query: 468 FGYVAP-EYSSTMVASLKGDVYGFGIVLLELLSGQKP-------------LDVAGAEEGF 513
Y AP + DV+ G VL ELL GQ + V G
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 514 KGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQV 571
+ ++ + + ++ E + + P R + +
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEA 300
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 2e-24
Identities = 55/283 (19%), Positives = 101/283 (35%), Gaps = 37/283 (13%)
Query: 309 GVSYKAVLPDASAL-AIKRLSACKLSE------KQFRSEMNRLGQLRHPNLVPLLGFCVV 361
YKA + + + AIK++ SE + E+ L +L HPN++ LL
Sbjct: 12 ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 71
Query: 362 EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPY 421
+ LV+ M + + VL S + +GL +LH
Sbjct: 72 KSNISLVFDFMETDLEVIIKDNS-------LVLTPSHIKAYMLMTLQGLEYLHQHW---I 121
Query: 422 MHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE-YSSTMV 480
+H+ + N +L+D++ ++ DFGLA+ GS + + V Y APE +
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV----VTRWYRAPELLFGARM 177
Query: 481 ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFK--------GNLVDWVNHLVIAG---- 528
+ D++ G +L ELL L + W + +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQV 571
+S + D+++ ++ + P R + Q
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQA 277
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 4e-24
Identities = 51/277 (18%), Positives = 91/277 (32%), Gaps = 42/277 (15%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSE-------KQFRSEMNRLGQLRHPNLVPLLGFCV 360
V K A K + + + E++ L +++HPN++ L
Sbjct: 24 AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 83
Query: 361 VEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPP 420
+ + +L+ + + G L+ L L G+ +LH
Sbjct: 84 NKTDVILILELVAGGELFDFLAEK-------ESLTEEEATEFLKQILNGVYYLH---SLQ 133
Query: 421 YMHQYISSNVILIDDDFDAR----ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYS 476
H + I++ D + I DFGLA + + + G +VAPE
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-----DFGNEFKNIFGTPEFVAPEIV 188
Query: 477 STMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK 536
+ L+ D++ G++ LLSG P F G+ V A +
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASP---------FLGDTKQETLANVSAVNYE---FE 236
Query: 537 SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573
Y F+R +V PK R ++ +
Sbjct: 237 DEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 100 bits (249), Expect = 4e-24
Identities = 48/283 (16%), Positives = 97/283 (34%), Gaps = 48/283 (16%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSE----------KQFRSEMNRLGQLR-HPNLVPLL 356
V + + P A+K + + E++ L ++ HPN++ L
Sbjct: 17 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 76
Query: 357 GFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHG 416
LV+ M G L+ L L +I + LH
Sbjct: 77 DTYETNTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKIMRALLEVICALH-- 127
Query: 417 CQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYS 476
+ +H+ + IL+DDD + ++TDFG + + + + G Y+APE
Sbjct: 128 -KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-----DPGEKLREVCGTPSYLAPEII 181
Query: 477 STMVA------SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530
+ + D++ G+++ LL+G P F + ++++G
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP---------FWHRKQMLMLRMIMSG-- 230
Query: 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573
+ S D + + +V +P+ R + +
Sbjct: 231 -NYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEALA 269
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 6e-23
Identities = 51/281 (18%), Positives = 90/281 (32%), Gaps = 34/281 (12%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSE---KQFRSEMNRLGQLRHPNLVPLLGFCVVEEE 364
GV YKA +A+K++ +E E++ L +L HPN+V LL E +
Sbjct: 16 GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75
Query: 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQ 424
LV++ + + + +GLA+ +H+
Sbjct: 76 LYLVFEFLHQDLKKFMDASA------LTGIPLPLIKSYLFQLLQGLAFC---HSHRVLHR 126
Query: 425 YISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE-YSSTMVASL 483
+ +LI+ + ++ DFGLAR G + V Y APE S
Sbjct: 127 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV----VTLWYRAPEILLGCKYYST 182
Query: 484 KGDVYGFGIVLLELLSGQKP-------------LDVAGAEEGFKGNLVDWVNHLVIAGRS 530
D++ G + E+++ + G + V + +
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQV 571
D S D++ L + P R S
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAA 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 96.7 bits (240), Expect = 1e-22
Identities = 40/200 (20%), Positives = 74/200 (37%), Gaps = 22/200 (11%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSE----KQFRSEMNRLGQLRHPNLVPLLGFCVVEE 363
G + + A+K L + + E L + HP ++ + G +
Sbjct: 18 GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 77
Query: 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMH 423
+ ++ ++ G L+SLL + L + ++
Sbjct: 78 QIFMIMDYIEGGELFSLLRKSQRF-------PNPVAKFYAAEV---CLALEYLHSKDIIY 127
Query: 424 QYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASL 483
+ + IL+D + +ITDFG A+ V + G Y+APE ST +
Sbjct: 128 RDLKPENILLDKNGHIKITDFGFAKYVPDVT-------YTLCGTPDYIAPEVVSTKPYNK 180
Query: 484 KGDVYGFGIVLLELLSGQKP 503
D + FGI++ E+L+G P
Sbjct: 181 SIDWWSFGILIYEMLAGYTP 200
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.7 bits (237), Expect = 3e-22
Identities = 45/285 (15%), Positives = 87/285 (30%), Gaps = 28/285 (9%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSE---KQFRSEMNRLGQLRHPNLVPLLGFCVVEEE 364
G +KA +A+K++ E E+ L L+H N+V L+ C +
Sbjct: 24 GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 83
Query: 365 RLLVYKHMPNGTLYSLLHGN-GVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMH 423
K H G+ + + S R+ L L++ + +H
Sbjct: 84 PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML---LNGLYYIHRNKILH 140
Query: 424 QYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE-YSSTMVAS 482
+ + + +LI D ++ DFGLAR + + + Y PE
Sbjct: 141 RDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYG 200
Query: 483 LKGDVYGFGIVLLELLSGQKPLDVAGAEEGFK----------------GNLVDWVNHLVI 526
D++G G ++ E+ + + + + + L +
Sbjct: 201 PPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLEL 260
Query: 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQV 571
+ V L D + + +V P R
Sbjct: 261 VKGQKRKVKDRLKAYVRDPYALDLID---KLLVLDPAQRIDSDDA 302
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.2 bits (233), Expect = 7e-22
Identities = 51/284 (17%), Positives = 87/284 (30%), Gaps = 35/284 (12%)
Query: 309 GVSYKA--VLPDASALAIKRLSACKLSEKQFRS------EMNRLGQLRHPNLVPLLGFCV 360
G +KA + +A+KR+ E S + L HPN+V L C
Sbjct: 21 GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 80
Query: 361 VEEER-----LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHH 415
V LV++H+ L + T + RGL +LH
Sbjct: 81 VSRTDRETKLTLVFEHVDQDLTTYLDKVPE------PGVPTETIKDMMFQLLRGLDFLHS 134
Query: 416 GCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEY 475
+H+ + IL+ ++ DFGLAR+ + S Y APE
Sbjct: 135 HR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV-----VTLWYRAPEV 186
Query: 476 SSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFK--------GNLVDWVNHLVIA 527
+ D++ G + E+ + + + DW + +
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQV 571
++ + D + C+ P R S Y
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.9 bits (225), Expect = 5e-21
Identities = 48/277 (17%), Positives = 92/277 (33%), Gaps = 52/277 (18%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSE-------KQFRSEMNRLGQLR--HPNLVPLLGF 358
G Y + + D +AIK + ++S+ + E+ L ++ ++ LL +
Sbjct: 18 GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 77
Query: 359 CVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQ 418
+ +L+ + G L + H
Sbjct: 78 FERPDSFVLILERPEPVQDLFDFITER------GALQEELARSFFWQVLEA---VRHCHN 128
Query: 419 PPYMHQYISSNVILID-DDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEY-S 476
+H+ I ILID + + ++ DFG L+ +D + F G Y PE+
Sbjct: 129 CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFD----GTRVYSPPEWIR 182
Query: 477 STMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDK 536
V+ GI+L +++ G P + EE +G +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFE--HDEEIIRGQV------------------- 221
Query: 537 SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573
+ + E +R C+ RP DRP+ ++
Sbjct: 222 -FFRQRVSSECQHLIR---WCLALRPSDRPTFEEIQN 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.8 bits (224), Expect = 8e-21
Identities = 43/281 (15%), Positives = 86/281 (30%), Gaps = 34/281 (12%)
Query: 309 GVSYKAVLPDASAL-AIKRLSACKLSE---KQFRSEMNRLGQLRHPNLVPLLGFCVVEEE 364
G +KA + + A+KR+ E E+ L +L+H N+V L +++
Sbjct: 16 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75
Query: 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQ 424
LV++ NG + + L L +H+
Sbjct: 76 LTLVFEFCDQDLKKYFDSCNGDLD-------PEIVKSF---LFQLLKGLGFCHSRNVLHR 125
Query: 425 YISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLK 484
+ +LI+ + + ++ +FGLAR G S+ V + + S
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV---TLWYRPPDVLFGAKLYSTS 182
Query: 485 GDVYGFGIVLLELLSGQKPL--------------DVAGAEEGFKGNLVDWVNHLVIAGRS 530
D++ G + EL + +PL + G + + +
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQV 571
+ L+ + + P R S +
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQ---NLLKCNPVQRISAEEA 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.3 bits (226), Expect = 1e-20
Identities = 40/271 (14%), Positives = 85/271 (31%), Gaps = 35/271 (12%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFC----VVEE 363
G + A+K L C + ++ + P++V ++ +
Sbjct: 26 GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR---ASQCPHIVRIVDVYENLYAGRK 82
Query: 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMH 423
L+V + + G L+S + G I + +LH H
Sbjct: 83 CLLIVMECLDGGELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYLH---SINIAH 134
Query: 424 QYISSNVILIDDDFD---ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMV 480
+ + +L ++TDFG A+ S + + YVAPE
Sbjct: 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT-----PYYVAPEVLGPEK 189
Query: 481 ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYG 540
D++ G+++ LL G P + + + + R +
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYPPF--------YSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 541 RGNDDEIMQFLRVACSCVVSRPKDRPSMYQV 571
+E+ +R + + + P R ++ +
Sbjct: 242 SEVSEEVKMLIR---NLLKTEPTQRMTITEF 269
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.0 bits (225), Expect = 1e-20
Identities = 50/265 (18%), Positives = 85/265 (32%), Gaps = 38/265 (14%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSEK----QFRSEMNRLGQLRHPNLVPLLGFCVVEE 363
G A+K L + K +E L RHP L L +
Sbjct: 19 GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78
Query: 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMH 423
V ++ G L+ L T R + ++ L + ++
Sbjct: 79 RLCFVMEYANGGELFFHLSRE----------RVFTEERARFYGAEIVSALEYLHSRDVVY 128
Query: 424 QYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASL 483
+ I +++D D +ITDFGL + +D + + G Y+APE
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEG----ISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 484 KGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGN 543
D +G G+V+ E++ G+ P F + + L++ R + R
Sbjct: 185 AVDWWGLGVVMYEMMCGRLP---------FYNQDHERLFELILMEEIR-------FPRTL 228
Query: 544 DDEIMQFLRVACSCVVSRPKDRPSM 568
E L + PK R
Sbjct: 229 SPEAKSLLA---GLLKKDPKQRLGG 250
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (215), Expect = 3e-19
Identities = 48/283 (16%), Positives = 96/283 (33%), Gaps = 36/283 (12%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSE---KQFRSEMNRLGQLRHPNLVPLLGFCVVEEE 364
G AV + +AIK+L SE K+ E+ L +RH N++ LL +E
Sbjct: 32 GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91
Query: 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQ 424
+ + + L + +GL ++H +H+
Sbjct: 92 LDDFTDFY---LVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHR 145
Query: 425 YISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPE-YSSTMVASL 483
+ + +++D + +I DFGLAR S + G + Y APE + M +
Sbjct: 146 DLKPGNLAVNEDCELKILDFGLARQADSE-------MTGYVVTRWYRAPEVILNWMRYTQ 198
Query: 484 KGDVYGFGIVLLELLSGQKP---------------LDVAGAEEGFKGNLVDWVNHLVIAG 528
D++ G ++ E+++G+ + E + D + +
Sbjct: 199 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 258
Query: 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQV 571
+ D + + L +V + R + +
Sbjct: 259 PELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTAGEA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.7 bits (198), Expect = 4e-17
Identities = 43/254 (16%), Positives = 86/254 (33%), Gaps = 32/254 (12%)
Query: 323 AIKRLSACKLSEK-----QFRSEMNRLGQLRH-PNLVPLLGFCVVEEERLLVYKHMPNGT 376
A+K L + +K R+E L +R P LV L E + L+ ++ G
Sbjct: 56 AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGE 115
Query: 377 LYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD 436
L++ L + T + + + L H + +++ I IL+D +
Sbjct: 116 LFTHLSQR----------ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN 165
Query: 437 FDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLE 496
+TDFGL++ + + + G + E+ D + G+++ E
Sbjct: 166 GHVVLTDFGLSKEFVADETERAYDFCGTI-EYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 224
Query: 497 LLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACS 556
LL+G P F + + + + Y + ++
Sbjct: 225 LLTGASP---------FTVDGEKNSQAEISRRILK---SEPPYPQEMSALAKDLIQ---R 269
Query: 557 CVVSRPKDRPSMYQ 570
++ PK R
Sbjct: 270 LLMKDPKKRLGCGP 283
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 80.3 bits (197), Expect = 5e-17
Identities = 44/287 (15%), Positives = 89/287 (31%), Gaps = 43/287 (14%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEERL 366
++A+ + + + +K L + +K+ + E+ L LR PN++ L R
Sbjct: 49 SEVFEAINITNNEKVVVKILK--PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106
Query: 367 --LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQ 424
LV++H+ N L L + L + H
Sbjct: 107 PALVFEHVNNTDFKQLYQT----------LTDYDIRFYMYEILKALDYCHS--MGIMHRD 154
Query: 425 YISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA-SL 483
NV++ + R+ D+GLA + + + + PE
Sbjct: 155 VKPHNVMIDHEHRKLRLIDWGLAEFY-----HPGQEYNVRVASRYFKGPELLVDYQMYDY 209
Query: 484 KGDVYGFGIVLLELLSGQKPL--------------DVAGAEEGF----KGNLVDWVNHLV 525
D++ G +L ++ ++P V G E+ + K N+
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 269
Query: 526 IAGRSRDVVDKSLYGRGNDDEIM-QFLRVACSCVVSRPKDRPSMYQV 571
I GR + N + + L + + R + +
Sbjct: 270 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 79.8 bits (196), Expect = 8e-17
Identities = 37/200 (18%), Positives = 68/200 (34%), Gaps = 22/200 (11%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSE----KQFRSEMNRLGQLRHPNLVPLLGFCVVEE 363
G + A+K L K+ + + +E L + P LV L
Sbjct: 55 GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMH 423
+V +++ G ++S L G +LH ++
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLTFEYLH---SLDLIY 164
Query: 424 QYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASL 483
+ + +LID ++TDFG A+ V R G +APE + +
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WTLCGTPEALAPEIILSKGYNK 217
Query: 484 KGDVYGFGIVLLELLSGQKP 503
D + G+++ E+ +G P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.5 bits (187), Expect = 1e-15
Identities = 47/287 (16%), Positives = 95/287 (33%), Gaps = 44/287 (15%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSE---KQFRSEMNRLGQLRHPNLVPLLGFCV---- 360
G A +A+K+LS S K+ E+ L ++H N++ LL
Sbjct: 32 GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91
Query: 361 -VEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQP 419
E + + H+ L +++ L + RGL ++H
Sbjct: 92 LEEFNDVYLVTHLMGADLNNIVKCQK--------LTDDHVQFLIYQILRGLKYIH---SA 140
Query: 420 PYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM 479
+H+ + + + +++D + +I DFGLAR D + + M
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMTGYVATRWYRAPEIMLNWM 194
Query: 480 VASLKGDVYGFGIVLLELLSGQKP---------------LDVAGAEEGFKGNLVDWVNHL 524
+ D++ G ++ ELL+G+ L E K + +
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQV 571
+ + ++ + G + + L +V R + Q
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAVDLLE---KMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.2 bits (181), Expect = 6e-15
Identities = 39/199 (19%), Positives = 74/199 (37%), Gaps = 16/199 (8%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSE---KQFRSEMNRLGQLRHPNLVPLLGFCVVEEE 364
G+ A +AIK+LS ++ K+ E+ + + H N++ LL ++
Sbjct: 31 GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK- 89
Query: 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQ 424
+ + L L + + LD + G+ LH +H+
Sbjct: 90 ---TLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHR 143
Query: 425 YISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLK 484
+ + I++ D +I DFGLAR S + + Y APE M
Sbjct: 144 DLKPSNIVVKSDCTLKILDFGLART-----AGTSFMMTPYVVTRYYRAPEVILGMGYKEN 198
Query: 485 GDVYGFGIVLLELLSGQKP 503
D++ G ++ E++ +
Sbjct: 199 VDIWSVGCIMGEMVRHKIL 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 73.1 bits (178), Expect = 2e-14
Identities = 30/207 (14%), Positives = 69/207 (33%), Gaps = 13/207 (6%)
Query: 309 GVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367
+ A + + + +A+K + K+ + E+ L ++ + +LL
Sbjct: 27 STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86
Query: 368 VY--KHMPNGTLYSLLHGNGVDNTLSGVL-------DWSTRLRIGMGASRGLAWLHHGCQ 418
+ PNG ++ +N L+ + +I GL ++H C
Sbjct: 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG 146
Query: 419 PPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST 478
+ NV++ D + +A L + ++ Y +PE
Sbjct: 147 IIHTDIK-PENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI--QTREYRSPEVLLG 203
Query: 479 MVASLKGDVYGFGIVLLELLSGQKPLD 505
D++ ++ EL++G +
Sbjct: 204 APWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 70.6 bits (171), Expect = 6e-14
Identities = 28/97 (28%), Positives = 44/97 (45%), Gaps = 2/97 (2%)
Query: 114 CKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSV 173
Q + ++ K LN L L NN++ G++P +++L L +V
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275
Query: 174 AGNDLSGTIPP--DLARFPEESFDGNSGLCGKPLGKC 208
+ N+L G IP +L RF ++ N LCG PL C
Sbjct: 276 SFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.1 bits (131), Expect = 7e-09
Identities = 20/76 (26%), Positives = 30/76 (39%), Gaps = 4/76 (5%)
Query: 63 CWNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQ 122
+ L L + ++ G LP+ L L SL++S N+L G IP L
Sbjct: 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--GGNLQRFDV 295
Query: 123 LDLSNNHL--SGPIPP 136
+NN P+P
Sbjct: 296 SAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 45.5 bits (106), Expect = 9e-06
Identities = 45/172 (26%), Positives = 72/172 (41%), Gaps = 29/172 (16%)
Query: 22 IEDDVKCLEGIQNSIKDPDGRLSWSFTNTTVGAICRLTGVACWNEKENRIISLTLSSMQL 81
D + L I+ + +P SW T GV C + +
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN--RTWLGVLCDTDTQT------------ 49
Query: 82 SGQLPESLHLCHSLQSLDLSDNSLSG--SIPVDLCKWLPYVVQLDLSNNH-LSGPIPPQI 138
+ + +LDLS +L IP L LPY+ L + + L GPIPP I
Sbjct: 50 -----------YRVNNLDLSGLNLPKPYPIPSSLAN-LPYLNFLYIGGINNLVGPIPPAI 97
Query: 139 VECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP 190
+ L+ L +++ +SG+IP +S++ L + N LSGT+PP ++ P
Sbjct: 98 AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLP 149
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 68.5 bits (166), Expect = 6e-13
Identities = 31/170 (18%), Positives = 57/170 (33%), Gaps = 28/170 (16%)
Query: 27 KCLEGIQNSIKDPDGRLSWSFTNTTVGAICRLTGVACWNEKENRIISLTLSSMQLSGQLP 86
L N +KD S + A +++ +A + + L L + Q+S P
Sbjct: 222 DELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLSGLTK-LTELKLGANQISNISP 280
Query: 87 --------------------ESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLS 126
+ +L L L N++S PV L +L +
Sbjct: 281 LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKL---QRLFFA 337
Query: 127 NNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGN 176
NN +S + +N L +N++S P + L R+ + +
Sbjct: 338 NNKVSDV--SSLANLTNINWLSAGHNQISDLTPL--ANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 66.9 bits (162), Expect = 2e-12
Identities = 35/175 (20%), Positives = 56/175 (32%), Gaps = 26/175 (14%)
Query: 28 CLEGIQNSIKDPDGRLSWSFTNTTVGAICRLTGVACWNEKENRIISLTLSSMQLSGQLPE 87
L N I D + + +L + N + L L++ Q+S P
Sbjct: 201 SLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTN-LTDLDLANNQISNLAP- 258
Query: 88 SLHLCHSLQSLDLSDNSLSGSIPVDLCK-------------------WLPYVVQLDLSNN 128
L L L L N +S P+ L + L L N
Sbjct: 259 -LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN 317
Query: 129 HLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183
++S P + L +L +NNK+S ++ L + S N +S P
Sbjct: 318 NISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.6 bits (129), Expect = 2e-08
Identities = 18/91 (19%), Positives = 32/91 (35%), Gaps = 4/91 (4%)
Query: 94 SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG----PIPPQIVECKFLNKLIL 149
+QSLD+ LS + +L L + L + L+ I + L +L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 150 SNNKLSGSIPFEVSRLDRLKEFSVAGNDLSG 180
+N+L V + + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.6 bits (129), Expect = 2e-08
Identities = 22/101 (21%), Positives = 38/101 (37%), Gaps = 14/101 (13%)
Query: 63 CWNEKENRIISLTLSSMQLSGQ----LPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLP 118
+ + + L L+ +S L +L HSL+ LDLS+N L + + L + +
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 422
Query: 119 ----YVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLS 155
+ QL L + + S + L L L
Sbjct: 423 QPGCLLEQLVLYDIYWSEEME------DRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (125), Expect = 5e-08
Identities = 19/88 (21%), Positives = 34/88 (38%), Gaps = 4/88 (4%)
Query: 73 SLTLSSMQLS-GQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWL---PYVVQLDLSNN 128
SL + +LS + E L L Q + L D L+ + D+ L P + +L+L +N
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 129 HLSGPIPPQIVECKFLNKLILSNNKLSG 156
L +++ + L
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 3e-07
Identities = 24/89 (26%), Positives = 37/89 (41%), Gaps = 8/89 (8%)
Query: 89 LHLCHSLQSLDLSDNSLSGSIPVDLCKWL---PYVVQLDLSNNHLSGPIPPQIVE----- 140
L+ L L+D +S S L L + +LDLSNN L Q+VE
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 141 CKFLNKLILSNNKLSGSIPFEVSRLDRLK 169
L +L+L + S + + L++ K
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 2e-04
Identities = 12/65 (18%), Positives = 23/65 (35%), Gaps = 8/65 (12%)
Query: 73 SLTLSSMQLSGQ----LPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPY----VVQLD 124
+ L L+ + +L + +L L+L N L + + L + +L
Sbjct: 31 VVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLS 90
Query: 125 LSNNH 129
L N
Sbjct: 91 LQNCC 95
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.5 bits (127), Expect = 2e-08
Identities = 30/112 (26%), Positives = 48/112 (42%), Gaps = 6/112 (5%)
Query: 92 CH-SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILS 150
C L+ + SD L +P DL P LDL NN ++ K L+ LIL
Sbjct: 8 CQCHLRVVQCSDLGLE-KVPKDL---PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILI 63
Query: 151 NNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGNSGLCG 202
NNK+S P + L +L+ ++ N L +P + + +E + +
Sbjct: 64 NNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITK 114
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 50.8 bits (120), Expect = 2e-07
Identities = 26/151 (17%), Positives = 54/151 (35%), Gaps = 9/151 (5%)
Query: 28 CLEGIQNSIKDPDGRLSWSFTNTTVGAICRLTGVACWNEKENRIISLTLSSMQLSGQLPE 87
L+ + + L I ++ + ++ L + ++ SG
Sbjct: 90 QLKELPEKMPKTLQELRVHENE-----ITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 144
Query: 88 SLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147
+ L + ++D +++ +IP L L +L L N ++ + L KL
Sbjct: 145 AFQGMKKLSYIRIADTNIT-TIPQGLPPSL---TELHLDGNKITKVDAASLKGLNNLAKL 200
Query: 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDL 178
LS N +S ++ L+E + N L
Sbjct: 201 GLSFNSISAVDNGSLANTPHLRELHLNNNKL 231
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 46.6 bits (109), Expect = 5e-06
Identities = 29/131 (22%), Positives = 44/131 (33%), Gaps = 17/131 (12%)
Query: 56 CRLTGVACWNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCK 115
C L V C S + L ++P+ L LDL +N ++ D
Sbjct: 10 CHLRVVQC-------------SDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKN 53
Query: 116 WLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAG 175
L + L L NN +S P L +L LS N+L L L+
Sbjct: 54 -LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEI 112
Query: 176 NDLSGTIPPDL 186
+ ++ L
Sbjct: 113 TKVRKSVFNGL 123
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 25/136 (18%), Positives = 49/136 (36%), Gaps = 25/136 (18%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSG--------------------SIPVD 112
+L L + ++S P + L+ L LS N L +
Sbjct: 59 TLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKS 118
Query: 113 LCKWLPYVVQLDLSNNHL--SGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKE 170
+ L ++ ++L N L SG K L+ + +++ ++ +IP + L E
Sbjct: 119 VFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTE 175
Query: 171 FSVAGNDLSGTIPPDL 186
+ GN ++ L
Sbjct: 176 LHLDGNKITKVDAASL 191
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 31/160 (19%), Positives = 59/160 (36%), Gaps = 20/160 (12%)
Query: 44 SWSFTNTTVGAICRLTGVACWNEKENRIIS-----------LTLSSMQLSGQLPESLHLC 92
+ GA + ++ + I + L L +++ SL
Sbjct: 135 PLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGL 194
Query: 93 HSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNN 152
++L L LS NS+S + P++ +L L+NN L +P + + K++ + L NN
Sbjct: 195 NNLAKLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 252
Query: 153 KLSG------SIPFEVSRLDRLKEFSVAGNDLS-GTIPPD 185
+S P ++ S+ N + I P
Sbjct: 253 NISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 292
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.7 bits (127), Expect = 3e-08
Identities = 22/107 (20%), Positives = 41/107 (38%), Gaps = 10/107 (9%)
Query: 63 CWNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQ 122
+ + S ++ L SL+ L++S+N L +P P + +
Sbjct: 254 NIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP----ALPPRLER 308
Query: 123 LDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLK 169
L S NHL+ +P + L +L + N L P ++ L+
Sbjct: 309 LIASFNHLAE-VPE---LPQNLKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 5e-04
Identities = 18/69 (26%), Positives = 28/69 (40%), Gaps = 6/69 (8%)
Query: 91 LCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILS 150
L L+L++ LS S+P + P++ L S N L+ +P K L +
Sbjct: 36 LDRQAHELELNNLGLS-SLP----ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNN 89
Query: 151 NNKLSGSIP 159
LS P
Sbjct: 90 LKALSDLPP 98
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (126), Expect = 3e-08
Identities = 20/96 (20%), Positives = 41/96 (42%), Gaps = 4/96 (4%)
Query: 96 QSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLS 155
Q+LDL+ +L + L V+ + + P+ + + + LSN+ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG--VIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIE 59
Query: 156 G-SIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP 190
++ +S+ +L+ S+ G LS I LA+
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS 95
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 5e-06
Identities = 17/92 (18%), Positives = 30/92 (32%), Gaps = 1/92 (1%)
Query: 56 CRLTGVACWNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCK 115
L +I+ + L E +Q +DLS++ + S +
Sbjct: 10 KNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVSTLHGILS 68
Query: 116 WLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147
+ L L LS PI + + L +L
Sbjct: 69 QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 100
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 51.7 bits (123), Expect = 3e-08
Identities = 24/179 (13%), Positives = 47/179 (26%), Gaps = 27/179 (15%)
Query: 298 AVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQ-----------FRSEMNRLGQ 346
A+ ++ + + +K S K+ F R +
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 347 LRHPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGA 406
L L G V + Y N L L+ + +
Sbjct: 63 NEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRV-----RVENPDEVLDMI 112
Query: 407 SRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDL 465
+A +H +H +S +L+ + I DF + V + + D+
Sbjct: 113 LEEVAKFYH---RGIVHGDLSQYNVLV-SEEGIWIIDFPQS--VEVGEEGWREILERDV 165
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.2 bits (118), Expect = 3e-07
Identities = 25/119 (21%), Positives = 47/119 (39%), Gaps = 2/119 (1%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNN 128
+ L L ++S + HSL L L N ++ P + L ++ L L N
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP-HAFRDLGRLMTLYLFAN 211
Query: 129 HLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLA 187
+LS + + L L L++N L++F + +++ ++P LA
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLA 269
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (99), Expect = 6e-05
Identities = 15/68 (22%), Positives = 25/68 (36%), Gaps = 7/68 (10%)
Query: 90 HLCHSLQSLDLSDNSLSGSIP-VDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148
+LQ L L+DN L WL + S++ + +P ++
Sbjct: 222 APLRALQYLRLNDNPWVCDCRARPLWAWLQ---KFRGSSSEVPCSLPQRLAGRDLKR--- 275
Query: 149 LSNNKLSG 156
L+ N L G
Sbjct: 276 LAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 24/141 (17%), Positives = 38/141 (26%), Gaps = 1/141 (0%)
Query: 79 MQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQI 138
QL P + H L +L L + L + L + L L +N L
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLD-RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF 149
Query: 139 VECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPEESFDGNS 198
+ L L L N++S L L + N ++ P
Sbjct: 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209
Query: 199 GLCGKPLGKCGGLSGKNLGII 219
L + L +
Sbjct: 210 ANNLSALPTEALAPLRALQYL 230
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 5e-07
Identities = 27/104 (25%), Positives = 33/104 (31%), Gaps = 23/104 (22%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIP--------------------VDL 113
L L+ L+ L + LDLS N L P VD
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
Query: 114 CKWLPYVVQLDLSNNHL-SGPIPPQIVECKFLNKLILSNNKLSG 156
LP + +L L NN L +V C L L L N L
Sbjct: 61 VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 1e-05
Identities = 23/107 (21%), Positives = 37/107 (34%), Gaps = 25/107 (23%)
Query: 96 QSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIP-------------------- 135
+ L L+ L+ ++ L V LDLS+N L P
Sbjct: 1 RVLHLAHKDLTVLCHLE---QLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN 57
Query: 136 -PQIVECKFLNKLILSNNKL-SGSIPFEVSRLDRLKEFSVAGNDLSG 180
+ L +L+L NN+L + + RL ++ GN L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.8 bits (87), Expect = 6e-04
Identities = 20/93 (21%), Positives = 31/93 (33%), Gaps = 3/93 (3%)
Query: 34 NSIKDPDGRLSWSFTNTTVGAICRLTGVACWNEKENRIISLTLSSMQL-SGQLPESLHLC 92
N ++ L+ + A R+ L L + +L + L C
Sbjct: 30 NRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSC 89
Query: 93 HSLQSLDLSDNSLSG--SIPVDLCKWLPYVVQL 123
L L+L NSL I L + LP V +
Sbjct: 90 PRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 5e-05
Identities = 28/147 (19%), Positives = 49/147 (33%), Gaps = 13/147 (8%)
Query: 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSG 132
L + L +L L + + + + + L + L + + L
Sbjct: 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF 70
Query: 133 PIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP-DLARFPE 191
P L++L LS N L S+ ++ + L+E ++GN L + L R+ E
Sbjct: 71 VAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEE 129
Query: 192 ESFD----------GNSGLCGKPLGKC 208
E G L P C
Sbjct: 130 EGLGGVPEQKLQCHGQGPLAHMPNASC 156
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 6e-05
Identities = 14/62 (22%), Positives = 24/62 (38%), Gaps = 4/62 (6%)
Query: 92 CHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSN 151
S ++ +L+ ++P DL K L LS N L ++ L +L L
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDLPKDT---TILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 152 NK 153
+
Sbjct: 65 AE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 8e-04
Identities = 19/99 (19%), Positives = 25/99 (25%), Gaps = 1/99 (1%)
Query: 56 CRLTGVACWNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCK 115
RLT + + + LP L N+ +P L
Sbjct: 110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLN 169
Query: 116 WLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKL 154
L + L L N L IP L L N
Sbjct: 170 GLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.002
Identities = 12/67 (17%), Positives = 26/67 (38%), Gaps = 3/67 (4%)
Query: 110 PVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLK 169
P+ + ++++ +L+ +PP + K L LS N L + RL
Sbjct: 2 PICEVSKVASHLEVNCDKRNLTA-LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLT 58
Query: 170 EFSVAGN 176
+ ++
Sbjct: 59 QLNLDRA 65
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 1e-04
Identities = 17/63 (26%), Positives = 28/63 (44%), Gaps = 5/63 (7%)
Query: 89 LHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148
L L +L DN +S P+ LP ++++ L NN +S P + L +
Sbjct: 169 LANLSKLTTLKADDNKISDISPL---ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 149 LSN 151
L+N
Sbjct: 224 LTN 226
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 6e-04
Identities = 14/76 (18%), Positives = 23/76 (30%), Gaps = 10/76 (13%)
Query: 90 HLCHSLQSLDLSDNSLSGSIPVDLCKWL-----PYVVQLDLSNNHLSGPIPPQIVECKF- 143
+L+ L L+D LS + + L L N + +
Sbjct: 240 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE 299
Query: 144 ----LNKLILSNNKLS 155
L L L+ N+ S
Sbjct: 300 KMPDLLFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 6e-04
Identities = 13/90 (14%), Positives = 31/90 (34%), Gaps = 3/90 (3%)
Query: 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWL---PYVVQLD 124
E + + L + + + L S++ + LS N++ L + + + +
Sbjct: 6 EGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAE 65
Query: 125 LSNNHLSGPIPPQIVECKFLNKLILSNNKL 154
S+ + L + +L KL
Sbjct: 66 FSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 0.001
Identities = 23/92 (25%), Positives = 35/92 (38%), Gaps = 2/92 (2%)
Query: 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLC-KWLPYVVQLDLSN 127
N + L S + L L SL+LS+N L + + P + L+LS
Sbjct: 42 NIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSG 100
Query: 128 NHLSGPIPPQIVECKFLNKLILSNNKLSGSIP 159
N L ++ L +L L N LS +
Sbjct: 101 NELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.002
Identities = 18/82 (21%), Positives = 31/82 (37%), Gaps = 4/82 (4%)
Query: 74 LTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGP 133
L L ++ + ++D SDN + +D L + L ++NN +
Sbjct: 23 LDLRGYKIP-VIENLGATLDQFDAIDFSDNEI---RKLDGFPLLRRLKTLLVNNNRICRI 78
Query: 134 IPPQIVECKFLNKLILSNNKLS 155
L +LIL+NN L
Sbjct: 79 GEGLDQALPDLTELILTNNSLV 100
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (83), Expect = 0.004
Identities = 11/60 (18%), Positives = 22/60 (36%), Gaps = 5/60 (8%)
Query: 91 LCH-SLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149
+CH S + ++ ++ IP DL + ++L L L K+ +
Sbjct: 5 ICHCSNRVFLCQESKVT-EIPSDLPRNA---IELRFVLTKLRVIQKGAFSGFGDLEKIEI 60
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 604 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.94 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.61 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.55 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.48 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.44 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.36 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.32 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.29 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.28 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.28 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.26 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.13 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.05 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.04 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.0 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.95 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.94 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.93 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.87 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.83 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.79 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.78 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.76 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.67 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.67 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.62 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.53 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.52 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.19 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.1 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.06 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.98 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.98 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.97 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.94 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.92 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.69 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.68 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.55 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.32 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.79 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.67 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.54 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.32 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.6 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.07 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 93.8 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-53 Score=420.71 Aligned_cols=257 Identities=24% Similarity=0.390 Sum_probs=202.4
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
++|+..+.||+|+||.||+|.+.+++.||||+++......++|.+|++++++++|||||+++|+|..++..++||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 46778899999999999999998889999999987777778999999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++.... ..++|..++.++.|+|+||.||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 85 g~L~~~l~~~~------~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 85 GCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred CcHHHHhhccc------cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 99999987653 35899999999999999999999 7899999999999999999999999999998775432
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhC-CCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSG-QKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
... .....||..|+|||++.+..++.++|||||||++|||+|+ ++||.... ..+... .+..+...
T Consensus 156 ~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--------~~~~~~-~i~~~~~~-- 221 (263)
T d1sm2a_ 156 YTS---STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVE-DISTGFRL-- 221 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--------HHHHHH-HHHHTCCC--
T ss_pred cee---ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--------HHHHHH-HHHhcCCC--
Confidence 221 1234589999999999999999999999999999999995 55554321 122222 22222211
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
..| ...++ ++.+++.+||+.||++||||+||++.|++|.++
T Consensus 222 ~~p----~~~~~---~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 222 YKP----RLAST---HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCC----TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCc----cccCH---HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 111 11223 445566699999999999999999999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-52 Score=421.76 Aligned_cols=259 Identities=22% Similarity=0.364 Sum_probs=195.2
Q ss_pred CCCcCcEEEecCCeEEEEEEeC-CC---CEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 296 SFAVENIIISTRTGVSYKAVLP-DA---SALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~~-~~---~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
+|...++||+|+||+||+|... ++ ..||||++.... ...++|.+|+++|++++|||||+++|++..++..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 3455689999999999999853 33 268999986532 33467999999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
|||++|+|.+++.... ..++|..++.++.|+|+||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 107 Ey~~~g~L~~~~~~~~------~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQND------GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp ECCTTEEHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EecCCCcceeeecccc------CCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceE
Confidence 9999999999987653 35899999999999999999999 78999999999999999999999999999997
Q ss_pred cCCCCCCC-CccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 450 VGSRDPND-SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 450 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
........ .....+..||+.|||||++.+..++.++|||||||++|||+| |+.||...... +.+ ..+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--------~~~-~~i~~ 248 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--------DVI-NAIEQ 248 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHH-HHHHT
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--------HHH-HHHHc
Confidence 75432221 111223457899999999999999999999999999999998 89999753221 112 22223
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
+..... ....++ .+.+++.+||+.||++||||.||++.|+++.+.
T Consensus 249 ~~~~~~------~~~~~~---~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 249 DYRLPP------PMDCPS---ALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp TCCCCC------CTTCCH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCC------CccchH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 322111 111223 445566699999999999999999999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=409.86 Aligned_cols=261 Identities=25% Similarity=0.392 Sum_probs=201.6
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
.++|...+.||+|+||+||+|+..+ .||||+++... ...+.|.+|++++++++|||||+++|++. ++..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 3568888999999999999998643 69999996532 33467999999999999999999999875 456899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++|+|.++++... ..+++..++.++.|+++||+||| +.+||||||||+|||+++++.+||+|||+|+..
T Consensus 84 y~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp CCCEEEHHHHHHTSC------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred cCCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeec
Confidence 999999999997553 35899999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCCCCccccCCCCcccccCccccCC---CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSST---MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
...... .......||+.|||||++.+ ..++.++|||||||++|||+||+.||...... ..+...+..
T Consensus 155 ~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~--------~~~~~~~~~ 224 (276)
T d1uwha_ 155 SRWSGS--HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--------DQIIFMVGR 224 (276)
T ss_dssp -------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--------HHHHHHHHH
T ss_pred cccCCc--ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH--------HHHHHHHhc
Confidence 432221 12233468999999998754 35899999999999999999999999753221 122233333
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
+........ . ....+++ +.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 225 ~~~~p~~~~-~-~~~~~~~---l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 225 GYLSPDLSK-V-RSNCPKA---MKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp TSCCCCGGG-S-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCcchh-c-cccchHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 322211111 1 1122334 44555599999999999999999999998874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-51 Score=408.25 Aligned_cols=257 Identities=23% Similarity=0.342 Sum_probs=206.7
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
++|...+.||+|+||.||+|.+.+++.||||+++......++|.+|++++++++|||||+++|++. ++..++||||+++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN 91 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCC
Confidence 567788999999999999999988899999999877677788999999999999999999999875 4567999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++..... ..++|..++.|+.||++||.||| +.+|+||||||+|||+++++.+||+|||+|+......
T Consensus 92 g~L~~~~~~~~~-----~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 92 GSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CBHHHHTTSHHH-----HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CcHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc
Confidence 999998865421 35899999999999999999999 7899999999999999999999999999999875432
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
.. ...+..||+.|||||++.+..++.++|||||||++|||+||..|+..... ..+ +...+..+.....
T Consensus 164 ~~---~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-------~~~-~~~~i~~~~~~~~- 231 (272)
T d1qpca_ 164 YT---AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPE-VIQNLERGYRMVR- 231 (272)
T ss_dssp EE---CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHH-HHHHHHTTCCCCC-
T ss_pred cc---cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-------HHH-HHHHHHhcCCCCC-
Confidence 11 11234589999999999888999999999999999999996665532211 111 1222223321111
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
+...+++ +.+++.+||+.||++||||+||++.|+.+..
T Consensus 232 -----p~~~~~~---l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 232 -----PDNCPEE---LYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -----CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----cccChHH---HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 1122333 4556669999999999999999999988654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-51 Score=402.06 Aligned_cols=254 Identities=19% Similarity=0.322 Sum_probs=211.8
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
++|+..+.||+|+||+||+|+.++++.||||+++.....+++|.+|++++++++|||||+++|+|.+++..++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 57888999999999999999998889999999988777788999999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.+++.... ..+++..+.+++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 84 g~l~~~~~~~~------~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 84 GCLLNYLREMR------HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp EEHHHHHHSGG------GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred CcHHHhhhccc------cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 99999976543 35889999999999999999999 7899999999999999999999999999998765432
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
... ..+..||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... + +...+..+....
T Consensus 155 ~~~---~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--------~-~~~~i~~~~~~~- 221 (258)
T d1k2pa_ 155 YTS---SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------E-TAEHIAQGLRLY- 221 (258)
T ss_dssp CCC---CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------H-HHHHHHTTCCCC-
T ss_pred cee---ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--------H-HHHHHHhCCCCC-
Confidence 221 223458999999999999999999999999999999998 89999754322 1 222333332211
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
.| ...+++ +.+++.+||+.||++|||+.||++.|.+|
T Consensus 222 -~p----~~~~~~---l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 222 -RP----HLASEK---VYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -CC----TTCCHH---HHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -Cc----ccccHH---HHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 11 122334 44555599999999999999999998654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-52 Score=417.37 Aligned_cols=260 Identities=22% Similarity=0.351 Sum_probs=211.4
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
.++|...+.||+|+||+||+|.. .+++.||||+++......++|.+|+++|++++|||||+++|+|.+++..++||||+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 35677889999999999999995 46889999999877777788999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++|+|.+++..... ..+++..++.++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++....
T Consensus 96 ~~g~l~~~l~~~~~-----~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 96 TYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp TTCBHHHHHHHSCT-----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred cCcchHHHhhhccc-----cchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999975432 36899999999999999999999 78999999999999999999999999999997644
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
... ....+..|++.|||||++.+..++.++|||||||++|||+||..|+..... ..+ +...+..+...+
T Consensus 168 ~~~---~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-------~~~-~~~~i~~~~~~~ 236 (287)
T d1opja_ 168 DTY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQ-VYELLEKDYRME 236 (287)
T ss_dssp SSS---EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHH-HHHHHHTTCCCC
T ss_pred CCc---eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-------HHH-HHHHHhcCCCCC
Confidence 321 122233578999999999999999999999999999999997777643211 111 222233332211
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
. ....++ ++.+++.+||+.||++||||.||++.|+.+.++
T Consensus 237 ~------~~~~~~---~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 237 R------PEGCPE---KVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp C------CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred C------CccchH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1 112233 445556699999999999999999999988654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-51 Score=409.33 Aligned_cols=260 Identities=21% Similarity=0.308 Sum_probs=199.5
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCC-----CEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDA-----SALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~-----~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
..|+..++||+|+||.||+|.+... ..||||+++... ...++|.+|++++++++|||||+++|++...+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577789999999999999986432 379999996533 234579999999999999999999999999999999
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
||||+.+|++.+++.... ..++|..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 87 v~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla 157 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD------GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLS 157 (283)
T ss_dssp EEECCTTEEHHHHHHHTT------TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEecccCcchhhhhccc------ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchh
Confidence 999999999999887553 35899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
+......... ....+..||+.|||||++.+..++.++|||||||++|||+||..|+..... ..+ +...+..
T Consensus 158 ~~~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-------~~~-~~~~i~~ 228 (283)
T d1mqba_ 158 RVLEDDPEAT-YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------NHE-VMKAIND 228 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHH-HHHHHHT
T ss_pred hcccCCCccc-eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-------HHH-HHHHHhc
Confidence 9775432211 122334589999999999999999999999999999999997666543211 111 1222333
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
+...+. +.+....+.+++.+||+.||++||||.||++.|+++.+.
T Consensus 229 ~~~~~~---------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 229 GFRLPT---------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp TCCCCC---------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cCCCCC---------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 322111 111223455666699999999999999999999998874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=397.66 Aligned_cols=244 Identities=21% Similarity=0.307 Sum_probs=201.5
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|.+.+.||+|+||+||+|+. .+++.||||++.... ...+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4688889999999999999995 578999999986432 23467899999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus 86 Ey~~~g~L~~~l~~~-------~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~ 155 (263)
T d2j4za1 86 EYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH 155 (263)
T ss_dssp ECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred eecCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeee
Confidence 999999999999754 35899999999999999999999 78999999999999999999999999999986
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
..... .....||+.|||||++.+..++.++|||||||++|||+||+.||...... +.. ..+..+.
T Consensus 156 ~~~~~------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~-~~i~~~~ 220 (263)
T d2j4za1 156 APSSR------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETY-KRISRVE 220 (263)
T ss_dssp CCCCC------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHH-HHHHTTC
T ss_pred cCCCc------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--------HHH-HHHHcCC
Confidence 64321 12235999999999999999999999999999999999999999753221 111 2222222
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.. . +...++++.++++ +||+.||++|||++|+++
T Consensus 221 ~~------~-p~~~s~~~~~li~---~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 FT------F-PDFVTEGARDLIS---RLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CC------C-CTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHT
T ss_pred CC------C-CccCCHHHHHHHH---HHccCCHhHCcCHHHHHc
Confidence 11 1 1123345555544 999999999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-50 Score=402.60 Aligned_cols=259 Identities=22% Similarity=0.360 Sum_probs=205.5
Q ss_pred cCCCcCcE-EEecCCeEEEEEEeC---CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 295 NSFAVENI-IISTRTGVSYKAVLP---DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 295 ~~~~~~~~-ig~G~~g~vy~~~~~---~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
++|...+. ||+|+||+||+|... ++..||||+++... ...++|.+|+++|++++|||||+++|++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34555664 999999999999753 35579999997543 334679999999999999999999999865 467899
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++|+|.+++...+ ..+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 87 mE~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 157 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSK 157 (285)
T ss_dssp EECCTTEEHHHHHTTCT------TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEeCCCCcHHHHhhccc------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhh
Confidence 99999999999986543 35899999999999999999999 7899999999999999999999999999999
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
.+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||...... + +...+..
T Consensus 158 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--------~-~~~~i~~ 227 (285)
T d1u59a_ 158 ALGADDSYYT-ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------E-VMAFIEQ 227 (285)
T ss_dssp ECTTCSCEEC-CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------H-HHHHHHT
T ss_pred cccccccccc-cccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--------H-HHHHHHc
Confidence 8754332111 1123358899999999988899999999999999999998 99999753221 1 2233344
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhc
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKH 582 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~ 582 (604)
+...+.. ...++ ++.+++.+||+.||++||||.+|++.|+.+..+.
T Consensus 228 ~~~~~~p------~~~~~---~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 228 GKRMECP------PECPP---ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp TCCCCCC------TTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCC------CcCCH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 4332221 12233 4455666999999999999999999998876554
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-50 Score=399.04 Aligned_cols=251 Identities=20% Similarity=0.242 Sum_probs=197.9
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5788899999999999999994 679999999986543 2335689999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+|+...
T Consensus 85 ~~gg~L~~~l~~~-------~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 85 CSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp CTTEEGGGGSBTT-------TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred cCCCcHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeec
Confidence 9999999999754 35899999999999999999999 7899999999999999999999999999999764
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVA-SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
..... ......+||+.|||||++.+..+ +.++||||+||++|||+||+.||....... .. .... .....
T Consensus 155 ~~~~~--~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~-~~~~-~~~~~ 224 (271)
T d1nvra_ 155 YNNRE--RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QE-YSDW-KEKKT 224 (271)
T ss_dssp ETTEE--CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS------HH-HHHH-HTTCT
T ss_pred cCCcc--ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH------HH-HHHH-hcCCC
Confidence 32211 11233469999999999887775 678999999999999999999997543211 11 1111 11111
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
..... ...++++. +++.+||+.||++|||++|+++
T Consensus 225 ~~~~~-----~~~s~~~~---~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 YLNPW-----KKIDSAPL---ALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TSTTG-----GGSCHHHH---HHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCcc-----ccCCHHHH---HHHHHHcCCChhHCcCHHHHhc
Confidence 11000 11223444 4555999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=398.11 Aligned_cols=248 Identities=19% Similarity=0.311 Sum_probs=203.0
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
++|...+.||+|+||+||+|. ..+|+.||||+++... ...+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 469999999999999999999 5679999999997543 34567999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++|+|.+++.+. .+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 100 ~gg~L~~~~~~~--------~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 100 AGGSLTDVVTET--------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp TTCBHHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCcHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 999999988653 4889999999999999999999 78999999999999999999999999999998754
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
..... ....||+.|||||++.+..++.++||||+||++|||+||+.||..... .+........+.. .
T Consensus 169 ~~~~~----~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~~~~~~~~-~ 235 (293)
T d1yhwa1 169 EQSKR----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIATNGTP-E 235 (293)
T ss_dssp TTCCB----CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHHCSC-C
T ss_pred ccccc----cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH--------HHHHHHHHhCCCC-C
Confidence 32221 233599999999999999999999999999999999999999975322 1222222222221 1
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
...+ ...++++.++ +.+||+.||++|||+.|+++
T Consensus 236 ~~~~----~~~s~~~~~l---i~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 LQNP----EKLSAIFRDF---LNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CSSG----GGSCHHHHHH---HHHHTCSSTTTSCCHHHHTT
T ss_pred CCCc----ccCCHHHHHH---HHHHccCChhHCcCHHHHhc
Confidence 1111 1123444444 45999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=400.47 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=191.0
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEe--CCeeeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVV--EEERLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lv 368 (604)
++|+..+.||+|+||.||+|+ ..+|+.||||.++.... ..+.+.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 578889999999999999998 56799999999975432 23568899999999999999999999865 4567999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcC--CCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGC--QPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~--~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
|||+++|+|.+++...... ...+++..+..++.|++.||.|||+.. ..+|+||||||+|||+++++.+||+|||+
T Consensus 84 mEy~~~g~L~~~i~~~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 84 MEYCEGGDLASVITKGTKE---RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EECCTTEEHHHHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EecCCCCcHHHHHHhcccc---CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 9999999999998643211 135899999999999999999999532 24599999999999999999999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
++........ .....||+.|||||++.+..++.++|||||||++|||+||+.||...... + +...+.
T Consensus 161 a~~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--------~-~~~~i~ 227 (269)
T d2java1 161 ARILNHDTSF----AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--------E-LAGKIR 227 (269)
T ss_dssp HHHC---------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------H-HHHHHH
T ss_pred eeecccCCCc----cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--------H-HHHHHH
Confidence 9987543222 12345899999999999999999999999999999999999999753221 1 222233
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.+....+. ...++++.++ +.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~------~~~s~~l~~l---i~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 228 EGKFRRIP------YRYSDELNEI---ITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HTCCCCCC------TTSCHHHHHH---HHHHTCSSGGGSCCHHHHHT
T ss_pred cCCCCCCC------cccCHHHHHH---HHHHcCCChhHCcCHHHHHh
Confidence 33332211 1223445554 45999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=395.94 Aligned_cols=249 Identities=22% Similarity=0.327 Sum_probs=196.7
Q ss_pred cEEEecCCeEEEEEEeCC---CCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 301 NIIISTRTGVSYKAVLPD---ASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~---~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
+.||+|+||.||+|.+.+ ++.||||+++... ...++|.+|+++|++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998543 4689999996532 224679999999999999999999999865 457899999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|.++++.. ..++|..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 92 g~L~~~l~~~-------~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 92 GPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp EEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred CcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence 9999999865 35899999999999999999999 7899999999999999999999999999999775432
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCcccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDV 533 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (604)
... .......||+.|||||++.+..++.++|||||||++|||+| |+.||...... + +...+..+...+.
T Consensus 162 ~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--------~-~~~~i~~~~~~~~ 231 (277)
T d1xbba_ 162 NYY-KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------E-VTAMLEKGERMGC 231 (277)
T ss_dssp SEE-EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------H-HHHHHHTTCCCCC
T ss_pred ccc-ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--------H-HHHHHHcCCCCCC
Confidence 211 11123358999999999998899999999999999999998 89999753221 1 2233333332221
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhch
Q 007423 534 VDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMA 579 (604)
Q Consensus 534 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~ 579 (604)
. ...+++ +.+++.+||+.||++||||+||.+.|+...
T Consensus 232 p------~~~~~~---~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 232 P------AGCPRE---MYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp C------TTCCHH---HHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred C------cccCHH---HHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 1 122334 445666999999999999999999887753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-50 Score=401.99 Aligned_cols=257 Identities=23% Similarity=0.352 Sum_probs=202.7
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecCC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMPN 374 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 374 (604)
++|.+.+.||+|+||.||+|+..+++.||||+++......+.|.+|+.++++++|||||+++|++. ++..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCC
Confidence 568888999999999999999988889999999877777788999999999999999999999985 5568999999999
Q ss_pred CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCCC
Q 007423 375 GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSRD 454 (604)
Q Consensus 375 gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 454 (604)
|+|..++..... ..++|..++.++.||++||+||| +.+|+||||||+|||+++++++||+|||+++......
T Consensus 96 g~l~~~~~~~~~-----~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 96 GSLLDFLKGETG-----KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CBHHHHHSHHHH-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred Cchhhhhhhccc-----ccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 999998875421 35899999999999999999999 7899999999999999999999999999998764332
Q ss_pred CCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccccc
Q 007423 455 PNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVV 534 (604)
Q Consensus 455 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (604)
... .....||+.|+|||++....++.++|||||||++|||+||..|+.... ...+.... +..+...+.
T Consensus 168 ~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-------~~~~~~~~-i~~~~~~~~- 235 (285)
T d1fmka3 168 YTA---RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREVLDQ-VERGYRMPC- 235 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-------CHHHHHHH-HHTTCCCCC-
T ss_pred cee---eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-------CHHHHHHH-HHhcCCCCC-
Confidence 211 122358999999999999999999999999999999999766664321 11222222 222222111
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 535 DKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 535 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
+ ...++ ++.+++.+||+.||++||||++|++.|+....
T Consensus 236 ~-----~~~~~---~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 236 P-----PECPE---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp C-----TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred C-----cccCH---HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 1 12233 44556669999999999999999999988654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=398.80 Aligned_cols=277 Identities=18% Similarity=0.250 Sum_probs=208.6
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCC----eeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE----ERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lv~e 370 (604)
++|...+.||+|+||.||+|+. +|+.||||+++........+..|+..+.+++|||||++++++..++ ..++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 3566778999999999999997 6889999999754433333445666667889999999999998654 5789999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcC-----CCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGC-----QPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
||++|+|.++|++. .++|..++.++.|+|.||+|+|+.. .++|+||||||+|||+++++.+||+|||
T Consensus 82 y~~~g~L~~~l~~~--------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY--------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp CCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred cccCCCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 99999999999754 4889999999999999999999531 4799999999999999999999999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCCC------CCCcccchhhHHHHHHHHHhCCCCCCCCCcccccc-----
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM------VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFK----- 514 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~----- 514 (604)
+++.................||+.|||||++.+. .++.++|||||||++|||+||..|+..........
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 9998754433222223345699999999987654 26789999999999999999998885433221111
Q ss_pred -CcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcC
Q 007423 515 -GNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHG 583 (604)
Q Consensus 515 -~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~ 583 (604)
....+........+..+.-+.... ...+....+.+++.+||+.||++||||.||++.|+++.++-+
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGG---GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ccchHHHHHHHHhccccCCCCCccc---CChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 112233333333333322111111 122455667788889999999999999999999999987654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=398.38 Aligned_cols=250 Identities=18% Similarity=0.203 Sum_probs=199.4
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
+.|++.+.||+|+||.||+|. ..+++.||||+++... ...+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 457888999999999999999 4678999999996543 33467899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++|+|.+++.+.. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus 92 ~~g~L~~~~~~~~------~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 92 AGGAVDAVMLELE------RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp TTEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred CCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 9999999986542 35899999999999999999999 78999999999999999999999999999976532
Q ss_pred CCCCCCccccCCCCcccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSS-----TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
.. .......||+.|||||++. ...++.++|||||||++|||+||+.||......+ ..... ..
T Consensus 163 ~~----~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--------~~~~i-~~ 229 (288)
T d2jfla1 163 TI----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--------VLLKI-AK 229 (288)
T ss_dssp HH----HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--------HHHHH-HH
T ss_pred Cc----ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--------HHHHH-Hc
Confidence 11 1112345999999999873 4568999999999999999999999997643322 11122 22
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
+.......+ ...++++. +++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~----~~~s~~~~---~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 230 SEPPTLAQP----SRWSSNFK---DFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SCCCCCSSG----GGSCHHHH---HHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCCcc----ccCCHHHH---HHHHHHccCChhHCcCHHHHhc
Confidence 222111111 11234444 4555999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=386.91 Aligned_cols=243 Identities=23% Similarity=0.314 Sum_probs=191.5
Q ss_pred CcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEe----CCeeeEEe
Q 007423 298 AVENIIISTRTGVSYKAVL-PDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV----EEERLLVY 369 (604)
Q Consensus 298 ~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lv~ 369 (604)
...+.||+|+||+||+|.. .+++.||||++.... ...+.|.+|+++|++++|||||++++++.. +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 4556899999999999994 568899999986543 234568999999999999999999999875 34579999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCC--ceecCCCCCeEEeC-CCCCeEEcccCC
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPP--YMHQYISSNVILID-DDFDARITDFGL 446 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--iiH~dlk~~NiLl~-~~~~~kl~DFGl 446 (604)
||+++|+|.+++... ..+++..+..++.|+++||+||| +.+ |+||||||+|||++ +++.+||+|||+
T Consensus 92 E~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp ECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred eCCCCCcHHHHHhcc-------ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 999999999999764 35899999999999999999999 555 99999999999997 578999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
++..... ......||+.|||||++.+ .++.++|||||||++|||+||+.||..... ... +...+.
T Consensus 162 a~~~~~~------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-------~~~-~~~~i~ 226 (270)
T d1t4ha_ 162 ATLKRAS------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQ-IYRRVT 226 (270)
T ss_dssp GGGCCTT------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHH-HHHHHT
T ss_pred ceeccCC------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-------HHH-HHHHHH
Confidence 9865322 1223469999999998865 599999999999999999999999964321 111 222222
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.+.....++. ..++++. +++.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~-----~~~~~~~---~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 227 SGVKPASFDK-----VAIPEVK---EIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TTCCCGGGGG-----CCCHHHH---HHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCCcccCc-----cCCHHHH---HHHHHHccCCHhHCcCHHHHhC
Confidence 3322222211 1233444 4555999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=403.66 Aligned_cols=199 Identities=21% Similarity=0.345 Sum_probs=176.2
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
.++|+..+.||+|+||+||+|. ..+|+.||||+++... ...+++.+|+++|++++|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 5689999999999999999999 5678999999996532 335679999999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+++|+|.+++.+. ..+++..+..++.|++.||.|||+ ..+|+||||||+|||+++++.+||+|||+|+..
T Consensus 85 y~~gg~L~~~l~~~-------~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp CCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred cCCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 99999999999754 358999999999999999999994 248999999999999999999999999999976
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
..... ...+||+.|||||++.+..++.++||||+||++|||+||+.||...
T Consensus 156 ~~~~~------~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 156 IDSMA------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp HHHTC---------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred CCCcc------ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 43211 1235999999999999999999999999999999999999999754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-49 Score=399.62 Aligned_cols=269 Identities=23% Similarity=0.338 Sum_probs=211.4
Q ss_pred HHHHhhcCCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEE
Q 007423 289 DLLAATNSFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCV 360 (604)
Q Consensus 289 ~l~~~~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 360 (604)
+++...++|+..+.||+|+||+||+|+.. +++.||||+++... ...++|.+|++++++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 44445678999999999999999999853 45789999997543 23467999999999999999999999999
Q ss_pred eCCeeeEEeeecCCCchhhhhccCCCC-----------------CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCcee
Q 007423 361 VEEERLLVYKHMPNGTLYSLLHGNGVD-----------------NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMH 423 (604)
Q Consensus 361 ~~~~~~lv~ey~~~gsL~~~l~~~~~~-----------------~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH 423 (604)
..+..+++|||+++|+|.++++..... ......++|..++.|+.|++.||+||| +.+|||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEe
Confidence 999999999999999999999643211 011134899999999999999999999 789999
Q ss_pred cCCCCCeEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCC-C
Q 007423 424 QYISSNVILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQ-K 502 (604)
Q Consensus 424 ~dlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~-~ 502 (604)
|||||+|||+|.++.+||+|||+++......... ......|++.|+|||.+.+..+|.++|||||||++|||+||. +
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYK--ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCcccc--ccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999999999999999999998764332211 112335889999999999999999999999999999999986 5
Q ss_pred CCCCCCccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 503 PLDVAGAEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 503 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
||..... .+ +...+..+...+.. ...+ .++.+|+.+||+.||++||||.||++.|++|.|
T Consensus 242 p~~~~~~--------~e-~~~~v~~~~~~~~p------~~~~---~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 242 PYYGMAH--------EE-VIYYVRDGNILACP------ENCP---LELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTTTSCH--------HH-HHHHHHTTCCCCCC------TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCCCH--------HH-HHHHHHcCCCCCCC------ccch---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 6754322 12 22234444433221 1122 345566679999999999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=405.55 Aligned_cols=260 Identities=23% Similarity=0.309 Sum_probs=201.9
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCC-C-----CEEEEEEecccc--ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPD-A-----SALAIKRLSACK--LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEER 365 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~-~-----~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 365 (604)
++|...+.||+|+||+||+|+... + ..||||++.... ...+.+.+|+.++.++ +|||||++++++...+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578888999999999999998532 2 369999986532 2335789999999998 899999999999999999
Q ss_pred eEEeeecCCCchhhhhccCCCCC----------------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDN----------------TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSN 429 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~----------------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~ 429 (604)
++|||||++|+|.++|+...... .....++|..++.++.|+++||+||| +.+||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchh
Confidence 99999999999999997653210 01135899999999999999999999 789999999999
Q ss_pred eEEeCCCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 007423 430 VILIDDDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAG 508 (604)
Q Consensus 430 NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~ 508 (604)
|||++.++.+||+|||+|+........ ....+..||+.|||||++.+..++.++|||||||++|||+| |+.||....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNY--VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccccccCCeEEEeeccccccccCCCce--eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999876443221 12223357999999999999999999999999999999998 899997543
Q ss_pred ccccccCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007423 509 AEEGFKGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLK 576 (604)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 576 (604)
..+ -+...+..+...+. +...+++ +.+++.+||+.||++||||+||++.|.
T Consensus 272 ~~~--------~~~~~~~~~~~~~~------p~~~~~~---l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDA--------NFYKLIQNGFKMDQ------PFYATEE---IYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSH--------HHHHHHHTTCCCCC------CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH--------HHHHHHhcCCCCCC------CCcCCHH---HHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 221 12222333322111 1122344 445555999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=395.00 Aligned_cols=259 Identities=22% Similarity=0.347 Sum_probs=205.1
Q ss_pred CcEEEecCCeEEEEEEeCCC----CEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEe-CCeeeEEeeec
Q 007423 300 ENIIISTRTGVSYKAVLPDA----SALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV-EEERLLVYKHM 372 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~~~~~----~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lv~ey~ 372 (604)
.++||+|+||+||+|.+.++ ..||||+++... ...++|.+|+++|++++|||||+++|++.. ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999996432 368999997432 334679999999999999999999999876 46889999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
++|+|.+++.... ..+++..++.++.|+++||.|+| +++|+||||||+|||+++++.+||+|||+++....
T Consensus 112 ~~g~l~~~~~~~~------~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 112 KHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp TTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred ecCchhhhhcccc------ccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 9999999988653 34788999999999999999999 78999999999999999999999999999998765
Q ss_pred CCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
..........+..||+.|+|||......++.++||||||+++|||+||+.||...... .++. ..+..+....
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-------~~~~-~~i~~g~~~~ 254 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-------FDIT-VYLLQGRRLL 254 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CH-HHHHTTCCCC
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-------HHHH-HHHHcCCCCC
Confidence 4433333334456899999999999999999999999999999999988887642211 1111 2223333221
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCC
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGF 584 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~ 584 (604)
.+ ...++ .+.+++.+||+.||++||+|.||++.|+++.+++..
T Consensus 255 --~p----~~~~~---~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 255 --QP----EYCPD---PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp --CC----TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred --Cc----ccCcH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 11 12233 445566699999999999999999999999886544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.8e-49 Score=397.61 Aligned_cols=243 Identities=24% Similarity=0.297 Sum_probs=197.0
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc----cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL----SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
.|+..+.||+|+||+||+|+ ..+++.||||+++.... ..+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 48888999999999999998 56789999999965432 22568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
||++|+|..++... ..+++..+..++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+|+..
T Consensus 96 ~~~~g~l~~~~~~~-------~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK-------KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (309)
T ss_dssp CCSEEHHHHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred ecCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeeccccccc
Confidence 99999998776544 35899999999999999999999 789999999999999999999999999999865
Q ss_pred CCCCCCCCccccCCCCcccccCccccCC---CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSST---MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
.... ...||+.|||||++.+ ..++.++|||||||++|||++|+.||..... .+...... .
T Consensus 166 ~~~~--------~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--------~~~~~~i~-~ 228 (309)
T d1u5ra_ 166 APAN--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIA-Q 228 (309)
T ss_dssp SSBC--------CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHH-H
T ss_pred CCCC--------ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHH-h
Confidence 3321 2359999999998753 4589999999999999999999999974322 11122222 2
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
+...... ....++++.++++ +||+.||++|||+.|+++
T Consensus 229 ~~~~~~~-----~~~~s~~~~~li~---~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 229 NESPALQ-----SGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp SCCCCCS-----CTTSCHHHHHHHH---HHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCC-----CCCCCHHHHHHHH---HHCcCChhHCcCHHHHHh
Confidence 2222211 1223455555555 999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=391.22 Aligned_cols=248 Identities=19% Similarity=0.226 Sum_probs=200.1
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|.+.+.||+|+||+||+|+. .+++.||||+++... ...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5688999999999999999994 679999999996432 23467899999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|.+++... +.+++.....++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+|+.
T Consensus 88 Ey~~gg~L~~~~~~~-------~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~ 157 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 157 (288)
T ss_dssp CCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EccCCCCHHHhhhcc-------CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEeccccccee
Confidence 999999999998765 35899999999999999999999 78999999999999999999999999999998
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
+....... ......||+.|||||++.+..++.++||||+||++|||+||+.||...+.. + +...+..+.
T Consensus 158 ~~~~~~~~--~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~-~~~~i~~~~ 226 (288)
T d1uu3a_ 158 LSPESKQA--RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY--------L-IFQKIIKLE 226 (288)
T ss_dssp CC------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------H-HHHHHHTTC
T ss_pred cccCCccc--ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH--------H-HHHHHHcCC
Confidence 75332211 122345999999999999999999999999999999999999999753221 1 112222222
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.. + ....++++.++ +.+||+.||++|||++|+++
T Consensus 227 ~~------~-p~~~s~~~~~l---i~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 227 YD------F-PEKFFPKARDL---VEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CC------C-CTTCCHHHHHH---HHTTSCSSGGGSTTSGGGTC
T ss_pred CC------C-CccCCHHHHHH---HHHHccCCHhHCcCHHHHcC
Confidence 11 1 11223444444 45999999999999999754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=387.76 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=196.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEe-CCeeeEEeeecC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVV-EEERLLVYKHMP 373 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lv~ey~~ 373 (604)
++|+..+.||+|+||.||+|.. .|+.||||+++.+. ..++|.+|++++++++|||||+++|+|.. .+..++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 4577789999999999999998 47789999997543 45679999999999999999999999865 456899999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCCC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGSR 453 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~~ 453 (604)
+|+|.++|..... ..++|..++.++.||+.||.||| +.+|+||||||+|||++.++.+|++|||+++.....
T Consensus 85 ~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 85 KGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp TEEHHHHHHHHHH-----HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 9999999975421 24899999999999999999999 789999999999999999999999999999876432
Q ss_pred CCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHcCCccc
Q 007423 454 DPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSRD 532 (604)
Q Consensus 454 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (604)
.. ...++..|+|||++.+..++.++|||||||++|||+| |+.||...... .+..+ +..+...+
T Consensus 157 ~~-------~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-----~~~~~----i~~~~~~~ 220 (262)
T d1byga_ 157 QD-------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPR----VEKGYKMD 220 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----GHHHH----HTTTCCCC
T ss_pred Cc-------cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-----HHHHH----HHcCCCCC
Confidence 21 1237889999999988899999999999999999999 68887643221 22222 23332222
Q ss_pred cccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 533 VVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 533 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
.. ...++++. +++.+||+.||++||||.||+++|++|+.
T Consensus 221 ~~------~~~~~~~~---~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 221 AP------DGCPPAVY---EVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CC------TTCCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC------ccCCHHHH---HHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 21 11233444 55559999999999999999999999865
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=386.85 Aligned_cols=256 Identities=21% Similarity=0.326 Sum_probs=195.6
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCC----CCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPD----ASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~----~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv 368 (604)
++|...+.||+|+||.||+|+... +..||||+++... ...+.|.+|++++++++|||||+++|++. ++..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 568888999999999999998532 3468999986533 23467999999999999999999999985 5678999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++|+|.+++.... ..+++..++.++.|+++||.||| +.+|+||||||+||++++++.+||+|||+++
T Consensus 86 ~E~~~~g~l~~~~~~~~------~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EECCTTEEHHHHHHHTT------TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEeccCCcHHhhhhccC------CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhhe
Confidence 99999999999886553 35899999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHHc
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVIA 527 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 527 (604)
.......... ....||+.|+|||++.+..++.++|||||||++|||+| |++||......+ + ...+..
T Consensus 157 ~~~~~~~~~~---~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-----~----~~~i~~ 224 (273)
T d1mp8a_ 157 YMEDSTYYKA---SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----V----IGRIEN 224 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----H----HHHHHT
T ss_pred eccCCcceec---cceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-----H----HHHHHc
Confidence 7643322211 22347899999999999999999999999999999998 899997643321 1 122233
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 528 GRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 528 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
+..... . ...+++ +.+++.+||+.||++|||+.||++.|+.|.++
T Consensus 225 ~~~~~~-~-----~~~~~~---~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 225 GERLPM-P-----PNCPPT---LYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp TCCCCC-C-----TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCC-C-----CCCCHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 332221 1 122344 44555599999999999999999999998765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=396.62 Aligned_cols=256 Identities=22% Similarity=0.398 Sum_probs=200.6
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCC----EEEEEEeccc--cccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeE
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDAS----ALAIKRLSAC--KLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLL 367 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~----~vAvK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 367 (604)
.+|+..++||+|+||+||+|.. .+|+ .||||+++.. ....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 3588899999999999999984 4454 5899988643 23457899999999999999999999999865 5678
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLA 447 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla 447 (604)
++||+.+|+|.+++.... ..+++..++.++.|||.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 88 v~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla 158 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA 158 (317)
T ss_dssp EEECCTTCBHHHHHHHTS------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred EEEeccCCcccccccccc------cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccc
Confidence 899999999999887653 35899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
+......... ......||+.|||||++.+..++.++|||||||++|||+| |++||+.....+ +...+.
T Consensus 159 ~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---------~~~~i~ 227 (317)
T d1xkka_ 159 KLLGAEEKEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILE 227 (317)
T ss_dssp HHTTTTCC----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---------HHHHHH
T ss_pred eecccccccc--cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---------HHHHHH
Confidence 9875433221 1223358999999999998999999999999999999999 889987543221 122233
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
.+...... ...+ ..+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 228 ~~~~~~~p------~~~~---~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 228 KGERLPQP------PICT---IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HTCCCCCC------TTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCC------cccC---HHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 33221110 1122 345556669999999999999999999988764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-48 Score=391.02 Aligned_cols=250 Identities=18% Similarity=0.248 Sum_probs=186.9
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
+.|...+.||+|+||+||+|.. .+++.||||++.... ...+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 5688899999999999999994 578999999997543 2235688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC---CCCCeEEcccCCcc
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID---DDFDARITDFGLAR 448 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~---~~~~~kl~DFGla~ 448 (604)
+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||+. +++.+||+|||+++
T Consensus 89 ~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 89 VSGGELFDRIVEK-------GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp CCSCBHHHHHHTC-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred cCCCcHHHhhhcc-------cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeE
Confidence 9999999999764 35999999999999999999999 78999999999999994 57899999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
....... ....+||+.|||||++.+..++.++|||||||++|||+||+.||...... + ....+..+
T Consensus 159 ~~~~~~~-----~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~-~~~~i~~~ 224 (307)
T d1a06a_ 159 MEDPGSV-----LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--------K-LFEQILKA 224 (307)
T ss_dssp -------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------H-HHHHHHTT
T ss_pred EccCCCe-----eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--------H-HHHHHhcc
Confidence 7643221 12335999999999999999999999999999999999999999753221 1 11122222
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.... +... ....++++.+ ++.+||+.||++|||+.|+++.
T Consensus 225 ~~~~--~~~~-~~~~s~~~~~---li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 225 EYEF--DSPY-WDDISDSAKD---FIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCCC--CTTT-TTTSCHHHHH---HHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCC--CCcc-ccCCCHHHHH---HHHHHccCCHhHCcCHHHHhcC
Confidence 2111 1111 1122344444 4559999999999999999763
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=383.25 Aligned_cols=249 Identities=19% Similarity=0.268 Sum_probs=200.7
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc-------ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK-------LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 366 (604)
+.|...+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+++|++++|||||++++++.+++..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5688999999999999999994 679999999986422 23577999999999999999999999999999999
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC----CeEEc
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF----DARIT 442 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~----~~kl~ 442 (604)
+|||||++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++ .+|++
T Consensus 90 iv~E~~~gg~L~~~i~~~-------~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK-------ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEcCCCccccchhccc-------cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEec
Confidence 999999999999999764 35899999999999999999999 78999999999999998776 49999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHH
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVN 522 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 522 (604)
|||+++........ ....||+.|+|||++.+..++.++|||||||++|||+||+.||...... +...
T Consensus 160 DfG~a~~~~~~~~~-----~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~ 226 (293)
T d1jksa_ 160 DFGLAHKIDFGNEF-----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLA 226 (293)
T ss_dssp CCTTCEECTTSCBC-----SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHH
T ss_pred chhhhhhcCCCccc-----cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH--------HHHH
Confidence 99999877433221 2235899999999999999999999999999999999999999754321 1111
Q ss_pred HHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 523 HLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 523 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
. +..+.... .+... ...+.++. +++.+||+.||++|||++|+++
T Consensus 227 ~-i~~~~~~~--~~~~~-~~~s~~~~---~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 227 N-VSAVNYEF--EDEYF-SNTSALAK---DFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp H-HHTTCCCC--CHHHH-TTSCHHHH---HHHHTTSCSSGGGSCCHHHHHH
T ss_pred H-HHhcCCCC--Cchhc-CCCCHHHH---HHHHHHccCChhHCcCHHHHhc
Confidence 1 22221110 00000 11233444 4555999999999999999976
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.1e-47 Score=391.76 Aligned_cols=251 Identities=19% Similarity=0.324 Sum_probs=202.1
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
++|.+.+.||+|+||.||+|+ ..+|+.||||++.... ...+.+.+|+++|++++|||||++++++.+++..++|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 478899999999999999999 4679999999997644 33467899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC--CCCCeEEcccCCcccc
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID--DDFDARITDFGLARLV 450 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~--~~~~~kl~DFGla~~~ 450 (604)
++|+|.+++.... ..+++..+..++.||+.||.||| +.+||||||||+|||++ .++.+||+|||+++.+
T Consensus 106 ~gg~L~~~l~~~~------~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 106 SGGELFEKVADEH------NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp CSCBHHHHHTCTT------SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred CCCCHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 9999999996543 35899999999999999999999 78999999999999996 4678999999999987
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
..... .....||+.|||||++.+..++.++||||+||++|||+||+.||...+. .+....... +..
T Consensus 177 ~~~~~-----~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~-~~~ 242 (350)
T d1koaa2 177 DPKQS-----VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVKS-CDW 242 (350)
T ss_dssp CTTSC-----EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-TCC
T ss_pred ccccc-----cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-CCC
Confidence 54322 1223589999999999999999999999999999999999999975322 122222222 111
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
. .+.... ...++++.+ ++.+||+.||++|||+.|+++.
T Consensus 243 ~--~~~~~~-~~~s~~~~~---li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 243 N--MDDSAF-SGISEDGKD---FIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp C--SCCGGG-GGCCHHHHH---HHHHHCCSSGGGSCCHHHHHHS
T ss_pred C--CCcccc-cCCCHHHHH---HHHHHccCChhHCcCHHHHhcC
Confidence 1 001000 112344444 4459999999999999999873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=390.17 Aligned_cols=263 Identities=26% Similarity=0.393 Sum_probs=203.5
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC-CCC--EEEEEEeccc--cccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP-DAS--ALAIKRLSAC--KLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~-~~~--~vAvK~l~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lv 368 (604)
++|+..+.||+|+||+||+|... ++. .||||+++.. ....++|.+|+++|+++ +|||||+++|+|..++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56788899999999999999854 444 5788887543 23345799999999998 799999999999999999999
Q ss_pred eeecCCCchhhhhccCCCC---------CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCe
Q 007423 369 YKHMPNGTLYSLLHGNGVD---------NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDA 439 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~ 439 (604)
|||+++|+|.++|+..... ......++|..+..++.|+|+||.|+| +.+|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 9999999999999754210 011246999999999999999999999 7899999999999999999999
Q ss_pred EEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCC-CCCCCCccccccCcHH
Q 007423 440 RITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQK-PLDVAGAEEGFKGNLV 518 (604)
Q Consensus 440 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~-p~~~~~~~~~~~~~~~ 518 (604)
||+|||+++........ ....||..|+|||.+....++.++|||||||++|||+||.. ||..... .
T Consensus 167 kl~DfG~a~~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~--------~ 233 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK-----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------A 233 (309)
T ss_dssp EECCTTCEESSCEECCC---------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------H
T ss_pred EEccccccccccccccc-----cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH--------H
Confidence 99999999865432221 12248999999999999999999999999999999999764 6654321 1
Q ss_pred HHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcC
Q 007423 519 DWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHG 583 (604)
Q Consensus 519 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~ 583 (604)
+ +...+..+...+.. ...+++ +.+++.+||+.||++||||.||++.|+++.++..
T Consensus 234 ~-~~~~i~~~~~~~~~------~~~~~~---~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 234 E-LYEKLPQGYRLEKP------LNCDDE---VYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp H-HHHHGGGTCCCCCC------TTBCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred H-HHHHHHhcCCCCCC------ccCCHH---HHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 1 12222233221111 112334 4455559999999999999999999999987543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.6e-47 Score=391.75 Aligned_cols=250 Identities=19% Similarity=0.260 Sum_probs=202.1
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc-ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK-LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
+.|++.+.||+|+||.||+|. ..+|+.||||+++... ...+.+.+|+++|++++|||||++++++.+++..++|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 568899999999999999999 4679999999997543 33467889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC--CCCCeEEcccCCcccc
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID--DDFDARITDFGLARLV 450 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~--~~~~~kl~DFGla~~~ 450 (604)
++|+|.+++.... ..+++.....++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||+|+.+
T Consensus 109 ~gg~L~~~~~~~~------~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 109 SGGELFDRIAAED------YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp CCCBHHHHTTCTT------CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred CCChHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceec
Confidence 9999999876543 35899999999999999999999 78999999999999998 6789999999999987
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCc
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRS 530 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (604)
..... .....||+.|||||++.+..++.++||||+||++|||+||+.||...... +.... +..+..
T Consensus 180 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~-i~~~~~ 245 (352)
T d1koba_ 180 NPDEI-----VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--------ETLQN-VKRCDW 245 (352)
T ss_dssp CTTSC-----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHH-HHHCCC
T ss_pred CCCCc-----eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH-HHhCCC
Confidence 54321 12235899999999999999999999999999999999999999753221 11112 222221
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 531 RDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 531 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
. ..... ....++++.+ ++.+||+.||++|||+.|+++
T Consensus 246 ~--~~~~~-~~~~s~~~~~---li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 246 E--FDEDA-FSSVSPEAKD---FIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp C--CCSST-TTTSCHHHHH---HHHTTSCSSGGGSCCHHHHHT
T ss_pred C--CCccc-ccCCCHHHHH---HHHHHccCChhHCcCHHHHhc
Confidence 1 01111 1122344444 455999999999999999976
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=383.66 Aligned_cols=246 Identities=22% Similarity=0.244 Sum_probs=202.1
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|...+.||+|+||.||+|+ ..+|+.||||++++.. ...+++.+|+.+|++++|||||++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 578899999999999999999 5689999999997532 23467899999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
|||++|+|.+++... ..++......++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+|+.
T Consensus 85 ey~~gg~L~~~~~~~-------~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~ 154 (337)
T d1o6la_ 85 EYANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp ECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred eccCCCchhhhhhcc-------cCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccc
Confidence 999999999999865 35888999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
....... ....+||+.|||||++.+..++.++||||+||++|||+||++||...+.. +.. .....+.
T Consensus 155 ~~~~~~~----~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--------~~~-~~i~~~~ 221 (337)
T d1o6la_ 155 GISDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLF-ELILMEE 221 (337)
T ss_dssp SCCTTCC----BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHH-HHHHHCC
T ss_pred cccCCcc----cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH--------HHH-HHHhcCC
Confidence 6433222 22345999999999999999999999999999999999999999754321 111 2222222
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS-----MYQVYE 573 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~ 573 (604)
.. . +...++++.+++ .+||+.||++||+ +.|+++
T Consensus 222 ~~------~-p~~~s~~~~dli---~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 IR------F-PRTLSPEAKSLL---AGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CC------C-CTTSCHHHHHHH---HHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CC------C-CccCCHHHHHHH---HhhccCCchhhcccccccHHHHHc
Confidence 11 1 112234445544 4999999999995 788866
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-46 Score=376.46 Aligned_cols=259 Identities=20% Similarity=0.279 Sum_probs=200.6
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc----cHHHHHHHHHHHhccCCCCccceeeEEEeCC----ee
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL----SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE----ER 365 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~ 365 (604)
++|.+.+.||+|+||.||+|. ..+|+.||||+++.... ..+.|.+|++++++++|||||++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 568889999999999999999 56799999999975332 2356899999999999999999999998654 37
Q ss_pred eEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFG 445 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFG 445 (604)
|+||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++..+++|||
T Consensus 87 ~lvmE~~~g~~L~~~~~~~-------~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCT
T ss_pred EEEEECCCCCEehhhhccc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhh
Confidence 8999999999999988755 35899999999999999999999 7899999999999999999999999999
Q ss_pred CccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHH
Q 007423 446 LARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 446 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
.++......... .......||+.|||||++.+..++.++|||||||++|||+||+.||..... .+......
T Consensus 157 ~~~~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~~~ 227 (277)
T d1o6ya_ 157 IARAIADSGNSV-TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHV 227 (277)
T ss_dssp TCEECC-----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHH
T ss_pred hhhhhccccccc-cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH--------HHHHHHHH
Confidence 998664332211 122334699999999999999999999999999999999999999975322 22222333
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhch
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-SMYQVYESLKSMA 579 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~ev~~~L~~i~ 579 (604)
..+... +.......++++.++++ +||+.||++|| |++|+.+.|.++.
T Consensus 228 ~~~~~~----~~~~~~~~s~~l~~li~---~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 228 REDPIP----PSARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HCCCCC----GGGTSSSCCHHHHHHHH---HHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred hcCCCC----CchhccCCCHHHHHHHH---HHccCCHhHCHhHHHHHHHHHHHHh
Confidence 332221 11111223445555555 99999999999 8999999988764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=383.55 Aligned_cols=266 Identities=19% Similarity=0.267 Sum_probs=197.8
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEecccc--ccHHHHHHHHHHHhcc-CCCCccceeeEEEeC-C
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACK--LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVE-E 363 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~ 363 (604)
.++|...+.||+|+||.||+|... +++.||||+++... ...+++.+|+.++.++ +|+|||.+++++... .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 357888899999999999999842 34689999997533 3345688888888777 689999999998765 4
Q ss_pred eeeEEeeecCCCchhhhhccCCCCC---------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDN---------TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID 434 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~ 434 (604)
..++|||||++|+|.++++...... .....+++..++.++.|+++||.||| +.+|+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeEC
Confidence 6899999999999999997543210 01235899999999999999999999 78999999999999999
Q ss_pred CCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhC-CCCCCCCCccccc
Q 007423 435 DDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSG-QKPLDVAGAEEGF 513 (604)
Q Consensus 435 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg-~~p~~~~~~~~~~ 513 (604)
+++.+||+|||+|+......... ......||+.|||||++.+..++.++|||||||++|||+|| ++||.....
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~---- 242 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYV--RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---- 242 (299)
T ss_dssp GGGCEEECC------CCSCTTSC--CTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC----
T ss_pred CCCcEEEccCcchhhcccccccc--ccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999998764432221 12234589999999999999999999999999999999997 457754322
Q ss_pred cCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 514 KGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
.+.+...+..+...... ...++ ++.+++.+||+.||++||||.||++.|+++++.
T Consensus 243 ----~~~~~~~~~~~~~~~~~------~~~~~---~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 243 ----DEEFCRRLKEGTRMRAP------DYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp ----SHHHHHHHHHTCCCCCC------TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHhcCCCCCCC------ccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 12233333444332221 11223 455666699999999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=380.68 Aligned_cols=256 Identities=21% Similarity=0.326 Sum_probs=192.9
Q ss_pred cCCCcCcEEEecCCeEEEEEEeC--CC--CEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLP--DA--SALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERL 366 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~--~~--~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 366 (604)
++|+..+.||+|+||.||+|+.. ++ ..||||+++... ...++|.+|+++|++++|||||+++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56888899999999999999842 23 368999986532 223679999999999999999999999965 4678
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
+||||+++|++.+++.... ..+++..++.++.|+|+||.||| +.+|+||||||+|||++.++++||+|||+
T Consensus 87 lv~e~~~~~~l~~~~~~~~------~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl 157 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL 157 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG------GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred eeeeeecCcchhhhhhccc------CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchh
Confidence 9999999999999887543 35999999999999999999999 78999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccccCcHHHHHHHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
++......... .......|+..|+|||++.+..++.++|||||||++|||+| |+.||..... .+......
T Consensus 158 ~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--------~~~~~~i~ 228 (273)
T d1u46a_ 158 MRALPQNDDHY-VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKID 228 (273)
T ss_dssp CEECCC-CCEE-EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHH
T ss_pred hhhcccCCCcc-eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--------HHHHHHHH
Confidence 99875432211 11122347889999999999999999999999999999998 8999975322 12222222
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSM 578 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i 578 (604)
..+...+.. ...+.+ +.+++.+||+.||++||||.||.+.|++.
T Consensus 229 ~~~~~~~~~------~~~~~~---l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 229 KEGERLPRP------EDCPQD---IYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TSCCCCCCC------TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hCCCCCCCc------ccccHH---HHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 232221111 122234 44555599999999999999999988764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.7e-46 Score=378.86 Aligned_cols=244 Identities=19% Similarity=0.249 Sum_probs=200.8
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|.+.+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688899999999999999994 679999999996432 23467899999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+++|+|..++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 E~~~gg~l~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~ 153 (316)
T d1fota_ 84 DYIEGGELFSLLRKS-------QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKY 153 (316)
T ss_dssp CCCCSCBHHHHHHHT-------SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eecCCcccccccccc-------ccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceE
Confidence 999999999998765 35788888999999999999999 88999999999999999999999999999998
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
..... ....||+.|||||++.+..++.++||||+||++|||+||+.||...+. .+.... +..+.
T Consensus 154 ~~~~~-------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~-i~~~~ 217 (316)
T d1fota_ 154 VPDVT-------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEK-ILNAE 217 (316)
T ss_dssp CSSCB-------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHH-HHHCC
T ss_pred ecccc-------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH--------HHHHHH-HHcCC
Confidence 74322 123599999999999999999999999999999999999999975322 111222 22222
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYES 574 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~ 574 (604)
.. + ....++++.++++ +||+.||++|| |++|+++.
T Consensus 218 ~~--~-----p~~~s~~~~~li~---~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 LR--F-----PPFFNEDVKDLLS---RLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CC--C-----CTTSCHHHHHHHH---HHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CC--C-----CCCCCHHHHHHHH---HHhhhCHHhccccchhhHHHHHcC
Confidence 11 1 1122344555544 99999999996 89998763
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=387.25 Aligned_cols=265 Identities=22% Similarity=0.312 Sum_probs=207.5
Q ss_pred cCCCcCcEEEecCCeEEEEEEe------CCCCEEEEEEecccc--ccHHHHHHHHHHHhcc-CCCCccceeeEEEeCCee
Q 007423 295 NSFAVENIIISTRTGVSYKAVL------PDASALAIKRLSACK--LSEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEEER 365 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~------~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 365 (604)
++|...+.||+|+||.||+|++ .+++.||||+++... ....+|.+|+.+++++ +|||||+++|+|..++..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5677789999999999999984 346789999997543 2345789999999999 699999999999999999
Q ss_pred eEEeeecCCCchhhhhccCCCCC-----------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC
Q 007423 366 LLVYKHMPNGTLYSLLHGNGVDN-----------TLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID 434 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~~~-----------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~ 434 (604)
++|||||++|+|.++++...... .....+++..++.++.||++||+||| +.+|+||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccccc
Confidence 99999999999999997643210 11235899999999999999999999 78999999999999999
Q ss_pred CCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccc
Q 007423 435 DDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGF 513 (604)
Q Consensus 435 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~ 513 (604)
.++.+|++|||+++....... ........||+.|+|||++.+..++.++|||||||++|||+| |++||......
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--- 254 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--- 254 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTT--SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---
T ss_pred ccCcccccccchheeccCCCc--ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH---
Confidence 999999999999997754322 122234468999999999999999999999999999999999 55555432211
Q ss_pred cCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHh
Q 007423 514 KGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEK 581 (604)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~ 581 (604)
+-+...+..+..... ....++ .+.+++.+||+.||++||||.||+++|++++.+
T Consensus 255 -----~~~~~~i~~~~~~~~------~~~~~~---~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 255 -----SKFYKMIKEGFRMLS------PEHAPA---EMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp -----HHHHHHHHHTCCCCC------CTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHHHHHhcCCCCCC------cccccH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 112223333322111 112233 455566699999999999999999999987664
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=379.46 Aligned_cols=263 Identities=21% Similarity=0.322 Sum_probs=203.2
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCC--------CCEEEEEEeccccc--cHHHHHHHHHHHhcc-CCCCccceeeEEEeCC
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPD--------ASALAIKRLSACKL--SEKQFRSEMNRLGQL-RHPNLVPLLGFCVVEE 363 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~--------~~~vAvK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 363 (604)
++|...+.||+|+||.||+|+... +..||||+++.... ...++.+|+..+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 567788999999999999998422 34799999976442 346788999999888 8999999999999999
Q ss_pred eeeEEeeecCCCchhhhhccCCCC---------CCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVD---------NTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID 434 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~ 434 (604)
..++||||+++|+|.++|...... ......+++..++.++.|++.||+||| +.+||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeec
Confidence 999999999999999999755321 011245899999999999999999999 78999999999999999
Q ss_pred CCCCeEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCccccc
Q 007423 435 DDFDARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLS-GQKPLDVAGAEEGF 513 (604)
Q Consensus 435 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~ellt-g~~p~~~~~~~~~~ 513 (604)
.++.+||+|||+++.......... .....|++.|+|||.+.+..++.++|||||||++|||+| |++||.....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---- 243 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKK--TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 243 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCC--CTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred CCCCeEeccchhhccccccccccc--cccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH----
Confidence 999999999999997754332221 223358899999999999999999999999999999998 6888864322
Q ss_pred cCcHHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 514 KGNLVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
+.+...+..+...+.. ...+++ +.+++.+||+.||++||||.||++.|++|..
T Consensus 244 -----~~~~~~i~~~~~~~~p------~~~~~~---l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 -----EELFKLLKEGHRMDKP------SNCTNE---LYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -----HHHHHHHHTTCCCCCC------SSCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHcCCCCCCC------ccchHH---HHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1122333333322211 122333 4556669999999999999999999999865
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.7e-46 Score=371.70 Aligned_cols=249 Identities=19% Similarity=0.287 Sum_probs=199.1
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc----------cHHHHHHHHHHHhccC-CCCccceeeEEEeC
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL----------SEKQFRSEMNRLGQLR-HPNLVPLLGFCVVE 362 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~----------~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~ 362 (604)
++|+..+.||+|+||+||+|+ ..+|+.||||+++.... ..+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 578889999999999999999 46799999999865321 1235889999999997 99999999999999
Q ss_pred CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEc
Q 007423 363 EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARIT 442 (604)
Q Consensus 363 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~ 442 (604)
+..|+||||+++|+|.++|+.. ..+++.....++.|+++||+||| +.+|+||||||+|||++.++.+||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~ 152 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLT 152 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred cceEEEEEcCCCchHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEc
Confidence 9999999999999999999754 46999999999999999999999 7899999999999999999999999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccC------CCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCc
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSS------TMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGN 516 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~ 516 (604)
|||+++........ ....||..|+|||++. ...++.++||||+||++|||+||+.||......
T Consensus 153 DFG~a~~~~~~~~~-----~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~------ 221 (277)
T d1phka_ 153 DFGFSCQLDPGEKL-----REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------ 221 (277)
T ss_dssp CCTTCEECCTTCCB-----CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------
T ss_pred cchheeEccCCCce-----eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH------
Confidence 99999987543221 2235899999999864 345788999999999999999999999754221
Q ss_pred HHHHHHHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 517 LVDWVNHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
.....+..+..... .+. ....++++. +++.+||+.||++|||+.||++
T Consensus 222 ---~~~~~i~~~~~~~~-~~~--~~~~s~~~~---~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 222 ---LMLRMIMSGNYQFG-SPE--WDDYSDTVK---DLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp ---HHHHHHHHTCCCCC-TTT--GGGSCHHHH---HHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---HHHHHHHhCCCCCC-Ccc--cccCCHHHH---HHHHHHccCChhHCcCHHHHHc
Confidence 12222233322111 100 011234444 4555999999999999999865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=378.94 Aligned_cols=250 Identities=17% Similarity=0.230 Sum_probs=202.3
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeecC
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHMP 373 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 373 (604)
++|.+.+.||+|+||+||+|. ..+++.||||.++........+.+|+++|++++|||||++++++.+++..|+|||||+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 568889999999999999999 4578899999998766666778999999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC--CCCeEEcccCCccccC
Q 007423 374 NGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD--DFDARITDFGLARLVG 451 (604)
Q Consensus 374 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~--~~~~kl~DFGla~~~~ 451 (604)
+|+|.+++.... ..+++.....++.|++.||.||| +.+|+||||||+|||++. ...+||+|||+++...
T Consensus 85 gg~L~~~i~~~~------~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 85 GLDIFERINTSA------FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCBHHHHHTSSS------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred CCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 999999997653 35899999999999999999999 789999999999999984 4589999999998764
Q ss_pred CCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
.... .....+|+.|+|||...+..++.++||||+||++|||+||+.||...... +...... .+...
T Consensus 156 ~~~~-----~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--------~~~~~i~-~~~~~ 221 (321)
T d1tkia_ 156 PGDN-----FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENIM-NAEYT 221 (321)
T ss_dssp TTCE-----EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHH-HTCCC
T ss_pred cCCc-----ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--------HHHHHHH-hCCCC
Confidence 3221 12234899999999999999999999999999999999999999754321 1122222 22111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 532 DVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 532 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
++.... ...++++.+ ++.+||+.||++|||+.|+++
T Consensus 222 --~~~~~~-~~~s~~~~~---li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 222 --FDEEAF-KEISIEAMD---FVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --CCHHHH-TTSCHHHHH---HHHTTSCSSGGGSCCHHHHHH
T ss_pred --CChhhc-cCCCHHHHH---HHHHHccCChhHCcCHHHHhc
Confidence 011000 112334444 455999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=380.65 Aligned_cols=264 Identities=22% Similarity=0.326 Sum_probs=207.3
Q ss_pred hcCCCcCcEEEecCCeEEEEEEeC------CCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 007423 294 TNSFAVENIIISTRTGVSYKAVLP------DASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEER 365 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 365 (604)
.++|...+.||+|+||+||+|... +++.||||+++... .....|.+|++++++++|||||+++|++..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 356778899999999999999853 35789999997543 2234689999999999999999999999999999
Q ss_pred eEEeeecCCCchhhhhccCCC---CCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEc
Q 007423 366 LLVYKHMPNGTLYSLLHGNGV---DNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARIT 442 (604)
Q Consensus 366 ~lv~ey~~~gsL~~~l~~~~~---~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~ 442 (604)
++||||+++|+|.+++..... .......+++..+..++.|+|+||.||| +.+|+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence 999999999999999864311 0001134789999999999999999999 7899999999999999999999999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCC-CCCCCCCccccccCcHHHHH
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQ-KPLDVAGAEEGFKGNLVDWV 521 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~ 521 (604)
|||+++....... ........||+.|+|||.+.+..++.++|||||||++|||+||. .||.... ..++.
T Consensus 176 DFGla~~~~~~~~--~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~--------~~~~~ 245 (308)
T d1p4oa_ 176 DFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--------NEQVL 245 (308)
T ss_dssp CTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--------HHHHH
T ss_pred ecccceeccCCcc--eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC--------HHHHH
Confidence 9999987643321 11222335899999999999999999999999999999999985 6665322 22333
Q ss_pred HHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchH
Q 007423 522 NHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAE 580 (604)
Q Consensus 522 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~ 580 (604)
. .+..+...+..+ ..+ ..+.+++.+||+.||++||||.||++.|++..+
T Consensus 246 ~-~i~~~~~~~~p~------~~~---~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 246 R-FVMEGGLLDKPD------NCP---DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp H-HHHTTCCCCCCT------TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred H-HHHhCCCCCCcc------cch---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 2 233333322211 122 345566669999999999999999999988755
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.1e-45 Score=381.28 Aligned_cols=247 Identities=21% Similarity=0.283 Sum_probs=194.5
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHH---HHHHHhccCCCCccceeeEEEeCCeee
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRS---EMNRLGQLRHPNLVPLLGFCVVEEERL 366 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~---Ei~~l~~l~H~niv~l~g~~~~~~~~~ 366 (604)
++|.+.+.||+|+||.||+|+ ..+|+.||||++.... .....+.+ |+++++.++|||||++++++..++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 578899999999999999999 4579999999986432 12233444 477788889999999999999999999
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
+||||+++|+|.++|... ..+++.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 84 ivmE~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGl 153 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-------GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGL 153 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred EEEEecCCCcHHHHHHhc-------ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeece
Confidence 999999999999999765 35889999999999999999999 78999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHH
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLV 525 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 525 (604)
|+....... ....||+.|||||++.. ..++.++|||||||++|||+||+.||......+ ... +....
T Consensus 154 a~~~~~~~~------~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~-~~~~~ 221 (364)
T d1omwa3 154 ACDFSKKKP------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHE-IDRMT 221 (364)
T ss_dssp CEECSSSCC------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-----HHH-HHHHS
T ss_pred eeecCCCcc------cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-----HHH-HHHhc
Confidence 997754322 12359999999998864 568999999999999999999999997543221 111 11110
Q ss_pred HcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 007423 526 IAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS-----MYQVYE 573 (604)
Q Consensus 526 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~ 573 (604)
... .. . .....++++.+++. +||+.||++||| ++|+++
T Consensus 222 ~~~---~~---~-~~~~~s~~~~~li~---~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 222 LTM---AV---E-LPDSFSPELRSLLE---GLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSC---CC---C-CCSSSCHHHHHHHH---HHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ccC---CC---C-CCCCCCHHHHHHHH---HHcccCHHHhCCCcccCHHHHHc
Confidence 010 00 0 11123344555554 999999999999 678765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-45 Score=378.15 Aligned_cols=243 Identities=18% Similarity=0.192 Sum_probs=200.3
Q ss_pred cCCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEecccc----ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACK----LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVY 369 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ 369 (604)
++|.+.+.||+|+||.||+|+. .+|+.||||+++... ...+.+.+|+++|++++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5789999999999999999984 679999999996432 23467899999999999999999999999999999999
Q ss_pred eecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccc
Q 007423 370 KHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARL 449 (604)
Q Consensus 370 ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~ 449 (604)
||+.+|+|.+++... ..+++.....++.|++.||.||| +.+||||||||+|||++.++.+||+|||+|+.
T Consensus 121 e~~~~g~l~~~l~~~-------~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~ 190 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp ECCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ccccccchhhhHhhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeee
Confidence 999999999999765 35899999999999999999999 78999999999999999999999999999998
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
..... ....||+.|||||++.+..++.++|||||||++|||+||+.||..... .... ..+..+.
T Consensus 191 ~~~~~-------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~-~~i~~~~ 254 (350)
T d1rdqe_ 191 VKGRT-------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIY-EKIVSGK 254 (350)
T ss_dssp CSSCB-------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH-HHHHHCC
T ss_pred ccccc-------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--------HHHH-HHHhcCC
Confidence 74321 123589999999999999999999999999999999999999975321 1112 2222222
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007423 530 SRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRP-----SMYQVYE 573 (604)
Q Consensus 530 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 573 (604)
... ....++++.++++ +||+.||++|+ |++|+++
T Consensus 255 ~~~-------p~~~s~~~~~li~---~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 VRF-------PSHFSSDLKDLLR---NLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCC-------CTTCCHHHHHHHH---HHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCC-------CccCCHHHHHHHH---HHhhhCHHhccccccccHHHHHc
Confidence 111 1122344555544 99999999994 8999876
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=377.79 Aligned_cols=252 Identities=16% Similarity=0.219 Sum_probs=193.4
Q ss_pred cCCCcC-cEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhcc-CCCCccceeeEEEe----CCeeeE
Q 007423 295 NSFAVE-NIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQL-RHPNLVPLLGFCVV----EEERLL 367 (604)
Q Consensus 295 ~~~~~~-~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~~~l 367 (604)
++|.+. ++||+|+||.||+|+ ..+++.||||+++.. +.+.+|++++.++ +|||||++++++.+ +...|+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 567765 469999999999998 577999999999642 4577899987655 89999999999875 456899
Q ss_pred EeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC---CCCeEEccc
Q 007423 368 VYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD---DFDARITDF 444 (604)
Q Consensus 368 v~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~---~~~~kl~DF 444 (604)
|||||++|+|.++|..... ..+++.....++.|++.||+||| +.+|+||||||+|||+++ ++.+||+||
T Consensus 87 vmEy~~gg~L~~~i~~~~~-----~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDRGD-----QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEECCCSEEHHHHHHSCSC-----CCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEECCCCCcHHHHHHhcCC-----CCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccc
Confidence 9999999999999976432 35899999999999999999999 789999999999999985 567999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
|+|+........ ....||+.|||||++.+..++.++|||||||++|||+||+.||......+.. ..+...
T Consensus 159 G~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-----~~~~~~ 228 (335)
T d2ozaa1 159 GFAKETTSHNSL-----TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----PGMKTR 228 (335)
T ss_dssp TTCEECCCCCCC-----CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------C
T ss_pred ceeeeccCCCcc-----ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH-----HHHHHH
Confidence 999977543322 2235999999999999999999999999999999999999999754322110 001000
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
...+.. ............++.+++.+||+.||++|||+.|+++.
T Consensus 229 i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 229 IRMGQY------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCSCSS------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000100 00000011122345566669999999999999999763
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=376.86 Aligned_cols=246 Identities=21% Similarity=0.246 Sum_probs=198.1
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc----ccHHHHHHHHHHHh-ccCCCCccceeeEEEeCCeeeEE
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK----LSEKQFRSEMNRLG-QLRHPNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~----~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~lv 368 (604)
++|...+.||+|+||+||+|+ ..+++.||||+++... ...+.+..|+.++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 578889999999999999999 4679999999996432 23356777777765 68999999999999999999999
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
|||+++|+|.+++... ..++......++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++
T Consensus 82 mEy~~~g~L~~~i~~~-------~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~ 151 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK 151 (320)
T ss_dssp EECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EeecCCCcHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhh
Confidence 9999999999999765 35889999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcC
Q 007423 449 LVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAG 528 (604)
Q Consensus 449 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (604)
......... ....||+.|+|||++.+..++.++||||+||++|||+||+.||...+.. .+...+..+
T Consensus 152 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---------~~~~~i~~~ 218 (320)
T d1xjda_ 152 ENMLGDAKT----NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---------ELFHSIRMD 218 (320)
T ss_dssp CCCCTTCCB----CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHC
T ss_pred hcccccccc----cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---------HHHHHHHcC
Confidence 764332221 2235999999999999999999999999999999999999999754321 122222222
Q ss_pred CccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 007423 529 RSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMY-QVYE 573 (604)
Q Consensus 529 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-ev~~ 573 (604)
... . +...++++.++ +.+||+.||++|||+. |+++
T Consensus 219 ~~~------~-p~~~s~~~~dl---i~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 NPF------Y-PRWLEKEAKDL---LVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCC------C-CTTSCHHHHHH---HHHHSCSSGGGSBTTBSCGGG
T ss_pred CCC------C-CccCCHHHHHH---HHHhcccCCCCCcCHHHHHHh
Confidence 211 1 11223444444 4599999999999995 6753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=369.95 Aligned_cols=255 Identities=21% Similarity=0.195 Sum_probs=189.4
Q ss_pred CcEEEecCCeEEEEEE-eCCCCEEEEEEecccccc------HHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeeec
Q 007423 300 ENIIISTRTGVSYKAV-LPDASALAIKRLSACKLS------EKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 300 ~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
.++||+|+||+||+|+ ..+|+.||||+++..... .+.+.+|++++++++|||||++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 4789999999999999 467999999999653321 145889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccCC
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVGS 452 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~~ 452 (604)
+++++..+.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~~~~~~~~~~-------~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~ 152 (299)
T d1ua2a_ 83 ETDLEVIIKDNS-------LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 152 (299)
T ss_dssp SEEHHHHHTTCC-------SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred cchHHhhhhhcc-------cCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCC
Confidence 998777666533 35788899999999999999999 78999999999999999999999999999987654
Q ss_pred CCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCCcc
Q 007423 453 RDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGRSR 531 (604)
Q Consensus 453 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (604)
..... ....||+.|+|||++.. ..++.++|||||||++|||+||++||......+ ....+..........
T Consensus 153 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-----~l~~i~~~~~~~~~~ 223 (299)
T d1ua2a_ 153 PNRAY----THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-----QLTRIFETLGTPTEE 223 (299)
T ss_dssp CCCCC----CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHHHCCCCTT
T ss_pred Ccccc----cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-----HHHHHHHhcCCCChh
Confidence 32222 22358999999998765 457999999999999999999999997543221 111111111000000
Q ss_pred ccccc---------cccCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 532 DVVDK---------SLYGRGND-----DEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 532 ~~~d~---------~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
...+. ........ ....++.+++.+||+.||++|||+.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000 00000000 01134556666999999999999999976
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=365.61 Aligned_cols=260 Identities=20% Similarity=0.248 Sum_probs=194.4
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
++|+..+.||+|+||.||+|+ ..+|+.||||+++.... ..+++.+|+++|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 578889999999999999999 57799999999965432 23678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+.+ ++.+++..... ..+++..+..++.|++.||.||| +.+||||||||+|||++.++.+||+|||+|+..
T Consensus 82 ~~~~-~~~~~~~~~~~-----~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASAL-----TGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF 152 (298)
T ss_dssp CCSE-EHHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred ecCC-chhhhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceec
Confidence 9976 44444433221 35899999999999999999999 789999999999999999999999999999887
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHHcCC
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMV-ASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVIAGR 529 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (604)
...... .....||+.|+|||...... ++.++||||+||++|||++|+.||...+..+. +.......+.
T Consensus 153 ~~~~~~----~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~-------~~~i~~~~~~ 221 (298)
T d1gz8a_ 153 GVPVRT----YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-------LFRIFRTLGT 221 (298)
T ss_dssp CCCSBC----TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHHHCC
T ss_pred cCCccc----ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH-------HHHHHHhcCC
Confidence 543322 22335899999999876655 58899999999999999999999975432111 1111111111
Q ss_pred ccccccc----------cc--cCCCC-H----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 530 SRDVVDK----------SL--YGRGN-D----DEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 530 ~~~~~d~----------~l--~~~~~-~----~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
..+...+ .. ..... . ....++.+++.+||+.||++|||+.|+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 222 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1100000 00 00000 0 011344555669999999999999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=365.71 Aligned_cols=238 Identities=20% Similarity=0.333 Sum_probs=191.3
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccccc-------HHHHHHHHHHHhccC--CCCccceeeEEEeCCe
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLS-------EKQFRSEMNRLGQLR--HPNLVPLLGFCVVEEE 364 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~-------~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~ 364 (604)
++|.+.+.||+|+||+||+|+ ..+|+.||||+++..... .+++.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 468889999999999999999 567999999998643211 134678999999996 8999999999999999
Q ss_pred eeEEeeecCC-CchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC-CCCeEEc
Q 007423 365 RLLVYKHMPN-GTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD-DFDARIT 442 (604)
Q Consensus 365 ~~lv~ey~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~-~~~~kl~ 442 (604)
.++||||+.+ +++.+++... ..+++.....++.|+++||+||| +.+|+||||||+|||++. ++.+||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~-------~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~ 153 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER-------GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLI 153 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred EEEEEEeccCcchHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEEC
Confidence 9999999976 6788888654 35899999999999999999999 789999999999999984 5789999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHH
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVA-SLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWV 521 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 521 (604)
|||+|+...... .....||+.|+|||++.+..+ +.++||||+||++|||+||+.||....
T Consensus 154 DFG~a~~~~~~~------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------- 214 (273)
T d1xwsa_ 154 DFGSGALLKDTV------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------- 214 (273)
T ss_dssp CCTTCEECCSSC------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------
T ss_pred ccccceeccccc------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------
Confidence 999998754321 123359999999999876665 567899999999999999999996421
Q ss_pred HHHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 522 NHLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 522 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
. ...+.. ... ...++++.++++ +||+.||++|||++|+++
T Consensus 215 -~-i~~~~~--~~~-----~~~s~~~~~li~---~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 215 -E-IIRGQV--FFR-----QRVSSECQHLIR---WCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -H-HHHCCC--CCS-----SCCCHHHHHHHH---HHTCSSGGGSCCHHHHHT
T ss_pred -H-Hhhccc--CCC-----CCCCHHHHHHHH---HHccCCHhHCcCHHHHhc
Confidence 1 111111 111 122345555554 999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-43 Score=357.36 Aligned_cols=199 Identities=23% Similarity=0.288 Sum_probs=170.5
Q ss_pred cCCCcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEeee
Q 007423 295 NSFAVENIIISTRTGVSYKAVLPDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 371 (604)
++|...+.||+|+||+||+|+..+|+.||||+++.... ..+++.+|+.+|++++|||||++++++..++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 47888899999999999999988999999999965432 246799999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCccccC
Q 007423 372 MPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLVG 451 (604)
Q Consensus 372 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~~ 451 (604)
+.++.+..+.... ..++......++.|++.||+||| +.+||||||||+|||++.++.+|++|||.+....
T Consensus 82 ~~~~~~~~~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~ 151 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE-------GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFG 151 (286)
T ss_dssp CSEEHHHHHHTST-------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred ehhhhHHHHHhhc-------CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecc
Confidence 9887776666543 35999999999999999999999 7899999999999999999999999999998875
Q ss_pred CCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 452 SRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 452 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
...... ....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 152 ~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 152 IPVRKY----THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp C-------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCcccc----ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 432221 22248899999998765 45799999999999999999999999754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=355.61 Aligned_cols=262 Identities=18% Similarity=0.172 Sum_probs=191.8
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEe--------C
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVV--------E 362 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------~ 362 (604)
++|++.+.||+|+||+||+|+ ..+|+.||||++.... ...+++.+|+++|++++||||+++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 578889999999999999999 4689999999986432 233678999999999999999999999865 3
Q ss_pred CeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEc
Q 007423 363 EERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARIT 442 (604)
Q Consensus 363 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~ 442 (604)
+..++||||+.++.+....... ..++......++.|++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~-------~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~ 159 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVL-------VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLA 159 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTT-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEEC
T ss_pred ceEEEEEeccCCCccchhhhcc-------cccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEee
Confidence 4578999999887766554433 35788899999999999999999 7899999999999999999999999
Q ss_pred ccCCccccCCCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHH
Q 007423 443 DFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWV 521 (604)
Q Consensus 443 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 521 (604)
|||+++.................||+.|+|||++.+. .++.++||||+||++|||+||+.||......+ ...-+
T Consensus 160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-----~~~~i 234 (318)
T d3blha1 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-----QLALI 234 (318)
T ss_dssp CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHH
T ss_pred ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-----HHHHH
Confidence 9999987754332222223344699999999987654 68999999999999999999999997533211 00111
Q ss_pred HHHHHcCCcccccccc-------------ccCCCC-HHH------HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007423 522 NHLVIAGRSRDVVDKS-------------LYGRGN-DDE------IMQFLRVACSCVVSRPKDRPSMYQVYE 573 (604)
Q Consensus 522 ~~~~~~~~~~~~~d~~-------------l~~~~~-~~~------~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 573 (604)
... .+....-.... ...... .+. ...+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 235 SQL--CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHH--HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHh--cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 111 11111000000 000000 111 123456777999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-43 Score=355.89 Aligned_cols=259 Identities=20% Similarity=0.238 Sum_probs=191.1
Q ss_pred hcCCCcCcEEEecCCeEEEEEEe-CC-CCEEEEEEeccccc---cHHHHHHHHHHHhcc---CCCCccceeeEEEe----
Q 007423 294 TNSFAVENIIISTRTGVSYKAVL-PD-ASALAIKRLSACKL---SEKQFRSEMNRLGQL---RHPNLVPLLGFCVV---- 361 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~~-~~-~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~---- 361 (604)
.++|++.+.||+|+||+||+|+. .+ ++.||||+++.... ....+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46799999999999999999984 44 66799999864322 223567788877666 89999999999864
Q ss_pred -CCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeE
Q 007423 362 -EEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDAR 440 (604)
Q Consensus 362 -~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~k 440 (604)
....+++|||+++|++........ ..+++.....++.|++.||+||| +.+|+||||||+|||+++++.+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~------~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~k 156 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE------PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIK 156 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT------TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEE
T ss_pred cCceEEEEEEeccCCchhhhhhccC------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCee
Confidence 246789999999887765544332 35889999999999999999999 78999999999999999999999
Q ss_pred EcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHH
Q 007423 441 ITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDW 520 (604)
Q Consensus 441 l~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 520 (604)
|+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||+||+.||......+. +..
T Consensus 157 l~dfg~~~~~~~~~-----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~----~~~- 226 (305)
T d1blxa_ 157 LADFGLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ----LGK- 226 (305)
T ss_dssp ECSCCSCCCCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHH-
T ss_pred ecchhhhhhhcccc-----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH----HHH-
Confidence 99999988653221 22334699999999999999999999999999999999999999975432211 000
Q ss_pred HHHHHHcCCcccc------ccc--------c--ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 521 VNHLVIAGRSRDV------VDK--------S--LYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 521 ~~~~~~~~~~~~~------~d~--------~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
+............ ... . ......++++. +++.+||+.||++|||+.|+++.
T Consensus 227 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~---dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 227 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGK---DLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHH---HHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHH---HHHHHHCcCChhHCcCHHHHhcC
Confidence 1111000000000 000 0 00111233444 45559999999999999998763
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.7e-42 Score=349.32 Aligned_cols=271 Identities=17% Similarity=0.140 Sum_probs=209.6
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccCC-CCccceeeEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLRH-PNLVPLLGFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lv~ey~ 372 (604)
++|.+.+.||+|+||+||+|+ ..+|+.||||.++... ..+++.+|++.++.+.| +|++.+++++..+...++||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 578889999999999999999 5578999999986432 23457889999999975 89999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCC-----CCCeEEcccCCc
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDD-----DFDARITDFGLA 447 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~-----~~~~kl~DFGla 447 (604)
+|+|.++++... ..+++.....++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+|
T Consensus 84 -~~~l~~~~~~~~------~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 84 -GPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp -CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred -CCCHHHHHHhhc------cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEccccee
Confidence 679999987653 35899999999999999999999 899999999999999974 567999999999
Q ss_pred cccCCCCCCC---CccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHH
Q 007423 448 RLVGSRDPND---SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHL 524 (604)
Q Consensus 448 ~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 524 (604)
+......... ........||+.|||||++.+..++.++|||||||++|||+||+.||......... .....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~--~~~~~i~~~ 231 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK--QKYERIGEK 231 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH--HHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH--HHHHHHHhc
Confidence 9875432211 11223446999999999999999999999999999999999999999754322110 011111111
Q ss_pred HHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCCCC
Q 007423 525 VIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSEP 587 (604)
Q Consensus 525 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~~ 587 (604)
....... .+. ...+++ +.+++..|+..+|++||+++.+.+.|+++.++.+..+.
T Consensus 232 ~~~~~~~-----~l~-~~~p~~---l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~ 285 (293)
T d1csna_ 232 KQSTPLR-----ELC-AGFPEE---FYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285 (293)
T ss_dssp HHHSCHH-----HHT-TTSCHH---HHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSC
T ss_pred cCCCChH-----Hhc-CCCCHH---HHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCC
Confidence 1111111 111 112234 44455599999999999999999999999988877753
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.1e-43 Score=353.16 Aligned_cols=270 Identities=17% Similarity=0.191 Sum_probs=200.3
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCcccee-eEEEeCCeeeEEeeec
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLL-GFCVVEEERLLVYKHM 372 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~-g~~~~~~~~~lv~ey~ 372 (604)
+.|.+.+.||+|+||+||+|+ ..+|+.||||.+.... ..+++..|++++++++|+|++..+ ++....+..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 468889999999999999998 4678999999986543 234688999999999887766554 4556778889999999
Q ss_pred CCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeC---CCCCeEEcccCCccc
Q 007423 373 PNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILID---DDFDARITDFGLARL 449 (604)
Q Consensus 373 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~---~~~~~kl~DFGla~~ 449 (604)
. |++.+.+.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++ .+..+||+|||+|+.
T Consensus 86 ~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 86 G-PSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp C-CBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred C-Cchhhhhhhcc------CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 5 46666665432 35899999999999999999999 78999999999999976 456799999999998
Q ss_pred cCCCCCCC---CccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHHHHHH
Q 007423 450 VGSRDPND---SSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVNHLVI 526 (604)
Q Consensus 450 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 526 (604)
........ ........||+.|||||.+.+..++.++|||||||++|||+||+.||.......... ....+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~-~~~~~~~~~~~ 234 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKKMS 234 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHH
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH-HHHHhhcccCC
Confidence 75433221 112234469999999999999999999999999999999999999997644322111 11111111000
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhchHhcCCCC
Q 007423 527 AGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYESLKSMAEKHGFSE 586 (604)
Q Consensus 527 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~i~~~~~~~~ 586 (604)
... +.+. ...+++ +.+++.+||+.||++||++.++.+.|+.+..+.+...
T Consensus 235 -~~~-----~~~~-~~~p~~---~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 284 (299)
T d1ckia_ 235 -TPI-----EVLC-KGYPSE---FATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284 (299)
T ss_dssp -SCH-----HHHT-TTSCHH---HHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCC
T ss_pred -CCh-----hHhc-cCCCHH---HHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCC
Confidence 000 1111 122334 4445559999999999999999999999877666554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-43 Score=360.37 Aligned_cols=266 Identities=21% Similarity=0.196 Sum_probs=189.9
Q ss_pred CCCcCcEEEecCCeEEEEEEe-CCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCccceeeEEEeC------CeeeEE
Q 007423 296 SFAVENIIISTRTGVSYKAVL-PDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLVPLLGFCVVE------EERLLV 368 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~lv 368 (604)
+|...++||+|+||+||+|+. .+|+.||||+++.... .+.+|+++|++++|||||++++++... .+.++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 577789999999999999994 5799999999975432 234799999999999999999998653 247899
Q ss_pred eeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCC-CCeEEcccCCc
Q 007423 369 YKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDD-FDARITDFGLA 447 (604)
Q Consensus 369 ~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~-~~~kl~DFGla 447 (604)
|||+++|.+..+.+.... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.+ ..+||+|||++
T Consensus 98 ~Ey~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRA----KQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EECCSEEHHHHHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EeccCCccHHHHHhhhhc----cCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccch
Confidence 999987644333321111 135899999999999999999999 8999999999999999976 48999999999
Q ss_pred cccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccC-------cHHH
Q 007423 448 RLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKG-------NLVD 519 (604)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~-------~~~~ 519 (604)
+......... ...||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+.... ...+
T Consensus 171 ~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 171 KQLVRGEPNV-----SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245 (350)
T ss_dssp EECCTTSCCC-----SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred hhccCCcccc-----cccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence 8775433222 2358999999997654 5689999999999999999999999975432211100 0000
Q ss_pred HHHHHHH---cCCccccccc---cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhch
Q 007423 520 WVNHLVI---AGRSRDVVDK---SLYGRGNDDEIMQFLRVACSCVVSRPKDRPSMYQVYES--LKSMA 579 (604)
Q Consensus 520 ~~~~~~~---~~~~~~~~d~---~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~--L~~i~ 579 (604)
+...... .......... .......+++ +.+++.+||+.||++|||+.|+++. ++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~---~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPE---AIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHH---HHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHH---HHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0000000 0000000000 0011112334 4455559999999999999999864 45543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=355.79 Aligned_cols=203 Identities=21% Similarity=0.288 Sum_probs=167.4
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc--ccHHHHHHHHHHHhccCCCCccceeeEEEeCC----eee
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK--LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE----ERL 366 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~ 366 (604)
+.+|...+.||+|+||+||+|+ ..+|+.||||+++... ...+++.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4568888999999999999998 5689999999997543 23467899999999999999999999997653 235
Q ss_pred EEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCC
Q 007423 367 LVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGL 446 (604)
Q Consensus 367 lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGl 446 (604)
++++|+.+|+|.+++... .+++..+..++.|+++||+||| +.+||||||||+|||+++++.+||+|||+
T Consensus 87 ~l~~~~~~g~L~~~l~~~--------~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEeecCCchhhhhhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCc
Confidence 556777899999999753 4899999999999999999999 78999999999999999999999999999
Q ss_pred ccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 007423 447 ARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVAG 508 (604)
Q Consensus 447 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~~ 508 (604)
++......... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||....
T Consensus 156 a~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 156 ARVADPDHDHT-GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp CEECCGGGCBC-CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eeeccCCCccc-eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 98764432211 12234468999999998744 567889999999999999999999997543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-42 Score=344.34 Aligned_cols=198 Identities=21% Similarity=0.239 Sum_probs=172.1
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEecccc---ccHHHHHHHHHHHhccCCCCccceeeEEEeCCeeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACK---LSEKQFRSEMNRLGQLRHPNLVPLLGFCVVEEERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lv~e 370 (604)
++|...+.||+|+||+||+|+ ..+++.||||+++... ...+++.+|++++++++||||+++++++......++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 468888999999999999999 5688999999996533 234678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcccCCcccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDFGLARLV 450 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~~~ 450 (604)
|+.++++..++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||.++..
T Consensus 82 ~~~~~~l~~~~~~~-------~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~ 151 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-------GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAF 151 (292)
T ss_dssp CCSEEHHHHHHHTT-------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred eccccccccccccc-------cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcc
Confidence 99999998887654 35889999999999999999999 789999999999999999999999999999987
Q ss_pred CCCCCCCCccccCCCCcccccCccccCCCC-CCcccchhhHHHHHHHHHhCCCCCCC
Q 007423 451 GSRDPNDSSFVHGDLGEFGYVAPEYSSTMV-ASLKGDVYGFGIVLLELLSGQKPLDV 506 (604)
Q Consensus 451 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~k~DV~SfGvvl~elltg~~p~~~ 506 (604)
........ ...++..|+|||.+.... ++.++||||+||++|||++|+.||..
T Consensus 152 ~~~~~~~~----~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 152 GIPVRCYS----AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CSCCSCCC----SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred cCCCccce----eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 54332221 224678899999877654 68999999999999999999999754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-42 Score=353.68 Aligned_cols=195 Identities=24% Similarity=0.300 Sum_probs=162.2
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeCC------
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVEE------ 363 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 363 (604)
.+.|...+.||+|+||+||+|. ..+|+.||||+++.... ..+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 3578888999999999999999 56799999999975332 2357889999999999999999999998654
Q ss_pred eeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEcc
Q 007423 364 ERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITD 443 (604)
Q Consensus 364 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~D 443 (604)
..++||||+ +.+|..+++.. .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+|++|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~D 164 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE--------KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILD 164 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred eEEEEEecc-cccHHHHHHhc--------cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccc
Confidence 469999999 55788777543 4899999999999999999999 78999999999999999999999999
Q ss_pred cCCccccCCCCCCCCccccCCCCcccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 444 FGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSST-MVASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 444 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
||+++...... ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 165 fg~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 165 FGLARQADSEM-------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp CTTCEECCSSC-------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccceeccCCcc-------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 99998764322 22358999999998765 45789999999999999999999999764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-42 Score=350.74 Aligned_cols=251 Identities=19% Similarity=0.247 Sum_probs=194.6
Q ss_pred cCCCcCcEEEecCCeEEEEEEe----CCCCEEEEEEecccc-----ccHHHHHHHHHHHhccCC-CCccceeeEEEeCCe
Q 007423 295 NSFAVENIIISTRTGVSYKAVL----PDASALAIKRLSACK-----LSEKQFRSEMNRLGQLRH-PNLVPLLGFCVVEEE 364 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~~----~~~~~vAvK~l~~~~-----~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~ 364 (604)
++|...+.||+|+||+||+|+. .+|+.||||.++... ...+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999983 247899999986532 223568899999999977 899999999999999
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEccc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDF 444 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DF 444 (604)
.+++|||+.+|+|.+++... ..++......++.|++.||.|+| +.+|+||||||+|||++.++.+||+||
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-------~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DF 173 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDF 173 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred eeeeeecccccHHHHHHHhc-------ccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeec
Confidence 99999999999999999765 34677888899999999999999 789999999999999999999999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCccccccCcHHHHHH
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM--VASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKGNLVDWVN 522 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 522 (604)
|+++.+...... ......|++.|+|||.+... .++.++||||+||++|||+||+.||......+. ......
T Consensus 174 G~a~~~~~~~~~---~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~----~~~i~~ 246 (322)
T d1vzoa_ 174 GLSKEFVADETE---RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAEISR 246 (322)
T ss_dssp SEEEECCGGGGG---GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHHHHH
T ss_pred cchhhhcccccc---cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHH
Confidence 999876432211 12233589999999987654 468899999999999999999999976543321 111111
Q ss_pred HHHHcCCccccccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 007423 523 HLVIAGRSRDVVDKSLYGRGNDDEIMQFLRVACSCVVSRPKDRPS-----MYQVYE 573 (604)
Q Consensus 523 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~ 573 (604)
.. ..... .. ....++++.+++ .+||+.||++||| ++|+++
T Consensus 247 ~~-~~~~~------~~-~~~~s~~~~~li---~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 247 RI-LKSEP------PY-PQEMSALAKDLI---QRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HH-HHCCC------CC-CTTSCHHHHHHH---HHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred hc-ccCCC------CC-cccCCHHHHHHH---HHHcccCHHHcCCCCcccHHHHHc
Confidence 11 11111 01 112234444444 4999999999994 788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.9e-41 Score=347.70 Aligned_cols=193 Identities=18% Similarity=0.298 Sum_probs=166.2
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccC-CCCccceeeEEEeC--CeeeEEee
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLR-HPNLVPLLGFCVVE--EERLLVYK 370 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lv~e 370 (604)
++|.+.+.||+|+||+||+|+ ..+++.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 579999999999999999999 467999999999753 3567899999999995 99999999999854 46899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCC-CeEEcccCCccc
Q 007423 371 HMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDF-DARITDFGLARL 449 (604)
Q Consensus 371 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~-~~kl~DFGla~~ 449 (604)
|+++|+|..+. ..++...+..++.|++.||.||| +.+|+||||||+|||++.++ .+||+|||+|+.
T Consensus 113 ~~~~~~L~~~~----------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 113 HVNNTDFKQLY----------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp CCCSCBGGGTT----------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred ecCCCcHHHHh----------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeeccccccee
Confidence 99999997764 24889999999999999999999 78999999999999998654 699999999987
Q ss_pred cCCCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 450 VGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 450 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
....... ....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus 180 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 180 YHPGQEY-----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp CCTTCCC-----CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccCCCcc-----cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 7543322 223589999999987664 4799999999999999999999999753
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=343.71 Aligned_cols=262 Identities=21% Similarity=0.204 Sum_probs=186.5
Q ss_pred cCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeC------Ce
Q 007423 295 NSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVE------EE 364 (604)
Q Consensus 295 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~ 364 (604)
++|.+.++||+|+||+||+|. ..+|+.||||+++.... ..+++.+|+.++++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 568888999999999999999 55799999999975432 235688999999999999999999999643 57
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEccc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDF 444 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DF 444 (604)
.|+||||+.++ +.+.+. ..+++.....++.|++.||.||| +.+|+||||||+|||++.++.+|++||
T Consensus 97 ~~iv~Ey~~~~-l~~~~~---------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df 163 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ---------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_dssp EEEEEECCSEE-HHHHHT---------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEeccchH-HHHhhh---------cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeech
Confidence 89999999765 445443 24889999999999999999999 789999999999999999999999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCccccccC---------
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFKG--------- 515 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~~--------- 515 (604)
|+++........ ....+|+.|+|||++.+..+++++||||+||+++||++|+.||...+.......
T Consensus 164 ~~~~~~~~~~~~-----~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~ 238 (355)
T d2b1pa1 164 GLARTAGTSFMM-----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_dssp CC--------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred hhhhcccccccc-----ccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCC
Confidence 998876443221 223489999999999999999999999999999999999999975432110000
Q ss_pred -----cHHHHHHHHHHcCC-cc-----ccccccccCCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007423 516 -----NLVDWVNHLVIAGR-SR-----DVVDKSLYGRG---NDDEIMQFLRVACSCVVSRPKDRPSMYQVYES 574 (604)
Q Consensus 516 -----~~~~~~~~~~~~~~-~~-----~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 574 (604)
.............. .. ........... .......+.+++.+|++.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000111111110 00 00111111111 11233456777779999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=344.55 Aligned_cols=196 Identities=21% Similarity=0.295 Sum_probs=164.5
Q ss_pred hcCCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccc---cHHHHHHHHHHHhccCCCCccceeeEEEeC-----Ce
Q 007423 294 TNSFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKL---SEKQFRSEMNRLGQLRHPNLVPLLGFCVVE-----EE 364 (604)
Q Consensus 294 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 364 (604)
+++|...+.||+|+||+||+|+ ..+|+.||||+++.... ..+++.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4578889999999999999999 56899999999975432 335688999999999999999999998643 34
Q ss_pred eeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCCeEEccc
Q 007423 365 RLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFDARITDF 444 (604)
Q Consensus 365 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~~kl~DF 444 (604)
.+++++|+.+|+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|++||
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~--------~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~df 165 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ--------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDF 165 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEeecCCchhhhcccc--------cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCcccccccccccccccc
Confidence 57778888999999999643 4899999999999999999999 789999999999999999999999999
Q ss_pred CCccccCCCCCCCCccccCCCCcccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 007423 445 GLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTM-VASLKGDVYGFGIVLLELLSGQKPLDVA 507 (604)
Q Consensus 445 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~SfGvvl~elltg~~p~~~~ 507 (604)
|++...... ..+..|+..|+|||...+. .++.++||||+||++|||++|+.||...
T Consensus 166 g~a~~~~~~-------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 166 GLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp ----CCTGG-------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred chhcccCcc-------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 999765321 2234589999999986654 4689999999999999999999999754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.9e-37 Score=319.74 Aligned_cols=264 Identities=14% Similarity=0.127 Sum_probs=188.6
Q ss_pred CCCcCcEEEecCCeEEEEEE-eCCCCEEEEEEeccccccHHHHHHHHHHHhccC-----------CCCccceeeEEEe--
Q 007423 296 SFAVENIIISTRTGVSYKAV-LPDASALAIKRLSACKLSEKQFRSEMNRLGQLR-----------HPNLVPLLGFCVV-- 361 (604)
Q Consensus 296 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~-- 361 (604)
+|.+.++||+|+||+||+|+ ..+|+.||||+++......+.+.+|++++++++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 48889999999999999999 568999999999876555677889999988875 5789999998864
Q ss_pred CCeeeEEeeecCCCchhhh-hccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC--
Q 007423 362 EEERLLVYKHMPNGTLYSL-LHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD-- 438 (604)
Q Consensus 362 ~~~~~lv~ey~~~gsL~~~-l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~-- 438 (604)
....+++++++..+..... ..... ...+++..+..++.|++.||+|||+ ..+|+||||||+|||++.++.
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYE-----HRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTT-----TSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTT
T ss_pred ccceeeeeeeccccccccccccccc-----ccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccc
Confidence 3456677777665543332 22221 1357889999999999999999995 478999999999999986543
Q ss_pred ----eEEcccCCccccCCCCCCCCccccCCCCcccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCCCCcccccc
Q 007423 439 ----ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVAPEYSSTMVASLKGDVYGFGIVLLELLSGQKPLDVAGAEEGFK 514 (604)
Q Consensus 439 ----~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~SfGvvl~elltg~~p~~~~~~~~~~~ 514 (604)
+|++|||.++...... ....||+.|+|||+.....++.++||||+||+++||++|+.||..........
T Consensus 167 ~~~~~kl~dfg~s~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEHY-------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp TEEEEEECCCTTCEETTBCC-------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred ccceeeEeeccccccccccc-------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence 8999999998653221 12358999999999998899999999999999999999999997543211111
Q ss_pred CcHHHHHHHHHHcCCc-----------ccccc---------c----------cccCCCCHHHHHHHHHHHhhccCCCCCC
Q 007423 515 GNLVDWVNHLVIAGRS-----------RDVVD---------K----------SLYGRGNDDEIMQFLRVACSCVVSRPKD 564 (604)
Q Consensus 515 ~~~~~~~~~~~~~~~~-----------~~~~d---------~----------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~ 564 (604)
...........-|.. ....+ . .............+.+++.+|++.||++
T Consensus 240 -~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~ 318 (362)
T d1q8ya_ 240 -DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 318 (362)
T ss_dssp -HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred -hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence 111111111010100 00000 0 0011223455667888888999999999
Q ss_pred CCCHHHHHHH
Q 007423 565 RPSMYQVYES 574 (604)
Q Consensus 565 RPs~~ev~~~ 574 (604)
|||++|+++.
T Consensus 319 Rpta~e~L~H 328 (362)
T d1q8ya_ 319 RADAGGLVNH 328 (362)
T ss_dssp CBCHHHHHTC
T ss_pred CcCHHHHhcC
Confidence 9999999874
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.94 E-value=6.7e-28 Score=244.40 Aligned_cols=184 Identities=33% Similarity=0.530 Sum_probs=145.2
Q ss_pred CchhhHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCC--CccccccCCC-CCCcEEEEEecCCccee--eCCcccccCCCC
Q 007423 21 SIEDDVKCLEGIQNSIKDPDGRLSWSFTNTTVGAIC--RLTGVACWNE-KENRIISLTLSSMQLSG--QLPESLHLCHSL 95 (604)
Q Consensus 21 ~~~~d~~al~~~~~~~~~~~~~~~w~~~~~~~~~~c--~~~gv~c~~~-~~~~v~~l~l~~n~l~g--~~p~~l~~l~~L 95 (604)
+.++|++||++||+.+.||....+|..+ +++| .|.||+|+.. ...||+.|+|++|+++| .+|+++++|++|
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~l~sW~~~----~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L 78 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTTLSSWLPT----TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCTT----SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCHHHHHHHHHHHHHCCCCCcCCCCCCC----CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccc
Confidence 4678999999999999988532389642 4678 4999999753 23489999999999998 689999999999
Q ss_pred CEEEcCC-CCCCCcCChhhhhcCCCCcEEEccCCcCCC------------------------------------------
Q 007423 96 QSLDLSD-NSLSGSIPVDLCKWLPYVVQLDLSNNHLSG------------------------------------------ 132 (604)
Q Consensus 96 ~~L~Ls~-N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g------------------------------------------ 132 (604)
++|||++ |+|+|.||.++.. |++|++|+|++|++.|
T Consensus 79 ~~L~Ls~~N~l~g~iP~~i~~-L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~ 157 (313)
T d1ogqa_ 79 NFLYIGGINNLVGPIPPAIAK-LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGG-CTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred ccccccccccccccccccccc-ccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecc
Confidence 9999996 8999999988754 5555555555554433
Q ss_pred ------CCccc---------------------------------------------------------------------
Q 007423 133 ------PIPPQ--------------------------------------------------------------------- 137 (604)
Q Consensus 133 ------~iP~~--------------------------------------------------------------------- 137 (604)
.+|..
T Consensus 158 ~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~ 237 (313)
T d1ogqa_ 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 22221
Q ss_pred --ccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCCCCC--CCCCCCcccCCCCCCCCCCCCCCC
Q 007423 138 --IVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPD--LARFPEESFDGNSGLCGKPLGKCG 209 (604)
Q Consensus 138 --~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~--~~~~~~~~~~~n~~lcg~p~~~c~ 209 (604)
++.+++|+.|+|++|+|+|.+|..++++++|++|+|++|+|+|+||.. +..+....+.+|+.+||.|++.|.
T Consensus 238 ~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c~ 313 (313)
T d1ogqa_ 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPACT 313 (313)
T ss_dssp GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCCCC
Confidence 122356778899999999999999999999999999999999999963 345566778999999999988884
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1.5e-22 Score=189.33 Aligned_cols=162 Identities=12% Similarity=0.095 Sum_probs=118.5
Q ss_pred CcCcEEEecCCeEEEEEEeCCCCEEEEEEeccccc-------------------cHHHHHHHHHHHhccCCCCccceeeE
Q 007423 298 AVENIIISTRTGVSYKAVLPDASALAIKRLSACKL-------------------SEKQFRSEMNRLGQLRHPNLVPLLGF 358 (604)
Q Consensus 298 ~~~~~ig~G~~g~vy~~~~~~~~~vAvK~l~~~~~-------------------~~~~~~~Ei~~l~~l~H~niv~l~g~ 358 (604)
.+.+.||+|+||+||+|...+|+.||||.++.... ....+.+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45689999999999999988999999998753211 01234578899999999999988765
Q ss_pred EEeCCeeeEEeeecCCCchhhhhccCCCCCCCCCCCCHHHHHHHHHHHHHHhhHhhhcCCCCceecCCCCCeEEeCCCCC
Q 007423 359 CVVEEERLLVYKHMPNGTLYSLLHGNGVDNTLSGVLDWSTRLRIGMGASRGLAWLHHGCQPPYMHQYISSNVILIDDDFD 438 (604)
Q Consensus 359 ~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH~dlk~~NiLl~~~~~ 438 (604)
. ..+++|||++++.+.++ +......++.|+++++.||| +.+|+||||||+|||++++ .
T Consensus 83 ~----~~~lvme~~~~~~~~~l--------------~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~ 140 (191)
T d1zara2 83 E----GNAVLMELIDAKELYRV--------------RVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-G 140 (191)
T ss_dssp E----TTEEEEECCCCEEGGGC--------------CCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-E
T ss_pred c----CCEEEEEeeccccccch--------------hhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-C
Confidence 3 23799999988665432 22334578999999999999 7899999999999999975 4
Q ss_pred eEEcccCCccccCCCCCCCCccccCCCCcccccC------ccccCCCCCCcccchhhHHHHH
Q 007423 439 ARITDFGLARLVGSRDPNDSSFVHGDLGEFGYVA------PEYSSTMVASLKGDVYGFGIVL 494 (604)
Q Consensus 439 ~kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~t~k~DV~SfGvvl 494 (604)
++|+|||+|+....... ..|.. .+.+ ...|+.++|+||..--+
T Consensus 141 ~~liDFG~a~~~~~~~~------------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 141 IWIIDFPQSVEVGEEGW------------REILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EEECCCTTCEETTSTTH------------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EEEEECCCcccCCCCCc------------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99999999976532110 01111 0111 34578899999975433
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.61 E-value=1.1e-15 Score=142.05 Aligned_cols=127 Identities=21% Similarity=0.251 Sum_probs=106.7
Q ss_pred CCCccccccCCCC--------CCcEEEEEecCCcceeeC-CcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEc
Q 007423 55 ICRLTGVACWNEK--------ENRIISLTLSSMQLSGQL-PESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDL 125 (604)
Q Consensus 55 ~c~~~gv~c~~~~--------~~~v~~l~l~~n~l~g~~-p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~l 125 (604)
.|.|+.|.|++.. ...++.|+|++|+|++.+ +..+.++++|+.|+|++|.+++..+..+ ..+++|+.|+|
T Consensus 7 ~C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~-~~~~~L~~L~L 85 (192)
T d1w8aa_ 7 HCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF-EGASHIQELQL 85 (192)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTT-TTCTTCCEEEC
T ss_pred EEcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccc-ccccccceeee
Confidence 3678889996432 236889999999998766 4567899999999999999996655555 45899999999
Q ss_pred cCCcCCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCC
Q 007423 126 SNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTI 182 (604)
Q Consensus 126 s~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~i 182 (604)
++|++++..|..+.++++|+.|+|++|+|++..|..+..+++|++|+|++|.+.+..
T Consensus 86 s~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred ccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence 999999777777899999999999999999888888899999999999999987654
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.55 E-value=5.2e-15 Score=137.45 Aligned_cols=135 Identities=22% Similarity=0.319 Sum_probs=114.1
Q ss_pred cccccCCCCCCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccc
Q 007423 59 TGVACWNEKENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQI 138 (604)
Q Consensus 59 ~gv~c~~~~~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~ 138 (604)
.|.+|.. +.++.++|+|+ .+|+.+. +++++|+|++|.|++.++...+..+++|+.|+|++|++.+..+..+
T Consensus 4 ~~C~C~~------~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~ 74 (192)
T d1w8aa_ 4 AMCHCEG------TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF 74 (192)
T ss_dssp TTSEEET------TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTT
T ss_pred CCCEEcC------CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccc
Confidence 3667742 36899999999 7888774 7899999999999988877766679999999999999999999999
Q ss_pred cCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCC---cccCCCCCCCC
Q 007423 139 VECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE---ESFDGNSGLCG 202 (604)
Q Consensus 139 ~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~---~~~~~n~~lcg 202 (604)
..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++-.|..+..++. ....+|+..|.
T Consensus 75 ~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 75 EGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp TTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred ccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 99999999999999999888888999999999999999999665666665543 44567766553
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.48 E-value=7e-14 Score=119.74 Aligned_cols=102 Identities=29% Similarity=0.364 Sum_probs=90.0
Q ss_pred EEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeecccc
Q 007423 73 SLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNN 152 (604)
Q Consensus 73 ~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~N 152 (604)
.|+|++|+++ .++ .+..+++|++|||++|.++ .+|+.+.. +++|++|++++|++++ +| .+..+++|+.|++++|
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~-l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAA-LRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGG-CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhh-hhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 6899999998 455 5999999999999999998 79988765 9999999999999984 56 5999999999999999
Q ss_pred ccccCC-ChhhhcCCCccEEEccCCcccC
Q 007423 153 KLSGSI-PFEVSRLDRLKEFSVAGNDLSG 180 (604)
Q Consensus 153 ~l~g~~-p~~~~~l~~L~~l~l~~N~l~g 180 (604)
+++... +..+..+++|+.|++++|+++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 998533 3568899999999999999973
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.44 E-value=2e-14 Score=144.04 Aligned_cols=109 Identities=30% Similarity=0.406 Sum_probs=96.0
Q ss_pred EEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeeccc
Q 007423 72 ISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSN 151 (604)
Q Consensus 72 ~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~ 151 (604)
..++++++.+.|.+|..++.+++|+.|++++|+++|.+| ++.. +++|+.|+|++|+|+|.+|..++++++|++|+|++
T Consensus 200 ~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~-~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~ 277 (313)
T d1ogqa_ 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGL-SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277 (313)
T ss_dssp SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCC-CTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred ccccccccccccccccccccccccccccccccccccccc-cccc-ccccccccCccCeecccCChHHhCCCCCCEEECcC
Confidence 357777888888888888899999999999999998876 4544 89999999999999999999999999999999999
Q ss_pred cccccCCChhhhcCCCccEEEccCCc-ccCC-CC
Q 007423 152 NKLSGSIPFEVSRLDRLKEFSVAGND-LSGT-IP 183 (604)
Q Consensus 152 N~l~g~~p~~~~~l~~L~~l~l~~N~-l~g~-ip 183 (604)
|+|+|.+|. ++++++|+.+++++|+ +.|. +|
T Consensus 278 N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~plp 310 (313)
T d1ogqa_ 278 NNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp SEEEEECCC-STTGGGSCGGGTCSSSEEESTTSS
T ss_pred CcccccCCC-cccCCCCCHHHhCCCccccCCCCC
Confidence 999999994 6889999999999998 5654 44
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=1.4e-12 Score=127.31 Aligned_cols=130 Identities=29% Similarity=0.327 Sum_probs=85.1
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCC----------------------cCChhhhhcCCCCcEEEccC
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSG----------------------SIPVDLCKWLPYVVQLDLSN 127 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g----------------------~ip~~~~~~l~~L~~l~ls~ 127 (604)
+++.|+|++|+|+. +|. ++.+++|++|+|++|.+++ .++......+.+++.|++++
T Consensus 56 ~L~~L~L~~N~l~~-l~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~ 133 (266)
T d1p9ag_ 56 RLTQLNLDRAELTK-LQV-DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133 (266)
T ss_dssp TCCEEECTTSCCCE-EEC-CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTT
T ss_pred cccccccccccccc-ccc-ccccccccccccccccccccccccccccccccccccccccceeeccccccccccccccccc
Confidence 45555555555552 322 3455555555555555542 22222223355566666666
Q ss_pred CcCCCCCcccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCC---CcccCCCCCCCC
Q 007423 128 NHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP---EESFDGNSGLCG 202 (604)
Q Consensus 128 N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n~~lcg 202 (604)
|.+++..|..+..+++|+.|++++|+|++..|..+..+++|+.|+|++|+|+ .||..+...+ .....|||..|.
T Consensus 134 n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred cccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence 6666444455567888899999999999877778888999999999999998 8887765544 345678888875
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=9.5e-13 Score=129.69 Aligned_cols=133 Identities=26% Similarity=0.306 Sum_probs=105.7
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
.+++.|+|++|.+.+..+..+..+++|+.+++++|+|+ .||...+..+++|+.|+|++|++++..|..+.++++|+.++
T Consensus 105 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~-~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~ 183 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (284)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred ccCCEEecCCcccccccccccchhcccchhhhcccccc-ccChhHhccccchhhcccccCcccccchhhhccccccchhh
Confidence 46888889998888766777888888999999999998 56655555588899999999998877777788889999999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCC---CcccCCCCCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP---EESFDGNSGLCG 202 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n~~lcg 202 (604)
+++|++++..|..+..+++|+.|++++|.+++..|..+..++ ...+.+|+..|.
T Consensus 184 l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred hhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 999999988888888888999999999998876665555443 445567776663
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=1.7e-12 Score=127.80 Aligned_cols=115 Identities=20% Similarity=0.146 Sum_probs=103.4
Q ss_pred CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCccccee
Q 007423 68 ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKL 147 (604)
Q Consensus 68 ~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l 147 (604)
...+..+++++|+|++..+..+..+++|+.|+|++|+|++ +|+..+..+++|+.+++++|++++..|..+..+++|+.|
T Consensus 128 ~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~-l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L 206 (284)
T d1ozna_ 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206 (284)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred hcccchhhhccccccccChhHhccccchhhcccccCcccc-cchhhhccccccchhhhhhccccccChhHhhhhhhcccc
Confidence 3468999999999997667789999999999999999984 555555569999999999999999999999999999999
Q ss_pred eccccccccCCChhhhcCCCccEEEccCCcccCCCC
Q 007423 148 ILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 148 ~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 183 (604)
|+++|++++..|..+..+.+|+.|++++|.+.+..+
T Consensus 207 ~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp ECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred cccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 999999999888999999999999999999987654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.28 E-value=2.5e-12 Score=115.38 Aligned_cols=106 Identities=20% Similarity=0.199 Sum_probs=88.9
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
.++..|+|++|+++ .+|.....+++|+.||||+|.++ .++. + ..+++|++|+|++|+++...|..+..+++|+.|+
T Consensus 18 ~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~~-~-~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~ 93 (162)
T d1a9na_ 18 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-F-PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 93 (162)
T ss_dssp TSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EECC-C-CCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred CcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccCC-c-ccCcchhhhhcccccccCCCccccccccccccce
Confidence 36789999999998 46776788999999999999998 6753 4 4499999999999999854444456799999999
Q ss_pred ccccccccCCC--hhhhcCCCccEEEccCCccc
Q 007423 149 LSNNKLSGSIP--FEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 149 ls~N~l~g~~p--~~~~~l~~L~~l~l~~N~l~ 179 (604)
|++|+++. ++ ..+..+++|+.|++++|+++
T Consensus 94 L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 94 LTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG
T ss_pred eccccccc-cccccccccccccchhhcCCCccc
Confidence 99999984 33 46788999999999999986
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.28 E-value=7.2e-12 Score=122.06 Aligned_cols=111 Identities=25% Similarity=0.223 Sum_probs=95.3
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
.+++.|+|++|.+.+..+..+..+.+|+.|++++|.++ .+|..+...++.|+.|++++|++++..|..+..+++|+.|+
T Consensus 100 ~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~-~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~ 178 (266)
T d1p9ag_ 100 PALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178 (266)
T ss_dssp TTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEE
T ss_pred cccccccccccccceeeccccccccccccccccccccc-eeccccccccccchhcccccccccccCccccccccccceee
Confidence 45666777777766655666777888888999999998 67777666799999999999999988788899999999999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGT 181 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ 181 (604)
|++|+|+ .+|..+..+.+|+.|+|++|.+.+.
T Consensus 179 Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp CCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred cccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence 9999999 8999999999999999999998754
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=8.5e-12 Score=111.08 Aligned_cols=103 Identities=19% Similarity=0.156 Sum_probs=84.3
Q ss_pred EecCCcceeeCCcccccCCCCCEEEcCCCC-CCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeeccccc
Q 007423 75 TLSSMQLSGQLPESLHLCHSLQSLDLSDNS-LSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNK 153 (604)
Q Consensus 75 ~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~-l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~N~ 153 (604)
+.+++++. .+|..+..+++|++|+|++|+ ++ .||...+..+++|+.|+|++|+++..-|..+..+++|++|+|++|+
T Consensus 14 ~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 14 RCTRDGAL-DSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp ECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EecCCCCc-cCcccccCccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 33445554 467788899999999998665 77 7887666669999999999999997667889999999999999999
Q ss_pred cccCCChhhhcCCCccEEEccCCcccC
Q 007423 154 LSGSIPFEVSRLDRLKEFSVAGNDLSG 180 (604)
Q Consensus 154 l~g~~p~~~~~l~~L~~l~l~~N~l~g 180 (604)
|+ .+|.......+|+.|+|++|.|..
T Consensus 92 l~-~l~~~~~~~~~l~~L~L~~Np~~C 117 (156)
T d2ifga3 92 LE-SLSWKTVQGLSLQELVLSGNPLHC 117 (156)
T ss_dssp CS-CCCSTTTCSCCCCEEECCSSCCCC
T ss_pred Cc-ccChhhhccccccccccCCCcccC
Confidence 99 666665556689999999998853
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.13 E-value=7.1e-11 Score=100.58 Aligned_cols=99 Identities=29% Similarity=0.361 Sum_probs=80.6
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCC-cccccCCccccee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPI-PPQIVECKFLNKL 147 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~i-P~~~~~~~~L~~l 147 (604)
..++.|+|++|.|+ .+|+.++.+++|+.|++++|.++ .+| .+.. +++|++|++++|+++..- +..+..+++|+.|
T Consensus 20 ~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~-l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L 95 (124)
T d1dcea3 20 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVAN-LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 95 (124)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTT-CSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred CCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-cccc-ccccCeEECCCCccCCCCCchhhcCCCCCCEE
Confidence 46899999999998 68989999999999999999998 566 4655 999999999999998432 2568999999999
Q ss_pred eccccccccC--CCh-hhhcCCCccEE
Q 007423 148 ILSNNKLSGS--IPF-EVSRLDRLKEF 171 (604)
Q Consensus 148 ~ls~N~l~g~--~p~-~~~~l~~L~~l 171 (604)
++++|.++.. ++. ....+++|+.+
T Consensus 96 ~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 96 NLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp ECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred ECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 9999999853 222 33445666654
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.05 E-value=1.9e-10 Score=113.98 Aligned_cols=110 Identities=23% Similarity=0.328 Sum_probs=90.3
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.+++++|+++ .+|..+ +++|+.|++++|..++.+|..+.. ++.+++|++++|.+++..|..+.++++|+.|+
T Consensus 150 ~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~-~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~ 225 (305)
T d1xkua_ 150 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKG-LNNLAKLGLSFNSISAVDNGSLANTPHLRELH 225 (305)
T ss_dssp TTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTT-CTTCCEEECCSSCCCEECTTTGGGSTTCCEEE
T ss_pred cccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhc-cccccccccccccccccccccccccccceeee
Confidence 35788889998887 466543 688999999999998887776654 88899999999999887788888899999999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPP 184 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~ 184 (604)
|++|+|+ .+|..+.++++|++|+|++|+++ .|+.
T Consensus 226 L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~ 259 (305)
T d1xkua_ 226 LNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGS 259 (305)
T ss_dssp CCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCT
T ss_pred ccccccc-ccccccccccCCCEEECCCCccC-ccCh
Confidence 9999988 67888888999999999999887 5553
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.04 E-value=2.9e-10 Score=112.56 Aligned_cols=106 Identities=25% Similarity=0.297 Sum_probs=59.4
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
+++.|++++|..++..+..+.+++.++.|++++|.+++..|..+ ..+++|++|+|++|.|+ .+|..+..+++|++|+|
T Consensus 172 ~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~-~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~L 249 (305)
T d1xkua_ 172 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSL-ANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 249 (305)
T ss_dssp TCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTG-GGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred ccCEEECCCCcCCCCChhHhhccccccccccccccccccccccc-cccccceeeeccccccc-ccccccccccCCCEEEC
Confidence 45566666666666556666666666666666666653333333 33566666666666665 45556666666666666
Q ss_pred cccccccCCCh-------hhhcCCCccEEEccCCcc
Q 007423 150 SNNKLSGSIPF-------EVSRLDRLKEFSVAGNDL 178 (604)
Q Consensus 150 s~N~l~g~~p~-------~~~~l~~L~~l~l~~N~l 178 (604)
++|+|+ .|+. ....+.+|+.|++++|.+
T Consensus 250 s~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~ 284 (305)
T d1xkua_ 250 HNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPV 284 (305)
T ss_dssp CSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSS
T ss_pred CCCccC-ccChhhccCcchhcccCCCCEEECCCCcC
Confidence 666665 2221 122344566666666655
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.00 E-value=2.3e-10 Score=102.19 Aligned_cols=89 Identities=19% Similarity=0.148 Sum_probs=76.7
Q ss_pred cccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeeccccccccCCChhhhcCC
Q 007423 87 ESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLD 166 (604)
Q Consensus 87 ~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~ 166 (604)
+.+.++..|++|||++|.++ .||..+ ..+++|+.|||++|+++ .++ .+..+++|+.|+|++|+++...+..+..++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~-~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~ 87 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLG-ATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALP 87 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGG-GGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccc-cccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccc
Confidence 34678889999999999998 788544 45999999999999998 564 588999999999999999965555567899
Q ss_pred CccEEEccCCccc
Q 007423 167 RLKEFSVAGNDLS 179 (604)
Q Consensus 167 ~L~~l~l~~N~l~ 179 (604)
+|+.|++++|+++
T Consensus 88 ~L~~L~L~~N~i~ 100 (162)
T d1a9na_ 88 DLTELILTNNSLV 100 (162)
T ss_dssp TCCEEECCSCCCC
T ss_pred ccccceecccccc
Confidence 9999999999987
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.95 E-value=9.1e-10 Score=102.80 Aligned_cols=103 Identities=28% Similarity=0.368 Sum_probs=77.3
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
.+++.|+|++|++++ ++ .++++++|+.|+|++|.++ .+|. +.. +++|+.|++++|.+. .++ .+..+++|+.++
T Consensus 68 ~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~~-l~~-l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~ 140 (210)
T d1h6ta2 68 PNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLSS-LKD-LKKLKSLSLEHNGIS-DIN-GLVHLPQLESLY 140 (210)
T ss_dssp TTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGGG-GTT-CTTCCEEECTTSCCC-CCG-GGGGCTTCCEEE
T ss_pred CCCCEEeCCCccccC-cc-ccccCcccccccccccccc-cccc-ccc-ccccccccccccccc-ccc-cccccccccccc
Confidence 468899999999986 44 3788999999999999998 4663 444 888999999888876 333 567777777777
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSG 180 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g 180 (604)
+++|.+++. ..+..+++|+.+++++|++++
T Consensus 141 ~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~ 170 (210)
T d1h6ta2 141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISD 170 (210)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCC
T ss_pred ccccccccc--ccccccccccccccccccccc
Confidence 777777642 345667777777777777764
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.94 E-value=1.8e-11 Score=113.52 Aligned_cols=106 Identities=25% Similarity=0.278 Sum_probs=83.7
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|+|++|+++ .++ .+..|++|+.|+|++|.++ .||..... ++.|+.|++++|+++. ++ .+..+++|+.|+
T Consensus 48 ~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~-~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~ 121 (198)
T d1m9la_ 48 KACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAV-ADTLEELWISYNQIAS-LS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHH-HHHCCEEECSEEECCC-HH-HHHHHHHSSEEE
T ss_pred cccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccc-cccccccccccccccc-cc-cccccccccccc
Confidence 46888999999988 465 5888999999999999987 77754433 6779999999999874 43 478888999999
Q ss_pred ccccccccCCC-hhhhcCCCccEEEccCCcccC
Q 007423 149 LSNNKLSGSIP-FEVSRLDRLKEFSVAGNDLSG 180 (604)
Q Consensus 149 ls~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~g 180 (604)
|++|+++..-. ..+..+++|+.|++++|++..
T Consensus 122 L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred cccchhccccccccccCCCccceeecCCCcccc
Confidence 99999874321 467888899999999998763
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.93 E-value=1.3e-09 Score=96.48 Aligned_cols=111 Identities=16% Similarity=0.110 Sum_probs=89.7
Q ss_pred cccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCc-CCCCCcccccCCcccceeeccccccccCCChhhhcCCC
Q 007423 89 LHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNH-LSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVSRLDR 167 (604)
Q Consensus 89 l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~-l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~ 167 (604)
.+.+...+.++.++|++. .+|..+.. +++|+.|+|++|+ ++..-+..+.++++|+.|+|++|+|+..-|..+..+++
T Consensus 4 ~C~c~~~~~l~c~~~~~~-~~p~~l~~-l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~ 81 (156)
T d2ifga3 4 ACCPHGSSGLRCTRDGAL-DSLHHLPG-AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81 (156)
T ss_dssp SSCCSSSSCEECCSSCCC-TTTTTSCS-CSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSC
T ss_pred CCCcCCCCeEEecCCCCc-cCcccccC-ccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccc
Confidence 345666778999999998 78888755 8999999998765 77555567899999999999999999877888999999
Q ss_pred ccEEEccCCcccCCCCCCCC-C--CCCcccCCCCCCCC
Q 007423 168 LKEFSVAGNDLSGTIPPDLA-R--FPEESFDGNSGLCG 202 (604)
Q Consensus 168 L~~l~l~~N~l~g~ip~~~~-~--~~~~~~~~n~~lcg 202 (604)
|+.|+|++|+++ .+|.... . +......+|+.-|.
T Consensus 82 L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~ 118 (156)
T d2ifga3 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCS 118 (156)
T ss_dssp CCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred ccceeccCCCCc-ccChhhhccccccccccCCCcccCC
Confidence 999999999998 6776433 2 33455678887774
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.87 E-value=3.4e-09 Score=97.87 Aligned_cols=103 Identities=25% Similarity=0.366 Sum_probs=72.6
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
.+++.|+|++|++++. ++ ++++++|++|++++|.+. .+|. +. .++.|+.|++++|.+... ..+..+++|+.|+
T Consensus 62 ~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~-~~~~-l~-~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~ 134 (199)
T d2omxa2 62 NNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA-DITP-LA-NLTNLTGLTLFNNQITDI--DPLKNLTNLNRLE 134 (199)
T ss_dssp TTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCGG-GT-TCTTCSEEECCSSCCCCC--GGGTTCTTCSEEE
T ss_pred CCcCcCccccccccCc-cc-ccCCcccccccccccccc-cccc-cc-cccccccccccccccccc--cccchhhhhHHhh
Confidence 4678888888888763 33 788888888888888876 4553 43 377777777777777642 2366777777777
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSG 180 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g 180 (604)
+++|+++. +| .+..+++|+.|++++|++++
T Consensus 135 l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~ 164 (199)
T d2omxa2 135 LSSNTISD-IS-ALSGLTSLQQLNFSSNQVTD 164 (199)
T ss_dssp CCSSCCCC-CG-GGTTCTTCSEEECCSSCCCC
T ss_pred hhhhhhcc-cc-cccccccccccccccccccC
Confidence 77777763 33 46677777777777777764
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.83 E-value=2.8e-09 Score=108.43 Aligned_cols=106 Identities=25% Similarity=0.375 Sum_probs=85.7
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
.+++.|++++|++++. + .+..++.++.++++.|.+++ ++ .+. .++.++.|+|++|++++. + .+..+++|+.|+
T Consensus 263 ~~L~~L~l~~~~l~~~-~-~~~~~~~l~~l~~~~n~l~~-~~-~~~-~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~ 335 (384)
T d2omza2 263 TKLTELKLGANQISNI-S-PLAGLTALTNLELNENQLED-IS-PIS-NLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLF 335 (384)
T ss_dssp TTCSEEECCSSCCCCC-G-GGTTCTTCSEEECCSSCCSC-CG-GGG-GCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEE
T ss_pred ccCCEeeccCcccCCC-C-cccccccccccccccccccc-cc-ccc-hhcccCeEECCCCCCCCC-c-ccccCCCCCEEE
Confidence 4689999999999863 3 47888999999999999985 33 343 488999999999999864 3 378889999999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip 183 (604)
|++|+|++ +| .+..+++|+.|++++|++++-.|
T Consensus 336 L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 336 FANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp CCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred CCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh
Confidence 99999985 45 68889999999999999986543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.79 E-value=7.5e-09 Score=95.50 Aligned_cols=102 Identities=21% Similarity=0.387 Sum_probs=86.8
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
.+++.|++++|+++. ++ .+..+++|++|+|++|.+++ +++ +.. +++|+.|++++|.+. .+| .+.++..|+.|+
T Consensus 40 ~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~-l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~ 112 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTD-ITP-LKN-LTKLVDILMNNNQIA-DIT-PLANLTNLTGLT 112 (199)
T ss_dssp TTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTT-CTTCCEEECCSSCCC-CCG-GGTTCTTCSEEE
T ss_pred cCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccC-ccc-ccC-Ccccccccccccccc-ccc-cccccccccccc
Confidence 367899999999984 43 58899999999999999995 443 544 999999999999987 455 488999999999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCccc
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 179 (604)
+++|.+.... .+..+++|+.|++++|++.
T Consensus 113 l~~~~~~~~~--~~~~l~~L~~L~l~~n~l~ 141 (199)
T d2omxa2 113 LFNNQITDID--PLKNLTNLNRLELSSNTIS 141 (199)
T ss_dssp CCSSCCCCCG--GGTTCTTCSEEECCSSCCC
T ss_pred cccccccccc--ccchhhhhHHhhhhhhhhc
Confidence 9999998643 4778999999999999986
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.78 E-value=6.8e-09 Score=105.44 Aligned_cols=119 Identities=30% Similarity=0.367 Sum_probs=94.3
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|++++|.+++.. .+..+++|+.|++++|.+++. ++ +.. ++.++.++++.|++++ + ..+..+.+++.|+
T Consensus 241 ~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~-~~-~~~-~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ 313 (384)
T d2omza2 241 TNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNI-SP-LAG-LTALTNLELNENQLED-I-SPISNLKNLTYLT 313 (384)
T ss_dssp TTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCC-GG-GTT-CTTCSEEECCSSCCSC-C-GGGGGCTTCSEEE
T ss_pred cccchhccccCccCCCC--cccccccCCEeeccCcccCCC-Cc-ccc-cccccccccccccccc-c-cccchhcccCeEE
Confidence 46889999999998743 388999999999999999854 43 333 8899999999999986 3 4588899999999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCCC---cccCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFPE---ESFDGNS 198 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~---~~~~~n~ 198 (604)
+++|++++..| +..+++|+.|++++|++++ +| .++.++. ....+|.
T Consensus 314 ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~ 362 (384)
T d2omza2 314 LYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQ 362 (384)
T ss_dssp CCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSC
T ss_pred CCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCc
Confidence 99999997543 7889999999999999974 44 4555443 3344553
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.78 E-value=1.4e-08 Score=95.67 Aligned_cols=104 Identities=24% Similarity=0.410 Sum_probs=56.0
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCc-------------
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIP------------- 135 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP------------- 135 (604)
.+++.|+|++|++++..| +..+++|+.|++++|.++ .++. +.. ++.|+.+++++|...+..+
T Consensus 63 ~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~~-l~~-l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~ 137 (227)
T d1h6ua2 63 NNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVSA-IAG-LQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD 137 (227)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCGG-GTT-CTTCCEEECTTSCCCCCGGGTTCTTCCEEECC
T ss_pred CCCcEeecCCceeecccc--cccccccccccccccccc-cccc-ccc-cccccccccccccccccchhccccchhhhhch
Confidence 467888888888875332 677777777777777665 4442 222 4555555555444433211
Q ss_pred -------ccccCCcccceeeccccccccCCChhhhcCCCccEEEccCCccc
Q 007423 136 -------PQIVECKFLNKLILSNNKLSGSIPFEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 136 -------~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 179 (604)
..+..+.+|+.|++++|.+++.. .+..+++|+.|++++|+++
T Consensus 138 ~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~ 186 (227)
T d1h6ua2 138 LNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKIS 186 (227)
T ss_dssp SSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred hhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccC
Confidence 11233444555555555554322 2445555555555555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.76 E-value=1.3e-08 Score=94.75 Aligned_cols=102 Identities=21% Similarity=0.292 Sum_probs=87.2
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
.++.|++++|.++. ++ .+..+++|++|+|++|.+++ +|+ +. .+++|+.|++++|++++ +| .+..+++|+.|++
T Consensus 47 ~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~~-~~-~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 47 SIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IKP-LA-NLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (210)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GT-TCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred CccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-ccc-cc-cCccccccccccccccc-cc-ccccccccccccc
Confidence 57889999999985 33 48899999999999999995 553 44 49999999999999984 66 5899999999999
Q ss_pred cccccccCCChhhhcCCCccEEEccCCcccC
Q 007423 150 SNNKLSGSIPFEVSRLDRLKEFSVAGNDLSG 180 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g 180 (604)
++|.++. ++ .+..++.|+.+++++|.++.
T Consensus 120 ~~~~~~~-~~-~l~~l~~l~~l~~~~n~l~~ 148 (210)
T d1h6ta2 120 EHNGISD-IN-GLVHLPQLESLYLGNNKITD 148 (210)
T ss_dssp TTSCCCC-CG-GGGGCTTCCEEECCSSCCCC
T ss_pred ccccccc-cc-cccccccccccccccccccc
Confidence 9999873 43 57889999999999999875
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.67 E-value=7.2e-10 Score=102.42 Aligned_cols=90 Identities=20% Similarity=0.325 Sum_probs=78.3
Q ss_pred eCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeeccccccccCCChhhh
Q 007423 84 QLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLILSNNKLSGSIPFEVS 163 (604)
Q Consensus 84 ~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~ 163 (604)
.+|.++..|++|++|+|++|.++ .|+ .+.. +++|+.|+|++|+++ .+|.....+.+|+.|++++|+++. ++ .+.
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~-l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~ 112 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSG-MENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIE 112 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHH-HTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccC-CccccChhhcccccc-cccccccccccccccccccccccc-cc-ccc
Confidence 35678999999999999999998 786 4655 999999999999997 688766777889999999999985 44 578
Q ss_pred cCCCccEEEccCCccc
Q 007423 164 RLDRLKEFSVAGNDLS 179 (604)
Q Consensus 164 ~l~~L~~l~l~~N~l~ 179 (604)
.+++|+.|++++|+++
T Consensus 113 ~l~~L~~L~L~~N~i~ 128 (198)
T d1m9la_ 113 KLVNLRVLYMSNNKIT 128 (198)
T ss_dssp HHHHSSEEEESEEECC
T ss_pred ccccccccccccchhc
Confidence 8999999999999997
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.67 E-value=1.3e-08 Score=96.64 Aligned_cols=99 Identities=14% Similarity=0.183 Sum_probs=48.5
Q ss_pred cCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcc-cccCCcccceeecc-cccc
Q 007423 77 SSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPP-QIVECKFLNKLILS-NNKL 154 (604)
Q Consensus 77 ~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~-~~~~~~~L~~l~ls-~N~l 154 (604)
++++|+ .+|+.+. +++++|||++|+++ .||...+..+++|++|+|++|.+...+|. .+..+++++.+++. .|++
T Consensus 16 ~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l 91 (242)
T d1xwdc1 16 QESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNL 91 (242)
T ss_dssp ESCSCS-SCCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTC
T ss_pred eCCCCC-CcCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccc
Confidence 334444 3444332 34555555555554 44443333355555555555555443332 34445555555543 2445
Q ss_pred ccCCChhhhcCCCccEEEccCCccc
Q 007423 155 SGSIPFEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 155 ~g~~p~~~~~l~~L~~l~l~~N~l~ 179 (604)
+...|..+..+++|+.+++++|.+.
T Consensus 92 ~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 92 LYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp CEECTTSEECCTTCCEEEEESCCCC
T ss_pred cccccccccccccccccccchhhhc
Confidence 5444444555555555555555554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.62 E-value=3.1e-08 Score=93.17 Aligned_cols=111 Identities=28% Similarity=0.360 Sum_probs=82.8
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.++++++...+. ..+...+.+..+.++++.+....+ +.. .++|+.|++++|.+++.. .++++++|+.|+
T Consensus 107 ~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~--~~~-~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~ 179 (227)
T d1h6ua2 107 QSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNISP--LAG-LTNLQYLSIGNAQVSDLT--PLANLSKLTTLK 179 (227)
T ss_dssp TTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCGG--GGG-CTTCCEEECCSSCCCCCG--GGTTCTTCCEEE
T ss_pred cccccccccccccccc--chhccccchhhhhchhhhhchhhh--hcc-ccccccccccccccccch--hhcccccceecc
Confidence 4678889998887753 346778888899998888875433 333 788899999998887432 378888999999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCCCC
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLARFP 190 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~ 190 (604)
|++|++++ +| .+..+++|+.|++++|+++ .+|+ +..++
T Consensus 180 Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt-~i~~-l~~l~ 217 (227)
T d1h6ua2 180 ADDNKISD-IS-PLASLPNLIEVHLKNNQIS-DVSP-LANTS 217 (227)
T ss_dssp CCSSCCCC-CG-GGGGCTTCCEEECTTSCCC-BCGG-GTTCT
T ss_pred cCCCccCC-Ch-hhcCCCCCCEEECcCCcCC-CCcc-cccCC
Confidence 99999885 44 3788889999999999887 4543 34433
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.53 E-value=7.1e-08 Score=91.34 Aligned_cols=124 Identities=17% Similarity=0.200 Sum_probs=95.9
Q ss_pred CCccccccCCCC--------CCcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEcc-
Q 007423 56 CRLTGVACWNEK--------ENRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLS- 126 (604)
Q Consensus 56 c~~~gv~c~~~~--------~~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls- 126 (604)
|....|.|...+ ...++.|+|++|+++...+..|.++++|++|+|++|.+...+|...+..++.++.|++.
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 566677775321 13689999999999864455789999999999999999988887666669999999886
Q ss_pred CCcCCCCCcccccCCcccceeeccccccccCCC-hhhhcCCCccEEEccCCccc
Q 007423 127 NNHLSGPIPPQIVECKFLNKLILSNNKLSGSIP-FEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 127 ~N~l~g~iP~~~~~~~~L~~l~ls~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~ 179 (604)
.|++....|..+.++++|+.|++++|+++...+ ..+..+..+..+..+++.+.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~ 141 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH 141 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCC
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccc
Confidence 577887777888999999999999999985433 23445566666666776664
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.52 E-value=1.1e-07 Score=94.73 Aligned_cols=103 Identities=31% Similarity=0.349 Sum_probs=82.7
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceeec
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLIL 149 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~l 149 (604)
+++.|+|++|+|+ .+|+. +++|++|+|++|+|+ .||.. +.+|+.|++++|+++ .++. + .+.|++|++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L 105 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGV 105 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS-CCCS-C--CTTCCEEEC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccc-hhhh-h--ccccccccc
Confidence 5779999999998 58864 578999999999999 89864 567999999999997 4553 2 136999999
Q ss_pred cccccccCCChhhhcCCCccEEEccCCcccCCCCCCCCC
Q 007423 150 SNNKLSGSIPFEVSRLDRLKEFSVAGNDLSGTIPPDLAR 188 (604)
Q Consensus 150 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~ 188 (604)
++|+++ .+|. ++.++.|+.|++++|.++. +|.....
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~~~~ 141 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDLPPS 141 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCCCTT
T ss_pred cccccc-cccc-hhhhccceeeccccccccc-ccccccc
Confidence 999998 5774 5789999999999999873 4444333
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.19 E-value=1.2e-07 Score=97.99 Aligned_cols=109 Identities=28% Similarity=0.333 Sum_probs=83.3
Q ss_pred cEEEEEecCCcceee-CCcccccCCCCCEEEcCCCCCCC----cCChhhhhcCCCCcEEEccCCcCCCC----Cccccc-
Q 007423 70 RIISLTLSSMQLSGQ-LPESLHLCHSLQSLDLSDNSLSG----SIPVDLCKWLPYVVQLDLSNNHLSGP----IPPQIV- 139 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~-~p~~l~~l~~L~~L~Ls~N~l~g----~ip~~~~~~l~~L~~l~ls~N~l~g~----iP~~~~- 139 (604)
+|+.||+++|++++. +..-+..+++|+.|+|++|.++- .|+..+. .+++|+.|||++|.++.. +...+.
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~-~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALR-VNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHH-TCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHh-cCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 689999999999864 23446778999999999999871 3333343 489999999999998521 222222
Q ss_pred CCcccceeeccccccccC----CChhhhcCCCccEEEccCCccc
Q 007423 140 ECKFLNKLILSNNKLSGS----IPFEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 140 ~~~~L~~l~ls~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~ 179 (604)
...+|+.|+|++|+++.. ++..+..+++|+.|++++|.++
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 235799999999999854 4566778899999999999875
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.10 E-value=3.1e-07 Score=89.27 Aligned_cols=121 Identities=19% Similarity=0.227 Sum_probs=57.2
Q ss_pred cEEEEEecCCcceeeCCcccccCCCCCEEEcCCC-CCCCcCChhhhhcCCCCcEEEccCC-cCCC-CCcccccC-Ccccc
Q 007423 70 RIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDN-SLSGSIPVDLCKWLPYVVQLDLSNN-HLSG-PIPPQIVE-CKFLN 145 (604)
Q Consensus 70 ~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N-~l~g~ip~~~~~~l~~L~~l~ls~N-~l~g-~iP~~~~~-~~~L~ 145 (604)
+++.|+|+++++++..+..++.+++|+.|+|+++ .++..--..+...+++|++|+++++ +++. .++..+.. +++|+
T Consensus 72 ~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~ 151 (284)
T d2astb2 72 KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETIT 151 (284)
T ss_dssp CCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCC
T ss_pred CcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccc
Confidence 4566666666666555556666666666666663 4431100112233566666666653 2321 11111221 23455
Q ss_pred eeeccc--cccccC-CChhhhcCCCccEEEccCC-cccCCCCCCCCCCC
Q 007423 146 KLILSN--NKLSGS-IPFEVSRLDRLKEFSVAGN-DLSGTIPPDLARFP 190 (604)
Q Consensus 146 ~l~ls~--N~l~g~-~p~~~~~l~~L~~l~l~~N-~l~g~ip~~~~~~~ 190 (604)
.|++++ ++++.. +.....++++|+.|++++| .+++..+..+++++
T Consensus 152 ~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~ 200 (284)
T d2astb2 152 QLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200 (284)
T ss_dssp EEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred hhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence 555543 222211 2222344566777777764 35544444444433
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.06 E-value=8e-07 Score=78.57 Aligned_cols=91 Identities=26% Similarity=0.283 Sum_probs=64.0
Q ss_pred eCCcccccCCCCCEEEcCCCCCCCcCCh--hhhhcCCCCcEEEccCCcCCCCCcc-cccCCcccceeeccccccccCCCh
Q 007423 84 QLPESLHLCHSLQSLDLSDNSLSGSIPV--DLCKWLPYVVQLDLSNNHLSGPIPP-QIVECKFLNKLILSNNKLSGSIPF 160 (604)
Q Consensus 84 ~~p~~l~~l~~L~~L~Ls~N~l~g~ip~--~~~~~l~~L~~l~ls~N~l~g~iP~-~~~~~~~L~~l~ls~N~l~g~~p~ 160 (604)
.++.....+++|++|+|++|+++ .++. .....+++|+.|+|++|+++. +++ ......+|+.|+|++|.++.....
T Consensus 56 ~l~~~~~~~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~~~~ 133 (162)
T d1koha1 56 TLRIIEENIPELLSLNLSNNRLY-RLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDTFRD 133 (162)
T ss_dssp HHHHHHHHCTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSSSSS
T ss_pred hhHHHHHhCCCCCEeeCCCcccc-CCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcCccc
Confidence 34444567899999999999998 3432 223448999999999999974 443 333455789999999999876653
Q ss_pred -------hhhcCCCccEEEccCCcc
Q 007423 161 -------EVSRLDRLKEFSVAGNDL 178 (604)
Q Consensus 161 -------~~~~l~~L~~l~l~~N~l 178 (604)
.+..+++|+.|| |+.+
T Consensus 134 ~~~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 134 QSTYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp HHHHHHHHHTTSTTCCEET--TEEC
T ss_pred chhHHHHHHHHCCCCCEEC--cCCC
Confidence 245678888775 5544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.98 E-value=9.9e-06 Score=77.00 Aligned_cols=128 Identities=13% Similarity=0.048 Sum_probs=84.1
Q ss_pred CeEEEEEEeCCCCEEEEEEecccc-ccHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeeEEeeecCCCchhhhhccCC
Q 007423 308 TGVSYKAVLPDASALAIKRLSACK-LSEKQFRSEMNRLGQLR-HPNLVPLLGFCVVEEERLLVYKHMPNGTLYSLLHGNG 385 (604)
Q Consensus 308 ~g~vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~ 385 (604)
...||+... ++..+.||+..... .....+.+|...++.+. +--+-+++.+...++..++||+++++.++.+.....
T Consensus 27 ~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~- 104 (263)
T d1j7la_ 27 PAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE- 104 (263)
T ss_dssp SSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC-
T ss_pred CCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc-
Confidence 457998865 55567788875432 22335678888877663 333556777888888999999999998876543211
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHhhHhhhc-------------------------------------------------
Q 007423 386 VDNTLSGVLDWSTRLRIGMGASRGLAWLHHG------------------------------------------------- 416 (604)
Q Consensus 386 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~------------------------------------------------- 416 (604)
.. ...++.++++.+..||..
T Consensus 105 --------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (263)
T d1j7la_ 105 --------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDF 173 (263)
T ss_dssp --------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHH
T ss_pred --------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHH
Confidence 11 122334444444444420
Q ss_pred -------CCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 417 -------CQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 417 -------~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
....++|+|+.+.|||++++..+-|.||+.+.
T Consensus 174 l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 174 LKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01237899999999999987666799998665
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.98 E-value=9.6e-06 Score=80.14 Aligned_cols=95 Identities=31% Similarity=0.393 Sum_probs=74.3
Q ss_pred CcEEEEEecCCcceeeCCcccccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCCCcccccCCcccceee
Q 007423 69 NRIISLTLSSMQLSGQLPESLHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGPIPPQIVECKFLNKLI 148 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~iP~~~~~~~~L~~l~ 148 (604)
..++.|+|++|+|+ .+|.. +.+|+.|++++|+++ .|+. + .+.|++|+|++|.++ .+|. ++.+++|+.|+
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~-l---p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~ 126 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD-L---PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIID 126 (353)
T ss_dssp TTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS-C---CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEE
T ss_pred CCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh-h---ccccccccccccccc-cccc-hhhhccceeec
Confidence 46899999999999 78865 458999999999998 6763 2 356999999999998 6775 68899999999
Q ss_pred ccccccccCCChhhhcCCCccEEEccCCcc
Q 007423 149 LSNNKLSGSIPFEVSRLDRLKEFSVAGNDL 178 (604)
Q Consensus 149 ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l 178 (604)
+++|.+++..+ . ...+..+.+..+..
T Consensus 127 l~~~~~~~~~~-~---~~~l~~l~~~~~~~ 152 (353)
T d1jl5a_ 127 VDNNSLKKLPD-L---PPSLEFIAAGNNQL 152 (353)
T ss_dssp CCSSCCSCCCC-C---CTTCCEEECCSSCC
T ss_pred ccccccccccc-c---cccccchhhccccc
Confidence 99999985433 2 34556666655544
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.97 E-value=5.2e-07 Score=93.02 Aligned_cols=111 Identities=20% Similarity=0.238 Sum_probs=63.3
Q ss_pred CcEEEEEecCCcceeeCCccc-----ccCCCCCEEEcCCCCCCCcCChhh---hhcCCCCcEEEccCCcCCCC----Ccc
Q 007423 69 NRIISLTLSSMQLSGQLPESL-----HLCHSLQSLDLSDNSLSGSIPVDL---CKWLPYVVQLDLSNNHLSGP----IPP 136 (604)
Q Consensus 69 ~~v~~l~l~~n~l~g~~p~~l-----~~l~~L~~L~Ls~N~l~g~ip~~~---~~~l~~L~~l~ls~N~l~g~----iP~ 136 (604)
..+..+++++|.++..-...+ ...+.|+.+++++|.++..-...+ ....+.|+.|+|++|+++.. ++.
T Consensus 283 ~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~ 362 (460)
T d1z7xw1 283 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 362 (460)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhh
Confidence 346667777777653222221 123567777777777764322211 12245677777777776532 333
Q ss_pred ccc-CCcccceeecccccccc----CCChhhhcCCCccEEEccCCccc
Q 007423 137 QIV-ECKFLNKLILSNNKLSG----SIPFEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 137 ~~~-~~~~L~~l~ls~N~l~g----~~p~~~~~l~~L~~l~l~~N~l~ 179 (604)
.+. ....|++|+|++|+|+. .++..+...++|++|++++|+++
T Consensus 363 ~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~ 410 (460)
T d1z7xw1 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410 (460)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred hhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCC
Confidence 333 34557777777777763 24444555677777777777765
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.94 E-value=2.6e-07 Score=81.81 Aligned_cols=93 Identities=24% Similarity=0.246 Sum_probs=65.6
Q ss_pred cccCCCCCEEEcCCCCCCCcCChhhhhcCCCCcEEEccCCcCCCC--CcccccCCcccceeeccccccccCCChhhhcCC
Q 007423 89 LHLCHSLQSLDLSDNSLSGSIPVDLCKWLPYVVQLDLSNNHLSGP--IPPQIVECKFLNKLILSNNKLSGSIPFEVSRLD 166 (604)
Q Consensus 89 l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~l~ls~N~l~g~--iP~~~~~~~~L~~l~ls~N~l~g~~p~~~~~l~ 166 (604)
+..+..+..|++.+|..+ .++ .+...++.|++|+||+|+++.. ++..+..+++|+.|+|++|+++..-+-......
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~-~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~ 115 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLR-IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL 115 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHH-HHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTC
T ss_pred hhhccchhhcchhhhHhh-hhH-HHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhcc
Confidence 444555555555554432 333 3444589999999999999853 345577899999999999999953332334456
Q ss_pred CccEEEccCCcccCCCC
Q 007423 167 RLKEFSVAGNDLSGTIP 183 (604)
Q Consensus 167 ~L~~l~l~~N~l~g~ip 183 (604)
.|+.+++++|+++....
T Consensus 116 ~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 116 KLEELWLDGNSLSDTFR 132 (162)
T ss_dssp CCSSCCCTTSTTSSSSS
T ss_pred ccceeecCCCCcCcCcc
Confidence 79999999999976544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.92 E-value=1.2e-06 Score=87.48 Aligned_cols=17 Identities=47% Similarity=0.892 Sum_probs=8.2
Q ss_pred cccCCCCCEEEcCCCCC
Q 007423 89 LHLCHSLQSLDLSDNSL 105 (604)
Q Consensus 89 l~~l~~L~~L~Ls~N~l 105 (604)
+..+++|+.|+|++|.+
T Consensus 211 l~~~~~L~~L~Ls~N~i 227 (344)
T d2ca6a1 211 LAYCQELKVLDLQDNTF 227 (344)
T ss_dssp GGGCTTCCEEECCSSCC
T ss_pred hcchhhhcccccccccc
Confidence 34444455555554444
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.69 E-value=2.3e-05 Score=75.57 Aligned_cols=108 Identities=24% Similarity=0.328 Sum_probs=81.6
Q ss_pred CcEEEEEecCC-ccee-eCCccccc-CCCCCEEEcCCC--CCCCcCChhhhhcCCCCcEEEccCC-cCCCCCcccccCCc
Q 007423 69 NRIISLTLSSM-QLSG-QLPESLHL-CHSLQSLDLSDN--SLSGSIPVDLCKWLPYVVQLDLSNN-HLSGPIPPQIVECK 142 (604)
Q Consensus 69 ~~v~~l~l~~n-~l~g-~~p~~l~~-l~~L~~L~Ls~N--~l~g~ip~~~~~~l~~L~~l~ls~N-~l~g~iP~~~~~~~ 142 (604)
.+++.|+|++. +++. .+...+.. ++.|+.|+|++. .++..--..+...+++|+.|+|++| .+++..+..+.+++
T Consensus 121 ~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~ 200 (284)
T d2astb2 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200 (284)
T ss_dssp TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred HhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence 46899999984 5543 23333444 478999999864 4443222234455899999999985 57877888899999
Q ss_pred ccceeeccc-cccccCCChhhhcCCCccEEEccCC
Q 007423 143 FLNKLILSN-NKLSGSIPFEVSRLDRLKEFSVAGN 176 (604)
Q Consensus 143 ~L~~l~ls~-N~l~g~~p~~~~~l~~L~~l~l~~N 176 (604)
+|++|+|++ +++++.....++++++|+.|+++++
T Consensus 201 ~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 201 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 999999999 6788777778889999999999887
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.68 E-value=4e-06 Score=83.40 Aligned_cols=110 Identities=15% Similarity=0.201 Sum_probs=65.8
Q ss_pred CcEEEEEecCCcce--e--eC---------CcccccCCCCCEEEcCCCCCCCc----CChhhhhcCCCCcEEEccCCcCC
Q 007423 69 NRIISLTLSSMQLS--G--QL---------PESLHLCHSLQSLDLSDNSLSGS----IPVDLCKWLPYVVQLDLSNNHLS 131 (604)
Q Consensus 69 ~~v~~l~l~~n~l~--g--~~---------p~~l~~l~~L~~L~Ls~N~l~g~----ip~~~~~~l~~L~~l~ls~N~l~ 131 (604)
..++.|+|++|.++ | .+ .......+.|+.|++++|.++-. +...+ ...+.|+.|+|++|+++
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l-~~~~~L~~L~L~~n~i~ 199 (344)
T d2ca6a1 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF-QSHRLLHTVKMVQNGIR 199 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH-HHCTTCCEEECCSSCCC
T ss_pred ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchh-hhhhhhccccccccccc
Confidence 35778888887652 1 11 11123566777777777776521 11122 22567777777777765
Q ss_pred CC-----CcccccCCcccceeeccccccccC----CChhhhcCCCccEEEccCCccc
Q 007423 132 GP-----IPPQIVECKFLNKLILSNNKLSGS----IPFEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 132 g~-----iP~~~~~~~~L~~l~ls~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~ 179 (604)
.. +...+..+++|+.|+|++|.++.. +...+...+.|+.|++++|.++
T Consensus 200 ~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 200 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp HHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred ccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccC
Confidence 21 233455667777777777777532 3344566677777777777765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.55 E-value=0.00017 Score=67.63 Aligned_cols=73 Identities=14% Similarity=0.152 Sum_probs=51.6
Q ss_pred EecC-CeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCC--CccceeeEEEeCCeeeEEeeecCCCchh
Q 007423 304 ISTR-TGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHP--NLVPLLGFCVVEEERLLVYKHMPNGTLY 378 (604)
Q Consensus 304 g~G~-~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~~~~~~lv~ey~~~gsL~ 378 (604)
..|. ...||+....++..+.+|.-.... ...+..|++.++.+... .+-+++++..+++..+++|+|+++.++.
T Consensus 19 ~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 19 TIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp SCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred CCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 3444 357899988888888889865432 23467788887776432 3456677777888899999999886653
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.32 E-value=5e-05 Score=66.90 Aligned_cols=108 Identities=13% Similarity=0.197 Sum_probs=68.8
Q ss_pred CcEEEEEecCC-cceee----CCcccccCCCCCEEEcCCCCCCCc----CChhhhhcCCCCcEEEccCCcCCCC----Cc
Q 007423 69 NRIISLTLSSM-QLSGQ----LPESLHLCHSLQSLDLSDNSLSGS----IPVDLCKWLPYVVQLDLSNNHLSGP----IP 135 (604)
Q Consensus 69 ~~v~~l~l~~n-~l~g~----~p~~l~~l~~L~~L~Ls~N~l~g~----ip~~~~~~l~~L~~l~ls~N~l~g~----iP 135 (604)
..++.|+|+++ .++.. +-..+...+.|+.|+|++|.++-. +...+ ...+.|+.|+|++|.++.. +-
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L-~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELI-ETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHH-HHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhh-hhcccccceeeehhhcchHHHHHHH
Confidence 45788888864 45432 334566778888888888888621 11122 2257788888888887642 22
Q ss_pred ccccCCcccceeeccccccccC-------CChhhhcCCCccEEEccCCc
Q 007423 136 PQIVECKFLNKLILSNNKLSGS-------IPFEVSRLDRLKEFSVAGND 177 (604)
Q Consensus 136 ~~~~~~~~L~~l~ls~N~l~g~-------~p~~~~~l~~L~~l~l~~N~ 177 (604)
..+...++|+.|+|++|.+... +...+..-++|+.|+++.+.
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 3456677788888888865521 33444555778888776654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.79 E-value=0.0025 Score=63.83 Aligned_cols=74 Identities=16% Similarity=0.072 Sum_probs=46.2
Q ss_pred cEEEecCCeEEEEEEeCC-CCEEEEEEecc----c----cccHHHHHHHHHHHhccC-C--CCccceeeEEEeCCeeeEE
Q 007423 301 NIIISTRTGVSYKAVLPD-ASALAIKRLSA----C----KLSEKQFRSEMNRLGQLR-H--PNLVPLLGFCVVEEERLLV 368 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~-~~~vAvK~l~~----~----~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~~~~~lv 368 (604)
+.||.|....||+....+ ++.|.||.-.. . ....++...|.+.|+.+. + ..+.+++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 467889999999998654 67899996432 1 112234556888777662 2 234444443 45667899
Q ss_pred eeecCCCc
Q 007423 369 YKHMPNGT 376 (604)
Q Consensus 369 ~ey~~~gs 376 (604)
|||+++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.67 E-value=0.00044 Score=60.55 Aligned_cols=89 Identities=15% Similarity=0.101 Sum_probs=63.0
Q ss_pred ccCCCCCEEEcCCC-CCCCc----CChhhhhcCCCCcEEEccCCcCCC----CCcccccCCcccceeeccccccccC---
Q 007423 90 HLCHSLQSLDLSDN-SLSGS----IPVDLCKWLPYVVQLDLSNNHLSG----PIPPQIVECKFLNKLILSNNKLSGS--- 157 (604)
Q Consensus 90 ~~l~~L~~L~Ls~N-~l~g~----ip~~~~~~l~~L~~l~ls~N~l~g----~iP~~~~~~~~L~~l~ls~N~l~g~--- 157 (604)
.+.+.|++|+|+++ .++.. +-..+ ...+.|+.|+|++|.+.- .+...+...+.|+.|+|++|.++..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L-~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~ 90 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAA-CNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 90 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHH-TTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHH-hhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHH
Confidence 45789999999974 46421 11112 235789999999999862 2334456678899999999999853
Q ss_pred -CChhhhcCCCccEEEccCCccc
Q 007423 158 -IPFEVSRLDRLKEFSVAGNDLS 179 (604)
Q Consensus 158 -~p~~~~~l~~L~~l~l~~N~l~ 179 (604)
+-..+...++|+.|++++|.+.
T Consensus 91 ~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 91 RLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHHHhCCcCCEEECCCCcCC
Confidence 2234556678999999998654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.54 E-value=0.0077 Score=58.32 Aligned_cols=69 Identities=13% Similarity=0.070 Sum_probs=48.8
Q ss_pred CeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCc-----cce--eeEEEeCCeeeEEeeecCCCc
Q 007423 308 TGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNL-----VPL--LGFCVVEEERLLVYKHMPNGT 376 (604)
Q Consensus 308 ~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~ni-----v~l--~g~~~~~~~~~lv~ey~~~gs 376 (604)
--.||+...++|+.+++|..+....+.+++..|.+.+..+....+ +.. -......+..+.+++++++..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 457999999999999999987666667788889988877742222 111 112344667889999997643
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.32 E-value=0.00055 Score=59.76 Aligned_cols=110 Identities=14% Similarity=0.164 Sum_probs=74.7
Q ss_pred CcEEEEEecC-Ccceee----CCcccccCCCCCEEEcCCCCCCCcCChhh---hhcCCCCcEEEccCCcCCCC----Ccc
Q 007423 69 NRIISLTLSS-MQLSGQ----LPESLHLCHSLQSLDLSDNSLSGSIPVDL---CKWLPYVVQLDLSNNHLSGP----IPP 136 (604)
Q Consensus 69 ~~v~~l~l~~-n~l~g~----~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~---~~~l~~L~~l~ls~N~l~g~----iP~ 136 (604)
..++.|+|++ +.++.. +-..+...+.|++|+|++|.++..--..+ ....+.|+.+++++|.++.. +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 4678888987 456432 33456678999999999998874321111 23368899999999988633 234
Q ss_pred cccCCcccce--eecccccccc----CCChhhhcCCCccEEEccCCcc
Q 007423 137 QIVECKFLNK--LILSNNKLSG----SIPFEVSRLDRLKEFSVAGNDL 178 (604)
Q Consensus 137 ~~~~~~~L~~--l~ls~N~l~g----~~p~~~~~l~~L~~l~l~~N~l 178 (604)
.+...++|+. |++++|.+.. .+...+...++|+.|+++.|+.
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 5667778876 5556777754 3445566778999999987754
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.60 E-value=0.039 Score=52.66 Aligned_cols=162 Identities=10% Similarity=0.040 Sum_probs=81.8
Q ss_pred cCHHHHHHhhcCCCcCcEEE-----ecCCeEEEEEEeCCCCEEEEEEeccccccHHHHHHHHHHHhccCCCCc-----cc
Q 007423 285 VKLADLLAATNSFAVENIII-----STRTGVSYKAVLPDASALAIKRLSACKLSEKQFRSEMNRLGQLRHPNL-----VP 354 (604)
Q Consensus 285 ~~~~~l~~~~~~~~~~~~ig-----~G~~g~vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~ni-----v~ 354 (604)
++.+|+.....+|...++.. .|---+.|+....+|+ +++|+.... ...+++..|++++..+.+.++ +.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccce
Confidence 45567777777887755443 4445678999887765 888887542 223445566777666633221 11
Q ss_pred e---eeEEEeCCeeeEEeeecCCCchhh--------------hhcc--CCCCCCCCCCCCHH--H---------------
Q 007423 355 L---LGFCVVEEERLLVYKHMPNGTLYS--------------LLHG--NGVDNTLSGVLDWS--T--------------- 398 (604)
Q Consensus 355 l---~g~~~~~~~~~lv~ey~~~gsL~~--------------~l~~--~~~~~~~~~~l~~~--~--------------- 398 (604)
. ..+....+....++.+..+..... .++. .............. .
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 1 001122445566677666533311 0110 00000000001100 0
Q ss_pred -HHHHHHHHHHHhhHhh-hcCCCCceecCCCCCeEEeCCCCCeEEcccCCcc
Q 007423 399 -RLRIGMGASRGLAWLH-HGCQPPYMHQYISSNVILIDDDFDARITDFGLAR 448 (604)
Q Consensus 399 -~~~ia~~ia~gL~yLH-~~~~~~iiH~dlk~~NiLl~~~~~~kl~DFGla~ 448 (604)
....+......+.-.+ .....++||+|+.+.||+++++...-|.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111111111111111 1235689999999999999988777899999764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.07 E-value=0.087 Score=52.00 Aligned_cols=72 Identities=14% Similarity=0.140 Sum_probs=45.9
Q ss_pred cEEEecCCeEEEEEEeCCC--------CEEEEEEeccccccHHHHHHHHHHHhccCCCCcc-ceeeEEEeCCeeeEEeee
Q 007423 301 NIIISTRTGVSYKAVLPDA--------SALAIKRLSACKLSEKQFRSEMNRLGQLRHPNLV-PLLGFCVVEEERLLVYKH 371 (604)
Q Consensus 301 ~~ig~G~~g~vy~~~~~~~--------~~vAvK~l~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lv~ey 371 (604)
+.|+.|-.-.+|+...+++ ..|.++.... ........+|..+++.+.-.+++ ++++++. + .+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceEEEE
Confidence 4677788889999886543 4456655542 22233455788888887534454 6666653 2 578999
Q ss_pred cCCCch
Q 007423 372 MPNGTL 377 (604)
Q Consensus 372 ~~~gsL 377 (604)
+++..+
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=93.80 E-value=0.012 Score=50.68 Aligned_cols=90 Identities=17% Similarity=0.202 Sum_probs=60.0
Q ss_pred cccCCCCCEEEcCC-CCCCCcCChhhh---hcCCCCcEEEccCCcCCCC----CcccccCCcccceeeccccccccC---
Q 007423 89 LHLCHSLQSLDLSD-NSLSGSIPVDLC---KWLPYVVQLDLSNNHLSGP----IPPQIVECKFLNKLILSNNKLSGS--- 157 (604)
Q Consensus 89 l~~l~~L~~L~Ls~-N~l~g~ip~~~~---~~l~~L~~l~ls~N~l~g~----iP~~~~~~~~L~~l~ls~N~l~g~--- 157 (604)
..+.+.|++|+|++ |.++-..=..++ ...+.|+.|+|++|.++.. +-..+...++|+.+++++|.++..
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~ 92 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 92 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence 45678999999997 556522111122 2368899999999988643 223345678899999999998743
Q ss_pred -CChhhhcCCCccEEEcc--CCcc
Q 007423 158 -IPFEVSRLDRLKEFSVA--GNDL 178 (604)
Q Consensus 158 -~p~~~~~l~~L~~l~l~--~N~l 178 (604)
+-..+...++|+.++|+ +|.+
T Consensus 93 ~l~~~l~~~~~L~~l~L~l~~n~i 116 (166)
T d1io0a_ 93 ALVEALQSNTSLIELRIDNQSQPL 116 (166)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCC
T ss_pred HHHHHHHhCccccEEeeccCCCcC
Confidence 22455666788876664 4444
|